PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Duan, QL; Wang, XX; Gong, W; Ni, L; Chen, C; He, XX; Chen, FQ; Yang, L; Wang, PH; Wang, DW				Duan, Quanlu; Wang, Xingxu; Gong, Wei; Ni, Li; Chen, Chen; He, Xingxing; Chen, Fuqiong; Yang, Lei; Wang, Peihua; Wang, Dao Wen			ER Stress Negatively Modulates the Expression of the miR-199a/214 Cluster to Regulates Tumor Survival and Progression in Human Hepatocellular Cancer	PLOS ONE			English	Article							NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; MICRORNA EXPRESSION; OVARIAN-CANCER; SUPPRESSES TUMORIGENICITY; ANTICANCER STRATEGY; CELL-PROLIFERATION; CARCINOMA CELLS; RECEPTOR-ALPHA; TARGETING PTEN	Background: Recent studies have emphasized causative links between microRNAs (miRNAs) deregulation and tumor development. In hepatocellular carcinoma (HCC), more and more miRNAs were identified as diagnostic and prognostic cancer biomarkers, as well as additional therapeutic tools. This study aimed to investigate the functional significance and regulatory mechanism of the miR-199a2/214 cluster in HCC progression. Methods and Findings: In this study, we showed that miR-214, as well as miR-199a-3p and miR-199a-5p levels were significantly reduced in the majority of examined 23 HCC tissues and HepG2 and SMMC-7721 cell lines, compared with their nontumor counterparts. To further explore the role of miR-214 in hepatocarcinogenesis, we disclosed that the ER stress-induced pro-survival factor XBP-1 is a target of miR-214 by using western blot assay and luciferase reporter assay. Re-expression of miR-214 in HCC cell lines (HepG2 and SMMC-7721) inhibited proliferation and induced apoptosis. Furthermore, ectopic expression of miR-214 dramatically suppressed the ability of HCC cells to form colonies in vitro and to develop tumors in a subcutaneous xenotransplantation model of the BALB/c athymic nude mice. Moreover, reintroduction of XBP-1s attenuated miR-214-mediated suppression of HCC cells proliferation, colony and tumor formation. To further understand the mechanism of the miR-199a/214 cluster down-expression in HCC, we found that thapsigargin (TG) and tunicamycin (TM) or hypoxia-induced unfolded protein response (UPR) suppresses the expression of the miR-199a/214 cluster in HCC cells. By promoter analysis of the miR-199a2/214 gene, we conjectured NFkB as a potential negative regulator. We further found that UPR and LPS-induced NF kappa B activation suppressed miR-199a2/214 transcription, and this suppression was reversed by NF kappa B inhibition in HCC cells. Conclusions: Our study suggest that modulation of miR-214 levels may provide a new therapeutic approach for cancer treatment and revealed that UPR may offer a new explanation for why the miR-199a/214 cluster were down-regulated in the progression in HCC.	[Duan, Quanlu; Wang, Xingxu; Gong, Wei; Ni, Li; Chen, Chen; Chen, Fuqiong; Yang, Lei; Wang, Peihua; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Wuhan 430074, Peoples R China; [Duan, Quanlu; Wang, Xingxu; Gong, Wei; Ni, Li; Chen, Chen; Chen, Fuqiong; Yang, Lei; Wang, Peihua; Wang, Dao Wen] Huazhong Univ Sci & Technol, Gene Therapy Ctr, Wuhan 430074, Peoples R China; [He, Xingxing] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Liver Dis, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Duan, QL (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Wuhan 430074, Peoples R China.	cyc.chenchen@gmail.com; dwwang@tjh.tjmu.edu.cn	, Chen/R-4321-2019; Wang, Xingxu/AAF-4769-2020	Wang, Dao Wen/0000-0002-9774-3980	National Natural Science Foundation of China [30930039, 81000097, 30770882]; National Basic Research Program of China (973 Program) [2007CB512004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants from the National Natural Science Foundation of China (No. 30930039, 81000097 and 30770882), and National Basic Research Program of China (973 Program No. 2007CB512004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Ding H, 2010, CIRC RES, V106, P1145, DOI 10.1161/CIRCRESAHA.109.215616; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Guo J, 2004, CLIN CANCER RES, V10, P3333, DOI 10.1158/1078-0432.CCR-03-0366; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Liu LP, 2010, CANCER INVEST, V28, P443, DOI 10.3109/07357900903405959; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Liu XD, 2010, MOL BIOL REP, V37, P2235, DOI 10.1007/s11033-009-9710-4; Nana-Sinkam SP, 2011, TRANSL RES, V157, P216, DOI 10.1016/j.trsl.2011.01.013; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Qiao L, 2006, HUM GENE THER, V17, P280, DOI 10.1089/hum.2006.17.280; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu N., 2011, FEBS J; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yeung ML, 2011, PHARM RES-DORDR, V28, P3043, DOI 10.1007/s11095-011-0526-2; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang S, 2011, ONCOGENE IN PRESS; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	62	113	118	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31518	10.1371/journal.pone.0031518	http://dx.doi.org/10.1371/journal.pone.0031518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359598	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200067
J	Hirotsu, N; Wada, K; Oshitani, H				Hirotsu, Nobuo; Wada, Koji; Oshitani, Hitoshi			Risk Factors of Household Transmission of Pandemic (H1N1) 2009 among Patients Treated with Antivirals: A Prospective Study at a Primary Clinic in Japan	PLOS ONE			English	Article							INFLUENZA-A H1N1; SECONDARY ATTACK RATES; VIRUS-INFECTION; UNITED-STATES; OSELTAMIVIR; CONTACTS; THERAPY; ILLNESS	Background: Household transmission of influenza can affect the daily lives of patients and their families and be a trigger for community transmission, thus it is necessary to take precautions to prevent household transmission. We aimed to determine the risks of household transmission of pandemic (H1N1) 2009 influenza virus from an index patient who visited a primary clinic and was treated with antiviral drugs. Methods: We followed up all the patients who were diagnosed with influenza A by rapid diagnostic test with a questionnaire or interview from July 2009 to April 2010. Secondary cases were defined as patients visiting the clinic or other clinics and being positive for influenza A by rapid diagnostic test within 7 days of onset of an index patient. Logistic regression analysis was used to explore the association between household transmission and the studied variables. Results: We recruited 591 index patients and 1629 household contacts. The crude secondary attack rate was 7.3% [95% confidence interval (CI): 6.1-8.7]. Age of index patients (0-6 years old: odds ratio 2.56; 95% CI: 1.31-4.01; 7-12 years old: 2.44, 1.31-3.72; 30-39 years old 3.88; 2.09-5.21; 40 years old or more 2.76; 1.17-4.53) and number of household members with five or more (3.09, 2.11-4.07), medication started >= 48 hours from the onset of fever (2.38, 1.17-3.87) were significantly associated with household transmission. Conclusions: Household transmission was associated with index patients aged <= 12 years old and adults >= 30 years with children, with more than five persons in the household, and medication initiated >= 48 hours from the onset of fever among the population, in which, antiviral treatment was given to all patients. We need to warn patients at high risk of household transmission to take additional precautions.	[Hirotsu, Nobuo] Hirotsu Clin, Kawasaki, Kanagawa, Japan; [Wada, Koji] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan	Kitasato University; Tohoku University	Hirotsu, N (corresponding author), Hirotsu Clin, Kawasaki, Kanagawa, Japan.	kwada-sgy@umin.ac.jp	Oshitani, Hitoshi/AAE-4349-2019		Ministry of Health; Labour and Welfare	Ministry of Health; Labour and Welfare	This study was funded by a research project for emerging and re-emerging infectious diseases, Ministry of Health, This work was supported by Labour and Welfare (H23-Emerging infectious diseases-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carcione D, 2011, EUROSURVEILLANCE, V16, P32; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hama R, 2007, BMJ-BRIT MED J, V335, P59, DOI 10.1136/bmj.39262.448877.BE; Hayward A, 2010, CLIN INFECT DIS, V50, P715, DOI 10.1086/650459; Hirotsu N, 2007, INTRAFAMILIAL TRANSM, P54; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; Komiya N, 2010, J INFECTION, V61, P284, DOI 10.1016/j.jinf.2010.06.019; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Loustalot F, 2011, CLIN INFECT DIS, V52, pS146, DOI 10.1093/cid/ciq057; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; National Institute of Infectious Diseaes Japan, 2009, REP SURV ANT INFL CA; National Institute of Infectious Diseaes Japan, 2009, CURR SIT PAND INFL H, VNational Institute of Infectious Diseaes, Japan; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nishiura H, 2011, J INT MED RES, V39, P619, DOI 10.1177/147323001103900231; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Pebody RG, 2011, EMERG INFECT DIS, V17, P990, DOI [10.3201/eid1706.101161, 10.3201/eid/1706.101161]; Savage R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-234; Simmerman JM, 2010, CLIN INFECT DIS, V51, P1053, DOI 10.1086/656581; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Wada K, 2010, INFLUENZA OTHER RESP, V4, P179, DOI 10.1111/j.1750-2659.2010.00143.x; Yang Y, 2010, PLOS ONE, V5; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31519	10.1371/journal.pone.0031519	http://dx.doi.org/10.1371/journal.pone.0031519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359599	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200068
J	Ziebarth, JD; Cook, MN; Wang, XS; Williams, RW; Lu, L; Cui, Y				Ziebarth, Jesse D.; Cook, Melloni N.; Wang, Xusheng; Williams, Robert W.; Lu, Lu; Cui, Yan			Treatment- and Population-Dependent Activity Patterns of Behavioral and Expression QTLs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED MOUSE STRAINS; ETHANOL SENSITIVITY; GENE-EXPRESSION; ALCOHOL DEPENDENCE; SYSTEMS GENETICS; MESSENGER-RNA; BRAIN; STRESS; NETWORKS	Genetic control of gene expression and higher-order phenotypes is almost invariably dependent on environment and experimental conditions. We use two families of recombinant inbred strains of mice (LXS and BXD) to study treatment-and genotype-dependent control of hippocampal gene expression and behavioral phenotypes. We analyzed responses to all combinations of two experimental perturbations, ethanol and restraint stress, in both families, allowing for comparisons across 8 combinations of treatment and population. We introduce the concept of QTL activity patterns to characterize how associations between genomic loci and traits vary across treatments. We identified several significant behavioral QTLs and many expression QTLs (eQTLs). The behavioral QTLs are highly dependent on treatment and population. We classified eQTLs into three groups: cis-eQTLs (expression variation that maps to within 5 Mb of the cognate gene), syntenic trans-eQTLs (the gene and the QTL are on the same chromosome but not within 5 Mb), and non-syntenic trans-eQTLs (the gene and the QTL are on different chromosomes). We found that most non-syntenic trans-eQTLs were treatment-specific whereas both classes of syntenic eQTLs were more conserved across treatments. We also found there was a correlation between regions along the genome enriched for eQTLs and SNPs that were conserved across the LXS and BXD families. Genes with eQTLs that co-localized with the behavioral QTLs and displayed similar QTL activity patterns were identified as potential candidate genes associated with the phenotypes, yielding identification of novel genes as well as genes that have been previously associated with responses to ethanol.	[Ziebarth, Jesse D.; Williams, Robert W.; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA; [Ziebarth, Jesse D.; Cui, Yan] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN USA; [Cook, Melloni N.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Wang, Xusheng; Williams, Robert W.; Lu, Lu] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA; [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenert, Nantong, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; Nantong University	Ziebarth, JD (corresponding author), Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA.	lulu@uthsc.edu; ycui2@uthsc.edu	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022; Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Cui, Yan/0000-0002-7577-6845	University of Tennessee Center for Integrative and Translational Genomics; NIH [U01 AA014425, AA013499, AA017590]; Department of Defense [W81XHW-05-01-0227]; National Natural Science Foundation of China [30771200, 30971591]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA017590, U01AA013499, U01AA014425] Funding Source: NIH RePORTER	University of Tennessee Center for Integrative and Translational Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by The University of Tennessee Center for Integrative and Translational Genomics; NIH Grants U01 AA014425, AA013499, AA017590; a Department of Defense grant W81XHW-05-01-0227; and National Natural Science Foundation of China Grants 30771200 and 30971591. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bardag-Gorce F, 2009, ALCOHOL CLIN EXP RES, V33, P684, DOI 10.1111/j.1530-0277.2008.00885.x; Bennett B, 2008, GENES BRAIN BEHAV, V7, P659, DOI 10.1111/j.1601-183X.2008.00403.x; Bennett B, 2002, ALCOHOL CLIN EXP RES, V26, P149, DOI 10.1111/j.1530-0277.2002.tb02519.x; Bennett B, 2006, J PHARMACOL EXP THER, V319, P299, DOI 10.1124/jpet.106.103572; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Bousios S, 2001, J STEROID BIOCHEM, V78, P401, DOI 10.1016/S0960-0760(01)00123-6; Brady KT, 1999, ALCOHOL RES HEALTH, V23, P263; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; Browman KE, 2000, ALCOHOL CLIN EXP RES, V24, P17, DOI 10.1111/j.1530-0277.2000.tb04547.x; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Damodaran S, 2006, EUR J PHARMACOL, V547, P75, DOI 10.1016/j.ejphar.2006.08.005; Darbandi-Tonkabon R, 2004, J PHARMACOL EXP THER, V308, P502, DOI 10.1124/jpet.103.058123; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; Downing C, 2006, ALCOHOL CLIN EXP RES, V30, P1111, DOI 10.1111/j.1530-0277.2006.00137.x; Edenberg HJ, 2006, HUM MOL GENET, V15, P1539, DOI 10.1093/hmg/ddl073; Ehlers CL, 2010, ADDICT BIOL, V15, P185, DOI 10.1111/j.1369-1600.2009.00195.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Hitzemann R, 2004, ALCOHOL CLIN EXP RES, V28; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Li Y, 2008, TRENDS GENET, V24, P518, DOI 10.1016/j.tig.2008.08.001; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu H, 2011, NUTR NEUROSCI, V14, P80, DOI 10.1179/1476830511Y.0000000004; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Petrie J, 2001, ALCOHOL CLIN EXP RES, V25, P819, DOI 10.1097/00000374-200106000-00005; Prescott CA, 2006, MOL PSYCHIATR, V11, P603, DOI 10.1038/sj.mp.4001811; Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Ryabinin AE, 1998, PSYCHOPHARMACOLOGY, V139, P34, DOI 10.1007/s002130050687; Ryabinin AE, 1997, MOL PSYCHIATR, V2, P32, DOI 10.1038/sj.mp.4000206; Sayette MA, 1999, ALCOHOL RES HEALTH, V23, P250; Schmidt MV, 2007, BRAIN RES, V1174, P1, DOI 10.1016/j.brainres.2007.08.023; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Song M, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/545176; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P381, DOI 10.1113/jphysiol.2004.079582; Thome J, 2001, BIOL PSYCHIAT, V50, P809, DOI 10.1016/S0006-3223(01)01229-X; Treadwell JA, 2004, NEUROCHEM RES, V29, P357, DOI 10.1023/B:NERE.0000013738.06437.a6; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Winkler A, 1999, MOL BRAIN RES, V72, P166, DOI 10.1016/S0169-328X(99)00218-1; Yau JLW, 2001, NEUROSCI LETT, V309, P141, DOI 10.1016/S0304-3940(01)02054-7; Yore MA, 2010, NEUROSCIENCE, V169, P1017, DOI 10.1016/j.neuroscience.2010.05.053; Yun SJ, 2002, NEUROSCI LETT, V318, P85, DOI 10.1016/S0304-3940(01)02492-2; Zhou Y, 2010, BRAIN RES, V1314, P235, DOI 10.1016/j.brainres.2009.11.015; Ziebarth JD, 2010, BIOM SCI ENG C BSEC, V2010, P1; ZOELLER RT, 1994, MOL BRAIN RES, V24, P185; Zuo LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026726	63	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31805	10.1371/journal.pone.0031805	http://dx.doi.org/10.1371/journal.pone.0031805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359631	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200100
J	Khalili, D; Mosavi-Jarrahi, A; Eskandari, F; Mousavi-Jarrahi, Y; Hadaegh, F; Mohagheghi, M; Azizi, F				Khalili, Davood; Mosavi-Jarrahi, Alireza; Eskandari, Fatemeh; Mousavi-Jarrahi, Yasaman; Hadaegh, Farzad; Mohagheghi, Mohammadali; Azizi, Fereidoun			Evaluation of Cause of Deaths' Validity Using Outcome Measures from a Prospective, Population Based Cohort Study in Tehran, Iran	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; UNDERLYING CAUSE; UNITED-STATES; CERTIFICATES; MORTALITY; ACCURACY; CANCER; STATISTICS; VALIDATION	Objective: The aim of this study was to evaluate the validity of cause of death stated in death certificates in Tehran using outcome measures of the Tehran Lipid and Glucose Study (TLGS), an ongoing prospective cohort study. Methods: The cohort was established in 1999 in a population of 15005 people, 3 years old and over, living in Tehran; 3551 individuals were added to this population three years later. As part of cohort's outcome measures, deaths occurring in the cohort are investigated by a panel of medical specialists (Cohort Outcome Panel-COP) and underlying cause of death is determined for each death. The cause of death assigned in a deceased's original death certificate was evaluated against the cause of death determined by COP and sensitivity and positive predictive values (PPV) were determined. In addition, determinants of assigning accurate underlying cause of death were determined using logistic regression model. Result: A total of 231 death certificates were evaluated. The original death certificates over reported deaths due to neoplasms and underreported death due to circulatory system and transport accidents. Neoplasms with sensitivity of 0.91 and PPV of 0.71 were the most valid category. The disease of circulatory system showed moderate degree of validity with sensitivity of 0.67 and PPV of 0.78. The result of logistic regression indicated if the death certificate is issued by a general practitioner, there is 2.3 (95% CI 1.1, 5.1) times chance of being misclassified compared with when it is issued by a specialist. If the deceased is more than 60 years, the chance of misclassification would be 2.5 times (95% CI of 1.1, 5.9) compared with when the deceased is less than 60 years.	[Khalili, Davood; Eskandari, Fatemeh; Hadaegh, Farzad; Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Khalili, Davood; Mosavi-Jarrahi, Alireza] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Mosavi-Jarrahi, Alireza] Shahid Beheshti Univ Med Sci, Sch Med, Dept Social Med & Publ Hlth, Hlth Metr Res Ctr, Tehran, Iran; [Mosavi-Jarrahi, Alireza; Mousavi-Jarrahi, Yasaman; Mohagheghi, Mohammadali] Univ Tehran Med Sci, Canc Res Ctr, Inst Canc, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences	Khalili, D (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	rmosavi@yahoo.com	hadaegh, farzad/K-2460-2017; jarrahi, Alireza Mosavi/AAT-5728-2020; Azizi, Fereidoun/ABD-4136-2021; Mohagheghi, Mohammad Ali/AAL-3598-2020; Khalili, Davood/T-2913-2017	Azizi, Fereidoun/0000-0002-6470-2517; Mohagheghi, Mohammad Ali/0000-0003-4153-0991; Khalili, Davood/0000-0003-4956-1039; hadaegh, farzad/0000-0002-0352-8666; Hadaegh, Farzad/0000-0002-8935-2744	Marhomeh Khanom Sohrabi fund; Research Institute for Endocrine Sciences, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran	Marhomeh Khanom Sohrabi fund; Research Institute for Endocrine Sciences, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran	This study was funded partially by a grant from the Marhomeh Khanom Sohrabi fund (a charity fund allocated to research on cancer and managed by the Cancer Institute, Tehran, Iran) and the other part of the fund was granted by the Research Institute for Endocrine Sciences, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgeJohansson Lars, 2005B67 WHOFIC; ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; Alperovitch A, 2009, EUR J EPIDEMIOL, V24, P669, DOI 10.1007/s10654-009-9383-2; Azizi F, 2000, CVD PREVENTION INTER, V3, P242; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Billett J, 2005, J PUBLIC HEALTH, V27, P270, DOI 10.1093/pubmed/fdi043; CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; Goldoni CA, 2009, CANCER CAUSE CONTROL, V20, P533, DOI 10.1007/s10552-008-9261-3; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Khosravi A, 2007, B WORLD HEALTH ORGAN, V85, P607, DOI 10.2471/BLT.06.038802; KIRCHER T, 1987, JAMA-J AM MED ASSOC, V258, P349, DOI 10.1001/jama.258.3.349; Kircher T, 1987, J Am Med Rec Assoc, V58, P47; LEE PN, 1994, APMIS, V102, P1; Lenfant C, 1998, ANN INTERN MED, V129, P1066, DOI 10.7326/0003-4819-129-12-199812150-00013; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; Mohammed MA, 2004, BMJ-BRIT MED J, V328, P1474, DOI 10.1136/bmj.328.7454.1474; Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777; PERCY C, 1990, PUBLIC HEALTH REP, V105, P361; PERCY CL, 1990, ANN NY ACAD SCI, V609, P87, DOI 10.1111/j.1749-6632.1990.tb32059.x; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Rosenberg H M, 1999, Vital Health Stat 2, P1; Rosenberg HM, 1999, J HIST MED ALL SCI, V54, P133, DOI 10.1093/jhmas/54.2.133; Sington JD, 2002, J CLIN PATHOL, V55, P499, DOI 10.1136/jcp.55.7.499; SORLIE P D, 1987, MMJ (Maryland Medical Journal), V36, P339; VELLACOTT KD, 1984, J ROY SOC MED, V77, P22	28	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31427	10.1371/journal.pone.0031427	http://dx.doi.org/10.1371/journal.pone.0031427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355365	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300065
J	Kuo, TY; Hsi, E; Yang, IP; Tsai, PC; Wang, JY; Juo, SHH				Kuo, Tai-Yue; Hsi, Edward; Yang, I-Ping; Tsai, Pei-Chien; Wang, Jaw-Yuan; Juo, Suh-Hang Hank			Computational Analysis of mRNA Expression Profiles Identifies MicroRNA-29a/c as Predictor of Colorectal Cancer Early Recurrence	PLOS ONE			English	Article							BIOCONDUCTOR PACKAGE; MIRNAS; IMPACT; TOOLS; SURVEILLANCE; BIOMARKERS; MIRBASE; BIOLOGY; COLON	Colorectal cancer (CRC) is one of the leading malignant cancers with a rapid increase in incidence and mortality. The recurrences of CRC after curative resection are sometimes unavoidable and often take place within the first year after surgery. MicroRNAs may serve as biomarkers to predict early recurrence of CRC, but identifying them from over 1,400 known human microRNAs is challenging and costly. An alternative approach is to analyze existing expression data of messenger RNAs (mRNAs) because generally speaking the expression levels of microRNAs and their target mRNAs are inversely correlated. In this study, we extracted six mRNA expression data of CRC in four studies (GSE12032, GSE17538, GSE4526 and GSE17181) from the gene expression omnibus (GEO). We inferred microRNA expression profiles and performed computational analysis to identify microRNAs associated with CRC recurrence using the IMRE method based on the MicroCosm database that includes 568,071 microRNA-target connections between 711 microRNAs and 20,884 gene targets. Two microRNAs, miR-29a and miR-29c, were disclosed and further meta-analysis of the six mRNA expression datasets showed that these two microRNAs were highly significant based on the Fisher p-value combination (p = 9.14x10(-9) for miR-29a and p = 1.14x10(-6) for miR-29c). Furthermore, these two microRNAs were experimentally tested in 78 human CRC samples to validate their effect on early recurrence. Our empirical results showed that the two microRNAs were significantly down-regulated (p = 0.007 for miR-29a and p = 0.007 for miR-29c) in the early-recurrence patients. This study shows the feasibility of using mRNA profiles to indicate microRNAs. We also shows miR-29a/c could be potential biomarkers for CRC early recurrence.	[Kuo, Tai-Yue; Yang, I-Ping; Tsai, Pei-Chien; Wang, Jaw-Yuan; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Hsi, Edward] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hsi, Edward; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Yang, I-Ping] Shu Zen Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, TY (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net; hjuo@kmu.edu.tw	Jaw-Yuan, Wang/AFS-8845-2022; Hsi, Edward/A-1356-2013; Juo, Suh-Hang/C-9545-2009	Jaw-Yuan, Wang/0000-0002-7705-2621; Hsi, Edward/0000-0002-8272-6707; Tsai, Pei-Chien/0000-0002-5044-6727	Kaohsiung Medical University Hospital [KMUH98-8I04]; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taiwan, Republic of China [DOH100-TD-C-111-002]; National Science Council of the Republic of China [NSC 99-2320-B-037-014-MY3, NSC 94-2314B037-104]	Kaohsiung Medical University Hospital; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taiwan, Republic of China; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Kaohsiung Medical University Hospital (KMUH98-8I04) (http://www.kmuh.org.tw/), Excellence for Cancer Research Center Grant through funding by the Department of Health, Executive Yuan, Taiwan, Republic of China (DOH100-TD-C-111-002) (http://science.doh.gov.tw/), and the National Science Council of the Republic of China (NSC 99-2320-B-037-014-MY3 and NSC 94-2314B037-104) (http://www.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam MI, 2009, BRIT J SURG, V96, P702, DOI 10.1002/bjs.6628; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker H, 1995, Praxis (Bern 1994), V84, P1371; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brosens RP, 2010, CELL ONCOL; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fisher RA, 1932, STAT METHODS RES WOR, P4; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497; Longo WE, 2002, SURG CLIN N AM, V82, P1091, DOI 10.1016/S0039-6109(02)00050-6; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; Manne U, 2010, BIOMARK MED, V4, P761, DOI 10.2217/BMM.10.87; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Scheid S, 2004, IEEE ACM T COMPUT BI, V1, P98, DOI 10.1109/TCBB.2004.24; Scheid S, 2005, BIOINFORMATICS, V21, P2921, DOI 10.1093/bioinformatics/bti436; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Tsai HL, 2009, INT J COLORECTAL DIS, V24, P177, DOI 10.1007/s00384-008-0594-x; Watanabe T, 2009, CANCER, V115, P283, DOI 10.1002/cncr.24023; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wolpin BM, 2007, CA-CANCER J CLIN, V57, P168, DOI 10.3322/canjclin.57.3.168; Xi YG, 2007, CANCER INFORM, V3, P245; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300	46	57	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31587	10.1371/journal.pone.0031587	http://dx.doi.org/10.1371/journal.pone.0031587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348113	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900057
J	Lin, C; Wu, MH; Dong, JY				Lin, Chen; Wu, Menghua; Dong, Jianyong			Quercetin-4 '-O-beta-D-glucopyranoside (QODG) Inhibits Angiogenesis by Suppressing VEGFR2-Mediated Signaling in Zebrafish and Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FOCAL ADHESION KINASE; ACTIN-BASED MOTILITY; TUMOR ANGIOGENESIS; POLY(ADP-RIBOSE) POLYMERASE; IN-VIVO; TYROSINE KINASE; ANTICANCER THERAPY; ICE/CED-3 PROTEASE	Background: Angiogenesis plays an important role in many physiological and pathological processes. Identification of small molecules that block angiogenesis and are safe and affordable has been a challenge in drug development. Hypericum attenuatum Choisy is a Chinese herb medicine commonly used for treating hemorrhagic diseases. The present study investigates the anti-angiogenic effects of quercetin-4'-O-beta-D-glucopyranoside (QODG), a flavonoid isolated from Hypericum attenuatum Choisy, in vivo and in vitro, and clarifies the underlying mechanism of the activity. Methodology/Principal Findings: Tg(fli1:EGFP) transgenic zebrafish embryos were treated with different concentrations of quercetin-4'-O-beta-D-glucopyranoside (QODG) (20, 60, 180 mu M) from 6 hours post fertilisation (hpf) to 72 hpf, and adult zebrafish were allowed to recover in different concentrations of QODG (20, 60, 180 mu M) for 7 days post amputation (dpa) prior morphological observation and angiogenesis phenotypes assessment. Human umbilical vein endothelial cells (HUVECs) were treated with or without VEGF and different concentrations of QODG (5, 20, 60, 180 mu M), then tested for cell viability, cell migration, tube formation and apoptosis. The role of VEGFR2-mediated signaling pathway in QODG-inhibited angiogenesis was evaluated using quantitative real-time PCR (qRT-PCR) and Western blotting. Conclusion/Significance: Quercetin-4'-O-beta-D-glucopyranoside (QODG) was shown to inhibit angiogenesis in human umbilical vein endothelial cells (HUVECs) in vitro and zebrafish in vivo via suppressing VEGF-induced phosphorylation of VEGFR2. Our results further indicate that QODG inhibits angiogenesis via inhibition of VEGFR2-mediated signaling with the involvement of some key kinases such as c-Src, FAK, ERK, AKT, mTOR and S6K and induction of apoptosis. Together, this study reveals, for the first time, that QODG acts as a potent VEGFR2 kinase inhibitor, and exerts the anti-angiogenic activity at least in part through VEGFR2-mediated signaling pathway.	[Lin, Chen; Wu, Menghua; Dong, Jianyong] Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Lin, C (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China.	jiany_d163@163.com			Science and Technology Commission of Zhejiang Province [Y2101196]; Promotion Program of Fresh Talent Program for Science and Technology Department of Zhejiang Province [2010R413042]	Science and Technology Commission of Zhejiang Province; Promotion Program of Fresh Talent Program for Science and Technology Department of Zhejiang Province	This work was supported by a grant from the Science and Technology Commission of Zhejiang Province (Ref. No. Y2101196) and a grant from the Promotion Program of Fresh Talent Program for Science and Technology Department of Zhejiang Province (Ref. No. 2010R413042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Ahmad S, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-15; Ali N, 2005, J PHARMACOL SCI, V98, P130, DOI 10.1254/jphs.FP0040850; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERGER NA, 1985, BIOCHEMISTRY-US, V24, P4352, DOI 10.1021/bi00337a015; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Buchler P, 2004, CANCER-AM CANCER SOC, V100, P201, DOI 10.1002/cncr.11873; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cheng SH, 2001, AQUAT TOXICOL, V52, P61, DOI 10.1016/S0166-445X(00)00130-2; Childs S, 2002, DEVELOPMENT, V129, P973; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Cho CH, 2004, AM J PHYSIOL-HEART C, V286, pH1881, DOI 10.1152/ajpheart.00786.2003; Chou MT, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-32; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Compagni A, 2000, BRIT J CANCER, V83, P1; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; Ding Li-li, 2010, Yaoxue Xuebao, V45, P456; Dona M, 2004, CANCER RES, V64, P6225, DOI 10.1158/0008-5472.CAN-04-0280; Dong DF, 2009, CANCER LETT, V285, P218, DOI 10.1016/j.canlet.2009.05.021; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Eberhard A, 2000, CANCER RES, V60, P1388; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Foekens JA, 2001, CANCER RES, V61, P5407; FOLKMAN J, 1974, CANCER RES, V34, P2109; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanhan D, 1996, CELL, V86, P353; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Huang CC, 2009, DEV BIOL, V332, P360, DOI 10.1016/j.ydbio.2009.06.003; IIJIMA K, 1993, KIDNEY INT, V44, P959, DOI 10.1038/ki.1993.337; Itakura J, 2000, INT J CANCER, V85, P27; Ito N, 1998, J BIOL CHEM, V273, P23410, DOI 10.1074/jbc.273.36.23410; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kanda S, 2007, INT J MOL MED, V20, P113; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Liu BY, 2010, MOL VIS, V16, P184; Makovets'ka O Iu, 2000, Ukr Biokhim Zh (1999), V72, P110; Martinez-Poveda B, 2005, INT J CANCER, V117, P775, DOI 10.1002/ijc.21246; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsuo M, 2007, EUR J CANCER, V43, P1748, DOI 10.1016/j.ejca.2007.04.024; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Pang XF, 2009, CANCER RES, V69, P518, DOI 10.1158/0008-5472.CAN-08-2531; Patan S, 2004, CANC TREAT, V117, P3; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Qi JH, 2001, EXP CELL RES, V263, P173, DOI 10.1006/excr.2000.5102; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; SEETHARAM L, 1995, ONCOGENE, V10, P135; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Smith BD, 2000, J CLIN ONCOL, V18, P2046, DOI 10.1200/JCO.2000.18.10.2046; Spiekermann K, 2002, EXP HEMATOL, V30, P767, DOI 10.1016/S0301-472X(02)00837-8; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tang JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011822; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; Verheul HMW, 1997, CLIN CANCER RES, V3, P2187; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; Wedge SR, 2002, CANCER RES, V62, P4645; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zheng LH, 2007, CANCER BIOL THER, V6, P775, DOI 10.4161/cbt.6.5.4002; Zhong HZ, 2007, CURR TOP MED CHEM, V7, P1379	117	30	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31708	10.1371/journal.pone.0031708	http://dx.doi.org/10.1371/journal.pone.0031708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348123	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900060
J	Noordam, R; Jansen, SWM; Akintola, AA; Oei, NYL; Maier, AB; Pijl, H; Slagboom, PE; Westendorp, RGJ; van der Grond, J; de Craen, AJM; van Heemst, D				Noordam, Raymond; Jansen, Steffy W. M.; Akintola, Abimbola A.; Oei, Nicole Y. L.; Maier, Andrea B.; Pijl, Hanno; Slagboom, P. Eline; Westendorp, Rudi G. J.; van der Grond, Jeroen; de Craen, Anton J. M.; van Heemst, Diana		Leiden Longevity Study Grp	Familial Longevity Is Marked by Lower Diurnal Salivary Cortisol Levels: The Leiden Longevity Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; NONAGENARIAN SIBLINGS; DIABETES-MELLITUS; PLASMA-CORTISOL; AXIS; MEN; AGE; SENSITIVITY	Background: Reported findings are inconsistent whether hypothalamic-pituitary-adrenal (HPA) signaling becomes hyperactive with increasing age, resulting in increasing levels of cortisol. Our previous research strongly suggests that offspring from long-lived families are biologically younger. In this study we assessed whether these offspring have a lower HPA axis activity, as measured by lower levels of cortisol and higher cortisol feedback sensitivity. Methods: Salivary cortisol levels were measured at four time points within the first hour upon awakening and at two time points in the evening in a cohort comprising 149 offspring and 154 partners from the Leiden Longevity Study. A dexamethasone suppression test was performed as a measure of cortisol feedback sensitivity. Age, gender and body mass index, smoking and disease history (type 2 diabetes and hypertension) were considered as possible confounding factors. Results: Salivary cortisol secretion was lower in offspring compared to partners in the morning (Area Under the Curve = 15.6 versus 17.1 nmol/L, respectively; p = 0.048) and in the evening (Area Under the Curve = 3.32 versus 3.82 nmol/L, respectively; p = 0.024). Salivary cortisol levels were not different after dexamethasone (0.5 mg) suppression between offspring and partners (4.82 versus 5.26 nmol/L, respectively; p = 0.28). Conclusion: Offspring of nonagenarian siblings are marked by a lower HPA axis activity (reflected by lower diurnal salivary cortisol levels), but not by a difference in cortisol feedback sensitivity. Further in-depth studies aimed at characterizing the HPA axis in offspring and partners are needed.	[Noordam, Raymond; Jansen, Steffy W. M.; Akintola, Abimbola A.; Oei, Nicole Y. L.; Maier, Andrea B.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Oei, Nicole Y. L.; van der Grond, Jeroen] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Pijl, Hanno] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands; [Oei, Nicole Y. L.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Maier, Andrea B.; Slagboom, P. Eline; Westendorp, Rudi G. J.; de Craen, Anton J. M.; van Heemst, Diana] Netherlands Consortium Healthy Ageing, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Noordam, R (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	d.van_heemst@lumc.nl	Akintola, Abi/T-5361-2019; Oei, Nicole/T-1219-2019; Maier, Andrea/W-7060-2019; Maier, Andrea B./Q-5548-2019; Slagboom, P. Eline/R-4790-2016; Pijl, Hanno/W-8719-2018	Maier, Andrea/0000-0001-7206-1724; Slagboom, P. Eline/0000-0002-2875-4723; Noordam, Raymond/0000-0001-7801-809X; Pijl, Hanno/0000-0002-3076-1551	European Commission [Health-F2-2010-259772]; Innovation Oriented research Program on Genomics [IGE01014, IGE5007]; Centre for Medical Systems Biology; Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO) [05040202, 050-060-810]; Netherlands Genomics Initiative [NCHA 050-060-810]	European Commission(European CommissionEuropean Commission Joint Research Centre); Innovation Oriented research Program on Genomics; Centre for Medical Systems Biology; Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative	This study was funded by the European Commission funded project Switchbox (FP7, Health-F2-2010-259772), the Innovation Oriented research Program on Genomics (SenterNovem; IGE01014 and IGE5007), the Centre for Medical Systems Biology, the Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO; 05040202 and 050-060-810. NCHA). PES is supported by an unrestricted grant from the Netherlands Genomics Initiative (NCHA 050-060-810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M, 2003, PSYCHONEUROENDOCRINO, V28, P121, DOI 10.1016/S0306-4530(02)00003-3; BEYER HS, 1988, ENDOCRINOLOGY, V123, P2117, DOI 10.1210/endo-123-4-2117; Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010; DODT C, 1994, EUR J ENDOCRINOL, V131, P443, DOI 10.1530/eje.0.1310443; Hatzinger M, 2011, J PSYCHIAT RES; Heaney JL, 2011, PSYCHONEUROENDOCRINO; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Knoops AJG, 2010, ENDOCRINE, V37, P231, DOI 10.1007/s12020-009-9291-y; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Pruessner M, 2003, PSYCHOSOM MED, V65, P92, DOI 10.1097/01.PSY.0000040950.22044.10; ROTHUIZEN J, 1993, ENDOCRINOLOGY, V132, P161, DOI 10.1210/en.132.1.161; Rozing MP, 2009, AGING-US, V1, P714, DOI 10.18632/aging.100071; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Tafet GE, 2001, COGN AFFECT BEHAV NE, V1, P388, DOI 10.3758/CABN.1.4.388; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Walker BR, 2000, J INTERN MED, V247, P198, DOI 10.1046/j.1365-2796.2000.00609.x; Walker BR, 1998, HYPERTENSION, V31, P891, DOI 10.1161/01.HYP.31.4.891; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31166	10.1371/journal.pone.0031166	http://dx.doi.org/10.1371/journal.pone.0031166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348049	gold, Green Published			2022-12-27	WOS:000302733900027
J	Chambers, AL; Brownlee, PM; Durley, SC; Beacham, T; Kent, NA; Downs, JA				Chambers, Anna L.; Brownlee, Peter M.; Durley, Samuel C.; Beacham, Tracey; Kent, Nicholas A.; Downs, Jessica A.			The Two Different Isoforms of the RSC Chromatin Remodeling Complex Play Distinct Roles in DNA Damage Responses	PLOS ONE			English	Article							STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; CHECKPOINT; GENE; ADAPTATION; INDUCTION	The RSC chromatin remodeling complex has been implicated in contributing to DNA double-strand break (DSB) repair in a number of studies. Both survival and levels of H2A phosphorylation in response to damage are reduced in the absence of RSC. Importantly, there is evidence for two isoforms of this complex, defined by the presence of either Rsc1 or Rsc2. Here, we investigated whether the two isoforms of RSC provide distinct contributions to DNA damage responses. First, we established that the two isoforms of RSC differ in the presence of Rsc1 or Rsc2 but otherwise have the same subunit composition. We found that both rsc1 and rsc2 mutant strains have intact DNA damage-induced checkpoint activity and transcriptional induction. In addition, both strains show reduced non-homologous end joining activity and have a similar spectrum of DSB repair junctions, suggesting perhaps that the two complexes provide the same functions. However, the hypersensitivity of a rsc1 strain cannot be complemented with an extra copy of RSC2, and likewise, the hypersensitivity of the rsc2 strain remains unchanged when an additional copy of RSC1 is present, indicating that the two proteins are unable to functionally compensate for one another in DNA damage responses. Rsc1, but not Rsc2, is required for nucleosome sliding flanking a DNA DSB. Interestingly, while swapping the domains from Rsc1 into the Rsc2 protein does not compromise hypersensitivity to DNA damage suggesting they are functionally interchangeable, the BAH domain from Rsc1 confers upon Rsc2 the ability to remodel chromatin at a DNA break. These data demonstrate that, despite the similarity between Rsc1 and Rsc2, the two different isoforms of RSC provide distinct functions in DNA damage responses, and that at least part of the functional specificity is dictated by the BAH domains.	[Chambers, Anna L.; Brownlee, Peter M.; Downs, Jessica A.] Univ Sussex, Med Res Council Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Durley, Samuel C.; Beacham, Tracey; Kent, Nicholas A.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	University of Sussex; Cardiff University	Chambers, AL (corresponding author), Univ Sussex, Med Res Council Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	j.a.downs@sussex.ac.uk	Kent, Nicholas/A-4503-2010	Kent, Nicholas/0000-0002-4114-1307; Beacham, Tracey/0000-0001-5552-2330; Downs, Jessica/0000-0002-6600-849X; Durley, Samuel/0000-0002-1316-2426; Chambers, Anna/0000-0001-8133-6240	Cancer Research UK [CEA C7905/A10269]; BBSRC [BB/F012810/1]; Biotechnology and Biological Sciences Research Council [BB/F012810/1] Funding Source: researchfish; Medical Research Council [G0801130B] Funding Source: researchfish; Worldwide Cancer Research [12-1118] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	ALC, PMB, and JAD are supported by Cancer Research UK CEA C7905/A10269. NAK is supported by BBSRC grant BB/F012810/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Bungard D, 2004, EUKARYOT CELL, V3, P910, DOI 10.1128/EC.3.4.910-918.2004; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Horikawa I, 2002, DNA SEQUENCE, V13, P211, DOI 10.1080/1042517021000021590; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Kent NA, 2007, J BIOL CHEM, V282, P27693, DOI 10.1074/jbc.M704707200; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276	24	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32016	10.1371/journal.pone.0032016	http://dx.doi.org/10.1371/journal.pone.0032016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359657	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200126
J	De Cian, A; Praly, E; Ding, FY; Singh, V; Lavelle, C; Le Cam, E; Croquette, V; Pietrement, O; Bensimon, D				De Cian, Anne; Praly, Elise; Ding, Fangyuan; Singh, Vijender; Lavelle, Christophe; Le Cam, Eric; Croquette, Vincent; Pietrement, Olivier; Bensimon, David			ATP-Independent Cooperative Binding of Yeast Isw1a to Bare and Nucleosomal DNA	PLOS ONE			English	Article							SINGLE-MOLECULE; RNA-POLYMERASE; REAL-TIME; CHROMATIN; TRANSLOCATION; MECHANISM; PROTEIN; SWI/SNF; GENE; RSC	Among chromatin remodeling factors, the ISWI family displays a nucleosome-enhanced ATPase activity coupled to DNA translocation. While these enzymes are known to bind to DNA, their activity has not been fully characterized. Here we use TEM imaging and single molecule manipulation to investigate the interaction between DNA and yeast Isw1a. We show that Isw1a displays a highly cooperative ATP-independent binding to and bridging between DNA segments. Under appropriate tension, rare single nucleation events can sometimes be observed and loop DNA with a regular step. These nucleation events are often followed by binding of successive complexes bridging between nearby DNA segments in a zipper-like fashion, as confirmed by TEM observations. On nucleosomal substrates, we show that the specific ATP-dependent remodeling activity occurs in the context of cooperative Isw1a complexes bridging extranucleosomal DNA. Our results are interpreted in the context of the recently published partial structure of Isw1a and support its acting as a "protein ruler'' (with possibly more than one tick).	[De Cian, Anne; Le Cam, Eric; Pietrement, Olivier] CNRS, UMR 8126, Villejuif, France; [De Cian, Anne; Le Cam, Eric; Pietrement, Olivier] Univ Paris 11, Villejuif, France; [Praly, Elise; Ding, Fangyuan; Croquette, Vincent; Bensimon, David] Ecole Normale Super, CNRS, Lab Phys Stat, UMR 8550, Paris, France; [Singh, Vijender] Univ Dundee, Wellcome Trust Bioctr, Dundee, Scotland; [Lavelle, Christophe] CNRS, UMR 7196, INSERM, U565, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; University of Dundee; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN)	De Cian, A (corresponding author), CNRS, UMR 8126, Villejuif, France.	olivier.pietrement@igr.fr; david@lps.ens.fr	Lavelle, Christophe/F-2377-2013; Ding, Fangyuan/I-4787-2014; Bensimon, David/E-7768-2015; PIETREMENT, Olivier/T-2555-2017	Bensimon, David/0000-0003-1971-9907; Le cam, Eric/0000-0002-6832-6117; PIETREMENT, Olivier/0000-0002-0018-7202; Ding, Fangyuan/0000-0003-0118-5441; DE CIAN, Anne/0000-0002-1737-2543; Croquette, Vincent/0000-0003-1400-0039	Association pour la Recherche sur le Cancer; Ministry of Instruction and Research; Region Ile-de-France; Wellcome Trust; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [06PCV0005 PCV FaRC]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministry of Instruction and Research; Region Ile-de-France(Region Ile-de-France); Wellcome Trust(Wellcome Trust); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	ADC was funded by the Association pour la Recherche sur le Cancer, and EP was funded by the Ministry of Instruction and Research. OP and ELC acknowledge support from the Region Ile-de-France in the framework of C'nano-IdF. VS acknowledges support from the Wellcome Trust. VC, DB, CL, OP, and ELC acknowledge support from the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (no06PCV0005 PCV FaRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Charvin G, 2005, BIOPHYS J, V89, P384, DOI 10.1529/biophysj.105.060202; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Chin J, 2004, METHOD ENZYMOL, V376, P3; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Dupaigne P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003643; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; JULICHER F, 1995, PHYS REV LETT, V75, P2618, DOI 10.1103/PhysRevLett.75.2618; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lavelle C, 2009, BIOCHEM CELL BIOL, V87, P307, DOI 10.1139/O08-123; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; MANNING GS, 1985, CELL BIOPHYS, V7, P57, DOI 10.1007/BF02788639; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Okada M, 1998, MOL CELL BIOL, V18, P2455, DOI 10.1128/MCB.18.5.2455; Pinskaya M, 2009, MOL CELL BIOL, V29, P2419, DOI 10.1128/MCB.01050-08; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Pusarla RH, 2005, FEBS J, V272, P5149, DOI 10.1111/j.1742-4658.2005.04930.x; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shukla MS, 2010, P NATL ACAD SCI USA, V107, P1936, DOI 10.1073/pnas.0904497107; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; van der Heijden T, 2008, MOL CELL, V30, P530, DOI 10.1016/j.molcel.2008.03.010; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; Varga-Weisz PD, 2006, CURR OPIN GENET DEV, V16, P151, DOI 10.1016/j.gde.2006.02.006; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wiggins PA, 2009, BIOPHYS J, V97, P1997, DOI 10.1016/j.bpj.2009.06.051; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	51	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31845	10.1371/journal.pone.0031845	http://dx.doi.org/10.1371/journal.pone.0031845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359636	Green Published, gold			2022-12-27	WOS:000302796200105
J	Kempf, M; Bakour, S; Flaudrops, C; Berrazeg, M; Brunel, JM; Drissi, M; Mesli, E; Touati, A; Rolain, JM				Kempf, Marie; Bakour, Sofiane; Flaudrops, Christophe; Berrazeg, Meryem; Brunel, Jean-Michel; Drissi, Mourad; Mesli, Esma; Touati, Abdelaziz; Rolain, Jean-Marc			Rapid Detection of Carbapenem Resistance in Acinetobacter baumannii Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry	PLOS ONE			English	Article							IDENTIFICATION; BACTERIA; EPIDEMIOLOGY; HOSPITALS; IMIPENEM; COLISTIN; GENES	Rapid detection of carbapenem-resistant Acinetobacter baumannii strains is critical and will benefit patient care by optimizing antibiotic therapies and preventing outbreaks. Herein we describe the development and successful application of a mass spectrometry profile generated by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) that utilized the imipenem antibiotic for the detection of carbapenem resistance in a large series of A. baumannii clinical isolates from France and Algeria. A total of 106 A. baumannii strains including 63 well-characterized carbapenemase-producing and 43 non-carbapenemase-producing strains, as well as 43 control strains (7 carbapenem-resistant and 36 carbapenem-sensitive strains) were studied. After an incubation of bacteria with imipenem for up to 4 h, the mixture was centrifuged and the supernatant analyzed by MALDI-TOF MS. The presence and absence of peaks representing imipenem and its natural metabolite was analyzed. The result was interpreted as positive for carbapenemase production if the specific peak for imipenem at 300.0 m/z disappeared during the incubation time and if the peak of the natural metabolite at 254.0 m/z increased as measured by the area under the curves leading to a ratio between the peak for imipenem and its metabolite being <0.5. This assay, which was applied to the large series of A. baumannii clinical isolates, showed a sensitivity of 100.0% and a specificity of 100.0%. Our study is the first to demonstrate that this quick and simple assay can be used as a routine tool as a point-of-care method for the identification of A. baumannii carbapenemase-producers in an effort to prevent outbreaks and the spread of uncontrollable superbugs.	[Kempf, Marie; Bakour, Sofiane; Flaudrops, Christophe; Berrazeg, Meryem; Brunel, Jean-Michel; Rolain, Jean-Marc] Aix Marseille Univ, URMITE, CNRS,Fac Med & Pharm, IRD,INSERM,UMR 6236, Marseille, France; [Bakour, Sofiane; Touati, Abdelaziz] Univ A MIRA Bejaia, Dept Microbiol, FSNV, Bejaia, Algeria; [Drissi, Mourad; Mesli, Esma] Univ Abou Bekr Belkaid Tlemcen, Lab Antibiot Antifong Physicochim Synth & Act Bio, Tilimsen, Algeria	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite de Bejaia; Universite Abou Bekr Belkaid	Kempf, M (corresponding author), Aix Marseille Univ, URMITE, CNRS,Fac Med & Pharm, IRD,INSERM,UMR 6236, Marseille, France.	jean-marc.rolain@univmed.fr	TOUATI, Abdelaziz/N-5759-2016; Rolain, Jean-Marc/Y-3788-2019; Bakour, Sofiane/I-3528-2019	TOUATI, Abdelaziz/0000-0002-7479-2456; Rolain, Jean-Marc/0000-0002-2402-4467; bakour, sofiane/0000-0002-3436-7391; jean michel, brunel/0000-0002-9355-8980; KEMPF, Marie/0000-0002-2943-7500	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was partly funded by CNRS. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnin RA, 2011, CLIN MICROBIOL INFEC, V17, P1524, DOI 10.1111/j.1469-0691.2011.03622.x; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Coelho JM, 2006, J CLIN MICROBIOL, V44, P3623, DOI 10.1128/JCM.00699-06; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; He C, 2011, INT J ANTIMICROB AG, V38, P257, DOI 10.1016/j.ijantimicag.2011.04.015; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Karah N, 2011, MICROB DRUG RESIST, V17, P545, DOI 10.1089/mdr.2011.0089; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Kusradze I, 2011, INT J ANTIMICROB AG, V38, P164, DOI 10.1016/j.ijantimicag.2011.03.021; Lee K, 2003, J CLIN MICROBIOL, V41, P4623, DOI 10.1128/JCM.41.10.4623-4629.2003; Markelz AE, 2011, ANTIMICROB AGENTS CH, V55, P4707, DOI 10.1128/AAC.00112-11; Mezzatesta ML, 2012, CLIN MICROBIOL INFEC, V18, P160, DOI 10.1111/j.1469-0691.2011.03527.x; Michalopoulos AS, 2005, CLIN MICROBIOL INFEC, V11, P115, DOI 10.1111/j.1469-0691.2004.01043.x; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2011, J ANTIMICROB CHEMOTH, V66, P1070, DOI 10.1093/jac/dkr056; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Rolain JM, 2011, J INFECT DIS, V204, P1146, DOI 10.1093/infdis/jir475; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; SWANSON DJ, 1986, ANTIMICROB AGENTS CH, V29, P936, DOI 10.1128/AAC.29.5.936; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Vitorino R, 2011, METHODS MOL BIOL, V790, P31, DOI 10.1007/978-1-61779-319-6_3; Zarrilli Raffaele, 2009, J Infect Dev Ctries, V3, P335, DOI 10.3855/jidc.240	25	111	124	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31676	10.1371/journal.pone.0031676	http://dx.doi.org/10.1371/journal.pone.0031676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359616	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200085
J	Paik, JK; Kim, JY; Kim, OY; Lee, Y; Jeong, TS; Sweeney, G; Jang, Y; Lee, JH				Paik, Jean Kyung; Kim, Ji Young; Kim, Oh Yoen; Lee, Yonghee; Jeong, Tae-Sook; Sweeney, Gary; Jang, Yangsoo; Lee, Jong Ho			Circulating and PBMC Lp-PLA(2) Associate Differently with Oxidative Stress and Subclinical Inflammation in Nonobese Women (Menopausal Status)	PLOS ONE			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; CORONARY-ARTERY-DISEASE; INTERLEUKIN-6 GENE-EXPRESSION; PHOSPHOLIPASE A(2) ACTIVITY; C-REACTIVE PROTEIN; PLASMA PAF-ACETYLHYDROLASE; LOW-DENSITY-LIPOPROTEIN; MIDDLE-AGED MEN; RISK-FACTORS; LUDWIGSHAFEN RISK	Background: This study aimed to determine the association of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in circulation and peripheral blood mononuclear cells (PBMCs) with inflammatory and oxidative stress markers in nonobese women and according to menopausal status. Lp-PLA(2) activity, a marker for cardiovascular risk is associated with inflammation and oxidative stress. Methodology/Principal Findings: Eighty postmenopausal women (53.0 +/- 4.05 yr) and 96 premenopausal women (39.7 +/- 9.25 yr) participated in this study. Lp-PLA(2) activities, interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, and IL-1 beta in plasma as well as in PBMCs were measured. Plasma ox-LDL was also measured. Postmenopausal women demonstrated higher circulating levels of ox-LDL and IL-6, as well as IL-6, TNF-alpha, and IL-1 beta in PBMCs, than premenopausal women. In both groups, plasma Lp-PLA(2) activity positively correlated with Lp-PLA(2) activity in PBMCs and plasma ox-LDL. In premenopausal women, Lp-PLA(2) activities in plasma and PBMCs positively correlated with IL-6, TNF-alpha, and IL-1 beta in PBMCs. In postmenopausal women, plasma ox-LDL positively correlated with PBMC cytokine production. In subgroup analysis of postmenopausal women according to plasma ox-LDL level (median level: 48.715 U/L), a significant increase in Lp-PLA(2) activity in the plasma but not the PBMCs was found in the high ox-LDL subgroup. Plasma Lp-PLA(2) activity positively correlated with unstimulated PBMC Lp-PLA(2) activity in the low ox-LDL subgroup (r = 0.627, P<0.001), whereas in the high ox-LDL circulating Lp-PLA(2) activity positively correlated with plasma ox-LDL (r = 0.390, P = 0.014) but not with Lp-PLA(2) activity in PBMCs. Conclusions/Significance: The lack of relation between circulating Lp-PLA(2) activity and Lp-PLA(2) activity in PBMCs was found in postmenopausal women with high ox-LDL. This may indicate other sources of circulating Lp-PLA(2) activity except PBMC in postmenopausal women with high ox-LDL. We also demonstrated that circulating Lp-PLA(2) and PBMC secreted Lp-PLA(2) associate differently with markers of oxidative stress and sub clinical inflammation in nonobese women, particularly according to the menopausal states.	[Paik, Jean Kyung; Kim, Ji Young; Kim, Oh Yoen; Jang, Yangsoo; Lee, Jong Ho] Yonsei Univ, Res Inst Sci Aging, Seoul 120749, South Korea; [Paik, Jean Kyung; Kim, Ji Young; Kim, Oh Yoen; Lee, Yonghee; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea; [Jeong, Tae-Sook] Korea Res Inst Biosci & Biotechnol, Natl Res Lab Lipid Metab & Atherosclerosis, Taejon, South Korea; [Sweeney, Gary] Inst Pasteur Korea, Seoul, South Korea; [Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Jang, Yangsoo] Yonsei Univ, Coll Med, Div Cardiol, Seoul, South Korea; [Jang, Yangsoo] Yonsei Univ, Coll Med, Cardiovasc Genome Ctr, Seoul, South Korea; [Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Med Res Inst, Seoul, South Korea	Yonsei University; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Institut Pasteur Korea; York University - Canada; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Paik, JK (corresponding author), Yonsei Univ, Res Inst Sci Aging, Seoul 120749, South Korea.	jhleeb@yonsei.ac.kr	Jang, Yang Soo/D-4803-2012; Kim, Oh Yoen/AAA-6492-2022	Jang, Yangsoo/0000-0002-2169-3112	National Research Foundation, Ministry of Education, Science and Technology, Seoul, Korea [2010-0000317, 2010-0015017, M10642120002-06N4212-00210]	National Research Foundation, Ministry of Education, Science and Technology, Seoul, Korea	This work was supported by the National Research Foundation, Ministry of Education, Science and Technology (2010-0000317, 2010-0015017, and M10642120002-06N4212-00210), Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 1999, BIOCHEM BIOPH RES CO, V261, P511, DOI 10.1006/bbrc.1999.1066; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Brilakis ES, 2005, EUR HEART J, V26, P137, DOI 10.1093/eurheartj/ehi010; Caivano M, 2000, J IMMUNOL, V164, P3018, DOI 10.4049/jimmunol.164.6.3018; Carpenter KLH, 2001, FEBS LETT, V505, P357, DOI 10.1016/S0014-5793(01)02840-X; Caslake MJ, 2003, CURR OPIN LIPIDOL, V14, P347, DOI 10.1097/00041433-200308000-00002; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; Detopoulou P, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-19; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Gerber Y, 2006, ARTERIOSCL THROM VAS, V26, P2517, DOI 10.1161/01.ATV.0000240406.89440.0c; Hatoum IJ, 2010, AM J CLIN NUTR, V91, P786, DOI 10.3945/ajcn.2009.28870; Iribarren C, 2005, ARTERIOSCL THROM VAS, V25, P216, DOI 10.1161/01.ATV.0000148322.89911.44; Karabina SA, 2006, BBA-MOL CELL BIOL L, V1761, P1351, DOI 10.1016/j.bbalip.2006.05.008; Karasawa K, 2003, PROG LIPID RES, V42, P93, DOI 10.1016/S0163-7827(02)00049-8; Khuseyinova N, 2005, ATHEROSCLEROSIS, V182, P181, DOI 10.1016/j.atherosclerosis.2004.10.046; Kim JY, 2008, AM J CLIN NUTR, V88, P630, DOI 10.1093/ajcn/88.3.630; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; LIAPIKOS TA, 1994, BBA-LIPID LIPID MET, V1212, P353, DOI 10.1016/0005-2760(94)90210-0; Liu H, 2005, CYTOKINE, V31, P251, DOI 10.1016/j.cyto.2004.12.008; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Ninio E, 2005, CURR OPIN CLIN NUTR, V8, P123, DOI 10.1097/00075197-200503000-00004; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Paik JK, 2010, CLIN CHIM ACTA, V411, P486, DOI 10.1016/j.cca.2009.12.021; Papanicolaou DA, 2000, J CLIN ENDOCR METAB, V85, P1331, DOI 10.1210/jc.85.3.1331; Persson M, 2007, ATHEROSCLEROSIS, V190, P388, DOI 10.1016/j.atherosclerosis.2006.02.016; Rachon D, 2002, J ENDOCRINOL, V172, P387, DOI 10.1677/joe.0.1720387; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Silva IT, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-170; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; TARBET EB, 1991, J BIOL CHEM, V266, P16667; TSAOUSSIS V, 1994, J LIPID MEDIAT CELL, V9, P317; von Haehling S, 2003, INT J CARDIOL, V90, P197, DOI 10.1016/S0167-5273(02)00566-1; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Winkler K, 2005, CIRCULATION, V111, P980, DOI 10.1161/01.CIR.0000156457.35971.C8; Winkler K, 2007, CLIN CHEM, V53, P1440, DOI 10.1373/clinchem.2007.086298; Yang EH, 2006, ARTERIOSCL THROM VAS, V26, P106, DOI 10.1161/01.ATV.0000191655.87296.ab; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7	42	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29675	10.1371/journal.pone.0029675	http://dx.doi.org/10.1371/journal.pone.0029675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359537	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200006
J	van der Tol, A; Van Biesen, W; Van Laecke, S; Bogaerts, K; De Lombaert, K; Warrinnier, H; Vanholder, R				van der Tol, Arjan; Van Biesen, Wim; Van Laecke, Steven; Bogaerts, Kris; De Lombaert, Koen; Warrinnier, Hans; Vanholder, Raymond			Statin Use and the Presence of Microalbuminuria. Results from the ERICABEL Trial: A Non-Interventional Epidemiological Cohort Study	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; URINARY ALBUMIN EXCRETION; NORD-TRONDELAG HEALTH; CARDIOVASCULAR EVENTS; RENAL-DISEASE; ROSUVASTATIN; ATORVASTATIN; METAANALYSIS; CHOLESTEROL; SIMVASTATIN	Background: Microalbuminuria (MAU) is considered as a predictor or marker of cardiovascular and renal events. Statins are widely prescribed to reduce cardiovascular risk and to slow down progression of kidney disease. But statins may also generate tubular MAU. The current observational study evaluated the impact of statin use on the interpretation of MAU as a predictor or marker of cardiovascular or renal disease. Methodology/Principal Findings: We used cross-sectional data of ERICABEL, a cohort with 1,076 hypertensive patients. MAU was defined as albuminuria >= 20 mg/l. A propensity score was created to correct for "bias by indication" to receive a statin. As expected, subjects using statins vs. no statins had more cardiovascular risk factors, pointing to bias by indication. Statin users were more likely to have MAU (OR: 2.01, 95%CI: 1.34-3.01). The association between statin use and MAU remained significant after adjusting for the propensity to receive a statin based on cardiovascular risk factors (OR: 1.82, 95%CI: 1.14-2.91). Next to statin use, only diabetes (OR: 1.92, 95%CI: 1.00-3.66) and smoking (OR: 1.49, 95%CI: 0.99-2.26) were associated with MAU. Conclusions: Use of statins is independently associated with MAU, even after adjusting for bias by indication to receive a statin. In the hypothesis that this MAU is of tubular origin, statin use can result in incorrect labeling of subjects as having a predictor or marker of cardiovascular or renal risk. In addition, statin use affected the association of established cardiovascular risk factors with MAU, blurring the interpretation of multivariable analyses.	[van der Tol, Arjan; Van Biesen, Wim; Van Laecke, Steven; Vanholder, Raymond] Univ Hosp Ghent, Div Renal, Dept Internal Med, Ghent, Belgium; [Bogaerts, Kris] Interuniv Ctr Biostat & Stat Bioinformat, Louvain, Belgium; [De Lombaert, Koen; Warrinnier, Hans] Hoffman La Roche Ltd, Brussels, Belgium	Ghent University; Ghent University Hospital	van der Tol, A (corresponding author), Univ Hosp Ghent, Div Renal, Dept Internal Med, Ghent, Belgium.	Arjan.vandertol@ugent.be		Bogaerts, Kris/0000-0003-0188-8665; Van Laecke, Steven/0000-0001-7628-8491	F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	The funder of this study was F. Hoffmann-La Roche Ltd. The funder had a role in data collection because the ERICABEL study was initiated by F. Hoffmann-La Roche Ltd. The funder had no other role in the study design, analysis, decision to publish, or preparation of the manuscript.	Atthobari J, 2006, NEPHROL DIAL TRANSPL, V21, P3106, DOI 10.1093/ndt/gfl244; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barnieh L, 2011, J NEPHROLOGY; Bigazzi R, 1998, J HYPERTENS, V16, P1325, DOI 10.1097/00004872-199816090-00014; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Corna D, 2007, AM J NEPHROL, V27, P630, DOI 10.1159/000108359; DESLYPERE JP, 1990, LANCET, V336, P1453, DOI 10.1016/0140-6736(90)93164-K; Douglas K, 2006, ANN INTERN MED, V145, P117, DOI 10.7326/0003-4819-145-2-200607180-00009; Frank EH, 2009, HMISC HARRELL MISCER; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hallan H, 2003, SCAND J UROL NEPHROL, V37, P151, DOI 10.1080/00365590310008901; Heinze G., 2011, EUROPEAN HEART J; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Klausen KP, 2005, HYPERTENSION, V46, P33, DOI 10.1161/01.HYP.0000169153.78459.50; Knight SF, 2010, AM J PHYSIOL-RENAL, V298, pF86, DOI 10.1152/ajprenal.00351.2009; Kostapanos MS, 2007, J CARDIOVASC PHARM T, V12, P292, DOI 10.1177/1074248407306676; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; Mogensen CE, 1999, DIABETOLOGIA, V42, P263, DOI 10.1007/s001250051151; Park JK, 2009, J HYPERTENS, V27, P599, DOI 10.1097/HJH.0b013e32831ef369; Pollock CA, 2007, CURR OPIN NEPHROL HY, V16, P359, DOI 10.1097/MNH.0b013e3281eb9059; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2004, MULTIPLE IMPUTATION; Rutter MK, 2011, DIABETIC MED, V28, P100, DOI 10.1111/j.1464-5491.2010.03139.x; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Sidaway JE, 2004, J AM SOC NEPHROL, V15, P2258, DOI 10.1097/01.ASN.0000138236.82706.EE; Sorof J, 2006, DIABETES RES CLIN PR, V72, P81, DOI 10.1016/j.diabres.2005.09.004; Van der Tol A, 2011, ACTA CLIN BELG, V66, P171; van der Tol A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013328; van Zyl-Smit R, 2004, NEPHROL DIAL TRANSPL, V19, P3176, DOI 10.1093/ndt/gfh474; Verhulst A, 2004, J AM SOC NEPHROL, V15, P2249, DOI 10.1097/01.ASN.0000136778.32499.05; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6	33	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31639	10.1371/journal.pone.0031639	http://dx.doi.org/10.1371/journal.pone.0031639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359611	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200080
J	Inoue, S; Patil, R; Portilla-Arias, J; Ding, H; Konda, B; Espinoza, A; Mongayt, D; Markman, JL; Elramsisy, A; Phillips, HW; Black, KL; Holler, E; Ljubimova, JY				Inoue, Satoshi; Patil, Rameshwar; Portilla-Arias, Jose; Ding, Hui; Konda, Bindu; Espinoza, Andres; Mongayt, Dmitriy; Markman, Janet L.; Elramsisy, Adam; Phillips, H. Westley; Black, Keith L.; Holler, Eggehard; Ljubimova, Julia Y.			Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-CELLS; POLYMALIC ACID; IN-VITRO; ANTIBODY; ANTISENSE; LIPOSOMES; DELIVERY; TRANSFERRIN; APOPTOSIS	Treatment options for triple negative breast cancer (TNBC) are generally limited to cytotoxic chemotherapy. Recently, anti-epidermal growth factor receptor (EGFR) therapy has been introduced for TNBC patients. We engineered a novel nanobioconjugate based on a poly(beta-L-malic acid) (PMLA) nanoplatform for TNBC treatment. The nanobioconjugate carries anti-tumor nucleosome-specific monoclonal antibody (mAb) 2C5 to target breast cancer cells, anti-mouse transferrin receptor (TfR) antibody for drug delivery through the host endothelial system, and Morpholino antisense oligonucleotide (AON) to inhibit EGFR synthesis. The nanobioconjugates variants were: (1) P (BioPolymer) with AON, 2C5 and anti-TfR for tumor endothelial and cancer cell targeting, and EGFR suppression (P/AON/2C5/TfR), and (2) P with AON and 2C5 (P/AON/2C5). Controls included (3) P with 2C5 but without AON (P/2C5), (4) PBS, and (5) P with PEG and leucine ester (LOEt) for endosomal escape (P/mPEG/LOEt). Drugs were injected intravenously to MDA-MB-468 TNBC bearing mice. Tissue accumulation of injected nanobioconjugates labeled with Alexa Fluor 680 was examined by Xenogen IVIS 200 (live imaging) and confocal microscopy of tissue sections. Levels of EGFR, phosphorylated and total Akt in tumor samples were detected by western blotting. In vitro western blot showed that the leading nanobioconjugate P/AON/2C5/TfR inhibited EGFR synthesis significantly better than naked AON. In vivo imaging revealed that 2C5 increased drug-tumor accumulation. Significant tumor growth inhibition was observed in mice treated with the lead nanobioconjugate (1) [P = 0.03 vs. controls; P<0.05 vs. nanobioconjugate variant (2)]. Lead nanobioconjugate (1) also showed stronger inhibition of EGFR expression and Akt phosphorylation than other treatments. Treatment of TNBC with the new nanobioconjugate results in tumor growth arrest by inhibiting EGFR and its downstream signaling intermediate, phosphorylated Akt. The nanobioconjugate represents a new generation of nanodrugs for treatment of TNBC.	[Inoue, Satoshi; Patil, Rameshwar; Portilla-Arias, Jose; Ding, Hui; Konda, Bindu; Espinoza, Andres; Markman, Janet L.; Elramsisy, Adam; Phillips, H. Westley; Black, Keith L.; Holler, Eggehard; Ljubimova, Julia Y.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Mongayt, Dmitriy] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA	Cedars Sinai Medical Center; Northeastern University	Inoue, S (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.	ljubimovaj@cshs.org	Holler, Eggehard Josef/H-7408-2014; PORTILLA-ARIAS, JOSE/C-3223-2008	Holler, Eggehard Josef/0000-0001-8582-2190; PORTILLA-ARIAS, JOSE/0000-0003-1105-1842; Markman, Janet/0000-0003-4691-2964; Black, Keith/0000-0002-0546-4934	National Institutes of Health [R01 CA123495, R01 CA CA136841]; Winnick Family Foundation [M01 RR00425]; NATIONAL CANCER INSTITUTE [R01CA136841, R01CA123495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winnick Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health (R01 CA123495 and R01 CA CA136841) to JYL and the Winnick Family Foundation(M01 RR00425) to JYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Agrawal A, 2005, ENDOCR-RELAT CANCER, V12, pS135, DOI 10.1677/erc.1.01059; Atkinson RL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001447; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Baselga J, 2002, ONCOLOGIST, V7, P2; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054; BUSCH RK, 1994, CANCER LETT, V86, P151, DOI 10.1016/0304-3835(94)90073-6; Chandna P, 2010, PHARM RES-DORDR, V27, P2296, DOI 10.1007/s11095-010-0235-2; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Ding H, 2010, P NATL ACAD SCI USA, V107, P18143, DOI 10.1073/pnas.1003919107; El Bayoumil T, 2009, CLIN CANCER RES, V15, P1973, DOI 10.1158/1078-0432.CCR-08-2392; Elbayoumi TA, 2008, INT J PHARMACEUT, V357, P272, DOI 10.1016/j.ijpharm.2008.01.041; Elbayoumi TA, 2007, J LIPOSOME RES, V17, P1, DOI 10.1080/08982100601186474; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; Fujita M, 2007, J CONTROL RELEASE, V122, P356, DOI 10.1016/j.jconrel.2007.05.032; Fujita Manabu, 2006, Angiogenesis, V9, P183, DOI 10.1007/s10456-006-9046-9; Gasslmaier B, 1997, EUR J BIOCHEM, V250, P308, DOI 10.1111/j.1432-1033.1997.0308a.x; Gasslmaier B, 2000, EUR J BIOCHEM, V267, P5101, DOI 10.1046/j.1432-1327.2000.01573.x; Gupta B, 2005, J DRUG TARGET, V13, P337, DOI 10.1080/10611860500286239; Herbst RS, 2006, J CLIN ONCOL, V24, P190, DOI 10.1200/JCO.2005.04.8678; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Inoue S, 2005, MOL THER, V12, P707, DOI 10.1016/j.ymthe.2005.05.015; Inoue S, 2011, CANCER RES, V71, P1454, DOI 10.1158/0008-5472.CAN-10-3093; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kang CS, 2006, CANCER GENE THER, V13, P530, DOI 10.1038/sj.cgt.7700932; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Lee BS, 2006, BIOCONJUGATE CHEM, V17, P317, DOI 10.1021/bc0502457; Liu D, 2010, MED ONCOL; Liu X, 2008, CANCER GENE THER, V15, P126, DOI 10.1038/sj.cgt.7701111; Ljubimova JY, 2008, NANOMEDICINE-UK, V3, P247, DOI 10.2217/17435889.3.2.247; Ljubimova JY, 2008, CHEM-BIOL INTERACT, V171, P195, DOI 10.1016/j.cbi.2007.01.015; Lorenz MR, 2006, BIOMATERIALS, V27, P2820, DOI 10.1016/j.biomaterials.2005.12.022; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Modi S, 2006, CLIN BREAST CANCER, V7, P270, DOI 10.3816/CBC.2006.n.040; Nahta R, 2007, MOL CANCER THER, V6, P667, DOI 10.1158/1535-7163.MCT-06-0423; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Sekhon HS, 2008, LUNG CANCER, V60, P347, DOI 10.1016/j.lungcan.2007.10.028; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Vert M., 2002, BIOPOLYMERS A, V3a, P75; Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4; Wu B, 2010, GENE THER, V17, P132, DOI 10.1038/gt.2009.120; Xia CQ, 2001, PHARM RES-DORDR, V18, P191, DOI 10.1023/A:1011032502097	47	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31070	10.1371/journal.pone.0031070	http://dx.doi.org/10.1371/journal.pone.0031070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355336	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300036
J	Lafontaine, J; Rodier, F; Ouellet, V; Mes-Masson, AM				Lafontaine, Julie; Rodier, Francis; Ouellet, Veronique; Mes-Masson, Anne-Marie			Necdin, a p53-Target Gene, Is an Inhibitor of p53-Mediated Growth Arrest	PLOS ONE			English	Article							CELL-CYCLE ARREST; POLYOMAVIRUS LARGE; DNA METHYLTRANSFERASE; NUCLEAR-PROTEIN; TRANSCRIPTION FACTOR; SUPPRESSOR NECDIN; ZINC-BINDING; P53 PROTEIN; IN-VITRO; EXPRESSION	In vitro, cellular immortalization and transformation define a model for multistep carcinogenesis and current ongoing challenges include the identification of specific molecular events associated with steps along this oncogenic pathway. Here, using NIH3T3 cells, we identified transcriptionally related events associated with the expression of Polyomavirus Large-T antigen (PyLT), a potent viral oncogene. We propose that a subset of these alterations in gene expression may be related to the early events that contribute to carcinogenesis. The proposed tumor suppressor Necdin, known to be regulated by p53, was within a group of genes that was consistently upregulated in the presence of PyLT. While Necdin is induced following p53 activation with different genotoxic stresses, Necdin induction by PyLT did not involve p53 activation or the Rb-binding site of PyLT. Necdin depletion by shRNA conferred a proliferative advantage to NIH3T3 and PyLT-expressing NIH3T3 (NIHLT) cells. In contrast, our results demonstrate that although overexpression of Necdin induced a growth arrest in NIH3T3 and NIHLT cells, a growing population rapidly emerged from these arrested cells. This population no longer showed significant proliferation defects despite high Necdin expression. Moreover, we established that Necdin is a negative regulator of p53-mediated growth arrest induced by nutlin-3, suggesting that Necdin upregulation could contribute to the bypass of a p53-response in p53 wild type tumors. To support this, we characterized Necdin expression in low malignant potential ovarian cancer (LMP) where p53 mutations rarely occur. Elevated levels of Necdin expression were observed in LMP when compared to aggressive serous ovarian cancers. We propose that in some contexts, the constitutive expression of Necdin could contribute to cancer promotion by delaying appropriate p53 responses and potentially promote genomic instability.	[Lafontaine, Julie; Rodier, Francis; Ouellet, Veronique; Mes-Masson, Anne-Marie] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Lafontaine, Julie; Rodier, Francis; Ouellet, Veronique; Mes-Masson, Anne-Marie] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Rodier, Francis] Univ Montreal, Dept Radiol Radiooncol & Med Nucl, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Lafontaine, J (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada.	Anne-Marie.Mes-Masson@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Rodier, Francis/0000-0003-2523-309X	Canadian Institute of Health Research (CIHR) [MOP - 36056]; Fonds de recherche du Quebec - Sante; Institut du Cancer de Montreal; Institut du cancer de Montreal Canderel	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Institut du Cancer de Montreal; Institut du cancer de Montreal Canderel	This research was supported by a Canadian Institute of Health Research (CIHR) grant to A.-M.M.-M. (MOP - 36056) (http://www.cihr-irsc.gc.ca/). A.-M.M.-M. and F.R. are Scientists of the Centre de recherche du CHUM which receives funding from the Fonds de recherche du Quebec - Sante. Tumor banking was supported by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec (FRSQ) (http://www.frsq.gouv.qc.ca/en/index.shtml), affiliated with the Canadian Tumor Repository Network (CTRNet) (http://www.ctrnet.ca/). V.O. was supported by studentships from the CIHR and the Canderel fund of the Institut du Cancer de Montreal. J.L. is the recipient of an Institut du cancer de Montreal Canderel scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Andrieu D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-56; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Benjamin TL, 2001, VIROLOGY, V289, P167, DOI 10.1006/viro.2001.1124; Calabrese V, 2009, MOL CELL, V36, P754, DOI 10.1016/j.molcel.2009.09.044; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chapman EJ, 2008, MOL CANCER RES, V6, P1154, DOI 10.1158/1541-7786.MCR-07-2168; Chung JH, 2010, CELL CYCLE, V9, P2102, DOI 10.4161/cc.9.11.11849; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Desjardins P, 1997, VIRUS RES, V47, P85, DOI 10.1016/S0168-1702(96)01404-9; Dey D, 2002, J VIROL, V76, P9526, DOI 10.1128/JVI.76.18.9526-9532.2002; Dilworth S M, 1990, Semin Cancer Biol, V1, P407; Doherty J, 1997, ONCOGENE, V14, P1923, DOI 10.1038/sj.onc.1201025; Drakos E, 2007, CLIN CANCER RES, V13, P3380, DOI 10.1158/1078-0432.CCR-06-2581; DYSON N, 1990, J VIROL, V64, P1353, DOI 10.1128/JVI.64.3.1353-1356.1990; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; Flatt PM, 2000, MOL CELL BIOL, V20, P4210, DOI 10.1128/MCB.20.12.4210-4223.2000; Friedman ER, 2007, BIOCHEM BIOPH RES CO, V363, P113, DOI 10.1016/j.bbrc.2007.08.108; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Ghebranious N, 1998, ONCOGENE, V17, P3385, DOI 10.1038/sj.onc.1202573; GJORUP OV, 1994, P NATL ACAD SCI USA, V91, P12125, DOI 10.1073/pnas.91.25.12125; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARPER JW, 1993, CELL, V75, P805; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hu Y, 2002, J BIOL CHEM, V277, P44462, DOI 10.1074/jbc.M205784200; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; KAUTIAINEN TL, 1986, J BIOL CHEM, V261, P1594; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Koebel Martin, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800077X; Korotchkina LG, AGING ALBANY NY, V2, P344; Kruger M, 2004, EMBO J, V23, P4353, DOI 10.1038/sj.emboj.7600431; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kurokawa K, 1999, ONCOGENE, V18, P2718, DOI 10.1038/sj.onc.1202628; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Lane DP, 1953, AGING-US, V2, P748; LAROSE A, 1991, J VIROL, V65, P2308, DOI 10.1128/JVI.65.5.2308-2313.1991; LEBEL M, 1995, CELL GROWTH DIFFER, V6, P1591; LEBEL M, 1994, EXP CELL RES, V213, P12, DOI 10.1006/excr.1994.1167; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; LOEBER G, 1989, J VIROL, V63, P94, DOI 10.1128/JVI.63.1.94-100.1989; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marti A, 1999, J GEN VIROL, V80, P2917, DOI 10.1099/0022-1317-80-11-2917; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; McCabe M, 2006, ONCOGENE, V25, P2727, DOI 10.1038/sj.onc.1209266; McCabe MT, 2006, CANCER RES, V66, P385, DOI 10.1158/0008-5472.CAN-05-2020; MCINTYRE MC, 1993, J VIROL, V67, P3142, DOI 10.1128/JVI.67.6.3142-3150.1993; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Moon HE, 2005, FEBS LETT, V579, P3797, DOI 10.1016/j.febslet.2005.05.072; Murphy NC, 2008, BRIT J CANCER, V98, P537, DOI 10.1038/sj.bjc.6604177; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilon AA, 1996, J VIROL, V70, P4457, DOI 10.1128/JVI.70.7.4457-4465.1996; Pilon AA, 1996, VIRUS RES, V46, P171, DOI 10.1016/S0168-1702(96)01382-2; RASSOULZADEGAN M, 1982, NATURE, V300, P713, DOI 10.1038/300713a0; Rodier F, 2000, ONCOGENE, V19, P6261, DOI 10.1038/sj.onc.1204015; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; ROSE PE, 1995, J VIROL, V69, P2842, DOI 10.1128/JVI.69.5.2842-2849.1995; RUBIN H, 1989, P NATL ACAD SCI USA, V86, P1860, DOI 10.1073/pnas.86.6.1860; Rubin H, 2001, CANCER RES, V61, P799; Rudlowski C, 2006, INT J GYNECOL CANCER, V16, P183, DOI 10.1111/j.1525-1438.2006.00307.x; SCHLEGEL R, 1978, CELL, V14, P587, DOI 10.1016/0092-8674(78)90244-1; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Shields JM, 2002, J BIOL CHEM, V277, P9790, DOI 10.1074/jbc.M110086200; SILVER J, 1978, CELL, V15, P485, DOI 10.1016/0092-8674(78)90018-1; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; STEWART N, 1995, ONCOGENE, V10, P109; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; TISHLER RB, 1993, CANCER RES, V53, P2212; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Trinh DLN, 2010, ONCOTARGET, V1, P396, DOI 10.18632/oncotarget.174; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; Wang L, 2011, WORLD J GASTROENTERO, V17, P1434, DOI 10.3748/wjg.v17.i11.1434; Whiteside TL, 2010, J ALLERGY CLIN IMMUN, V125, pS272, DOI 10.1016/j.jaci.2009.09.045; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-93	108	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31916	10.1371/journal.pone.0031916	http://dx.doi.org/10.1371/journal.pone.0031916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355404	gold, Green Submitted, Green Published			2022-12-27	WOS:000302741300104
J	Su, MW; Tung, KY; Liang, PH; Tsai, CH; Kuo, NW; Lee, YL				Su, Ming-Wei; Tung, Kuan-Yen; Liang, Pi-Hui; Tsai, Ching-Hui; Kuo, Nai-Wei; Lee, Yungling Leo			Gene-Gene and Gene-Environmental Interactions of Childhood Asthma: A Multifactor Dimension Reduction Approach	PLOS ONE			English	Article							BODY-MASS INDEX; GLUTATHIONE-S-TRANSFERASE; SERUM IGE LEVELS; OXIDATIVE STRESS; INTERLEUKIN-4 RECEPTOR; BRONCHITIC SYMPTOMS; AIR-POLLUTION; ATOPIC ASTHMA; OBESITY; CHILDREN	Background: The importance of gene-gene and gene-environment interactions on asthma is well documented in literature, but a systematic analysis on the interaction between various genetic and environmental factors is still lacking. Methodology/Principal Findings: We conducted a population-based, case-control study comprised of seventh-grade children from 14 Taiwanese communities. A total of 235 asthmatic cases and 1,310 non-asthmatic controls were selected for DNA collection and genotyping. We examined the gene-gene and gene-environment interactions between 17 single-nucleotide polymorphisms in antioxidative, inflammatory and obesity-related genes, and childhood asthma. Environmental exposures and disease status were obtained from parental questionnaires. The model-free and non-parametrical multifactor dimensionality reduction (MDR) method was used for the analysis. A three-way gene-gene interaction was elucidated between the gene coding glutathione S-transferase P (GSTP1), the gene coding interleukin-4 receptor alpha chain (IL4Ra) and the gene coding insulin induced gene 2 (INSIG2) on the risk of lifetime asthma. The testing-balanced accuracy on asthma was 57.83% with a cross-validation consistency of 10 out of 10. The interaction of preterm birth and indoor dampness had the highest training-balanced accuracy at 59.09%. Indoor dampness also interacted with many genes, including IL13, beta-2 adrenergic receptor (ADRB2), signal transducer and activator of transcription 6 (STAT6). We also used likelihood ratio tests for interaction and chi-square tests to validate our results and all tests showed statistical significance. Conclusions/Significance: The results of this study suggest that GSTP1, INSIG2 and IL4Ra may influence the lifetime asthma susceptibility through gene-gene interactions in schoolchildren. Home dampness combined with each one of the genes STAT6, IL13 and ADRB2 could raise the asthma risk.	[Su, Ming-Wei; Tung, Kuan-Yen; Tsai, Ching-Hui; Kuo, Nai-Wei; Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Tung, Kuan-Yen; Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Liang, Pi-Hui] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Su, MW (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	leolee@ntu.edu.tw	Lee, Yungling/S-7011-2018; Liang, Pi-hui/D-4166-2012	Lee, Yungling/0000-0002-2234-9479; Liang, Pi-hui/0000-0001-6668-4642	Taiwan National Science Council [98-2314-B-002-138-MY3, 96-2314-B-006-053, 95-2314-B-006-103]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants #98-2314-B-002-138-MY3, #96-2314-B-006-053 and #95-2314-B-006-103 from Taiwan National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Chan IHS, 2006, J ALLERGY CLIN IMMUN, V117, P127, DOI 10.1016/j.jaci.2005.09.031; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; FRYER AA, 1986, BIOCHIM BIOPHYS ACTA, V883, P448, DOI 10.1016/0304-4165(86)90283-7; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Greene CS, 2010, BIOCOMPUT-PAC SYM, P327; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hancox RJ, 2005, AM J RESP CRIT CARE, V171, P440, DOI 10.1164/rccm.200405-623OC; Heijink IH, 2002, IMMUNOLOGY, V107, P316, DOI 10.1046/j.1365-2567.2002.01501.x; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Husemoen LLN, 2008, ALLERGY, V63, P575, DOI 10.1111/j.1398-9995.2007.01613.x; Hwang BF, 2010, CHEST, V138, P956, DOI 10.1378/chest.09-2600; Islam T, 2007, THORAX, V62, P957, DOI 10.1136/thx.2007.078964; Jaakkola JJK, 2005, ENVIRON HEALTH PERSP, V113, P357, DOI 10.1289/ehp.7242; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Komakula S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-32; Lawson Joshua A, 2005, Can Respir J, V12, P321; McLeish S, 2007, ARCH DIS CHILD, V92, P1032, DOI 10.1136/adc.2006.112185; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Moore JH, 2010, ADV GENET, V72, P101, DOI [10.1016/B978-0-12-380862-2.00005-9, 10.1016/S0065-2660(10)72005-8]; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Motsinger AA, 2006, GENET EPIDEMIOL, V30, P546, DOI 10.1002/gepi.20166; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Salam MT, 2007, THORAX, V62, P1050, DOI 10.1136/thx.2007.080127; Sandford AJ, 2000, J ALLERGY CLIN IMMUN, V106, P135, DOI 10.1067/mai.2000.107926; Schedel M, 2004, J ALLERGY CLIN IMMUN, V114, P1100, DOI 10.1016/j.jaci.2004.07.048; Shaheen SO, 1999, THORAX, V54, P396, DOI 10.1136/thx.54.5.396; Shin HD, 2004, HUM MOL GENET, V13, P397, DOI 10.1093/hmg/ddh036; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Silverstein MD, 2001, J PEDIATR-US, V139, P278, DOI 10.1067/mpd.2001.115573; Simoni M, 2005, OCCUP ENVIRON MED, V62, P616, DOI 10.1136/oem.2004.018291; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; Soares ML, 2005, HUM MOL GENET, V14, P543, DOI 10.1093/hmg/ddi051; Spee-van der Wekke J, 1998, J EPIDEMIOL COMMUN H, V52, P359, DOI 10.1136/jech.52.6.359; Sutherland ER, 2008, IMMUNOL ALLERGY CLIN, V28, P589, DOI 10.1016/j.iac.2008.03.003; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; ten Have WHO, 2007, CLIN EXP ALLERGY, V37, P1827, DOI 10.1111/j.1365-2222.2007.02841.x; Trabetti E, 1999, J MED GENET, V36, P323; Tsai CH, 2011, OCCUP ENV MED; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Tung KY, 2010, CHEST; van Rooyen JM, 2008, EXP CLIN ENDOCR DIAB, V116, P236, DOI 10.1055/s-2007-992785; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835; Wang WH, PULMONARY F IN PRESS; Weiss K B, 1994, Pediatr Allergy Immunol, V5, P7, DOI 10.1111/j.1399-3038.1994.tb00341.x; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; White SR, 2010, AM J PHYSIOL-LUNG C, V299, pL681, DOI 10.1152/ajplung.00422.2009; Wills-Karp M, 2003, CURR OPIN PULM MED, V9, P21, DOI 10.1097/00063198-200301000-00004	59	46	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30694	10.1371/journal.pone.0030694	http://dx.doi.org/10.1371/journal.pone.0030694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355322	Green Submitted, gold, Green Published			2022-12-27	WOS:000302741300022
J	Menon, R; Yu, J; Basanta-Henry, P; Brou, L; Berga, SL; Fortunato, SJ; Taylor, RN				Menon, Ramkumar; Yu, Jie; Basanta-Henry, Patrice; Brou, Lina; Berga, Sarah L.; Fortunato, Stephen J.; Taylor, Robert N.			Short Fetal Leukocyte Telomere Length and Preterm Prelabor Rupture of the Membranes	PLOS ONE			English	Article							PREMATURE RUPTURE; OXIDATIVE STRESS; QUANTITATIVE PCR; INFECTION; LABOR; ATTRITION; BIOMARKER; MORTALITY; SEQUENCE; ENZYMES	Background: Rupture of the fetal membranes is a common harbinger of imminent labor and delivery. Telomere shortening is a surrogate for oxidative stress (OS) and senescence. Fetal leukocyte and placental membrane DNA telomere lengths were evaluated to determine their association with preterm prelabor rupture of the membranes (pPROM) or spontaneous preterm births with intact membranes (PTB), compared to term birth. Methods: Telomere lengths were quantified in cord blood leukocytes (n = 133) from three major groups: 1) pPROM (n = 28), 2) PTB (n = 69) and 3) uncomplicated full term births (controls, n = 35), using real-time quantitative PCR. Placental membrane specimens (n = 18) were used to correlate fetal leukocyte and placental telomere lengths. Telomere length differences among the groups were analyzed by ANOVA. Pearson correlation coefficients determined relationships between leukocyte and placental membrane telomere lengths. Results: In pregnancies with intact membranes, fetal leukocyte telomere length was inversely proportional to gestational age. The mean telomere length decreased as gestation progressed, with the shortest at term. pPROM had telomere lengths (9962 +/- 3124 bp) that were significantly shorter than gestational age-matched PTB (11546 +/- 4348 bp, p = 0.04), but comparable to term births (9011 +/- 2497 bp, p = 0.31). Secondary analyses revealed no effects of race (African American vs. Caucasian) or intraamniotic infection on telomere length. A strong Pearson's correlation was noted between fetal leukocyte and placental membrane telomere lengths (rho = 0.77; p<0.01). Conclusions: Fetal leukocyte telomere length is reduced in pPROM compared to PTB but is similar to term births. pPROM represents a placental membrane disease likely mediated by OS-induced senescence.	[Menon, Ramkumar] Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX USA; [Yu, Jie; Basanta-Henry, Patrice; Berga, Sarah L.; Taylor, Robert N.] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Yu, Jie; Berga, Sarah L.; Taylor, Robert N.] Wake Forest Univ, Bowman Gray Sch Med, Dept Obstet & Gynecol, Winston Salem, NC 27103 USA; [Brou, Lina] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Fortunato, Stephen J.] Perinatal Res Ctr, Nashville, TN USA	University of Texas System; University of Texas Medical Branch Galveston; Emory University; Wake Forest University; Wake Forest Baptist Medical Center; Emory University	Menon, R (corresponding author), Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX USA.	ram.menon@utmb.edu	Fortunato, Stephen J/L-7545-2013					Athayde N, 1998, AM J OBSTET GYNECOL, V179, P1248, DOI 10.1016/S0002-9378(98)70141-3; Babizhayev MA, 2010, TELOMERE LENGTH IS B; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Fortunato SJ, 1997, AM J OBSTET GYNECOL, V177, P731, DOI 10.1016/S0002-9378(97)70260-6; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gomez R, 1997, INFECT DIS CLIN N AM, V11, P135, DOI 10.1016/S0891-5520(05)70347-0; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hayflick L, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1180; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Menon R, 2006, AM J OBSTET GYNECOL, V194, P1609, DOI 10.1016/j.ajog.2006.02.052; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Menon R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-62; Mercer BM, 1997, INFECT DIS CLIN N AM, V11, P177, DOI 10.1016/S0891-5520(05)70348-2; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; VadilloOrtega F, 1996, AM J OBSTET GYNECOL, V174, P1371, DOI 10.1016/S0002-9378(96)70687-7	31	108	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31136	10.1371/journal.pone.0031136	http://dx.doi.org/10.1371/journal.pone.0031136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348044	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900024
J	Sinha, R; Kundrotas, PJ; Vakser, IA				Sinha, Rohita; Kundrotas, Petras J.; Vakser, Ilya A.			Protein Docking by the Interface Structure Similarity: How Much Structure Is Needed?	PLOS ONE			English	Article							PREDICTING 3D STRUCTURES; BINDING-SITES; FUNCTIONAL SITES; SEQUENCE; CONSERVATION; RECOGNITION; COMPLEXES; ALGORITHM; ALIGNMENTS; CAPRI	The increasing availability of co-crystallized protein-protein complexes provides an opportunity to use template-based modeling for protein-protein docking. Structure alignment techniques are useful in detection of remote target-template similarities. The size of the structure involved in the alignment is important for the success in modeling. This paper describes a systematic large-scale study to find the optimal definition/size of the interfaces for the structure alignment-based docking applications. The results showed that structural areas corresponding to the cutoff values <12 angstrom across the interface inadequately represent structural details of the interfaces. With the increase of the cutoff beyond 12 angstrom, the success rate for the benchmark set of 99 protein complexes, did not increase significantly for higher accuracy models, and decreased for lower-accuracy models. The 12 angstrom cutoff was optimal in our interface alignment-based docking, and a likely best choice for the large-scale (e. g., on the scale of the entire genome) applications to protein interaction networks. The results provide guidelines for the docking approaches, including high-throughput applications to modeled structures.	[Sinha, Rohita; Kundrotas, Petras J.; Vakser, Ilya A.] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Vakser, Ilya A.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Sinha, R (corresponding author), Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA.	pkundro@ku.edu; vakser@ku.edu			National Institutes of Health [R01 GM074255]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM074255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki AK, 2004, BIOINFORMATICS, V20, P1087, DOI 10.1093/bioinformatics/bth044; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Binkowski TA, 2005, PROTEIN SCI, V14, P2972, DOI 10.1110/ps.051759005; Cammer SA, 2003, J MOL BIOL, V334, P387, DOI 10.1016/j.jmb.2003.09.062; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Douguet D, 2006, BIOINFORMATICS, V22, P2612, DOI 10.1093/bioinformatics/btl447; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Fetrow JS, 2001, PROTEIN SCI, V10, P1005, DOI 10.1110/ps.49201; Gao M, 2011, PROTEINS, V79, P1623, DOI 10.1002/prot.22987; Gao Y, 2007, PROTEINS, V69, P845, DOI 10.1002/prot.21714; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gunther S, 2007, PROTEINS, V69, P839, DOI 10.1002/prot.21746; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hunjan J, 2008, PROTEINS, V72, P344, DOI 10.1002/prot.21930; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Kundrotas PJ, 2008, INT J BIOL MACROMOL, V43, P198, DOI 10.1016/j.ijbiomac.2008.05.004; Kundrotas PJ, 2006, BBA-PROTEINS PROTEOM, V1764, P1498, DOI 10.1016/j.bbapap.2006.08.002; Kundrotas PJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000727; La D, 2009, BIOINFORMATICS, V25, P2843, DOI 10.1093/bioinformatics/btp542; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; MITCHELL EM, 1990, J MOL BIOL, V212, P151, DOI 10.1016/0022-2836(90)90312-A; Nicola G, 2007, BIOINFORMATICS, V23, P789, DOI 10.1093/bioinformatics/btm018; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ogmen U, 2005, NUCLEIC ACIDS RES, V33, pW331, DOI 10.1093/nar/gki585; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Rossi A, 2006, PROTEIN SCI, V15, P2366, DOI 10.1110/ps.062247506; Russell RB, 2004, CURR OPIN STRUC BIOL, V14, P313, DOI 10.1016/j.sbi.2004.04.006; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Sinha R, 2010, PROTEINS, V78, P3235, DOI 10.1002/prot.22812; Stark A, 2004, STRUCTURE, V12, P1405, DOI 10.1016/j.str.2004.05.012; Tovchigrechko A, 2002, PROTEIN SCI, V11, P1888, DOI 10.1110/ps.4730102; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Tuncbag N, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035006; Vakser IA, 2008, CURR PHARM BIOTECHNO, V9, P57, DOI 10.2174/138920108783955209; Wilkins AD, 2010, PROTEIN SCI, V19, P1296, DOI 10.1002/pro.406; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	50	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31349	10.1371/journal.pone.0031349	http://dx.doi.org/10.1371/journal.pone.0031349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348074	Green Published, gold			2022-12-27	WOS:000302733900043
J	Thuret, S; Thallmair, M; Horky, LL; Gage, FH				Thuret, Sandrine; Thallmair, Michaela; Horky, Laura L.; Gage, Fred H.			Enhanced Functional Recovery in MRL/MpJ Mice after Spinal Cord Dorsal Hemisection	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR BETA-1; ADULT-RAT; GENE-EXPRESSION; AXONAL REGENERATION; X-IRRADIATION; MRL MICE; PROTECTIVE AUTOIMMUNITY; CELLULAR-LOCALIZATION; ACTIVE IMMUNIZATION	Adult MRL/MpJ mice have been shown to possess unique regeneration capabilities. They are able to heal an ear-punched hole or an injured heart with normal tissue architecture and without scar formation. Here we present functional and histological evidence for enhanced recovery following spinal cord injury (SCI) in MRL/MpJ mice. A control group (C57BL/6 mice) and MRL/MpJ mice underwent a dorsal hemisection at T9 (thoracic vertebra 9). Our data show that MRL/MpJ mice recovered motor function significantly faster and more completely. We observed enhanced regeneration of the corticospinal tract (CST). Furthermore, we observed a reduced astrocytic response and fewer micro-cavities at the injury site, which appear to create a more growth-permissive environment for the injured axons. Our data suggest that the reduced astrocytic response is in part due to a lower lesion-induced increase of cell proliferation post-SCI, and a reduced astrocytic differentiation of the proliferating cells. Interestingly, we also found an increased number of proliferating microglia, which could be involved in the MRL/MpJ spinal cord repair mechanisms. Finally, to evaluate the molecular basis of faster spinal cord repair, we examined the difference in gene expression changes in MRL/MpJ and C57BL/6 mice after SCI. Our microarray data support our histological findings and reveal a transcriptional profile associated with a more efficient spinal cord repair in MRL/MpJ mice.	[Thuret, Sandrine; Thallmair, Michaela; Horky, Laura L.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Thuret, S (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	sandrine.1.thuret@kcl.ac.uk; gage@salk.edu	Thuret, Sandrine/Y-5784-2019	Thuret, Sandrine/0000-0003-1260-8083	Paralyzed Veterans of America Spinal Cord Research Foundation; Paralysis Project of America; Deutsche Forschungsgemeinschaft; Christopher and Dana Reeve Foundation	Paralyzed Veterans of America Spinal Cord Research Foundation; Paralysis Project of America; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Christopher and Dana Reeve Foundation	ST was supported by the Paralyzed Veterans of America Spinal Cord Research Foundation (www.pva.org) and the Paralysis Project of America (www.paralysisproject.org). MT was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de/). Additional support was provided by the Christopher and Dana Reeve Foundation (www.christopherreeve.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Aimone JB, 2004, J NEUROSCI METH, V135, P27, DOI 10.1016/j.jneumeth.2003.11.016; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Blankenhorn EP, 2003, MAMM GENOME, V14, P250, DOI 10.1007/s00335-002-2222-3; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Choubey D, 1997, ONCOGENE, V15, P291, DOI 10.1038/sj.onc.1201184; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Datta B, 1998, MOL CELL BIOL, V18, P1074, DOI 10.1128/MCB.18.2.1074; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davis TA, 2005, BLOOD CELL MOL DIS, V34, P17, DOI 10.1016/j.bcmd.2004.10.001; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Ellis RC, 2005, EXP NEUROL, V193, P19, DOI 10.1016/j.expneurol.2004.11.034; Ellis RC, 2004, J NEUROCHEM, V88, P689, DOI 10.1046/j.1471-4159.2003.02197.x; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fitch MT, 1999, J NEUROSCI, V19, P8182; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.0.CO;2-J; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Gourevitch DL, 2009, WOUND REPAIR REGEN, V17, P447, DOI 10.1111/j.1524-475X.2009.00492.x; Hampton DW, 2004, NEUROSCIENCE, V127, P821, DOI 10.1016/j.neuroscience.2004.05.057; Hashimoto M, 2005, ACTA NEUROPATHOL, V109, P165, DOI 10.1007/s00401-004-0926-z; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Heber-Katz E, 2004, WOUND REPAIR REGEN, V12, P384, DOI 10.1111/j.1067-1927.2004.012308.x; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; HENRICHNOACK P, 1996, STROKE, V27, P1615; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Ibarra A, 2004, EUR J NEUROSCI, V19, P2984, DOI 10.1111/j.0953-816X.2004.03402.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; King VR, 2004, NEUROSCIENCE, V126, P173, DOI 10.1016/j.neuroscience.2004.03.035; Kostyk SK, 2008, NEUROSCIENCE, V156, P498, DOI 10.1016/j.neuroscience.2008.08.013; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Li XM, 2001, HEREDITY, V86, P668, DOI 10.1046/j.1365-2540.2001.00879.x; Li XM, 2001, MAMM GENOME, V12, P52, DOI 10.1007/s003350010230; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; Masinde G, 2005, BIOCHEM BIOPH RES CO, V330, P117, DOI 10.1016/j.bbrc.2005.02.143; Masinde GL, 2001, GENOME RES, V11, P2027, DOI 10.1101/gr.203701; McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Min W, 1996, MOL CELL BIOL, V16, P359; Mittelbronn M, 2001, ACTA NEUROPATHOL, V101, P249; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; Rajnoch C, 2003, DEV DYNAM, V226, P388, DOI 10.1002/dvdy.10242; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Ridet JL, 2000, EXP NEUROL, V161, P1, DOI 10.1006/exnr.1999.7206; Schmitt Caroline, 2006, Spine J, V6, P113, DOI 10.1016/j.spinee.2005.05.379; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Thuret S, 2009, HIPPOCAMPUS, V19, P658, DOI 10.1002/hipo.20550; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Wang H, 1999, GENOMICS, V60, P281, DOI 10.1006/geno.1999.5923; Whiteside G, 1998, BRAIN RES PROTOC, V2, P160, DOI 10.1016/S1385-299X(97)00032-9; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Zeman RJ, 2001, EXP NEUROL, V172, P228, DOI 10.1006/exnr.2001.7803; Zhang SX, 2005, HISTOL HISTOPATHOL, V20, P519, DOI 10.14670/HH-20.519	85	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30904	10.1371/journal.pone.0030904	http://dx.doi.org/10.1371/journal.pone.0030904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348029	Green Published, gold			2022-12-27	WOS:000302733900017
J	Yu, SW; Liao, FX; Wang, FM; Wen, WW; Li, JJ; Mei, HW; Luo, LJ				Yu, Shunwu; Liao, Fengxian; Wang, Feiming; Wen, Weiwei; Li, Jiajia; Mei, Hanwei; Luo, Lijun			Identification of Rice Transcription Factors Associated with Drought Tolerance Using the Ecotilling Method	PLOS ONE			English	Article							CONTRASTING MOISTURE REGIMES; INDUCED POINT MUTATIONS; GENETIC-VARIATION; FREEZING TOLERANCE; SALT TOLERANCE; ORYZA-SATIVA; MAPPING QTLS; INBRED LINES; UPLAND RICE; ARABIDOPSIS	The drought tolerance (DT) of plants is a complex quantitative trait. Under natural and artificial selection, drought tolerance represents the crop survival ability and production capacity under drought conditions (Luo, 2010). To understand the regulation mechanism of varied drought tolerance among rice genotypes, 95 diverse rice landraces or varieties were evaluated within a field screen facility based on the 'line-source soil moisture gradient', and their resistance varied from extremely resistant to sensitive. The method of Ecotype Targeting Induced Local Lesions in Genomes (Ecotilling) was used to analyze the diversity in the promoters of 24 transcription factor families. The bands separated by electrophoresis using Ecotilling were converted into molecular markers. STRUCTURE analysis revealed a value of K = 2, namely, the population with two subgroups (i.e., indica and japonica), which coincided very well with the UPGMA clusters (NTSYS-pc software) using distance-based analysis and InDel markers. Then the association analysis between the promoter diversity of these transcription factors and the DT index/level of each variety was performed. The results showed that three genes were associated with the DT index and that five genes were associated with the DT level. The sequences of these associated genes are complex and variable, especially at approximately 1000 bp upstream of the transcription initiation sites. The study illuminated that association analysis aimed at Ecotilling diversity of natural groups could facilitate the isolation of rice genes related to complex quantitative traits.	[Yu, Shunwu; Liao, Fengxian; Wang, Feiming; Wen, Weiwei; Li, Jiajia; Mei, Hanwei; Luo, Lijun] Shanghai Acad Agr Sci, Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China; [Luo, Lijun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Shanghai Academy of Agricultural Sciences; Huazhong Agricultural University	Yu, SW (corresponding author), Shanghai Acad Agr Sci, Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China.	lijun@sagc.org.cn	li, jia/GVT-7587-2022; Wen, Weiwei/AAU-5240-2021		National Natural Science Foundation of China [30830071]; China National High-Tech Program (863) [2006AA02Z115, 2010AA101806]; National Key Technologies Research and Development Program [2008ZX08001-003]; Shanghai Municipal Science and Technology Commission [2009DJ1400501]; Shanghai Science and Technology Talent Project [11XD1404300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National High-Tech Program (863)(National High Technology Research and Development Program of China); National Key Technologies Research and Development Program(National Key Technology R&D Program); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Science and Technology Talent Project	This work was supported by the National Natural Science Foundation of China (Grant No: 30830071), the China National High-Tech Program (863) (Grant No: 2006AA02Z115), the National Key Technologies Research and Development Program (Grant No: 2008ZX08001-003), the Key Basic Research Project of Shanghai Municipal Science and Technology Commission (Grant No: 2009DJ1400501), the Shanghai Science and Technology Talent Project (Grant No: 11XD1404300) and the China National High-Tech Program (863) (Grant No: 2010AA101806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; Gady ALF, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-13; [高凤华 Gao F H], 2009, [科学通报, Chinese Science Bulletin], V54, P2305; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ishimaru K, 2001, PLANT PHYSIOL BIOCH, V39, P173, DOI 10.1016/S0981-9428(00)01232-8; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liao F, 2009, MODERN AGR SCI, V16, P1; Liu HY, 2005, CHINESE SCI BULL, V50, P317, DOI 10.1360/982004-619; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Price AH, 2002, FIELD CROP RES, V76, P11, DOI 10.1016/S0378-4290(02)00012-6; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Sun MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018385; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Wang H.H., 2004, RESILIENT CROPS WATE, P75; Wen WW, 2009, THEOR APPL GENET, V119, P459, DOI 10.1007/s00122-009-1052-z; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu X, 2005, MOL PLANT BREED, V3, P634; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062	49	37	39	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30765	10.1371/journal.pone.0030765	http://dx.doi.org/10.1371/journal.pone.0030765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348023	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900013
J	Orliac, MJ; Argot, C; Gilissen, E				Orliac, Maeva J.; Argot, Christine; Gilissen, Emmanuel			Digital Cranial Endocast of Hyopsodus (Mammalia, "Condylarthra''): A Case of Paleogene Terrestrial Echolocation?	PLOS ONE			English	Article							EVOLUTION; BRAIN; SHREW; SPECIALIZATIONS; INSECTIVORA; PALEOCENE; PRIMATES	We here describe the endocranial cast of the Eocene archaic ungulate Hyopsodus lepidus AMNH 143783 (Bridgerian, North America) reconstructed from X-ray computed microtomography data. This represents the first complete cranial endocast known for Hyopsodontinae. The Hyopsodus endocast is compared to other known "condylarthran'' endocasts, i. e. those of Pleuraspidotherium (Pleuraspidotheriidae), Arctocyon (Arctocyonidae), Meniscotherium (Meniscotheriidae), Phenacodus (Phenacodontidae), as well as to basal perissodactyls (Hyracotherium) and artiodactyls (Cebochoerus, Homacodon). Hyopsodus presents one of the highest encephalization quotients of archaic ungulates and shows an "advanced version'' of the basal ungulate brain pattern, with a mosaic of archaic characters such as large olfactory bulbs, weak ventral expansion of the neopallium, and absence of neopallium fissuration, as well as more specialized ones such as the relative reduction of the cerebellum compared to cerebrum or the enlargement of the inferior colliculus. As in other archaic ungulates, Hyopsodus midbrain exposure is important, but it exhibits a dorsally protruding largely developed inferior colliculus, a feature unique among "Condylarthra''. A potential correlation between the development of the inferior colliculus in Hyopsodus and the use of terrestrial echolocation as observed in extant tenrecs and shrews is discussed. The detailed analysis of the overall morphology of the postcranial skeleton of Hyopsodus indicates a nimble, fast moving animal that likely lived in burrows. This would be compatible with terrestrial echolocation used by the animal to investigate subterranean habitat and/or to minimize predation during nocturnal exploration of the environment.	[Orliac, Maeva J.] Univ Montpellier 2, ISE M UMR 5554, Montpellier, France; [Argot, Christine] Museum Natl Hist Nat, UMR CR2P 7207, Paris, France; [Gilissen, Emmanuel] Royal Museum Cent Afr, Dept African Zool, Tervuren, Belgium; [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, Brussels, Belgium; [Gilissen, Emmanuel] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Royal Museum for Central Africa; Universite Libre de Bruxelles; University of Arkansas System; University of Arkansas Fayetteville	Orliac, MJ (corresponding author), Univ Montpellier 2, ISE M UMR 5554, Montpellier, France.	maeva.orliac@univ-montp2.fr	Orliac, Maeva J/ABB-3310-2021	Orliac, Maeva J/0000-0002-8922-8356	ANR (ERC) [ANR-08-JCJC-0017-01]	ANR (ERC)(French National Research Agency (ANR))	This work has been conducted with the support of the ANR (ERC programme Palasiafrica (ANR-08-JCJC-0017-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 1999, EVOLVING BRAINS, P98; Archibald J. David, 1998, P292; BARTON RA, 1995, PHILOS T ROY SOC B, V348, P381, DOI 10.1098/rstb.1995.0076; Bottorff W., 1995, THRINAXODON DIGITAL; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; BUCHLER ER, 1976, ANIM BEHAV, V24, P858, DOI 10.1016/S0003-3472(76)80016-4; BUTLER AB, 1996, COMP VERTEBRATE NEUR, P514; Casseday JH, 2002, SPR HDB AUD, V15, P238; Catania KC, 2005, ANAT REC PART A, V287A, P1038, DOI 10.1002/ar.a.20265; Catania KC, 2000, BRAIN BEHAV EVOLUT, V55, P311, DOI 10.1159/000006666; Catania KC, 2006, CURR OPIN NEUROBIOL, V16, P467, DOI 10.1016/j.conb.2006.06.010; Cope ED, 1884, 3 US GEOL SURV, VIII; Damuth J, 1990, ESTIMATION BIOL IMPL, P229; DECHASEAUX C, 1969, Annales de Paleontologie Vertebres, V55, P195; Douady CJ, 2003, MOL PHYLOGENET EVOL, V28, P285, DOI 10.1016/S1055-7903(03)00119-2; Edinger T., 1929, P1; EDINGER T, 1964, AM ZOOL, V4, P5; Edinger T., 1975, Advances Anat Embryol Cell Biol, V49, P1; Edinger Tilly, 1948, MEM GEOL SOC AMER, V25, P1; EISENBERG JF, 1981, MAMMALIAN RAD, P610; Flynn J. J., 1991, AM MUS NOVIT, V3007, P1; FORSMAN KA, 1988, J ZOOL, V216, P655, DOI 10.1111/j.1469-7998.1988.tb02463.x; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; Gazin C. L., 1968, Smithsonian Miscellaneous Collections, V153, P1; Gazin C. L., 1965, SMITHSONIAN MISCELLA, V149, P1; Gingerich Philip D., 2005, Contributions from the Museum of Paleontology University of Michigan, V31, P185; Gould E., 1969, Communications in Behavioral Biology (Ser A), V3, P11; GOULD E, 1964, J EXP ZOOL, V156, P19, DOI 10.1002/jez.1401560103; GOULD EDWIN, 1965, PROC AMER PHIL SOC, V109, P352; Jakobs C, 1943, REV GEOGR AM, V19, P307; Janis Christine M., 1998, P247; Jerison H.J., 2009, EVOLUTIONARY NEUROSC, P497; Jerison H.J., 1973, EVOLUTION BRAIN INTE, P482; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Ladeveze S, 2010, J VERTEBR PALEONTOL, V30, P1559, DOI 10.1080/02724634.2010.501440; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Macrini TE, 2007, J VERTEBR PALEONTOL, V27, P99, DOI 10.1671/0272-4634(2007)27[99:DCEOPA]2.0.CO;2; Macrini TE, 2009, J VERTEBR PALEONTOL, V29, P1199, DOI 10.1671/039.029.0413; Maisey JG, 2005, B AM MUS NAT HIST, P1; Malmierca Manuel S., 2004, Neuroembryology and Aging, V3, P215, DOI 10.1159/000096799; Malmierca MS, 2002, J NEUROSCI, V22, P10891; Marino Lori, 2003, Anatomical Record, V272B, P107, DOI 10.1002/ar.b.10018; Marino Lori, 2000, Journal of Mammalian Evolution, V7, P81, DOI 10.1023/A:1009417831601; Matthew WD, 1928, P ZOOL SOC LOND, V1927, P947; Minoprio JDL, 1954, ACTA ZOOL LILLOANA, V3, P5; Prothero D.R., 1988, Systematics Association Special Volume Series, P201; RADINSKY L, 1977, PALEOBIOLOGY, V3, P333, DOI 10.1017/S0094837300005509; RADINSKY L, 1978, AM NAT, V112, P815, DOI 10.1086/283325; RADINSKY L, 1973, BRAIN BEHAV EVOLUT, V7, P169, DOI 10.1159/000124409; RADINSKY L, 1976, Fieldiana Geology, V33, P323; RADINSKY L, 1976, SCIENCE, V194, P626, DOI 10.1126/science.790567; RADINSKY LB, 1968, J MORPHOL, V124, P167, DOI 10.1002/jmor.1051240204; REHKAMPER G, 1986, J HIRNFORSCH, V27, P391; Rose K.D., 2006, BEGINNING AGE MAMMAL, P428; ROSE KD, 1980, SCIENCE, V208, P744, DOI 10.1126/science.208.4445.744; Rose KD, 1999, J VERTEBR PALEONTOL, V19, P355, DOI 10.1080/02724634.1999.10011147; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; RUSSELL DONALD E., 1965, MEM MUS NAT D HBT NATUR SER C SCI TERRE, V16, P1; SIMPSON GEORGE GAYLORD, 1933, AMER MUS NOVITATES, V622, P1; Starck D, 1963, ZOOL ANZ, V171, P350; Stephan H., 1991, COMP BRAIN RES MAMMA, V1, P573; Symonds MRE, 2005, BIOL REV, V80, P93, DOI 10.1017/S1464793104006566; Teeling EC, 2009, TRENDS ECOL EVOL, V24, P351, DOI 10.1016/j.tree.2009.02.012; Tilney F, 1933, B NEUROL I NEW YORK, P430; TOMASI TE, 1979, J MAMMAL, V60, P751, DOI 10.2307/1380190; van Valen L., 1978, Evolutionary Theory, V4, P45; Williamson T. E., 1992, B NEW MEXICO MUSEUM, V1, P1; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048	69	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30000	10.1371/journal.pone.0030000	http://dx.doi.org/10.1371/journal.pone.0030000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347998	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730900004
J	Chand, AL; Wijayakumara, DD; Knower, KC; Herridge, KA; Howard, TL; Lazarus, KA; Clyne, CD				Chand, Ashwini L.; Wijayakumara, Dhilushi D.; Knower, Kevin C.; Herridge, Kerrie A.; Howard, Tamara L.; Lazarus, Kyren A.; Clyne, Colin D.			The Orphan Nuclear Receptor LRH-1 and ER alpha Activate GREB1 Expression to Induce Breast Cancer Cell Proliferation	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; FEEDBACK-REGULATION; GENE-EXPRESSION; HOMOLOG-1 LRH-1; GRANULOSA-CELLS; AROMATASE; STEROIDOGENESIS; TRANSCRIPTION	Background: Liver Receptor Homolog 1 (LRH-1, NR5A2) is an orphan nuclear receptor that is over-expressed in cancers in tissues such as the breast, colon and pancreas. LRH-1 plays important roles in embryonic development, steroidogenesis and cholesterol homeostasis. In tumor cells, LRH-1 induces proliferation and cell cycle progression. High LRH-1 expression is demonstrated in breast cancers, positively correlating with ER alpha status and aromatase activity. LRH-1 dependent cellular mechanisms in breast cancer epithelial cells are poorly defined. Hence in the present study we investigated the actions of LRH-1 in estrogen receptor alpha (ER alpha) positive breast cancer cells. Results: The study aimed to investigate LRH-1 dependent mechanisms that promote breast cancer proliferation. We identified that LRH-1 regulated the expression of Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in MCF-7 and MDA-MB-231 cells. Over-expression of LRH-1 increased GREB1 mRNA levels while knockdown of LRH-1 reduced its expression. GREB1 is a well characterised ER alpha target gene, with three estrogen response elements (ERE) located on its promoter. Chromatin immunoprecipitation studies provided evidence of the co-localisation of LRH-1 and ER alpha at all three EREs. With electrophoretic mobility shift assays, we demonstrated direct binding of LRH-1 to EREs located on GREB1 and Trefoil Factor 1 (TFF1, pS2) promoters. LRH-1 and ER alpha co-operatively activated transcription of ERE luciferase reporter constructs suggesting an overlap in regulation of target genes in breast cancer cells. Over-expression of LRH-1 resulted in an increase in cell proliferation. This effect was more pronounced with estradiol treatment. In the presence of ICI 182,780, an ER alpha antagonist, LRH-1 still induced proliferation. Conclusions: We conclude that in ER-positive breast cancer cells, LRH-1 promotes cell proliferation by enhancing ER alpha mediated transcription of target genes such as GREB-1. Collectively these findings indicate the importance of LRH-1 in the progression of hormone-dependent breast cancer and implicate LRH-1 as a potential avenue for drug development.	[Chand, Ashwini L.; Wijayakumara, Dhilushi D.; Knower, Kevin C.; Herridge, Kerrie A.; Howard, Tamara L.; Lazarus, Kyren A.; Clyne, Colin D.] Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia	Monash University; Prince Henry's Institute of Medical Research	Chand, AL (corresponding author), Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia.	colin.clyne@princehenrys.org	Chand, Ashwini L/D-1531-2017; Knower, Kevin/C-2869-2014	Chand, Ashwini L/0000-0002-1245-729X; 	Victorian Government through the Victorian Cancer Agency; United States Department of Defense; Victorian Government	Victorian Government through the Victorian Cancer Agency; United States Department of Defense(United States Department of Defense); Victorian Government	This research was supported by the Victorian Government, through the Victorian Cancer Agency's funding of the Victorian Breast Cancer Research Consortium and Early Career Seed Grant, Cancer Council Victoria (to CDC), the United States Department of Defense (to ALC and KCK), and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annicotte JS, 2005, ONCOGENE, V24, P8167, DOI 10.1038/sj.onc.1208950; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Chand AL, 2011, STEROIDS, V76, P741, DOI 10.1016/j.steroids.2011.02.024; Chu S, 2004, MOL ENDOCRINOL, V18, P1919, DOI 10.1210/me.2004-0021; Clyne CD, 2004, MOL CELL ENDOCRINOL, V215, P39, DOI 10.1016/j.mce.2003.11.001; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dunbier AK, 2010, J CLIN ONCOL, V28, P1161, DOI 10.1200/JCO.2009.23.9616; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Ghosh MG, 2000, CANCER RES, V60, P6367; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hnatyszyn HJ, 2010, BREAST CANCER RES TR, V122, P371, DOI 10.1007/s10549-009-0584-x; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Kim JW, 2004, J CLIN ENDOCR METAB, V89, P3042, DOI 10.1210/jc.2003-031599; Labelle-Dumais C, 2006, DEV DYNAM, V235, P3359, DOI 10.1002/dvdy.20996; Lee YK, 2002, J BIOL CHEM, V277, P2463, DOI 10.1074/jbc.M105161200; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo Y, 2001, J BIOL CHEM, V276, P24767, DOI 10.1074/jbc.M100912200; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Miki Y, 2006, CANCER LETT, V244, P24, DOI 10.1016/j.canlet.2005.11.038; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Power KA, 2003, BREAST CANCER RES TR, V81, P209, DOI 10.1023/A:1026114501364; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Saxena D, 2007, ENDOCRINOLOGY, V148, P726, DOI 10.1210/en.2006-0108; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Simpson ER, 2001, ANN NY ACAD SCI, V949, P58; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Thiruchelvam PTR, 2011, BREAST CANCER RES TR, V127, P385, DOI 10.1007/s10549-010-0994-9; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang SL, 2008, MOL CELL BIOCHEM, V308, P93, DOI 10.1007/s11010-007-9616-1; Zeleniuch-Jacquotte A, 2004, BRIT J CANCER, V90, P153, DOI 10.1038/sj.bjc.6601517; Zhou J, 2005, CANCER RES, V65, P657	41	43	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31593	10.1371/journal.pone.0031593	http://dx.doi.org/10.1371/journal.pone.0031593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359603	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200072
J	Singh, P; Mishra, SK; Noel, S; Sharma, S; Rath, SK				Singh, Prabhat; Mishra, Shrawan Kumar; Noel, Sanjeev; Sharma, Sharad; Rath, Srikanta Kumar			Acute Exposure of Apigenin Induces Hepatotoxicity in Swiss Mice	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN-70 HSP70; LIPID-PEROXIDATION; CELL-DEATH; FLAVONOIDS; DAMAGE; ASSAY; ACTIVATION; EXPRESSION; BIOMARKERS; APOPTOSIS	Apigenin, a dietary flavonoid, is reported to have several therapeutic effects in different diseases including cancer. Toxicity of Apigenin is however, least explored, and reports are scanty in literature. This warrants dose-specific evaluation of toxicity in vivo. In the present study, Apigenin was administered intraperitoneally to Swiss mice at doses of 25, 50, 100 and 200 mg/kg. Serum levels of alanine amino transferase (ALT), aspartate amino transferase (AST) and alkaline phosphatase (ALP) were measured along with the examination of liver histology, reactive oxygen species (ROS) in blood, lipid peroxidation (LPO), glutathione level, superoxide dismutase activity, catalase activity, glutathione S-transferase activity and gene expression in liver tissue. Increase in ALT, AST, ALP, ROS, ratio of oxidized to reduced glutathione (GSSG/GSH) and LPO, altered enzyme activities along with damaged histoarchitecture in the liver of 100 or 200 mg/kg Apigenin treated animals were found. Microarray analysis revealed the differential expression of genes that correspond to different biologically relevant pathways including oxidative stress and apoptosis. In conclusion, these results suggested the oxidative stress induced liver damage which may be due to the regulation of multiple genes by Apigenin at higher doses in Swiss mice.	[Singh, Prabhat; Mishra, Shrawan Kumar; Noel, Sanjeev; Sharma, Sharad; Rath, Srikanta Kumar] Cent Drug Res Inst CSIR, Div Toxicol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, P (corresponding author), Cent Drug Res Inst CSIR, Div Toxicol, Lucknow, Uttar Pradesh, India.	skrath@cdri.res.in	Mishra, Shrawan K/J-7972-2013; Mishra, Shrawan/N-1592-2019	Mishra, Shrawan/0000-0001-5513-9876	Council of Scientific and Industrial Research (CSIR) Network [NWP0034]	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research (CSIR) Network project NWP0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ENZYMATIC BASIS DETO; Chuang CM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-49; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; ELIA G, 1994, BIOCHEM J, V300, P201, DOI 10.1042/bj3000201; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; Ghribi O, 2001, BRAIN RES, V903, P66, DOI 10.1016/S0006-8993(01)02406-4; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HOSOKAWA N, 1990, CELL STRUCT FUNCT, V15, P393, DOI 10.1247/csf.15.393; Kachadourian R, 2006, FREE RADICAL BIO MED, V41, P65, DOI 10.1016/j.freeradbiomed.2006.03.002; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Miyoshi N, 2007, ARCH BIOCHEM BIOPHYS, V466, P274, DOI 10.1016/j.abb.2007.07.026; Morrissey C, 2005, PROSTATE, V63, P131, DOI 10.1002/pros.20167; Mullie P, 2007, PLANT FOOD HUM NUTR, V62, P93, DOI 10.1007/s11130-007-0047-7; Noel S, 2007, TOXICOLOGY, V239, P96, DOI 10.1016/j.tox.2007.06.098; Noel S, 2006, TOXICOL IN VITRO, V20, P1168, DOI 10.1016/j.tiv.2006.03.007; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Patel D, 2007, INT J ONCOL, V30, P233; Poli M, 2010, NEUROBIOL DIS, V39, P204, DOI 10.1016/j.nbd.2010.04.009; Sahu SC, 1997, FOOD CHEM TOXICOL, V35, P443, DOI 10.1016/S0278-6915(97)00011-2; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Stroheker T, 2004, FOOD CHEM TOXICOL, V42, P887, DOI 10.1016/j.fct.2004.01.012; Sugihara N, 1999, FREE RADICAL BIO MED, V27, P1313, DOI 10.1016/S0891-5849(99)00167-7; Tsuji PA, 2008, CHEM-BIOL INTERACT, V171, P37, DOI 10.1016/j.cbi.2007.08.007; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vargo MA, 2006, BIOCHEM PHARMACOL, V72, P681, DOI 10.1016/j.bcp.2006.06.010; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Xu LT, 2008, IMMUNOL LETT, V121, P74, DOI 10.1016/j.imlet.2008.08.004; Zhang YH, 2000, GEN PHARMACOL-VASC S, V35, P341, DOI 10.1016/S0306-3623(02)00113-1	38	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31964	10.1371/journal.pone.0031964	http://dx.doi.org/10.1371/journal.pone.0031964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359648	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200117
J	Yang, JM; Ip, SP; Xian, YF; Zhao, M; Lin, ZX; Yeung, JHK; Chan, RCY; Lee, SS; Che, CT				Yang, Jia-Ming; Ip, Siu-Po; Xian, Yanfang; Zhao, Ming; Lin, Zhi-Xiu; Yeung, John Hok Keung; Chan, Raphael Chiu Yeung; Lee, Shui-Shan; Che, Chun-Tao			Impact of the Herbal Medicine Sophora flavescens on the Oral Pharmacokinetics of Indinavir in Rats: The Involvement of CYP3A and P-Glycoprotein	PLOS ONE			English	Article							HIV-PROTEASE INHIBITOR; IN-VITRO; LIQUID-CHROMATOGRAPHY; CYTOCHROME P450S; METABOLISM; INDUCTION; EXTRACT; DEXAMETHASONE; EXPRESSION; FLAVONOIDS	Sophora flavescens is a Chinese medicinal herb used for the treatment of gastrointestinal hemorrhage, skin diseases, pyretic stranguria and viral hepatitis. In this study the herb-drug interactions between S. flavescens and indinavir, a protease inhibitor for HIV treatment, were evaluated in rats. Concomitant oral administration of Sophora extract (0.158 g/kg or 0.63 g/kg, p.o.) and indinavir (40 mg/kg, p.o.) in rats twice a day for 7 days resulted in a dose-dependent decrease of plasma indinavir concentrations, with 55%-83% decrease in AUC(0-infinity) and 38%-78% reduction in C-max. The CL (Clearance)/F (fraction of dose available in the systemic circulation) increased up to 7.4-fold in Sophora-treated rats. Oxymatrine treatment (45 mg/kg, p.o.) also decreased indinavir concentrations, while the ethyl acetate fraction of Sophora extract had no effect. Urinary indinavir (24-h) was reduced, while the fraction of indinavir in faeces was increased after Sophora treatment. Compared to the controls, multiple dosing of Sophora extract elevated both mRNA and protein levels of P-gp in the small intestine and liver. In addition, Sophora treatment increased intestinal and hepatic mRNA expression of CYP3A1, but had less effect on CYP3A2 expression. Although protein levels of CYP3A1 and CYP3A2 were not altered by Sophora treatment, hepatic CYP3A activity increased in the Sophora-treated rats. All available data demonstrated that Sophora flavescens reduced plasma indinavir concentration after multiple concomitant doses, possibly through hepatic CYP3A activity and induction of intestinal and hepatic P-gp. The animal study would be useful for predicting potential interactions between natural products and oral pharmaceutics and understanding the mechanisms prior to human studies. Results in the current study suggest that patients using indinavir might be cautioned in the use of S. flavescens extract or Sophora-derived products.	[Yang, Jia-Ming; Ip, Siu-Po; Xian, Yanfang; Zhao, Ming; Lin, Zhi-Xiu; Che, Chun-Tao] Chinese Univ Hong Kong, Sch Chinese Med, Shatin, Hong Kong, Peoples R China; [Yeung, John Hok Keung] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Chan, Raphael Chiu Yeung; Lee, Shui-Shan] Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Lee, Shui-Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [Zhao, Ming; Che, Chun-Tao] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yang, JM (corresponding author), Chinese Univ Hong Kong, Sch Chinese Med, Shatin, Hong Kong, Peoples R China.	chect@uic.edu	Xian, Yan-Fang/AAA-6876-2020; Chan, Raphael Chiu Yeung/J-9649-2013; Lee, Shui Shan/B-9374-2008; Ip, Paul/M-8831-2014; Che, Chun-Tao/AAV-2795-2020; Lin, Zhi-Xiu/H-2807-2016	Lee, Shui Shan/0000-0003-1448-765X; Ip, Paul/0000-0001-8657-6585; 	Food and Health Bureau, Hong Kong Special Administrative Region Government [HHSRF-6902777]; Chinese University of Hong Kong	Food and Health Bureau, Hong Kong Special Administrative Region Government; Chinese University of Hong Kong(Chinese University of Hong Kong)	The research reported in this manuscript has been partially supported by the Health and Health Services Research Fund of the Food and Health Bureau, Hong Kong Special Administrative Region Government (HHSRF-6902777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript. This study was also supported by internal university funds from the Chinese University of Hong Kong; no additional outside funding received for this study.	Agus HH, 2009, PHYTOTHER RES, V23, P1763, DOI 10.1002/ptr.2848; [Anonymous], CDER CBER GUID IND D; Azzam HS, 2007, LIVER INT, V27, P17, DOI 10.1111/j.1478-3231.2006.01408.x; Benet LZ, 2004, INT J PHARM, V277, P3, DOI 10.1016/j.ijpharm.2002.12.002; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; Chen X, 2004, J CHROMATOGR B, V812, P149, DOI 10.1016/j.jchromb.2004.08.032; Chiba M, 1996, DRUG METAB DISPOS, V24, P307; Chiba M, 1997, BIOCHEM PHARMACOL, V53, P1187, DOI 10.1016/S0006-2952(97)00100-7; Clevenbergh P, 1999, AIDS REV, V1, P156; DiCenzo R, 2003, PHARMACOTHERAPY, V23, P866, DOI 10.1592/phco.23.7.866.32723; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051; Gui FS, 2007, LINCHUANG HE SHIYAN, V6, P151; Hamidi M, 2006, LIFE SCI, V79, P991, DOI 10.1016/j.lfs.2006.05.010; He N, 2011, BIOSCI TRENDS, V5, P1, DOI 10.5582/bst.2011.v5.1.1; Ho YF, 2009, LIFE SCI, V85, P296, DOI 10.1016/j.lfs.2009.06.008; Hochman JH, 2000, J PHARMACOL EXP THER, V292, P310; Hong-Li S, 2008, PHYTOTHER RES, V22, P985, DOI 10.1002/ptr.2452; Huang LY, 2001, DRUG METAB DISPOS, V29, P754; Kennedy DA, 2010, EXPERT OPIN DRUG SAF, V9, P79, DOI 10.1517/14740330903405593; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Kivisto KT, 2004, FUND CLIN PHARMACOL, V18, P621, DOI 10.1111/j.1472-8206.2004.00291.x; Li CQ, 2005, WORLD J GASTROENTERO, V11, P426; Lin JH, 1996, DRUG METAB DISPOS, V24, P1111; Lin JUN, 1999, DRUG METAB DISPOS, V27, P1187; Liu Y, 2009, BRAIN RES, V1268, P174, DOI 10.1016/j.brainres.2009.02.069; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P315, DOI 10.1097/QAI.0b013e31802ea499; Mei Q, 2004, J PHARM SCI-US, V93, P2488, DOI 10.1002/jps.20102; National Committee of Chinese Pharmacopoeia, 2010, PHARM PEOPL REP CHIN, P61; Pal D, 2006, LIFE SCI, V78, P2131, DOI 10.1016/j.lfs.2005.12.010; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; Rezk NL, 2006, THER DRUG MONIT, V28, P517, DOI 10.1097/00007691-200608000-00006; Sadler BM, 2001, ANTIMICROB AGENTS CH, V45, P30, DOI 10.1128/AAC.45.1.30-37.2001; Slain D, 2005, PHARMACOTHERAPY, V25, P165, DOI 10.1592/phco.25.2.165.56945; Solas C, 2002, J ACQ IMMUN DEF SYND, V29, P374, DOI 10.1097/00126334-200204010-00008; Sun MY, 2007, PHYTOTHER RES, V21, P269, DOI 10.1002/ptr.2066; Ueng YF, 2010, DRUG METAB PHARMACOK, V25, P560, DOI 10.2133/dmpk.DMPK-10-RG-055; Ueng YF, 2009, J ETHNOPHARMACOL, V126, P437, DOI 10.1016/j.jep.2009.09.018; Wang LY, 2010, DRUG METAB DISPOS, V38, P2226, DOI 10.1124/dmd.110.035253; Wu CY, 2005, PHARM RES-DORDR, V22, P11, DOI 10.1007/s11095-004-9004-4; Yuan F, 2010, BASIC CLIN PHARMACOL, V107, P906, DOI 10.1111/j.1742-7843.2010.00596.x; Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311; Zhang L, 2007, J PHARMACEUT BIOMED, V44, P1019, DOI 10.1016/j.jpba.2007.04.019	44	15	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31312	10.1371/journal.pone.0031312	http://dx.doi.org/10.1371/journal.pone.0031312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359586	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200055
J	Rossi, M; Bolz, C; Revez, J; Javed, S; El-Najjar, N; Anderl, F; Hyytiainen, H; Vuorela, P; Gerhard, M; Hanninen, ML				Rossi, Mirko; Bolz, Christian; Revez, Joana; Javed, Sundus; El-Najjar, Nahed; Anderl, Florian; Hyytiainen, Heidi; Vuorela, Pia; Gerhard, Markus; Hanninen, Marja-Liisa			Evidence for Conserved Function of gamma-Glutamyltranspeptidase in Helicobacter Genus	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENOME SEQUENCE; CRYSTAL-STRUCTURE; BILIARY-TRACT; PYLORI; EXPRESSION; GLUTATHIONE; PROTEIN; BILE; IDENTIFICATION	The confounding consequences of Helicobacter bilis infection in experimental mice populations are well recognized, but the role of this bacterium in human diseases is less known. Limited data are available on virulence determinants of this species. In Helicobacter pylori, gamma-glutamyltranspeptidase (gamma GT) contributes to the colonization of the gastric mucosa and to the pathogenesis of peptic ulcer. The role of gamma GT in H. bilis infections remains unknown. The annotated genome sequence of H. bilis revealed two putative ggt genes and our aim was to characterize these H. bilis gamma GT paralogues. We performed a phylogenetic analysis to understand the evolution of Helicobacter gamma GTs and to predict functional activities of these two genes. In addition, both copies of H. bilis gamma GTs were expressed as recombinant proteins and their biochemical characteristics were analysed. Functional complementation of Esherichia coli deficient in gamma GT activity and deletion of gamma GT in H. bilis were performed. Finally, the inhibitory effect of T-cell and gastric cell proliferation by H. bilis gamma GT was assessed. Our results indicated that one gene is responsible for gamma GT activity, while the other showed no gamma GT activity due to lack of autoprocessing. Although both H. bilis and H. pylori gamma GTs exhibited a similar affinity to L-Glutamine and c-Glutamyl-p-nitroanilide, the H. bilis gamma GT was significantly less active. Nevertheless, H. bilis gamma GT inhibited T-cell proliferation at a similar level to that observed for H. pylori. Finally, we showed a similar suppressive influence of both H. bilis and H. pylori gamma GTs on AGS cell proliferation mediated by an apoptosis-independent mechanism. Our data suggest a conserved function of gamma GT in the Helicobacter genus. Since gamma GT is present only in a few enterohepatic Helicobacter species, its expression appears not to be essential for colonization of the lower gastrointestinal tract, but it could provide metabolic advantages in colonization capability of different niches.	[Rossi, Mirko; Revez, Joana; Hyytiainen, Heidi; Hanninen, Marja-Liisa] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Bolz, Christian; Javed, Sundus; Anderl, Florian; Gerhard, Markus] Tech Univ Munich, Dept Med Microbiol Immunol & Hyg, Munich, Germany; [El-Najjar, Nahed; Vuorela, Pia] Abo Akad Univ, Dept Biosci, Turku, Finland	University of Helsinki; Technical University of Munich; Abo Akademi University	Rossi, M (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	mirko.rossi@helsinki.fi	Rossi, Mirko/D-1509-2012; El-Najjar, Nahed/I-2755-2019; Gerhard, Markus/N-3387-2014; Javed, Sundus/AAY-2257-2020; Gerhard, Markus/P-8996-2019; Javed, Sundus/AAS-1576-2020	Rossi, Mirko/0000-0002-1585-6384; El-Najjar, Nahed/0000-0002-2278-8586; Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Javed, Sundus/0000-0001-8352-8078	Academy of Finland, Center of Excellence [118602]; Academy of Finland [132940]	Academy of Finland, Center of Excellence(Academy of Finland); Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland, Center of Excellence, decision number 118602, and Academy of Finland, Postdoctoral Researcher's project, decision number 132940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Arnold IC, 2011, GENOME BIOL EVOL, V3, P302, DOI 10.1093/gbe/evr022; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Boanca G, 2006, J BIOL CHEM, V281, P19029, DOI 10.1074/jbc.M603381200; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; Busiello I, 2004, CELL MICROBIOL, V6, P255, DOI 10.1046/j.1462-5822.2004.00366.x; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Choo KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S2; de Laureto PP, 2002, PROTEIN SCI, V11, P2932, DOI 10.1110/ps.0205802; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fox JG, 2007, GUT, V56, P898, DOI 10.1136/gut.2006.115428; Fox JG, 2009, J CLIN MICROBIOL, V47, P3673, DOI 10.1128/JCM.00879-09; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Fox JG, 2004, COMPARATIVE MED, V54, P571; FOX JG, 1995, J CLIN MICROBIOL, V33, P445, DOI 10.1128/JCM.33.2.445-454.1995; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hannula M, 2007, INT J SYST EVOL MICR, V57, P444, DOI 10.1099/ijs.0.64462-0; Hynes SO, 2004, HELICOBACTER, V9, P313, DOI 10.1111/j.1083-4389.2004.00237.x; Hynes SO, 2003, INFECT IMMUN, V71, P2976, DOI 10.1128/IAI.71.5.2976-2980.2003; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kostia S, 2003, J MED MICROBIOL, V52, P103, DOI 10.1099/jmm.0.04920-0; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liang H, 2006, NUCLEIC ACIDS RES, V34, pW382, DOI 10.1093/nar/gkl272; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Matsukura N, 2002, JPN J CANCER RES, V93, P842, DOI 10.1111/j.1349-7006.2002.tb01327.x; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; McGovern KJ, 2001, INFECT IMMUN, V69, P4168, DOI 10.1128/IAI.69.6.4168-4173.2001; Minami H, 2004, J BACTERIOL, V186, P1213, DOI 10.1128/JB.186.4.1213-1214.2004; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; Murata H, 2004, ALIMENT PHARM THER, V20, P90, DOI 10.1111/j.1365-2036.2004.01972.x; Murray PR, 2010, ARCH DERMATOL, V146, P523, DOI 10.1001/archdermatol.2010.86; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; On S. L. W., 2005, BERGEYS MANUAL SYS C, V2, P1169; Ong PL, 2008, BIOCHEM BIOPH RES CO, V366, P294, DOI 10.1016/j.bbrc.2007.11.063; OTOOLE PW, 2010, BMC GENOMICS, V11, DOI DOI 10.1186/1471-2164-11-164; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; ROMERO S, 1988, J CLIN MICROBIOL, V26, P142, DOI 10.1128/JCM.26.1.142-143.1988; Rossi M, 2008, VET MICROBIOL, V129, P304, DOI 10.1016/j.vetmic.2007.11.014; Rossi M, 2010, INT J SYST EVOL MICR, V60, P2392, DOI 10.1099/ijs.0.016287-0; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Schott T, 2011, J BACTERIOL, V193, P4565, DOI 10.1128/JB.05439-11; Shibayama K, 2003, MOL MICROBIOL, V47, P443, DOI 10.1046/j.1365-2958.2003.03305.x; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Solnick JV, 2001, CLIN MICROBIOL REV, V14, P59, DOI 10.1128/CMR.14.1.59-97.2001; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; Suzuki H, 2004, APPL ENVIRON MICROB, V70, P6324, DOI 10.1128/AEM.70.10.6324-6328.2004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vermoote M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-51; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Vorobjova T, 2006, DIGEST LIVER DIS, V38, P171, DOI 10.1016/j.dld.2005.12.008; Wachino JI, 2010, HELICOBACTER, V15, P184, DOI 10.1111/j.1523-5378.2010.00755.x; WAGNER A, 2003, ENCY LIFE SCI, DOI DOI 10.1128/AEM.02693-07; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Whary MT, 2006, LAB ANIMAL, V35, P25, DOI 10.1038/laban0706-25; Williams K, 2009, BIOCHEMISTRY-US, V48, P2459, DOI 10.1021/bi8014955; Yamada C, 2008, APPL ENVIRON MICROB, V74, P3400, DOI 10.1128/AEM.02693-07; Young VB, 2004, INFECT IMMUN, V72, P2521, DOI 10.1128/IAI.72.5.2521-2527.2004; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093	68	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30543	10.1371/journal.pone.0030543	http://dx.doi.org/10.1371/journal.pone.0030543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348013	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400002
J	Chen, SH; Luo, JJ; Hu, MY; Geng, P; Zhang, YB				Chen, Shaohua; Luo, Jianjun; Hu, Meiying; Geng, Peng; Zhang, Yanbo			Microbial Detoxification of Bifenthrin by a Novel Yeast and Its Potential for Contaminated Soils Treatment	PLOS ONE			English	Article							PYRETHROID INSECTICIDES; BIODEGRADATION; CHLORPYRIFOS; STRAIN; TOXICITY; 3,5,6-TRICHLORO-2-PYRIDINOL; DEGRADATION; HYDROLYSIS; PESTICIDES; RESIDUES	Bifenthrin is one the most widespread pollutants and has caused potential effect on aquatic life and human health, yet little is known about microbial degradation in contaminated regions. A novel yeast strain ZS-02, isolated from activated sludge and identified as Candida pelliculosa based on morphology, API test and 18S rDNA gene analysis, was found highly effective in degrading bifenthrin over a wide range of temperatures (20-40 degrees C) and pH (5-9). On the basis of response surface methodology (RSM), the optimal degradation conditions were determined to be 32.3 degrees C and pH 7.2. Under these conditions, the yeast completely metabolized bifenthrin (50 mg.L-1) within 8 days. This strain utilized bifenthrin as the sole carbon source for growth as well as co-metabolized it in the presence of glucose, and tolerated concentrations as high as 600 mg.L-1 with a q(max), K-s and K-i of 1.7015 day(-1), 86.2259 mg.L-1 and 187.2340 mg.L-1, respectively. The yeast first degraded bifenthrin by hydrolysis of the carboxylester linkage to produce cyclopropanecarboxylic acid and 2-methyl-3-biphenylyl methanol. Subsequently, 2-methyl-3-biphenylyl methanol was further transformed by biphenyl cleavage to form 4-trifluoromethoxy phenol, 2-chloro-6-fluoro benzylalcohol, and 3,5-dimethoxy phenol, resulting in its detoxification. Eventually, no persistent accumulative product was detected by gas chromatopraphy-mass spectrometry (GC-MS) analysis. This is the first report of a novel pathway of degradation of bifenthrin by hydrolysis of ester linkage and cleavage of biphenyl in a microorganism. Furthermore, strain ZS-02 degraded a variety of pyrethroids including bifenthrin, cyfluthrin, deltamethrin, fenvalerate, cypermethrin, and fenpropathrin. In different contaminated soils introduced with strain ZS-02, 65-75% of the 50 mg.kg(-1) bifenthrin was eliminated within 10 days, suggesting the yeast could be a promising candidate for remediation of environments affected by bifenthrin. Finally, this is the first described yeast capable of degrading bifenthrin.	[Chen, Shaohua; Luo, Jianjun; Hu, Meiying; Geng, Peng; Zhang, Yanbo] S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Peoples R China	South China Agricultural University	Chen, SH (corresponding author), S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Peoples R China.	humy@scau.edu.cn	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Natural Science Foundation [30871660]; Project of Scientific Technological Planning of Guangdong Province, People's Republic of China [2009B020310005]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Scientific Technological Planning of Guangdong Province, People's Republic of China	The authors gratefully acknowledge the grants from the National Natural Science Foundation (No. 30871660) and Project of Scientific Technological Planning of Guangdong Province (No. 2009B020310005), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari RA, 2011, ECOTOX ENVIRON SAFE, V74, P150, DOI 10.1016/j.ecoenv.2010.08.036; Anwar S, 2009, J HAZARD MATER, V168, P400, DOI 10.1016/j.jhazmat.2009.02.059; BARNETT JA, 2000, YEASTS CHARACTERISTI; Baskaran S, 1999, PESTIC SCI, V55, P1222, DOI 10.1002/(SICI)1096-9063(199912)55:12<1222::AID-PS83>3.0.CO;2-7; Chen SH, 2011, APPL MICROB IN PRESS; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, J HAZARD MATER, V187, P433, DOI 10.1016/j.jhazmat.2011.01.049; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P755, DOI 10.1007/s00253-010-3035-z; Cycon M, 2009, CHEMOSPHERE, V76, P494, DOI 10.1016/j.chemosphere.2009.03.023; Dal Bello G, 2008, J PHYTOPATHOL, V156, P257, DOI 10.1111/j.1439-0434.2007.01351.x; Dritsa V, 2009, WATER AIR SOIL POLL, V204, P19, DOI 10.1007/s11270-009-0022-z; Dutta R, 2011, TOXICOLOGY, V285, P126, DOI 10.1016/j.tox.2011.04.012; Fenlon KA, 2011, CHEMOSPHERE, V82, P163, DOI 10.1016/j.chemosphere.2010.10.027; Grant RJ, 2002, J APPL MICROBIOL, V92, P534, DOI 10.1046/j.1365-2672.2002.01558.x; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Hintzen EP, 2009, ENVIRON POLLUT, V157, P110, DOI 10.1016/j.envpol.2008.07.023; Holmes RW, 2008, ENVIRON SCI TECHNOL, V42, P7003, DOI 10.1021/es801346g; Jin YX, 2011, FISH SHELLFISH IMMUN, V30, P1049, DOI 10.1016/j.fsi.2011.02.001; Laffin B, 2010, TOXICOLOGY, V267, P39, DOI 10.1016/j.tox.2009.10.003; Laskowski Dennis A., 2002, V174, P49; Lee S, 2004, ENVIRON TOXICOL CHEM, V23, P1, DOI 10.1897/03-114; Liu J, 2011, TOXICOLOGY, V282, P47, DOI 10.1016/j.tox.2011.01.007; MALONEY SE, 1993, APPL ENVIRON MICROB, V59, P2007, DOI 10.1128/AEM.59.7.2007-2013.1993; Mohapatra S, 2009, PESTIC RES J, V19, P110; Mohapatra Soudamini, 2007, Pesticide Research Journal, V19, P110; Perry MJ, 2007, REPROD TOXICOL, V23, P113, DOI 10.1016/j.reprotox.2006.08.005; Riederer AM, 2010, ENVIRON SCI TECHNOL, V44, P483, DOI 10.1021/es902479h; Sambrook J., 2001, MOL CLONING LAB MANU; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Singh BK, 2006, SOIL BIOL BIOCHEM, V38, P2682, DOI 10.1016/j.soilbio.2006.04.019; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Sorensen SR, 2001, APPL ENVIRON MICROB, V67, P5403, DOI 10.1128/AEM.67.12.5403-5409.2001; Tallur PN, 2008, BIODEGRADATION, V19, P77, DOI 10.1007/s10532-007-9116-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tewary DK, 2005, FOOD CONTROL, V16, P231, DOI 10.1016/j.foodcont.2004.02.004; U.S. EPA, 2015, 740C15003 US EPA; Wang BZ, 2011, WORLD J MICROB BIOT, V27, P2315, DOI 10.1007/s11274-011-0698-2; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wang C, 2009, J ENVIRON SCI, V21, P1710, DOI 10.1016/S1001-0742(08)62477-8; Wang LM, 2007, ENVIRON SCI TECHNOL, V41, P6124, DOI 10.1021/es070220d; Wang YQ, 2009, J HAZARD MATER, V169, P1163, DOI 10.1016/j.jhazmat.2009.04.002; Weston DP, 2011, ENVIRON POLLUT, V159, P3051, DOI 10.1016/j.envpol.2011.04.008; Weston DP, 2009, ENVIRON POLLUT, V157, P287, DOI 10.1016/j.envpol.2008.06.037; WHO, 2009, WHO REC CLASS PEST H; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; Xu GM, 2008, INT BIODETER BIODEGR, V62, P51, DOI 10.1016/j.ibiod.2007.12.001; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P7139, DOI 10.1016/j.biortech.2011.03.086; Zhang C, 2010, BIORESOURCE TECHNOL, V101, P3423, DOI 10.1016/j.biortech.2009.12.083; Zhang SB, 2011, BIODEGRADATION, V22, P869, DOI 10.1007/s10532-010-9444-y	52	45	52	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30862	10.1371/journal.pone.0030862	http://dx.doi.org/10.1371/journal.pone.0030862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348025	gold, Green Submitted, Green Published			2022-12-27	WOS:000302733900014
J	Manfredi, LR; Baker, AT; Elias, DO; Dammann, JF; Zielinski, MC; Polashock, VS; Bensmaia, SJ				Manfredi, Louise R.; Baker, Andrew T.; Elias, Damian O.; Dammann, John F., III; Zielinski, Mark C.; Polashock, Vicky S.; Bensmaia, Sliman J.			The Effect of Surface Wave Propagation on Neural Responses to Vibration in Primate Glabrous Skin	PLOS ONE			English	Article							MECHANORECEPTIVE AFFERENTS; POPULATION RESPONSE; FLUTTER-VIBRATION; TACTILE; INTENSITY; STIMULUS; MODEL; DISCRIMINATION; PERCEPTION; MECHANICS	Because tactile perception relies on the response of large populations of receptors distributed across the skin, we seek to characterize how a mechanical deformation of the skin at one location affects the skin at another. To this end, we introduce a novel non-contact method to characterize the surface waves produced in the skin under a variety of stimulation conditions. Specifically, we deliver vibrations to the fingertip using a vibratory actuator and measure, using a laser Doppler vibrometer, the surface waves at different distances from the locus of stimulation. First, we show that a vibration applied to the fingertip travels at least the length of the finger and that the rate at which it decays is dependent on stimulus frequency. Furthermore, the resonant frequency of the skin matches the frequency at which a subpopulation of afferents, namely Pacinian afferents, is most sensitive. We show that this skin resonance can lead to a two-fold increase in the strength of the response of a simulated afferent population. Second, the rate at which vibrations propagate across the skin is dependent on the stimulus frequency and plateaus at 7 m/s. The resulting delay in neural activation across locations does not substantially blur the temporal patterning in simulated populations of afferents for frequencies less than 200 Hz, which has important implications about how vibratory frequency is encoded in the responses of somatosensory neurons. Third, we show that, despite the dependence of decay rate and propagation speed on frequency, the waveform of a complex vibration is well preserved as it travels across the skin. Our results suggest, then, that the propagation of surface waves promotes the encoding of spectrally complex vibrations as the entire neural population is exposed to essentially the same stimulus. We also discuss the implications of our results for biomechanical models of the skin.	[Manfredi, Louise R.; Dammann, John F., III; Zielinski, Mark C.; Bensmaia, Sliman J.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Baker, Andrew T.; Polashock, Vicky S.] Kimberly Clark Inc, Roswell, GA USA; [Elias, Damian O.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of Chicago; Kimberly-Clark; University of California System; University of California Berkeley	Manfredi, LR (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	sliman@uchicago.edu	Manfredi, Louise/HGA-8471-2022; Elias, Damian O/C-4954-2013	Zielinski, Mark/0000-0002-6950-6689; Manfredi, Louise Rosanna/0000-0003-0660-3980				Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Bensmaia SJ, 2008, BEHAV BRAIN RES, V190, P165, DOI 10.1016/j.bbr.2008.02.044; BOLANOWSKI SJ, 1984, J NEUROPHYSIOL, V51, P793, DOI 10.1152/jn.1984.51.4.793; Brisben AJ, 1999, J NEUROPHYSIOL, V81, P1548, DOI 10.1152/jn.1999.81.4.1548; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; Dong Y, 2010, THESIS J HOPKINS U B; Franke EK, 1951, 6464 AIR FORC; FREEMAN AW, 1982, J PHYSIOL-LONDON, V323, P43, DOI 10.1113/jphysiol.1982.sp014060; Gerling GJ, 2008, SOMATOSENS MOT RES, V25, P61, DOI 10.1080/08990220701838996; Harvey MA, PROCESSING SPECTRALL; Hollins M, 2002, BEHAV BRAIN RES, V135, P51, DOI 10.1016/S0166-4328(02)00154-7; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHNSON KO, 1974, J NEUROPHYSIOL, V37, P48, DOI 10.1152/jn.1974.37.1.48; Kim SS, 2010, J NEUROPHYSIOL, V104, P1484, DOI 10.1152/jn.00187.2010; Klatzky RL, 1999, PERCEPT PSYCHOPHYS, V61, P591, DOI 10.3758/BF03205532; LaMotte RH, 2000, J NEUROPHYSIOL, V83, P1777, DOI 10.1152/jn.2000.83.4.1777; Mihalas S., 2011, NEURAL COMPUT, V21, P704; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MRIDHA M, 1992, J BIOMECH, V25, P1213, DOI 10.1016/0021-9290(92)90077-E; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1204, DOI 10.1152/jn.1981.46.6.1204; POTTS RO, 1983, J BIOMECH, V16, P365, DOI 10.1016/0021-9290(83)90070-2; PUBOLS BH, 1987, SOMATOSENS MOT RES, V4, P273, DOI 10.3109/07367228709144611; Scheibert J, 2009, SCIENCE, V323, P1503, DOI 10.1126/science.1166467; Sripati AP, 2006, J NEUROPHYSIOL, V95, P3852, DOI 10.1152/jn.01240.2005; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; VERRILLO RT, 1962, J ACOUST SOC AM, V34, P1768, DOI 10.1121/1.1909124; VONGIERKE HE, 1952, J APPL PHYSIOL, V4, P886, DOI 10.1152/jappl.1952.4.12.886; Wu John Z., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P55, DOI 10.1080/10255840600603641; Wu JZ, 2003, ANN BIOMED ENG, V31, P867, DOI 10.1114/1.1581290; Yau Jeffrey M, 2009, Commun Integr Biol, V2, P344; Yoshioka T, 2007, SOMATOSENS MOT RES, V24, P53, DOI 10.1080/08990220701318163	36	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31203	10.1371/journal.pone.0031203	http://dx.doi.org/10.1371/journal.pone.0031203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348055	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900031
J	Yi, ZH; Li, ZZ; Yu, SY; Yuan, CM; Hong, W; Wang, ZW; Cui, J; Shi, TL; Fang, YR				Yi, Zhenghui; Li, Zezhi; Yu, Shunying; Yuan, Chengmei; Hong, Wu; Wang, Zuowei; Cui, Jian; Shi, Tieliu; Fang, Yiru			Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; BIPOLAR DISORDER; MOOD DISORDERS; SUBTHRESHOLD DEPRESSION; MICROARRAY ANALYSIS; BEHAVIORAL-MODELS; BRAIN; SCHIZOPHRENIA; POSTMORTEM; DISEASE	Subsyndromal symptomatic depression (SSD) is a subtype of subthreshold depressive and also lead to significant psychosocial functional impairment as same as major depressive disorder (MDD). Several studies have suggested that SSD is a transitory phenomena in the depression spectrum and is thus considered a subtype of depression. However, the pathophysioloy of depression remain largely obscure and studies on SSD are limited. The present study compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD, and matched controls (8 subjects in each group). Support vector machines (SVMs) were utilized for training and testing on candidate signature expression profiles from signature selection step. Firstly, we identified 63 differentially expressed SSD signatures in contrast to control (P<=5.0E-4) and 30 differentially expressed MDD signatures in contrast to control, respectively. Then, 123 gene signatures were identified with significantly differential expression level between SSD and MDD. Secondly, in order to conduct priority selection for biomarkers for SSD and MDD together, we selected top gene signatures from each group of pair-wise comparison results, and merged the signatures together to generate better profiles used for clearly classify SSD and MDD sets in the same time. In details, we tried different combination of signatures from the three pair-wise compartmental results and finally determined 48 gene expression signatures with 100% accuracy. Our finding suggested that SSD and MDD did not exhibit the same expressed genome signature with peripheral blood leukocyte, and blood cell-derived RNA of these 48 gene models may have significant value for performing diagnostic functions and classifying SSD, MDD, and healthy controls.	[Yi, Zhenghui; Li, Zezhi; Yuan, Chengmei; Hong, Wu; Wang, Zuowei; Fang, Yiru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Yu, Shunying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Genet, Shanghai 200030, Peoples R China; [Cui, Jian; Shi, Tieliu] E China Normal Univ, Coll Life Sci, Ctr Bioinformat, Shanghai 200062, Peoples R China; [Cui, Jian; Shi, Tieliu] E China Normal Univ, Coll Life Sci, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Yi, ZH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China.	yirufang@yahoo.com.cn	Li, Zezhi/I-5524-2018		National Natural Science Foundation of China [30971047, 81000581]; Ministry of Science and Technology of China [2006AA02Z430, 2008ZX09312, 2004BA720A21-02]; Science and Technology Commission of Shanghai Municipality [064119533]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China(30971047, 81000581), National High-tech R&D Program (863 Program, 2006AA02Z430, Ministry of Science and Technology of China), National Key Project for IND (investigational new drug)(2008ZX09312, Ministry of Science and Technology of China), "10th Five-Year Plan" of National Key Technologies R&D Program (2004BA720A21-02, Ministry of Science and Technology of China), and the "Climbing Action" Program (064119533, Science and Technology Commission of Shanghai Municipality). The funding organizations had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Psychiatric Association, 2001, DIAGN STAT MAN MENT; Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Ayuso-Mateos JL, 2010, BRIT J PSYCHIAT, V196, P365, DOI 10.1192/bjp.bp.109.071191; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Baumeister H, 2010, AM J PSYCHIAT, V167, P866, DOI 10.1176/appi.ajp.2010.10030398; BEAN AJ, 1992, NEUROSCIENCE, V50, P259, DOI 10.1016/0306-4522(92)90421-W; Blazer DG, 2000, COMPR TEXTB PSYCHIAT, V7th, P1298; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Chuan SK, 2008, INT PSYCHOGERIATR, V20, P188, DOI 10.1017/S1041610207006187; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P4; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Forsell Y, 2007, DEPRESS ANXIETY, V24, P62, DOI 10.1002/da.20231; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Goldney RD, 2004, SOC PSYCH PSYCH EPID, V39, P293, DOI 10.1007/s00127-004-0745-5; Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694; Judd LL, 1997, J AFFECT DISORDERS, V45, P5, DOI 10.1016/S0165-0327(97)00055-4; Judd LL, 1994, J CLIN PSYCHIAT, V55, pS18; Kang HJ, 2007, J NEUROSCI, V27, P13329, DOI 10.1523/JNEUROSCI.4083-07.2007; Karsten J, 2010, J AFFECT DISORDERS, V123, P230, DOI 10.1016/j.jad.2009.10.013; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Lampe JW, 2004, CANCER EPIDEM BIOMAR, V13, P445; Le Hellard S, 2010, MOL PSYCHIATR, V15, P463, DOI 10.1038/mp.2008.110; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Ma J, 2003, J MOL CELL CARDIOL, V35, P993, DOI 10.1016/S0022-2828(03)00179-2; Madia F, 2009, J PERIPHER NERV SYST, V14, P107, DOI 10.1111/j.1529-8027.2009.00220.x; Maier W, 1997, J AFFECT DISORDERS, V45, P41, DOI 10.1016/S0165-0327(97)00058-X; Marshall A, 1998, NAT BIOTECHNOL, V16, P731; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Pandey GN, 2008, J AM ACAD CHILD PSY, V47, P1077, DOI 10.1097/CHI.0b013e31817eecd9; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; SHERBOURNE CD, 1994, AM J PSYCHIAT, V151, P1777; SHIMOJO M, 1993, NEUROSCI LETT, V151, P170, DOI 10.1016/0304-3940(93)90013-B; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Spijker S, 2010, BIOL PSYCHIAT, V68, P179, DOI 10.1016/j.biopsych.2010.03.017; Struyf J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-531; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Thase ME, 2000, COMPREHENSIVE TXB PS, P1318; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161	50	56	61	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31283	10.1371/journal.pone.0031283	http://dx.doi.org/10.1371/journal.pone.0031283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348066	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900038
J	Drummond, EBM; Vellend, M				Drummond, Emily B. M.; Vellend, Mark			Genotypic Diversity Effects on the Performance of Taraxacum officinale Populations Increase with Time and Environmental Favorability	PLOS ONE			English	Article							EXPERIMENTAL PLANT-COMMUNITIES; GENETIC DIVERSITY; PRODUCTIVITY RELATIONSHIPS; ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; RESOURCE AVAILABILITY; BIODIVERSITY; GRASSLAND; COMPLEMENTARITY; DISTURBANCE	Within-population genetic diversity influences many ecological processes, but few studies have examined how environmental conditions may impact these short-term diversity effects. Over four growing seasons, we followed experimental populations of a clonal, ubiquitous weed, Taraxacum officinale, with different numbers of genotypes in relatively favorable fallow field and unfavorable mowed lawn environmental treatments. Population performance (measured as total leaf area, seed production or biomass) clearly and consistently increased with diversity, and this effect became stronger over the course of the experiment. Diversity effects were stronger, and with different underlying mechanisms, in the fallow field versus the mowed lawn. Large genotypes dominated in the fallow field driving overyielding (via positive selection effects), whereas in the mowed lawn, where performance was limited by regular disturbance, there was evidence for complementarity among genotypes (with one compact genotype in particular performing better in mixture than monoculture). Hence, we predict stronger genotypic diversity effects in environments where intense intraspecific competition enhances genotypic differences. Our four-year field experiment plus seedling establishment trials indicate that genotypic diversity effects have far-reaching and context-dependent consequences across generations.	[Drummond, Emily B. M.; Vellend, Mark] Univ British Columbia, Dept Bot, Biodivers Res Ctr, Vancouver, BC, Canada; [Vellend, Mark] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of British Columbia; University of Sherbrooke	Drummond, EBM (corresponding author), Univ British Columbia, Dept Bot, Biodivers Res Ctr, Vancouver, BC, Canada.	ebmd@interchange.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [311785-2010]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC: http://www.nserc-crsng.gc.ca), Discovery Grant #311785-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BELL G, 1991, EVOLUTION, V45, P1036, DOI 10.1111/j.1558-5646.1991.tb04368.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2005, ECOLOGY, V86, P716, DOI 10.1890/03-0727; Cardinale BJ, 2002, ECOLOGY, V83, P1915; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Charmantier A, 2005, P ROY SOC B-BIOL SCI, V272, P1415, DOI 10.1098/rspb.2005.3117; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; De Meester L, 2007, OECOLOGIA, V153, P431, DOI 10.1007/s00442-007-0721-3; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Dzialowski AR, 2008, FRESHWATER BIOL, V53, P148, DOI 10.1111/j.1365-2427.2007.01883.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; FORD H, 1981, BIOL J LINN SOC, V15, P355, DOI 10.1111/j.1095-8312.1981.tb00769.x; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Fridley JD, 2010, ECOLOGY, V91, P2272, DOI 10.1890/09-1240.1; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Gamfeldt L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021972; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; He JS, 2002, OIKOS, V97, P337, DOI 10.1034/j.1600-0706.2002.970304.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hiddink JG, 2009, OIKOS, V118, P1892, DOI 10.1111/j.1600-0706.2009.17556.x; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2009, ECOLOGY, V90, P1412, DOI 10.1890/07-2030.1; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kaiser J, 2000, SCIENCE, V289, P1282, DOI 10.1126/science.289.5483.1282; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; KING LM, 1993, EVOLUTION, V47, P136, DOI 10.1111/j.1558-5646.1993.tb01205.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kotowska AM, 2010, J ECOL, V98, P237, DOI 10.1111/j.1365-2745.2009.01606.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lecerf A, 2010, RIVER RES APPL, V26, P45, DOI 10.1002/rra.1286; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; LYMAN JC, 1984, HEREDITY, V53, P1, DOI 10.1038/hdy.1984.58; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Munzbergova Z, 2009, BASIC APPL ECOL, V10, P411, DOI 10.1016/j.baae.2008.10.005; Mulder CPH, 1999, ECOL LETT, V2, P237; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Parker JD, 2010, ECOL LETT, V13, P553, DOI 10.1111/j.1461-0248.2010.01452.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Smithson JB, 1996, ANN APPL BIOL, V128, P127, DOI 10.1111/j.1744-7348.1996.tb07096.x; SOLBRIG OT, 1977, J ECOL, V65, P427, DOI 10.2307/2259492; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Vavrek MC, 1996, ECOLOGY, V77, P2098, DOI 10.2307/2265704; Vellend M, 2010, OECOLOGIA, V162, P371, DOI 10.1007/s00442-009-1480-0; Vellend M, 2009, WEED SCI, V57, P410, DOI 10.1614/WS-09-004.1; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitlock R, 2007, J ECOL, V95, P895, DOI 10.1111/j.1365-2745.2007.01275.x; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	63	34	36	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30314	10.1371/journal.pone.0030314	http://dx.doi.org/10.1371/journal.pone.0030314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348004	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900008
J	Luo, CW; Tsementzi, D; Kyrpides, N; Read, T; Konstantinidis, KT				Luo, Chengwei; Tsementzi, Despina; Kyrpides, Nikos; Read, Timothy; Konstantinidis, Konstantinos T.			Direct Comparisons of Illumina vs. Roche 454 Sequencing Technologies on the Same Microbial Community DNA Sample	PLOS ONE			English	Article							GENOME; GENERATION; ALIGNMENT; CATALOG; BLAST	Next-generation sequencing (NGS) is commonly used in metagenomic studies of complex microbial communities but whether or not different NGS platforms recover the same diversity from a sample and their assembled sequences are of comparable quality remain unclear. We compared the two most frequently used platforms, the Roche 454 FLX Titanium and the Illumina Genome Analyzer (GA) II, on the same DNA sample obtained from a complex freshwater planktonic community. Despite the substantial differences in read length and sequencing protocols, the platforms provided a comparable view of the community sampled. For instance, derived assemblies overlapped in similar to 90% of their total sequences and in situ abundances of genes and genotypes (estimated based on sequence coverage) correlated highly between the two platforms (R-2>0.9). Evaluation of base-call error, frameshift frequency, and contig length suggested that Illumina offered equivalent, if not better, assemblies than Roche 454. The results from metagenomic samples were further validated against DNA samples of eighteen isolate genomes, which showed a range of genome sizes and G+C% content. We also provide quantitative estimates of the errors in gene and contig sequences assembled from datasets characterized by different levels of complexity and G+C% content. For instance, we noted that homopolymer-associated, single-base errors affected similar to 1% of the protein sequences recovered in Illumina contigs of 10 x coverage and 50% G+C; this frequency increased to similar to 3% when non-homopolymer errors were also considered. Collectively, our results should serve as a useful practical guide for choosing proper sampling strategies and data possessing protocols for future metagenomic studies.	[Luo, Chengwei; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Luo, Chengwei; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Ctr Bioinformat & Computat Genom, Atlanta, GA 30332 USA; [Tsementzi, Despina; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Kyrpides, Nikos] Joint Genome Inst, Dept Energy DOE, Walnut Creek, CA USA; [Read, Timothy] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Emory University	Luo, CW (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	kostas@ce.gatech.edu	Kyrpides, Nikos C./A-6305-2014; Konstantinidis, Kostas/ABE-7113-2020; Read, Timothy/E-6240-2011	Kyrpides, Nikos C./0000-0002-6131-0462; Konstantinidis, Kostas/0000-0002-0954-4755; Tsementzi, Despina/0000-0002-4578-1918; Read, Timothy/0000-0001-8966-9680	U.S. Department of Energy [DE-SC0004601]; Georgia Research Alliance and the Atlanta Clinical and Translational Sciences Institute; Onassis Scholarship Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); Georgia Research Alliance and the Atlanta Clinical and Translational Sciences Institute; Onassis Scholarship Foundation	This research was supported, in part, by the U.S. Department of Energy (award DE-SC0004601). The Emory Genome Center acknowledges the Georgia Research Alliance and the Atlanta Clinical and Translational Sciences Institute for funding for major equipment purchases. DT acknowledges the support of the Onassis Scholarship Foundation. No additional external funding was received for this study. The sponsors of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dolan PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-250; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Luo C, 2011, ISME J; Mackelprang R, 2011, NATURE; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Schroder J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012681; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	30	342	383	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30087	10.1371/journal.pone.0030087	http://dx.doi.org/10.1371/journal.pone.0030087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347999	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730900005
J	Chakraborty, S; Rao, BJ				Chakraborty, Sandeep; Rao, Basuthkar J.			A Measure of the Promiscuity of Proteins and Characteristics of Residues in the Vicinity of the Catalytic Site That Regulate Promiscuity	PLOS ONE			English	Article							LATENT EVOLUTIONARY POTENTIALS; COMPUTATIONAL ENZYME DESIGN; DIRECTED EVOLUTION; DIVERGENT EVOLUTION; ENOLASE SUPERFAMILY; ELECTROSTATICS; PREDICTION; BIOLOGY; SPECIFICITY; PERSPECTIVE	Promiscuity, the basis for the evolution of new functions through 'tinkering' of residues in the vicinity of the catalytic site, is yet to be quantitatively defined. We present a computational method Promiscuity Indices Estimator (PROMISE) - based on signatures derived from the spatial and electrostatic properties of the catalytic residues, to estimate the promiscuity (PromIndex) of proteins with known active site residues and 3D structure. PromIndex reflects the number of different active site signatures that have congruent matches in close proximity of its native catalytic site, the quality of the matches and difference in the enzymatic activity. Promiscuity in proteins is observed to follow a lognormal distribution (mu = 0.28, sigma = 1.1 reduced chi-square = 3.0E-5). The PROMISE predicted promiscuous functions in any protein can serve as the starting point for directed evolution experiments. PROMISE ranks carboxypeptidase A and ribonuclease A amongst the more promiscuous proteins. We have also investigated the properties of the residues in the vicinity of the catalytic site that regulates its promiscuity. Linear regression establishes a weak correlation (R-2 similar to 0.1) between certain properties of the residues (charge, polar, etc) in the neighborhood of the catalytic residues and PromIndex. A stronger relationship states that most proteins with high promiscuity have high percentages of charged and polar residues within a radius of 3 angstrom of the catalytic site, which is validated using one-tailed hypothesis tests (P-values similar to 0.05). Since it is known that these characteristics are key factors in catalysis, their relationship with the promiscuity index cross validates the methodology of PROMISE.	[Chakraborty, Sandeep; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjrao@tifr.res.in			Tata Institute of Fundamental Research (Department of Atomic Energy)	Tata Institute of Fundamental Research (Department of Atomic Energy)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Babtie A, 2010, CURR OPIN CHEM BIOL, V14, P200, DOI 10.1016/j.cbpa.2009.11.028; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chakraborty S, PLOS ONE IN PRESS; Cohen-Gihon I, 2011, MOL BIOSYST, V7, P784, DOI 10.1039/c0mb00182a; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Copley Shelley D, 2009, F1000 Biol Rep, V1, P91, DOI 10.3410/B1-91; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DePristo MA, 2007, HFSP J, V1, P94, DOI 10.2976/1.2754665; Di Nardo G, 2009, J BIOL INORG CHEM, V14, P497, DOI 10.1007/s00775-009-0465-0; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Fernandez A, 2005, J BIOMOL STRUCT DYN, V22, P615, DOI 10.1080/07391102.2005.10531228; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Gronholm T, 2007, MATH BIOSCI, V210, P659, DOI 10.1016/j.mbs.2007.07.004; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kristensen DM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-17; Leitgeb S, 2010, CHEMBIOCHEM, V11, P502, DOI 10.1002/cbic.200900688; LEWIS EB, 1951, COLD SPRING HARB SYM, V16, P159, DOI 10.1101/SQB.1951.016.01.014; Lombard J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-232; Martin AC, 1998, STRUCTURE, V6, P875, DOI 10.1016/S0969-2126(98)00089-6; Nagatani RA, 2007, BIOCHEMISTRY-US, V46, P6688, DOI 10.1021/bi700507d; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nielsen JE, 1999, EUR J BIOCHEM, V264, P816, DOI 10.1046/j.1432-1327.1999.00664.x; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Park C, 2003, BIOCHEMISTRY-US, V42, P3509, DOI 10.1021/bi026076k; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wroe R, 2007, HFSP J, V1, P79, DOI [10.2976/1.2739116, 10.2976/1.2739116/10.2976/1]; YAMAMURA K, 1976, J CHEM SOC CHEM COMM, P830, DOI 10.1039/c39760000830; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	69	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32011	10.1371/journal.pone.0032011	http://dx.doi.org/10.1371/journal.pone.0032011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359655	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200124
J	Haddaway, NR; Wilcox, RH; Heptonstall, REA; Griffiths, HM; Mortimer, RJG; Christmas, M; Dunn, AM				Haddaway, Neal R.; Wilcox, Ruth H.; Heptonstall, Rachael E. A.; Griffiths, Hannah M.; Mortimer, Robert J. G.; Christmas, Martin; Dunn, Alison M.			Predatory Functional Response and Prey Choice Identify Predation Differences between Native/Invasive and Parasitised/Unparasitised Crayfish	PLOS ONE			English	Article							PACIFASTACUS-LENIUSCULUS; IMPACT; PARASITES; GROWTH; STREAM; FISH; BIODIVERSITY; COMPETITION; INVASION; DISEASE	Background: Invasive predators may change the structure of invaded communities through predation and competition with native species. In Europe, the invasive signal crayfish Pacifastacus leniusculus is excluding the native white clawed crayfish Austropotamobius pallipes. Methodology and Principal Findings: This study compared the predatory functional responses and prey choice of native and invasive crayfish and measured impacts of parasitism on the predatory strength of the native species. Invasive crayfish showed a higher (>10%) prey (Gammarus pulex) intake rate than (size matched) natives, reflecting a shorter (16%) prey handling time. The native crayfish also showed greater selection for crustacean prey over molluscs and bloodworm, whereas the invasive species was a more generalist predator. A. pallipes parasitised by the microsporidian parasite Thelohania contejeani showed a 30% reduction in prey intake. We suggest that this results from parasite-induced muscle damage, and this is supported by a reduced (38%) attack rate and increased (30%) prey handling time. Conclusions and Significance: Our results indicate that the per capita (i.e., functional response) difference between the species may contribute to success of the invader and extinction of the native species, as well as decreased biodiversity and biomass in invaded rivers. In addition, the reduced predatory strength of parasitized natives may impair their competitive abilities, facilitating exclusion by the invader.	[Haddaway, Neal R.] Bangor Univ, Sch Environm Nat Resources & Geog, Coll Nat Sci, Bangor, Gwynedd, Wales; [Haddaway, Neal R.; Wilcox, Ruth H.; Heptonstall, Rachael E. A.; Griffiths, Hannah M.; Dunn, Alison M.] Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Mortimer, Robert J. G.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Christmas, Martin] Environm Agcy, Leeds, W Yorkshire, England	Bangor University; University of Leeds; University of Leeds	Haddaway, NR (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Coll Nat Sci, Bangor, Gwynedd, Wales.	a.dunn@leeds.ac.uk		Mortimer, Robert/0000-0003-1292-8861; Haddaway, Neal R/0000-0003-3902-2234; Dunn, Alison/0000-0002-4855-1077	NERC CASE; British Environment Agency	NERC CASE(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Environment Agency	This work was funded by a NERC (www.nerc.ac.uk) CASE PhD studentship in partnership with the British Environment Agency (www.environment-agency.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Bates D., 2008, LME4 LINEAR MIXED EF; Bolker B., 2009, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker BM, 2010, EMDBOOK ECOLOGICAL M; Bollache L, 2004, ARCH HYDROBIOL, V160, P57, DOI 10.1127/0003-9136/2004/0160-0057; Bollache L, 2008, BIOL LETTERS, V4, P166, DOI 10.1098/rsbl.2007.0554; Crawford L, 2006, AQUAT CONSERV, V16, P611, DOI 10.1002/aqc.761; Dick JTA, 2010, BIOL LETT; Dorn NJ, 1999, VIE MILIEU, V49, P229; Dunn AM, 2009, ADV PARASIT, V68, P161, DOI 10.1016/S0065-308X(08)00607-6; Dunn AM, 2011, INT J PARAS IN PRESS; Dunn JC, 2009, BIOL INVASIONS, V11, P315, DOI 10.1007/s10530-008-9249-7; EGGLESTON DB, 1990, J EXP MAR BIOL ECOL, V143, P73, DOI 10.1016/0022-0981(90)90112-P; Ellis BK, 2011, P NATL ACAD SCI USA, V108, P1070, DOI 10.1073/pnas.1013006108; Everard M., 2009, ENV LAW MANAGEMENT, V21, P250; Gherardi F., 1999, CRAYFISH EUROPE ALIE; Gherardi Francesca, 2007, BFPP Connaisance et Gestion Patrimoine Aquatique, V387, P7; Goddard J.S., 1988, P145; Guan Rui-Zhang, 1994, Freshwater Forum, V4, P155; Guan RZ, 1999, FISH RES, V42, P245, DOI 10.1016/S0165-7836(99)00044-2; Guan RZ, 1996, AQUAT LIVING RESOUR, V9, P265, DOI 10.1051/alr:1996030; HANSON JM, 1990, FRESHWATER BIOL, V24, P69, DOI 10.1111/j.1365-2427.1990.tb00308.x; Hassell MP., 1978, DYNAMICS ARTHROPOD P; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich DM, 1999, CRUSTACEAN ISS, V11, P281; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; Hooff RC, 2004, MAR ECOL PROG SER, V277, P167, DOI 10.3354/meps277167; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Imhoff Emily M., 2009, P49; IUCN, 2011, CONS DIV LIF; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; MacNeil C, 2003, FRESHWATER BIOL, V48, P2085, DOI 10.1046/j.1365-2427.2003.01145.x; MacNeil C, 2003, P ROY SOC B-BIOL SCI, V270, P1309, DOI 10.1098/rspb.2003.2358; Maitland Peter S., 2001, Glasgow Naturalist, V23, P26; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Morgan JF, 2007, EVID-BASED MENT HEAL, V10, P34, DOI 10.1136/ebmh.10.2.34; Mouritsen KN, 2005, OIKOS, V108, P344, DOI 10.1111/j.0030-1299.2005.13507.x; Nystrom P, 1996, FRESHWATER BIOL, V36, P631, DOI 10.1046/j.1365-2427.1996.d01-528.x; Oidtmann B., 1996, FRESHWATER CRAYFISH, V11, P465; Olden JD, 2009, AQUAT ECOL, V43, P1073, DOI 10.1007/s10452-009-9244-9; Peay S, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2010003; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pulliam H, 1989, PERSPECTIVES ECOLOGI, P23; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; R Development Core Team, 2005, R LANG ENV STAT COMP; Radford IJ, 2007, AUSTRAL ECOL, V32, P338, DOI 10.1111/j.1442-9993.2007.01700.x; Rehage JS, 2005, ECOL FRESHW FISH, V14, P352, DOI 10.1111/j.1600-0633.2005.00109.x; Renai B, 2004, BIOL INVASIONS, V6, P89, DOI 10.1023/B:BINV.0000010126.94675.50; Reynolds J., 2011, MANAGEMENT FRESHWATE; Reynolds JD, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011024; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; Rogers D, 2003, CONSERVING NATURA 20, V8; Royama T., 1971, Researches Popul Ecol Kyoto Univ, V1, P1; Rushton SP, 2000, J APPL ECOL, V37, P997, DOI 10.1046/j.1365-2664.2000.00553.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; SETTLE WH, 1990, ECOLOGY, V71, P1461, DOI 10.2307/1938283; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Stenroth P, 2003, FRESHWATER BIOL, V48, P466, DOI 10.1046/j.1365-2427.2003.01020.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; TRUDGILL N, 2000, N AM SIGNAL CRAYFISH; VINSON SB, 1970, J INSECT PHYSIOL, V16, P1329, DOI 10.1016/0022-1910(70)90132-0; Vogt G, 1999, CRUSTACEAN ISS, V11, P87; Wilmers CC, 2006, ECOL LETT, V9, P383, DOI 10.1111/j.1461-0248.2006.00890.x; ZARET TM, 1973, SCIENCE, V182, P449, DOI 10.1126/science.182.4111.449	69	81	82	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32229	10.1371/journal.pone.0032229	http://dx.doi.org/10.1371/journal.pone.0032229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359673	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302796200142
J	Jindrichova, M; Lansdell, SJ; Millar, NS				Jindrichova, Marie; Lansdell, Stuart J.; Millar, Neil S.			Changes in Temperature Have Opposing Effects on Current Amplitude in alpha 7 and alpha 4 beta 2 Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATORS; SENSITIVE EXPRESSION; DROSOPHILA; CHANNELS; AGONIST; BINDING; DESENSITIZATION; PHARMACOLOGY; ACTIVATION; TARGETS	We have examined the effect of temperature on the electrophysiological properties of three neuronal nicotinic acetylcholine receptor (nAChR) subtypes: the rapidly desensitizing homomeric alpha 7 nAChR, the more slowly desensitizing heteromeric alpha 4 beta 2 nAChR and on alpha 7 nAChRs containing a transmembrane mutation (L247T) that results in dramatically reduced desensitization. In all cases, the functional properties of receptors expressed in Xenopus oocytes at room temperature (RT; 21 degrees C) were compared to those recorded at either physiological temperature (37 degrees C) or at lower temperature (4 degrees C). Alterations in temperature had dramatically differing effects on the amplitude of whole-cell responses detected with these three nAChR subtypes. Compared to responses at RT, the amplitude of agonist-evoked responses with alpha 4 beta 2 nAChRs was increased at high temperature (125 +/- 9%, n=6, P<0.01) and reduced at low temperature (47 +/- 5%, n=6, P<0.01), whereas the amplitude of alpha 7 responses was reduced at high temperature (27 +/- 7%, n = 11, P<0.001) and increased at low temperatures (224 +/- 16%, n = 10, P<0.001). In contrast to the effects of temperature on alpha 4 beta 2 and wild type alpha 7 nAChRs, the amplitude of alpha 7 nAChRs containing the L247T mutation was unaffected by changes in temperature. In addition, changes in temperature had little or no effect on current amplitude when alpha 7 nAChRs were activated by the largely non-desensitizing allosteric agonist 4BP-TQS. Despite these differing effects of temperature on the amplitude of agonist-evoked responses in different nAChRs, changes in temperature had a consistent effect on the rate of receptor desensitization on all subtypes examined. In all cases, higher temperature resulted in increased rates of desensitization. Thus, it appears that the differing effects of temperature on the amplitudes of whole-cell responses cannot be explained by temperature-induced changes in receptor desensitization rates.	[Jindrichova, Marie; Lansdell, Stuart J.; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Jindrichova, Marie] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic	University of London; University College London; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Jindrichova, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	n.millar@ucl.ac.uk	Jindrichova, Marie/H-4320-2014; Jindrichova, Marie/C-3401-2012		Federation of European Biochemical Societies (FEBS); Wellcome Trust [WT085141]	Federation of European Biochemical Societies (FEBS); Wellcome Trust(Wellcome TrustEuropean Commission)	MJ was supported by a Short Term Fellowship from Federation of European Biochemical Societies (FEBS). SJL was supported by a grant awarded to NSM from The Wellcome Trust (WT085141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bertrand S, 1997, NEUROREPORT, V8, P3591, DOI 10.1097/00001756-199711100-00034; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; BREGESTOVSKI PD, 1972, NATURE, V236, P453, DOI 10.1038/236453a0; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; D'hoedt D, 2009, EXPERT OPIN THER TAR, V13, P395, DOI [10.1517/14728220902841045 , 10.1517/14728220902841045]; DICKINSON R, 1995, BRIT J PHARMACOL, V116, P2949, DOI 10.1111/j.1476-5381.1995.tb15949.x; DILGER JP, 1991, BIOCHIM BIOPHYS ACTA, V1063, P253, DOI 10.1016/0005-2736(91)90379-M; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gupta S, 2011, BIOPHYS J, V100, P895, DOI 10.1016/j.bpj.2010.12.3727; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; HEAD SD, 1983, J PHYSIOL-LONDON, V334, P441, DOI 10.1113/jphysiol.1983.sp014505; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; Khmyz V, 2008, EUR J PHYSL, V456, P399; KORDAS M, 1972, J PHYSIOL-LONDON, V224, P333, DOI 10.1113/jphysiol.1972.sp009898; Korinek M, 2010, NEUROSCIENCE, V165, P736, DOI 10.1016/j.neuroscience.2009.10.058; Lansdell SJ, 2004, J NEUROCHEM, V90, P479, DOI 10.1111/j.1471-4159.2004.02499.x; Lansdell SJ, 1997, J NEUROCHEM, V68, P1812; Lansdell SJ, 2008, J NEUROCHEM, V105, P1573, DOI 10.1111/j.1471-4159.2008.05235.x; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; Millar NS, 2009, BIOCHEM PHARMACOL, V78, P766, DOI 10.1016/j.bcp.2009.06.015; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Nelson ME, 2001, J GEN PHYSIOL, V118, P563, DOI 10.1085/jgp.118.5.563; PAULSON HL, 1990, J CELL BIOL, V110, P1705, DOI 10.1083/jcb.110.5.1705; QUARTARARO N, 1988, PFLUG ARCH EUR J PHY, V411, P101, DOI 10.1007/BF00581653; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Rollema H, 2007, TRENDS PHARMACOL SCI, V28, P316, DOI 10.1016/j.tips.2007.05.003; SINE SM, 1984, BIOPHYS J, V45, P175, DOI 10.1016/S0006-3495(84)84146-6; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sitzia F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00081; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809; Zanello LP, 1996, BIOPHYS J, V70, P2155, DOI 10.1016/S0006-3495(96)79781-3	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32073	10.1371/journal.pone.0032073	http://dx.doi.org/10.1371/journal.pone.0032073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359659	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200128
J	Lund, TC; Stadem, PS; Panoskaltsis-Mortari, A; Raymond, G; Miller, WP; Tolar, J; Orchard, PJ				Lund, Troy C.; Stadem, Paul S.; Panoskaltsis-Mortari, Angela; Raymond, Gerald; Miller, Weston P.; Tolar, Jakub; Orchard, Paul J.			Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity	PLOS ONE			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; MULTIPLE-SCLEROSIS; CHEMOKINE RECEPTORS; DISEASE; CHITOTRIOSIDASE; TRANSPLANTATION; CXCR4/CXCL12; ACCUMULATION; INFLAMMATION; MECHANISMS	Background: X-linked adrenoleukodystrophy (ALD) is a metabolic, peroxisomal disease that results from a mutation in the ABCD1 gene. The most severe course of ALD progression is the cerebral inflammatory and demyelinating form of the disease, cALD. To date there is very little information on the cytokine mediators in the cerebral spinal fluid (CSF) of these boys. Methodology/Principal Findings: Measurement of 23 different cytokines was performed on CSF and serum of boys with cerebral ALD and patients without ALD. Significant elevations in CSF IL-8 (29.3 +/- 2.2 vs 12.8 +/- 1.1 pg/ml, p = 0.0001), IL-1ra (166 +/- 30 vs 8.6 +/- 6.5 pg/ml, p = 0.005), MCP-1 (610 +/- 47 vs 328 +/- 34 pg/ml, p = 0.002), and MIP-1b (14.2 +/- 1.3 vs 2.0 +/- 1.4 pg/ml, p<0.0001) were found in boys with cALD versus the control group. The only serum cytokine showing an elevation in the ALD group was SDF-1 (2124 +/- 155 vs 1175 +/- 125 pg/ml, p = 0.0001). The CSF cytokines of IL-8 and MCP-1b correlated with the Loes MRI severity score (p = 0.04 and p = 0.008 respectively), as well as the serum SDF-1 level (p = 0.002). Finally, CSF total protein was also significantly elevated in boys with cALD and correlated with both IL-8, MCP-1b (p = 0.0001 for both), as well as Loes MRI severity score (p = 0.0007). Conclusions/Significance: IL-8, IL-1ra, MCP-1, MIP-1b and CSF total protein were significantly elevated in patients with cALD; IL-8, MCP-1b, and CSF total protein levels correlated with disease severity determined by MRI. This is the largest report of CSF cytokine levels in cALD to date, and identification of these key cytokines will provide further insight into disease progression and perhaps lead to improved targeted therapies.	[Lund, Troy C.; Stadem, Paul S.; Panoskaltsis-Mortari, Angela; Miller, Weston P.; Tolar, Jakub; Orchard, Paul J.] Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA; [Raymond, Gerald] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA	University of Minnesota System; University of Minnesota Twin Cities; Kennedy Krieger Institute	Lund, TC (corresponding author), Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA.	lundx072@umn.edu		Tolar, Jakub/0000-0002-0957-4380	Children's Cancer Research Fund	Children's Cancer Research Fund	This work was funded, in part, by the Children's Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Casal JA, 2003, CLIN BIOCHEM, V36, P553, DOI 10.1016/S0009-9120(03)00093-6; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Deon M, 2006, J NEUROL SCI, V247, P157, DOI 10.1016/j.jns.2006.04.004; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hallegua DS, 2002, ANN RHEUM DIS, V61, P960, DOI 10.1136/ard.61.11.960; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Hudspeth MP, 2007, J NEUROIMMUNOL, V182, P5, DOI 10.1016/j.jneuroim.2006.10.009; Koehne P, 2002, CHILD NERV SYST, V18, P137, DOI 10.1007/s00381-002-0567-2; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; LOES DJ, 1994, AM J NEURORADIOL, V15, P1761; McGuinness MC, 1997, J NEUROIMMUNOL, V75, P174, DOI 10.1016/S0165-5728(97)00020-9; MCGUINNESS MC, 1995, J NEUROIMMUNOL, V61, P161, DOI 10.1016/0165-5728(95)00084-F; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Miller WP, 2011, BLOOD; Moll NM, 2009, ARCH NEUROL-CHICAGO, V66, P44, DOI 10.1001/archneurol.2008.512; Orchard PJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-144; Paintlia AS, 2003, NEUROBIOL DIS, V14, P425, DOI 10.1016/j.nbd.2003.08.013; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; PHILLIPS JP, 1994, PEDIATR NEUROL, V10, P289, DOI 10.1016/0887-8994(94)90124-4; Polgreen LE, 2011, EUROPEAN J PEDIAT; POWERS JM, 1992, J NEUROPATH EXP NEUR, V51, P630, DOI 10.1097/00005072-199211000-00007; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; Sotgiu S, 2006, MULT SCLER J, V12, P551, DOI 10.1177/1352458506070614; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Zajkowska J, 2011, ADV MED SCI, P1	29	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32218	10.1371/journal.pone.0032218	http://dx.doi.org/10.1371/journal.pone.0032218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359672	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200141
J	Medrano, LM; Garcia-Magarinos, M; Dema, B; Espino, L; Maluenda, C; Polanco, I; Figueredo, MA; Fernandez-Arquero, M; Nunez, C				Maria Medrano, Luz; Garcia-Magarinos, Manuel; Dema, Barbara; Espino, Laura; Maluenda, Carlos; Polanco, Isabel; Angeles Figueredo, M.; Fernandez-Arquero, Miguel; Nunez, Concepcion			Th17-Related Genes and Celiac Disease Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK VARIANTS; TH17 CELLS; IL23R; INTERLEUKIN-23; INFLAMMATION; EPISTASIS; PSORIASIS; COLITIS; GLIADIN	Th17 cells are known to be involved in several autoimmune or inflammatory diseases. In celiac disease (CD), recent studies suggest an implication of those cells in disease pathogenesis. We aimed at studying the role of genes relevant for the Th17 immune response in CD susceptibility. A total of 101 single nucleotide polymorphisms (SNPs), mainly selected to cover most of the variability present in 16 Th17-related genes (IL23R, RORC, IL6R, IL17A, IL17F, CCR6, IL6, JAK2, TNFSF15, IL23A, IL22, STAT3, TBX21, SOCS3, IL12RB1 and IL17RA), were genotyped in 735 CD patients and 549 ethnically matched healthy controls. Case-control comparisons for each SNP and for the haplotypes resulting from the SNPs studied in each gene were performed using chi-square tests. Gene-gene interactions were also evaluated following different methodological approaches. No significant results emerged after performing the appropriate statistical corrections. Our results seem to discard a relevant role of Th17 cells on CD risk.	[Maria Medrano, Luz; Dema, Barbara; Espino, Laura; Angeles Figueredo, M.; Fernandez-Arquero, Miguel; Nunez, Concepcion] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, UGC Inmunol, Hosp Clin San Carlos, Madrid, Spain; [Garcia-Magarinos, Manuel] Univ Santiago de Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Santiago De Compostela, Spain; [Garcia-Magarinos, Manuel] Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Spain; [Garcia-Magarinos, Manuel] Univ Publ Navarra, Dept Estadist & IO, Pamplona, Spain; [Maluenda, Carlos] Hosp Clin San Carlos, Serv Pediat, Madrid, Spain; [Polanco, Isabel] Hosp La Paz, Serv Gastroenterol Pediat, Madrid, Spain	Hospital Clinico San Carlos; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidad Publica de Navarra; Hospital Clinico San Carlos; Hospital Universitario La Paz	Medrano, LM (corresponding author), Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, UGC Inmunol, Hosp Clin San Carlos, Madrid, Spain.	conchita.npardo@gmail.com	Núñez, Concepción/H-8517-2017; de dios, luz maria medrano/K-1946-2016; Garcia-Magariños, Manuel/K-2252-2014; Dema, Barbara/AAM-2354-2020	de dios, luz maria medrano/0000-0003-3717-5384; Garcia-Magariños, Manuel/0000-0001-8257-8719; Nunez, Concepcion/0000-0002-9489-1603; Espino-Paisan, Laura/0000-0001-9136-4106	Fondo de Investigaciones Sanitarias [CP08/00213]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by a grant from "Fondo de Investigaciones Sanitarias" (CP08/00213). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush WS, 2011, GENES IMMUN, V12, P335, DOI 10.1038/gene.2011.3; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dema B, 2009, HUM IMMUNOL, V70, P191, DOI 10.1016/j.humimm.2009.01.010; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lees CW, 2011, GUT; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nunez C, 2008, GENES IMMUN, V9, P289, DOI 10.1038/gene.2008.16; Oukka M, 2008, ANN RHEUM DIS, V67, P26, DOI 10.1136/ard.2008.098004; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	26	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31244	10.1371/journal.pone.0031244	http://dx.doi.org/10.1371/journal.pone.0031244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359581	Green Published, gold			2022-12-27	WOS:000302796200050
J	Oakley, S; Vedula, LS; Bu, WM; Meng, QC; Xi, J; Liu, RY; Eckenhoff, RG; Loll, PJ				Oakley, Simon; Vedula, L. Sangeetha; Bu, Weiming; Meng, Qing Cheng; Xi, Jin; Liu, Renyu; Eckenhoff, Roderic G.; Loll, Patrick J.			Recognition of Anesthetic Barbiturates by a Protein Binding Site: A High Resolution Structural Analysis	PLOS ONE			English	Article							GABA(A) RECEPTOR; ION-CHANNEL; IDENTIFICATION; PROPOFOL; SENSITIVITY; MODULATION; ETOMIDATE; QUALITY; BUNDLE; SET	Barbiturates potentiate GABA actions at the GABA(A) receptor and act as central nervous system depressants that can induce effects ranging from sedation to general anesthesia. No structural information has been available about how barbiturates are recognized by their protein targets. For this reason, we tested whether these drugs were able to bind specifically to horse spleen apoferritin, a model protein that has previously been shown to bind many anesthetic agents with affinities that are closely correlated with anesthetic potency. Thiopental, pentobarbital, and phenobarbital were all found to bind to apoferritin with affinities ranging from 10-500 mu M, approximately matching the concentrations required to produce anesthetic and GABAergic responses. X-ray crystal structures were determined for the complexes of apoferritin with thiopental and pentobarbital at resolutions of 1.9 and 2.0 angstrom, respectively. These structures reveal that the barbiturates bind to a cavity in the apoferritin shell that also binds haloalkanes, halogenated ethers, and propofol. Unlike these other general anesthetics, however, which rely entirely upon van der Waals interactions and the hydrophobic effect for recognition, the barbiturates are recognized in the apoferritin site using a mixture of both polar and nonpolar interactions. These results suggest that any protein binding site that is able to recognize and respond to the chemically and structurally diverse set of compounds used as general anesthetics is likely to include a versatile mixture of both polar and hydrophobic elements.	[Oakley, Simon; Vedula, L. Sangeetha; Bu, Weiming; Meng, Qing Cheng; Xi, Jin; Liu, Renyu; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Drexel University	Oakley, S (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	ploll@drexelmed.edu		Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health/National Institute of General Medical Sciences [P01 GM055876]; U.S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health/National Institute of General Medical Sciences [P01 GM055876]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We thank the staff of beam line X6A of the National Synchrotron Light Source (NSLS), which is supported by the National Institute of General Medical Sciences, National Institutes of Health. The NSLS at Brookhaven National Laboratory is supported by the U.S. Department of Energy.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDREWS PR, 1982, ANESTHESIOLOGY, V57, P314, DOI 10.1097/00000542-198210000-00014; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bertaccini EJ, 2007, ANESTH ANALG, V104, P318, DOI 10.1213/01.ane.0000253029.67331.8d; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Chang CSS, 2003, J BIOL CHEM, V278, P42821, DOI 10.1074/jbc.M306978200; Cheng TJ, 2007, J CHEM INF MODEL, V47, P2140, DOI 10.1021/ci700257y; DINGEMANSE J, 1990, J PHARM SCI, V79, P207, DOI 10.1002/jps.2600790305; Eckenhoff R G, 2001, Mol Interv, V1, P258; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk MJ, 2006, CURR BIOL, V16, P1641, DOI 10.1016/j.cub.2006.06.072; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Granier T, 1997, ACTA CRYSTALLOGR D, V53, P580, DOI 10.1107/S0907444997003314; Jenkins A, 2002, NEUROPHARMACOLOGY, V43, P669, DOI 10.1016/S0028-3908(02)00175-2; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Krasowski MD, 2002, J MED CHEM, V45, P3210, DOI 10.1021/jm010461a; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazarenko RM, 2010, J NEUROSCI, V30, P7691, DOI 10.1523/JNEUROSCI.1655-10.2010; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Lopez-Munoz Francisco, 2005, Neuropsychiatr Dis Treat, V1, P329; Ma DJ, 2008, BIOPHYS J, V94, P4454, DOI 10.1529/biophysj.107.117838; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mecozzi S, 1998, CHEM-EUR J, V4, P1016, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1016::AID-CHEM1016>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Rho JM, 1996, J PHYSIOL-LONDON, V497, P509, DOI 10.1113/jphysiol.1996.sp021784; Sandorfy C, 2004, ANESTHESIOLOGY, V101, P1225, DOI 10.1097/00000542-200411000-00024; Schofield CM, 2005, BRAIN RES, V1032, P30, DOI 10.1016/j.brainres.2004.11.002; Tomlin SL, 1999, ANESTHESIOLOGY, V90, P1714, DOI 10.1097/00000542-199906000-00029; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; YAKUSHIJI T, 1989, BRAIN RES, V488, P357, DOI 10.1016/0006-8993(89)90730-0	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32070	10.1371/journal.pone.0032070	http://dx.doi.org/10.1371/journal.pone.0032070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359658	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200127
J	Wang, CY; Tsai, AC; Peng, CY; Chang, YL; Lee, KH; Teng, CM; Pan, SL				Wang, Chih-Ya; Tsai, An-Chi; Peng, Chieh-Yu; Chang, Ya-Ling; Lee, Kuo-Hsiung; Teng, Che-Ming; Pan, Shiow-Lin			Dehydrocostuslactone Suppresses Angiogenesis In Vitro and In Vivo through Inhibition of Akt/GSK-3 beta and mTOR Signaling Pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; CYCLIN D1; CANCER CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; SAUSSUREA-LAPPA; TUMOR-GROWTH; AKT; LACTONE; EXPRESSION	The traditional Chinese medicine component dehydrocostuslactone (DHC) isolated from Saussurea costus (Falc.) Lipschitz, has been shown to have anti-cancer activity. Angiogenesis is an essential process in the growth and progression of cancer. In this study, we demonstrated, for the first time, the anti-angiogenic mechanism of action of DHC to be via the induction of cell cycle progression at the G0/G1 phase due to abrogation of the Akt/glycogen synthase kinase-3 beta (GSK-3 beta)/cyclin D1 and mTOR signaling pathway. First, we demonstrated that DHC has an anti-angiogenic effect in the matrigel-plug nude mice model and an inhibitory effect on human umbilical vein endothelial cell (HUVEC) proliferation and capillary-like tube formation in vitro. DHC caused G0/G1 cell cycle arrest, which was associated with the down-regulation of cyclin D1 expression, leading to the suppression of retinoblastoma protein phosphorylation and subsequent inhibition of cyclin A and cdk2 expression. With respect to the molecular mechanisms underlying the DHC-induced cyclin D1 down-regulation, this study demonstrated that DHC significantly inhibits Akt expression, resulting in the suppression of GSK-3b phosphorylation and mTOR expression. These effects are capable of regulating cyclin D1 degradation, but they were significantly reversed by constitutively active myristoylated (myr)-Akt. Furthermore, the abrogation of tube formation induced by DHC was also reversed by overexpression of Akt. And the co-treatment with LiCl and DHC significantly reversed the growth inhibition induced by DHC. Taken together, our study has identified Akt/GSK-3 beta and mTOR as important targets of DHC and has thus highlighted its potential application in angiogenesis-related diseases, such as cancer.	[Wang, Chih-Ya; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Tsai, An-Chi; Pan, Shiow-Lin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town, Taiwan; [Peng, Chieh-Yu] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Peng, Chieh-Yu] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wang, CY (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	cmteng@ntu.edu.tw; apan0826@nhri.org.tw	Pan, Shiow-Lin/C-1372-2010	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan [NSC 99-2320-B400-008-MY3, NSC 99-2628-B002-024-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Grants from the National Science Council of Taiwan (NSC 99-2320-B400-008-MY3) and (NSC 99-2628-B002-024-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHEN HC, 1995, ANTIVIR RES, V27, P99, DOI 10.1016/0166-3542(94)00083-K; Choi EJ, 2009, INT J MOL MED, V23, P211, DOI 10.3892/ijmm_00000119; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; El Sayed KA, 2005, MINI-REV MED CHEM, V5, P971, DOI 10.2174/138955705774575291; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Hanai J, 2002, J BIOL CHEM, V277, P16464, DOI 10.1074/jbc.M112274200; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200; Kuo PL, 2009, MOL CANCER THER, V8, P1328, DOI 10.1158/1535-7163.MCT-08-0914; Lee HJ, 1999, PLANTA MED, V65, P104, DOI 10.1055/s-1999-13968; Matsuda H, 2000, TETRAHEDRON, V56, P7763, DOI 10.1016/S0040-4020(00)00696-7; Nelsen CJ, 2003, J BIOL CHEM, V278, P3656, DOI 10.1074/jbc.M209374200; Oh GS, 2004, IMMUNOPHARM IMMUNOT, V26, P163, DOI 10.1081/IPH-120037712; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; TANIGUCHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P2064, DOI 10.1271/bbb.59.2064; Tsai AC, 2010, CANCER LETT, V292, P163, DOI 10.1016/j.canlet.2009.11.020; Yasui M, 2006, CLIN CANCER RES, V12, P4720, DOI 10.1158/1078-0432.CCR-05-1213; Yuan TL, 2008, P NATL ACAD SCI USA, V105, P9739, DOI 10.1073/pnas.0804123105; Yuuya S, 1999, J NAT PROD, V62, P22, DOI 10.1021/np980092u	44	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31195	10.1371/journal.pone.0031195	http://dx.doi.org/10.1371/journal.pone.0031195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359572	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200041
J	Wang, YZ; Wang, X; Ye, L; Li, JL; Song, L; Fulambarkar, N; Ho, WZ				Wang, Yizhong; Wang, Xu; Ye, Li; Li, Jieliang; Song, Li; Fulambarkar, Nilija; Ho, Wenzhe			Morphine Suppresses IFN Signaling Pathway and Enhances AIDS Virus Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C-VIRUS; INTERFERON REGULATORY FACTOR; GENE-EXPRESSION; INNATE IMMUNITY; ANTIVIRAL ACTIVITY; HIV-1 REPLICATION; TYPE-1 INFECTION; ALPHA EXPRESSION; HUMAN-MONOCYTES	Background: Opioids exert a profound influence on immunomodulation and enhance HIV infection and replication. However, the mechanism(s) of their action remains to be determined. We thus investigated the impact of morphine on the intracellular innate antiviral immunity. Methodology/Principal Findings: Seven-day-cultured macrophages were infected with equal amounts of cell-free HIV Bal or SIV Delta(B670) for 2 h at 37 degrees C after 24 h of treatment with or without morphine. Effect of morphine on HIV/SIV infection and replication was evaluated by HIV/SIV RT activity assay and indirect immunofluorescence for HIV p24 or SIV p28 antigen. The mRNA expression of cellular factors suppressed or induced by morphine treatment was analyzed by the real-time RTPCR. We demonstrated that morphine treatment of human blood monocyte-derived macrophages significantly inhibited the expression of interferons (IFN-alpha, IFN-beta and IFN-lambda) and IFN-inducible genes (APOBEC3C/3F/3G and 3H). The further experiments showed that morphine suppressed the expression of several key elements ( RIG-I and IRF-7) in IFN signaling pathway. In addition, morphine treatment induced the expression of suppressor of cytokine signaling protein-1, 2, 3 (SOCS- 2, 3) and protein inhibitors of activated STAT-1, 3, X, Y (PIAS-1, 3, X, Y), the key negative regulators of IFN signaling pathway. Conclusions: These findings indicate that morphine impairs intracellular innate antiviral mechanism(s) in macrophages, contributing to cell susceptibility to AIDS virus infection.	[Wang, Yizhong; Wang, Xu; Ye, Li; Li, Jieliang; Song, Li; Fulambarkar, Nilija; Ho, Wenzhe] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Ye, Li; Ho, Wenzhe] Wuhan Univ, Ctr Anim Expt, ABSL Lab 3, Wuhan, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Wuhan University	Wang, YZ (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.	wenzheho@temple.edu			National Institutes of Health [DA12815, DA22177, DA27550]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022177, R01DA012815, R01DA027550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health [grant numbers DA12815, DA22177, and DA27550]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCABES P, 1995, CLIN INFECT DIS, V20, P1467, DOI 10.1093/clinids/20.6.1467; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; BATTJES RJ, 1988, B NARCOTICS, V40, P21; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; CHUANG LF, 1993, BIOCHEM BIOPH RES CO, V195, P1165, DOI 10.1006/bbrc.1993.2167; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; DONAHOE RM, 1993, ADV EXP MED BIOL, V335, P21; Donahoe RM, 1998, J NEUROIMMUNOL, V83, P77, DOI 10.1016/S0165-5728(97)00224-5; Donahoe RM, 2009, JAIDS-J ACQ IMM DEF, V50, P241, DOI 10.1097/QAI.0b013e3181967354; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Guo CJ, 2002, J INVEST MED, V50, P435, DOI 10.1136/jim-50-06-03; HASSAN NF, 1986, J IMMUNOL METHODS, V95, P273, DOI 10.1016/0022-1759(86)90415-1; HO WZ, 1992, J VIROL, V66, P573, DOI 10.1128/JVI.66.1.573-579.1992; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kumar R, 2004, J VIROL, V78, P11425, DOI 10.1128/JVI.78.20.11425-11428.2004; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Li Y, 2003, PEDIATR RES, V54, P282, DOI 10.1203/01.PDR.0000074973.83826.4C; Li Y, 2007, J INFECT DIS, V196, P719, DOI 10.1086/520093; Mahajan SD, 2005, CURR HIV RES, V3, P277, DOI 10.2174/1570162054368048; Mahajan SD, 2002, J IMMUNOL, V169, P3589, DOI 10.4049/jimmunol.169.7.3589; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; Miyagi T, 2000, J BIOL CHEM, V275, P31305, DOI 10.1074/jbc.M001269200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nair MPN, 1997, CLIN DIAGN LAB IMMUN, V4, P127, DOI 10.1128/CDLI.4.2.127-132.1997; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; PETERSON PK, 1990, AIDS, V4, P869, DOI 10.1097/00002030-199009000-00006; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Risdahl JM, 1998, J NEUROIMMUNOL, V83, P4, DOI 10.1016/S0165-5728(97)00216-6; RONALD PJM, 1994, AIDS, V8, P339, DOI 10.1097/00002030-199403000-00007; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Specter S, 1994, J Fla Med Assoc, V81, P485; Steele AD, 2003, VIROLOGY, V309, P99, DOI 10.1016/S0042-6822(03)00015-1; StollKeller F, 1997, INT J IMMUNOPHARMACO, V19, P95, DOI 10.1016/S0192-0561(97)00017-9; Suzuki S, 2002, J INFECT DIS, V185, P1826, DOI 10.1086/340816; Suzuki S, 2002, EXP CELL RES, V280, P192, DOI 10.1006/excr.2002.5638; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Wang FX, 2008, J GEN VIROL, V89, P722, DOI 10.1099/vir.0.83530-0; Wang J, 2008, ARCH IMMUNOL THER EX, V56, P299, DOI 10.1007/s00005-008-0035-0; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Ye L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009602; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854; Zhang T, 2006, REV MED VIROL, V16, P311, DOI 10.1002/rmv.508	69	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31167	10.1371/journal.pone.0031167	http://dx.doi.org/10.1371/journal.pone.0031167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359571	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200040
J	Carthey, AJR; Banks, PB				Carthey, Alexandra J. R.; Banks, Peter B.			When Does an Alien Become a Native Species? A Vulnerable Native Mammal Recognizes and Responds to Its Long-Term Alien Predator	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; PREY; INVADERS; MARSUPIALS; AUSTRALIA; PATTERNS; NAIVETE; DINGOES; ECOLOGY	The impact of alien predators on native prey populations is often attributed to prey naivete 'towards a novel threat. Yet evolutionary theory predicts that alien predators cannot remain eternally novel; prey species must either become extinct or learn and adapt to the new threat. As local enemies lose their naivete' and coexistence becomes possible, an introduced species must eventually become 'native'. But when exactly does an alien become a native species? The dingo (Canis lupus dingo) was introduced to Australia about 4000 years ago, yet its native status remains disputed. To determine whether a vulnerable native mammal (Perameles nasuta) recognizes the close relative of the dingo, the domestic dog (Canis lupus familiaris), we surveyed local residents to determine levels of bandicoot visitation to yards with and without resident dogs. Bandicoots in this area regularly emerge from bushland to forage in residential yards at night, leaving behind tell-tale deep, conical diggings in lawns and garden beds. These diggings were less likely to appear at all, and appeared less frequently and in smaller quantities in yards with dogs than in yards with either resident cats (Felis catus) or no pets. Most dogs were kept indoors at night, meaning that bandicoots were not simply chased out of the yards or killed before they could leave diggings, but rather they recognized the threat posed by dogs and avoided those yards. Native Australian mammals have had thousands of years experience with wild dingoes, which are very closely related to domestic dogs. Our study suggests that these bandicoots may no longer be naive towards dogs. We argue that the logical criterion for determining native status of a long-term alien species must be once its native enemies are no longer naive.	[Carthey, Alexandra J. R.; Banks, Peter B.] Univ New S Wales, Ecol & Evolut Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Carthey, AJR (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	alex.carthey@sydney.edu.au		Carthey, Alexandra Jane Repin/0000-0002-0472-2217; Banks, Peter/0000-0002-4340-6495	Royal Zoological Society of NSW; Hermon Slade Foundation [HSF 10/10]	Royal Zoological Society of NSW; Hermon Slade Foundation	This work was funded by an Ethel Mary Read Grant from the Royal Zoological Society of NSW (http://www.rzsnsw.org.au/), and by the Hermon Slade Foundation (Grant HSF 10/10 http://www.hermonslade.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Carlsson NOL, 2010, BIOL INVASIONS, V12, P633, DOI 10.1007/s10530-009-9470-z; Chew MK, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P35; Corbett L. K., 1995, DINGO AUSTR ASIA; Cox GW, 2004, ALIEN SPECIES EVOLUT; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Diamond J., 1986, COMMUNITY ECOL, P65; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickman C. R., 2008, MAMMALS AUSTR, P189; Elledge AE, 2006, MAMMAL REV, V36, P142, DOI 10.1111/j.1365-2907.2006.00086.x; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Johnson CN, 2009, AUSTRAL ECOL, V34, P35, DOI 10.1111/j.1442-9993.2008.01878.x; Jones Menna A., 2003, P422; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Mech LD, 2001, J WILDLIFE MANAGE, V65, P998, DOI 10.2307/3803048; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Pollock MS, 2003, ENVIRON BIOL FISH, V66, P313, DOI 10.1023/A:1023905824660; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Scott LK, 1999, WILDLIFE RES, V26, P805, DOI 10.1071/WR98074; Short J, 2002, BIOL CONSERV, V103, P283, DOI 10.1016/S0006-3207(01)00139-2; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Vermeij GJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P315; Webb JK, 2008, AUSTRAL ECOL, V33, P821, DOI 10.1111/j.1442-9993.2008.01847.x	36	63	65	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31804	10.1371/journal.pone.0031804	http://dx.doi.org/10.1371/journal.pone.0031804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355396	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300096
J	Sakaguchi, H; Tsunoda, M; Wada, K; Ohta, H; Kawashima, M; Yoshino, Y; Aizawa, Y				Sakaguchi, Hiroko; Tsunoda, Masashi; Wada, Koji; Ohta, Hiroshi; Kawashima, Masatoshi; Yoshino, Yae; Aizawa, Yoshiharu			Assessment of Border Control Measures and Community Containment Measures Used in Japan during the Early Stages of Pandemic (H1N1) 2009	PLOS ONE			English	Article							INFLUENZA-A H1N1; INTERNATIONAL AIRPORT; VIRUS-INFECTION; FACE MASKS; TRANSMISSION; SPREAD; SARS; QUARANTINE; FEVER; CHINA	Background: In the early stages of Pandemic (H1N1) 2009, border control measures were taken by quarantine stations to block the entry of infected individuals into Japan and community containment measures were implemented to prevent the spreading. The objectives of this study were to describe these measures and the characteristics of infected individuals, and to assess the measures' effectiveness. Methodology/Principal Findings: Border control and community containment measures implemented from April to June (Period I: April 28-May 21, Period II: May 22-June 18) 2009 were described. Number of individuals identified and disease characteristics were analyzed. For entry screening, a health declaration form and an infrared thermoscanner were used to detect symptomatic passengers. Passengers indicated for the rapid influenza test underwent the test followed by RT-PCR. Patients positive for H1N1 were isolated, and close contacts were quarantined. Entry cards were handed out to all asymptomatic passengers informing them about how to contact a health center in case they developed symptoms. Nine individuals were identified by entry screening and 1 during quarantine to have Pandemic (H1N1) 2009. Health monitoring by health centers was performed in period I for passengers arriving from affected countries and in period II for those who had come into contact with the individuals identified by entry screening. Health monitoring identified 3 infected individuals among 129,546 in Period I and 5 among 746 in Period II. Enhanced surveillance, which included mandatory reporting of details of the infected individuals, identified 812 individuals, 141 (18%) of whom had a history of international travel. Twenty-four of these 141 passengers picked up by enhanced surveillance had been developing symptoms on entry and were missed at screening. Conclusion/Significance: Symptomatic passengers were detected by the various entry screening measures put in place. Enhanced surveillance provided data for the improvement of public health measures in future pandemics.	[Sakaguchi, Hiroko; Kawashima, Masatoshi; Yoshino, Yae] Kitasato Univ, Grad Sch Med Sci, Dept Occupat Hlth, Sagamihara, Kanagawa 228, Japan; [Tsunoda, Masashi; Aizawa, Yoshiharu] Kitasato Univ, Sch Med, Dept Prevent Med, Sagamihara, Kanagawa 228, Japan; [Wada, Koji; Ohta, Hiroshi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University	Sakaguchi, H (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Occupat Hlth, Sagamihara, Kanagawa 228, Japan.	mtsunoda@med.kitasato-u.ac.jp			Ministry of Health, Labour and Welfare [H23-Policy-033]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was funded by a research project for Emerging and Re-emerging Infectious Diseases of the Ministry of Health, Labour and Welfare (H23-Policy-033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho M, 2010, EUROSURVEILLANCE, V15, P14; Arguin PM, 2009, EMERG INFECT DIS, V15, P1713, DOI 10.3201/eid1511.091426; Baker MG, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2424; Bradley Michael, 2008, REGIONAL ALASKA TRIB; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Del Valle SY, 2010, AM J INFECT CONTROL, V38, P676, DOI 10.1016/j.ajic.2010.03.012; Department of Quarantine Narita Airport Quarantine Station, 2009, REP RESP PAND INFL N; European Centre for Disease Prevention and Control, 2009, ECDC RISK ASS PAND H; Foxwell AR, 2011, EMERG INFECT DIS, V17, P1188, DOI 10.3201/eid1707.101135; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Lance C, 2011, PLOS ONE, V6; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Malone JD, 2009, TRAVEL MED INFECT DI, V7, P181, DOI 10.1016/j.tmaid.2009.02.006; McBride WJH, 2010, AUST NZ J PUBL HEAL, V34, P5, DOI 10.1111/j.1753-6405.2010.00466.x; Ministry of Education Culture Sports Science and Technology, 2009, DAIL REP SCH CLOS AS; Miyamura T, 2011, PANDEMIC H1N1 2009 J; Mutsch M, 2005, CLIN INFECT DIS, V40, P1282, DOI 10.1086/429243; NEC Avio Infrared Technologies Co. Ltd, 2001, TVS 500EX; Ng EYK, 2005, MED PHYS, V32, P93, DOI 10.1118/1.1819532; Nishiura H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-111; Ooi PL, 2005, AM J INFECT CONTROL, V33, P252, DOI 10.1016/j.ajic.2004.08.007; Pang XH, 2011, EMERG INFECT DIS, V17, P1824, DOI 10.3201/eid1710.101344; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Shimada T, 2009, EUROSURVEILLANCE, V14; The Governmental Committee of Action Plans against Influenza Pandemic in Japan, 2009, GUID PREV CONTR PAND; Wada Koji, 2011, Nihon Koshu Eisei Zasshi, V58, P259; World Health Organization, 2010, WEEKLY EPIDEMIOLOGIC, V85, P185; World Health Organization, 2009, TECHN ADV CAS MAN IN; Yasuda H, 2009, EUROSURVEILLANCE, V14, P12	40	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31289	10.1371/journal.pone.0031289	http://dx.doi.org/10.1371/journal.pone.0031289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355354	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300054
J	Sharma, RI; Snedeker, JG				Sharma, Ram I.; Snedeker, Jess G.			Paracrine Interactions between Mesenchymal Stem Cells Affect Substrate Driven Differentiation toward Tendon and Bone Phenotypes	PLOS ONE			English	Article							MARROW STROMAL CELLS; ROTATOR CUFF; IN-VITRO; PROLIFERATION; MATRIX; REPAIR; EXPRESSION; OSTEOGENESIS; ANGIOGENESIS; TENOMODULIN	We investigated substrate dependent paracrine signaling between subpopulations of bone marrow stromal cells (BMSCs) that may affect the formation, or perhaps malformation, of the regenerating tendon to bone enthesis. Polyacrylamide substrates approximating the elastic modulus of tendon granulation tissue and the osteoid of healing bone (10-90 kPa) were functionalized with whole length fibronectin (Fn), type-I collagen (Col), or a mixed ligand solution (Fn/Col), and BMSCs were cultured in growth media alone or media supplemented with soluble Col or Fn. More rigid substrates with a narrow mechanical gradient (70-90 kPa) robustly induced osteogenic cell differentiation when functionalized with either Col or Fn. On broader mechanical gradient substrates (with a linear elastic modulus gradient from 10-90 kPa), cell differentiation was markedly osteogenic on subregions of Fn functionalized substrates above 20 kPa, but osteogenic activity was inhibited on all subregions of Col substrates. Osteogenic behavior was not observed when cells were cultured on Fn substrates if Col was present either in the media or on the substrate (Fn/Col). Tenogenic differentiation markers were observed only on Col substrates with moderate rigidity (similar to 30-50 kPa). Tenogenic differentiation was unaltered by soluble or substrate bound Fn. Co-culture of narrow gradient subsections revealed that any inclusion of tenogenic substrates (30-50 kPa, Col), caused otherwise osteogenic substrates to not develop markers of osteogenic differentiation, while increasing cell proliferation. These apparently paracrine effects could be mediated by bone morphogenetic protein-2 (BMP-2), as first confirmed by gene-level expression of BMP-2 and the transcription factor Smad8, and verified by BMP-2 media supplementation at levels similar to observed cell-secreted concentrations, which arrested osteogenic differentiation in 14 day cultures. Thus, cell instructive biomaterials with engineered mechanical and biochemical properties represent potentially powerful tools for directing BMSC differentiation to tendon and bone, however paracrine signals from tenogenic cells may delay osteogenesis at the healing enthesis.	[Sharma, Ram I.; Snedeker, Jess G.] Univ Zurich Balgrist, Dept Orthoped, Zurich, Switzerland; [Sharma, Ram I.; Snedeker, Jess G.] Swiss Fed Inst Technol EHT Zurich, Dept Mech Engn, Zurich, Switzerland	University of Zurich	Sharma, RI (corresponding author), Univ Zurich Balgrist, Dept Orthoped, Zurich, Switzerland.	snedeker@ethz.ch	Snedeker, Jess G./X-2098-2019; Snedeker, Jess/C-2105-2009	Snedeker, Jess G./0000-0002-8115-0275; Snedeker, Jess/0000-0002-8115-0275	Bonizzi Theler Foundation	Bonizzi Theler Foundation	This work was generously supported by the Bonizzi Theler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Bleuming SA, 2007, CANCER RES, V67, P8149, DOI 10.1158/0008-5472.CAN-06-4659; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Bullough R, 2008, DISABIL REHABIL, V30, P1746, DOI 10.1080/09638280701788258; Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5; Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen X, 2009, STEM CELLS, V27, P1276, DOI 10.1002/stem.61; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Giuliani N, 2009, EXP HEMATOL, V37, P879, DOI 10.1016/j.exphem.2009.04.004; Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002; Javazon EH, 2007, WOUND REPAIR REGEN, V15, P350, DOI 10.1111/j.1524-475X.2007.00237.x; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Liu SB, 2009, CHINESE MED J-PEKING, V122, P839, DOI 10.3760/cma.j.issn.0366-6999.2009.07.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McFarlin K, 2006, WOUND REPAIR REGEN, V14, P471, DOI 10.1111/j.1743-6109.2006.00153.x; Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x; Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rak-Mardyla A, 2010, J PHYSIOL PHARMACOL, V61, P451; Rodeo SA, 2010, J BONE JOINT SURG AM, V92A, P2491, DOI 10.2106/JBJS.J.01174; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Southwood M, 2008, J PATHOL, V214, P85, DOI 10.1002/path.2261; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wulsten D, 2011, EUR CELLS MATER, V21, P177, DOI 10.22203/eCM.v021a14; Zumstein MA, 2008, J BONE JOINT SURG AM, V90A, P2423, DOI 10.2106/JBJS.G.00677	50	63	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31504	10.1371/journal.pone.0031504	http://dx.doi.org/10.1371/journal.pone.0031504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355373	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300073
J	Castoe, TA; Poole, AW; de Koning, APJ; Jones, KL; Tomback, DF; Oyler-McCance, SJ; Fike, JA; Lance, SL; Streicher, JW; Smith, EN; Pollock, DD				Castoe, Todd A.; Poole, Alexander W.; de Koning, A. P. Jason; Jones, Kenneth L.; Tomback, Diana F.; Oyler-McCance, Sara J.; Fike, Jennifer A.; Lance, Stacey L.; Streicher, Jeffrey W.; Smith, Eric N.; Pollock, David D.			Rapid Microsatellite Identification from Illumina Paired-End Genomic Sequencing in Two Birds and a Snake	PLOS ONE			English	Article							REPEAT ARRAYS; MARKERS; SIZE	Identification of microsatellites, or simple sequence repeats (SSRs), can be a time-consuming and costly investment requiring enrichment, cloning, and sequencing of candidate loci. Recently, however, high throughput sequencing (with or without prior enrichment for specific SSR loci) has been utilized to identify SSR loci. The direct "Seq-to-SSR'' approach has an advantage over enrichment-based strategies in that it does not require a priori selection of particular motifs, or prior knowledge of genomic SSR content. It has been more expensive per SSR locus recovered, however, particularly for genomes with few SSR loci, such as bird genomes. The longer but relatively more expensive 454 reads have been preferred over less expensive Illumina reads. Here, we use Illumina paired-end sequence data to identify potentially amplifiable SSR loci (PALs) from a snake (the Burmese python, Python molurus bivittatus), and directly compare these results to those from 454 data. We also compare the python results to results from Illumina sequencing of two bird genomes (Gunnison Sage-grouse, Centrocercus minimus, and Clark's Nutcracker, Nucifraga columbiana), which have considerably fewer SSRs than the python. We show that direct Illumina Seq-to-SSR can identify and characterize thousands of potentially amplifiable SSR loci for as little as $10 per sample - a fraction of the cost of 454 sequencing. Given that Illumina Seq-to-SSR is effective, inexpensive, and reliable even for species such as birds that have few SSR loci, it seems that there are now few situations for which prior hybridization is justifiable.	[Castoe, Todd A.; Poole, Alexander W.; de Koning, A. P. Jason; Jones, Kenneth L.; Pollock, David D.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Tomback, Diana F.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Oyler-McCance, Sara J.; Fike, Jennifer A.] US Geol Survey Ft Collins Sci Ctr, Ft Collins, CO USA; [Lance, Stacey L.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Streicher, Jeffrey W.; Smith, Eric N.] Univ Texas Arlington, Dept Biol & Amphibian, Arlington, TX 76019 USA; [Streicher, Jeffrey W.; Smith, Eric N.] Univ Texas Arlington, Reptile Divers Res Ctr, Arlington, TX 76019 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; United States Department of the Interior; United States Geological Survey; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington	Castoe, TA (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	David.Pollock@ucdenver.edu	Jones, Kenneth/GXF-4945-2022; Pollock, David D/M-4740-2016; Lance, Stacey/K-9203-2013	Pollock, David D/0000-0002-7627-4214; Lance, Stacey/0000-0003-2686-1733; Streicher, Jeffrey/0000-0002-3738-4162; Oyler-McCance, Sara/0000-0003-1599-8769; de Koning, A.P. Jason/0000-0001-5450-5600	National Institutes of Health [GM083127]; University of Colorado; CRISP (University of Colorado Denver, Denver campus); Department of Energy [DE-FC09-07SR22506]; Colorado Division of Wildlife; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; CRISP (University of Colorado Denver, Denver campus); Department of Energy(United States Department of Energy (DOE)); Colorado Division of Wildlife; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the support of the National Institutes of Health (R01, GM083127) and University of Colorado setup funds to DDP, and a CRISP Award (University of Colorado Denver, Denver campus) to DFT. SLL was partially supported by the Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation. The Gunnison Sage-grouse sample was obtained as the result of previous research funded by the Colorado Division of Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Castoe TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-406; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Castoe TA, 2011, STAND GENOMIC SCI, V4, P257, DOI 10.4056/sigs.1664145; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; De Smet WHO, 1981, ACTA ZOOL PATHOL ANT, V76, P119; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hughes AL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-12; Jennings TN, 2011, MOL ECOL RESOUR; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Rozen S, 2000, Methods Mol Biol, V132, P365; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819	20	191	198	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30953	10.1371/journal.pone.0030953	http://dx.doi.org/10.1371/journal.pone.0030953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348032	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400008
J	Wang, Z; Sokolovska, A; Seymour, R; Sundberg, JP; HogenEsch, H				Wang, Zhe; Sokolovska, Anna; Seymour, Rosemarie; Sundberg, John P.; HogenEsch, Harm			SHARPIN Is Essential for Cytokine Production, NF-kappa B Signaling, and Induction of Th1 Differentiation by Dendritic Cells	PLOS ONE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; RECEPTOR 2; PROTEIN; MICE; ACTIVATION; INFLAMMATION; EXPRESSION; TYPE-1; IL-12; DYSREGULATION	Spontaneous mutations of the Sharpin (SHANK-associated RH domain-interacting protein, other aliases: Rbckl1, Sipl1) gene in mice result in systemic inflammation that is characterized by chronic proliferative dermatitis and dysregulated secretion of T helper1 (Th1) and Th2 cytokines. The cellular and molecular mechanisms underlying this inflammatory phenotype remain elusive. Dendritic cells may contribute to the initiation and progression of the phenotype of SHARPIN-deficient mice because of their pivotal role in innate and adaptive immunity. Here we show by flow cytometry that SHARPIN-deficiency did not alter the distribution of different DC subtypes in the spleen. In response to TOLL-like receptor (TLR) agonists LPS and poly I:C, cultured bone marrow-derived dendritic cells (BMDC) from WT and mutant mice exhibited similar increases in expression of co-stimulatory molecules CD40, CD80, and CD86. However, stimulated SHARPIN-deficient BMDC had reduced transcription and secretion of pro-inflammatory mediators IL6, IL12P70, GMCSF, and nitric oxide. Mutant BMDC had defective activation of NF-kappa B signaling, whereas the MAPK1/3 (ERK1/2) and MAPK11/12/13/14 (p38 MAP kinase isoforms) and TBK1 signaling pathways were intact. A mixed lymphocyte reaction showed that mutant BMDC only induced a weak Th1 immune response but stimulated increased Th2 cytokine production from allogeneic naive CD4(+) T cells. In conclusion, loss of Sharpin in mice significantly affects the immune function of DC and this may partially account for the systemic inflammation and Th2-biased immune response.	[Wang, Zhe; Sokolovska, Anna; HogenEsch, Harm] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Seymour, Rosemarie; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jackson Laboratory	Wang, Z (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	hogenesch@purdue.edu	Wang, Zhe/O-6663-2016; Wang, Zhe/N-6846-2015	HogenEsch, Harm/0000-0002-2738-9189	National Institutes of Health [AR49288]; North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Institutes of Health (AR49288) and a North American Hair Research Society Mentorship Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barchet W, 2005, EUR J IMMUNOL, V35, P236, DOI 10.1002/eji.200425583; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107, DOI 10.3109/01913129509014610; Hermans IF, 1999, J IMMUNOL, V163, P77; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kanangat S, 1996, J IMMUNOL, V156, P1110; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liang Y, 2011, J DERMATOL SCI, V63, P148, DOI 10.1016/j.jdermsci.2011.04.012; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SIELING PA, 1994, J IMMUNOL, V153, P3639; Sieling PA, 2003, J IMMUNOL, V170, P194, DOI 10.4049/jimmunol.170.1.194; Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045; Steinman RM, 2010, EUR J IMMUNOL, V40, P2085, DOI 10.1002/eji.201040733; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P3804, DOI 10.4049/jimmunol.165.7.3804; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zak DE, 2011, P NATL ACAD SCI USA, V108, P11536, DOI 10.1073/pnas.1107577108	56	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31809	10.1371/journal.pone.0031809	http://dx.doi.org/10.1371/journal.pone.0031809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348129	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400048
J	Bekmetjev, A; VanBruggen, D; McLellan, B; DeWinkle, B; Lunderberg, E; Tintle, N				Bekmetjev, Airat; VanBruggen, Dirk; McLellan, Brian; DeWinkle, Benjamin; Lunderberg, Eric; Tintle, Nathan			The Cost-Effectiveness of Reclassification Sampling for Prevalence Estimation	PLOS ONE			English	Article							PROBABILITY MODEL; ASSOCIATION; DESIGNS; ERRORS; CLASSIFICATION; SPECIFICITY; SENSITIVITY	Background: Typically, a two-phase (double) sampling strategy is employed when classifications are subject to error and there is a gold standard (perfect) classifier available. Two-phase sampling involves classifying the entire sample with an imperfect classifier, and a subset of the sample with the gold-standard. Methodology/Principal Findings: In this paper we consider an alternative strategy termed reclassification sampling, which involves classifying individuals using the imperfect classifier more than one time. Estimates of sensitivity, specificity and prevalence are provided for reclassification sampling, when either one or two binary classifications of each individual using the imperfect classifier are available. Robustness of estimates and design decisions to model assumptions are considered. Software is provided to compute estimates and provide advice on the optimal sampling strategy. Conclusions/Significance: Reclassification sampling is shown to be cost-effective (lower standard error of estimates for the same cost) for estimating prevalence as compared to two-phase sampling in many practical situations.	[Bekmetjev, Airat; VanBruggen, Dirk; McLellan, Brian; DeWinkle, Benjamin; Lunderberg, Eric] Hope Coll, Dept Math, Holland, MI 49423 USA; [Tintle, Nathan] Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA USA	Hope College	Bekmetjev, A (corresponding author), Hope Coll, Dept Math, Holland, MI 49423 USA.	ntintle@dordt.edu		Tintle, Nathan/0000-0003-1447-9107	National Institutes of Health [R15-HG004543]; Hope College Howard Hughes Medical Institute; Michigan Space Grant Consortium; Tanis Fund for Statistics Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG004543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope College Howard Hughes Medical Institute; Michigan Space Grant Consortium; Tanis Fund for Statistics Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was funded in part by a grant from the National Institutes of Health, R15-HG004543. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Human Genome Research Institute or the National Institutes of Health. Dirk Van Bruggen received support from a computational science and modeling scholar award from the Hope College Howard Hughes Medical Institute program, as well as a fellowship from the Michigan Space Grant Consortium. Additionally, this project received support from the Tanis Fund for Statistics Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers B, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1433; Casella G., 2002, STAT INFERENCE, V2nd; Cochran WG., 1963, SAMPLING TECHNIQUES; Fujisawa H, 2000, BIOMETRICS, V56, P706, DOI 10.1111/j.0006-341X.2000.00706.x; KOCH GG, 1969, J AM STAT ASSOC, V64, P852; McNamee R, 2003, INT J EPIDEMIOL, V32, P1072, DOI 10.1093/ije/dyg230; McNamee R, 2002, STAT MED, V21, P3609, DOI 10.1002/sim.1318; Nofuentes JAR, 2005, BIOMETRICAL J, V47, P442, DOI 10.1002/bimj.200410134; Schill W, 2006, STAT MED, V25, P1646, DOI 10.1002/sim.2307; SUTCLIFFE JP, 1965, PSYCHOMETRIKA, V30, P129, DOI 10.1007/BF02289444; SUTCLIFFE JP, 1965, PSYCHOMETRIKA, V30, P73, DOI 10.1007/BF02289748; TENENBEIN A, 1970, J AM STAT ASSOC, V65, P1350, DOI 10.2307/2284301; Tintle N, 2009, ANN HUM GENET, V73, P370, DOI 10.1111/j.1469-1809.2009.00516.x; Tintle NL, 2007, STAT APPL GENET MOL, V6; Tintle NL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S154; Wruck LM, 2006, STAT MED, V25, P3458, DOI 10.1002/sim.2451	16	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32058	10.1371/journal.pone.0032058	http://dx.doi.org/10.1371/journal.pone.0032058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925BB	22348146	Green Published, gold			2022-12-27	WOS:000302733900065
J	Buchanan, B; Kilby, JD; Huckell, BB; O'Brien, MJ; Collard, M				Buchanan, Briggs; Kilby, J. David; Huckell, Bruce B.; O'Brien, Michael J.; Collard, Mark			A Morphometric Assessment of the Intended Function of Cached Clovis Points	PLOS ONE			English	Article							MEASUREMENT ERROR; ALLOMETRY; SITE; ARTIFACTS; DISCOVERY; MAMMOTH; PLAINS; ORIGIN; FORM	A number of functions have been proposed for cached Clovis points. The least complicated hypothesis is that they were intended to arm hunting weapons. It has also been argued that they were produced for use in rituals or in connection with costly signaling displays. Lastly, it has been suggested that some cached Clovis points may have been used as saws. Here we report a study in which we morphometrically compared Clovis points from caches with Clovis points recovered from kill and camp sites to test two predictions of the hypothesis that cached Clovis points were intended to arm hunting weapons: 1) cached points should be the same shape as, but generally larger than, points from kill/camp sites, and 2) cached points and points from kill/camp sites should follow the same allometric trajectory. The results of the analyses are consistent with both predictions and therefore support the hypothesis. A follow-up review of the fit between the results of the analyses and the predictions of the other hypotheses indicates that the analyses support only the hunting equipment hypothesis. We conclude from this that cached Clovis points were likely produced with the intention of using them to arm hunting weapons.	[Buchanan, Briggs; Collard, Mark] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada; [Buchanan, Briggs; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Buchanan, Briggs; O'Brien, Michael J.; Collard, Mark] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Kilby, J. David] Eastern New Mexico Univ, Dept Anthropol & Appl Archaeol, Portales, NM USA; [Huckell, Bruce B.] Univ New Mexico, Maxwell Museum Anthropol, Albuquerque, NM 87131 USA; [Huckell, Bruce B.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	Simon Fraser University; Simon Fraser University; University of Missouri System; University of Missouri Columbia; University of New Mexico; University of New Mexico	Buchanan, B (corresponding author), Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada.	mcollard@sfu.ca		Buchanan, Briggs/0000-0002-5684-9615; Kilby, David/0000-0003-2185-7065; Collard, Mark/0000-0002-2725-4989	National Science Foundation; Social Sciences and Humanities Research Council; University of New Mexico; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Simon Fraser University	National Science Foundation(National Science Foundation (NSF)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); University of New Mexico; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University	BB's work on this study was supported by a National Science Foundation Doctoral Dissertation Improvement Grant and postdoctoral fellowship grants from the National Science Foundation and the Social Sciences and Humanities Research Council. JDK's work on the study was supported by a National Science Foundation Doctoral Dissertation Improvement Grant and the University of New Mexico. MC's work on this study was supported by the Canada Research Chairs Program, the Social Sciences and Humanities Research Council, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund and Simon Fraser University was supported by a National Science Foundation Doctoral Dissertation Improvement Grant and the University of New Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A. D., 1972, PLAINS ANTHROPOL, V17, P55; [Anonymous], 1999, FENN CACHE CLO VIS W; Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Bamforth DB, 2009, J ANTHROPOL ARCHAEOL, V28, P142, DOI 10.1016/j.jaa.2009.01.002; Bement LC, 2003, CURRENT RES PLEISTOC, V20, P5; Bement LC, 2010, AM ANTIQUITY, V75, P907, DOI 10.7183/0002-7316.75.4.907; Benjamini Y, 2001, ANN STAT, V29, P1165; Blackmore Howard, 2000, HUNTING WEAPONS MIDD; Boldurian AnthonyT., 1999, CLOVIS REVISITED NEW; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; Buchanan B, 2006, J ARCHAEOL SCI, V33, P185, DOI 10.1016/j.jas.2005.07.008; Buchanan B, 2005, THESIS U NEW MEXICO; Buchanan B, 2007, J ANTHROPOL ARCHAEOL, V26, P366, DOI 10.1016/j.jaa.2007.02.005; Buchanan B, 2009, AM ANTIQUITY, V74, P279, DOI 10.1017/S0002731600048605; Butler B.Robert., 1965, TEBIWA, V8, P38; Butler B.Robert., 1963, TEBIWA, V6, P22; Cheshier J, 2006, AM ANTIQUITY, V71, P353, DOI 10.2307/40035908; Collins M. B., 1999, CLOVIS BLADE TECHNOL; COTTER JOHN LAMBERT, 1937, PROC ACAD NAT SCI PHILADELPHIA, V89, P1; CROMPTON RH, 1993, J HUM EVOL, V25, P175, DOI 10.1006/jhev.1993.1043; Ellis Christopher J., 2009, PAINTING BROAD BRUSH, P319; Figgins JesseD., 1933, P COLORADO MUSEUM NA, V12; Frison G.C., 1986, COLBY MAMMOTH SITE T; FRISON GC, 1989, AM ANTIQUITY, V54, P766, DOI 10.2307/280681; Gillespie J., 2007, CANADIAN J ARCHAEOLO, V31, P171; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Gowlett J.A.J., 1994, AFR ARCHAEOL REV, V12, P3, DOI DOI 10.1007/BF01953037); Gramly R. M., 1999, LAMB SITE PIONEERING; Gramly R. M., 1993, RICHEY CLOVIS CACHE; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P15625, DOI 10.1073/pnas.0704215104; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Haury EW, 1953, AM ANTIQUITY, V19, P1, DOI 10.2307/276409; HAURY EW, 1959, AM ANTIQUITY, V25, P2, DOI 10.2307/276674; Haynes C., 2007, MURRAY SPRINGS CLOVI; Haynes G., 2002, EARLY SETTLEMENT N A; Haynes G, 2007, SCIENCE, V317, DOI 10.1126/science.1141960; Haynes Jr CV, 1998, GEOARCHAEOLOGY, V13, P201; Hemmings, 1970, THESIS U ARIZONA TUC; Hester JJ, 1972, FORT BURGWIN RES CTR, P8; HOLLIDAY VT, 1994, QUATERNARY RES, V41, P234, DOI 10.1006/qres.1994.1025; Huckell BB, 2006, FLAKED STONE A UNPUB; Huckell BB, 2011, J ARCHAEOL SCI, V38, P965, DOI 10.1016/j.jas.2010.11.011; Iovita R, 2011, J HUM EVOL, V61, P61, DOI 10.1016/j.jhevol.2011.02.007; Iovita R, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P235, DOI 10.1007/978-1-4419-6861-6_10; JOLICOEUR P, 1984, BIOMETRICS, V40, P685, DOI 10.2307/2530911; Jones J.Scott., 1996, THESIS OREGON STATE; Jones S., 1994, CURR RES PLEISTOCENE, V11, P42; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Kilby J. D., 2008, THESIS; KUHRY B, 1977, SYST ZOOL, V26, P201, DOI 10.2307/2412842; LAHREN L, 1974, SCIENCE, V186, P147, DOI 10.1126/science.186.4159.147; LEAMY L, 1982, EVOLUTION, V36, P1200, DOI 10.1111/j.1558-5646.1982.tb05489.x; Leonhardy FC, CONTRIBUTIONS MUSEUM, P1; Lyman RL, 1998, J ARCHAEOL SCI, V25, P887, DOI 10.1006/jasc.1997.0270; McPherron S., 2006, AXE AGE ACHEULIAN TO, P267; McPherron S. P., 1999, PREHISTOIRE EUROPEEN, V14, P9; McPherron S. P., 2003, PREHISTORIC BIFACES, P55; Meltzer D.J., 2002, 1 AM PLEISTOCENE COL, P27; Morrow JE, 2002, PLAINS ANTHROPOL, V47, P307, DOI 10.1080/2052546.2002.11949250; Morrow JE., 2006, PALEOINDIAN ARCHAEOL, P123; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Owsley DW, 2001, PLAINS ANTHROPOL, V46, P115, DOI 10.1080/2052546.2001.11932062; Sellards EH, 1938, BULL GEOL SOC AM, V49, P999; Shott MJ, 2007, LITHIC TECHNOL, V32, P203; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Speth JD, 2013, QUATERN INT, V285, P111, DOI 10.1016/j.quaint.2010.10.027; Stanford DennisJ., 1988, CURR RES PLEISTOCENE, V5, P21; Strauss RE, 2003, J VERTEBR PALEONTOL, V23, P284, DOI 10.1671/0272-4634(2003)023[0284:EOTPAE]2.0.CO;2; Strauss RE, 2010, MORPHOMETRICS NONMOR, P73, DOI [10.1007/978-3-540-95853-6_4, DOI 10.1007/978-3-540-95853-6_4]; Taylor DC, 1969, P MONT ACAD SCI, V29, P147; Waguespack NM, 2009, ANTIQUITY, V83, P786, DOI 10.1017/S0003598X00098999; WARNICA JM, 1966, AM ANTIQUITY, V31, P345, DOI 10.2307/2694737; Wilke P. J., 1991, J CALIFORNIA GREAT B, V13, P242; Woods JC, 1985, IDAHO ARCHAEOLOGIST, V8, P3; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588	77	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30530	10.1371/journal.pone.0030530	http://dx.doi.org/10.1371/journal.pone.0030530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	924ZX	22348012	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900011
J	Casadevall, A; Nakouzi, A; Crippa, PR; Eisner, M				Casadevall, Arturo; Nakouzi, Antonio; Crippa, Pier R.; Eisner, Melvin			Fungal Melanins Differ in Planar Stacking Distances	PLOS ONE			English	Article							X-RAY CHARACTERIZATION	Melanins are notoriously difficult to study because they are amorphous, insoluble and often associated with other biological materials. Consequently, there is a dearth of structural techniques to study this enigmatic pigment. Current models of melanin structure envision the stacking of planar structures. X ray diffraction has historically been used to deduce stacking parameters. In this study we used X ray diffraction to analyze melanins derived from Cryptococcus neoformans, Aspergillus niger, Wangiella dermatitides and Coprinus comatus. Analysis of melanin in melanized C. neoformans encapsulated cells was precluded by the fortuitous finding that the capsular polysaccharide had a diffraction spectrum that was similar to that of isolated melanin. The capsular polysaccharide spectrum was dominated by a broad non-Bragg feature consistent with origin from a repeating structural motif that may arise from inter-molecular interactions and/or possibly gel organization. Hence, we isolated melanin from each fungal species and compared diffraction parameters. The results show that the inferred stacking distances of fungal melanins differ from that reported for synthetic melanin and neuromelanin, occupying intermediate position between these other melanins. These results suggest that all melanins have a fundamental diffracting unit composed of planar graphitic assemblies that can differ in stacking distance. The stacking peak appears to be a distinguishing universal feature of melanins that may be of use in characterizing these enigmatic pigments.	[Casadevall, Arturo; Nakouzi, Antonio] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Casadevall, Arturo; Nakouzi, Antonio] Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA; [Crippa, Pier R.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy; [Eisner, Melvin] Univ Houston, Dept Phys, Houston, TX USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Parma; University of Houston System; University of Houston	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	arturo.casadevall@einstein.yu.edu			United States National Institutes of Health; PHS [AI052733, AI03314, HL059842, AI033774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733, R01AI033774] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was received from the United States National Institutes of Health. AC is supported by PHS grants numbers AI052733, AI03314, HL059842, AI033774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; CHENG J, 1994, PIGM CELL RES, V7, P255, DOI 10.1111/j.1600-0749.1994.tb00060.x; CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Frases S, 2008, EUKARYOT CELL, V7, P319, DOI 10.1128/EC.00378-07; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Tian SY, 2003, BIOCHEMISTRY-US, V42, P8105, DOI 10.1021/bi0341859; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; ZAJAC GW, 1994, BBA-GEN SUBJECTS, V1199, P271, DOI 10.1016/0304-4165(94)90006-X; Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	17	19	21	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30299	10.1371/journal.pone.0030299	http://dx.doi.org/10.1371/journal.pone.0030299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359541	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200010
J	Hothorn, T; Brandl, R; Muller, J				Hothorn, Torsten; Brandl, Roland; Mueller, Joerg			Large-Scale Model-Based Assessment of Deer-Vehicle Collision Risk	PLOS ONE			English	Article							ROE-DEER; CAPREOLUS-CAPREOLUS; POPULATION-DENSITY; BODY-MASS; FORESTS; REGENERATION; PENNSYLVANIA; HERBIVORES; REDUCTION; EUROPE	Ungulates, in particular the Central European roe deer Capreolus capreolus and the North American white-tailed deer Odocoileus virginianus, are economically and ecologically important. The two species are risk factors for deer-vehicle collisions and as browsers of palatable trees have implications for forest regeneration. However, no large-scale management systems for ungulates have been implemented, mainly because of the high efforts and costs associated with attempts to estimate population sizes of free-living ungulates living in a complex landscape. Attempts to directly estimate population sizes of deer are problematic owing to poor data quality and lack of spatial representation on larger scales. We used data on >74,000 deer-vehicle collisions observed in 2006 and 2009 in Bavaria, Germany, to model the local risk of deer-vehicle collisions and to investigate the relationship between deer-vehicle collisions and both environmental conditions and browsing intensities. An innovative modelling approach for the number of deer-vehicle collisions, which allows nonlinear environment-deer relationships and assessment of spatial heterogeneity, was the basis for estimating the local risk of collisions for specific road types on the scale of Bavarian municipalities. Based on this risk model, we propose a new "deer-vehicle collision index" for deer management. We show that the risk of deer-vehicle collisions is positively correlated to browsing intensity and to harvest numbers. Overall, our results demonstrate that the number of deer-vehicle collisions can be predicted with high precision on the scale of municipalities. In the densely populated and intensively used landscapes of Central Europe and North America, a model-based risk assessment for deer-vehicle collisions provides a cost-efficient instrument for deer management on the landscape scale. The measures derived from our model provide valuable information for planning road protection and defining hunting quota. Open-source software implementing the model can be used to transfer our modelling approach to wildlife-vehicle collisions elsewhere.	[Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Brandl, Roland] Univ Marburg, Fachbereich Biol, D-3550 Marburg, Germany; [Mueller, Joerg] Natl Pk Verwaltung Bayer Wald, Grafenau, Germany; [Mueller, Joerg] Tech Univ Munich, Lehrstuhl Terr Okol, Munich, Germany	University of Munich; Philipps University Marburg; Technical University of Munich	Hothorn, T (corresponding author), Univ Munich, Inst Stat, Munich, Germany.	Torsten.Hothorn@stat.uni-muenchen.de		Muller, Jorg/0000-0002-1409-1586				Baiser B, 2008, BIOL INVASIONS, V10, P785, DOI 10.1007/s10530-008-9247-9; BASHORE TL, 1985, J WILDLIFE MANAGE, V49, P769, DOI 10.2307/3801709; BELLIS ED, 1971, J WILDLIFE MANAGE, V35, P232, DOI 10.2307/3799596; Boulesteix AL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-78; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Collier BA, 2007, J WILDLIFE MANAGE, V71, P277, DOI 10.2193/2005-728; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; *DTSCH JAGDSCH, 2010, DJV HDB JAGD; Ellenberg H, 1978, SPIXIANA S, V2, P5; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Farrell MC, 2007, J WILDLIFE MANAGE, V71, P2727, DOI 10.2193/2006-085; Forstliches Gutachten, 2009, FORSTL GUT SIT WALDV; Gill RMA, 2010, FORESTRY, V83, P53, DOI 10.1093/forestry/cpp031; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Gill RMA, 1997, J APPL ECOL, V34, P1273, DOI 10.2307/2405237; Gkritza K, 2010, ACCIDENT ANAL PREV, V42, P1916, DOI 10.1016/j.aap.2010.05.013; Hewison AJM, 2009, ECOGRAPHY, V32, P1062, DOI 10.1111/j.1600-0587.2009.05888.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofner B, 2011, J COMPUT GRAPH STAT, V20, P956, DOI 10.1198/jcgs.2011.09220; Hofner B, 2011, ECOLOGY, V92, P1895, DOI 10.1890/10-2276.1; Hothorn T, 2011, ECOL MONOGR, V81, P329, DOI 10.1890/10-0602.1; Hothorn T, 2010, FOREST ECOL MANAG, V260, P1416, DOI 10.1016/j.foreco.2010.07.019; Hothorn T, 2010, J MACH LEARN RES, V11, P2109; Iverson AL, 1999, OHIO J SCI, V99, P84; JAHN LAURENCE R., 1959, JOUR WILDLIFE MANAGEMENT, V23, P187, DOI 10.2307/3797639; Jenkins KJ, 2008, J APPL ECOL, V45, P1339, DOI 10.1111/j.1365-2664.2008.01512.x; Joyce TL, 2001, WILDLIFE SOC B, V29, P281; KENNEL E, 1988, ALLGEMEINE FORSTZEIT, V43, P21; Kuiters AT, 2002, BIOL CONSERV, V105, P65, DOI 10.1016/S0006-3207(01)00204-X; Latham J, 1997, J ZOOL, V242, P681, DOI 10.1111/j.1469-7998.1997.tb05820.x; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Millington JDA, 2010, FOREST ECOL MANAG, V259, P1102, DOI 10.1016/j.foreco.2009.12.020; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Mysterud A, 2008, PHILOS T R SOC B, V363, P2359, DOI 10.1098/rstb.2007.2206; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reimoser S, 2009, ECOL MODEL, V220, P2231, DOI 10.1016/j.ecolmodel.2009.05.022; Rooney TP, 2002, FOREST ECOL MANAG, V163, P119, DOI 10.1016/S0378-1127(01)00532-1; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Schwabe KA, 2002, J AGR RESOUR ECON, V27, P261; Seiler A, 2005, J APPL ECOL, V42, P371, DOI 10.1111/j.1365-2664.2005.01013.x; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Senn J, 2003, FOREST ECOL MANAG, V181, P151, DOI 10.1016/S0378-1127(03)00129-4; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Toigo C, 2006, ECOGRAPHY, V29, P301, DOI 10.1111/j.2006.0906-7590.04394.x; Tremblay JP, 2007, J APPL ECOL, V44, P552, DOI 10.1111/j.1365-2664.2007.01290.x	50	43	43	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29510	10.1371/journal.pone.0029510	http://dx.doi.org/10.1371/journal.pone.0029510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359535	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200004
J	Liu, JM; Zhu, CX; Shi, YJ; Li, H; Wang, LP; Qin, ST; Kang, SE; Huang, YP; Jin, YM; Lin, JJ				Liu, Jinming; Zhu, Chunxia; Shi, Yaojun; Li, Hao; Wang, Lanpin; Qin, Shangtian; Kang, Saie; Huang, Yanpin; Jin, Yamei; Lin, Jiaojiao			Surveillance of Schistosoma japonicum Infection in Domestic Ruminants in the Dongting Lake Region, Hunan Province, China	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; TRANSMISSION	Background: Schistosomiasis japonica is prevalent in Asian countries and it remains a major public health problem in China. The major endemic foci are the marsh and lake regions of southern China, particularly the Dongting Lake region bordering Hunan and Hubei provinces, and the Poyang Lake region in Jiangxi province. Domestic ruminants, especially bovines, have long been considered to play a major role in the transmission of Schistosoma japonicum to humans. Methods and Findings: A miracidial hatching technique was used to investigate the prevalence of S. japonicum infections in domestic ruminants and field feces collected from two towns located to the south and east of Dongting Lake, Hunan province, between 2005 and 2010. The overall prevalence of infection was not significantly reduced from 4.93% in 2005 to 3.64% in 2008, after which it was maintained at this level. Bovines comprised 23.5-58.2% of the total infected ruminants, while goats comprised 41.8-76.5%. Infection rates in cattle and goats were significantly higher than those found in buffalo in most study years. The prevalence in buffalo younger than three years was significantly higher than that in those aged over three years. All the positive field samples of feces were derived from bovines in Nandashan. In Matang Town, 61.22% of the positive field feces were from bovines, while the rest were from goats. The positive rates for field feces were approximately the same in April and November/October. Conclusions: The present study found that bovines and goats are major sources of S. japonicum infection in the Dongting lake region and there was age-related resistance in buffalo. Both bovines and goats should be treated equally when controlling S. japonicum infections in the Dongting lake region. It is essential to conduct an additional mass treatment in late March or early April, in addition to the original treatment scheme.	[Liu, Jinming; Shi, Yaojun; Li, Hao; Jin, Yamei; Lin, Jiaojiao] Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Minist Agr,Shanghai Vet Res Inst, Shanghai, Peoples R China; [Zhu, Chunxia; Wang, Lanpin; Qin, Shangtian] Hunan Anim Dis Control Ctr, Changsha, Hunan, Peoples R China; [Kang, Saie] Yueyang Cty Anim Husb Bur, Yueyang, Peoples R China; [Huang, Yanpin] Yuanjiang Municipal Anim Husb & Fishery Bur, Yuanjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, JM (corresponding author), Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Minist Agr,Shanghai Vet Res Inst, Shanghai, Peoples R China.	jimyliu@shvri.ac.cn			Ministry of Agriculture of China [200903036]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (Project No. 200903036) from Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MG, 1993, HUMAN SCHISTOSOMIASI, P241; Dai ZhuoJian, 2004, Southwest China Journal of Agricultural Sciences, V17, P393; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Gray DJ, 2007, AM J TROP MED HYG, V77, P866, DOI 10.4269/ajtmh.2007.77.866; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Hao Yang, 2010, Chinese Journal of Schistosomiasis Control, V22, P521; Hao Yang, 2009, Chinese Journal of Schistosomiasis Control, V21, P451; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Morel CM, 2000, PARASITOL TODAY, V16, P522, DOI 10.1016/S0169-4758(00)01815-9; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; WHO, 2002, WHO TECH REP SER; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423	16	30	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31876	10.1371/journal.pone.0031876	http://dx.doi.org/10.1371/journal.pone.0031876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359638	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200107
J	McMurdo, MET; Argo, I; Crombie, IK; Feng, ZQ; Sniehotta, FF; Vadiveloo, T; Witham, MD; Donnan, PT				McMurdo, Marion E. T.; Argo, Ishbel; Crombie, Iain K.; Feng, Zhiqiang; Sniehotta, Falko F.; Vadiveloo, Thenmalar; Witham, Miles D.; Donnan, Peter T.			Social, Environmental and Psychological Factors Associated with Objective Physical Activity Levels in the Over 65s	PLOS ONE			English	Article							ACCELEROMETER; VALIDITY; HEALTH; IMPACT; QUESTIONNAIRE; BEHAVIOR; PROGRAM; PEOPLE; WOMEN; SF-36	Objective: To assess physical activity levels objectively using accelerometers in community dwelling over 65 s and to examine associations with health, social, environmental and psychological factors. Design: Cross sectional survey. Setting: 17 general practices in Scotland, United Kingdom. Participants: Random sampling of over 65 s registered with the practices in four strata young-old (65-80 years), old-old (over 80 years), more affluent and less affluent groups. Main Outcome Measures: Accelerometry counts of activity per day. Associations between activity and Theory of Planned Behaviour variables, the physical environment, health, wellbeing and demographic variables were examined with multiple regression analysis and multilevel modelling. Results: 547 older people (mean (SD) age 79(8) years, 54% female) were analysed representing 94% of those surveyed. Accelerometry counts were highest in the affluent younger group, followed by the deprived younger group, with lowest levels in the deprived over 80 s group. Multiple regression analysis showed that lower age, higher perceived behavioural control, the physical function subscale of SF-36, and having someone nearby to turn to were all independently associated with higher physical activity levels (R-2 = 0.32). In addition, hours of sunshine were independently significantly associated with greater physical activity in a multilevel model. Conclusions: Other than age and hours of sunlight, the variables identified are modifiable, and provide a strong basis for the future development of novel multidimensional interventions aimed at increasing activity participation in later life.	[McMurdo, Marion E. T.; Crombie, Iain K.; Vadiveloo, Thenmalar; Donnan, Peter T.] Univ Dundee, Div Populat Hlth Sci, Dundee, Tayside, Scotland; [Feng, Zhiqiang] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Sniehotta, Falko F.] Newcastle Univ, Ctr Translat Res Publ Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Dundee; University of St Andrews; Newcastle University - UK	McMurdo, MET (corresponding author), Univ Dundee, Div Populat Hlth Sci, Dundee, Tayside, Scotland.	m.e.t.mcmurdo@dundee.ac.uk	Sniehotta, Falko/ABF-7131-2021; Sniehotta, Falko F/C-5481-2008	Sniehotta, Falko/0000-0003-1738-4269; Sniehotta, Falko F/0000-0003-1738-4269; Donnan, Peter/0000-0001-7828-0610; Witham, Miles/0000-0002-1967-0990; Vadiveloo, Thenmalar/0000-0001-5531-6289	Scottish Executive grant [CZH/4/518]; University of Dundee; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish; Chief Scientist Office [CZG/2/569, CZH/4/518] Funding Source: researchfish	Scottish Executive grant; University of Dundee; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This study was funded by Scottish Executive grant CZH/4/518. The sponsor was the University of Dundee. Neither funder nor sponsor had a role in the design, conduct or interpretation of the study.	ABBASI AA, 1995, AM J MED SCI, V310, P229; Ashford S, 2010, BRIT J HEALTH PSYCH, V15, P265, DOI 10.1348/135910709X461752; Baert V, 2011, AGEING RES REV, V10, P464, DOI 10.1016/j.arr.2011.04.001; Baker PRA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub2; Butler L, 2004, HLTH PROMOT J AUSTR, V2004, P134, DOI DOI 10.1071/HE04134; Cattan M, 2011, HEALTH SOC CARE COMM, V19, P198, DOI 10.1111/j.1365-2524.2010.00967.x; Cunningham GO, 2004, AM J HEALTH PROMOT, V18, P435, DOI 10.4278/0890-1171-18.6.435; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Department of Health, 2000, HLTH SURV ENGL; Environmental Systems Research Institute, ARCGIS 9 3; Fox KR, 2011, HEALTH PLACE, V17, P633, DOI 10.1016/j.healthplace.2011.01.002; Hagger MS, 2002, BRIT J HEALTH PSYCH, V7, P283, DOI 10.1348/135910702760213689; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Harper R, 2003, MEASURING SOCIAL CAP; Harris TJ, 2009, MED SCI SPORT EXER, V41, P1392, DOI 10.1249/MSS.0b013e31819b3533; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Kochersberger G, 1996, ARCH PHYS MED REHAB, V77, P793, DOI 10.1016/S0003-9993(96)90258-0; Litwin H, 2001, GERONTOLOGIST, V41, P516, DOI 10.1093/geront/41.4.516; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; McMurdo MET, 2010, J AM GERIATR SOC, V58, P2099, DOI 10.1111/j.1532-5415.2010.03127.x; MCMURDO MET, 1995, AGE AGEING, V24, P425, DOI 10.1093/ageing/24.5.425; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; ONS, 2011, ONS POSTC DIR US GUI; Pollard B, 2001, SOC SCI MED, V52, P921, DOI 10.1016/S0277-9536(00)00194-5; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; ROWLAND L, 1994, J EPIDEMIOL COMMUN H, V48, P123, DOI 10.1136/jech.48.2.123; Sumukadas D, 2009, J EPIDEMIOL COMMUN H, V63, P305, DOI 10.1136/jech.2008.080838; Sumukadas D, 2008, AGING CLIN EXP RES, V20, P15; Talbot LA, 2002, AM J CARDIOL, V89, P1187, DOI 10.1016/S0002-9149(02)02302-0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; van Stralen MM, 2009, HEALTH PSYCHOL REV, V3, P147, DOI 10.1080/17437190903229462; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	37	37	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31878	10.1371/journal.pone.0031878	http://dx.doi.org/10.1371/journal.pone.0031878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359640	Green Published, gold			2022-12-27	WOS:000302796200109
J	Hess, S; Sausen, N; Melkonian, M				Hess, Sebastian; Sausen, Nicole; Melkonian, Michael			Shedding Light on Vampires: The Phylogeny of Vampyrellid Amoebae Revisited	PLOS ONE			English	Article							REVISED CLASSIFICATION; SEQUENCE ALIGNMENT; FILOSE AMEBA; CERCOZOA; DNA; PERFORATION; SEAVIEW; REVEALS; CONIDIA; TREE	With the advent of molecular phylogenetic techniques the polyphyly of naked filose amoebae has been proven. They are interspersed in several supergroups of eukaryotes and most of them already found their place within the tree of life. Although the `vampire amoebae' have attracted interest since the middle of the 19th century, the phylogenetic position and even the monophyly of this traditional group are still uncertain. In this study clonal co-cultures of eight algivorous vampyrellid amoebae and the respective food algae were established. Culture material was characterized morphologically and a molecular phylogeny was inferred using SSU rDNA sequence comparisons. We found that the limnetic, algivorous vampyrellid amoebae investigated in this study belong to a major clade within the Endomyxa CAVALIER-SMITH, 2002 (Cercozoa), grouping together with a few soil-dwelling taxa. They split into two robust clades, one containing species of the genus Vampyrella CIENKOWSKI, 1865, the other containing the genus Leptophrys HERTWIG & LESSER, 1874, together with terrestrial members. Supported by morphological data these clades are designated as the two families Vampyrellidae ZOPF, 1885, and Leptophryidae fam. nov. Furthermore the order Vampyrellida WEST, 1901 was revised and now corresponds to the major vampyrellid clade within the Endomyxa, comprising the Vampyrellidae and Leptophryidae as well as several environmental sequences. In the light of the presented phylogenetic analyses morphological and ecological aspects, the feeding strategy and nutritional specialization within the vampyrellid amoebae are discussed.	[Hess, Sebastian; Sausen, Nicole; Melkonian, Michael] Univ Cologne, Inst Bot, Cologne Bioctr, Cologne, Germany	University of Cologne	Hess, S (corresponding author), Univ Cologne, Inst Bot, Cologne Bioctr, Gyrhofstr 15, Cologne, Germany.	shess@uni-bonn.de	Hess, Sebastian/AAT-8824-2021					Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ANDERSON TR, 1980, SOIL BIOL BIOCHEM, V12, P159, DOI 10.1016/0038-0717(80)90053-X; Bass D, 2005, PROTIST, V156, P149, DOI 10.1016/j.protis.2005.03.001; Bass D, 2004, INT J SYST EVOL MICR, V54, P2393, DOI 10.1099/ijs.0.63229-0; Bass D, 2009, PROTIST, V160, P75, DOI 10.1016/j.protis.2008.07.002; CANN JP, 1979, ARCH PROTISTENKD, V122, P226, DOI 10.1016/S0003-9365(79)80034-2; CANTER HM, 1973, ZOOL J LINN SOC-LOND, V52, P63; Canter-Lund H, 1994, FRESHWATER ALGAE THE; Cash J., 1904, Journal of the Linnean Society, Vxxix, P218; Cash J, 1905, BRIT FRESHWATER RHIZ; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Cienkowski L., 1881, TRAVEAUX SOC IMPERIA, V12, P130; Cienkowski L, 1865, ARCH MIKROSK ANAT, V5, P203, DOI DOI 10.1007/BF02961414; Cienkowski L, 1876, ARCH MIKROSK ANAT, V12, P15; de SAEDELEER HENRI, 1934, MEM MUS ROY HIST NAT BELGIQUE, V60, P1; Dobell Clifford, 1913, Archiv fuer Protistenkunde Jena, V31; DOFLEIN F, 1916, LEHRBUCH PROTOZOENKU; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gromov BV, 1976, MIKROORGANISMY PARAZ; Haeckel E, 1870, STUDIEN MONEREN ANDE; Hall R.P., 1953, PROTOZOOLOGY; Hertwig R, 1874, ARCH MIKROSK ANAT, V10, P61; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; HOMMA Y, 1984, Annals of the Phytopathological Society of Japan, V50, P229, DOI 10.3186/jjphytopath.50.229; HOMMA Y, 1979, PHYTOPATHOLOGY, V69, P1118, DOI 10.1094/Phyto-69-1118; HONIGBERG BM, 1964, J PROTOZOOL, V11, P7, DOI 10.1111/j.1550-7408.1964.tb01715.x; HOOGENRAAD H. R., 1927, BIOL ZENTRALBL, V47, P517; Howe AT, 2011, PROTIST, V162, P332, DOI 10.1016/j.protis.2010.10.002; HULSMANN N, 1993, J EUKARYOT MICROBIOL, V40, P141, DOI 10.1111/j.1550-7408.1993.tb04894.x; IVANI MOMILO, 1934, CELLULE, V43, P149; Kepner WA, 1906, AM NAT, V40, P335, DOI 10.1086/278621; Klein J, 1882, BOT ZBL, V11, P247; Klein J, 1882, BOT CENTRALBL, V11, P187; Kudo RR., 1946, PROTOZOOLOGY, P778; Leidy J, 1879, FRESH WATER RHIZOPOD; Lloyd FE, 1926, SCIENCE, V63, P364, DOI 10.1126/science.63.1631.364; LOEBLICH ALFRED R., 1965, PROC BIOL SOC WASH, V78, P115; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Marin B, 1998, PROTIST, V149, P265, DOI 10.1016/S1434-4610(98)70033-1; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; OLD KM, 1977, T BRIT MYCOL SOC, V68, P277, DOI 10.1016/S0007-1536(77)80018-1; OLD KM, 1978, SOIL BIOL BIOCHEM, V10, P93, DOI 10.1016/0038-0717(78)90077-9; OLD KM, 1980, PROTISTOLOGICA, V16, P277; OLD KM, 1980, SOIL BIOL BIOCHEM, V12, P169, DOI 10.1016/0038-0717(80)90054-1; PAGE FC, 1987, ARCH PROTISTENKD, V133, P199, DOI 10.1016/S0003-9365(87)80053-2; Page FC, 1991, PROTOZOENFAUNA, V2, P297; Pakzad U, 2003, UNTERSUCHUNGEN MYKOP; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; PATTERSON DJ, 1983, J PROTOZOOL, V30, P301, DOI 10.1111/j.1550-7408.1983.tb02920.x; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; PATTERSON DJ, 1987, J PROTOZOOL, V34, P63, DOI 10.1111/j.1550-7408.1987.tb03133.x; Pawlowski Jan, 2008, Protistology, V5, P281; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Penard E, 1904, HELIOZOAIRES EAU DOU; PERNIN P, 1976, PROTISTOLOGICA, V12, P555; Poche Franz, 1913, Archiv fuer Protistenkunde Jena, V30; Poisson B., 1933, Compte Rendu des Seances de la Societe de Biologie Paris, V113, P1149; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rolleston G, 1888, FORMS ANIMAL LIFE MA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROPSTORF P, 1994, J EUKARYOT MICROBIOL, V41, P18, DOI 10.1111/j.1550-7408.1994.tb05930.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAYRE RM, 1973, J NEMATOL, V5, P258; Schepotieff A, 1912, ZOOL JB ABT F ANAT, V32, P367; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tregouboff G, 1866, TRAITE ZOOLOGIE PROT, P437; VALKANOV A., 1940, ARCH PROTISTENK, V93, P225; WEBER AP, 1952, NATURE, V169, P834, DOI 10.1038/169834b0; West G. S., 1901, Journal of the Linnean Society, Vxxviii, P308; WINSLOW R. D., 1957, TIJDSCHR PLANTENZIEKTEN, V63, P242, DOI 10.1007/BF01988794; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Zettler LAA, 2001, J EUKARYOT MICROBIOL, V48, P293, DOI 10.1111/j.1550-7408.2001.tb00317.x; Zopf, 1885, MORPHOLOGIE BIOL NIE, P45; Zopf W, 1885, HDB BOT, P1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; ZWILLENBERG L. O., 1953, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V19, P101, DOI 10.1007/BF02594837	84	61	62	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31165	10.1371/journal.pone.0031165	http://dx.doi.org/10.1371/journal.pone.0031165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355342	Green Submitted, gold, Green Published			2022-12-27	WOS:000302741300042
J	Kingston, A; Collerton, J; Davies, K; Bond, J; Robinson, L; Jagger, C				Kingston, Andrew; Collerton, Joanna; Davies, Karen; Bond, John; Robinson, Louise; Jagger, Carol			Losing the Ability in Activities of Daily Living in the Oldest Old: A Hierarchic Disability Scale from the Newcastle 85+ Study	PLOS ONE			English	Article							PATTERNS; MOBILITY; DECLINE; GO	Objective: To investigate the order in which 85 year olds develop difficulty in performing a wide range of daily activities covering basic personal care, household care and mobility. Design: Cross-sectional analysis of baseline data from a cohort study. Setting: Newcastle upon Tyne and North Tyneside, UK. Participants: Individuals born in 1921, registered with participating general practices. Measurements: Detailed health assessment including 17 activities of daily living related to basic personal care, household care and mobility. Questions were of the form 'Can you ...' rather than 'Do you ...' Principal Component Analysis (PCA) was used to confirm a single underlying dimension for the items and Mokken Scaling was used to determine a subsequent hierarchy. Validity of the hierarchical scale was assessed by its associations with known predictors of disability. Results: 839 people within the Newcastle 85+ study for whom complete information was available on self-reported Activities of Daily Living (ADL). PCA confirmed a single underlying dimension; Mokken scaling confirmed a hierarchic scale where 'Cutting toenails' was the first item with which participants had difficulty and 'feeding' the last. The ordering of loss differed between men and women. Difficulty with 'shopping' and 'heavy housework' were reported earlier by women whilst men reported 'walking 400 yards' earlier. Items formed clusters corresponding to strength, balance, lower and upper body involvement and domains specifically required for balance and upper/lower limb functional integrity. Conclusion: This comprehensive investigation of ordering of ability in activities in 85 year olds will inform researchers and practitioners assessing older people for onset of disability and subsequent care needs.	[Kingston, Andrew; Collerton, Joanna; Davies, Karen; Bond, John; Robinson, Louise; Jagger, Carol] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bond, John; Robinson, Louise] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Kingston, A (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	andrew.kingston@ncl.ac.uk; carol.jagger@ncl.ac.uk		Kingston, Andrew/0000-0003-4211-7007; Jagger, Carol/0000-0002-6377-9926; Davies, Karen/0000-0002-2820-9397; Robinson, Louise/0000-0003-0209-2503	Medical Research Council; Biotechnology and Biological Sciences Research Council [G0500997]; Newcastle Healthcare Charity; Newcastle Primary Care Trust; North Tyneside Primary Care Trust; Medical Research Council [MR/J50001X/1, G0500997] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10260] Funding Source: researchfish; MRC [MR/J50001X/1, G0500997] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle Healthcare Charity; Newcastle Primary Care Trust; North Tyneside Primary Care Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The baseline phase of the Newcastle 85+ Study was supported by a combined grant from the Medical Research Council and Biotechnology and Biological Sciences Research Council (reference G0500997), and a grant from the Newcastle Healthcare Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are greatly indebted to the participants in the study for the generous donation of their time and personal information to make the study possible. We thank the research nurses (Brenda Balderson, Sally Barker, Julie Burrows, June Edwards, Julie Ferguson, Gill Hedley, Joan Hughes, Judith Hunt, Julie Kimber, and Victoria Raynor), data manager (Pauline Potts) and study secretary (Lucy Farfort) for outstanding work at all times. We acknowledge, with gratitude, the support of Newcastle and North Tyneside Primary Care Trusts and local general practices, and the advice given by the Newcastle and North Tyneside 1 Research Ethics Committee. We thank Rudi Westendorp and Jacobijn Gussekloo (Leiden University Medical Centre, the Netherlands) for generously sharing with us their experiences of the Leiden 85+ Study. We also thank Tom Kirkwood, Thomas von Zglinicki, Martin Eccles and Carmen Martin-Ruiz for helpful comments on drafts of the manuscript.	Bischoff HA, 2003, AGE AGEING, V32, P315, DOI 10.1093/ageing/32.3.315; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Deeg DJH, CALCULATION HLTH EXP; Diesfeldt HEA, 2004, INT J GERIATR PSYCH, V19, P1065, DOI 10.1002/gps.1212; Dunlop DD, 1997, AM J PUBLIC HEALTH, V87, P378, DOI 10.2105/AJPH.87.3.378; Ferrucci L, 1998, GERONTOLOGIST, V38, P286, DOI 10.1093/geront/38.3.286; Glass TA, 1998, GERONTOLOGIST, V38, P101, DOI 10.1093/geront/38.1.101; JAGGER C, 1992, INT J GERIATR PSYCH, V7, P659, DOI 10.1002/gps.930070907; Jagger C, 2001, J AM GERIATR SOC, V49, P404, DOI 10.1046/j.1532-5415.2001.49083.x; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KEMPEN GIJM, 1995, J CLIN EPIDEMIOL, V48, P1299, DOI 10.1016/0895-4356(95)00043-7; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; MOLLOY DW, 1991, AM J PSYCHIAT, V148, P102; Njegovan V, 2001, J GERONTOL A-BIOL, V56, pM638, DOI 10.1093/gerona/56.10.M638; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; United Nations Department of Economic and Social Affairs, 2002, WORLD POP AG 1950 20; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Weiss CO, 2007, J GERONTOL A-BIOL, V62, P167, DOI 10.1093/gerona/62.2.167	24	69	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31665	10.1371/journal.pone.0031665	http://dx.doi.org/10.1371/journal.pone.0031665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355385	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300085
J	Lehner, M; Gotz, G; Proff, J; Schaft, N; Dorrie, J; Full, F; Ensser, A; Muller, YA; Cerwenka, A; Abken, H; Parolini, O; Ambros, PF; Kovar, H; Holter, W				Lehner, Manfred; Goetz, Gabriel; Proff, Julia; Schaft, Niels; Doerrie, Jan; Full, Florian; Ensser, Armin; Muller, Yves A.; Cerwenka, Adelheid; Abken, Hinrich; Parolini, Ornella; Ambros, Peter F.; Kovar, Heinrich; Holter, Wolfgang			Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection	PLOS ONE			English	Article							RECOMBINANT IMMUNORECEPTORS; ADOPTIVE IMMUNOTHERAPY; CD28 COSTIMULATION; PROGNOSTIC-FACTORS; LYMPHOCYTES; CYTOTOXICITY; ACTIVATION; DNAM-1; SECRETION; ASYMMETRY	We explored the possibility to target Ewing's sarcoma family of tumors (ESFT) by redirecting T cells. To this aim, we considered NKG2D-ligands (NKG2D-Ls) as possible target antigens. Detailed analysis of the expression of MICA, MICB, ULBP-1, -2, and -3 in fourteen ESFT cell lines revealed consistent expression of at least one NKG2D-L. Thus, for redirecting T cells, we fused a CD3 zeta/CD28-derived signaling domain to the ectodomain of NKG2D, however, opposite transmembrane orientation of this signaling domain and NKG2D required inverse orientation fusion of either of them. We hypothesized that the particularly located C-terminus of the NKG2D ectodomain should allow reengineering of the membrane anchoring from a native N-terminal to an artificial C-terminal linkage. Indeed, the resulting chimeric NKG2D receptor (chNKG2D) was functional and efficiently mediated ESFT cell death triggered by activated T cells. Notably, ESFT cells with even low NKG2D-L expression were killed by CD8(pos) and also CD4(pos) cells. Both, mRNA transfection and lentiviral transduction resulted in high level surface expression of chNKG2D. However, upon target-cell recognition receptor surface levels were maintained by tranfected RNA only during the first couple of hours after transfection. Later, target-cell contact resulted in strong and irreversible receptor down-modulation, whereas lentivirally mediated expression of chNKG2D remained constant under these conditions. Together, our study defines NKG2D-Ls as targets for a CAR-mediated T cell based immunotherapy of ESFT. A comparison of two different methods of gene transfer reveals strong differences in the susceptibility to ligand-induced receptor down-modulation with possible implications for the applicability of RNA transfection.	[Lehner, Manfred; Goetz, Gabriel; Proff, Julia; Holter, Wolfgang] Univ Erlangen Nurnberg, Lab Cellular Therapy, Childrens Univ Hosp, Univ Klinikum Erlangen, D-91054 Erlangen, Germany; [Schaft, Niels; Doerrie, Jan] Univ Erlangen Nurnberg, Dept Dermatol, Univ Klinikum Erlangen, Erlangen, Germany; [Full, Florian; Ensser, Armin] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany; [Muller, Yves A.] Univ Erlangen Nurnberg, Lehrstuhl Biotech, Dept Biol, Erlangen, Germany; [Cerwenka, Adelheid] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Abken, Hinrich] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Parolini, Ornella] Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy; [Ambros, Peter F.; Kovar, Heinrich] St Anna Hosp, CCRI, Vienna, Austria	University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; Saint Anna Children's Hospital	Lehner, M (corresponding author), Univ Erlangen Nurnberg, Lab Cellular Therapy, Childrens Univ Hosp, Univ Klinikum Erlangen, D-91054 Erlangen, Germany.	manfred.lehner@uk-erlangen.de	Ambros, Peter/AAA-1266-2021; Muller, Yves A/R-5397-2016; Schaft, Niels/H-3713-2011; Dörrie, Jan/H-3678-2011; PAROLINI, ORNELLA/C-7946-2013; PAROLINI, ORNELLA/ABI-7862-2020	Ambros, Peter/0000-0002-5507-7211; Muller, Yves A/0000-0003-0519-8928; Schaft, Niels/0000-0001-8236-9298; Dörrie, Jan/0000-0002-3478-0741; PAROLINI, ORNELLA/0000-0002-5211-6430; PAROLINI, ORNELLA/0000-0002-5211-6430; Cerwenka, Adelheid/0000-0001-6977-3536; Lehner, Manfred/0000-0002-5776-4218; Full, Florian/0000-0003-1900-5891; Kovar, Heinrich/0000-0001-6873-9109	Wilhelm Sander-Foundation [2002.034.1, 2009.002.1]; Staedtler-Foundation [24/09]; Interdisciplinary Center for Clinical Research (IZKF: Genesis, Diagnostics and Therapy of Inflammation Processes); German Research Foundation (DFG) [SCHA 1247/1-1, EN 423/2-1, SFB796]; Fondazione Berlucchi, Brescia, Italy	Wilhelm Sander-Foundation; Staedtler-Foundation; Interdisciplinary Center for Clinical Research (IZKF: Genesis, Diagnostics and Therapy of Inflammation Processes); German Research Foundation (DFG)(German Research Foundation (DFG)); Fondazione Berlucchi, Brescia, Italy	This work was financially supported by the Wilhelm Sander-Foundation (project Nr. 2002.034.1 and 2009.002.1), Staedtler-Foundation (project 24/09), the Interdisciplinary Center for Clinical Research (IZKF: Genesis, Diagnostics and Therapy of Inflammation Processes), the German Research Foundation (DFG: project SCHA 1247/1-1), EN 423/2-1, and SFB796) and a grant from the Fondazione Berlucchi, Brescia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber A, 2008, EXP HEMATOL, V36, P1318, DOI 10.1016/j.exphem.2008.04.010; Barber A, 2007, CANCER RES, V67, P5003, DOI 10.1158/0008-5472.CAN-06-4047; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Birkholz K, 2009, GENE THER, V16, P596, DOI 10.1038/gt.2008.189; Brinkrolf P, 2009, INT J CANCER, V125, P879, DOI 10.1002/ijc.24461; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Full F, 2010, J VIROL, V84, P4083, DOI 10.1128/JVI.02117-09; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Hombach A, 2001, J IMMUNOL, V167, P6123, DOI 10.4049/jimmunol.167.11.6123; James SE, 2010, J IMMUNOL, V184, P4284, DOI 10.4049/jimmunol.0903701; James ST, 2008, J IMMUNOL, V180, P7028, DOI 10.4049/jimmunol.180.10.7028; Kloess S, 2010, EUR J IMMUNOL, V40, P3255, DOI 10.1002/eji.201040568; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; KOVAR H, 1993, ONCOGENE, V8, P2683; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Leavey PJ, 2008, PEDIATR BLOOD CANCER, V51, P334, DOI 10.1002/pbc.21618; Lehner M, 2007, J IMMUNOTHER, V30, P312, DOI 10.1097/01.cji.0000211345.11707.46; Loskog A, 2006, LEUKEMIA, V20, P1819, DOI 10.1038/sj.leu.2404366; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Meidenbauer N, 2003, J IMMUNOL, V170, P2161, DOI 10.4049/jimmunol.170.4.2161; Miser JS, 2007, PEDIATR BLOOD CANCER, V49, P894, DOI 10.1002/pbc.21233; Mitchell MS, 2002, J CLIN ONCOL, V20, P1075, DOI 10.1200/JCO.20.4.1075; Mitsiades N, 1998, AM J PATHOL, V153, P1947, DOI 10.1016/S0002-9440(10)65708-2; Molinero LL, 2002, J LEUKOCYTE BIOL, V71, P791; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Rodriguez-Galindo C, 2007, CANCER-AM CANCER SOC, V110, P375, DOI 10.1002/cncr.22821; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; de Hooge ASK, 2007, CLIN CANCER RES, V13, P206, DOI 10.1158/1078-0432.CCR-06-1457; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salmon P, 2000, BLOOD, V96, P3392; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sun Q, 2002, BLOOD, V99, P3302, DOI 10.1182/blood.V99.9.3302; Textor S, 2008, INT J CANCER, V123, P2343, DOI 10.1002/ijc.23733; Thomas S, 2011, BLOOD, V118, P319, DOI 10.1182/blood-2010-12-326736; van Valen F, 1999, HUMAN CELL CULTURE, V1, P55; Van Valen F, 2000, INT J CANCER, V88, P252, DOI 10.1002/1097-0215(20001015)88:2<252::AID-IJC17>3.0.CO;2-U; Verhoeven DHJ, 2008, MOL IMMUNOL, V45, P3917, DOI 10.1016/j.molimm.2008.06.016; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Zhang T, 2005, BLOOD, V106, P1544, DOI 10.1182/blood-2004-11-4365; Zhang T, 2006, CANCER RES, V66, P5927, DOI 10.1158/0008-5472.CAN-06-0130; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880	51	85	98	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31210	10.1371/journal.pone.0031210	http://dx.doi.org/10.1371/journal.pone.0031210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355347	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300047
J	Li, P; Zhu, SY				Li, Ping; Zhu, Shunyi			Mutational Analysis of the Analgesic Peptide DrTx(1-42) Revealing a Functional Role of the Amino-Terminal Turn	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNELS; ANTINOCICEPTIVE ACTIVITY; PAIN PATHWAYS; MICE; CONOTOXIN; DRUGS; DROSOTOXIN; DROSOMYCIN; ACID	Background: DrTx(1-42) (a carboxyl-terminally truncated version of drosotoxin) is a potent and selective blocker of tetrodotoxin-resistant (TTX-R) Na+ channels in rat dorsal root ganglion neurons with analgesic activity. This purpose is to identify key amino acids which are responsible for both blocking and analgesic effects of DrTx(1-42). Methods: On the basis of previous study, we designed five mutants of DrTx(1-42) (delN, D8A, D8K, G9A, and G9R) in the amino-terminal turn (N-turn) region, a proposed functional region located in the amino-terminus of the molecule. All these mutants were expressed in E. coli and purified by RP-HPLC. Electrophysiological properties of these analogues were examined by whole-cell patch-clamp recordings and their antinociceptive effects were investigated by the formalin test and acetic acid induced writhing test. Results: All the mutants except for G9A possess a similar secondary structure to that of DrTx(1-42), as identified by circular dichroism analysis. Three mutants (delN, D8A and G9A) were found almost inactive to TTX-R Na+ channels, whereas D8K retains similar activity and G9R showed decreased potency when compared with the wild-type molecule. Consistent with the electrophysiological observations, D8K and G9R exhibited antinociceptive effects in the second phase (inflammatory pain) of the formalin test and the acetic acid induced writhing test, while delN, D8A and G9A lack such effects. Conclusions: Our results show that the N-turn is closely related to function of DrTx(1-42). The mutant (D8A) as a control peptide further reveals that a charged residue at site 8 of the N-terminus is important for channel blockade and analgesic activity. This study indicates that blocking of voltage-gated TTX-R Na+ channel in DRG neurons contributes to analgesic effect in rat inflammatory pain. Structural and functional data described here offers support for the development of novel analgesic drugs through targeting TTX-R Na+ channels.	[Li, Ping; Zhu, Shunyi] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, P (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	Zhusy@ioz.ac.cn			National Natural Science Foundation of China [30730015, 30921006]; National Basic Research Program of China [2010CB945300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grants 30730015 and 30921006) and the National Basic Research Program of China (Grant 2010CB945300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Arihan O, 2009, J ETHNOPHARMACOL, V125, P274, DOI 10.1016/j.jep.2009.06.032; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; DERAEDT R, 1980, EUR J PHARMACOL, V61, P17, DOI 10.1016/0014-2999(80)90377-5; Ekberg J, 2008, INT J BIOCHEM CELL B, V40, P2363, DOI 10.1016/j.biocel.2007.08.017; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P2005, DOI 10.1016/j.biocel.2006.06.008; Gao B, 2008, INSECT MOL BIOL, V17, P405, DOI 10.1111/j.1365-2583.2008.00810.x; Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018; Ikeda Y, 2001, LIFE SCI, V69, P2911, DOI 10.1016/S0024-3205(01)01374-1; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; Martinez V, 1999, PAIN, V81, P179, DOI 10.1016/S0304-3959(99)00008-1; Romeo S, 2008, BBA-GEN SUBJECTS, V1780, P750, DOI 10.1016/j.bbagen.2008.01.012; Sakaue A, 2004, J PHARMACOL SCI, V95, P181, DOI 10.1254/jphs.FPJ03087X; Silos-Santiago I, 2008, CURR OPIN INVEST DR, V9, P83; Silver K, 2010, INT J BIOCHEM CELL B, V42, P2030, DOI 10.1016/j.biocel.2010.09.007; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Xiao YC, 2005, J BIOL CHEM, V280, P12069, DOI 10.1074/jbc.M411651200; Yu YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019865; Zhang ZT, 2010, DEV COMP IMMUNOL, V34, P953, DOI 10.1016/j.dci.2010.04.003; Zhu SY, 2008, MOL IMMUNOL, V45, P2531, DOI 10.1016/j.molimm.2008.01.007; Zhu SY, 2011, BIOCHEM PHARMACOL, V81, P425, DOI 10.1016/j.bcp.2010.10.015; Zhu SY, 2010, BIOCHEM PHARMACOL, V80, P1296, DOI 10.1016/j.bcp.2010.07.008	26	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31830	10.1371/journal.pone.0031830	http://dx.doi.org/10.1371/journal.pone.0031830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355398	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300098
J	Starkhammar, M; Georen, SK; Swedin, L; Dahlen, SE; Adner, M; Cardell, LO				Starkhammar, Magnus; Georen, Susanna Kumlien; Swedin, Linda; Dahlen, Sven-Erik; Adner, Mikael; Cardell, Lars Olaf			Intranasal Administration of poly(I:C) and LPS in BALB/c Mice Induces Airway Hyperresponsiveness and Inflammation via Different Pathways	PLOS ONE			English	Article							SMOOTH-MUSCLE; BRADYKININ; ASTHMA	Background: Bacterial and viral infections are known to promote airway hyperresponsiveness (AHR) in asthmatic patients. The mechanism behind this reaction is poorly understood, but pattern recognizing Toll-like receptors (TLRs) have recently been suggested to play a role. Materials and Methods: To explore the relation between infection-induced airway inflammation and the development of AHR, poly(I:C) activating TLR3 and LPS triggering TLR4, were chosen to represent viral and bacterial induced interactions, respectively. Female BALB/c or MyD88-deficient C57BL/6 mice were treated intranasally with either poly(I:C), LPS or PBS (vehicle for the control group), once a day, during 4 consecutive days. Results: When methacholine challenge was performed on day 5, BALB/c mice responded with an increase in airway resistance. The maximal resistance was higher in the poly(I:C) and LPS treated groups than among the controls, indicating development of AHR in response to repeated TLR activation. The proportion of lymphocytes in broncheoalveolar lavage fluid (BALF) increased after poly(I:C) treatment whereas LPS enhanced the amount of neutrophils. A similar cellular pattern was seen in lung tissue. Analysis of 21 inflammatory mediators in BALF revealed that the TLR response was receptor-specific. MyD88-deficient C57BL/6 mice responded to poly (I:C) with an influx of lymphocytes, whereas LPS caused no inflammation. Conclusion: In vivo activation of TLR3 and TLR4 in BALB/c mice both caused AHR in conjunction with a local inflammatory reaction. The AHR appeared to be identical regardless of which TLR that was activated, whereas the inflammation exhibited a receptor specific profile in terms of both recruited cells and inflammatory mediators. The inflammatory response caused by LPS appeared to be dependent on MyD88 pathway. Altogether the presented data indicate that the development of AHR and the induction of local inflammation might be the result of two parallel events, rather than one leading to another.	[Starkhammar, Magnus; Georen, Susanna Kumlien; Cardell, Lars Olaf] Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden; [Starkhammar, Magnus; Georen, Susanna Kumlien; Swedin, Linda; Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Natl Inst Environm Med, Unit Expt Asthma & Allergy Res, Stockholm, Sweden; [Swedin, Linda; Dahlen, Sven-Erik; Adner, Mikael; Cardell, Lars Olaf] Karolinska Inst, Ctr Allergy Reseach, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Starkhammar, M (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255	Swedish Medical Research Council; The Swedish Heart Lung Foundation; Swedish Asthma and Allergy Foundation; The Stockholm County Council (ALF); Vinnova (CiDAT); Tore Nilsson's Foundation for Medical Research; Magnus Bergvalls Foundation; The Centre for Allergy Reseach, Karolinska Institutet	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); The Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Foundation; The Stockholm County Council (ALF)(Stockholm County Council); Vinnova (CiDAT)(Vinnova); Tore Nilsson's Foundation for Medical Research; Magnus Bergvalls Foundation; The Centre for Allergy Reseach, Karolinska Institutet	This study was financially supported by the Swedish Medical Research Council, The Swedish Heart Lung Foundation, the Swedish Asthma and Allergy Foundation, The Stockholm County Council (ALF), Vinnova (CiDAT), Tore Nilsson's Foundation for Medical Research, Magnus Bergvalls Foundation and by The Centre for Allergy Reseach, Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adner M, 2002, BRIT J PHARMACOL, V137, P971, DOI 10.1038/sj.bjp.0704928; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bachar O, 2006, AM J PHYSIOL-LUNG C, V291, pL322, DOI 10.1152/ajplung.00141.2006; Bozanicha EM, 2008, RESP PHYSIOL NEUROBI, V162, P190, DOI 10.1016/j.resp.2008.06.011; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Bryborn M, 2004, CLIN EXP ALLERGY, V34, P1291, DOI 10.1111/j.1365-2222.2004.02031.x; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Ekman AK, 2009, INT ARCH ALLERGY IMM, V149, P154, DOI 10.1159/000189199; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Fransson M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-17; Huang TJ, 1999, AM J RESP CRIT CARE, V160, P1717, DOI 10.1164/ajrccm.160.5.9901029; Komlosi ZI, 2006, CLIN EXP ALLERGY, V36, P951, DOI 10.1111/j.1365-2222.2006.02514.x; Luo SF, 2000, BRIT J PHARMACOL, V130, P1799, DOI 10.1038/sj.bjp.0703489; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Mansson A, 2006, IMMUNOLOGY, V118, P539, DOI 10.1111/j.1365-2567.2006.02392.x; Mansson A, 2009, J LEUKOCYTE BIOL, V85, P719, DOI 10.1189/jlb.0808494; Micillo E, 2000, ALLERGY, V55, P42; Newcomb Dawn C, 2009, Proc Am Thorac Soc, V6, P266, DOI 10.1513/pats.200806-056RM; Okuma T, 2004, J PATHOL, V204, P594, DOI 10.1002/path.1667; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Rodrigo GJ, 2004, CHEST, V125, P1081, DOI 10.1378/chest.125.3.1081; Safholm J, 2011, PULM PHARMACOL THER, V24, P361, DOI 10.1016/j.pupt.2011.01.001; Shan XY, 2006, AM J PHYSIOL-LUNG C, V291, pL324, DOI 10.1152/ajplung.00056.2006; Simpson JL, 2008, PAEDIATR RESPIR REV, V9, P263, DOI 10.1016/j.prrv.2008.05.007; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Tliba O, 2008, CURR ALLERGY ASTHM R, V8, P262, DOI 10.1007/s11882-008-0043-5; Togbe D, 2006, J LEUKOCYTE BIOL, V80, P451, DOI 10.1189/jlb.0206099	31	41	46	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32110	10.1371/journal.pone.0032110	http://dx.doi.org/10.1371/journal.pone.0032110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355412	Green Submitted, gold, Green Published			2022-12-27	WOS:000302741300112
J	Vos, M; Quince, C; Pijl, AS; de Hollander, M; Kowalchuk, GA				Vos, Michiel; Quince, Christopher; Pijl, Agata S.; de Hollander, Mattias; Kowalchuk, George A.			A Comparison of rpoB and 16S rRNA as Markers in Pyrosequencing Studies of Bacterial Diversity	PLOS ONE			English	Article							POPULATION-STRUCTURE; RARE BIOSPHERE; SEQUENCE; EBURST; GENES; IDENTIFICATION; PATTERNS	Background: The 16S rRNA gene is the gold standard in molecular surveys of bacterial and archaeal diversity, but it has the disadvantages that it is often multiple-copy, has little resolution below the species level and cannot be readily interpreted in an evolutionary framework. We compared the 16S rRNA marker with the single-copy, protein-coding rpoB marker by amplifying and sequencing both from a single soil sample. Because the higher genetic resolution of the rpoB gene prohibits its use as a universal marker, we employed consensus-degenerate primers targeting the Proteobacteria. Methodology/Principal Findings: Pyrosequencing can be problematic because of the poor resolution of homopolymer runs. As these erroneous runs disrupt the reading frame of protein-coding sequences, removal of sequences containing nonsense mutations was found to be a valuable filter in addition to flowgram-based denoising. Although both markers gave similar estimates of total diversity, the rpoB marker revealed more species, requiring an order of magnitude fewer reads to obtain 90% of the true diversity. The application of population genetic methods was demonstrated on a particularly abundant sequence cluster. Conclusions/Significance: The rpoB marker can be a complement to the 16S rRNA marker for high throughput microbial diversity studies focusing on specific taxonomic groups. Additional error filtering is possible and tests for recombination or selection can be employed.	[Vos, Michiel; Pijl, Agata S.; de Hollander, Mattias; Kowalchuk, George A.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Quince, Christopher] Univ Glasgow, Dept Civil Engn, Glasgow G12 8QQ, Lanark, Scotland; [Kowalchuk, George A.] Free Univ Amsterdam, Inst Ecol Sci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Glasgow; Vrije Universiteit Amsterdam	Vos, M (corresponding author), Univ Exeter, Coastal Pathogen Grp, European Ctr Environm & Human Hlth, Peninsula Coll Med & Dent, Exeter, Devon, England.	michiel.vos@pcmd.ac.uk	Kowalchuk, George A/C-4298-2011; Pijl, A/D-4220-2012; KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X; Kowalchuk, George/0000-0003-3866-0832; Quince, Christopher/0000-0003-1884-8440	Netherlands Organisation for Scientific Research (NWO); EPSRC [EP/H003851/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by a Netherlands Organisation for Scientific Research (NWO) Vici grant to Dr. Kowalchuk (http://www.nwo.nl/nwohome.nsf/pages/sppd_5r2qe7_eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Ben Salah I, 2008, MICROBIOL-SGM, V154, P3715, DOI 10.1099/mic.0.2008/020164-0; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Gaget V, 2011, INT J SYST EVOL MICR, V61, P170, DOI 10.1099/ijs.0.019018-0; Hou XL, 2008, EUR J CLIN MICROBIOL, V27, P587, DOI 10.1007/s10096-008-0477-7; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Minegishi H, 2010, INT J SYST EVOL MICR, V60, P2398, DOI 10.1099/ijs.0.017160-0; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oakley BB, 2012, ISME J, V6, P905, DOI 10.1038/ismej.2011.165; Olvera A, 2006, MICROBIOL-SGM, V152, P3683, DOI 10.1099/mic.0.29254-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Salerno A, 2007, J BACTERIOL, V189, P7808, DOI 10.1128/JB.00796-07; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Walsh DA, 2004, MOL BIOL EVOL, V21, P2340, DOI 10.1093/molbev/msh248; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zamborsky DJ, 2011, APPL ENVIRON MICROB, V77, P642, DOI 10.1128/AEM.02105-10	45	75	77	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30600	10.1371/journal.pone.0030600	http://dx.doi.org/10.1371/journal.pone.0030600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355318	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300018
J	Nakamura, S; Imai, S; Ogishima, H; Tsuruma, K; Shimazawa, M; Hara, H				Nakamura, Shinsuke; Imai, Shunsuke; Ogishima, Hiromi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki			Morphological and Functional Changes in the Retina after Chronic Oxygen-Induced Retinopathy	PLOS ONE			English	Article							OSCILLATORY POTENTIALS; DIABETIC-RETINOPATHY; MILD RETINOPATHY; B-WAVE; BARRIER FUNCTION; MUDPUPPY RETINA; TIGHT JUNCTIONS; PRIMATE RETINA; MOUSE RETINA; PREMATURITY	The mouse model of oxygen-induced retinopathy (OIR) has been widely used for studies of retinopathy of prematurity (ROP). This disorder, characterized by abnormal vascularization of the retina, tends to occur in low birth weight neonates after exposure to high supplemental oxygen. Currently, the incidence of ROP is increasing because of increased survival of these infants due to medical progress. However, little is known about changes in the chronic phase after ROP. Therefore, in this study, we examined morphological and functional changes in the retina using a chronic OIR model. Both the a- and b-waves in the OIR model recovered in a time-dependent manner at 4 weeks (w), 6 w, and 8 w, but the oscillatory potential (OP) amplitudes remained depressed following a return to normoxic conditions. Furthermore, decrease in the thicknesses of the inner plexiform layer (IPL) and inner nuclear layer (INL) at postnatal day (P) 17, 4 w, and 8 w and hyperpermeability of blood vessels were observed in conjunction with the decrease in the expression of claudin-5 and occludin at 8 w. The chronic OIR model revealed the following: (1) a decrease in OP amplitudes, (2) morphological abnormalities in the retinal cells (limited to the IPL and INL) and blood vessels, and (3) an increase in retinal vascular permeability via the impairment of the tight junction proteins. These findings suggest that the experimental animal model used in this study is suitable for elucidating the pathogenesis of ROP and may lead to the development of potential therapeutic agents for ROP treatment.	[Nakamura, Shinsuke; Imai, Shunsuke; Ogishima, Hiromi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan	Gifu Pharmaceutical University	Nakamura, S (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp			Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding was provided by Gifu Pharmaceutical University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P5788, DOI 10.1167/iovs.07-0881; Banin E, 2006, INVEST OPHTH VIS SCI, V47, P2125, DOI 10.1167/iovs.05-1096; Bui Bang Viet, 2002, Documenta Ophthalmologica, V104, P17, DOI 10.1023/A:1014401502915; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Chikaraishi Y, 2007, EXP EYE RES, V84, P529, DOI 10.1016/j.exer.2006.11.007; Cideciyan AV, 1996, VISION RES, V36, P2609, DOI 10.1016/0042-6989(95)00327-4; Cunha-Vaz JG, 1997, DOC OPHTHALMOL, V93, P149, DOI 10.1007/BF02569055; Dembinska O, 2001, INVEST OPHTH VIS SCI, V42, P1111; DICK E, 1978, BRAIN RES, V154, P388; Downie LE, 2007, J COMP NEUROL, V504, P404, DOI 10.1002/cne.21449; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fulton AB, 2001, ARCH OPHTHALMOL-CHIC, V119, P499; Fulton AB, 1996, J OPT SOC AM A, V13, P566, DOI 10.1364/JOSAA.13.000566; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GARIANO RF, 1994, INVEST OPHTH VIS SCI, V35, P3442; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Greenstein VC, 2000, INVEST OPHTH VIS SCI, V41, P3643; Hansen RM, 2000, INVEST OPHTH VIS SCI, V41, P320; HARA A, 1994, DOC OPHTHALMOL, V88, P39, DOI 10.1007/BF01203700; HEYNEN H, 1985, VISION RES, V25, P1365, DOI 10.1016/0042-6989(85)90214-7; HOLOPIGIAN K, 1992, INVEST OPHTH VIS SCI, V33, P2773; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Imai S, 2010, J PHARMACOL EXP THER, V335, P645, DOI 10.1124/jpet.110.171298; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; KOROL S, 1975, BRAIN RES, V97, P235, DOI 10.1016/0006-8993(75)90447-3; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Lelong DC, 2007, STROKE, V38, P3237, DOI 10.1161/STROKEAHA.107.499319; LI CX, 1990, J CELL SCI, V97, P231; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P5447, DOI 10.1167/iovs.06-0702; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P2639, DOI 10.1167/iovs.06-0016; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; Moskowitz A, 2005, DOC OPHTHALMOL, V110, P265, DOI 10.1007/s10633-005-1983-x; Nakamura S, 2010, EXP EYE RES, V90, P137, DOI 10.1016/j.exer.2009.09.022; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Rangaswamy NV, 2006, INVEST OPHTH VIS SCI, V47, P753, DOI 10.1167/iovs.05-1051; Recchia FM, 2010, INVEST OPHTH VIS SCI, V51, P1098, DOI 10.1167/iovs.09-4006; Reisner DS, 1997, INVEST OPHTH VIS SCI, V38, P1175; REYNAUD X, 1995, INVEST OPHTH VIS SCI, V36, P2071; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2148; Uemura AK, 2006, EXP CELL RES, V312, P676, DOI 10.1016/j.yexcr.2005.10.030; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; XU XJ, 1994, J NEUROPHYSIOL, V72, P96, DOI 10.1152/jn.1994.72.1.96; YONEMURA D, 1962, ARCH OPHTHALMOL-CHIC, V68, P19; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9	51	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32167	10.1371/journal.pone.0032167	http://dx.doi.org/10.1371/journal.pone.0032167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348151	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400064
J	Anderson, DE; Castan, A; Bisaillon, M; von Messling, V				Anderson, Danielle E.; Castan, Alexandre; Bisaillon, Martin; von Messling, Veronika			Elements in the Canine Distemper Virus M 3 ' UTR Contribute to Control of Replication Efficiency and Virulence	PLOS ONE			English	Article							MESSENGER-RNA; WILD-TYPE; UNTRANSLATED REGIONS; F GENE; PROTEIN EXPRESSION; MEASLES VIRUSES; GENOME REGION; DISEASE VIRUS; TRANSCRIPTION; CYTOPATHOGENICITY	Canine distemper virus (CDV) is a negative-sense, single-stranded RNA virus within the genus Morbillivirus and the family Paramyxoviridae. The Morbillivirus genome is composed of six transcriptional units that are separated by untranslated regions (UTRs), which are relatively uniform in length, with the exception of the UTR between the matrix (M) and fusion (F) genes. This UTR is at least three times longer and in the case of CDV also highly variable. Exchange of the M-F region between different CDV strains did not affect virulence or disease phenotype, demonstrating that this region is functionally interchangeable. Viruses carrying the deletions in the M 3' UTR replicated more efficiently, which correlated with a reduction of virulence, suggesting that overall length as well as specific sequence motifs distributed throughout the region contribute to virulence.	[Anderson, Danielle E.; Castan, Alexandre; von Messling, Veronika] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Anderson, Danielle E.; von Messling, Veronika] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore; [Bisaillon, Martin] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); National University of Singapore; University of Sherbrooke	Anderson, DE (corresponding author), Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada.	veronika.vonmessling@duke-nus.edu.sg	Anderson, Danielle/HCH-2004-2022	Anderson, Danielle/0000-0003-4791-5024	Canadian Institutes of Health Research (CIHR) [MOP-66989]; Canadian Foundation for Innovation (CFI) [9488]; Fonds de la Recherche en Sante Quebec (FRSQ); Fondation Armand-Frappier Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Fondation Armand-Frappier Scholarship	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP-66989) and the Canadian Foundation for Innovation (CFI; 9488) to V.v.M., a Fonds de la Recherche en Sante Quebec (FRSQ) fellowship to D.E.A, and a Fondation Armand-Frappier Scholarship to A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Anderson DE, 2008, J VIROL, V82, P10510, DOI 10.1128/JVI.01419-08; Baricevic M, 2007, VIRUS GENES, V35, P17, DOI 10.1007/s11262-006-0035-2; Bonami F, 2007, J VIROL, V81, P12066, DOI 10.1128/JVI.00818-07; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; Cherpillod P, 1999, J VIROL, V73, P2263, DOI 10.1128/JVI.73.3.2263-2269.1999; Cherpillod P, 2004, ARCH VIROL, V149, P1971, DOI 10.1007/s00705-004-0342-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Heider A, 1997, ARCH VIROL, V142, P2521, DOI 10.1007/s007050050259; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kim SH, 2010, J VIROL, V84, P2629, DOI 10.1128/JVI.02049-09; Liermann H, 1998, VIRUS GENES, V17, P259, DOI 10.1023/A:1008069805011; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Moretti S, 2008, NUCLEIC ACIDS RES, V36, pW10, DOI 10.1093/nar/gkn278; Parks GD, 2001, J VIROL, V75, P2213, DOI 10.1128/JVI.75.5.2213-2223.2001; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Plumet S, 2005, J VIROL, V79, P6900, DOI 10.1128/JVI.79.11.6900-6908.2005; Rennick LJ, 2007, J GEN VIROL, V88, P2710, DOI 10.1099/vir.0.83106-0; Rudd PA, 2006, J VIROL, V80, P9361, DOI 10.1128/JVI.01034-06; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; Siemetzki U, 2009, VIRUS RES, V144, P27, DOI 10.1016/j.virusres.2009.03.016; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Valsamakis A, 1998, J VIROL, V72, P7754, DOI 10.1128/JVI.72.10.7754-7761.1998; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; von Messling V, 2004, P NATL ACAD SCI USA, V101, P14216, DOI 10.1073/pnas.0403597101; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; von Messling V, 2002, J VIROL, V76, P4172, DOI 10.1128/JVI.76.9.4172-4180.2002; von Messling V, 1999, J CLIN MICROBIOL, V37, P1049, DOI 10.1128/JCM.37.4.1049-1056.1999; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wiener D, 2010, VIRUS RES, V153, P234, DOI 10.1016/j.virusres.2010.08.007; Yan YQ, 2009, J VIROL, V83, P5943, DOI 10.1128/JVI.00188-09; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31561	10.1371/journal.pone.0031561	http://dx.doi.org/10.1371/journal.pone.0031561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348107	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900054
J	Lock, FE; Ryan, KR; Poulter, NS; Parsons, M; Hotchin, NA				Lock, Frances E.; Ryan, Katie R.; Poulter, Natalie S.; Parsons, Maddy; Hotchin, Neil A.			Differential Regulation of Adhesion Complex Turnover by ROCK1 and ROCK2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VENTRAL BODY-WALL; RHO-KINASE-II; TYROSINE PHOSPHORYLATION; KERATINOCYTE DIFFERENTIATION; MATRIX ADHESIONS; MIGRATING CELLS; FOCAL CONTACTS; DISTINCT ROLES; STRESS FIBERS	Background: ROCK1 and ROCK2 are serine/threonine kinases that function downstream of the small GTP-binding protein RhoA. Rho signalling via ROCK regulates a number of cellular functions including organisation of the actin cytoskeleton, cell adhesion and cell migration. Methodology/Principal Findings: In this study we use RNAi to specifically knockdown ROCK1 and ROCK2 and analyse their role in assembly of adhesion complexes in human epidermal keratinocytes. We observe that loss of ROCK1 inhibits signalling via focal adhesion kinase resulting in a failure of immature adhesion complexes to form mature stable focal adhesions. In contrast, loss of ROCK2 expression results in a significant reduction in adhesion complex turnover leading to formation of large, stable focal adhesions. Interestingly, loss of either ROCK1 or ROCK2 expression significantly impairs cell migration indicating both ROCK isoforms are required for normal keratinocyte migration. Conclusions: ROCK1 and ROCK2 have distinct and separate roles in adhesion complex assembly and turnover in human epidermal keratinocytes.	[Lock, Frances E.; Ryan, Katie R.; Poulter, Natalie S.; Hotchin, Neil A.] Univ Birmingham, Sch Biosci, Edgbaston, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of Birmingham; University of London; King's College London	Lock, FE (corresponding author), British Columbia Canc Agcy, Integrat Oncol Dept, Vancouver, BC V5Z 4E6, Canada.	n.a.hotchin@bham.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; Hotchin, Neil/0000-0002-1844-7607; Poulter, Natalie/0000-0002-3187-2130	Cancer Research UK [C20692]	Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK Project Grant (C20692) to NAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; Ren XD, 2000, J CELL SCI, V113, P3673; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	45	57	58	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31423	10.1371/journal.pone.0031423	http://dx.doi.org/10.1371/journal.pone.0031423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348083	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900046
J	Simmons, AN; Thayer, RE; Spadoni, AD; Matthews, SC; Strigo, IA; Tapert, SF				Simmons, Alan N.; Thayer, Rachel E.; Spadoni, Andrea D.; Matthews, Scott C.; Strigo, Irina A.; Tapert, Susan F.			The Parametric, Psychological, Neuropsychological, and Neuroanatomical Properties of Self and World Evaluation	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SUBJECT DIFFUSION DATA; BRAIN-DEVELOPMENT; PSYCHIATRIC-DISORDERS; SPATIAL STATISTICS; VOXELWISE ANALYSIS; SUBSTANCE-ABUSE; MR-IMAGES; REGISTRATION; INTELLIGENCE	Background: As an individual moves from adolescence to adulthood, they need to form a new sense of self as their environment changes from a limited to a more expansive structure. During this critical stage in development the last dramatic steps of neural development occur and numerous psychiatric conditions begin to manifest. Currently, there is no measure that aids in the quantification of how the individual is adapting to, and conceptualizing their role in, these new structures. To fill this gap we created the Self and World Evaluation Expressions Test(SWEET). Method: Sixty-five young adults (20.6 years-old), 36 with a history of drug use, completed the SWEET. A factor analysis was performed on the SWEET and the resultant factors were correlated with psychological, neuropsychological, and neuroanatomical battery that included both T1-wieghted and diffusion tensor magnetic resonance imaging scans. Results: We derived four factors: Self, Social-Emotional, Financial-Intellectual, and Spirituality. While showing limited relationships to psychological and neuropsychological measures, both white matter integrity and gray matter density showed significant relationships with SWEET factors. Conclusions: These findings suggest that while individual responses may not be indicative of psychological or cognitive processes they may relate to changes in brain structure. Several of these structures, such as the negative correlation of the affective impact of world with the dorsal anterior corpus callosum white matter integrity have been observed in psychiatric conditions (e. g., obsessive-compulsive disorder). Further longitudinal research using the SWEET may help understand the impact of dramatic shifts in self/world conceptualization and potentially link these shifts to underlying changes in brain structure.	[Simmons, Alan N.; Thayer, Rachel E.; Spadoni, Andrea D.; Matthews, Scott C.; Tapert, Susan F.] VA San Diego Healthcare Syst, San Diego, CA USA; [Simmons, Alan N.; Spadoni, Andrea D.; Matthews, Scott C.; Strigo, Irina A.; Tapert, Susan F.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Simmons, AN (corresponding author), VA San Diego Healthcare Syst, San Diego, CA USA.	alan@ucsd.edu	Simmons, Alan N/A-9815-2008; Tapert, Susan/AAE-8208-2020; Tapert, Susan/AHD-0909-2022; strigo, irina A/L-9882-2016	Simmons, Alan N/0000-0003-3963-2112; Tapert, Susan/0000-0001-7259-6112; Tapert, Susan/0000-0001-7259-6112; strigo, irina A/0000-0002-8799-716X; Spadoni, Andrea/0000-0002-8367-6406; Thayer, Rachel Erin/0000-0003-1333-8142	National Institute on Drug Abuse [R01 DA021182]; National Institute of Alcohol Abuse and Alcoholism [R01 AA13419]; VA Merit grant; VA Center of Excellence in Stress and Mental Health; Veterans Health Administration; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021182] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); VA Merit grant; VA Center of Excellence in Stress and Mental Health; Veterans Health Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was made possible by funding from the National Institute on Drug Abuse (R01 DA021182, PI: Tapert), the National Institute of Alcohol Abuse and Alcoholism (R01 AA13419, PI: Tapert), a VA Merit grant (PI: Simmons), and the VA Center of Excellence in Stress and Mental Health (ANS, IAS, SCM). Salary support was provided via a Veterans Health Administration Clinical Science R&D Career Development Award-2 (SCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Andersson J. L., 2007, TR07JA2 FMRIB AN GRO; Arnett JJ, 2002, AM PSYCHOL, V57, P774, DOI [10.1037/0003-066X.57.10.774, 10.1037//0003-066X.57.10.774]; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Bava S, 2010, BRAIN COGNITION, V72, P347, DOI 10.1016/j.bandc.2009.10.012; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII, P1; Benedetti F, 2011, BIOL PSYCHIAT, V69, P309, DOI 10.1016/j.biopsych.2010.07.028; BUKSTEIN OG, 1989, AM J PSYCHIAT, V146, P1131; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Delis D. C., 2000, CVLT 2 CALIFORNIA VE; Delis D. C., 2001, D KEFS EXAMINERS MAN; Dolcos F, 2006, NEUROREPORT, V17, P1591, DOI 10.1097/01.wnr.0000236860.24081.be; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Frodl T, 2008, MOL PSYCHIATR, V13, P1093, DOI 10.1038/mp.2008.62; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; GREENBAUM PE, 1991, J AM ACAD CHILD PSY, V30, P575, DOI 10.1097/00004583-199107000-00008; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Harman H. H., 1976, MODERN FACTOR ANAL; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; James A, 2011, SCHIZOPHR RES, V128, P91, DOI 10.1016/j.schres.2011.02.014; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kohlberg L, 1981, PHILOS MORAL DEV MOR, V1; Kroger J., 2007, IDENTITY DEV ADOLESC; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; McIntosh AM, 2008, BIOL PSYCHIAT, V64, P1088, DOI 10.1016/j.biopsych.2008.07.026; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mroczkowski MM, 2011, DEPRESS ANXIETY; Nagel BJ, 2006, NEUROREPORT, V17, P1427, DOI 10.1097/01.wnr.0000233099.97784.45; Oetting ER, 1998, SUBST USE MISUSE, V33, P995, DOI 10.3109/10826089809056252; PETRAITIS J, 1995, PSYCHOL BULL, V117, P67, DOI 10.1037/0033-2909.117.1.67; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; RASMUSSEN SA, 1988, PSYCHOPHARMACOL BULL, V24, P466; Robins L.N., 1991, PSYCHIAT DISORDERS A; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sprooten E, 2009, MOL PSYCHIATR, V14, P237, DOI 10.1038/mp.2008.136; Szeszko PR, 2005, ARCH GEN PSYCHIAT, V62, P782, DOI 10.1001/archpsyc.62.7.782; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	59	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31509	10.1371/journal.pone.0031509	http://dx.doi.org/10.1371/journal.pone.0031509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925BB	22348093	Green Published, Green Submitted			2022-12-27	WOS:000302733900050
J	Bernhardsson, S; Mitarai, N; Sneppen, K				Bernhardsson, Sebastian; Mitarai, Namiko; Sneppen, Kim			Protein Localization with Flexible DNA or RNA	PLOS ONE			English	Article							NUCLEAR-MATRIX; GENE-EXPRESSION; X-CHROMOSOME; TRANSCRIPTION; CHROMATIN; IDENTIFICATION; INACTIVATION; ARCHITECTURE; DYNAMICS; MOBILITY	Localization of activity is ubiquitous in life, and also within sub-cellular compartments. Localization provides potential advantages as different proteins involved in the same cellular process may supplement each other on a fast timescale. It might also prevent proteins from being active in other regions of the cell. However localization is at odds with the spreading of unbound molecules by diffusion. We model the cost and gain for specific enzyme activity using localization strategies based on binding to sites of intermediate specificity. While such bindings in themselves decrease the activity of the protein on its target site, they may increase protein activity if stochastic motion allows the acting protein to touch both the intermediate binding site and the specific site simultaneously. We discuss this strategy in view of recent suggestions on long non-coding RNA as a facilitator of localized activity of chromatin modifiers.	[Bernhardsson, Sebastian; Mitarai, Namiko; Sneppen, Kim] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Bernhardsson, Sebastian] Swedish Def Res Agcy, FOI, Tumba, Sweden	University of Copenhagen; Niels Bohr Institute; FOI - Swedish Defence Research Agency; Saab Group	Bernhardsson, S (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	sebbeb@nbi.dk	Mitarai, Namiko/AAK-8531-2021; Mitarai, Namiko/M-4575-2014	Mitarai, Namiko/0000-0003-0116-7606; Mitarai, Namiko/0000-0003-0116-7606; Sneppen, Kim/0000-0001-9820-3567	European Community [HEALTH-F4-2008-223545]; Danish National Research Foundation	European Community(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F4-2008-223545. The research is also supported by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Brunagel G, 2002, CANCER RES, V62, P2437; BURT DW, 1982, MOL GEN GENET, V185, P468, DOI 10.1007/BF00334142; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Katherine P, 1998, SCIENCE, V282, P1516; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Moorefield KS, 2006, MOL BIOL CELL, V17, P1711, DOI 10.1091/mbc.E05-11-1063; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sneppen K., 2005, PHYS MOL BIOL; Stein GS, 2005, AM J PATHOL, V166, P959, DOI 10.1016/S0002-9440(10)62317-6; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e29218	10.1371/journal.pone.0029218	http://dx.doi.org/10.1371/journal.pone.0029218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347995	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730900003
J	Traviss, GD; West, RM; House, AO				Traviss, Gemma D.; West, Robert M.; House, Allan O.			Maternal Mental Health and Its Association with Infant Growth at 6 Months in Ethnic Groups: Results from the Born-in-Bradford Birth Cohort Study	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; FAILURE-TO-THRIVE; POSTNATAL DEPRESSION; BABIES BORN; PREGNANCY; ANXIETY; POSTPARTUM; PREVALENCE; STRESS; WEIGHT	Objective: To identify factors associated with infant growth up to 6 months, with a particular focus on maternal distress, and to explore the effect of ethnicity on any relation between maternal distress and infant growth. Methods: Cohort study recruiting White and Pakistani women in the United Kingdom (UK). Infant growth was measured at birth and 6 months. Standard assessment of mental health (GHQ-28) was undertaken in pregnancy (26-28 weeks gestation) and 6 months postpartum. Modelling included social deprivation, ethnicity, and other known influences on infant growth such as maternal smoking and alcohol consumption. Results: Maternal distress improved markedly from pregnancy to 6 months postpartum. At both times Pakistani women had more somatic and depression symptoms than White women. Depression in pregnancy (GHQ subscale D) was associated with lower infant growth at 6 months. Self-reported social dysfunction in pregnancy (GHQ subscale C) was associated with lower gestational age.. Pakistani women reported higher GHQ scores during pregnancy associated with smaller infants at birth. They lived in areas of higher social deprivation, reported less alcohol consumption and smoking postnatally, all independent influences on growth at 6 months. Conclusions: Maternal mental health in pregnancy is an independent influence on infant growth up to 6 months and is associated with ethnicity which was itself associated with deprivation in our sample. There is a complex relationship between symptoms of maternal distress, ethnicity, deprivation, health behaviours, and early infant growth. Measures should include both emotional and somatic symptoms and interventions to reduce risks of poor early growth need to include psychological and social components.	[Traviss, Gemma D.; West, Robert M.; House, Allan O.] Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Psychiat & Behav Sci, Leeds, W Yorkshire, England	University of Leeds	Traviss, GD (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Psychiat & Behav Sci, Leeds, W Yorkshire, England.	g.traviss@leeds.ac.uk	West, Robert M/C-3834-2008	West, Robert M/0000-0001-7305-3654; House, Allan/0000-0001-8721-8026; Traviss-Turner, Gemma/0000-0002-1770-6216	National Institute for Health Research (NIHR) [RP-PG-0407-10044]; Cancer Research UK [14135] Funding Source: researchfish; National Institute for Health Research [PB-PG-0408-16119] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This publication presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (Grant number: RP-PG-0407-10044)(http://www.ccf.nihr.ac.uk/PGfAR/Pages/Home.aspx). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERIBIGBE YA, 1992, SOC PSYCH PSYCH EPID, V27, P280; [Anonymous], 2010, R LANG ENV STAT COMP; Avan B, 2010, ARCH DIS CHILD, V95, P690, DOI 10.1136/adc.2009.164848; Banks MH, 1983, PSYCHOL MED, V12, P789; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Blair PS, 2004, INT J EPIDEMIOL, V33, P839, DOI 10.1093/ije/dyh100; Blissett J, 2007, INT J OBESITY, V31, P1520, DOI 10.1038/sj.ijo.0803661; Cohen J., 2003, APPL MULTIPLE REGRES; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; DHAWAN S, 1995, BRIT MED J, V311, P86, DOI 10.1136/bmj.311.6997.86; Diego MA, 2005, INFANT BEHAV DEV, V28, P155, DOI 10.1016/j.infbeh.2005.02.002; Drewett R, 2004, J CHILD PSYCHOL PSYC, V45, P359, DOI 10.1111/j.1469-7610.2004.00226.x; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gennaro S, 2003, JOGNN-J OBST GYN NEO, V32, P668, DOI 10.1177/0884217503257484; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Grote V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-14; Harpham T, 2005, J EPIDEMIOL COMMUN H, V59, P1060, DOI 10.1136/jech.2005.039180; Hedegaard M, 1996, ACTA OBSTET GYN SCAN, V75, P32, DOI 10.3109/00016349609033280; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; Hurley KM, 2008, J NUTR, V138, P799, DOI 10.1093/jn/138.4.799; Institute of Medicine, 1985, PREV LOW BIRTHW SUMM; Johnson W, 2009, INT J NURS STUD, V46, P310, DOI 10.1016/j.ijnurstu.2008.10.003; Jones NA, 1998, INFANT BEHAV DEV, V21, P537; Karacam Z, 2009, MIDWIFERY, V25, P344, DOI 10.1016/j.midw.2007.03.006; Kelly RH, 2001, GEN HOSP PSYCHIAT, V23, P107, DOI 10.1016/S0163-8343(01)00129-3; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Lundy BL, 1999, INFANT BEHAV DEV, V22, P119, DOI 10.1016/S0163-6383(99)80009-5; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Margetts BM, 2002, J EPIDEMIOL COMMUN H, V56, P684, DOI 10.1136/jech.56.9.684; Meer S, BR J PSYCHIAT UNPUB; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Raynor P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-327; Riaz H, 1998, ACTA PSYCHIAT SCAND, V97, P427, DOI 10.1111/j.1600-0447.1998.tb10027.x; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Sallow B.L., 2003, PSYCHOL HEAL MED, V8, P213, DOI [DOI 10.1080/1354850031000087591, 10.1080/1354850031000087591]; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Siefert K, 2000, AM J ORTHOPSYCHIAT, V70, P510, DOI 10.1037/h0087688; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Swallow B L, 2004, J Obstet Gynaecol, V24, P28; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Werneke U, 2000, PSYCHOL MED, V30, P823, DOI 10.1017/S0033291799002287; WILSON M, 1994, PSYCHOL MED, V24, P113, DOI 10.1017/S003329170002688X	51	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30707	10.1371/journal.pone.0030707	http://dx.doi.org/10.1371/journal.pone.0030707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348019	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900013
J	Cheng, LT; Nagata, S; Hirano, K; Yamaguchi, S; Horie, S; Ainscough, J; Tada, T				Cheng, Li-Tao; Nagata, Shogo; Hirano, Kunio; Yamaguchi, Shinpei; Horie, Shigeo; Ainscough, Justin; Tada, Takashi			Cure of ADPKD by Selection for Spontaneous Genetic Repair Events in Pkd1-Mutated iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; POLYCYSTIC KIDNEY-DISEASE; GENERATION; FIBROBLASTS; MUTATIONS; NUCLEASES	Induced pluripotent stem cells (iPSCs) generated by epigenetic reprogramming of personal somatic cells have limited therapeutic capacity for patients suffering from genetic disorders. Here we demonstrate restoration of a genomic mutation heterozygous for Pkd1 (polycystic kidney disease 1) deletion (Pkd1(+/-) to Pkd1(+/R+)) by spontaneous mitotic recombination. Notably, recombination between homologous chromosomes occurred at a frequency of 1 similar to 2 per 10,000 iPSCs. Southern blot hybridization and genomic PCR analyses demonstrated that the genotype of the mutation-restored iPSCs was indistinguishable from that of the wild-type cells. Importantly, the frequency of cyst generation in kidneys of adult chimeric mice containing Pkd1(+/R+) iPSCs was significantly lower than that of adult chimeric mice with parental Pkd1(+/-) iPSCs, and indistinguishable from that of wild-type mice. This repair step could be directly incorporated into iPSC development programmes prior to cell transplantation, offering an invaluable step forward for patients carrying a wide range of genetic disorders.	[Cheng, Li-Tao; Nagata, Shogo; Hirano, Kunio; Yamaguchi, Shinpei; Tada, Takashi] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Cheng, Li-Tao] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China; [Nagata, Shogo; Yamaguchi, Shinpei; Tada, Takashi] JST CREST, Kawaguchi, Saitama, Japan; [Horie, Shigeo] Teikyo Univ, Dept Urol, Tokyo 173, Japan; [Ainscough, Justin] Univ Leeds, LIGHT, Leeds, W Yorkshire, England	Kyoto University; Peking University; Japan Science & Technology Agency (JST); Teikyo University; University of Leeds	Cheng, LT (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.	ttada@frontier.kyoto-u.ac.jp	Yamaguchi, Shinpei/HCH-5553-2022	Ainscough, Justin/0000-0003-0231-433X; Yamaguchi, Shinpei/0000-0002-9377-4835	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Core Research for Evolutional Science and Technology (Japan Science and Technology Agency); Takeda Science foundation; Takeda Science Foundation, JAPAN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science foundation(Takeda Science Foundation (TSF)); Takeda Science Foundation, JAPAN(Takeda Science Foundation (TSF))	This work was funded by grants from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology and the Core Research for Evolutional Science and Technology (Japan Science and Technology Agency) to TT, and the Takeda Science foundation to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Gen Kondoh and Ms Hitomi Watanabe for generating chimeras. L. T. C. is a postdoctoral fellow supported by the Takeda Science Foundation, JAPAN. K. H is a fellow of JSPS.	Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; GARDNER KD, 1988, ANNU REV MED, V39, P185, DOI 10.1146/annurev.me.39.020188.001153; Happe H, 2011, BBA-MOL BASIS DIS, V1812, P1249, DOI 10.1016/j.bbadis.2011.05.005; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; KIPPS TJ, 1986, EMBO J, V5, P263, DOI 10.1002/j.1460-2075.1986.tb04208.x; Lefebvre L, 2001, NAT GENET, V27, P257, DOI 10.1038/85808; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Muto S, 2002, HUM MOL GENET, V11, P1731, DOI 10.1093/hmg/11.15.1731; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	20	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e32018	10.1371/journal.pone.0032018	http://dx.doi.org/10.1371/journal.pone.0032018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347511	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730200039
J	Lewis, MB				Lewis, Michael B.			A Facial Attractiveness Account of Gender Asymmetries in Interracial Marriage	PLOS ONE			English	Article							RACIAL INTERMARRIAGE; TRENDS; EDUCATION; SELECTION; PATTERNS; RACE	Background: In the US and UK, more Black men are married to White women than vice versa and there are more White men married to Asian women than vice versa. Models of interracial marriage, based on the exchange of racial status for other capital, cannot explain these asymmetries. A new explanation is offered based on the relative perceived facial attractiveness of the different race-by-gender groups. Method and Findings: This explanation was tested using a survey of perceived facial attractiveness. This found that Black males are perceived as more attractive than White or East Asian males whereas among females, it is the East Asians that are perceived as most attractive on average. Conclusions: Incorporating these attractiveness patterns into the model of marriage decisions produces asymmetries in interracial marriage similar to those in the observed data in terms of direction and relative size. This model does not require differences in status between races nor different strategies based on gender. Predictions are also generated regarding the relative attractiveness of those engaging in interracial marriage.	Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	Cardiff University	Lewis, MB (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.	LewisMB@cf.ac.uk	Lewis, Michael/D-1488-2009	Lewis, Michael/0000-0002-5735-5318				BAGLEY C, 1972, PHYLON, V33, P373, DOI 10.2307/273684; Batson CD, 2006, J MARRIAGE FAM, V68, P658, DOI 10.1111/j.1741-3737.2006.00281.x; BECKER GS, 1973, J POLIT ECON, V81, P813, DOI 10.1086/260084; Belletti NE, 2008, RACISM IN THE 21ST CENTURY: AN EMPIRICAL ANALYSIS OF SKIN COLOR, P93, DOI 10.1007/978-0-387-79098-5_6; Belot M, 2010, ECON HUM BIOL, V8, P361, DOI 10.1016/j.ehb.2010.09.004; Buss D.M., 2006, PSIHOLOGIJSKE TEME, V15, P239; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; CASSIDY ML, 1989, J COMP FAM STUD, V20, P1; Crowder KD, 2000, J MARRIAGE FAM, V62, P792, DOI 10.1111/j.1741-3737.2000.00792.x; Davis K, 1941, AM ANTHROPOL, V43, P376, DOI 10.1525/aa.1941.43.3.02a00030; EDWARDS JN, 1969, J MARRIAGE FAM, V31, P518, DOI 10.2307/349775; ELDER GH, 1969, AM SOCIOL REV, V34, P519, DOI 10.2307/2091961; Frost P., 1994, HUMAN EVOLUTION, V9, P141, DOI DOI 10.1007/BF02437260; Fryer RG, 2007, J ECON PERSPECT, V21, P71, DOI 10.1257/jep.21.2.71; Fu VK, 2001, DEMOGRAPHY, V38, P147, DOI 10.2307/3088297; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gullickson A, 2006, J FAM HIST, V31, P289, DOI 10.1177/0363199006288393; Jacobs JA, 2002, SOCIOL FORUM, V17, P621, DOI 10.1023/A:1021029507937; KALMIJN M, 1993, SOC FORCES, V72, P119, DOI 10.2307/2580162; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lewis MB, 2011, PERS INDIV DIFFER, V50, P159, DOI 10.1016/j.paid.2010.09.018; Lewis MB, 2010, PERCEPTION, V39, P136, DOI 10.1068/p6626; Madrigal L, 2007, AM J PHYS ANTHROPOL, V132, P470, DOI 10.1002/ajpa.20453; Merton RK, 1941, PSYCHIATR, V4, P361, DOI 10.1080/00332747.1941.11022354; Muttarak R, 2010, BRIT J SOCIOL, V61, P275, DOI 10.1111/j.1468-4446.2010.01313.x; Porterfield Ernest, 1978, BLACK WHITE MIXED MA; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; STEVENS G, 1990, SOC PSYCHOL QUART, V53, P62, DOI 10.2307/2786870; VANDENBERGHE PL, 1986, ETHNIC RACIAL STUD, V9, P87, DOI 10.1080/01419870.1986.9993516; WADE TJ, 1991, BASIC APPL SOC PSYCH, V12, P405, DOI 10.1207/s15324834basp1204_3; ZOHAR A, 1989, BEHAV BRAIN SCI, V12, P38, DOI 10.1017/S0140525X00024262	31	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31703	10.1371/journal.pone.0031703	http://dx.doi.org/10.1371/journal.pone.0031703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZQ	22347504	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000302730200032
J	Sudduth, TL; Wilson, JG; Everhart, A; Colton, CA; Wilcock, DM				Sudduth, Tiffany L.; Wilson, Joan G.; Everhart, Angela; Colton, Carol A.; Wilcock, Donna M.			Lithium Treatment of APPSwDI/NOS2-/- Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; A-BETA; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; MEMORY DEFICITS; NITRIC-OXIDE; PATHOLOGY; PROTEIN; PHOSPHORYLATION; UBIQUITINATION	Lithium is an anti-psychotic that has been shown to prevent the hyperphosphorylation of tau protein through the inhibition of glycogen-synthase kinase 3-beta (GSK3 beta). We recently developed a mouse model that progresses from amyloid pathology to tau pathology and neurodegeneration due to the genetic deletion of NOS2 in an APP transgenic mouse; the APPSwDI/NOS2-/- mouse. Because this mouse develops tau pathology, amyloid pathology and neuronal loss we were interested in the effect anti-tau therapy would have on amyloid pathology, learning and memory. We administered lithium in the diets of APPSwDI/NOS2-/- mice for a period of eight months, followed by water maze testing at 12 months of age, immediately prior to sacrifice. We found that lithium significantly lowered hyperphosphorylated tau levels as measured by Western blot and immunocytochemistry. However, we found no apparent neuroprotection, no effect on spatial memory deficits and an increase in histological amyloid deposition. A beta levels measured biochemically were unaltered. We also found that lithium significantly altered the neuroinflammatory phenotype of the brain, resulting in enhanced alternative inflammatory response while concurrently lowering the classical inflammatory response. Our data suggest that lithium may be beneficial for the treatment of tauopathies but may not be beneficial for the treatment of Alzheimer's disease.	[Sudduth, Tiffany L.; Wilcock, Donna M.] Univ Kentucky, Sanders Brown Ctr Aging, Dept Physiol, Lexington, KY 40536 USA; [Wilson, Joan G.; Everhart, Angela; Colton, Carol A.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA	University of Kentucky; Duke University	Sudduth, TL (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Dept Physiol, Lexington, KY 40536 USA.	donna.wilcock@uky.edu	Wilcock, Donna M/J-7517-2016	Colton, Carol/0000-0003-3305-370X	Alzheimer's Association [NIRG-09-133302]	Alzheimer's Association(Alzheimer's Association)	This work was supported by the Alzheimer's Association New Investigator Research Grant NIRG-09-133302 (DMW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Bleau G, 1999, EXS, V87, P211; Bouchard M, 2011, CAN J NEUROL SCI, V38, P547, DOI 10.1017/S0317167100012087; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; COLTON CA, 2009, CNS NEUROL DISORD DR; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044; Gong CX, 2010, DRUG AGING, V27, P351, DOI 10.2165/11536110-000000000-00000; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; HogenEsch H, 2006, EXP DERMATOL, V15, P808, DOI 10.1111/j.1600-0625.2006.00483.x; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Laubach VE, 1998, AM J PHYSIOL-HEART C, V275, pH2211, DOI 10.1152/ajpheart.1998.275.6.H2211; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Li HF, 2011, J CEREBR BLOOD F MET, V31, P2106, DOI 10.1038/jcbfm.2011.75; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Rapaport MH, 2001, BIOL PSYCHIAT, V50, P217, DOI 10.1016/S0006-3223(01)01144-1; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Wagner DA, 1996, NEUROPHARMACOLOGY, V35, P29, DOI 10.1016/0028-3908(95)00177-8; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wilcock DM, 2004, NEUROBIOL DIS, V15, P11, DOI 10.1016/j.nbd.2003.09.015; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Wilcock DM, 2009, J NEUROSCI, V29, P7957, DOI 10.1523/JNEUROSCI.1339-09.2009	38	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31993	10.1371/journal.pone.0031993	http://dx.doi.org/10.1371/journal.pone.0031993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347510	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730200038
J	Chadefaux, T; Helbing, D				Chadefaux, Thomas; Helbing, Dirk			The Rationality of Prejudices	PLOS ONE			English	Article							COOPERATION; EMERGENCE; EVOLUTION; CHOICE; MODELS	We model an N-player repeated prisoner's dilemma in which players are given traits (e. g., height, age, wealth) which, we assume, affect their behavior. The relationship between traits and behavior is unknown to other players. We then analyze the performance of "prejudiced" strategies-strategies that draw inferences based on the observation of some or all of these traits, and extrapolate the inferred behavior to other carriers of these traits. Such prejudiced strategies have the advantage of learning rapidly, and hence of being well adapted to rapidly changing conditions that might result, for example, from high migration or birth rates. We find that they perform remarkably well, and even systematically outperform both Tit-For-Tat and ALLD when the population changes rapidly.	[Chadefaux, Thomas; Helbing, Dirk] Swiss Fed Inst Technol Zurich, Chair Sociol Particular Modeling & Simulat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Chadefaux, T (corresponding author), Swiss Fed Inst Technol Zurich, Chair Sociol Particular Modeling & Simulat, Zurich, Switzerland.	thomas.chadefaux@gess.ethz.ch		Chadefaux, Thomas/0000-0002-8456-8124				Ambady N, 2002, SURGERY, V132, P5, DOI 10.1067/msy.2002.124733; AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BENDOR J, 1991, J CONFLICT RESOLUT, V35, P691, DOI 10.1177/0022002791035004007; CASE A, 2006, 12466 NAT BUR EC RES; Chadefaux T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013471; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Gladwell M, 2005, POWER THINKING THINK; GLANCE NS, 1993, J MATH SOCIOL, V17, P281, DOI 10.1080/0022250X.1993.9990112; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Helbing D, 2011, J MATH SOCIOL, V35, P177, DOI 10.1080/0022250X.2010.532258; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Lewicki P., 1986, NONCONSCIOUS SOCIAL; MACY MW, 1991, AM J SOCIOL, V97, P808, DOI 10.1086/229821; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Myers D. G., 2004, INTUITION ITS POWERS; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Quillian L, 2006, ANNU REV SOCIOL, V32, P299, DOI 10.1146/annurev.soc.32.061604.123132; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; SIMON HA, 1959, AM ECON REV, V49, P253; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	29	0	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30902	10.1371/journal.pone.0030902	http://dx.doi.org/10.1371/journal.pone.0030902			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359554	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200023
J	Dudkiewicz, M; Szczepinska, T; Grynberg, M; Pawlowski, K				Dudkiewicz, Malgorzata; Szczepinska, Teresa; Grynberg, Marcin; Pawlowski, Krzysztof			A Novel Protein Kinase-Like Domain in a Selenoprotein, Widespread in the Tree of Life	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; ABC-TRANSPORTER; SUBCELLULAR-LOCALIZATION; STRUCTURE CLASSIFICATION; COMPARATIVE GENOMICS; ASSEMBLY PROTEINS; CRYSTAL-STRUCTURE	Selenoproteins serve important functions in many organisms, usually providing essential oxidoreductase enzymatic activity, often for defense against toxic xenobiotic substances. Most eukaryotic genomes possess a small number of these proteins, usually not more than 20. Selenoproteins belong to various structural classes, often related to oxidoreductase function, yet a few of them are completely uncharacterised. Here, the structural and functional prediction for the uncharacterised selenoprotein O (SELO) is presented. Using bioinformatics tools, we predict that SELO protein adopts a three-dimensional fold similar to protein kinases. Furthermore, we argue that despite the lack of conservation of the "classic" catalytic aspartate residue of the archetypical His-Arg-Asp motif, SELO kinases might have retained catalytic phosphotransferase activity, albeit with an atypical active site. Lastly, the role of the selenocysteine residue is considered and the possibility of an oxidoreductase-regulated kinase function for SELO is discussed. The novel kinase prediction is discussed in the context of functional data on SELO orthologues in model organisms, FMP40 a.k.a.YPL222W (yeast), and ydiU (bacteria). Expression data from bacteria and yeast suggest a role in oxidative stress response. Analysis of genomic neighbourhoods of SELO homologues in the three domains of life points toward a role in regulation of ABC transport, in oxidative stress response, or in basic metabolism regulation. Among bacteria possessing SELO homologues, there is a significant over-representation of aquatic organisms, also of aerobic ones. The selenocysteine residue in SELO proteins occurs only in few members of this protein family, including proteins from Metazoa, and few small eukaryotes (Ostreococcus, stramenopiles). It is also demonstrated that enterobacterial mchC proteins involved in maturation of bactericidal antibiotics, microcins, form a distant subfamily of the SELO proteins. The new protein structural domain, with a putative kinase function assigned, expands the known kinome and deserves experimental determination of its biological role within the cell-signaling network.	[Szczepinska, Teresa; Pawlowski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Warsaw University of Life Sciences	Dudkiewicz, M (corresponding author), Warsaw Univ Life Sci, Warsaw, Poland.	k.pawlowski@nencki.gov.pl	Pawłowski, Krzysztof/C-2949-2013; Pawlowski, Krzysztof/E-3262-2012; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Dudkiewicz, Malgorzata/0000-0003-4432-2530; Grynberg, Marcin/0000-0003-1887-7209	Polish Ministry of Science and Higher Education [N N301 3165 33]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	MD, KP, TS and MG were supported by the Polish Ministry of Science and Higher Education grant N N301 3165 33. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; Andreeva A, 2010, ACTA CRYSTALLOGR F, V66, P1190, DOI 10.1107/S1744309110007177; [Anonymous], 2007, TREE LIFE WEB PROJEC; Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Arenas FA, 2010, PLOS ONE, V6; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; ARMSTRONG RN, 1979, BIOCHEMISTRY-US, V18, P1230, DOI 10.1021/bi00574a018; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Azpiroz MF, 2009, MICROB PATHOGENESIS, V47, P274, DOI 10.1016/j.micpath.2009.09.003; Azpiroz MF, 2001, ANTIMICROB AGENTS CH, V45, P969, DOI 10.1128/AAC.45.3.969-972.2001; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; BENNER SA, 1991, ADV ENZYME REGUL, V31, P121, DOI 10.1016/0065-2571(91)90012-B; Bhattacharjee A, 2009, BIOCHEM BIOPH RES CO, V388, P612, DOI 10.1016/j.bbrc.2009.08.077; Bodenmiller B, 2010, METHOD ENZYMOL, V470, P317, DOI 10.1016/S0076-6879(10)70013-6; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; BOSSEMEYER D, 1993, NATURE, V363, P590, DOI 10.1038/363590a0; BRAMSON HN, 1984, CRC CR REV BIOCH MOL, V15, P93, DOI 10.3109/10409238409102298; Brooijmans N, 2010, PROTEIN SCI, V19, P763, DOI 10.1002/pro.355; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Costa SCP, 2010, MICROBES INFECT, V12, P182, DOI 10.1016/j.micinf.2009.12.003; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Ambrosio K, 2009, PROTEINS, V76, P995, DOI 10.1002/prot.22408; Neto JFD, 2009, NUCLEIC ACIDS RES, V37, P4812, DOI 10.1093/nar/gkp509; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Djordjevic S, 2002, TRENDS BIOCHEM SCI, V27, P426, DOI 10.1016/S0968-0004(02)02136-9; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Du SQ, 2010, BBA-GEN SUBJECTS, V1800, P511, DOI 10.1016/j.bbagen.2010.01.005; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Eglen R, 2011, PHARM THER; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Finn R. D., 2009, NUCL ACIDS RES; Fomenko DE, 2003, BIOCHEMISTRY-US, V42, P11214, DOI 10.1021/bi034459s; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Goonesekere NCW, 2010, COMPUT BIOL CHEM, V34, P210, DOI 10.1016/j.compbiolchem.2010.04.001; GRANOT J, 1979, FEBS LETT, V103, P265, DOI 10.1016/0014-5793(79)81342-3; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Ishii A, 2005, EXTREMOPHILES, V9, P65, DOI 10.1007/s00792-004-0414-3; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jaroszewski L, 2009, METHODS MOL BIOL, V569, P129, DOI 10.1007/978-1-59745-524-4_7; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kannan N, 2008, CELL, V133, P204, DOI 10.1016/j.cell.2008.04.005; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim MJ, 2011, MOL MICROBIOL, V79, P1194, DOI 10.1111/j.1365-2958.2010.07500.x; Klemm P, 2007, INFECT IMMUN, V75, P3688, DOI 10.1128/IAI.01730-06; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kornev AP, 2009, STRUCTURE, V17, P5, DOI 10.1016/j.str.2008.12.005; Krupa A, 2002, PROTEIN SCI, V11, P1580, DOI 10.1110/ps.3560102; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2000, BIOINFORMATICS, V16, P1105, DOI 10.1093/bioinformatics/16.12.1105; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; LORD JM, 1972, BIOCHIM BIOPHYS ACTA, V267, P227, DOI 10.1016/0005-2728(72)90111-9; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Manning BD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe15; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Nolan EM, 2008, BIOCHEMISTRY-US, V47, P9289, DOI 10.1021/bi800826j; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; Pawlowski Krzysztof, 2008, Briefings in Functional Genomics & Proteomics, V7, P283, DOI 10.1093/bfgp/eln033; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pei J, 2007, BIOINFORMATICS; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poey ME, 2006, ANTIMICROB AGENTS CH, V50, P1411, DOI 10.1128/AAC.50.4.1411-1418.2006; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Rock C, 2010, PROSTAG LEUKOTR ESS, V83, P203, DOI 10.1016/j.plefa.2010.08.006; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santiago APSA, 2008, BIOCHIMIE, V90, P1566, DOI 10.1016/j.biochi.2008.06.013; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Smajs D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-288; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Steinbacher S, 1999, EMBO J, V18, P2923, DOI 10.1093/emboj/18.11.2923; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Trent MS, 1999, BIOCHEMISTRY-US, V38, P3433, DOI 10.1021/bi982491u; TROWER MK, 1990, NUCLEIC ACIDS RES, V18, P4615, DOI 10.1093/nar/18.15.4615; Vassiliadis G, 2010, ANTIMICROB AGENTS CH, V54, P288, DOI 10.1128/AAC.00744-09; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vieira-Silva S, 2008, MOL BIOL EVOL, V25, P1931, DOI 10.1093/molbev/msn142; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; YOON MY, 1987, BIOCHEMISTRY-US, V26, P4118, DOI 10.1021/bi00387a056; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	154	44	46	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32138	10.1371/journal.pone.0032138	http://dx.doi.org/10.1371/journal.pone.0032138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359664	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200133
J	Kanehira, M; Kikuchi, T; Ohkouchi, S; Shibahara, T; Tode, N; Santoso, A; Daito, H; Ohta, H; Tamada, T; Nukiwa, T				Kanehira, Masahiko; Kikuchi, Toshiaki; Ohkouchi, Shinya; Shibahara, Taizou; Tode, Naoki; Santoso, Arif; Daito, Hisayoshi; Ohta, Hiromitsu; Tamada, Tsutomu; Nukiwa, Toshihiro			Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO; STEM/PROGENITOR CELLS; SELF-RENEWAL; RECEPTORS; LPA; DIFFERENTIATION; TELOMERASE; MECHANISMS; THERAPIES	Marrow stromal cells (MSCs) isolated from mesenchymal tissues can propagate in vitro to some extent and differentiate into various tissue lineages to be used for cell-based therapies. Cellular senescence, which occurs readily in continual MSC culture, leads to loss of these characteristic properties, representing one of the major limitations to achieving the potential of MSCs. In this study, we investigated the effect of lysophosphatidic acid (LPA), a ubiquitous metabolite in membrane phospholipid synthesis, on the senescence program of human MSCs. We show that MSCs preferentially express the LPA receptor subtype 1, and an abrogation of the receptor engagement with the antagonistic compound Ki16425 attenuates senescence induction in continually propagated human MSCs. This anti-aging effect of Ki16425 results in extended rounds of cellular proliferation, increased clonogenic potential, and retained plasticity for osteogenic and adipogenic differentiation. Expressions of p16(Ink4a), Rb, p53, and p21(Cip1), which have been associated with cellular senescence, were all reduced in human MSCs by the pharmacological inhibition of LPA signaling. Disruption of this signaling pathway was accompanied by morphological changes such as cell thinning and elongation as well as actin filament deformation through decreased phosphorylation of focal adhesion kinase. Prevention of LPA receptor engagement also promoted ubiquitination-mediated c-Myc elimination in MSCs, and consequently the entry into a quiescent state, G(0) phase, of the cell cycle. Collectively, these results highlight the potential of pharmacological intervention against LPA signaling for blunting senescence-associated loss of function characteristic of human MSCs.	[Kanehira, Masahiko; Shibahara, Taizou; Tode, Naoki; Santoso, Arif; Daito, Hisayoshi; Nukiwa, Toshihiro] Tohoku Univ, Dept Resp Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kikuchi, Toshiaki; Ohkouchi, Shinya; Ohta, Hiromitsu; Tamada, Tsutomu; Nukiwa, Toshihiro] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Kanehira, M (corresponding author), Tohoku Univ, Dept Resp Med, Grad Sch Med, Sendai, Miyagi 980, Japan.	kikuchi@rm.med.tohoku.ac.jp	Ohkouchi, Shinya/AEV-0334-2022	Ohkouchi, Shinya/0000-0002-4658-6487; Santoso, Arif/0000-0003-4125-005X	Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan); Core Research for Evolutional Science and Technology Program; Japan Science and Technology Agency (Tokyo, Japan); Grants-in-Aid for Scientific Research [21590980] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology Program(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (Tokyo, Japan)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research and Network Medicine Global-COE Program from the Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan), the Core Research for Evolutional Science and Technology Program and the Adaptable and Seamless Technology Transfer Program of the Japan Science and Technology Agency (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Beausejour C., 2007, V180, P67; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen JH, 2008, STEM CELLS, V26, P135, DOI 10.1634/stemcells.2007-0098; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Flores I, 2010, FEBS LETT, V584, P3826, DOI 10.1016/j.febslet.2010.07.042; Florian MC, 2010, STEM CELLS, V28, P1623, DOI 10.1002/stem.481; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gendaszewska-Darmach E, 2008, ACTA BIOCHIM POL, V55, P227, DOI 10.18388/abp.2008_3070; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Katsube Y, 2008, BIOCHEM BIOPH RES CO, V368, P256, DOI 10.1016/j.bbrc.2008.01.051; Krtolica A, 2005, INT J BIOCHEM CELL B, V37, P935, DOI 10.1016/j.biocel.2004.10.007; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Lee MJ, 2008, J CELL BIOCHEM, V104, P499, DOI 10.1002/jcb.21641; Li ZW, 2010, J CELL BIOCHEM, V111, P811, DOI 10.1002/jcb.22731; Liu XB, 2009, STEM CELLS DEV, V18, P947, DOI 10.1089/scd.2008.0352; Liu YB, 2010, J CELL BIOCHEM, V109, P794, DOI 10.1002/jcb.22471; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mansell JP, 2011, PROSTAG OTH LIPID M, V95, P45, DOI [10.1016/j.prostaglandins.2011.05.003, 10.1016/j.prostaglandins.2011.05.002]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	52	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32185	10.1371/journal.pone.0032185	http://dx.doi.org/10.1371/journal.pone.0032185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359668	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200137
J	Lo, WC; Dai, T; Liu, YY; Wang, LF; Hwang, JK; Lyu, PC				Lo, Wei-Cheng; Dai, Tian; Liu, Yen-Yi; Wang, Li-Fen; Hwang, Jenn-Kang; Lyu, Ping-Chiang			Deciphering the Preference and Predicting the Viability of Circular Permutations in Proteins	PLOS ONE			English	Article							RELATIVE SOLVENT ACCESSIBILITY; STRUCTURAL SIMILARITY; MOLECULAR EVOLUTION; AMINO-ACIDS; STABILITY; LIGATION; DATABASE; DYNAMICS; PROGRAM; BINDING	Circular permutation (CP) refers to situations in which the termini of a protein are relocated to other positions in the structure. CP occurs naturally and has been artificially created to study protein function, stability and folding. Recently CP is increasingly applied to engineer enzyme structure and function, and to create bifunctional fusion proteins unachievable by tandem fusion. CP is a complicated and expensive technique. An intrinsic difficulty in its application lies in the fact that not every position in a protein is amenable for creating a viable permutant. To examine the preferences of CP and develop CP viability prediction methods, we carried out comprehensive analyses of the sequence, structural, and dynamical properties of known CP sites using a variety of statistics and simulation methods, such as the bootstrap aggregating, permutation test and molecular dynamics simulations. CP particularly favors Gly, Pro, Asp and Asn. Positions preferred by CP lie within coils, loops, turns, and at residues that are exposed to solvent, weakly hydrogen-bonded, environmentally unpacked, or flexible. Disfavored positions include Cys, bulky hydrophobic residues, and residues located within helices or near the protein's core. These results fostered the development of an effective viable CP site prediction system, which combined four machine learning methods, e. g., artificial neural networks, the support vector machine, a random forest, and a hierarchical feature integration procedure developed in this work. As assessed by using the hydrofolate reductase dataset as the independent evaluation dataset, this prediction system achieved an AUC of 0.9. Large-scale predictions have been performed for nine thousand representative protein structures; several new potential applications of CP were thus identified. Many unreported preferences of CP are revealed in this study. The developed system is the best CP viability prediction method currently available. This work will facilitate the application of CP in research and biotechnology.	[Lo, Wei-Cheng; Dai, Tian; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Lo, Wei-Cheng; Liu, Yen-Yi; Wang, Li-Fen; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Dai, Tian] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Lyu, Ping-Chiang] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University; Emory University; National Tsing Hua University	Lo, WC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	jkhwang@cc.nctu.edu.tw; pclyu@life.nthu.edu.tw		Lo, Wei-Cheng/0000-0001-8865-5113; Liu, Yen-Yi/0000-0001-8386-4418	National Science Council, Taiwan; NSC [99-2745-B-009-001-ASP]; Ministry of Education, Taiwan; Development Plan for World Class University and Research Centers of Excellence (MOU ATU);  [99-2811-M-007-073];  [99-3112-B-007-003]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Development Plan for World Class University and Research Centers of Excellence (MOU ATU); ; 	This work was funded by the National Science Council, Taiwan (http://www.nsc.gov.tw) with NSC grant number 99-2745-B-009-001-ASP (Academic Summit Program) to JH; 99-2811-M-007-073 and 99-3112-B-007-003 to PL. The Ministry of Education, Taiwan (http://english.moe.gov.tw/) also funded this study with the Development Plan for World Class University and Research Centers of Excellence (MOU ATU Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2005, J MOL BIOL, V353, P1161, DOI 10.1016/j.jmb.2005.08.070; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aranko AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005185; Arnold FH, 2006, NAT BIOTECHNOL, V24, P328, DOI 10.1038/nbt0306-328; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bakan A, 2010, PYGNM 0 1 PYTHON PAC; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Bulaj G, 2004, PROTEIN SCI, V13, P1182, DOI 10.1110/ps.03563704; CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen J, 2004, PROTEINS, V57, P153, DOI 10.1002/prot.20175; Chen LN, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-18; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Crasto CJ, 2001, PROTEINS, V42, P399, DOI 10.1002/1097-0134(20010215)42:3<399::AID-PROT100>3.0.CO;2-E; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; ELARABATY M, 1989, AIAA COMPUTERS IN AEROSPACE VII CONFERENCE, PTS 1 AND 2, P300; Garrett R, 2008, BIOCHEMISTRY-US, P134; Gebhard LG, 2006, J MOL BIOL, V358, P280, DOI 10.1016/j.jmb.2006.01.095; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Guerler A, 2010, NUCLEIC ACIDS RES, V38, pW46, DOI 10.1093/nar/gkq314; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Hesterberg T, 2005, BOOTSTRAP METHODS PE, P1411; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Hubbard S. J., 1993, NACCESS; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Jeltsch A, 1999, J MOL EVOL, V49, P161, DOI 10.1007/PL00006529; JONES BE, 1995, PROTEIN SCI, V4, P167; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kojima M, 2005, J BIOSCI BIOENG, V100, P197, DOI 10.1263/jbb.100.197; Kundu S, 2002, BIOPHYS J, V83, P723, DOI 10.1016/S0006-3495(02)75203-X; Kuzmanic A, 2010, BIOPHYS J, V98, P861, DOI 10.1016/j.bpj.2009.11.011; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li L, 2001, J MOL BIOL, V306, P121, DOI 10.1006/jmbi.2000.4375; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang HK, 2005, PROTEINS, V59, P58, DOI 10.1002/prot.20386; Lin CP, 2008, PROTEINS, V72, P929, DOI 10.1002/prot.21983; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r11; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Lo WC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-307; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; Moreau RJ, 2009, J AM CHEM SOC, V131, P13107, DOI 10.1021/ja904271k; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nakamura T, 1999, J BIOL CHEM, V274, P19041, DOI 10.1074/jbc.274.27.19041; Nelson DL, 2004, LEHNINGER PRINCIPLES, P75; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; NISHIKAWA K, 1986, J BIOCHEM-TOKYO, V100, P1043, DOI 10.1093/oxfordjournals.jbchem.a121783; Noguchi T, 2001, NUCLEIC ACIDS RES, V29, P219, DOI 10.1093/nar/29.1.219; Ostermeier M, 2005, PROTEIN ENG DES SEL, V18, P359, DOI 10.1093/protein/gzi048; Paluszewski M, 2008, LECT N BIOINFORMAT, V5251, P382, DOI 10.1007/978-3-540-87361-7_32; Panchenko AR, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-10; Paszkiewicz KH, 2006, BIOINFORMATICS, V22, P1353, DOI 10.1093/bioinformatics/btl095; Pearson W R, 2000, Methods Mol Biol, V132, P185; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peisajovich SG, 2006, NAT GENET, V38, P168, DOI 10.1038/ng1717; Pintar A, 2003, BIOPHYS J, V84, P2553, DOI 10.1016/S0006-3495(03)75060-7; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Pommie C, 2004, J MOL RECOGNIT, V17, P17, DOI 10.1002/jmr.647; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P179, DOI 10.1016/S0968-0004(00)89003-9; Qian Z, 2005, J AM CHEM SOC, V127, P13466, DOI 10.1021/ja053932h; Quinlan JR, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P725; Remy I, 2007, NAT PROTOC, V2, P2120, DOI 10.1038/nprot.2007.266; Ribeiro EA, 2005, BIOCHEMISTRY-US, V44, P4699, DOI 10.1021/bi047908c; Schwartz TU, 2004, PROTEIN SCI, V13, P2814, DOI 10.1110/ps.04917504; Shih CH, 2007, PROTEINS, V68, P34, DOI 10.1002/prot.21430; Shih ESC, 2010, SEQUENCE GENOME ANAL, P63; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsai LC, 2003, J MOL BIOL, V330, P607, DOI 10.1016/S0022-2836(03)00630-2; Uliel S, 2001, PROTEIN ENG, V14, P533, DOI 10.1093/protein/14.8.533; Uliel S, 1999, BIOINFORMATICS, V15, P930, DOI 10.1093/bioinformatics/15.11.930; van Erkel AR, 1998, EUR J RADIOL, V27, P88, DOI 10.1016/S0720-048X(97)00157-5; VANDRUNEN R, 1995, ABSTR PAP AM CHEM S, V209, P49; Vogel C, 2006, BIOESSAYS, V28, P973, DOI 10.1002/bies.20474; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiner J, 2005, BIOINFORMATICS, V21, P932, DOI 10.1093/bioinformatics/bti085; Werbos P. J., 1994, ROOTS BACKPROPAGATIO; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zavodszky M, 2001, PROTEIN SCI, V10, P149, DOI 10.1110/ps.26801; Zhang H, 2009, PROTEINS, V76, P617, DOI 10.1002/prot.22375; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng WJ, 2008, BIOPHYS J, V94, P3853, DOI 10.1529/biophysj.107.125831; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	98	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31791	10.1371/journal.pone.0031791	http://dx.doi.org/10.1371/journal.pone.0031791			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359629	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200098
J	Permyakov, S; Suzina, N; Valiakhmetov, A				Permyakov, Sergey; Suzina, Nataliya; Valiakhmetov, Airat			Activation of H+-ATPase of the Plasma Membrane of Saccharomyces cerevisiae by Glucose: The Role of Sphingolipid and Lateral Enzyme Mobility	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; P-TYPE ATPASES; CELL-SURFACE; ELECTRON CRYOMICROSCOPY; RAFT ASSOCIATION; BASE SYNTHESIS; CLUSTER SIZES; YEAST; OLIGOMERIZATION; DELIVERY	Activation of the plasma membrane H+-ATPase of the yeast Saccharomyces cerevisiae by glucose is a complex process that has not yet been completely elucidated. This study aimed to shed light on the role of lipids and the lateral mobility of the enzyme complex during its activation by glucose. The significance of H+-ATPase oligomerization for the activation of H+-ATPase by glucose was shown using the strains lcb1-100 and erg6, with the disturbed synthesis of sphyngolipid and ergosterol, respectively. Experiments with GFP-fused H+-ATPase showed a decrease in fluorescence anisotropy during the course of glucose activation, suggesting structural reorganization of the molecular domains. An immunogold assay showed that the incubation with glucose results in the spatial redistribution of ATPase complexes in the plasma membrane. The data suggest that (1) to be activated by glucose, H+-ATPase is supposed to be in an oligomeric state, and (2) glucose activation is accompanied by the spatial movements of H+-ATPase clusters in the PM.	[Permyakov, Sergey] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia; [Suzina, Nataliya; Valiakhmetov, Airat] Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Permyakov, S (corresponding author), Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia.	airatv@ibpm.pushchino.ru	Suzina, Nataliya E/G-7972-2014; Permyakov, Sergei/O-1386-2019; Valiakhmetov, Airat/AAN-1307-2020; Permyakov, Sergei E./B-8156-2011	Suzina, Nataliya E/0000-0002-4960-1910; Permyakov, Sergei/0000-0003-4086-3137; Valiakhmetov, Airat/0000-0002-4739-0806; Permyakov, Sergei E./0000-0003-4086-3137	Russian Foundation for Basic Research [10-04-01248]; Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	This work was funded by the Russian Foundation for Basic Research grant #10-04-01248; Program of the Russian Academy of Sciences "Molecular and Cell Biology." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Brachmann CB, 1998, YEAST, V14, P115; Campetelli AN, 2005, FEBS J, V272, P5742, DOI 10.1111/j.1742-4658.2005.04959.x; CHADWICK CC, 1987, ARCH BIOCHEM BIOPHYS, V252, P348, DOI 10.1016/0003-9861(87)90041-5; CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x; ERASO P, 1994, J BIOL CHEM, V269, P10393; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; LACOWICZ JR, 2006, PRINCIPLES FLUORESCE; Lakowicz JR, 1999, ANAL BIOCHEM, V267, P397, DOI 10.1006/abio.1998.3029; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Permyakov EA, 1993, LUMINESCENT SPECTROS; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; RAO R, 1992, ANN NY ACAD SCI, V671, P195, DOI 10.1111/j.1749-6632.1992.tb43796.x; Rhee KH, 2002, EMBO J, V21, P3582, DOI 10.1093/emboj/cdf385; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Serrano R., 1991, MOL CELLULAR BIOL YE, P523; SETOYOUNG D, 1992, BIOCHIM BIOPHYS ACTA, V1102, P213, DOI 10.1016/0167-4838(92)90512-C; Souza MAA, 2001, MICROBIOL-SGM, V147, P2849, DOI 10.1099/00221287-147-10-2849; STEWART DJ, 1974, ANAL BIOCHEM, V62, P349, DOI 10.1016/0003-2697(74)90167-5; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; [No title captured]	47	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30966	10.1371/journal.pone.0030966	http://dx.doi.org/10.1371/journal.pone.0030966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359558	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200027
J	Ueno, T; Masuda, N; Kume, S; Kume, K				Ueno, Taro; Masuda, Naoki; Kume, Shoen; Kume, Kazuhiko			Dopamine Modulates the Rest Period Length without Perturbation of Its Power Law Distribution in Drosophila melanogaster	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; FLIGHT SEARCH PATTERNS; LOCOMOTOR-ACTIVITY; ANIMAL BEHAVIOR; REMOTE-CONTROL; SLEEP; TEMPERATURE; AROUSAL; NEURONS; DYNAMICS	We analyzed the effects of dopamine signaling on the temporal organization of rest and activity in Drosophila melanogaster. Locomotor behaviors were recorded using a video-monitoring system, and the amounts of movements were quantified by using an image processing program. We, first, confirmed that rest bout durations followed long-tailed (i.e., power-law) distributions, whereas activity bout durations did not with a strict method described by Clauset et al. We also studied the effects of circadian rhythm and ambient temperature on rest bouts and activity bouts. The fraction of activity significantly increased during subjective day and at high temperature, but the power-law exponent of the rest bout distribution was not affected. The reduction in rest was realized by reduction in long rest bouts. The distribution of activity bouts did not change drastically under the above mentioned conditions. We then assessed the effects of dopamine. The distribution of rest bouts became less long-tailed and the time spent in activity significantly increased after the augmentation of dopamine signaling. Administration of a dopamine biosynthesis inhibitor yielded the opposite effects. However, the distribution of activity bouts did not contribute to the changes. These results suggest that the modulation of locomotor behavior by dopamine is predominantly controlled by changing the duration of rest bouts, rather than the duration of activity bouts.	[Ueno, Taro; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Dept Stem Cell Biol, Inst Embryol & Genet, Kumamoto, Japan; [Masuda, Naoki] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Masuda, Naoki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kume, Shoen] Kumamoto Univ, Global COE Program, Kumamoto, Japan	Kumamoto University; University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University	Ueno, T (corresponding author), Kumamoto Univ, Dept Stem Cell Biol, Inst Embryol & Genet, Kumamoto, Japan.	kkume@kumamoto-u.ac.jp	Ueno, Taro/AAN-7260-2021; Kume, Shoen/M-4356-2016	Ueno, Taro/0000-0003-3697-4301; Kume, Shoen/0000-0002-4292-205X; Kume, Kazuhiko/0000-0003-4232-1657; Masuda, Naoki/0000-0003-1567-801X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [17024049, 20115009, 20760258]; Japanese Society for the Promotion of Science (JSPS) [17300105, 22300132]; 21st Century Center of Excellence (COE); MEXT; Grants-in-Aid for Scientific Research [20115009, 23681033] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid (17024049) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Grants-in-Aid (17300105, 22300132) from the Japanese Society for the Promotion of Science (JSPS) to KK; a 21st Century Center of Excellence (COE) grant; and a Global COE grant from MEXT. NM acknowledges support through the Grants-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology"(20115009) and the Grant-in-Aid for Scientific Research (20760258) from MEXT, Japan. TU is a global COE junior research associate and JSPS fellow. SK is a member of the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; BRAND AH, 1993, DEVELOPMENT, V118, P401; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Efron B, 1993, INTRO BOOTSTRAP, P16; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gall AJ, 2009, SLEEP, V32, P920, DOI 10.1093/sleep/32.7.920; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Koganezawa M, 2009, J THEOR BIOL, V260, P353, DOI 10.1016/j.jtbi.2009.06.018; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Loeb J, 1917, J BIOL CHEM, V32, P103; Makos MA, 2009, ANAL CHEM, V81, P1848, DOI 10.1021/ac802297b; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin JR, 2003, BEHAV PROCESS, V64, P145, DOI 10.1016/S0376-6357(03)00132-3; Martin JR, 2001, J NEUROGENET, V15, P205, DOI 10.3109/01677060109167377; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; NEWBY LM, 1991, GENETICS, V128, P571; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; R Core Team, 2020, R LANG ENV STAT COMP; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SEWELL DF, 1979, ANIM BEHAV, V27, P312, DOI 10.1016/0003-3472(79)90155-6; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SHIMADA I, 1993, BIOL CYBERN, V68, P477, DOI 10.1007/BF00200806; Slawson Justin B, 2009, J Vis Exp, DOI 10.3791/1096; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587	52	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32007	10.1371/journal.pone.0032007	http://dx.doi.org/10.1371/journal.pone.0032007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359653	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200122
J	Zhang, P; Roberts, RE; Liu, ZY; Meng, X; Tang, J; Sun, L; Yu, YZ				Zhang, Ping; Roberts, Robert E.; Liu, Zhuoya; Meng, Xian; Tang, Jie; Sun, Lin; Yu, Yizhen			Hostility, Physical Aggression and Trait Anger as Predictors for Suicidal Behavior in Chinese Adolescents: A School-Based Study	PLOS ONE			English	Article							VIOLENCE PREVENTION; YOUTH; RISK; QUESTIONNAIRE; POPULATION; ATTEMPTERS; CHILDHOOD; IDEATION; VERSION	Purpose: This study explored the extent to which trait aggression is associated with suicidal behavior in a nationwide school-based sample of adolescents. Methods: A nationwide sample of 14,537 high school students in urban areas of China was recruited. Information concerning suicide ideation, plans, attempts, trait aggression and other risk factors was collected by a self-reported questionnaire. Multivariate regression analyses were employed to predict suicidal behavior. Results: Approximately 18.5% of students reported suicide ideation, 8.7% reported suicide plans, and 4.1% reported attempts during the past one year. Hostility and trait anger had a significant positive association with suicidal ideation. Hostility and physical aggression were positively related to suicide plans. Hostility had a positive correlation with suicide attempts, while trait anger was inversely associated with suicide attempts. Conclusions: This study suggests that hostility, physical aggression and trait anger may be able to be used to predict suicidal behavior among adolescents. Suicide prevention programs should target at attenuating the severity of hostility, anger and physical aggression. But teachers and parents should also give close attention to students with low trait anger.	[Zhang, Ping; Liu, Zhuoya; Meng, Xian; Tang, Jie; Sun, Lin; Yu, Yizhen] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Peoples R China; [Roberts, Robert E.] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Div Hlth Promot & Behav Sci, Houston, TX USA	Huazhong University of Science & Technology; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Zhang, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Peoples R China.	yuyizhen650@163.com	Jie, Tang/AAS-7192-2021	Tang, Jie/0000-0002-0568-8444	National Natural Science Foundation of China [30972496]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China, and the grant number is 30972496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Buss AH., 2000, AGGRESSION QUESTIONN; Chinese Students' Constitution and Health Research Groups, 2008, REP 2005 NAT SURV CO; Conner KR, 2009, J ABNORM PSYCHOL, V118, P235, DOI 10.1037/a0014659; Cui S, 2011, CHILD CARE HLTH DEV, V37, P692, DOI 10.1111/j.1365-2214.2010.01181.x; Dumais A, 2005, AM J PSYCHIAT, V162, P1375, DOI 10.1176/appi.ajp.162.7.1375; Else IRN, 2009, AGGRESS VIOLENT BEH, V14, P470, DOI 10.1016/j.avb.2009.07.009; Evans E, 2005, SUICIDE LIFE-THREAT, V35, P239, DOI 10.1521/suli.2005.35.3.239; Felsten G, 1999, BEHAV RES THER, V37, P87, DOI 10.1016/S0005-7967(98)00104-1; GARRISON CZ, 1993, AM J PUBLIC HEALTH, V83, P179, DOI 10.2105/AJPH.83.2.179; Giegling I, 2009, J PSYCHIATR RES, V43, P1262, DOI 10.1016/j.jpsychires.2009.04.013; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Gould MS, 2001, SUICIDE LIFE-THREAT, V31, P6, DOI 10.1521/suli.31.1.5.6.24219; Gould MS, 1998, J AM ACAD CHILD PSY, V37, P915, DOI 10.1097/00004583-199809000-00011; Greening L, 2010, SUICIDE LIFE-THREAT, V40, P337, DOI 10.1521/suli.2010.40.4.337; Groholt B, 2000, J AM ACAD CHILD PSY, V39, P868, DOI 10.1097/00004583-200007000-00015; Hirvikoski T, 2012, EUR PSYCHIAT, V27, P536, DOI 10.1016/j.eurpsy.2011.04.004; Hu Y., 2003, CHINA REV, V3, P49, DOI DOI 10.2307/23461904; Ji JL, 2001, HARVARD REV PSYCHIAT, V9, P1; Keilp JG, 2006, PSYCHOL MED, V36, P1779, DOI 10.1017/S0033291706008725; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Law Samuel, 2008, Curr Psychiatry Rep, V10, P80; Lee A, 2009, HEALTH PROMOT INT, V24, P156, DOI 10.1093/heapro/dap011; Liu XC, 2005, J ADOLESCENT HEALTH, V37, P443, DOI 10.1016/j.jadohealth.2004.08.027; Lubell KM, 2006, AGGRESS VIOLENT BEH, V11, P167, DOI 10.1016/j.avb.2005.07.006; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Maxwell JP, 2008, PERS INDIV DIFFER, V44, P943, DOI 10.1016/j.paid.2007.10.037; Maxwell JP, 2007, J PERS ASSESS, V88, P284, DOI 10.1080/00223890701317004; National Bureau of Statistics of China, 2008, CHIN CIT STAT YB; Nickerson AB, 2009, SCHOOL PSYCHOL REV, V38, P218; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Park HS, 2008, J KOREAN ACAD NURS, V38, P513, DOI 10.4040/jkan.2008.38.4.513; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Placidi GPA, 2001, BIOL PSYCHIAT, V50, P783, DOI 10.1016/S0006-3223(01)01170-2; Pompili M, 2008, PSYCHOPATHOLOGY, V41, P313, DOI 10.1159/000146069; Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; SHAFFER D, 1974, J CHILD PSYCHOL PSYC, V15, P275, DOI 10.1111/j.1469-7610.1974.tb01252.x; Swogger MT, 2011, PSYCHIAT RES, V185, P363, DOI 10.1016/j.psychres.2010.07.036; Thompson MP, 2011, J ADOLESCENT HEALTH, V48, P391, DOI 10.1016/j.jadohealth.2010.07.018; Vermeiren R, 2003, J AM ACAD CHILD PSY, V42, P41, DOI 10.1097/00004583-200301000-00009; Vijayakumar Lakshmi, 2004, World Psychiatry, V3, P158; Wasserman Danuta, 2005, World Psychiatry, V4, P114; World Health Organization , 1999, WORLD HLTH REP 1999; Xiong C, 2008, CHIN J HLTH PSYCHOL, V16, P9; [杨海燕 YANG Hai-yang], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P107; Yip PSF, 2005, SOC PSYCH PSYCH EPID, V40, P792, DOI 10.1007/s00127-005-0952-8; Yu H, 2002, POPULATION EC, V6, P9; Zhang J, 2011, SOC SCI MED, V72, P2003, DOI 10.1016/j.socscimed.2011.03.048; Zhang P., 2011, CHIN J SCH HLTH, V32, P897	52	37	38	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31044	10.1371/journal.pone.0031044	http://dx.doi.org/10.1371/journal.pone.0031044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359563	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200032
J	Huard, B; Tran, NL; Benkhoucha, M; Manzin-Lorenzi, C; Santiago-Raber, ML				Huard, Bertrand; Ngoc Lan Tran; Benkhoucha, Mahdia; Manzin-Lorenzi, Celine; Santiago-Raber, Marie-Laure			Selective APRIL Blockade Delays Systemic Lupus Erythematosus in Mouse	PLOS ONE			English	Article							DEFICIENT MICE; AUTOIMMUNE-DISEASE; MONOCYTE SUBSET; B-CELLS; BAFF; RECEPTOR; TACI; BCMA; PROLIFERATION; PROTEOGLYCANS	SLE pathogenesis is complex, but it is now widely accepted that autoantibodies play a key role in the process by forming excessive immune complexes; their deposits within tissues leading to inflammation and functional damages. A proliferation inducing ligand (APRIL) is a member of the tumor necrosis factor (TNF) superfamily mediating antibody-producing plasma cell (PC)-survival that may be involved in the duration of pathogenic autoantibodies in lupus. We found significant increases of APRIL at the mRNA and protein levels in bone marrow but not spleen cells from NZB/W lupus mice, as compared to control mice. Selective antibody-mediated APRIL blockade delays disease development in this model by preventing proteinuria, kidney lesions, and mortality. Notably, this was achieved by decreasing anti-DNA and anti-chromatin autoantibody levels, without any perturbation of B- and T- cell homeostasis. Thus, anti-APRIL treatment may constitute an alternative therapy in SLE highly specific to PCs compared to other B-cell targeting therapies tested in this disease, and likely to be associated with less adverse effects than any anti-inflammatory and immunosuppressant agents previously used.	[Huard, Bertrand; Ngoc Lan Tran; Benkhoucha, Mahdia; Manzin-Lorenzi, Celine; Santiago-Raber, Marie-Laure] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Huard, Bertrand] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland	University of Geneva; University of Geneva	Huard, B (corresponding author), Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland.	marie.santiago@unige.ch	huard, bertrand/L-8011-2013	huard, bertrand/0000-0003-1358-6576; Tran, Ngoc Lan/0000-0003-4270-376X	Alliance for Lupus Research; Swiss National Science Foundation; Leenaards Foundation	Alliance for Lupus Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation	This work was supported by grants from the Alliance for Lupus Research, Swiss National Science Foundation, and Leenaards Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2005, ARTHRITIS RHEUM-US, V52, P2790, DOI 10.1002/art.21365; Burjanadze M, 2009, HISTOL HISTOPATHOL, V24, P1061, DOI 10.14670/HH-24.1061; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; George-Chandy A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2484; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Haubitz M, 2010, BIOL-TARGETS THER, V4, P263, DOI 10.2147/BTT.S7581; Hegazy M, 2010, CLIN IMMUNOL, V135, P118, DOI 10.1016/j.clim.2009.12.012; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; IZUI S, 1988, EUR J IMMUNOL, V18, P911, DOI 10.1002/eji.1830180612; Kawasaki A, 2007, RHEUMATOLOGY, V46, P776, DOI 10.1093/rheumatology/kem019; Kikuchi S, 2006, J IMMUNOL, V176, P3240, DOI 10.4049/jimmunol.176.5.3240; Koyama T, 2005, ANN RHEUM DIS, V64, P1065, DOI 10.1136/ard.2004.022491; Levesque MC, 2009, CLIN EXP IMMUNOL, V157, P198, DOI 10.1111/j.1365-2249.2009.03979.x; Liu WM, 2004, ARTHRITIS RHEUM-US, V50, P1884, DOI 10.1002/art.20290; Matthes T, 2011, BLOOD IN PRESS; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ramanujam M, 2004, J IMMUNOL, V173, P3524, DOI 10.4049/jimmunol.173.5.3524; Ramanujam M, 2010, ARTHRITIS RHEUM-US, V62, P1457, DOI 10.1002/art.27368; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schwaller J, 2007, BLOOD, V109, P331, DOI 10.1182/blood-2006-02-001800; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tsantikos E, 2010, J IMMUNOL, V184, P1348, DOI 10.4049/jimmunol.0901878; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Yang M, 2005, J IMMUNOL, V175, P2814, DOI 10.4049/jimmunol.175.5.2814; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	29	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31837	10.1371/journal.pone.0031837	http://dx.doi.org/10.1371/journal.pone.0031837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355399	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300099
J	Meda, SA; Pryweller, JR; Thornton-Wells, TA				Meda, Shashwath A.; Pryweller, Jennifer R.; Thornton-Wells, Tricia A.			Regional Brain Differences in Cortical Thickness, Surface Area and Subcortical Volume in Individuals with Williams Syndrome	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; BEHAVIORAL-PHENOTYPE; GENETIC INFLUENCES; WHITE-MATTER; ABNORMALITIES; COGNITION; CHILDREN; ANXIETY; CORTEX; CONNECTIVITY	Williams syndrome (WS) is a rare genetic neurodevelopmental disorder characterized by increased non-social anxiety, sensitivity to sounds and hypersociability. Previous studies have reported contradictory findings with regard to regional brain variation in WS, relying on only one type of morphological measure (usually volume) in each study. The present study aims to contribute to this body of literature and perhaps elucidate some of these discrepancies by examining concurrent measures of cortical thickness, surface area and subcortical volume between WS subjects and typically-developing (TD) controls. High resolution MRI scans were obtained on 31 WS subjects and 50 typically developing control subjects. We derived quantitative regional estimates of cortical thickness, cortical surface area, and subcortical volume using FreeSurfer software. We evaluated between-group ROI differences while controlling for total intracranial volume. In post-hoc exploratory analyses within the WS group, we tested for correlations between regional brain variation and Beck Anxiety Inventory scores. Consistent with our hypothesis, we detected complex patterns of between-group cortical variation, which included lower surface area in combination with greater thickness in the following cortical regions: post central gyrus, cuneus, lateral orbitofrontal cortex and lingual gyrus. Additional cortical regions showed between-group differences in one (but not both) morphological measures. Subcortical volume was lower in the basal ganglia and the hippocampus in WS versus TD controls. Exploratory correlations revealed that anxiety scores were negatively correlated with gray matter surface area in insula, OFC, rostral middle frontal, superior temporal and lingual gyrus. Our results were consistent with previous reports showing structural alterations in regions supporting the socio-affective and visuospatial impairments in WS. However, we also were able to effectively capture novel and complex patterns of cortical differences using both surface area and thickness. In addition, correlation results implicate specific brain regions in levels of anxiety in WS, consistent with previous reports investigating general anxiety disorders in the general population.	[Meda, Shashwath A.; Thornton-Wells, Tricia A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet & Res, Nashville, TN 37232 USA; [Pryweller, Jennifer R.] Vanderbilt Univ, Grad Sch, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Meda, SA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet & Res, Nashville, TN 37232 USA.	t.thornton-wells@vanderbilt.edu	Thornton-Wells, Tricia/C-3490-2012; Thornton-Wells, Tricia/A-7852-2009	Thornton-Wells, Tricia/0000-0002-5467-2270	National Institute of Health Roadmap for Medical Research [T32 MH075883]; National Institutes of Health/National Institute of Child Health and Development [P30-HD15052, 1-UL1-RR024975]; National Institute of Mental Health [K01-MH083052]; Vanderbilt University; National Institute of Aging [P30AG036445-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, KL2RR024977, UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH083052, T32MH075883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG036445] Funding Source: NIH RePORTER	National Institute of Health Roadmap for Medical Research; National Institutes of Health/National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Vanderbilt University; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the following grants: National Institute of Health Roadmap for Medical Research, Grant T32 MH075883; National Institutes of Health/National Institute of Child Health and Development P30-HD15052 to the Vanderbilt Kennedy Center, National Center for Research Resources (Vanderbilt Clinical and Translational Science Award grant 1-UL1-RR024975); National Institute of Mental Health K01-MH083052; a Vanderbilt University Discovery Grant, and National Institute of Aging P30AG036445-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus LR, 2011, MAGN RESON IMAGING, V29, P1165, DOI 10.1016/j.mri.2011.07.012; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Avery SN, 2012, NEUROIMAGE, V59, P887, DOI 10.1016/j.neuroimage.2011.09.065; Boddaert N, 2006, NEUROIMAGE, V30, P721, DOI 10.1016/j.neuroimage.2005.10.051; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Cohen JD, 2010, J PSYCHIATR RES, V44, P81, DOI 10.1016/j.jpsychires.2009.07.001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P553, DOI 10.1016/S0006-3223(01)01375-0; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ding JR, 2011, MAGN RESON IMAGING, V29, P701, DOI 10.1016/j.mri.2011.02.013; Doyle TF, 2004, AM J MED GENET A, V124A, P263, DOI 10.1002/ajmg.a.20416; Dykens EM, 2005, AM J MENT RETARD, V110, P346, DOI 10.1352/0895-8017(2005)110[346:MAAIWS]2.0.CO;2; Dykens EM, 2003, DEV NEUROPSYCHOL, V23, P291, DOI 10.1207/S15326942DN231&2_13; Dykens EM, 1999, AM J MENT RETARD, V104, P158, DOI 10.1352/0895-8017(1999)104<0158:RBPPIW>2.0.CO;2; Eckert MA, 2006, CELL MOL LIFE SCI, V63, P1867, DOI 10.1007/s00018-005-5553-x; Eckert MA, 2006, NEUROIMAGE, V32, P1001, DOI 10.1016/j.neuroimage.2006.05.014; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gaser C, 2006, NEUROIMAGE, V33, P46, DOI 10.1016/j.neuroimage.2006.06.018; Hocking DR, 2011, J NEUROL SCI, V301, P51, DOI 10.1016/j.jns.2010.11.001; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Jackowski AP, 2009, EUR J PAEDIATR NEURO, V13, P305, DOI 10.1016/j.ejpn.2008.07.002; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Jarrold C, 1999, NEUROPSYCHOLOGIA, V37, P637, DOI 10.1016/S0028-3932(98)00128-6; Killgore WDS, 2011, DEPRESS ANXIETY, V28, P243, DOI 10.1002/da.20788; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Levitin DJ, 2005, J CHILD PSYCHOL PSYC, V46, P514, DOI 10.1111/j.1469-7610.2004.00376.x; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Levitin DJ, 2003, NEUROIMAGE, V18, P74, DOI 10.1006/nimg.2002.1297; Marenco S, 2007, P NATL ACAD SCI USA, V104, P15117, DOI 10.1073/pnas.0704311104; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Mervis CB, 2010, AM J MED GENET C, V154C, P229, DOI 10.1002/ajmg.c.30263; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Mobbs D, 2007, BIOL PSYCHIAT, V62, P256, DOI 10.1016/j.biopsych.2006.05.041; Morris CA, 2010, AM J MED GENET C, V154C, P427, DOI 10.1002/ajmg.c.30286; Munoz KE, 2010, NEUROIMAGE, V50, P340, DOI 10.1016/j.neuroimage.2009.11.069; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paul BM, 2002, NEUROREPORT, V13, P1115, DOI 10.1097/00001756-200207020-00009; Perez-Garcia D, 2011, RES DEV DISABIL, V32, P643, DOI 10.1016/j.ridd.2010.12.005; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pietrini F, 2010, RIV PSICHIATR, V45, P349; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Rosso Isabelle M, 2010, Depress Anxiety, V27, P1104, DOI 10.1002/da.20765; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; Thornton-Wells TA, 2011, DEV COGN NEUROS-NETH, V1, P295, DOI 10.1016/j.dcn.2011.03.003; Thornton-Wells TA, 2010, AJIDD-AM J INTELLECT, V115, P172, DOI 10.1352/1944-7588-115.172; Tsai SW, 2008, PEDIATR INT, V50, P221, DOI 10.1111/j.1442-200X.2008.02563.x; UDWIN O, 1991, J CLIN EXP NEUROPSYC, V13, P232, DOI 10.1080/01688639108401040; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Zhao Xiao-hu, 2006, Zhonghua Yi Xue Za Zhi, V86, P955	61	47	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31913	10.1371/journal.pone.0031913	http://dx.doi.org/10.1371/journal.pone.0031913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355403	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300103
J	Corkrey, R; Olley, J; Ratkowsky, D; McMeekin, T; Ross, T				Corkrey, Ross; Olley, June; Ratkowsky, David; McMeekin, Tom; Ross, Tom			Universality of Thermodynamic Constants Governing Biological Growth Rates	PLOS ONE			English	Article							PROTEIN-FOLDING THERMODYNAMICS; HEAT-CAPACITY CHANGE; TEMPERATURE-DEPENDENCE; GLOBULAR-PROTEINS; ESCHERICHIA-COLI; ELEVATED-TEMPERATURES; DENATURATION; BACTERIA; SIZE; DISSOLUTION	Background: Mathematical models exist that quantify the effect of temperature on poikilotherm growth rate. One family of such models assumes a single rate-limiting 'master reaction' using terms describing the temperature-dependent denaturation of the reaction's enzyme. We consider whether such a model can describe growth in each domain of life. Methodology/Principal Findings: A new model based on this assumption and using a hierarchical Bayesian approach fits simultaneously 95 data sets for temperature-related growth rates of diverse microorganisms from all three domains of life, Bacteria, Archaea and Eukarya. Remarkably, the model produces credible estimates of fundamental thermodynamic parameters describing protein thermal stability predicted over 20 years ago. Conclusions/Significance: The analysis lends support to the concept of universal thermodynamic limits to microbial growth rate dictated by protein thermal stability that in turn govern biological rates. This suggests that the thermal stability of proteins is a unifying property in the evolution and adaptation of life on earth. The fundamental nature of this conclusion has importance for many fields of study including microbiology, protein chemistry, thermal biology, and ecological theory including, for example, the influence of the vast microbial biomass and activity in the biosphere that is poorly described in current climate models.	[Corkrey, Ross; Olley, June; Ratkowsky, David; McMeekin, Tom; Ross, Tom] Univ Tasmania, Sch Agr Sci, Tasmanian Inst Agr, Hobart, Tas, Australia	University of Tasmania	Corkrey, R (corresponding author), Univ Tasmania, Sch Agr Sci, Tasmanian Inst Agr, Hobart, Tas, Australia.	scorkrey@utas.edu.au	Corkrey, Ross/D-8999-2012; Corkrey, Stephen/C-2424-2014	Corkrey, Stephen/0000-0002-2242-2891; Ross, Tom/0000-0001-9916-7772				[Anonymous], MARCH 2008 WORKSH; BILLING E, 1974, J APPL BACTERIOL, V37, P643, DOI 10.1111/j.1365-2672.1974.tb00488.x; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; COULTATE TP, 1975, J BACTERIOL, V121, P55, DOI 10.1128/JB.121.1.55-64.1975; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Franks F, DESCRIPTION CLASSIFI; Gilks W.R., 1996, MARKOV CHAIN MONTE C, P89; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Graziano G, 2008, J THERM ANAL CALORIM, V93, P429, DOI 10.1007/s10973-007-8698-z; Graziano G, 1998, THERMOCHIM ACTA, V321, P23, DOI 10.1016/S0040-6031(98)00435-3; Graziano G, 1996, J AM CHEM SOC, V118, P1831, DOI 10.1021/ja9521942; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hanu FJ, 1962, J BACTERIOL, V95, P736; Honda S, 2004, STRUCTURE, V12, P1507, DOI 10.1016/j.str.2004.05.022; INGRAHAM JL, 1958, J BACTERIOL, V76, P75, DOI 10.1128/JB.76.1.75-80.1958; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; Jiang X, 2000, PROTEIN SCI, V9, P403; JOHNSON FH, 1946, J CELL COMPAR PHYSL, V28, P47, DOI 10.1002/jcp.1030280104; Kimball J, 2006, PROTEINS; Knies JL, 2010, AM NAT, V176, P227, DOI 10.1086/653662; Liu L, 2000, BIOPHYS CHEM, V84, P239, DOI 10.1016/S0301-4622(00)00130-7; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677; McMeekin TA, PREDICTIVE MICROBIOL; MENNETT RH, 1971, APPL MICROBIOL, V22, P772, DOI 10.1128/AEM.22.5.772-776.1971; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; NG H, 1962, J BACTERIOL, V84, P331, DOI 10.1128/JB.84.2.331-339.1962; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; Ragone R, 2004, PROTEINS, V54, P323, DOI 10.1002/prot.10574; RAISON JK, 1973, J BIOENERG, V4, P285, DOI 10.1007/BF01516063; Raison JK, 1973, RATE CONTROL BIOL PR, V27, P485; Ratkowsky DA, 2005, J THEOR BIOL, V233, P351, DOI 10.1016/j.jtbi.2004.10.016; RON EZ, 1990, ANTON LEEUW INT J G, V58, P169, DOI 10.1007/BF00548929; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; SHAW MK, 1967, J BACTERIOL, V93, P1332, DOI 10.1128/JB.93.4.1332-1336.1967; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	44	52	52	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32003	10.1371/journal.pone.0032003	http://dx.doi.org/10.1371/journal.pone.0032003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348140	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400058
J	Chen, Q; Verguts, T				Chen, Qi; Verguts, Tom			Spatial Intuition in Elementary Arithmetic: A Neurocomputational Account	PLOS ONE			English	Article							OPERATIONAL MOMENTUM; NUMERICAL ESTIMATION; PARIETAL CORTEX; NUMBER LINE; REPRESENTATIONS; PERCEPTION; MOVEMENTS	Elementary arithmetic (e. g., addition, subtraction) in humans has been shown to exhibit spatial properties. Its exact nature has remained elusive, however. To address this issue, we combine two earlier models for parietal cortex: A model we recently proposed on number-space interactions and a modeling framework of parietal cortex that implements radial basis functions for performing spatial transformations. Together, they provide us with a framework in which elementary arithmetic is based on evolutionarily more basic spatial transformations, thus providing the first implemented instance of Dehaene and Cohen's recycling hypothesis.	[Chen, Qi] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; [Verguts, Tom] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Yeshiva University; Ghent University	Chen, Q (corresponding author), Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Philadelphia, PA 19141 USA.	ChenQi.Research@gmail.com	Verguts, Tom/A-4792-2008	Verguts, Tom/0000-0002-7783-4754	BOF from Ghent University [01D02106]; Ghent University GOA [BOF08/GOA/011]	BOF from Ghent University; Ghent University GOA(Ghent University)	QC and TV were supported by a BOF grant (BOF grant 01D02106) from Ghent University awarded to QC and a Ghent University GOA grant BOF08/GOA/011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barth HC, 2011, DEVELOPMENTAL SCI, V14, P125, DOI 10.1111/j.1467-7687.2010.00962.x; Chen Q, 2010, COGNITIVE PSYCHOL, V60, P218, DOI 10.1016/j.cogpsych.2010.01.001; Cordes S, 2007, PERCEPT PSYCHOPHYS, V69, P1185, DOI 10.3758/BF03193955; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 2007, ATTENTION PERFORM, V22, P527, DOI DOI 10.1093/ACPR0F:0S0/9780199231447.003.0024; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Knops A, 2009, ATTEN PERCEPT PSYCHO, V71, P803, DOI 10.3758/APP.71.4.803; McCrink K, 2007, PERCEPT PSYCHOPHYS, V69, P1324, DOI 10.3758/BF03192949; McCrink K, 2009, J EXP CHILD PSYCHOL, V103, P400, DOI 10.1016/j.jecp.2009.01.013; Pinhas M, 2008, COGNITION, V109, P408, DOI 10.1016/j.cognition.2008.09.003; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; SALINAS E, 1995, J NEUROSCI, V15, P6461; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Verguts T, 2005, MEM COGNITION, V33, P1, DOI 10.3758/BF03195293; Viarouge A, 2010, EXP PSYCHOL, V57, P446, DOI 10.1027/1618-3169/a000055	25	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31180	10.1371/journal.pone.0031180	http://dx.doi.org/10.1371/journal.pone.0031180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348052	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900029
J	Hensel, N; Ratzka, A; Brinkmann, H; Klimaschewski, L; Grothe, C; Claus, P				Hensel, Niko; Ratzka, Andreas; Brinkmann, Hella; Klimaschewski, Lars; Grothe, Claudia; Claus, Peter			Analysis of the Fibroblast Growth Factor System Reveals Alterations in a Mouse Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							SEVERE SMA MICE; SIGNALING PATHWAYS; SURVIVAL FACTOR; NEUROTROPHIC FACTORS; MOTONEURON PROTEIN; NEURITE OUTGROWTH; SINGLE NUCLEOTIDE; FACTOR RECEPTOR-1; SKELETAL-MUSCLE; GENE-EXPRESSION	The monogenetic disease Spinal Muscular Atrophy (SMA) is characterized by a progressive loss of motoneurons leading to muscle weakness and atrophy due to severe reduction of the Survival of Motoneuron (SMN) protein. Several models of SMA show deficits in neurite outgrowth and maintenance of neuromuscular junction (NMJ) structure. Survival of motoneurons, axonal outgrowth and formation of NMJ is controlled by neurotrophic factors such as the Fibroblast Growth Factor (FGF) system. Besides their classical role as extracellular ligands, some FGFs exert also intracellular functions controlling neuronal differentiation. We have previously shown that intracellular FGF-2 binds to SMN and regulates the number of a subtype of nuclear bodies which are reduced in SMA patients. In the light of these findings, we systematically analyzed the FGF-system comprising five canonical receptors and 22 ligands in a severe mouse model of SMA. In this study, we demonstrate widespread alterations of the FGF-system in both muscle and spinal cord. Importantly, FGF-receptor 1 is upregulated in spinal cord at a pre-symptomatic stage as well as in a mouse motoneuron-like cell-line NSC34 based model of SMA. Consistent with that, phosphorylations of FGFR-downstream targets Akt and ERK are increased. Moreover, ERK hyper-phosphorylation is functionally linked to FGFR-1 as revealed by receptor inhibition experiments. Our study shows that the FGF system is dysregulated at an early stage in SMA and may contribute to the SMA pathogenesis.	[Hensel, Niko; Ratzka, Andreas; Brinkmann, Hella; Grothe, Claudia; Claus, Peter] Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany; [Hensel, Niko; Grothe, Claudia; Claus, Peter] Ctr Syst Neurosci, Hannover, Germany; [Klimaschewski, Lars] Innsbruck Med Univ, Div Neuroanat, Innsbruck, Austria	Hannover Medical School; Medical University of Innsbruck	Hensel, N (corresponding author), Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany.	claus.peter@mh-hannover.de	Ratzka, Andreas/H-7917-2012; Claus, Peter/A-7978-2008; Klimaschewski, Lars/AAR-2384-2020	Claus, Peter/0000-0003-3824-9445; Klimaschewski, Lars/0000-0003-3211-0047	German National Academic Foundation; Deutsche Forschungsgemeinschaft (DFG)	German National Academic Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was partially financed by the German National Academic Foundation. Publications costs were sponsored (Open Access Publication) by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Bruns AF, 2009, P NATL ACAD SCI USA, V106, P12747, DOI 10.1073/pnas.0900122106; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Claus P, 2004, BIOCHEM J, V384, P559, DOI 10.1042/BJ20040801; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Eash J, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-32; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Garces A, 2000, J NEUROSCI RES, V60, P1, DOI 10.1002/(SICI)1097-4547(20000401)60:1<1::AID-JNR1>3.0.CO;2-P; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gringel S, 2004, BIOL CHEM, V385, P1203, DOI 10.1515/BC.2004.156; GROTHE C, 1992, J NEUROSCI RES, V32, P317, DOI 10.1002/jnr.490320304; Grothe C, 1996, DEV DYNAM, V206, P310, DOI 10.1002/(SICI)1097-0177(199607)206:3<310::AID-AJA8>3.0.CO;2-L; Guettier-Sigrist S, 2002, MUSCLE NERVE, V25, P700, DOI 10.1002/mus.10081; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hausott B, 2008, NEUROSCIENCE, V153, P461, DOI 10.1016/j.neuroscience.2008.01.083; Hausott B, 2009, ANAT REC, V292, P1976, DOI 10.1002/ar.20964; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; HUGHES RA, 1993, NEURON, V10, P369, DOI 10.1016/0896-6273(93)90327-N; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jungnickel J, 2005, NEUROSCIENCE, V134, P1343, DOI 10.1016/j.neuroscience.2005.04.066; Kuninger D, 2006, AM J PHYSIOL-CELL PH, V291, pC699, DOI 10.1152/ajpcell.00056.2006; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li PP, 2011, MOL BIOL CELL, V22, P2480, DOI 10.1091/mbc.E11-03-0198; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Marics I, 2002, DEVELOPMENT, V129, P4559; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Martinez-Hernandez R, 2009, J NEUROPATH EXP NEUR, V68, P474, DOI 10.1097/NEN.0b013e3181a10ea1; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nakamua S, 1999, GLIA, V28, P53, DOI 10.1002/(SICI)1098-1136(199910)28:1<53::AID-GLIA7>3.0.CO;2-V; Nolle A, 2011, HUM MOL GEN IN PRESS, DOI [10.1093/hmg/ddr1425, DOI 10.1093/HMG/DDR1425]; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Ratzka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023564; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Sen A, 2011, J CELL BIOL, V192, P481, DOI 10.1083/jcb.201004016; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Slotkin TA, 2008, BRAIN RES BULL, V76, P424, DOI 10.1016/j.brainresbull.2008.01.001; Slotkin TA, 2007, ENVIRON HEALTH PERSP, V115, P909, DOI 10.1289/ehp.9901; Soundararajan P, 2010, J NEUROSCI, V30, P6595, DOI 10.1523/JNEUROSCI.4932-09.2010; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Umemori H, 2009, DEV GROWTH DIFFER, V51, P263, DOI 10.1111/j.1440-169X.2008.01079.x; van Bergeijk J, 2007, FASEB J, V21, P1492, DOI 10.1096/fj.06-7136com; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Weston CA, 2007, J CELL SCI, V120, P868, DOI 10.1242/jcs.03367; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	65	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31202	10.1371/journal.pone.0031202	http://dx.doi.org/10.1371/journal.pone.0031202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348054	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900030
J	Laarakker, MC; Reinders, NR; Bruining, H; Ophoff, RA; Kas, MJH				Laarakker, Marijke C.; Reinders, Niels R.; Bruining, Hilgo; Ophoff, Roel A.; Kas, Martien J. H.			Sex-Dependent Novelty Response in Neurexin-1 alpha Mutant Mice	PLOS ONE			English	Article							GENDER-DIFFERENCES; SYNAPSE FORMATION; ALPHA-NEUREXINS; AUTISM; SCHIZOPHRENIA; DISORDERS; NEUROLIGIN-1; IMPAIRMENTS; VALIDATION; DISRUPTION	Neurexin-1 alpha (NRXN1 alpha) belongs to the family of cell adhesion molecules (CAMs), which are involved in the formation of neuronal networks and synapses. NRXN1 alpha gene mutations have been identified in neuropsychiatric diseases including Schizophrenia (SCZ) and Autism Spectrum Disorder (ASD). In order to get a better understanding of the pleiotropic behavioral manifestations caused by NRXN1 alpha gene mutations, we performed a behavioral study of Nrxn1 alpha heterozygous knock-out (+/-) mice and observed increased responsiveness to novelty and accelerated habituation to novel environments compared to wild type (+/+) litter-mates. However, this effect was mainly observed in male mice, strongly suggesting that gender-specific mechanisms play an important role in Nrxn1 alpha-induced phenotypes.	[Laarakker, Marijke C.; Reinders, Niels R.; Bruining, Hilgo; Kas, Martien J. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Div Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Bruining, Hilgo; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Div Neurosci, Dept Psychiat, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	Laarakker, MC (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst, Div Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	m.j.h.kas@umcutrecht.nl	Reinders, Niels/ABI-6180-2020; Kas, Martien J./G-8269-2018	Kas, Martien J./0000-0002-4471-8618				Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; CASTLE DJ, 1995, SCHIZOPHRENIA BULL, V21, P1; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Miller BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014458; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mori A, 2002, NEUROSCI RES, V43, P251, DOI 10.1016/S0168-0102(02)00041-X; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rinehart NJ, 2011, CURR TOP BEHAV NEURO, V8, P209, DOI 10.1007/7854_2010_96; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Shah AK, 2010, NEUROSCI LETT, V475, P80, DOI 10.1016/j.neulet.2010.03.047; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takahashi A, 2008, GENES BRAIN BEHAV, V7, P849, DOI 10.1111/j.1601-183X.2008.00419.x; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; VANENGELAND H, 1991, PSYCHIAT RES, V38, P27, DOI 10.1016/0165-1781(91)90050-Y; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Zhang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013093; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	38	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31503	10.1371/journal.pone.0031503	http://dx.doi.org/10.1371/journal.pone.0031503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348092	Green Submitted, gold, Green Published			2022-12-27	WOS:000302733900049
J	Martins, YC; Zanini, GM; Frangos, JA; Carvalho, LJM				Martins, Yuri C.; Zanini, Graziela M.; Frangos, John A.; Carvalho, Leonardo J. M.			Efficacy of Different Nitric Oxide-Based Strategies in Preventing Experimental Cerebral Malaria by Plasmodium berghei ANKA	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; L-ARGININE; ENDOTHELIAL DYSFUNCTION; COGNITIVE IMPAIRMENT; FUNCTIONAL RECOVERY; CHILDREN; PHARMACOKINETICS; BIOAVAILABILITY; RAT; METABOLISM	Background: Low nitric oxide (NO) bioavailability plays a role in the pathogenesis of human as well as of experimental cerebral malaria (ECM) caused by Plasmodium berghei ANKA (PbA). ECM is partially prevented by administration of the NO-donor dipropylenetriamine NONOate (DPTA-NO) at high concentration (1 mg/mouse), which also induces major side effects such as a sharp drop in blood pressure. We asked whether alternative strategies to improve NO bioavailability with minor side effects would also be effective in preventing ECM. Methodology/Principal Findings: Mice were infected with PbA and prophylactically treated twice a day with bolus injections of L-arginine, N omega-hydroxy-nor-Arginine (nor-NOHA), tetrahydrobiopterin (BH4), separately or combined, sodium nitrite, sildenafil or sildenafil plus DPTA-NO starting on day 0 of infection. L-arginine and BH4 supplementation, with or without arginase inhibition by nor-NOHA, increased plasma nitrite levels but failed to protect against ECM development. Accordingly, prophylactic treatment with continuous delivery of L-arginine using osmotic pumps also did not improve survival. Similar outcomes were observed with sodium nitrite sildenafil (aimed at inhibiting phosphodiesterase-5) or with DPTA-NO. However, sildenafil (0.1 mg/mouse) in combination with a lower dose (0.1 mg/mouse) of DPTA-NO decreased ECM incidence (82 +/- 7.4% mortality in the saline group and 38 +/- 10.6% in the treated group; p<0.05). The combined prophylactic therapy did not aggravate anemia, had delayed effects in systolic, diastolic and mean arterial blood pressure and induced lower effects in pulse pressure when compared to DPTA-NO 1 mg/mouse. Conclusions/Significance: These data show that sildenafil lowers the amount of NO-donor needed to prevent ECM, resulting also in lesser side effects. Prophylactic L-arginine when given in bolus or continuous delivery and bolus BH4 supplementation, with or without arginase inhibition, were able to increase NO bioavailability in PbA-infected mice but failed to decrease ECM incidence in the doses and protocol used.	[Martins, Yuri C.; Zanini, Graziela M.; Frangos, John A.; Carvalho, Leonardo J. M.] La Jolla Bioengn Inst, Ctr Malaria Res, San Diego, CA USA; [Martins, Yuri C.] Univ Fed Rio de Janeiro, Inst Microbiol, Lab Inflammat & Immun, BR-21941 Rio De Janeiro, Brazil; [Zanini, Graziela M.] Fiocruz MS, Evandro Chagas Clin Res Inst, Parasitol Serv, BR-21045900 Rio De Janeiro, Brazil; [Carvalho, Leonardo J. M.] Fiocruz MS, Inst Oswaldo Cruz, Malaria Res Lab, BR-21045900 Rio De Janeiro, Brazil	La Jolla Bioengineering Institute; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Martins, YC (corresponding author), La Jolla Bioengn Inst, Ctr Malaria Res, San Diego, CA USA.	ymartins@ljbi.org	Carvalho, Leonardo J. M./K-7174-2013; Martins, Yuri Chaves/E-1637-2013	Martins, Yuri/0000-0003-4220-4979; Zanini, Graziela/0000-0003-4466-3124	National Institutes of Health [R01-HL087290, R01-HL087290-1 S1, R01-AI082610]; CNPq (Brazil); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov) grants R01-HL087290, R01-HL087290-1 S1 and R01-AI082610 (LJMC). GMZ was recipient of a CNPq (Brazil; http://www.cnpq.br) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Astrand A, 2004, AM J PHYSIOL-REG I, V287, pR749, DOI 10.1152/ajpregu.00134.2004; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Bratt JM, 2010, TOXICOL APPL PHARM, V242, P1, DOI 10.1016/j.taap.2009.09.018; Cabrales P, 2011, J INFECT DIS; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; CAMPISTRON G, 1982, EUR J DRUG METAB PH, V7, P307, DOI 10.1007/BF03189634; CAMPISTRON G, 1982, EUR J DRUG METAB PH, V7, P315, DOI 10.1007/BF03189635; Carvalho LJM, 2010, TRENDS PARASITOL, V26, P271, DOI 10.1016/j.pt.2010.03.001; Clemmer L, 2011, ANTIMICROB AGENTS CH, V55, P1383, DOI 10.1128/AAC.01277-10; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crabtree MJ, 2011, NITRIC OXIDE BIOL CH; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Faiz MA, 2005, LANCET, V366, P717; Fernando SD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-366; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hattori Y, 2007, ARTERIOSCL THROM VAS, V27, P865, DOI 10.1161/01.ATV.0000258946.55438.0e; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Kharitonov S, 1997, EUR RESPIR J, V10, P1683, DOI 10.1183/09031936.97.10071683; Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Libonati RMF, 2006, NEUROIMMUNOMODULAT, V13, P28, DOI 10.1159/000093271; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; Martins YC, MALAR J, V85; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Mun CH, 2010, ANAT CELL BIOL, V43, P230, DOI 10.5115/acb.2010.43.3.230; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Pluta RM, 2011, ACTA NEUROCHIR SUPPL, V110, P7, DOI 10.1007/978-3-7091-0353-1_2; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Renia L, 2010, TRENDS PARASITOL, V26, P275, DOI 10.1016/j.pt.2010.03.005; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Rodrigo Regina, 2006, Neuropsychiatr Dis Treat, V2, P53; Shinozaki K, 2000, CIRC RES, V87, P566, DOI 10.1161/01.RES.87.7.566; Stevenson MM, 2010, TRENDS PARASITOL, V26, P274, DOI 10.1016/j.pt.2010.03.008; VALLANCE P, 1992, J CARDIOVASC PHARM, V20, pS60, DOI 10.1097/00005344-199204002-00018; Verhaar MC, 2004, HEART, V90, P494, DOI 10.1136/hrt.2003.029405; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; Weitzberg E, 2010, ANESTHESIOLOGY, V113, P1460, DOI 10.1097/ALN.0b013e3181fcf3cc; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yeo TW, 2008, ANTIMICROB AGENTS CH, V52, P4381, DOI 10.1128/AAC.00421-08; Yeo TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002347; Yeo TW, 2008, J INFECT DIS, V198, P602, DOI 10.1086/590209; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59	59	27	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32048	10.1371/journal.pone.0032048	http://dx.doi.org/10.1371/journal.pone.0032048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348145	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900064
J	Barboni, B; Curini, V; Russo, V; Mauro, A; Di Giacinto, O; Marchisio, M; Alfonsi, M; Mattioli, M				Barboni, Barbara; Curini, Valentina; Russo, Valentina; Mauro, Annunziata; Di Giacinto, Oriana; Marchisio, Marco; Alfonsi, Melissa; Mattioli, Mauro			Indirect Co-Culture with Tendons or Tenocytes Can Program Amniotic Epithelial Cells towards Stepwise Tenogenic Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-SITU HYBRIDIZATION; REGENERATIVE MEDICINE; CLINICAL-APPLICATIONS; ACHILLES-TENDON; SHEEP TENDON; FETAL SHEEP; OLD-AGE; SCLERAXIS; EXPRESSION	Background: Amniotic epithelial cells (AEC) have potential applications in cell-based therapy. Thus far their ability to differentiate into tenocytes has not been investigated although a cell source providing a large supply of tenocytes remains a priority target of regenerative medicine in order to respond to the poor self-repair capability of adult tendons. Starting from this premise, the present research has been designed firstly to verify whether the co-culture with adult primary tenocytes could be exploited in order to induce tenogenic differentiation in AEC, as previously demonstrated in mesenchymal stem cells. Since the co-culture systems inducing cell differentiation takes advantage of specific soluble paracrine factors released by tenocytes, the research has been then addressed to study whether the co-culture could be improved by making use of the different cell populations present within tendon explants or of the high regenerative properties of fetal derived cell/tissue. Methodology/Principal Findings: Freshly isolated AEC, obtained from ovine fetuses at mid-gestation, were co-incubated with explanted tendons or primary tenocytes obtained from fetal or adult calcaneal tendons. The morphological and functional analysis indicated that AEC possessed tenogenic differentiation potential. However, only AEC exposed to fetal-derived cell/tissues developed in vitro tendon-like three dimensional structures with an expression profile of matrix (COL1 and THSB4) and mesenchymal/tendon related genes (TNM, OCN and SCXB) similar to that recorded in native ovine tendons. The tendon-like structures displayed high levels of organization as documented by the cell morphology, the newly deposited matrix enriched in COL1 and widespread expression of gap junction proteins (Connexin 32 and 43). Conclusions/Significance: The co-culture system improves its efficiency in promoting AEC differentiation by exploiting the inductive tenogenic soluble factors released by fetal tendon cells or explants. The co-cultural system can be proposed as a low cost and easy technique to engineer tendon for biological study and cell therapy approach.	[Barboni, Barbara; Curini, Valentina; Russo, Valentina; Mauro, Annunziata; Di Giacinto, Oriana; Mattioli, Mauro] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Marchisio, Marco] Univ G dAnnunzio, Dept Biomorphol, Chieti, Italy; [Alfonsi, Melissa] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy; [Barboni, Barbara; Curini, Valentina; Russo, Valentina; Mauro, Annunziata; Marchisio, Marco; Alfonsi, Melissa; Mattioli, Mauro] StemTeCh Grp, Chieti, Italy	University of Teramo; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Barboni, B (corresponding author), Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy.	valentinacurini@yahoo.it	Russo, Valentina/G-8209-2011; Curini, Valentina VC/C-1094-2016	Russo, Valentina/0000-0003-4368-2534; Curini, Valentina VC/0000-0002-2335-3154; MAURO, ANNUNZIATA/0000-0003-3907-0244; Marchisio, Marco/0000-0003-3058-3422	Tercas Foundation	Tercas Foundation	This work was supported by a Tercas Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141; Avila M, 2001, CORNEA, V20, P414, DOI 10.1097/00003226-200105000-00016; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; BAKER H, 1968, BRIT J DERMATOL, V80, P367, DOI 10.1111/j.1365-2133.1968.tb12322.x; BANES A, 1999, CLIN ORTHOP RELAT R, V367, P356; Barboni B, 2009, HUM GENE THER, V20, P1494; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Brent AE, 2005, DEVELOPMENT, V132, P515, DOI 10.1242/dev.01605; Canela Andres, 2007, Methods Mol Biol, V371, P45; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen WH, 2009, ARTHRITIS RHEUM-US, V60, P450, DOI 10.1002/art.24265; Csaki C, 2009, HISTOCHEM CELL BIOL, V131, P251, DOI 10.1007/s00418-008-0524-6; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; delaSena C, 1995, HEREDITAS, V123, P269; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Hampson K, 2008, TOPICS TISSUE ENG, P1; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; HOLMPEDERSEN P, 1972, SCAND J PLAST RECON, V6, P24, DOI 10.3109/02844317209103455; Hori J, 2006, CORNEA, V25, pS53, DOI 10.1097/01.ico.0000247214.31757.5c; Hou Y, 2009, MATRIX BIOL, V28, P324, DOI 10.1016/j.matbio.2009.04.007; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Kostrominova TY, 2009, HISTOL HISTOPATHOL, V24, P541, DOI 10.14670/HH-24.541; Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539; Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Lu XY, 2010, MOL VIS, V16, P611; Luo Q, 2009, CYTOTECHNOLOGY, V61, P1, DOI 10.1007/s10616-009-9233-9; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; Marongiu F, 2011, HEPATOLOGY, V53, P1719, DOI 10.1002/hep.24255; Mattioli M, 2011, CELL BIOL INT; McNeilly CM, 1996, J ANAT, V189, P593; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; MERRILEES MJ, 1980, AM J ANAT, V157, P87, DOI 10.1002/aja.1001570109; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki T, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt66; Miscia S, 2009, NEUROBIOL AGING, V30, P394, DOI 10.1016/j.neurobiolaging.2007.07.011; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Muttini A, 2010, VET RES COMMUN, V34, pS117, DOI 10.1007/s11259-010-9396-z; NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396; Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72; Ouyang HW, 2005, J BIOMED MATER RES B, V75B, P264, DOI 10.1002/jbm.b.30281; Parolini O, 2011, PLACENTA, V32, pS283, DOI 10.1016/j.placenta.2011.04.009; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Pennisi E, 2002, SCIENCE, V295, P1011, DOI 10.1126/science.295.5557.1011; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Piccin D, 2010, DIS MODEL MECH, V3, P421, DOI 10.1242/dmm.003137; Pittenger M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P309; Roth GS, 1997, J GERONTOL A-BIOL, V52, pB98, DOI 10.1093/gerona/52A.2.B98; Russo V, 2006, J HISTOCHEM CYTOCHEM, V54, P443, DOI 10.1369/jhc.4A6603.2006; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shaw SWS, 2011, CURR OPIN OBSTET GYN, V23, P109, DOI 10.1097/GCO.0b013e32834457b1; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Silva H., 2008, STEMBOOK; Stalling SS, 2008, CLIN ORTHOP RELAT R, V466, P3130, DOI 10.1007/s11999-008-0391-4; Stanley RL, 2007, J ANAT, V211, P325, DOI 10.1111/j.1469-7580.2007.00781.x; STROCCHI R, 1991, FOOT ANKLE, V12, P100, DOI 10.1177/107110079101200207; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Ueta M, 2002, CLIN EXP IMMUNOL, V129, P464, DOI 10.1046/j.1365-2249.2002.01945.x; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang QW, 2005, J BIOSCI BIOENG, V100, P418, DOI 10.1263/jbb.100.418; Wei XL, 2011, BIOCHEM BIOPH RES CO, V406, P204, DOI 10.1016/j.bbrc.2011.02.015; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312; Yang JH, 2007, HUM REPROD, V22, P945, DOI 10.1093/humrep/del493; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Yin Z, 2010, EXPERT OPIN BIOL TH, V10, P689, DOI 10.1517/14712591003769824; Yuge I, 2004, TRANSPLANTATION, V77, P1452, DOI 10.1097/00007890-200405150-00023	73	52	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30974	10.1371/journal.pone.0030974	http://dx.doi.org/10.1371/journal.pone.0030974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348033	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730900017
J	Zhi, D; Chen, R				Zhi, Degui; Chen, Rui			Statistical Guidance for Experimental Design and Data Analysis of Mutation Detection in Rare Monogenic Mendelian Diseases by Exome Sequencing	PLOS ONE			English	Article							ASSOCIATION; VARIANTS; DEFICIENCY; STRATEGIES; DISCOVERY; CAPTURE; GENE	Recently, whole-genome sequencing, especially exome sequencing, has successfully led to the identification of causal mutations for rare monogenic Mendelian diseases. However, it is unclear whether this approach can be generalized and effectively applied to other Mendelian diseases with high locus heterogeneity. Moreover, the current exome sequencing approach has limitations such as false positive and false negative rates of mutation detection due to sequencing errors and other artifacts, but the impact of these limitations on experimental design has not been systematically analyzed. To address these questions, we present a statistical modeling framework to calculate the power, the probability of identifying truly disease-causing genes, under various inheritance models and experimental conditions, providing guidance for both proper experimental design and data analysis. Based on our model, we found that the exome sequencing approach is well-powered for mutation detection in recessive, but not dominant, Mendelian diseases with high locus heterogeneity. A disease gene responsible for as low as 5% of the disease population can be readily identified by sequencing just 200 unrelated patients. Based on these results, for identifying rare Mendelian disease genes, we propose that a viable approach is to combine, sequence, and analyze patients with the same disease together, leveraging the statistical framework presented in this work.	[Zhi, Degui] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine	Zhi, D (corresponding author), Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	dzhi@ms.soph.uab.edu; ruichen@bcm.edu			National Institutes of Health (NIH) [R00 RR024163, R01EY018571]; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024163] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018571] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institutes of Health (NIH) Grants R00 RR024163 to DZ and R01EY018571 to RC. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Liu DJJ, 2010, AM J HUM GENET, V87, P790, DOI 10.1016/j.ajhg.2010.10.025; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323	29	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31358	10.1371/journal.pone.0031358	http://dx.doi.org/10.1371/journal.pone.0031358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348076	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900025
J	Malou, N; Tran, TNN; Nappez, C; Signoli, M; Le Forestier, C; Castex, D; Drancourt, M; Raoult, D				Malou, Nada; Thi-Nguyen-Ny Tran; Nappez, Claude; Signoli, Michel; Le Forestier, Cyrille; Castex, Dominique; Drancourt, Michel; Raoult, Didier			Immuno-PCR - A New Tool for Paleomicrobiology: The Plague Paradigm	PLOS ONE			English	Article							YERSINIA-PESTIS DNA; MEDIEVAL SKELETAL FINDS; RAPID DIAGNOSTIC-TEST; DENTAL-PULP; BARTONELLA-QUINTANA; MOLECULAR-DETECTION; F1 ANTIGEN; ANCIENT; TUBERCULOSIS; PALAEOMICROBIOLOGY	Background: The cause of past plague pandemics was controversial but several research teams used PCR techniques and dental pulp as the primary material to reveal that they were caused by Yersinia pestis. However, the degradation of DNA limits the ability to detect ancient infections. Methods: We used for the first time immuno-PCR to detect Yersinia pestis antigens; it can detect protein concentrations 70 times lower than the standard ELISA. After determining the cut-off value, we tested 34 teeth that were obtained from mass graves of plague, and compared previous PCR results with ELISA and immuno-PCR results. Results: The immuno-PCR technique was the most sensitive (14 out of 34) followed by the PCR technique (10 out of 34) and ELISA (3 out of 34). The combination of these three methods identified 18 out of 34 (53%) teeth as presumably being from people with the plague. Conclusion: Immuno-PCR is specific (no false-positive samples were found) and more sensitive than the currently used method to detect antigens of ancient infections in dental pulp. The combination of three methods, ELISA, PCR and immuno-PCR, increased the capacity to identify ancient pathogens in dental pulp.	[Malou, Nada; Thi-Nguyen-Ny Tran; Nappez, Claude; Drancourt, Michel; Raoult, Didier] Aix Marseille Univ, Fac Med, URMITE, CNRS,UMR 6236,IRD 198, Marseille, France; [Signoli, Michel] Aix Marseille Univ, CNRS, EFS, UMR 6578, Marseille, France; [Le Forestier, Cyrille] Inst Natl Rec Archeol Prevent, Ctr Etud Prehist, Direct Interreg Ctr, UMR 6130, Ile De France, France; [Castex, Dominique] Univ Bordeaux, UMR 5199, Lab Anthropol Populat Passe, Bordeaux, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux	Malou, N (corresponding author), Aix Marseille Univ, Fac Med, URMITE, CNRS,UMR 6236,IRD 198, Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Aboudharam G, 2005, MICROB PATHOGENESIS, V38, P47, DOI 10.1016/j.micpath.2004.10.004; Aboudharam G, 2004, EUR J CLIN MICROBIOL, V23, P920, DOI 10.1007/s10096-004-1244-z; Al Moussawi K, 2011, J INFECT DIS, V204, P44, DOI 10.1093/infdis/jir219; Bianucci R, 2008, AM J PHYS ANTHROPOL, V136, P361, DOI 10.1002/ajpa.20818; Bianucci R, 2007, CR BIOL, V330, P747, DOI 10.1016/j.crvi.2007.07.007; Bianucci R, 2009, J ARCHAEOL SCI, V36, P616, DOI 10.1016/j.jas.2008.10.007; Cerutti N, 2007, PLAGUE ANCIENT REMAI, P241; Djelouadji Z, 2011, LANCET INFECT DIS, V11, P641, DOI 10.1016/S1473-3099(11)70093-7; DONAT R, 2008, VILARNAU VILLAGE MOY; Donoghue HD, 2011, CLIN MICROBIOL INFEC, V17, P821, DOI 10.1111/j.1469-0691.2011.03554.x; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Drancourt M, 2002, MICROBES INFECT, V4, P105, DOI 10.1016/S1286-4579(01)01515-5; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Drancourt M, 2005, EMERG INFECT DIS EME; Drancourt M, 2007, EMERG INFECT DIS, V13, P332, DOI 10.3201/eid1302.060197; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Hadjouis D, 2008, BIOM HUM ANTHROPOL, V26, P69; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Malou N, 2011, TRENDS MICROBIOL, V19, P295, DOI 10.1016/j.tim.2011.03.004; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Niemeyer CM, 2005, TRENDS BIOTECHNOL, V23, P208, DOI 10.1016/j.tibtech.2005.02.006; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Papagrigorakis MJ, 2006, INT J INFECT DIS, V10, P206, DOI 10.1016/j.ijid.2005.09.001; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pfeiffer H, 1999, INT J LEGAL MED, V112, P142, DOI 10.1007/s004140050219; Prentice M, 2004, LANCET INFECT DIS, V4, P72, DOI 10.1016/S1473-3099(04)00923-5; Pusch CM, 2004, LANCET INFECT DIS, V4, P484, DOI 10.1016/S1473-3099(04)01099-0; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Raoult D, 2002, LANCET INFECT DIS, V2, P459, DOI 10.1016/S1473-3099(02)00341-9; Raoult D, 2008, PALEOMICROBIOLOGY HU; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Sanz JC, 2006, APMIS, V114, P788, DOI 10.1111/j.1600-0463.2006.apm_463.x; Schuenemann VJ, 2011, P NATL ACAD SCI US; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Spigelman M, 1993, INT J OSTEOARCHAEOL, V3, P137, DOI DOI 10.1002/0A.1390030211; Taubenberger JK, 2003, AVIAN DIS, V47, P789, DOI 10.1637/0005-2086-47.s3.789; Tran TNN, 2011, AM J PHYS ANTHROPOL, V145, P489, DOI 10.1002/ajpa.21510; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016735; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017319; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; Wiechmann I, 2010, EMERG INFECT DIS, V16, P1806, DOI 10.3201/eid1611.100598; Zink AR, 2003, EPIDEMIOL INFECT, V130, P239, DOI 10.1017/S0950268802008257; Zink AR, 2003, J CLIN MICROBIOL, V41, P359, DOI 10.1128/JCM.41.1.359-367.2003	45	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31744	10.1371/journal.pone.0031744	http://dx.doi.org/10.1371/journal.pone.0031744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347507	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200035
J	Martinerie, L; Pussard, E; Meduri, G; Delezoide, AL; Boileau, P; Lombes, M				Martinerie, Laetitia; Pussard, Eric; Meduri, Geri; Delezoide, Anne-Lise; Boileau, Pascal; Lombes, Marc			Lack of Renal 11 Beta-Hydroxysteroid Dehydrogenase Type 2 at Birth, a Targeted Temporal Window for Neonatal Glucocorticoid Action in Human and Mice	PLOS ONE			English	Article							APPARENT MINERALOCORTICOID EXCESS; PARTIAL ALDOSTERONE RESISTANCE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GENE-EXPRESSION; IN-UTERO; PRENATAL DEXAMETHASONE; RECEPTOR EXPRESSION; FETAL MEMBRANES; BLOOD-PRESSURE; HUMAN PLACENTA	Background: Glucocorticoid hormones play a major role in fetal organ maturation. Yet, excessive glucocorticoid exposure in utero can result in a variety of detrimental effects, such as growth retardation and increased susceptibility to the development of hypertension. To protect the fetus, maternal glucocorticoids are metabolized into inactive compounds by placental 11beta-hydroxysteroid dehydrogenase type2 (11 beta HSD2). This enzyme is also expressed in the kidney, where it prevents illicit occupation of the mineralocorticoid receptor by glucocorticoids. We investigated the role of renal 11 beta HSD2 in the control of neonatal glucocorticoid metabolism in the human and mouse. Methods: Cortisol (F) and cortisone (E) concentrations were measured in maternal plasma, umbilical cord blood and human newborn urine using HPLC. 11 beta HSD2 activity was indirectly assessed by comparing the F/E ratio between maternal and neonatal plasma (placental activity) and between plasma and urine in newborns (renal activity). Direct measurement of renal 11 beta HSD2 activity was subsequently evaluated in mice at various developmental stages. Renal 11 beta HSD2 mRNA and protein expression were analyzed by quantitative RT-PCR and immunohistochemistry during the perinatal period in both species. Results: We demonstrate that, at variance with placental 11 beta HSD2 activity, renal 11 beta HSD2 activity is weak in newborn human and mouse and correlates with low renal mRNA levels and absence of detectable 11 beta HSD2 protein. Conclusions: We provide evidence for a weak or absent expression of neonatal renal 11 beta HSD2 that is conserved among species. This temporal and tissue-specific 11 beta HSD2 expression could represent a physiological window for glucocorticoid action yet may constitute an important predictive factor for adverse outcomes of glucocorticoid excess through fetal programming.	[Martinerie, Laetitia; Pussard, Eric; Meduri, Geri; Lombes, Marc] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Martinerie, Laetitia; Pussard, Eric; Lombes, Marc] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Martinerie, Laetitia; Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Pussard, Eric; Meduri, Geri] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Delezoide, Anne-Lise] Univ Paris Diderot, Serv Biol Dev, Hop Robert Debre, AP HP, Paris, France; [Delezoide, Anne-Lise; Boileau, Pascal; Lombes, Marc] PremUp Fdn, Paris, France; [Boileau, Pascal] Univ Paris 11, Serv Pediat & Reanimat Neonatale, Hop Antoine Beclere, AP HP, Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay	Martinerie, L (corresponding author), INSERM, U693, F-94275 Le Kremlin Bicetre, France.	marc.lombes@u-psud.fr	Boileau, Pascal/AAG-9683-2021; Boileau, Pascal/H-7508-2015; PUSSARD, Eric/S-6059-2018; Lombes, Marc/L-5933-2018; pussard, eric/J-9916-2013; Martinerie, Laetitia/S-7493-2018	Boileau, Pascal/0000-0001-9755-6467; Boileau, Pascal/0000-0001-9755-6467; Lombes, Marc/0000-0003-3189-023X; 	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Sud 11, France	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Sud 11, France	This work was supported by fundings from Institut National de la Sante et de la Recherche Medicale (Inserm) and Universite Paris-Sud 11, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaidy N, 2003, J CLIN ENDOCR METAB, V88, P5033, DOI 10.1210/jc.2002-021915; Atanasov AG, 2007, J AM SOC NEPHROL, V18, P1262, DOI 10.1681/ASN.2006111235; Aucott SW, 2008, PEDIATRICS, V122, P775, DOI 10.1542/peds.2007-2252; Baum M, 2010, AM J PHYSIOL-RENAL, V298, pF235, DOI 10.1152/ajprenal.00288.2009; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; BROWN RW, 1993, ENDOCRINOLOGY, V132, P2614, DOI 10.1210/en.132.6.2614; Brown RW, 1996, ENDOCRINOLOGY, V137, P794, DOI 10.1210/en.137.2.794; Condon J, 1998, J CLIN ENDOCR METAB, V83, P4490, DOI 10.1210/jc.83.12.4490; Condon J, 1997, MOL CELL ENDOCRINOL, V127, P121, DOI 10.1016/S0303-7207(97)04000-8; Diaz R, 1998, J NEUROSCI, V18, P2570; Diederich S, 2002, J CLIN ENDOCR METAB, V87, P5695, DOI 10.1210/jc.2002-020970; Dodic M, 1999, TRENDS ENDOCRIN MET, V10, P86, DOI 10.1016/S1043-2760(98)00125-8; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Farman N, 2000, KIDNEY INT, V57, P1364, DOI 10.1046/j.1523-1755.2000.00976.x; Gwathmey TM, 2011, HYPERTENSION, V57, P620, DOI 10.1161/HYPERTENSIONAHA.110.164970; Hirasawa G, 1999, J CLIN ENDOCR METAB, V84, P1453, DOI 10.1210/jc.84.4.1453; Holmes MC, 2006, NEUROSCIENCE, V137, P865, DOI 10.1016/j.neuroscience.2005.09.037; Huh SY, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-25; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Hundertmark S, 2001, HORM METAB RES, V33, P78, DOI 10.1055/s-2001-12429; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Kajantie E, 2003, J CLIN ENDOCR METAB, V88, P493, DOI 10.1210/jc.2002-021378; Lin CL, 1997, J CLIN ENDOCR METAB, V82, P151, DOI 10.1210/jc.82.1.151; Martinerie L, 2009, PEDIATR RES, V66, P323, DOI 10.1203/PDR.0b013e3181b1bbec; Martinerie L, 2009, ENDOCRINOLOGY, V150, P4414, DOI 10.1210/en.2008-1498; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Mune T, 1996, HYPERTENSION, V27, P1193, DOI 10.1161/01.HYP.27.6.1193; MURPHY BEP, 1973, J CLIN ENDOCR METAB, V36, P1037, DOI 10.1210/jcem-36-5-1037; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; Pasqualini JR, 2005, J STEROID BIOCHEM, V97, P401, DOI 10.1016/j.jsbmb.2005.08.004; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Sloboda DM, 2000, J ENDOCRINOL, V165, P79, DOI 10.1677/joe.0.1650079; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P885, DOI 10.1210/jc.80.3.885; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; THONY HC, 1995, EUR J PEDIATR, V154, pS65, DOI 10.1007/BF02191509; ULICK S, 1979, J CLIN ENDOCR METAB, V49, P757, DOI 10.1210/jcem-49-5-757; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3; Wyrwoll CS, 2007, HYPERTENSION, V50, P579, DOI 10.1161/HYPERTENSIONAHA.107.091603; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31949	10.1371/journal.pone.0031949	http://dx.doi.org/10.1371/journal.pone.0031949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359645	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200114
J	Zhang, LL; Hong, Z; Lin, WY; Shao, RX; Goto, K; Hsu, VW; Chung, RT				Zhang, Leiliang; Hong, Zhi; Lin, Wenyu; Shao, Run-Xuan; Goto, Kaku; Hsu, Victor W.; Chung, Raymond T.			ARF1 and GBF1 Generate a PI4P-Enriched Environment Supportive of Hepatitis C Virus Replication	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; 4-KINASE III ALPHA; TELAPREVIR; PEGINTERFERON; REGULATORS; RIBAVIRIN; LIPIDS; TRAFFICKING; RECRUITMENT; PHOSPHATASE	Cellular levels of phosphatidylinositol 4-phosphate (PI4P) have been shown to be upregulated during RNA replication of several viruses, including the HCV replicon model. However, whether PI4P is required in an infectious HCV model remains unknown. Moreover, it is not established whether the host transport machinery is sequestered by the generation of PI4P during HCV infection. Here we found that PI4P was enriched in HCV replication complexes when Huh7.5.1 cells were infected with JFH1. HCV replication was inhibited upon overexpression of the PI4P phosphatase Sac1. The PI4P kinase PI4KIII beta was also found to be required for HCV replication. Moreover, the vesicular transport proteins ARF1 and GBF1 colocalized with PI4KIII beta and were both required for HCV replication. During authentic HCV infection, PI4P plays an integral role in virus replication.	[Zhang, Leiliang; Hong, Zhi] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Zhang, Leiliang; Hong, Zhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Leiliang; Lin, Wenyu; Shao, Run-Xuan; Goto, Kaku; Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA USA; [Hsu, Victor W.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA; [Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, LL (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China.	rtchung@partners.org			National Institutes of Health (NIH) [AI069939, AI082630, DK078772]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2011IPB108]; NIH-MGH Center for Human Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, R01AI069939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098079, K24DK078772] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Pathogen Biology, Chinese Academy of Medical Sciences; NIH-MGH Center for Human Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants AI069939, AI082630 and DK078772 (to RTC) from the National Institutes of Health (NIH), 2011IPB108 from Intramural Research Program of the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (to LZ), and NIH-MGH Center for Human Immunology Pilot/Feasibility Study Grant (to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207-7216.2005; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; Berger KL, 2011, J VIROL, V85, P8870, DOI 10.1128/JVI.00059-11; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Bostan N, 2010, CRIT REV MICROBIOL, V36, P91, DOI 10.3109/10408410903357455; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jang Jae Young, 2010, Korean J Hepatol, V16, P263, DOI 10.3350/kjhep.2010.16.3.263; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krauss M, 2007, FEBS LETT, V581, P2105, DOI 10.1016/j.febslet.2007.01.089; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Liu Y, 2009, ADV ENZYME REGUL, V49, P75, DOI 10.1016/j.advenzreg.2009.01.006; Matto M, 2011, J VIROL, V85, P946, DOI 10.1128/JVI.00753-10; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhang LL, 2009, P NATL ACAD SCI USA, V106, P163, DOI 10.1073/pnas.0811631106	46	47	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32135	10.1371/journal.pone.0032135	http://dx.doi.org/10.1371/journal.pone.0032135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359663	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200132
J	Delorme, A; Palmer, J; Onton, J; Oostenveld, R; Makeig, S				Delorme, Arnaud; Palmer, Jason; Onton, Julie; Oostenveld, Robert; Makeig, Scott			Independent EEG Sources Are Dipolar	PLOS ONE			English	Article							BLIND SOURCE SEPARATION; EVENT-RELATED POTENTIALS; COMPONENT ANALYSIS; VISUAL-CORTEX; ELECTROENCEPHALOGRAPHIC DATA; NEURONAL AVALANCHES; WORKING-MEMORY; BRAIN SOURCES; RESPONSES; DYNAMICS	Independent component analysis (ICA) and blind source separation (BSS) methods are increasingly used to separate individual brain and non-brain source signals mixed by volume conduction in electroencephalographic (EEG) and other electrophysiological recordings. We compared results of decomposing thirteen 71-channel human scalp EEG datasets by 22 ICA and BSS algorithms, assessing the pairwise mutual information (PMI) in scalp channel pairs, the remaining PMI in component pairs, the overall mutual information reduction (MIR) effected by each decomposition, and decomposition 'dipolarity' defined as the number of component scalp maps matching the projection of a single equivalent dipole with less than a given residual variance. The least well-performing algorithm was principal component analysis (PCA); best performing were AMICA and other likelihood/mutual information based ICA methods. Though these and other commonly-used decomposition methods returned many similar components, across 18 ICA/BSS algorithms mean dipolarity varied linearly with both MIR and with PMI remaining between the resulting component time courses, a result compatible with an interpretation of many maximally independent EEG components as being volume-conducted projections of partially-synchronous local cortical field activity within single compact cortical domains. To encourage further method comparisons, the data and software used to prepare the results have been made available (http://sccn.ucsd.edu/wiki/BSSComparison).	[Delorme, Arnaud; Palmer, Jason; Onton, Julie; Makeig, Scott] Univ Calif San Diego, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Delorme, Arnaud] Univ Toulouse 3, Ctr Rech Cerveau & Cognit, F-31062 Toulouse, France; [Oostenveld, Robert] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Delorme, Arnaud] CNRS, CERCO, Toulouse, France; [Onton, Julie] Naval Hlth Res Ctr, San Diego, CA USA	University of California System; University of California San Diego; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Delorme, A (corresponding author), Univ Calif San Diego, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA.	arno@ucsd.edu	Delorme, Arnaud/F-8917-2011; Oostenveld, Robert/D-3259-2009	Oostenveld, Robert/0000-0002-1974-1293; Delorme, Arnaud/0000-0002-0799-3557	Swartz Foundation (Old Field NY); National Institute of Mental Health USA [RO1-NS047293-01A1]; National Science Foundation USA [NSF IIS-0613595]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047293] Funding Source: NIH RePORTER	Swartz Foundation (Old Field NY); National Institute of Mental Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation USA(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a gift from the Swartz Foundation (Old Field NY) and by grants from the National Institute of Mental Health USA (RO1-NS047293-01A1) and the National Science Foundation USA (NSF IIS-0613595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin Acar Z, 2009, PATACH BASIS ELECTRO; Akalin Acar Z, 2011, J NEUROSCIE IN PRESS; Akalin Acar Z, 2011, ADAPTIVE MIXTURE IND; Amari S, 1999, NEURAL COMPUT, V11, P1875, DOI 10.1162/089976699300015990; Anemuller J, 2003, NEURAL NETWORKS, V16, P1311, DOI 10.1016/j.neunet.2003.08.003; Beggs JM, 2003, J NEUROSCI, V23, P11167; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Belouchrani A, 2000, ELECTRON LETT, V36, P2050, DOI 10.1049/el:20001436; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Chen Y, 2008, IEEE ENG MED BIO, P1879, DOI 10.1109/IEMBS.2008.4649552; Cichocki A., 2012, ADAPTIVE BLIND SIGNA, DOI DOI 10.1002/0470845899; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Crespo-Garcia M, 2008, ANN BIOMED ENG, V36, P467, DOI 10.1007/s10439-008-9442-y; Cruces S, 2002, NEUROCOMPUTING, V49, P87, DOI 10.1016/S0925-2312(02)00525-8; Dehghani N, 2010, J NEUROPHYSIOL, V104, P179, DOI 10.1152/jn.00198.2010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, J NEUROSCI, V27, P11949, DOI 10.1523/JNEUROSCI.3477-07.2007; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Dien J, 2006, HUM BRAIN MAPP; Dyrholm M, 2007, NEURAL COMPUT, V19, P934, DOI 10.1162/neco.2007.19.4.934; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Freeman WJ, 1975, MASS ACTION NERVOUS; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Gomez-Herrero G, 2008, NEUROIMAGE, V43, P497, DOI 10.1016/j.neuroimage.2008.07.032; Grau C, 2007, NEUROIMAGE, V36, P522, DOI 10.1016/j.neuroimage.2007.03.027; Hoffmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003004; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kang K, 2010, J COMPUT NEUROSCI, V29, P495, DOI 10.1007/s10827-009-0190-2; Karvanen J, 2002, SIGNAL PROCESS, V82, P663, DOI 10.1016/S0165-1684(01)00213-4; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lee TW, 2000, COMPUT MATH APPL, V39, P1, DOI 10.1016/S0898-1221(00)00101-2; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, ADV NEUR IN, V8, P145; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MOCKS J, 1986, ELECTROEN CLIN NEURO, V65, P393, DOI 10.1016/0168-5597(86)90018-3; MODDEMEIJER R, 1989, SIGNAL PROCESS, V16, P233, DOI 10.1016/0165-1684(89)90132-1; Mullen T, 2011, MODELING CORTICAL SO; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Onton J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.061.2009; Palmer JA, 2008, INT CONF ACOUST SPEE, P1805, DOI 10.1109/ICASSP.2008.4517982; Palmer JA, 2007, LECT NOTES COMPUTER; Pham DT, 1997, IEEE T SIGNAL PROCES, V45, P1712, DOI 10.1109/78.599941; Robinson PA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041904; Sarnthein J, 2005, INT J PSYCHOPHYSIOL, V57, P87, DOI 10.1016/j.ijpsycho.2005.03.015; SCHERG M, 1991, Brain Topography, V4, P143, DOI 10.1007/BF01132771; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550	56	503	512	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30135	10.1371/journal.pone.0030135	http://dx.doi.org/10.1371/journal.pone.0030135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355308	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300008
J	Rosenthal, LA; Szakaly, RJ; Amineva, SP; Xing, YN; Hill, MR; Palmenberg, AC; Gern, JE; Sorkness, RL				Rosenthal, Louis A.; Szakaly, Renee J.; Amineva, Svetlana P.; Xing, Yina; Hill, Marchel R.; Palmenberg, Ann C.; Gern, James E.; Sorkness, Ronald L.			Lower Respiratory Tract Infection Induced by a Genetically Modified Picornavirus in Its Natural Murine Host	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; EXPERIMENTAL RHINOVIRUS INFECTION; LOWER AIRWAY RESPONSES; VIRUS-INDUCED ASTHMA; NF-KAPPA-B; POLY(C) TRACT; IN-VITRO; VIRAL-INFECTIONS; MONOCYTIC CELLS; INFLAMMATION	Infections with the picornavirus, human rhinovirus (HRV), are a major cause of wheezing illnesses and asthma exacerbations. In developing a murine model of picornaviral airway infection, we noted the absence of murine rhinoviruses and that mice are not natural hosts for HRV. The picornavirus, mengovirus, induces lethal systemic infections in its natural murine hosts, but small genetic differences can profoundly affect picornaviral tropism and virulence. We demonstrate that inhalation of a genetically attenuated mengovirus, vMC(0), induces lower respiratory tract infections in mice. After intranasal vMC(0) inoculation, lung viral titers increased, peaking at 24 h postinoculation with viral shedding persisting for 5 days, whereas HRV-A01a lung viral titers decreased and were undetectable 24 h after intranasal inoculation. Inhalation of vMC(0), but not vehicle or UV-inactivated vMC(0), induced an acute respiratory illness, with body weight loss and lower airway inflammation, characterized by increased numbers of airway neutrophils and lymphocytes and elevated pulmonary expression of neutrophil chemoattractant CXCR2 ligands (CXCL1, CXCL2, CXCL5) and interleukin-17A. Mice inoculated with vMC(0), compared with those inoculated with vehicle or UV-inactivated vMC(0), exhibited increased pulmonary expression of interferon (IFN-alpha, IFN-beta, IFN-lambda), viral RNA sensors [toll-like receptor (TLR) 3, TLR7, nucleotide-binding oligomerization domain containing 2 (NOD2)], and chemokines associated with HRV infection in humans (CXCL10, CCL2). Inhalation of vMC(0), but not vehicle or UV-inactivated vMC(0), was accompanied by increased airway fluid myeloperoxidase levels, an indicator of neutrophil activation, increased MUC5B gene expression, and lung edema, a sign of infection-related lung injury. Consistent with experimental HRV inoculations of nonallergic, nonasthmatic human subjects, there were no effects on airway hyperresponsiveness after inhalation of vMC(0) by healthy mice. This novel murine model of picornaviral airway infection and inflammation should be useful for defining mechanisms of HRV pathogenesis in humans.	[Rosenthal, Louis A.; Szakaly, Renee J.; Xing, Yina; Sorkness, Ronald L.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Amineva, Svetlana P.; Gern, James E.; Sorkness, Ronald L.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Hill, Marchel R.; Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Sorkness, Ronald L.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rosenthal, LA (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	lar@medicine.wisc.edu			National Institutes of Health [U19 AI070503]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health (http://www.nih.gov/) grant U19 AI070503 to LAR, ACP, and JEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini B, 1997, J ALLERGY CLIN IMMUN, V99, P618, DOI 10.1016/S0091-6749(97)70022-8; Avila PC, 2000, J ALLERGY CLIN IMMUN, V105, P923, DOI 10.1067/mai.2000.106214; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Contoli M, 2005, CLIN EXP ALLERGY, V35, P137, DOI 10.1111/j.1365-2222.2005.02163.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Gouw HWFM, 1998, EUR RESPIR J, V11, P126, DOI 10.1183/09031936.98.11010126; DeMore JP, 2009, J ALLERGY CLIN IMMUN, V124, P245, DOI 10.1016/j.jaci.2009.05.030; Denlinger LC, 2009, AM J RESP CRIT CARE, V179, P265, DOI 10.1164/rccm.200802-293OC; Donninger H, 2003, J INFECT DIS, V187, P1809, DOI 10.1086/375246; DUKE GM, 1990, NATURE, V343, P474, DOI 10.1038/343474a0; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Fuji N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027247; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1872, DOI 10.1164/ajrccm.155.6.9196088; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1159, DOI 10.1164/ajrccm.155.3.9117003; Gern JE, 1996, J IMMUNOL, V156, P621; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Grunberg K, 1997, CLIN EXP ALLERGY, V27, P36, DOI 10.1111/j.1365-2222.1997.tb00670.x; Grunberg K, 2002, EUR RESPIR J, V20, P274; Hall DJ, 2005, J IMMUNOL, V174, P8056, DOI 10.4049/jimmunol.174.12.8056; Hewson CA, 2010, EUR RESPIR J, V36, P1425, DOI 10.1183/09031936.00026910; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jarjour NN, 2000, J ALLERGY CLIN IMMUN, V105, P1169, DOI 10.1067/mai.2000.106376; Jartti T, 2008, EUR RESPIR J, V32, P314, DOI 10.1183/09031936.00161907; Kelly JT, 2008, J ALLERGY CLIN IMMUN, V122, P671, DOI 10.1016/j.jaci.2008.08.013; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Kuo C, 2011, AM J PHYSIOL-LUNG C, V300, pL951, DOI 10.1152/ajplung.00411.2010; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Malmstrom K, 2006, J ALLERGY CLIN IMMUN, V118, P591, DOI 10.1016/j.jaci.2006.04.032; Martin LR, 2000, J VIROL, V74, P3074, DOI 10.1128/JVI.74.7.3074-3081.2000; Martin LR, 1996, J VIROL, V70, P2027, DOI 10.1128/JVI.70.3.2027-2031.1996; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Osorio JE, 1996, VIROLOGY, V223, P344, DOI 10.1006/viro.1996.0485; Osorio JE, 2000, VIRAL IMMUNOL, V13, P27, DOI 10.1089/vim.2000.13.27; PALMENBERG AC, 1994, ARCH VIROL, P67; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Rosenthal LA, 2010, IMMUNOL ALLERGY CLIN, V30, P497, DOI 10.1016/j.iac.2010.08.005; Rosenthal LA, 2010, J ALLERGY CLIN IMMUN, V125, P1212, DOI 10.1016/j.jaci.2010.04.002; Rosenthal LA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-122; Rueckert R R, 1981, Methods Enzymol, V78, P315; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sajjan U, 2009, AM J PHYSIOL-LUNG C, V297, pL931, DOI 10.1152/ajplung.00150.2009; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Singh AM, 2007, AM J RESP CRIT CARE, V175, P108, DOI 10.1164/rccm.200603-435PP; Skoner DP, 1996, EUR RESPIR J, V9, P1402, DOI 10.1183/09031936.96.09071402; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sorkness RL, 1999, AM J RESP CRIT CARE, V160, P705, DOI 10.1164/ajrccm.160.2.9810002; Sorkness RL, 2007, AM J PHYSIOL-LUNG C, V292, pL85, DOI 10.1152/ajplung.00234.2006; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Wos M, 2008, AM J RESP CRIT CARE, V177, P1082, DOI 10.1164/rccm.200607-973OC; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC; Yuta A, 1998, AM J PHYSIOL-LUNG C, V274, pL1017, DOI 10.1152/ajplung.1998.274.6.L1017; Zambrano JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/mai.2003.1396; Zhu Z, 1997, AM J PHYSIOL-LUNG C, V273, pL814, DOI 10.1152/ajplung.1997.273.4.L814	76	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32061	10.1371/journal.pone.0032061	http://dx.doi.org/10.1371/journal.pone.0032061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355409	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300109
J	Schomacker, H; Hebner, RM; Boonyaratanakornkit, J; Surman, S; Amaro-Carambot, E; Collins, PL; Schmidt, AC				Schomacker, Henrick; Hebner, Rebecca M.; Boonyaratanakornkit, Jim; Surman, Sonja; Amaro-Carambot, Emerito; Collins, Peter L.; Schmidt, Alexander C.			The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome	PLOS ONE			English	Article							SENDAI-VIRUS; V-PROTEIN; VACCINE CANDIDATES; ALPHA-INTERFERON; RNA-SYNTHESIS; NUCLEAR ACCUMULATION; MANNOSE 6-PHOSPHATE; NONHUMAN-PRIMATES; GAMMA-INTERFERON; PREVENTING STAT1	Interferons (IFNs) play a crucial role in the antiviral immune response. Whereas the C proteins of wild-type human parainfluenza virus type 1 (WT HPIV1) inhibit both IFN-beta induction and signaling, a HPIV1 mutant encoding a single amino acid substitution (F170S) in the C proteins is unable to block either host response. Here, signaling downstream of the type 1 IFN receptor was examined in Vero cells to define at what stage WT HPIV1 can block, and F170S HPIV1 fails to block, IFN signaling. WT HPIV1 inhibited phosphorylation of both Stat1 and Stat2, and this inhibition was only slightly reduced for F170S HPIV1. Degradation of Stat1 or Stat2 was not observed. The HPIV1 C proteins were found to accumulate in the perinuclear space, often forming large granules, and co-localized with Stat1 and the cation-independent mannose 6-phosphate receptor (M6PR) that is a marker for late endosomes. Upon stimulation with IFN-beta, both the WT and F170S C proteins remained in the perinuclear space, but only the WT C proteins prevented Stat1 translocation to the nucleus. In addition, WT HPIV1 C proteins, but not F170S C proteins, co-immunoprecipitated both phosphorylated and unphosphorylated Stat1. Our findings suggest that the WT HPIV1 C proteins form a stable complex with Stat1 in perinuclear granules that co-localize with M6PR, and that this direct interaction between the WT HPIV1 C proteins and Stat1 is the basis for the ability of HPIV1 to inhibit IFN signaling. The F170S mutation in HPIV1 C did not prevent perinuclear co-localization with Stat1, but apparently weakened this interaction such that, upon IFN stimulation, Stat1 was translocated to the nucleus to induce an antiviral response.	[Schomacker, Henrick; Hebner, Rebecca M.; Boonyaratanakornkit, Jim; Surman, Sonja; Amaro-Carambot, Emerito; Collins, Peter L.; Schmidt, Alexander C.] NIAID, RNA Viruses Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schomacker, H (corresponding author), NIAID, RNA Viruses Sect, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	schmidta@niaid.nih.gov		Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NIH; MedImmune, LLC	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MedImmune, LLC(AstraZenecaMedimmune)	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. This research was also supported in part by a cooperative research and development agreement (CRADA) between NIH and MedImmune, LLC, for the development of HPIV, RSV and HPMV vaccines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Bartlett EJ, 2005, VACCINE, V23, P4631, DOI 10.1016/j.vaccine.2005.04.035; Bartlett EJ, 2008, J VIROL, V82, P8965, DOI 10.1128/JVI.00853-08; Bartlett EJ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-67; Boonyaratanakornkit J, 2010, J VIROL; Boonyaratanakornkit JB, 2009, J VIROL, V83, P1892, DOI 10.1128/JVI.01373-08; Bousse T, 2006, VIRUS RES, V121, P23, DOI 10.1016/j.virusres.2006.03.012; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Durbin AP, 1999, VIROLOGY, V261, P319, DOI 10.1006/viro.1999.9878; GALINSKI MS, 1992, VIROLOGY, V186, P543, DOI 10.1016/0042-6822(92)90020-P; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garcin D, 2000, J VIROL, V74, P8823, DOI 10.1128/JVI.74.19.8823-8830.2000; Garcin D, 2004, J VIROL, V78, P8799, DOI 10.1128/JVI.78.16.8799-8811.2004; Garcin D, 2003, J VIROL, V77, P2321, DOI 10.1128/JVI.77.4.2321-2329.2003; Garcin D, 2002, VIROLOGY, V295, P256, DOI 10.1006/viro.2001.1342; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 1997, VIROLOGY, V238, P424, DOI 10.1006/viro.1997.8836; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gosselin-Grenet AS, 2007, VIROLOGY, V365, P101, DOI 10.1016/j.virol.2007.03.039; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Itoh M, 1992, Uirusu, V42, P111; Itoh M, 1997, J GEN VIROL, V78, P3207, DOI 10.1099/0022-1317-78-12-3207; Itoh M, 1998, J VIROL, V72, P2927, DOI 10.1128/JVI.72.4.2927-2934.1998; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; Kiyotani K, 2007, VIROLOGY, V359, P82, DOI 10.1016/j.virol.2006.08.053; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; KOMADA H, 1992, J GEN VIROL, V73, P875, DOI 10.1099/0022-1317-73-4-875; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; LODISH H, 2000, MOL CELL BIOL, P712; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Marx A, 1997, J INFECT DIS, V176, P1423, DOI 10.1086/514137; Nishio M, 1997, J GEN VIROL, V78, P1303, DOI 10.1099/0022-1317-78-6-1303; Nishio M, 2002, VIROLOGY, V300, P92, DOI 10.1006/viro.2002.1509; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Reed G, 1997, J INFECT DIS, V175, P807, DOI 10.1086/513975; REICHELDERFER TE, 1958, SCIENCE, V128, P779, DOI 10.1126/science.128.3327.779; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Saito S, 2002, VIROLOGY, V293, P205, DOI 10.1006/viro.2001.1250; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Schaap-Nutt A, 2010, VIROLOGY, V406, P65, DOI 10.1016/j.virol.2010.07.011; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Van Cleve W, 2006, VIROLOGY, V352, P61, DOI 10.1016/j.virol.2006.04.011; Weinberg GA, 2009, J PEDIATR-US, V154, P694, DOI 10.1016/j.jpeds.2008.11.034; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Young DF, 2000, VIROLOGY, V269, P383, DOI 10.1006/viro.2000.0240; Zuniga EI, 2007, CURR TOP MICROBIOL, V316, P337	66	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e28382	10.1371/journal.pone.0028382	http://dx.doi.org/10.1371/journal.pone.0028382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355301	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300001
J	Senderovich, Y; Ken-Dror, S; Vainblat, I; Blau, D; Izhaki, I; Halpern, M				Senderovich, Yigal; Ken-Dror, Shifra; Vainblat, Irina; Blau, Dvora; Izhaki, Ido; Halpern, Malka			A Molecular Study on the Prevalence and Virulence Potential of Aeromonas spp. Recovered from Patients Suffering from Diarrhea in Israel	PLOS ONE			English	Article							CHIRONOMID EGG MASSES; III SECRETION SYSTEM; VIBRIO-CHOLERAE; GENUS AEROMONAS; GENES; IDENTIFICATION; INFECTIONS; HYDROPHILA; CHILDREN; BACTERIA	Background: Species of the genus Aeromonas are native inhabitants of aquatic environments and have recently been considered emerging human pathogens. Although the gastrointestinal tract is by far the most common anatomic site from which aeromonads are recovered, their role as etiologic agents of bacterial diarrhea is still disputed. Aeromonas-associated diarrhea is a phenomenon occurring worldwide; however, the exact prevalence of Aeromonas infections on a global scale is unknown. Methodology/Principal Findings: The prevalence and virulence potential of Aeromonas in patients suffering from diarrhea in Israel was studied using molecular methods. 1,033 diarrheal stools were sampled between April and September 2010 and Aeromonas species were identified in 17 (similar to 2%) patients by sequencing the rpoD gene. Aeromonas species identity and abundance was: A. caviae (65%), A. veronii (29%) and Aeromonas taiwanensis (6%). This is the first clinical record of A. taiwanensis as a diarrheal causative since its recent discovery from a wound infection in a patient in Taiwan. Most of the patients (77%) from which Aeromonas species were isolated were negative for any other pathogens. The patients ranged from 1 to 92 years in age. Aeromonas isolates were found to possess different virulence-associated genes: ahpB (88%), pla/lip/lipH3/apl-1 (71%), act/hlyA/aerA (35%), alt (18%), ast (6%), fla (65%), lafA (41%), TTSS ascV (12%), TTSS ascF-ascG (12%), TTSS-dependent ADP-ribosylating toxins aexU (41%) and aexT (6%) in various combinations. Most of the identified strains were resistant to beta-lactam antibiotics but susceptible to third-generation cephalosporin antibiotics. Conclusions: Aeromonas may be a causative agent of diarrhea in patients in Israel and therefore should be included in routine bacteriological screenings.	[Senderovich, Yigal; Izhaki, Ido; Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Ken-Dror, Shifra; Vainblat, Irina; Blau, Dvora] Clalit Hlth Serv Haifa, Microbiol Lab, Haifa, Israel; [Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Oranim, Tivon, Israel	University of Haifa; Clalit Health Services; University of Haifa	Senderovich, Y (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019; Izhaki, Ido/I-9712-2019; Izhaki, Ido/D-5586-2011	Halpern, Malka/0000-0002-3407-2198; Izhaki, Ido/0000-0002-4525-4683; Izhaki, Ido/0000-0002-4525-4683	Research Authority, University of Haifa, Israel	Research Authority, University of Haifa, Israel	This study was supported by the Research Authority, University of Haifa, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R. K., 1998, Journal of Communicable Diseases, V30, P71; Aguilera-Arreola MG, 2005, FEMS MICROBIOL LETT, V242, P231, DOI 10.1016/j.femsle.2004.11.011; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; Alperi A, 2010, INT J SYST EVOL MICR, V60, P2048, DOI 10.1099/ijs.0.014621-0; Anaissie EJ, 2002, ARCH INTERN MED, V162, P1483, DOI 10.1001/archinte.162.13.1483; Bin Kingombe CI, 1999, APPL ENVIRON MICROB, V65, P5293; Borchardt MA, 2003, EMERG INFECT DIS, V9, P224; Broza M, 2005, ENVIRON MICROBIOL, V7, P576, DOI 10.1111/j.1462-2920.2005.00745.x; Broza M, 2001, NATURE, V412, P40, DOI 10.1038/35083691; BURKE V, 1983, J INFECT DIS, V148, P68, DOI 10.1093/infdis/148.1.68; Chacon MR, 2004, J CLIN MICROBIOL, V42, P1285, DOI 10.1128/JCM.42.3.1285-1287.2004; ECHEVERRIA P, 1981, J INFECT DIS, V143, P767, DOI 10.1093/infdis/143.6.767; Essers B, 2000, CLIN INFECT DIS, V31, P192, DOI 10.1086/313901; Figueras MI, 2007, J MED MICROBIOL, V56, P996, DOI 10.1099/jmm.0.47062-0; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Garcia LS, 2010, CLIN MICROBIOLOGY PR; GOLIK A, 1990, J CLIN GASTROENTEROL, V12, P148, DOI 10.1097/00004836-199004000-00007; Halpern M, 2002, HYDROBIOLOGIA, V470, P49, DOI 10.1023/A:1015665027535; Heuzenroeder MW, 1999, FEMS MICROBIOL LETT, V174, P131, DOI 10.1016/S0378-1097(99)00130-5; Janda JM, 2006, REV MED MICROBIOL, V17, P27; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JONES BL, 1995, J ANTIMICROB CHEMOTH, V35, P453, DOI 10.1093/jac/35.4.453; Jorgensen JH, 2010, M45A2 CLSINCCLS; Figueras MJ, 2011, ENV MICROBIOL REP, V3, P239, DOI 10.1111/j.1758-2229.2010.00216.x; Kong RYC, 1999, MAR POLLUT BULL, V38, P802, DOI 10.1016/S0025-326X(99)00044-2; Miller RA, 2003, J CLIN MICROBIOL, V41, P4318, DOI 10.1128/JCM.41.9.4318-4323.2003; MORGAN DR, 1985, INFECT IMMUN, V50, P62, DOI 10.1128/IAI.50.1.62-65.1985; MOYER NP, 1987, J CLIN MICROBIOL, V25, P2044, DOI 10.1128/JCM.25.11.2044-2048.1987; Murray PR, 2003, MANUAL CLIN MICROBIO, p[654, 902]; OGUNSANYA TI, 1994, J MED MICROBIOL, V40, P10, DOI 10.1099/00222615-40-1-10; Ormen O, 2003, MICROB PATHOGENESIS, V35, P189, DOI 10.1016/S0882-4010(03)00124-4; Pablos M, 2010, EUR J CLIN MICROBIOL, V29, P1163, DOI 10.1007/s10096-010-0982-3; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; Senderovich Y, 2008, ISME J, V2, P276, DOI 10.1038/ismej.2007.114; Silver AC, 2009, DNA CELL BIOL, V28, P383, DOI 10.1089/dna.2009.0867; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Sun XB, 2007, J HAZARD MATER, V142, P348, DOI 10.1016/j.jhazmat.2006.08.030; Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004	39	51	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30070	10.1371/journal.pone.0030070	http://dx.doi.org/10.1371/journal.pone.0030070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355306	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300006
J	Wicklein, D; Leal, NR; Salamon, J; Thamer, M; Herrmann, H; Valent, P; Schumacher, U; Ullrich, S				Wicklein, Daniel; Leal, Nuno Ramos; Salamon, Johannes; Thamer, Mohammed; Herrmann, Harald; Valent, Peter; Schumacher, Udo; Ullrich, Sebastian			Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model	PLOS ONE			English	Article							HYPEREOSINOPHILIC SYNDROME; IN-VITRO; GRANULOCYTIC SARCOMA; KINASE INHIBITOR; APOPTOSIS; FUSION; ARREST; AGENT; MICE	We developed a xenograft model of human Chronic Eosinophilic Leukemia (CEL) to study disease progression and remission-induction under therapy with tyrosine kinase inhibitors using imatinib and nilotinib as examples. The FIP1L1/PDGFRA+ human CEL cell lineEOL-1 was injected intravenously into scid mice, and MR imaging and FACS analysis of mouse blood samples were performed to monitor disease development and the effects of imatinib and nilotinib. Organ infiltration was analyzed in detail by immunohistochemistry after sacrifice. All animals developed CEL and within one week of therapy, complete remissions were seen with both imatinib and nilotinib, resulting in reduced total tumor volumes by MR-imaging and almost complete disappearance of EOL-1 cells in the peripheral blood and in tissues. The new model system is feasible for the evaluation of new tyrosine kinase inhibitors and our data suggest that nilotinib may be a valuable additional targeted drug active in patients with FIP1L1/PDGFRA+ CEL.	[Wicklein, Daniel; Leal, Nuno Ramos; Thamer, Mohammed; Schumacher, Udo; Ullrich, Sebastian] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany; [Wicklein, Daniel] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany; [Salamon, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Radiol, Hamburg, Germany; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna	Wicklein, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany.	d.wicklein@uke.de	Gamperl, Susi/V-2715-2019; Valent, Peter/B-8533-2016; Test, PV/U-9451-2019; Test, Test/Y-7921-2019; Hermann, Harald/E-7073-2018	Gamperl, Susi/0000-0003-0456-5095; Valent, Peter/0000-0003-0456-5095; Hermann, Harald/0000-0002-5095-4641				BRODSKY I, 1966, CANCER RES, V26, P198; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Crane MM, 2010, J ALLERGY CLIN IMMUN, V126, P179, DOI 10.1016/j.jaci.2010.03.035; Flavell DJ, 2000, BRIT J CANCER, V83, P1755, DOI 10.1054/bjoc.2000.1565; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Helbig G, 2008, BRIT J HAEMATOL, V141, P200, DOI 10.1111/j.1365-2141.2008.07033.x; Helbig G, 2010, HEMATOL ONCOL, V28, P93, DOI 10.1002/hon.919; Henschler R, 2005, LEUKEMIA RES, V29, P1191, DOI 10.1016/j.leukres.2005.03.019; Ikezoe T, 2010, LEUKEMIA RES, V34, pE200, DOI 10.1016/j.leukres.2010.02.024; Ishihara K, 2008, BIOCHEM BIOPH RES CO, V366, P1007, DOI 10.1016/j.bbrc.2007.12.063; Lierman E, 2009, LEUKEMIA, V23, P845, DOI 10.1038/leu.2009.2; Ma SK, 1999, HUM PATHOL, V30, P864, DOI 10.1016/S0046-8177(99)90149-1; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Metzgeroth G, 2008, BRIT J HAEMATOL, V143, P707, DOI 10.1111/j.1365-2141.2008.07294.x; Nishioka C, 2008, BLOOD, V111, P5086, DOI 10.1182/blood-2007-06-098079; Park KU, 2001, AM J PATHOL, V159, P2011, DOI 10.1016/S0002-9440(10)63052-0; Paydas S, 2006, LEUKEMIA LYMPHOMA, V47, P2527, DOI 10.1080/10428190600967196; Roufosse FE, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-37; SAITO H, 1985, BLOOD, V66, P1233; Simon HU, 2010, J ALLERGY CLIN IMMUN, V126, P45, DOI 10.1016/j.jaci.2010.03.042; Tabouret E, 2010, LEUK RES; Tefferi A, 2010, MAYO CLIN PROC, V85, P158, DOI 10.4065/mcp.2009.0503; Thies A, 2007, BRIT J CANCER, V96, P609, DOI 10.1038/sj.bjc.6603594; Valent P, 2009, BLOOD REV, V23, P157, DOI 10.1016/j.blre.2009.01.001; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30567	10.1371/journal.pone.0030567	http://dx.doi.org/10.1371/journal.pone.0030567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348015	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400003
J	Petrovic, MM; Nowacki, J; Olivo, V; Tsaneva-Atanasova, K; Randall, AD; Mellor, JR				Petrovic, Milos M.; Nowacki, Jakub; Olivo, Valeria; Tsaneva-Atanasova, Krasimira; Randall, Andrew D.; Mellor, Jack R.			Inhibition of Post-Synaptic Kv7/KCNQ/M Channels Facilitates Long-Term Potentiation in the Hippocampus	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; SK CHANNELS; MUSCARINIC MODULATION; SYNAPTIC PLASTICITY; DENDRITIC SPINES; RAT HIPPOCAMPUS; INTRINSIC PLASTICITY; MOUSE HIPPOCAMPUS; NMDA RECEPTORS; CLAMP ANALYSIS	Activation of muscarinic acetylcholine receptors (mAChR) facilitates the induction of synaptic plasticity and enhances cognitive function. In the hippocampus, M-1 mAChR on CA1 pyramidal cells inhibit both small conductance Ca2+-activated KCa2 potassium channels and voltage-activated Kv7 potassium channels. Inhibition of KCa2 channels facilitates long-term potentiation (LTP) by enhancing Ca2+ calcium influx through postsynaptic NMDA receptors (NMDAR). Inhibition of Kv7 channels is also reported to facilitate LTP but the mechanism of action is unclear. Here, we show that inhibition of Kv7 channels with XE-991 facilitated LTP induced by theta burst pairing at Schaffer collateral commissural synapses in rat hippocampal slices. Similarly, negating Kv7 channel conductance using dynamic clamp methodologies also facilitated LTP. Negation of Kv7 channels by XE-991 or dynamic clamp did not enhance synaptic NMDAR activation in response to theta burst synaptic stimulation. Instead, Kv7 channel inhibition increased the amplitude and duration of the after-depolarisation following a burst of action potentials. Furthermore, the effects of XE-991 were reversed by re-introducing a Kv7-like conductance with dynamic clamp. These data reveal that Kv7 channel inhibition promotes NMDAR opening during LTP induction by enhancing depolarisation during and after bursts of postsynaptic action potentials. Thus, during the induction of LTP M-1 mAChRs enhance NMDAR opening by two distinct mechanisms namely inhibition of KCa2 and Kv7 channels.	[Petrovic, Milos M.; Olivo, Valeria; Randall, Andrew D.; Mellor, Jack R.] Univ Bristol, Sch Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol, Avon, England; [Nowacki, Jakub; Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England; [Petrovic, Milos M.] Univ Belgrade, Sch Med, Inst Med Psychol, Belgrade, Serbia	University of Bristol; University of Bristol; University of Belgrade	Petrovic, MM (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol, Avon, England.	Jack.Mellor@bristol.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; MELLOR, Jack/B-4548-2019	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; MELLOR, Jack/0000-0002-7706-8105; Randall, Andrew/0000-0001-8852-3671	Wellcome Trust [085354]; Engineering and Physical Sciences Research Council [EP/E032249/1]; Marie Curie Intra-European fellowship [237622]; BBSRC [BB/K000454/1] Funding Source: UKRI; EPSRC [EP/E032249/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K000454/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie Intra-European fellowship(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust, grant number 085354; Engineering and Physical Sciences Research Council, grant number EP/E032249/1; and Marie Curie Intra-European fellowship number 237622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Aramakis VB, 1999, SYNAPSE, V32, P262, DOI 10.1002/(SICI)1098-2396(19990615)32:4<262::AID-SYN3>3.3.CO;2-A; Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; BODDEKE EWGM, 1992, EUR J PHARMACOL, V222, P21, DOI 10.1016/0014-2999(92)90457-F; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown JT, 2011, EUR J NEUROSCI, V33, P879, DOI 10.1111/j.1460-9568.2010.07565.x; Brown JT, 2009, J PHYSIOL-LONDON, V587, P1265, DOI 10.1113/jphysiol.2008.167007; Buchanan KA, 2007, J PHYSIOL-LONDON, V585, P429, DOI 10.1113/jphysiol.2007.142984; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dean B, 2003, CURR MOL MED, V3, P419, DOI 10.2174/1566524033479654; Destexhe A, 2009, DYNAMIC CLAMP PRINCI; Faber ESL, 2010, J PHYSIOL-LONDON, V588, P1281, DOI 10.1113/jphysiol.2009.185645; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fontan-Lozano A, 2011, HIPPOCAMPUS, V21, P22, DOI 10.1002/hipo.20717; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Gu N, 2008, J NEUROPHYSIOL, V100, P2589, DOI 10.1152/jn.90433.2008; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Lampe BJ, 1997, NEUROSCI LETT, V222, P135, DOI 10.1016/S0304-3940(97)13347-X; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Ma MH, 1996, J NEUROSCI, V16, P4089; MADISON DV, 1987, J NEUROSCI, V7, P733; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKRAM H, 1992, J PHYSIOL-LONDON, V447, P513, DOI 10.1113/jphysiol.1992.sp019015; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nowacki J, 2011, PROG BIOPHYS MOL BIO, V105, P34, DOI 10.1016/j.pbiomolbio.2010.09.020; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Robinson HPC, 2008, J NEUROSCI METH, V169, P271, DOI 10.1016/j.jneumeth.2007.10.016; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Soldovieri MV, 2007, J NEUROSCI, V27, P4919, DOI 10.1523/JNEUROSCI.0580-07.2007; Song MK, 2009, NEUROSCI LETT, V461, P25, DOI 10.1016/j.neulet.2009.05.042; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Wu WW, 2008, J NEUROPHYSIOL, V100, P1897, DOI 10.1152/jn.90346.2008; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	56	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30402	10.1371/journal.pone.0030402	http://dx.doi.org/10.1371/journal.pone.0030402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348007	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900008
J	Sorensen, SW; Sansom, SL; Brooks, JT; Marks, G; Begier, EM; Buchacz, K; DiNenno, EA; Mermin, JH; Kilmarx, PH				Sorensen, Stephen W.; Sansom, Stephanie L.; Brooks, John T.; Marks, Gary; Begier, Elizabeth M.; Buchacz, Kate; DiNenno, Elizabeth A.; Mermin, Jonathan H.; Kilmarx, Peter H.			A Mathematical Model of Comprehensive Test-and-Treat Services and HIV Incidence among Men Who Have Sex with Men in the United States	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEW-YORK-CITY; MALE CIRCUMCISION; MEDICAL-CARE; ANAL INTERCOURSE; PERSONS AWARE; TRANSMISSION; PREVENTION; RISK; POPULATION	Background: Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerful interventions for reducing HIV incidence. A test-and-treat strategy may have long-term effects on the epidemic among urban men who have sex with men (MSM) in the United States and may achieve the 5-year goals of the 2010 National AIDS Strategy that include: 1) lowering to 25% the annual number of new infections, 2) reducing by 30% the HIV transmission rate, 3) increasing to 90% the proportion of persons living with HIV infection who know their HIV status, 4) increasing to 85% the proportion of newly diagnosed patients linked to clinical care, and 5) increasing by 20% the proportion of HIV-infected MSM with an undetectable HIV RNA viral load. Methods and Findings: We constructed a dynamic compartmental model among MSM in an urban population (based on New York City) that projects new HIV infections over time. We compared the cumulative number of HIV infections in 20 years, assuming current annual testing rate and treatment practices, with new infections after improvements in the annual HIV testing rate, notification of test results, linkage to care, initiation of antiretroviral therapy (ART) and viral load suppression. We also assessed whether five of the national HIV prevention goals could be met by the year 2015. Over a 20-year period, improvements in test-and-treat practice decreased the cumulative number of new infections by a predicted 39.3% to 69.1% in the urban population based on New York City. Institution of intermediate improvements in services would be predicted to meet at least four of the five goals of the National HIV/AIDS Strategy by the 2015 target. Conclusions: Improving the five components of a test-and-treat strategy could substantially reduce HIV incidence among urban MSM, and meet most of the five goals of the National HIV/AIDS Strategy.	[Sorensen, Stephen W.; Sansom, Stephanie L.; Brooks, John T.; Marks, Gary; Buchacz, Kate; DiNenno, Elizabeth A.; Mermin, Jonathan H.; Kilmarx, Peter H.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Begier, Elizabeth M.] New York City Dept Hlth & Mental Hyg, New York, NY USA	Centers for Disease Control & Prevention - USA; New York City Department of Health & Mental Hygiene	Sansom, SL (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	sos9@cdc.gov	Mermin, Jonathan/J-9847-2012	Kilmarx, Peter/0000-0001-6464-3345				[Anonymous], COCHRANE DATABASE SY; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Cambiano V, 2010, AIDS, V24, P1153, DOI 10.1097/QAD.0b013e32833847af; Center for Disease Control and Prevention, 2010, HIV GAY BIS OTH MEN; Centers for Disease Control and Prevention, 2009, HIV SURV REP; Charlebois ED, 2011, CLIN INFECT DIS, V52, P1046, DOI 10.1093/cid/cir085; Charurat M, 2010, PATIENT RETENTION AD; Cohen MS, 2010, CLIN INFECT DIS, V51, P1323, DOI 10.1086/656810; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Crosby R, 2002, SEX TRANSM INFECT, V78, P228, DOI 10.1136/sti.78.4.228; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; GIESECKE J, 1992, INT J STD AIDS, V3, P255, DOI 10.1177/095646249200300405; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Kalichman SC, 2010, AIDS PATIENT CARE ST, V24, P271, DOI 10.1089/apc.2009.0309; Kassler WJ, 1997, AIDS, V11, P1045, DOI 10.1097/00002030-199708000-00014; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2001, J ACQ IMMUN DEF SYND, V27, P79, DOI 10.1097/00126334-200105010-00013; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mckinney CM, 2008, SEX TRANSM DIS, V35, P814, DOI 10.1097/OLQ.0b013e318175d899; Mocroft A, 2010, ANTIVIR THER, V15, P563, DOI 10.3851/IMP1559; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero Michael J, 2008, Top HIV Med, V16, P156; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; New York City Department of Health and Mental Hygiene, 2010, NEW YORK CIT HIV AID; Nguyen TQ, 2008, AIDS, V22, P281, DOI 10.1097/QAD.0b013e3282f2ef58; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Pund B, 2011, NATL ADAP MONITORING; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	54	62	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e29098	10.1371/journal.pone.0029098	http://dx.doi.org/10.1371/journal.pone.0029098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347994	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900002
J	Botero, CA; Rubenstein, DR				Botero, Carlos A.; Rubenstein, Dustin R.			Fluctuating Environments, Sexual Selection and the Evolution of Flexible Mate Choice in Birds	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; FEMALE CHOICE; BRAIN SIZE; TEMPORAL DYNAMICS; GOOD GENES; DIVORCE; VARIABILITY; PATTERNS; ECOLOGY; TIT	Environmentally-induced fluctuation in the form and strength of natural selection can drive the evolution of morphology, physiology, and behavior. Here we test the idea that fluctuating climatic conditions may also influence the process of sexual selection by inducing unexpected reversals in the relative quality or sexual attractiveness of potential breeding partners. Although this phenomenon, known as 'ecological cross-over', has been documented in a variety of species, it remains unclear the extent to which it has driven the evolution of major interspecific differences in reproductive behavior. We show that after controlling for potentially influential life history and demographic variables, there are significant positive associations between the variability and predictability of annual climatic cycles and the prevalence of infidelity and divorce within populations of a taxonomically diverse array of socially monogamous birds. Our results are consistent with the hypothesis that environmental factors have shaped the evolution of reproductive flexibility and suggest that in the absence of severe time constraints, secondary mate choice behaviors can help prevent, correct, or minimize the negative consequences of ecological cross-overs. Our findings also illustrate how a basic evolutionary process like sexual selection is susceptible to the increasing variability and unpredictability of climatic conditions that is resulting from climate change.	[Botero, Carlos A.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Rubenstein, Dustin R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	The National Evolutionary Synthesis Center; Columbia University	Botero, CA (corresponding author), N Carolina State Univ, Initiat Biocomplex, Raleigh, NC 27695 USA.	cabotero@ncsu.edu	Rubenstein, Dustin R./N-9302-2019; Rubenstein, Dustin R/A-3451-2015	Rubenstein, Dustin R./0000-0002-4999-3723; Rubenstein, Dustin R/0000-0002-4999-3723; Botero, Carlos A./0000-0003-0955-2795	National Evolutionary Synthesis Center (NESCent), NSF [EF-0905606]; Columbia University	National Evolutionary Synthesis Center (NESCent), NSF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Columbia University	The authors acknowledge the National Evolutionary Synthesis Center (NESCent), NSF #EF-0905606, for fostering this collaboration, as well as for funding C.A.B. D.R.R was funded by Columbia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 1985, THEORY PRACTICE ECON; BENNETT PM, 1985, J ZOOL, V207, P151; Birkhead T.R., 1996, Oxford Ornithology Series, V6, P323; Botero CA, 2009, CURR BIOL, V19, P1151, DOI 10.1016/j.cub.2009.04.061; Candolin U, 2007, J EVOLUTION BIOL, V20, P233, DOI 10.1111/j.1420-9101.2006.01207.x; CEZILLY F, 1995, P ROY SOC B-BIOL SCI, V262, P7, DOI 10.1098/rspb.1995.0169; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; Cockburn A, 2008, P R SOC B, V275, P605, DOI 10.1098/rspb.2007.0916; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Deaner RO, 1999, P ROY SOC B-BIOL SCI, V266, P687, DOI 10.1098/rspb.1999.0690; DHONDT AA, 1994, J ANIM ECOL, V63, P979, DOI 10.2307/5274; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Ens Bruno J., 1996, Oxford Ornithology Series, V6, P344; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Gerlach NM, 2012, P ROY SOC B-BIOL SCI, V279, P860, DOI 10.1098/rspb.2011.1547; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; GILBURN AS, 1994, P ROY SOC B-BIOL SCI, V255, P159, DOI 10.1098/rspb.1994.0023; GILLESPIE JH, 1989, GENETICS, V121, P129; Gosden TP, 2008, EVOLUTION, V62, P845, DOI 10.1111/j.1558-5646.2008.00323.x; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Houerou H. N. le, 1989, The grazing land ecosystems of the African Sahel.; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jeschke JM, 2008, BEHAV ECOL SOCIOBIOL, V63, P1, DOI 10.1007/s00265-008-0646-9; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kraaijeveld K, 2003, P ROY SOC B-BIOL SCI, V270, P1785, DOI 10.1098/rspb.2003.2450; Kutner M., 2005, APPL LINEAR STAT MOD; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Le Hou?rou H.N., 2009, BIOCLIMATOLOGY BIOGE; Lesna I, 1999, NATURE, V401, P581, DOI 10.1038/44125; Li WH, 2011, J CLIMATE, V24, P1499, DOI 10.1175/2010JCLI3829.1; Mauck RA, 1999, AM NAT, V154, P99, DOI 10.1086/303216; MOLLER AP, 1993, AM NAT, V142, P118, DOI 10.1086/285531; Morrissey MB, 2011, EVOLUTION IN PRESS; Nettle D, 1998, J ANTHROPOL ARCHAEOL, V17, P354, DOI 10.1006/jaar.1998.0328; ORELL M, 1994, ANIM BEHAV, V48, P1143, DOI 10.1006/anbe.1994.1347; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; Robinson MR, 2008, CURR BIOL, V18, P751, DOI 10.1016/j.cub.2008.04.059; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schuck-Paim C, 2008, BRAIN BEHAV EVOLUT, V71, P200, DOI 10.1159/000119710; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Sol D, 2006, J ORNITHOL, V147, P34; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol Daniel, 2009, P111; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Welch AM, 2003, EVOLUTION, V57, P883; Westneat D.F., 1990, Current Ornithology, V7, P331; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	73	73	73	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32311	10.1371/journal.pone.0032311	http://dx.doi.org/10.1371/journal.pone.0032311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359681	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200150
J	McIntyre, JB; Bose, P; Klimowicz, AC; Brockton, NT; Petrillo, S; Matthews, W; Easaw, J; Magliocco, A; Dort, JC				McIntyre, John B.; Bose, Pinaki; Klimowicz, Alexander C.; Brockton, Nigel T.; Petrillo, Stephanie; Matthews, Wayne; Easaw, Jay; Magliocco, Anthony; Dort, Joseph C.			Specific and Sensitive Hydrolysis Probe-Based Real-Time PCR Detection of Epidermal Growth Factor Receptor Variant III in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							LUNG-CANCER; NECK-CANCER; KINASE INHIBITORS; EGF RECEPTOR; COPY NUMBER; PHASE-II; EXPRESSION; HEAD; EGFRVIII; GENE	Background: The tumor-specific EGFR deletion mutant, EGFRvIII, is characterised by ligand-independent constitutive signalling. Tumors expressing EGFRvIII are resistant to current EGFR-targeted therapy. The frequency of EGFRvIII in head and neck squamous cell carcinoma (HNSCC) is disputed and may vary by specific sub-site. The purpose of this study was to measure the occurrence of EGFRvIII mutations in a specific HNSCC subsite, oral squamous cell carcinoma (OSCC), using a novel real-time PCR assay. Methodology: Pre-treatment Formalin Fixed Paraffin Embedded (FFPE) cancer specimens from 50 OSCC patients were evaluated for the presence of EGFRvIII using a novel hydrolysis probe-based real-time PCR assay. EGFR protein expression in tumor samples was quantified using fluorescent immunohistochemistry (IHC) and AQUA (R) technology. Principal findings: We detected EGFRvIII in a single OSCC patient in our cohort (2%). We confirmed the validity of our detection technique in an independent cohort of glioblastoma patients. We also compared the sensitivity and specificity of our novel real-time EGFRvIII detection assay to conventional RT-PCR and direct sequencing. Our assay can specifically detect EGFRvIII and can discriminate against wild-type EGFR in FFPE tumor samples. AQUAnalysis (R) revealed that the presence of EGFRvIII transcript is associated with very high EGFR protein expression (98th percentile). Contrary to previous reports, only 44% of OSCC over-expressed EGFR in our study. Conclusion and Significance: Our results suggest that the EGFRvIII mutation is rare in OSCC and corroborate previous reports of EGFRvIII expression only in tumors with extreme over-expression of EGFR. We conclude that EGFRvIII-specific therapies may not be ideally suited as first-line treatment in OSCC. Furthermore, highly specific and sensitive methods, such as the real-time RT-PCR assay and AQUAnalysis (R) described here, will provide accurate assessment of EGFR mutation frequency and EGFR expression, and will facilitate the selection of optimal tailored therapies for OSCC patients.	[McIntyre, John B.] Univ Calgary, Dept Pathol & Lab Med, Tom Baker Canc Ctr, Calgary, AB, Canada; [Bose, Pinaki; Klimowicz, Alexander C.; Petrillo, Stephanie; Magliocco, Anthony] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Brockton, Nigel T.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Matthews, Wayne; Dort, Joseph C.] Univ Calgary, Dept Surg, Div Otolaryngol Head & Neck Surg, Calgary, AB, Canada; [Easaw, Jay] Univ Calgary, Div Neurosurg, Dept Clin Neurosci, Calgary, AB, Canada	Tom Baker Cancer Clinic; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary	McIntyre, JB (corresponding author), Univ Calgary, Dept Pathol & Lab Med, Tom Baker Canc Ctr, Calgary, AB, Canada.	jdort@ucalgary.ca	Brockton, Nigel/AAE-6893-2020; Brockton, Nigel/AAV-2010-2021; McIntyre, JB/ABE-9340-2021	Brockton, Nigel/0000-0002-5434-2490; 	Ohlson Research Initiative within the University of Calgary - Faculty of Medicine; Southern Alberta Cancer Research Institute (SACRI)	Ohlson Research Initiative within the University of Calgary - Faculty of Medicine; Southern Alberta Cancer Research Institute (SACRI)	Yes, we have the following competing interest. This study was funded by the Ohlson Research Initiative, which functions within the University of Calgary - Faculty of Medicine as well as the Southern Alberta Cancer Research Institute (SACRI). The corresponding author (JCD) is the Director of the Ohlson Research Initiative. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chau NG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-11; DEPALAZZO IEG, 1993, CANCER RES, V53, P3217; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Farah CS, 2008, AUST DENT J, V53, P2, DOI 10.1111/j.1834-7819.2007.00002.x; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; GRANDIS JR, 1993, J CELL BIOCHEM, P188; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Lammering G, 2004, CLIN CANCER RES, V10, P6732, DOI 10.1158/1078-0432.CCR-04-0393; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Monteiro LS, 2010, J ORAL PATHOL MED, V39, P571, DOI 10.1111/j.1600-0714.2009.00876.x; Montgomery RB, 2000, J BIOL CHEM, V275, P17358, DOI 10.1074/jbc.M000966200; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Olapade-Olaopa EO, 2000, BRIT J CANCER, V82, P186; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; Pao W, 2009, CLIN CANCER RES, V15, P5317, DOI 10.1158/1078-0432.CCR-09-0913; Sasaki H, 2007, ONCOL REP, V17, P319; Siu LL, 2007, J CLIN ONCOL, V25, P2178, DOI 10.1200/JCO.2006.07.6547; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Takes RP, 1998, ANTICANCER RES, V18, P4793; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Wikstrand CJ, 1997, CANCER RES, V57, P4130; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; YAMAZAKI H, 1990, JPN J CANCER RES, V81, P773, DOI 10.1111/j.1349-7006.1990.tb02644.x; Yang BB, 2009, AURIS NASUS LARYNX, V36, P682, DOI 10.1016/j.anl.2009.03.002; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966; Zhang ZF, 2010, ONCOTARGET, V1, P497	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31723	10.1371/journal.pone.0031723	http://dx.doi.org/10.1371/journal.pone.0031723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359620	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200089
J	Menkhorst, EM; Lane, N; Winship, AL; Li, P; Yap, J; Meehan, K; Rainczuk, A; Stephens, A; Dimitriadis, E				Menkhorst, Ellen Melaleuca; Lane, Natalie; Winship, Amy Louise; Li, Priscilla; Yap, Joanne; Meehan, Katie; Rainczuk, Adam; Stephens, Andrew; Dimitriadis, Evdokia			Decidual-Secreted Factors Alter Invasive Trophoblast Membrane and Secreted Proteins Implying a Role for Decidual Cell Regulation of Placentation	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-I; ENDOMETRIAL STROMAL CELLS; NATURAL-KILLER-CELLS; BREAST-CANCER CELLS; PROTEOMIC ANALYSIS; GROWTH-FACTOR; PROLACTIN PRODUCTION; CONDITIONED MEDIUM; SERINE PROTEASES; CATHEPSIN-C	Inadequate or inappropriate implantation and placentation during the establishment of human pregnancy is thought to lead to first trimester miscarriage, placental insufficiency and other obstetric complications. To create the placental blood supply, specialized cells, the 'extravillous trophoblast' (EVT) invade through the differentiated uterine endometrium (the decidua) to engraft and remodel uterine spiral arteries. We hypothesized that decidual factors would regulate EVT function by altering the production of EVT membrane and secreted factors. We used a proteomics approach to identify EVT membrane and secreted proteins regulated by decidual cell factors. Human endometrial stromal cells were decidualized in vitro by treatment with estradiol (10(-8) M), medroxyprogesterone acetate (10(-7) M) and cAMP (0.5 mM) for 14 days. Conditioned media (CM) was collected on day 2 (non-decidualized CM) and 14 (decidualized CM) of treatment. Isolated primary EVT cultured on Matrigel (TM) were treated with media control, non-decidualized or decidualized CM for 16 h. EVT CM was fractionated for proteins <30 kDa using size-exclusion affinity nanoparticles (SEAN) before trypsin digestion and HPLC-MS/MS. 43 proteins produced by EVT were identified; 14 not previously known to be expressed in the placenta and 12 which had previously been associated with diseases of pregnancy including preeclampsia. Profilin 1, lysosome associated membrane glycoprotein 1 (LAMP1), dipeptidyl peptidase 1 (DPP1/cathepsin C) and annexin A2 expression by interstitial EVT in vivo was validated by immunhistochemistry. Decidual CM regulation in vitro was validated by western blotting: decidualized CM upregulated profilin 1 in EVT CM and non-decidualized CM upregulated annexin A2 in EVT CM and pro-DPP1 in EVT cell lysate. Here, non-decidualized factors induced protease expression by EVT suggesting that non-decidualized factors may induce a pro-inflammatory cascade. Preeclampsia is a pro-inflammatory condition. Overall, we have demonstrated the potential of a proteomics approach to identify novel proteins expressed by EVT and to uncover the mechanisms leading to disease states.	[Menkhorst, Ellen Melaleuca; Lane, Natalie; Winship, Amy Louise; Li, Priscilla; Yap, Joanne; Meehan, Katie; Rainczuk, Adam; Stephens, Andrew; Dimitriadis, Evdokia] Prince Henrys Inst, Clayton, Vic, Australia	Prince Henry's Institute of Medical Research	Menkhorst, EM (corresponding author), Prince Henrys Inst, Clayton, Vic, Australia.	evdokia.dimitriadis@princehenrys.org	dimitriadis, e/AAD-7601-2021; Stephens, Andrew/G-5161-2013; Meehan, Katie/H-5431-2014; Menkhorst, Ellen/P-5759-2014; Menkhorst, Ellen/AAU-4329-2021	Meehan, Katie/0000-0002-9179-4592; Menkhorst, Ellen/0000-0003-2440-6665; Dimitriadis, Eva/0000-0001-8698-1927; Winship, Amy/0000-0001-7848-1447; dimitriadis, eva/0000-0003-1425-950X	National Health and Medical Research Council (NHMRC) (Australia) [GNT0388901, 611827, 550905]; Victorian Government	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	The work was supported by National Health and Medical Research Council (NHMRC) (Australia) Project Grant (GNT0388901) to ED, and by the Victorian Government's Operational Infrastructure Support Program. EMM was supported by a NHMRC (Australia) Postdoctoral Training Fellowship (#611827). ED was supported by a NHMRC (Australia) Career Development Fellowship (#550905). EMM received travel support from The CASS Foundation. PHI Data Audit 11-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Aplin JD, 2010, INT J DEV BIOL, V54, P323, DOI 10.1387/ijdb.082759ja; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Benson GV, 1996, DEVELOPMENT, V122, P2687; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cartwright JE, 2002, PLACENTA, V23, P232, DOI 10.1053/plac.2001.0760; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Centlow M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458748; Dimitriadis E, 2005, J CLIN ENDOCR METAB, V90, P3458, DOI 10.1210/jc.2004-1014; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Dimitriadis E, 2006, ENDOCRINOLOGY, V147, P3809, DOI 10.1210/en.2006-0264; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; GILABERT J, 1990, THROMB HAEMOSTASIS, V63, P361; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Grobman WA, 2001, OBSTET GYNECOL, V97, P521, DOI 10.1016/S0029-7844(00)01193-5; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Hoang VM, 2001, BIOCHEMISTRY-US, V40, P4077, DOI 10.1021/bi0023910; Hu R, 2007, PLACENTA, V28, P399, DOI 10.1016/j.placenta.2006.07.005; Hu Y, 2010, PLACENTA, V31, P213, DOI 10.1016/j.placenta.2009.12.011; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jarvenpaa J, 2007, GYNECOL ENDOCRINOL, V23, P351, DOI 10.1080/09513590701350291; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; KaczanBourgois D, 1996, PLACENTA, V17, P669, DOI 10.1016/S0143-4004(96)80017-8; Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Lash GE, 2011, HUM REPROD, V26, P2289, DOI 10.1093/humrep/der198; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Li ZY, 2008, INT J CANCER, V123, P2377, DOI 10.1002/ijc.23808; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; Meade JL, 2009, J IMMUNOL, V183, P803, DOI 10.4049/jimmunol.0713829; Mellembakken JR, 2002, HYPERTENSION, V39, P155, DOI 10.1161/hy0102.100778; Methot N, 2008, MOL PHARMACOL, V73, P1857, DOI 10.1124/mol.108.045682; Methot N, 2007, J BIOL CHEM, V282, P20836, DOI 10.1074/jbc.M702615200; MUNO D, 1993, ARCH BIOCHEM BIOPHYS, V306, P103, DOI 10.1006/abbi.1993.1486; Naruse K, 2009, PLACENTA, V30, P398, DOI 10.1016/j.placenta.2009.02.002; NG LC, 1994, PLACENTA, V15, P201, DOI 10.1016/S0143-4004(05)80456-4; Nilsson U, 2010, REPROD FERT DEVELOP, V22, P71; Paradela A, 2005, J PROTEOME RES, V4, P2435, DOI 10.1021/pr050308v; Paule S, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-50; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Podack ER, 1999, P NATL ACAD SCI USA, V96, P8312, DOI 10.1073/pnas.96.15.8312; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Rainczuk A, 2010, PROTEOMICS, V10, P332, DOI 10.1002/pmic.200900187; Rao NV, 1997, J BIOL CHEM, V272, P10260; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sharma M, 2010, EXP MOL PATHOL, V88, P278, DOI 10.1016/j.yexmp.2010.01.001; Shibata E, 2001, PLACENTA, V22, P566, DOI 10.1053/plac.2001.0693; Sifakis S, 2010, THROMB RES, V125, P326, DOI 10.1016/j.thromres.2009.11.033; Sun LZ, 2007, GYNECOL OBSTET INVES, V64, P17, DOI 10.1159/000098399; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Tjoa ML, 2004, HYPERTENS PREGNANCY, V23, P171, DOI 10.1081/PRG-120028292; Tranquilli AL, 2007, CYTOKINE, V40, P82, DOI 10.1016/j.cyto.2007.08.010; Tsai CY, 2008, J BIOL CHEM, V283, P26302, DOI 10.1074/jbc.C800117200; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Yan GR, 2011, OMICS, V15, P83, DOI 10.1089/omi.2010.0056; Yap J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-73; Yarmola EG, 2009, BIOESSAYS, V31, P1150, DOI 10.1002/bies.200900049; Yun SP, 2011, J CELL PHYSIOL, V226, P559, DOI 10.1002/jcp.22366; Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390; Zhu XM, 2009, PLACENTA, V30, P74, DOI 10.1016/j.placenta.2008.09.013; Zou L, 2010, J CELL PHYSIOL, V223, P623, DOI 10.1002/jcp.22058	81	36	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31418	10.1371/journal.pone.0031418	http://dx.doi.org/10.1371/journal.pone.0031418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359590	gold, Green Published			2022-12-27	WOS:000302796200059
J	Wulfmeyer, T; Polzer, C; Hiepler, G; Hamacher, K; Shoeman, R; Dunigan, DD; Van Etten, JL; Lolicato, M; Moroni, A; Thiel, G; Meckel, T				Wulfmeyer, Timo; Polzer, Christian; Hiepler, Gregor; Hamacher, Kay; Shoeman, Robert; Dunigan, David D.; Van Etten, James L.; Lolicato, Marco; Moroni, Anna; Thiel, Gerhard; Meckel, Tobias			Structural Organization of DNA in Chlorella Viruses	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BINDING PROTEINS; GRANULOSIS-VIRUS; BASIC-PROTEIN; HOST-CELLS; BACTERIOPHAGE; INFECTION; PBCV-1; ORIGIN; DEPOLARIZATION	Chlorella viruses have icosahedral capsids with an internal membrane enclosing their large dsDNA genomes and associated proteins. Their genomes are packaged in the particles with a predicted DNA density of ca. 0.2 bp nm(-3). Occasionally infection of an algal cell by an individual particle fails and the viral DNA is dynamically ejected from the capsid. This shows that the release of the DNA generates a force, which can aid in the transfer of the genome into the host in a successful infection. Imaging of ejected viral DNA indicates that it is intimately associated with proteins in a periodic fashion. The bulk of the protein particles detected by atomic force microscopy have a size of similar to 60 kDa and two proteins (A278L and A282L) of about this size are among 6 basic putative DNA binding proteins found in a proteomic analysis of DNA binding proteins packaged in the virion. A combination of fluorescence images of ejected DNA and a bioinformatics analysis of the DNA reveal periodic patterns in the viral DNA. The periodic distribution of GC rich regions in the genome provides potential binding sites for basic proteins. This DNA/protein aggregation could be responsible for the periodic concentration of fluorescently labeled DNA observed in ejected viral DNA. Collectively the data indicate that the large chlorella viruses have a DNA packaging strategy that differs from bacteriophages; it involves proteins and share similarities to that of chromatin structure in eukaryotes.	[Wulfmeyer, Timo; Hamacher, Kay] Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany; [Shoeman, Robert] Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany; [Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Lolicato, Marco; Moroni, Anna] Univ Milan, Dept Biol, Milan, Italy; [Lolicato, Marco; Moroni, Anna] Univ Milan, CNR IBF Mi, Milan, Italy	Technical University of Darmstadt; Max Planck Society; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	Wulfmeyer, T (corresponding author), Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	Lolicato, Marco/ABC-6878-2020; Meckel, Tobias/F-4372-2010; Dunigan, David/AAF-1386-2019; moroni, anna/H-2097-2014; Lolicato, Marco/AAL-3614-2020	Lolicato, Marco/0000-0002-2022-7961; Meckel, Tobias/0000-0003-0759-2072; moroni, anna/0000-0002-1860-406X; Lolicato, Marco/0000-0002-2022-7961; Hamacher, Kay/0000-0002-6921-8345; Thiel, Gerhard/0000-0002-2335-1351; Dunigan, David D/0000-0001-9496-5396	Deutsche Forschungsgemeinschaft [DFG-TH558/16]; National Science Foundation [NSF-EPSCoR EPS-1004094]; Department of Energy (DOE) [DE-FG36-08GO88055, DOE-DE-EE0003142]; National Institutes of Health/National Center for Research Resources (NIH/NCRR) [P20RR15635]; Fonds der Chemischen Industrie; Vigoni program; Center of Smart Interfaces at TU-Darmstadt; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Department of Energy (DOE)(United States Department of Energy (DOE)); National Institutes of Health/National Center for Research Resources (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Vigoni program; Center of Smart Interfaces at TU-Darmstadt; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by: 1) Deutsche Forschungsgemeinschaft (DFG-TH558/16), 2) Vigoni program, 3) National Science Foundation Experimental Program to Stimulate Competitive Research (NSF-EPSCoR EPS-1004094), 4) Department of Energy (DOE DE-FG36-08GO88055; DOE-DE-EE0003142), 5) National Institutes of Health/National Center for Research Resources (NIH/NCRR P20RR15635), and 6) Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Center of Smart Interfaces at TU-Darmstadt for providing measuring time and support for the AFM. We acknowledge the assistance of the Ron Cerny and the Nebraska Center for Mass Spectrometry for PBCV-1 proteomic analyses.	Agarkova I, 2008, J VIROL, V82, P12181, DOI 10.1128/JVI.01687-08; AMES BN, 1960, J BIOL CHEM, V235, P769; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bremm S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-330; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Cavalcanti MCO, 2009, ANIM REPROD SCI, V111, P220, DOI 10.1016/j.anireprosci.2008.03.018; Cherrier MV, 2009, P NATL ACAD SCI USA, V106, P11085, DOI 10.1073/pnas.0904716106; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Frohns F, 2006, J VIROL, V80, P2437, DOI 10.1128/JVI.80.5.2437-2444.2006; FUNK CJ, 1993, VIROLOGY, V193, P396, DOI 10.1006/viro.1993.1136; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Greiner T, 2009, J GEN VIROL, V90, P2033, DOI 10.1099/vir.0.010629-0; HAAS R, 1982, J MOL BIOL, V159, P71, DOI 10.1016/0022-2836(82)90032-8; Hamacher K, 2008, GENE, V422, P30, DOI 10.1016/j.gene.2008.06.007; Hoshina R, 2010, PHYCOL RES, V58, P188, DOI 10.1111/j.1440-1835.2010.00579.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Koonin EV, 2010, INTERVIROLOGY, V53, P284, DOI 10.1159/000312913; Kumetsov Y, 2008, J VIROL, V82, P7551, DOI 10.1128/JVI.00016-08; Kuznetsov YG, 2005, J STRUCT BIOL, V149, P256, DOI 10.1016/j.jsb.2004.10.007; Kuznetsov YG, 2010, VIROLOGY, V404, P127, DOI 10.1016/j.virol.2010.05.007; Li ZD, 2008, BIOPHYS J, V94, P737, DOI 10.1529/biophysj.107.112508; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; MEINTS RH, 1988, VIROLOGY, V164, P15, DOI 10.1016/0042-6822(88)90614-9; MEINTS RH, 1984, VIROLOGY, V138, P341, DOI 10.1016/0042-6822(84)90358-1; Neupartl M, 2008, VIROLOGY, V372, P340, DOI 10.1016/j.virol.2007.10.024; ORE A, 1956, SCIENCE, V124, P430, DOI 10.1126/science.124.3219.430; PFISTER H, 1978, MED MICROBIOL IMMUN, V166, P13, DOI 10.1007/BF02121129; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SERWER P, 1986, J MOL BIOL, V190, P509, DOI 10.1016/0022-2836(86)90019-7; TAN KB, 1977, P NATL ACAD SCI USA, V74, P2805, DOI 10.1073/pnas.74.7.2805; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; TWEETEN KA, 1980, J VIROL, V33, P866, DOI 10.1128/JVI.33.2.866-876.1980; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; Villarreal LP, 2000, J VIROL, V74, P7079, DOI 10.1128/JVI.74.15.7079-7084.2000; Wang ML, 2010, J VIROL, V84, P8821, DOI 10.1128/JVI.00072-10; Yamada T, 1996, VIROLOGY, V219, P395, DOI 10.1006/viro.1996.0265; Yan XD, 2000, NAT STRUCT BIOL, V7, P101, DOI 10.1038/72360; Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108	45	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30133	10.1371/journal.pone.0030133	http://dx.doi.org/10.1371/journal.pone.0030133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359540	gold, Green Published			2022-12-27	WOS:000302796200009
J	Xia, JY; Wan, SQ				Xia, Jianyang; Wan, Shiqiang			The Effects of Warming-Shifted Plant Phenology on Ecosystem Carbon Exchange Are Regulated by Precipitation in a Semi-Arid Grassland	PLOS ONE			English	Article							CLIMATE-CHANGE; REPRODUCTIVE PHENOLOGY; FLOWERING PHENOLOGY; SOIL RESPIRATION; TEMPERATURE; RESPONSES; GROWTH; COMMUNITY; DIOXIDE; INCREASES	Background: The longer growing season under climate warming has served as a crucial mechanism for the enhancement of terrestrial carbon (C) sink over the past decades. A better understanding of this mechanism is critical for projection of changes in C cycling of terrestrial ecosystems. Methodology/Principal Findings: A 4-year field experiment with day and night warming was conducted to examine the responses of plant phenology and their influences on plant coverage and ecosystem C cycling in a temperate steppe in northern China. Greater phenological responses were observed under night than day warming. Both day and night warming prolonged the growing season by advancing phenology of early-blooming species but without changing that of late-blooming species. However, no warming response of vegetation coverage was found for any of the eight species. The variances in species-level coverage and ecosystem C fluxes under different treatments were positively dependent upon the accumulated precipitation within phenological duration but not the length of phenological duration. Conclusions/Significance: These plants' phenology is more sensitive to night than day warming, and the warming effects on ecosystem C exchange via shifting plant phenology could be mediated by precipitation patterns in semi-arid grasslands.	[Xia, Jianyang; Wan, Shiqiang] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Wan, Shiqiang] Henan Univ, Key Lab Plant Stress Biol, Coll Life Sci, Kaifeng, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Henan University	Xia, JY (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	swan@ibcas.ac.cn	Wan, Shiqiang/B-5799-2009; Xia, Jianyang/S-9499-2019; Wan, Shiqiang/L-9166-2019; Xia, Jianyang/A-7886-2008	Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; 	National Natural Science Foundation of China [30925009, 90511006]; Ministry of Science and Technology [2007CB106803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was financially supported by the National Natural Science Foundation of China (30925009, 90511006) and the Ministry of Science and Technology (2007CB106803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2000, INT J BIOMETEOROL, V44, P159, DOI 10.1007/s004840000069; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Baptist F, 2010, PLANT BIOLOGY, V12, P755, DOI 10.1111/j.1438-8677.2009.00286.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Dhakhwa GB, 1998, CLIMATIC CHANGE, V40, P647, DOI 10.1023/A:1005339800665; [董文军 Dong Wenjun], 2011, [生态学报, Acta Ecologica Sinica], V31, P2169; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Forrest J, 2010, ECOLOGY, V91, P431, DOI 10.1890/09-0099.1; Gimenez-Benavides L, 2007, NEW PHYTOL, V173, P367, DOI 10.1111/j.1469-8137.2006.01932.x; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Gu Shiliang, 1998, 生物数学学报, V13, P426; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Hooper DU, 1998, ECOLOGY, V79, P704, DOI 10.1890/0012-9658(1998)079[0704:TROCAC]2.0.CO;2; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; LECHOWICZ MJ, 1984, AM NAT, V124, P821, DOI 10.1086/284319; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2003, CLIMATIC CHANGE, V57, P243, DOI 10.1023/A:1022880418362; Menzel A, 2000, INT J BIOMETEOROL, V44, P76, DOI 10.1007/s004840000054; Menzel A, PHENOLOGY INTEGRATIV, P319; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Niemand C, 2005, METEOROL Z, V14, P197, DOI 10.1127/0941-2948/2005/0022; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; Prieto P, 2008, ANN BOT-LONDON, V102, P275, DOI 10.1093/aob/mcn090; Prieto P, 2009, GLOBAL ECOL BIOGEOGR, V18, P473, DOI 10.1111/j.1466-8238.2009.00460.x; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 1996, AGR FOREST METEOROL, V80, P215, DOI 10.1016/0168-1923(95)02299-6; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Slaney M, 2007, TREE PHYSIOL, V27, P301, DOI 10.1093/treephys/27.2.301; Solomon S., 2007, PHYS SCI BASIS WORKI; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; Xia J, 2009, BIOGEOSCIENCES, V6, P1361, DOI 10.5194/bg-6-1361-2009; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Ziska LH, 1996, AUST J PLANT PHYSIOL, V23, P791, DOI 10.1071/PP9960791	56	40	46	10	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32088	10.1371/journal.pone.0032088	http://dx.doi.org/10.1371/journal.pone.0032088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359660	gold, Green Published			2022-12-27	WOS:000302796200129
J	Bachmaier, K; Guzman, E; Kawamura, T; Gao, XP; Malik, AB				Bachmaier, Kurt; Guzman, Edgar; Kawamura, Takeshi; Gao, Xiaopei; Malik, Asrar B.			Sphingosine Kinase 1 Mediation of Expression of the Anaphylatoxin Receptor C5L2 Dampens the Inflammatory Response to Endotoxin	PLOS ONE			English	Article							LYMPHOCYTE EGRESS; HUMAN NEUTROPHILS; KEY ROLE; C5A; 1-PHOSPHATE; COMPLEMENT; SPHINGOSINE-1-PHOSPHATE; S1P; PROTEIN; PERMEABILITY	The complement anaphylatoxin C5a has a pathogenetic role in endotoxin-induced lung inflammatory injury by regulating phagocytic cell migration and activation. Endotoxin and C5a activate the enzyme sphingosine kinase (Sphk) 1 to generate the signaling lipid sphingosine-1-phosphate (S1P), a critical regulator of phagocyte function. We assessed the function of Sphk1 and S1P in experimental lung inflammatory injury and determined their roles in anaphylatoxin receptor signaling and on the expression of the two C5a receptors, C5aR (CD88) and C5L2, on phagocytes. We report that Sphk1 gene deficient (Sphk1(-/-)) mice had augmented lung inflammatory response to endotoxin compared to wild type mice. Sphk1 was required for C5a-mediated reduction in cytokine and chemokine production by macrophages. Moreover, neutrophils from Sphk1(-/-) mice failed to upregulate the anaphylatoxin receptor C5L2 in response to LPS. Exogenous S1P restored C5L2 cell surface expression of Sphk1(-/-) mouse neutrophils to wild type levels but had no effect on cell surface expression of the other anaphylatoxin receptor, CD88. These results provide the first genetic evidence of the crucial role of Sphk1 in regulating the balance between expression of CD88 and C5L2 in phagocytes. S1P-mediated up-regulation of C5L2 is a novel therapeutic target for mitigating endotoxin-induced lung inflammatory injury.	[Bachmaier, Kurt; Guzman, Edgar; Kawamura, Takeshi; Gao, Xiaopei; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bachmaier, K (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60607 USA.	kbachmai@uic.edu	Bachmaier, Kurt/AHC-5491-2022; Bachmaier, Kurt/B-6331-2014	Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Malik, Asrar/0000-0002-8205-7128	United States National Institutes of Health [HL060678, HL077806, HL45638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL045638, P01HL077806] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States National Institutes of Health grants HL060678, HL077806, and HL45638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Camerer E, 2006, BLOOD, V107, P3912, DOI 10.1182/blood-2005-08-3130; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Di AK, 2010, J BIOL CHEM, V285, P15848, DOI 10.1074/jbc.M109.075549; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; Flierl MA, 2008, FASEB J, V22, P3483, DOI 10.1096/fj.08-110595; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Huber-Lang M, 2005, J IMMUNOL, V174, P1104, DOI 10.4049/jimmunol.174.2.1104; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Jacobson JR, 2007, CURR DRUG TARGETS, V8, P509, DOI 10.2174/138945007780362719; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu HB, 2008, PANCREAS, V36, pE10, DOI 10.1097/MPA.0b013e31815f3905; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Pushparaj PN, 2008, INT J BIOCHEM CELL B, V40, P1817, DOI 10.1016/j.biocel.2008.01.015; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Wang LY, 2010, CLIN IMMUNOL, V137, P157, DOI 10.1016/j.clim.2010.05.012; Ward PA, 2004, MOL IMMUNOL, V41, P323; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	47	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30742	10.1371/journal.pone.0030742	http://dx.doi.org/10.1371/journal.pone.0030742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355325	Green Published, gold			2022-12-27	WOS:000302741300025
J	Eerland, A; Guadalupe, TM; Franken, IHA; Zwaan, RA				Eerland, Anita; Guadalupe, Tulio M.; Franken, Ingmar H. A.; Zwaan, Rolf A.			Posture as Index for Approach-Avoidance Behavior	PLOS ONE			English	Article							AUTOMATIC EVALUATION; MOTIVATION	Approach and avoidance are two behavioral responses that make people tend to approach positive and avoid negative situations. This study examines whether postural behavior is influenced by the affective state of pictures. While standing on the Wii (TM) Balance Board, participants viewed pleasant, neutral, and unpleasant pictures (passively viewing phase). Then they had to move their body to the left or the right (lateral movement phase) to make the next picture appear. We recorded movements in the anterior-posterior direction to examine approach and avoidant behavior. During passively viewing, people approached pleasant pictures. They avoided unpleasant ones while they made a lateral movement. These findings provide support for the idea that we tend to approach positive and avoid negative situations.	[Eerland, Anita; Franken, Ingmar H. A.; Zwaan, Rolf A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands; [Guadalupe, Tulio M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Erasmus University Rotterdam; Max Planck Society	Eerland, A (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	eerland@fsw.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694; Zwaan, Rolf/0000-0001-9967-7879				Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bargh JA, 1996, J EXP SOC PSYCHOL, V32, P104, DOI 10.1006/jesp.1996.0005; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; Lang P.J., 2008, A8 U FLOR; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Rutherford HJV, 2011, EMOT REV, V3, P333, DOI 10.1177/1754073911402392; SOLARZ AK, 1960, J EXP PSYCHOL, V59, P239, DOI 10.1037/h0047274; Stins JF, 2011, EXP BRAIN RES, V212, P603, DOI 10.1007/s00221-011-2767-z; van Dantzig S, 2008, Q J EXP PSYCHOL, V61, P1298, DOI 10.1080/17470210802027987	13	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31291	10.1371/journal.pone.0031291	http://dx.doi.org/10.1371/journal.pone.0031291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355355	Green Published, gold			2022-12-27	WOS:000302741300055
J	George, SZ; Childs, JD; Teyhen, DS; Wu, SS; Wright, AC; Dugan, JL; Robinson, ME				George, Steven Z.; Childs, John D.; Teyhen, Deydre S.; Wu, Samuel S.; Wright, Alison C.; Dugan, Jessica L.; Robinson, Michael E.			Predictors of Occurrence and Severity of First Time Low Back Pain Episodes: Findings from a Military Inception Cohort	PLOS ONE			English	Article							BECK DEPRESSION INVENTORY; CORE STABILIZATION EXERCISES; RANDOMIZED CLINICAL-TRIAL; RISK-FACTORS; FOLLOW-UP; PSYCHOSOCIAL EDUCATION; SUBGROUPING PATIENTS; SCIENTIFIC EVIDENCE; PRIMARY PREVENTION; DISABILITY BEGINS	Primary prevention studies suggest that additional research on identifying risk factors predictive of low back pain (LBP) is necessary before additional interventions can be developed. In the current study we assembled a large military cohort that was initially free of LBP and followed over 2 years. The purposes of this study were to identify baseline variables from demographic, socioeconomic, general health, and psychological domains that were predictive of a) occurrence; b) time; and c) severity for first episode of self-reported LBP. Baseline and outcome measures were collected via web-based surveillance system or phone to capture monthly information over 2 years. The assembled cohort consisted of 1230 Soldiers who provided self-report data with 518 (42.1%) reporting at least one episode of LBP over 2 years. Multivariate logistic regression analysis indicated that gender, active duty status, mental and physical health scores were significant predictors of LBP. Cox regression revealed that the time to first episode of LBP was significantly shorter for Soldiers that were female, active duty, reported previous injury, and had increased BMI. Multivariate linear regression analysis investigated severity of the first episode by identifying baseline predictors of pain intensity, disability, and psychological distress. Education level and physical fitness were consistent predictors of pain intensity, while gender, smoking status, and previous injury status were predictors of disability. Gender, smoking status, physical health scores, and beliefs of back pain were consistent predictors of psychological distress. These results provide additional data to confirm the multi-factorial nature of LBP and suggest future preventative interventions focus on multi-modal approaches that target modifiable risk factors specific to the population of interest.	[George, Steven Z.] Univ Florida, Dept Phys Therapy, Gainesville, FL 32610 USA; [George, Steven Z.; Robinson, Michael E.] Univ Florida, Ctr Pain Res & Behav Hlth, Gainesville, FL USA; [Childs, John D.; Teyhen, Deydre S.; Wright, Alison C.; Dugan, Jessica L.] Baylor Univ, USA, Doctoral Program Phys Therapy MCCS HGE PT, Army Med Dept Ctr, Ft Sam Houston, TX USA; [Wu, Samuel S.] Univ Florida, Dept Biostat, Gainesville, FL USA; [Robinson, Michael E.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Baylor University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	George, SZ (corresponding author), Univ Florida, Dept Phys Therapy, Gainesville, FL 32610 USA.	szgeorge@phhp.ufl.edu	Robinson, Michael E/B-9765-2014	George, Steven/0000-0003-4988-9421	Department of Defense [PR054098]; University of Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of Florida(University of Florida); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The POLM trial was supported by the Peer-Review Medical Research Program of the Department of Defense (PR054098). All authors were independent from this funding program. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaret MC, 2004, EUR J PAIN, V8, P273, DOI 10.1016/j.ejpain.2003.09.005; Bigos SJ, 2009, SPINE J, V9, P147, DOI 10.1016/j.spinee.2008.11.001; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Burton AK, 2005, BEST PRACT RES CL RH, V19, P541, DOI 10.1016/j.berh.2005.03.001; Carey TS, 1999, MED CARE, V37, P157, DOI 10.1097/00005650-199902000-00006; Carragee EJ, 2009, SPINE, V34, P978, DOI 10.1097/BRS.0b013e318198d517; CHIBNALL JT, 1994, CLIN J PAIN, V10, P261, DOI 10.1097/00002508-199412000-00004; Childs JD, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-132; Childs JD, 2010, PHYS THER, V90, P1404, DOI 10.2522/ptj.20090389; Childs JD, 2009, MED SCI SPORT EXER, V41, P2072, DOI 10.1249/MSS.0b013e3181a84db2; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Cohen SP, 2009, ARCH INTERN MED, V169, P1916, DOI 10.1001/archinternmed.2009.380; Cote P, 2001, MED CARE, V39, P956, DOI 10.1097/00005650-200109000-00006; Coudeyre E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000706; Croft PR, 1999, SPINE, V24, P1556, DOI 10.1097/00007632-199908010-00009; Elders LAM, 2004, SPINE, V29, pE101, DOI 10.1097/01.BRS.0000115125.60331.72; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Foster NE, 2011, MANUAL THER, V16, P3, DOI 10.1016/j.math.2010.05.013; Frank JW, 1996, SPINE, V21, P2918, DOI 10.1097/00007632-199612150-00025; Frank JW, 1996, SPINE, V21, P2908, DOI 10.1097/00007632-199612150-00024; Fritz JM, 2007, J ORTHOP SPORT PHYS, V37, P290, DOI 10.2519/jospt.2007.2498; George SZ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-128; George SZ, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-92; George SZ, 2009, EUR SPINE J, V18, P1050, DOI 10.1007/s00586-009-1016-7; George SZ, 2003, SPINE, V28, P2551, DOI 10.1097/01.BRS.0000096677.84605.A2; Guzman J, 2007, SPINE, V32, P807, DOI 10.1097/01.brs.0000259080.51541.17; IJzelenberg W, 2004, SPINE, V29, P1362, DOI 10.1097/01.BRS.0000127188.58944.1E; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Lincoln Andrew E, 2002, Work, V18, P99; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Mantyselka P, 2001, PAIN, V89, P175, DOI 10.1016/S0304-3959(00)00361-4; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Mortimer M, 2003, SCAND J PUBLIC HEALT, V31, P194, DOI 10.1080/14034940210134086; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; Osman A, 2002, J BEHAV MED, V25, P155, DOI 10.1023/A:1014884704974; Papageorgiou AC, 1997, SPINE, V22, P1137, DOI 10.1097/00007632-199705150-00014; Park H, 2001, AM J IND MED, V40, P646, DOI 10.1002/ajim.10025; Power C, 2001, AM J PUBLIC HEALTH, V91, P1671, DOI 10.2105/AJPH.91.10.1671; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Schotte CKW, 1997, J AFFECT DISORDERS, V46, P115, DOI 10.1016/S0165-0327(97)00094-3; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stevenson JM, 2001, SPINE, V26, P1370, DOI 10.1097/00007632-200106150-00022; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Symonds TL, 1996, OCCUP MED-OXFORD, V46, P25, DOI 10.1093/occmed/46.1.25; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whisman MA, 2000, J CLIN PSYCHOL, V56, P545, DOI 10.1002/(SICI)1097-4679(200004)56:4<545::AID-JCLP7>3.0.CO;2-U; Yip VYB, 2004, J ADV NURS, V46, P430, DOI 10.1111/j.1365-2648.2004.03009.x	51	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30597	10.1371/journal.pone.0030597	http://dx.doi.org/10.1371/journal.pone.0030597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355317	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300017
J	Ho, KM; Litton, E; Geelhoed, E; Gope, M; Burrell, M; Coribel, J; McDowall, A; Rao, S				Ho, Kwok M.; Litton, Edward; Geelhoed, Elizabeth; Gope, Monica; Burrell, Maxine; Coribel, Jacqueline; McDowall, Angela; Rao, Sudhakar			Effect of an Injury Awareness Education Program on Risk-Taking Behaviors and Injuries in Juvenile Justice Offenders: A Retrospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ALCOHOL; TRAUMA; STATES	Background: Risk-taking behavior is a leading cause of injury and death amongst young people. Methodology and Principal Findings: This was a retrospective cohort study on the effectiveness of a 1-day youth injury awareness education program (Prevent Alcohol and Risk-related Trauma in Youth, P.A.R.T.Y.) program in reducing risk taking behaviors and injuries of juvenille justice offenders in Western Australia. Of the 3659 juvenile justice offenders convicted by the court magistrates between 2006 and 2010, 225 were referred to the P.A.R.T.Y. education program. In a before and after survey of these 225 participants, a significant proportion of them stated that they were more receptive to modifying their risk-taking behavior (21% before vs. 57% after). Using data from the Western Australia Police and Department of Health, the incidence of subsequent offences and injuries of all juvenile justice offenders was assessed. The incidence of subsequent traffic or violence-related offences was significantly lower for those who had attended the program compared to those who did not (3.6% vs. 26.8%; absolute risk reduction [ARR] = 23.2%, 95% confidence interval [CI] 19.9%-25.8%; number needed to benefit = 4.3, 95% CI 3.9-5.1; p = 0.001), as were injuries leading to hospitalization (0% vs. 1.6% including 0.2% fatality; ARR = 1.6%, 95% CI 1.2%-2.1%) and alcohol or drug-related offences (0% vs. 2.4%; ARR 2.4%, 95% CI 1.9%-2.9%). In the multivariate analysis, only P.A.R.T.Y. education program attendance (odds ratio [OR] 0.10, 95% CI 0.05-0.21) and a higher socioeconomic background (OR 0.97 per decile increment in Index of Relative Socioeconomic Advantage and Disadvantage, 95% CI 0.93-0.99) were associated with a lower risk of subsequent traffic or violence-related offences. Significance: Participation in an injury education program involving real-life trauma scenarios was associated with a reduced subsequent risk of committing violence-or traffic-related offences, injuries, and death for juvenille justice offenders.	[Ho, Kwok M.; Litton, Edward; Coribel, Jacqueline] Royal Perth Hosp, Dept Intens Care, Perth, WA, Australia; [Ho, Kwok M.; Geelhoed, Elizabeth] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Litton, Edward] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Gope, Monica; Burrell, Maxine] Royal Perth Hosp, Dept Emergency Med, Perth, WA, Australia; [McDowall, Angela; Rao, Sudhakar] Royal Perth Hosp, State Trauma Unit, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital	Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care, Perth, WA, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010; litton, edward/C-5384-2017	Ho, Kwok M./0000-0002-6705-6004; litton, edward/0000-0002-5125-6829; Geelhoed, Elizabeth/0000-0001-6718-9264	State Health Research Advisory Council (SHRAC) of Western Australia [11698]	State Health Research Advisory Council (SHRAC) of Western Australia	We would like to thank the State Health Research Advisory Council (SHRAC) of Western Australia for funding this study (grant number 11698) and Western Australia Police in providing the data for this study. No funding was received from NIH, Wellcome Trust or NHMRC for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 20390 AUSTR BUR STAT; [Anonymous], 2004, 3311 5 55 001 DEMOGR; [Anonymous], MORT SURV SER; Banfield J, OUTCOMES INJURY AWAR; Banfield JM, 2011, J TRAUMA, V70, P732, DOI 10.1097/TA.0b013e31820783a3; Ch'ng CW, 2007, EMERG MED AUSTRALAS, V19, P359, DOI 10.1111/j.1742-6723.2007.00958.x; Chapman A, MEASURING ROAD CRASH; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; Eldridge D, 2008, AIHW B; Ho KM, 2011, BRIT J ANAESTH, V106, P528, DOI 10.1093/bja/aeq417; Ho KM, 2008, MED J AUSTRALIA, V189, P26, DOI 10.5694/j.1326-5377.2008.tb01890.x; Ho KM, 2011, CHEST, V140, P1436, DOI 10.1378/chest.11-1444; Ho KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003226; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howat Peter, 2004, Traffic Inj Prev, V5, P208; Petrie DJ, 2010, ADDICT BEHAV, V35, P359, DOI 10.1016/j.addbeh.2009.10.022; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39	18	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31776	10.1371/journal.pone.0031776	http://dx.doi.org/10.1371/journal.pone.0031776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355394	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300094
J	Smith, BJ; Cote, PD				Smith, Benjamin J.; Cote, Patrice D.			Reduced Retinal Function in the Absence of Na(v)1.6	PLOS ONE			English	Article							CONE BIPOLAR CELLS; SODIUM-CHANNELS; A-WAVE; MAMMALIAN RETINA; ELECTRORETINOGRAM; PHOTORECEPTORS; RESPONSES; NEURONS; MACAQUE; MOUSE	Background: Mice with a function-blocking mutation in the Scn8a gene that encodes Na(v)1.6, a voltage-gated sodium channel (VGSC) isoform normally found in several types of retinal neurons, have previously been found to display a profoundly abnormal dark adapted flash electroretinogram. However the retinal function of these mice in light adapted conditions has not been studied. Methodology/Principal Findings: In the present report we reveal that during light adaptation these animals are shown to have electroretinograms with significant decreases in the amplitude of the a-and b-waves. The percent decrease in the a-and b-waves substantially exceeds the acute effect of VGSC block by tetrodotoxin in control littermates. Intravitreal injection of CoCl2 or CNQX to isolate the a-wave contributions of the photoreceptors in littermates revealed that at high background luminance the cone-isolated component of the a-wave is of the same amplitude as the a-wave of mutants. Conclusions/Significance: Our results indicate that Scn8a mutant mice have reduced function in both rod and the cone retinal pathways. The extent of the reduction in the cone pathway, as quantified using the ERG b-wave, exceeds the reduction seen in control littermates after application of TTX, suggesting that a defect in cone photoreceptors contributes to the reduction. Unless the postreceptoral component of the a-wave is increased in Scn8a mutant mice, the reduction in the b-wave is larger than can be accounted for by reduced photoreceptor function alone. Our data suggests that the reduction in the light adapted ERG of Scn8a mutant mice is caused by a combination of reduced cone photoreceptor function and reduced depolarization of cone ON bipolar cells. This raises the possibility that Na(v)1.6 augments signaling in cone bipolar cells.	[Smith, Benjamin J.; Cote, Patrice D.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Cote, Patrice D.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Smith, BJ (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	patrice@dal.ca		Cote, Patrice/0000-0002-4189-7526	Natural Sciences and Engineering Research Council of Canada [326943-06]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (grant number, 326943-06; www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P635; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Cote PD, 2005, J NEUROSCI, V25, P5046, DOI 10.1523/JNEUROSCI.4692-04.2005; Cui JJ, 2008, VISUAL NEUROSCI, V25, P635, DOI 10.1017/S0952523808080851; Dang TM, 2011, DOC OPHTHALMOL, V122, P149, DOI 10.1007/s10633-011-9269-y; De Repentigny Y, 2001, HUM MOL GENET, V10, P1819, DOI 10.1093/hmg/10.17.1819; Holzhausen LC, 2009, J COMP NEUROL, V517, P633, DOI 10.1002/cne.22176; Ichinose T, 2005, J NEUROSCI, V25, P1856, DOI 10.1523/jneurosci.5208-04.2005; Ichinose T, 2007, J NEUROSCI, V27, P4756, DOI 10.1523/JNEUROSCI.0183-07.2007; Kurimoto Y, 2009, EXP EYE RES, V88, P92, DOI 10.1016/j.exer.2008.10.012; Miura G, 2009, EXP EYE RES, V89, P49, DOI 10.1016/j.exer.2009.02.009; Mojumder DK, 2007, MOL VIS, V13, P2163; Mojumder DK, 2008, J PHYSIOL-LONDON, V586, P2551, DOI 10.1113/jphysiol.2008.150755; Ohkuma M, 2007, PHOTOCHEM PHOTOBIOL, V83, P317, DOI 10.1562/2006-06-15-RA-923; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; Popova E, 2010, VISION RES, V50, P88, DOI 10.1016/j.visres.2009.10.015; Robson JG, 2003, J PHYSIOL-LONDON, V547, P509, DOI 10.1113/jphysiol.2002.030304; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Shirato S, 2008, EXP EYE RES, V86, P914, DOI 10.1016/j.exer.2008.03.008; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31476	10.1371/journal.pone.0031476	http://dx.doi.org/10.1371/journal.pone.0031476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355369	Green Published, gold			2022-12-27	WOS:000302741300069
J	Soares, SC; Abreu, VAC; Ramos, RTJ; Cerdeira, L; Silva, A; Baumbach, J; Trost, E; Tauch, A; Hirata, R; Mattos-Guaraldi, AL; Miyoshi, A; Azevedo, V				Soares, Siomar C.; Abreu, Vinicius A. C.; Ramos, Rommel T. J.; Cerdeira, Louise; Silva, Artur; Baumbach, Jan; Trost, Eva; Tauch, Andreas; Hirata, Raphael, Jr.; Mattos-Guaraldi, Ana L.; Miyoshi, Anderson; Azevedo, Vasco			PIPS: Pathogenicity Island Prediction Software	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; COMPLETE GENOME SEQUENCE; PROKARYOTIC GENOMES; CORYNEBACTERIUM-GLUTAMICUM; IDENTIFICATION; DNA; VIRULENCE; DATABASE; GENES; TOOL	The adaptability of pathogenic bacteria to hosts is influenced by the genomic plasticity of the bacteria, which can be increased by such mechanisms as horizontal gene transfer. Pathogenicity islands play a major role in this type of gene transfer because they are large, horizontally acquired regions that harbor clusters of virulence genes that mediate the adhesion, colonization, invasion, immune system evasion, and toxigenic properties of the acceptor organism. Currently, pathogenicity islands are mainly identified in silico based on various characteristic features: (1) deviations in codon usage, G+C content or dinucleotide frequency and (2) insertion sequences and/or tRNA genetic flanking regions together with transposase coding genes. Several computational techniques for identifying pathogenicity islands exist. However, most of these techniques are only directed at the detection of horizontally transferred genes and/or the absence of certain genomic regions of the pathogenic bacterium in closely related non-pathogenic species. Here, we present a novel software suite designed for the prediction of pathogenicity islands (pathogenicity island prediction software, or PIPS). In contrast to other existing tools, our approach is capable of utilizing multiple features for pathogenicity island detection in an integrative manner. We show that PIPS provides better accuracy than other available software packages. As an example, we used PIPS to study the veterinary pathogen Corynebacterium pseudotuberculosis, in which we identified seven putative pathogenicity islands.	[Soares, Siomar C.; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Abreu, Vinicius A. C.; Azevedo, Vasco] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Ramos, Rommel T. J.; Cerdeira, Louise; Silva, Artur] Fed Univ Para, Dept Genet, BR-66059 Belem, Para, Brazil; [Baumbach, Jan] Max Planck Inst Informat, Dept Comp Sci, Saarbrucken, Saarland, Germany; [Trost, Eva; Tauch, Andreas] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Nordrhein Westf, Germany; [Hirata, Raphael, Jr.; Mattos-Guaraldi, Ana L.] Univ Estado Rio De Janeiro, Fac Med Sci, Microbiol & Immunol Discipline, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal do Para; Max Planck Society; University of Bielefeld; Universidade do Estado do Rio de Janeiro	Soares, SC (corresponding author), Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil.	vasco@icb.ufmg.br	Luiz Silva, Artur da Costa da/AAI-3516-2021; Azevedo, Vasco A.C/F-4315-2011; Abreu, Vinicius AC/G-3694-2014; Ramos, Rommel Thiago Juca/L-9329-2013; Silva, Artur/E-1474-2014; Cerdeira, Louise/C-3749-2013; de Castro Soares, Siomar/I-2705-2012; Hirata, Raphael Jr./F-9256-2012; de Mattos Guaraldi, Ana Luíza/AAL-5335-2021; Azevedo, Vasco/B-1556-2019; Cerdeira, Louise Teixeira/AAR-4668-2020; Hirata Junior, Raphael/O-9845-2015	Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Azevedo, Vasco A.C/0000-0002-4775-2280; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Silva, Artur/0000-0002-4082-1132; Cerdeira, Louise/0000-0002-4495-2615; de Castro Soares, Siomar/0000-0001-7299-3724; de Mattos Guaraldi, Ana Luíza/0000-0003-2522-0416; Azevedo, Vasco/0000-0002-4775-2280; Trost, Eva/0000-0002-1924-1416; Hirata Junior, Raphael/0000-0003-3091-6020; Baumbach, Jan/0000-0002-0282-0462	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MAPA) [578219/2008-5]; Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG) [APQ-01004-08]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MAPA)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from the Brazilian Funding Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant CNPq/MAPA; http://cnpq.br/) [grant number 578219/2008-5] and Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG; http://www.fapemig.br/) [grant number APQ-01004-08]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLUM G, 1994, INFECT IMMUN, V62, P606, DOI 10.1128/IAI.62.2.606-614.1994; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao JX, 2010, RES MICROBIOL, V161, P1, DOI 10.1016/j.resmic.2009.10.007; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hadfield TL, 2000, J INFECT DIS, V181, pS116, DOI 10.1086/315551; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hochhut Bianca, 2005, V12, P234, DOI 10.1159/000081698; Hou YM, 1999, TRENDS BIOCHEM SCI, V24, P295, DOI 10.1016/S0968-0004(99)01428-0; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Jain R, 2008, ICIT 2008: PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY, P131, DOI 10.1109/ICIT.2008.42; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lio P, 2000, BIOINFORMATICS, V16, P932, DOI 10.1093/bioinformatics/16.10.932; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mantri Y, 2004, NUCLEIC ACIDS RES, V32, pD55, DOI 10.1093/nar/gkh059; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; Merkl R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-22; Oren A, 2004, PHILOS T R SOC B, V359, P623, DOI 10.1098/rstb.2003.1458; Ou HY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj005; Pundhir Sachin, 2008, In Silico Biology, V8, P223; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Schumann W, 2007, J BIOSCIENCES, V32, P549, DOI 10.1007/s12038-007-0054-8; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; van Passel MWJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh115; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Zhang CT, 2004, NAT BIOTECHNOL, V22, P1078, DOI 10.1038/nbt0904-1078b; Zhang CT, 2001, J BIOMOL STRUCT DYN, V19, P333, DOI 10.1080/07391102.2001.10506743; Zhang R, 2004, BIOINFORMATICS, V20, P612, DOI 10.1093/bioinformatics/btg453; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; ZWEIG MH, 1993, CLIN CHEM, V39, P561	50	50	51	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30848	10.1371/journal.pone.0030848	http://dx.doi.org/10.1371/journal.pone.0030848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355329	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300029
J	Zito, CR; Jilaveanu, LB; Anagnostou, V; Rimm, D; Bepler, G; Maira, SM; Hackl, W; Camp, R; Kluger, HM; Chao, HH				Zito, Christopher R.; Jilaveanu, Lucia B.; Anagnostou, Valsamo; Rimm, David; Bepler, Gerold; Maira, Sauveur-Michel; Hackl, Wolfgang; Camp, Robert; Kluger, Harriet M.; Chao, Herta H.			Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; DUAL PI3K/MTOR INHIBITOR; P85 REGULATORY SUBUNIT; GROWTH-FACTOR RECEPTOR; AKT/PROTEIN-KINASE-B; ONCOGENIC K-RAS; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN TARGET; NEGATIVE REGULATION; APOPTOSIS	Introduction: We assessed expression of p85 and p110 alpha PI3K subunits in non-small cell lung cancer (NSCLC) specimens and the association with mTOR expression, and studied effects of targeting the PI3K/AKT/mTOR pathway in NSCLC cell lines. Methods: Using Automated Quantitative Analysis we quantified expression of PI3K subunits in two cohorts of 190 and 168 NSCLC specimens and correlated it with mTOR expression. We studied effects of two PI3K inhibitors, LY294002 and NVP-BKM120, alone and in combination with rapamycin in 6 NSCLC cell lines. We assessed activity of a dual PI3K/mTOR inhibitor, NVP-BEZ235 alone and with an EGFR inhibitor. Results: p85 and p110 alpha tend to be co-expressed (p<0.001); p85 expression was higher in adenocarcinomas than squamous cell carcinomas. High p85 expression was associated with advanced stage and poor survival. p110 alpha expression correlated with mTOR (rho = 0.276). In six NSCLC cell lines, addition of rapamycin to LY294002 or NVP-BKM120 was synergistic. Even very low rapamycin concentrations (1 nM) resulted in sensitization to PI3K inhibitors. NVP-BEZ235 was highly active in NSCLC cell lines with IC(50)s in the nanomolar range and resultant down-regulation of pAKT and pP70S6K. Adding Erlotinib to NVP-BEZ235 resulted in synergistic growth inhibition. Conclusions: The association between PI3K expression, advanced stage and survival in NSCLC suggests that it might be a valuable drug target. Concurrent inhibition of PI3K and mTOR is synergistic in vitro, and a dual PI3K/mTOR inhibitor was highly active. Adding EGFR inhibition resulted in further growth inhibition. Targeting the PI3K/AKT/mTOR pathway at multiple levels should be tested in clinical trials for NSCLC.	[Zito, Christopher R.; Jilaveanu, Lucia B.; Anagnostou, Valsamo; Rimm, David; Camp, Robert; Kluger, Harriet M.; Chao, Herta H.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Chao, Herta H.] VA Connecticut Healthcare Syst, Med Serv, West Haven, CT USA; [Bepler, Gerold] Karmanos Canc Inst, Detroit, MI USA; [Maira, Sauveur-Michel; Hackl, Wolfgang] Novartis Inst Biomed Res, Cambridge, MA USA; [Zito, Christopher R.; Jilaveanu, Lucia B.; Anagnostou, Valsamo; Rimm, David; Camp, Robert; Kluger, Harriet M.; Chao, Herta H.] Yale Comprehens Canc, New Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Barbara Ann Karmanos Cancer Institute; Novartis	Zito, CR (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	herta.chao@yale.edu		Rimm, David/0000-0001-5820-4397	American Association for Cancer Research; Yale SPORE in Skin Cancer [1 P50 CA121974]; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER	American Association for Cancer Research; Yale SPORE in Skin Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Career Development Award of the American Association for Cancer Research to Dr. Chao. Dr. Kluger is supported by the Yale SPORE in Skin Cancer, 1 P50 CA121974 (to R. Halaban). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2010, AM CANC SOC CANC FAC; Anagnostou VK, 2009, CLIN CANCER RES, V15, P4157, DOI 10.1158/1078-0432.CCR-09-0099; Anagnostou VK, 2009, J CLIN ONCOL, V27, P271, DOI 10.1200/JCO.2008.17.0043; Aziz SA, 2010, CLIN CANCER RES, V16, P6029, DOI 10.1158/1078-0432.CCR-10-1490; Bendell JC, 2011, J CLIN ONCOL    1227; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Brognard J, 2001, CANCER RES, V61, P3986; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; BURRIS H, 2010, J CLIN ONCOL S, V28, pS15; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Edling CE, 2010, CLIN CANCER RES, V16, P4928, DOI 10.1158/1078-0432.CCR-10-1210; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Herrera VA, 2011, ANTICANCER RES, V31, P849; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lee HY, 2004, BIOCHEM PHARMACOL, V68, P1119, DOI 10.1016/j.bcp.2004.05.033; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Lee HY, 2003, J BIOL CHEM, V278, P23630, DOI 10.1074/jbc.M300997200; Lin XB, 2001, LANGENBECK ARCH SURG, V386, P293, DOI 10.1007/s004230100203; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Tsao MS, 1996, EXP CELL RES, V223, P268, DOI 10.1006/excr.1996.0081; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	55	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31331	10.1371/journal.pone.0031331	http://dx.doi.org/10.1371/journal.pone.0031331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355357	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300057
J	Andrade, LH; Wang, YP; Andreoni, S; Silveira, CM; Alexandrino-Silva, C; Siu, ER; Nishimura, R; Anthony, JC; Gattaz, WF; Kessler, RC; Viana, MC				Andrade, Laura Helena; Wang, Yuan-Pang; Andreoni, Solange; Silveira, Camila Magalhaes; Alexandrino-Silva, Clovis; Siu, Erica Rosanna; Nishimura, Raphael; Anthony, James C.; Gattaz, Wagner Farid; Kessler, Ronald C.; Viana, Maria Carmen			Mental Disorders in Megacities: Findings from the Sao Paulo Megacity Mental Health Survey, Brazil	PLOS ONE			English	Article							DSM-IV DISORDERS; PSYCHIATRIC MORBIDITY; 12-MONTH PREVALENCE; GENERAL-POPULATION; CATCHMENT-AREA; SERVICE USE; UNMET NEED; SEVERITY; ORGANIZATION; COMORBIDITY	Background: World population growth is projected to be concentrated in megacities, with increases in social inequality and urbanization-associated stress. Sao Paulo Metropolitan Area (SPMA) provides a forewarning of the burden of mental disorders in urban settings in developing world. The aim of this study is to estimate prevalence, severity, and treatment of recently active DSM-IV mental disorders. We examined socio-demographic correlates, aspects of urban living such as internal migration, exposure to violence, and neighborhood-level social deprivation with 12-month mental disorders. Methods and Results: A representative cross-sectional household sample of 5,037 adults was interviewed face-to-face using the WHO Composite International Diagnostic Interview (CIDI), to generate diagnoses of DSM-IV mental disorders within 12 months of interview, disorder severity, and treatment. Administrative data on neighborhood social deprivation were gathered. Multiple logistic regression was used to evaluate individual and contextual correlates of disorders, severity, and treatment. Around thirty percent of respondents reported a 12-month disorder, with an even distribution across severity levels. Anxiety disorders were the most common disorders (affecting 19.9%), followed by mood (11%), impulse-control (4.3%), and substance use (3.6%) disorders. Exposure to crime was associated with all four types of disorder. Migrants had low prevalence of all four types compared to stable residents. High urbanicity was associated with impulse-control disorders and high social deprivation with substance use disorders. Vulnerable subgroups were observed: women and migrant men living in most deprived areas. Only one-third of serious cases had received treatment in the previous year. Discussion: Adults living in Sao Paulo megacity had prevalence of mental disorders at greater levels than similar surveys conducted in other areas of the world. Integration of mental health promotion and care into the rapidly expanding Brazilian primary health system should be strengthened. This strategy might become a model for poorly resourced and highly populated developing countries.	[Andrade, Laura Helena; Wang, Yuan-Pang; Silveira, Camila Magalhaes; Alexandrino-Silva, Clovis; Siu, Erica Rosanna; Viana, Maria Carmen] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil; [Andreoni, Solange] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil; [Nishimura, Raphael] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Anthony, James C.] Michigan State Univ, Coll Human Med, Dept Epidemiol, E Lansing, MI 48824 USA; [Gattaz, Wagner Farid] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Lab Neurosci LIM 27, Sao Paulo, Brazil; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Michigan System; University of Michigan; Michigan State University; Michigan State University College of Human Medicine; Universidade de Sao Paulo; Harvard University; Harvard Medical School	Andrade, LH (corresponding author), Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil.	Andradelhsgandr@usp.br	Gattaz, Wagner F/C-4456-2012; Andreoni, Solange/GNW-4057-2022; Silveira, Camila M/C-6467-2015; Siu, Erica R/J-9116-2012; Silveira, Camila/E-1087-2012; Anthony, Jim/H-3637-2011; Wang, Yuan-Pang/A-4863-2008; Andrade, Laura Helena S. G./F-3023-2010; Alexandrino-Silva, Clóvis/G-3154-2012; Viana, Maria Carmen/B-6047-2013	Andreoni, Solange/0000-0003-4589-9876; Silveira, Camila M/0000-0002-1598-4896; Siu, Erica R/0000-0001-7492-7579; Anthony, Jim/0000-0001-7176-0929; Wang, Yuan-Pang/0000-0001-7076-8312; Andrade, Laura Helena S. G./0000-0002-2362-3521; Viana, Maria Carmen/0000-0002-0464-4845	State of Sao Paulo Research Foundation, Brazil (FAPESP) [03/00204-3]; Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil; United States National Institutes of Mental Health [R01MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center (FIRCA) [R03-TW006481]; Pan American Health Organization; Eli Lilly; Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; Shire; FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069864, R13MH066849, R01MH070884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558, K05DA015799] Funding Source: NIH RePORTER	State of Sao Paulo Research Foundation, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil; United States National Institutes of Mental Health; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center (FIRCA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly(Eli Lilly); Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Shire; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Sao Paulo Megacity Mental Health Survey was funded by the State of Sao Paulo Research Foundation, Brazil (FAPESP Grant 03/00204-3, URL: http://www.fapesp.br/materia/176/projeto-tematico/projeto-tematico.htm). Instrument development was supported by the Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria - FACITEC 002/2003). The sub-project on violence and trauma was supported by the Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil. The Sao Paulo Megacity Mental Health Survey is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the WMH staff for assistance with instrumentation, fieldwork, and data analysis. The main coordination center activities, at Harvard University, were supported by the United States National Institutes of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly and Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. The authors declare that the funders of the SPMHS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also declare that the commercial funders of the Harvard coordination center had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida N, 1997, BRIT J PSYCHIAT, V171, P524, DOI 10.1192/bjp.171.6.524; Andrade L, 2002, SOC PSYCH PSYCH EPID, V37, P316, DOI 10.1007/s00127-002-0551-x; Andrade LH, 2008, SOC PSYCH PSYCH EPID, V43, P45, DOI 10.1007/s00127-007-0263-3; [Anonymous], 2000, Bull World Health Organ, V78, P413; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Benegal V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000170; Bromet EJ, 2005, SOC PSYCH PSYCH EPID, V40, P681, DOI 10.1007/s00127-005-0927-9; CEM (Centro de Estudos da Metropole), MAP VULN SOC; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; EATON WW, 1991, J NERV MENT DIS, V179, P689, DOI 10.1097/00005053-199111000-00007; Ermínia Maricato, 2003, Estud. av., V17, P151, DOI 10.1590/S0103-40142003000200013; Feijo Mello M, 2009, EPIDEMIOLOGIA TRASTO, P101; First MB, 2002, STRUCTURED CLIN INTE; Guanais Frederico C, 2010, BMJ, V341, pc6542, DOI 10.1136/bmj.c6542; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; HARPHAM T, 1994, SOC SCI MED, V39, P233, DOI 10.1016/0277-9536(94)90332-8; Harris M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4945; Hennigan T, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5453; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; IBGE, 2001, CENS DEM POP AN 2000; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 1997, PSYCHOL MED, V27, P861, DOI 10.1017/S0033291797004807; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634; Kovess-Masfety V, 2005, CAN J PSYCHIAT, V50, P926, DOI 10.1177/070674370505001407; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Llacer A, 2007, J EPIDEMIOL COMMUN H, V61, P4, DOI 10.1136/jech.2007.061770; Loch AA, 2011, EUR ARCH PSY CLIN N, V261, P519, DOI 10.1007/s00406-011-0204-8; Malmusi D, 2010, SOC SCI MED, V71, P1610, DOI 10.1016/j.socscimed.2010.07.043; Maricato E, 2008, CLUSTER CITTA DESIGN, V7, P118; Maricato Erminia, 2011, Estud. av., V25, P7, DOI 10.1590/S0103-40142011000100002; Medina-Mora ME, 2005, PSYCHOL MED, V35, P1773, DOI 10.1017/S0033291705005672; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Nascimento Andreia de Fatima, 2009, Rev Saude Publica, V43 Suppl 1, P8; Paiva CEP., 2009, ENGENHARIA, V596, P511; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Paykel E, 2003, INT REV PSYCHIATR, V15, P97, DOI 10.1080/0954026021000046001; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Peen J, 2007, SOC PSYCH PSYCH EPID, V42, P984, DOI 10.1007/s00127-007-0256-2; Pessoto UC, 2007, CIENC SAUDE COLETIVA, V12, P351, DOI 10.1590/S1413-81232007000200011; Posada J, 2004, MEDUNAB, V7, P65; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Research Triangle Institute, 2002, SUDAAN PROF SOFTW SU; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; SPENGLER PA, 1988, COMPR PSYCHIAT, V29, P309, DOI 10.1016/0010-440X(88)90054-5; The World Bank, GINI IND; Thornicroft G, 1999, MENT HLTH MATR MAN I; Thornicroft G, 2010, WORLD PSYCHIATRY, V9, P67; Peres MFT, 2008, REV PANAM SALUD PUBL, V23, P268; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Turner RJ, 2003, ADDICTION, V98, P305, DOI 10.1046/j.1360-0443.2003.00312.x; UN-Habitat, 2006, STAT WORLDS CIT 2006; Vaughn MG, 2010, ANN EPIDEMIOL, V20, P281, DOI 10.1016/j.annepidem.2009.11.011; Viana MC, 2009, REV BRAS PSIQUIATR, V31, P375, DOI 10.1590/S1516-44462009000400016; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1; Vorcaro CMR, 2001, ACTA PSYCHIAT SCAND, V104, P257, DOI 10.1034/j.1600-0447.2001.00440.x; Wang P, 2011, OXFORD TXB COMMUNITY; Wells JE, 2006, AUST NZ J PSYCHIAT, V40, P845, DOI 10.1111/j.1440-1614.2006.01903.x; WHO, 2003, PLANN BUDG DEL SERV; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; World Health Organization, 2007, MONITORING EVALUATIO; World Health Organization, 2010, WORLD HLTH STAT HLTH; World Health Organization, 2007, OUR CIT OUR HLTH OUR	72	200	217	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31879	10.1371/journal.pone.0031879	http://dx.doi.org/10.1371/journal.pone.0031879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925CF	22348135	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400054
J	El-Murr, N; Abidi, Z; Wanherdrick, K; Svrcek, M; Gaub, MP; Flejou, JF; Hamelin, R; Duval, A; Lesuffleur, T				El-Murr, Nizar; Abidi, Zoulira; Wanherdrick, Kristell; Svrcek, Magali; Gaub, Marie-Pierre; Flejou, Jean-Francois; Hamelin, Richard; Duval, Alex; Lesuffleur, Thecla			MiRNA Genes Constitute New Targets for Microsatellite Instability in Colorectal Cancer	PLOS ONE			English	Article							FAMILIAL PREDISPOSITION; INTERNATIONAL CRITERIA; MICRORNA BIOGENESIS; INSTITUTE WORKSHOP; REPEAT SEQUENCES; TARBP2 MUTATION; EXPRESSION; RECOGNITION; DROSHA	Mismatch repair-deficient colorectal cancers (CRC) display widespread instability at DNA microsatellite sequences (MSI). Although MSI has been reported to commonly occur at coding repeats, leading to alterations in the function of a number of genes encoding cancer-related proteins, nothing is known about the putative impact of this process on non-coding microRNAs. In miRbase V15, we identified very few human microRNA genes with mono- or di-nucleotide repeats (n = 27). A mutational analysis of these sequences in a large series of MSI CRC cell lines and primary tumors underscored instability in 15 of the 24 microRNA genes successfully studied at variable frequencies ranging from 2.5% to 100%. Following a maximum likelihood statistical method, microRNA genes were separated into two groups that differed significantly in their mutation frequencies and in their tendency to represent mutations that may or may not be under selective pressures during MSI tumoral progression. The first group included 21 genes that displayed no or few mutations in CRC. The second group contained three genes, i.e., hsa-mir-1273c, hsa-mir-1303 and hsa-mir-567, with frequent (>= 80%) and sometimes bi-allelic mutations in MSI tumors. For the only one expressed in colonic tissues, hsa-mir-1303, no direct link was found between the presence or not of mono- or bi-allelic alterations and the levels of mature miR expression in MSI cell lines, as determined by sequencing and quantitative PCR respectively. Overall, our results provide evidence that DNA repeats contained in human miRNA genes are relatively rare and preserved from mutations due to MSI in MMR-deficient cancer cells. Functional studies are now required to conclude whether mutated miRNAs, and especially the miR-1303, might have a role in MSI tumorigenesis.	[El-Murr, Nizar; Abidi, Zoulira; Wanherdrick, Kristell; Svrcek, Magali; Flejou, Jean-Francois; Hamelin, Richard; Duval, Alex; Lesuffleur, Thecla] Ctr Rech St Antoine, INSERM, UMRS 938, Equipe Instabilite Microsatellites & Canc, Paris, France; [El-Murr, Nizar; Abidi, Zoulira; Wanherdrick, Kristell; Svrcek, Magali; Flejou, Jean-Francois; Hamelin, Richard; Duval, Alex; Lesuffleur, Thecla] UPMC Univ Pierre & Marie Curie, Paris, France; [Svrcek, Magali; Flejou, Jean-Francois] Hop St Antoine, AP HP, Serv Anat & Cytol Pathol, Paris, France; [Gaub, Marie-Pierre] INSERM, U682, Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	El-Murr, N (corresponding author), Ctr Rech St Antoine, INSERM, UMRS 938, Equipe Instabilite Microsatellites & Canc, Paris, France.	thecla.lesuffleur@inserm.fr	lesuffleur, thecla/AAC-2980-2020	El-Murr, Nizar/0000-0001-7793-9436	LNCC (Ligue Nationale Contre le Cancer); Institut National de la Sante et de la Recherche Medicale (INSERM)	LNCC (Ligue Nationale Contre le Cancer); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	N El-Murr is a recipient of a LNCC (Ligue Nationale Contre le Cancer) fellowship. This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Duval A, 2002, CANCER RES, V62, P2447; Duval A, 2001, HUM MOL GENET, V10, P513, DOI 10.1093/hmg/10.5.513; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garre P, 2010, NAT GENET, V42, P817, DOI 10.1038/ng1010-817; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Melo SA, 2011, FEBS LETT IN PRESS; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Perucho M, 1999, CANCER RES, V59, P249; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645	35	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31862	10.1371/journal.pone.0031862	http://dx.doi.org/10.1371/journal.pone.0031862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348132	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400052
J	Zhang, WS; Edwards, A; Zhu, DX; Flemington, EK; Deininger, P; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Zhu, Dongxiao; Flemington, Erik K.; Deininger, Prescott; Zhang, Kun			miRNA-Mediated Relationships between Cis-SNP Genotypes and Transcript Intensities in Lymphocyte Cell Lines	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RANDOMLY MATING POPULATIONS; MICRORNA TARGET SITES; LINKAGE DISEQUILIBRIUM; GENE-EXPRESSION; HUMAN-DISEASE; PARKINSON-DISEASE; BINDING-SITE; ASSOCIATION; RESISTANCE	In metazoans, miRNAs regulate gene expression primarily through binding to target sites in the 3' UTRs (untranslated regions) of messenger RNAs (mRNAs). Cis-acting variants within, or close to, a gene are crucial in explaining the variability of gene expression measures. Single nucleotide polymorphisms (SNPs) in the 3' UTRs of genes can affect the base-pairing between miRNAs and mRNAs, and hence disrupt existing target sites (in the reference sequence) or create novel target sites, suggesting a possible mechanism for cis regulation of gene expression. Moreover, because the alleles of different SNPs within a DNA sequence of limited length tend to be in strong linkage disequilibrium (LD), we hypothesize the variants of miRNA target sites caused by SNPs potentially function as bridges linking the documented cis-SNP markers to the expression of the associated genes. A large-scale analysis was herein performed to test this hypothesis. By systematically integrating multiple latest information sources, we found 21 significant gene-level SNP-involved miRNA-mediated post-transcriptional regulation modules (SNP-MPRMs) in the form of SNP-miRNA-mRNA triplets in lymphocyte cell lines for the CEU and YRI populations. Among the cognate genes, six including ALG8, DGKE, GNA12, KLF11, LRPAP1, and MMAB are related to multiple genetic diseases such as depressive disorder and Type-II diabetes. Furthermore, we found that similar to 35% of the documented transcript intensity-related cis-SNPs (similar to 950) in a recent publication are identical to, or in significant linkage disequilibrium (LD) (p<0.01) with, one or multiple SNPs located in miRNA target sites. Based on these associations (or identities), 69 significant exon-level SNP-MPRMs and 12 disease genes were further determined for two populations. These results provide concrete in silico evidence for the proposed hypothesis. The discovered modules warrant additional follow-up in independent laboratory studies.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA 70125 USA; [Zhu, Dongxiao] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Flemington, Erik K.] Tulane Univ, Ctr Hlth Sci, Dept Pathol, New Orleans, LA 70118 USA; [Deininger, Prescott] Tulane Sch Publ Hlth & Trop Med, Tulane Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; Wayne State University; Tulane University; Tulane University	Zhang, WS (corresponding author), Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA 70125 USA.	kzhang@xula.edu	Zhu, Dongxiao/G-4049-2010	Deininger, Prescott/0000-0002-1067-3028	NIH [NCRR P20RR016456, RCMI 5G12RR026260-03, R21LM010137S1]; Louisiana BOR award [LEQSF(2008-11)-RD-A-32]; NSF [EPS-1006891]; NATIONAL CANCER INSTITUTE [R01CA138268] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456, G12RR026260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana BOR award; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants (NCRR P20RR016456, RCMI 5G12RR026260-03, R21LM010137S1 to DZ), a Louisiana BOR award to ZK (LEQSF(2008-11)-RD-A-32) and an NSF grant EPS-1006891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Bansal A, 2007, BIOINFORMATICS GENET; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Brown EM, HAPMAP HAPLOTYPE MAP, P35; Brown EM, 2007, HAPMAP HAPLOTYPE MAP, P35; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Gan SQ, 2008, ASIAN AUSTRAL J ANIM, V21, P928, DOI 10.5713/ajas.2008.70473; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hartl D., 1989, PRINCIPLES POPULATIO; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Shu Y, 2010, MOL BIOL REP; Simko I, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-135; Smith WJM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-27; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Wang D., 2010, PLOS ONE, V5; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Weir BS, 1996, GENETIC DATA ANAL, p[xii, 445]; Yamaguchi-Kabata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003393; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	54	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31429	10.1371/journal.pone.0031429	http://dx.doi.org/10.1371/journal.pone.0031429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348086	Green Submitted, gold, Green Published			2022-12-27	WOS:000302737400022
J	Granich, R; Kahn, JG; Bennett, R; Holmes, CB; Garg, N; Serenata, C; Sabin, ML; Makhlouf-Obermeyer, C; Mack, CD; Williams, P; Jones, L; Smyth, C; Kutch, KA; Lo, YR; Vitoria, M; Souteyrand, Y; Crowley, S; Korenromp, EL; Williams, BG				Granich, Reuben; Kahn, James G.; Bennett, Rod; Holmes, Charles B.; Garg, Navneet; Serenata, Celicia; Sabin, Miriam Lewis; Makhlouf-Obermeyer, Carla; Mack, Christina De Filippo; Williams, Phoebe; Jones, Louisa; Smyth, Caoimhe; Kutch, Kerry A.; Lo Ying-Ru; Vitoria, Marco; Souteyrand, Yves; Crowley, Siobhan; Korenromp, Eline L.; Williams, Brian G.			Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; HETEROSEXUAL TRANSMISSION; RISK; INFECTION; ACCESS; HAART; CARE; MORTALITY; BEHAVIOR	Background: Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa. Methods: We model a best case scenario of 90% annual HIV testing coverage in adults 15-49 years old and four ART eligibility scenarios: CD4 count <200 cells/mm(3) (current practice), CD4 count <350, CD4 count <500, all CD4 levels. 2011-2050 outcomes include deaths, disability adjusted life years (DALYs), HIV infections, cost, and cost per DALY averted. Service and ART costs reflect South African data and international generic prices. ART reduces transmission by 92%. We conducted sensitivity analyses. Results: Expanding ART to CD4 count <350 cells/mm(3) prevents an estimated 265,000 (17%) and 1.3 million (15%) new HIV infections over 5 and 40 years, respectively. Cumulative deaths decline 15%, from 12.5 to 10.6 million; DALYs by 14% from 109 to 93 million over 40 years. Costs drop $504 million over 5 years and $3.9 billion over 40 years with breakeven by 2013. Compared with the current scenario, expanding to <500 prevents an additional 585,000 and 3 million new HIV infections over 5 and 40 years, respectively. Expanding to all CD4 levels decreases HIV infections by 3.3 million (45%) and costs by $10 billion over 40 years, with breakeven by 2023. By 2050, using higher ART and monitoring costs, all CD4 levels saves $0.6 billion versus current; other ART scenarios cost $9-194 per DALY averted. If ART reduces transmission by 99%, savings from all CD4 levels reach $17.5 billion. Sensitivity analyses suggest that poor retention and predominant acute phase transmission reduce DALYs averted by 26% and savings by 7%. Conclusion: Increasing the provision of ART to <350 cells/mm(3) may significantly reduce costs while reducing the HIV burden. Feasibility including HIV testing and ART uptake, retention, and adherence should be evaluated.	[Granich, Reuben; Sabin, Miriam Lewis; Makhlouf-Obermeyer, Carla; Williams, Phoebe; Jones, Louisa; Smyth, Caoimhe; Kutch, Kerry A.; Lo Ying-Ru; Vitoria, Marco; Souteyrand, Yves; Crowley, Siobhan] World Hlth Org, HIV AIDS Dept, Geneva, Switzerland; [Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Holmes, Charles B.] Off US Global AIDS Coordinator, Dept State, Washington, DC USA; [Garg, Navneet] Vestergaard Frandsen, Lausanne, Switzerland; [Serenata, Celicia] S African Natl AIDS Council, Johannesburg, South Africa; [Mack, Christina De Filippo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Korenromp, Eline L.] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Williams, Brian G.] S African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa	World Health Organization; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; National Research Foundation - South Africa	Granich, R (corresponding author), World Hlth Org, HIV AIDS Dept, Geneva, Switzerland.	granichr@who.int	Williams, Phoebe/GLQ-9150-2022	Williams, Phoebe CM/0000-0003-2250-0594; Williams, Brian/0000-0002-3174-4876; Sabin, Miriam/0000-0002-7758-8338	World Health Organization; U.S. National Institute of Drug Abuse [R01 DA15612]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); U.S. National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the World Health Organization and by the U.S. National Institute of Drug Abuse, under grant number R01 DA15612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; [Anonymous], PROGR REP 2011 GLOB; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Beck EJ, 2010, CURR OPIN HIV AIDS, V5, P215, DOI 10.1097/COH.0b013e32833860e9; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cohen J, 2008, SCIENCE, V321, P512, DOI 10.1126/science.321.5888.512; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; DESROSIERS R, 2008, 15 C RETR OPP INF CR; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, 17 C RETR OPP INF CR; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Futures Institute, 2011, FUT I SPECTR; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; Holmes Charles, 2009, COMMUNICATION   0828; Holmes Charles, 2009, COMMUNICATION   0906; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Jones L, 2010, CURRENT HIV RES; Kahn J, 2009, C HIV PATH TREATM PR; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kleijnen J, 1998, BRIT MED J, V316, P299, DOI 10.1136/bmj.316.7127.299; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lugada E, 2010, 18 INT AIDS C 2010 V; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; National AIDS and STI Control Programme MoH-K, 2008, KAIS 2007 KEN AIDS I; National Department of Health South Africa, 2010, 2010 CLIN GUID MAN H; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Piot P, 2002, LANCET, V360, P86, DOI 10.1016/S0140-6736(02)09342-X; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Resch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025310; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Rosen S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-24; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Seranata Celicia, 2009, COMMUNICATION   0929; Seranata Celicia, 2009, COMMUNICATION   1125; Seranata Celicia, 2009, COMMUNICATION   0925; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; South African Government Information, 2010, OUTL NAT HIV COUNS T; South African Government Information, 2008, HIV AIDS STI STRAT P; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, GLOBAL FUND FIGHT AI; Tovanabutra S, 2002, J ACQ IMMUN DEF SYND, V29, P275, DOI 10.1097/00126334-200203010-00008; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2011, WORLD AIDS DAY REP 2; UNAIDS, 2011, AIDS 30 NAT CROSS RO; UNAIDS, 2007, FIN RES REQ ACH UN A; United Nations General Assembly, 2011, UN UN ACC ZER NEW HI; University of Washington, 2011, PIV STUD AFR FINDS H; USAID, 2009, COMP PROGR MAK HIV A; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Venkatesh KK, 2010, AIDS, V24, P2687, DOI 10.1097/QAD.0b013e32833e78d4; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; WHO, 2010, ANT THER HIV INF AD; WHO CHOICE, 2010, INT AR COST EFF WHO; Williams B, SPECTRUM MODEL V 3 3; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2009, RAP ADV ANT THER HIV	86	104	107	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30216	10.1371/journal.pone.0030216	http://dx.doi.org/10.1371/journal.pone.0030216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348000	Green Published, gold			2022-12-27	WOS:000302733900004
J	Xie, BW; Mol, IM; Keereweer, S; van Beek, ER; Que, I; Snoeks, TJA; Chan, A; Kaijzel, EL; Lowik, CWGM				Xie, Bang-Wen; Mol, Isabel M.; Keereweer, Stijn; van Beek, Ermond R.; Que, Ivo; Snoeks, Thomas J. A.; Chan, Alan; Kaijzel, Eric L.; Lowik, Clemens W. G. M.			Dual-Wavelength Imaging of Tumor Progression by Activatable and Targeting Near-Infrared Fluorescent Probes in a Bioluminescent Breast Cancer Model	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGF RECEPTOR; MAMMARY-CARCINOMA; IN-VIVO; METASTASIS; MOUSE; AGENT; MICE; OVEREXPRESSION; ANGIOGENESIS	Bioluminescence imaging (BLI) has shown its appeal as a sensitive technique for in vivo whole body optical imaging. However, the development of injectable tumor-specific near-infrared fluorescent (NIRF) probes makes fluorescence imaging (FLI) a promising alternative to BLI in situations where BLI cannot be used or is unwanted (e.g., spontaneous transgenic tumor models, or syngeneic mice to study immune effects). In this study, we addressed the questions whether it is possible to detect tumor progression using FLI with appropriate sensitivity and how FLI correlates with BLI measurements. In addition, we explored the possibility to simultaneously detect multiple tumor characteristics by dual-wavelength FLI (similar to 700 and similar to 800 nm) in combination with spectral unmixing. Using a luciferase-expressing 4T1-luc2 mouse breast cancer model and combinations of activatable and targeting NIRF probes, we showed that the activatable NIRF probes (ProSense680 and MMPSense680) and the targeting NIRF probes (IRDye 800CW 2-DG and IRDye 800CW EGF) were either activated by or bound to 4T1-luc2 cells. In vivo, we implanted 4T1-luc2 cells orthotopically in nude mice and were able to follow tumor progression longitudinally both by BLI and dual-wavelength FLI. We were able to reveal different probe signals within the tumor, which co-localized with immuno-staining. Moreover, we observed a linear correlation between the internal BLI signals and the FLI signals obtained from the NIRF probes. Finally, we could detect pulmonary metastases both by BLI and FLI and confirmed their presence histologically. Taken together, these data suggest that dual-wavelength FLI is a feasible approach to simultaneously detect different features of one tumor and to follow tumor progression with appropriate specificity and sensitivity. This study may open up new perspectives for the detection of tumors and metastases in various experimental models and could also have clinical applications, such as image-guided surgery.	[Xie, Bang-Wen; Mol, Isabel M.; van Beek, Ermond R.; Que, Ivo; Snoeks, Thomas J. A.; Kaijzel, Eric L.; Lowik, Clemens W. G. M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Keereweer, Stijn] Erasmus MC, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands; [Chan, Alan] Univ Twente, Percuros BV, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Twente	Xie, BW (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands.	B.Xie@lumc.nl	Kaijzel, Eric/GZN-2333-2022; Snoeks, Thomas/E-9742-2010	Snoeks, Thomas/0000-0003-3866-346X; Chan, Alan/0000-0001-6949-9274; Kaijzel, Eric/0000-0003-3118-9910	Center for Translational Molecular Medicine [03O-202]; Dutch Cancer Society Koningin Wilhelmina Fonds [UL2007-3801]	Center for Translational Molecular Medicine; Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding)	This research was performed within the framework of the Center for Translational Molecular Medicine, project MUSIS (grant 03O-202). This study is also supported by Dutch Cancer Society Koningin Wilhelmina Fonds (UL2007-3801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Bhardwaj V, 2009, PHARM RES-DORDR, V26, P2495, DOI 10.1007/s11095-009-9965-4; Bonine-Summers AR, 2007, CANCER BIOL THER, V6, P561, DOI 10.4161/cbt.6.4.3851; Castano AP, 2006, BRIT J CANCER, V94, P391, DOI 10.1038/sj.bjc.6602953; Chen JQ, 2005, CIRCULATION, V111, P1800, DOI 10.1161/01.CIR.0000160936.91849.9F; Chia JS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-175; Ciampricotti M, 2010, J PATHOL; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Frangioni JV, 2008, J CLIN ONCOL, V26, P4012, DOI 10.1200/JCO.2007.14.3065; Garcia M, 1996, STEM CELLS, V14, P642, DOI 10.1002/stem.140642; Giancotti V, 2006, CANCER LETT, V243, P145, DOI 10.1016/j.canlet.2006.01.035; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kaijzel EL, 2009, CLIN EXP METASTAS, V26, P371, DOI 10.1007/s10585-008-9217-8; Ke S, 2003, CANCER RES, V63, P7870; Keereweer S, 2010, MOL IMAGING BIOL; Keppler D, 1996, BIOCHEM CELL BIOL, V74, P799, DOI 10.1139/o96-086; KIM ES, 2010, BREAST CANC RES TREA; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Kovar JL, 2007, ANAL BIOCHEM, V361, P47, DOI 10.1016/j.ab.2006.11.021; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LACROIX H, 1989, ONCOGENE, V4, P145; Levenson RM, 2008, ILAR J, V49, P78, DOI 10.1093/ilar.49.1.78; Levitzki A, 2003, LUNG CANCER, V41, pS9, DOI 10.1016/S0169-5002(03)00134-X; Mayes PA, 2008, BIOTECHNIQUES, V45, P459, DOI 10.2144/000112946; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Patel S, 2011, CLIN BIOCH; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pulaski BA, 1998, CANCER RES, V58, P1486; Rice BW, 2009, NAT BIOTECHNOL, V27, P624, DOI 10.1038/nbt0709-624; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Stebbing J, 2011, J CLIN PATHOL; van der Vorst JR, 2011, INT J GYNECOL CANCER, V21, P1472, DOI 10.1097/IGC.0b013e31822b451d; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	44	35	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31875	10.1371/journal.pone.0031875	http://dx.doi.org/10.1371/journal.pone.0031875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348134	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900062
J	Hosomi, A; Nakanishi, T; Fujita, T; Tamai, I				Hosomi, Atsushi; Nakanishi, Takeo; Fujita, Takuya; Tamai, Ikumi			Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN-2; ORGANIC ANION TRANSPORTER-2; II RECEPTOR BLOCKERS; APICAL MEMBRANE; URATE; IDENTIFICATION; EXCRETION; DRUGS; HEMODIALYSIS; INVOLVEMENT	Urinary excretion accounts for two-thirds of total elimination of uric acid and the remainder is excreted in feces. However, the mechanism of extra-renal elimination is poorly understood. In the present study, we aimed to clarify the mechanism and the extent of elimination of uric acid through liver and intestine using oxonate-treated rats and Caco-2 cells as a model of human intestinal epithelium. In oxonate-treated rats, significant amounts of externally administered and endogenous uric acid were recovered in the intestinal lumen, while biliary excretion was minimal. Accordingly, direct intestinal secretion was thought to be a substantial contributor to extra-renal elimination of uric acid. Since human efflux transporter BCRP/ABCG2 accepts uric acid as a substrate and genetic polymorphism causing a decrease of BCRP activity is known to be associated with hyperuricemia and gout, the contribution of rBcrp to intestinal secretion was examined. rBcrp was confirmed to transport uric acid in a membrane vesicle study, and intestinal regional differences of expression of rBcrp mRNA were well correlated with uric acid secretory activity into the intestinal lumen. Bcrp1 knockout mice exhibited significantly decreased intestinal secretion and an increased plasma concentration of uric acid. Furthermore, a Bcrp inhibitor, elacridar, caused a decrease of intestinal secretion of uric acid. In Caco-2 cells, uric acid showed a polarized flux from the basolateral to apical side, and this flux was almost abolished in the presence of elacridar. These results demonstrate that BCRP contributes at least in part to the intestinal excretion of uric acid as extra-renal elimination pathway in humans and rats.	[Hosomi, Atsushi; Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa, Japan; [Fujita, Takuya] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Japan	Kanazawa University; Ritsumeikan University	Hosomi, A (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa, Japan.	tamai@p.kanazawa-u.ac.jp	Nakanishi, Takeo/C-3891-2015; Fujita, Takuya/AAC-3442-2022; TAMAI, Ikumi/D-8412-2015	Nakanishi, Takeo/0000-0002-6561-7138; Fujita, Takuya/0000-0002-7724-6522; 	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bakhiya N, 2003, CELL PHYSIOL BIOCHEM, V13, P249, DOI 10.1159/000074539; BERGER L, 1975, AM J MED, V59, P605, DOI 10.1016/0002-9343(75)90222-3; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Dautrey S, 1995, Drugs, V49 Suppl 2, P310; Enomoto A, 2002, J PHARMACOL EXP THER, V301, P797, DOI 10.1124/jpet.301.3.797; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Hamada T, 2002, INTERNAL MED, V41, P793, DOI 10.2169/internalmedicine.41.793; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Iwanaga T, 2007, J PHARMACOL EXP THER, V320, P211, DOI 10.1124/jpet.106.112755; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Jutabha P, 2011, J PHARMACOL SCI, V115, P249, DOI 10.1254/jphs.10228SC; Jutabha P, 2010, J BIOL CHEM, V285, P35123, DOI 10.1074/jbc.M110.121301; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kountouras J, 1996, HEPATOLOGY, V23, P229; Li Y, 2008, DRUG METAB PHARMACOK, V23, P263, DOI 10.2133/dmpk.23.263; Maliepaard M, 2001, CANCER RES, V61, P3458; Manolis AJ, 2000, CLIN THER, V22, P1186, DOI 10.1016/S0149-2918(00)83062-3; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Matsson P, 2009, PHARM RES-DORDR, V26, P1816, DOI 10.1007/s11095-009-9896-0; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nakanishi T, 2011, DRUG METAB DISPOS, V39, P984, DOI 10.1124/dmd.111.038059; Naruhashi K, 2002, ANTIMICROB AGENTS CH, V46, P344, DOI 10.1128/AAC.46.2.344-349.2002; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Nozaki Y, 2007, J PHARMACOL EXP THER, V322, P1162, DOI 10.1124/jpet.107.121491; Ohno I, 2009, INTERNAL MED, V48, P415, DOI 10.2169/internalmedicine.48.1817; Poguntke M, 2010, EXPERT OPIN DRUG MET, V6, P1363, DOI 10.1517/17425255.2010.519700; Sato M, 2008, PHARM RES-DORDR, V25, P639, DOI 10.1007/s11095-007-9401-6; Sato M, 2011, BBA-BIOMEMBRANES, V1808, P1441, DOI 10.1016/j.bbamem.2010.11.002; Sato M, 2010, BIOL PHARM BULL, V33, P498, DOI 10.1248/bpb.33.498; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; SHINOSAKI T, 1991, JPN J PHARMACOL, V55, P461, DOI 10.1254/jjp.55.461; SNAITH ML, 1971, ANN RHEUM DIS, V30, P285, DOI 10.1136/ard.30.3.285; SORENSEN LB, 1975, NEPHRON, V14, P7, DOI 10.1159/000180432; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; Tanaka Y, 2005, BIOCHEM BIOPH RES CO, V326, P181, DOI 10.1016/j.bbrc.2004.11.012; TSUJI A, 1987, J PHARMACOL EXP THER, V241, P594; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; VARELAECHAVARRIA A, 1988, FASEB J, V2, P3092, DOI 10.1096/fasebj.2.15.3192041; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; YONETANI Y, 1983, JPN J PHARMACOL, V33, P947, DOI 10.1254/jjp.33.947; YU TF, 1959, J CLIN INVEST, V38, P1298, DOI 10.1172/JCI103905	50	146	169	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30456	10.1371/journal.pone.0030456	http://dx.doi.org/10.1371/journal.pone.0030456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348008	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730900009
J	Casolari, JM; Thompson, MA; Salzman, J; Champion, LM; Moerner, WE; Brown, PO				Casolari, Jason M.; Thompson, Michael A.; Salzman, Julia; Champion, Lowry M.; Moerner, W. E.; Brown, Patrick O.			Widespread mRNA Association with Cytoskeletal Motor Proteins and Identification and Dynamics of Myosin-Associated mRNAs in S. cerevisiae	PLOS ONE			English	Article							POINT-SPREAD FUNCTION; CLASS-V MYOSIN; GENOMIC INTEGRATION METHOD; SINGLE-PARTICLE TRACKING; ACTIN-PATCH MOVEMENT; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; BINDING PROTEIN; GENE-EXPRESSION; XENOPUS-OOCYTES	Programmed mRNA localization to specific subcellular compartments for localized translation is a fundamental mechanism of post-transcriptional regulation that affects many, and possibly all, mRNAs in eukaryotes. We describe her e a systematic approach to identify the RNA cargoes associated with the cytoskeletal motor proteins of Saccharomyces cerevisiae in combination with live-cell 3D super-localization microscopy of endogenously tagged mRNAs. Our analysis identified widespread association of mRNAs with cytoskeletal motor proteins, including association of Myo3 with mRNAs encoding key regulators of actin branching and endocytosis such as WASP and WIP. Using conventional fluorescence microscopy and expression of MS2-tagged mRNAs from endogenous loci, we observed a strong bias for actin patch nucleator mRNAs to localize to the cell cortex and the actin patch in a Myo3- and F-actin dependent manner. Use of a double-helix point spread function (DH-PSF) microscope allowed super-localization measurements of single mRNPs at a spatial precision of 25 nm in x and y and 50 nm in z in live cells with 50 ms exposure times, allowing quantitative profiling of mRNP dynamics. The actin patch mRNA exhibited distinct and characteristic diffusion coefficients when compared to a control mRNA. In addition, disruption of F-actin significantly expanded the 3D confinement radius of an actin patch nucleator mRNA, providing a quantitative assessment of the contribution of the actin cytoskeleton to mRNP dynamic localization. Our results provide evidence for specific association of mRNAs with cytoskeletal motor proteins in yeast, suggest that different mRNPs have distinct and characteristic dynamics, and lend insight into the mechanism of actin patch nucleator mRNA localization to actin patches.	[Casolari, Jason M.; Salzman, Julia; Champion, Lowry M.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Casolari, Jason M.; Salzman, Julia; Champion, Lowry M.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Thompson, Michael A.; Moerner, W. E.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Salzman, Julia] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Casolari, JM (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@stanford.edu	Moerner, William E/C-3260-2008	Moerner, William E/0000-0002-2830-209X	National Institutes of Health [R01CA77097, R01CA111487]; National Institute of General Medical Sciences [R01GM085437]; Jane Coffin Childs Memorial Research Fund; National Science Foundation; Bert and DeeDee McMurtry Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA077097, R01CA111487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Jane Coffin Childs Memorial Research Fund; National Science Foundation(National Science Foundation (NSF)); Bert and DeeDee McMurtry Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01CA77097 and R01CA111487) to POB and a grant from the National Institute of General Medical Sciences (R01GM085437) to WEM. JMC acknowledges the Jane Coffin Childs Memorial Research Fund for a postdoctoral fellowship and MAT acknowledges support from a National Science Foundation Graduate Research Fellowship and a Bert and DeeDee McMurtry Stanford Graduate Fellowship. POB is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Akhtar N, 2000, FEBS LETT, V483, P87, DOI 10.1016/S0014-5793(00)02087-1; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Betley JN, 2004, CURR BIOL, V14, P219, DOI 10.1016/j.cub.2004.01.028; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Boldogh IR, 2004, MOL BIOL CELL, V15, P3994, DOI 10.1091/mbc.E04-01-0053; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; Bouzigues C, 2007, BIOPHYS J, V92, P654, DOI 10.1529/biophysj.106.094524; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Carlsson AE, 2002, BIOPHYS J, V82, P2333, DOI 10.1016/S0006-3495(02)75579-3; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Chung SL, 2010, J CELL BIOL, V189, P755, DOI 10.1083/jcb.200912011; Condeelis J, 2005, BIOL CELL, V97, P97; CRABEEL M, 1981, P NATL ACAD SCI-BIOL, V78, P5026, DOI 10.1073/pnas.78.8.5026; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Deng YF, 2008, GENE DEV, V22, P1037, DOI 10.1101/gad.1611308; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Duncan MC, 2001, NAT CELL BIOL, V3, P687, DOI 10.1038/35083087; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Zimmermann M, 1987, Schmerz, V1, P1, DOI 10.1016/S0890-4065(87)80018-X; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Haim L, 2007, NAT METHODS, V4, P409, DOI 10.1038/NMETH1040; Haim-Vilmovsky L, 2009, NAT PROTOC, V4, P1274, DOI 10.1038/nprot.2009.115; Hallett MA, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-16; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Itoh T, 2004, EMBO J, V23, P2520, DOI 10.1038/sj.emboj.7600271; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Iwase M, 2001, GENES GENET SYST, V76, P335, DOI 10.1266/ggs.76.335; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Jonsdottir GA, 2004, CURR BIOL, V14, P1604, DOI 10.1016/j.cub.2004.08.055; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Laakso JM, 2010, P NATL ACAD SCI USA, V107, P698, DOI 10.1073/pnas.0911426107; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; LOWARY PT, 1987, NUCLEIC ACIDS RES, V15, P10483, DOI 10.1093/nar/15.24.10483; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Mochida J, 2002, GENETICS, V160, P923; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Pavani SRP, 2008, OPT EXPRESS, V16, P3484, DOI 10.1364/OE.16.003484; Pavani SRP, 2008, OPT EXPRESS, V16, P22048, DOI 10.1364/OE.16.022048; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tang FS, 2003, NATURE, V422, P87, DOI 10.1038/nature01453; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Thompson MA, 2010, P NATL ACAD SCI USA, V107, P17864, DOI 10.1073/pnas.1012868107; Thompson MA, 2010, NANO LETT, V10, P211, DOI 10.1021/nl903295p; Tolliday N, 2003, MOL BIOL CELL, V14, P798, DOI 10.1091/mbc.E02-09-0558; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vrljic Marija, 2007, V398, P193, DOI 10.1007/978-1-59745-513-8_14; Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WITHERELL GW, 1991, PROG NUCLEIC ACID RE, V40, P185; Yoon YJ, 2004, DEVELOPMENT, V131, P3035, DOI 10.1242/dev.01170; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	136	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31912	10.1371/journal.pone.0031912	http://dx.doi.org/10.1371/journal.pone.0031912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359641	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200110
J	Tsuda, K; Yamanaka, K; Kitagawa, H; Akeda, T; Naka, M; Niwa, K; Nakanishi, T; Kakeda, M; Gabazza, EC; Mizutani, H				Tsuda, Kenshiro; Yamanaka, Keiichi; Kitagawa, Hiroshi; Akeda, Tomoko; Naka, Masanao; Niwa, Kaori; Nakanishi, Takehisa; Kakeda, Masato; Gabazza, Esteban C.; Mizutani, Hitoshi			Calcineurin Inhibitors Suppress Cytokine Production from Memory T Cells and Differentiation of Naive T Cells into Cytokine-Producing Mature T Cells	PLOS ONE			English	Article							INTERLEUKIN-17 FAMILY; INTERFERON-GAMMA; PSORIASIS; CYCLOSPORINE; INFLAMMATION; TACROLIMUS; ALPHA; IL-4	T cells have been classified as belonging to the Th1 or Th2 subsets according to the production of defining cytokines such as IFN-gamma and IL-4. The discovery of the Th17 lineage and regulatory T cells shifted the simple concept of the Th1/Th2 balance into a 4-way mechanistic pathway of local and systemic immunological activity. Clinically, the blockage of cytokine signals or non-specific suppression of cytokine predominance by immunosuppressants is the first-line treatment for inflammatory T cell-mediated disorders. Cyclosporine A (CsA) and Tacrolimus (Tac) are commonly used immunosuppressants for the treatment of autoimmune disease, psoriasis, and atopic disorders. Many studies have shown that these compounds suppress the activation of the calcium-dependent phosphatase calcineurin, thereby inhibiting T-cell activation. Although CsA and Tac are frequently utilized, their pharmacological mechanisms have not yet been fully elucidated. In the present study, we focused on the effects of CsA and Tac on cytokine secretion from purified human memory CD4(+)T cells and the differentiation of naive T cells into cytokine-producing memory T cells. CsA or Tac significantly inhibited IFN-gamma, IL-4, and IL-17 production from memory T cells. These compounds also inhibited T cell differentiation into the Th1, Th2, and Th17 subsets, even when used at a low concentration. This study provided critical information regarding the clinical efficacies of CsA and Tac as immunosuppressants.	[Tsuda, Kenshiro; Yamanaka, Keiichi; Kitagawa, Hiroshi; Akeda, Tomoko; Naka, Masanao; Niwa, Kaori; Nakanishi, Takehisa; Kakeda, Masato; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan	Mie University; Mie University	Tsuda, K (corresponding author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	yamake@clin.medic.mie-u.ac.jp		Gabazza, Esteban/0000-0001-5748-1499; Nakanishi, Takehisa/0000-0002-4035-1695; Kakeda, Masato/0000-0001-9011-3655	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591643, 21591461]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	KY (23591643) and HM (21591461) received grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other authors do not receive any financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brune A, 2007, PEDIATR DERMATOL, V24, P76, DOI 10.1111/j.1525-1470.2007.00341.x; DELPRETE G, 1992, ALLERGY, V47, P450; Grinyo JM, 2004, TRANSPLANTATION, V78, P1400, DOI 10.1097/01.TP.0000141227.63639.63; Ioannou Y, 2000, ARTHRITIS RHEUM-US, V43, P1431, DOI 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kobayashi T, 2007, J VET MED SCI, V69, P887, DOI 10.1292/jvms.69.887; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nakanishi Kenji, 2010, Allergology International, V59, P137, DOI 10.2332/allergolint.10-RAI-0208; Schulze-Koops H, 2001, BEST PRACT RES CL RH, V15, P677, DOI 10.1053/berh.2001.0187; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; Yamamoto T, 2006, J EUR ACAD DERMATOL, V20, P1137, DOI 10.1111/j.1468-3083.2006.01630.x; Yamanaka K, 2011, CURR PROBL DERMATOL, V41, P80, DOI 10.1159/000323299	15	77	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31465	10.1371/journal.pone.0031465	http://dx.doi.org/10.1371/journal.pone.0031465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359594	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200063
J	de Vries, M; Vosters, S; Merkx, G; D'Hauwers, K; Wansink, DG; Ramos, L; de Boer, P				de Vries, Marieke; Vosters, Sanne; Merkx, Gerard; D'Hauwers, Kathleen; Wansink, Derick G.; Ramos, Liliana; de Boer, Peter			Human Male Meiotic Sex Chromosome Inactivation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MALE GERM-CELLS; Y-CHROMOSOME; XY BODY; RNA-SYNTHESIS; TRANSLOCATION CARRIERS; MOUSE SPERMATOCYTES; MALE-INFERTILITY; MALE-FERTILITY; HUMAN TESTIS	In mammalian male gametogenesis the sex chromosomes are distinctive in both gene activity and epigenetic strategy. At first meiotic prophase the heteromorphic X and Y chromosomes are placed in a separate chromatin domain called the XY body. In this process, X, Y chromatin becomes highly phosphorylated at S139 of H2AX leading to the repression of gonosomal genes, a process known as meiotic sex chromosome inactivation (MSCI), which has been studied best in mice. Post-meiotically this repression is largely maintained. Disturbance of MSCI in mice leads to harmful X, Y gene expression, eventuating in spermatocyte death and sperm heterogeneity. Sperm heterogeneity is a characteristic of the human male. For this reason we were interested in the efficiency of MSCI in human primary spermatocytes. We investigated MSCI in pachytene spermatocytes of seven probands: four infertile men and three fertile controls, using direct and indirect in situ methods. A considerable degree of variation in the degree of MSCI was detected, both between and within probands. Moreover, in post-meiotic stages this variation was observed as well, indicating survival of spermatocytes with incompletely inactivated sex chromosomes. Furthermore, we investigated the presence of H3K9me3 posttranslational modifications on the X and Y chromatin. Contrary to constitutive centromeric heterochromatin, this heterochromatin marker did not specifically accumulate on the XY body, with the exception of the heterochromatic part of the Y chromosome. This may reflect the lower degree of MSCI in man compared to mouse. These results point at relaxation of MSCI, which can be explained by genetic changes in sex chromosome composition during evolution and candidates as a mechanism behind human sperm heterogeneity.	[de Vries, Marieke; Vosters, Sanne; Ramos, Liliana; de Boer, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Merkx, Gerard] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [D'Hauwers, Kathleen] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Wansink, Derick G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	de Vries, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands.	P.deBoer@obgyn.umcn.nl	d'Hauwers, K W M/CAH-0797-2022; Wansink, Derick G./F-3404-2010; d'Hauwers, K W M/L-4353-2015; Ramos, L./L-4590-2015; de Vries, Marieke/P-6000-2015					Achame EM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-367; Ashley T, 2004, CHROMOSOMA, V113, P126, DOI 10.1007/s00412-004-0293-5; Baarends WM, 2007, J CELL SCI, V120, P1841, DOI 10.1242/jcs.03451; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; Blanco J, 2001, HUM REPROD, V16, P887, DOI 10.1093/humrep/16.5.887; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Bustamante CD, 2009, NAT GENET, V41, P8, DOI 10.1038/ng0109-8; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; de Boer P, 2004, CYTOGENET GENOME RES, V105, P36, DOI 10.1159/000078007; de Mateo S, 2011, INT J ANDROL, V34, P256, DOI 10.1111/j.1365-2605.2010.01080.x; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; DEBOER P, 1976, J REPROD FERTIL, V48, P249, DOI 10.1530/jrf.0.0480249; DEBOER P, 1986, CHROMOSOMA, V93, P326, DOI 10.1007/BF00327591; Dixson AF, 2004, PHYSIOL BEHAV, V83, P361, DOI 10.1016/j.physbeh.2004.08.022; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Hall H, 2006, CURR OPIN GENET DEV, V16, P323, DOI 10.1016/j.gde.2006.04.011; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; HELLER CG, 1964, RECENT PROG HORM RES, V20, P545; HEYTING C, 1991, METHOD CELL BIOL, V35, P177; Homolka D, 2007, GENOME RES, V17, P1431, DOI 10.1101/gr.6520107; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Ichijima Y, 2011, GENE DEV, V25, P959, DOI 10.1101/gad.2030811; Inagaki A, 2010, EPIGENETICS-US, V5, P255, DOI 10.4161/epi.5.4.11518; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; KOOPMAN P, 1991, TRENDS GENET, V7, P132, DOI 10.1016/0168-9525(91)90458-3; Lefievre L, 2007, REPRODUCTION, V133, P675, DOI 10.1530/REP-06-0332; Lewis SEM, 2007, REPRODUCTION, V134, P31, DOI 10.1530/REP-07-0152; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Martin RH, 2008, HUM REPROD UPDATE, V14, P379, DOI 10.1093/humupd/dmn017; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; McVicar CM, 2005, HUM REPROD, V20, P2795, DOI 10.1093/humrep/dei138; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; MULUGETA A, 2010, PLOS ONE, V0005; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Navarro-Costa P, 2010, HUM REPROD UPDATE, V16, P525, DOI 10.1093/humupd/dmq005; Navarro-Costa P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/936569; Oates RD, 2002, HUM REPROD, V17, P2813, DOI 10.1093/humrep/17.11.2813; Oliver-Bonet M, 2005, CYTOGENET GENOME RES, V111, P343, DOI 10.1159/000086908; Oliver-Bonet M, 2005, MOL HUM REPROD, V11, P517, DOI 10.1093/molehr/gah193; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Reynard LN, 2009, J CELL SCI, V122, P4239, DOI 10.1242/jcs.049916; RICHLER C, 1994, MOL BIOL CELL, V5, P1341, DOI 10.1091/mbc.5.12.1341; ROWLEY MJ, 1971, Z ZELLFORSCH MIK ANA, V115, P461, DOI 10.1007/BF00335713; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; SAUSSINE C, 1994, ANDROLOGIA, V26, P139; Schimenti J, 2005, NAT GENET, V37, P11, DOI 10.1038/ng0105-11; Schoenmakers S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000466; Sciurano R, 2007, HUM REPROD, V22, P142, DOI 10.1093/humrep/del330; Silber SJ, 2000, HUM REPROD, V15, P2278, DOI 10.1093/humrep/15.11.2278; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI 10.2217/epi.09.22; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Solari AJ, 1997, CHROMOSOME RES, V5, P467, DOI 10.1023/A:1018469030537; SOLARI AJ, 1967, CHROMOSOMA, V22, P16, DOI 10.1007/BF00291284; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Sousa AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018112; SPEED RM, 1991, HUM GENET, V87, P416; SPEED RM, 1986, CHROMOSOMA, V93, P267, DOI 10.1007/BF00292748; TRES LL, 1975, CHROMOSOMA, V53, P141, DOI 10.1007/BF00333042; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; van der Laan R, 2004, J CELL SCI, V117, P5023, DOI 10.1242/jcs.01368; Yamauchi Y, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r66; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576	76	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31485	10.1371/journal.pone.0031485	http://dx.doi.org/10.1371/journal.pone.0031485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355370	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300070
J	Krill, AL; Platek, SM				Krill, Austen L.; Platek, Steven M.			Working Together May Be Better: Activation of Reward Centers during a Cooperative Maze Task	PLOS ONE			English	Article							EVENT-RELATED FMRI; ORBITOFRONTAL CORTEX; SOCIAL COGNITION; BASAL GANGLIA; SELF; MIND; HYPOTHESIS; MECHANISMS; EVOLUTION	Humans use theory of mind when predicting the thoughts and feelings and actions of others. There is accumulating evidence that cooperation with a computerized game correlates with a unique pattern of brain activation. To investigate the neural correlates of cooperation in real-time we conducted an fMRI hyperscanning study. We hypothesized that real-time cooperation to complete a maze task, using a blind-driving paradigm, would activate substrates implicated in theory of mind. We also hypothesized that cooperation would activate neural reward centers more than when participants completed the maze themselves. Of interest and in support of our hypothesis we found left caudate and putamen activation when participants worked together to complete the maze. This suggests that cooperation during task completion is inherently rewarding. This finding represents one of the first discoveries of a proximate neural mechanism for group based interactions in real-time, which indirectly supports the social brain hypothesis.	[Krill, Austen L.; Platek, Steven M.] Georgia Gwinnett Coll, Sch Liberal Arts, Lawrenceville, GA USA; [Krill, Austen L.; Platek, Steven M.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Platek, Steven M.] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr, Liverpool L69 3BX, Merseyside, England	University System of Georgia; Georgia Gwinnett College; University of Liverpool; University of Liverpool	Krill, AL (corresponding author), Georgia Gwinnett Coll, Sch Liberal Arts, Lawrenceville, GA USA.	akrill@ggc.edu			Pioneer Fund	Pioneer Fund	This work was partially funded by a grant from the Pioneer Fund (a private organization) to SMP. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Frank R. H., 1988, PASSIONS REASON; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Gusnard D., 2006, SOCIAL NEUROSCIENCE; Hamilton D, 1964, J THEO BIO, V7, P1; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Lissek S, 2008, PUBLIC LIB SCI, V3; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Platek SM, 2005, NEUROIMAGE, V25, P1336, DOI 10.1016/j.neuroimage.2004.12.037; Premack D., 1978, BEHAVIORAL BRAIN SCI, V4, P515, DOI [10.1017/S0140525X00076512, DOI 10.1017/S0140525X00076512]; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Trivers RL, 1971, Q REV BIOL, P4635; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789	37	29	30	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30613	10.1371/journal.pone.0030613	http://dx.doi.org/10.1371/journal.pone.0030613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355319	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300019
J	Torner, N; Broner, S; Martinez, A; Tortajada, C; de Olalla, PG; Barrabeig, I; Sala, M; Camps, N; Minguell, S; Alvarez, J; Ferrus, G; Torra, R; Godoy, P; Dominguez, A				Torner, Nuria; Broner, Sonia; Martinez, Ana; Tortajada, Cecilia; Garcia de Olalla, Patricia; Barrabeig, Irene; Sala, MariaRosa; Camps, Neus; Minguell, Sofia; Alvarez, Josep; Ferrus, Gloria; Torra, Roser; Godoy, Pere; Dominguez, Angela		Hepatitis A Surveillance Grp	Factors Associated to Duration of Hepatitis A Outbreaks: Implications for Control	PLOS ONE			English	Article							DAY-CARE; VACCINE; IMMUNIZATION; EPIDEMIOLOGY; INFECTION; DISEASE	Even though hepatitis A mass vaccination effectiveness is high, outbreaks continue to occur. The aim of this study was to investigate the association between duration and characteristics of hepatitis A outbreaks. Hepatitis A (HA) outbreaks reported between 1991 and 2007 were studied. An outbreak was defined as >= 2 epidemiologically-linked cases with >= 1 case laboratory-confirmed by detection of HA immunoglobulin M (IgM) antibodies. Relationships between explanatory variables and outbreak duration were assessed by logistic regression. During the study period, 268 outbreaks (rate 2.45 per million persons-year) and 1396 cases (rate 1.28 per 10(5) persons-year) were reported. Factors associated with shorter duration were time to intervention (OR = 0.96; 95% CI: 0.94-0.98) and school setting (OR = 0.39; 95% CI: 0.16-0.92). In person-to-person transmission outbreaks only time to intervention was associated with shorter outbreak duration (OR = 0.96; 95% CI: 0.95-0.98). The only variables associated with shorter outbreak duration were early administration of IG or vaccine and a school setting. Timely reporting HA outbreaks was associated with outbreak duration. Making confirmed HA infections statutory reportable for clinical laboratories could diminish outbreak duration.	[Torner, Nuria; Martinez, Ana; Barrabeig, Irene; Sala, MariaRosa; Camps, Neus; Minguell, Sofia; Alvarez, Josep; Ferrus, Gloria; Torra, Roser; Godoy, Pere] Generalitat Catalonia, Dept Hlth, Barcelona, Spain; [Torner, Nuria; Broner, Sonia; Garcia de Olalla, Patricia; Godoy, Pere; Dominguez, Angela] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Torner, Nuria; Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain; [Tortajada, Cecilia; Garcia de Olalla, Patricia] Publ Hlth Agcy Barcelona, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Public Health Agency of Barcelona	Torner, N (corresponding author), Generalitat Catalonia, Dept Hlth, Barcelona, Spain.	nuria.torner@gencat.cat	Sala, Maria/H-2562-2013; , Nuria/AAG-8951-2019; Godoy, Pere/A-7662-2010	Sala, Maria/0000-0002-9955-8746; , Nuria/0000-0003-0143-5295; Godoy, Pere/0000-0002-2896-7286; Barrabeig, Irene/0000-0003-4789-7620; Tortajada, Cecilia/0000-0001-7320-3632	CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; Centros de Investigacion Biomedica en Red; AGAUR [2009/SGR 42]	CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; Centros de Investigacion Biomedica en Red; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was partially funded by CIBER Epidemiologia y Salud Publica (CIBERESP), Spain, [Centros de Investigacion Biomedica en Red) and by AGAUR (expedient number 2009/SGR 42). [Agencia de Gestio d'Ajuts Universitaris i de Recerca] www10.gencat.net/agaur_web/AppJava/castellano/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamson R, 2010, AM J PUBLIC HEALTH, V100, P1249, DOI 10.2105/AJPH.2009.178335; Belmaker I, 2007, PEDIATR INFECT DIS J, V26, P36, DOI 10.1097/01.inf.0000247105.45185.13; Comm Infect Dis, 2007, PEDIATRICS, V120, P189, DOI 10.1542/peds.2007-1088; Craig AS, 2007, AM J MED SCI, V334, P180, DOI 10.1097/MAJ.0b013e3181425411; Craig AS, 1998, CLIN INFECT DIS, V27, P531, DOI 10.1086/514700; Diel R, 2001, EUR J EPIDEMIOL, V17, P175, DOI 10.1023/A:1017972820699; Dominguez A, 2008, VACCINE, V26, P1737, DOI 10.1016/j.vaccine.2008.01.048; Hauri AM, 2006, VACCINE, V24, P5684, DOI 10.1016/j.vaccine.2006.04.053; Hershey JH, 2005, AM J MED, V118, P100, DOI 10.1016/j.amjmed.2005.07.028; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Llach-Berne M, 2006, ENFERM INFEC MICR CL, V24, P431, DOI 10.1157/13091780; Lopalco PL, 2005, J VIRAL HEPATITIS, V12, P315, DOI 10.1111/j.1365-2893.2005.00593.x; Luyten J, 2009, PHARMACOECONOMICS, V27, P379, DOI 10.2165/00019053-200927050-00003; Novak R., 2007, Morbidity and Mortality Weekly Report, V56, P1080; Oviedo M, 2006, ANN EPIDEMIOL, V16, P812, DOI 10.1016/j.annepidem.2006.02.005; Shen YG, 2008, WORLD J GASTROENTERO, V14, P2771, DOI 10.3748/wjg.14.2771; Steffen R, 2005, AM J MED, V118, P46, DOI 10.1016/j.amjmed.2005.07.016; Taylor-Robinson D C, 2007, Euro Surveill, V12, pE5; Torner N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015699; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546	20	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31339	10.1371/journal.pone.0031339	http://dx.doi.org/10.1371/journal.pone.0031339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355358	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300058
J	Wang, H; Yin, YG; Li, W; Zhao, XH; Yu, Y; Zhu, JK; Qin, ZX; Wang, Q; Wang, K; Lu, W; Liu, J; Huang, L				Wang, Hang; Yin, Yangguang; Li, Wei; Zhao, Xiaohui; Yu, Yang; Zhu, Jinkun; Qin, Zhexue; Wang, Qiang; Wang, Kui; Lu, Wei; Liu, Jie; Huang, Lan			Over-Expression of PDGFR-beta Promotes PDGF-Induced Proliferation, Migration, and Angiogenesis of EPCs through PI3K/Akt Signaling Pathway	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SMOOTH-MUSCLE-CELLS; FACTOR RECEPTOR-BETA; FACTOR-B-CHAIN; GROWTH-FACTOR; BONE-MARROW; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; MESSENGER-RNA; GENE-TRANSFER	The proliferation, migration, and angiogenesis of endothelial progenitor cells (EPCs) play critical roles in postnatal neovascularization and re-endothelialization following vascular injury. Here we evaluated whether the over-expression of platelet-derived growth factor receptor-beta (PDGFR-beta) can enhance the PDGF-BB-stimulated biological functions of EPCs through the PDGFR-beta/phosphoinositide 3-kinase (PI3K)/Akt signaling pathway. We first confirmed the expression of endogenous PDGFR-beta and its plasma membrane localization in spleen-derived EPCs. We then demonstrated that the PDGFR-beta over-expression in EPCs enhanced the PDGF-BB-induced proliferation, migration, and angiogenesis of EPCs. Using AG1295 (a PDGFR kinase inhibitor), LY294002 (a PI3K inhibitor), and sc-221226 (an Akt inhibitor), we further showed that the PI3K/Akt signaling pathway participates in the PDGF-BB-induced proliferation, migration, and angiogenesis of EPCs. In addition, the PI3K/Akt signaling pathway is required for PDGFR-beta over-expression to enhance these PDGF-BB-induced phenotypes.	[Wang, Hang; Li, Wei; Zhao, Xiaohui; Yu, Yang; Zhu, Jinkun; Qin, Zhexue; Wang, Qiang; Wang, Kui; Lu, Wei; Liu, Jie; Huang, Lan] Third Mil Med Univ, Inst Cardiovasc Sci, Xinqiao Hosp, Chongqing, Peoples R China; [Yin, Yangguang] Third Mil Med Univ, Emergency Dept, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Wang, H (corresponding author), Third Mil Med Univ, Inst Cardiovasc Sci, Xinqiao Hosp, Chongqing, Peoples R China.	huanglan260@126.com			National Natural Science Foundation of China [30900620, 81000070]; Science Foundation of the Third Military Medical University [2009XQN33]; Natural Foundation of Chongqing [CSTC,2009BB5020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Third Military Medical University; Natural Foundation of Chongqing	This work was supported by grants from the National Natural Science Foundation of China (No. 30900620) and the Science Foundation of the Third Military Medical University (No. 2009XQN33). This study was also supported in part by grants from the National Natural Science Foundation of China (NO. 81000070) and the Natural Foundation of Chongqing (No. CSTC,2009BB5020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bao HF, 1999, BLOOD, V93, P3757, DOI 10.1182/blood.V93.11.3757.411a34_3757_3773; Behrendt D, 2002, AM J CARDIOL, V90, p40L, DOI 10.1016/S0002-9149(02)02963-6; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deguchi J, 1999, GENE THER, V6, P956, DOI 10.1038/sj.gt.3300918; DeMali KA, 1997, J BIOL CHEM, V272, P9011; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Guo SF, 2011, CELL BIOL INT, V35, P545, DOI 10.1042/CBI20100401; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; HERMANSON M, 1992, CANCER RES, V52, P3213; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HOLMGREN L, 1991, DEVELOPMENT, V113, P749; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Levitzki A, 2005, CARDIOVASC RES, V65, P581, DOI 10.1016/j.cardiores.2004.08.008; LINDNER V, 1995, CIRC RES, V76, P951, DOI 10.1161/01.RES.76.6.951; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Majumdar K, 2009, SURG NEUROL, V72, P54, DOI 10.1016/j.surneu.2008.10.001; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; PLATE KH, 1992, LAB INVEST, V67, P529; Raica M, 2010, PHARMACEUTICALS, V3, P572, DOI 10.3390/ph3030572; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Siow RCM, 2007, CARDIOVASC RES, V75, P659, DOI 10.1016/j.cardiores.2007.06.007; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; von Ballmoos MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014107; Vrekoussis T, 2007, ONCOL REP, V17, P1115; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yin YG, 2007, J CARDIOVASC PHARM, V50, P61, DOI 10.1097/FJC.0b013e3180587e4d; Zhao XH, 2008, MICROVASC RES, V75, P45, DOI 10.1016/j.mvr.2007.02.009; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	48	69	84	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30503	10.1371/journal.pone.0030503	http://dx.doi.org/10.1371/journal.pone.0030503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355314	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300014
J	Mian, I; Pierre-Louis, WS; Dole, N; Gilberti, RM; Dodge-Kafka, K; Tirnauer, JS				Mian, Isma; Pierre-Louis, Willythssa Stephie; Dole, Neha; Gilberti, Renee M.; Dodge-Kafka, Kimberly; Tirnauer, Jennifer S.			LKB1 Destabilizes Microtubules in Myoblasts and Contributes to Myoblast Differentiation	PLOS ONE			English	Article							MUSCLE-CELL-DIFFERENTIATION; TUMOR-SUPPRESSOR KINASE; MYOGENIC DIFFERENTIATION; GENE-PRODUCT; PROTEIN; POLARIZATION; ACTIVATION; POLARITY; DYNAMICS; STRAD	Background: Skeletal muscle myoblast differentiation and fusion into multinucleate myotubes is associated with dramatic cytoskeletal changes. We find that microtubules in differentiated myotubes are highly stabilized, but premature microtubule stabilization blocks differentiation. Factors responsible for microtubule destabilization in myoblasts have not been identified. Findings: We find that a transient decrease in microtubule stabilization early during myoblast differentiation precedes the ultimate microtubule stabilization seen in differentiated myotubes. We report a role for the serine-threonine kinase LKB1 in both microtubule destabilization and myoblast differentiation. LKB1 overexpression reduced microtubule elongation in a Nocodazole washout assay, and LKB1 RNAi increased it, showing LKB1 destabilizes microtubule assembly in myoblasts. LKB1 levels and activity increased during myoblast differentiation, along with activation of the known LKB1 substrates AMP-activated protein kinase (AMPK) and microtubule affinity regulating kinases (MARKs). LKB1 overexpression accelerated differentiation, whereas RNAi impaired it. Conclusions: Reduced microtubule stability precedes myoblast differentiation and the associated ultimate microtubule stabilization seen in myotubes. LKB1 plays a positive role in microtubule destabilization in myoblasts and in myoblast differentiation. This work suggests a model by which LKB1-induced microtubule destabilization facilitates the cytoskeletal changes required for differentiation. Transient destabilization of microtubules might be a useful strategy for enhancing and/or synchronizing myoblast differentiation.	[Mian, Isma; Pierre-Louis, Willythssa Stephie; Dole, Neha; Gilberti, Renee M.; Tirnauer, Jennifer S.] Ctr Mol Med, Farmington, CT 06030 USA; [Dodge-Kafka, Kimberly] Univ Connecticut, Ctr Hlth, Calhoun Ctr Cardiol, Farmington, CT USA	University of Connecticut	Mian, I (corresponding author), Ctr Mol Med, Farmington, CT 06030 USA.	tirnauer@uchc.edu	Gilberti, Renee M./AAN-2226-2021	Dole, Neha/0000-0003-4675-2649	University of Connecticut Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082705] Funding Source: NIH RePORTER	University of Connecticut Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded from startup funds from the University of Connecticut Health Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; ANTIN PB, 1981, J CELL BIOL, V90, P300, DOI 10.1083/jcb.90.2.300; Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chang W, 2002, J BIOL CHEM, V277, P30690, DOI 10.1074/jbc.M204930200; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Gammon A, 2009, BEST PRACT RES CL GA, V23, P219, DOI 10.1016/j.bpg.2009.02.007; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; Maiato H, 2004, INT REV CYTOL, V241, P53, DOI 10.1016/S0074-7696(04)41002-X; Mangan ME, 1996, DEVELOPMENT, V122, P771; Mohun Tim, 1992, Current Opinion in Cell Biology, V4, P923, DOI 10.1016/0955-0674(92)90119-W; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shelly M, 2011, DEV NEUROBIOLOGY; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Vaahtomeri K, 2008, J CELL SCI, V121, P3531, DOI 10.1242/jcs.032706; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; WARREN RH, 1968, J CELL BIOL, V39, P544, DOI 10.1083/jcb.39.3.544; WARREN RH, 1974, J CELL BIOL, V63, P550, DOI 10.1083/jcb.63.2.550; Wei CJ, 2005, CANCER RES, V65, P11297, DOI 10.1158/0008-5472.CAN-05-0716; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255	49	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31583	10.1371/journal.pone.0031583	http://dx.doi.org/10.1371/journal.pone.0031583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348111	gold, Green Published, Green Submitted			2022-12-27	WOS:000302737400037
J	Qiu, MZ; Qiu, HJ; Wang, ZQ; Ren, C; Wang, DS; Zhang, DS; Luo, HY; Li, YH; Xu, RH				Qiu, Miao-zhen; Qiu, Hui-juan; Wang, Zhi-qiang; Ren, Chao; Wang, De-shen; Zhang, Dong-sheng; Luo, Hui-yan; Li, Yu-hong; Xu, Rui-hua			The Tumor-Log Odds of Positive Lymph Nodes-Metastasis Staging System, a Promising New Staging System for Gastric Cancer after D2 Resection in China	PLOS ONE			English	Article							TNM CLASSIFICATION; JOINT-COMMITTEE; RATIO; NUMBER; CARCINOMA; EDITION; IMPACT; UNION; LEVEL	Background: In this study, we established a hypothetical tumor-lodds-metastasis (TLM) and tumor-ratio-metastasis (TRM) staging system. Moreover, we compared them with the 7th edition of American Joint Committee on Cancer tumor-nodesmetastasis (AJCC TNM) staging system in gastric cancer patients after D2 resection. Methods: A total of 1000 gastric carcinoma patients receiving treatment in our center were selected for the analysis. Finally, 730 patients who received D2 resection were retrospectively studied. Patients were staged using the TLM, TRM and the 7th edition AJCC TNM system. Survival analysis was performed with a Cox regression model. We used two parameters to compare the TNM, TRM and TLM staging system, the -2log likelihood and the hazard ratio. Results: The cut points of lymph node ratio (LNR) were set as 0, 0-0.3, 0.3-0.6, 0.6-1.0. And for the log odds of positive lymph nodes (LODDS), the cut points were established as <= -0.5, -0.5-0, 0-0.5, >0.5. There were significant differences in survival among patients in different LODDS classifications for each pN or LNR groups. When stratified by the LODDS classifications, the prognosis was highly homologous between those in the according pN or LNR classifications. Multivariate analysis showed that TLM staging system was better than the TRM or TNM system for the prognostic evaluation. Conclusions: The TLM system was superior to the TRM or TNM system for prognostic assessment of gastric adenocarcinoma patients after D2 resection.	[Qiu, Miao-zhen; Qiu, Hui-juan; Wang, Zhi-qiang; Ren, Chao; Wang, De-shen; Zhang, Dong-sheng; Luo, Hui-yan; Li, Yu-hong; Xu, Rui-hua] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Qiu, Miao-zhen; Wang, Zhi-qiang; Ren, Chao; Wang, De-shen; Zhang, Dong-sheng; Luo, Hui-yan; Li, Yu-hong; Xu, Rui-hua] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Qiu, Hui-juan] Sun Yat Sen Univ, Dept Tradit Chinese Med, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Qiu, MZ (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	xurh@sysucc.org.cn	xu, rui/GRX-5734-2022; Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022; Xu, Rui-Hua/AAW-4766-2021; 骆, 卉妍/GWR-3383-2022	Xu, Rui-Hua/0000-0001-9771-8534; 骆, 卉妍/0000-0001-6312-9299	National Natural Science Foundation of China [30672408]; Guangzhou Bureau of Science and Technology [2006Z3-E0041]; Sun Yat-sen University (China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Bureau of Science and Technology; Sun Yat-sen University (China)	This work was supported by National Natural Science Foundation of China grant 30672408 Guangzhou Bureau of Science and Technology grant 2006Z3-E0041 and Sun Yat-sen University 985 Program Initiation Fund (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando E, 2002, ANN SURG ONCOL, V9, P775, DOI 10.1245/ASO.2002.10.011; Bouvier AM, 2002, CANCER, V94, P2862, DOI 10.1002/cncr.10550; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ichikura T, 2003, WORLD J SURG, V27, P330, DOI 10.1007/s00268-002-6730-9; Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lee HK, 2001, BRIT J SURG, V88, P1408, DOI 10.1046/j.0007-1323.2001.01875.x; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P17; Nio Y, 2003, ANTICANCER RES, V23, P697; Qiu MZ, 2011, ANN SURG ONCOL, V18, P1869, DOI 10.1245/s10434-010-1542-x; Shen JY, 2007, CANCER-AM CANCER SOC, V110, P745, DOI 10.1002/cncr.22837; Sun Z, 2009, ANN ONCOL, V20, P897, DOI 10.1093/annonc/mdn707; Sun Z, 2010, CANCER-AM CANCER SOC, V116, P2571, DOI 10.1002/cncr.24989; Vinh-Hung V, 2004, BREAST CANCER RES, V6, pR680, DOI 10.1186/bcr934; Wang JP, 2008, J GASTROINTEST SURG, V12, P1790, DOI 10.1007/s11605-008-0651-3; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716; Yildirim E, 2007, WORLD J SURG, V31, P276, DOI 10.1007/s00268-006-0487-5; Yoo CH, 1999, WORLD J SURG, V23, P492, DOI 10.1007/PL00012337	19	60	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31736	10.1371/journal.pone.0031736	http://dx.doi.org/10.1371/journal.pone.0031736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348125	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400045
J	Sulsky, SI; Carlton, L; Bochmann, F; Ellegast, R; Glitsch, U; Hartmann, B; Pallapies, D; Seidel, D; Sun, Y				Sulsky, Sandra I.; Carlton, Laura; Bochmann, Frank; Ellegast, Rolf; Glitsch, Ulrich; Hartmann, Bernd; Pallapies, Dirk; Seidel, D.; Sun, Yi			Epidemiological Evidence for Work Load as a Risk Factor for Osteoarthritis of the Hip: A Systematic Review	PLOS ONE			English	Review							OF-RHEUMATOLOGY CRITERIA; CROSS-SECTIONAL SURVEY; KNEE OSTEOARTHRITIS; MUSCULOSKELETAL DISORDERS; OCCUPATIONAL FACTORS; ULM OSTEOARTHRITIS; PHYSICAL-ACTIVITY; COXARTHROSIS; JOINT; POPULATION	Objective: Osteoarthritis of the hip (OA) is a common degenerative disorder of the joint cartilage that presents a major public health problem worldwide. While intrinsic risk factors (e.g, body mass and morphology) have been identified, external risk factors are not well understood. In this systematic review, the evidence for workload as a risk factor for hip OA is summarized and used to derive recommendations for prevention and further research. Methods: Epidemiological studies on workload or occupation and osteoarthritis of the hip were identified through database and bibliography searches. Using pre-defined quality criteria, 30 studies were selected for critical evaluation; six of these provided quantitative exposure data. Results: Study results were too heterogeneous to develop pooled risk estimates by specific work activities. The weight of evidence favors a graded association between long-term exposure to heavy lifting and risk of hip OA. Long-term exposure to standing at work might also increase the risk of hip OA. Conclusions: It is not possible to estimate a quantitative dose-response relationship between workload and hip OA using existing data, but there is enough evidence available to identify job-related heavy lifting and standing as hazards, and thus to begin developing recommendations for preventing hip OA by limiting the amount and duration of these activities. Future research to identify specific risk factors for work-related hip OA should focus on implementing rigorous study methods with quantitative exposure measures and objective diagnostic criteria.	[Sulsky, Sandra I.; Carlton, Laura] ENVIRON Int Corp, Amherst, MA USA; [Bochmann, Frank; Ellegast, Rolf; Glitsch, Ulrich; Sun, Yi] Inst Arbeitsschutz Deutsch Gesetzlichen Unfallver, St Augustin, Germany; [Hartmann, Bernd; Seidel, D.] Arbeitsmed Sicherheitstech Dienst, Berufsgenossenschaft Bauwirtschaft BG BAU, Berlin, Germany; [Pallapies, Dirk] Inst Pravent, Bochum, Germany; [Pallapies, Dirk] Arbeitsmed Deutsch Gesetzlichen Unfallversicherun, Bochum, Germany	Ruhr University Bochum	Sulsky, SI (corresponding author), ENVIRON Int Corp, Amherst, MA USA.	ssulsky@environcorp.com						ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; Aluoch MA, 2009, AAOHN J, V57, P283, DOI 10.3928/08910162-20090625-10; BADLEY EM, 1995, J RHEUMATOL, V22, P19; Barrero LH, 2009, SCAND J WORK ENV HEA, V35, P245, DOI 10.5271/sjweh.1335; Benke G, 2000, ANN OCCUP HYG, V44, P475, DOI 10.1093/annhyg/44.6.475; Bierma-Zeinstra S, 1999, J RHEUMATOL, V26, P1129; Bierma-Zeinstra SMA, 2007, NAT CLIN PRACT RHEUM, V3, P78, DOI 10.1038/ncprheum0423; Bolm-Audorff U, 2000, ARBEITSMED SOZIALMED, V35, P471; Chitnavis J, 2000, RHEUMATOLOGY, V39, P612, DOI 10.1093/rheumatology/39.6.612; Coggon D, 1998, AM J EPIDEMIOL, V147, P523; Cooper C, 1998, AM J EPIDEMIOL, V147, P516; CROFT P, 1994, J RHEUMATOL, V21, P591; CROFT P, 1992, SCAND J WORK ENV HEA, V18, P59, DOI 10.5271/sjweh.1608; CUNNINGHAM RJ, 1992, BRIT MED J, V305, P118, DOI 10.1136/bmj.305.6845.118-c; Cvijetic Selma, 1999, Arhiv za Higijenu Rada i Toksikologiju, V50, P371; D'Souza JC, 2005, J OCCUP REHABIL, V15, P129, DOI 10.1007/s10926-005-1215-y; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; Dahaghin S, 2005, ARTHRITIS RHEUM, V52, P3520, DOI 10.1002/art.21375; Drawer S, 2001, BRIT J SPORT MED, V35, P402, DOI 10.1136/bjsm.35.6.402; Elsner G, 1995, Z GESUNDHEITSWISS, V3, P131, DOI [10.1007/BF02959989, DOI 10.1007/BF02959989]; Euler U, 2010, SEARCH DOCUMENTATION; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Flugsrud GB, 2002, ARTHRITIS RHEUM, V46, P675, DOI 10.1002/art.10115; Gunther KP, 1998, ANN RHEUM DIS, V57, P717, DOI 10.1136/ard.57.12.717; HELIOVAARA M, 1993, ACTA ORTHOP SCAND, V64, P513, DOI 10.3109/17453679308993681; Jacobsen S, 2005, RHEUMATOLOGY, V44, P211, DOI 10.1093/rheumtology/keh436; Jacobsen S, 2004, OSTEOARTHR CARTILAGE, V12, P698, DOI 10.1016/j.joca.2004.06.002; Jarvholm B, 2008, OCCUP ENVIRON MED, V65, P275, DOI 10.1136/oem.2007.033365; Jensen LK, 2008, OCCUP ENVIRON MED, V65, P6, DOI 10.1136/oem.2006.032409; Jensen LK, 2006, OSTEOARTHRITIS HIP K, P1; Juhakoski R, 2009, RHEUMATOLOGY, V48, P83, DOI 10.1093/rheumatology/ken427; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kettunen JA, 2001, AM J SPORT MED, V29, P2, DOI 10.1177/03635465010290010801; KUJALA UM, 1994, BRIT MED J, V308, P819; Kujala UM, 1994, BRIT MED J, V308, P308; Lau E.M.C., 2007, HONG KONG MED J, V13, pS9; Lau EC, 2000, AM J EPIDEMIOL, V152, P855, DOI 10.1093/aje/152.9.855; LAWRENCE JS, 1966, BRIT J IND MED, V23, P42; Lievense A, 2001, J RHEUMATOL, V28, P2520; LINDBERG H, 1984, CLIN ORTHOP RELAT R, P159; Lissner L, 2004, AM J EPIDEMIOL, V159, P304, DOI 10.1093/aje/kwh048; Maetzel A, 1997, J RHEUMATOL, V24, P1599; MARTI B, 1989, BRIT MED J, V299, P91, DOI 10.1136/bmj.299.6691.91; Merx H, 2007, Z ORTHOP UNFALLCHIR, V145, P421, DOI 10.1055/s-2007-965552; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; Okunribido O, 2009, RR706 HSL, VRR706, P1; OLSEN O, 1994, SCAND J WORK ENV HEA, V20, P184, DOI 10.5271/sjweh.1410; PEROSH Working Group, 2011, CLEAR SYST REV OCC S; Pope DP, 2003, ANN RHEUM DIS, V62, P322, DOI 10.1136/ard.62.4.322; Reijman M, 2005, BMJ-BRIT MED J, V330, P1183, DOI 10.1136/bmj.38442.457488.8F; Riyazi N, 2008, OSTEOARTHR CARTILAGE, V16, P654, DOI 10.1016/j.joca.2007.10.012; ROACH KE, 1994, J RHEUMATOL, V21, P2334; Rossignol M, 2005, Occup Environ Med, V62, P772, DOI 10.1136/oem.2005.020057; Rossignol M, 2003, OCCUP ENVIRON MED, V60, P882, DOI 10.1136/oem.60.11.882; Sandmark H, 2000, OCCUP ENVIRON MED, V57, P673, DOI 10.1136/oem.57.10.673; Schmitt H, 2006, ORTHOPADE, V35, P1087, DOI 10.1007/s00132-006-0998-7; Schmitt H, 2004, ACTA ORTHOP SCAND, V75, P34, DOI 10.1080/00016470410001708060; Schouten JSAG, 2002, CURR OPIN RHEUMATOL, V14, P89, DOI 10.1097/00002281-200203000-00002; Shepard GJ, 2003, BRIT J SPORT MED, V37, P80, DOI 10.1136/bjsm.37.1.80; SPECTOR TD, 1994, ANN RHEUM DIS, V53, P143, DOI 10.1136/ard.53.2.143; Sun Y, 1997, Z ORTHOP GRENZGEB, V135, P184, DOI 10.1055/s-2008-1039578; Sun Y, 1997, SCAND J RHEUMATOL, V26, P155, DOI 10.3109/03009749709065675; Sun Y, 2000, SCAND J RHEUMATOL, V29, P380; Symmons D, 2006, GLOBAL BURDEN DIS 20; Teitz CC, 1998, CLIN J SPORT MED, V8, P255, DOI 10.1097/00042752-199810000-00001; Thelin A, 2004, AM J IND MED, V45, P202, DOI 10.1002/ajim.10330; THELIN A, 1990, AM J IND MED, V18, P339, DOI 10.1002/ajim.4700180316; Thelin A, 2007, AM J IND MED, V50, P604, DOI 10.1002/ajim.20484; Tuchsen F, 2003, ANN RHEUM DIS, V62, P1100, DOI 10.1136/ard.62.11.1100; VANDIJK CN, 1995, AM J SPORT MED, V23, P295; Vignon E, 2006, JOINT BONE SPINE, V73, P442, DOI 10.1016/j.jbspin.2006.03.001; VINGARD E, 1991, SCAND J WORK ENV HEA, V17, P104, DOI 10.5271/sjweh.1727; Vingard E, 1997, ANN RHEUM DIS, V56, P293, DOI 10.1136/ard.56.5.293; VINGARD E, 1991, INT J EPIDEMIOL, V20, P1025, DOI 10.1093/ije/20.4.1025; Vingard E, 1998, AM J SPORT MED, V26, P78, DOI 10.1177/03635465980260013101; Vingard E, 1997, ACTA ORTHOP SCAND, V68, P216, DOI 10.3109/17453679708996687; VINGARD E, 1993, AM J SPORT MED, V21, P195, DOI 10.1177/036354659302100206; WHO, 1993, EP CHRON RHEUM ATL S; WIKTORIN C, 1993, SCAND J WORK ENV HEA, V19, P208, DOI 10.5271/sjweh.1481; Yoshimura N, 2000, J RHEUMATOL, V27, P434; Zhang YQ, 2008, RHEUM DIS CLIN N AM, V34, P515, DOI 10.1016/j.rdc.2008.05.007	82	52	52	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31521	10.1371/journal.pone.0031521	http://dx.doi.org/10.1371/journal.pone.0031521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348095	gold, Green Published, Green Submitted			2022-12-27	WOS:000302737400027
J	Gingaras, C; Danielson, BP; Vigil, KJ; Vey, E; Arduino, RC; Kimata, JT				Gingaras, Cosmina; Danielson, Bryan P.; Vigil, Karen J.; Vey, Elana; Arduino, Roberto C.; Kimata, Jason T.			Absence of XMRV in Peripheral Blood Mononuclear Cells of ARV-Treatment Naive HIV-1 Infected and HIV-1/HCV Coinfected Individuals and Blood Donors	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; HUMAN-IMMUNODEFICIENCY-VIRUS; PROSTATE-CANCER; INFECTIOUS RETROVIRUS; NO ASSOCIATION; MOUSE DNA; PCR; CONTAMINATION; PREVALENCE	Background: Xenotropic murine leukemia virus-related virus (XMRV) has been found in the prostatic tissue of prostate cancer patients and in the blood of chronic fatigue syndrome patients. However, numerous studies have found little to no trace of XMRV in different human cohorts. Based on evidence suggesting common transmission routes between XMRV and HIV-1, HIV-1 infected individuals may represent a high-risk group for XMRV infection and spread. Methodology/Principal Findings: DNA was isolated from the peripheral blood mononuclear cells (PBMCs) of 179 HIV-1 infected treatment naive patients, 86 of which were coinfected with HCV, and 54 healthy blood donors. DNA was screened for XMRV provirus with two sensitive, published PCR assays targeting XMRV gag and env and one sensitive, published nested PCR assay targeting env. Detection of XMRV was confirmed by DNA sequencing. One of the 179 HIV-1 infected patients tested positive for gag by non-nested PCR whereas the two other assays did not detect XMRV in any specimen. All healthy blood donors were negative for XMRV proviral sequences. Sera from 23 HIV-1 infected patients (15 HCV+) and 12 healthy donors were screened for the presence of XMRV-reactive antibodies by Western blot. Thirteen sera (57%) from HIV-1(+) patients and 6 sera (50%) from healthy donors showed reactivity to XMRV-infected cell lysate. Conclusions/Significance: The virtual absence of XMRV in PBMCs suggests that XMRV is not associated with HIV-1 infected or HIV-1/HCV coinfected patients, or blood donors. Although we noted isolated incidents of serum reactivity to XMRV, we are unable to verify the antibodies as XMRV specific.	[Gingaras, Cosmina] Baylor Coll Med, Dept Pediat, Sect Retrovirol, Houston, TX 77030 USA; [Danielson, Bryan P.; Kimata, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Vigil, Karen J.; Vey, Elana; Arduino, Roberto C.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX USA; [Gingaras, Cosmina] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Gingaras, C (corresponding author), Baylor Coll Med, Dept Pediat, Sect Retrovirol, Houston, TX 77030 USA.	jkimata@bcm.edu	Vigil, Karen/HGB-5512-2022	Kimata, Jason/0000-0002-0504-0090	Dan L. Duncan Cancer Center [P30 CA125123]; Baylor-UT CFAR [P30 AI036211]; Baylor Pediatric AIDS Initiative National Institutes of Health (NIH) from the Fogarty International Center of the NIH [D43 TW001036]; NIH [T32 AI007471]; FOGARTY INTERNATIONAL CENTER [D43TW001036] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007471, P30AI036211] Funding Source: NIH RePORTER	Dan L. Duncan Cancer Center; Baylor-UT CFAR; Baylor Pediatric AIDS Initiative National Institutes of Health (NIH) from the Fogarty International Center of the NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by pilot funding from the Dan L. Duncan Cancer Center (P30 CA125123) and in part by the Baylor-UT CFAR (P30 AI036211). CG was supported by the Baylor Pediatric AIDS Initiative National Institutes of Health (NIH) training grant from the Fogarty International Center of the NIH (D43 TW001036). BD was supported in part by an NIH training grant in molecular virology (T32 AI007471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Balada E, 2010, INT REV IMMUNOL, V29, P351, DOI 10.3109/08830185.2010.485333; Barnes E, 2010, J INFECT DIS, V202, P1482, DOI 10.1086/657167; Bogerd HP, 2011, VIROLOGY, V410, P234, DOI 10.1016/j.virol.2010.11.011; CHESEBRO B, 1983, VIROLOGY, V127, P134, DOI 10.1016/0042-6822(83)90378-1; Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; CUSSENOT O, 1991, J UROLOGY, V146, P881, DOI 10.1016/S0022-5347(17)37953-3; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; DEGEORGES A, 1995, INT J CANCER, V62, P724, DOI 10.1002/ijc.2910620613; Dupressoir A, 1997, ONCOGENE, V14, P2951, DOI 10.1038/sj.onc.1201148; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Fischer N, 2010, EMERGING INFECT DISE, V16; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Gray ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018096; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Kunstman KJ, 2010, AIDS, V24, P1784, DOI 10.1097/QAD.0b013e32833b76fb; Lawoko A, 2000, J MED VIROL, V62, P435, DOI 10.1002/1096-9071(200012)62:4<435::AID-JMV7>3.0.CO;2-R; Lintas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016609; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; LUEDERS KK, 1977, CELL, V12, P963, DOI 10.1016/0092-8674(77)90161-1; Maggi F, 2011, CLIN MICROBIOLOGY IN; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Moles JP, 2003, VIRUS RES, V94, P97, DOI 10.1016/S0168-1702(03)00137-0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Qiu X, 2011, TRANSFUSION; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-14; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tang SX, 2011, TRANSFUSION, V51, P463, DOI 10.1111/j.1537-2995.2010.02932.x; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31398	10.1371/journal.pone.0031398	http://dx.doi.org/10.1371/journal.pone.0031398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348082	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900045
J	Mueller, EE; Schaier, E; Brunner, SM; Eder, W; Mayr, JA; Egger, SF; Nischler, C; Oberkofler, H; Reitsamer, HA; Patsch, W; Sperl, W; Kofler, B				Mueller, Edith E.; Schaier, Elena; Brunner, Susanne M.; Eder, Waltraud; Mayr, Johannes A.; Egger, Stefan F.; Nischler, Christian; Oberkofler, Hannes; Reitsamer, Herbert A.; Patsch, Wolfgang; Sperl, Wolfgang; Kofler, Barbara			Mitochondrial Haplogroups and Control Region Polymorphisms in Age-Related Macular Degeneration: A Case-Control Study	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; COMPLEMENT FACTOR-H; DNA HAPLOGROUPS; HUMAN MTDNA; DISEASE; DYSFUNCTION; RETINOPATHY; MUTATION; CANCER; DAMAGE	Background: Onset and development of the multifactorial disease age-related macular degeneration (AMD) are highly interrelated with mitochondrial functions such as energy production and free radical turnover. Mitochondrial dysfunction and overproduction of reactive oxygen species may contribute to destruction of the retinal pigment epithelium, retinal atrophy and choroidal neovascularization, leading to AMD. Consequently, polymorphisms of the mitochondrial genome (mtDNA) are postulated to be susceptibility factors for this disease. Previous studies from Australia and the United States detected associations of mitochondrial haplogroups with AMD. The aim of the present study was to test these associations in Middle European Caucasians. Methodology/Principal Findings: Mitochondrial haplogroups (combinations of mtDNA polymorphisms) and mitochondrial CR polymorphisms were analyzed in 200 patients with wet AMD (choroidal neovascularization, CNV), in 66 patients with dry AMD, and in 385 controls from Austria by means of multiplex primer extension analysis and sequencing, respectively. In patients with CNV, haplogroup H was found to be significantly less frequent compared to controls, and haplogroup J showed a trend toward a higher frequency compared to controls. Five CR polymorphisms were found to differ significantly in the two study populations compared to controls, and all, except one (T152C), are linked to those haplogroups. Conclusions/Significance: It can be concluded that haplogroup J is a risk factor for AMD, whereas haplogroup H seems to be protective for AMD.	[Mueller, Edith E.; Schaier, Elena; Brunner, Susanne M.; Eder, Waltraud; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria; [Egger, Stefan F.; Nischler, Christian; Reitsamer, Herbert A.] Paracelsus Med Univ, Dept Ophthalmol, Salzburg, Austria; [Oberkofler, Hannes; Patsch, Wolfgang] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Mueller, EE (corresponding author), Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria.	b.kofler@salk.at		Kofler, Barbara/0000-0002-1198-4776; Brunner, Susanne Maria/0000-0002-9623-1115; Mayr, Johannes/0000-0001-6970-336X	Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg	Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg	The study was supported by the "Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg'' (www.mito-center.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ebner S, 2009, PLOS ONE IN PRESS; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Loueslati BY, 2010, GENET MOL RES, V9, P1690, DOI 10.4238/vol9-3gmr778; Meyer S, 1999, GENETICS, V152, P1103; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Pereira L, 2005, INT J ANDROL, V28, P241, DOI 10.1111/j.1365-2605.2005.00539.x; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Schmuczerova J, 2009, MUTAT RES-FUND MOL M, V666, P1, DOI 10.1016/j.mrfmmm.2009.03.002; Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086	27	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30874	10.1371/journal.pone.0030874	http://dx.doi.org/10.1371/journal.pone.0030874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348027	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900016
J	Shetty, G; Comish, PB; Weng, CCY; Matin, A; Meistrich, ML				Shetty, Gunapala; Comish, Paul B.; Weng, Connie C. Y.; Matin, Angabin; Meistrich, Marvin L.			Fetal Radiation Exposure Induces Testicular Cancer in Genetically Susceptible Mice	PLOS ONE			English	Article							GERM-CELL TUMORS; CARCINOMA-IN-SITU; MOUSE SPERMATOGENESIS; RISK; TERATOMA; TESTIS; DMRT1; GENES; UTERO	The prevalence of testicular germ cell tumors (TGCT), a common solid tissue malignancy in young men, has been annually increasing at an alarming rate of 3%. Since the majority of testicular cancers are derived from germ cells at the stage of transformation of primordial germ cell (PGC) into gonocytes, the increase has been attributed to maternal/fetal exposures to environmental factors. We examined the effects of an estrogen (diethylstilbestrol, DES), an antiandrogen (flutamide), or radiation on the incidence of testicular germ cell tumors in genetically predisposed 129.MOLF-L1 (L1) congenic mice by exposing them to these agents on days 10.5 and 11.5 of pregnancy. Neither flutamide nor DES produced noticeable increases in testis cancer incidence at 4 weeks of age. In contrast, two doses of 0.8-Gy radiation increased the incidence of TGCT from 45% to 100% in the offspring. The percentage of mice with bilateral tumors, weights of testes with TGCT, and the percentage of tumors that were clearly teratomas were higher in the irradiated mice than in controls, indicating that irradiation induced more aggressive tumors and/or more foci of initiation sites in each testis. This radiation dose did not disrupt spermatogenesis, which was qualitatively normal in tumor-free testes although they were reduced in size. This is the first proof of induction of testicular cancer by an environmental agent and suggests that the male fetus of women exposed to radiation at about 5-6 weeks of pregnancy might have an increased risk of developing testicular cancer. Furthermore, it provides a novel tool for studying the molecular and cellular events of testicular cancer pathogenesis.	[Shetty, Gunapala; Comish, Paul B.; Weng, Connie C. Y.; Meistrich, Marvin L.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Matin, Angabin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shetty, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	sgunapal@mdanderson.org		Shetty, Gunapala/0000-0001-5786-0667	National Institutes of Health [CA 16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Florence M. Thomas Professorship in Cancer Research (to Marvin L Meistrich) and Cancer Center Support Grant CA 16672 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN LM, 1986, CANCER RES, V46, P4812; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kangasniemi M, 1996, ENDOCRINOLOGY, V137, P949, DOI 10.1210/en.137.3.949; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Matin A, 1999, NAT GENET, V23, P237, DOI 10.1038/13874; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Skinner Michael K., 2007, Critical Reviews in Oncogenesis, V13, P75; STEVENS LC, 1966, J NATL CANCER I, V37, P859; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Traina ME, 2003, REPROD TOXICOL, V17, P25, DOI 10.1016/S0890-6238(02)00101-6; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; WALKER AH, 1990, BRIT J CANCER, V62, P599, DOI 10.1038/bjc.1990.337; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Youngren KK, 2003, HUM MOL GENET, V12, P389, DOI 10.1093/hmg/ddg036; Zhu R, 2007, MAMM GENOME, V18, P584, DOI 10.1007/s00335-007-9036-2	28	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32064	10.1371/journal.pone.0032064	http://dx.doi.org/10.1371/journal.pone.0032064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348147	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900066
J	Zhao, P; Dong, ZM; Duan, J; Wang, GH; Wang, LY; Li, YS; Xiang, ZH; Xia, QY				Zhao, Ping; Dong, Zhaoming; Duan, Jun; Wang, Genhong; Wang, Lingyan; Li, Youshan; Xiang, Zhonghuai; Xia, Qingyou			Genome-Wide Identification and Immune Response Analysis of Serine Protease Inhibitor Genes in the Silkworm, Bombyx mori	PLOS ONE			English	Article							KAZAL-TYPE INHIBITOR; MANDUCA-SEXTA; PROTEINASE-INHIBITORS; EXTRACELLULAR-MATRIX; ANOPHELES-GAMBIAE; CHYMOTRYPSIN INHIBITORS; MELANIZATION CASCADE; EXPRESSION ANALYSIS; DROSOPHILA-SERPINS; TRYPSIN-INHIBITORS	In most insect species, a variety of serine protease inhibitors (SPIs) have been found in multiple tissues, including integument, gonad, salivary gland, and hemolymph, and are required for preventing unwanted proteolysis. These SPIs belong to different families and have distinct inhibitory mechanisms. Herein, we predicted and characterized potential SPI genes based on the genome sequences of silkworm, Bombyx mori. As a result, a total of eighty SPI genes were identified in B. mori. These SPI genes contain 10 kinds of SPI domains, including serpin, Kunitz_BPTI, Kazal, TIL, amfpi, Bowman-Birk, Antistasin, WAP, Pacifastin, and alpha-macroglobulin. Sixty-three SPIs contain single SPI domain while the others have at least two inhibitor units. Some SPIs also contain non-inhibitor domains for protein-protein interactions, including EGF, ADAM_spacer, spondin_N, reeler, TSP_1 and other modules. Microarray analysis showed that fourteen SPI genes from lineage-specific TIL family and Group F of serpin family had enriched expression in the silk gland. The roles of SPIs in resisting pathogens were investigated in silkworms when they were infected by four pathogens. Microarray and qRT-PCR experiments revealed obvious up-regulation of 8, 4, 3 and 3 SPI genes after infection with Escherichia coli, Bacillus bombysepticus, Beauveria bassiana or B. mori nuclear polyhedrosis virus (BmNPV), respectively. On the contrary, 4, 11, 7 and 9 SPI genes were down-regulated after infection with E. coli, B. bombysepticus, B. bassiana or BmNPV, respectively. These results suggested that these SPI genes may be involved in resistance to pathogenic microorganisms. These findings may provide valuable information for further clarifying the roles of SPIs in the development, immune defence, and efficient synthesis of silk gland protein.	[Zhao, Ping; Dong, Zhaoming; Duan, Jun; Wang, Genhong; Wang, Lingyan; Li, Youshan; Xiang, Zhonghuai; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Duan, Jun; Wang, Genhong; Xia, Qingyou] Chongqing Univ, Inst Agr & Life Sci, Chongqing 630044, Peoples R China	Southwest University - China; Chongqing University	Zhao, P (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Dong, Zhaoming/AAK-1802-2021; Wang, Genhong/AAC-3055-2019; Dong, Zhaoming/AAW-3060-2021	Dong, Zhaoming/0000-0001-5665-9953; Wang, Genhong/0000-0002-5598-7282; Dong, Zhaoming/0000-0001-5665-9953; Duan, Jun/0000-0003-2279-9290; Xia, Qingyou/0000-0002-9263-2886	National Natural Science Foundation of China [30972147]; National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; Graduate Technological Innovation Foundation of Southwest University of China [kb2010003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Graduate Technological Innovation Foundation of Southwest University of China	This work was supported by grants from the National Natural Science Foundation of China (No. 30972147), the National Basic Research Program of China (No.2012CB114600), the National Hi-Tech Research and Development Program of China (No. 2011AA100306) and the Graduate Technological Innovation Foundation of Southwest University of China (No. kb2010003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; ASO Y, 1994, BIOCHEM MOL BIOL INT, V33, P751; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Bhanumathy CD, 2002, DEV DYNAM, V223, P59, DOI 10.1002/dvdy.1235; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; BOIGEGRAIN RA, 1992, BIOCHEM BIOPH RES CO, V189, P790, DOI 10.1016/0006-291X(92)92271-X; Breugelmans B, 2009, INSECT BIOCHEM MOLEC, V39, P430, DOI 10.1016/j.ibmb.2009.03.005; CASTILLO GM, 1993, FEBS LETT, V318, P292, DOI 10.1016/0014-5793(93)80531-X; CHEN L, 1992, J BIOL CHEM, V267, P12380; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COLEMAN S, 1995, INSECT BIOCHEM MOLEC, V25, P203, DOI 10.1016/0965-1748(94)00055-M; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; DENG LR, 1990, INSECT BIOCHEM, V20, P531; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; EGUCHI M, 1994, J BIOCHEM-TOKYO, V115, P881, DOI 10.1093/oxfordjournals.jbchem.a124434; EGUCHI M, 1993, COMP BIOCHEM PHYS B, V104, P537, DOI 10.1016/0305-0491(93)90279-E; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eum JH, 2007, DEV COMP IMMUNOL, V31, P1107, DOI 10.1016/j.dci.2007.02.002; FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216; FUJII H, 1989, COMP BIOCHEM PHYS B, V94, P149, DOI 10.1016/0305-0491(89)90026-6; Fujii Hiroshi, 1996, Journal of Sericultural Science of Japan, V65, P334; Fujii Hiroshi, 1996, Journal of Sericultural Science of Japan, V65, P385; Garrett M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-489; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hamdaoui A, 1998, FEBS LETT, V422, P74, DOI 10.1016/S0014-5793(97)01585-8; HANSCHKE R, 1975, ACTA BIOL MED GER, V34, P531; Hayakawa Y, 1998, J INSECT PHYSIOL, V44, P859, DOI 10.1016/S0022-1910(98)00017-1; He NJ, 2004, BIOSCI BIOTECH BIOCH, V68, P835, DOI 10.1271/bbb.68.835; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Idoji Y, 2008, INT J MOL MED, V21, P461; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; KANG SH, 1980, BIOCHIM BIOPHYS ACTA, V611, P379, DOI 10.1016/0005-2744(80)90075-3; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; KANOST MR, 1990, INSECT BIOCHEM, V20, P141, DOI 10.1016/0020-1790(90)90006-G; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kramerova IA, 2003, DEV DYNAM, V226, P634, DOI 10.1002/dvdy.10265; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Kurioka Akira, 1999, Journal of Sericultural Science of Japan, V68, P397; Kurioka Akira, 2000, Journal of Sericultural Science of Japan, V69, P63; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ling EJ, 2009, INSECT BIOCHEM MOLEC, V39, P263, DOI 10.1016/j.ibmb.2008.12.006; Morita  T., 1961, ZOOL MAG, V70, P53; Nardi JB, 1999, INSECT BIOCHEM MOLEC, V29, P883, DOI 10.1016/S0965-1748(99)00064-8; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Nukumi N, 2007, CANCER LETT, V252, P65, DOI 10.1016/j.canlet.2006.12.005; Otlewski J, 1999, ACTA BIOCHIM POL, V46, P531, DOI 10.18388/abp.1999_4128; Pham TN, 1996, J BIOCHEM, V119, P428; RAMESH N, 1988, J BIOL CHEM, V263, P11523; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Reichhart JM, 2011, METHOD ENZYMOL, V499, P205, DOI 10.1016/B978-0-12-386471-0.00011-0; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Rester U, 1999, J MOL BIOL, V293, P93, DOI 10.1006/jmbi.1999.3162; SASAKI T, 1990, AGR BIOL CHEM TOKYO, V54, P131, DOI 10.1080/00021369.1990.10869888; SHINOHARA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1067, DOI 10.1271/bbb.57.1067; Shirai Koji, 1997, Journal of Sericultural Science of Japan, V66, P253; Shrivastava B, 2003, INSECT BIOCHEM MOLEC, V33, P1025, DOI 10.1016/S0965-1748(03)00117-6; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; THOMAS DJ, 1989, BIOCHEM J, V259, P905, DOI 10.1042/bj2590905; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Tripathi LP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-549; Tzarfati-Majar V, 2001, P NATL ACAD SCI USA, V98, P4722, DOI 10.1073/pnas.081062398; Walker LA, 2009, FUNGAL GENET BIOL, V46, P210, DOI 10.1016/j.fgb.2008.10.012; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xiao T, 2000, PROTEIN SCI, V9, P1889, DOI 10.1110/ps.9.10.1889; Zhao P, 2007, PROTEIN J, V26, P349, DOI 10.1007/s10930-007-9077-0; Zhao P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-405; Zhao QL, 2004, J FAC AGR KYUSHU U, V49, P93; Zheng QL, 2007, COMP BIOCHEM PHYS B, V146, P234, DOI 10.1016/j.cbpb.2006.10.106; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	90	68	80	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31168	10.1371/journal.pone.0031168	http://dx.doi.org/10.1371/journal.pone.0031168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348050	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900028
J	Aranday-Cortes, E; Hogarth, PJ; Kaveh, DA; Whelan, AO; Villarreal-Ramos, B; Lalvani, A; Vordermeier, HM				Aranday-Cortes, Elihu; Hogarth, Philip J.; Kaveh, Daryan A.; Whelan, Adam O.; Villarreal-Ramos, Bernardo; Lalvani, Ajit; Vordermeier, H. Martin			Transcriptional Profiling of Disease-Induced Host Responses in Bovine Tuberculosis and the Identification of Potential Diagnostic Biomarkers	PLOS ONE			English	Article							DELTA-T-CELLS; GAMMA-INTERFERON PRODUCTION; MYCOBACTERIUM-BOVIS; BCG VACCINATION; TH17 CELLS; INFECTION; CD4(+); CATTLE; IL-22; IP-10	Bovine tuberculosis (bTb) remains a major and economically important disease of livestock. Improved ante-mortem diagnostic tools would help to underpin novel control strategies. The definition of biomarkers correlating with disease progression could have impact on the rational design of novel diagnostic approaches for bTb. We have used a murine bTb model to identify promising candidates in the host transcriptome post-infection. RNA from in vitro-stimulated splenocytes and lung cells from BALB/c mice infected aerogenically with Mycobacterium bovis were probed with high-density microarrays to identify possible biomarkers of disease. In antigen-stimulated splenocytes we found statistically significant differential regulation of 1109 genes early (3 days) after infection and 1134 at a later time-point post-infection (14 days). 618 of these genes were modulated at both time points. In lung cells, 282 genes were significantly modulated post-infection. Amongst the most strongly up-regulated genes were: granzyme A, granzyme B, cxcl9, interleukin-22, and ccr6. The expression of 14 out of the most up-regulated genes identified in the murine studies was evaluated using in vitro with antigen-stimulated PBMC from uninfected and naturally infected cattle. We show that the expression of cxcl9, cxcl10, granzyme A and interleukin-22 was significantly increased in PBMC from infected cattle compared to naive animals following PPD stimulation in vitro. Thus, murine transcriptome analysis can be used to predict immunological responses in cattle allowing the prioritisation of CXCLl9, CXCL10, Granzyme A and IL-22 as potential additional readout systems for the ante-mortem diagnosis of bovine tuberculosis.	[Aranday-Cortes, Elihu; Hogarth, Philip J.; Kaveh, Daryan A.; Whelan, Adam O.; Villarreal-Ramos, Bernardo; Vordermeier, H. Martin] Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, TB Immunol Grp, London, England	Veterinary Laboratories Agency; Imperial College London	Aranday-Cortes, E (corresponding author), Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England.	martin.vordermeier@ahvla.gsi.gov.uk	Vordermeier, H Martin/C-6936-2011; Whelan, Adam O/C-9497-2011; Hogarth, Philip/C-6085-2011; Aranday-Cortes, Elihu/G-3706-2012	Hogarth, Philip/0000-0002-6343-7846; Lalvani, Ajit/0000-0002-2396-246X; Kaveh, Daryan/0000-0002-1451-0082; Aranday-Cortes, Elihu/0000-0003-2637-2307	Department for Environment, Food and Rural Affairs, United Kingdom	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Blanco FC, 2011, TUBERCULOSIS, V91, P57, DOI 10.1016/j.tube.2010.11.007; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Clark S, 2011, J ALLERGY CLIN IMMUN, V128, P838, DOI 10.1016/j.jaci.2011.05.025; Cortes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011319; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Gormley E, 2006, VET MICROBIOL, V112, P171, DOI 10.1016/j.vetmic.2005.11.029; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hogarth PJ, 2005, VACCINE, V23, P2557, DOI 10.1016/j.vaccine.2004.11.030; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1946, DOI 10.1128/CVI.00377-10; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; Vordermeier M, 2011, TROP ANIM HLTH PROD; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Waters W Ray, 2011, Clin Dev Immunol, V2011, P768542, DOI 10.1155/2011/768542; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09; Yao SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000789; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zarate-Blades CR, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/192630; Zeng GC, 2011, J IMMUNOL, V187, P190, DOI 10.4049/jimmunol.1004129	52	46	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30626	10.1371/journal.pone.0030626	http://dx.doi.org/10.1371/journal.pone.0030626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359547	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000302796200016
J	Spencer, JD; Hains, DS; Porter, E; Bevins, CL; DiRosario, J; Becknell, B; Wang, HY; Schwaderer, AL				Spencer, John David; Hains, David S.; Porter, Edith; Bevins, Charles L.; DiRosario, Julianne; Becknell, Brian; Wang, Huanyu; Schwaderer, Andrew L.			Human Alpha Defensin 5 Expression in the Human Kidney and Urinary Tract	PLOS ONE			English	Article							HUMAN BETA-DEFENSIN-1; ANTIMICROBIAL PEPTIDES; MECHANISM; INFECTION; INNATE; MOLECULES; BINDING	Background: The mechanisms that maintain sterility in the urinary tract are incompletely understood. Recent studies have implicated the importance of antimicrobial peptides (AMP) in protecting the urinary tract from infection. Here, we characterize the expression and relevance of the AMP human alpha-defensin 5 (HD5) in the human kidney and urinary tract in normal and infected subjects. Methodology/Principal Findings: Using RNA isolated from human kidney, ureter, and bladder tissue, we performed quantitative real-time PCR to show that DEFA5, the gene encoding HD5, is constitutively expressed throughout the urinary tract. With pyelonephritis, DEFA5 expression significantly increased in the kidney. Using immunoblot analysis, HD5 production also increased with pyelonephritis. Immunostaining localized HD5 to the urothelium of the bladder and ureter. In the kidney, HD5 was primarily produced in the distal nephron and collecting tubules. Using immunoblot and ELISA assays, HD5 was not routinely detected in non-infected human urine samples while mean urinary HD5 production increased with E. coli urinary tract infection. Conclusions/Significance: DEFA5 is expressed throughout the urinary tract in non-infected subjects. Specifically, HD5 is expressed throughout the urothelium of the lower urinary tract and in the collecting tubules of the kidney. With infection, HD5 expression increases in the kidney and levels become detectable in the urine. To our knowledge, our findings represent the first to quantitate HD5 expression and production in the human kidney. Moreover, this is the first report to detect the presence of HD5 in infected urine samples. Our results suggest that HD5 may have an important role in maintaining urinary tract sterility.	[Spencer, John David; Becknell, Brian] Nationwide Childrens Hosp, Pediat Nephrol Fellowship Program, Columbus, OH USA; [Spencer, John David; Hains, David S.; Becknell, Brian; Schwaderer, Andrew L.] Nationwide Childrens Hosp, Div Nephrol, Dept Pediat, Columbus, OH USA; [Hains, David S.; DiRosario, Julianne; Wang, Huanyu; Schwaderer, Andrew L.] Nationwide Childrens Hosp, Ctr Clin & Translat Res, Res Inst, Columbus, OH USA; [Porter, Edith] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA; [Bevins, Charles L.] Univ Calif Davis, Dept Microbiol & Immunol, Sch Med, Davis, CA 95616 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; California State University System; California State University Los Angeles; University of California System; University of California Davis	Spencer, JD (corresponding author), Nationwide Childrens Hosp, Pediat Nephrol Fellowship Program, Columbus, OH USA.	andrew.schwaderer@nationwidechildrens.org	Bevins, Charles L/P-4438-2015; Hains, David/E-3186-2011; Hains, David/AAR-1112-2020; Becknell, Michael/E-6995-2014; Schwaderer, Andrew/E-4049-2011; Wang, Huanyu/W-3145-2019	Bevins, Charles L/0000-0003-2725-2622; Wang, Huanyu/0000-0002-5982-6371; Hains, David/0000-0001-6511-9561	Research Institute at Nationwide Children's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JDS received intramural support from The Research Institute at Nationwide Children's Hospital. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; CARONE FA, 1982, J LAB CLIN MED, V100, P1; Chon CH, 2001, PEDIATR CLIN N AM, V48, P1441, DOI 10.1016/S0031-3955(05)70385-0; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Com E, 2003, BIOL REPROD, V68, P95, DOI 10.1095/biolreprod.102.005389; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Ganz T, 2001, Semin Respir Infect, V16, P4; Ganz T, 2001, J INFECT DIS, V183, pS41, DOI 10.1086/318838; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Liu LD, 1997, GENOMICS, V43, P316, DOI 10.1006/geno.1997.4801; LIVOLSI VA, 1993, CANCER, V71, P1391, DOI 10.1002/1097-0142(19930215)71:4<1391::AID-CNCR2820710434>3.0.CO;2-X; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nitschke M, 2002, EXP NEPHROL, V10, P332, DOI 10.1159/000065296; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Quayle AJ, 1998, AM J PATHOL, V152, P1247; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shen B, 2005, J CLIN PATHOL, V58, P687, DOI 10.1136/jcp.2004.022426; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Spencer JD, 2011, KIDNEY INT; Tikhonov I, 1997, NEPHROL DIAL TRANSPL, V12, P2557, DOI 10.1093/ndt/12.12.2557; Townes CL, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.08.019; VALORE EV, 1992, BLOOD, V79, P1538; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Wang AP, 2010, AFR J MICROBIOL RES, V4, P626; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Weichhart T, 2008, EUR J CLIN INVEST, V38, P29, DOI 10.1111/j.1365-2362.2008.02006.x; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zhang Dai, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P13	41	54	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31712	10.1371/journal.pone.0031712	http://dx.doi.org/10.1371/journal.pone.0031712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359618	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200087
J	Xie, L; Luo, CL; Zhang, CG; Zhang, R; Tang, J; Nie, QH; Ma, L; Hu, XX; Li, N; Da, Y; Zhang, XQ				Xie, Liang; Luo, Chenglong; Zhang, Chengguang; Zhang, Rong; Tang, Jun; Nie, Qinghua; Ma, Li; Hu, Xiaoxiang; Li, Ning; Da, Yang; Zhang, Xiquan			Genome-Wide Association Study Identified a Narrow Chromosome 1 Region Associated with Chicken Growth Traits	PLOS ONE			English	Article							ABDOMINAL FAT WEIGHT; BODY-WEIGHT; QUANTITATIVE TRAITS; F-2 INTERCROSS; LOCI; EXPRESSION; GENES; FOXO1; QTL; PREDICTION	Chicken growth traits are important economic traits in broilers. A large number of studies are available on finding genetic factors affecting chicken growth. However, most of these studies identified chromosome regions containing putative quantitative trait loci and finding causal mutations is still a challenge. In this genome-wide association study (GWAS), we identified a narrow 1.5 Mb region (173.5-175 Mb) of chicken (Gallus gallus) chromosome (GGA) 1 to be strongly associated with chicken growth using 47,678 SNPs and 489 F2 chickens. The growth traits included aggregate body weight (BW) at 0-90 d of age measured weekly, biweekly average daily gains (ADG) derived from weekly body weight, and breast muscle weight (BMW), leg muscle weight (LMW) and wing weight (WW) at 90 d of age. Five SNPs in the 1.5 Mb KPNA3-FOXO1A region at GGA1 had the highest significant effects for all growth traits in this study, including a SNP at 8.9 Kb upstream of FOXO1A for BW at 22-48 d and 70 d, a SNP at 1.9 Kb downstream of FOXO1A for WW, a SNP at 20.9 Kb downstream of ENSGALG00000022732 for ADG at 29-42 d, a SNP in INTS6 for BW at 90 d, and a SNP in KPNA3 for BMW and LMW. The 1.5 Mb KPNA3-FOXO1A region contained two microRNA genes that could bind to messenger ribonucleic acid (mRNA) of IGF1, FOXO1A and KPNA3. It was further indicated that the 1.5 Mb GGA1 region had the strongest effects on chicken growth during 22-42 d.	[Xie, Liang; Luo, Chenglong; Zhang, Chengguang; Zhang, Rong; Tang, Jun; Nie, Qinghua; Zhang, Xiquan] Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Ma, Li; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Luo, Chenglong] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Xie, Liang] Hainan Acad Agr Sci, Inst Anim Sci & Vet, Haikou, Hainan, Peoples R China; [Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; China Agricultural University	Xie, L (corresponding author), Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China.	yda@umn.edu; xqzhang@scau.edu.cn	ma, li/C-1585-2014; Ma, Li/B-1844-2010		National High Technology Research and Development Program of China (863 Program) [2006AA10A120, 2010AA10A102];  [CARS-42-G05]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); 	This research was supported by funding for China Agriculture Research System (CARS-42-G05) and by the National High Technology Research and Development Program of China (863 Program), projects 2006AA10A120 and 2010AA10A102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambo M, 2009, ANIM GENET, V40, P200, DOI 10.1111/j.1365-2052.2008.01824.x; Ankra-Badu GA, 2010, ANIM GENET, V41, P400, DOI 10.1111/j.1365-2052.2009.02017.x; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Atzmon G, 2006, ANIM GENET, V37, P352, DOI 10.1111/j.1365-2052.2006.01487.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Besnier F, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-3; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Cho JE, 2010, J APPL PHYSIOL, V108, P137, DOI 10.1152/japplphysiol.00704.2009; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Ensembl Genome Browser, 2011, ENSEMBL RELEASE 63; Gao Y, 2006, ANIM GENET, V37, P276, DOI 10.1111/j.1365-2052.2006.01428.x; Gao Y, 2009, ANIM GENET, V40, P952, DOI 10.1111/j.1365-2052.2009.01911.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Groenen M, 2009, PLANT AN GEN 17 C TO; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hu ZL, 2010, 9 WORLD C GEN APPL L; IBM Research, 2001, RNA22 MICRORNA TARG; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Le Rouzic A, 2008, GENETICS, V179, P1591, DOI 10.1534/genetics.108.089300; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Lei MM, 2005, POULTRY SCI, V84, P1191, DOI 10.1093/ps/84.8.1191; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu X, 2008, POULTRY SCI, V87, P1314, DOI 10.3382/ps.2007-00512; Liu X, 2007, POULTRY SCI, V86, P1084, DOI 10.1093/ps/86.6.1084; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mao YC, 2006, PHYSIOL GENOMICS, V28, P46, DOI 10.1152/physiolgenomics.00096.2006; Marklund S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-665; Minitab Inc, 2011, MIN 16; National Center for Biotechnology Information, 2011, ENTR GEN; Rao Y, 2007, GENET SEL EVOL, V39, P569, DOI 10.1051/gse:2007022; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; Uemoto Y, 2009, POULTRY SCI, V88, P477, DOI 10.3382/ps.2008-00296; Wahlberg P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-248; WANG S, 2011, SNPEVG GRAPHICAL TOO; Whitehead Institute for Biomedical Research, 2011, TARGETSCAN REL 5 2; Yuan YA, 2011, MOL CELL BIOCHEM, V348, P77, DOI 10.1007/s11010-010-0640-1; Zavadil J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012362; Zhou H, 2007, POULTRY SCI, V86, P255, DOI 10.3382/ps.2007-00267	49	86	100	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30910	10.1371/journal.pone.0030910	http://dx.doi.org/10.1371/journal.pone.0030910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359555	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200024
J	Bourlier, V; Sengenes, C; Zakaroff-Girard, A; Decaunes, P; Wdziekonski, B; Galitzky, J; Villageois, P; Esteve, D; Chiotasso, P; Dani, C; Bouloumie, A				Bourlier, Virginie; Sengenes, Coralie; Zakaroff-Girard, Alexia; Decaunes, Pauline; Wdziekonski, Brigitte; Galitzky, Jean; Villageois, Phi; Esteve, David; Chiotasso, Patrick; Dani, Christian; Bouloumie, Anne			TGFbeta Family Members Are Key Mediators in the Induction of Myofibroblast Phenotype of Human Adipose Tissue Progenitor Cells by Macrophages	PLOS ONE			English	Article							INSULIN-RESISTANCE; HUMAN OBESITY; CHRONIC INFLAMMATION; GENE-EXPRESSION; TGF-BETA; FIBROSIS; INFILTRATION; ACTIVATION; MECHANISMS; MATRIX	Objective: The present study was undertaken to characterize the remodeling phenotype of human adipose tissue (AT) macrophages (ATM) and to analyze their paracrine effects on AT progenitor cells. Research Design and Methods: The phenotype of ATM, immunoselected from subcutaneous (Sc) AT originating from subjects with wide range of body mass index and from paired biopsies of Sc and omental (Om) AT from obese subjects, was studied by gene expression analysis in the native and activated states. The paracrine effects of ScATM on the phenotype of human ScAT progenitor cells (CD34(+)CD31(-)) were investigated. Results: Two main ATM phenotypes were distinguished based on gene expression profiles. For ScAT-derived ATM, obesity and adipocyte-derived factors favored a pro-fibrotic/remodeling phenotype whereas the OmAT location and hypoxic culture conditions favored a pro-angiogenic phenotype. Treatment of native human ScAT progenitor cells with ScATM-conditioned media induced the appearance of myofibroblast-like cells as shown by expression of both alpha-SMA and the transcription factor SNAIL, an effect mimicked by TGF beta 1 and activinA. Immunohistochemical analyses showed the presence of double positive alpha-SMA and CD34 cells in the stroma of human ScAT. Moreover, the mRNA levels of SNAIL and SLUG in ScAT progenitor cells were higher in obese compared with lean subjects. Conclusions: Human ATM exhibit distinct pro-angiogenic and matrix remodeling/fibrotic phenotypes according to the adiposity and the location of AT, that may be related to AT microenvironment including hypoxia and adipokines. Moreover, human ScAT progenitor cells have been identified as target cells for ScATM-derived TGF beta and as a potential source of fibrosis through their induction of myofibroblast-like cells.	[Bourlier, Virginie; Sengenes, Coralie; Zakaroff-Girard, Alexia; Decaunes, Pauline; Galitzky, Jean; Esteve, David; Bouloumie, Anne] Univ Toulouse 3, UMR1048, INSERM, Inst Malad Metabol & Cardiovasc I2MC, F-31062 Toulouse, France; [Wdziekonski, Brigitte; Villageois, Phi; Dani, Christian] Univ Nice Sophia Antipolis, Fac Med, CNRS, UMR6543, Nice, France; [Chiotasso, Patrick] Hop Purpan, Serv Chirurg Digest, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse	Bourlier, V (corresponding author), Univ Toulouse 3, UMR1048, INSERM, Inst Malad Metabol & Cardiovasc I2MC, F-31062 Toulouse, France.	virginie.bourlier@inserm.fr	Galitzky, Jean/R-6599-2017; DANI, Christian/G-3639-2014; Bouloumie-Diehl, Anne/M-4446-2017; Sengenes, Coralie/GSN-0709-2022	DANI, Christian/0000-0003-3228-0230; Bouloumie-Diehl, Anne/0000-0001-5496-8891; Sengenes, Coralie/0000-0002-4820-6660; BOURLIER, Virginie/0000-0003-2407-6408	INSERM; ALFEDIAM/Roche Diagnostic; European Union Commission [HEALTH-F2-2008-2011 00]; Clarins SA	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ALFEDIAM/Roche Diagnostic; European Union Commission(European Commission); Clarins SA	This work was supported by INSERM, a grant from ALFEDIAM/Roche Diagnostic, the European Union Commission (Collaborative Project ADAPT (www.adapt-eu.net), Contract No. HEALTH-F2-2008-2011 00) and Clarins SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sivakumar P, 2008, INFLAMM RES, V57, P410, DOI 10.1007/s00011-008-7166-y; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Villaret A, 2010, DIABETES, V59, P2755, DOI 10.2337/db10-0398; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	38	56	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31274	10.1371/journal.pone.0031274	http://dx.doi.org/10.1371/journal.pone.0031274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355352	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300052
J	Huang, X; Hepkema, B; Nolte, I; Kushekhar, K; Jongsma, T; Veenstra, R; Poppema, S; Gao, ZF; Visser, L; Diepstra, A; van den Berg, A				Huang, Xin; Hepkema, Bouke; Nolte, Ilja; Kushekhar, Kushi; Jongsma, Theo; Veenstra, Rianne; Poppema, Sibrand; Gao, Zifen; Visser, Lydia; Diepstra, Arjan; van den Berg, Anke			HLA-A*02:07 Is a Protective Allele for EBV Negative and a Susceptibility Allele for EBV Positive Classical Hodgkin Lymphoma in China	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HLA CLASS-I; NASOPHARYNGEAL CARCINOMA; INFECTIOUS-MONONUCLEOSIS; T-LYMPHOCYTES; EPITOPES; IDENTIFICATION; RESPONSES; PEPTIDES; DISEASE	HLA-A2 protects from EBV+ classical Hodgkin lymphoma (cHL) in Western Europe, but it is unknown whether this protective effect also exists in the Chinese population. We investigated the association of HLA-A2 and specific common and well documented HLA-A2 subtypes with EBV stratified cHL patients (n = 161) from the northern part of China. Quantitative-PCR and sequence-based subtyping was performed to identify HLA-A2 positive samples and their subtypes. 67 (42%) of the cHL patients were EBV+. There were no significant differences in percentages of HLA-A2 positivity between cHL and controls (65% vs 66%) and between EBV+ and EBV- cHL patients (70% vs 61%). The frequency distribution of HLA-A2 subtypes was significantly different between EBV stratified cHL subgroups and controls. This difference was most striking for the HLAA*02:07 type with a frequency of 38% in EBV+ cHL, 8% in EBV- cHL and 20% in controls. Significant differences were also observed for the HLA-A*02:07, HLA-A2 (non-02:07) and the A2-negative typings between EBV+ cHL vs controls (p = 0.028), EBV- cHL vs controls (p = 0.045) and EBV+ vs EBV- cHL cases (p = 2 x 10(-5)). In conclusion, HLA-A*02: 07 is a predisposing allele for EBV+ cHL and a protective allele for EBV- cHL in the northern Chinese population.	[Huang, Xin; Kushekhar, Kushi; Veenstra, Rianne; Poppema, Sibrand; Visser, Lydia; Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Huang, Xin; Gao, Zifen] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Hepkema, Bouke; Jongsma, Theo] Univ Groningen, Dept Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Unit Genet Epidemiol & Bioinformat, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Peking University; University of Groningen; University of Groningen	Huang, X (corresponding author), Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands.	a.van.den.berg01@umcg.nl	van den Berg, Anke/H-1718-2011; Visser, Lydia/D-7675-2012; Poppema, Sibrand/D-1204-2012	van den Berg, Anke/0000-0002-8894-2638; Kushekhar, Kushi/0000-0003-2380-6309; Diepstra, Arjan/0000-0001-9239-1050	University Medical Center Groningen; Dutch Cancer Society [KWF: RUG 2009-4313]	University Medical Center Groningen; Dutch Cancer Society(KWF Kankerbestrijding)	This work is supported by a Bernoulli Bursary, University Medical Center Groningen and by a grant from the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambinder Richard F, 2007, Hematology Am Soc Hematol Educ Program, P204, DOI 10.1182/asheducation-2007.1.204; Brennan RM, 2008, BLOOD, V112, P2589, DOI 10.1182/blood-2008-06-162883; Browning M, 1996, IMMUNOL TODAY, V17, P165, DOI 10.1016/0167-5699(96)80614-1; Burt RD, 1996, CANCER EPIDEM BIOMAR, V5, P879; Carbone A, 2009, CURR OPIN HIV AIDS, V4, P3, DOI 10.1097/COH.0b013e32831a722b; Cheng Liang-Hong, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P321; Chiang AKS, 1996, INT J CANCER, V68, P285, DOI 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hjalgrim H, 2010, P NATL ACAD SCI USA, V107, P6400, DOI 10.1073/pnas.0915054107; Hollsberg P, 2002, SCAND J IMMUNOL, V55, P189, DOI 10.1046/j.0300-9475.2001.01043.x; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett AF, 1996, ANN ONCOL, V7, P5; Khanna R, 1998, EUR J IMMUNOL, V28, P451, DOI 10.1002/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.0.CO;2-U; KRAUSA P, 1995, TISSUE ANTIGENS, V45, P223, DOI 10.1111/j.1399-0039.1995.tb02444.x; Kruger S, 2003, J IMMUNOTHER, V26, P212, DOI 10.1097/00002371-200305000-00005; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Pasini E, 2009, INT J CANCER, V125, P1358, DOI 10.1002/ijc.24515; Poppema S, 1996, BAILLIERE CLIN HAEM, V9, P447, DOI 10.1016/S0950-3536(96)80020-5; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Sidney J, 1997, HUM IMMUNOL, V58, P12, DOI 10.1016/S0198-8859(97)00206-1; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Straathof KC, 2005, J IMMUNOL, V175, P4137, DOI 10.4049/jimmunol.175.6.4137; SUDO T, 1995, J IMMUNOL, V155, P4749; Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219	25	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31865	10.1371/journal.pone.0031865	http://dx.doi.org/10.1371/journal.pone.0031865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355400	gold, Green Submitted, Green Published			2022-12-27	WOS:000302741300100
J	Lysholm, F; Wetterbom, A; Lindau, C; Darban, H; Bjerkner, A; Fahlander, K; Lindberg, AM; Persson, B; Allander, T; Andersson, B				Lysholm, Fredrik; Wetterbom, Anna; Lindau, Cecilia; Darban, Hamid; Bjerkner, Annelie; Fahlander, Kristina; Lindberg, A. Michael; Persson, Bengt; Allander, Tobias; Andersson, Bjorn			Characterization of the Viral Microbiome in Patients with Severe Lower Respiratory Tract Infections, Using Metagenomic Sequencing	PLOS ONE			English	Article							VIRUS TTV; SYNCYTIAL VIRUS; IDENTIFICATION; PREVALENCE; PARVOVIRUS; CHILDREN; SAMPLES	The human respiratory tract is heavily exposed to microorganisms. Viral respiratory tract pathogens, like RSV, influenza and rhinoviruses cause major morbidity and mortality from respiratory tract disease. Furthermore, as viruses have limited means of transmission, viruses that cause pathogenicity in other tissues may be transmitted through the respiratory tract. It is therefore important to chart the human virome in this compartment. We have studied nasopharyngeal aspirate samples submitted to the Karolinska University Laboratory, Stockholm, Sweden from March 2004 to May 2005 for diagnosis of respiratory tract infections. We have used a metagenomic sequencing strategy to characterize viruses, as this provides the most unbiased view of the samples. Virus enrichment followed by 454 sequencing resulted in totally 703,790 reads and 110,931 of these were found to be of viral origin by using an automated classification pipeline. The snapshot of the respiratory tract virome of these 210 patients revealed 39 species and many more strains of viruses. Most of the viral sequences were classified into one of three major families; Paramyxoviridae, Picornaviridae or Orthomyxoviridae. The study also identified one novel type of Rhinovirus C, and identified a number of previously undescribed viral genetic fragments of unknown origin.	[Lysholm, Fredrik; Persson, Bengt] Linkoping Univ, IFM Bioinformat, Linkoping, Sweden; [Lysholm, Fredrik; Persson, Bengt] Linkoping Univ, Swedish E Sci Res Ctr SeRC, Linkoping, Sweden; [Lysholm, Fredrik; Wetterbom, Anna; Darban, Hamid; Bjerkner, Annelie; Persson, Bengt; Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Sci Life Lab, Stockholm, Sweden; [Lindau, Cecilia; Bjerkner, Annelie; Fahlander, Kristina; Allander, Tobias] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Lab Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden; [Lindberg, A. Michael] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Linkoping University; Linkoping University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Linnaeus University	Lysholm, F (corresponding author), Linkoping Univ, IFM Bioinformat, Linkoping, Sweden.	bjorn.andersson@ki.se	Andersson, Bjorn/G-9832-2013; Lindberg, A. Michael/B-8465-2013	Andersson, Bjorn/0000-0002-4624-0259; Lindberg, A. Michael/0000-0003-3841-4826; Persson, Bengt/0000-0003-3165-5344	Swedish Research Council [2010-3754]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Swedish Research Council, 2010-3754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2008, WORLD HLTH REPORT 20; Bizzintino J, 2010, EUR RESP J; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Goh S, 2009, EMERG INFECT DIS, V15, P489, DOI 10.3201/eid1503.081206; Gunnarsson RK, 2001, FAM PRACT, V18, P266, DOI 10.1093/fampra/18.3.266; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hershenson MB, 2006, AM J RESP CRIT CARE, V174, P1284, DOI 10.1164/rccm.200609-1387ED; Hino S, 2002, REV MED VIROL, V12, P151, DOI 10.1002/rmv.351; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001; Rosario K, 2009, APPL ENVIRON MICROB, V75, P7261, DOI 10.1128/AEM.00410-09; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Smit AFA, UNPUB; Thom K, 2003, VIROLOGY, V306, P324, DOI 10.1016/S0042-6822(02)00049-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vasilyev EV, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-134; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	41	124	130	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30875	10.1371/journal.pone.0030875	http://dx.doi.org/10.1371/journal.pone.0030875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355331	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300031
J	Mei, H; Chen, W; Jiang, F; He, J; Srinivasan, S; Smith, EN; Schork, N; Murray, S; Berenson, GS				Mei, Hao; Chen, Wei; Jiang, Fan; He, Jiang; Srinivasan, Sathanur; Smith, Erin N.; Schork, Nicholas; Murray, Sarah; Berenson, Gerald S.			Longitudinal Replication Studies of GWAS Risk SNPs Influencing Body Mass Index over the Course of Childhood and Adulthood	PLOS ONE			English	Article							OBESITY; VARIANTS; LOCI; DISEASES; BOGALUSA; WEIGHT; BIRTH; GENE; FTO	Genome-wide association studies (GWAS) have identified multiple common variants associated with body mass index (BMI). In this study, we tested 23 genotyped GWAS-significant SNPs (p-value<5*10-8) for longitudinal associations with BMI during childhood (3-17 years) and adulthood (18-45 years) for 658 subjects. We also proposed a heuristic forward search for the best joint effect model to explain the longitudinal BMI variation. After using false discovery rate (FDR) to adjust for multiple tests, childhood and adulthood BMI were found to be significantly associated with six SNPs each (q-value<0.05), with one SNP associated with both BMI measurements: KCTD15 rs29941 (q-value<7.6*10-4). These 12 SNPs are located at or near genes either expressed in the brain (BDNF, KCTD15, TMEM18, MTCH2, and FTO) or implicated in cell apoptosis and proliferation (FAIM2, MAP2K5, and TFAP2B). The longitudinal effects of FAIM2 rs7138803 on childhood BMI and MAP2K5 rs2241423 on adulthood BMI decreased as age increased (q-value<0.05). The FTO candidate SNPs, rs6499640 at the 5'-end and rs1121980 and rs8050136 downstream, were associated with childhood and adulthood BMI, respectively, and the risk effects of rs6499640 and rs1121980 increased as birth weight decreased. The best joint effect model for childhood and adulthood BMI contained 14 and 15 SNPs each, with 11 in common, and the percentage of explained variance increased from 0.17% and 9.0*10(-6)% to 2.22% and 2.71%, respectively. In summary, this study evidenced the presence of long-term major effects of genes on obesity development, implicated in pathways related to neural development and cell metabolism, and different sets of genes associated with childhood and adulthood BMI, respectively. The gene effects can vary with age and be modified by prenatal development. The best joint effect model indicated that multiple variants with effects that are weak or absent alone can nevertheless jointly exert a large longitudinal effect on BMI.	[Mei, Hao; He, Jiang] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA; [Chen, Wei; Srinivasan, Sathanur; Berenson, Gerald S.] Tulane Univ, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70118 USA; [Jiang, Fan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Smith, Erin N.] Univ Calif San Diego, Sch Med, Dept Pediat & Radys, La Jolla, CA 92093 USA; [Schork, Nicholas; Murray, Sarah] Scripps Genom Med & Scripps Translat Sci Inst, La Jolla, CA USA	Tulane University; Tulane University; Shanghai Jiao Tong University; University of California System; University of California San Diego	Mei, H (corresponding author), Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA.	berenson@tulane.edu	He, Jiang/AAF-5303-2020; Jiang, Fan/AGX-9052-2022; Jiang, Fan/AHA-6297-2022; Smith, Erin/E-5933-2011	He, Jiang/0000-0002-8286-9652; Jiang, Fan/0000-0003-0634-101X; Schork, Nicholas/0000-0003-0920-5013	National Institute of Child Health and Human Development [HD-061437, HD-062783]; National Institute on Aging [AG-16592]; National Institutes of Health/National Center for Research Resources [UL1 RR025774]; NHLBI [U01HL072507, R01HL087263, R01HL090682]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061437, R03HD062783] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087263, U01HL072507, R01HL090682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants HD-061437 and HD-062783 from the National Institute of Child Health and Human Development, AG-16592 from the National Institute on Aging and in part by National Institutes of Health/National Center for Research Resources Grant UL1 RR025774 and NHLBI research grants (U01HL072507, R01HL087263, and R01HL090682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenson GS, 1995, AM J MED SCI, V310, pS133, DOI 10.1097/00000441-199512000-00024; Berenson GS., 1980, CARDIOVASCULAR RISK; Broyles S, 2010, PEDIATRICS, V125, P900, DOI 10.1542/peds.2009-2748; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FABSITZ RR, 1992, INT J OBESITY, V16, P657; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman W, QUANTO 1 1 COMPUTER; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; Jurvansuu J, 2008, CANCER RES, V68, P4614, DOI 10.1158/0008-5472.CAN-07-5291; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mei H, 2010, HUM GENET, V128, P589, DOI 10.1007/s00439-010-0883-7; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Webber LS, 1995, AM J MED SCI, V310, pS53, DOI 10.1097/00000441-199512000-00010; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williamson JA, 1996, GENOMICS, V35, P262, DOI 10.1006/geno.1996.0351; Yerushalmi GM, 2002, NEOPLASIA, V4, P510, DOI 10.1038/sj.neo.7900272; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	36	45	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31470	10.1371/journal.pone.0031470	http://dx.doi.org/10.1371/journal.pone.0031470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355368	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300068
J	Shome, S; Dasgupta, PS; Basu, S				Shome, Saurav; Dasgupta, Partha Sarathi; Basu, Sujit			Dopamine Regulates Mobilization of Mesenchymal Stem Cells during Wound Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MARROW STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; VASCULAR-PERMEABILITY; ADIPOSE-TISSUE; IN-VIVO; DIABETIC MICE; TUMOR-GROWTH; MIGRATION	Angiogenesis is an important step in the complex biological and molecular events leading to successful healing of dermal wounds. Among the different cellular effectors of wound angiogenesis, the role of mesenchymal stem cells (MSCs) is of current interest due to their transdifferentiation and proangiogenic potentials. Skin is richly innervated by sympathetic nerves which secrete dopamine (DA) and we have recently shown that concentration of DA present in synaptic cleft can significantly inhibit wound tissue neovascularization. As recent reports indicate that MSCs by mobilizing into wound bed play an important role in promoting wound angiogenesis, we therefore investigated the effect of DA on the migration of MSCs in wound tissues. DA acted through its D-2 receptors present in the MSCs to inhibit their mobilization to the wound beds by suppressing Akt phosphorylation and actin polymerization. In contrast, this inhibitory effect of DA was reversed after treatment with specific DA D-2 receptor antagonist. Increased mobilization of MSCs was demonstrated in the wound site following blockade of DA D-2 receptor mediated actions, and this in turn was associated with significantly more angiogenesis in wound tissues. This study is of translational value and indicates use of DA D-2 receptor antagonists to stimulate mobilization of these stem cells for faster regeneration of damaged tissues.	[Shome, Saurav; Dasgupta, Partha Sarathi] Chittaranjan Natl Canc Inst, Dept Signal Transduct & Biogen Amines, Kolkata, W Bengal, India; [Basu, Sujit] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Dorthy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Shome, S (corresponding author), Chittaranjan Natl Canc Inst, Dept Signal Transduct & Biogen Amines, Kolkata, W Bengal, India.	partha42002@yahoo.com; sujit.basu@osumc.edu			DRDO (Defence Research and Development Organisation, Government of India) [DLS/81/48222/LSRB-117/ID/2006]; National Institutes of Health, USA [R01-CA124763]; CSIR (Council of Scientific and Industrial Research, Government of India) [9/30(54)/2009-EMR-1]; NATIONAL CANCER INSTITUTE [R01CA124763] Funding Source: NIH RePORTER	DRDO (Defence Research and Development Organisation, Government of India)(Defence Research & Development Organisation (DRDO)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSIR (Council of Scientific and Industrial Research, Government of India)(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by DRDO (Defence Research and Development Organisation, Government of India) Grants DLS/81/48222/LSRB-117/ID/2006 to Dr. Dasgupta and National Institutes of Health, USA R01-CA124763 to Dr. Basu; CSIR (Council of Scientific and Industrial Research, Government of India) Pre-doctoral Fellowship 9/30(54)/2009-EMR-1 (Dr. Shome). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartunek J, 2007, AM J PHYSIOL-HEART C, V292, pH1095, DOI 10.1152/ajpheart.01009.2005; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Berthoud HR, 2006, AM J PHYSIOL-REG I, V291, pR1240, DOI 10.1152/ajpregu.00428.2006; Busletta C, 2011, STEM CELLS, V29, P952, DOI 10.1002/stem.642; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chiou WF, 2007, LIFE SCI, V81, P109, DOI 10.1016/j.lfs.2007.04.028; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; Ferrari A, 2001, J BIOMED MATER RES, V56, P361, DOI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Javazon EH, 2007, WOUND REPAIR REGEN, V15, P350, DOI 10.1111/j.1524-475X.2007.00237.x; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Lau K, 2009, EXP DERMATOL, V18, P921, DOI 10.1111/j.1600-0625.2009.00942.x; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Li LR, 2011, CELL BIOL INT, V35, P961, DOI 10.1042/CBI20100544; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Nissen NN, 1998, AM J PATHOL, V152, P1445; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ritter E, 2008, ANN SURG, V247, P310, DOI 10.1097/SLA.0b013e31816401d5; Romijn JA, 2005, CURR OPIN CLIN NUTR, V8, P440, DOI 10.1097/01.mco.0000172586.09762.55; Rubi B, 2010, ENDOCRINOLOGY, V151, P5570, DOI 10.1210/en.2010-0745; Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Sarkar C, 2004, AM J PHYSIOL-HEART C, V287, pH1554, DOI 10.1152/ajpheart.00272.2004; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; Seiffert K, 2008, NEUROIMMUNOLOGY SKIN, P65; Shi EY, 2007, ANN THORAC SURG, V83, P1484, DOI 10.1016/j.athoracsur.2006.11.048; Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017; Shome S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025215; Sorrell JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt30; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Vargovic P, 2011, FEBS LETT, V585, P2279, DOI 10.1016/j.febslet.2011.06.001; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420	60	28	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31682	10.1371/journal.pone.0031682	http://dx.doi.org/10.1371/journal.pone.0031682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355389	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300089
J	Gempe, T; Stach, S; Bienefeld, K; Beye, M				Gempe, Tanja; Stach, Silke; Bienefeld, Kaspar; Beye, Martin			Mixing of Honeybees with Different Genotypes Affects Individual Worker Behavior and Transcription of Genes in the Neuronal Substrate	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DIVISION-OF-LABOR; HYGIENIC BEHAVIOR; TASK SPECIALIZATION; RESPONSE THRESHOLDS; FORAGING BEHAVIOR; BEE; COLONY; ORGANIZATION; HYMENOPTERA	Division of labor in social insects has made the evolution of collective traits possible that cannot be achieved by individuals alone. Differences in behavioral responses produce variation in engagement in behavioral tasks, which as a consequence, generates a division of labor. We still have little understanding of the genetic components influencing these behaviors, although several candidate genomic regions and genes influencing individual behavior have been identified. Here, we report that mixing of worker honeybees with different genotypes influences the expression of individual worker behaviors and the transcription of genes in the neuronal substrate. These indirect genetic effects arise in a colony because numerous interactions between workers produce interacting phenotypes and genotypes across organisms. We studied hygienic behavior of honeybee workers, which involves the cleaning of diseased brood cells in the colony. We mixed,500 newly emerged honeybee workers with genotypes of preferred Low (L) and High (H) hygienic behaviors. The L/H genotypic mixing affected the behavioral engagement of L worker bees in a hygienic task, the cooperation among workers in uncapping single brood cells, and switching between hygienic tasks. We found no evidence that recruiting and task-related stimuli are the primary source of the indirect genetic effects on behavior. We suggested that behavioral responsiveness of L bees was affected by genotypic mixing and found evidence for changes in the brain in terms of 943 differently expressed genes. The functional categories of cell adhesion, cellular component organization, anatomical structure development, protein localization, developmental growth and cell morphogenesis were overrepresented in this set of 943 genes, suggesting that indirect genetic effects can play a role in modulating and modifying the neuronal substrate. Our results suggest that genotypes of social partners affect the behavioral responsiveness and the neuronal substrate of individual workers, indicating a complex genetic architecture underlying the expression of behavior.	[Gempe, Tanja; Beye, Martin] Univ Dusseldorf, Dept Genet, Dusseldorf, Germany; [Stach, Silke; Bienefeld, Kaspar] Inst Bee Res, Hohen Neuendorf, Germany	Heinrich Heine University Dusseldorf	Gempe, T (corresponding author), Univ Dusseldorf, Dept Genet, Dusseldorf, Germany.	martin.beye@uni-duesseldorf.de			Deuteche Bundesstiftung Umwelt (DBU)	Deuteche Bundesstiftung Umwelt (DBU)	This work was supported by the Deuteche Bundesstiftung Umwelt (DBU) http://www.dbu.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, VITAM HORM, V83, P401, DOI 10.1016/S0083-6729(10)83017-1; Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; [Anonymous], 1971, INSECT SOC; Arathi HS, 2001, ANIM BEHAV, V62, P57, DOI 10.1006/anbe.2000.1731; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bienefeld K., 2001, P 37 INT AP C; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; CALDERONE NW, 1992, BEHAV ECOL SOCIOBIOL, V30, P219, DOI 10.1007/BF00166706; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DRELLER C, 1995, NATURWISSENSCHAFTEN, V82, P243, DOI 10.1007/BF01133602; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; FEWELL JH, 1993, EXPERIENTIA, V49, P1106, DOI 10.1007/BF01929923; FRUMHOFF PC, 1988, NATURE, V333, P358, DOI 10.1038/333358a0; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh Claudia, 2010, Front Biosci (Schol Ed), V2, P268; Guzman-Novoa E, 2002, BEHAV GENET, V32, P95, DOI 10.1023/A:1015245605670; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Holldobler B., 1990, pi; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; HUNT GJ, 1995, GENETICS, V141, P1537; Hunt GJ, 1998, GENETICS, V148, P1203; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Keller L, 2009, PHILOS T R SOC B, V364, P3209, DOI 10.1098/rstb.2009.0108; Lapidge KL, 2002, NATURWISSENSCHAFTEN, V89, P565, DOI 10.1007/s00114-002-0371-6; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; Linksvayer TA, 2009, AM NAT, V173, pE99, DOI 10.1086/596527; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; MICHENER CD, 1974, SOCIAL BEHAV BEES; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; MORITZ RFA, 1987, BEHAV ECOL SOCIOBIOL, V21, P53, DOI 10.1007/BF00324435; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; OLDROYD BP, 1994, BEHAV ECOL SOCIOBIOL, V34, P25, DOI 10.1007/BF00175455; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Page RE, 2000, J HERED, V91, P474, DOI 10.1093/jhered/91.6.474; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1988, NATURE, V333, P356, DOI 10.1038/333356a0; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; ROTHENBUHLER WC, 1964, AM ZOOL, V4, P111; Rueppell O, 2006, GENETICS, V172, P243, DOI 10.1534/genetics.105.046490; Seeley TD., 1985, HONEYBEE ECOLOGY, DOI [10.1515/9781400857876, DOI 10.1515/9781400857876]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Thakur RK, 1998, APIDOLOGIE, V29, P431, DOI DOI 10.1051/APIDO:19980502; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0	60	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31653	10.1371/journal.pone.0031653	http://dx.doi.org/10.1371/journal.pone.0031653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348118	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400040
J	Haines, B; Li, PA				Haines, Bryan; Li, P. Andy			Overexpression of Mitochondrial Uncoupling Protein 2 Inhibits Inflammatory Cytokines and Activates Cell Survival Factors after Cerebral Ischemia	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; NECROSIS-FACTOR-ALPHA; BROWN ADIPOSE-TISSUE; BRAIN-INJURY; OXIDATIVE STRESS; ARTERY OCCLUSION; TRANSGENIC MICE; FOCAL ISCHEMIA; RAT-BRAIN; STROKE	Mitochondria play a critical role in cell survival and death after cerebral ischemia. Uncoupling proteins (UCPs) are inner mitochondrial membrane proteins that disperse the mitochondrial proton gradient by translocating H+ across the inner membrane in order to stabilize the inner mitochondrial membrane potential (Delta psi(m)) and reduce the formation of reactive oxygen species. Previous studies have demonstrated that mice transgenically overexpressing UCP2 (UCP2 Tg) in the brain are protected from cerebral ischemia, traumatic brain injury and epileptic challenges. This study seeks to clarify the mechanisms responsible for neuroprotection after transient focal ischemia. Our hypothesis is that UCP2 is neuroprotective by suppressing innate inflammation and regulating cell cycle mediators. PCR gene arrays and protein arrays were used to determine mechanisms of damage and protection after transient focal ischemia. Our results showed that ischemia increased the expression of inflammatory genes and suppressed the expression of anti-apoptotic and cell cycle genes. Overexpression of UCP2 blunted the ischemia-induced increase in IL-6 and decrease in Bcl2. Further, UCP2 increased the expression of cell cycle genes and protein levels of phospho-AKT, PKC and MEK after ischemia. It is concluded that the neuroprotective effects of UCP2 against ischemic brain injury are associated with inhibition of pro-inflammatory cytokines and activation of cell survival factors.	[Haines, Bryan] Buck Inst Res Aging, Novato, CA 94945 USA; [Li, P. Andy] N Carolina Cent Univ, Dept Pharmaceut Sci, BRITE, Durham, NC USA	Buck Institute for Research on Aging; University of North Carolina; North Carolina Central University	Haines, B (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	pli@nccu.edu			National Institutes of Health [R01DK075476-06]; Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was funded by the National Institutes of Health R01DK075476-06. The BRITE program is partially funded by the Golden Leaf Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bernardi R, 2000, ONCOGENE, V19, P2447, DOI 10.1038/sj.onc.1203564; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Clark CB, 2009, FREE RADICAL BIO MED, V47, P1440, DOI 10.1016/j.freeradbiomed.2009.08.012; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Dang S, 2011, NEUROL RES, V33, P520, DOI 10.1179/016164111X13007856084287; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Ding XL, 2000, AM J PATHOL, V157, P1983, DOI 10.1016/S0002-9440(10)64837-7; Elzer JG, J CEREB BLOOD FLOW M, V30, P935; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Gao QL, 2006, MOL THER, V13, P928, DOI 10.1016/j.ymthe.2005.12.009; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; Iijima T, 2003, BRAIN RES, V993, P140, DOI 10.1016/j.brainres.2003.09.041; Ishibashi N, 2002, J IMMUNOL, V168, P1926, DOI 10.4049/jimmunol.168.4.1926; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kim HS, 2007, DIABETES RES CLIN PR, V77, pS46, DOI 10.1016/j.diabres.2007.01.032; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Li PA, 1998, BRAIN RES, V804, P36, DOI 10.1016/S0006-8993(98)00651-9; Li Y, 1997, J CEREBR BLOOD F MET, V17, P846, DOI 10.1097/00004647-199708000-00003; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Lu D, 1997, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V13, P224; Macdonald K, 1999, CIRC RES, V84, P820; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Minami M, 2006, J PHARMACOL SCI, V100, P461, DOI 10.1254/jphs.CRJ06005X; Mori M, 2004, CELL DEATH DIFFER, V11, P1223, DOI 10.1038/sj.cdd.4401483; Nakagomi T, 1996, NEUROL RES, V18, P559; Nakase T, 2007, NEUROPATHOLOGY, V27, P442, DOI 10.1111/j.1440-1789.2007.00815.x; NICHOLLS DG, 1977, EUR J BIOCHEM, V75, P601, DOI 10.1111/j.1432-1033.1977.tb11560.x; Ouyang YB, 2004, CELL CALCIUM, V36, P303, DOI 10.1016/j.ceca.2004.02.015; Ouyang YB, 2006, CELL STRESS CHAPERON, V11, P180, DOI 10.1379/CSC-182R.1; Palgrave CJ, 2011, J VIROL, V85, P6008, DOI 10.1128/JVI.00331-11; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004; Yoshitomi H, 1999, BIOCHEM J, V340, P397, DOI 10.1042/0264-6021:3400397; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13	52	29	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31739	10.1371/journal.pone.0031739	http://dx.doi.org/10.1371/journal.pone.0031739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348126	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400046
J	Drotz, MK; Brodin, T; Saura, A; Giles, BE				Drotz, Marcus K.; Brodin, Tomas; Saura, Anssi; Giles, Barbara E.			Ecotype Differentiation in the Face of Gene Flow within the Diving Beetle Agabus bipustulatus (Linnaeus, 1767) in Northern Scandinavia	PLOS ONE			English	Article							ALPHA-GLYCEROPHOSPHATE DEHYDROGENASE; NATURAL-SELECTION; SYMPATRIC SPECIATION; POPULATION-STRUCTURE; COLEOPTERA; DIVERGENCE; PREFERENCE; HEMIPTERA; ONTOGENY	The repeated occurrence of habitat-specific polyphyletic evolved ecotypes throughout the ranges of widely distributed species implies that multiple, independent and parallel selection events have taken place. Ecological transitions across altitudinal gradients over short geographical distances are often associated with variation in habitat-related fitness, these patterns suggest the action of strong selective forces. Genetic markers will therefore contribute differently to differences between ecotypes in local hybrid zones. Here we have studied the adaptive divergence between ecotypes of the water beetle Agabus bipustulatus along several parallel altitudinal gradients in northern Scandinavia. This water beetle is well known for its remarkable morphological variation associated with mountain regions throughout the western Palaearctic. Two morphological ecotypes are recognised: a montane type with reduced flight muscles and a lowland type with fully developed muscles. Using a multilocus survey of allozyme variation and a morphological analysis with landmark-based morphometrics, across thirty-three populations and seven altitudinal gradients, we studied the local adaptive process of gene flow and selection in detail. Populations were sampled at three different elevations: below, at and above the tree line. The results indicate that the levels of divergence observed between ecotypes in morphology and allele frequencies at alpha-Glycerophosphate dehydrogenase relative to those shown by neutral molecular markers reflects local diversifying selection in situ. Four main lines of evidence are shown here: (1) A repeated morphological pattern of differentiation is observed across all altitudinal transects, with high reclassification probabilities. (2) Allele and genotype frequencies at the alpha-Gpdh locus are strongly correlated with altitude, in sharp contrast to the presumable neutral markers. (3) Genetic differentiation is two to three times higher among populations across the tree line than among populations at or below. (4) Genetic differentiation between ecotypes within independent mountain areas is reflected by different sets of allozymes.	[Drotz, Marcus K.] Lake Vanem Museum Nat & Cultural Hist, Lidkoping, Sweden; [Brodin, Tomas; Giles, Barbara E.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Saura, Anssi] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University; Umea University	Drotz, MK (corresponding author), Lake Vanem Museum Nat & Cultural Hist, Lidkoping, Sweden.	Marcus.Drotz@lidkoping.se		Brodin, Tomas/0000-0003-1086-7567	Sven and Lilly Lawski Foundation; Lidkopings municipality; Nilsson-Ehle Foundation	Sven and Lilly Lawski Foundation; Lidkopings municipality; Nilsson-Ehle Foundation	MKD was supported by the Sven and Lilly Lawski Foundation (www.handelsbanken.se), and the Lidkopings municipality (www.lidkoping.se) concerning wage funds. Nilsson-Ehle Foundation (http://www.fysiografen.se/stipendier/) gave financial support for sample collection, travel and analytic costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrino J, 2005, EVOLUTION, V59, P1334; Andersson J, 2005, BIOL J LINN SOC, V85, P341, DOI 10.1111/j.1095-8312.2005.00501.x; [Anonymous], 2020, ECONOMIST 0326; Aube C, 1837, ICONOGRAPHIE HIST NA, V5; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Barton NH, 2001, DISPERSAL, P330; BEWLEY GC, 1974, J INSECT PHYSIOL, V20, P153, DOI 10.1016/0022-1910(74)90130-9; Bilton David, 1994, Entomologisk Tidskrift, V115, P23; BILTON DT, 1992, HEREDITY, V69, P503, DOI 10.1038/hdy.1992.165; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P153; Coltman DW, 2005, NATURE, V433, P23, DOI 10.1038/433023a; Davy-Bowker John, 2002, Aquatic Ecology, V36, P435, DOI 10.1023/A:1016550127986; De Marzo L., 1974, Entomologica Bari, V10, P81; De Marzo L., 1973, Entomologica Bari, V9, P47; Dhuyvetter H, 2007, EVOLUTION, V61, P184, DOI 10.1111/j.1558-5646.2007.00015.x; Drotz MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009034; Drotz MK, 2003, BIOL J LINN SOC, V79, P653, DOI 10.1046/j.1095-8312.2003.00214.x; Drotz MK, 2001, BIOL J LINN SOC, V73, P11, DOI 10.1006/bijl.2001.0491; ERIKSSON U, 1972, Acta Societatis pro Fauna et Flora Fennica, V80, P121; Falkenstrom G, 1940, ARK ZOOL, V32, P1; GOUDET J, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P81; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Goudet J, 2004, PCAGEN; Grahame JW, 2006, EVOLUTION, V60, P268; GRELL EH, 1967, SCIENCE, V158, P1319, DOI 10.1126/science.158.3806.1319; HOLMGREN B, 1996, ECOLOGICAL B, V45, P159; Jackson D. J., 1956, Journal of the Linnean Society London, V43, P18; Jackson D. J., 1952, Proceedings of the Royal Entomological Society of London (A), V27, P57; Jackson D. J., 1956, Proceedings of the Linnean Society of London, V167, P76; Jackson DJ, 1957, T ROYAL ENTOMOLOGICA, V100, P53; JOHANNESSON K, 1995, P NATL ACAD SCI USA, V92, P2602, DOI 10.1073/pnas.92.7.2602; Johannesson K, 2001, TRENDS ECOL EVOL, V16, P148, DOI 10.1016/S0169-5347(00)02078-4; Johansson F, 2006, ICHTHYOL RES, V53, P63, DOI 10.1007/s10228-005-0316-0; Kullman L, 2001, AMBIO, V30, P72, DOI 10.1639/0044-7447(2001)030[0072:CCWATL]2.0.CO;2; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIEBHERR JK, 1986, ANN ENTOMOL SOC AM, V79, P424, DOI 10.1093/aesa/79.3.424; LIEBHERR JK, 1988, EVOLUTION, V42, P129, DOI [10.2307/2409121, 10.1111/j.1558-5646.1988.tb04113.x]; Lundkvist E, 2002, ANN ZOOL FENN, V39, P109; Lundmark M, 2001, INSECT SYST EVOL, V32, P241, DOI 10.1163/187631201X00182; NEI M, 1978, GENETICS, V89, P583; NILSSON A N, 1985, Notulae Entomologicae, V65, P137; Nilsson Anders N., 1995, Fauna Entomologica Scandinavica, V32, P1; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Nosil P, 2007, GENETICA, V129, P309, DOI 10.1007/s10709-006-0013-6; Panova M, 2006, MOL ECOL, V15, P4021, DOI 10.1111/j.1365-294X.2006.03067.x; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; PREZIOSI RF, 1992, EVOLUTION, V46, P430, DOI [10.2307/2409862, 10.1111/j.1558-5646.1992.tb02049.x]; Ribera I, 1995, CAN J ZOOL, V73, P2343, DOI 10.1139/z95-275; Rohlf F.J., 1993, CONTRIB MORPHOMETRIC, P132; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf JF, 1998, RELATIVE WARPS VERSI; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schneider P., 1986, Entomologica Basiliensia, V11, P451; Sharp D, 1882, SCI T R DUBLIN SOC Z, VZ, P17; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1973, GENETICS, V75, P733; SMITH DS, 1964, J MORPHOL, V114, P107, DOI 10.1002/jmor.1051140106; SOUTHWOOD TRE, 1962, BIOL REV, V37, P171, DOI 10.1111/j.1469-185X.1962.tb01609.x; Storz JF, 2004, EVOLUTION, V58, P1342; Suselbeck G, 1987, THESIS A LUDWIGS U F; Umetri A, 1996, COMPUTER SOFTWARE SI; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, GENETIC DATA ANAL; WRIGHT DA, 1969, BIOCHEM GENET, V3, P343, DOI 10.1007/BF00485718; ZERA AJ, 1981, EVOLUTION, V35, P218, DOI 10.1111/j.1558-5646.1981.tb04881.x	72	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31381	10.1371/journal.pone.0031381	http://dx.doi.org/10.1371/journal.pone.0031381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348080	gold, Green Submitted, Green Published			2022-12-27	WOS:000302733900044
J	Lynd, A; Lycett, GJ				Lynd, Amy; Lycett, Gareth John			Development of the Bi-Partite Gal4-UAS System in the African Malaria Mosquito, Anopheles gambiae	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; GERMLINE TRANSFORMATION; DROSOPHILA; VECTOR; ZEBRAFISH; SUSCEPTIBILITY; TRANSGENESIS; DOWNSTREAM; PLASMODIUM; INFECTION	Functional genetic analysis in Anopheles gambiae would be greatly improved by the development of a binary expression system, which would allow the more rapid and flexible characterisation of genes influencing disease transmission, including those involved in insecticide resistance, parasite interaction, host and mate seeking behaviour. The Gal4-UAS system, widely used in Drosophila melanogaster functional genetics, has been significantly modified to achieve robust application in several different species. Towards this end, previous work generated a series of modified Gal4 constructs that were up to 20 fold more active than the native gene in An. gambiae cells. To examine the Gal4-UAS system in vivo, transgenic An. gambiae driver lines carrying a modified Gal4 gene under the control of the carboxypeptidase promoter, and responder lines carrying UAS regulated luciferase and eYFP reporter genes have been created. Crossing of the Gal4 and UAS lines resulted in progeny that expressed both reporters in the expected midgut specific pattern. Although there was minor variation in reporter gene activity between the different crosses examined, the tissue specific expression pattern was consistent regardless of the genomic location of the transgene cassettes. The results show that the modified Gal4-UAS system can be used to successfully activate expression of transgenes in a robust and tissue specific manner in Anopheles gambiae. The midgut driver and dual reporter responder constructs are the first to be developed and tested successfully in transgenic An. gambiae and provide the basis for further advancement of the system in this and other insect species.	[Lynd, Amy; Lycett, Gareth John] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Lynd, A (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	gjlycett@liv.ac.uk	Lynd, Amy/C-8938-2013; Lynd, Amy/AAE-9640-2020	Lynd, Amy/0000-0001-6054-0525; Lycett, Gareth/0000-0002-2422-053X	European Commission [223726]; Biotechnology and Biological Sciences Research Council [BB/F021933/1]; BBSRC [BB/F021933/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded through the European Commission Grant No. 223726 (TransMalariaBloc) and a Biotechnology and Biological Sciences Research Council grant BB/F021933/1 awarded to G.J.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amenya DA, 2010, J INSECT PHYSIOL, V56, P1414, DOI 10.1016/j.jinsphys.2010.04.013; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; CARTER MJ, 1993, NUCLEIC ACIDS RES, V21, P1044, DOI 10.1093/nar/21.4.1044; Catteruccia F, 2009, METHODS MOL BIOL, V555, P63, DOI 10.1007/978-1-60327-295-7_5; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Franz AW, 2011, INSECT MOL BIOL; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Kobayashi I, 2011, ARCH INSECT BIOCHEM, V76, P195, DOI 10.1002/arch.20402; Kokoza VA, 2011, INSECT BIOCHEM MOLEC, V41, P637, DOI 10.1016/j.ibmb.2011.04.004; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lombardo Fabrizio, 2009, BMC Res Notes, V2, P24, DOI 10.1186/1756-0500-2-24; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Lycett GJ, 2012, INSECT MOL BIOL, V21, P79, DOI 10.1111/j.1365-2583.2011.01112.x; Lycett GJ, 2004, GENETICS, V167, P1781, DOI 10.1534/genetics.104.028175; Lynd A, 2011, INSECT MOL BIOL, V20, P599, DOI 10.1111/j.1365-2583.2011.01090.x; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Nirmala X, 2005, INSECT MOL BIOL, V14, P95, DOI 10.1111/j.1365-2583.2005.00535.x; Nolan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016471; Ogura E, 2009, DEV DYNAM, V238, P641, DOI 10.1002/dvdy.21863; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Patterson G, 2001, J CELL SCI, V114, P837; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Roman G, 2004, BIOESSAYS, V26, P1243, DOI 10.1002/bies.20120; Rund SS, 2011, P NATL ACAD SCI US; Sarkar A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-27; Schinko JB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-53; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	60	34	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31552	10.1371/journal.pone.0031552	http://dx.doi.org/10.1371/journal.pone.0031552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348104	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000302733900052
J	Vanneste, S; Joos, K; De Ridder, D				Vanneste, Sven; Joos, Kathleen; De Ridder, Dirk			Prefrontal Cortex Based Sex Differences in Tinnitus Perception: Same Tinnitus Intensity, Same Tinnitus Distress, Different Mood	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; GENDER-DIFFERENCES; ANTERIOR THALAMUS; EMOTIONAL MEMORY; AUDITORY-CORTEX; TIME-COURSE; ACTIVATION; LOCALIZATION; DEPRESSION	Background: Tinnitus refers to auditory phantom sensation. It is estimated that for 2% of the population this auditory phantom percept severely affects the quality of life, due to tinnitus related distress. Although the overall distress levels do not differ between sexes in tinnitus, females are more influenced by distress than males. Typically, pain, sleep, and depression are perceived as significantly more severe by female tinnitus patients. Studies on gender differences in emotional regulation indicate that females with high depressive symptoms show greater attention to emotion, and use less anti-rumination emotional repair strategies than males. Methodology: The objective of this study was to verify whether the activity and connectivity of the resting brain is different for male and female tinnitus patients using resting-state EEG. Conclusions: Females had a higher mean score than male tinnitus patients on the BDI-II. Female tinnitus patients differ from male tinnitus patients in the orbitofrontal cortex (OFC) extending to the frontopolar cortex in beta1 and beta2. The OFC is important for emotional processing of sounds. Increased functional alpha connectivity is found between the OFC, insula, subgenual anterior cingulate (sgACC), parahippocampal (PHC) areas and the auditory cortex in females. Our data suggest increased functional connectivity that binds tinnitus-related auditory cortex activity to auditory emotion-related areas via the PHC-sgACC connections resulting in a more depressive state even though the tinnitus intensity and tinnitus-related distress are not different from men. Comparing male tinnitus patients to a control group of males significant differences could be found for beta3 in the posterior cingulate cortex (PCC). The PCC might be related to cognitive and memory-related aspects of the tinnitus percept. Our results propose that sex influences in tinnitus research cannot be ignored and should be taken into account in functional imaging studies related to tinnitus.	[Vanneste, Sven; Joos, Kathleen; De Ridder, Dirk] Univ Antwerp Hosp, TRI & Dept Neurosurg, Antwerp, Belgium	University of Antwerp	Vanneste, S (corresponding author), Univ Antwerp Hosp, TRI & Dept Neurosurg, Antwerp, Belgium.	sven.vanneste@ua.ac.be		Vanneste, Sven/0000-0003-1513-5752				Angrilli A, 2008, NEUROPSYCHOLOGIA, V46, P1179, DOI 10.1016/j.neuropsychologia.2007.10.018; Beauregard M, 2007, PROG NEUROBIOL, V81, P218, DOI 10.1016/j.pneurobio.2007.01.005; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Boutros NN, 2008, HIPPOCAMPUS, V18, P310, DOI 10.1002/hipo.20388; Brown GW, 1989, DEPRESSION; Butler T, 2007, HUM BRAIN MAPP, V28, P1206, DOI 10.1002/hbm.20340; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Congedo M., 2002, EUREKA VERSION 3 0 C; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Dineen R, 1997, BRIT J AUDIOL, V31, P27, DOI 10.3109/03005364000000006; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Erlandsson Soly I., 2001, Noise Health, V3, P39; Frank E., 2011, J NEUROL; Frank G, 2010, EUR J NEUROL, V17, P951, DOI 10.1111/j.1468-1331.2010.02956.x; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Hetrick WP, 1996, BIOL PSYCHIAT, V39, P51, DOI 10.1016/0006-3223(95)00067-4; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Kaiser A, 2007, INT J PSYCHOPHYSIOL, V63, P192, DOI 10.1016/j.ijpsycho.2006.03.008; Kilpatrick LA, 2006, NEUROIMAGE, V30, P452, DOI 10.1016/j.neuroimage.2005.09.065; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Kropotov, 2009, QUANTITATIVE EEG EVE; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Laufer I, 2009, NEUROIMAGE, V44, P546, DOI 10.1016/j.neuroimage.2008.09.010; Lazarus R.S., 1984, EMOTION ADAPTATION; Ledoux JE, 1997, PHILOS T ROY SOC B, V352, P1719, DOI 10.1098/rstb.1997.0154; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Mak AKY, 2009, NEUROPSYCHOLOGIA, V47, P2900, DOI 10.1016/j.neuropsychologia.2009.06.017; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; NOLENHOEKSEMA S, 1994, PSYCHOL BULL, V115, P424, DOI 10.1037/0033-2909.115.3.424; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Plewnia C, 2007, J NEUROL NEUROSUR PS, V78, P152, DOI 10.1136/jnnp.2006.095612; Ruytjens L, 2007, EUR J NUCL MED MOL I, V34, P2073, DOI 10.1007/s00259-007-0517-z; Ruytjens L, 2007, AUDIOL NEURO-OTOL, V12, P371, DOI 10.1159/000106480; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schneider P, 2009, NEUROIMAGE, V45, P927, DOI 10.1016/j.neuroimage.2008.12.045; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Thayer JF, 2003, COGNITIVE THER RES, V27, P349, DOI 10.1023/A:1023922618287; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; van Noorden MS, 2010, J AFFECT DISORDERS, V125, P116, DOI 10.1016/j.jad.2009.12.007; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Volz KG, 2009, PROG BRAIN RES, V174, P61, DOI 10.1016/S0079-6123(09)01306-5; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; WHEELER RE, 1993, PSYCHOPHYSIOLOGY, V30, P82, DOI 10.1111/j.1469-8986.1993.tb03207.x; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115; Zald DH, 2002, P NATL ACAD SCI USA, V99, P2450, DOI 10.1073/pnas.042457199; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	78	54	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31182	10.1371/journal.pone.0031182	http://dx.doi.org/10.1371/journal.pone.0031182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348053	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730900022
J	Ruan, XY; Kocher, JPA; Pommier, Y; Liu, HF; Reinhold, WC				Ruan, Xiaoyang; Kocher, Jean-Pierre A.; Pommier, Yves; Liu, Hongfang; Reinhold, William C.			Mass Homozygotes Accumulation in the NCI-60 Cancer Cell Lines As Compared to HapMap Trios, and Relation to Fragile Site Location	PLOS ONE			English	Article							MAINTAINS GENOMIC STABILITY; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; SUBSTRATE LENGTH; OVARIAN-CANCER; HETEROZYGOSITY; TUMOR; COMMON; EXPRESSION; IDENTIFICATION	Runs of homozygosity (ROH) represents extended length of homozygotes on a long genomic distance. In oncology, it is known as loss of heterozygosity (LOH) if identified exclusively in cancer cell rather than in matched control cell. Studies have identified several genomic regions which show consistent ROH in different kinds of carcinoma. To query whether this consistency can be observed on broader spectrum, both in more cancer types and in wider genomic regions, we investigated ROH patterns in the National Cancer Institute 60 cancer cell line panel (NCI-60) and HapMap Caucasian healthy trio families. Using results from Affymetrix 500 K SNP arrays, we report a genome wide significant association of ROH regions between the NCI-60 and HapMap samples, with much a higher level of ROH (11 fold) in the cancer cell lines. Analysis shows that more severe ROH found in cancer cells appears to be the extension of existing ROH in healthy state. In the HapMap trios, the adult subgroup had a slightly but significantly higher level (1.02 fold) of ROH than did the young subgroup. For several ROH regions we observed the co-occurrence of fragile sites (FRAs). However, FRA on the genome wide level does not show a clear relationship with ROH regions.	[Ruan, Xiaoyang; Kocher, Jean-Pierre A.; Liu, Hongfang] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Ruan, Xiaoyang; Pommier, Yves; Liu, Hongfang; Reinhold, William C.] NCI, Mol Pharmacol Lab, Bethesda, MD 20892 USA	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ruan, XY (corresponding author), Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA.	liu.hongfang@mayo.edu; wcr@mail.nih.gov	Reinhold, William/J-6704-2017	Reinhold, William/0000-0001-5513-9323	National Institutes of Health, Center for Cancer Research, National Cancer Institute; National Science Foundation [ABI: 0845523]; National Institute of Health [R01LM009959A1]; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009959] Funding Source: NIH RePORTER	National Institutes of Health, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute, and also by National Science Foundation ABI: 0845523 and National Institute of Health R01LM009959A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Arlt MF, 2002, GENE CHROMOSOME CANC, V33, P82, DOI 10.1002/gcc.10000; Assie G, 2008, JAMA-J AM MED ASSOC, V299, P1437, DOI 10.1001/jama.299.12.1437; Bacolod MD, 2008, CANCER RES, V68, P2610, DOI 10.1158/0008-5472.CAN-07-5250; Bacolod MD, 2009, CANCER RES, V69, P723, DOI 10.1158/0008-5472.CAN-08-3543; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Barnes RL, 2007, NUCLEIC ACIDS RES, V35, P3478, DOI 10.1093/nar/gkm249; Beroukhim R, 2006, PLOS COMPUT BIOL, V2, P323, DOI 10.1371/journal.pcbi.0020041; Blackburn AC, 2004, CANCER RES, V64, P5140, DOI 10.1158/0008-5472.CAN-03-3435; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carr LL, 2008, EXP GERONTOL, V43, P123, DOI 10.1016/j.exger.2007.10.010; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Denison SR, 2003, GENE CHROMOSOME CANC, V38, P40, DOI 10.1002/gcc.10236; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Finnis M, 2005, HUM MOL GENET, V14, P1341, DOI 10.1093/hmg/ddi144; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He M, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-10; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Johrer K, 2005, CLIN CANCER RES, V11, P2459, DOI 10.1158/1078-0432.CCR-04-0405; Kitamura T, 2010, P NATL ACAD SCI USA, V107, P13063, DOI 10.1073/pnas.1002372107; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Limongi MZ, 2003, GENOMICS, V81, P93, DOI 10.1016/S0888-7543(03)00007-7; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Moragoda L, 2002, AM J PHYSIOL-GASTR L, V282, pG932, DOI 10.1152/ajpgi.00312.2001; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sato E, 2007, BRIT J CANCER, V96, P1735, DOI 10.1038/sj.bjc.6603790; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; SHEN P, 1986, GENETICS, V112, P441; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Velickovic M, 1999, CANCER RES, V59, P1323; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wing W, 2006, ANAL GENE EXPRESSION, P120; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2000, CANCER RES, V60, P2504; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	46	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31628	10.1371/journal.pone.0031628	http://dx.doi.org/10.1371/journal.pone.0031628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347499	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730200028
J	Ng, CA; Perry, MD; Tan, PS; Hill, AP; Kuchel, PW; Vandenberg, JI				Chai Ann Ng; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Kuchel, Philip W.; Vandenberg, Jamie I.			The S4-S5 Linker Acts as a Signal Integrator for hERG K+ Channel Activation and Deactivation Gating	PLOS ONE			English	Article							AMINO-TERMINAL DOMAIN; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; XENOPUS OOCYTES; VOLTAGE SENSOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MOLECULAR-BASIS; N-TERMINUS; INACTIVATION	Human ether-a-go-go-related gene (hERG) K+ channels have unusual gating kinetics. Characterised by slow activation/deactivation but rapid inactivation/recovery from inactivation, the unique gating kinetics underlie the central role hERG channels play in cardiac repolarisation. The slow activation and deactivation kinetics are regulated in part by the S4-S5 linker, which couples movement of the voltage sensor domain to opening of the activation gate at the distal end of the inner helix of the pore domain. It has also been suggested that cytosolic domains may interact with the S4-S5 linker to regulate activation and deactivation kinetics. Here, we show that the solution structure of a peptide corresponding to the S4-S5 linker of hERG contains an amphipathic helix. The effects of mutations at the majority of residues in the S4-S5 linker of hERG were consistent with the previously identified role in coupling voltage sensor movement to the activation gate. However, mutations to Ser543, Tyr545, Gly546 and Ala548 had more complex phenotypes indicating that these residues are involved in additional interactions. We propose a model in which the S4-S5 linker, in addition to coupling VSD movement to the activation gate, also contributes to interactions that stabilise the closed state and a separate set of interactions that stabilise the open state. The S4-S5 linker therefore acts as a signal integrator and plays a crucial role in the slow deactivation kinetics of the channel.	[Chai Ann Ng; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Chai Ann Ng; Kuchel, Philip W.; Vandenberg, Jamie I.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Kuchel, Philip W.] Agcy Sci Technol & Res, Mech Syst Biol NMR Grp, Singapore Bioimaging Consortium, Singapore, Singapore; [Chai Ann Ng; Hill, Adam P.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia	Victor Chang Cardiac Research Institute; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); University of New South Wales Sydney	Ng, CA (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450; Kuchel, Philip/0000-0003-4100-7332	Australian Research Council [DP0986316]; National Health & Medical Research Council [459401, 1010029]; National Heart Foundation of Australia [G09S-]	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was funded by grants from the Australian Research Council (DP0986316; http://www.arc.gov.au/), the National Health & Medical Research Council (459401 and 1010029; http://www.nhmrc.gov.au/), National Heart Foundation of Australia (G09S-(50www.heartfoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Alonso-Ron C, 2008, BIOPHYS J, V94, P3893, DOI 10.1529/biophysj.107.116731; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bax A, 1985, MLEV 17 BASED 2 DIME, P355; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Case D.A., 2022, AMBER 2020; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gayen S, 2011, J PEPT SCI; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Kumar A, 1980, BIOCH BIOPHYS RES CO, V95; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Perry M, 2007, P NATL ACAD SCI USA, V104, P13827, DOI 10.1073/pnas.0703934104; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; Saenen JB, 2006, BIOPHYS J, V91, P4381, DOI 10.1529/biophysj.106.087247; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schonherr R, 1996, J PHYSL LOND; Shaka AJ, 1988, J MAGN RESON, P96; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zou AR, 1997, AM J PHYSIOL-HEART C, V272, pH1309, DOI 10.1152/ajpheart.1997.272.3.H1309	50	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31640	10.1371/journal.pone.0031640	http://dx.doi.org/10.1371/journal.pone.0031640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359612	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200081
J	Kennedy, A; Gruen, ML; Gutierrez, DA; Surmi, BK; Orr, JS; Webb, CD; Hasty, AH				Kennedy, Arion; Gruen, Marnie L.; Gutierrez, Dario A.; Surmi, Bonnie K.; Orr, Jeb S.; Webb, Corey D.; Hasty, Alyssa H.			Impact of Macrophage Inflammatory Protein-1 alpha Deficiency on Atherosclerotic Lesion Formation, Hepatic Steatosis, and Adipose Tissue Expansion	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; REDUCES ATHEROSCLEROSIS; KNOCKOUT MICE; FATTY LIVER; ACCUMULATION; CHEMOKINES; HYPERLIPIDEMIA; ABSENCE	Macrophage inflammatory protein-1 alpha (CCL3) plays a well-known role in infectious and viral diseases; however, its contribution to atherosclerotic lesion formation and lipid metabolism has not been determined. Low density lipoprotein receptor deficient (LDLR-/-) mice were transplanted with bone marrow from CCL3(-/-) or C57BL/6 wild type donors. After 6 and 12 weeks on western diet (WD), recipients of CCL3(-/-) marrow demonstrated lower plasma cholesterol and triglyceride concentrations compared to recipients of C57BL/6 marrow. Atherosclerotic lesion area was significantly lower in female CCL3(-/-) recipients after 6 weeks and in male CCL3(-/-) recipients after 12 weeks of WD feeding (P<0.05). Surprisingly, male CCL3(-/-) recipients had a 50% decrease in adipose tissue mass after WD-feeding, and plasma insulin, and leptin levels were also significantly lower. These results were specific to CCL3, as LDLR-/- recipients of monocyte chemoattractant protein(-/-) (CCL2) marrow were not protected from the metabolic consequences of high fat feeding. Despite these improvements in LDLR-/- recipients of CCL3(-/-) marrow in the bone marrow transplantation (BMT) model, double knockout mice, globally deficient in both proteins, did not have decreased body weight, plasma lipids, or atherosclerosis compared with LDLR-/- controls. Finally, there were no differences in myeloid progenitors or leukocyte populations, indicating that changes in body weight and plasma lipids in CCL3(-/-) recipients was not due to differences in hematopoiesis. Taken together, these data implicate a role for CCL3 in lipid metabolism in hyperlipidemic mice following hematopoietic reconstitution.	[Kennedy, Arion; Gruen, Marnie L.; Gutierrez, Dario A.; Surmi, Bonnie K.; Orr, Jeb S.; Webb, Corey D.; Hasty, Alyssa H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Kennedy, A (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	alyssa.hasty@vanderbilt.edu	Hasty, Alyssa/AAA-2757-2020	Hasty, Alyssa/0000-0001-7302-8045; Kennedy, Arion/0000-0002-8443-3131	American Diabetes Association (ADA) [1-07-CD-10, 7-10-MI-05]; Molecular Endocrinology Training Grant [DK07563]; NIH NRSA [DK091128, DK091040]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Vanderbilt Digestive Disease Research Center [DK058404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, F31DK091128, U24DK059637, F32DK091040, P60DK020593, P30DK020593] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); Molecular Endocrinology Training Grant; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Career Development Award from the American Diabetes Association (ADA) to AH Hasty (1-07-CD-10). Both A. Kennedy and D. Gutierrez were supported by the Molecular Endocrinology Training Grant (DK07563) during their first year of training. A. Kennedy is currently supported by a Postdoctoral Fellowship from the ADA (7-10-MI-05), D. Gutierrez is supported by an NIH NRSA (DK091128), and J. Orr is supported by an NIH NRSA (DK091040). Insulin and leptin assays were performed in the Analytical Services Core of the Diabetes Research and Training Center (DK20593)/MMPC (DK59637). Fluorescence imaging of CD4 positive cells in lesions were performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126) with the expert assistance of Carol Ann Bonner. Liver TG fatty acid analyses were performed in the Lipid Core of the MMPC. Flow Cytometry experiments were performed in the VMC Flow Cytometry Shared Resource supported by the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; BROXMEYER HE, 1990, BLOOD, V76, P1110; Coenen KR, 2007, AM J PHYSIOL-ENDOC M, V293, pE492, DOI 10.1152/ajpendo.00171.2007; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Dol F, 2001, J CARDIOVASC PHARM, V38, P395, DOI 10.1097/00005344-200109000-00008; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gruen ML, 2006, ATHEROSCLEROSIS, V186, P54, DOI 10.1016/j.atherosclerosis.2005.07.007; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gutierrez DA, 2011, DIABETES, V60, P2820, DOI 10.2337/db11-0314; Holven KB, 2003, EUR HEART J, V24, P1756, DOI 10.1016/S0195-668X(03)00467-6; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; MAZE R, 1992, J IMMUNOL, V149, P1004; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Namiki M, 2002, ARTERIOSCL THROM VAS, V22, P115, DOI 10.1161/hq0102.102278; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Parissis JT, 2000, AM J CARDIOL, V85, P777, DOI 10.1016/S0002-9149(99)00862-0; Potteaux S, 2005, MOL MED, V11, P16, DOI [10.2119/2005-00028.Poffeaux, 10.2119/2005-00028.Potteaux]; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Soehnlein O, 2009, J CELL MOL MED, V13, P4293, DOI 10.1111/j.1582-4934.2009.00965.x; Surmi BK, 2010, AM J PHYSIOL-ENDOC M, V299, pE437, DOI 10.1152/ajpendo.00050.2010; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Waehre T, 2003, J AM COLL CARDIOL, V41, P1460, DOI 10.1016/S0735-1097(03)00263-8; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Wilcox J N, 1994, J Atheroscler Thromb, V1 Suppl 1, pS10; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	43	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31508	10.1371/journal.pone.0031508	http://dx.doi.org/10.1371/journal.pone.0031508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359597	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200066
J	Lu, YH; Pang, YP; Park, Y; Gao, XW; Yao, JX; Zhang, X; Zhu, KY				Lu, Yanhui; Pang, Yuan-Ping; Park, Yoonseong; Gao, Xiwu; Yao, Jianxiu; Zhang, Xin; Zhu, Kun Yan			Genome Organization, Phylogenies, Expression Patterns, and Three-Dimensional Protein Models of Two Acetylcholinesterase Genes from the Red Flour Beetle	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER ACETYLCHOLINESTERASE; CDNA-ENCODING ACETYLCHOLINESTERASE; AMINO-ACID SUBSTITUTION; ACTIVE-SITE GORGE; MOLECULAR-DYNAMICS; X-RAY; INSECTICIDE-INSENSITIVITY; IRREVERSIBLE INHIBITORS; CRYSTAL-STRUCTURE; POINT MUTATION	Since the report of a paralogous acetylcholinesterase (AChE, EC3.1.1.7) gene in the greenbug (Schizaphis graminum) in 2002, two different AChE genes (Ace1 and Ace2) have been identified in each of at least 27 insect species. However, the gene models of Ace1 and Ace2, and their molecular properties have not yet been comprehensively analyzed in any insect species. In this study, we sequenced the full-length cDNAs, computationally predicted the corresponding three-dimensional protein models, and profiled developmental stage and tissue-specific expression patterns of two Ace genes from the red flour beetle (Tribolium castaneum; TcAce1 and TcAce2), a globally distributed major pest of stored grain products and an emerging model organism. TcAce1 and TcAce2 encode 648 and 604 amino acid residues, respectively, and have conserved motifs including a choline-binding site, a catalytic triad, and an acyl pocket. Phylogenetic analysis show that both TcAce genes are grouped into two insect Ace clusters and TcAce1 is completely diverged from TcAce2, suggesting that these two genes evolve from their corresponding Ace gene lineages in insect species. In addition, TcAce1 is located on chromosome 5, whereas TcAce2 is located on chromosome 2. Reverse transcription polymerase chain reaction (PCR) and quantitative real-time PCR analyses indicate that both genes are virtually transcribed in all the developmental stages and predominately expressed in the insect brain. Our computational analyses suggest that the TcAce1 protein is a robust acetylcholine (ACh) hydrolase and has susceptibility to sulfhydryl agents whereas the TcAce2 protein is not a catalytically efficient ACh hydrolase.	[Lu, Yanhui; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN USA; [Lu, Yanhui; Park, Yoonseong; Yao, Jianxiu; Zhang, Xin; Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	China Agricultural University; Mayo Clinic; Kansas State University	Lu, YH (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	pang@mayo.edu; kzhu@ksu.edu	Lu, gls19581211!/L-6918-2019; Park, Yoonseong/J-5861-2013	Zhu, Kun Yan/0000-0001-9372-8030; Pang, Yuan-Ping/0000-0003-0838-2560; Park, Yoonseong/0000-0003-1191-7335	Kansas Agricultural Experiment Station; Arthropod Genomics Center; Kansas State University; China Scholarship Council; U.S. Department of Agriculture [USDA/NIFA 2009-05236]; University of Minnesota Supercomputing Institute	Kansas Agricultural Experiment Station; Arthropod Genomics Center; Kansas State University; China Scholarship Council(China Scholarship Council); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); University of Minnesota Supercomputing Institute	This study was supported by the Kansas Agricultural Experiment Station and the Arthropod Genomics Center funded by K-State Targeted Excellence program at Kansas State University to KYZ, China Scholarship Council to YL, and the U.S. Department of Agriculture (USDA/NIFA 2009-05236) to YPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Ming-Shun Chen for his helpful comments on an earlier draft of this manuscript. The computational studies were supported in part by the University of Minnesota Supercomputing Institute. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by Kansas State University or the Mayo Clinic. This paper is contribution No. 11-210-J from the Kansas Agricultural Experiment Station. The T. castaneum voucher specimens (voucher No. 159) are located in the Kansas State University Museum of Entomological and Prairie Arthropod Research, Manhattan, Kansas, United States of America.	Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baek JH, 2005, PESTIC BIOCHEM PHYS, V81, P164, DOI 10.1016/j.pestbp.2004.12.003; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cassanelli S, 2006, INSECT BIOCHEM MOLEC, V36, P642, DOI 10.1016/j.ibmb.2006.05.007; Chen HJ, 2009, INSECT SCI, V16, P297, DOI 10.1111/j.1744-7917.2009.01259.x; Chen MH, 2006, GENOME, V49, P239, DOI 10.1139/G05-104; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Gao JR, 2002, INSECT BIOCHEM MOLEC, V32, P765, DOI 10.1016/S0965-1748(01)00159-X; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; GNAGEY AL, 1987, J BIOL CHEM, V262, P13290; Guedes RNC, 1997, PESTIC BIOCHEM PHYS, V58, P55, DOI 10.1006/pest.1997.2285; HAAS R, 1988, BIOCHEMISTRY-US, V27, P6453, DOI 10.1021/bi00417a038; HALISCAK JP, 1983, J ECON ENTOMOL, V76, P717, DOI 10.1093/jee/76.4.717; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim JI, 2006, INSECT MOL BIOL, V15, P513, DOI 10.1111/j.1365-2583.2006.00666.x; Kono Y, 2006, PESTIC BIOCHEM PHYS, V85, P123, DOI 10.1016/j.pestbp.2005.12.002; Kozaki T, 2008, ARCH INSECT BIOCHEM, V67, P130, DOI 10.1002/arch.20229; Lang GJ, 2010, PESTIC BIOCHEM PHYS, V98, P175, DOI 10.1016/j.pestbp.2010.06.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2007, BIOCHEM BIOPH RES CO, V353, P591, DOI 10.1016/j.bbrc.2006.12.088; Lee DW, 2006, BBA-GEN SUBJECTS, V1760, P125, DOI 10.1016/j.bbagen.2005.10.009; Lee SW, 2007, J MED ENTOMOL, V44, P72, DOI 10.1603/0022-2585(2007)44[72:MCOTAC]2.0.CO;2; Li F, 2002, GENOME, V45, P1134, DOI 10.1139/G02-085; Li HR, 2005, INSECT BIOCHEM MOLEC, V35, P847, DOI 10.1016/j.ibmb.2005.03.004; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; Mori A, 2001, INSECT MOL BIOL, V10, P197, DOI 10.1046/j.1365-2583.2001.00255.x; Mori A, 2007, INSECT BIOCHEM MOLEC, V37, P667, DOI 10.1016/j.ibmb.2007.03.014; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Nachon F, 2008, FEBS J, V275, P2659, DOI 10.1111/j.1742-4658.2008.06413.x; Nardi F, 2009, INSECT MOL BIOL, V18, P45, DOI 10.1111/j.1365-2583.2008.00848.x; Ni XY, 2003, APPL ENTOMOL ZOOL, V38, P49, DOI 10.1303/aez.2003.49; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Pang Y-P, 2011, CURR DRUG T IN PRESS; Pang YP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000058; Pang YP, 2007, BIOORG MED CHEM LETT, V17, P197, DOI 10.1016/j.bmcl.2006.09.073; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006851; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004349; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; Sanson B, 2009, J MED CHEM, V52, P7593, DOI 10.1021/jm900433t; SCHRAG JD, 1993, J MOL BIOL, V230, P575, DOI 10.1006/jmbi.1993.1171; Seino A, 2007, PESTIC BIOCHEM PHYS, V88, P92, DOI 10.1016/j.pestbp.2006.09.005; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Soderlund D. M., 1990, PESTICIDE RESISTANCE, P58; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Xu YC, 2008, BIOPHYS J, V95, P2500, DOI 10.1529/biophysj.108.129601; Zhu KY, 1996, PESTIC BIOCHEM PHYS, V55, P100, DOI 10.1006/pest.1996.0039; ZHU KY, 1992, INSECT BIOCHEM MOLEC, V22, P245, DOI 10.1016/0965-1748(92)90061-I; Zhu KY, 1995, INSECT BIOCHEM MOLEC, V25, P1129, DOI 10.1016/0965-1748(95)00055-0; [No title captured]	71	33	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32288	10.1371/journal.pone.0032288	http://dx.doi.org/10.1371/journal.pone.0032288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359679	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200148
J	Machado, MV; Ferreira, DMS; Castro, RE; Silvestre, AR; Evangelista, T; Coutinho, J; Carepa, F; Costa, A; Rodrigues, CMP; Cortez-Pinto, H				Machado, Mariana Verdelho; Ferreira, Duarte M. S.; Castro, Rui E.; Silvestre, Ana Rita; Evangelista, Teresinha; Coutinho, Joao; Carepa, Fatima; Costa, Adilia; Rodrigues, Cecilia M. P.; Cortez-Pinto, Helena			Liver and Muscle in Morbid Obesity: The Interplay of Fatty Liver and Insulin Resistance	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATIVE CAPACITY; LIPID-METABOLISM; ADIPOSE-TISSUE; FOLLOW-UP; SENSITIVITY; ADIPONECTIN; STEATOHEPATITIS; HOMEOSTASIS; EXPRESSION	Introduction: Nonalcoholic fatty liver disease (NAFLD) can be seen as a manifestation of overnutrition. The muscle is a central player in the adaptation to energy overload, and there is an association between fatty-muscle and -liver. We aimed to correlate muscle morphology, mitochondrial function and insulin signaling with NAFLD severity in morbid obese patients. Methods: Liver and deltoid muscle biopsies were collected during bariatric surgery in NAFLD patients. NAFLD Activity Score and Younossi's classification for nonalcoholic steatohepatitis (NASH) were applied to liver histology. Muscle evaluation included morphology studies, respiratory chain complex I to IV enzyme assays, and analysis of the insulin signaling cascade. A healthy lean control group was included for muscle morphology and mitochondrial function analyses. Results: Fifty one NAFLD patients were included of whom 43% had NASH. Intramyocellular lipids (IMCL) were associated with the presence of NASH (OR 12.5, p<0.001), progressive hepatic inflammation (p = 0.029) and fibrosis severity (p = 0.010). There was a trend to an association between IMCL and decreased Akt phosphorylation (p = 0.059), despite no association with insulin resistance. In turn, hepatic steatosis (p = 0.015) and inflammation (p = 0.013) were associated with decreased Akt phosphoryation. Citrate synthase activity was lower in obese patients (p = 0.047) whereas complex I (p = 0.040) and III (p = 0.036) activities were higher, compared with controls. Finally, in obese patients, complex I activity increased with progressive steatosis (p = 0.049) and with a trend with fibrosis severity (p = 0.056). Conclusions: In morbid obese patients, presence of IMCL associates with NASH and advanced fibrosis. Muscle mitochondrial dysfunction does not appear to be a major driving force contributing to muscle fat accumulation, insulin resistance or liver disease. Importantly, insulin resistance in muscle might occur at a late point in the insulin signaling cascade and be associated with IMCL and NAFLD severity.	[Machado, Mariana Verdelho; Cortez-Pinto, Helena] Hosp Santa Maria, Dept Gastroenterol, Unidade Nutr & Metab, Fac Med Lisboa,IMM, Lisbon, Portugal; [Ferreira, Duarte M. S.; Castro, Rui E.; Rodrigues, Cecilia M. P.] Univ Lisbon, Res Inst Med & Pharmaceut Sci iMed UL, Fac Pharm, P-1699 Lisbon, Portugal; [Silvestre, Ana Rita; Evangelista, Teresinha] Hosp Santa Maria, Dept Neuropatol, Lisbon, Portugal; [Coutinho, Joao; Carepa, Fatima] Hosp Santa Maria, Dept Cirurgia, Lisbon, Portugal; [Costa, Adilia] Hosp Santa Maria, Dept Anat Patol, Lisbon, Portugal	Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Hospital Santa Maria	Machado, MV (corresponding author), Hosp Santa Maria, Dept Gastroenterol, Unidade Nutr & Metab, Fac Med Lisboa,IMM, Lisbon, Portugal.	hlcortezpinto@netcabo.pt	Castro, Rui E/I-2975-2013; Rodrigues, Cecilia MP/M-3572-2013; Evangelista, Teresinha/AAF-3216-2020; Cortez-Pinto, Helena/AAN-2712-2020; iMed.ULisboa, CellFun/A-4244-2014; Cortez-Pinto, Helena/A-3586-2012; de Carvalho, Mamede/I-6295-2019; Ferreira, Duarte M Sacramento/E-4270-2012; Castro, Rui E/AAG-4179-2021	Castro, Rui E/0000-0002-7417-0091; Rodrigues, Cecilia MP/0000-0002-4829-754X; Evangelista, Teresinha/0000-0002-1329-9131; Cortez-Pinto, Helena/0000-0002-8537-8744; de Carvalho, Mamede/0000-0001-7556-0158; Ferreira, Duarte M Sacramento/0000-0001-5940-7102; Castro, Rui E/0000-0002-7417-0091	FCT, Portugal [PTDC/SAU-OSM/100878/2008]	FCT, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by a grant: PTDC/SAU-OSM/100878/2008, from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Alves RMP, 2010, J GERONTOL A-BIOL, V65, P832, DOI 10.1093/gerona/glq081; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240; Chanseaume E, 2007, OBESITY, V15, P50, DOI 10.1038/oby.2007.511; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dengel DR, 1996, J APPL PHYSIOL, V81, P318, DOI 10.1152/jappl.1996.81.1.318; Dube JJ, 2011, DIABETOLOGIA, V54, P1147, DOI 10.1007/s00125-011-2065-0; Eckardt K, 2011, REV ENDOCR METAB DIS, V12, P163, DOI 10.1007/s11154-011-9168-2; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ellis BA, 2000, AM J PHYSIOL-ENDOC M, V279, pE554, DOI 10.1152/ajpendo.2000.279.3.E554; Ferreira DMS, 2011, DIABETOLOGIA, V54, P1788, DOI 10.1007/s00125-011-2130-8; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Genuth S, 2003, DIABETES CARE, V26, P3160; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Group NHBPEPW, 1993, ARCH INTERN MED, V153, P325; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hawley JA, 2007, DIABETOLOGIA, V50, P699, DOI 10.1007/s00125-007-0595-2; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kitajima Y, 2010, J GASTROENTEROL, V45, P218, DOI 10.1007/s00535-009-0147-2; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kraegen EW, 2008, P NATL ACAD SCI USA, V105, P7627, DOI 10.1073/pnas.0803901105; Kuhlmann J, 2003, DIABETES, V52, P138, DOI 10.2337/diabetes.52.1.138; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; Perseghin G, 2002, AM J PHYSIOL-ENDOC M, V283, pE556, DOI 10.1152/ajpendo.00127.2002; Polyzos SA, 2011, METABOLISM, V60, P313, DOI 10.1016/j.metabol.2010.09.003; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Ramalho RM, 2006, EUR J GASTROEN HEPAT, V18, P21, DOI 10.1097/00042737-200601000-00005; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; Thrush AB, 2009, J CLIN ENDOCR METAB, V94, P5053, DOI 10.1210/jc.2008-2565; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	55	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31738	10.1371/journal.pone.0031738	http://dx.doi.org/10.1371/journal.pone.0031738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359625	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200094
J	Mehes, E; Mones, E; Nemeth, V; Vicsek, T				Mehes, Elod; Mones, Enys; Nemeth, Valeria; Vicsek, Tamas			Collective Motion of Cells Mediates Segregation and Pattern Formation in Co-Cultures	PLOS ONE			English	Article							DIFFERENTIAL ADHESION; BROWNIAN-MOTION; RAC; RECONSTRUCTION; MORPHOGENESIS; SIMULATION; MIGRATION; TISSUES	Pattern formation by segregation of cell types is an important process during embryonic development. We show that an experimentally yet unexplored mechanism based on collective motility of segregating cells enhances the effects of known pattern formation mechanisms such as differential adhesion, mechanochemical interactions or cell migration directed by morphogens. To study in vitro cell segregation we use time-lapse videomicroscopy and quantitative analysis of the main features of the motion of individual cells or groups. Our observations have been extensive, typically involving the investigation of the development of patterns containing up to 200,000 cells. By either comparing keratocyte types with different collective motility characteristics or increasing cells' directional persistence by the inhibition of Rac1 GTP-ase we demonstrate that enhanced collective cell motility results in faster cell segregation leading to the formation of more extensive patterns. The growth of the characteristic scale of patterns generally follows an algebraic scaling law with exponent values up to 0.74 in the presence of collective motion, compared to significantly smaller exponents in case of diffusive motion.	[Mehes, Elod; Mones, Enys; Nemeth, Valeria; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences	Mehes, E (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	emehes@angel.elte.hu	Mehes, Elod/AAD-8229-2019	Mones, Enys/0000-0001-7724-0094	European Union ERC COLLMOT	European Union ERC COLLMOT	European Union ERC COLLMOT Project, http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmonte JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.248702; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; DUNN GA, 1987, J CELL SCI, P81; Foty RA, 1996, DEVELOPMENT, V122, P1611; Furth R, 1920, Z PHYS, V2, P244, DOI 10.1007/BF01328731; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Henkes S, 2011, ARXIV11074072V1; Kabla AJ, 2011, ARXIV11084286V1QBIOC; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; McCandlish SR, 2011, ARXIV11102479V2; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Murray JD, 2003, CR BIOL, V326, P239, DOI 10.1016/S1631-0691(03)00065-9; Nakajima A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033035; Ornstein LS, 1919, P K AKAD WET-AMSTERD, V21, P96; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Szabo A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046007; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	28	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31711	10.1371/journal.pone.0031711	http://dx.doi.org/10.1371/journal.pone.0031711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359617	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200086
J	Perrault, JR; Miller, DL; Eads, E; Johnson, C; Merrill, A; Thompson, LJ; Wyneken, J				Perrault, Justin R.; Miller, Debra L.; Eads, Erica; Johnson, Chris; Merrill, Anita; Thompson, Larry J.; Wyneken, Jeanette			Maternal Health Status Correlates with Nest Success of Leatherback Sea Turtles (Dermochelys coriacea) from Florida	PLOS ONE			English	Article							CHELONIA-MYDAS; CARETTA-CARETTA; GREEN TURTLES; HEMATOLOGICAL PARAMETERS; REPRODUCTIVE-CYCLE; BREEDING SUCCESS; TRACE-ELEMENTS; NORTH-CAROLINA; BLOOD VALUES; ENERGY	Of the seven sea turtle species, the critically endangered leatherback sea turtle (Dermochelys coriacea) exhibits the lowest and most variable nest success (i.e., hatching success and emergence success) for reasons that remain largely unknown. In an attempt to identify or rule out causes of low reproductive success in this species, we established the largest sample size (n = 60-70 for most values) of baseline blood parameters (protein electrophoresis, hematology, plasma biochemistry) for this species to date. Hematologic, protein electrophoretic and biochemical values are important tools that can provide information regarding the physiological condition of an individual and population health as a whole. It has been proposed that the health of nesting individuals affects their reproductive output. In order to establish correlations with low reproductive success in leatherback sea turtles from Florida, we compared maternal health indices to hatching success and emergence success of their nests. As expected, hatching success (median = 57.4%) and emergence success (median = 49.1%) in Floridian leatherbacks were low during the study period (2007-2008 nesting seasons), a trend common in most nesting leatherback populations (average global hatching success = similar to 50%). One protein electrophoretic value (gamma globulin protein) and one hematologic value (red blood cell count) significantly correlated with hatching success and emergence success. Several maternal biochemical parameters correlated with hatching success and/or emergence success including alkaline phosphatase activity, blood urea nitrogen, calcium, calcium: phosphorus ratio, carbon dioxide, cholesterol, creatinine, and phosphorus. Our results suggest that in leatherbacks, physiological parameters correlate with hatching success and emergence success of their nests. We conclude that long-term and comparative studies are needed to determine if certain individuals produce nests with lower hatching success and emergence success than others, and if those individuals with evidence of chronic suboptimal health have lower reproductive success.	[Perrault, Justin R.; Wyneken, Jeanette] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Miller, Debra L.; Merrill, Anita] Univ Georgia, Coll Vet Med, Vet Diagnost & Invest Lab, Tifton, GA USA; [Eads, Erica] Univ Tennessee, Coll Vet Med, Knoxville, TN USA; [Johnson, Chris] Loggerhead Marinelife Ctr, Juno Beach, FL USA; [Thompson, Larry J.] Nestle Purina PetCare, St Louis, MO USA	State University System of Florida; Florida Atlantic University; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Nestle SA	Perrault, JR (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.	jperrau2@fau.edu		Miller, Debra/0000-0002-8544-174X; Perrault, Justin/0000-0002-5046-6701	Florida Sea Turtle License Plate grant [07-004R]; Nelligan Sea Turtle Research Fund	Florida Sea Turtle License Plate grant; Nelligan Sea Turtle Research Fund	Our study was supported in part by a Florida Sea Turtle License Plate grant (grant #07-004R) to Debra L. Miller (URL: http://www.helpingseaturtles.org/grants.php). The University of Georgia Veterinary Diagnostic and Investigational Laboratory provided equipment and personnel for sample analyses (URL: http://www.vet.uga.edu/dlab/index.php). Partial funding for travel was provided by the Nelligan Sea Turtle Research Fund (URL: https://fauf.fau.edu/NetCommunity/SSLPage.aspx?pid = 1766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Alkindi AYA, 2001, PAKISTAN J BIOL SCI, V4, P608; Apanius V., 2008, ORNITHOL MONOGR, V65, P1, DOI [10.1525/om.2008.65.1.1, DOI 10.1525/OM.2008.65.1.1]; Bell BA, 2004, BIOL CONSERV, V115, P131, DOI 10.1016/S0006-3207(03)00102-2; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Bjorndal Karen A., 1997, P199; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; BUSTARD HR, 1968, ECOLOGY, V49, P269, DOI 10.2307/1934455; Calix M., 2018, EUROPEAN RED LIST SA; Campbell T., 2006, REPTILE MED SURG, P453, DOI 10.1016/B0-72-169327-X/50032-8; Campbell Terry W., 1996, P248; Carminati CE., 1994, P 14 ANN S SEA TURTL, P203; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Casey J, 2010, J EXP BIOL, V213, P3961, DOI 10.1242/jeb.048611; Chaffin K, 2008, J WILDLIFE DIS, V44, P670, DOI 10.7589/0090-3558-44.3.670; Cheeks R, 1997, THESIS FLORIDA ATLAN; Chesley LC, 1934, BIOL BULL-US, V66, P133, DOI 10.2307/1537327; COTTRAL GE, 1952, ANN NY ACAD SCI, V55, P221, DOI 10.1111/j.1749-6632.1952.tb26538.x; Cray C, 1998, J AVIAN MED SURG, V12, P4; CUTTING JA, 1973, BIOCHIM BIOPHYS ACTA, V298, P951, DOI 10.1016/0005-2736(73)90398-2; Deem SL, 2006, J ZOO WILDLIFE MED, V37, P464, DOI 10.1638/05-102.1; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Dessaner H. C., 1970, P1; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Dufva R, 1996, J AVIAN BIOL, V27, P83, DOI 10.2307/3676964; DUGUY R., 1970, BIOL REPTILIA, P93; Dunbar MR, 2005, J ZOO WILDLIFE MED, V36, P422, DOI 10.1638/04-065.1; Dutton P.H., 1996, P INT S SEA TURTL CO, V396, P17, DOI [10.1051/parasite/2014024, DOI 10.1051/PARASITE/2014024]; Dutton Peter, 1994, Marine Turtle Newsletter, V67, P13; DUTTON PH, 1995, THESIS TEXAS A M U C; Eales J.G., 1979, P341; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Evans EW, 2003, DUNCAN PRASSES VET L, P162; Field CL, 2001, THROMB RES, V101, P267, DOI 10.1016/S0049-3848(00)00392-3; Fukushi K, 2005, BUNSEKI KAGAKU, V54, P175, DOI 10.2116/bunsekikagaku.54.175; George RH, 1996, BIOL SEA TURTLES, P363; Gicking John C., 2004, Journal of Herpetological Medicine and Surgery, V14, P13; Graveland J, 1997, J ANIM ECOL, V66, P279, DOI 10.2307/6028; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M, 2003, CRC MAR BIOL SER, P135; Hamann Mark, 2006, Endangered Species Research, V2, P81, DOI 10.3354/esr002081; Harms CA, 2007, VET REC, V161, P15, DOI 10.1136/vr.161.1.15; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; Harris HS, 2011, J WILDLIFE DIS, V47, P321, DOI 10.7589/0090-3558-47.2.321; Hasbun CR, 1998, COMP HAEMATOL INT, V8, P174, DOI 10.1007/BF02642510; Hatch MI, 2010, J ORNITHOL, V151, P545, DOI 10.1007/s10336-009-0487-y; Hernandez R, 2007, CHELONIAN CONSERV BI, V6, P79, DOI 10.2744/1071-8443(2007)6[79:NDAHSO]2.0.CO;2; Honarvar S, 2011, HERPETOLOGICA, V67, P222, DOI 10.1655/HERPETOLOGICA-D-10-00061.1; Hsieh YHP, 2001, HYDROBIOLOGIA, V451, P11, DOI 10.1023/A:1011875720415; HUNT JR, 1970, BRIT POULTRY SCI, V11, P259, DOI 10.1080/00071667008415813; Innis C, 2010, CHELONIAN CONSERV BI, V9, P205, DOI 10.2744/CCB-0838.1; JACOBSON E, 2008, ESTABLISHING PLASMA; Keller JM, 2004, ENVIRON HEALTH PERSP, V112, P1074, DOI 10.1289/ehp.6923; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; LANCE V, 1983, CAN J ZOOL, V61, P1744, DOI 10.1139/z83-225; LOEKEN MR, 1983, IMMUNOLOGY, V49, P21; LUTCAVAGE M, 1986, COPEIA, P796, DOI 10.2307/1444962; LUTCAVAGE ME, 1990, PHYSIOL ZOOL, V63, P1012, DOI 10.1086/physzool.63.5.30152626; Lutcavage Molly E., 1997, P277; MASAT RJ, 1968, COMP BIOCHEM PHYSIOL, V25, P119, DOI 10.1016/0010-406X(68)90918-3; Masello JF, 2004, J AVIAN BIOL, V35, P445, DOI 10.1111/j.0908-8857.2004.03278.x; MCKNIGHT GS, 1980, J BIOL CHEM, V255, P144; Miller J.D., 1999, IUCN SSC MARINE TURT, V4; Miller Jeffrey D., 1997, P51; MORTIMER JA, 1990, COPEIA, P802, DOI 10.2307/1446446; MUSQUERA S, 1976, COMP BIOCHEM PHYS A, V55, P225, DOI 10.1016/0300-9629(76)90136-5; NATT MP, 1952, POULTRY SCI, V31, P735, DOI 10.3382/ps.0310735; Perrault J, 2011, MAR POLLUT BULL, V62, P1671, DOI 10.1016/j.marpolbul.2011.06.009; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; RAMSAY WNM, 1954, BIOCHEM J, V58, P313, DOI 10.1042/bj0580313; Rostal David C., 1996, Chelonian Conservation and Biology, V2, P230; Rostal DC, 1998, GEN COMP ENDOCR, V109, P232, DOI 10.1006/gcen.1997.7026; Rostal DC, 2001, GEN COMP ENDOCR, V122, P139, DOI 10.1006/gcen.2001.7615; SAKAI H, 1995, MAR POLLUT BULL, V30, P347, DOI 10.1016/0025-326X(94)00185-C; Sokal R.R., 2012, BIOMETRY; Soslau G, 2005, COMP BIOCHEM PHYS B, V142, P353, DOI 10.1016/j.cbpb.2005.08.006; Soslau G, 2004, COMP BIOCHEM PHYS B, V138, P399, DOI 10.1016/j.cbpc.2004.05.004; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Stein Geoff, 1996, P473; STEWART K, 2007, THESIS DUKE U DURHAM; Stewart Kelly, 2006, Chelonian Research Monographs, V3, P144; STONEBURNER DL, 1980, J HERPETOL, V14, P171, DOI 10.2307/1563850; Storelli MM, 2005, ENVIRON POLLUT, V135, P163, DOI 10.1016/j.envpol.2004.09.005; Swimmer JY, 2000, J WILDLIFE DIS, V36, P102, DOI 10.7589/0090-3558-36.1.102; Sypek J., 1988, P211; Thompson MB, 2002, COMP BIOCHEM PHYS A, V133, P529, DOI 10.1016/S1095-6433(02)00188-5; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; WOOD FE, 1984, HERPETOLOGICA, V40, P331; Wyneken J, 2001, NMFSSEFSC470 NOAA, DOI DOI 10.1007/SPRINGERREFERENCE_; Zaias Julia, 2002, Journal of Herpetological Medicine and Surgery, V12, P30	93	43	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31841	10.1371/journal.pone.0031841	http://dx.doi.org/10.1371/journal.pone.0031841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359635	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200104
J	Yang, CY; Wang, LL; Siva, VS; Shi, XW; Jiang, QF; Wang, JJ; Zhang, H; Song, LS				Yang, Chuanyan; Wang, Lingling; Siva, Vinu S.; Shi, Xiaowei; Jiang, Qiufen; Wang, Jingjing; Zhang, Huan; Song, Linsheng			A Novel Cold-Regulated Cold Shock Domain Containing Protein from Scallop Chlamys farreri with Nucleic Acid-Binding Activity	PLOS ONE			English	Article							Y-BOX PROTEIN; MESSENGER-RNA; ESCHERICHIA-COLI; CSPA-FAMILY; FUNCTIONAL-PROPERTIES; FREEZING-TOLERANCE; GENE; TRANSCRIPTION; TRANSLATION; IDENTIFICATION	Background: The cold shock domain (CSD) containing proteins (CSDPs) are one group of the evolutionarily conserved nucleic acid-binding proteins widely distributed in bacteria, plants, animals, and involved in various cellular processes, including adaptation to low temperature, cellular growth, nutrient stress and stationary phase. Methodology: The cDNA of a novel CSDP was cloned from Zhikong scallop Chlamys farreri (designated as CfCSP) by expressed sequence tag (EST) analysis and rapid amplification of cDNA ends (RACE) approach. The full length cDNA of CfCSP was of 1735 bp containing a 927 bp open reading frame which encoded an N-terminal CSD with conserved nucleic acids binding motif and a C-terminal domain with four Arg-Gly-Gly (RGG) repeats. The CSD of CfCSP shared high homology with the CSDs from other CSDPs in vertebrate, invertebrate and bacteria. The mRNA transcripts of CfCSP were mainly detected in the tissue of adductor and also marginally detectable in gill, hepatopancreas, hemocytes, kidney, mantle and gonad of healthy scallop. The relative expression level of CfCSP was up-regulated significantly in adductor and hemocytes at 1 h and 24 h respectively after low temperature treatment (P < 0.05). The recombinant CfCSP protein (rCfCSP) could bind ssDNA and in vitro transcribed mRNA, but it could not bind dsDNA. BX04, a cold sensitive Escherichia coli CSP quadruple-deletion mutant, was used to examine the cold adaptation ability of CfCSP. After incubation at 17 degrees C for 120 h, the strain of BX04 containing the vector pINIII showed growth defect and failed to form colonies, while strain containing pINIII-CSPA or pINIII-CfCSP grew vigorously, indicating that CfCSP shared a similar function with E. coli CSPs for the cold adaptation. Conclusions: These results suggest that CfCSP is a novel eukaryotic cold-regulated nucleic acid-binding protein and may function as an RNA chaperone in vivo during the cold adaptation process.	[Yang, Chuanyan; Wang, Lingling; Siva, Vinu S.; Shi, Xiaowei; Jiang, Qiufen; Wang, Jingjing; Zhang, Huan; Song, Linsheng] Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [Yang, Chuanyan; Siva, Vinu S.; Shi, Xiaowei; Jiang, Qiufen; Wang, Jingjing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, CY (corresponding author), Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China (973 program) [2010CB126404]; National Science Foundation of China [30925028]; Shandong Provincial Natural Science Foundation, China [JQ201110]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This research was supported by National Basic Research Program of China (973 program, no. 2010CB126404), and grants from the National Science Foundation of China (no. 30925028 to LS) and Shandong Provincial Natural Science Foundation, China (no. JQ201110 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; BOUVET P, 1994, CELL, V77, P931, DOI 10.1016/0092-8674(94)90141-4; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Fusaro AF, 2007, PLANTA, V225, P1339, DOI 10.1007/s00425-006-0444-4; Franco GR, 1997, GENE, V198, P5, DOI 10.1016/S0378-1119(97)00261-8; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266; Gupta-Malhotra M, 2003, CARDIOLOGY, V99, P121, DOI 10.1159/000070668; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Karlson D, 2003, PLANT PHYSIOL, V131, P12, DOI 10.1104/pp.014472; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Keresztessy Z, 1998, PLANT J, V14, P523, DOI 10.1046/j.1365-313X.1998.00149.x; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kim MH, 2009, J BIOL CHEM, V284, P23454, DOI 10.1074/jbc.M109.025791; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Li FM, 2010, FISH SHELLFISH IMMUN, V29, P521, DOI 10.1016/j.fsi.2010.05.015; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; Matsumoto K, 2003, BIOCHEM BIOPH RES CO, V306, P53, DOI 10.1016/S0006-291X(03)00909-4; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Nakaminami K, 2005, FEBS LETT, V579, P4887, DOI 10.1016/j.febslet.2005.07.074; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Pelletier M, 2000, NUCLEIC ACIDS RES, V28, P1266, DOI 10.1093/nar/28.5.1266; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2002, J BIOL CHEM, V277, P46706, DOI 10.1074/jbc.M208118200; Pisarev AV, 2002, J BIOL CHEM, V277, P15445, DOI 10.1074/jbc.M111954200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; RANJAN M, 1993, GENE DEV, V7, P1725, DOI 10.1101/gad.7.9.1725; Salvetti A, 1998, DEV BIOL, V201, P217, DOI 10.1006/dbio.1998.8996; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; SKEHEL PA, 1994, GENE, V145, P231, DOI 10.1016/0378-1119(94)90011-6; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sommerville J, 1999, BIOESSAYS, V21, P319, DOI 10.1002/(SICI)1521-1878(199904)21:4<319::AID-BIES8>3.3.CO;2-V; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Thieringer HA, 1998, BIOESSAYS, V20, P49; Thieringer HA, 1997, NUCLEIC ACIDS RES, V25, P4764, DOI 10.1093/nar/25.23.4764; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; Wang N, 2000, MOL MICROBIOL, V38, P526, DOI 10.1046/j.1365-2958.2000.02146.x; Weber MHW, 2002, NUCLEIC ACIDS RES, V30, P375, DOI 10.1093/nar/30.1.375; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yang CY, 2012, PLOS ONE IN PRESS; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P418, DOI 10.1016/j.dci.2009.11.012	54	18	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32012	10.1371/journal.pone.0032012	http://dx.doi.org/10.1371/journal.pone.0032012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359656	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200125
J	Zhou, MY; Xu, AM; Tam, PKH; Lam, KSL; Huang, BS; Liang, Y; Lee, IK; Wu, DH; Wang, Y				Zhou, Mingyan; Xu, Aimin; Tam, Paul K. H.; Lam, Karen S. L.; Huang, Bosheng; Liang, Yan; Lee, In-Kyu; Wu, Donghai; Wang, Yu			Upregulation of UCP2 by Adiponectin: The Involvement of Mitochondrial Superoxide and hnRNP K	PLOS ONE			English	Article							FATTY LIVER-DISEASES; UNCOUPLING PROTEIN-2; NONALCOHOLIC STEATOHEPATITIS; TNF-ALPHA; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; MICE; OBESITY; GENE; ACTIVATION	Background: The adipocyte-derived hormone adiponectin elicits protective functions against fatty liver diseases and hepatic injuries at least in part by stimulating the expression of a mitochondrial inner membrane transporter, uncoupling protein 2 (UCP2). The present study was designed to investigate the cellular and molecular mechanisms underlying adiponectin-induced UCP2 expression. Methodology/Principal Findnigs: Mice were treated with adiponectin and/or different drug inhibitors. Parenchymal (PCs) and nonparenchymal (NPCs) cells were fractionated from the liver tissues for mitochondria isolation, Western blotting and quantitative PCR analysis. Mitochondrial superoxide production was monitored by MitoSOX staining and flow cytometry analysis. Compared to control mice, the expression of UCP2 was significantly lower in NPCs, but not PCs of adiponectin knockout mice (AKO). Both chronic and acute treatment with adiponectin selectively increased the mRNA and protein abundance of UCP2 in NPCs, especially in the enriched endothelial cell fractions. The transcription inhibitor actinomycin D could not block adiponectin-induced UCP2 expression, whereas the protein synthesis inhibitor cycloheximide inhibited the elevation of UCP2 protein but not its mRNA levels. Mitochondrial content of heterogeneous nuclear ribonucleoprotein K (hnRNP K), a nucleic acid binding protein involved in regulating mRNA transportation and stabilization, was significantly enhanced by adiponectin, which also evoked a transient elevation of mitochondrial superoxide. Rotenone, an inhibitor of mitochondrial respiratory complex I, abolished adiponectin-induced superoxide production, hnRNP K recruitment and UCP2 expression. Conclusions/Significance: Mitochondrial superoxide production stimulated by adiponectin serves as a trigger to initiate the translocation of hnRNP K, which in turn promotes UCP2 expressions in liver.	[Zhou, Mingyan; Xu, Aimin; Huang, Bosheng; Liang, Yan; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tam, Paul K. H.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Taegu, South Korea; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Kyungpook National University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zhou, MY (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	yuwanghk@hku.hk	Xu, Aimin/D-3291-2013; Lee, In-Kyu/AAR-6374-2021; /C-4405-2009	Xu, Aimin/0000-0002-0668-033X; /0000-0001-6231-3035; wang, yu/0000-0001-8697-2940	Research Grants Council of Hong Kong [HKU777908M]; National Basic Research Program of China [2010CB945500]; US National Institutes of Health [HL-51586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China(National Basic Research Program of China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by Research Grants Council of Hong Kong (Project no. HKU777908M), the National Basic Research Program of China (2010CB945500). Adiponectin knockout mice were kindly provided by Dr. Lawrence Chan at Baylor College of Medicine, who generated these mice with the support of the US National Institutes of Health grant HL-51586. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Aygun C, 2006, EUR J GASTROEN HEPAT, V18, P175, DOI 10.1097/00042737-200602000-00010; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Baffy G, 2005, FRONT BIOSCI-LANDMRK, V10, P2082, DOI 10.2741/1683; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Balmer Maria Luisa, 2011, Ther Umsch, V68, P183, DOI 10.1024/0040-5930/a000148; Baranova A, 2006, OBES SURG, V16, P1118, DOI 10.1381/096089206778392149; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Ding XK, 2005, AM J PATHOL, V166, P1655, DOI 10.1016/S0002-9440(10)62476-5; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fulop P, 2006, HEPATOLOGY, V44, P592, DOI 10.1002/hep.21310; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020; Klimek-Tomczak K, 2006, ACTA BIOCHIM POL, V53, P169; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Machado M, 2006, CURR OPIN CLIN NUTR, V9, P637, DOI 10.1097/01.mco.0000241677.40170.17; Mangge H, 2010, CURR MED CHEM, V17, P4511, DOI 10.2174/092986710794183006; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Matsumoto H, 2006, WORLD J GASTROENTERO, V12, P3352, DOI 10.3748/wjg.v12.i21.3352; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Musso G, 2008, HEPATOLOGY, V47, P1167, DOI 10.1002/hep.22142; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Ostrowski J, 2004, J BIOL CHEM, V279, P54599, DOI 10.1074/jbc.M406753200; Ostrowski J, 2002, J BIOL CHEM, V277, P6303, DOI 10.1074/jbc.M110267200; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; Sennello JA, 2005, ENDOCRINOLOGY, V146, P2157, DOI 10.1210/en.2004-1572; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Vuppalanchi R, 2005, J CLIN GASTROENTEROL, V39, P237, DOI 10.1097/01.mcg.0000152747.79773.2f; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2009, ARQ BRAS ENDOCRINOL, V53, P201, DOI 10.1590/S0004-27302009000200012; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wree A, 2011, DIGESTION, V83, P124, DOI 10.1159/000318741; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yoneda M, 2007, ALCOHOL CLIN EXP RES, V31, p15S, DOI 10.1111/j.1530-0277.2006.00281.x; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444; Zhou MY, 2010, J HEPATOL, V53, P1108, DOI 10.1016/j.jhep.2010.05.034; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	59	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32349	10.1371/journal.pone.0032349	http://dx.doi.org/10.1371/journal.pone.0032349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359684	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200153
J	Chuang, SF; Su, LH; Cho, CC; Pan, YJ; Sun, CH				Chuang, Shen-Fung; Su, Li-Hsin; Cho, Chao-Cheng; Pan, Yu-Jiao; Sun, Chin-Hung			Functional Redundancy of Two Pax-Like Proteins in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DOMAIN-DNA COMPLEX; PAIRED DOMAIN; PRIMITIVE EUKARYOTE; CELL-DIFFERENTIATION; CRYSTAL-STRUCTURE; BINDING-SITES; ENCYSTATION; EXPRESSION; IDENTIFICATION	The protozoan Giardia lamblia differentiates from a pathogenic trophozoite into an infectious cyst to survive outside of the host. During encystation, genes encoding cyst wall proteins (CWPs) are coordinately induced. Pax family transcription factors are involved in a variety of developmental processes in animals. Nine Pax proteins have been found to play an important role in tissue and organ development in humans. To understand the progression from primitive to more complex eukaryotic cells, we tried to identify putative pax genes in the G. lamblia genome and found two genes, pax1 and pax2, with limited similarity. We found that Pax1 may transactivate the encystation-induced cwp genes and interact with AT-rich initiatior elements that are essential for promoter activity and transcription start site selection. In this study, we further characterized Pax2 and found that, like Pax1, Pax2 was present in Giardia nuclei and it may specifically bind to the AT-rich initiator elements of the encystation-induced cwp1-3 and myb2 genes. Interestingly, overexpression of Pax2 increased the cwp1-3 and myb2 gene expression and cyst formation. Deletion of the C-terminal paired domain or mutation of the basic amino acids of the paired domain resulted in a decrease of nuclear localization, DNA-binding activity, and transactivation activity of Pax2. These results are similar to those found in the previous Pax1 study. In addition, the profiles of gene expression in the Pax2 and Pax1 overexpressing cells significantly overlap in the same direction and ERK1 associated complexes may phosphorylate Pax2 and Pax1, suggesting that Pax2 and Pax1 may be downstream components of a MAPK/ERK1 signaling pathway. Our results reveal functional redundancy between Pax2 and Pax1 in up-regulation of the key encystation-induced genes. These results illustrate functional redundancy of a gene family can occur in order to increase maintenance of important gene function in the protozoan organism G. lamblia.	[Chuang, Shen-Fung; Su, Li-Hsin; Cho, Chao-Cheng; Pan, Yu-Jiao; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 10764, Taiwan	National Taiwan University	Chuang, SF (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 10764, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, NSC 100-2325-B-002 - 039]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council grants NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, and NSC 100-2325-B-002 - 039, and the National Health Research Institutes grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amin NM, 2009, DEV BIOL, V331, P350, DOI 10.1016/j.ydbio.2009.05.538; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; CAI JX, 1994, MECH DEVELOP, V47, P139, DOI 10.1016/0925-4773(94)90086-8; Carranza PG, 2010, MICROBES INFECT, V12, P71, DOI 10.1016/j.micinf.2009.09.008; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Ellis JG, 2003, J BIOL CHEM, V278, P1936, DOI 10.1074/jbc.M209274200; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; HAGMAN J, 1994, CURR OPIN IMMUNOL, V6, P222, DOI 10.1016/0952-7915(94)90095-7; Hanevik K, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-27; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Morken MH, 2009, SCAND J GASTROENTERO, V44, P308, DOI 10.1080/00365520802588091; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Nornes S, 1996, J BIOL CHEM, V271, P26914, DOI 10.1074/jbc.271.43.26914; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; Phelps DE, 1996, J BIOL CHEM, V271, P7978, DOI 10.1074/jbc.271.14.7978; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stuart ET, 1996, CELL GROWTH DIFFER, V7, P405; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Su LH, 2011, J BIOL CHEM, V286, P34101, DOI 10.1074/jbc.M111.280206; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wang YT, 2010, J BIOL CHEM, V285, P32213, DOI 10.1074/jbc.M110.156620; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432	80	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30614	10.1371/journal.pone.0030614	http://dx.doi.org/10.1371/journal.pone.0030614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355320	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300020
J	Prasad, P; Kumar, A; Gupta, R; Juyal, RC; Thelma, BK				Prasad, Pushplata; Kumar, Ashok; Gupta, Rajiva; Juyal, Ramesh C.; Thelma, B. K.			Caucasian and Asian Specific Rheumatoid Arthritis Risk Loci Reveal Limited Replication and Apparent Allelic Heterogeneity in North Indians	PLOS ONE			English	Article							PADI4 GENE; ASSOCIATION; POLYMORPHISM	Genome-wide association studies and meta-analysis indicate that several genes/loci are consistently associated with rheumatoid arthritis (RA) in European and Asian populations. To evaluate the transferability status of these findings to an ethnically diverse north Indian population, we performed a replication analysis. We investigated the association of 47 single-nucleotide polymorphisms (SNPs) at 43 of these genes/loci with RA in a north Indian cohort comprising 983 RA cases and 1007 age and gender matched controls. Genotyping was done using Infinium human 660w-quad. Association analysis by chi-square test implemented in plink was carried out in two steps. Firstly, association of the index or surrogate SNP (r2>0.8, calculated from reference GIH Hap-Map population) was tested. In the second step, evidence for allelic/locus heterogeneity at aforementioned genes/loci was assessed for by testing additional flanking SNPs in linkage equilibrium with index/surrogate marker. Of the 44 European specific index SNPs, neither index nor surrogate SNPs were present for nine SNPs in the genotyping array. Of the remaining 35, associations were replicated at seven genes namely PTPN22 (rs1217407, p = 3 x 10(-3)); IL2-21 (rs13119723, p = 0.008); HLA-DRB1 (rs660895, p = 2.56 x 10(-5); rs6457617, p = 1.6 x 10(-09); rs13192471, p = 6.7 x 10(-16)); TNFA1P3 (rs9321637, p = 0.03); CCL21 (rs13293020, p = 0.01); IL2RA (rs2104286, p = 1.9 x 10(-4)) and ZEB1 (rs2793108, p = 0.006). Of the three Asian specific loci tested, rs2977227 in PADI4 showed modest association (p < 0.02). Further, of the 140 SNPs (in LE with index/surrogate variant) tested, association was observed at 11 additional genes: PTPRC, AFF3, CD28, CTLA4, PXK, ANKRD55, TAGAP, CCR6, BLK, CD40 and IL2RB. This study indicates limited replication of European and Asian index SNPs and apparent allelic heterogeneity in RA etiology among north Indians warranting independent GWAS in this population. However, replicated associations of HLA-DRB1, PTPN22 (which confer similar to 50% of the heritable risk to RA) and IL2RA suggest that cross-ethnicity fine mapping of such loci is apposite for identification of causal variants.	[Prasad, Pushplata; Thelma, B. K.] Univ Delhi, Dept Genet, New Delhi, India; [Kumar, Ashok; Gupta, Rajiva] Ex All India Inst Med Sci, New Delhi, India; [Kumar, Ashok] Fortis Flt Lt Rajan Dhall Hosp, Dept Rheumatol, New Delhi, India; [Gupta, Rajiva] Medanta Bone & Joint Inst, Div Rheumatol & Clin Immunol, Medanta The Medicity, Gurgaon, India; [Juyal, Ramesh C.] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Prasad, P (corresponding author), Univ Delhi, Dept Genet, South Campus, New Delhi, India.	bktlab@gmail.com	Singh, Pushplata/ABH-9083-2020	Singh, Pushplata/0000-0002-4273-6898; Thelma, B.K/0000-0002-2154-5443	Department of Biotechnology, New Delhi, India [BT/01/COE/07/UDSC]	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	Research grant # BT/01/COE/07/UDSC from Department of Biotechnology, New Delhi, India is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; Brahmachari SK, 2008, J GENET, V87, P3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caponi L, 2005, ANN RHEUM DIS, V64, P587, DOI 10.1136/ard.2004.026831; Chang M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000107; De Almeida DE, 2010, J IMMUNOL, V185, P1927, DOI 10.4049/jimmunol.0904002; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Hollis-Moffatt JE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3053; Hu XL, 2006, ARTHRITIS RHEUM, V54, P1022, DOI 10.1002/art.21636; Juyal G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016565; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Martinez A, 2005, RHEUMATOLOGY, V44, P1263, DOI 10.1093/rheumatology/kei008; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUMAN GENETICS, V81; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; TANEJA V, 1992, INDIAN J MED RES-B, V96, P16; Taneja V, 1996, HUM IMMUNOL, V46, P35, DOI 10.1016/0198-8859(95)00165-4	21	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31584	10.1371/journal.pone.0031584	http://dx.doi.org/10.1371/journal.pone.0031584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355377	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300077
J	Rehman, I; Evans, CA; Glen, A; Cross, SS; Eaton, CL; Down, J; Pesce, G; Phillips, JT; Yen, OS; Thalmann, GN; Wright, PC; Hamdy, FC				Rehman, Ishtiaq; Evans, Caroline A.; Glen, Adam; Cross, Simon S.; Eaton, Colby L.; Down, Jenny; Pesce, Giancarlo; Phillips, Joshua T.; Yen, Ow Saw; Thalmann, George N.; Wright, Phillip C.; Hamdy, Freddie C.			iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer	PLOS ONE			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; CARCINOMA ONCOGENE PTI-1; HUMAN PLASMA PROTEOME; MASS-SPECTROMETRY; BONE METASTASIS; OVARIAN-CANCER; CELL-LINES; NUDE-MICE; EXPRESSION; PROTEINS	A major challenge in the management of patients with prostate cancer is identifying those individuals at risk of developing metastatic disease, as in most cases the disease will remain indolent. We analyzed pooled serum samples from 4 groups of patients (n = 5 samples/group), collected prospectively and actively monitored for a minimum of 5 yrs. Patients groups were (i) histological diagnosis of benign prostatic hyperplasia with no evidence of cancer 'BPH', (ii) localised cancer with no evidence of progression, `non-progressing' (iii) localised cancer with evidence of biochemical progression, `progressing', and (iv) bone metastasis at presentation `metastatic'. Pooled samples were immuno-depleted of the 14 most highly abundant proteins and analysed using a 4-plex iTRAQ approach. Overall 122 proteins were identified and relatively quantified. Comparisons of progressing versus non-progressing groups identified the significant differential expression of 25 proteins (p<0.001). Comparisons of metastatic versus progressing groups identified the significant differential expression of 23 proteins. Mapping the differentially expressed proteins onto the prostate cancer progression pathway revealed the dysregulated expression of individual proteins, pairs of proteins and `panels' of proteins to be associated with particular stages of disease development and progression. The median immunostaining intensity of eukaryotic translation elongation factor 1 alpha 1 (eEF1A1), one of the candidates identified, was significantly higher in osteoblasts in close proximity to metastatic tumour cells compared with osteoblasts in control bone (p = 0.0353, Mann Whitney U). Our proteomic approach has identified leads for potentially useful serum biomarkers associated with the metastatic progression of prostate cancer. The panels identified, including eEF1A1 warrant further investigation and validation.	[Rehman, Ishtiaq; Evans, Caroline A.; Glen, Adam; Eaton, Colby L.; Down, Jenny; Pesce, Giancarlo] Univ Sheffield, Sch Med, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield, S Yorkshire, England; [Evans, Caroline A.; Yen, Ow Saw; Wright, Phillip C.] Univ Sheffield, Biol & Environm Syst Grp, Dept Chem & Biol Engn, ChELSI Inst, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Fac Med Dent & Hlth, Dept Neurosci, Sheffield, S Yorkshire, England; [Phillips, Joshua T.] City Hosp, Dept Urol, Birmingham, W Midlands, England; [Thalmann, George N.] Univ Bern, Dept Urol, InselspitalInselspital, Bern, Switzerland; [Hamdy, Freddie C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Birmingham; University of Bern; University Hospital of Bern; University of Oxford	Rehman, I (corresponding author), Univ Sheffield, Sch Med, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield, S Yorkshire, England.	i.rehman@sheffield.ac.uk	Pesce, Giancarlo/K-2804-2019; Pesce, Giancarlo/K-4539-2019; pesce, giancarlo/G-3644-2013; Pesce, Giancarlo/F-5815-2012	Pesce, Giancarlo/0000-0003-4925-6325; Hamdy, Freddie/0000-0003-2627-2154; Cross, Simon/0000-0003-2044-1754; Wright, Phillip/0000-0002-8834-0426; Glen, Adam/0000-0002-9709-5776	EU [FP6-LSH-5-2004-018858, LSHC-CT-2004-503011]; NCRI ProMPT (Prostate cancer Mechanisms of progression and Treatment); Engineering and Physical Sciences Research (EPSRC) [EP/E036252/1, GR/S84347/01]; Roche Diagnostics, Penzberg, Germany; Engineering and Physical Sciences Research Council [GR/S84347/01, EP/E036252/1] Funding Source: researchfish; EPSRC [EP/E036252/1] Funding Source: UKRI	EU(European Commission); NCRI ProMPT (Prostate cancer Mechanisms of progression and Treatment); Engineering and Physical Sciences Research (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Roche Diagnostics, Penzberg, Germany; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grants from PROMET (project no. FP6-LSH-5-2004-018858), and P-MARK (contract no. LSHC-CT-2004-503011), under the sixth EU Framework programme and the NCRI ProMPT (Prostate cancer Mechanisms of progression and Treatment) collaborative grant to Dr. Hamdy, and grants from Engineering and Physical Sciences Research (EPSRC) to Dr. Wright: EP/E036252/1 and GR/S84347/01. We are grateful to Dr. Nicholas Hoyle at Roche Diagnostics, Penzberg, Germany for his support towards consumables and reagents for the project. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We are grateful to Dr. Nicholas Hoyle at Roche Diagnostics, Penzberg, Germany for his support towards consumables and reagents for the project. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Bandow JE, 2010, PROTEOMICS, V10, P1416, DOI 10.1002/pmic.200900431; Boylan KLM, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-31; Burgess EF, 2008, PROTEOM CLIN APPL, V2, P1223, DOI 10.1002/prca.200780073; Byrne JC, 2009, J PROTEOME RES, V8, P942, DOI 10.1021/pr800570s; Cima I., 2011, P NATL ACAD SCI US; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Drake RR, 2009, J PROTEOMICS, V72, P907, DOI 10.1016/j.jprot.2009.01.007; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Glen A, 2010, PROSTATE, V70, P1313, DOI 10.1002/pros.21167; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Gross M, 2007, CLIN CANCER RES, V13, P1979, DOI 10.1158/1078-0432.CCR-06-1156; Huang WC, 2006, CANCER RES, V66, P9108, DOI 10.1158/0008-5472.CAN-06-1996; Jackson D, 2007, CLIN CANCER RES, V13, P7370, DOI 10.1158/1078-0432.CCR-07-0747; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; LaSpina M, 2008, CAN J UROL, V15, P3; Le L, 2005, CLIN CHEM, V51, P695, DOI 10.1373/clinchem.2004.041087; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Lu Y, 2004, CLIN EXP METASTAS, V21, P399, DOI 10.1007/s10585-005-0056-6; Malik G, 2010, CANCER RES, V70, P4327, DOI 10.1158/0008-5472.CAN-09-3312; Martin DB, 2004, CANCER RES, V64, P347, DOI 10.1158/0008-5472.CAN-03-2062; Mbeunkui F, 2007, J PROTEOME RES, V6, P2993, DOI 10.1021/pr060629m; Mikolajczyk SD, 2004, CLIN BIOCHEM, V37, P519, DOI 10.1016/j.clinbiochem.2004.05.016; Noirel J, 2011, CURR PROTEOMICS, V8, P17, DOI 10.2174/157016411794697408; Ow SY, 2009, J PROTEOME RES; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Pieper R, 2003, PROTEOMICS, V3, P422, DOI 10.1002/pmic.200390057; PRINS RC, 2010, UROL ONCOL; Qian WJ, 2008, MOL CELL PROTEOMICS, V7, P1963, DOI 10.1074/mcp.M800008-MCP200; Rehman I, 2004, HUM PATHOL, V35, P1385, DOI 10.1016/j.humpath.2004.07.015; Rehman I, 2004, BRIT J CANCER, V91, P739, DOI 10.1038/sj.bjc.6602034; Rosenzweig CN, 2009, J UROLOGY, V181, P1407, DOI 10.1016/j.juro.2008.10.142; SHEN RQ, 1995, P NATL ACAD SCI USA, V92, P6778, DOI 10.1073/pnas.92.15.6778; Sun W, 2005, EUR J MASS SPECTROM, V11, P575, DOI 10.1255/ejms.776; Sun YL, 1997, CANCER RES, V57, P18; THALMANN GN, 1994, CANCER RES, V54, P2577; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tonack S, 2009, J PROTEOMICS, V73, P352, DOI 10.1016/j.jprot.2009.07.009; van Gils MPMQ, 2005, EUR UROL, V48, P1031, DOI 10.1016/j.eururo.2005.06.009; WARD AM, 1977, BRIT J UROL, V49, P411, DOI 10.1111/j.1464-410X.1977.tb04168.x; YOSHIMURA S, 1978, CANCER RES, V38, P3474; Zhang WM, 2000, UROLOGY, V56, P267, DOI 10.1016/S0090-4295(00)00609-9; Zhang WM, 2000, SCAND J CLIN LAB INV, V60, P51, DOI 10.1080/713783586; Zhu G, 2009, MOL MED, V15, P363, DOI 10.2119/molmed.2009.00082; Zhu QY, 2009, CANCER INVEST, V27, P794, DOI 10.1080/07357900802175617; Zhu XY, 2011, INT J CANCER, V129, P2847, DOI 10.1002/ijc.25947	53	49	57	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30885	10.1371/journal.pone.0030885	http://dx.doi.org/10.1371/journal.pone.0030885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355332	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302741300032
J	Chiarelli, LR; Morera, SM; Bianchi, P; Fermo, E; Zanella, A; Galizzi, A; Valentini, G				Chiarelli, Laurent R.; Morera, Simone M.; Bianchi, Paola; Fermo, Elisa; Zanella, Alberto; Galizzi, Alessandro; Valentini, Giovanna			Molecular Insights on Pathogenic Effects of Mutations Causing Phosphoglycerate Kinase Deficiency	PLOS ONE			English	Article							CHRONIC HEMOLYTIC-ANEMIA; HUMAN 3-PHOSPHOGLYCERATE KINASE; MYOPATHIC FORM; NEUROLOGICAL DYSFUNCTION; NUCLEOSIDE ANALOGS; MISSENSE MUTATION; PGK DEFICIENCY; VARIANT; ENZYME; GENE	Phosphoglycerate kinase (PGK) catalyzes an important ATP-generating step in glycolysis. PGK1 deficiency is an uncommon X-linked inherited disorder, generally characterized by various combinations of non-spherocytic hemolytic anemia, neurological dysfunctions, and myopathies. Patients rarely exhibit all three clinical features. To provide a molecular framework to the different pathological manifestations, all known mutations were reviewed and 16 mutant enzymes, obtained as recombinant forms, were functionally and structurally characterized. Most mutations heavily affect thermal stability and to a different extent catalytic efficiency, in line with the remarkably low PGK activity clinically observed in the patients. Mutations grossly impairing protein stability, but moderately affecting kinetic properties (p.I47N, p.L89P, p.C316R, p.S320N, and p.A354P) present the most homogeneous correlation with the clinical phenotype. Patients carrying these mutations display hemolytic anemia and neurological disorders, and, except for p.A354P variant, no myopaty. Variants highly perturbed in both catalytic efficiency (p.G158V, p.D164V, p.K191del, D285V, p.D315N, and p.T378P) and heat stability (all, but p.T378P) result to be mainly associated with myopathy alone. Finally, mutations faintly affecting molecular properties (p.R206P, p.E252A, p.I253T, p.V266M, and p.D268N) correlate with a wide spectrum of clinical symptoms. These are the first studies that correlate the clinical symptoms with the molecular properties of the mutant enzymes. All findings indicate that the different clinical manifestations associated with PGK1 deficiency chiefly depend on the distinctive type of perturbations caused by mutations in the PGK1 gene, highlighting the need for determination of the molecular properties of PGK variants to assist in prognosis and genetic counseling. However, the clinical symptoms can not be understood only on the bases of molecular properties of the mutant enzyme. Different (environmental, metabolic, genetic and/or epigenetic) intervening factors can contribute toward the expression of PGK deficient clinical phenotypes.	[Chiarelli, Laurent R.; Morera, Simone M.; Galizzi, Alessandro; Valentini, Giovanna] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Bianchi, Paola; Fermo, Elisa; Zanella, Alberto] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Ematol 2, Milan, Italy	University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico	Chiarelli, LR (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	giovale@unipv.it	Chiarelli, Laurent Roberto/J-8368-2016; Fermo, Elisa/K-2282-2015; Bianchi, Paola/L-2531-2016	Chiarelli, Laurent Roberto/0000-0003-0348-9764; Fermo, Elisa/0000-0003-2812-8711; Bianchi, Paola/0000-0001-5976-5233	University of Pavia "Fondi per la Ricerca di Ateneo"	University of Pavia "Fondi per la Ricerca di Ateneo"	This study was supported by grants from the University of Pavia "Fondi per la Ricerca di Ateneo." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly J, 2000, EUR J NEUROL, V7, P111, DOI 10.1046/j.1468-1331.2000.00012.x; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; Beutler E, 2007, BRIT J HAEMATOL, V136, P3, DOI 10.1111/j.1365-2141.2006.06351.x; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; COHENSOLAL M, 1994, BLOOD, V84, P898, DOI 10.1182/blood.V84.3.898.bloodjournal843898; Flanagan JM, 2006, BRIT J HAEMATOL, V134, P233, DOI 10.1111/j.1365-2141.2006.06143.x; FUJII H, 1980, J BIOL CHEM, V255, P6421; FUJII H, 1992, BLOOD, V79, P1582; FUJII H, 1981, P NATL ACAD SCI-BIOL, V78, P2587, DOI 10.1073/pnas.78.4.2587; FUJII H, 1980, P NATL ACAD SCI-BIOL, V77, P5461, DOI 10.1073/pnas.77.9.5461; Gallois-Montbrun S, 2004, BIOCHEM PHARMACOL, V68, P1749, DOI 10.1016/j.bcp.2004.06.012; Gondeau C, 2008, NUCLEIC ACIDS RES, V36, P3620, DOI 10.1093/nar/gkn212; Goossens M, 1981, Methods Enzymol, V76, P805; Hamano T, 2000, NEUROLOGY, V54, P1188, DOI 10.1212/WNL.54.5.1188; HJELM M, 1980, J LAB CLIN MED, V96, P1015; JINDAL HK, 1990, J BIOL CHEM, V265, P6540; Ramirez-Bajo MJ, 2011, BLOOD CELL MOL DIS, V46, P206, DOI 10.1016/j.bcmd.2010.12.009; KRAUS AP, 1968, BIOCHEM BIOPH RES CO, V30, P173, DOI 10.1016/0006-291X(68)90466-X; KRIETSCH WKG, 1980, AM J HUM GENET, V32, P364; Krishnan P, 2003, J BIOL CHEM, V278, P36726, DOI 10.1074/jbc.M307052200; Krustrup P, 2003, J PHYSIOL-LONDON, V549, P255, DOI 10.1113/jphysiol.2002.035089; Kugler W, 2000, HUM MUTAT, V15, P261, DOI 10.1002/(SICI)1098-1004(200003)15:3<261::AID-HUMU7>3.0.CO;2-T; LARSSONR.M, 1967, BIOCHIM BIOPHYS ACTA, V132, P33, DOI 10.1016/0005-2744(67)90189-1; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAEDA M, 1991, BLOOD, V77, P1348; MAEDA M, 1992, BLOOD, V79, P2759; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MICHELSON AM, 1985, P NATL ACAD SCI USA, V82, P6965, DOI 10.1073/pnas.82.20.6965; Morimoto A, 2003, BRIT J HAEMATOL, V122, P1009, DOI 10.1046/j.1365-2141.2003.04543.x; Noel N, 2006, BRIT J HAEMATOL, V132, P523, DOI 10.1111/j.1365-2141.2005.05882.x; Ookawara T, 1996, ARCH BIOCHEM BIOPHYS, V327, P35, DOI 10.1006/abbi.1996.0089; Palmai Z, 2009, PROTEINS, V77, P319, DOI 10.1002/prot.22437; Rhodes M, 2011, BRIT J HAEMATOL, V152, P500, DOI 10.1111/j.1365-2141.2010.08474.x; SCOPES RK, 1978, EUR J BIOCHEM, V85, P503, DOI 10.1111/j.1432-1033.1978.tb12266.x; Shichijo S, 2004, CLIN CANCER RES, V10, P5828, DOI 10.1158/1078-0432.CCR-04-0350; Shirakawa K, 2006, NEUROLOGY, V66, P925, DOI 10.1212/01.wnl.0000203500.63884.39; Sotiriou E, 2010, MUSCLE NERVE, V41, P707, DOI 10.1002/mus.21612; Spiegel R, 2009, NEUROMUSCULAR DISORD, V19, P207, DOI 10.1016/j.nmd.2008.12.004; Sugie H, 1998, J CHILD NEUROL, V13, P95, DOI 10.1177/088307389801300212; Svaasand EK, 2007, MUSCLE NERVE, V36, P679, DOI 10.1002/mus.20859; SVIRKLYS LG, 1986, J INHERIT METAB DIS, V9, P374, DOI 10.1007/BF01800488; Szilagyi AN, 1998, BIOCHEMISTRY-US, V37, P8551, DOI 10.1021/bi973072k; Tabatabaie L, 2010, MOL GENET METAB, V99, P256, DOI 10.1016/j.ymgme.2009.10.012; TSUJINO S, 1994, ANN NEUROL, V35, P349, DOI 10.1002/ana.410350316; TURNER G, 1995, BRIT J HAEMATOL, V91, P60, DOI 10.1111/j.1365-2141.1995.tb05245.x; Valentin C, 1998, HUM MUTAT, V12, P280, DOI 10.1002/(SICI)1098-1004(1998)12:4<280::AID-HUMU10>3.3.CO;2-Z; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; Vas M, 2010, CURR PROTEIN PEPT SC, V11, P118, DOI 10.2174/138920310790848403; WILLARD HF, 1985, HUM GENET, V71, P138; Yoshida A, 1995, BLOOD CELL MOL DIS, V21, P179, DOI 10.1006/bcmd.1995.0020; Zerrad L, 2011, J BIOL CHEM, V286, P14040, DOI 10.1074/jbc.M110.206813	52	49	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32065	10.1371/journal.pone.0032065	http://dx.doi.org/10.1371/journal.pone.0032065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348148	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400062
J	Cleland, TP; Voegele, K; Schweitzer, MH				Cleland, Timothy P.; Voegele, Kristyn; Schweitzer, Mary H.			Empirical Evaluation of Bone Extraction Protocols	PLOS ONE			English	Article							PROTEIN SEQUENCES; OSTEOCALCIN PROTEIN; ACID RACEMIZATION; MASS SPECTROMETRY; MATRIX PROTEINS; SOFT-TISSUE; FOSSIL BONE; COLLAGEN; ELECTROPHORESIS; IDENTIFICATION	The application of high-resolution analytical techniques to characterize ancient bone proteins requires clean, efficient extraction to obtain high quality data. Here, we evaluated many different protocols from the literature on ostrich cortical bone and moa cortical bone to evaluate their yield and relative purity using the identification of antibody-antigen complexes on enzyme-linked immunosorbent assay and gel electrophoresis. Moa bone provided an ancient comparison for the effectiveness of bone extraction protocols tested on ostrich bone. For the immunological part of this study, we focused on collagen I, osteocalcin, and hemoglobin because collagen and osteocalcin are the most abundant proteins in the mineralized extracellular matrix and hemoglobin is common in the vasculature. Most of these procedures demineralize the bone first, and then the remaining organics are chemically extracted. We found that the use of hydrochloric acid, rather than ethylenediaminetetraacetic acid, for demineralization resulted in the cleanest extractions because the acid was easily removed. In contrast, the use of ethylenediaminetetraacetic acid resulted in smearing upon electrophoretic separation, possibly indicating these samples were not as pure. The denaturing agents sodium dodecyl sulfate, urea, and guanidine HCl have been used extensively for the solubilization of proteins in non-biomineralized tissue, but only the latter has been used on bone. We show that all three denaturing agents are effective for extracting bone proteins. One additional method tested uses ammonium bicarbonate as a solubilizing buffer that is more appropriate for post-extraction analyses (e.g., proteomics) by removing the need for desalting. We found that both guanidine HCl and ammonium bicarbonate were effective for extracting many bone proteins, resulting in similar electrophoretic patterns. With the increasing use of proteomics, a new generation of scientists are now interested in the study of proteins from not only extant bone but also from ancient bone.	[Cleland, Timothy P.; Schweitzer, Mary H.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] US Amer Coll, N Carolina Museum Nat Sci, Moorhead, MN USA	University of North Carolina; North Carolina State University	Cleland, TP (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA.	tpclelan@ncsu.edu	schweitzer, mary h/A-6756-2010; Cleland, Timothy/ABE-8424-2021; Cleland, Timothy/P-9960-2019; Cleland, Timothy/A-6754-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; Cleland, Timothy/0000-0001-9198-2828; Cleland, Timothy/0000-0001-9198-2828; Cleland, Timothy/0000-0001-9198-2828; 	National Science Foundation [DGE-0750733, EAR 0541744]; David and Lucille Packard Foundation	National Science Foundation(National Science Foundation (NSF)); David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This research was funded by the National Science Foundation (http://www.nsf.gov) (DGE-0750733 to TPC and EAR 0541744 to MHS) and the David and Lucille Packard Foundation (http://www.packard.org/) to MHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; BADA JL, 1985, ANNU REV EARTH PL SC, V13, P241; Borja C, 1997, AM J PHYS ANTHROPOL, V103, P433, DOI 10.1002/(SICI)1096-8644(199708)103:4<433::AID-AJPA1>3.0.CO;2-O; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; Buckley M, 2008, J ARCHAEOL SCI, V35, P1756, DOI 10.1016/j.jas.2007.11.022; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a; CHILD AM, 1992, J ARCHAEOL SCI, V19, P39, DOI 10.1016/0305-4403(92)90005-N; Clementz MT, 2009, GEOL J, V44, P605, DOI 10.1002/gj.1173; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COLLINS MJ, 1995, J ARCHAEOL SCI, V22, P175, DOI 10.1006/jasc.1995.0019; Craig OE, 2002, J ARCHAEOL SCI, V29, P1077, DOI 10.1006/jasc.2001.0757; Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5; Dobberstein RC, 2009, ARCHAEOL ANTHROP SCI, V1, P31, DOI 10.1007/s12520-009-0002-7; Embery G, 2003, CONNECT TISSUE RES, V44, P41, DOI 10.1080/03008200390152070; Fountoulakis M, 1998, J CHROMATOGR A, V826, P109, DOI 10.1016/S0021-9673(98)00721-3; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; FRANZEN A, 1984, BIOCHEM J, V224, P47, DOI 10.1042/bj2240047; Fridriksson EK, 1999, J AM SOC MASS SPECTR, V10, P453, DOI 10.1016/S1044-0305(99)00012-4; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; GERSTENFELD LC, 1994, CALCIFIED TISSUE INT, V55, P230, DOI 10.1007/BF00425880; GREENE RF, 1974, J BIOL CHEM, V249, P5388; GURLEY LR, 1991, J PROTEIN CHEM, V10, P75, DOI 10.1007/BF01024658; HEDGES REM, 1995, J ARCHAEOL SCI, V22, P201, DOI 10.1006/jasc.1995.0022; HELFMAN PM, 1975, P NATL ACAD SCI USA, V72, P2891, DOI 10.1073/pnas.72.8.2891; Humpula JF, 2007, GEOCHIM COSMOCHIM AC, V71, P5956, DOI 10.1016/j.gca.2007.09.003; Jiang XG, 2007, J PROTEOME RES, V6, P2287, DOI 10.1021/pr070056t; Lecuyer C, 2003, PALAEOGEOGR PALAEOCL, V193, P457, DOI 10.1016/S0031-0182(03)00261-X; LOWENSTEIN JM, 1981, NATURE, V291, P409, DOI 10.1038/291409a0; LOWENSTEIN JM, 1981, PHILOS T ROY SOC B, V292, P143, DOI 10.1098/rstb.1981.0022; LOWENSTEIN JM, 1991, PHILOS T ROY SOC B, V333, P375, DOI 10.1098/rstb.1991.0087; LOWENSTEIN JM, 1985, EXPERIENTIA, V41, P1192, DOI 10.1007/BF01951724; McCarthy J, 2003, J PROTEOME RES, V2, P239, DOI 10.1021/pr025564b; Nielsen-Marsh CM, 2005, P NATL ACAD SCI USA, V102, P4409, DOI 10.1073/pnas.0500450102; Nielsen-Marsh CM, 2002, GEOLOGY, V30, P1099, DOI 10.1130/0091-7613(2002)030<1099:SPOOPA>2.0.CO;2; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Ostrom PH, 2000, GEOCHIM COSMOCHIM AC, V64, P1043, DOI 10.1016/S0016-7037(99)00381-6; PEPINSKY RB, 1991, ANAL BIOCHEM, V195, P177, DOI 10.1016/0003-2697(91)90315-K; Prigodich RV, 1997, ARCH BIOCHEM BIOPHYS, V345, P339, DOI 10.1006/abbi.1997.0254; Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526; RAINEY WE, 1984, NATURWISSENSCHAFTEN, V71, P586, DOI 10.1007/BF01189187; Richter KK, 2011, J ARCHAEOL SCI, V38, P1502, DOI 10.1016/j.jas.2011.02.014; Rutherfurd SM, 2001, AMINO ACID ANAL; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schreiweis MA, 2007, J CELL BIOCHEM, V101, P466, DOI 10.1002/jcb.21196; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2008, CR PALEVOL, V7, P159, DOI 10.1016/j.crpv.2008.02.005; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2002, J MOL EVOL, V55, P696, DOI 10.1007/s00239-002-2365-6; SEMAL P, 1995, J ARCHAEOL SCI, V22, P463, DOI 10.1006/jasc.1995.0045; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHOSHANI J, 1985, PALEOBIOLOGY, V11, P429, DOI 10.1017/S0094837300011714; Simo C, 2003, ELECTROPHORESIS, V24, P834, DOI 10.1002/elps.200390105; TERMINE JD, 1981, J BIOL CHEM, V256, P403; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; Tuross N, 2002, ARCHAEOMETRY, V44, P427, DOI 10.1111/1475-4754.00075; TUROSS N, 1988, GEOCHIM COSMOCHIM AC, V52, P929, DOI 10.1016/0016-7037(88)90364-X; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WENDEL M, 1995, J BIOL CHEM, V270, P6125, DOI 10.1074/jbc.270.11.6125; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zylberberg L, 2004, CR PALEVOL, V3, P591, DOI 10.1016/j.crpv.2004.07.012	69	43	43	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31443	10.1371/journal.pone.0031443	http://dx.doi.org/10.1371/journal.pone.0031443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348088	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400024
J	Edelman, AJ				Edelman, Andrew J.			Positive Interactions between Desert Granivores: Localized Facilitation of Harvester Ants by Kangaroo Rats	PLOS ONE			English	Article							CHIHUAHUAN-DESERT; POGONOMYRMEX-RUGOSUS; DIPODOMYS-SPECTABILIS; SPATIAL-DISTRIBUTION; COMMUNITY STRUCTURE; NEW-MEXICO; MOUNDS; COMPETITION; RODENTS; SCALE	Facilitation, when one species enhances the environment or performance of another species, can be highly localized in space. While facilitation in plant communities has been intensely studied, the role of facilitation in shaping animal communities is less well understood. In the Chihuahuan Desert, both kangaroo rats and harvester ants depend on the abundant seeds of annual plants. Kangaroo rats, however, are hypothesized to facilitate harvester ants through soil disturbance and selective seed predation rather than competing with them. I used a spatially explicit approach to examine whether a positive or negative interaction exists between banner-tailed kangaroo rat (Dipodomys spectabilis) mounds and rough harvester ant (Pogonomyrmex rugosus) colonies. The presence of a scale-dependent interaction between mounds and colonies was tested by comparing fitted spatial point process models with and without interspecific effects. Also, the effect of proximity to a mound on colony mortality and spatial patterns of surviving colonies was examined. The spatial pattern of kangaroo rat mounds and harvester ant colonies was consistent with a positive interspecific interaction at small scales (<10 m). Mortality risk of vulnerable, recently founded harvester ant colonies was lower when located close to a kangaroo rat mound and proximity to a mound partly predicted the spatial pattern of surviving colonies. My findings support localized facilitation of harvester ants by kangaroo rats, likely mediated through ecosystem engineering and foraging effects on plant cover and composition. The scale-dependent effect of kangaroo rats on abiotic and biotic factors appears to result in greater founding and survivorship of young colonies near mounds. These results suggest that soil disturbance and foraging by rodents can have subtle impacts on the distribution and demography of other species.	[Edelman, Andrew J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Edelman, AJ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	aedelman@uwyo.edu	Edelman, Andrew J/C-2810-2012	Edelman, Andrew J/0000-0002-7980-9739	Sevilleta Long Term Ecological Research Site Graduate Student Summer Grant; American Society of Mammalogists Shadle; Southwestern Association of Naturalists; T E, Inc.	Sevilleta Long Term Ecological Research Site Graduate Student Summer Grant; American Society of Mammalogists Shadle; Southwestern Association of Naturalists; T E, Inc.	This research was funded by the Sevilleta Long Term Ecological Research Site Graduate Student Summer Grant, American Society of Mammalogists Shadle Fellowship and Grant-in-Aid, Southwestern Association of Naturalists Howard McCarley Student Research Award, T & E, Inc. Grant for Conservation Biology Research, National Science Foundation Teaching Fellowship in K-12 Education, and the University of New Mexico Gaudin Scholarship in Mammalogy, Grove Summer Scholarship, Student Research Allocation Committee Research Grant, Biology Graduate Student Organization Research Grant, Graduate Research Development Fund, Regents' Graduate Fellowship, and Biocomplexity Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J R STAT SOC B, V67, P617, DOI 10.1111/j.1467-9868.2005.00519.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2006, LECT NOTES STAT, V185, P23, DOI DOI 10.1007/0-387-31144-0_2; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; BROWN JH, 1977, SCIENCE, V196, P880, DOI 10.1126/science.196.4292.880; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; CHEW RM, 1992, J ARID ENVIRON, V22, P375, DOI 10.1016/S0140-1963(18)30580-9; Davidson AD, 2007, ECOGRAPHY, V30, P515, DOI 10.1111/j.0906-7590.2007.05032.x; DAVIDSON DW, 1977, ECOLOGY, V58, P711, DOI 10.2307/1936208; DAVIDSON DW, 1984, ECOLOGY, V65, P1780, DOI 10.2307/1937774; DAVIDSON DW, 1977, ECOLOGY, V58, P725, DOI 10.2307/1936209; DAVIDSON DW, 1985, ECOLOGY, V66, P486, DOI 10.2307/1940397; De la Cruz M., 2008, INTRO ANALISIS ESPAC, P76; Edelman AJ, 2011, ETHOLOGY, V117, P430, DOI 10.1111/j.1439-0310.2011.01890.x; Fortin MJ., 2005, SPATIAL ANAL GUIDE E, P365, DOI [10.1017/CBO9780511542039, DOI 10.1017/CBO9780511542039]; GORDON DM, 1992, ANN ENTOMOL SOC AM, V85, P44, DOI 10.1093/aesa/85.1.44; Gordon DM, 1998, J ANIM ECOL, V67, P141, DOI 10.1046/j.1365-2656.1998.00169.x; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1995, ANIM BEHAV, V49, P649, DOI 10.1016/0003-3472(95)80198-7; Guo QF, 1996, OECOLOGIA, V106, P247, DOI 10.1007/BF00328605; HESKE EJ, 1993, OECOLOGIA, V95, P520, DOI 10.1007/BF00317436; Holdenried R., 1957, Journal of Mammalogy, V38, P330, DOI 10.2307/1376232; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Illian J, 2008, STAT ANAL MODELLING; INOUYE RS, 1980, ECOLOGY, V61, P1344, DOI 10.2307/1939043; Johnson RA, 1998, INSECT SOC, V45, P255, DOI 10.1007/s000400050086; Johnson RA, 2000, ECOL ENTOMOL, V25, P403, DOI 10.1046/j.1365-2311.2000.00286.x; Johnson RA, 2001, ANNU REV ENTOMOL, V46, P1, DOI 10.1146/annurev.ento.46.1.1; Koontz TL, 2010, J ARID ENVIRON, V74, P1156, DOI 10.1016/j.jaridenv.2010.03.008; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Olano JM, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest:2008074; MOORHEAD DL, 1988, AM MIDL NAT, V120, P443, DOI 10.2307/2426018; MOROKA N, 1982, J RANGE MANAGE, V35, P707, DOI 10.2307/3898244; Parmenter Robert R., 1995, P196; Perry GLW, 2008, J VEG SCI, V19, P705, DOI 10.3170/2008-8-18441; REICHMAN OJ, 1985, J MAMMAL, V66, P643, DOI 10.2307/1380790; RISSING SW, 1988, ECOLOGY, V69, P809, DOI 10.2307/1941030; SAMSON DA, 1992, OIKOS, V65, P61, DOI 10.2307/3544888; Schooley RL, 2000, OECOLOGIA, V125, P142, DOI 10.1007/PL00008885; Schooley RL, 2003, J ARID ENVIRON, V53, P183, DOI 10.1006/jare.2002.1037; Schooley RL, 2001, LANDSCAPE ECOL, V16, P267, DOI 10.1023/A:1011122218548; SCHRODER GD, 1975, J MAMMAL, V56, P363, DOI 10.2307/1379366; SCHRODER GD, 1979, ECOLOGY, V60, P657, DOI 10.2307/1936601; Stoyan D, 2000, STAT SCI, V15, P61; VALONE TJ, 1994, ECOLOGY, V75, P252, DOI 10.2307/1939400; Vorhies CT, 1922, US DEP AGRIC B, V1091, P1; WHITFORD WG, 1976, INSECT SOC, V23, P117, DOI 10.1007/BF02223846; WIERNASZ DC, 1995, J ANIM ECOL, V64, P519, DOI 10.2307/5654; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138	54	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30914	10.1371/journal.pone.0030914	http://dx.doi.org/10.1371/journal.pone.0030914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348030	Green Published, gold			2022-12-27	WOS:000302737400007
J	Kuhn, S; Ingham, N; Pearson, S; Gribble, SM; Clayton, S; Steel, KP; Marcotti, W				Kuhn, Stephanie; Ingham, Neil; Pearson, Selina; Gribble, Susan M.; Clayton, Stephen; Steel, Karen P.; Marcotti, Walter			Auditory Function in the Tc1 Mouse Model of Down Syndrome Suggests a Limited Region of Human Chromosome 21 Involved in Otitis Media	PLOS ONE			English	Article							POTASSIUM CURRENT; HEARING-LOSS; HAIR-CELLS; INNER; EXPRESSION; GENE; CURRENTS; MIR-96; HUMAN-CHROMOSOME-21; MATURATION	Down syndrome is one of the most common congenital disorders leading to a wide range of health problems in humans, including frequent otitis media. The Tc1 mouse carries a significant part of human chromosome 21 (Hsa21) in addition to the full set of mouse chromosomes and shares many phenotypes observed in humans affected by Down syndrome with trisomy of chromosome 21. However, it is unknown whether Tc1 mice exhibit a hearing phenotype and might thus represent a good model for understanding the hearing loss that is common in Down syndrome. In this study we carried out a structural and functional assessment of hearing in Tc1 mice. Auditory brainstem response (ABR) measurements in Tc1 mice showed normal thresholds compared to littermate controls and ABR waveform latencies and amplitudes were equivalent to controls. The gross anatomy of the middle and inner ears was also similar between Tc1 and control mice. The physiological properties of cochlear sensory receptors (inner and outer hair cells: IHCs and OHCs) were investigated using single-cell patch clamp recordings from the acutely dissected cochleae. Adult Tc1 IHCs exhibited normal resting membrane potentials and expressed all K+ currents characteristic of control hair cells. However, the size of the large conductance (BK) Ca2+ activated K+ current (I-K,I-f), which enables rapid voltage responses essential for accurate sound encoding, was increased in Tc1 IHCs. All physiological properties investigated in OHCs were indistinguishable between the two genotypes. The normal functional hearing and the gross structural anatomy of the middle and inner ears in the Tc1 mouse contrast to that observed in the Ts65Dn model of Down syndrome which shows otitis media. Genes that are trisomic in Ts65Dn but disomic in Tc1 may predispose to otitis media when an additional copy is active.	[Kuhn, Stephanie; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Ingham, Neil; Pearson, Selina; Gribble, Susan M.; Clayton, Stephen; Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge, England	University of Sheffield; Wellcome Trust Sanger Institute	Kuhn, S (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	kps@sanger.ac.uk; w.marcotti@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478	Wellcome Trust [088719, 077189]; Royal Society; Medical Research Council [G0300212, MC_qA137918] Funding Source: researchfish; RNID [G41] Funding Source: researchfish; MRC [G0300212, MC_qA137918] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust (088719) and The Royal Society to WM, and a grant from the Wellcome Trust (077189) to KPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford KA, 2010, BLOOD, V115, P2928, DOI 10.1182/blood-2009-06-227629; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Bilgin H, 1996, ARCH OTOLARYNGOL, V122, P271; DALLOS P, 1992, SOC GEN PHY, V47, P371; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Johnson SL, 2009, J PHYSIOL-LONDON, V587, P1715, DOI 10.1113/jphysiol.2009.168542; Johnson SL, 2010, NAT NEUROSCI, V13, P45, DOI 10.1038/nn.2456; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mikaelian D, 1965, ACTA OTO-LARYNGOL, V59, P451, DOI DOI 10.3109/00016486509124579; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Quina LA, 2009, J NEUROSCI, V29, P14309, DOI 10.1523/JNEUROSCI.2430-09.2009; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Ryugo D.K., 1992, Springer Handbook of Auditory Research, V1, P23; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Shott SR, 2001, INT J PEDIATR OTORHI, V61, P199, DOI 10.1016/S0165-5876(01)00572-9; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31433	10.1371/journal.pone.0031433	http://dx.doi.org/10.1371/journal.pone.0031433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348087	Green Published, Green Accepted, gold			2022-12-27	WOS:000302737400023
J	Tkint, T; Verheyen, E; De Kegel, B; Helsen, P; Adriaens, D				Tkint, Tim; Verheyen, Erik; De Kegel, Barbara; Helsen, Philippe; Adriaens, Dominique			Dealing with Food and Eggs in Mouthbrooding Cichlids: Structural and Functional Trade-Offs in Fitness Related Traits	PLOS ONE			English	Article							TREWAVAS 1933 PISCES; LAKE VICTORIA; CONSTRUCTIONAL MORPHOLOGY; PHENOTYPIC PLASTICITY; HAPLOCHROMIS-PICEATUS; SEXUAL-DIMORPHISM; FISHES TELEOSTEI; PARENTAL CARE; CONSTRAINTS; CONSEQUENCES	Background: As in any vertebrate, heads of fishes are densely packed with functions. These functions often impose conflicting mechanical demands resulting in trade-offs in the species-specific phenotype. When phenotypical traits are linked to gender-specific parental behavior, we expect sexual differences in these trade-offs. This study aims to use mouthbrooding cichlids as an example to test hypotheses on evolutionary trade-offs between intricately linked traits that affect different aspects of fitness. We focused on the oral apparatus, which is not only equipped with features used to feed and breathe, but is also used for the incubation of eggs. We used this approach to study mouthbrooding as part of an integrated functional system with diverging performance requirements and to explore gender-specific selective environments within a species. Methodology/Principal Findings: Because cichlids are morphologically very diverse, we hypothesize that the implications of the added constraint of mouthbrooding will primarily depend on the dominant mode of feeding of the studied species. To test this, we compared the trade-off for two maternal mouthbrooding cichlid species: a "suction feeder'' (Haplochromis piceatus) and a "biter'' (H. fischeri). The comparison of morphology and performance of both species revealed clear interspecific and intersex differences. Our observation that females have larger heads was interpreted as a possible consequence of the fact that in both the studied species mouthbrooding is done by females only. As hypothesized, the observed sexual dimorphism in head shape is inferred as being suboptimal for some aspects of the feeding performance in each of the studied species. Our comparison also demonstrated that the suction feeding species had smaller egg clutches and more elongated eggs. Conclusions/Significance: Our findings support the hypothesis that there is a trade-off between mouthbrooding and feeding performance in the two studied haplochromine cichlids, stressing the importance of including species-specific information at the gender level when addressing interspecific functional/morphological differences.	[Tkint, Tim; De Kegel, Barbara; Adriaens, Dominique] Univ Ghent, Dept Biol, Res Grp Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium; [Verheyen, Erik; Helsen, Philippe] Royal Belgian Inst Nat Sci, Vertebrate Dept, Brussels, Belgium; [Verheyen, Erik; Helsen, Philippe] Univ Antwerp, Dept Biol, Res Grp Evolutionary Ecol, B-2020 Antwerp, Belgium	Ghent University; Royal Belgian Institute of Natural Sciences; University of Antwerp	Tkint, T (corresponding author), Univ Ghent, Dept Biol, Res Grp Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium.	Tim.tkint@Ugent.be	VERHEYEN, ERIK K/E-5550-2013; Adriaens, Dominique/G-1587-2010; Helsen, Philippe/K-8660-2018	VERHEYEN, ERIK K/0000-0001-7157-1474; Adriaens, Dominique/0000-0003-3610-2773; 	Research Foundation Flanders [1.1.A72.10.N.00, 3G014911]; Belspo project [MO/36/013]	Research Foundation Flanders(FWO); Belspo project(Belgian Federal Science Policy Office)	This study is funded by the Research Foundation Flanders (www.fwo.be)(1.1.A72.10.N.00), FWO project: 3G014911 (http://www.fwo.be), and Belspo project: MO/36/013 (http://www.belspo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSTER HA, 1985, J COMP PHYSIOL B, V155, P685, DOI 10.1007/BF00694582; Albertson RC, 2006, HEREDITY, V97, P211, DOI 10.1038/sj.hdy.6800864; Albertson RC, 2001, J EXP ZOOL, V289, P385, DOI 10.1002/jez.1020; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; ANKER GC, 1978, NETH J ZOOL, V28, P234, DOI 10.1163/002829678X00071; Balshine-Earn S, 1998, P ROY SOC B-BIOL SCI, V265, P2217, DOI 10.1098/rspb.1998.0562; BAREL CDN, 1977, NETH J ZOOL, V27, P333; BAREL CDN, 1983, NETH J ZOOL, V33, P357; BAREL CDN, 1989, ACTA MORPHOL NEER SC, V27, P83; BAREL CDN, 1984, NETH J ZOOL, V34, P439, DOI 10.1163/002829684X00263; Barnett A, 2005, MAR BIOL, V148, P205, DOI 10.1007/s00227-005-0052-z; Bouton N, 2002, BIOL J LINN SOC, V76, P39, DOI 10.1111/j.1095-8312.2002.tb01712.x; Bouton N, 2002, BIOL J LINN SOC, V77, P185, DOI 10.1046/j.1095-8312.2002.00093.x; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; de Jong IML, 2009, J MORPHOL, V270, P519, DOI 10.1002/jmor.10716; Devaere S, 2005, J NAT HIST, V39, P1653, DOI 10.1080/00222930400020103; deVisser J, 1996, J MORPHOL, V228, P1, DOI 10.1002/(SICI)1097-4687(199604)228:1<1::AID-JMOR1>3.0.CO;2-B; Donev A, 2004, SCIENCE, V303, P990, DOI 10.1126/science.1093010; DROST MR, 1986, J ZOOL, V209, P239, DOI 10.1111/j.1469-7998.1986.tb03579.x; Duponchelle F, 2008, P NATL ACAD SCI USA, V105, P15475, DOI 10.1073/pnas.0802343105; Erlandsson A, 1997, S AFR J SCI, V93, P498; Fryer G, 1972, CICHLID FISHES GREAT; GALIS F, 1993, J EXP ZOOL, V267, P137, DOI 10.1002/jez.1402670207; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gillooly JF, 2008, BIOL LETTERS, V4, P123, DOI 10.1098/rsbl.2007.0460; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Herler J, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-4; Herrel A, 1998, NETH J ZOOL, V48, P1; HESS HC, 1993, B MAR SCI, V52, P806; Hoogerhoud RJC, 1978, BAREL CDN INTEGRATED, P52; Hulsey CD, 2007, P ROY SOC B-BIOL SCI, V274, P1867, DOI 10.1098/rspb.2007.0444; Hulsey CD, 2006, EVOLUTION, V60, P2096, DOI 10.1111/j.0014-3820.2006.tb01847.x; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; KATUNZI EFB, 1983, NETH J ZOOL, V33, P337; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Liem K.F., 1991, P231; LIEM KF, 1980, AM ZOOL, V20, P295; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; MCKAYE KR, 1990, AM NAT, V135, P597, DOI 10.1086/285064; Okuda N, 2002, ZOOL SCI, V19, P801, DOI 10.2108/zsj.19.801; OLIVEIRA RF, 1995, J FISH BIOL, V46, P1055, DOI 10.1006/jfbi.1995.0100; Ostlund-Nilsson S, 2004, P ROY SOC B-BIOL SCI, V271, P1015, DOI 10.1098/rspb.2004.2700; OTTEN E, 1983, NETH J ZOOL, V33, P55, DOI 10.1163/002829683X00048; Parnell NF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-122; Rice AN, 2002, J EXP BIOL, V205, P3519; Rohlf F.J., 2008, TPSDIG 2 12; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; ROHLF FJ, 2003, TPSSMALL 1 20; Schurch R, 2005, BEHAVIOUR, V142, P265, DOI 10.1163/1568539053778274; SLOOTWEG R, 1987, OECOLOGIA, V74, P193, DOI 10.1007/BF00379359; TAYLOR W R, 1985, Cybium, V9, P107; Van der Sluijs I, 2008, J EVOLUTION BIOL, V21, P480, DOI 10.1111/j.1420-9101.2007.01495.x; Van Wassenbergh S, 2007, J EXP BIOL, V210, P27, DOI 10.1242/jeb.02619; Van Wassenbergh S, 2009, J EXP BIOL, V212, P116, DOI 10.1242/jeb.023929; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; WESTNEAT MW, 1994, ZOOMORPHOLOGY, V114, P103, DOI 10.1007/BF00396643; WITTE F, 1990, NETH J ZOOL, V40, P278; WITTE F, 1984, NETH J ZOOL, V34, P596	62	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31117	10.1371/journal.pone.0031117	http://dx.doi.org/10.1371/journal.pone.0031117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348043	gold, Green Published, Green Submitted			2022-12-27	WOS:000302737400010
J	Yoffe, C; Lotan, T; Benayhau, Y				Yoffe, Chen; Lotan, Tamar; Benayhau, Yehuda			A Modified View on Octocorals: Heteroxenia fuscescens Nematocysts Are Diverse, Featuring Both an Ancestral and a Novel Type	PLOS ONE			English	Article							EVOLUTION; ANTHOZOA; CNIDARIA; HYDRA; CNIDOGENESIS; SYSTEMATICS; CAPSULE; PROTEIN; CORALS	Cnidarians are characterized by the presence of stinging cells containing nematocysts, a sophisticated injection system targeted mainly at prey-capture and defense. In the anthozoan subclass Octocorallia nematocytes have been considered to exist only in low numbers, to be small, and all of the ancestral atrichous-isorhiza type. This study, in contrast, revealed numerous nematocytes in the octocoral Heteroxenia fuscescens. The study demonstrates the applicability of cresyl-violet dye for differential staining and stimulating discharge of the nematocysts. In addition to the atrichous isorhiza-type of nematocysts, a novel type of macrobasic-mastigophore nematocysts was found, featuring a shaft, uniquely comprised of three loops and densely packed arrow-like spines. In contrast to the view that octocorals possess a single type of nematocyst, Heteroxenia fuscescens features two distinct types, indicating for the first time the diversification and complexity of nematocysts for Octocorallia.	[Yoffe, Chen; Benayhau, Yehuda] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Lotan, Tamar] Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-31999 Haifa, Israel	Tel Aviv University; University of Haifa	Yoffe, C (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	YehudaB@tauex.tau.ac.il		Lotan, Tamar/0000-0002-1679-4904	Israel Cohen Chair in Environmental Zoology	Israel Cohen Chair in Environmental Zoology	This research was in part supported by the Israel Cohen Chair in Environmental Zoology to YB. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk P, 2008, J MOL BIOL, V376, P1008, DOI 10.1016/j.jmb.2007.10.090; Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Barneah O, 2004, MAR ECOL PROG SER, V275, P89, DOI 10.3354/meps275089; Ben-David-Zaslow R, 1999, MAR BIOL, V133, P553, DOI 10.1007/s002270050495; CHENG TC, 1974, J INVERTEBR PATHOL, V23, P303, DOI 10.1016/0022-2011(74)90095-0; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Fautin DG, 2009, TOXICON, V54, P1054, DOI 10.1016/j.toxicon.2009.02.024; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; Hwang JS, 2008, MOL BIOL EVOL, V25, P2009, DOI 10.1093/molbev/msn154; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; Kass-Simon G, 2002, CAN J ZOOL, V80, P1772, DOI 10.1139/Z02-135; Mariscal R.N., 1974, pUnpaginated; MARISCAL RN, 1976, CELL TISSUE RES, V168, P465, DOI 10.1007/BF00215997; Mariscal RN, 1977, 3RD P INT COR REEF S, P127; Mcfadden CS, 2010, INTEGR COMP BIOL, V50, pE113; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Ostman C, 2000, SCI MAR, V64, P31; Piraino S., 1993, Oebalia, V19, P67; SAMMARCO PW, 1992, MAR ECOL PROG SER, V88, P93, DOI 10.3354/meps088093; SCHLICHTER D, 1982, OECOLOGIA, V53, P40, DOI 10.1007/BF00377134; SCHMIDT H, 1982, HELGOLANDER MEERESUN, V35, P97, DOI 10.1007/BF02289837; SCHMIDT H, 1981, HELGOLANDER MEERESUN, V34, P463, DOI 10.1007/BF01995918; SEBENS KP, 1988, BIOL BULL, V175, P378, DOI 10.2307/1541729; TARDENT P, 1995, BIOESSAYS, V17, P351, DOI 10.1002/bies.950170411; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Weill R, 1930, BIOL BULL, P141; WEILL ROBERT, 1934, TRAV STAT ZOOL WIMEREUX, V10, P1; Yacobovitch T, 2003, MAR BIOL, V142, P1055, DOI 10.1007/s00227-003-1035-6	30	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31902	10.1371/journal.pone.0031902	http://dx.doi.org/10.1371/journal.pone.0031902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348137	Green Published, gold			2022-12-27	WOS:000302737400056
J	Duboue, ER; Borowsky, RL				Duboue, Erik R.; Borowsky, Richard L.			Altered Rest-Activity Patterns Evolve via Circadian Independent Mechanisms in Cave Adapted Balitorid Loaches	PLOS ONE			English	Article							SLEEP; CLOCK	Circadian rhythms and rest homeostasis are independent processes, each regulating important components of rest-activity patterns. Evolutionarily, the two are distinct from one another; total rest time is maintained unaffected even when circadian pacemaker cells are ablated. Throughout the animal kingdom, there exists a huge variation in rest-activity patterns, yet it is unclear how these behaviors have evolved. Here we show that four species of balitorid cavefish have greatly reduced rest times in comparison to rest times of their surface relatives. All four cave species retained biological rhythmicity, and in three of the four there is a pronounced 24-hour rhythm; in the fourth there is an altered rhythmicity of 38-40 hours. Thus, consistent changes in total rest have evolved in these species independent of circadian rhythmicity. Taken together, our data suggest that consistent reduction in total rest times were accomplished evolutionarily through alterations in rest homeostasis.	[Duboue, Erik R.; Borowsky, Richard L.] NYU, Dept Biol, New York, NY 10003 USA	New York University	Duboue, ER (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	rb4@nyu.edu			National Science Foundation [INT-9605200, IOS-0821982]	National Science Foundation(National Science Foundation (NSF))	This research was funded by National Science Foundation grants INT-9605200 and IOS-0821982 to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; Borbely AA, 1996, PROG BRAIN RES, V111, P343, DOI 10.1016/S0079-6123(08)60417-3; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; GARDNER GF, 1980, GENETICS, V96, P877; Horne J, 2009, NEUROSCI BIOBEHAV R, V33, P466, DOI 10.1016/j.neubiorev.2008.12.002; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Trajano E, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P1, DOI 10.1201/EBK1578086702-f; Trajano E, 2009, BIOL RHYTHM RES, V40, P477, DOI 10.1080/09291010902731205; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zepelin H, 2000, PRINCIPLES PRACTICE, P82	20	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30868	10.1371/journal.pone.0030868	http://dx.doi.org/10.1371/journal.pone.0030868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348026	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900015
J	Mariyanna, L; Priyadarshini, P; Hofmann-Sieber, H; Krepstakies, M; Walz, N; Grundhoff, A; Buchholz, F; Hildt, E; Hauber, J				Mariyanna, Lakshmikanth; Priyadarshini, Poornima; Hofmann-Sieber, Helga; Krepstakies, Marcel; Walz, Nicole; Grundhoff, Adam; Buchholz, Frank; Hildt, Eberhard; Hauber, Joachim			Excision of HIV-1 Proviral DNA by Recombinant Cell Permeable Tre-Recombinase	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; PENETRATING PEPTIDES; MOLECULAR-MECHANISMS; PROTEIN TRANSDUCTION; MAMMALIAN-CELLS; DELIVERY; DRUG; INFECTION; CRE; VECTORS	Over the previous years, comprehensive studies on antiretroviral drugs resulted in the successful introduction of highly active antiretroviral therapy (HAART) into clinical practice for treatment of HIV/AIDS. However, there is still need for new therapeutic approaches, since HAART cannot eradicate HIV-1 from the infected organism and, unfortunately, can be associated with long-term toxicity and the development of drug resistance. In contrast, novel gene therapy strategies may have the potential to reverse the infection by eradicating HIV-1. For example, expression of long terminal repeat (LTR)0specific recombinase (Tre-recombinase) has been shown to result in chromosomal excision of proviral DNA and, in consequence, in the eradication of HIV-1 from infected cell cultures. However, the delivery of Tre-recombinase currently depends on the genetic manipulation of target cells, a process that is complicating such therapeutic approaches and, thus, might be undesirable in a clinical setting. In this report we demonstrate that E. coli expressed Tre-recombinases, tagged either with the protein transduction domain (PTD) from the HIV-1 Tat trans-activator or the translocation motif (TLM) of the Hepatitis B virus PreS2 protein, were able to translocate efficiently into cells and showed significant recombination activity on HIV-1 LTR sequences. Tre activity was observed using episomal and stable integrated reporter constructs in transfected HeLa cells. Furthermore, the TLM-tagged enzyme was able to excise the full-length proviral DNA from chromosomal integration sites of HIV-1-infected HeLa and CEM-SS cells. The presented data confirm Tre-recombinase activity on integrated HIV-1 and provide the basis for the non-genetic transient application of engineered recombinases, which may be a valuable component of future HIV eradication strategies.	[Mariyanna, Lakshmikanth; Priyadarshini, Poornima; Hofmann-Sieber, Helga; Krepstakies, Marcel; Walz, Nicole; Grundhoff, Adam; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Buchholz, Frank] Tech Univ Dresden, Univ Hosp, Dept Med Syst Biol, Dresden, Germany; [Buchholz, Frank] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany; [Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-6070 Langen, Germany	Heinrich Pette Institute; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Paul Ehrlich Institute	Mariyanna, L (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	joachim.hauber@hpi.uni-hamburg.de	Mariyanna, Lakshmikanth/ABG-4596-2021; Hildt, Eberhard/A-1040-2015; Buchholz, Frank/B-4700-2017	Mariyanna, Lakshmikanth/0000-0001-5969-1246; Buchholz, Frank/0000-0002-4577-3344; Mariyanna, Lakshmikanth/0000-0001-6561-2049; , Poornima Priyadarshini/0000-0002-7449-5777; Grundhoff, Adam/0000-0003-0940-7045	Federal Ministry of Education and Research [GO-Bio FKZ0315090]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant of the Federal Ministry of Education and Research (GO-Bio FKZ0315090; http://www.bmbf.de) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Baum C, 2006, MOL THER, V13, P1050, DOI 10.1016/j.ymthe.2006.03.007; Bian J, 2007, CIRC RES, V100, P1626, DOI 10.1161/01.RES.0000269778.75877.68; Blackard JT, 1999, VIROLOGY, V254, P220, DOI 10.1006/viro.1998.9504; Brandenburg B, 2005, HEPATOLOGY, V42, P1300, DOI 10.1002/hep.20950; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Buchholz F, 2011, METHODS, V53, P102, DOI 10.1016/j.ymeth.2010.06.014; Cafardi JA, 2011, J INVEST DERMATOL, V131, P559, DOI 10.1038/jid.2010.394; Calmy A, 2009, ANTIVIR THER, V14, P165; Cao GD, 2002, J NEUROSCI, V22, P5423; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; Deeks SG, 2010, NAT BIOTECHNOL, V28, P807, DOI 10.1038/nbt0810-807; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Deshayes S, 2008, ADV DRUG DELIVER REV, V60, P537, DOI 10.1016/j.addr.2007.09.005; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Douglas JT, 2007, MOL BIOTECHNOL, V36, P71, DOI 10.1007/s12033-007-0021-5; Eekels JJM, 2011, ANTIVIR RES, V89, P43, DOI 10.1016/j.antiviral.2010.11.005; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hafner A, 2003, EMBO REP, V4, P767, DOI 10.1038/sj.embor.embor903; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hillemann A, 2005, J HEPATOL, V43, P442, DOI 10.1016/j.jhep.2005.02.031; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; Lindsay MA, 2002, CURR OPIN PHARMACOL, V2, P587, DOI 10.1016/S1471-4892(02)00199-6; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Martin JC, 2010, ANTIVIR RES, V85, P34, DOI 10.1016/j.antiviral.2009.10.006; McColl DJ, 2010, ANTIVIR RES, V85, P101, DOI 10.1016/j.antiviral.2009.11.004; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Patsch C, 2011, METHODS, V53, P386, DOI 10.1016/j.ymeth.2010.12.018; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Rapoport M, 2009, EXPERT OPIN DRUG DEL, V6, P453, DOI [10.1517/17425240902887029, 10.1517/17425240902887029 ]; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Richman DD, 2006, ANTIVIR RES, V71, P117, DOI 10.1016/j.antiviral.2006.03.004; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Scherr Michaela, 2002, Current Gene Therapy, V2, P45, DOI 10.2174/1566523023348237; Stoeckl L, 2006, P NATL ACAD SCI USA, V103, P6730, DOI 10.1073/pnas.0509765103; ter Brake O, 2009, GENE THER, V16, P148, DOI 10.1038/gt.2008.124; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; van Lunzen J, 2011, CURR HIV AIDS REP; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003; Will E, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf059	65	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31576	10.1371/journal.pone.0031576	http://dx.doi.org/10.1371/journal.pone.0031576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348110	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900056
J	Kruijt, B; van den Berg, TJTP				Kruijt, Bastiaan; van den Berg, Thomas J. T. P.			Optical Scattering Measurements of Laser Induced Damage in the Intraocular Lens	PLOS ONE			English	Article							LIGHT-SCATTERING; STRAYLIGHT; OPACIFICATION	This study optically determines whether the amount of light scatter due to laser-induced damage to the intraocular lens (IOL) is significant in relation to normal straylight values in the human eye. Two IOLs with laser-induced damage were extracted from two donor eyes. Each IOL had 15 pits and/or cracks. The surface area of each pit was measured using a microscope. For 6 pits per intraocular lens the point spread function (PSF) in terms of straylight was measured and the total straylight for all 15 pits was estimated. The damage in the IOLs was scored as mild/moderate. The total damaged surface areas, for a 3.5 mm pupil, in the two IOLs were 0.13% (0.0127 mm(2)) and 0.66% (0.064 mm(2)), respectively. The angular dependence of the straylight caused by the damage was similar to that of the normal PSF. The total average contribution to straylight was log(s) = -0.82 and -0.42, much less than the straylight value of the normal eye. The straylight due to normal levels of laser induced damage of the IOL is much lower than normal straylight values found clinically for the normal eye and may therefore be considered not significant.	[Kruijt, Bastiaan; van den Berg, Thomas J. T. P.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kruijt, B (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.	t.j.vandenberg@nin.knaw.nl						Awasthi N, 2009, ARCH OPHTHALMOL-CHIC, V127, P555, DOI 10.1001/archophthalmol.2009.3; Bath P E, 1985, J Am Intraocul Implant Soc, V11, P253; BATH PE, 1987, J CATARACT REFR SURG, V13, P47, DOI 10.1016/S0886-3350(87)80010-X; BATH PE, 1987, J CATARACT REFR SURG, V13, P309, DOI 10.1016/S0886-3350(87)80076-7; Boerner C F, 1984, J Am Intraocul Implant Soc, V10, P81; Coppens JE, 2006, EXP EYE RES, V82, P688, DOI 10.1016/j.exer.2005.09.007; Dick B, 1997, KLIN MONATSBL AUGENH, V211, P263, DOI 10.1055/s-2008-1035133; Fallor M K, 1985, J Am Intraocul Implant Soc, V11, P564; Holladay J T, 1985, J Am Intraocul Implant Soc, V11, P18; MAMALIS N, 1990, J CATARACT REFR SURG, V16, P495, DOI 10.1016/S0886-3350(13)80806-1; Newland TJ, 1999, J CATARACT REFR SURG, V25, P72, DOI 10.1016/S0886-3350(99)80014-5; Smith SG, 1992, EUR J IMPLANT REFRAC, V4, P157; STARK WJ, 1985, OPHTHALMOLOGY, V92, P209; Trinavarat A, 2001, J CATARACT REFR SURG, V27, P775, DOI 10.1016/S0886-3350(00)00855-5; van Bree MCJ, 2008, J CATARACT REFR SURG, V34, P1681, DOI 10.1016/j.jcrs.2008.06.014; van Bree MCJ, 2011, INVEST OPHTH VIS SCI, V52, P5587, DOI 10.1167/iovs.10-7073; van den Berg TJTP, 2009, OPHTHAL PHYSL OPT, V29, P345, DOI 10.1111/j.1475-1313.2009.00638.x; Van den Berg TJTP., 2010, ENCY EYE, V3, P173; van der Meulen IJE, 2009, BRIT J OPHTHALMOL, V93, P830, DOI 10.1136/bjo.2008.151324; vandenBerg TJTP, 1996, INVEST OPHTH VIS SCI, V37, P1157; Vos J., 1999, CIE COLLECT, V135, P1; Vos J. J., 1984, CIE Journal, V3, P39	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31764	10.1371/journal.pone.0031764	http://dx.doi.org/10.1371/journal.pone.0031764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348128	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730900029
J	Deco, G; Hugues, E				Deco, Gustavo; Hugues, Etienne			Balanced Input Allows Optimal Encoding in a Stochastic Binary Neural Network Model: An Analytical Study	PLOS ONE			English	Article							AREA V4; ATTENTION; INHIBITION; MECHANISMS; CORTEX	Recent neurophysiological experiments have demonstrated a remarkable effect of attention on the underlying neural activity that suggests for the first time that information encoding is indeed actively influenced by attention. Single cell recordings show that attention reduces both the neural variability and correlations in the attended condition with respect to the non-attended one. This reduction of variability and redundancy enhances the information associated with the detection and further processing of the attended stimulus. Beyond the attentional paradigm, the local activity in a neural circuit can be modulated in a number of ways, leading to the general question of understanding how the activity of such circuits is sensitive to these relatively small modulations. Here, using an analytically tractable neural network model, we demonstrate how this enhancement of information emerges when excitatory and inhibitory synaptic currents are balanced. In particular, we show that the network encoding sensitivity - as measured by the Fisher information-is maximized at the exact balance. Furthermore, we find a similar result for a more realistic spiking neural network model. As the regime of balanced inputs has been experimentally observed, these results suggest that this regime is functionally important from an information encoding standpoint.	[Deco, Gustavo; Hugues, Etienne] Univ Pompeu Fabra, Ctr Brain & Cognit, Barcelona, Spain; [Deco, Gustavo] Univ Pompeu Fabra, ICREA, Barcelona, Spain	Pompeu Fabra University; University of Barcelona; ICREA; Pompeu Fabra University	Deco, G (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit, Barcelona, Spain.	gustavo.deco@upf.edu	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; DECO, GUSTAVO/A-6341-2008; Hugues, Etienne/D-7988-2014	DECO, GUSTAVO/0000-0002-8995-7583; Hugues, Etienne/0000-0002-6008-2381	European Union [269921, 269459]; Spanish Research Project [SAF2010-16085]; CONSOLIDER-INGENIO Programme [CSD2007-00012]; ICREA Funding Source: Custom	European Union(European Commission); Spanish Research Project(Spanish Government); CONSOLIDER-INGENIO Programme(Spanish Government); ICREA(ICREA)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreements no. 269921(BrainScaleS) and no. 269459 (Coronet), from the Spanish Research Project SAF2010-16085 and from the CONSOLIDER-INGENIO 2010 Programme CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buice MA, 2009, PROG BIOPHYS MOL BIO, V99, P53, DOI 10.1016/j.pbiomolbio.2009.07.003; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Deco G, 2005, J NEUROPHYSIOL, V94, P295, DOI 10.1152/jn.01095.2004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hertz J., 1990, INTRO THEORY NEURAL; Hugues E, 2010, J PHYSIOL-PARIS, V104, P84, DOI 10.1016/j.jphysparis.2009.11.006; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rolls E. T., 2010, NOISY BRAIN; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30723	10.1371/journal.pone.0030723	http://dx.doi.org/10.1371/journal.pone.0030723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359550	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200019
J	Liu, CY; Li, JJ; Gao, JH; Shen, ZC; Lu, BR; Lin, CY				Liu, Chengyi; Li, Jingjing; Gao, Jianhua; Shen, Zhicheng; Lu, Bao-Rong; Lin, Chaoyang			A Built-In Mechanism to Mitigate the Spread of Insect-Resistance and Herbicide-Tolerance Transgenes into Weedy Rice Populations	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENE FLOW; BACILLUS-THURINGIENSIS; CULTIVATED RICE; CRY1AB GENE; DIFFERENTIATION; BEHAVIOR	Background: The major challenge of cultivating genetically modified (GM) rice (Oryza sativa) at the commercial scale is to prevent the spread of transgenes from GM cultivated rice to its coexisting weedy rice (O. sativa f. spontanea). The strategic development of GM rice with a built-in control mechanism can mitigate transgene spread in weedy rice populations. Methodology/Principal Findings: An RNAi cassette suppressing the expression of the bentazon detoxifying enzyme CYP81A6 was constructed into the T-DNA which contained two tightly linked transgenes expressing the Bt insecticidal protein Cry1Ab and the glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), respectively. GM rice plants developed from this T-DNA were resistant to lepidopteran pests and tolerant to glyphosate, but sensitive to bentazon. The application of bentazon of 2000 mg/L at the rate of 40 mL/m(2), which is approximately the recommended dose for the field application to control common rice weeds, killed all F-2 plants containing the transgenes generated from the Crop-weed hybrids between a GM rice line (CGH-13) and two weedy rice strains (PI-63 and PI-1401). Conclusions/Significance: Weedy rice plants containing transgenes from GM rice through gene flow can be selectively killed by the spray of bentazon when a non-GM rice variety is cultivated alternately in a few-year interval. The built-in control mechanism in combination of cropping management is likely to mitigate the spread of transgenes into weedy rice populations.	[Liu, Chengyi; Li, Jingjing; Gao, Jianhua; Shen, Zhicheng; Lin, Chaoyang] Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Bao-Rong] Fudan Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Inst Biodivers Sci, Shanghai 200433, Peoples R China	Zhejiang University; Fudan University	Liu, CY (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	chylin@zju.edu.cn	Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390	National Natural Science Foundation of China [31021003, 30900950]; Department of Agriculture of China [2011ZX08011-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Agriculture of China	This work was suppored by the National Natural Science Foundation of China (31021003 and 30900950) and Grants from the Department of Agriculture of China (2011ZX08011-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2005, PLANT BIOTECHNOL J, V3, P275, DOI 10.1111/j.1467-7652.2005.00130.x; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Cao QJ, 2007, WEED BIOL MANAG, V7, P97, DOI 10.1111/j.1445-6664.2007.00241.x; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Ferrero A, 1999, CROP PROT, V18, P245, DOI 10.1016/S0261-2194(99)00022-8; HUBER R, 1994, REV ENVIRON CONTAM T, V137, P111; Jiang H., 1985, CROP GENET RES, V2, P4; Lin CY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001818; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Lu BR, 2003, PROG NAT SCI-MATER, V13, P17; Madsen KH, 2002, WEED TECHNOL, V16, P215, DOI 10.1614/0890-037X(2002)016[0215:RAOHRC]2.0.CO;2; Messeguer J, 2004, MOL BREEDING, V13, P103, DOI 10.1023/B:MOLB.0000012285.39859.9d; Olofsdotter M, 2000, ANN APPL BIOL, V137, P279, DOI 10.1111/j.1744-7348.2000.tb00069.x; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Shu QY, 2000, MOL BREEDING, V6, P433, DOI 10.1023/A:1009658024114; Song ZP, 2006, EVOL ECOL, V20, P501, DOI 10.1007/s10682-006-9113-0; Sun J.D., 2005, WEED SCI CHINA, V2, P21; [王黎明 Wang Liming], 2009, [植物保护, Plant Protection], V35, P14; Wang W.X., 2005, WEED SCI CHINA, V2, P1; Xia HB, 2011, NEW PHYTOL, V191, P1119, DOI 10.1111/j.1469-8137.2011.03766.x; Xia HB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016189, 10.1371/journal.pone.0028553]; Ye GY, 2003, CROP PROT, V22, P171, DOI 10.1016/S0261-2194(02)00142-4; Yu GQ, 2005, BIOCHEM GENET, V43, P261, DOI 10.1007/s10528-005-5218-3; Zhang CX, 2000, WILD WEEDY RICE RICE	27	12	15	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31625	10.1371/journal.pone.0031625	http://dx.doi.org/10.1371/journal.pone.0031625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359609	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200078
J	Rieppo, L; Rieppo, J; Jurvelin, JS; Saarakkala, S				Rieppo, Lassi; Rieppo, Jarno; Jurvelin, Jukka S.; Saarakkala, Simo			Fourier Transform Infrared Spectroscopic Imaging and Multivariate Regression for Prediction of Proteoglycan Content of Articular Cartilage	PLOS ONE			English	Article							FEMORAL-HEAD CARTILAGE; ENGINEERED CARTILAGE; CHEMICAL COMPOSITION; COLLAGEN; GLYCOSAMINOGLYCANS; DEGENERATION; SECTIONS; MATRIX; AGE	Fourier Transform Infrared (FT-IR) spectroscopic imaging has been earlier applied for the spatial estimation of the collagen and the proteoglycan (PG) contents of articular cartilage (AC). However, earlier studies have been limited to the use of univariate analysis techniques. Current analysis methods lack the needed specificity for collagen and PGs. The aim of the present study was to evaluate the suitability of partial least squares regression (PLSR) and principal component regression (PCR) methods for the analysis of the PG content of AC. Multivariate regression models were compared with earlier used univariate methods and tested with a sample material consisting of healthy and enzymatically degraded steer AC. Chondroitinase ABC enzyme was used to increase the variation in PG content levels as compared to intact AC. Digital densitometric measurements of Safranin O -stained sections provided the reference for PG content. The results showed that multivariate regression models predict PG content of AC significantly better than earlier used absorbance spectrum (i.e. the area of carbohydrate region with or without amide I normalization) or second derivative spectrum univariate parameters. Increased molecular specificity favours the use of multivariate regression models, but they require more knowledge of chemometric analysis and extended laboratory resources for gathering reference data for establishing the models. When true molecular specificity is required, the multivariate models should be used.	[Rieppo, Lassi; Jurvelin, Jukka S.; Saarakkala, Simo] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Rieppo, Lassi] Kuopio Univ Hosp, Dept Clin Neurophysiol, SF-70210 Kuopio, Finland; [Rieppo, Jarno] Univ Eastern Finland, Dept Anat, Inst Biomed, Kuopio, Finland; [Rieppo, Jarno] Iisalmi Hosp, Iisalmi, Finland; [Saarakkala, Simo] Univ Oulu, Dept Diagnost Radiol, Oulu, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Oulu	Rieppo, L (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.	lassi.rieppo@uef.fi	Jurvelin, Jukka S/A-1111-2015; Saarakkala, Simo/F-5839-2013	Saarakkala, Simo/0000-0003-2850-5484	University of Eastern Finland [5741]; Academy of Finland [127198]; Kuopio University Hospital (EVO) [5257]; Finnish Cultural Foundation; Instrumentarium Science Foundation; National Graduate School of Musculoskeletal Disorders and Biomaterials	University of Eastern Finland; Academy of Finland(Academy of Finland); Kuopio University Hospital (EVO); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instrumentarium Science Foundation; National Graduate School of Musculoskeletal Disorders and Biomaterials	The financial support from the University of Eastern Finland (project 5741 and the strategic funding), Academy of Finland (project 127198), Kuopio University Hospital (EVO grant 5257), North Savo Regional Fund of The Finnish Cultural Foundation, Instrumentarium Science Foundation and National Graduate School of Musculoskeletal Disorders and Biomaterials is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013; Baykal D, 2010, APPL SPECTROSC, V64, P1160, DOI 10.1366/000370210792973604; Bonifacio A, 2010, ANALYST, V135, P3193, DOI 10.1039/c0an00459f; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; Jackson M, 1997, BIOPHYS CHEM, V68, P109, DOI 10.1016/S0301-4622(97)80555-8; Julkunen P, 2008, J BIOMECH, V41, P1978, DOI 10.1016/j.jbiomech.2008.03.026; Kim M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922329; Kiraly K, 1996, HISTOCHEM J, V28, P577, DOI 10.1007/BF02331378; KIVIRANTA I, 1985, HISTOCHEMISTRY, V82, P249, DOI 10.1007/BF00501401; Klein TJ, 2007, J BIOMECH, V40, P182, DOI 10.1016/j.jbiomech.2005.11.002; Kohler A, 2007, ANAL BIOANAL CHEM, V389, P1143, DOI 10.1007/s00216-007-1414-9; Korhonen RK, 2002, MED ENG PHYS, V24, P99, DOI 10.1016/S1350-4533(01)00123-0; Mark H, 2003, SPECTROSCOPY, V18, P25; Martens H., 1992, MULTIVARIATE CALIBRA; Martens HA, 1998, CHEMOMETR INTELL LAB, V44, P99, DOI 10.1016/S0169-7439(98)00167-1; Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Rieppo J, 2004, APPL SPECTROSC, V58, P137, DOI 10.1366/000370204322729577; Rieppo J, 2003, CELLS TISSUES ORGANS, V175, P121, DOI 10.1159/000074628; Rieppo J, 2009, OSTEOARTHR CARTILAGE, V17, P448, DOI 10.1016/j.joca.2008.09.004; Rieppo L, 2010, MICROSC RES TECHNIQ, V73, P503, DOI 10.1002/jemt.20789; Saarakkala S, 2010, CARTILAGE, V1, P262, DOI 10.1177/1947603510368689; Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Theodoropoulos JS, 2011, CLIN ORTHOP RELAT R, V469, P2785, DOI 10.1007/s11999-011-1856-4; VENN M, 1977, ANN RHEUM DIS, V36, P121, DOI 10.1136/ard.36.2.121; VENN MF, 1978, ANN RHEUM DIS, V37, P168, DOI 10.1136/ard.37.2.168; Wang QG, 2010, EUR CELLS MATER, V19, P86, DOI 10.22203/eCM.v019a09; Yin JH, 2010, APPL SPECTROSC, V64, P1199, DOI 10.1366/000370210793335124	32	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32344	10.1371/journal.pone.0032344	http://dx.doi.org/10.1371/journal.pone.0032344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359683	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200152
J	Taheri-Talesh, N; Xiong, Y; Oakley, BR				Taheri-Talesh, Naimeh; Xiong, Yi; Oakley, Berl R.			The Functions of Myosin II and Myosin V Homologs in Tip Growth and Septation in Aspergillus nidulans	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MOTOR-LIKE DOMAIN; FUNGUS USTILAGO-MAYDIS; SPINDLE POLE BODY; ACTIN CYTOSKELETON; HYPHAL GROWTH; GAMMA-TUBULIN; FILAMENTOUS FUNGUS; POLARIZED GROWTH; CHITIN SYNTHASES	Because of the industrial and medical importance of members of the fungal genus Aspergillus, there is considerable interest in the functions of cytoskeletal components in growth and secretion in these organisms. We have analyzed the genome of Aspergillus nidulans and found that there are two previously unstudied myosin genes, a myosin II homolog, myoB (product = MyoB) and a myosin V homolog, myoE (product = MyoE). Deletions of either cause significant growth defects. MyoB localizes in strings that coalesce into contractile rings at forming septa. It is critical for septation and normal deposition of chitin but not for hyphal extension. MyoE localizes to the Spitzenkorper and to moving puncta in the cytoplasm. Time-lapse imaging of SynA, a v-SNARE, reveals that in myoE deletion strains vesicles no longer localize to the Spitzenkorper. Tip morphology is slightly abnormal and branching occurs more frequently than in controls. Tip extension is slower than in controls, but because hyphal diameter is greater, growth (increase in volume/time) is only slightly reduced. Concentration of vesicles into the Spitzenkorper before incorporation into the plasma membrane is, thus, not required for hyphal growth but facilitates faster tip extension and a more normal hyphal shape.	[Taheri-Talesh, Naimeh; Oakley, Berl R.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Xiong, Yi; Oakley, Berl R.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University of Kansas; University System of Ohio; Ohio State University	Taheri-Talesh, N (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	boakley@ku.edu	Xiong, Yi/E-3083-2010	Oakley, Berl/0000-0002-3046-8240	National Institute of General Medical Sciences; University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031837] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences, http://www.nigms.nih.gov/, and the University of Kansas Endowment Fund, http://www.kuendowment.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Bartnicki-Garcia S, 2000, BIOPHYS J, V79, P2382, DOI 10.1016/S0006-3495(00)76483-6; Bartnicki-Garcia S., 1990, TIP GROWTH PLANT FUN, P211; BARTNICKIGARCIA S, 1995, EXP MYCOL, V19, P153, DOI 10.1006/emyc.1995.1017; BARTNICKIGARCIA S, 1989, PROTOPLASMA, V153, P46, DOI 10.1007/BF01322464; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Canovas D, 2011, EUKARYOT CELL, V10, P302, DOI 10.1128/EC.00201-10; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; Fernandez-Abalos JM, 1998, MOL MICROBIOL, V27, P121, DOI 10.1046/j.1365-2958.1998.00664.x; FIDDY C, 1976, J GEN MICROBIOL, V97, P169, DOI 10.1099/00221287-97-2-169; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Gierz G, 2001, J THEOR BIOL, V208, P151, DOI 10.1006/jtbi.2000.2209; GROVE SN, 1970, J BACTERIOL, V104, P989, DOI 10.1128/JB.104.2.989-1009.1970; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Heath I. Brent, 1996, Mycoscience, V37, P71; HEATH IB, 2000, ACTIN DYNAMIC FRAMEW, P275; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Jung MK, 2001, MOL BIOL CELL, V12, P2119, DOI 10.1091/mbc.12.7.2119; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; Laporte D, 2010, SEMIN CELL DEV BIOL, V21, P892, DOI 10.1016/j.semcdb.2010.08.004; Lee SB, 1990, PCR PROTOCOLS GUIDE, P282, DOI DOI 10.1016/B978-0-12-372180-8.50038-X; Martin MA, 1997, J CELL SCI, V110, P623; MCGOLDRICK CA, 1995, J CELL BIOL, V128, P577, DOI 10.1083/jcb.128.4.577; Mishra M, 2008, CURR BIOL, V18, pR247, DOI 10.1016/j.cub.2008.01.029; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; OAKLEY CE, 1987, GENE, V53, P293, DOI 10.1016/0378-1119(87)90019-9; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; Pearson CL, 2004, MOL BIOL CELL, V15, P3658, DOI 10.1091/mbc.E03-11-0803; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Schuchardt I, 2005, MOL BIOL CELL, V16, P5191, DOI 10.1091/mbc.E05-04-0272; Schuster M, 2011, EMBO J; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Steinberg G, 2007, NAT REV MICROBIOL, V5, P309, DOI 10.1038/nrmicro1618; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Szewczyk E, 2011, FUNGAL GENET BIOL, V48, P998, DOI 10.1016/j.fgb.2011.07.003; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Takeshita N, 2005, MOL BIOL CELL, V16, P1961, DOI 10.1091/mbc.E04-09-0761; Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45; Tsuizaki M, 2009, BIOSCI BIOTECH BIOCH, V73, P1163, DOI 10.1271/bbb.90074; Virag A, 2006, MYCOL RES, V110, P4, DOI 10.1016/j.mycres.2005.09.005; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; Weber I, 2003, PLANT CELL, V15, P2826, DOI 10.1105/tpc.016246; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350; Wolkow TD, 1996, J CELL SCI, V109, P2179; Woo M, 2003, FEMS MICROBIOL LETT, V218, P195, DOI 10.1111/j.1574-6968.2003.tb11518.x; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009; Yamashita RA, 1998, J BIOL CHEM, V273, P14644, DOI 10.1074/jbc.273.23.14644; Yamashita RA, 2000, CELL MOTIL CYTOSKEL, V45, P163, DOI 10.1002/(SICI)1097-0169(200002)45:2<163::AID-CM7>3.0.CO;2-D; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004	61	66	70	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31218	10.1371/journal.pone.0031218	http://dx.doi.org/10.1371/journal.pone.0031218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359575	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200044
J	Virgilio, M; Jordaens, K; Breman, FC; Backeljau, T; De Meyer, M				Virgilio, Massimiliano; Jordaens, Kurt; Breman, Floris C.; Backeljau, Thierry; De Meyer, Marc			Identifying Insects with Incomplete DNA Barcode Libraries, African Fruit Flies (Diptera: Tephritidae) as a Test Case	PLOS ONE			English	Article							IDENTIFICATION; TAXONOMY; RATES; FULL	We propose a general working strategy to deal with incomplete reference libraries in the DNA barcoding identification of species. Considering that (1) queries with a large genetic distance with their best DNA barcode match are more likely to be misidentified and (2) imposing a distance threshold profitably reduces identification errors, we modelled relationships between identification performances and distance thresholds in four DNA barcode libraries of Diptera (n = 4270), Lepidoptera (n = 7577), Hymenoptera (n = 2067) and Tephritidae (n = 602 DNA barcodes). In all cases, more restrictive distance thresholds produced a gradual increase in the proportion of true negatives, a gradual decrease of false positives and more abrupt variations in the proportions of true positives and false negatives. More restrictive distance thresholds improved precision, yet negatively affected accuracy due to the higher proportions of queries discarded (viz. having a distance query-best match above the threshold). Using a simple linear regression we calculated an ad hoc distance threshold for the tephritid library producing an estimated relative identification error <0.05. According to the expectations, when we used this threshold for the identification of 188 independently collected tephritids, less than 5% of queries with a distance query-best match below the threshold were misidentified. Ad hoc thresholds can be calculated for each particular reference library of DNA barcodes and should be used as cut-off mark defining whether we can proceed identifying the query with a known estimated error probability (e.g. 5%) or whether we should discard the query and consider alternative/complementary identification methods.	[Virgilio, Massimiliano; Jordaens, Kurt; Breman, Floris C.; De Meyer, Marc] Royal Museum Cent Africa, Tervuren, Belgium; [Virgilio, Massimiliano; Backeljau, Thierry] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Jordaens, Kurt; Breman, Floris C.] Joint Expt Mol Unit, Tervuren, Belgium; [Backeljau, Thierry] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium	Royal Museum for Central Africa; Royal Belgian Institute of Natural Sciences; University of Antwerp	Virgilio, M (corresponding author), Royal Museum Cent Africa, Tervuren, Belgium.	massimilano.virgilio@africamuseum.be		Virgilio, Massimiliano/0000-0002-1323-6886	Belgian Science Policy (BELSPO) [MO/37/029]	Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office)	Massimiliano Virgilio was funded by the Belgian Science Policy (BELSPO) Action 1 project MO/37/029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, FRUIT FLIES EC SIGNI; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Barr NB, 2012, ANN ENTOMOL SOC AM, V105, P339, DOI 10.1603/AN11100; De Meyer M, 2005, INSECT SYST EVOL, V36, P459, DOI 10.1163/187631205794761012; Ekesi S, 2007, FIELD GUIDE MANAGEME; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, INSECT BIODIVERSITY; Hebert Paul D. N., 2004, PLoS Biology, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Virgilio M, 2009, MOL PHYLOGENET EVOL, V51, P531, DOI 10.1016/j.ympev.2009.01.003; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Yoo HS, 2006, MOL CELLS, V22, P323	28	65	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31581	10.1371/journal.pone.0031581	http://dx.doi.org/10.1371/journal.pone.0031581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359600	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200069
J	Wang, JH; Shih, KS; Liou, JP; Wu, YW; Chang, ASY; Wang, KL; Tsai, CL; Yang, CR				Wang, Jyh-Horng; Shih, Kao-Shang; Liou, Jing-Ping; Wu, Yi-Wen; Chang, Anita Shin-Yuan; Wang, Kang-Li; Tsai, Ching-Lin; Yang, Chia-Ron			Anti-Arthritic Effects of Magnolol in Human Interleukin 1 beta-Stimulated Fibroblast-Like Synoviocytes and in a Rat Arthritis Model	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; IN-VITRO; EXPRESSION; OSTEOARTHRITIS; HONOKIOL; CELLS; OFFICINALIS; INHIBITION; CYTOKINES	Fibroblast-like synoviocytes (FLS) play an important role in the pathologic processes of destructive arthritis by producing a number of catabolic cytokines and metalloproteinases (MMPs). The expression of these mediators is controlled at the transcriptional level. The purposes of this study were to evaluate the anti-arthritic effects of magnolol (5,5'-Diallyl-biphenyl2,2'-diol), the major bioactive component of the bark of Magnolia officinalis, by examining its inhibitory effects on inflammatory mediator secretion and the NF-kappa B and AP-1 activation pathways and to investigate its therapeutic effects on the development of arthritis in a rat model. The in vitro anti-arthritic activity of magnolol was tested on interleukin (IL)-1 beta-stimulated FLS by measuring levels of IL-6, cyclooxygenase-2, prostaglandin E-2, and matrix metalloproteinases (MMPs) by ELISA and RT-PCR. Further studies on how magnolol inhibits IL-1 beta-stimulated cytokine expression were performed using Western blots, reporter gene assay, electrophoretic mobility shift assay, and confocal microscope analysis. The in vivo antiarthritic effects of magnolol were evaluated in a Mycobacterium butyricum-induced arthritis model in rats. Magnolol markedly inhibited IL-1 beta (10 ng/mL)-induced cytokine expression in a concentration-dependent manner (2.5-25 mu g/mL). In clarifying the mechanisms involved, magnolol was found to inhibit the IL-1 beta-induced activation of the IKK/I kappa B/NF-kappa B and MAPKs pathways by suppressing the nuclear translocation and DNA binding activity of both transcription factors. In the animal model, magnolol (100 mg/kg) significantly inhibited paw swelling and reduced serum cytokine levels. Our results demonstrate that magnolol inhibits the development of arthritis, suggesting that it might provide a new therapeutic approach to inflammatory arthritis diseases.	[Wang, Jyh-Horng; Wu, Yi-Wen; Tsai, Ching-Lin] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Shih, Kao-Shang] Shin Kong Wu Ho Su Mem Hosp, Dept Orthoped, Taipei, Taiwan; [Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chang, Anita Shin-Yuan; Wang, Kang-Li; Yang, Chia-Ron] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; National Taiwan University	Wang, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan.	cryang@ntu.edu.tw		YANG, CHIA-RON/0000-0001-5990-1346; Wang, Jyh- Horng/0000-0002-1531-5297	National Science Council of Taiwan [NSC100-2320-B-002-004-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work received grant support from National Science Council of Taiwan (NSC100-2320-B-002-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2008, NAT BIOTECHNOL, V26, P817, DOI 10.1038/nbt1412; [Anonymous], 2011, WHO FOOD ADDITIVES S, P64; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005; Belcaro G, 2010, ALTERN MED REV, V15, P337; Boileau C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2649; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen PH, 2008, J IMMUNOL, V181, P8441, DOI 10.4049/jimmunol.181.12.8441; Chen YH, 2002, BRIT J PHARMACOL, V135, P37, DOI 10.1038/sj.bjp.0704458; Cooles FAH, 2011, CURR OPIN RHEUMATOL, V23, P233, DOI 10.1097/BOR.0b013e32834518a3; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; Feldmann M, 2002, ANN RHEUM DIS, V61, P13; Gaby A R, 1999, Altern Med Rev, V4, P392; HOLOSHITZ J, 1983, SCIENCE, V219, P56, DOI 10.1126/science.6336851; Hwang ES, 2010, BIOSCI BIOTECH BIOCH, V74, P961, DOI 10.1271/bbb.90785; Jacobs JWG, 2001, CLIN RHEUMATOL, V20, P192, DOI 10.1007/PL00011199; Jawan B, 2003, J SURG RES, V110, P378, DOI 10.1016/S0022-4804(03)00034-9; Kao YH, 2010, PHYTOMEDICINE, V17, P469, DOI 10.1016/j.phymed.2009.07.012; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kim HM, 2007, INT IMMUNOPHARMACOL, V7, P1083, DOI 10.1016/j.intimp.2007.04.004; Kim KR, 2010, J PHARMACOL SCI, V114, P69, DOI 10.1254/jphs.10070FP; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Lin YR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-94; Matsuda H, 2001, CHEM PHARM BULL, V49, P716, DOI 10.1248/cpb.49.716; Park J, 2004, EUR J PHARMACOL, V496, P189, DOI 10.1016/j.ejphar.2004.05.047; Schuehly W., 2009, Inflammopharmacology, V17, P106, DOI 10.1007/s10787-009-7013-y; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shen YC, 1998, EUR J PHARMACOL, V343, P79, DOI 10.1016/S0014-2999(97)01519-7; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Suleyman H, 2010, INFLAMMATION, V33, P224, DOI 10.1007/s10753-009-9176-5; TENG CM, 1991, J PHARM PHARMACOL, V43, P667, DOI 10.1111/j.2042-7158.1991.tb03561.x; TENG CM, 1990, LIFE SCI, V47, P1153, DOI 10.1016/0024-3205(90)90176-R; Tsai YC, 2010, EUR J PHARMACOL, V641, P67, DOI 10.1016/j.ejphar.2010.05.011; Tse AKW, 2007, MOL IMMUNOL, V44, P2647, DOI 10.1016/j.molimm.2006.12.004; WANG JP, 1995, J PHARM PHARMACOL, V47, P857, DOI 10.1111/j.2042-7158.1995.tb05754.x; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106	38	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31368	10.1371/journal.pone.0031368	http://dx.doi.org/10.1371/journal.pone.0031368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359588	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200057
J	Adams, J; Tyrrell, R; Adamson, AJ; White, M				Adams, Jean; Tyrrell, Rachel; Adamson, Ashley J.; White, Martin			Effect of Restrictions on Television Food Advertising to Children on Exposure to Advertisements for 'Less Healthy' Foods: Repeat Cross-Sectional Study	PLOS ONE			English	Article							INFORMATION PROGRAM; CANADA; IMPACT; UK	Background: In 2007, new scheduling restrictions on television food advertising to children in the UK were announced. The aim of the restrictions was to "reduce significantly the exposure of children under 16 to high fat, salt or sugar (HFSS) advertising". We explored the impact of the restrictions on relative exposure to HFSS food advertising among all viewers and among child television viewers, as well as adherence to the restrictions. Methods: We conducted two cross-sectional studies of all advertisements broadcast in one region of the UK over one week periods - the first (week 1) six months before the restrictions were introduced, and the second (week 2) six months after. Data on what products were advertised were linked to data on how many people watched each advertisement. Nutritional content of foods advertised was added to the dataset and used to calculate HFSS status. Relative exposure was calculated as the proportion of all advertising person-minute-views (PMVs) that were for HFSS foods. Results: 1,672,417 advertising PMV were included. 14.6% of advertising PMV were for food and 51.1% of these were for HFSS food. Relative exposure of all viewers to HFSS food advertising increased between study weeks 1 and 2 (odds ratio (99% confidence intervals) = 1.54 (1.51 to 1.57)). Exposure of children to HFSS food advertising did not change between study weeks 1 and 2 (odds ratio (99% confidence intervals) = 1.05 (0.99 to 1.12)). There was almost universal adherence to the restrictions. Conclusions: Despite good adherence to the restrictions, they did not change relative exposure of children to HFSS advertising and were associated with an increase in relative exposure of all viewers to HFSS advertising. Stronger restrictions targeting a wider range of advertisements are necessary to reduce exposure of children to marketing of less healthful foods.	[Adams, Jean; Tyrrell, Rachel; Adamson, Ashley J.; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tyrrell, Rachel; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Adams, J (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	j.m.adams@ncl.ac.uk	Adams, Jean/G-2402-2010	Adams, Jean/0000-0002-5733-7830; White, Martin/0000-0002-1861-6757; Tyrrell-Smith, Rachel/0000-0002-2686-6289; Adamson, Ashley/0000-0003-3735-2846	National Prevention Research Initiative; British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Food Standards Agency; Medical Research Council; Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorate; Stroke Association; Welsh Assembly Government; World Cancer Research Fund; Fuse - the Centre for Translational Research in Public Health; National Institute for Health Research under UK Clinical Research Collaboration; National Institute of Health Research; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [G0701873, G0900686] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0701873, G0900686] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/008] Funding Source: researchfish	National Prevention Research Initiative(Diabetes UK); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Food Standards Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorate; Stroke Association; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Fuse - the Centre for Translational Research in Public Health; National Institute for Health Research under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); National Institute of Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded through the National Prevention Research Initiative (http://www.nri.org.uk) with the support of the following organisations: British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Food Standards Agency; Medical Research Council; Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorate; The Stroke Association; Welsh Assembly Government; and World Cancer Research Fund. The award was administered by the Medical Research Council [G0701873]. JA, AJA and MW receive salary support from Fuse - the Centre for Translational Research in Public Health which is funded by the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration (www.ukcrc.org). At the time of funding, AJA received salary support from an National Institute of Health Research Public Health Career Scientist fellowship (www.nihr.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, ARCH DIS CHILD, V94, P658, DOI 10.1136/adc.2008.151019; Adams J, 2009, BRIT J NUTR, V102, P584, DOI 10.1017/S0007114509220848; Butland BJ, 2007, FORESIGHT TACKLING O; CAIRNS G, 2009, EXTENT NATURE EFFECT; Caraher M, 2006, PUBLIC HEALTH NUTR, V9, P596, DOI 10.1079/PHN2005879; Chan W, 1995, MEAT POULTRY GAME S; Chan W, 1994, MISCELLANEOUS FOOD S; Chan W, 1996, MEAT PRODUCTS DISH S; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hastings G., 2007, EXTENT NATURE EFFECT; Hastings G., 2003, REV RES EFFECTS FOOD; Hawkes C, 2005, NUTR BULL, V30, P374, DOI 10.1111/j.1467-3010.2005.00526.x; HAWKES C., 2004, MARKETING FOOD CHILD; Hawkes C, 2011, PUBLIC HEALTH NUTR, V14, P1403, DOI 10.1017/S1368980011000607; Holland B, 1992, FRUIT NUTS S; Holland B, 1992, VEGETABLE DISHES S; Holland B, 1993, FISH FISH PRODUCTS S; Holland B, 1991, VEGETABLES HERBS S S; Holland B., 1989, MILK PRODUCTS EGGS S; Holland B, 1988, CEREALS CEREAL PRO S; McGinnis J.M., 2006, FOOD MARKETING CHILD; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Ofcom, 2007, TEL ADV FOOD DRINK P; Ofcom, 2010, HFSS ADV RESTR FIN R; Ofcom, 2008, CHANG NAT BAL TEL FO; Stockley, 2005, NUTRIENT PROFILES DE; van Raaij J, 2009, PUBLIC HEALTH NUTR, V12, P325, DOI 10.1017/S1368980008003376; *WHO, 2010, SET REC MARK FOODS N; Williams P, 2003, HEALTH PROMOT INT, V18, P51, DOI 10.1093/heapro/18.1.51; World Health Organization, 2010, GLAB STAT REP NONC D; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	31	67	69	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31578	10.1371/journal.pone.0031578	http://dx.doi.org/10.1371/journal.pone.0031578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355376	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300076
J	Zhang, YC; Mao, LY; Wang, H; Brocker, C; Yin, XJ; Vasiliou, V; Fei, ZJ; Wang, XP				Zhang, Yucheng; Mao, Linyong; Wang, Hua; Brocker, Chad; Yin, Xiangjing; Vasiliou, Vasilis; Fei, Zhangjun; Wang, Xiping			Genome-Wide Identification and Analysis of Grape Aldehyde Dehydrogenase (ALDH) Gene Superfamily	PLOS ONE			English	Article							2 P5CS GENES; ARABIDOPSIS-THALIANA; PROLINE ACCUMULATION; STRESS REGULATION; DROUGHT STRESS; EXPRESSION; SEQUENCE; PLANTS; SALT; EVOLUTIONARY	Background: The completion of the grape genome sequencing project has paved the way for novel gene discovery and functional analysis. Aldehyde dehydrogenases (ALDHs) comprise a gene superfamily encoding NAD(P)(+)-dependent enzymes that catalyze the irreversible oxidation of a wide range of endogenous and exogenous aromatic and aliphatic aldehydes. Although ALDHs have been systematically investigated in several plant species including Arabidopsis and rice, our knowledge concerning the ALDH genes, their evolutionary relationship and expression patterns in grape has been limited. Methodology/Principal Findings: A total of 23 ALDH genes were identified in the grape genome and grouped into ten families according to the unified nomenclature system developed by the ALDH Gene Nomenclature Committee (AGNC). Members within the same grape ALDH families possess nearly identical exon-intron structures. Evolutionary analysis indicates that both segmental and tandem duplication events have contributed significantly to the expansion of grape ALDH genes. Phylogenetic analysis of ALDH protein sequences from seven plant species indicates that grape ALDHs are more closely related to those of Arabidopsis. In addition, synteny analysis between grape and Arabidopsis shows that homologs of a number of grape ALDHs are found in the corresponding syntenic blocks of Arabidopsis, suggesting that these genes arose before the speciation of the grape and Arabidopsis. Microarray gene expression analysis revealed large number of grape ALDH genes responsive to drought or salt stress. Furthermore, we found a number of ALDH genes showed significantly changed expressions in responses to infection with different pathogens and during grape berry development, suggesting novel roles of ALDH genes in plant-pathogen interactions and berry development. Conclusion: The genome-wide identification, evolutionary and expression analysis of grape ALDH genes should facilitate research in this gene family and provide new insights regarding their evolution history and functional roles in plant stress tolerance.	[Zhang, Yucheng; Yin, Xiangjing; Wang, Xiping] NW A&F Univ, Coll Hort, Key Lab Hort Plant Biol & Germplasm Innovat NW Ch, Minist Agr, Yangling, Shaanxi, Peoples R China; [Zhang, Yucheng; Wang, Hua] NW A&F Univ, Coll Enol, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China; [Mao, Linyong; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Brocker, Chad; Vasiliou, Vasilis] Univ Colorado, Anschutz Med Ctr, Dept Pharmaceut Sci, Mol Toxicol & Environm Hlth Sci Program, Aurora, CO USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA; [Wang, Xiping] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Cornell University; Boyce Thompson Institute for Plant Research; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of Agriculture (USDA); Northwest A&F University - China	Wang, XP (corresponding author), NW A&F Univ, Coll Hort, Key Lab Hort Plant Biol & Germplasm Innovat NW Ch, Minist Agr, Yangling, Shaanxi, Peoples R China.	zf25@cornell.edu; wangxiping@nwsuaf.edu.cn	Fei, Zhangjun/H-5152-2012	Brocker, Chad/0000-0003-4262-3567; vasiliou, vasilis/0000-0003-2552-3118	National Natural Science Foundation of China [30871701, 31071782, 30671446]; National Institutes of Health (NIH) [R01EY17963, F31AA018248]; NATIONAL EYE INSTITUTE [R01EY017963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA018248] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Natural Science Foundation of China (30871701, 31071782, and 30671446), Program for New Century Excellent Talents in University (NCET). Additional support was provided, in part, by the National Institutes of Health (NIH) grants R01EY17963 (VV) and F31AA018248 (CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black WJ, 2009, PHARMACOGENET GENOM, V19, P893, DOI 10.1097/FPC.0b013e3283329023; Brocker C, 2011, CHEM-BIOL INTERACT, V191, P269, DOI 10.1016/j.cbi.2011.02.016; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; ISHITANI M, 1995, PLANT MOL BIOL, V27, P307, DOI 10.1007/BF00020185; Jackson Brian, 2011, Human Genomics, V5, P283; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; KELLY GJ, 1973, PLANT PHYSIOL, V52, P674, DOI 10.1104/pp.52.6.674; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kotchoni S. O., 2003, Bulgarian Journal of Plant Physiology, P37; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Lehmann S, 2010, AMINO ACIDS, V39, P949, DOI 10.1007/s00726-010-0525-3; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ling KS, 2004, J GEN VIROL, V85, P2099, DOI 10.1099/vir.0.80007-0; Liu F, 2002, PLANT PHYSIOL, V130, P1657, DOI 10.1104/pp.012336; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Oguchi K, 2004, PLANT CELL REP, V22, P848, DOI 10.1007/s00299-004-0778-y; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riera M, 2005, PHYSIOL PLANTARUM, V123, P111, DOI 10.1111/j.1399-3054.2005.00469.x; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Stines AP, 1999, PLANT PHYSIOL, V120, P923, DOI 10.1104/pp.120.3.923; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Strizhov N, 1997, PLANT J, V12, P557, DOI 10.1046/j.1365-313X.1997.00557.x; Su M, 2011, PLANT SCI, V181, P652, DOI 10.1016/j.plantsci.2011.03.002; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang XP, 2007, DNA SEQUENCE, V18, P9, DOI 10.1080/10425170600724618; Wise Roger P., 2007, V406, P347; WITZ G, 1989, FREE RADICAL BIO MED, V7, P333, DOI 10.1016/0891-5849(89)90137-8; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	65	44	54	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32153	10.1371/journal.pone.0032153	http://dx.doi.org/10.1371/journal.pone.0032153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355416	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300116
J	Arnold, SA; Rivera, LB; Carbon, JG; Toombs, JE; Chang, CL; Bradshaw, AD; Brekken, RA				Arnold, Shanna A.; Rivera, Lee B.; Carbon, Juliet G.; Toombs, Jason E.; Chang, Chi-Lun; Bradshaw, Amy D.; Brekken, Rolf A.			Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGF beta Activation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; RECEPTOR-TYPE-I; AORTIC-ANEURYSM; MARFAN-SYNDROME; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; MESANGIAL CELLS; MURINE MODEL; MOUSE MODEL	Pancreatic adenocarcinoma, a desmoplastic disease, is the fourth leading cause of cancer-related death in the Western world due, in large part, to locally invasive primary tumor growth and ensuing metastasis. SPARC is a matricellular protein that governs extracellular matrix (ECM) deposition and maturation during tissue remodeling, particularly, during wound healing and tumorigenesis. In the present study, we sought to determine the mechanism by which lack of host SPARC alters the tumor microenvironment and enhances invasion and metastasis of an orthotopic model of pancreatic cancer. We identified that levels of active TGF beta 1 were increased significantly in tumors grown in SPARC-null mice. TGF beta 1 contributes to many aspects of tumor development including metastasis, endothelial cell permeability, inflammation and fibrosis, all of which are altered in the absence of stromal-derived SPARC. Given these results, we performed a survival study to assess the contribution of increased TGF beta 1 activity to tumor progression in SPARC-null mice using losartan, an angiotensin II type 1 receptor antagonist that diminishes TGF beta 1 expression and activation in vivo. Tumors grown in SPARC-null mice progressed more quickly than those grown in wild-type littermates leading to a significant reduction in median survival. However, median survival of SPARC-null animals treated with losartan was extended to that of losartan-treated wild-type controls. In addition, losartan abrogated TGF beta induced gene expression, reduced local invasion and metastasis, decreased vascular permeability and altered the immune profile of tumors grown in SPARC-null mice. These data support the concept that aberrant TGF beta 1-activation in the absence of host SPARC contributes significantly to tumor progression and suggests that SPARC, by controlling ECM deposition and maturation, can regulate TGFb availability and activation.	[Arnold, Shanna A.; Rivera, Lee B.; Carbon, Juliet G.; Toombs, Jason E.; Chang, Chi-Lun; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Arnold, Shanna A.; Rivera, Lee B.; Carbon, Juliet G.; Toombs, Jason E.; Chang, Chi-Lun; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Pharmacol, Dallas, TX 75390 USA; [Bradshaw, Amy D.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of South Carolina	Arnold, SA (corresponding author), Vanderbilt Univ, Ctr Med, Dept Pathol, Nashville, TN 37232 USA.	rolf.brekken@utsouthwestern.edu			Effie Marie Cain Scholarship in Angiogenesis Research; National Institutes of Health [R01 CA118240, T32 GM0070602, T32 GM008203]; NATIONAL CANCER INSTITUTE [R01CA118240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	Effie Marie Cain Scholarship in Angiogenesis Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by The Effie Marie Cain Scholarship in Angiogenesis Research (to RAB), and the National Institutes of Health (R01 CA118240 to RAB; T32 GM0070602 to SAA; T32 GM008203 to LBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J KIDNEY DIS, V39, P486, DOI 10.1053/ajkd.2002.31392; An JB, 2010, HYPERTENS RES, V33, P831, DOI 10.1038/hr.2010.79; Arnold S, 2008, EXP BIOL MED, V233, P860, DOI 10.3181/0801-RM-12; Arnold SA, 2010, DIS MODEL MECH, V3, P57, DOI 10.1242/dmm.003228; Beyer M, 2009, CURR PHARM DESIGN, V15, P1879, DOI 10.2174/138161209788453211; Bornstein P, 2002, METHOD CELL BIOL, V69, P7, DOI 10.1016/S0091-679X(02)69003-X; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cao X, 2009, IMMUNOL RES; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; DASCH JR, 1989, J IMMUNOL, V142, P1536; de la Cruz-Merino L, 2009, CLIN TRANSL ONCOL, V11, P715, DOI 10.1007/s12094-009-0433-8; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; FORD R, 1993, EXP CELL RES, V206, P261, DOI 10.1006/excr.1993.1146; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Galgani M, 2009, CURR MED CHEM; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Kelly RJ, 2009, J IMMUNOTOXICOL; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Laviades C, 2000, HYPERTENSION, V36, P517, DOI 10.1161/01.HYP.36.4.517; Li HY, 2008, J MED CHEM, V51, P2302, DOI 10.1021/jm701199p; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Mazzocca A, 2009, HEPATOLOGY, V50, P1140, DOI 10.1002/hep.23118; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mendis DB, 1998, NEUROCHEM RES, V23, P1117, DOI 10.1023/A:1020720405428; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; Nadal JA, 2002, AM J PHYSIOL-HEART C, V282, pH739, DOI 10.1152/ajpheart.00656.2001; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Noguchi R, 2009, ONCOL REP, V22, P355, DOI 10.3892/or_00000445; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pavasant P, 2003, ARCH ORAL BIOL, V48, P717, DOI 10.1016/S0003-9969(03)00134-1; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406; Rivera LB, 2011, J CELL BIOL, V193, P1305, DOI 10.1083/jcb.201011143; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan Q, 2002, J CELL SCI, V115, P2747; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634; Zhou Y, 2006, BIOCHEM BIOPH RES CO, V339, P633, DOI 10.1016/j.bbrc.2005.11.060	64	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31384	10.1371/journal.pone.0031384	http://dx.doi.org/10.1371/journal.pone.0031384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348081	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400020
J	Mei, HF; Jin, XB; Zhu, JY; Zeng, AH; Wu, Q; Lu, XM; Li, XB; Shen, J				Mei, Han-fang; Jin, Xiao-bao; Zhu, Jia-yong; Zeng, Ai-hua; Wu, Qiang; Lu, Xue-mei; Li, Xiao-bo; Shen, Juan			beta-defensin 2 as an Adjuvant Promotes Anti-Melanoma Immune Responses and Inhibits the Growth of Implanted Murine Melanoma In Vivo	PLOS ONE			English	Article							DENDRITIC CELLS; ANTITUMOR IMMUNITY; ADAPTIVE IMMUNITY; INDUCTION; VACCINE; BETA-DEFENSIN-2; ACTIVATION; INNATE; ANTIGEN; NK	beta-defensin 2 is a small antimicrobial peptide of the innate immune system and has been thought to regulate anti-tumor immunity. However, little is known on whether beta-defensin 2 could modulate melanoma-specific NK and T cell responses. In this study, we first cloned the murine beta-defensin 2 gene by RT-PCR and generated the beta-defensin 2 stably expressing B16 cells (B16-mBD2). Subsequently, we evaluated whether vaccination with irradiated B16-mBD2 could modulate the growth of implanted B16 cells and determined the potential mechanisms underlying the action of B16-mBD2 vaccine in modulating the growth of B16 tumors in C57BL/6. We found that vaccination with irradiated B16-mBD2, but not with control B16-p or parental B16, inhibited the development and progression of B16 tumors, and prolonged the survival of tumor-bearing mice. However, vaccination with irradiated B16-mBD2 failed to inhibit the development of B16 tumors in the CD4(+)- or CD8(+)-depleted recipients. Furthermore, vaccination with irradiated B16-mBD2 stimulated strong NK activity and promoted potent B16-specific CTL responses, accompanied by augmenting IFN-gamma and IL-12, but not IL-4, responses in the recipient mice. Moreover, vaccination with irradiated B16-mBD2 promoted the infiltration of CD8(+) and CD4(+) T, NK cells and macrophages in the tumor tissues. These data suggest beta-defensin 2 may act as a positive regulator, promoting anti-tumor NK and T cell responses in vivo. Therefore, beta-defensin 2 may be used for the development of immunotherapy for the intervention of melanoma.	[Mei, Han-fang; Jin, Xiao-bao; Zhu, Jia-yong; Zeng, Ai-hua; Wu, Qiang; Lu, Xue-mei; Li, Xiao-bo; Shen, Juan] Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Bioact Subst, Guangzhou, Guangdong, Peoples R China; [Mei, Han-fang; Jin, Xiao-bao; Wu, Qiang; Li, Xiao-bo] Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Sch Basic Sci, Guangzhou, Guangdong, Peoples R China; [Mei, Han-fang] Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Dept Biochem & Mol Biol, Guangzhou, Guangdong, Peoples R China; [Mei, Han-fang; Wu, Qiang; Lu, Xue-mei; Li, Xiao-bo; Shen, Juan] So Med Univ, Inst Trop Med & Publ Hlth, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Southern Medical University - China	Mei, HF (corresponding author), Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Bioact Subst, Guangzhou, Guangdong, Peoples R China.	zhujiayong2@163.com			National Natural Science Foundation of China [36071832]; Medical and Scientific Research Foundation of Guangdong Province [A2011304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Scientific Research Foundation of Guangdong Province	This study was supported by the grants from the National Natural Science Foundation of China (No. 36071832) and the Medical and Scientific Research Foundation of Guangdong Province (A2011304). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Jean CB, 2005, EXPERT OPIN EMERG DR, V10, P393; Kalinski P, 2006, IMMUNOL RES, V36, P137, DOI 10.1385/IR:36:1:137; Lapteva N, 2009, MOL THER, V17, P1626, DOI 10.1038/mt.2009.111; Lu Y, 2007, BIOMATERIALS, V28, P3255, DOI 10.1016/j.biomaterials.2007.03.028; Ma XT, 2006, CANCER RES, V66, P1169, DOI 10.1158/0008-5472.CAN-05-2891; Marko L, 2008, EXPERT OPIN BIOL TH, V8, P315; Mochimaru H, 2008, INVEST OPHTH VIS SCI, V49, P2172, DOI 10.1167/iovs.07-1396; Morton D L, 2004, Dev Biol (Basel), V116, P209; Rossi GR, 2005, CANCER RES, V65, P10555, DOI 10.1158/0008-5472.CAN-05-0627; Seliger B, 2001, CANCER RES, V61, P1095; WALLACK MK, 1983, J BIOL RESP MODIF, V2, P586; Wang YS, 2007, CLIN CANCER RES, V13, P6779, DOI 10.1158/1078-0432.CCR-07-1587; Xia DJ, 2003, J MOL MED, V81, P585, DOI 10.1007/s00109-003-0472-5; Xu B, 2007, GENE THER, V14, P1181, DOI 10.1038/sj.gt.3302966; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Zhang W, 2008, BIOCHEM BIOPH RES CO, V376, P10, DOI 10.1016/j.bbrc.2008.08.061	22	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31328	10.1371/journal.pone.0031328	http://dx.doi.org/10.1371/journal.pone.0031328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348070	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900041
J	Roll, JD; Reuther, GW				Roll, J. Devon; Reuther, Gary W.			ALK-Activating Homologous Mutations in LTK Induce Cellular Transformation	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; RECEPTOR TYROSINE KINASE; ACUTE MYELOID-LEUKEMIA; NON-HODGKINS-LYMPHOMA; LUNG-CANCER; GROWTH-FACTOR; MONOCLONAL-ANTIBODIES; EML4-ALK FUSION; GENE; IDENTIFICATION	Leukocyte tyrosine kinase (LTK) is a receptor tyrosine kinase reported to be overexpressed in human leukemia. Though much regarding the function of LTK remains unknown, it shares a high degree of similarity with anaplastic lymphoma kinase (ALK), which is found mutated in human cancer. In order to determine if LTK has transforming potential, we created two LTK mutants, F568L and R669Q, that correspond to two well-characterized activating mutations of ALK (F1174L and R1275Q). LTK-F568L, but not wildtype LTK or LTK-R669Q, transformed hematopoietic cells to cytokine independence. LTK-F568L exhibited a stronger ability to induce loss of contact inhibition and anchorage-independent growth of epithelial cells compared to LTK-R669Q, while wildtype LTK was non-transforming in the same cells. Likewise, LTK-F568L induced greater neurite outgrowth of PC12 cells than R669Q, while wildtype LTK could not. Correlating with transforming activity, LTK-F568L displayed significantly enhanced tyrosine phosphorylation compared to wildtype LTK and LTK-R668Q and induced activation of various signaling proteins including Shc, ERK and the JAK/STAT pathway. Expression of wildtype LTK or LTK-R669Q generally led to weaker activation of signaling proteins than expression of LTK-F568L, or no activation at all. Thus, mutating LTK at residue F568, and to a lesser extent at R669, activates the receptor tyrosine kinase, inducing cell signaling that results in transforming properties. These studies suggest that aberrant activation of LTK may contribute to neoplastic cell growth.	[Roll, J. Devon; Reuther, Gary W.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Roll, JD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	gary.reuther@moffitt.org	Reuther, Gary/AFR-2892-2022	Migliaccio, Antimo/0000-0002-4197-2055	Moffitt Cancer Center	Moffitt Cancer Center	This project was funded by the Moffitt Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardini E, 2010, CANCER LETT, V299, P81, DOI 10.1016/j.canlet.2010.09.001; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BERNARDS A, 1990, EMBO J, V9, P2279, DOI 10.1002/j.1460-2075.1990.tb07399.x; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; Blaikie PA, 1997, J BIOL CHEM, V272, P20671, DOI 10.1074/jbc.272.33.20671; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Di Nicolantonio F, 2006, CURR OPIN ONCOL, V18, P69, DOI 10.1097/01.cco.0000198020.91724.48; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Finnon R, 2002, MOL CARCINOGEN, V34, P64, DOI 10.1002/mc.10054; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Honda H, 1999, ONCOGENE, V18, P3821, DOI 10.1038/sj.onc.1202736; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; KOZUTSUMI H, 1994, ONCOGENE, V9, P2991; KOZUTSUMI H, 1993, BIOCHEM BIOPH RES CO, V190, P674, DOI 10.1006/bbrc.1993.1101; KROLEWSKI JJ, 1991, EMBO J, V10, P2911, DOI 10.1002/j.1460-2075.1991.tb07841.x; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li N, 2004, HUM MOL GENET, V13, P171, DOI 10.1093/hmg/ddh020; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MARU Y, 1990, ONCOGENE RES, V5, P199; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V358, P399, DOI 10.1016/j.bbrc.2007.04.137; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; Reuther GW, 2000, MOL CELL BIOL, V20, P8655, DOI 10.1128/MCB.20.23.8655-8666.2000; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SALCINI AE, 1994, ONCOGENE, V9, P2827; Sasaki T, 2011, CLIN CANC RES; Savage KJ, 2007, BLOOD REV, V21, P201, DOI 10.1016/j.blre.2007.03.001; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; TOYOSHIMA H, 1993, P NATL ACAD SCI USA, V90, P5404, DOI 10.1073/pnas.90.12.5404; UENO H, 1995, J BIOL CHEM, V270, P20135, DOI 10.1074/jbc.270.34.20135; Ueno H, 1997, ONCOGENE, V14, P3067, DOI 10.1038/sj.onc.1201153; Ueno H, 1996, J BIOL CHEM, V271, P27707, DOI 10.1074/jbc.271.44.27707; Wang Feng-Hua, 2009, Ai Zheng, V28, P49; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331; Yamada S, 2008, NEUROREPORT, V19, P1733, DOI 10.1097/WNR.0b013e3283186bf8; Yuan Y, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-16	59	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31733	10.1371/journal.pone.0031733	http://dx.doi.org/10.1371/journal.pone.0031733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347506	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200034
J	Chiang, CH; Huang, PH; Chung, FP; Chen, ZY; Leu, HB; Huang, CC; Wu, TC; Chen, JW; Lin, SJ				Chiang, Chia-Hung; Huang, Po-Hsun; Chung, Fa-Po; Chen, Zu-Yin; Leu, Hsin-Bang; Huang, Chin-Chou; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong			Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; INCREASED CARDIOVASCULAR RISK; METABOLIC SYNDROME; GENERAL-POPULATION; INSULIN-RESISTANCE; PERIPHERAL-BLOOD; DYSFUNCTION; ATHEROSCLEROSIS; PREVALENCE	Objectives: Nonalcoholic fatty liver disease (NAFLD) is associated with advanced atherosclerosis and a higher risk of cardiovascular disease. Increasing evidence suggests that injured endothelial monolayer is regenerated by circulating bone marrow derived-endothelial progenitor cells (EPCs), and levels of circulating EPCs reflect vascular repair capacity. However, the relation between NAFLD and EPC remains unclear. Here, we tested the hypothesis that patients with nonalcoholic fatty liver disease (NAFLD) might have decreased endothelial progenitor cell (EPC) levels and attenuated EPC function. Methods and Results: A total of 312 consecutive patients undergoing elective coronary angiography because of suspected coronary artery disease were screened and received examinations of abdominal ultrasonography between July 2009 and November 2010. Finally, 34 patients with an ultrasonographic diagnosis of NAFLD, and 68 age-and sex-matched controls without NAFLD were enrolled. Flow cytometry with quantification of EPC markers (defined as CD34(+), CD34(+)KDR(+), and CD34(+)KDR(+)CD133(+))in peripheral blood samples was used to assess circulating EPC numbers. The adhesive function, and migration, and tube formation capacities of EPCs were also determined in NAFLD patients and controls. Patients with NAFLD had a significantly higher incidence of metabolic syndrome, previous myocardial infarction, hyperuricemia, and higher waist circumference, body mass index, fasting glucose and triglyceride levels. In addition, patients with NAFLD had significantly decreased circulating EPC levels (all P<0.05), attenuated EPC functions, and enhanced systemic inflammation compared to controls. Multivariate logistic regression analysis showed that circulating EPC level (CD34(+)KDR(+) [cells/10(5) events]) was an independent reverse predictor of NAFLD (Odds ratio: 0.78; 95% confidence interval: 0.69-0.89, P<0.001). Conclusions: NAFLD patients have decreased circulating EPC numbers and functions than those without NAFLD, which may be one of the mechanisms to explain atherosclerotic disease progression and enhanced cardiovascular risk in patients with NAFLD.	[Chiang, Chia-Hung; Huang, Po-Hsun; Chung, Fa-Po; Chen, Zu-Yin; Leu, Hsin-Bang; Huang, Chin-Chou; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Huang, Po-Hsun; Leu, Hsin-Bang; Wu, Tao-Cheng; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Chung, Fa-Po; Chen, Zu-Yin; Leu, Hsin-Bang; Huang, Chin-Chou; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chiang, CH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw			UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-99-2911-I-009-101]; Taipei Veterans General Hospital [VGH-V98B1-003, VGH-V100E2-002]; Ministry of Education;  [NSC 97-2314-B-075-039];  [NSC 98-2314-B-075-035]	UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education; ; 	This study was supported in part by research grants from the NSC 97-2314-B-075-039, NSC 98-2314-B-075-035, and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101 from the National Science Council; VGH-V98B1-003 and VGH-V100E2-002 from Taipei Veterans General Hospital, and also a grant from the Ministry of Education "Aim for the Top University" Plan. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, DIABETIC MED, V22, P1129, DOI 10.1111/j.1464-5491.2005.01748.x; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Chen JZ, 2004, CLIN SCI, V107, P273, DOI 10.1042/CS20030389; Chiang CH, 2010, CLIN BIOCHEM, V43, P1399, DOI 10.1016/j.clinbiochem.2010.09.003; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Drexler H, 1999, J MOL CELL CARDIOL, V31, P51, DOI 10.1006/jmcc.1998.0843; ELHASSAN AY, 1992, BRIT J RADIOL, V65, P774, DOI 10.1259/0007-1285-65-777-774; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huang PH, 2008, CORONARY ARTERY DIS, V19, P187, DOI 10.1097/MCA.0b013e3282f399e2; Huang PH, 2007, HEART, V93, P1064, DOI 10.1136/hrt.2006.107763; Huang PH, 2010, J HYPERTENS, V28, P1655, DOI 10.1097/HJH.0b013e32833a4d0a; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Jepsen P, 2003, HEPATO-GASTROENTEROL, V50, P2101; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Koh JH, 2009, DIABETES CARE, V32, P147, DOI 10.2337/dc08-1379; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Lin YC, 2005, WORLD J GASTROENTERO, V11, P4838, DOI 10.3748/wjg.v11.i31.4838; Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351; Miller-Kasprzak E, 2011, OBESITY, V19, P736, DOI 10.1038/oby.2010.169; Mirbagheri SA, 2007, LIVER INT, V27, P891, DOI 10.1111/j.1478-3231.2007.01531.x; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Senturk O, 2008, INTERN MED J, V38, P183, DOI 10.1111/j.1445-5994.2007.01481.x; Sung KC, 2009, ATHEROSCLEROSIS, V203, P581, DOI 10.1016/j.atherosclerosis.2008.07.024; Tarantino G, 2007, J GASTROEN HEPATOL, V22, P293, DOI 10.1111/j.1440-1746.2007.04824.x; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Verhaar MC, 1998, CARDIOVASC DRUG THER, V12, P125, DOI 10.1023/A:1007737412395; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Vlachopoulos C, 2010, AM J HYPERTENS, V23, P1183, DOI 10.1038/ajh.2010.144; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8	43	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31799	10.1371/journal.pone.0031799	http://dx.doi.org/10.1371/journal.pone.0031799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359630	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200099
J	Cournil, A; Eymard-Duvernay, S; Diouf, A; Moquet, C; Coutherut, J; Gueye, NFN; Cames, C; Taverne, B; Bork, K; Sow, PS; Delaporte, E				Cournil, Amandine; Eymard-Duvernay, Sabrina; Diouf, Assane; Moquet, Claire; Coutherut, Julie; Gueye, Ndeye Fatou Ngom; Cames, Cecile; Taverne, Bernard; Bork, Kirsten; Sow, Papa Salif; Delaporte, Eric		ANRS 1215 Study Grp	Reduced Quantitative Ultrasound Bone Mineral Density in HIV-Infected Patients on Antiretroviral Therapy in Senegal	PLOS ONE			English	Article							ABACAVIR-LAMIVUDINE; FRACTURE RISK; TENOFOVIR DF; OSTEOPOROSIS; PREVALENCE; EFAVIRENZ; WOMEN; MEN; EMTRICITABINE; COMBINATION	Background: Bone status in HIV-infected patients on antiretroviral treatment (ART) is poorly documented in resource-limited settings. We compared bone mineral density between HIV-infected patients and control subjects from Dakar, Senegal. Methods: A total of 207 (134 women and 73 men) HIV-infected patients from an observational cohort in Dakar (ANRS 1215) and 207 age-and sex-matched controls from the general population were enrolled. Bone mineral density was assessed by quantitative ultrasound (QUS) at the calcaneus, an alternative to the reference method (i.e. dual X-absorptiometry), often not available in resource-limited countries. Results: Mean age was 47.0 (+/- 8.5) years. Patients had received ART for a median duration of 8.8 years; 45% received a protease inhibitor and 27% tenofovir; 84% had undetectable viral load. Patients had lower body mass index (BMI) than controls (23 versus 26 kg/m(2), P<0.001). In unadjusted analysis, QUS bone mineral density was lower in HIV-infected patients than in controls (difference: -0.36 standard deviation, 95% confidence interval (CI): -0.59;-0.12, P = 0.003). Adjusting for BMI, physical activity, smoking and calcium intake attenuated the difference (-0.27, CI: -0.53; -0.002, P = 0.05). Differences in BMI between patients and controls explained a third of the difference in QUS bone mineral density. Among patients, BMI was independently associated with QUS bone mineral density (P<0.001). An association between undetectable viral load and QUS bone density was also suggested (beta = 0.48, CI: 0.02; 0.93; P = 0.04). No association between protease inhibitor or tenofovir use and QUS bone mineral density was found. Conclusion: Senegalese HIV-infected patients had reduced QUS bone mineral density in comparison with control subjects, in part related to their lower BMI. Further investigation is needed to clarify the clinical significance of these observations.	[Cournil, Amandine; Eymard-Duvernay, Sabrina; Moquet, Claire; Cames, Cecile; Bork, Kirsten; Delaporte, Eric] Univ Montpellier I, Inst Rech Dev, UMI 233, Montpellier, France; [Diouf, Assane; Sow, Papa Salif] Fann Univ, Reg Res & Training Ctr HIV AIDS, Teaching Hosp, Dakar, Senegal; [Coutherut, Julie; Taverne, Bernard] Univ Montpellier I, Inst Rech Dev, UMI 233, Dakar, Senegal; [Gueye, Ndeye Fatou Ngom] Fann Univ, Ambulatory Care Unit, Teaching Hosp, Dakar, Senegal; [Sow, Papa Salif] Fann Univ, Dept Infect Dis, Teaching Hosp, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Cournil, A (corresponding author), Univ Montpellier I, Inst Rech Dev, UMI 233, Montpellier, France.	amandine.cournil@ird.fr	Delaporte, Eric/J-5397-2018; Desclaux, Alice/D-9566-2017	Delaporte, Eric/0000-0002-1822-9853; Cames, Cecile/0000-0001-8374-7107; Laurent, Christian/0000-0003-2658-7113; Bork, Kirsten/0000-0002-5909-7332; Desclaux, Alice/0000-0002-4268-2818	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [1215, 1290]; Institut de Recherche pour le Developpement (IRD)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); Institut de Recherche pour le Developpement (IRD)	The study was funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS, Projects 1215 and 1290) and the Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015; Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05; Aspray TJ, 1996, J BONE MINER RES, V11, P1019; Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660; Bolland MJ, 2011, J CLIN ENDOCR METAB, V96, P2721, DOI 10.1210/jc.2011-0591; Briot K, 2011, BONE, V48, P1133, DOI 10.1016/j.bone.2011.01.015; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Brown TT, 2009, JAIDS-J ACQ IMM DEF, V51, P554, DOI 10.1097/QAI.0b013e3181adce44; Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/00002030-200309050-00010; Calmy A, 2009, J INFECT DIS, V200, P1746, DOI 10.1086/644785; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; Constant Deborah, 2009, Arch Osteoporos, V4, P55; Desclaux A, 2003, AIDS, V17, pS95, DOI 10.1097/00002030-200317003-00013; Dolan SE, 2006, J CLIN ENDOCR METAB, V91, P2938, DOI 10.1210/jc.2006-0127; Dop M-C, 2003, OUTILS ENQUETE ALIME; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Fernandez-Rivera J, 2003, HIV CLIN TRIALS, V4, P337, DOI 10.1310/4X0H-UVMJ-BHYW-CPFB; Fessel WJ, 2003, AIDS, V17, P255, DOI 10.1097/00002030-200301240-00016; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Guglielmi G, 2010, RADIOL CLIN N AM, V48, P577, DOI 10.1016/j.rcl.2010.02.013; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Hans D, 2008, J BONE MINER RES, V23, P1045, DOI 10.1359/JBMR.080229; Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1; Krieg MA, 2008, J CLIN DENSITOM, V11, P163, DOI 10.1016/j.jocd.2007.12.011; Landman Roland, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P379, DOI 10.1177/1545109709344352; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Melton LJ, 2002, OSTEOPOROSIS INT, V13, P551, DOI 10.1007/s001980200072; Moayyeri A, 2009, J BONE MINER RES, V24, P1319, DOI [10.1359/jbmr.090212, 10.1359/JBMR.090212]; Nam HS, 2010, OSTEOPOROSIS INT, V21, P2115, DOI 10.1007/s00198-010-1188-3; Ndiaye S, 2005, SENEGAL DEMOGRAPHIC; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; VanderJagt DJ, 2001, CALCIFIED TISSUE INT, V68, P277, DOI 10.1007/BF02390834; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Yin M, 2005, OSTEOPOROSIS INT, V16, P1345, DOI 10.1007/s00198-005-1845-0; Zebaze RMD, 2003, OSTEOPOROSIS INT, V14, P301, DOI 10.1007/s00198-002-1356-1	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31726	10.1371/journal.pone.0031726	http://dx.doi.org/10.1371/journal.pone.0031726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359621	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200090
J	Dong, SZ; Zeng, QW; Mitchell, ES; Xiu, J; Duan, Y; Li, CX; Tiwari, JK; Hu, YH; Cao, XH; Zhao, Z				Dong, Suzhen; Zeng, Qingwen; Mitchell, E. Siobhan; Xiu, Jin; Duan, Yale; Li, Chunxia; Tiwari, Jyoti K.; Hu, Yinghe; Cao, Xiaohua; Zhao, Zheng			Curcumin Enhances Neurogenesis and Cognition in Aged Rats: Implications for Transcriptional Interactions Related to Growth and Synaptic Plasticity	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; ADENYLYL-CYCLASE; OXIDATIVE STRESS; SPATIAL MEMORY; MESSENGER-RNA; EXPRESSION; NEURONS; IMPAIRMENT	Background: Curcumin has been demonstrated to have many neuroprotective properties, including improvement of cognition in humans and neurogenesis in animals, yet the mechanism of such effects remains unclear. Methodology: We assessed behavioural performance and hippocampal cell proliferation in aged rats after 6- and 12-week curcumin-fortified diets. Curcumin enhanced non-spatial and spatial memory, as well as dentate gyrate cell proliferation as compared to control diet rats. We also investigated underlying mechanistic pathways that might link curcumin treatment to increased cognition and neurogenesis via exon array analysis of cortical and hippocampal mRNA transcription. The results revealed a transcriptional network interaction of genes involved in neurotransmission, neuronal development, signal transduction, and metabolism in response to the curcumin treatment. Conclusions: The results suggest a neurogenesis- and cognition-enhancing potential of prolonged curcumin treatment in aged rats, which may be due to its diverse effects on genes related to growth and plasticity.	[Dong, Suzhen; Zeng, Qingwen; Duan, Yale; Li, Chunxia; Hu, Yinghe; Cao, Xiaohua; Zhao, Zheng] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Dong, Suzhen; Hu, Yinghe] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Mitchell, E. Siobhan] Unilever R&D, Vlaardingen, Netherlands; [Xiu, Jin] Unilever R&D, Shanghai, Peoples R China; [Tiwari, Jyoti K.] Unilever R&D, Bangalore, Karnataka, India	East China Normal University; East China Normal University; Unilever; Unilever; Unilever	Dong, SZ (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China.	xhcao@brain.ecnu.edu.cn; zzhao@brain.ecnu.edu.cn		tiwari, jyoti kumar/0000-0002-6154-6512; Mitchell, Ellen/0000-0001-7851-6283; Duan, Yale/0000-0001-5166-4091				Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Alvania RS, 2006, NEURON, V50, P813, DOI 10.1016/j.neuron.2006.06.001; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Baxter KK, 2009, ASN NEURO, V1, DOI 10.1042/AN20090036; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Berberoglu MA, 2009, GENE EXPR PATTERNS, V9, P411, DOI 10.1016/j.gep.2009.06.002; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Calabrese V, 2008, NEUROCHEM RES, V33, P2444, DOI 10.1007/s11064-008-9775-9; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Conboy L, 2009, BIOCHEM PHARMACOL, V77, P1254, DOI 10.1016/j.bcp.2008.12.011; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gaudreault SB, 2004, NEUROBIOL AGING, V25, P753, DOI 10.1016/j.neurobiolaging.2003.07.004; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Ishrat T, 2009, EUR NEUROPSYCHOPHARM, V19, P636, DOI 10.1016/j.euroneuro.2009.02.002; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Kang SK, 2006, STEM CELLS DEV, V15, P165, DOI 10.1089/scd.2006.15.165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kuhad A, 2007, EUR J PHARMACOL, V576, P34, DOI 10.1016/j.ejphar.2007.08.001; Kumar A, 2007, J MED FOOD, V10, P486, DOI 10.1089/jmf.2006.076; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Matsuda S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-41; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Meneses A, 2007, BEHAV BRAIN RES, V184, P81, DOI 10.1016/j.bbr.2007.06.026; Mons N, 2004, NEUROBIOL AGING, V25, P1095, DOI 10.1016/j.neurobiolaging.2003.10.014; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Ono K, 2006, CURR PHARM DESIGN, V12, P4357, DOI 10.2174/138161206778793010; Pei JJ, 2002, ACTA NEUROPATHOL, V104, P369, DOI 10.1007/s00401-002-0565-1; Reeta KH, 2009, BRAIN RES, V1301, P52, DOI 10.1016/j.brainres.2009.09.027; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Shan Q, 2008, J NEUROSCI, V28, P12864, DOI 10.1523/JNEUROSCI.2413-08.2008; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; SQUIRE LR, 1993, TRENDS NEUROSCI, V16, P56, DOI 10.1016/0166-2236(93)90016-F; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Xu Y, 2009, NEUROPHARMACOLOGY, V57, P463, DOI 10.1016/j.neuropharm.2009.06.010; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Zhang L, 2006, J ALZHEIMERS DIS, V10, P1; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y	59	116	125	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31211	10.1371/journal.pone.0031211	http://dx.doi.org/10.1371/journal.pone.0031211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359574	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200043
J	Dubrovska, A; Elliott, J; Salamone, RJ; Telegeev, GD; Stakhovsky, AE; Schepotin, IB; Yan, F; Wang, Y; Bouchez, LC; Kularatne, SA; Watson, J; Trussell, C; Reddy, VA; Cho, CY; Schultz, PG				Dubrovska, Anna; Elliott, Jimmy; Salamone, Richard J.; Telegeev, Gennady D.; Stakhovsky, Alexander E.; Schepotin, Ihor B.; Yan, Feng; Wang, Yan; Bouchez, Laure C.; Kularatne, Sumith A.; Watson, James; Trussell, Christopher; Reddy, Venkateshwar A.; Cho, Charles Y.; Schultz, Peter G.			CXCR4 Expression in Prostate Cancer Progenitor Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELLS; STEM/PROGENITOR CELLS; TUMOR-GROWTH; IDENTIFICATION; MIGRATION; ADHESION; ALPHA(V)BETA(3); PROLIFERATION; MAINTENANCE	Tumor progenitor cells represent a population of drug-resistant cells that can survive conventional chemotherapy and lead to tumor relapse. However, little is known of the role of tumor progenitors in prostate cancer metastasis. The studies reported herein show that the CXCR4/CXCL12 axis, a key regulator of tumor dissemination, plays a role in the maintenance of prostate cancer stem-like cells. The CXCL4/CXCR12 pathway is activated in the CD44(+)/CD133(+) prostate progenitor population and affects differentiation potential, cell adhesion, clonal growth and tumorigenicity. Furthermore, prostate tumor xenograft studies in mice showed that a combination of the CXCR4 receptor antagonist AMD3100, which targets prostate cancer stem-like cells, and the conventional chemotherapeutic drug Taxotere, which targets the bulk tumor, is significantly more effective in eradicating tumors as compared to monotherapy.	[Dubrovska, Anna; Bouchez, Laure C.; Kularatne, Sumith A.; Reddy, Venkateshwar A.; Schultz, Peter G.] Scripps Res Inst, La Jolla, CA 92037 USA; [Elliott, Jimmy; Salamone, Richard J.; Yan, Feng; Wang, Yan; Watson, James; Trussell, Christopher; Reddy, Venkateshwar A.; Cho, Charles Y.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Stakhovsky, Alexander E.; Schepotin, Ihor B.] Natl Canc Inst, Kiev, Ukraine; [Telegeev, Gennady D.] Inst Mol Biol & Genet NAS Ukraine, Kiev, Ukraine	Scripps Research Institute; Novartis; Ministry of Health of Ukraine; National Cancer Institute; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Dubrovska, A (corresponding author), Tech Univ Dresden, Med Fac Dresden Carl Gustav Carus, D-01062 Dresden, Germany.	anna.dubrovska@oncoray.de; schultz@scripps.edu	Dubrovska, Anna/AAE-8514-2019	Dubrovska, Anna/0000-0002-3375-1500; bouchez, laure/0000-0003-4583-6760	Susan G. Komen for the Cure [PDF0707903]; Novartis Research Foundation; Skaggs Institute for Chemical Biology	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Novartis Research Foundation; Skaggs Institute for Chemical Biology	This study was supported by Susan G. Komen for the Cure Grant PDF0707903 (to A.D). This work was supported by the Novartis Research Foundation and The Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; Barretina J, 2003, ANN HEMATOL, V82, P500, DOI 10.1007/s00277-003-0679-0; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; NEAL DE, 2005, J CELL SCI, V117, P3539; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Sun YX, 2007, PROSTATE, V67, P61, DOI 10.1002/pros.20500; Taichman RS, 2002, CANCER RES, V62, P1832; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; VANDERCAPPELLEN J, 2008, CANC LETT, V28, P226, DOI DOI 10.1007/S00277-003-0679-0; Vishnu P, 2010, ONCOTARGETS THER, V3, P39; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Zeng Z, 2006, MOL CANCER THER, V5, P3113, DOI 10.1158/1535-7163.MCT-06-0228; Zheng DQ, 1999, CANCER RES, V59, P1655; Zhu SK, 2008, CIRCULATION, V118, P2156, DOI 10.1161/CIRCULATIONAHA.108.787200; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350	44	95	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31226	10.1371/journal.pone.0031226	http://dx.doi.org/10.1371/journal.pone.0031226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359577	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200046
J	Gao, DY; Chen, JF; Chen, MS; Meyers, BC; Jackson, S				Gao, Dongying; Chen, Jinfeng; Chen, Mingsheng; Meyers, Blake C.; Jackson, Scott			A Highly Conserved, Small LTR Retrotransposon that Preferentially Targets Genes in Grass Genomes	PLOS ONE			English	Article							PLANT TRANSPOSABLE ELEMENTS; RICE ORYZA-SATIVA; EVOLUTIONARY DYNAMICS; DNA METHYLATION; REPEAT; FAMILY; RECOMBINATION; GENETICS; REGIONS; BARLEY	LTR retrotransposons are often the most abundant components of plant genomes and can impact gene and genome evolution. Most reported LTR retrotransposons are large elements (>4 kb) and are most often found in heterochromatic (gene poor) regions. We report the smallest LTR retrotransposon found to date, only 292 bp. The element is found in rice, maize, sorghum and other grass genomes, which indicates that it was present in the ancestor of grass species, at least 50-80 MYA. Estimated insertion times, comparisons between sequenced rice lines, and mRNA data indicate that this element may still be active in some genomes. Unlike other LTR retrotransposons, the small LTR retrotransposons (SMARTs) are distributed throughout the genomes and are often located within or near genes with insertion patterns similar to MITEs (miniature inverted repeat transposable elements). Our data suggests that insertions of SMARTs into or near genes can, in a few instances, alter both gene structures and gene expression. Further evidence for a role in regulating gene expression, SMART-specific small RNAs (sRNAs) were identified that may be involved in gene regulation. Thus, SMARTs may have played an important role in genome evolution and genic innovation and may provide a valuable tool for gene tagging systems in grass.	[Gao, Dongying; Jackson, Scott] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Gao, Dongying; Jackson, Scott] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Chen, Jinfeng; Chen, Mingsheng] Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China; [Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Delaware; University of Delaware	Gao, DY (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	sjackson@uga.edu	Meyers, Blake/B-6535-2012; Chen, Jinfeng/K-4024-2015; Chen, Jinfeng/ABE-4816-2020	Meyers, Blake/0000-0003-3436-6097; Chen, Jinfeng/0000-0002-5628-6322; jackson, scott/0000-0002-3172-1607	National Science Foundation DBI [0603927, 0424833, 30770143, 2010B0527]	National Science Foundation DBI(National Science Foundation (NSF))	This study was supported by grants from The National Science Foundation DBI 0603927 and 0424833 to SAJ and grants #30770143 and #2010B0527 to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2007, PLANT J, V52, P342, DOI 10.1111/j.1365-313X.2007.03242.x; Bai L, 2011, GENETICS, V187, P749, DOI 10.1534/genetics.110.124149; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Charles M, 2009, MOL BIOL EVOL, V26, P1651, DOI 10.1093/molbev/msp076; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Ehrlich S. D., 1989, MOBILE DNA-UK, P799; Fernandes J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r82; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gao DY, 2009, PLANT J, V60, P820, DOI 10.1111/j.1365-313X.2009.04005.x; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jiang N, 2002, GENETICS, V161, P1293; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kalendar R, 2008, P NATL ACAD SCI USA, V105, P5833, DOI 10.1073/pnas.0709698105; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Malik HS, 2001, GENOME RES, V11, P1187, DOI 10.1101/gr.185101; Marin I, 2000, MOL BIOL EVOL, V17, P1040, DOI 10.1093/oxfordjournals.molbev.a026385; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maxwell PH, 2006, NUCLEIC ACIDS RES, V34, P5498, DOI 10.1093/nar/gkl709; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Neumann P, 2003, PLANT MOL BIOL, V53, P399, DOI 10.1023/B:PLAN.0000006945.77043.ce; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pelissier T, 1996, GENETICA, V97, P141, DOI 10.1007/BF00054621; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Roulin A, 2008, PLANT J, V53, P950, DOI 10.1111/j.1365-313X.2007.03388.x; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shirasu K, 2000, GENOME RES, V10, P908, DOI 10.1101/gr.10.7.908; Soleimani VD, 2006, GENOME, V49, P389, DOI 10.1139/G05-119; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vitte C, 2003, MOL BIOL EVOL, V20, P528, DOI 10.1093/molbev/msg055; Vitte C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-218; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wendel JF, 2000, P NATL ACAD SCI USA, V97, P6250, DOI 10.1073/pnas.97.12.6250; Wessler SR, 2001, PLANT PHYSIOL, V125, P149, DOI 10.1104/pp.125.1.149; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yan HH, 2010, PLANT J, V63, P353, DOI 10.1111/j.1365-313X.2010.04246.x; Yang G, 2001, MOL GENET GENOMICS, V266, P417, DOI 10.1007/s004380100530; Ying SY, 2010, METHODS MOL BIOL, V629, P203, DOI 10.1007/978-1-60761-657-3_14; Zhang CH, 2008, PLANT CELL, V20, P995, DOI 10.1105/tpc.107.055350	71	40	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32010	10.1371/journal.pone.0032010	http://dx.doi.org/10.1371/journal.pone.0032010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359654	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200123
J	Hu, XH; Kuhn, JR				Hu, Xiaohua; Kuhn, Jeffrey R.			Actin Filament Attachments for Sustained Motility In Vitro Are Maintained by Filament Bundling	PLOS ONE			English	Article							GROWTH-FACTOR INCREASES; ARP2/3 COMPLEX; F-ACTIN; CAPPING PROTEIN; N-WASP; INTRACELLULAR MAGNESIUM; DENDRITIC ORGANIZATION; NETWORK FORMATION; FORCE GENERATION; BINDING-SITES	We reconstructed cellular motility in vitro from individual proteins to investigate how actin filaments are organized at the leading edge. Using total internal reflection fluorescence microscopy of actin filaments, we tested how profilin, Arp2/3, and capping protein (CP) function together to propel thin glass nanofibers or beads coated with N-WASP WCA domains. Thin nanofibers produced wide comet tails that showed more structural variation in actin filament organization than did bead substrates. During sustained motility, physiological concentrations of Mg2+ generated actin filament bundles that processively attached to the nanofiber. Reduction of total Mg2+ abolished particle motility and actin attachment to the particle surface without affecting actin polymerization, Arp2/3 nucleation, or filament capping. Analysis of similar motility of microspheres showed that loss of filament bundling did not affect actin shell formation or symmetry breaking but eliminated sustained attachments between the comet tail and the particle surface. Addition of Mg2+, Lys-Lys(2+), or fascin restored both comet tail attachment and sustained particle motility in low Mg2+ buffers. TIRF microscopic analysis of filaments captured by WCA-coated beads in the absence of Arp2/3, profilin, and CP showed that filament bundling by polycation or fascin addition increased barbed end capture by WCA domains. We propose a model in which CP directs barbed ends toward the leading edge and polycation-induced filament bundling sustains processive barbed end attachment to the leading edge.	[Hu, Xiaohua; Kuhn, Jeffrey R.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hu, XH (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jrkuhn@vt.edu			Burroughs Wellcome Fund [1003964]; Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust [J-991]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust	This work was supported by an Interfaces in Science Career Award from the Burroughs Wellcome Fund (Award 1003964) and a Research Grant (Award J-991) from the Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Bernardini D, 2005, FRONT BIOSCI-LANDMRK, V10, P1177, DOI 10.2741/1610; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; BONDER EM, 1983, CELL, V34, P491, DOI 10.1016/0092-8674(83)90382-3; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DABIRI GA, 1990, P NATL ACAD SCI USA, V87, P6068, DOI 10.1073/pnas.87.16.6068; Dayel MJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000201; DELATOUR V, 2008, BIOPHYS J; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Dickinson RB, 2008, CELL MOL BIOENG, V1, P110, DOI 10.1007/s12195-008-0027-5; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Footer MJ, 2008, J BIOL CHEM, V283, P23852, DOI 10.1074/jbc.M803448200; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644; Gunther T, 2006, MAGNESIUM RES, V19, P225; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Higley S, 1997, CURR OPIN CELL BIOL, V9, P62, DOI 10.1016/S0955-0674(97)80153-6; Hong BZ, 2006, BIOCHEM BIOPH RES CO, V347, P496, DOI 10.1016/j.bbrc.2006.06.125; Hong BZ, 2009, MOL CELLS, V28, P13, DOI 10.1007/s10059-009-0103-2; Hosek M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051907; Ideses Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003297; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kohler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002736; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lapidos Karen A., 2001, Angiogenesis, V4, P21, DOI 10.1023/A:1016619414817; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; MATSUNO K, 1993, THROMB RES, V69, P131, DOI 10.1016/0049-3848(93)90010-L; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Misra A, 2007, BIOCHEM BIOPH RES CO, V364, P908, DOI 10.1016/j.bbrc.2007.10.086; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mullins RD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003392; Nuccitelli R, 1994, PRACTICAL GUIDE STUD; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; Ono S, 1997, J BIOL CHEM, V272, P2527; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paluch E, 2006, BIOPHYS J, V91, P3113, DOI 10.1529/biophysj.106.088054; Pasic L, 2008, J BIOL CHEM, V283, P9814, DOI 10.1074/jbc.M710475200; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Popp D, 2007, J MOL BIOL, V368, P365, DOI 10.1016/j.jmb.2007.01.087; Popp D, 2006, BIOCHEM BIOPH RES CO, V351, P348, DOI 10.1016/j.bbrc.2006.10.041; Rebowski G, 2010, J MOL BIOL, V403, P11, DOI 10.1016/j.jmb.2010.08.040; Reymann AC, 2010, NAT MATER, V9, P827, DOI 10.1038/nmat2855; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rubin H, 2007, ARCH BIOCHEM BIOPHYS, V458, P16, DOI 10.1016/j.abb.2006.03.026; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schwartz IM, 2004, CURR BIOL, V14, P1094, DOI 10.1016/j.cub.2004.06.023; Sengupta K, 2006, BIOPHYS J, V91, P4638, DOI [10.1529/biophysj.105.080382, 10.1529/biophysj.106.080382]; Soo FS, 2005, P NATL ACAD SCI USA, V102, P16233, DOI 10.1073/pnas.0507022102; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suzuki A, 1996, BIOCHEMISTRY-US, V35, P5238, DOI 10.1021/bi952693f; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Takaya J, 1998, EXP MOL PATHOL, V65, P104, DOI 10.1006/exmp.1998.2232; TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148	103	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31385	10.1371/journal.pone.0031385	http://dx.doi.org/10.1371/journal.pone.0031385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359589	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200058
J	Parczewski, M; Leszczyszyn-Pynka, M; Bander, D; Urbanska, A; Boron-Kaczmarska, A				Parczewski, Milosz; Leszczyszyn-Pynka, Magdalena; Bander, Dorota; Urbanska, Anna; Boron-Kaczmarska, Anna			HIV-1 Subtype D Infections among Caucasians from Northwestern Poland-Phylogenetic and Clinical Analysis	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; DISEASE PROGRESSION; RECOMBINANT STRAINS; HIGH PREVALENCE; VIRAL SUBTYPE; TYPE-1; TRANSMISSION; EPIDEMIC; MUTATIONS; INDIVIDUALS	Background: HIV-1 subtype D infections, which are associated with a faster rate of progression and lymphocyte CD4 decline, cognitive deficit and higher mortality, have rarely been found in native Europeans. In Northwestern Poland, however, infections with this subtype had been identified. This study aimed to analyze the sequence and clinical data for patients with subtype D using molecular phylogeography and identify transmission clusters and ancestry, as well as drug resistance, baseline HIV tropism and antiretroviral treatment efficacy. Methods: Phylogenetic analyses of local HIV-1 subtype D sequences were performed, with time to the most recent common ancestor inferred using Bayesian modeling. Sequence and drug resistance data were linked with the clinical and epidemiological information. Results: Subtype D was found in 24 non-immigrant Caucasian, heterosexually infected patients (75% of females, median age at diagnosis of 49.5 years; IQR: 29-56 years). Partial pol sequences clustered monophyletically with the clades of Ugandan origin and no evidence of transmission from other European countries was found. Time to the most common recent ancestor was 1989.24 (95% HPD: 1968.83-1994.46). Baseline drug resistance to nucleoside reverse transcriptase inhibitors was observed in 54.5% of cases (mutations: M41L, K103N, T215S/D) with evidence of clustering, no baseline integrase or protease resistance and infrequent non-R5 tropism (13.6%). Virologic failure was observed in 60% of cases and was associated with poor adherence (p<0.001) and subsequent development of drug resistance (p = 0.008, OR: 20 (95%CI: 1.7-290). Conclusions: Local subtype D represented an independently transmitted network with probably single index case, high frequency of primary drug resistance and evidence of transmission clusters.	[Parczewski, Milosz; Leszczyszyn-Pynka, Magdalena; Bander, Dorota; Urbanska, Anna; Boron-Kaczmarska, Anna] Pomeranian Med Univ, Dept Infect Dis & Hepatol, Szczecin, Poland	Pomeranian Medical University	Parczewski, M (corresponding author), Pomeranian Med Univ, Dept Infect Dis & Hepatol, Szczecin, Poland.	mparczewski@yahoo.co.uk	Parczewski, Milosz/I-1869-2014; Parczewski, Milosz/AAV-4280-2021	Parczewski, Milosz/0000-0003-1869-1084; Parczewski, Milosz/0000-0003-1869-1084; Bander, Dorota/0000-0002-1717-6198	Polish Ministry of Science IUVENTUS PLUS [IP2010 030570]	Polish Ministry of Science IUVENTUS PLUS	The study was supported by the project of the Polish Ministry of Science IUVENTUS PLUS IP2010 030570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audelin AM, 2011, AIDS RES HUM RETROV, V27, P1284, DOI 10.1089/aid.2010.0368; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bander Dorota, 2009, Przegl Epidemiol, V63, P61; Barlow KL, 2001, AIDS RES HUM RETROV, V17, P467, DOI 10.1089/088922201750102607; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bousheri S, 2009, JAIDS-J ACQ IMM DEF, V52, P548, DOI 10.1097/QAI.0b013e3181c1d456; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Buonaguro Luigi, 2008, Infect Agent Cancer, V3, P13, DOI 10.1186/1750-9378-3-13; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; de Felipe B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-416; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Frange P, 2010, J CLIN MICROBIOL, V48, P3487, DOI 10.1128/JCM.00704-10; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrigan PR DW, 2002, 14 INT AIDS C SPAIN; Holguin A, 2002, AIDS RES HUM RETROV, V18, P523, DOI 10.1089/088922202317406682; Holguin A, 2002, AIDS, V16, P1163, DOI 10.1097/00002030-200205240-00010; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Lai A, 2012, AIDS RES HUM RETROV, V28, P857, DOI [10.1089/aid.2011.0245, 10.1089/AID.2011.0245]; Lamers SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016659; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lutalo T, 2007, AIDS, V21, pS15, DOI 10.1097/01.aids.0000299406.44775.de; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Parczewski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022215; Parczewski M, 2010, J MED VIROL, V82, P1306, DOI 10.1002/jmv.21797; PATRASCU IV, 1993, AIDS RES HUM RETROV, V9, P99, DOI 10.1089/aid.1993.9.99; Raymond S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-56; Reekie J, 2010, HIV MED, V11, P469, DOI 10.1111/j.1468-1293.2009.00816.x; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Skoura L, 2011, J ANTIMICROB CHEMOTH, V66, P2831, DOI 10.1093/jac/dkr386; Stanczak GP, 2010, J MED VIROL, V82, P1291, DOI 10.1002/jmv.21782; Stanczak Grzegorz Piotr, 2007, Przegl Epidemiol, V61, P29; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2001, CLIN INFECT DIS, V32, P1732, DOI 10.1086/320764; Vachot L, 2004, AIDS RES HUM RETROV, V20, P687, DOI 10.1089/0889222041524607; Van Laethem K, 2008, J VIROL METHODS, V153, P176, DOI 10.1016/j.jviromet.2008.07.008; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Werbinska-Sienkiewicz Beata, 2011, Przegl Epidemiol, V65, P289; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Zetterberg V, 2004, AIDS RES HUM RETROV, V20, P1148, DOI 10.1089/aid.2004.20.1148	64	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31674	10.1371/journal.pone.0031674	http://dx.doi.org/10.1371/journal.pone.0031674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359615	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200084
J	Quinzii, CM; Tadesse, S; Naini, A; Hirano, M				Quinzii, Catarina M.; Tadesse, Saba; Naini, Ali; Hirano, Michio			Effects of Inhibiting CoQ(10) Biosynthesis with 4-nitrobenzoate in Human Fibroblasts	PLOS ONE			English	Article							COENZYME-Q BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GENE ENCODES; DEFICIENCY; UBIQUINONE; Q(10); MUTANT; NEPHROPATHY; RESPIRATION	Coenzyme Q(10) (CoQ(10)) is a potent lipophilic antioxidant in cell membranes and a carrier of electrons in the mitochondrial respiratory chain. We previously characterized the effects of varying severities of CoQ(10) deficiency on ROS production and mitochondrial bioenergetics in cells harboring genetic defects of CoQ(10) biosynthesis. We observed a unimodal distribution of ROS production with CoQ(10) deficiency: cells with <20% of CoQ(10) and 50-70% of CoQ(10) did not generate excess ROS while cells with 30-45% of CoQ(10) showed increased ROS production and lipid peroxidation. Because our previous studies were limited to a small number of mutant cell lines with heterogeneous molecular defects, here, we treated 5 control and 2 mildly CoQ(10) deficient fibroblasts with varying doses of 4-nitrobenzoate (4-NB), an analog of 4-hydroxybenzoate (4-HB) and inhibitor of 4-para-hydroxybenzoate: polyprenyl transferase (COQ2) to induce a range of CoQ(10) deficiencies. Our results support the concept that the degree of CoQ(10) deficiency in cells dictates the extent of ATP synthesis defects and ROS production and that 40-50% residual CoQ(10) produces maximal oxidative stress and cell death.	[Quinzii, Catarina M.; Tadesse, Saba; Naini, Ali; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA; [Naini, Ali] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University	Quinzii, CM (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.	mh29@columbia.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development [K23 HD065871, 1R01 HD057543]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057543, K23HD065871] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by K23 HD065871 (CMQ) and 1R01 HD057543 (MH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Busso C, 2010, FEBS LETT, V584, P1609, DOI 10.1016/j.febslet.2010.03.024; Cotan D, 2011, FASEB J IN PRESS; Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Earls LR, 2010, P NATL ACAD SCI USA, V107, P14460, DOI 10.1073/pnas.0910630107; Emmanuele V, 2011, CLIN GENETIC H UNPUB; Falk MJ, 2011, EMBO MOL MED, V3, P410, DOI 10.1002/emmm.201100149; Forsman U, 2010, NAT CHEM BIOL, V6, P515, DOI [10.1038/NCHEMBIO.372, 10.1038/nchembio.372]; Geromel V, 2001, FREE RADICAL RES, V35, P11, DOI 10.1080/10715760100300551; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Gonzalez-Aragon D, 2005, BIOFACTORS, V25, P31, DOI 10.1002/biof.5520250105; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Miki R, 2008, FEBS J, V275, P5309, DOI 10.1111/j.1742-4658.2008.06661.x; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Nakai D, 2004, AGING CELL, V3, P273, DOI 10.1111/j.1474-9728.2004.00116.x; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Peng M, 2004, KIDNEY INT, V66, P20, DOI 10.1111/j.1523-1755.2004.00702.x; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728; Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108; Rahman S, 2011, NEUROMUSCUL IN PRESS; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rodriguez-Aguilera JC, 2005, AGEING RES REV, V4, P41, DOI 10.1016/j.arr.2004.09.001; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009	43	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30606	10.1371/journal.pone.0030606	http://dx.doi.org/10.1371/journal.pone.0030606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359546	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200015
J	Sajic, M; Hunt, DPJ; Lee, W; Compston, DAS; Schweimer, JV; Gregson, NA; Chandran, S; Smith, KJ				Sajic, Marija; Hunt, David P. J.; Lee, Woojin; Compston, D. Alastair S.; Schweimer, Judith V.; Gregson, Norman A.; Chandran, Siddharthan; Smith, Kenneth J.			Mesenchymal Stem Cells Lack Efficacy in the Treatment of Experimental Autoimmune Neuritis despite In Vitro Inhibition of T-Cell Proliferation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; STROMAL CELLS; BONE-MARROW; ENCEPHALOMYELITIS; TRANSPLANTATION; DISEASES	Mesenchymal stem cells have been demonstrated to ameliorate experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, prompting clinical trials in multiple sclerosis which are currently ongoing. An important question is whether this therapeutic effect generalises to other autoimmune neurological diseases. We performed two trials of efficacy of MSCs in experimental autoimmune neuritis (EAN) in Lewis (LEW/Han (M)Hsd) rats, a model of human autoimmune inflammatory neuropathies. No differences between the groups were found in clinical, histological or electrophysiological outcome measures. This was despite the ability of mesenchymal stem cells to inhibit proliferation of CD4+ T-cells in vitro. Therefore the efficacy of MSCs observed in autoimmune CNS demyelination models do not necessarily generalise to the treatment of other forms of neurological autoimmunity.	[Sajic, Marija; Hunt, David P. J.; Lee, Woojin; Gregson, Norman A.; Smith, Kenneth J.] UCL, Inst Neurol, Dept Neuroinflammat, London, England; [Hunt, David P. J.; Compston, D. Alastair S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Schweimer, Judith V.] Kings Coll London, Dept Neuroimmunol, London WC2R 2LS, England; [Hunt, David P. J.; Chandran, Siddharthan] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	University of London; University College London; University of Cambridge; University of London; King's College London; University of Edinburgh	Sajic, M (corresponding author), UCL, Inst Neurol, Dept Neuroinflammat, London, England.	david.hunt@hgu.mrc.ac.uk	Schweimer, Judith/AAP-9802-2020; Schweimer, Judith/GWZ-7711-2022; Smith, Kenneth/I-9197-2014; Sajic, Marija/G-4035-2012	Schweimer, Judith/0000-0002-5968-3534; Smith, Kenneth/0000-0003-4408-7809; Sajic, Marija/0000-0002-4050-7477	Brain entrance scholarship; Wellcome Trust; Medical Research Council, United Kingdom; Multiple Sclerosis Society of Great Britian & Northern Ireland; European Union; Brain Research Trust; National Institute for Health Research Biomedical Research; MRC [G0800954] Funding Source: UKRI; Medical Research Council [G0800954] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish	Brain entrance scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Multiple Sclerosis Society of Great Britian & Northern Ireland; European Union(European Commission); Brain Research Trust; National Institute for Health Research Biomedical Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	DH is funded by a Brain entrance scholarship (Guarantors of Brain) and by the Wellcome Trust. KJS is funded by the Medical Research Council, United Kingdom, the Multiple Sclerosis Society of Great Britian & Northern Ireland, the European Union (FP6 NeuroproMiSe) and the Brain Research Trust. SC is supported by the National Institute for Health Research Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechtold DA, 2005, BRAIN, V128, P18, DOI 10.1093/brain/awh328; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Freedman MS, 2010, MULT SCLER J, V16, P503, DOI 10.1177/1352458509359727; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Hadden RDM, 2002, NEUROPATH APPL NEURO, V28, P489, DOI 10.1046/j.1365-2990.2002.00421.x; Hughes RAC, 2006, J PERIPHER NERV SYST, V11, P30, DOI 10.1111/j.1085-9489.2006.00061.x; Hunt DPJ, 2008, CELL TRANSPLANT, V17, P865, DOI 10.3727/096368908786516738; Hunt DP, 2010, STEM CELLS DEV, V19, P1055, DOI 10.1089/scd.2009.0371; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Maurer M, 2002, NEUROMUSCULAR DISORD, V12, P405, DOI 10.1016/S0960-8966(01)00302-9; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Sajic M, 2011, MULT SCLER      0930; Tyndall A, 2009, BONE MARROW TRANSPL, V43, P821, DOI 10.1038/bmt.2009.63; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2008, AUTOIMMUNITY, V41, P592, DOI 10.1080/08916930802200166; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	21	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30708	10.1371/journal.pone.0030708	http://dx.doi.org/10.1371/journal.pone.0030708			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359549	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200018
J	Schnell, R; Oehlmann, W; Sandalova, T; Braun, Y; Huck, C; Maringer, M; Singh, M; Schneider, G				Schnell, Robert; Oehlmann, Wulf; Sandalova, Tatyana; Braun, Yvonne; Huck, Carmen; Maringer, Marko; Singh, Mahavir; Schneider, Gunter			Tetrahydrodipicolinate N-Succinyltransferase and Dihydrodipicolinate Synthase from Pseudomonas aeruginosa: Structure Analysis and Gene Deletion	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACTIVE-SITE; MYCOBACTERIUM-TUBERCULOSIS; 3-DIMENSIONAL STRUCTURE; LYSINE BIOSYNTHESIS; RESOLUTION; CRYSTALLOGRAPHY; REPLACEMENT; SPECIFICITY	The diaminopimelic acid pathway of lysine biosynthesis has been suggested to provide attractive targets for the development of novel antibacterial drugs. Here we report the characterization of two enzymes from this pathway in the human pathogen Pseudomonas aeruginosa, utilizing structural biology, biochemistry and genetics. We show that tetrahydrodipicolinate N-succinyltransferase (DapD) from P. aeruginosa is specific for the L-stereoisomer of the amino substrate L-2-aminopimelate, and its D-enantiomer acts as a weak inhibitor. The crystal structures of this enzyme with L-2-aminopimelate and D-2-aminopimelate, respectively, reveal that both compounds bind at the same site of the enzyme. Comparison of the binding interactions of these ligands in the enzyme active site suggests misalignment of the amino group of D-2-aminopimelate for nucleophilic attack on the succinate moiety of the co-substrate succinyl-CoA as the structural basis of specificity and inhibition. P. aeruginosa mutants where the dapA gene had been deleted were viable and able to grow in a mouse lung infection model, suggesting that DapA is not an optimal target for drug development against this organism. Structure-based sequence alignments, based on the DapA crystal structure determined to 1.6 angstrom resolution revealed the presence of two homologues, PA0223 and PA4188, in P. aeruginosa that could substitute for DapA in the P. aeruginosa PAO1 Delta dapA mutant. In vitro experiments using recombinant PA0223 protein could however not detect any DapA activity.	[Schnell, Robert; Sandalova, Tatyana; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Oehlmann, Wulf; Braun, Yvonne; Singh, Mahavir] LIONEX Diagnost & Therapeut, Braunschweig, Germany; [Huck, Carmen; Maringer, Marko] Mfd Diagnost GmbH, Wendelsheim, Germany	Karolinska Institutet; Lionex Diagnostics & Therapeutics GmbH	Schnell, R (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	info@lionex.de; gunter.schneider@ki.se		Schneider, Gunter/0000-0003-0622-5713; Sandalova, Tatyana/0000-0002-7694-6420; SCHNELL, ROBERT/0000-0001-7530-3629	European Commission [223461]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the Seventh Framework Program of the European Commission (FP7/2007-2013) under grant agreement no 223461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; Beaman TW, 2002, PROTEIN SCI, V11, P974, DOI 10.1110/ps.4310102; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P10363, DOI 10.1021/bi980759b; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BERGES DA, 1986, J BIOL CHEM, V261, P6160; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; da Costa TPS, 2010, BIOCHIMIE, V92, P837, DOI 10.1016/j.biochi.2010.03.004; Devenish SRA, 2009, BBA-PROTEINS PROTEOM, V1794, P1168, DOI 10.1016/j.bbapap.2009.02.003; Dobson RCJ, 2005, BIOCHEMISTRY-US, V44, P13007, DOI 10.1021/bi051281w; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2009, BIOCHIMIE, V91, P1036, DOI 10.1016/j.biochi.2009.05.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel C, 1996, CURR OPIN STRUC BIOL, V6, P790, DOI 10.1016/S0959-440X(96)80009-1; Evans G, 2011, ARCH BIOCHEM BIOPHYS, V512, P154, DOI 10.1016/j.abb.2011.05.014; Girish TS, 2008, FEBS LETT, V582, P2923, DOI 10.1016/j.febslet.2008.07.035; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kaur N, 2011, INT J BIOL MACROMOL, V48, P779, DOI 10.1016/j.ijbiomac.2011.03.002; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; MIRWALDT C, 1995, J MOL BIOL, V246, P227, DOI 10.1006/jmbi.1994.0078; Mooij WTM, 2009, STRUCTURE, V17, P183, DOI 10.1016/j.str.2008.12.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen L, 2008, FEBS LETT, V582, P623, DOI 10.1016/j.febslet.2008.01.032; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; Schuldt L, 2009, J MOL BIOL, V389, P863, DOI 10.1016/j.jmb.2009.04.046; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zavascki AP, 2010, EXPERT REV ANTI-INFE, V8, P71, DOI 10.1586/ERI.09.108	44	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31133	10.1371/journal.pone.0031133	http://dx.doi.org/10.1371/journal.pone.0031133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359568	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200037
J	Andersson, GKS; Rundlof, M; Smith, HG				Andersson, Georg K. S.; Rundlof, Maj; Smith, Henrik G.			Organic Farming Improves Pollination Success in Strawberries	PLOS ONE			English	Article							PORTUGAL SELECTION; FLORAL VISITORS; DIVERSITY; BIODIVERSITY; INCREASES; ABUNDANCE; BEES; LANDSCAPES; BENEFITS; RIBATEJO	Pollination of insect pollinated crops has been found to be correlated to pollinator abundance and diversity. Since organic farming has the potential to mitigate negative effects of agricultural intensification on biodiversity, it may also benefit crop pollination, but direct evidence of this is scant. We evaluated the effect of organic farming on pollination of strawberry plants focusing on (1) if pollination success was higher on organic farms compared to conventional farms, and (2) if there was a time lag from conversion to organic farming until an effect was manifested. We found that pollination success and the proportion of fully pollinated berries were higher on organic compared to conventional farms and this difference was already evident 2-4 years after conversion to organic farming. Our results suggest that conversion to organic farming may rapidly increase pollination success and hence benefit the ecosystem service of crop pollination regarding both yield quantity and quality.	[Andersson, Georg K. S.; Smith, Henrik G.] Lund Univ, Ctr Environm & Climate Res, Lund, Sweden; [Andersson, Georg K. S.; Rundlof, Maj; Smith, Henrik G.] Lund Univ, Dept Biol, Lund, Sweden; [Rundlof, Maj] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Lund University; Lund University; Swedish University of Agricultural Sciences	Andersson, GKS (corresponding author), Lund Univ, Ctr Environm & Climate Res, Lund, Sweden.	georg.andersson@biol.lu.se	Andersson, Georg/AAD-5985-2021; Rundlöf, Maj/AAB-7401-2022	Andersson, Georg/0000-0002-9669-6895; Rundlöf, Maj/0000-0003-3014-1544	Swedish Reseasrch Council FORMAS [1680]	Swedish Reseasrch Council FORMAS	This work was supported by The Swedish Reseasrch Council FORMAS: http://www.formas.se/default_529.aspx; Grant number in 2009: 1680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano S., 2009, Advances in Horticultural Science, V23, P246; Albano S., 2009, Advances in Horticultural Science, V23, P238; Andersson G. K. S., 2010, Aspects of Applied Biology, P381; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Bissonette J. A., 2007, TEMPORAL DIMENSIONS; Brittain C, 2010, BIOL CONSERV, V143, P1860, DOI 10.1016/j.biocon.2010.04.029; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; Diekotter T, 2010, AGR ECOSYST ENVIRON, V137, P108, DOI 10.1016/j.agee.2010.01.008; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Ekroos J, 2010, AGR ECOSYST ENVIRON, V135, P288, DOI 10.1016/j.agee.2009.10.007; European Commission (EC), OFFICIAL J EUROPEAN; FAO, 2011, CROP PROD DAT 2008; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Fuller RJ, 2005, BIOL LETTERS, V1, P431, DOI 10.1098/rsbl.2005.0357; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Ghazoul J, 2010, FRONT ECOL ENVIRON, V8, P9, DOI 10.1890/10.WB.001; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Jonason D, 2011, J APPL ECOL, V48, P543, DOI 10.1111/j.1365-2664.2011.01989.x; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2009, FOREST ECOL MANAG, V258, P1838, DOI 10.1016/j.foreco.2009.05.005; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lopez-Medina J, 2006, ACTA HORTIC, P77, DOI 10.17660/ActaHortic.2006.708.8; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rundlof M, 2008, BIOL CONSERV, V141, P417, DOI 10.1016/j.biocon.2007.10.011; Rundlof M, 2006, J APPL ECOL, V43, P1121, DOI 10.1111/j.1365-2664.2006.01233.x; Rundlof M, 2010, ECOGRAPHY, V33, P514, DOI 10.1111/j.1600-0587.2009.05938.x; Smith HG, 2010, OECOLOGIA, V162, P1071, DOI 10.1007/s00442-010-1588-2; Stockdale EA, 2001, ADV AGRON, V70, P261, DOI 10.1016/S0065-2113(01)70007-7; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Vergara CH, 2009, AGR ECOSYST ENVIRON, V129, P117, DOI 10.1016/j.agee.2008.08.001; With K.A., 2007, TEMPORAL DIMENSIONS, P43	43	52	54	2	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31599	10.1371/journal.pone.0031599	http://dx.doi.org/10.1371/journal.pone.0031599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355380	Green Published, gold			2022-12-27	WOS:000302741300080
J	Flouris, AD; Metsios, GS; Carrill, AE; Jamurtas, AZ; Stivaktakis, PD; Tzatzarakis, MN; Tsatsakis, AM; Koutedakis, Y				Flouris, Andreas D.; Metsios, Giorgos S.; Carrill, Andres E.; Jamurtas, Athanasios Z.; Stivaktakis, Polychronis D.; Tzatzarakis, Manolis N.; Tsatsakis, Aristidis M.; Koutedakis, Yiannis			Respiratory and Immune Response to Maximal Physical Exertion following Exposure to Secondhand Smoke in Healthy Adults	PLOS ONE			English	Article							PASSIVE SMOKING; TOBACCO-SMOKE; CIGARETTE-SMOKING; CARBON-MONOXIDE; LUNG-FUNCTION; PREVALENCE; RISK; OCCUPATION; MARKERS	We assessed the cardiorespiratory and immune response to physical exertion following secondhand smoke (SHS) exposure through a randomized crossover experiment. Data were obtained from 16 (8 women) non-smoking adults during and following a maximal oxygen uptake cycling protocol administered at baseline and at 0-, 1-, and 3-hours following 1-hour of SHS set at bar/restaurant carbon monoxide levels. We found that SHS was associated with a 12% decrease in maximum power output, an 8.2% reduction in maximal oxygen consumption, a 6% increase in perceived exertion, and a 6.7% decrease in time to exhaustion (P<0.05). Moreover, at 0-hours almost all respiratory and immune variables measured were adversely affected (P<0.05). For instance, FEV1 values at 0-hours dropped by 17.4%, while TNF-alpha increased by 90.1% (P<0.05). At 3-hours mean values of cotinine, perceived exertion and recovery systolic blood pressure in both sexes, IL4, TNF-alpha and IFN-gamma in men, as well as FEV1/FVC, percent predicted FEV1, respiratory rate, and tidal volume in women remained different compared to baseline (P<0.05). It is concluded that a 1-hour of SHS at bar/restaurant levels adversely affects the cardiorespiratory and immune response to maximal physical exertion in healthy nonsmokers for at least three hours following SHS.	[Flouris, Andreas D.; Carrill, Andres E.; Koutedakis, Yiannis] Ctr Res & Technol, Inst Human Performance & Rehabil, FAME Lab, Thessaly, Greece; [Flouris, Andreas D.; Carrill, Andres E.] Biomnic Ltd, Dept Res & Technol Dev, Trikala, Greece; [Metsios, Giorgos S.; Koutedakis, Yiannis] Wolverhampton Univ, Sch Sports Performing Arts & Leisure, Wolverhampton WV1 1DJ, W Midlands, England; [Jamurtas, Athanasios Z.; Koutedakis, Yiannis] Univ Thessaly, Dept Exercise Sci, Trikala, Greece; [Stivaktakis, Polychronis D.; Tzatzarakis, Manolis N.; Tsatsakis, Aristidis M.] Univ Crete, Sch Med, Ctr Toxicol Sci & Res, Iraklion, Greece	University of Wolverhampton; University of Thessaly; University of Crete	Flouris, AD (corresponding author), Ctr Res & Technol, Inst Human Performance & Rehabil, FAME Lab, Thessaly, Greece.	andreasflouris@gmail.com	KOURETAS, DEMETRIOS/ABE-8519-2020; Flouris, Andreas/GXG-4893-2022; Jamurtas, Athanasios/Y-4568-2019; Tsatsakis, Aristidis M./H-2890-2013; Flouris, Andreas/I-5930-2014	KOURETAS, DEMETRIOS/0000-0002-7469-6640; Tsatsakis, Aristidis M./0000-0003-3824-2462; Koutedakis, Yiannis/0000-0002-7065-9447; Flouris, Andreas/0000-0002-9823-3915; Stivaktakis, Polychronis/0000-0001-6004-2948; Jamurtas, Thanasis/0000-0001-5115-9490; Carrillo, Andres/0000-0002-2293-079X				ANDERSON R, 1991, AM REV RESPIR DIS, V144, P570, DOI 10.1164/ajrccm/144.3_Pt_1.570; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bang KM, 2001, AM J IND MED, V40, P233, DOI 10.1002/ajim.1094; Baur X, 1999, INT ARCH OCC ENV HEA, V72, P69, DOI 10.1007/s004200050341; Benowitz NL, 1999, ENVIRON HEALTH PERSP, V107, P349, DOI 10.2307/3434427; Bettcher D. W., 2007, Morbidity and Mortality Weekly Report, V56, P497; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Centers for Disease Control and Prevention, 2006, HLTH CONS INV EXP TO; Chiu YH, 2010, ENVIRON HEALTH PERSP, V118, P216, DOI 10.1289/ehp.0900892; Corrado D, 2006, HERZ, V31, P553, DOI 10.1007/s00059-006-2885-8; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; Flouris AD, 2011, HEART, V97, P1626, DOI 10.1136/hrt.2009.190744corr1; Flouris AD, 2006, INT J SPORTS MED, V27, P137, DOI 10.1055/s-2005-837660; Flouris AD, 2005, CAN J APPL PHYSIOL, V30, pS28; Flouris AD, 2008, AM J PHYSIOL-ENDOC M, V294, pE456, DOI 10.1152/ajpendo.00699.2007; Flouris AD, 2007, ARCH DIS CHILD, V92, P521, DOI 10.1136/adc.2006.099796; Flouris AD, 2010, HEART, V96, P860, DOI 10.1136/hrt.2009.190744; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; Goniewicz Maciej Lukasz, 2009, Central European Journal of Public Health, V17, P220; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Jo WK, 2004, ENVIRON RES, V94, P309, DOI 10.1016/S0013-9351(03)00135-X; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Lee DJ, 2007, J OCCUP ENVIRON MED, V49, P75, DOI 10.1097/JOM.0b013e31802ec68c; LEONE A, 1991, INT J CARDIOL, V33, P247, DOI 10.1016/0167-5273(91)90354-R; Mahmud A, 2004, BRIT J CLIN PHARMACO, V57, P37, DOI 10.1046/j.1365-2125.2003.01958.x; Massarelli N., 2010, EUROPEAN UNION LABOU; McArdle WD., 2001, EXERCISE PHYSL ENERG; Metsios GS, 2007, J CLIN ENDOCR METAB, V92, P208, DOI 10.1210/jc.2006-0762; NELSON DE, 1994, J OCCUP ENVIRON MED, V36, P516; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Panagiotakos DB, 2004, AM J MED, V116, P145, DOI 10.1016/j.amjmed.2003.07.019; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; Sidorkewicz N, 2006, MED SCI SPORT EXER, V38, pS457, DOI 10.1249/00005768-200605001-02795; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO, P12; URCH RB, 1988, ENVIRON RES, V47, P34, DOI 10.1016/S0013-9351(88)80019-7; Wortley PM, 2002, J OCCUP ENVIRON MED, V44, P503, DOI 10.1097/00043764-200206000-00010	37	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31880	10.1371/journal.pone.0031880	http://dx.doi.org/10.1371/journal.pone.0031880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355401	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300101
J	Prince, LR; Graham, KJ; Connolly, J; Anwar, S; Ridley, R; Sabroe, I; Foster, SJ; Whyte, MKB				Prince, Lynne R.; Graham, Kirstie J.; Connolly, John; Anwar, Sadia; Ridley, Robert; Sabroe, Ian; Foster, Simon J.; Whyte, Moira K. B.			Staphylococcus aureus Induces Eosinophil Cell Death Mediated by alpha-hemolysin	PLOS ONE			English	Article							ATOPIC-DERMATITIS; CATIONIC PROTEIN; BETA-BARREL; TOXIN; APOPTOSIS; VIRULENCE; SKIN; INFECTION; DISEASE; NECROSIS	Staphylococcus aureus, a major human pathogen, exacerbates allergic disorders, including atopic dermatitis, nasal polyps and asthma, which are characterized by tissue eosinophilia. Eosinophils, via their destructive granule contents, can cause significant tissue damage, resulting in inflammation and further recruitment of inflammatory cells. We hypothesised that the relationship between S. aureus and eosinophils may contribute to disease pathology. We found that supernatants from S. aureus (SH1000 strain) cultures cause rapid and profound eosinophil necrosis, resulting in dramatic cell loss within 2 hours. This is in marked contrast to neutrophil granulocytes where no significant cell death was observed (at equivalent dilutions). Supernatants prepared from a strain deficient in the accessory gene regulator (agr) that produces reduced levels of many important virulence factors, including the abundantly produced alpha-hemolysin (Hla), failed to induce eosinophil death. The role of Hla in mediating eosinophil death was investigated using both an Hla deficient SH1000-modified strain, which did not induce eosinophil death, and purified Hla, which induced concentration-dependent eosinophil death via both apoptosis and necrosis. We conclude that S. aureus Hla induces aberrant eosinophil cell death in vitro and that this may increase tissue injury in allergic disease.	[Prince, Lynne R.; Graham, Kirstie J.; Anwar, Sadia; Ridley, Robert; Sabroe, Ian; Whyte, Moira K. B.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Connolly, John; Foster, Simon J.] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Prince, LR (corresponding author), Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England.	l.r.prince@sheffield.ac.uk	Sabroe, Ian/I-5981-2013; Sabroe, Ian/AAE-5858-2019	Sabroe, Ian/0000-0001-9750-8975; Prince, Lynne/0000-0001-6133-9372; Connolly, John/0000-0002-9232-7929	University of Sheffield; MRC [R/111251, G116/170]; Sheffield Cardiovascular Biomedical Research Unit; Medical Research Council [G116/170, G0501658] Funding Source: researchfish; MRC [G116/170, G0501658] Funding Source: UKRI	University of Sheffield; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sheffield Cardiovascular Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Russell Fellowship of University of Sheffield to LP, an MRC Clinical Fellowship to SA (Ref R/111251) and an MRC Senior Clinical Fellowship to IS (G116/170). www.mrc.ac.uk.IS is also supported by the Sheffield Cardiovascular Biomedical Research Unit. (http://www.shef.ac.uk/medicine/nihrbrus/cardiovascular-bru.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBUTHNOTT J P, 1970, P189; Bachert C, 2007, Chem Immunol Allergy, V93, P214, DOI 10.1159/000100897; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; Breuer K, 2005, CLIN EXP ALLERGY, V35, P1088, DOI 10.1111/j.1365-2222.2005.02295.x; Cooper EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-266; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; CZECH W, 1992, BRIT J DERMATOL, V126, P351, DOI 10.1111/j.1365-2133.1992.tb00677.x; da Silva MCA, 2004, AM J PHYSIOL-LUNG C, V287, pL543, DOI 10.1152/ajplung.00256.2003; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Dockrell DH, 2006, J LEUKOCYTE BIOL, V79, P904, DOI 10.1189/jlb.1005555; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; FADOK VA, 1992, J IMMUNOL, V148, P2207; FLAVAHAN NA, 1988, AM REV RESPIR DIS, V138, P685, DOI 10.1164/ajrccm/138.3.685; Gibson PG, 2003, THORAX, V58, P116, DOI 10.1136/thorax.58.2.116; Guzik TJ, 2005, CLIN EXP ALLERGY, V35, P448, DOI 10.1111/j.1365-2222.2005.02210.x; HASLETT C, 1985, AM J PATHOL, V119, P101; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; HENDERSON WR, 1980, J EXP MED, V152, P265, DOI 10.1084/jem.152.2.265; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huvenne W, 2010, CLIN EXP ALLERGY; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; KAGI MK, 1992, DERMATOLOGY, V185, P88, DOI 10.1159/000247419; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; LEUNG DYM, 1993, J CLIN INVEST, V92, P1374, DOI 10.1172/JCI116711; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Lim KG, 1996, J IMMUNOL, V156, P2566; McElroy MC, 1999, INFECT IMMUN, V67, P5541, DOI 10.1128/IAI.67.10.5541-5544.1999; Menestrina G, 2001, TOXICON, V39, P1661, DOI 10.1016/S0041-0101(01)00153-2; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Min DY, 2004, INT ARCH ALLERGY IMM, V133, P357, DOI 10.1159/000077355; Niimi A, 1998, CLIN EXP ALLERGY, V28, P233; NILSSON EJ, 1992, J AM ACAD DERMATOL, V27, P29, DOI 10.1016/0190-9622(92)70151-5; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; RING J, 1992, ALLERGY, V47, P265, DOI 10.1111/j.1398-9995.1992.tb02051.x; Sabroe I, 1999, J IMMUNOL, V162, P2946; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Serradell MC, 2007, VET IMMUNOL IMMUNOP, V117, P197, DOI 10.1016/j.vetimm.2007.03.007; Shin Myeong-Heon, 2000, Korean Journal of Parasitology, V38, P17, DOI 10.3347/kjp.2000.38.1.17; STERN M, 1992, J IMMUNOL, V148, P3543; Torrent M, 2009, BIOCH J; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Valeva A, 1997, P NATL ACAD SCI USA, V94, P11607, DOI 10.1073/pnas.94.21.11607; Walsh GM, 1998, J IMMUNOL METHODS, V217, P153, DOI 10.1016/S0022-1759(98)00103-3; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wichmann K, 2009, BRIT J DERMATOL, V161, P300, DOI 10.1111/j.1365-2133.2009.09229.x; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zhang N, 2005, RHINOLOGY, V43, P162	59	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31506	10.1371/journal.pone.0031506	http://dx.doi.org/10.1371/journal.pone.0031506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355374	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300074
J	Baucum, AJ; Strack, S; Colbran, RJ				Baucum, Anthony J., II; Strack, Stefan; Colbran, Roger J.			Age-Dependent Targeting of Protein Phosphatase 1 to Ca2+/Calmodulin-Dependent Protein Kinase II by Spinophilin in Mouse Striatum	PLOS ONE			English	Article							POSTSYNAPTIC DENSITY PROTEIN; DENDRITIC SPINE MORPHOLOGY; LONG-TERM POTENTIATION; F-ACTIN; SUBCELLULAR-LOCALIZATION; BINDING-PROTEIN; RAT-BRAIN; CAMKII; PHOSPHORYLATION; NEURABIN	Mechanisms underlying age-dependent changes of dendritic spines on striatal medium spiny neurons are poorly understood. Spinophilin is an F-actin- and protein phosphatase 1 (PP1)-binding protein that targets PP1 to multiple downstream effectors to modulate dendritic spine morphology and function. We found that calcium/calmodulin-dependent protein kinase II (CaMKII) directly and indirectly associates with N- and C-terminal domains of spinophilin, but F-actin can displace CaMKII from the N-terminal domain. Spinophilin co-localizes PP1 with CaMKII on the F-actin cytoskeleton in heterologous cells, and spinophilin co-localizes with synaptic CaMKII in neuronal cultures. Thr286 autophosphorylation enhances the binding of CaMKII to spinophilin in vitro and in vivo. Although there is no change in total levels of Thr286 autophosphorylation, maturation from postnatal day 21 into adulthood robustly enhances the levels of CaMKII that co-immunoprecipitate with spinophilin from mouse striatal extracts. Moreover, N- and C-terminal domain fragments of spinophilin bind more CaMKII from adult vs. postnatal day 21 striatal lysates. Total levels of other proteins that interact with C-terminal domains of spinophilin decrease during maturation, perhaps reducing competition for CaMKII binding to the C-terminal domain. In contrast, total levels of alpha-internexin and binding of alpha-internexin to the spinophilin N-terminal domain increases with maturation, perhaps bridging an indirect interaction with CaMKII. Moreover, there is an increase in the levels of myosin Va, alpha-internexin, spinophilin, and PP1 in striatal CaMKII immune complexes isolated from adult and aged mice compared to those from postnatal day 21. These changes in spinophilin/CaMKII interactomes may contribute to changes in striatal dendritic spine density, morphology, and function during normal postnatal maturation and aging.	[Baucum, Anthony J., II; Strack, Stefan; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Vanderbilt Kennedy Ctr,Ctr Mol Neurosci, Nashville, TN 37212 USA	Vanderbilt University	Baucum, AJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Vanderbilt Kennedy Ctr,Ctr Mol Neurosci, Nashville, TN 37212 USA.	Anthony.Baucum@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013	Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health (NIH) [R01-MH063232, NS037508, T32-MH65215, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Vanderbilt-Kennedy Center; United Negro College/Merck Science Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, P60DK020593, U24DK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215, R01MH063232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Kennedy Center; United Negro College/Merck Science Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-MH063232 and NS037508 and by a Hobbs Discovery Grant from the Vanderbilt-Kennedy Center. AJB was supported by a NIH Training Grant in Neurogenomics (T32-MH65215) and by a fellowship from the United Negro College Fund/Merck Science Initiative. Confocal microscopy was performed in the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126). Immunoblot development by Odyssey system was performed in the Vanderbilt Molecular Biology Cell Resource Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Baucum AJ, 2010, MOL CELL PROTEOMICS, V9, P1243, DOI 10.1074/mcp.M900387-MCP200; BENSON DL, 1992, NEUROSCIENCE, V46, P851, DOI 10.1016/0306-4522(92)90189-9; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bodhinathan K, 2010, J NEUROSCI, V30, P1914, DOI 10.1523/JNEUROSCI.5485-09.2010; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; BROCKE L, 1995, J NEUROSCI, V15, P6797; Brown AM, 2008, J BIOL CHEM, V283, P14286, DOI 10.1074/jbc.M801377200; Brown AM, 2005, EUR J NEUROSCI, V22, P247, DOI 10.1111/j.1460-9568.2005.04190.x; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Carmody LC, 2004, J BIOL CHEM, V279, P21714, DOI 10.1074/jbc.M402261200; Carmody LC, 2008, FASEB J, V22, P1660, DOI 10.1096/fj.07-092841; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Cheng HY, 2001, MOL CELL BIOL, V21, P6170, DOI 10.1128/MCB.21.18.6170-6180.2001; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; DOSEMECI A, 1993, J NEUROCHEM, V61, P550; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Grossman SD, 2004, J NEUROCHEM, V90, P317, DOI 10.1111/j.1471-4159.2004.02491.x; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; LEVINE MS, 1986, DEV BRAIN RES, V24, P47, DOI 10.1016/0165-3806(86)90172-0; LEVINE MS, 1986, NEUROBIOL AGING, V7, P277, DOI 10.1016/0197-4580(86)90008-4; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Logue JS, 2010, FEBS J, V277, P4370, DOI 10.1111/j.1742-4658.2010.07866.x; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Norris CM, 1998, J NEUROPHYSIOL, V80, P1567, DOI 10.1152/jn.1998.80.3.1567; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rao MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017087; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sanabria H, 2009, J BIOL CHEM, V284, P9770, DOI 10.1074/jbc.M809518200; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Strack S, 1999, J COMP NEUROL, V413, P373; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P46535, DOI 10.1074/jbc.M206960200; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yoshimura Y, 1997, J BIOL CHEM, V272, P26354, DOI 10.1074/jbc.272.42.26354; Yoshimura Y, 2000, MOL BRAIN RES, V81, P118, DOI 10.1016/S0169-328X(00)00170-4; Zhang GR, 2009, NEUROSCIENCE, V159, P308, DOI 10.1016/j.neuroscience.2008.06.068; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	72	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31554	10.1371/journal.pone.0031554	http://dx.doi.org/10.1371/journal.pone.0031554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348105	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900053
J	Wang, DJ; Legesse-Miller, A; Johnson, EL; Coller, HA				Wang, David J.; Legesse-Miller, Aster; Johnson, Elizabeth L.; Coller, Hilary A.			Regulation of the let-7a-3 Promoter by NF-kappa B	PLOS ONE			English	Article							MICRORNA GENE-EXPRESSION; LUNG-CANCER; CELLS; BIOGENESIS; DIFFERENTIATION; BLOCKADE; LIN28; PROLIFERATION; URIDYLATION; SURVIVAL	Changes in microRNA expression have been linked to a wide array of pathological states. However, little is known about the regulation of microRNA expression. The let-7 microRNA is a tumor suppressor that inhibits cellular proliferation and promotes differentiation, and is frequently lost in tumors. We investigated the transcriptional regulation of two let-7 family members, let-7a-3 and let-7b, which form a microRNA cluster and are located 864 bp apart on chromosome 22q13.31. Previous reports present conflicting data on the role of the NF-kappa B transcription factor in regulating let-7. We cloned three fragments upstream of the let-7a-3/let-7b miRNA genomic region into a plasmid containing a luciferase reporter gene. Ectopic expression of subunits of NF-kappa B (p50 or p65/RelA) significantly increased luciferase activity in HeLa, 293, 293T and 3T3 cells, indicating that the let-7a-3/let-7b promoter is highly responsive to NF-kappa B. Mutation of a putative NF-kappa B binding site at bp -833 reduced basal promoter activity and decreased promoter activity in the presence of p50 or p65 overexpression. Mutation of a second putative binding site, at bp -947 also decreased promoter activity basally and in response to p65 induction, indicating that both sites contribute to NF-kappa B responsiveness. While the levels of the endogenous primary let-7a and let-7b transcript were induced in response to NF-kappa B overexpression in 293T cells, the levels of fully processed, mature let-7a and let-7b miRNAs did not increase. Instead, levels of Lin-28B, a protein that blocks let-7 maturation, were induced by NF-kappa B. Increased Lin-28B levels could contribute to the lack of an increase in mature let-7a and let-7b. Our results suggest that the final biological outcome of NF-kappa B activation on let-7 expression may vary depending upon the cellular context. We discuss our results in the context of NF-kappa B activity in repressing self-renewal and promoting differentiation.	[Wang, David J.; Legesse-Miller, Aster; Johnson, Elizabeth L.; Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Wang, DJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hcoller@princeton.edu		Johnson, Elizabeth/0000-0002-8290-1122	PhRMA Foundation [2007RSGl9572]; NIH/NIGMS [1R01 GM081686, 1R01 GM086465]; NIH/NCI [K01 CA128887]; Chinese Professionals Association of Canada; National Science Foundation [DGE-0646086]; NIGMS Center of Excellence [P50 GM071508]; NATIONAL CANCER INSTITUTE [K01CA128887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM081686, R01GM086465] Funding Source: NIH RePORTER	PhRMA Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Professionals Association of Canada; National Science Foundation(National Science Foundation (NSF)); NIGMS Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by PhRMA Foundation grant 2007RSGl9572 (http://www.phrmafoundation.org/); NIH/NIGMS 1R01 GM081686, NIH/NIGMS 1R01 GM086465, NIH/NCI K01 CA128887 to A. L. M.; a scholarship from the Chinese Professionals Association of Canada (http://www.chineseprofessionals.ca/) to D.J.W.; a National Science Foundation Graduate Research Fellowship DGE-0646086 to E.L.J.; and NIGMS Center of Excellence grant P50 GM071508. H. A. C. was the Milton E. Cassel scholar of the Rita Allen Foundation (http://www.ritaallenfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2007, CURR MOL MED, V7, P619, DOI 10.2174/156652407782564363; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179; Seitz CS, 2000, CANCER RES, V60, P4085; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	38	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31240	10.1371/journal.pone.0031240	http://dx.doi.org/10.1371/journal.pone.0031240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348059	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900034
J	Daw, TM; Cinner, JE; McClanahan, TR; Brown, K; Stead, SM; Graham, NAJ; Maina, J				Daw, Tim M.; Cinner, Joshua E.; McClanahan, Timothy R.; Brown, Katrina; Stead, Selina M.; Graham, Nicholas A. J.; Maina, Joseph			To Fish or Not to Fish: Factors at Multiple Scales Affecting Artisanal Fishers' Readiness to Exit a Declining Fishery	PLOS ONE			English	Article							RESILIENCE; MANAGEMENT; CAPACITY; RESOURCE	Globally, fisheries are challenged by the combined impacts of overfishing, degradation of ecosystems and impacts of climate change, while fisheries livelihoods are further pressured by conservation policy imperatives. Fishers' adaptive responses to these pressures, such as exiting from a fishery to pursue alternative livelihoods, determine their own vulnerability, as well as the potential for reducing fishing effort and sustaining fisheries. The willingness and ability to make particular adaptations in response to change, such as exiting from a declining fishery, is influenced by economic, cultural and institutional factors operating at scales from individual fishers to national economies. Previous studies of exit from fisheries at single or few sites, offer limited insight into the relative importance of individual and larger-scale social and economic factors. We asked 599 fishers how they would respond to hypothetical scenarios of catch declines in 28 sites in five western Indian Ocean countries. We investigated how socioeconomic variables at the individual-, household- and site-scale affected whether they would exit fisheries. Site-level factors had the greatest influence on readiness to exit, but these relationships were contrary to common predictions. Specifically, higher levels of infrastructure development and economic vitality - expected to promote exit from fisheries - were associated with less readiness to exit. This may be due to site level histories of exit from fisheries, greater specialisation of fishing households, or higher rewards from fishing in more economically developed sites due to technology, market access, catch value and government subsidies. At the individual and household scale, fishers from households with more livelihood activities, and fishers with lower catch value were more willing to exit. These results demonstrate empirically how adaptive responses to change are influenced by factors at multiple scales, and highlight the importance of understanding natural resource-based livelihoods in the context of the wider economy and society.	[Daw, Tim M.; Brown, Katrina] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [Daw, Tim M.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Cinner, Joshua E.; Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [McClanahan, Timothy R.; Maina, Joseph] Wildlife Conservat Soc, Marine Program, Bronx, NY USA; [Stead, Selina M.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Maina, Joseph] Macquarie Univ, Dept Biol Sci, Computat Ecol Grp, Sydney, NSW 2109, Australia	University of East Anglia; Stockholm University; James Cook University; Wildlife Conservation Society; Newcastle University - UK; Macquarie University	Daw, TM (corresponding author), Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England.	T.Daw@uea.ac.uk	McClanahan, Tim/K-4998-2019; Cinner, Joshua/AAA-6823-2021; Graham, Nicholas AJ/C-8360-2014; Cinner, Joshua e/E-8966-2011	Graham, Nicholas AJ/0000-0002-0304-7467; Cinner, Joshua e/0000-0003-2675-9317; Maina, Joseph/0000-0003-1268-6137; Daw, Tim M./0000-0001-6635-9153; McClanahan, Timothy/0000-0001-5821-3584	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management (MASMA); Western Indian Ocean Marine Science Association; Regional Coastal Management Programme Of The Indian Ocean Countries; ESRC [ES/F041357/1] Funding Source: UKRI; Economic and Social Research Council [ES/F041357/1] Funding Source: researchfish	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management (MASMA); Western Indian Ocean Marine Science Association; Regional Coastal Management Programme Of The Indian Ocean Countries; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was largely funded by the Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management (MASMA) program to the Wildlife Conservation Society and based on a workshop funded by Western Indian Ocean Marine Science Association and 'Regional Coastal Management Programme Of The Indian Ocean Countries'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2011, GLOBAL ENVIRON POLIT, V11, P1, DOI 10.1162/GLEP_a_00051; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], OCCUPATIONAL GEOGRAP; BAILEY C, 1982, SMALL SCALE FISHERIE; Bene C, 2003, WORLD DEV, V31, P949, DOI 10.1016/S0305-750X(03)00045-7; Blennow K, 2009, GLOBAL ENVIRON CHANG, V19, P100, DOI 10.1016/j.gloenvcha.2008.10.003; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cinner J, 2004, OCEAN COASTAL MANAGE, V47; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Coulthard S, 2008, GLOBAL ENVIRON CHANG, V18, P479, DOI 10.1016/j.gloenvcha.2008.04.003; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Engle NL, 2011, GLOBAL ENVIRON CHANG, V21, P647, DOI 10.1016/j.gloenvcha.2011.01.019; Frank E, 2011, GLOBAL ENVIRON CHANG, V21, P66, DOI 10.1016/j.gloenvcha.2010.11.001; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Henry G.T., 1990, PRACTICAL SAMPLING, V21; Hill NAO, 2012, CONSERV BIOL, V26, P324, DOI 10.1111/j.1523-1739.2011.01796.x; Ikiara MM, 1999, FISHERMANS RESISTANC; Jennings S, 1995, CORAL REEFS, V14, P225, DOI 10.1007/BF00334346; Marshall NA, 2007, RURAL SOCIOL, V72, P359, DOI 10.1526/003601107781799254; Marshall NA, 2010, GLOBAL ENVIRON CHANG, V20, P36, DOI 10.1016/j.gloenvcha.2009.10.003; Mascia MB, 2009, CONSERV BIOL, V23, P16, DOI 10.1111/j.1523-1739.2008.01050.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Muallil RN, 2011, FISH RES, V111, P74, DOI 10.1016/j.fishres.2011.06.013; OECD, 2007, STRUCT CHANG FISH DE; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pauly D., 1988, TROP COASTAL AREA MA, V3, P14; Pita C, 2010, J RURAL STUD, V26, P308, DOI 10.1016/j.jrurstud.2010.02.004; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P531, DOI 10.1016/S0964-5691(01)00064-3; Pollnac Richard B, RAPID ASSESSMENT MAN; Pradhan NC, 2004, FISH RES, V68, P209, DOI 10.1016/j.fishres.2003.12.006; R Core Team, 2018, R LANG ENV STAT COMP; Salayo N, 2008, MAR POLICY, V32, P692, DOI 10.1016/j.marpol.2007.12.001; Sievanen L, 2005, OCEAN COAST MANAGE, V48, P297, DOI 10.1016/j.ocecoaman.2005.04.015; Smith L. E. D., 2005, Water Policy, V7, P359; TERKLA DG, 1988, LAND ECON, V64, P73, DOI 10.2307/3146609; Vincent K, 2007, GLOBAL ENVIRON CHANG, V17, P12, DOI 10.1016/j.gloenvcha.2006.11.009; WARD JM, 1994, AM J AGR ECON, V76, P916, DOI 10.2307/1243751; World Bank, 2009, SUNK BILL EC JUST FI; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	48	133	134	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31460	10.1371/journal.pone.0031460	http://dx.doi.org/10.1371/journal.pone.0031460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348090	gold, Green Published, Green Accepted			2022-12-27	WOS:000302730900027
J	Diaz-Espinoza, R; Mukherjee, A; Soto, C				Diaz-Espinoza, Rodrigo; Mukherjee, Abhisek; Soto, Claudio			Kosmotropic Anions Promote Conversion of Recombinant Prion Protein into a PrPSc-Like Misfolded Form	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; AMYLOID FIBRIL FORMATION; IN-VITRO CONVERSION; MAMMALIAN PRIONS; SCRAPIE PRION; TRUNCATED FORMS; SALTS; AGGREGATION; TRANSITION; STABILITY	Prions are self-propagating proteins involved in transmissible spongiform encephalopaties in mammals. An aberrant conformation with amyloid-like features of a cell surface protein, termed prion protein (PrP), is thought to be the essential component of the infectious particle, though accessory co-factor molecules such as lipids and nucleotides may be involved. The cellular co-factors and environmental conditions implicated in PrP misfolding are not completely understood. To address this issue, several studies have been done inducing misfolding of recombinant PrP (recPrP) into classical amyloid structures using partially denaturing conditions. In this work, we report that misfolding of recPrP into PrPSc-like aggregates can be induced by simply incubating the protein in the presence of kosmotropic salts at concentrations that are known to retain or increase the stability of the protein. We used a simple experimental reaction (protein, buffer and salts) submitted to agitation/incubation cycles at physiological temperature and pH. The formation of protease resistant-recPrP was time and salt-concentration dependent and required the presence of kosmotropic anions such as F- or SO4-2. The molecular weights of the protease resistant recPrP fragments are reminiscent of those found in degradation assays of bona fide PrPSc. The aggregates also exhibited PrPSc-like ultrastructural features including rod-shape morphology under electron microscope, high beta-sheet content and thioflavin-T positive signal. The formation of recPrP aggregates with PrPSc biochemical features under conditions closer to physiological in the absence of organic co-factor molecules provides a simple setup that may prove helpful to understand the molecular mechanism of PrP misfolding.	[Diaz-Espinoza, Rodrigo; Mukherjee, Abhisek; Soto, Claudio] Univ Texas Houston Med Sch, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA; [Diaz-Espinoza, Rodrigo; Mukherjee, Abhisek] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston	Diaz-Espinoza, R (corresponding author), Univ Texas Houston Med Sch, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu	Diaz-Espinoza, Rodrigo/HDM-8819-2022		National Institutes of Health (NIH) [R01NS049173]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health (NIH) grant R01NS049173 to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; Benetti F, 2009, PRION, V3, P213, DOI 10.4161/pri.3.4.10181; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1994, BIOCHEM SOC T, V22, P163, DOI 10.1042/bst0220163; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Gomes MPB, 2008, PRION, V2, P64, DOI 10.4161/pri.2.2.6988; Grudzielanek S, 2005, J MOL BIOL, V351, P879, DOI 10.1016/j.jmb.2005.06.046; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MCKINLEY MP, 1986, J INFECT DIS, V154, P110, DOI 10.1093/infdis/154.1.110; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nandi PK, 2006, J MOL BIOL, V362, P810, DOI 10.1016/j.jmb.2006.07.060; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Post K, 1998, BIOL CHEM, V379, P1307, DOI 10.1515/bchm.1998.379.11.1307; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rezaei-Ghaleh N, 2007, ARCH BIOCHEM BIOPHYS, V457, P160, DOI 10.1016/j.abb.2006.10.031; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS DR, 1965, AM J CLIN PATHOL, V44, P59; Ronga L, 2006, J PEPT SCI, V12, P790, DOI 10.1002/psc.818; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Satoh K, 2003, J GEN VIROL, V84, P2885, DOI 10.1099/vir.0.19236-0; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2010, FRONT BIOSCI-LANDMRK, V15, P132, DOI 10.2741/3611; Sim VL, 2009, NEUROBIOL AGING, V30, P2031, DOI 10.1016/j.neurobiolaging.2008.02.016; Singh N, 2002, FRONT BIOSCI-LANDMRK, V7, pA60, DOI 10.2741/singh; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Supattapone S, 2010, SCIENCE, V327, P1091, DOI 10.1126/science.1187790; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200	61	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31678	10.1371/journal.pone.0031678	http://dx.doi.org/10.1371/journal.pone.0031678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347503	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200031
J	Dziewit, L; Baj, J; Szuplewska, M; Maj, A; Tabin, M; Czyzkowska, A; Skrzypczyk, G; Adamczuk, M; Sitarek, T; Stawinski, P; Tudek, A; Wanasz, K; Wardal, E; Piechucka, E; Bartosik, D				Dziewit, Lukasz; Baj, Jadwiga; Szuplewska, Magdalena; Maj, Anna; Tabin, Mateusz; Czyzkowska, Anna; Skrzypczyk, Grazyna; Adamczuk, Marcin; Sitarek, Tomasz; Stawinski, Piotr; Tudek, Agnieszka; Wanasz, Katarzyna; Wardal, Ewa; Piechucka, Ewa; Bartosik, Dariusz			Insights into the Transposable Mobilome of Paracoccus spp. (Alphaproteobacteria)	PLOS ONE			English	Article							FACULTATIVELY METHYLOTROPHIC BACTERIUM; GRAM-NEGATIVE BACTERIA; SP-NOV.; INSERTION-SEQUENCE; GENUS PARACOCCUS; PANTOTROPHUS DSM-11072; EMENDED DESCRIPTION; SP. NOV.; ELEMENTS; PLASMID	Several trap plasmids (enabling positive selection of transposition events) were used to identify a pool of functional transposable elements (TEs) residing in bacteria of the genus Paracoccus (Alphaproteobacteria). Complex analysis of 25 strains representing 20 species of this genus led to the capture and characterization of (i) 37 insertion sequences (ISs) representing 9 IS families (IS3, IS5, IS6, IS21, IS66, IS256, IS1182, IS1380 and IS1634), (ii) a composite transposon Tn6097 generated by two copies of the ISPfe2 (IS1634 family) containing two predicted genetic modules, involved in the arginine deiminase pathway and daunorubicin/doxorubicin resistance, (iii) 3 non-composite transposons of the Tn3 family, including Tn5393 carrying streptomycin resistance and (iv) a transposable genomic island TnPpa1 (45 kb). Some of the elements (e. g. Tn5393, Tn6097 and ISs of the IS903 group of the IS5 family) were shown to contain strong promoters able to drive transcription of genes placed downstream of the target site of transposition. Through the application of trap plasmid pCM132TC, containing a promoterless tetracycline resistance reporter gene, we identified five ways in which transposition can supply promoters to transcriptionally silent genes. Besides highlighting the diversity and specific features of several TEs, the analyses performed in this study have provided novel and interesting information on (i) the dynamics of the process of transposition (e. g. the unusually high frequency of transposition of TnPpa1) and (ii) structural changes in DNA mediated by transposition (e. g. the generation of large deletions in the recipient molecule upon transposition of ISPve1 of the IS21 family). We also demonstrated the great potential of TEs and transposition in the generation of diverse phenotypes as well as in the natural amplification and dissemination of genetic information (of adaptative value) by horizontal gene transfer, which is considered the driving force of bacterial evolution.	[Dziewit, Lukasz; Baj, Jadwiga; Szuplewska, Magdalena; Maj, Anna; Tabin, Mateusz; Czyzkowska, Anna; Skrzypczyk, Grazyna; Adamczuk, Marcin; Sitarek, Tomasz; Stawinski, Piotr; Tudek, Agnieszka; Wanasz, Katarzyna; Wardal, Ewa; Piechucka, Ewa; Bartosik, Dariusz] Univ Warsaw, Dept Bacterial Genet, Fac Biol, Inst Microbiol, Warsaw, Poland	University of Warsaw	Dziewit, L (corresponding author), Univ Warsaw, Dept Bacterial Genet, Fac Biol, Inst Microbiol, Warsaw, Poland.	bartosik@biol.uw.edu.pl	Tudek, Agnieszka/ABE-7845-2020; Wardal, Ewa/AAQ-9417-2021; Dziewit, Lukasz/L-1131-2016	Tudek, Agnieszka/0000-0002-6085-1072; Wardal, Ewa/0000-0003-3500-2199; Dziewit, Lukasz/0000-0002-5057-2811; Szuplewska, Magdalena/0000-0003-1900-4995; Bartosik, Dariusz/0000-0002-3589-8864	Ministry of Science and Higher Education, Poland [PBZ-MNiSW-04/I/2007]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education, Poland (grant PBZ-MNiSW-04/I/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartosik D, 2003, APPL ENVIRON MICROB, V69, P7002, DOI 10.1128/AEM.69.12.7002-7008.2003; Bartosik D, 2002, MICROBIOL-SGM, V148, P2847, DOI 10.1099/00221287-148-9-2847; Bartosik D, 2001, J BACTERIOL, V183, P6234, DOI 10.1128/JB.183.21.6234-6243.2001; Bartosik D, 2008, J BACTERIOL, V190, P3306, DOI 10.1128/JB.01878-07; Berry A, 2003, INT J SYST EVOL MICR, V53, P231, DOI 10.1099/ijs.0.02368-0; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bortosik D, 2003, J BACTERIOL, V185, P3753, DOI 10.1128/JB.185.13.3753-3763.2003; CAMPBELL A, 1979, PLASMID, V2, P466, DOI 10.1016/0147-619X(79)90030-1; Chalmers R, 1998, CELL, V93, P897, DOI 10.1016/S0092-8674(00)81449-X; Chandler M, 2002, MOBILE DNA, V2, P305; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Daneshvar MI, 2003, J CLIN MICROBIOL, V41, P1289, DOI 10.1128/JCM.41.3.1289-1294.2003; De Palmenaer D, 2004, MOL MICROBIOL, V53, P457, DOI 10.1111/j.1365-2958.2004.04146.x; De Palmenaer D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-18; Doronina NV, 2000, MICROBIOLOGY+, V69, P593, DOI 10.1007/BF02756814; Doronina NV, 1998, SYST APPL MICROBIOL, V21, P230, DOI 10.1016/S0723-2020(98)80027-1; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Dziewit L, 2011, J MICROBIOL METH, V86, P166, DOI 10.1016/j.mimet.2011.04.016; Dziewit L, 2010, APPL ENVIRON MICROB, V76, P1861, DOI 10.1128/AEM.01926-09; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; GAMPER M, 1991, J BACTERIOL, V173, P4742, DOI 10.1128/jb.173.15.4742-4750.1991; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; GERSTENBERG C, 1982, ARCH MICROBIOL, V133, P90, DOI 10.1007/BF00413517; Ghosh W, 2006, SYST APPL MICROBIOL, V29, P396, DOI 10.1016/j.syapm.2005.10.004; Grindley NDF, 2002, MOBILE DNA, P272; GUMPERT J, 1982, Z ALLG MIKROBIOL, V22, P687, DOI 10.1002/jobm.3630221002; Harker M, 1998, INT J SYST BACTERIOL, V48, P543, DOI 10.1099/00207713-48-2-543; Hubner A, 1997, J BACTERIOL, V179, P2717; Jordan SL, 1997, ARCH MICROBIOL, V168, P225, DOI 10.1007/s002030050492; KATAYAMA Y, 1995, MICROBIOL-UK, V141, P1469, DOI 10.1099/13500872-141-6-1469; Kelly DP, 2006, INT J SYST EVOL MICR, V56, P2495, DOI 10.1099/ijs.0.64401-0; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kim BY, 2006, INT J SYST EVOL MICR, V56, P2387, DOI 10.1099/ijs.0.64275-0; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kumaraswamy R, 2006, SYST APPL MICROBIOL, V29, P276, DOI 10.1016/j.syapm.2005.08.001; Kushner SR, 1978, GENET ENG N Y, P17; Kusumoto M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1152; Kwiatkowski AV, 1997, J BACTERIOL, V179, P5618, DOI 10.1128/jb.179.17.5618-5620.1997; L'abee-Lund TM, 2000, APPL ENVIRON MICROB, V66, P5533, DOI 10.1128/AEM.66.12.5533-5535.2000; La HJ, 2005, INT J SYST EVOL MICR, V55, P1657, DOI 10.1099/ijs.0.63494-0; Lee JH, 2004, INT J SYST EVOL MICR, V54, P1699, DOI 10.1099/ijs.0.63146-0; Li K, 2011, J BACTERIOL, V193, P1786, DOI 10.1128/JB.00014-11; Lipski A, 1998, INT J SYST BACTERIOL, V48, P529, DOI 10.1099/00207713-48-2-529; Liu XY, 2006, INT J SYST EVOL MICR, V56, P2693, DOI 10.1099/ijs.0.64548-0; Liu ZP, 2008, INT J SYST EVOL MICR, V58, P257, DOI 10.1099/ijs.0.65237-0; Maghnouj A, 1998, J BACTERIOL, V180, P6468, DOI 10.1128/JB.180.24.6468-6475.1998; Mahillon J, 1998, APMIS, V106, P29; Malta S, 2010, MICROBIOL RES, V165, P427, DOI 10.1016/j.micres.2009.11.006; Mikosa M, 2006, MICROBIOL-SGM, V152, P1063, DOI 10.1099/mic.0.28603-0; NAKATSU C, 1991, P NATL ACAD SCI USA, V88, P8312, DOI 10.1073/pnas.88.19.8312; Ogwang S, 2011, J BIOL CHEM, V286, P15377, DOI 10.1074/jbc.M111.231076; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Pukall R, 2003, INT J SYST EVOL MICR, V53, P443, DOI 10.1099/ijs.0.02352-0; Rainey FA, 1999, INT J SYST BACTERIOL, V49, P645, DOI 10.1099/00207713-49-2-645; ROGERS MB, 1994, J BACTERIOL, V176, P4376, DOI 10.1128/jb.176.14.4376-4384.1994; Roh SW, 2009, INT J SYST EVOL MICR, V59, P790, DOI 10.1099/ijs.0.65759-0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider D, 2000, PLASMID, V44, P201, DOI 10.1006/plas.2000.1483; SEKINE Y, 1989, P NATL ACAD SCI USA, V86, P4609, DOI 10.1073/pnas.86.12.4609; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Siguier P, 2009, RES MICROBIOL, V160, P232, DOI 10.1016/j.resmic.2009.02.003; Siller H, 1996, INT J SYST BACTERIOL, V46, P1125, DOI 10.1099/00207713-46-4-1125; Smorawinska M, 2012, FEMS MICROBIOL LETT, V326, P76, DOI 10.1111/j.1574-6968.2011.02432.x; Solyga Aleksandra, 2004, Polish Journal of Microbiology, V53, P139; SUNDIN GW, 1995, APPL ENVIRON MICROB, V61, P2891, DOI 10.1128/AEM.61.8.2891-2897.1995; Szuplewska M, 2009, FEMS MICROBIOL LETT, V292, P216, DOI 10.1111/j.1574-6968.2009.01495.x; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; URAKAMI T, 1989, INT J SYST BACTERIOL, V39, P116, DOI 10.1099/00207713-39-2-116; URAKAMI T, 1990, INT J SYST BACTERIOL, V40, P287, DOI 10.1099/00207713-40-3-287; VANDERPLOEG J, 1995, J BACTERIOL, V177, P1348, DOI 10.1128/jb.177.5.1348-1356.1995; VANSPANNING RJM, 1995, J BACTERIOL, V177, P4772, DOI 10.1128/jb.177.16.4772-4778.1995; Winterstein C, 1998, ARCH MICROBIOL, V169, P275, DOI 10.1007/s002030050572; Wood NJ, 2001, J BACTERIOL, V183, P3606, DOI 10.1128/JB.183.12.3606-3613.2001; Wyndham R. Campbell, 1994, Biodegradation, V5, P323, DOI 10.1007/BF00696468; ZHENG JH, 1995, MOL MICROBIOL, V16, P669, DOI 10.1111/j.1365-2958.1995.tb02429.x; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x; Zuniga M, 2002, MOL PHYLOGENET EVOL, V25, P429, DOI 10.1016/S1055-7903(02)00277-4	83	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32277	10.1371/journal.pone.0032277	http://dx.doi.org/10.1371/journal.pone.0032277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359677	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200146
J	He, DG; Li, H; Yusuf, N; Elmets, CA; Athar, M; Katiyar, SK; Xu, H				He, Donggou; Li, Hui; Yusuf, Nabiha; Elmets, Craig A.; Athar, Mohammad; Katiyar, Santosh K.; Xu, Hui			IL-17 Mediated Inflammation Promotes Tumor Growth and Progression in the Skin	PLOS ONE			English	Article							CD8(+) T-CELLS; INTERLEUKIN-17 FAMILY-MEMBERS; MYELOID SUPPRESSOR-CELLS; CHEMICAL CARCINOGENESIS; IMMUNE SUPPRESSION; MOUSE SKIN; CANCER; METASTASIS; MICROENVIRONMENT; TUMORIGENESIS	The mechanism for inflammation associated tumor development is a central issue for tumor biology and immunology and remains to be fully elucidated. Although IL-17 is implicated in association with inflammation mediated carcinogenesis, mechanisms are largely elusive. In the current studies, we showed that IL-17 receptor-A gene deficient (IL-17R-/-) mice were resistant to chemical carcinogen-induced cutaneous carcinogenesis, a well-established inflammation associated tumor model in the skin. The deficiency in IL-17R increased the infiltration of CD8+ T cells whereas it inhibited the infiltration of CD11b+ myeloid cells and development of myeloid derived suppressor cells. Inflammation induced skin hyperplasia and production of pro-tumor inflammatory molecules were inhibited in IL-17R-/- mice. We found that pre-existing inflammation in the skin increased the susceptibility to tumor growth, which was associated with increased development of tumor specific IL-17 producing T cells. This inflammation induced susceptibility to tumor growth was abrogated in IL-17R-/- mice. Finally, neutralizing IL-17 in mice that had already developed chemical carcinogen induced skin tumors could inhibit inflammation mediated tumor progression at late stages. These results demonstrate that IL-17 mediated inflammation is an important mechanism for inflammation mediated promotion of tumor development. The study has major implications for targeting IL-17 in prevention and treatment of tumors.	[He, Donggou; Li, Hui; Yusuf, Nabiha; Elmets, Craig A.; Athar, Mohammad; Katiyar, Santosh K.; Xu, Hui] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Yusuf, Nabiha; Elmets, Craig A.; Athar, Mohammad; Katiyar, Santosh K.; Xu, Hui] Univ Alabama Birmingham, Skin Dis Res Ctr, Birmingham, AL USA; [Yusuf, Nabiha; Elmets, Craig A.; Katiyar, Santosh K.; Xu, Hui] Birmingham VA Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	He, DG (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	xuhui@uab.edu			United States National Institutes of Health [ES017494, CA138998, AI071041, AR46256]; NATIONAL CANCER INSTITUTE [R01CA138998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046256, P30AR048311, P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017494] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by grants (AI071041 and AR46256 [HX] and ES017494 and CA138998 [MA]) from the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlund MG, 2005, ONCOLOGY-BASEL, V69, P28, DOI 10.1159/000086629; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Carlos TM, 2001, J LEUKOCYTE BIOL, V70, P171; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; DiGiovanni J, 1992, PHARMACOL THERAPEUT, V54, P63; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Owens DM, 1999, CARCINOGENESIS, V20, P1837, DOI 10.1093/carcin/20.9.1837; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tiano HF, 2002, CANCER RES, V62, P3395; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Whiteside TL, 2006, CANC TREAT, V130, P103; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yusuf N, 2008, CANCER RES, V68, P3924, DOI 10.1158/0008-5472.CAN-07-3059; Yusuf N, 2008, CANCER RES, V68, P615, DOI 10.1158/0008-5472.CAN-07-5219; Yusuf N, 2007, TOXICOL APPL PHARM, V224, P308, DOI 10.1016/j.taap.2006.12.009; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	63	56	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32126	10.1371/journal.pone.0032126	http://dx.doi.org/10.1371/journal.pone.0032126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359662	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200131
J	van Putten, M; Hulsker, M; Nadarajah, VD; van Heiningen, SH; van Huizen, E; van Iterson, M; Admiraal, P; Messemaker, T; den Dunnen, JT; 't Hoen, PAC; Aartsma-Rus, A				van Putten, Maaike; Hulsker, Margriet; Nadarajah, Vishna Devi; van Heiningen, Sandra H.; van Huizen, Ella; van Iterson, Maarten; Admiraal, Peter; Messemaker, Tobias; den Dunnen, Johan T.; 't Hoen, Peter A. C.; Aartsma-Rus, Annemieke			The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TRANSGENIC MDX MICE; GENE-EXPRESSION; X-CHROMOSOME; CARRIER MICE; FULL-LENGTH; RESTORATION; DMD; CARDIOMYOPATHY; INACTIVATION	Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exercise-induced damage. Upon exhaustion of the regenerative capacity, fibers will be replaced by fibrotic and fat tissue resulting in a progressive loss of function eventually leading to death in the early thirties. With several promising approaches for the treatment of DMD aiming at dystrophin restoration in clinical trials, there is an increasing need to determine more precisely which dystrophin levels are sufficient to restore muscle fiber integrity, protect against muscle damage and improve muscle function. To address this we generated a new mouse model (mdx-Xist(Delta hs)) with varying, low dystrophin levels (3-47%, mean 22.7%, stdev 12.1, n = 24) due to skewed X-inactivation. Longitudinal sections revealed that within individual fibers, some nuclei did and some did not express dystrophin, resulting in a random, mosaic pattern of dystrophin expression within fibers. Mdx-Xist(Delta hs), mdx and wild type females underwent a 12 week functional test regime consisting of different tests to assess muscle function at base line, or after chronic treadmill running exercise. Overall, mdx-Xist(Delta hs) mice with 3-14% dystrophin outperformed mdx mice in the functional tests. Improved histopathology was observed in mice with 15-29% dystrophin and these levels also resulted in normalized expression of pro-inflammatory biomarker genes, while for other parameters >30% of dystrophin was needed. Chronic exercise clearly worsened pathology, which needed dystrophin levels >20% for protection. Based on these findings, we conclude that while even dystrophin levels below 15% can improve pathology and performance, levels of >20% are needed to fully protect muscle fibers from exercise-induced damage.	[van Putten, Maaike; Hulsker, Margriet; Nadarajah, Vishna Devi; van Heiningen, Sandra H.; van Huizen, Ella; van Iterson, Maarten; Admiraal, Peter; Messemaker, Tobias; den Dunnen, Johan T.; 't Hoen, Peter A. C.; Aartsma-Rus, Annemieke] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Putten, M (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	a.m.rus@lumc.nl	Hoen, Peter A 't/D-3950-2018; dunnen, johan den/ABH-4228-2020	Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; V Nadarajah, Vishna Devi/0000-0002-7126-7189; van Putten, Maaike/0000-0002-0683-8897	FP6 [LSHM-CT-2006-036825]; FP7 BIO-NMD [FP7-HEALTH-241665]; Dutch organization for scientific research (NWO/ZonMW) [95100102]; Dutch Duchenne Parent Project	FP6(European Commission); FP7 BIO-NMD; Dutch organization for scientific research (NWO/ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Dutch Duchenne Parent Project	This work was supported by the FP6 funded TREAT-NMD network of excellence (LSHM-CT-2006-036825), the FP7 BIO-NMD project (FP7-HEALTH-241665), the Dutch organization for scientific research (NWO/ZonMW, 95100102), and the Dutch Duchenne Parent Project (www.duchenne.nl) and utilizes the infrastructure of the Center for Biomedical Genetics (the Netherlands) and the Center for Medical Systems Biology (the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2010, ANN NY ACAD SCI, V1214, P199, DOI 10.1111/j.1749-6632.2010.05836.x; AZOFEIFA J, 1995, HUM GENET, V96, P167, DOI 10.1007/BF00207374; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; BOYD Y, 1986, J MED GENET, V23, P484, DOI 10.1136/jmg.23.6.484; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Li DJ, 2008, AM J PATHOL, V172, P1332, DOI 10.2353/ajpath.2008.071042; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; Malik Vinod, 2010, Ther Adv Neurol Disord, V3, P379, DOI 10.1177/1756285610388693; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Newall AET, 2001, HUM MOL GENET, V10, P581, DOI 10.1093/hmg/10.6.581; NICHOLSON LVB, 1993, ARCH DIS CHILD, V68, P632, DOI 10.1136/adc.68.5.632; Ogata H, 2000, INTERNAL MED, V39, P34, DOI 10.2169/internalmedicine.39.34; PEGORARO E, 1995, NEUROLOGY, V45, P677, DOI 10.1212/WNL.45.4.677; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; SCHMIDTACHERT M, 1993, CLIN INVESTIGATOR, V71, P247; Senner CE, 2009, CURR OPIN GENET DEV, V19, P122, DOI 10.1016/j.gde.2009.03.003; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Soltanzadeh P, 2010, NEUROMUSCULAR DISORD, V20, P499, DOI 10.1016/j.nmd.2010.05.010; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Stillwell E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004759; TANAKA H, 1990, HISTOCHEMISTRY, V93, P447, DOI 10.1007/BF00266399; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; van Putten M, 2012, NEUROMUSCUL IN PRESS; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004	42	69	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31937	10.1371/journal.pone.0031937	http://dx.doi.org/10.1371/journal.pone.0031937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359642	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200111
J	Colombo, BM; Canevali, P; Magnani, O; Rossi, E; Puppo, F; Zocchi, MR; Poggi, A				Colombo, Barbara M.; Canevali, Paolo; Magnani, Ottavia; Rossi, Edoardo; Puppo, Francesco; Zocchi, Maria Raffaella; Poggi, Alessandro			Defective Expression and Function of the Leukocyte Associated Ig-like Receptor 1 in B Lymphocytes from Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article							CELL-ACTIVATION; KILLER-CELLS; LAIR-1; MOLECULE; SIGNAL; DIFFERENTIATION; IMMUNOGLOBULIN; PROLIFERATION; ENGAGEMENT; COLLAGENS	Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies and dysregulation of B cell function. The leukocyte associated Immunoglobulin (Ig)-like receptor (LAIR) 1 is a transmembrane molecule belonging to Ig superfamily which binds to different types of collagen. Herein, we have determined the expression and function of LAIR1 on B lymphocyte from SLE patients. LAIR1 expression in peripheral blood B lymphocytes from 54 SLE, 24 mixed connective tissue disease (MCTD), 20 systemic sclerosis (SSc) patients, 14 rheumatoid arthritis (RA) and 40 sex and age matched healthy donors (HD) have been analyzed by immunofluorescence. The effect of LAIR1 ligation by specific monoclonal antibodies, collagen or collagen producing mesenchymal stromal cells from reactive lymph nodes or bone marrow on Ig production by pokeweed mitogen and B cell receptor (BCR)-mediated NF-kB activation was assessed by ELISA and TransAM assay. The percentage of CD20(+) B lymphocytes lacking or showing reduced expression of LAIR1 was markedly increased in SLE and MCTD but not in SSc or RA patients compared to HD. The downregulation of LAIR1 expression was not dependent on corticosteroid therapy. Interestingly, LAIR1 engagement by collagen or collagen-producing mesenchymal stromal cells in SLE patients with low LAIR1 expression on B cells delivered a lower inhibiting signal on Ig production. In addition, NF-kB p65 subunit activation upon BCR and LAIR1 co-engagement was less inhibited in SLE patients than in HD. Our findings indicate defective LAIR1 expression and function in SLE B lymphocytes, possible contributing to an altered control of B lymphocytes behavior.	[Colombo, Barbara M.; Magnani, Ottavia; Puppo, Francesco] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Rossi, Edoardo] IRCCS AOU San Martino IST Natl Inst Canc Res, Dept Hematol, Genoa, Italy; [Canevali, Paolo; Poggi, Alessandro] IRCCS Azienso Osped Univ AOU San Martino, Natl Inst Canc Res, Lab Mol Oncol & Angiogenesis, Genoa, Italy; [Canevali, Paolo; Zocchi, Maria Raffaella] Ist Sci San Raffaele, Div Immunol Transplant & Infect Dis, I-20132 Milan, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Colombo, BM (corresponding author), Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy.	alessandro.poggi@istge.it	Poggi, Alessandro/K-6664-2016; Colombo, Barbara Maria/AAH-7821-2019	Poggi, Alessandro/0000-0002-1860-430X; Colombo, Barbara Maria/0000-0002-2693-611X; Zocchi, Maria Raffaella/0000-0002-0022-8385	Italian Association for Cancer Research [IG8761, IG8727]; Compagnia del San Paolo [2007.0265, 2010.14038]; Italian Ministry of Health	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Compagnia del San Paolo(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy)	This work has been supported by the Italian Association for Cancer Research (Grant n. IG8761 to A.P. and Grant n. IG8727 to MRZ), by the Compagnia del San Paolo (Grant n. 2007.0265 and Grant n. 2010.14038 to AP) and by the Italian Ministry of Health (Final.Min.Sal.2008-2009 Innovative therapeutic models for the treatment of hematological malignancies). The Compagnia del San Paolo is not a profit making body. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaccorsi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015080; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; de Vries ARV, 1999, EUR J IMMUNOL, V29, P3160; Doria A, 2010, AUTOIMMUN REV, V10, P55, DOI 10.1016/j.autrev.2010.08.014; Gayed M, 2010, CURR OPIN INVEST DR, V11, P1256; Hahn BH, 2011, ANN RHEUM DIS, V70, pI64, DOI 10.1136/ard.2010.142208; Horton HM, 2011, J IMMUNOL, V186, P4223, DOI 10.4049/jimmunol.1003412; Jansen CA, 2007, EUR J IMMUNOL, V37, P914, DOI 10.1002/eji.200636678; Jiang L, 2009, EUR J IMMUNOL, V39, P1167, DOI 10.1002/eji.200839188; La Cava A, 2010, EXPERT OPIN BIOL TH, V10, P1555, DOI 10.1517/14712598.2010.524923; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 1999, J IMMUNOL, V162, P5800; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Musso A, 2011, HAEMATOL-HEMATOL J, V96, P16, DOI 10.3324/haematol.2010.031633; POGGI A, 1995, EUR J IMMUNOL, V25, P369, DOI 10.1002/eji.1830250210; Poggi A, 2008, LEUKEMIA, V22, P980, DOI 10.1038/leu.2008.21; POGGI A, 1993, EUR J IMMUNOL, V23, P2454, DOI 10.1002/eji.1830231012; Poggi A, 1998, EUR J IMMUNOL, V28, P2086, DOI 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T; Poggi A, 2000, EUR J IMMUNOL, V30, P2751, DOI 10.1002/1521-4141(200010)30:10<2751::AID-IMMU2751>3.0.CO;2-L; Poggi A, 1997, INT IMMUNOL, V9, P1271, DOI 10.1093/intimm/9.9.1271; Poggi A, 2010, BRIT J HAEMATOL, V151, P252, DOI 10.1111/j.1365-2141.2010.08343.x; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Sestak AL, 2011, ANN RHEUM DIS, V70, pI37, DOI 10.1136/ard.2010.138057; Tang XB, 2009, J IMMUNOL, V182, P5446, DOI 10.4049/jimmunol.0804052; Traggiai E, 2008, STEM CELLS, V26, P562, DOI 10.1634/stemcells.2007-0528; Youinou P, 2011, CRIT REV IMMUNOL, V31, P31, DOI 10.1615/CritRevImmunol.v31.i1.30; ZOCCHI MR, 1987, J EXP MED, V166, P319, DOI 10.1084/jem.166.2.319; Zocchi MR, 2001, EUR J IMMUNOL, V31, P3667, DOI 10.1002/1521-4141(200112)31:12<3667::AID-IMMU3667>3.0.CO;2-G	34	31	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31903	10.1371/journal.pone.0031903	http://dx.doi.org/10.1371/journal.pone.0031903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355402	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300102
J	Prondvai, E; Stein, K; Osi, A; Sander, MP				Prondvai, Edina; Stein, Koen; Osi, Attila; Sander, Martin P.			Life History of Rhamphorhynchus Inferred from Bone Histology and the Diversity of Pterosaurian Growth Strategies	PLOS ONE			English	Article							DEVELOPMENTAL PLASTICITY; TRADE-OFFS; PATTERNS; BIRDS; EVOLUTION; PALEOHISTOLOGY; PHYSIOLOGY; ONTOGENY; ANATOMY	Background: Rhamphorhynchus from the Solnhofen Limestones is the most prevalent long tailed pterosaur with a debated life history. Whereas morphological studies suggested a slow crocodile-like growth strategy and superprecocial volant hatchlings, the only histological study hitherto conducted on Rhamphorhynchus concluded a relatively high growth rate for the genus. These controversial conclusions can be tested by a bone histological survey of an ontogenetic series of Rhamphorhynchus. Methodology/Principal Findings: Our results suggest that Bennett's second size category does not reflect real ontogenetic stage. Significant body size differences of histologically as well as morphologically adult specimens suggest developmental plasticity. Contrasting the 'superprecocial hatchling' hypothesis, the dominance of fibrolamellar bone in early juveniles implies that hatchlings sustained high growth rate, however only up to the attainment of 30-50% and 7-20% of adult wingspan and body mass, respectively. The early fast growth phase was followed by a prolonged, slow-growth phase indicated by parallel-fibred bone deposition and lines of arrested growth in the cortex, a transition which has also been observed in Pterodaustro. An external fundamental system is absent in all investigated specimens, but due to the restricted sample size, neither determinate nor indeterminate growth could be confirmed in Rhamphorhynchus. Conclusions/Significance: The initial rapid growth phase early in Rhamphorhynchus ontogeny supports the non-volant nature of its hatchlings, and refutes the widely accepted 'superprecocial hatchling' hypothesis. We suggest the onset of powered flight, and not of reproduction as the cause of the transition from the fast growth phase to a prolonged slower growth phase. Rapidly growing early juveniles may have been attended by their parents, or could have been independent precocial, but non-volant arboreal creatures until attaining a certain somatic maturity to get airborne. This study adds to the understanding on the diversity of pterosaurian growth strategies.	[Prondvai, Edina; Osi, Attila] Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary; [Stein, Koen; Sander, Martin P.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany	Eotvos Lorand University; Hungarian Academy of Sciences; University of Bonn	Prondvai, E (corresponding author), Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary.	edina.prondvai@gmail.com	Ősi, Attila/K-2414-2018; Prondvai, Edina/I-3178-2019; Stein, Koen HW/G-5731-2015	Ősi, Attila/0000-0003-2967-997X; Prondvai, Edina/0000-0002-1284-8311; Stein, Koen/0000-0003-4246-3225	ELTE-MTA (Eotvos Lorand University - Hungarian Academy of Sciences, Dinosaur Research Group); OTKA (Orszagos Tudomanyos Kutatasi Alap) [NF 84193]; Hantken Foundation; Eotvos Lorand University, Department of Paleontology; Hungarian Natural History Museum; Hungarian Academy of Sciences	ELTE-MTA (Eotvos Lorand University - Hungarian Academy of Sciences, Dinosaur Research Group); OTKA (Orszagos Tudomanyos Kutatasi Alap)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hantken Foundation; Eotvos Lorand University, Department of Paleontology; Hungarian Natural History Museum; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was funded by an ELTE-MTA "Lendulet" grant (Eotvos Lorand University - Hungarian Academy of Sciences, Dinosaur Research Group), and an OTKA (Orszagos Tudomanyos Kutatasi Alap, Hungarian Scientific Research Fund) grant NF 84193. Further financial support was provided by Hantken Foundation (http://www.friweb.hu/hantken/), Eotvos Lorand University, Department of Paleontology (http://paleo.elte.hu), Hungarian Natural History Museum (http://www.nhmus.hu), and Hungarian Academy of Sciences (http://mta.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Andrews R.M., 1982, Biology of Reptilia, V13, P273; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Cambra-Moo O, 2006, CR PALEVOL, V5, P685, DOI 10.1016/j.crpv.2005.12.018; CAMPOS DD, 1985, AN ACAD BRAS CIENC, V57, P141; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; Castanet J., 1993, BONE, P245; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy A., 2005, MICROSTRUCTURE DINOS; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Dalla Vecchia F., 1993, B SOC PALEONTOLOGICA, V32, P401; Dalla Vecchia FM, 2009, RIV ITAL PALEONTOL S, V115, P159, DOI 10.13130/2039-4942/6377; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; de Ricqles A, 2006, TRENDS ECOL EVOL, V21, P596, DOI 10.1016/j.tree.2006.08.005; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Francillon-Vieillot H., 1990, P471; GROSS WALTER, 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P731, DOI 10.1007/BF02118752; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Hutchison J.H., 1984, Journal of Vertebrate Paleontology, V3, P148; JACOBSEN T, 1989, J ZOOL, V219, P309, DOI 10.1111/j.1469-7998.1989.tb02583.x; Jenkins Farish A. Jr., 2001, Bulletin of the Museum of Comparative Zoology, V156, P151; Kozlowski J, 1996, P ROY SOC B-BIOL SCI, V263, P559, DOI 10.1098/rspb.1996.0084; Lincoln LJ, 1982, DICT ECOLOGY EVOLUTI; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Mangel M, 2001, EVOL ECOL RES, V3, P583; Osi A, 2010, ANAT REC, V293, P243, DOI 10.1002/ar.21053; Osi A, 2009, NEUES JAHRB GEOL P-A, V252, P167, DOI 10.1127/0077-7749/2009/0252-0167; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; Palmer C, 2011, P ROY SOC B-BIOL SCI, V278, P1881, DOI 10.1098/rspb.2010.2179; Ponton F, 2004, ACTA ORNITHOL, V39, P137, DOI 10.3161/068.039.0210; Prondvai E, 2008, HIST BIOL, V20, P237, DOI 10.1080/08912960902859334; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; RICKLEFS RE, 1980, AUK, V97, P768; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Rodrigues Taissa, 2008, Zitteliana Reihe B, V28, P219; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sayao Juliana M., 2003, Geological Society Special Publication, V217, P335, DOI 10.1144/GSL.SP.2003.217.01.21; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Seitz ALL, 1907, NOVA ACTA ABHANDLUNG, V87, P230; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P381; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Steel Lorna, 2008, Zitteliana Reihe B, V28, P109; Stein K., 2009, METHODS FOSSIL PREPA, P69; Tumarkin-Deratzian AR, 2007, J HERPETOL, V41, P341, DOI 10.1670/0022-1511(2007)41[341:FBIWAA]2.0.CO;2; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Unwin D, 2005, PTEROSAURS DEEP TIME, P140; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; VLECK D, 1984, PHYSIOL ZOOL, V57, P444, DOI 10.1086/physzool.57.4.30163346; WELLNHOFER P, 1985, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V187, P105; Wellnhofer P., 1975, PALAEONTOGRAPHICA A, V148, P132; WELLNHOFER P, 1978, HDB PALAOHERPETOL 19; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Wells N.A., 1989, Paleontological Society Special Publication, P120; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Wong S, 1999, THESIS GRIFFITH U QU, P64; Young B, 2006, WHEATERS FUNCTIONAL; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	70	45	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31392	10.1371/journal.pone.0031392	http://dx.doi.org/10.1371/journal.pone.0031392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355361	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000302741300061
J	Quicke, DLJ				Quicke, Donald L. J.			We Know Too Little about Parasitoid Wasp Distributions to Draw Any Conclusions about Latitudinal Trends in Species Richness, Body Size and Biology	PLOS ONE			English	Article							BRACONIDAE HYMENOPTERA ICHNEUMONOIDEA; ANOMALOUS DIVERSITY; COSTA-RICA; GRADIENTS; BUTTERFLIES; HYPOTHESIS; MORPHOLOGY; PATTERNS; HISTORY; FORESTS	Much has been written about latitudinal trends in parasitoid diversity and biology, though it is widely recognised that they are a comparatively poorly known group. Here I show that for both braconid and ichneumonid wasps there are highly significant relationships between body size and the mean recorded latitude of species. Numbers of species per genus (surrogates of clades) peaks in the temperate zone for both families contrasting with data from the virtually complete inventories for mammals, birds and monocot plants, suggesting massive under-description of tropical parasitoid faunas. If the ichneumonoids may be expected to show similar trends to mammals, birds and other groups, the implication is that taxonomic work both in terms of active generic revisions, but also likely, the collecting and processing of museum specimens, and selection of taxa for revision, is woefully inadequate to allow latitudinal patterns in biology to be analysed.	[Quicke, Donald L. J.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Quicke, Donald L. J.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England	Imperial College London; Natural History Museum London	Quicke, DLJ (corresponding author), Imperial Coll London, Dept Life Sci, Ascot, Berks, England.	d.quicke@imperial.ac.uk	Quicke, Donald LJ/I-5948-2012	Quicke, Donald/0000-0003-4471-6775				Belshaw R, 2002, SYST BIOL, V51, P450, DOI 10.1080/10635150290069896; BLACKBURN TM, 1994, P ROY SOC B-BIOL SCI, V257, P293, DOI 10.1098/rspb.1994.0128; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A., 2005, ENCY STAT SCI, V12, P7907, DOI DOI 10.1890/13-0133.1; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dolphin K, 2001, BIOL J LINN SOC, V73, P279, DOI 10.1006/bijl.2001.0537; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; GASTON KJ, 1993, J TROP ECOL, V9, P491, DOI 10.1017/S0266467400007550; GASTON KJ, 1995, BIODIVERS CONSERV, V4, P119, DOI 10.1007/BF00137780; Gauld Ian D., 1994, P279; GAULD ID, 1992, OIKOS, V65, P353, DOI 10.2307/3545032; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Hawkins B. A., 1994, PATTERN PROCESS HOST; HAWKINS BA, 1995, ECOL ENTOMOL, V20, P195, DOI 10.1111/j.1365-2311.1995.tb00446.x; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Horstmann Klaus, 1999, Ecotropica, V5, P1; JANZEN DH, 1981, ECOLOGY, V62, P532, DOI 10.2307/1937717; JANZEN DH, 1975, T ROY ENT SOC LONDON, V127, P33; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones OR, 2009, INSECT CONSERV DIVER, V2, P204, DOI 10.1111/j.1752-4598.2009.00057.x; Kindlmann Pavel, 2007, P246; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; OWEN DF, 1974, NATURE, V249, P583, DOI 10.1038/249583a0; Quicke D. L. J., 1997, PARASITIC WASPS; Quicke DLJ, 2009, J NAT HIST, V43, P1305, DOI 10.1080/00222930902807783; R Core Team, 2020, R LANG ENV STAT COMP; RATHCKE BJ, 1976, AM NAT, V110, P889; Saaksjarvi IE, 2004, ECOL ENTOMOL, V29, P735, DOI 10.1111/j.0307-6946.2004.00656.x; Santos AMC, 2011, ENTOMOL SCI, V14, P371, DOI 10.1111/j.1479-8298.2011.00481.x; Sharanowski BJ, 2011, SYST ENTOMOL, V36, P549, DOI 10.1111/j.1365-3113.2011.00580.x; Sime KR, 1998, J ANIM ECOL, V67, P387, DOI 10.1046/j.1365-2656.1998.00198.x; Skillen EL, 2000, ENVIRON ENTOMOL, V29, P460, DOI 10.1603/0046-225X-29.3.460; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Veijalainen A, 2012, INSECT CONS IN PRESS; Veijalainen A, 2011, ZOOKEYS, P59, DOI 10.3897/zookeys.124.1780; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yu DSK, 2016, TAXAPAD 2016 ICHNEUM	39	65	70	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32101	10.1371/journal.pone.0032101	http://dx.doi.org/10.1371/journal.pone.0032101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355411	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300111
J	Udayashankar, AP; Kossl, M; Nowotny, M				Udayashankar, Arun Palghat; Koessl, Manfred; Nowotny, Manuela			Tonotopically Arranged Traveling Waves in the Miniature Hearing Organ of Bushcrickets	PLOS ONE			English	Article							BASILAR-MEMBRANE; AUDITORY RECEPTORS; TETTIGONIIDAE ORTHOPTERA; FUNCTIONAL-ORGANIZATION; GUINEA-PIG; TRANSMISSION; EMISSIONS; MOTION	Place based frequency discrimination (tonotopy) is a fundamental property of the coiled mammalian cochlea. Sound vibrations mechanically conducted to the hearing organ manifest themselves into slow moving waves that travel along the length of the organ, also referred to as traveling waves. These traveling waves form the basis of the tonotopic frequency representation in the inner ear of mammals. However, so far, due to the secure housing of the inner ear, these waves only could be measured partially over small accessible regions of the inner ear in a living animal. Here, we demonstrate the existence of tonotopically ordered traveling waves covering most of the length of a miniature hearing organ in the leg of bushcrickets in vivo using laser Doppler vibrometery. The organ is only 1 mm long and its geometry allowed us to investigate almost the entire length with a wide range of stimuli (6 to 60 kHz). The tonotopic location of the traveling wave peak was exponentially related to stimulus frequency. The traveling wave propagated along the hearing organ from the distal (high frequency) to the proximal (low frequency) part of the leg, which is opposite to the propagation direction of incoming sound waves. In addition, we observed a non-linear compression of the velocity response to varying sound pressure levels. The waves are based on the delicate micromechanics of cellular structures different to those of mammals. Hence place based frequency discrimination by traveling waves is a physical phenomenon that presumably evolved in mammals and bushcrickets independently.	[Udayashankar, Arun Palghat; Koessl, Manfred; Nowotny, Manuela] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, AK Neurobiol & Biosensorik, Frankfurt, Germany	Goethe University Frankfurt	Udayashankar, AP (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, AK Neurobiol & Biosensorik, Frankfurt, Germany.	nowotny@bio.uni-frankfurt.de			German Research Foundation (DFG) [841/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) NO 841/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Bangert M, 1998, HEARING RES, V115, P27, DOI 10.1016/S0378-5955(97)00177-9; Bell A, 2004, PLOS BIOL, V2, P1521, DOI 10.1371/journal.pbio.0020337; Cooper NP, 1996, AUDIT NEUROSCI, V2, P207; de Boer E, 2008, J ACOUST SOC AM, V123, P1513, DOI 10.1121/1.2828064; de La Rochefoucauld O, 2007, BIOPHYS J, V93, P3434, DOI 10.1529/biophysj.107.109744; Dong W, 2008, J ACOUST SOC AM, V123, P222, DOI 10.1121/1.2816566; Emadi G, 2004, J NEUROPHYSIOL, V91, P474, DOI 10.1152/jn.00446.2003; FIELDEN A, 1960, J EXP BIOL, V37, P832; FRENCH AS, 1988, ANNU REV ENTOMOL, V33, P39, DOI 10.1146/annurev.en.33.010188.000351; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; HOFFMANN E, 1995, J ACOUST SOC AM, V98, P1845, DOI 10.1121/1.413371; Hummel J, 2011, J EXP BIOL, V214, P3596, DOI 10.1242/jeb.054445; JOHNSTONE BM, 1986, HEARING RES, V22, P147, DOI 10.1016/0378-5955(86)90090-0; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kossl M, 2008, J COMP PHYSIOL A, V194, P597, DOI 10.1007/s00359-008-0344-0; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Nowotny M, 2010, J COMP PHYSIOL A, V196, P939, DOI 10.1007/s00359-010-0577-6; OLDFIELD BP, 1986, J COMP PHYSIOL A, V158, P27, DOI 10.1007/BF00614517; OLDFIELD BP, 1982, J COMP PHYSIOL, V147, P461, DOI 10.1007/BF00612011; OLDFIELD BP, 1985, J EXP BIOL, V116, P493; OLDFIELD BP, 1984, J COMP PHYSIOL, V155, P689, DOI 10.1007/BF00610855; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; PEAKE WT, 1980, J ACOUST SOC AM, V67, P1736, DOI 10.1121/1.384300; Ren TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1226; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Rhode WS, 2007, J ACOUST SOC AM, V121, P2792, DOI 10.1121/1.2718397; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; SCHUMACHER R, 1975, Z MORPHOL TIERE, V81, P209, DOI 10.1007/BF00278370; Serbetcioglu MB, 1999, ACTA OTO-LARYNGOL, V119, P537; Stolting H, 1998, CELL TISSUE RES, V294, P377, DOI 10.1007/s004410051187; Sueur J, 2006, J EXP BIOL, V209, P4115, DOI 10.1242/jeb.02460; Tsuji J, 1997, J COMP NEUROL, V381, P188; Vater M, 2011, HEARING RES, V273, P89, DOI 10.1016/j.heares.2010.05.018; von Bekesy G, 1928, PHYS Z, V29, P793; vonBekesy G., 1960, EXPT HEARING; Windmill JFC, 2005, J EXP BIOL, V208, P157, DOI 10.1242/jeb.01332; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	42	30	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31008	10.1371/journal.pone.0031008	http://dx.doi.org/10.1371/journal.pone.0031008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348035	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900019
J	Cheng, Y; Thomas, A; Mardini, F; Bianchi, SL; Tang, JXX; Peng, J; Wei, HF; Eckenhoff, MF; Eckenhoff, RG; Levy, RJ				Cheng, Ying; Thomas, Adia; Mardini, Feras; Bianchi, Shannon L.; Tang, Junxia X.; Peng, Jun; Wei, Huafeng; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.; Levy, Richard J.			Neurodevelopmental Consequences of Sub-Clinical Carbon Monoxide Exposure in Newborn Mice	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; OCCURRING CELL-DEATH; CYTOCHROME-C; BRAIN-DEVELOPMENT; MATERNAL SMOKING; PASSIVE SMOKING; NERVOUS-SYSTEM; IN-VIVO; APOPTOSIS; CHILDREN	Carbon monoxide (CO) exposure at high concentrations results in overt neurotoxicity. Exposure to low CO concentrations occurs commonly yet is usually sub-clinical. Infants are uniquely vulnerable to a variety of toxins, however, the effects of postnatal sub-clinical CO exposure on the developing brain are unknown. Apoptosis occurs normally within the brain during development and is critical for synaptogenesis. Here we demonstrate that brief, postnatal sub-clinical CO exposure inhibits developmental neuroapoptosis resulting in impaired learning, memory, and social behavior. Three hour exposure to 5 ppm or 100 ppm CO impaired cytochrome c release, caspase-3 activation, and apoptosis in neocortex and hippocampus of 10 day old CD-1 mice. CO increased NeuN protein, neuronal numbers, and resulted in megalencephaly. CO-exposed mice demonstrated impaired memory and learning and reduced socialization following exposure. Thus, CO-mediated inhibition of neuroapoptosis might represent an important etiology of acquired neurocognitive impairment and behavioral disorders in children.	[Cheng, Ying; Thomas, Adia; Levy, Richard J.] George Washington Univ, Sch Med & Hlth Sci, Div Anesthesiol & Pain Med, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Mardini, Feras; Bianchi, Shannon L.; Tang, Junxia X.; Peng, Jun; Wei, Huafeng; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Children's National Health System; George Washington University; University of Pennsylvania	Cheng, Y (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Div Anesthesiol & Pain Med, Childrens Natl Med Ctr, Washington, DC 20052 USA.	rlevy@cnmc.org		Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [5K08GM074117-04, AG31742]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM074117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031742] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) 5K08GM074117-04 (RJL) and AG31742 (RGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai Y, 1998, ARCH NEUROL-CHICAGO, V55, P845, DOI 10.1001/archneur.55.6.845; Barnard-Brak L, 2011, PEDIATR NEUROL, V44, P97, DOI 10.1016/j.pediatrneurol.2010.09.011; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berman S, 2003, PEDIAT DECISION MAKI; Bernardini C, 2010, CELL STRESS CHAPERON, V15, P219, DOI 10.1007/s12192-009-0136-7; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Chan WY, 2002, ANAT RECORD, V267, P261, DOI 10.1002/ar.10100; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; DIGIOVANNI V, 1993, BRAIN RES, V616, P126; Eskenazi B, 1999, ENVIRON HEALTH PERSP, V107, P991, DOI 10.1289/ehp.99107991; Farahani R, 2008, PEDIATR PULM, V43, P20, DOI 10.1002/ppul.20729; Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721; FERRER I, 1990, NEUROSCIENCE, V39, P451, DOI 10.1016/0306-4522(90)90281-8; FERRER I, 1990, NEUROSCI RES, V8, P60, DOI 10.1016/0168-0102(90)90058-M; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gomez C, 2005, PREV MED, V40, P10, DOI 10.1016/j.ypmed.2004.04.049; Gorman D, 2003, TOXICOLOGY, V187, P25, DOI 10.1016/S0300-483X(03)00005-2; Gul I, 2011, ANGIOLOGY, V62, P245, DOI 10.1177/0003319710377077; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAUCK H, 1984, EUR J APPL PHYSIOL O, V53, P186, DOI 10.1007/BF00422585; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Hornig M, 2004, MOL PSYCHIATR, V9, P833, DOI 10.1038/sj.mp.4001529; JACOBS EE, 1960, J BIOL CHEM, V235, P531; Jain KK, 2009, TXB HYPERBARIC MED, P111; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Jo WK, 2004, ENVIRON RES, V94, P309, DOI 10.1016/S0013-9351(03)00135-X; Kabir Z, 2011, PEDIATRICS, V128, P263, DOI 10.1542/peds.2011-0023; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kao LW, 2005, MED CLIN N AM, V89, P1161, DOI 10.1016/j.mcna.2005.06.007; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Kapetanaki SM, 2009, BIOCHEMISTRY-US, V48, P1613, DOI 10.1021/bi801817v; Kim NH, 2004, B KOREAN CHEM SOC, V25, P1889; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kwon MS, 2010, KOREAN J PHYSIOL PHA, V14, P257, DOI 10.4196/kjpp.2010.14.5.257; McConnell SC, 2011, MOL CELL BIOL, V31, P876, DOI 10.1128/MCB.00725-10; Nasr V, 2010, BRIT J ANAESTH, V105, P836, DOI 10.1093/bja/aeq271; Olney Ann Haskins, 2007, Semin Pediatr Neurol, V14, P128, DOI 10.1016/j.spen.2007.07.004; OZAWA T, 1980, P NATL ACAD SCI-BIOL, V77, P5084, DOI 10.1073/pnas.77.9.5084; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Piel DA, 2007, CRIT CARE MED, V35, P2120, DOI 10.1097/01.CCM.0000278914.85340.FE; Proytcheva MA, 2009, AM J CLIN PATHOL, V131, P560, DOI 10.1309/AJCPTHBJ4I4YGZQC; Rauh Virginia A, 2010, Neoreviews, V11, P363; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rosenberg RE, 2009, J AUTISM DEV DISORD, V39, P1099, DOI 10.1007/s10803-009-0723-6; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Smithline HA, 2003, RESUSCITATION, V56, P97, DOI 10.1016/S0300-9572(02)00272-1; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512; Tanaka M, 2002, J BACTERIOL, V184, P840, DOI 10.1128/JB.184.3.840-845.2002; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Webber DS, 2003, J NEUROSCI RES, V74, P655, DOI 10.1002/jnr.10809; WEITZMAN M, 1992, PEDIATRICS, V90, P342; WINTER PM, 1976, JAMA-J AM MED ASSOC, V236, P1502, DOI 10.1001/jama.236.13.1502; Zhou HC, 2010, EXP BIOL MED, V235, P1236, DOI 10.1258/ebm.2010.010147	61	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e32029	10.1371/journal.pone.0032029	http://dx.doi.org/10.1371/journal.pone.0032029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348142	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730900030
J	Hugentobler, F; Yam, KK; Gillard, J; Mahbuba, R; Olivier, M; Cousineau, B				Hugentobler, Felix; Yam, Karen K.; Gillard, Joshua; Mahbuba, Raya; Olivier, Martin; Cousineau, Benoit			Immunization against Leishmania major Infection Using LACK- and IL-12-Expressing Lactococcus lactis Induces Delay in Footpad Swelling	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; TOXIN FRAGMENT-C; CUTANEOUS LEISHMANIASIS; TETANUS TOXIN; VISCERAL LEISHMANIASIS; LISTERIA-MONOCYTOGENES; ACID BACTERIA; T-CELLS; ANTIGEN; MICE	Background: Leishmania is a mammalian parasite affecting over 12 million individuals worldwide. Current treatments are expensive, cause severe side effects, and emerging drug resistance has been reported. Vaccination is the most cost-effective means to control infectious disease but currently there is no vaccine available against Leishmaniasis. Lactococcus lactis is a non-pathogenic, non-colonizing Gram-positive lactic acid bacterium commonly used in the dairy industry. Recently, L. lactis was used to express biologically active molecules including vaccine antigens and cytokines. Methodology/Principal findings: We report the generation of L. lactis strains expressing the protective Leishmania antigen, LACK, in the cytoplasm, secreted or anchored to the bacterial cell wall. L. lactis was also engineered to secrete biologically active single chain mouse IL-12. Subcutaneous immunization with live L. lactis expressing LACK anchored to the cell wall and L. lactis secreting IL-12 significantly delayed footpad swelling in Leishmania major infected BALB/c mice. The delay in footpad swelling correlated with a significant reduction of parasite burden in immunized animals compared to control groups. Immunization with these two L. lactis strains induced antigen-specific multifunctional T(H)1 CD4(+) and CD8(+) T cells and a systemic LACK-specific T(H)1 immune response. Further, protection in immunized animals correlated with a Leishmania-specific T(H)1 immune response post-challenge. L. lactis secreting mouse IL-12 was essential for directing immune responses to LACK towards a protective T(H)1 response. Conclusions/Significance: This report demonstrates the use of L. lactis as a live vaccine against L. major infection in BALB/c mice. The strains generated in this study provide the basis for the development of an inexpensive and safe vaccine against the human parasite Leishmania.	[Hugentobler, Felix; Yam, Karen K.; Gillard, Joshua; Mahbuba, Raya; Olivier, Martin; Cousineau, Benoit] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Olivier, Martin] McGill Univ, Ctr Hlth, Res Inst, Ctr Study Host Resistance, Montreal, PQ, Canada	McGill University; McGill University	Hugentobler, F (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Univ St, Montreal, PQ, Canada.	benoit.cousineau@mcgill.ca			Canadian Institutes of Health Research [CIHR89745]; McGill University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR89745) to BC and MO. BC is a McGill University William Dawson Scholar and a Chercheur-Boursier Senior from Fonds de la Recherche en Sante du Quebec (FRSQ). FH was the recipient of a F.C. Harrison Fellowship from McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Ait-Oudhia K, 2011, PARASITOL RES; Ameen M, 2010, CLIN EXP DERMATOL, V35, P699, DOI 10.1111/j.1365-2230.2010.03851.x; Bahey-El-Din M, 2010, CURR GENE THER, V10, P34, DOI 10.2174/156652310790945557; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Bermudez-Humaran LG, 2003, INFECT IMMUN, V71, P1887, DOI 10.1128/IAI.71.4.1887-1896.2003; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Casalta E, 2008, INT J FOOD MICROBIOL, V126, P271, DOI 10.1016/j.ijfoodmicro.2007.08.013; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gonzalo RM, 2001, MICROBES INFECT, V3, P701, DOI 10.1016/S1286-4579(01)01426-5; Grangette C, 2002, VACCINE, V20, P3304, DOI 10.1016/S0264-410X(02)00301-8; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kelly BL, 2003, J EXP MED, V198, P1689, DOI 10.1084/jem.20031162; Kobets T, 2010, NAT PROTOC, V5, P1074, DOI 10.1038/nprot.2010.68; Lange UG, 2004, INFECT IMMUN, V72, P4924, DOI 10.1128/IAI.72.8.4924-4928.2004; Le Loir Y, 1998, J BACTERIOL, V180, P1895, DOI 10.1128/JB.180.7.1895-1903.1998; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; MILLS DA, 1994, APPL ENVIRON MICROB, V60, P4413, DOI 10.1128/AEM.60.12.4413-4420.1994; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Norton PM, 1996, FEMS IMMUNOL MED MIC, V14, P167, DOI 10.1111/j.1574-695X.1996.tb00284.x; Pinto EF, 2004, INFECT IMMUN, V72, P4521, DOI 10.1128/IAI.72.8.4521-4527.2004; Prina E, 1996, J IMMUNOL, V156, P4318; Ribeiro LA, 2002, APPL ENVIRON MICROB, V68, P910, DOI 10.1128/AEM.68.2.910-916.2002; Robinson K, 2004, INFECT IMMUN, V72, P2753, DOI 10.1128/IAI.72.5.2753-2761.2004; Robinson K, 1997, NAT BIOTECHNOL, V15, P653, DOI 10.1038/nbt0797-653; Rottiers P, 2009, INT REV IMMUNOL, V28, P465, DOI 10.3109/08830180903197498; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Soussi N, 2000, INFECT IMMUN, V68, P1498, DOI 10.1128/IAI.68.3.1498-1506.2000; Soussi N, 2002, VACCINE, V20, P2702, DOI 10.1016/S0264-410X(02)00198-6; Sriraman K, 2008, APPL ENVIRON MICROB, V74, P7442, DOI 10.1128/AEM.00638-08; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Villatoro-Hernandez J, 2011, EXPERT OPIN BIOL THE; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Yam KK, 2008, VACCINE, V26, P2689, DOI 10.1016/j.vaccine.2008.03.024; Yam KK, 2011, J MED MICROBIOL	45	25	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30945	10.1371/journal.pone.0030945	http://dx.doi.org/10.1371/journal.pone.0030945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348031	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730900016
J	Lee, SS; Lam, ANS; Lee, CK; Wong, NS				Lee, Shui-Shan; Lam, Agnes N. S.; Lee, Chi-Kei; Wong, Ngai-Sze			Virtual versus Physical Channel for Sex Networking in Men Having Sex with Men of Sauna Customers in the City of Hong Kong	PLOS ONE			English	Article							HIV PREVENTION; RISK BEHAVIORS; INTERNET; INFECTION; PREVALENCE; EPIDEMIC; SYPHILIS; TRANSMISSION; PARTNERS; INCREASE	Background: Advances in communication technology may affect networking pattern, thereby influencing the dynamics of sex partnership. The aim of the study is to explore the impacts of partner sourcing through internet and related channels on exposure risk to sexually transmitted infections (STI) including HIV. Methods: Using venue-based sampling, a cross-sectional questionnaire survey was conducted at saunas frequented by men having sex with men (MSM) in Hong Kong. Comparison was made between MSM sourcing partners through physical venues alone versus concomitant users of physical and virtual channels, the latter referring to internet and smart-phone applications, using bivariate logistic regression. Results: Over a 7-week study period, 299 MSM were recruited from 9 saunas. Three main types of sex partners were distinguished: steady (46.8%), regular (26.4%) and casual (96.0%) partners. Users of sauna (n = 78) were compared with concomitant users of saunas and virtual channels (n = 179) for partner sourcing. Sauna-visiting virtual channel users were younger and inclined to use selected physical venues for sourcing partners. Smart-phone users ( n = 90) were not different from other internet-users in terms of age, education level and single/mixed self-identified body appearance. Classifying respondents into high risk and low risk MSM by their frequency of condom use, concomitant use of both sauna and virtual channels accounted for a higher proportion in the high risk category (71.6% vs. 58.2%, OR = 1.81, p<0.05). In virtual channel users, partner sourcing through smart-phone was not associated with a higher practice of unprotected sex. Conclusion: MSM sauna customers commonly use virtual channels for sex partner sourcing. Unprotected sex is more prevalent in sauna customers who use virtual channel for sex partner sourcing. While the popularity of smart-phone is rising, its use is not associated with increased behavioural risk for HIV/STI transmission.	[Lee, Shui-Shan; Lam, Agnes N. S.; Lee, Chi-Kei; Wong, Ngai-Sze] Chinese Univ Hong Kong, Prince Wales Hosp, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Lee, SS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; Wong, Ngai Sze/A-3145-2012	Lee, Shui Shan/0000-0003-1448-765X; Wong, Ngai Sze/0000-0003-3788-8114	Council for the AIDS Trust Fund, Hong Kong [MSS172R]	Council for the AIDS Trust Fund, Hong Kong	The study was supported by the Council for the AIDS Trust Fund, Hong Kong (http://www.atf.gov.hk), grant number MSS172R. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ECONOMIST; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bremer V, 2006, Euro Surveill, V11, P152; CHIN J, 1988, AIDS, V2, pS247, DOI 10.1097/00002030-198800001-00038; Jenness SM, 2010, AIDS BEHAV, V14, P1353, DOI 10.1007/s10461-010-9769-x; Lau JTF, 2003, AIDS EDUC PREV, V15, P516, DOI 10.1521/aeap.15.7.516.24046; Lee SS, 2011, PUBLIC HEALTH, V125, P433, DOI 10.1016/j.puhe.2011.03.010; Lee Shui Shan, 2009, J Infect Public Health, V2, P177, DOI 10.1016/j.jiph.2009.09.002; Liau A, 2006, SEX TRANSM DIS, V33, P576, DOI 10.1097/01.olq.0000204710.35332.c5; Likatavicius G, 2008, SEX TRANSM INFECT, V84, P499, DOI 10.1136/sti.2008.031419; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Quan VM, 2002, JAIDS-J ACQ IMM DEF, V31, P188, DOI 10.1097/00126334-200210010-00010; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Rosser BRS, 2011, AIDS BEHAV, V15, pS91, DOI 10.1007/s10461-011-9910-5; Rosser BRS, 2009, AIDS BEHAV, V13, P746, DOI 10.1007/s10461-008-9399-8; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Spielmann N, 2010, SEX TRANSM INFECT, V86, P331, DOI 10.1136/sti.2009.040857; Swendeman D, 2010, CURR OPIN PSYCHIATR, V23, P139, DOI 10.1097/YCO.0b013e328336656a; Tsui HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-232; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Wilson DP, 2009, JAIDS-J ACQ IMM DEF, V51, P356; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883; Youm Y, 2010, SEX TRANSM INFECT, V86, P24, DOI 10.1136/sti.2010.044008; Zhang M, 2011, AIDS RES HUM RE 0506	26	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31072	10.1371/journal.pone.0031072	http://dx.doi.org/10.1371/journal.pone.0031072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348038	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730900018
J	Tukvadze, N; Kempker, RR; Kalandadze, I; Kurbatova, E; Leonard, MK; Apsindzelashvili, R; Bablishvili, N; Kipiani, M; Blumberg, HM				Tukvadze, Nestani; Kempker, Russell R.; Kalandadze, Iagor; Kurbatova, Ekaterina; Leonard, Michael K.; Apsindzelashvili, Rusudan; Bablishvili, Nino; Kipiani, Maia; Blumberg, Henry M.			Use of a Molecular Diagnostic Test in AFB Smear Positive Tuberculosis Suspects Greatly Reduces Time to Detection of Multidrug Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; DRUG-RESISTANCE; MTBDRPLUS ASSAY; HIGH PREVALENCE; CHEMOTHERAPY; STRAINS	Background: The WHO has recommended the implementation of rapid diagnostic tests to detect and help combat M/XDR tuberculosis (TB). There are limited data on the performance and impact of these tests in field settings. Methods: The performance of the commercially available Genotype MTBDRplus molecular assay was compared to conventional methods including AFB smear, culture and drug susceptibility testing (DST) using both an absolute concentration method on Lowenstein-Jensen media and broth-based method using the MGIT 960 system. Sputum specimens were obtained from TB suspects in the country of Georgia who received care through the National TB Program. Results: Among 500 AFB smear-positive sputum specimens, 458 (91.6%) had both a positive sputum culture for Mycobacterium tuberculosis and a valid MTBDRplus assay result. The MTBDRplus assay detected isoniazid (INH) resistance directly from the sputum specimen in 159 (89.8%) of 177 specimens and MDR-TB in 109 (95.6%) of 114 specimens compared to conventional methods. There was high agreement between the MTBDRplus assay and conventional DST results in detecting MDR-TB (kappa = 0.95, p<0.01). The most prevalent INH resistance mutation was S315T (78%) in the katG codon and the most common rifampicin resistance mutation was S531L (68%) in the rpoB codon. Among 13 specimens from TB suspects with negative sputum cultures, 7 had a positive MTBDRplus assay (3 with MDR-TB). The time to detection of MDR-TB was significantly less using the MTBDRplus assay (4.2 days) compared to the use of standard phenotypic tests (67.3 days with solid media and 21.6 days with broth-based media). Conclusions: Compared to conventional methods, the MTBDRplus assay had high accuracy and significantly reduced time to detection of MDR-TB in an area with high MDR-TB prevalence. The use of rapid molecular diagnostic tests for TB and drug resistance should increase the proportion of patients promptly placed on appropriate therapy.	[Tukvadze, Nestani; Kalandadze, Iagor; Apsindzelashvili, Rusudan; Bablishvili, Nino; Kipiani, Maia] Natl Ctr TB & Lung Dis, Tbilisi, Georgia; [Kempker, Russell R.; Kurbatova, Ekaterina; Leonard, Michael K.; Blumberg, Henry M.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	Emory University	Tukvadze, N (corresponding author), Natl Ctr TB & Lung Dis, Tbilisi, Georgia.	marikushane@yahoo.com; rkempke@emory.edu	Blumberg, Henry/W-2156-2019	Blumberg, Henry/0000-0002-3110-2443	NIH Fogarty International Center [D43TW007124, D43TW007124-06S1]; Atlanta Clinical and Translational Science Institute [NIH/NCRR UL1RR025008]; U.S. Civilian and Research Development Foundation [CRDF GEB2-2935-TB-08]; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER	NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Atlanta Clinical and Translational Science Institute; U.S. Civilian and Research Development Foundation; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the NIH Fogarty International Center [D43TW007124 and D43TW007124-06S1], the Atlanta Clinical and Translational Science Institute [NIH/NCRR UL1RR025008], the U.S. Civilian and Research Development Foundation (CRDF GEB2-2935-TB-08), and the Emory Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anek-vorapong R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-123; [Anonymous], GENOTYPE MTBDRPLUS P; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; Dorman SE, 2010, CLIN INFECT DIS, V50, pS173, DOI 10.1086/651488; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Evans J, 2009, J ANTIMICROB CHEMOTH, V63, P11, DOI 10.1093/jac/dkn433; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Kent PT, 1985, GUIDE LEVEL 3 LAB; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Matthys F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007954; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Richards DC, 2006, INT J TUBERC LUNG D, V10, P396; WHO, 2009, WHOHTMTB2009422; World Health Organization, 2011, WHOHTMTB20113; World Health Organization, 2008, WHO POL STAT MOL LIN; World Health Organization, 2008, WHOHTMTB2008392; World Health Organization, 2010, WHOHTMTB20103; World Health Organization & Stop TB Partnership, 2010, WHOHTMSTB20102; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	26	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31563	10.1371/journal.pone.0031563	http://dx.doi.org/10.1371/journal.pone.0031563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347495	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200025
J	Czech, C; Berndt, P; Busch, K; Schmitz, O; Wiemer, J; Most, V; Hampel, H; Kastler, J; Senn, H				Czech, Christian; Berndt, Peter; Busch, Kristina; Schmitz, Oliver; Wiemer, Jan; Most, Veronique; Hampel, Harald; Kastler, Juergen; Senn, Hans			Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid	PLOS ONE			English	Article							SENILE DEMENTIA; CSF; CORTISOL; NOREPINEPHRINE; HOMOCYSTEINE; DIAGNOSTICS; DYSFUNCTION; BIOMARKERS; DISCOVERY; MARKERS	Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive loss of cognitive functions. Today the diagnosis of AD relies on clinical evaluations and is only late in the disease. Biomarkers for early detection of the underlying neuropathological changes are still lacking and the biochemical pathways leading to the disease are still not completely understood. The aim of this study was to identify the metabolic changes resulting from the disease phenotype by a thorough and systematic metabolite profiling approach. For this purpose CSF samples from 79 AD patients and 51 healthy controls were analyzed by gas and liquid chromatography-tandem mass spectrometry (GC-MS and LC-MS/MS) in conjunction with univariate and multivariate statistical analyses. In total 343 different analytes have been identified. Significant changes in the metabolite profile of AD patients compared to healthy controls have been identified. Increased cortisol levels seemed to be related to the progression of AD and have been detected in more severe forms of AD. Increased cysteine associated with decreased uridine was the best paired combination to identify light AD (MMSE>22) with specificity and sensitivity above 75%. In this group of patients, sensitivity and specificity above 80% were obtained for several combinations of three to five metabolites, including cortisol and various amino acids, in addition to cysteine and uridine.	[Czech, Christian; Berndt, Peter; Senn, Hans] F Hoffmann La Roche, Div Pharmaceut, Basel, Switzerland; [Busch, Kristina] Badisch Anylene & Soda Fabriques BASF SE, Limburgerhof, Germany; [Schmitz, Oliver; Wiemer, Jan; Kastler, Juergen] Metanomics, Berlin, Germany; [Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Most, Veronique] Forenap Pharma, Rouffach, France	Roche Holding; BASF; Goethe University Frankfurt	Czech, C (corresponding author), F Hoffmann La Roche, Div Pharmaceut, Basel, Switzerland.	christian.czech@roche.com		Hampel, Harald/0000-0003-0894-8982; Czech, Christian/0000-0001-7746-0134	F. Hoffman-La Roche	F. Hoffman-La Roche	This study was supported by F. Hoffman-La Roche. CC, HS, and PB are employees of F. Hoffmann-La Roche. KB, OS, JW and JK were employed by metanomics during the time of the study, all these authors contributed to all aspects of the study. The funders had no role in data collection. The funders of the study had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BEAL MF, 1986, PROG NEURO-PSYCHOPH, V10, P259, DOI 10.1016/0278-5846(86)90006-0; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; Choi YS, 2010, EXPERT REV PROTEOMIC, V7, P919, DOI 10.1586/EPR.10.75; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; Czech Christian, 2004, Current Neuropharmacology, V2, P295, DOI 10.2174/1570159043359666; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Elrod R, 1997, AM J PSYCHIAT, V154, P25; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Laske C, 2009, EUR ARCH PSY CLIN N, V259, P80, DOI 10.1007/s00406-008-0838-3; Lerner Alan J., 2000, Journal of Alzheimer's Disease, V2, P193; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McCaddon A, 2003, BIOL PSYCHIAT, V53, P254, DOI 10.1016/S0006-3223(02)01451-8; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; Otto M, 2008, METHODS, V44, P289, DOI 10.1016/j.ymeth.2007.06.012; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Popp J, 2009, J ALZHEIMERS DIS, V18, P819, DOI 10.3233/JAD-2009-1187; Popp J, 2009, NEUROBIOL AGING, V30, P498, DOI 10.1016/j.neurobiolaging.2007.07.007; R Core Team, 2018, R LANG ENV STAT COMP; REINIKAINEN KJ, 1990, J NEUROSCI RES, V27, P576, DOI 10.1002/jnr.490270419; REINIKAINEN KJ, 1988, NEUROBIOL AGING, V9, P245, DOI 10.1016/S0197-4580(88)80061-7; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Schlotterbeck G, 2006, PHARMACOGENOMICS, V7, P1055, DOI 10.2217/14622416.7.7.1055; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; SWEATMAN BC, 1993, J PHARMACEUT BIOMED, V11, P651, DOI 10.1016/0731-7085(93)80171-V; TOHGI H, 1992, J NEURAL TRANSM-PARK, V4, P69, DOI 10.1007/BF02257623; TOHGI H, 1994, NEUROSCI LETT, V177, P139, DOI 10.1016/0304-3940(94)90064-7; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Vogel T, 2009, INT J CLIN PRACT, V63, P1061, DOI 10.1111/j.1742-1241.2009.02026.x; Watson GS, 2006, NEUROBIOL AGING, V27, P38, DOI 10.1016/j.neurobiolaging.2004.11.011; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Yamada H, 2002, J ANAL TOXICOL, V26, P17, DOI 10.1093/jat/26.1.17; ZWEIG MH, 1993, CLIN CHEM, V39, P561	37	126	128	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31501	10.1371/journal.pone.0031501	http://dx.doi.org/10.1371/journal.pone.0031501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359596	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200065
J	Linnertz, C; Saunders, AM; Lutz, MW; Crenshaw, DM; Grossman, I; Burns, DK; Whitfield, KE; Hauser, MA; McCarthy, JJ; Ulmer, M; Allingham, R; Welsh-Bohmer, KA; Roses, AD; Chiba-Falek, O				Linnertz, Colton; Saunders, Ann M.; Lutz, Michael W.; Crenshaw, Donna M.; Grossman, Iris; Burns, Daniel K.; Whitfield, Keith E.; Hauser, Michael A.; McCarthy, Jeanette J.; Ulmer, Megan; Allingham, Rand; Welsh-Bohmer, Kathleen A.; Roses, Allen D.; Chiba-Falek, Ornit			Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations	PLOS ONE			English	Article							LENGTH; ONSET; AGE	We previously discovered that a polymorphic, deoxythymidine-homopolymer (poly-T, rs10524523) in intron 6 of the TOMM40 gene is associated with age-of-onset of Alzheimer's disease and with cognitive performance in elderly. Three allele groups were defined for rs10524523, hereafter '523', based on the number of 'T'-residues: 'Short' (S, T <= 19), 'Long' (L, 20 <= T <= 29) and 'Very Long' (VL, T >= 30). Homopolymers, particularly long homopolymers like '523', are difficult to genotype because 'slippage' occurs during PCR-amplification. We initially genotyped this locus by PCR-amplification followed by Sanger-sequencing. However, we recognized the need to develop a higher-throughput genotyping method that is also accurate and reliable. Here we describe a new '523' genotyping assay that is simple and inexpensive to perform in a standard molecular genetics laboratory. The assay is based on the detection of differences in PCR-fragment length using capillary electrophoresis. We discuss technical problems, solutions, and the steps taken for validation. We employed the novel assay to investigate the '523' allele frequencies in different ethnicities. Whites and Hispanics have similar frequencies of S/L/VL alleles (0.45/0.11/0.44 and 0.43/0.09/0.48, respectively). In African-Americans, the frequency of the L-allele (0.10) is similar to Whites and Hispanics; however, the S-allele is more prevalent (0.65) and the VL-allele is concomitantly less frequent (0.25). The allele frequencies determined using the new methodology are compared to previous reports for Ghanaian, Japanese, Korean and Han Chinese cohorts. Finally, we studied the linkage pattern between TOMM40-'523' and APOE alleles. In Whites and Hispanics, consistent with previous reports, the L is primarily linked to epsilon 4, while the majority of the VL and S are linked to epsilon 3. Interestingly, in African-Americans, Ghanaians and Japanese, there is an increased frequency of the '523'S-APOE epsilon 4 haplotype. These data may be used as references for '523' allele and '523'-APOE haplotype frequencies in diverse populations for the design of research studies and clinical trials.	[Linnertz, Colton; McCarthy, Jeanette J.; Roses, Allen D.; Chiba-Falek, Ornit] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Saunders, Ann M.; Lutz, Michael W.; Crenshaw, Donna M.; Roses, Allen D.] Duke Univ, Med Ctr, Deane Drug Discovery Inst, Durham, NC USA; [Saunders, Ann M.; Roses, Allen D.; Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA; [Grossman, Iris; Burns, Daniel K.] Cabernet Pharmaceut, Chapel Hill, NC USA; [Whitfield, Keith E.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Hauser, Michael A.; Ulmer, Megan] Duke Univ, Ctr Human Genet, Med Ctr, Durham, NC USA; [Allingham, Rand] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Welsh-Bohmer, Kathleen A.; Roses, Allen D.; Chiba-Falek, Ornit] Duke Univ, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Linnertz, C (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA.	o.chibafalek@duke.edu	Welsh-Bohmer, Kathleen/AAA-3178-2020	Carnes, Megan/0000-0002-7270-132X; Lutz, Michael/0000-0001-8809-5574	Ellison Medical Foundation [AG-NS-0441-08]; National Institute on Aging [1RC1AG035635-01]; NATIONAL INSTITUTE ON AGING [RC1AG035635] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by the Ellison Medical Foundation New Scholar award AG-NS-0441-08 (to OC-F). ADR and MWL are supported in part by National Institute on Aging Research Challenge Grant 1RC1AG035635-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caselli RJ, 2010, ALZHEIMERS DEMENT, V6, pS202; Chu SH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.016; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Grossman I, 2010, EPMA J, V1, P293, DOI 10.1007/s13167-010-0024-3; Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012; Koch W, 2002, CLIN CHEM LAB MED, V40, P1123, DOI 10.1515/CCLM.2002.197; Lutz MW, 2010, ALZHEIMERS DEMENT, V6, P125, DOI 10.1016/j.jalz.2010.01.011; Lutz MW, 2010, ANN M AM SOC HUM GEN; Maruszak A, 2011, J ALZHEIMERS DIS; Nelson Tamara, 2007, Metabolic Syndrome and Related Disorders, V5, P262, DOI 10.1089/met.2006.0035; Roses A, 2011, COMMENT ASS EXPRESSI; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69	12	41	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30994	10.1371/journal.pone.0030994	http://dx.doi.org/10.1371/journal.pone.0030994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359560	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200029
J	Tian, LL; Karimi, M; Loftin, SK; Brown, CA; Xia, HC; Xu, JB; Mach, RH; Perlmutter, JS				Tian, LinLin; Karimi, Morvarid; Loftin, Susan K.; Brown, Chris A.; Xia, HuChuan; Xu, JinBin; Mach, Robert H.; Perlmutter, Joel S.			No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MONKEY BRAIN; PATHOLOGICAL RESEARCH; STRIATAL DOPAMINE; NONHUMAN-PRIMATES; NERVE-TERMINALS; H-3 CFT; MPTP; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; MARKERS	Radioligands for DAT and VMAT2 are widely used presynaptic markers for assessing dopamine (DA) nerve terminals in Parkinson disease (PD). Previous in vivo imaging and postmortem studies suggest that these transporter sites may be regulated as the numbers of nigrostriatal neurons change in pathologic conditions. To investigate this issue, we used in vitro quantitative autoradioradiography to measure striatal DAT and VMAT2 specific binding in postmortem brain from 14 monkeys after unilateral internal carotid artery infusion of 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine (MPTP) with doses varying from 0 to 0.31 mg/kg. Quantitative estimates of the number of tyrosine hydroxylase (TH)-immunoreactive (ir) neurons in substantia nigra (SN) were determined with unbiased stereology, and quantitative autoradiography was used to measure DAT and VMAT2 striatal specific binding. Striatal VMAT2 and DAT binding correlated with striatal DA (r(s) = 0.83, r(s) = 0.80, respectively, both with n = 14, p < 0.001) but only with nigra TH-ir cells when nigral cell loss was 50% or less (r = 0.93, n = 8, p = 0.001 and r = 0.91, n = 8, p = 0.002 respectively). Reduction of VMAT2 and DAT striatal specific binding sites strongly correlated with each other (r = 0.93, n = 14, p < 0.0005). These similar changes in DAT and VMAT2 binding sites in the striatal terminal fields of the surviving nigrostriatal neurons demonstrate that there is no differential regulation of these two sites at 2 months after MPTP infusion.	[Tian, LinLin; Karimi, Morvarid; Loftin, Susan K.; Brown, Chris A.; Xia, HuChuan; Perlmutter, Joel S.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Xu, JinBin; Mach, Robert H.; Perlmutter, Joel S.] Washington Univ, Dept Radiol, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Dept Neurobiol, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Dept Occupat Therapy, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Dept Phys Therapy, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Tian, LL (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	joel@npg.wustl.edu	Xu, Jinbin/ABG-1280-2020; Brown, Christopher/AAZ-6852-2021; Tian, LinLin/A-5861-2012	Xu, Jinbin/0000-0002-2120-8287; Brown, Christopher/0000-0003-2057-3976; Tian, LinLin/0000-0001-9504-1718; Mach, Robert/0000-0002-7645-2869	National Institutes of Health [NS050425, NS058714, NS41509, NS075321]; Michael J. Fox Foundation; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; McDonnell Center for Higher Brain Function; Howard Hughes Medical Institute; Barnes-Jewish Hospital Foundation; Murphy Fund; Hartke Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075321, R03NS090214, R01NS058714, R01NS050425, R01NS041509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; McDonnell Center for Higher Brain Function; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Barnes-Jewish Hospital Foundation; Murphy Fund; Hartke Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health (NS050425, NS058714, NS41509, and NS075321) (http://www.nih.gov/); the Michael J. Fox Foundation (http://www.michaeljfox.org/); the American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University (http://stlapda.org/); the Greater St. Louis Chapter of the APDA (http://stlapda.org/); the McDonnell Center for Higher Brain Function (http://centerserv.wustl.edu/funding/); the Howard Hughes Medical Institute (http://www.hhmi.org/); the Barnes-Jewish Hospital Foundation Elliot H. Stein Family Fund and PD Research Fund (http://www.barnesjewish.org/giving/about-us); the Murphy Fund; the Hartke Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto A, 2008, CNS NEUROL DISORD-DR, V7, P187, DOI 10.2174/187152708784083858; ALBANESE A, 1993, NEUROSCIENCE, V55, P823, DOI 10.1016/0306-4522(93)90444-K; BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; Buchert R, 2003, J CEREBR BLOOD F MET, V23, P612, DOI 10.1097/01.WCB.0000060565.21994.07; Burke RE, 2008, J NEUROCHEM, V104, P875, DOI 10.1111/j.1471-4159.2007.05106.x; CANFIELD DR, 1990, SYNAPSE, V6, P189, DOI 10.1002/syn.890060211; CARLSSON A, 1976, J NEURAL TRANSM, V38, P271, DOI 10.1007/BF01249444; Chen MK, 2008, J NEUROCHEM, V105, P78, DOI 10.1111/j.1471-4159.2007.05108.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; De La Garza R, 1999, SYNAPSE, V34, P20, DOI 10.1002/(SICI)1098-2396(199910)34:1<20::AID-SYN3>3.3.CO;2-W; Doudet DJ, 2006, NEUROIMAGE, V30, P26, DOI 10.1016/j.neuroimage.2005.09.044; Frey K, 1997, EUR J PHARMACOL, V334, P273, DOI 10.1016/S0014-2999(97)01152-7; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HERKENHAM M, 1991, NEUROSCIENCE, V40, P133, DOI 10.1016/0306-4522(91)90180-V; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Jakowec MW, 2004, COMPARATIVE MED, V54, P497; Jourdain S, 2005, J NEUROENDOCRINOL, V17, P509, DOI 10.1111/j.1365-2826.2005.01337.x; Karimi M, 2006, J CHROMATOGR B, V836, P120, DOI 10.1016/j.jchromb.2006.03.027; KAUFMAN MJ, 1991, SYNAPSE, V9, P177, DOI 10.1002/syn.890090304; KILBOURN M, 1995, EUR J PHARMACOL, V278, P249, DOI 10.1016/0014-2999(95)00162-E; Kilbourn MR, 2000, SYNAPSE, V35, P250, DOI 10.1002/(SICI)1098-2396(20000315)35:4<250::AID-SYN2>3.0.CO;2-S; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kumar N, 2009, ANAT REC, V292, P976, DOI 10.1002/ar.20891; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; Nelson RJ, 2005, ILAR J, V46, P171, DOI 10.1093/ilar.46.2.171; Perlmutter JS, 1997, NEUROLOGY, V49, P1432, DOI 10.1212/WNL.49.5.1432; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; Ribeiro MJ, 2002, ARCH NEUROL-CHICAGO, V59, P580, DOI 10.1001/archneur.59.4.580; SCHERMAN D, 1988, J NEUROCHEM, V50, P1131, DOI 10.1111/j.1471-4159.1988.tb10583.x; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; Slifstein M, 2000, J NUCL MED, V41, P2083; SLOVITER RS, 1977, J NEUROCHEM, V28, P1129, DOI 10.1111/j.1471-4159.1977.tb10678.x; Soucy JP, 1997, SYNAPSE, V25, P163, DOI 10.1002/(SICI)1098-2396(199702)25:2<163::AID-SYN7>3.0.CO;2-A; Stephenson DT, 2007, CELL TRANSPLANT, V16, P229, DOI 10.3727/000000007783464704; Tabbal SD, 2006, NEUROSCIENCE, V141, P1281, DOI 10.1016/j.neuroscience.2006.04.072; Tedroff J, 1999, ANN NEUROL, V46, P359; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Wilson JM, 1996, NEUROLOGY, V47, P718, DOI 10.1212/WNL.47.3.718; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Xu JB, 2010, SYNAPSE, V64, P449, DOI 10.1002/syn.20748; Yee RE, 2001, MOVEMENT DISORD, V16, P838, DOI 10.1002/mds.1168	50	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31439	10.1371/journal.pone.0031439	http://dx.doi.org/10.1371/journal.pone.0031439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359591	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200060
J	Zhou, HW; DeLoid, G; Browning, E; Gregory, DJ; Tan, FX; Bedugnis, AS; Imrich, A; Koziel, H; Kramnik, I; Lu, Q; Kobzik, L				Zhou, Hongwei; DeLoid, Glen; Browning, Erica; Gregory, David J.; Tan, Fengxiao; Bedugnis, Alice S.; Imrich, Amy; Koziel, Henry; Kramnik, Igor; Lu, Quan; Kobzik, Lester			Genome-Wide RNAi Screen in IFN-gamma-Treated Human Macrophages Identifies Genes Mediating Resistance to the Intracellular Pathogen Francisella tularensis	PLOS ONE			English	Article							CD137 INDUCES PROLIFERATION; INNATE IMMUNE RECOGNITION; LIVE VACCINE STRAIN; REACTIVE NITROGEN; TULAREMIA VACCINE; GROWTH; ACTIVATION; INFECTION; SURVIVAL; CELLS	Interferon-gamma (IFN-gamma) inhibits intracellular replication of Francisella tularensis in human monocyte-derived macrophages (HMDM) and in mice, but the mechanisms of this protective effect are poorly characterized. We used genome-wide RNA interference (RNAi) screening in the human macrophage cell line THP-1 to identify genes that mediate the beneficial effects of IFN-gamma on F. tularensis infection. A primary screen identified similar to 200 replicated candidate genes. These were prioritized according to mRNA expression in IFN-gamma-primed and F. tularensis-challenged macrophages. A panel of 20 top hits was further assessed by re-testing using individual shRNAs or siRNAs in THP-1 cells, HMDMs and primary human lung macrophages. Six of eight validated genes tested were also found to confer resistance to Listeria monocytogenes infection, suggesting a broadly shared host gene program for intracellular pathogens. The F. tularensis-validated hits included 'druggable' targets such as TNFRSF9, which encodes CD137. Treating HMDM with a blocking antibody to CD137 confirmed a beneficial role of CD137 in macrophage clearance of F. tularensis. These studies reveal a number of important mediators of IFN-gamma activated host defense against intracellular pathogens, and implicate CD137 as a potential therapeutic target and regulator of macrophage interactions with Francisella tularensis.	[Zhou, Hongwei; DeLoid, Glen; Browning, Erica; Gregory, David J.; Tan, Fengxiao; Bedugnis, Alice S.; Imrich, Amy; Lu, Quan; Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Koziel, Henry] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02115 USA; [Kramnik, Igor] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Kobzik, Lester] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhou, HW (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	lkobzik@hsph.harvard.edu	Gregory, David/P-2582-2015	Gregory, David/0000-0001-6534-7150; Kramnik, Igor/0000-0001-6511-9246	Defense Threat Reduction Agency [HDTRA-1-06-C-0036]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Defense Threat Reduction Agency HDTRA-1-06-C-0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY LSD, 1992, J IMMUNOL, V148, P1829; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Chiu HC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-110; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; Cremer TJ, 2009, AUTOPHAGY, V5, P125, DOI 10.4161/auto.5.1.7305; DeLoid GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006209; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Jones JW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00016; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; NUTTER JE, 1966, J BACTERIOL, V92, P645, DOI 10.1128/JB.92.3.645-651.1966; Ouadrhiri Y, 1999, ANTIMICROB AGENTS CH, V43, P1242, DOI 10.1128/AAC.43.5.1242; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; POLSINELLI T, 1994, J IMMUNOL, V153, P1238; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2005, TRENDS MICROBIOL; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Sulahian TH, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-59; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Titball RW, 2003, TRENDS MICROBIOL, V11, P118, DOI 10.1016/S0966-842X(03)00020-9; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Yang IV, 2011, MOL IMMUNOL	41	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31752	10.1371/journal.pone.0031752	http://dx.doi.org/10.1371/journal.pone.0031752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359626	Green Published, gold			2022-12-27	WOS:000302796200095
J	Mistlberger, RE; Kent, BA; Chan, S; Patton, DF; Weinberg, A; Parfyonov, M				Mistlberger, Ralph E.; Kent, Brianne A.; Chan, Sofina; Patton, Danica F.; Weinberg, Alexander; Parfyonov, Maksim			Circadian Clocks for All Meal-Times: Anticipation of 2 Daily Meals in Rats	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEI; GARDEN WARBLERS; FOOD ACCESS; OSCILLATORS; RHYTHMS; DISSOCIATION; ENTRAINMENT; EXPRESSION; PACEMAKER; INTACT	Anticipation of a daily meal in rats has been conceptualized as a rest-activity rhythm driven by a food-entrained circadian oscillator separate from the pacemaker generating light-dark (LD) entrained rhythms. Rats can also anticipate two daily mealtimes, but whether this involves independently entrained oscillators, one 'continuously consulted' clock, cue-dependent non-circadian interval timing or a combination of processes, is unclear. Rats received two daily meals, beginning 3-h (meal 1) and 13-h (meal 2) after lights-on (LD 14: 10). Anticipatory wheel running began 68 +/- 8 min prior to meal 1 and 101 +/- 9 min prior to meal 2 but neither the duration nor the variability of anticipation bout lengths exhibited the scalar property, a hallmark of interval timing. Meal omission tests in LD and constant dark (DD) did not alter the timing of either bout of anticipation, and anticipation of meal 2 was not altered by a 3-h advance of meal 1. Food anticipatory running in this 2-meal protocol thus does not exhibit properties of interval timing despite the availability of external time cues in LD. Across all days, the two bouts of anticipation were uncorrelated, a result more consistent with two independently entrained oscillators than a single consulted clock. Similar results were obtained for meals scheduled 3-h and 10-h after lights-on, and for a food-bin measure of anticipation. Most rats that showed weak or no anticipation to one or both meals exhibited elevated activity at mealtime during 1 or 2 day food deprivation tests in DD, suggesting covert operation of circadian timing in the absence of anticipatory behavior. A control experiment confirmed that daytime feeding did not shift LD-entrained rhythms, ruling out displaced nocturnal activity as an explanation for daytime activity. The results favor a multiple oscillator basis for 2-meal anticipatory rhythms and provide no evidence for involvement of cue-dependent interval timing.	[Mistlberger, Ralph E.; Kent, Brianne A.; Chan, Sofina; Patton, Danica F.; Weinberg, Alexander; Parfyonov, Maksim] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Mistlberger, RE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Parfyonov, Maksim/AAP-7478-2020	Parfyonov, Maksim/0000-0003-0582-0852; Kent, Brianne/0000-0003-0074-028X	Natural Sciences and Engineering Research Council of Canada [RGPIN155172, RGPAS380285]; Canadian Institutes of Health Research [MOP77579]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Operating and Equipment grants from the Natural Sciences and Engineering Research Council of Canada (grants RGPIN155172, RGPAS380285; http://www.nserc-crsng.gc.ca) and by the Canadian Institutes of Health Research (grant MOP77579; http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2010, NEUROSCIENCE, V165, P1115, DOI 10.1016/j.neuroscience.2009.11.061; Aragona BJ, 2002, J BIOL RHYTHM, V17, P330, DOI 10.1177/074873002129002636; ASCHOFF J, 1986, MONIT ZOOL ITAL, V20, P195; Balsam P, 2009, EUR J NEUROSCI, V30, P1749, DOI 10.1111/j.1460-9568.2009.06967.x; BIEBACH H, 1989, ANIM BEHAV, V37, P353, DOI 10.1016/0003-3472(89)90083-3; BIEBACH H, 1991, J BIOL RHYTHM, V6, P353, DOI 10.1177/074873049100600406; BOLLES RC, 1973, J COMP PHYSIOL PSYCH, V83, P510, DOI 10.1037/h0034666; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; BOULOS Z, 1990, PHYSIOL BEHAV, V48, P523, DOI 10.1016/0031-9384(90)90294-E; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Crystal JD, 2001, J EXP PSYCHOL ANIM B, V27, P68, DOI 10.1037/0097-7403.27.1.68; Crystal JD, 2009, EUR J NEUROSCI, V30, P1756, DOI 10.1111/j.1460-9568.2009.06968.x; Daan S, 1984, ADAPTIVE STRATEGIES, P275; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; de Groot MHM, 2004, PHYSIOL BEHAV, V83, P447, DOI 10.1016/j.physbeh.2004.08.037; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Gibbon J., 1997, TIME BEHAV PSYCHOL N, P329, DOI DOI 10.1016/S0166-4115(97)80060-X; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Mendoza J, 2005, J NEUROSCI, V25, P1514, DOI 10.1523/JNEUROSCI.4397-04.2005; Mistlberger R.E., 2009, J CIRC RHYTHMS, V7, P1; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Papachristos EB, 2011, J BIOL RHYTHM, V26, P305, DOI 10.1177/0748730411410026; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; PERSONS JE, 1993, PHYSIOL BEHAV, V54, P55, DOI 10.1016/0031-9384(93)90043-F; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; TERMAN M, 1984, ANN NY ACAD SCI, V423, P470, DOI 10.1111/j.1749-6632.1984.tb23454.x; Van der Zee EA, 2008, CURR BIOL, V18, P844, DOI 10.1016/j.cub.2008.04.077; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; WHITE W, 1994, PHYSIOL BEHAV, V56, P17, DOI 10.1016/0031-9384(94)90256-9	49	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31772	10.1371/journal.pone.0031772	http://dx.doi.org/10.1371/journal.pone.0031772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355393	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300093
J	Saran, N; Pommerencke, J; Witzlau, K; Regelin, M; Krueger, A				Saran, Namita; Pommerencke, Jens; Witzlau, Katrin; Regelin, Malte; Krueger, Andreas			Extra-Thymic Physiological T Lineage Progenitor Activity Is Exclusively Confined to Cells Expressing either CD127, CD90, or High Levels of CD117	PLOS ONE			English	Article							BONE-MARROW; HEMATOPOIETIC PROGENITORS; LYMPHOID PROGENITORS; ADULT THYMUS; IN-VITRO; IDENTIFICATION; BLOOD; PRECURSORS; COMMITMENT; SELECTIN	T cell development depends on continuous recruitment of progenitors from bone marrow (BM) to the thymus via peripheral blood. However, both phenotype and functional characteristics of physiological T cell precursors remain ill-defined. Here, we characterized a putative CD135(+)CD27(+) T cell progenitor population, which lacked expression of CD127, CD90, and high levels of CD117 and was therefore termed triple negative precursor (TNP). TNPs were present in both BM and blood and displayed robust T lineage potential, but virtually no myeloid or B lineage potential, in vitro. However, TNPs did not efficiently generate T lineage progeny after intravenous or intrathymic transfer, suggesting that a physiological thymic microenvironment does not optimally support T cell differentiation from TNPs. Thus, we propose that physiological T cell precursors are confined to populations expressing either CD127, CD90, or high levels of CD117 in addition to CD135 and CD27 and that TNPs may have other physiological functions.	[Saran, Namita; Pommerencke, Jens; Witzlau, Katrin; Regelin, Malte; Krueger, Andreas] Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany	Hannover Medical School	Saran, N (corresponding author), Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany.	Krueger.andreas@mh-hannover.de	Krueger, Andreas/M-9769-2019; Krueger, Andreas/B-9427-2009	Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334	German Research Foundation (DFG) [KR2320/2-1, SFB738-A7, EXC62]; Braukmann-Wittenberg-Herz-Stiftung	German Research Foundation (DFG)(German Research Foundation (DFG)); Braukmann-Wittenberg-Herz-Stiftung	The work was supported by grants from the German Research Foundation (DFG, Emmy-Noether Program (KR2320/2-1), SFB738-A7, and EXC62, "Rebirth") to AK. Open Access Publication was supported by the DFG. NS and MR are scholars of the Hannover Biomedical Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Jasmin Bolter for technical assistance. We are grateful to Immo Prinz and Reinhold Forster for helpful discussions and critical reading of the manuscript. We would like to acknowledge the assistance of the Cell Sorting Core Facility of the Hannover Medical School supported in part by Braukmann-Wittenberg-Herz-Stiftung and German Research Foundation (DFG).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Chi AWS, 2011, BLOOD, V118, P2723, DOI 10.1182/blood-2010-09-309989; Dejbakhsh-Jones S, 1999, P NATL ACAD SCI USA, V96, P14493, DOI 10.1073/pnas.96.25.14493; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Gautreau L, 2007, J IMMUNOL, V179, P2925, DOI 10.4049/jimmunol.179.5.2925; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Krueger A, 2006, J EXP MED, V203, P1977, DOI 10.1084/jem.20060731; Krueger A, 2011, EUR J IMMUNOL, V41, P2145, DOI 10.1002/eji.201141850; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Saran N, 2010, BLOOD, V115, P1137, DOI 10.1182/blood-2009-07-230821; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Serwold T, 2009, BLOOD, V113, P807, DOI 10.1182/blood-2008-08-173682; Umland O, 2007, J IMMUNOL, V178, P4147, DOI 10.4049/jimmunol.178.7.4147; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Zakrzewski JL, 2008, NAT BIOTECHNOL, V26, P453, DOI 10.1038/nbt1395; Zakrzewski JL, 2006, NAT MED, V12, P1039, DOI 10.1038/nm1463; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30864	10.1371/journal.pone.0030864	http://dx.doi.org/10.1371/journal.pone.0030864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355330	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300030
J	Frange, P; Meyer, L; Deveau, C; Tran, L; Goujard, C; Ghosn, J; Girard, PM; Morlat, P; Rouzioux, C; Chaix, ML				Frange, Pierre; Meyer, Laurence; Deveau, Christiane; Tran, Laurent; Goujard, Cecile; Ghosn, Jade; Girard, Pierre-Marie; Morlat, Philippe; Rouzioux, Christine; Chaix, Marie-Laure		French ANRS CO6 PRIMO Cohort Study	Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE; TRANSMISSION EVENTS; HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL THERAPY; SEXUAL TRANSMISSION; STAGE; MEN; EPIDEMIC; RISK	Objective: To analyse the contribution of primary human immunodeficiency virus type 1 (HIV-1) infection (PHI) to the French viral epidemic. Methods: HIV-1 pol sequences included 987 PHI from the French ANRS PRIMO cohort between 1999 and 2010 and were analysed using a population-based phylogenetic approach. Clinical features, risk factors, sexual behaviour and drug resistance for clustered and nonclustered transmission events were ascertained. Results: Viruses from 125 (12.7%) of PHI cosegregated into 56 transmission chains, with increasing frequency during the last years (10.2% before 2006 versus 15.2% of clusters in 2006-2010, p = 0.02). The mean number of patients per cluster was 2.44. Compared to unique PHI, clusters involved more often men, infected through homosexual intercourse, of young age, with a high number of casual sexual partnerships and frequent previous HIV serological tests. Resistant strains were found in 16.0% and 11.1% of clusters and unique PHI, respectively (p = 0.11). Overall, 34% (n = 19) clusters included patients followed in French regions far apart, involving 13 clusters with at least one Parisian patient. Conclusions: PHIs are a significant source of onward transmission, especially in the MSM population. Recently infected people contribute to the spread of the viral epidemic throughout the French territory. Survey of transmitted drug resistance and behavioural characteristics of patients involved into clustered PHI may help to guide prevention and treatment interventions.	[Frange, Pierre; Ghosn, Jade; Rouzioux, Christine; Chaix, Marie-Laure] Univ Paris 05, Equipe Accueil 3620, Paris, France; [Frange, Pierre] Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Meyer, Laurence; Deveau, Christiane; Tran, Laurent; Goujard, Cecile] Univ Paris 11, Hop Bicetre, AP HP,Fac Med Paris Sud, INSERM,U1018,Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Goujard, Cecile; Ghosn, Jade] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France; [Girard, Pierre-Marie] Hop St Antoine, AP HP, Serv Malad Infect & Trop, F-75571 Paris, France; [Morlat, Philippe] Univ Bordeaux Segalen, CHU Bordeaux, Serv Med Interne & Malad Infect, Bordeaux, France; [Rouzioux, Christine; Chaix, Marie-Laure] Hop Necker Enfants Malad, AP HP, Virol Lab, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Frange, P (corresponding author), Univ Paris 05, Equipe Accueil 3620, Paris, France.	pierre.frange@nck.aphp.fr	Frange, Pierre/O-6311-2017		French National Agency for Research on AIDS [ANRS PRIMO CO06]; SIDACTION [BI22-1-01851]	French National Agency for Research on AIDS(ANRS); SIDACTION	This work was supported by grants from the French National Agency for Research on AIDS (no. ANRS PRIMO CO06) and by a scholarship (to PF) from SIDACTION (no. BI22-1-01851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; Chaix ML, 2003, AIDS, V17, P2635, DOI 10.1097/00002030-200312050-00011; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; Coutinho FAB, 2001, B MATH BIOL, V63, P1041, DOI 10.1006/bulm.2001.0257; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Frange P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-69; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Ghosn J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023301; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Hayes RJ, 2006, J INFECT DIS, V193, P604, DOI 10.1086/499606; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2005, AIDS, V19, P449, DOI 10.1097/01.aids.0000161778.15568.a1; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Lievre L, 2006, AIDS, V20, P2392, DOI 10.1097/QAD.0b013e32801104b0; Michel A. B., 2008, Bulletin Epidemiologique Hebdomadaire, P39; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pinkerton SD, 1996, EVALUATION REV, V20, P516, DOI 10.1177/0193841X9602000502; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Recordon-Pinson P, 2009, ANTIVIR THER, V14, P551; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salomon JA, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000327636.82542.87; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Yerly S, 2004, ANTIVIR THER, V9, P375; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	49	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31695	10.1371/journal.pone.0031695	http://dx.doi.org/10.1371/journal.pone.0031695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348121	Green Submitted, gold, Green Published			2022-12-27	WOS:000302737400043
J	Glaw, F; Kohler, J; Townsend, TM; Vences, M				Glaw, Frank; Koehler, Joern; Townsend, Ted M.; Vences, Miguel			Rivaling the World's Smallest Reptiles: Discovery of Miniaturized and Microendemic New Species of Leaf Chameleons (Brookesia) from Northern Madagascar	PLOS ONE			English	Article							LOWER SIZE LIMIT; BODY-SIZE; NICHE CONSERVATISM; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; EVOLUTION; CHAMAELEONIDAE; FROGS; BIOGEOGRAPHY; PATTERNS	Background: One clade of Malagasy leaf chameleons, the Brookesia minima group, is known to contain species that rank among the smallest amniotes in the world. We report on a previously unrecognized radiation of these miniaturized lizards comprising four new species described herein. Methodology/Principal Findings: The newly discovered species appear to be restricted to single, mostly karstic, localities in extreme northern Madagascar: Brookesia confidens sp. n. from Ankarana, B. desperata sp. n. from Foret d'Ambre, B. micra sp. n. from the islet Nosy Hara, and B. tristis sp. n. from Montagne des Francais. Molecular phylogenetic analyses based on one mitochondrial and two nuclear genes of all nominal species in the B. minima group congruently support that the four new species, together with B. tuberculata from Montagne d'Ambre in northern Madagascar, form a strongly supported clade. This suggests that these species have diversified in geographical proximity in this small area. All species of the B. minima group, including the four newly described ones, are characterized by very deep genetic divergences of 18-32% in the ND2 gene and >6% in the 16S rRNA gene. Despite superficial similarities among all species of this group, their status as separate evolutionary lineages is also supported by moderate to strong differences in external morphology, and by clear differences in hemipenis structure. Conclusion/Significance: The newly discovered dwarf chameleon species represent striking cases of miniaturization and microendemism and suggest the possibility of a range size-body size relationship in Malagasy reptiles. The newly described Brookesia micra reaches a maximum snout-vent length in males of 16 mm, and its total length in both sexes is less than 30 mm, ranking it among the smallest amniote vertebrates in the world. With a distribution limited to a very small islet, this species may represent an extreme case of island dwarfism.	[Koehler, Joern] Hess Landesmuseum Darmstadt, Darmstadt, Germany; [Townsend, Ted M.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, Braunschweig, Germany	California State University System; San Diego State University; Braunschweig University of Technology		m.vences@tu-bs.de		Kohler, Jorn/0000-0002-5250-2542; Vences, Miguel/0000-0003-0747-0817	Volkswagen Foundation; European Association of Zoos and Aquaria; Deutsche Forschungsgemeinschaft [VE247/3-1]	Volkswagen Foundation(Volkswagen); European Association of Zoos and Aquaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The field work for this research has been supported by the Volkswagen Foundation and the European Association of Zoos and Aquaria. Lab work received funding by the Deutsche Forschungsgemeinschaft (grant VE247/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PHYTOPATHOLOGY, DOI DOI 10.1094/PHYTO-04-15-0101-RVW; Blackburn DC, 2008, MOL PHYLOGENET EVOL, V49, P806, DOI 10.1016/j.ympev.2008.08.015; Bloxam Q.M.C, 1987, DODO, V24, P61; Boistel R, 2010, BIOL LETTERS, V6, P740, DOI 10.1098/rsbl.2010.0322; Brygoo E. R, 1969, Bull. Mus. natn. Hist. nat. Paris, V41, P833; Brygoo E.-R., 1978, Faune de Madagascar, V47, P1; Brygoo ER, 1975, B MUS NATN HIST NAT, V267, P1769; Carpenter AI, 2005, ORYX, V39, P375, DOI 10.1017/S0030605305001201; Clarke BT, 1996, SYM ZOOL S, P201; Cuadrado M, 2001, J ZOOL, V255, P425; D'Cruze N, 2007, HERPETOL CONSERV BIO, V2, P87; D'Cruze Neil, 2008, Madagascar Conservation & Development, V3, P44; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Estrada AR, 1996, COPEIA, P852, DOI 10.2307/1447647; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gehring Philip-Sebastian, 2008, Salamandra, V44, P129; Glaw F, 1999, J ZOOL, V247, P225, DOI 10.1111/j.1469-7998.1999.tb00986.x; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Glaw F, 2010, SALAMANDRA, V46, P83; Hanken J, 1998, COPEIA, P312; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hedges SB, 2008, ZOOTAXA, P1; Hedges SB, 2001, CARIBB J SCI, V37, P168; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KLAVER C, 1986, Bonner Zoologische Monographien, P1; KLAVER C. J. J, 1997, CHAMAELEONIDAE, V112; Kohler J, 2010, J ZOOL, V282, P21, DOI 10.1111/j.1469-7998.2010.00708.x; Kohler J, 2007, TROP ZOOL, V20, P215; Losos JB, 2008, ECOL LETT, V11, P1005, DOI 10.1111/j.1461-0248.2008.01232.x; Macey JR, 2000, SYST BIOL, V49, P233, DOI 10.1093/sysbio/49.2.233; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Metcalf CJE, 2007, TROP ZOOL, V20, P151; Miller M. A., 2010, CIPRES PORTALS; Mittermeier R.A., 2010, LEMURS MADAGASCAR; Mori A, 2006, PHOTOGRAPHIC GUIDE R; Mori Akira, 2006, Herpetological Natural History, V10, P31; Necas P, 2004, STUMMELSCHWANZCHAMAL; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Raselimanana A.P., 2008, MALAGASY NATURE, V1, P46; Raselimanana A. P., 2003, NATURAL HIST MADAGAS, P960; Ratsoavina FM, 2010, ZOOTAXA, P62; RAXWORTHY CJ, 1994, BIOL CONSERV, V69, P65, DOI 10.1016/0006-3207(94)90329-8; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; RAXWORTHY CJ, 1995, J ZOOL, V235, P525, DOI 10.1111/j.1469-7998.1995.tb01767.x; RIEPPEL O, 1987, ZOOL J LINN SOC-LOND, V89, P41, DOI 10.1111/j.1096-3642.1987.tb01343.x; Rodriguez A, 2011, BIOL LETTERS, V7, P414, DOI 10.1098/rsbl.2010.0844; Schimmenti G, 1996, ITAL J ZOOL, V63, P193, DOI 10.1080/11250009609356129; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend T, 2002, MOL PHYLOGENET EVOL, V23, P22, DOI 10.1006/mpev.2001.1076; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M, 2004, J ARID ENVIRON, V56, P329, DOI 10.1016/S0140-1963(03)00056-9; Vences Miguel, 2011, Herpetology Notes, V4, P239; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yeh J, 2002, EVOLUTION, V56, P628	66	75	77	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31314	10.1371/journal.pone.0031314	http://dx.doi.org/10.1371/journal.pone.0031314			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348069	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400014
J	Kamdem, C; Fouet, C; Etouna, J; Etoa, FX; Simard, F; Besansky, NJ; Costantini, C				Kamdem, Colince; Fouet, Caroline; Etouna, Joachim; Etoa, Francois-Xavier; Simard, Frederic; Besansky, Nora J.; Costantini, Carlo			Spatially Explicit Analyses of Anopheline Mosquitoes Indoor Resting Density: Implications for Malaria Control	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; VECTOR CONTROL; CULICIDAE; DIPTERA; HIGHLANDS; GAMBIAE; AGGREGATION; ABUNDANCE; PATTERNS; CAMEROON	Background: The question of sampling and spatial aggregation of malaria vectors is central to vector control efforts and estimates of transmission. Spatial patterns of anopheline populations are complex because mosquitoes' habitats and behaviors are strongly heterogeneous. Analyses of spatially referenced counts provide a powerful approach to delineate complex distribution patterns, and contributions of these methods in the study and control of malaria vectors must be carefully evaluated. Methodology/Principal Findings: We used correlograms, directional variograms, Local Indicators of Spatial Association (LISA) and the Spatial Analysis by Distance IndicEs (SADIE) to examine spatial patterns of Indoor Resting Densities (IRD) in two dominant malaria vectors sampled with a 565 km grid over a 2500 km(2) area in the forest domain of Cameroon. SADIE analyses revealed that the distribution of Anopheles gambiae was different from regular or random, whereas there was no evidence of spatial pattern in Anopheles funestus (Ia = 1.644, Pa<0.05 and Ia = 1.464, Pa>0.05, respectively). Correlograms and variograms showed significant spatial autocorrelations at small distance lags, and indicated the presence of large clusters of similar values of abundance in An. gambiae while An. funestus was characterized by smaller clusters. The examination of spatial patterns at a finer spatial scale with SADIE and LISA identified several patches of higher than average IRD (hot spots) and clusters of lower than average IRD (cold spots) for the two species. Significant changes occurred in the overall spatial pattern, spatial trends and clusters when IRDs were aggregated at the house level rather than the locality level. All spatial analyses unveiled scale-dependent patterns that could not be identified by traditional aggregation indices. Conclusions/Significance: Our study illustrates the importance of spatial analyses in unraveling the complex spatial patterns of malaria vectors, and highlights the potential contributions of these methods in malaria control.	[Kamdem, Colince; Fouet, Caroline; Simard, Frederic; Costantini, Carlo] IRD, Unite Mixte Rech MIVEGEC UM1 UM2 CNRS IRD 224 529, Montpellier, France; [Kamdem, Colince; Fouet, Caroline; Costantini, Carlo] OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Kamdem, Colince; Etoa, Francois-Xavier] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Etouna, Joachim] INC, Dept Rech Geog, Yaounde, Cameroon; [Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Institut de Recherche pour le Developpement (IRD); University of Yaounde I; University of Notre Dame	Kamdem, C (corresponding author), IRD, Unite Mixte Rech MIVEGEC UM1 UM2 CNRS IRD 224 529, Montpellier, France.	kamdem_d@yahoo.com	Frederic, SIMARD/AFV-5001-2022; SIMARD, Frederic/J-9489-2016; Costantini, Carlo/F-3470-2012	Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Costantini, Carlo/0000-0003-1016-129X	Institut de Recherche pour le Developpement (IRD); National Institutes of Health [R01-AI063508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Institut de Recherche pour le Developpement (IRD) and National Institutes of Health grant No R01-AI063508 to NJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L, 2006, AM J PREV MED, V30, pS3, DOI 10.1016/j.amepre.2005.09.015; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 2005, SPATIAL REGRESSION A; Antonio-Nkondjio C, 2005, T ROY SOC TROP MED H, V99, P347, DOI 10.1016/j.trstmh.2004.07.003; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Athanassiou CG, 2010, B ENTOMOL RES, V100, P395, DOI 10.1017/S000748530999037X; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Bivand R, 2010, SPDEP SPATIAL DEPEND; Brower JE, FIELD LAB METHODS GE, P273; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cliff A. D., 1969, LONDON PAPERS REGION, V1, P25; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Cressie NAC, STAT SPATIAL DATA, P920; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; Dungan JL, 2002, ECOGRAPHY, V25, P626, DOI 10.1034/j.1600-0587.2002.250510.x; FONDJO E, 1992, B SOC PATHOL EXOT, V85, P57; Fortin M-J, DALE MRT SPATIAL ANA, P380; Fortin MJ, 1999, ECOSCIENCE, V6, P636, DOI 10.1080/11956860.1999.11682547; Gaudart J, 2007, REV EPIDEMIOL SANTE, V55, P297, DOI 10.1016/j.respe.2007.04.003; Gillies MT, ANOPHELINAE AFRICA S, P143; Gillies MT, ANOPHELINAE AFRICA S, P343; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gimnig JE, 2006, ENV CHANGE MALARIA R, P27; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; Green JL, 2007, ECOL LETT, V10, P1037, DOI 10.1111/j.1461-0248.2007.01101.x; IWAO S, 1972, Researches on Population Ecology (Tokyo), V14, P97, DOI 10.1007/BF02511188; Jacob BG, 2011, ACTA TROP, V117, P61, DOI 10.1016/j.actatropica.2010.10.002; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Legendre P, NUMERICAL ECOLOGY, P853; Li L, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-50; Liebhold A. M., 1998, POPULATION COMMUNITY, P11; Lindblade KA, 2000, J MED ENTOMOL, V37, P664, DOI 10.1603/0022-2585-37.5.664; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Magbity EB, 2002, B ENTOMOL RES, V92, P483, DOI 10.1079/BER2002200; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morisita M., 1959, MEMOIRS FS KYUSHU U, V2, P215; Moss WJ, 2011, ACTA TROPIC IN PRESS; National Malaria Control Centre Ministry of Health Zambia, 2007, US GEOGR INF SYST TE; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; PITCAIRN MJ, 1994, J MED ENTOMOL, V31, P545, DOI 10.1093/jmedent/31.4.545; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675; R Core Team, 2020, R LANG ENV STAT COMP; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Ryan PA, 2004, J MED ENTOMOL, V41, P1143, DOI 10.1603/0022-2585-41.6.1143; Service MW, MOSQUITO ECOLOGY FIE, P988; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1984, ANNU REV ENTOMOL, V29, P321, DOI 10.1146/annurev.en.29.010184.001541; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67; Zillio T, 2010, ECOLOGY, V91, P3698, DOI 10.1890/09-2233.1	65	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31843	10.1371/journal.pone.0031843	http://dx.doi.org/10.1371/journal.pone.0031843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348131	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400051
J	Muniategui, A; Nogales-Cadenas, R; Vazquez, M; Aranguren, XL; Agirre, X; Luttun, A; Prosper, F; Pascual-Montano, A; Rubio, A				Muniategui, Ander; Nogales-Cadenas, Ruben; Vazquez, Miguel; Aranguren, Xabier L.; Agirre, Xabier; Luttun, Aernout; Prosper, Felipe; Pascual-Montano, Alberto; Rubio, Angel			Quantification of miRNA-mRNA Interactions	PLOS ONE			English	Article							WEB-BASED TOOL; EXPRESSION PROFILES; LYMPHOBLASTIC-LEUKEMIA; MICRORNA; TARGETS; DATABASE; IDENTIFICATION; GENECODIS; RESOURCE; GENES	miRNAs are small RNA molecules (' 22nt) that interact with their corresponding target mRNAs inhibiting the translation of the mRNA into proteins and cleaving the target mRNA. This second effect diminishes the overall expression of the target mRNA. Several miRNA-mRNA relationship databases have been deployed, most of them based on sequence complementarities. However, the number of false positives in these databases is large and they do not overlap completely. Recently, it has been proposed to combine expression measurement from both miRNA and mRNA and sequence based predictions to achieve more accurate relationships. In our work, we use LASSO regression with non-positive constraints to integrate both sources of information. LASSO enforces the sparseness of the solution and the non-positive constraints restrict the search of miRNA targets to those with down-regulation effects on the mRNA expression. We named this method TaLasso (miRNA-Target LASSO). We used TaLasso on two public datasets that have paired expression levels of human miRNAs and mRNAs. The top ranked interactions recovered by TaLasso are especially enriched (more than using any other algorithm) in experimentally validated targets. The functions of the genes with mRNA transcripts in the top-ranked interactions are meaningful. This is not the case using other algorithms. TaLasso is available as Matlab or R code. There is also a web-based tool for human miRNAs at http://talasso.cnb.csic.es/.	[Muniategui, Ander; Rubio, Angel] Univ Navarra, Grp Bioinformat CEIT & TECNUN, San Sebastian, Spain; [Nogales-Cadenas, Ruben; Pascual-Montano, Alberto] Natl Ctr Biotechnol CSIC, Madrid, Spain; [Vazquez, Miguel] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain; [Aranguren, Xabier L.; Luttun, Aernout] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Univ Navarra Clin, Dept Hematol, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Univ Navarra Clin, Area Cell Therapy, E-31080 Pamplona, Spain	University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); Centro Nacional de Investigaciones Oncologicas (CNIO); KU Leuven; University of Navarra; University of Navarra	Muniategui, A (corresponding author), Univ Navarra, Grp Bioinformat CEIT & TECNUN, San Sebastian, Spain.	arubio@ceit.es	Agirre, Xabier/ABE-4110-2020; Luttun, Aernout/AAZ-6540-2020; Rubio, Angel/Y-8610-2019; Prosper, Felipe/H-6859-2017; Rubio, Angel/O-6348-2014; Rubio, Angel/M-7387-2019; Vazquez, Miguel/I-2593-2015	Luttun, Aernout/0000-0001-7902-9524; Prosper, Felipe/0000-0001-6115-8790; Rubio, Angel/0000-0002-3274-2450; Rubio, Angel/0000-0002-3274-2450; Vazquez, Miguel/0000-0002-5713-1058; Muniategui, Ander/0000-0002-7416-912X; Aranguren, Xabier L./0000-0002-1834-603X	Basque Government (Programas de Formacion y Perfeccionamiento de Personal Investigador); Spanish Government [BIO2010-17527]; Madrid Government [CAM - S2010/BMD-2305]; Juan de la Cierva Spanish Government	Basque Government (Programas de Formacion y Perfeccionamiento de Personal Investigador)(Basque Government); Spanish Government(Spanish GovernmentEuropean Commission); Madrid Government; Juan de la Cierva Spanish Government(Spanish Government)	The work of AM was supported by the Basque Government (Programas de Formacion y Perfeccionamiento de Personal Investigador, http://www.hezkuntza.ejgv.euskadi.net/r43-5552/es/contenidos/informacion/dib4/es_2035/bfi_c.html). AP and RNC were partially supported by Spanish Government Grant BIO2010-17527 and the Madrid Government Grant CAM - S2010/BMD-2305. RNC also acknowledges the support of the Juan de la Cierva Spanish Government Research program. The authors acknowledge support from Integromics, S.L., for their support with their software Integromics Biomaker Discovery (R) and RealTime Statminer (R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Baldus CD, 2007, J CLIN ONCOL, V25, P3739, DOI 10.1200/JCO.2007.11.5253; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Corrada H, 2009, RCPLEX R INTERFACE C; Cover TM, 2006, ELEMENTS INFORM THEO, P776; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulci V, 2009, GENE CHROMOSOME CANC, V48, P1069, DOI 10.1002/gcc.20709; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jayaswal V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-138; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2011, BIOINFORMATICS; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Shahi P, 2006, NUCLEIC ACIDS RES, V34, pD115, DOI 10.1093/nar/gkj093; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yue D, 2009, CURR GENOMICS, V10, P478, DOI 10.2174/138920209789208219; Zhao HF, 2010, CRIT REV ONCOL HEMAT, V74, P149, DOI 10.1016/j.critrevonc.2009.05.001	39	60	64	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30766	10.1371/journal.pone.0030766	http://dx.doi.org/10.1371/journal.pone.0030766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348024	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400005
J	Pellinen, J; Szentirmai, E				Pellinen, Jacob; Szentirmai, Eva			The Effects of C75, an Inhibitor of Fatty Acid Synthase, on Sleep and Metabolism in Mice	PLOS ONE			English	Article							HORMONE SECRETAGOGUE-RECEPTOR; TUMOR-NECROSIS-FACTOR; BROWN ADIPOSE-TISSUE; FOOD-INTAKE; LITHIUM-CHLORIDE; MESSENGER-RNA; INSULIN SENSITIVITY; GHRELIN SECRETION; MOTOR-ACTIVITY; BODY-WEIGHT	Sleep is greatly affected by changes in metabolic state. A possible mechanism where energy-sensing and sleep-regulatory functions overlap is related to lipid metabolism. Fatty acid synthase (FAS) plays a central role in lipid metabolism as a key enzyme in the formation of long-chain fatty acids. We studied the effects of systemic administration of C75, an inhibitor of FAS, on sleep, behavioral activity and metabolic parameters in mice. Since the effects of C75 on feeding and metabolism are the opposite of ghrelin's and C75 suppresses ghrelin production, we also tested the role of ghrelin signaling in the actions of C75 by using ghrelin receptor knockout (KO) mice. After a transient increase in wakefulness, C75 elicited dose-dependent and long lasting inhibition of REMS, motor activity and feeding. Simultaneously, C75 significantly attenuated slow-wave activity of the electroencephalogram. Energy expenditure, body temperature and respiratory exchange ratio were suppressed. The diurnal rhythm of feeding was completely abolished by C75. There was significant correlation between the anorectic effects, the decrease in motor activity and the diminished energy expenditure after C75 injection. We found no significant difference between wild-type and ghrelin receptor KO mice in their sleep and metabolic responses to C75. The effects of C75 resemble to what was previously reported in association with visceral illness. Our findings suggest that sleep and metabolic effects of C75 in mice are independent of the ghrelin system and may be due to its aversive actions in mice.	[Pellinen, Jacob; Szentirmai, Eva] Washington State Univ, WWAMI Med Educ Program, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA	Washington State University; Washington State University; Washington State University	Pellinen, J (corresponding author), Washington State Univ, WWAMI Med Educ Program, Spokane, WA USA.	eszentirmai@wsu.edu	Pellinen, Jacob/ABH-4718-2020	Pellinen, Jacob/0000-0002-0747-7210	Washington State University	Washington State University	This work was supported by a Faculty Seed Grant to Dr. Szentirmai by Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Clegg DJ, 2002, DIABETES, V51, P3196, DOI 10.2337/diabetes.51.11.3196; DANGUIR J, 1976, PHARMACOL BIOCHEM BE, V5, P547, DOI 10.1016/0091-3057(76)90267-7; DANGUIR J, 1989, AM J PHYSIOL, V256, pR281, DOI 10.1152/ajpregu.1989.256.1.R281; DANGUIR J, 1984, BRAIN RES, V306, P97, DOI 10.1016/0006-8993(84)90359-7; DANGUIR J, 1979, J COMP PHYSIOL PSYCH, V93, P820, DOI 10.1037/h0077616; DANGUIR J, 1979, PHYSIOL BEHAV, V22, P735, DOI 10.1016/0031-9384(79)90240-3; DANGUIR J, 1987, APPETITE, V8, P49, DOI 10.1016/S0195-6663(87)80026-0; DANGUIR J, 1978, PHYSIOL BEHAV, V21, P769, DOI 10.1016/0031-9384(78)90017-3; Esposito M, 2012, EUR J NEUROSCI, V35, P233, DOI 10.1111/j.1460-9568.2011.07946.x; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; GU Y, 1993, NEUROSCI LETT, V157, P49, DOI 10.1016/0304-3940(93)90640-7; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hu ZY, 2005, P NATL ACAD SCI USA, V102, P3972, DOI 10.1073/pnas.0500619102; Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jones CA, 2008, BEHAV BRAIN RES, V187, P254, DOI 10.1016/j.bbr.2007.09.017; Kageyama H, 2010, NEUROPEPTIDES, V44, P133, DOI 10.1016/j.npep.2009.11.010; KAPAS L, 1992, AM J PHYSIOL, V263, pR703, DOI 10.1152/ajpregu.1992.263.3.R703; KAPAS L, 1988, BRAIN RES, V438, P155, DOI 10.1016/0006-8993(88)91334-0; KAPAS L, 1991, PHYSIOL BEHAV, V50, P1241, DOI 10.1016/0031-9384(91)90589-G; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Lamprecht R, 1995, NEUROREPORT, V7, P289, DOI 10.1097/00001756-199512290-00069; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Longo KA, 2008, REGUL PEPTIDES, V150, P55, DOI 10.1016/j.regpep.2008.03.011; Ma XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016391; Mano-Otagiri A, 2009, J ENDOCRINOL, V201, P341, DOI 10.1677/JOE-08-0374; MANSBACH RS, 1983, PHYSIOL BEHAV, V30, P179, DOI 10.1016/0031-9384(83)90002-1; Mansouri A, 2008, AM J PHYSIOL-REG I, V295, pR799, DOI 10.1152/ajpregu.90381.2008; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; NACHMAN M, 1973, PHYSIOL BEHAV, V10, P73, DOI 10.1016/0031-9384(73)90089-9; Pfluger PT, 2008, AM J PHYSIOL-GASTR L, V294, pG610, DOI 10.1152/ajpgi.00321.2007; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Rinaman L, 2007, AM J PHYSIOL-REG I, V293, pR1495, DOI 10.1152/ajpregu.00393.2007; Rohrbach KW, 2005, EUR J PHARMACOL, V511, P31, DOI 10.1016/j.ejphar.2005.01.034; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; SANGIAH S, 1982, LIFE SCI, V31, P763, DOI 10.1016/0024-3205(82)90702-0; Shemyakin A, 2001, AM J PHYSIOL-REG I, V280, pR1420, DOI 10.1152/ajpregu.2001.280.5.R1420; Shimokawa T, 2002, P NATL ACAD SCI USA, V99, P66, DOI 10.1073/pnas.012606199; SHOHAM S, 1987, AM J PHYSIOL, V253, pR142, DOI 10.1152/ajpregu.1987.253.1.R142; Sinton CM, 1999, J SLEEP RES, V8, P197, DOI 10.1046/j.1365-2869.1999.00158.x; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Szentirmai E, 2006, BRAIN RES, V1088, P131, DOI 10.1016/j.brainres.2006.02.072; Szentirmai E, 2007, AM J PHYSIOL-REG I, V292, pR575, DOI 10.1152/ajpregu.00448.2006; Szentirmai E, 2009, P NATL ACAD SCI USA, V106, P14069, DOI 10.1073/pnas.0903090106; Takahashi KA, 2004, ENDOCRINOLOGY, V145, P184, DOI 10.1210/en.2003-0337; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tolle V, 2002, ENDOCRINOLOGY, V143, P1353, DOI 10.1210/en.143.4.1353; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; VENKATAKRISHNABHATT H, 1978, BRAIN RES, V152, P97, DOI 10.1016/0006-8993(78)90136-1; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yasuda T, 2003, NEUROSCI LETT, V349, P75, DOI 10.1016/S0304-3940(03)00789-4; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	59	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30651	10.1371/journal.pone.0030651	http://dx.doi.org/10.1371/journal.pone.0030651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348016	gold, Green Submitted, Green Published			2022-12-27	WOS:000302733900010
J	He, Y; Zhou, Z; Hofstetter, WL; Zhou, YB; Hu, WX; Guo, CC; Wang, L; Guo, W; Pataer, A; Correa, AM; Lu, YL; Wang, J; Diao, LX; Byers, LA; Wistuba, II; Roth, JA; Swisher, SG; Heymach, JV; Fang, BL				He, Yong; Zhou, Zhen; Hofstetter, Wayne L.; Zhou, Yanbin; Hu, Wenxian; Guo, Chengcheng; Wang, Li; Guo, Wei; Pataer, Apar; Correa, Arlene M.; Lu, Yiling; Wang, Jing; Diao, Lixia; Byers, Lauren Averett; Wistuba, Ignacio I.; Roth, Jack A.; Swisher, Stephen G.; Heymach, John V.; Fang, Bingliang			Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters	PLOS ONE			English	Article							BREAST-CANCER; KINASE INHIBITORS; MESSENGER-RNA; ACTIVATION; MICROARRAYS; STAT5; CDNA; PROGNOSIS; DAMAGE; GENES	Background: Because cell signaling and cell metabolic pathways are executed through proteins, protein signatures in primary tumors are useful for identifying key nodes in signaling networks whose alteration is associated with malignancy and/or clinical outcomes. This study aimed to determine protein signatures in primary lung cancer tissues. Methodology/Principal Findings: We analyzed 126 proteins and/or protein phosphorylation sites in case-matched normal and tumor samples from 101 lung cancer patients with reverse-phase protein array (RPPA) assay. The results showed that 18 molecules were significantly different (p<0.05) by at least 30% between normal and tumor tissues. Most of those molecules play roles in cell proliferation, DNA repair, signal transduction and lipid metabolism, or function as cell surface/matrix proteins. We also validated RPPA results by Western blot and/or immunohistochemical analyses for some of those molecules. Statistical analyses showed that Ku80 levels were significantly higher in tumors of nonsmokers than in those of smokers. Cyclin B1 levels were significantly overexpressed in poorly differentiated tumors while Cox2 levels were significantly overexpressed in neuroendocrinal tumors. A high level of Stat5 is associated with favorable survival outcome for patients treated with surgery. Conclusions/Significance: Our results revealed that some molecules involved in DNA damage/repair, signal transductions, lipid metabolism, and cell proliferation were drastically aberrant in lung cancer tissues, and Stat5 may serve a molecular marker for prognosis of lung cancers.	[He, Yong] Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China; [Zhou, Zhen] Shanghai Jiao Tong Univ, Shanghai Chest Hosp Affiliated, Shanghai Lung Tumor Clin, Med Ctr, Shanghai 200030, Peoples R China; [He, Yong; Zhou, Zhen; Hofstetter, Wayne L.; Zhou, Yanbin; Hu, Wenxian; Guo, Chengcheng; Wang, Li; Guo, Wei; Pataer, Apar; Correa, Arlene M.; Roth, Jack A.; Swisher, Stephen G.; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Lu, Yiling] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Wang, Jing; Diao, Lixia] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Byers, Lauren Averett; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Thorac, Houston, TX 77030 USA; [Byers, Lauren Averett; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Med Oncol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Army Medical University; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	He, Y (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China.	jheymach@mdanderson.org; bfang@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	National Cancer Institute [R01CA-092487, RO1CA-124951]; National Institutes of Health [3P30CA-016672-32S3]; University of Texas MD Anderson Cancer Center [CA-016672]; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora and Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; Chapman Foundation; National Natural Science Foundation of China [81172113, 81071912]; Third Military Medical University of China; George O. Sweeney Fund for Esophageal Cancer Research; NATIONAL CANCER INSTITUTE [R01CA124951, P30CA016672, P50CA070907, R01CA092487] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora and Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; Chapman Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University of China; George O. Sweeney Fund for Esophageal Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Cancer Institute grants: R01CA-092487 (awarded to BF), RO1CA-124951 (awarded to BF), National Institutes of Health Core Grant 3P30CA-016672-32S3, The University of Texas MD Anderson Cancer Center Support Grant CA-016672 - Lung Program and Functional Proteomics Reverse-Phase Protein Array Core facility, the Homer Flower Gene Therapy Research Fund, the Charles Rogers Gene Therapy Fund, the Flora and Stuart Mason Lung Cancer Research Fund, the Charles B. Swank Memorial Fund for Esophageal Cancer Research, the George O. Sweeney Fund for Esophageal Cancer Research, the Phalan Thoracic Gene Therapy Fund, and the M. W. Elkins Endowed Fund for Thoracic Surgical Oncology, Chapman Foundation, the National Natural Science Foundation of China (81172113, 81071912) and "1510 project'' of Third Military Medical University of China (awarded to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hida T, 1998, CANCER RES, V58, P3761; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hsiao JR, 2003, BRIT J CANCER, V89, P344, DOI 10.1038/sj.bjc.6601003; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Lim JW, 2002, J BIOL CHEM, V277, P46093, DOI 10.1074/jbc.M206603200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Migita T, 2010, AM J PATHOL, V176, P1756, DOI 10.2353/ajpath.2010.090500; Moeller BJ, 2011, CLIN CANCER RES, V17, P2035, DOI 10.1158/1078-0432.CCR-10-2641; Nanjundan M, 2010, J THORAC ONCOL, V5, P1894, DOI 10.1097/JTO.0b013e3181f2a266; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Parrella P, 2006, J CLIN PATHOL, V59, P1181, DOI 10.1136/jcp.2005.031088; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Soria JC, 2000, CANCER RES, V60, P4000; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wei XL, 2009, J BIOL CHEM, V284, P16948, DOI 10.1074/jbc.M109.010256; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Wikman H, 2004, J PATHOL, V203, P584, DOI 10.1002/path.1552; Xing JL, 2008, CANCER-AM CANCER SOC, V112, P2756, DOI 10.1002/cncr.23533; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095; Yanagisawa K, 2007, JNCI-J NATL CANCER I, V99, P858, DOI 10.1093/jnci/djk197; Zhang PL, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-14	38	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31087	10.1371/journal.pone.0031087	http://dx.doi.org/10.1371/journal.pone.0031087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348039	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730900019
J	Bergwitz, C; Rasmussen, MD; DeRobertis, C; Wee, MJ; Sinha, S; Chen, HH; Huang, J; Perrimon, N				Bergwitz, Clemens; Rasmussen, Matthew D.; DeRobertis, Charles; Wee, Mark J.; Sinha, Sumi; Chen, Hway H.; Huang, Joanne; Perrimon, Norbert			Roles of Major Facilitator Superfamily Transporters in Phosphate Response in Drosophila	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INORGANIC-PHOSPHATE; SACCHAROMYCES-CEREVISIAE; VASCULAR CALCIFICATION; KINASE; CELLS; MELANOGASTER; CALCIUM; DIETARY; FAMILY	The major facilitator superfamily (MFS) transporter Pho84 and the type III transporter Pho89 are responsible for metabolic effects of inorganic phosphate in yeast. While the Pho89 ortholog Pit1 was also shown to be involved in phosphate-activated MAPK in mammalian cells, it is currently unknown, whether orthologs of Pho84 have a role in phosphate-sensing in metazoan species. We show here that the activation of MAPK by phosphate observed in mammals is conserved in Drosophila cells, and used this assay to characterize the roles of putative phosphate transporters. Surprisingly, while we found that RNAi-mediated knockdown of the fly Pho89 ortholog dPit had little effect on the activation of MAPK in Drosophila S2R+ cells by phosphate, two Pho84/SLC17A1-9 MFS orthologs (MFS10 and MFS13) specifically inhibited this response. Further, using a Xenopus oocyte assay, we show that MSF13 mediates uptake of [P-33]-orthophosphate in a sodium-dependent fashion. Consistent with a role in phosphate physiology, MSF13 is expressed highest in the Drosophila crop, midgut, Malpighian tubule, and hindgut. Altogether, our findings provide the first evidence that Pho84 orthologs mediate cellular effects of phosphate in metazoan cells. Finally, while phosphate is essential for Drosophila larval development, loss of MFS13 activity is compatible with viability indicating redundancy at the levels of the transporters.	[Bergwitz, Clemens; DeRobertis, Charles; Wee, Mark J.; Sinha, Sumi; Chen, Hway H.; Huang, Joanne] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Rasmussen, Matthew D.] MIT, Comp Sci & Artificial Intelligence Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bergwitz, C (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	cbergwitz@partners.org		Perrimon, Norbert/0000-0001-7542-472X	Harvard Catalyst; National institutes of Health, NIDDK [5K08DK078361]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078361] Funding Source: NIH RePORTER	Harvard Catalyst; National institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Harvard Catalyst, http://catalyst.harvard.edu/ and http://www.google.com/url?sa=t&rct=j&rct=j&q=&q=&esrc=s&esrc=s&source=web&source=web&cd=3&cd=3&ved=0CC0QFjAC&url=http%3A%2F%2Fcatalyst.harvard.edu%2Fservices%2Fpilotfunding%2Fdoc%2FHarvardCatalystyr2pilotawardees.pdf&ei=Q7LoTsvbA4Hs0gGX_bX-CQ&usg=AFQjCNH5urQAzoFgECvnBx7291P3xQFYyQ&sig2=2txR0jw1srrB3xu-3HwW4A, and the National institutes of Health, NIDDK 5K08DK078361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Bevington A, 1992, CLIN CHEM ENZYMOL CO, V4, P235; Bringhurst FR, 2006, ENDOCRINOLOGY, V5, P805; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chertow GM, 1999, CLIN NEPHROL, V51, P18; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Festing MH, 2009, GENESIS, V47, P858, DOI 10.1002/dvg.20577; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jaureguiberry G, 2008, AM J PHYSIOL-RENAL, V295, pF371, DOI 10.1152/ajprenal.00090.2008; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/JBMR.090508, 10.1359/jbmr.090508]; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Nair D, 1997, J BIOL CHEM, V272, P18920, DOI 10.1074/jbc.272.30.18920; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Razzaque MS, 2009, NEPHROL DIAL TRANSPL, V24, P4, DOI 10.1093/ndt/gfn620; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Segal D, 1996, SOMAT CELL MOLEC GEN, V22, P159, DOI 10.1007/BF02369906; Sims D, 2006, NUCLEIC ACIDS RES, V34, pD479, DOI 10.1093/nar/gkj038; Sprecher E, 2010, J INVEST DERMATOL, V130, P652, DOI 10.1038/jid.2009.337; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Suzuki A, 2010, J BONE MINER METAB, V28, P139, DOI 10.1007/s00774-009-0121-3; TENENHOUSE HS, 1989, BIOCHIM BIOPHYS ACTA, V984, P207, DOI 10.1016/0005-2736(89)90218-6; TOHE A, 1988, MOL GEN GENET, V214, P162, DOI 10.1007/BF00340196; Werner A, 2001, AM J PHYSIOL-REG I, V280, pR301, DOI 10.1152/ajpregu.2001.280.2.R301; Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034; Yamazaki M, 2010, J CELL BIOCH; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07	51	18	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31730	10.1371/journal.pone.0031730	http://dx.doi.org/10.1371/journal.pone.0031730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359624	Green Submitted, gold, Green Published			2022-12-27	WOS:000302796200093
J	Wu, KY; Koo, J; Jiang, XJ; Chen, R; Cohen, SN; Nathan, C				Wu, Kangyun; Koo, Jovanka; Jiang, Xiuju; Chen, Ran; Cohen, Stanley N.; Nathan, Carl			Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IFN-GAMMA; INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; OXIDATIVE-METABOLISM; IL-10 PRODUCTION; INNATE IMMUNITY; PKR; INTERLEUKIN-10; IDENTIFICATION	Host factors that microbial pathogens exploit for their propagation are potential targets for therapeuic countermeasures. No host enzyme has been identified whose genetic absence benefits the intact mammalian host in vivo during infection with Mycobacterium tuberculosis (Mtb), the leading cause of death from bacterial infection. Here, we report that the dsRNA-dependent protein kinase (PKR) is such an enzyme. PKR-deficient mice contained fewer viable Mtb and showed less pulmonary pathology than wild type mice. We identified two potential mechanisms for the protective effect of PKR deficiency: increased apoptosis of macrophages in response to Mtb and enhanced activation of macrophages in response to IFN-gamma. The restraining effect of PKR on macrophage activation was explained by its mediation of a previously unrecognized ability of IFN-gamma to induce low levels of the macrophage deactivating factor interleukin 10 (IL10). These observations suggest that PKR inhibitors may prove useful as an adjunctive treatment for tuberculosis.	[Wu, Kangyun; Koo, Jovanka; Jiang, Xiuju; Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Chen, Ran; Cohen, Stanley N.] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA	Cornell University; Stanford University	Wu, KY (corresponding author), Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63130 USA.	cnathan@med.cornell.edu		Wu, Kangyun/0000-0002-8093-094X	Department of Defense through Defense Threat Reduction Agency (DTRA) [HDTRA 01-06-C-0039]; William Randolph Hearst Foundation	Department of Defense through Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); William Randolph Hearst Foundation	This work was supported by the Transformational Medical Technologies program contract HDTRA 01-06-C-0039 to SNC and CN from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA). The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2008, BIOCHEMISTRY-US, V47, P4887, DOI 10.1021/bi702211j; Bando Y, 2005, NEUROCHEM INT, V46, P11, DOI 10.1016/j.neuint.2004.07.005; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bryk R, 2011, BIOORG MED CHEM LETT, V21, P4108, DOI 10.1016/j.bmcl.2011.04.149; Chakrabarti A, 2008, J BIOL CHEM, V283, P25132, DOI 10.1074/jbc.M804770200; Chang ACY, 2006, J VIROL, V80, P8705, DOI 10.1128/JVI.00475-06; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Davies Julian, 2009, P158; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Goodman AG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000438; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kockx MM, 1998, ARTERIOSCL THROM VAS, V18, P1519, DOI 10.1161/01.ATV.18.10.1519; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; McKenna SA, 2007, J BIOL CHEM, V282, P11474, DOI 10.1074/jbc.M700301200; Mhyre TR, 2008, NEUROBIOL AGING, V29, P1631, DOI 10.1016/j.neurobiolaging.2007.04.004; Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nathan C, 2009, CELL HOST MICROBE, V5, P220, DOI 10.1016/j.chom.2009.02.004; NATHAN CF, 1986, NEW ENGL J MED, V315, P6, DOI 10.1056/NEJM198607033150102; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Sharma B, 2011, J BIOL CHEM, V286, P27506, DOI 10.1074/jbc.M111.238501; SZUROSUDOL A, 1982, J EXP MED, V156, P945, DOI 10.1084/jem.156.4.945; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Uetani K, 2000, J IMMUNOL, V165, P988, DOI 10.4049/jimmunol.165.2.988; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Vogt G, 2011, J CLIN INVE IN PRESS; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	58	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30512	10.1371/journal.pone.0030512	http://dx.doi.org/10.1371/journal.pone.0030512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359543	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200012
J	Finlay, EK; Berry, DP; Wickham, B; Gormley, EP; Bradley, DG				Finlay, Emma K.; Berry, Donagh P.; Wickham, Brian; Gormley, Eamonn P.; Bradley, Daniel G.			A Genome Wide Association Scan of Bovine Tuberculosis Susceptibility in Holstein-Friesian Dairy Cattle	PLOS ONE			English	Article							RAW 264.7 CELLS; TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-BOVIS; GENETIC SUSCEPTIBILITY; NITRIC-OXIDE; TAURINE; CHLORAMINE; INFECTION; EXPRESSION; DISEASE	Background: Bovine tuberculosis is a significant veterinary and financial problem in many parts of the world. Although many factors influence infection and progression of the disease, there is a host genetic component and dissection of this may enlighten on the wider biology of host response to tuberculosis. However, a binary phenotype of presence/absence of infection presents a noisy signal for genomewide association study. Methodology/Principal Findings: We calculated a composite phenotype of genetic merit for TB susceptibility based on disease incidence in daughters of elite sires used for artificial insemination in the Irish dairy herd. This robust measure was compared with 44,426 SNP genotypes in the most informative 307 subjects in a genome wide association analysis. Three SNPs in a 65 kb genomic region on BTA 22 were associated (i.e. p<10(-5), peaking at position 59588069, p = 4.02 x 10(-6)) with tuberculosis susceptibility. Conclusions/Significance: A genomic region on BTA 22 was suggestively associated with tuberculosis susceptibility; it contains the taurine transporter gene SLC6A6, or TauT, which is known to function in the immune system but has not previously been investigated for its role in tuberculosis infection.	[Finlay, Emma K.; Bradley, Daniel G.] Trinity Coll Dublin, Dept Genet, Smurfit Inst, Dublin, Ireland; [Berry, Donagh P.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Fermoy, Cork, Ireland; [Wickham, Brian] Irish Cattle Breeding Federat, Bandon, Cork, Ireland; [Gormley, Eamonn P.] Univ Coll Dublin, Vet Sci Ctr, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland	Trinity College Dublin; Teagasc; University College Dublin	Finlay, EK (corresponding author), Trinity Coll Dublin, Dept Genet, Smurfit Inst, Dublin, Ireland.	dbradley@tcd.ie	Berry, Donagh/J-7616-2012; Gormley, Eamonn/AAU-6678-2020	Berry, Donagh/0000-0003-4349-1447; Gormley, Eamonn/0000-0003-3900-0393; Finlay, Emma/0000-0003-0621-2744; Bradley, Daniel G/0000-0001-7335-7092	Irish Department of Agriculture, Fisheries and Food [06409]; Science Foundation Ireland PI [09/IN.1/B2642]; European Union [KBBE-211602-MACROSYS]	Irish Department of Agriculture, Fisheries and Food; Science Foundation Ireland PI(Science Foundation Ireland); European Union(European Commission)	The work was funded by the Irish Department of Agriculture, Fisheries and Food's Research Stimulus Fund, grant number 06409. DGB is a Science Foundation Ireland PI, grant number 09/IN.1/B2642. We also acknowledge support from European Union Framework 7 Project Grant (No: KBBE-211602-MACROSYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Bellamy R, 2006, MICROBES INFECT, V8, P1119, DOI 10.1016/j.micinf.2005.10.025; Bermingham ML, 2010, J DAIRY SCI, V93, P5413, DOI 10.3168/jds.2009-2925; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Bishop SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008940; Brotherstone S, 2010, J DAIRY SCI, V93, P1234, DOI 10.3168/jds.2009-2609; Carmichael J., 1941, VET JOUR, V97, P329; Chandra N, 2011, TUBERCULOSIS EDINB; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Delic D, 2010, INFECT IMMUN, V78, P1642, DOI 10.1128/IAI.01159-09; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Falconer D. S., 1996, INTRO QUANTITATIVE G; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gilmour AR, 2009, ASREML USER GUIDE RE; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Li C, 2004, J ANIM SCI, V82, P967; Mackintosh CG, 2000, INFECT IMMUN, V68, P1620, DOI 10.1128/IAI.68.3.1620-1625.2000; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Mochizuki T, 2002, FEBS LETT, V517, P92, DOI 10.1016/S0014-5793(02)02584-X; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Park E, 1997, J LEUKOCYTE BIOL, V61, P161, DOI 10.1002/jlb.61.2.161; PARK E, 1993, J LEUKOCYTE BIOL, V54, P119, DOI 10.1002/jlb.54.2.119; Park E, 2002, CLIN IMMUNOL, V102, P179, DOI 10.1006/clim.2001.5160; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Perry B. D, 2002, INVESTING ANIMAL HLT; Phillips Clive J. C., 2002, Animal Health Research Reviews, V3, P3, DOI 10.1079/AHRR200236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn MR, 1996, IMMUNOL LETT, V50, P185, DOI 10.1016/0165-2478(96)02542-4; Raman K, 2010, MOL BIOSYST, V6, P516, DOI 10.1039/b912129c; Redmond HP, 1998, NUTRITION, V14, P599, DOI 10.1016/S0899-9007(98)00097-5; Redmond HP, 1995, SURG FORUM, V45, P573; RITACCO V, 1991, RES VET SCI, V50, P365, DOI 10.1016/0034-5288(91)90143-C; Rockel N, 2007, J IMMUNOL, V179, P3604, DOI 10.4049/jimmunol.179.6.3604; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Sheridan M, 2011, VET MICROBIOL, V151, P160, DOI 10.1016/j.vetmic.2011.02.040; Smith NH, 2011, INFECT GENET EVOL; Stapleton PP, 1997, J LEUKOCYTE BIOL, V61, P231, DOI 10.1002/jlb.61.2.231; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; Waters WR, 2011, CLIN DEV IMMUNOLOGY; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x	50	61	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30545	10.1371/journal.pone.0030545	http://dx.doi.org/10.1371/journal.pone.0030545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355315	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300015
J	Richer, MJ; Lavallee, DJ; Shanina, I; Horwitz, MS				Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.			Immunomodulation of Antigen Presenting Cells Promotes Natural Regulatory T Cells That Prevent Autoimmune Diabetes in NOD Mice	PLOS ONE			English	Article							TGF-BETA; CUTTING EDGE; COXSACKIEVIRUS INFECTION; VIRAL-INFECTIONS; INDUCTION; HOMEOSTASIS; VIRUS; FOXP3; COSTIMULATION; ACCELERATION	Progression towards type 1 diabetes (T1D) in susceptible patients is linked to a progressive decline in the capacity of regulatory T cells (Treg) to maintain tolerance. As such, therapies aimed at redressing the failing Treg compartment have been the subject of intense investigation. Treg dysfunction in T1D has recently been linked to a reduced capacity of antigen presenting cells (APCs) to maintain Treg function rather than Treg intrinsic defects. This suggests that therapies aimed simply at addressing the failing Treg compartment are unlikely to provide long-term protection. Here, we demonstrate that modulation of the inflammatory status of CD11b+CD11c- APCs favors the upregulation of protective Tregs in a mouse model of T1D. We further demonstrate that reduced expression of the costimulatory molecule CD40 plays a role in this increased immunoregulatory capacity. Strikingly, Treg upregulation resulted exclusively from an increase in natural Tregs rather than the peripheral conversion of conventional T cells. This suggests that modulation of CD11b+CD11c- APCs inflammatory properties favors the establishment of natural Treg responses that, unlike adaptive Treg responses, are likely to maintain tolerance to a broad range of antigens. As such, modulation of this APC subset represents a potential therapeutic avenue to reestablish peripheral tolerance and protect from autoimmune diseases such as T1D.	[Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Richer, MJ (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	mhorwitz@mail.ubc.ca			Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by grants from the Canadian Institutes of Health Research and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard P, 2006, DIABETES, V55, P2098, DOI 10.2337/db05-0810; Anderson AC, 2008, J IMMUNOL, V181, P7449, DOI 10.4049/jimmunol.181.11.7449; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Cui GL, 2009, CELL RES, V19, P574, DOI 10.1038/cr.2009.12; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Filippi CM, 2009, J CLIN INVEST, V119, P1515, DOI 10.1172/JCI38503; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Gaddy DF, 2010, DIABETES, V59, P3108, DOI 10.2337/db09-1886; Gregg RK, 2004, J IMMUNOL, V173, P7308, DOI 10.4049/jimmunol.173.12.7308; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Horwitz MS, 2006, VIRAL IMMUNOL, V19, P722, DOI 10.1089/vim.2006.19.722; Horwitz MS, 2004, CLIN IMMUNOL, V110, P134, DOI 10.1016/j.clim.2003.09.014; Horwitz MS, 2002, J CLIN INVEST, V109, P79, DOI 10.1172/JCI11198; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Jahromi MM, 2006, ANN NY ACAD SCI, V1079, P289, DOI 10.1196/annals.1375.044; Jin Y, 2009, CLIN IMMUNOL, V130, P272, DOI 10.1016/j.clim.2008.10.005; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; King C, 1998, IMMUNITY, V8, P601, DOI 10.1016/S1074-7613(00)80565-8; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Manirarora JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003739; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Richer MJ, 2008, DIABETES, V57, P1302, DOI 10.2337/db07-1460; Richer MJ, 2006, CLIN IMMUNOL, V121, P339, DOI 10.1016/j.clim.2006.07.009; Richer MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004127; Richer MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4241, DOI 10.2741/3002; Riedel MJ, 2010, GENE THER, V17, P171, DOI 10.1038/gt.2009.143; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Serreze DV, 2005, J VIROL, V79, P1045, DOI 10.1128/JVI.79.2.1045-1052.2005; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Walker LSK, 2008, EXPERT OPIN BIOL TH, V8, P1691, DOI 10.1517/14712598.8.11.1691 ; WEBB SR, 1976, J EXP MED, V143, P1239, DOI 10.1084/jem.143.5.1239; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	53	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31153	10.1371/journal.pone.0031153	http://dx.doi.org/10.1371/journal.pone.0031153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355341	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300041
J	Welker, MW; Reichert, D; Susser, S; Sarrazin, C; Martinez, Y; Herrmann, E; Zeuzem, S; Piiper, A; Kronenberger, B				Welker, Martin-Walter; Reichert, David; Susser, Simone; Sarrazin, Christoph; Martinez, Yolanda; Herrmann, Eva; Zeuzem, Stefan; Piiper, Albrecht; Kronenberger, Bernd			Soluble Serum CD81 Is Elevated in Patients with Chronic Hepatitis C and Correlates with Alanine Aminotransferase Serum Activity	PLOS ONE			English	Article							VIRUS ENVELOPE PROTEIN; ANTIVIRAL TREATMENT; IMMUNE-SYSTEM; INFECTION; EXOSOMES; CELLS; ENTRY; HCV; EXPRESSION; BINDING	Aim: Cellular CD81 is a well characterized hepatitis C virus (HCV) entry factor, while the relevance of soluble exosomal CD81 in HCV pathogenesis is poorly defined. We performed a case-control study to investigate whether soluble CD81 in the exosomal serum fraction is associated with HCV replication and inflammatory activity. Patients and Methods: Four cohorts were investigated, patients with chronic hepatitis C (n = 37), patients with chronic HCV infection and persistently normal ALT levels (n = 24), patients with long term sustained virologic response (SVR, n = 7), and healthy volunteers (n = 23). Concentration of soluble CD81 was assessed semi-quantitatively after differential centrifugation ranging from 200 g to 100,000 g in the fifth centrifugation fraction by immunoblotting and densitometry. Results: Soluble CD81 was increased in patients with chronic hepatitis C compared to healthy subjects (p = 0.03) and cured patients (p = 0.017). Patients with chronic HCV infection and persistently normal ALT levels and patients with long term SVR had similar soluble CD81 levels as healthy controls (p>0.2). Overall, soluble CD81 levels were associated with ALT levels (r = 0.334, p = 0.016) and severe liver fibrosis (p = 0.027). Conclusion: CD81 is increased in the exosomal serum fraction in patients with chronic hepatitis C and appears to be associated with inflammatory activity and severity of fibrosis.	[Welker, Martin-Walter; Reichert, David; Susser, Simone; Sarrazin, Christoph; Martinez, Yolanda; Zeuzem, Stefan; Piiper, Albrecht; Kronenberger, Bernd] Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ Frankfurt, Fachbereich Med, Inst Biostat & Math Modellierung, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Welker, MW (corresponding author), Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Theodor Stern Kai 7, Frankfurt, Germany.	Bernd.Kronenberger@kgu.de	Zeuzem, Stefan/AAE-7435-2019		clinical research unit [KFO 129]; German Research Foundation (DFG); Scolari Stiftung	clinical research unit; German Research Foundation (DFG)(German Research Foundation (DFG)); Scolari Stiftung	This study was supported by the clinical research unit KFO 129, funded by the German Research Foundation (DFG), and by the Scolari Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2002, ANN INTERN MED, V137, P961, DOI 10.7326/0003-4819-137-12-200212170-00009; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Bacon BR, 2002, HEPATOLOGY, V36, pS179, DOI 10.1053/jhep.2002.36386; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fritzsching B, 2002, J IMMUNOL, V169, P5531, DOI 10.4049/jimmunol.169.10.5531; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Kronenberger B, 2009, ANN HEPATOL, V8, P103, DOI 10.1016/S1665-2681(19)31786-7; Kronenberger B, 2006, J LEUKOCYTE BIOL, V80, P298, DOI 10.1189/jlb.0106047; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lange CM, 2010, ALIMENT PHARM THER, V32, P14, DOI 10.1111/j.1365-2036.2010.04317.x; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Martinot-Peignoux M, 2001, HEPATOLOGY, V34, P1000, DOI 10.1053/jhep.2001.28458; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Perelson AS, 2005, HEPATOLOGY, V42, P749, DOI 10.1002/hep.20882; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Puoti C, 2010, EUR J INTERN MED, V21, P57, DOI 10.1016/j.ejim.2009.12.006; Qazi KR, 2010, THORAX, V65, P1016, DOI 10.1136/thx.2009.132027; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Wack A, 2001, EUR J IMMUNOL, V31, P166, DOI 10.1002/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706; Whiteside TL, 2011, B CANCER, V98, pE25, DOI 10.1684/bdc.2010.1294; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Yoon JC, 2009, HEPATOLOGY, V49, P12, DOI 10.1002/hep.22624; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050; Zuckerman E, 2003, J VIROL, V77, P10432, DOI 10.1128/JVI.77.19.10432-10436.2003; Zuckerman E, 2003, J HEPATOL, V38, P674, DOI 10.1016/S0168-8278(03)00122-3	41	58	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30796	10.1371/journal.pone.0030796	http://dx.doi.org/10.1371/journal.pone.0030796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355327	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300027
J	Dasari, VR; Velpula, KK; Alapati, K; Gujrati, M; Tsung, AJ				Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Alapati, Kiranmai; Gujrati, Meena; Tsung, Andrew J.			Cord Blood Stem Cells Inhibit Epidermal Growth Factor Receptor Translocation to Mitochondria in Glioblastoma	PLOS ONE			English	Article							TYROSINE KINASES; C-SRC; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; LOCALIZED EGFR; CANCER; SURVIVAL; GLIOMA; STAT3; PHOSPHORYLATION	Background: Overexpression of EGFR is one of the most frequently diagnosed genetic aberrations of glioblastoma multiforme (GBM). EGFR signaling is involved in diverse cellular functions and is dependent on the type of preferred receptor complexes. EGFR translocation to mitochondria has been reported recently in different cancer types. However, mechanistic aspects of EGFR translocation to mitochondria in GBM have not been evaluated to date. Methodology/Principle Findings: In the present study, we analyzed the expression of EGFR in GBM-patient derived specimens using immunohistochemistry, reverse-transcription based PCR and Western blotting techniques. In clinical samples, EGFR co-localizes with FAK in mitochondria. We evaluated this previous observation in standard glioma cell lines and in vivo mice xenografts. We further analyzed the effect of human umbilical cord blood stem cells (hUCBSC) on the inhibition of EGFR expression and EGFR signaling in glioma cells and xenografts. Treatment with hUCBSC inhibited the expression of EGFR and its co-localization with FAK in glioma cells. Also, hUCBSC inhibited the co-localization of activated forms of EGFR, FAK and c-Src in mitochondria of glioma cells and xenografts. In addition, hUCBSC also inhibited EGFR signaling proteins in glioma cells both in vitro and in vivo. Conclusions/Significance: We have shown that hUCBSC treatments inhibit phosphorylation of EGFR, FAK and c-Src forms. Our findings associate EGFR expression and its localization to mitochondria with specific biological functions in GBM cells and provide relevant preclinical information that can be used for the development of effective hUCBSC-based therapies.	[Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Alapati, Kiranmai] Univ Illinois, Coll Med, Dept Canc Biol, Peoria, IL 61656 USA; [Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Alapati, Kiranmai] Univ Illinois, Coll Med, Dept Pharmacol, Peoria, IL 61656 USA; [Tsung, Andrew J.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA; [Tsung, Andrew J.] Univ Illinois, Coll Med, Illinois Neurol Inst, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Dasari, VR (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol, Peoria, IL 61656 USA.	Andrew.J.Tsung@INI.org	Alapati, Kiranmai/F-7171-2013; Dasari, Venkata Ramesh/B-3098-2009	Dasari, Venkata Ramesh/0000-0003-0819-2935	Illinois Neurological Institute	Illinois Neurological Institute	This research is supported by a grant from Illinois Neurological Institute (to AJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; CARPENTIER JL, 1986, EXP CELL RES, V166, P312, DOI 10.1016/0014-4827(86)90479-9; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011813; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Dasari VR, 2010, AGING ALBANY NY, V2, P1; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Fan QW, 2005, ONCOGENE, V24, P829, DOI 10.1038/sj.onc.1208227; Frederick L, 2000, CANCER RES, V60, P1383; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Hajnoczky G, 2007, SCIENCE, V315, P607, DOI 10.1126/science.1138825; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Velpula KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018017; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yao YA, 2010, ACTA BIOCH BIOPH SIN, V42, P763, DOI 10.1093/abbs/gmq090; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yue XJ, 2008, AUTOPHAGY, V4, P641, DOI 10.4161/auto.5971	51	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31884	10.1371/journal.pone.0031884	http://dx.doi.org/10.1371/journal.pone.0031884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348136	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400055
J	Fisher, JB; Kim, MS; Blinka, S; Ge, ZD; Wan, TN; Duris, C; Christian, D; Twaroski, K; North, P; Auchampach, J; Lough, J				Fisher, Joseph B.; Kim, Min-Su; Blinka, Steven; Ge, Zhi-Dong; Wan, Tina; Duris, Christine; Christian, Desirae; Twaroski, Kirk; North, Paula; Auchampach, John; Lough, John			Stress-Induced Cell-Cycle Activation in Tip60 Haploinsufficient Adult Cardiomyocytes	PLOS ONE			English	Article							CARDIAC MYOCYTES; GENE-EXPRESSION; BINDING DOMAIN; DNA-SYNTHESIS; P53 PATHWAY; HEART; PROLIFERATION; APOPTOSIS; PROTEIN; REPAIR	Background: Tat-interactive protein 60 (Tip60) is a member of the MYST family of histone acetyltransferases. Studies using cultured cells have shown that Tip60 has various functions including DNA repair, apoptosis and cell-cycle regulation. We globally ablated the Tip60 gene (Htatip), observing that Tip60-null embryos die at the blastocyst stage (Hu et al. Dev. Dyn. 238:2912;2009). Although adult heterozygous (Tip60(+/-)) mice reproduce normally without a haploinsufficient phenotype, stress caused by Myc over-expression induced B-cell lymphoma in Tip60(+/-) adults, suggesting that Tip60 is a tumor suppressor (Gorrini et al. Nature 448: 1063; 2007). These findings prompted assessment of whether Tip60, alternative splicing of which generates two predominant isoforms termed Tip60 alpha and Tip60 beta, functions to suppress the cell-cycle in adult cardiomyocytes. Methodology/Principal Findings: Western blotting revealed that Tip60 alpha is the predominant Tip60 isoprotein in the embryonic heart, transitioning at neonatal stages to Tip60 beta, which is the only isoprotein in the adult heart wherein it is highly enriched. Over-expression of Tip60 beta, but not Tip60 alpha, inhibited cell proliferation in NIH3T3 cells; and, Tip60-haploinsufficient cultured neonatal cardiomyocytes exhibited increased cell-cycle activity. To address whether Tip60 beta suppresses the cardiomyocyte cell-cycle in the adult heart, hypertrophic stress was induced in Tip60(+/+) and Tip(+/-) littermates via two methods, Myc over-expression and aortic banding. Based on immunostaining cell-cycle markers and western blotting cyclin D, stress increased cardiomyocyte cell-cycle mobilization in Tip60(+/-) hearts, in comparison with Tip60(+/+) littermates. Aortic-banded Tip60(+/-) hearts also exhibited significantly decreased apoptosis. Conclusions/Significance: These findings provide evidence that Tip60 may function in a tumor suppressor pathway(s) to maintain adult cardiomyocytes in replicative senescence.	[Fisher, Joseph B.; Kim, Min-Su; Blinka, Steven; Christian, Desirae; Twaroski, Kirk; Lough, John] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Fisher, Joseph B.; Kim, Min-Su; Blinka, Steven; Ge, Zhi-Dong; Wan, Tina; Christian, Desirae; Twaroski, Kirk; Auchampach, John; Lough, John] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Ge, Zhi-Dong; Wan, Tina; Auchampach, John] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Duris, Christine; North, Paula] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Fisher, JB (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jlough@mcw.edu		Blinka, Steven/0000-0002-0776-5677	National Institutes of Health [HL089471]; American Heart Association [0810108Z]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089471, R01HL077707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL089471 (JL) and by Predoctoral Fellowship #0810108Z from the American Heart Association (JBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Gehrking KM, 2011, HUM MOL GENET, V20, P2204, DOI 10.1093/hmg/ddr108; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; KIM KK, 1994, J BIOL CHEM, V269, P22607; Kim MS, 2006, J BIOL CHEM, V281, P15082, DOI 10.1074/jbc.M513593200; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; Meckert PC, 2005, CARDIOVASC RES, V67, P116, DOI 10.1016/j.cardiores.2005.02.017; Muckova K, 2006, AM J PHYSIOL-RENAL, V290, pF70, DOI 10.1152/ajprenal.00358.2004; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Pena AN, 2011, EXP CELL RES, V317, P1534, DOI 10.1016/j.yexcr.2011.02.001; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tyteca S, 2006, MOL CELL, V24, P807, DOI 10.1016/j.molcel.2006.12.005; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Xiao GS, 2001, CIRC RES, V89, P1122, DOI 10.1161/hh2401.100742; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252; Zhu WQ, 2009, PEDIATR CARDIOL, V30, P710, DOI 10.1007/s00246-009-9408-3	48	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31569	10.1371/journal.pone.0031569	http://dx.doi.org/10.1371/journal.pone.0031569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348108	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400036
J	Laing, ST; Ivens, A; Butler, V; Ravikumar, SP; Laing, R; Woods, DJ; Gilleard, JS				Laing, Steven T.; Ivens, Al; Butler, Victoria; Ravikumar, Sai P.; Laing, Roz; Woods, Debra J.; Gilleard, John S.			The Transcriptional Response of Caenorhabditis elegans to Ivermectin Exposure Identifies Novel Genes Involved in the Response to Reduced Food Intake	PLOS ONE			English	Article							GATED CHLORIDE CHANNEL; ANTHELMINTIC RESISTANCE; PARASITIC NEMATODE; PHARYNGEAL MUSCLE; C-ELEGANS; EXPRESSION; GLUTAMATE; TRANSPORT; SUBUNIT; DAUER	We have examined the transcriptional response of Caenorhabditis elegans following exposure to the anthelmintic drug ivermectin (IVM) using whole genome microarrays and real-time QPCR. Our original aim was to identify candidate molecules involved in IVM metabolism and/or excretion. For this reason the IVM tolerant strain, DA1316, was used to minimise transcriptomic changes related to the phenotype of drug exposure. However, unlike equivalent work with benzimidazole drugs, very few of the induced genes were members of xenobiotic metabolising enzyme families. Instead, the transcriptional response was dominated by genes associated with fat mobilization and fatty acid metabolism including catalase, esterase, and fatty acid CoA synthetase genes. This is consistent with the reduction in pharyngeal pumping, and consequential reduction in food intake, upon exposure of DA1316 worms to IVM. Genes with the highest fold change in response to IVM exposure, cyp-37B1, mtl-1 and scl-2, were comparably up-regulated in response to short-term food withdrawal (4 hr) independent of IVM exposure, and GFP reporter constructs confirm their expression in tissues associated with fat storage (intestine and hypodermis). These experiments have serendipitously identified novel genes involved in an early response of C. elegans to reduced food intake and may provide insight into similar processes in higher organisms.	[Laing, Steven T.; Laing, Roz] Univ Glasgow, Fac Vet Med, Glasgow, Strathclyde, Scotland; [Ivens, Al] Fios Genom Ltd, Edinburgh Technol Transfer Ctr, Edinburgh, Midlothian, Scotland; [Butler, Victoria; Ravikumar, Sai P.; Gilleard, John S.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Woods, Debra J.] Pfizer Anim Hlth, Res & Dev, Kalamazoo, MI USA	University of Glasgow; University of Edinburgh; University of Calgary; Pfizer	Laing, ST (corresponding author), Univ Glasgow, Fac Vet Med, Glasgow, Strathclyde, Scotland.	jsgillea@ucalgary.ca		Laing, Roz/0000-0002-6191-0759; Ivens, Al/0000-0002-0112-3876; Gilleard, John/0000-0002-6787-4699	Biotechnology and Biological Sciences Research Council CASE; Biosciences Knowledge Transfer Network; Pfizer Plc.; Pfizer Animal Health PLC.	Biotechnology and Biological Sciences Research Council CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biosciences Knowledge Transfer Network; Pfizer Plc.(Pfizer); Pfizer Animal Health PLC.	Dr. Steven Laing was supported by a Biotechnology and Biological Sciences Research Council CASE Studentship and the Biosciences Knowledge Transfer Network (formerly Genesis Faraday). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding was supplied by Pfizer Plc. Dr. Deborah Woods, who is employed by Pfizer, provided advice and support regarding the use of the HPLC-MS, so she had technical and intellectual input into that aspect.; The authors have read the journal's policy and have the following conflicts: One author (Al Ivens) is employed by Fios Genomics Ltd and another (Deborah Woods) is employed by Prizer Animal Health. In addition, the study received some funding support from Pfizer Animal Health PLC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ardelli BF, 2009, VET PARASITOL, V165, P96, DOI 10.1016/j.vetpar.2009.06.043; Ashrafi Kaveh, 2007, WormBook, P1; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brownlee DJA, 1997, PARASITOLOGY, V115, P553, DOI 10.1017/S0031182097001601; Churcher TS, 2009, P NATL ACAD SCI USA, V106, P16716, DOI 10.1073/pnas.0906176106; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Custodia N, 2001, ANN NY ACAD SCI, V948, P32; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Edward CL, 2008, VET REC, V162, P56, DOI 10.1136/vr.162.2.56; Etter A, 1996, J BIOL CHEM, V271, P16035, DOI 10.1074/jbc.271.27.16035; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fox LM, 2006, CURR OPIN INFECT DIS, V19, P588, DOI 10.1097/QCO.0b013e328010774c; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; Canga AG, 2009, VET J, V179, P25, DOI 10.1016/j.tvjl.2007.07.011; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Holden-Dye L, 2006, INT J PARASITOL, V36, P395, DOI 10.1016/j.ijpara.2005.11.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Johnstone IL, 1999, PRACT APPROACH SER, V213, P201; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kondoh M, 2003, TOXICOL LETT, V143, P301, DOI 10.1016/S0378-4274(03)00195-4; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Laing ST, 2010, BIOCHEM J, V432, P505, DOI 10.1042/BJ20101346; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Menzel R, 2007, J MOL BIOL, V370, P1, DOI 10.1016/j.jmb.2007.04.058; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pemberton DJ, 2001, MOL PHARMACOL, V59, P1037, DOI 10.1124/mol.59.5.1037; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Sargison ND, 2007, VET PARASITOL, V145, P65, DOI 10.1016/j.vetpar.2006.10.024; Shinogi M, 1999, BIOL PHARM BULL, V22, P132, DOI 10.1248/bpb.22.132; Sogawa N, 2003, METHOD FIND EXP CLIN, V25, P601, DOI 10.1358/mf.2003.25.8.778079; Stiernagle Theresa, 2006, WormBook, P1; Szewczyk NJ, 2006, J EXP BIOL, V209, P4129, DOI 10.1242/jeb.02492; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Vassilatis DK, 1997, J BIOL CHEM, V272, P33167, DOI 10.1074/jbc.272.52.33167; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Yates DM, 2003, INT J PARASITOL, V33, P1183, DOI 10.1016/S0020-7519(03)00172-3; Zheng J, 2012, INT J OBESITY, V36, P186, DOI 10.1038/ijo.2011.93	52	24	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31367	10.1371/journal.pone.0031367	http://dx.doi.org/10.1371/journal.pone.0031367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348077	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302737400018
J	Fu, J; Zhang, DF; Liu, YH; Ying, S; Shi, YS; Song, YC; Li, Y; Wang, TY				Fu, Jing; Zhang, Deng-Feng; Liu, Ying-Hui; Ying, Sheng; Shi, Yun-Su; Song, Yan-Chun; Li, Yu; Wang, Tian-Yu			Isolation and Characterization of Maize PMP3 Genes Involved in Salt Stress Tolerance	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNELS; NA+/H+ ANTIPORTER GENE; PLASMA-MEMBRANE; SUPEROXIDE-DISMUTASE; ION HOMEOSTASIS; CHLOROPHYLL FLUORESCENCE; SIGNAL-TRANSDUCTION; ENHANCED TOLERANCE; ARABIDOPSIS; PROTEIN	Plasma membrane protein 3 (PMP3), a class of small hydrophobic polypeptides with high sequence similarity, is responsible for salt, drought, cold, and abscisic acid. These small hydrophobic ploypeptides play important roles in maintenance of ion homeostasis. In this study, eight ZmPMP3 genes were cloned from maize and responsive to salt, drought, cold and abscisic acid. The eight ZmPMP3s were membrane proteins and their sequences in trans-membrane regions were highly conserved. Phylogenetic analysis showed that they were categorized into three groups. All members of group II were responsive to ABA. Functional complementation showed that with the exception of ZmPMP3-6, all were capable of maintaining membrane potential, which in turn allows for regulation of intracellular ion homeostasis. This process was independent of the presence of Ca2+. Lastly, over-expression of ZmPMP3-1 enhanced growth of transgenic Arabidopsis under salt condition. Through expression analysis of deduced downstream genes in transgenic plants, expression levels of three ion transporter genes and four important antioxidant genes in ROS scavenging system were increased significantly in transgenic plants during salt stress. This tolerance was likely achieved through diminishing oxidative stress due to the possibility of ZmPMP3-1's involvement in regulation of ion homeostasis, and suggests that the modulation of these conserved small hydrophobic polypeptides could be an effective way to improve salt tolerance in plants.	[Fu, Jing] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Fu, Jing; Zhang, Deng-Feng; Liu, Ying-Hui; Ying, Sheng; Shi, Yun-Su; Song, Yan-Chun; Li, Yu; Wang, Tian-Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Fu, J (corresponding author), China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China.	yuli@mail.caas.net.cn; wangtianyu@263.net			Ministry of Science and Technology of China [2011CB100100, 2009CB118401]; China Natural Science Foundation [30730063]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was partly supported by grants provided by the Ministry of Science and Technology of China (2011CB100100, 2009CB118401) and the China Natural Science Foundation (30730063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Badawi GH, 2004, PLANT SCI, V166, P919, DOI 10.1016/j.plantsci.2003.12.007; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Bihler H, 1998, FEBS LETT, V432, P59, DOI 10.1016/S0014-5793(98)00832-1; Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251; Chang-Qing Z, 2008, BMB REP, V41, P448, DOI 10.5483/BMBRep.2008.41.6.448; CHEESEMAN JM, 1985, PHYSIOL PLANTARUM, V65, P460, DOI 10.1111/j.1399-3054.1985.tb08674.x; Demidchik V, 2002, PLANT PHYSIOL, V128, P379, DOI 10.1104/pp.010524; Demidchik V, 2007, NEW PHYTOL, V175, P387, DOI 10.1111/j.1469-8137.2007.02128.x; Farooq S, 2006, J PLANT PHYSIOL, V163, P629, DOI 10.1016/j.jplph.2005.06.006; Feng DR, 2009, ENVIRON EXP BOT, V65, P395, DOI 10.1016/j.envexpbot.2008.12.009; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; GALVEZ AF, 1993, PLANT PHYSIOL, V103, P257, DOI 10.1104/pp.103.1.257; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gobert A, 2006, J EXP BOT, V57, P791, DOI 10.1093/jxb/erj064; GODDARD NJ, 1993, PLANT MOL BIOL, V23, P871, DOI 10.1007/BF00021541; GRADMANN D, 1993, J MEMBRANE BIOL, V136, P327; Guo KM, 2010, PHYSIOL PLANTARUM, V139, P303, DOI 10.1111/j.1399-3054.2010.01366.x; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Inada M, 2005, PLANTA, V220, P395, DOI 10.1007/s00425-004-1358-7; Koike M, 2008, MOL GENET GENOMICS, V280, P41, DOI 10.1007/s00438-008-0343-4; KRAUSE GH, 1984, PHOTOSYNTH RES, V5, P139, DOI 10.1007/BF00028527; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li YZ, 2010, ENVIRON EXP BOT, V69, P158, DOI 10.1016/j.envexpbot.2010.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina J, 2007, J EXP BOT, V58, P4333, DOI 10.1093/jxb/erm285; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Mitsuya S, 2005, PLANTA, V222, P1001, DOI 10.1007/s00425-005-0043-9; Mitsuya S, 2006, PHYSIOL PLANTARUM, V128, P95, DOI 10.1111/j.1399-3054.2006.00714.x; Morales MA, 1998, J PLANT PHYSIOL, V153, P174, DOI 10.1016/S0176-1617(98)80062-X; Morsy MR, 2005, GENE, V344, P171, DOI 10.1016/j.gene.2004.09.033; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Navarre C, 2000, EMBO J, V19, P2515, DOI 10.1093/emboj/19.11.2515; NEUHAUS G, 1993, CELL, V73, P937, DOI 10.1016/0092-8674(93)90272-R; Nylander M, 2001, PLANT MOL BIOL, V45, P341, DOI 10.1023/A:1006451914231; Ohta M, 2002, FEBS LETT, V532, P279, DOI 10.1016/S0014-5793(02)03679-7; Patrick IG, 1994, PLANT PHYSIOL, V104, P799; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; Sairam RK, 2005, BIOL PLANTARUM, V49, P85, DOI 10.1007/s10535-005-5091-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SEEMANN JR, 1985, PLANTA, V164, P151, DOI 10.1007/BF00396077; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shi HZ, 2002, NATURE, DOI [10.1083/nbt766, DOI 10.1083/NBT766]; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; Wang MY, 2007, PLANT MOL BIOL, V65, P733, DOI 10.1007/s11103-007-9238-8; Wang YH, 2004, PLANT SCI, V167, P671, DOI 10.1016/j.plantsci.2004.03.032; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Zhang YY, 2006, PLANTA, V224, P545, DOI 10.1007/s00425-006-0242-z; Zhao JF, 2009, PLANT MOL BIOL, V69, P661, DOI 10.1007/s11103-008-9445-y; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zorb C, 2005, J PLANT PHYSIOL, V162, P55, DOI 10.1016/j.jplph.2004.03.010	63	35	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31101	10.1371/journal.pone.0031101	http://dx.doi.org/10.1371/journal.pone.0031101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348040	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900022
J	Koikkalainen, J; Polonen, H; Mattila, J; van Gils, M; Soininen, H; Lotjonen, J				Koikkalainen, Juha; Polonen, Harri; Mattila, Jussi; van Gils, Mark; Soininen, Hilkka; Lotjonen, Jyrki		Alzheimers Dis Neuroimaging Initia	Improved Classification of Alzheimer's Disease Data via Removal of Nuisance Variability	PLOS ONE			English	Article							PERSONALIZED MEDICINE; DIAGNOSIS	Diagnosis of Alzheimer's disease is based on the results of neuropsychological tests and available supporting biomarkers such as the results of imaging studies. The results of the tests and the values of biomarkers are dependent on the nuisance features, such as age and gender. In order to improve diagnostic power, the effects of the nuisance features have to be removed from the data. In this paper, four types of interactions between classification features and nuisance features were identified. Three methods were tested to remove these interactions from the classification data. In stratified analysis, a homogeneous subgroup was generated from a training set. Data correction method utilized linear regression model to remove the effects of nuisance features from data. The third method was a combination of these two methods. The methods were tested using all the baseline data from the Alzheimer's Disease Neuroimaging Initiative database in two classification studies: classifying control subjects from Alzheimer's disease patients and discriminating stable and progressive mild cognitive impairment subjects. The results show that both stratified analysis and data correction are able to statistically significantly improve the classification accuracy of several neuropsychological tests and imaging biomarkers. The improvements were especially large for the classification of stable and progressive mild cognitive impairment subjects, where the best improvements observed were 6% units. The data correction method gave better results for imaging biomarkers, whereas stratified analysis worked well with the neuropsychological tests. In conclusion, the study shows that the excess variability caused by nuisance features should be removed from the data to improve the classification accuracy, and therefore, the reliability of diagnosis making.	[Koikkalainen, Juha; Polonen, Harri; Mattila, Jussi; van Gils, Mark; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Tampere, Finland; [Soininen, Hilkka] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	VTT Technical Research Center Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Koikkalainen, J (corresponding author), VTT Tech Res Ctr Finland, Tampere, Finland.	juha.koikkalainen@vtt.fi	Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013; Levey, Allan/F-2104-2011	Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Levey, Allan/0000-0002-3153-502X; van Gils, Mark/0000-0002-0029-1771; , Harri/0000-0002-3270-2897	European Commission; EU [224328-PredictAD, 270259-TBIcare]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, R01AG022374, P30AG010129, R01AG012101, K01AG030514, U19AG010483, U01AG024904, P30AG019610] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded under the 7th Framework Programme by the European Commission (http//cordis.europa.eu/; EU-Grant-224328-PredictAD; Name: From Patient Data to Personalized Healthcare in Alzheimer's Disease, and EU-Grant-270259-TBIcare; Name: Evidence-based Diagnostics and Treatment Planning Solution for Traumatic Brain Injuries). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASU D, 1977, J AM STAT ASSOC, V72, P355, DOI 10.2307/2286800; Beckett LA, 2010, ALZHEIMERS DEMENT, V6, P257, DOI 10.1016/j.jalz.2010.03.002; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cronk BB, 2010, ALZ DIS ASSOC DIS, V24, P126, DOI 10.1097/WAD.0b013e3181a6bf3f; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Kohannim O, 2010, NEUROBIOL AGING, V31, P1429, DOI 10.1016/j.neurobiolaging.2010.04.022; Mattila J, 2011, J ALZHEIMERS DIS, V27, P163, DOI 10.3233/JAD-2011-110365; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schilsky RL, 2010, NAT REV DRUG DISCOV, V9, P363, DOI 10.1038/nrd3181; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Wildt A., 1978, ANAL COVARIANCE	17	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31112	10.1371/journal.pone.0031112	http://dx.doi.org/10.1371/journal.pone.0031112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348041	Green Published, gold			2022-12-27	WOS:000302733900023
J	Pirko, I; Chen, Y; Lohrey, AK; McDole, J; Gamez, JD; Allen, KS; Pavelko, KD; Lindquist, DM; Dunn, RS; Macura, SI; Johnson, AJ				Pirko, Istvan; Chen, Yi; Lohrey, Anne K.; McDole, Jeremiah; Gamez, Jeffrey D.; Allen, Kathleen S.; Pavelko, Kevin D.; Lindquist, Diana M.; Dunn, R. Scott; Macura, Slobodan I.; Johnson, Aaron J.			Contrasting Roles for CD4 vs. CD8 T-Cells in a Murine Model of Virally Induced "T1 Black Hole" Formation	PLOS ONE			English	Article							INDUCED DEMYELINATING DISEASE; ENCEPHALOMYELITIS VIRUS-INFECTION; MULTIPLE-SCLEROSIS LESIONS; SPIN-ECHO MRI; THEILERS VIRUS; HYPOINTENSE LESIONS; VASCULAR-PERMEABILITY; GAMMA-INTERFERON; MOTOR FUNCTION; C57BL/6 MICE	MRI is sensitive to tissue pathology in multiple sclerosis (MS); however, most lesional MRI findings have limited correlation with disability. Chronic T1 hypointense lesions or "T1 black holes" (T1BH), observed in a subset of MS patients and thought to represent axonal damage, show moderate to strong correlation with disability. The pathogenesis of T1BH remains unclear. We previously reported the first and as of yet only model of T1BH formation in the Theiler's murine encephalitis virus induced model of acute CNS neuroinflammation induced injury, where CD8 T-cells are critical mediators of axonal damage and related T1BH formation. The purpose of this study was to further analyze the role of CD8 and CD4 T-cells through adoptive transfer experiments and to determine if the relevant CD8 T-cells are classic epitope specific lymphocytes or different subsets. C57BL/6 mice were used as donors and RAG-1 deficient mice as hosts in our adoptive transfer experiments. In vivo 3-dimensional MRI images were acquired using a 7 Tesla small animal MRI system. For image analysis, we used semi-automated methods in Analyze 9.1; transfer efficiency was monitored using FACS of brain infiltrating lymphocytes. Using a peptide depletion method, we demonstrated that the majority of CD8 T-cells are classic epitope specific cytotoxic cells. CD8 T-cell transfer successfully restored the immune system's capability to mediate T1BH formation in animals that lack adaptive immune system, whereas CD4 T-cell transfer results in an attenuated phenotype with significantly less T1BH formation. These findings demonstrate contrasting roles for these cell types, with additional evidence for a direct pathogenic role of CD8 T-cells in our model of T1 black hole formation.	[Pirko, Istvan; Gamez, Jeffrey D.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Chen, Yi; Lohrey, Anne K.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [McDole, Jeremiah] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Allen, Kathleen S.; Pavelko, Kevin D.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Lindquist, Diana M.; Dunn, R. Scott] Cincinnati Childrens Hosp, Med Ctr, Imaging Res Ctr, Cincinnati, OH USA; [Macura, Slobodan I.] Mayo Clin, Dept Biochem, NMR Core Facil, Rochester, MN USA	Mayo Clinic; University System of Ohio; University of Cincinnati; Washington University (WUSTL); Mayo Clinic; Cincinnati Children's Hospital Medical Center; Mayo Clinic	Pirko, I (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	pirko@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS058698]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058698] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health, National Institute of Neurological Disorders and Stroke R01 NS058698. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2000, NEUROIMAG CLIN N AM, V10, P739; Barkhof F, 2000, NEUROIMAG CLIN N AM, V10, pix; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; BORROW P, 1993, IMMUNOLOGY, V80, P502; Brahic M, 2002, VIROLOGY, V301, P1, DOI 10.1006/viro.2002.1607; Chang JR, 2000, VIROLOGY, V278, P346, DOI 10.1006/viro.2000.0646; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; Deb C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012478; Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Hill KE, 1998, J NEUROIMMUNOL, V85, P44, DOI 10.1016/S0165-5728(97)00263-4; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Inoue A, 1998, J IMMUNOL, V161, P5586; Johnson AJ, 2007, INT REV NEUROBIOL, V79, P73, DOI 10.1016/S0074-7742(07)79004-9; Johnson AJ, 2005, J IMMUNOL, V174, P6854, DOI 10.4049/jimmunol.174.11.6854; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Kang HS, 2010, J VIROL, V84, P2774, DOI 10.1128/JVI.01948-09; Karls KA, 2002, MULT SCLER J, V8, P469, DOI 10.1191/1352458502ms850oa; Kerkvliet J, 2009, J VIROL, V83, P12279, DOI 10.1128/JVI.00664-09; Losseff NA, 2001, J NEUROL, V248, P517, DOI 10.1007/s004150170163; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; McDole JR, 2010, AM J PATHOL; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Myoung J, 2007, VIROLOGY, V360, P159, DOI 10.1016/j.virol.2006.09.045; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Pirko I, 2004, NEUROIMAGE, V21, P576, DOI 10.1016/j.neuroimage.2003.09.037; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; PIRKO I, 2009, J NEUROL SCI; Pirko I, 2008, RADIOLOGY, V246, P790, DOI 10.1148/radiol.2463070338; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PULLEN LC, 1994, J NEUROIMMUNOL, V55, P143, DOI 10.1016/0165-5728(94)90004-3; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Robb RA, 1999, ANNU REV BIOMED ENG, V1, P377, DOI 10.1146/annurev.bioeng.1.1.377; Rodriguez M, 2003, J VIROL, V77, P12252, DOI 10.1128/JVI.77.22.12252-12265.2003; Sato F, 2010, PATHOPHYSIOLOGY; Suidan GL, 2010, J IMMUNOL, V184, P1031, DOI 10.4049/jimmunol.0902773; Suidan GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003037; Suidan GL, 2006, NEUROL RES, V28, P250, DOI 10.1179/016164106X98116; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; Tsunoda I, 2005, J VIROL, V79, P14640, DOI 10.1128/JVI.79.23.14640-14646.2005; Tsunoda I, 2002, J VIROL, V76, P12834, DOI 10.1128/JVI.76.24.12834-12844.2002; Tsunoda I, 2010, J NEUROIMMUNE PHARM, V5, P355, DOI 10.1007/s11481-009-9179-x; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; VANWALDERVEEN MAA, 1995, NEUROLOGY, V45, P1684, DOI 10.1212/WNL.45.9.1684; YAMADA M, 1990, J EXP MED, V171, P1893, DOI 10.1084/jem.171.6.1893	52	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31459	10.1371/journal.pone.0031459	http://dx.doi.org/10.1371/journal.pone.0031459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348089	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900048
J	Crespo, JA; Stockl, P; Ueberall, F; Jenny, M; Saria, A; Zernig, G				Crespo, Jose A.; Stoeckl, Petra; Ueberall, Florian; Jenny, Marcel; Saria, Alois; Zernig, Gerald			Activation of PKCzeta and PKMzeta in the Nucleus Accumbens Core Is Necessary for the Retrieval, Consolidation and Reconsolidation of Drug Memory	PLOS ONE			English	Article							PROTEIN-KINASE-C; COCAINE-SEEKING BEHAVIOR; RAT RUNWAY PROCEDURE; ACETYLCHOLINE; REINFORCEMENT; DOPAMINE; FOOD; REMIFENTANIL; INTERNEURONS; ACQUISITION	One of the greatest challenges in the treatment of substance dependence is to reverse the control that drug-associated stimuli have gained over the addict's behavior, as these drug-associated memories increase the risk of relapse even after long periods of abstinence. We report here that inhibition of the atypical protein kinase C isoform PKCzeta and its constitutively active isoform PKMzeta with the pseudosubstrate inhibitor ZIP administered locally into the nucleus accumbens core reversibly inhibited the retrieval of drug-associated memory and drug (remifentanil) seeking, whereas a scrambled ZIP peptide or staurosporine, an effective inhibitor of c/nPKC-, CaMKII-, and PKA kinases that does not affect PKCzeta/PKMzeta activity, was without effect on these memory processes. Acquisition or extinction of drug-associated memory remained unaffected by PKCzeta- and PKMzeta inhibition.	[Crespo, Jose A.; Stoeckl, Petra; Saria, Alois; Zernig, Gerald] Innsbruck Med Univ, Dept Gen Psychiat & Social Psychiat, Expt Psychiat Unit, Innsbruck, Austria; [Ueberall, Florian; Jenny, Marcel] Innsbruck Med Univ, Div Med Biochem, Innsbruck Bioctr, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Crespo, JA (corresponding author), Innsbruck Med Univ, Dept Gen Psychiat & Social Psychiat, Expt Psychiat Unit, Innsbruck, Austria.	gerald.zernig@i-med.ac.at			FWF [P18787-B05]; D.SwarovskiForschungsforderungsfonds [D-151840-012-011]; Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP)	FWF(Austrian Science Fund (FWF)); D.SwarovskiForschungsforderungsfonds; Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP)	This work was supported by FWF grant P18787-B05, by D.SwarovskiForschungsforderungsfonds grant D-151840-012-011, and by Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla H, 2003, BEHAV BRAIN RES, V147, P41, DOI 10.1016/S0166-4328(03)00136-0; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Crespo JA, 2005, PSYCHOPHARMACOLOGY, V183, P201, DOI 10.1007/s00213-005-0180-7; Crespo JA, 2008, NEUROPSYCHOPHARMACOL, V33, P3213, DOI 10.1038/npp.2008.48; Crespo JA, 2006, ANN NY ACAD SCI, V1074, P497, DOI 10.1196/annals.1369.050; Crespo JA, 2006, J NEUROSCI, V26, P6004, DOI 10.1523/JNEUROSCI.4494-05.2006; Dekker LV, 2003, PROTEIN KINASE C; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Epstein DH, 2009, ARCH GEN PSYCHIAT, V66, P88, DOI 10.1001/archgenpsychiatry.2008.509; Ettenberg A, 2009, PHARMACOL BIOCHEM BE, V91, P271, DOI 10.1016/j.pbb.2008.11.003; GEIST TD, 1990, PHARMACOL BIOCHEM BE, V36, P703, DOI 10.1016/0091-3057(90)90278-P; Hopf FW, 2005, J NEUROSCI, V25, P985, DOI 10.1523/JNEUROSCI.3099-04.2005; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Mark GP, 1999, PSYCHOPHARMACOLOGY, V143, P47, DOI 10.1007/s002130050918; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Narita M, 2001, NEUROSCIENCE, V103, P309, DOI 10.1016/S0306-4522(00)00572-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; Pratt WE, 2004, BEHAV NEUROSCI, V118, P730, DOI 10.1037/0735-7044.118.4.730; Preston KL, 2009, PSYCHOPHARMACOLOGY, V207, P291, DOI 10.1007/s00213-009-1655-8; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Theberge FRM, 2010, LEARN MEMORY, V17, P444, DOI 10.1101/lm.1757410; Wakionigg G, 2003, PHARMACOLOGY, V69, P180, DOI 10.1159/000073661; Wakonigg G, 2004, PHARMACOLOGY, V72, P225, DOI 10.1159/000080377; Wakonigg G, 2003, PSYCHOPHARMACOLOGY, V169, P52, DOI 10.1007/s00213-003-1488-9; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Zernig G, 2008, ADDICTION, V103, P2024, DOI 10.1111/j.1360-0443.2008.02348.x; Zernig G, 2007, PHARMACOLOGY, V80, P65, DOI 10.1159/000103923; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	36	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30502	10.1371/journal.pone.0030502	http://dx.doi.org/10.1371/journal.pone.0030502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348011	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900010
J	Ferriss, JS; Kim, YC; Duska, L; Birrer, M; Levine, DA; Moskaluk, C; Theodorescu, D; Lee, JK				Ferriss, J. Stuart; Kim, Youngchul; Duska, Linda; Birrer, Michael; Levine, Douglas A.; Moskaluk, Christopher; Theodorescu, Dan; Lee, Jae K.			Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; CANCER-CELLS; CHEMOSENSITIVITY; TRIAL; ASSAY; CLASSIFICATION; PACLITAXEL; DISCOVERY	Despite advances in radical surgery and chemotherapy delivery, ovarian cancer is the most lethal gynecologic malignancy. Standard therapy includes treatment with platinum-based combination chemotherapies yet there is no biomarker model to predict their responses to these agents. We here have developed and independently tested our multi-gene molecular predictors for forecasting patients' responses to individual drugs on a cohort of 55 ovarian cancer patients. To independently validate these molecular predictors, we performed microarray profiling on FFPE tumor samples of 55 ovarian cancer patients (UVA-55) treated with platinum-based adjuvant chemotherapy. Genome-wide chemosensitivity biomarkers were initially discovered from the in vitro drug activities and genomic expression data for carboplatin and paclitaxel, respectively. Multivariate predictors were trained with the cell line data and then evaluated with a historical patient cohort. For the UVA-55 cohort, the carboplatin, taxol, and combination predictors significantly stratified responder patients and non-responder patients (p = 0.019, 0.04, 0.014) with sensitivity = 91%, 96%, 93 and NPV = 57%, 67%, 67% in pathologic clinical response. The combination predictor also demonstrated a significant survival difference between predicted responders and non-responders with a median survival of 55.4 months vs. 32.1 months. Thus, COXEN single- and combination-drug predictors successfully stratified platinum resistance and taxane response in an independent cohort of ovarian cancer patients based on their FFPE tumor samples.	[Ferriss, J. Stuart] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA; [Kim, Youngchul; Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Duska, Linda] Univ Virginia, Thomton Gynecol Oncol Div, Dept Obstet & Gynecol, Charlottesville, VA USA; [Birrer, Michael] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Gynecol Serv, New York, NY 10021 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Moskaluk, Christopher] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Theodorescu, Dan] Univ Colorado, Dept Surg & Pharmacol, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Virginia; University of Virginia; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus	Ferriss, JS (corresponding author), Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA.	jkl7n@virginia.edu	Ferriss, James Stuart/I-2507-2019	Ferriss, James Stuart/0000-0002-2053-8604; Levine, Douglas/0000-0003-1038-8232	UVA Cancer Center and Experimental Therapeutics	UVA Cancer Center and Experimental Therapeutics	UVA Cancer Center and Experimental Therapeutics grants (JKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2010, CANC FACTS FIG; Berger ML, 2010, J CLIN ONCOL, V28, pE343, DOI 10.1200/JCO.2010.28.2475; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Cree IA, 2007, ANTI-CANCER DRUG, V18, P1093, DOI 10.1097/CAD.0b013e3281de727e; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Gallion H, 2006, INT J GYNECOL CANCER, V16, P194, DOI 10.1111/j.1525-1438.2006.00301.x; KERN DH, 1990, J NATL CANCER I, V82, P582, DOI 10.1093/jnci/82.7.582; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Lee JK, 2010, CLIN CANCER RES, V16, P711, DOI 10.1158/1078-0432.CCR-09-2247; Lee JK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r82; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Parmar MKB, 2003, LANCET, V361, P2099; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Smith SC, 2010, CANCER RES, V70, P1753, DOI 10.1158/0008-5472.CAN-09-3562; Soukup M, 2005, BIOINFORMATICS, V21, pI423, DOI 10.1093/bioinformatics/bti1020; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798; Zhou XHJ, 2005, NAT BIOTECHNOL, V23, P238, DOI 10.1038/nbt1058	19	73	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30550	10.1371/journal.pone.0030550	http://dx.doi.org/10.1371/journal.pone.0030550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348014	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730900012
J	Hoogman, M; Rijpkema, M; Janss, L; Brunner, H; Fernandez, G; Buitelaar, J; Franke, B; Arias-Vasquez, A				Hoogman, Martine; Rijpkema, Mark; Janss, Luc; Brunner, Han; Fernandez, Guillen; Buitelaar, Jan; Franke, Barbara; Arias-Vasquez, Alejandro			Current Self-Reported Symptoms of Attention Deficit/Hyperactivity Disorder Are Associated with Total Brain Volume in Healthy Adults	PLOS ONE			English	Article								Background: Reduced total brain volume is a consistent finding in children with Attention Deficit/Hyperactivity Disorder (ADHD). In order to get a better understanding of the neurobiology of ADHD, we take the first step in studying the dimensionality of current self-reported adult ADHD symptoms, by looking at its relation with total brain volume. Methodology/Principal Findings: In a sample of 652 highly educated adults, the association between total brain volume, assessed with magnetic resonance imaging, and current number of self-reported ADHD symptoms was studied. The results showed an association between these self-reported ADHD symptoms and total brain volume. Post-hoc analysis revealed that the symptom domain of inattention had the strongest association with total brain volume. In addition, the threshold for impairment coincides with the threshold for brain volume reduction. Conclusions/Significance: This finding improves our understanding of the biological substrates of self-reported ADHD symptoms, and suggests total brain volume as a target intermediate phenotype for future gene-finding in ADHD.	[Hoogman, Martine; Franke, Barbara; Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Hoogman, Martine; Brunner, Han; Franke, Barbara; Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Janss, Luc; Fernandez, Guillen; Buitelaar, Jan] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Hoogman, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.	m.hoogman@psy.umcn.nl	Buitelaar, J.K./AAY-7522-2020; Franke, Barbara/D-4836-2009; Buitelaar, Jan K/E-4584-2012; Brunner, Han/C-9928-2013; Vasquez, Alejandro Arias/E-4762-2012; Vasquez, A. Arias/L-4175-2015; Fernandez, Guillen/B-3771-2009; Hoogman, Martine/G-8958-2015; Rijpkema, Mark/D-1974-2010	Franke, Barbara/0000-0003-4375-6572; Buitelaar, Jan K/0000-0001-8288-7757; Vasquez, Alejandro Arias/0000-0002-4786-0169; Fernandez, Guillen/0000-0002-5522-0604; Hoogman, Martine/0000-0002-1261-7628; Rijpkema, Mark/0000-0002-8495-4703	Netherlands Organization for Scientific Research (NWO) [93511010]; Biobanking and Biomolecular Resources Research Initiative-NL (BBMRI-NL) [CP33]; Netherlands Brain Foundation (Hersenstichting Nederland) [15F07(2)27)]; NWO [480-05-003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Biobanking and Biomolecular Resources Research Initiative-NL (BBMRI-NL); Netherlands Brain Foundation (Hersenstichting Nederland); NWO(Netherlands Organization for Scientific Research (NWO))	This study was partly funded by a Horizon Grant of the Netherlands Organization for Scientific Research (NWO; grant number 93511010, granted to AAV), a grant of the Biobanking and Biomolecular Resources Research Initiative-NL (BBMRI-NL: grant number CP33), and a grant of the Netherlands Brain Foundation (Hersenstichting Nederland, grant number 15F07(2)27). Statistical analyses were carried out on the Genetic Cluster Computer (http//www.geneticcluster.org), which is financially supported by NWO (480-05-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA LG, 2010, J PSYCHIAT RES; Montes LGA, 2010, J PSYCHIATR NEUROSCI, V35, P238, DOI 10.1503/jpn.090099; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chen W, 2008, AM J MED GENET B, V147B, P1450, DOI 10.1002/ajmg.b.30672; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Cubillo A, 2010, EXPERT REV NEUROTHER, V10, P603, DOI 10.1586/ERN.10.4; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Frodl T, 2010, ACTA PSYCHIAT SCAND, V121, P111, DOI 10.1111/j.1600-0447.2009.01489.x; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Lubke GH, 2009, J AM ACAD CHILD PSY, V48, P1085, DOI 10.1097/CHI.0b013e3181ba3dbb; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Perlov E, 2008, J PSYCHIATR NEUROSCI, V33, P509; Poelmans G, 2011, AM J PSYCHIAT; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Seidman LJ, 2010, BIOL PSYCHIAT; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Solanto MV, 2007, J ABNORM CHILD PSYCH, V35, P729, DOI 10.1007/s10802-007-9123-6; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696	25	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31273	10.1371/journal.pone.0031273	http://dx.doi.org/10.1371/journal.pone.0031273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348063	Green Published, gold			2022-12-27	WOS:000302730900023
J	Cheng, YX; Luo, LZ; Jiang, XF; Sappington, TW				Cheng, Yun Xia; Luo, Li Zhi; Jiang, Xing Fu; Sappington, Thomas W.			Synchronized Oviposition Triggered by Migratory Flight Intensifies Larval Outbreaks of Beet Webworm	PLOS ONE			English	Article							LOXOSTEGE-STICTICALIS LEPIDOPTERA; HISTORY TRADE-OFFS; ARMYWORM MOTH; REPRODUCTION; DISPERSAL; BEHAVIOR; CAPABILITY; INSECTS; PHYSIOLOGY; PYRALIDAE	Identifying the reproductive consequences of insect migration is critical to understanding its ecological and evolutionary significance. However, many empirical studies are seemingly contradictory, making recognition of unifying themes elusive and controversial. The beet webworm, Loxostege sticticalis L. is a long-range migratory pest of many crops in the northern temperate zone from 36 degrees N to 55 degrees N, with larval populations often exploding in regions receiving immigrants. In laboratory experiments, we examined (i) the reproductive costs of migratory flight by tethered flight, and (ii) the reproductive traits contributing to larval outbreaks of immigrant populations. Our results suggest that the beet webworm does not initiate migratory flight until the 2nd or 3rd night after emergence. Preoviposition period, lifetime fecundity, mating capacity, and egg hatch rate for adults that experienced prolonged flight after the 2nd night did not differ significantly from unflown moths, suggesting these traits are irrelevant to the severity of beet webworm outbreaks after migration. However, the period of first oviposition, a novel parameter developed in this paper measuring synchrony of first egg-laying by cohorts of post-migratory females, for moths flown on d 3 and 5 of adulthood was shorter than that of unflown moths, indicating a tightened time-window for onset of oviposition after migration. The resulting synchrony of egg-laying will serve to increase egg and subsequent larval densities. A dense population offers potential selective advantages to the individual larvae comprising it, whereas the effect from the human standpoint is intensification of damage by an outbreak population. The strategy of synchronized oviposition may be common in other migratory insect pests, such as locust and armyworm species, and warrants further study.	[Cheng, Yun Xia; Luo, Li Zhi; Jiang, Xing Fu] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Sappington, Thomas W.] USDA ARS, Corn Insects & Crop Genet Res Unit, Genet Lab ISU, Ames, IA USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA)	Cheng, YX (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	lzluo@ippcaas.cn		Sappington, Thomas/0000-0002-4083-4101	National Natural Science Foundation of China [31071677]; National Department of Public Benefit [201003079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department of Public Benefit	This work was financially supported by projects of the National Natural Science Foundation of China (No: 31071677), and of the National Department of Public Benefit (No: 201003079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, ECONOMIST 0326; Bertram SM, 2007, ETHOLOGY, V113, P875, DOI 10.1111/j.1439-0310.2007.01399.x; Chen R. L., 1992, Acta Phytophylacica Sinica, V19, P171; COCKBAIN AJ, 1961, J EXP BIOL, V38, P181; DINGLE H, 1972, SCIENCE, V175, P1327, DOI 10.1126/science.175.4028.1327; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DIXON AFG, 1993, J ANIM ECOL, V62, P182, DOI 10.2307/5492; Dyakonova V, 2008, J INSECT BEHAV, V21, P172, DOI 10.1007/s10905-008-9117-4; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Frolov A.N., 2008, ENTOMOL REV, V88, P666; Guerra PA, 2007, J INSECT BEHAV, V20, P377, DOI 10.1007/s10905-007-9084-1; Guerra PA, 2009, BIOL LETTERS, V5, P229, DOI 10.1098/rsbl.2008.0570; GUNN A, 1989, PHYSIOL ENTOMOL, V14, P419, DOI 10.1111/j.1365-3032.1989.tb01111.x; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; HIGHNAM KC, 1964, J INSECT PHYSIOL, V10, P849, DOI 10.1016/0022-1910(64)90077-0; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Hu, 2001, CHINESE SCI ABSTRACT, V7, P662; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1631, DOI 10.1016/j.jinsphys.2010.06.006; Jiang XF, 2010, ENVIRON ENTOMOL, V39, P232, DOI 10.1603/EN08315; Johnson C.G., 1969, MIGRATION DISPERSAL, P763, DOI DOI 10.1007/978-3-642-61360-9_7; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; Knor I. B., 1993, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V72, P117; Kong HL, 2010, ENVIRON ENTOMOL, V39, P1579, DOI 10.1603/EN09314; Kong HL, 2011, ACTA ENTOMO IN PRESS, V54; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; Li Ke-Bin, 2005, Acta Entomologica Sinica, V48, P155; Luo L.Z., 1992, TRANSACTION ECOLOGIC, P303; Luo L.Z., 2009, PLANT PROT BEIJING, V35, P27; Luo Li-Zhi, 1993, Acta Entomologica Sinica, V36, P332; Luo Li-Zhi, 1993, Acta Entomologica Sinica, V36, P459; Luo Lizhi, 1999, Acta Entomologica Sinica, V42, P150; LUO LZ, 1998, J NATURAL DISASTERS, V7, P158; MASON LJ, 1989, ENVIRON ENTOMOL, V18, P980, DOI 10.1093/ee/18.6.980; MCANELLY ML, 1986, BIOL BULL, V170, P378, DOI 10.2307/1541849; MIKKOLA K, 1970, J ANIM ECOL, V39, P593, DOI 10.2307/2856; Pepper JH, 1938, ECOLOGY, V19, P565, DOI 10.2307/1930934; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; RILEY JR, 1983, ECOL ENTOMOL, V8, P395, DOI 10.1111/j.1365-2311.1983.tb00519.x; ROFF D, 1977, J ANIM ECOL, V46, P443, DOI 10.2307/3822; Rose DJW, 2000, AFRICAN ARMYWORM HDB; RYGG TD, 1966, ENTOMOL EXP APPL, V9, P74, DOI 10.1007/BF00341160; SLANSKY F, 1980, ENTOMOL EXP APPL, V28, P277, DOI 10.1007/BF00366314; Wang Chun-Rong, 2006, Chinese Bulletin of Entomology, V43, P98; Wei Q, 1987, PLANT DIS INSECT S1, P98; WILLERS JL, 1987, J INSECT PHYSIOL, V33, P803, DOI 10.1016/0022-1910(87)90027-8; Yin Jiao, 2005, Acta Ecologica Sinica, V25, P1844; Yue ZD, 1983, JILIN AGR SCI, P7881; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zhang SK, 1987, PLANT DIS INSECT S1, P82; 罗礼智, 2004, [植物保护, Plant Protection], V30, P86	53	26	43	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31562	10.1371/journal.pone.0031562	http://dx.doi.org/10.1371/journal.pone.0031562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347494	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200024
J	Green, J; Wang, D; Lilley, CJ; Urwin, PE; Atkinson, HJ				Green, Jayne; Wang, Dong; Lilley, Catherine J.; Urwin, Peter E.; Atkinson, Howard J.			Transgenic Potatoes for Potato Cyst Nematode Control Can Replace Pesticide Use without Impact on Soil Quality	PLOS ONE			English	Article							CONFERS RESISTANCE; GLOBODERA-PALLIDA; PLANT CYSTATIN; CELL-DEATH; EXPRESSION; DIVERSITY; FRAMEWORK; DISRUPTS	Current and future global crop yields depend upon soil quality to which soil organisms make an important contribution. The European Union seeks to protect European soils and their biodiversity for instance by amending its Directive on pesticide usage. This poses a challenge for control of Globodera pallida (a potato cyst nematode) for which both natural resistance and rotational control are inadequate. One approach of high potential is transgenically based resistance. This work demonstrates the potential in the field of a new transgenic trait for control of G. pallida that suppresses root invasion. It also investigates its impact and that of a second transgenic trait on the non-target soil nematode community. We establish that a peptide that disrupts chemoreception of nematodes without a lethal effect provides resistance to G. pallida in both a containment and a field trial when precisely targeted under control of a root tip-specific promoter. In addition we combine DNA barcoding and quantitative PCR to recognise nematode genera from soil samples without microscope-based observation and use the method for nematode faunal analysis. This approach establishes that the peptide and a cysteine proteinase inhibitor that offer distinct bases for transgenic plant resistance to G. pallida do so without impact on the nontarget nematode soil community.	[Green, Jayne; Wang, Dong; Lilley, Catherine J.; Urwin, Peter E.; Atkinson, Howard J.] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Green, J (corresponding author), Adv Technol Cambridge Ltd, Cambridge, England.	p.e.urwin@leeds.ac.uk		Urwin, Peter Edward/0000-0003-0398-2372	Biotechnology and Biological Sciences Research Council, United Kingdom [BB/D001749/1]; Natural Environment Research Council, United Kingdom; BBSRC [BB/D001749/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001749/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council, United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grant number BB/D001749/1 from the Biotechnology and Biological Sciences Research Council, United Kingdom. (http://www.bbsrc.ac.uk). DW was funded by a Dorothy Hodgkin post-graduate award from the Natural Environment Research Council, United Kingdom. (http://www.nerc.ac.uk) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, LAB METHODS WORK PLA; Atkinson HJ, 2004, DETERMINING RISKS SO; Baulcombe D., 2009, REAPING BENEFITS SCI, P72; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blum ES, 2008, CELL DEATH DIFFER, V15, P1124, DOI 10.1038/cdd.2008.56; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Canadian Food Inspection Agency Science Branch, 2008, OFF BIOT CONF RES FI; Celis C, 2004, NATURE, V432, P222, DOI 10.1038/nature03048; Clayton R, 2008, IMPACT REDUCED PESTI; Cowgill SE, 2004, MOL ECOL, V13, P639, DOI 10.1046/j.1365-294X.2004.02078.x; Cowgill SE, 2003, TRANSGENIC RES, V12, P439, DOI 10.1023/A:1024215922148; Cowgill SE, 2002, J APPL ECOL, V39, P915, DOI 10.1046/j.1365-2664.2002.00774.x; Dietze J., 1995, P24; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; EC Regulation, 2009, OFFICIAL J EUROPEAN, V52, P1; European Commission Joint Research Institute of Health and Consumer Protection, 2010, DEL REL ENV GMOS AN; European Community Commission, 2010, SOIL BIOD FUNCT THRE, DOI [10.2779/14571, DOI 10.2779/14571]; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Golden TR, 2007, AGING CELL, V6, P179, DOI 10.1111/j.1474-9726.2007.00273.x; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Ingham ER, 2000, SOIL BIOL PRIMER IOW; JEFFERIES RA, 1991, ANN APPL BIOL, V119, P387, DOI 10.1111/j.1744-7348.1991.tb04879.x; Leroy BLM, 2009, NEMATOLOGY, V11, P23, DOI 10.1163/156854108X398381; Lilley CJ, 2011, PLANT BIOTECHNOL J, V9, P151, DOI 10.1111/j.1467-7652.2010.00542.x; Lilley CJ, 2004, PLANT BIOTECHNOL J, V2, P3, DOI 10.1046/j.1467-7652.2003.00037.x; Liu B, 2005, PLANT BIOTECHNOL J, V3, P487, DOI 10.1111/j.1467-7652.2005.00139.x; Qian H, 2008, FASEB J, V22, P3247, DOI 10.1096/fj.08-110502; Sanchez-Moreno S, 2008, BIOL FERT SOILS, V44, P727, DOI 10.1007/s00374-007-0256-0; Sanchez-Moreno S, 2006, NEMATOLOGY, V8, P703, DOI 10.1163/156854106778877857; Trudgill David L., 1998, P117; Trudgill DL, 2003, ANN APPL BIOL, V143, P73, DOI 10.1111/j.1744-7348.2003.tb00271.x; Twining S, 2009, 20092 POT COUNC LTD; Urwin PE, 2003, MOL BREEDING, V12, P263, DOI 10.1023/A:1026352620308; URWIN PE, 1995, PLANT J, V8, P121, DOI 10.1046/j.1365-313X.1995.08010121.x; Urwin PE, 2001, MOL BREEDING, V8, P95, DOI 10.1023/A:1011942003994; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017475; Winter MD, 2002, PARASITOLOGY, V125, P561, DOI 10.1017/S0031182002002482	39	21	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30973	10.1371/journal.pone.0030973	http://dx.doi.org/10.1371/journal.pone.0030973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359559	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200028
J	Hotte, M; Dauphin, F; Freret, T; Boulouard, M; Levallet, G				Hotte, Maite; Dauphin, Francois; Freret, Thomas; Boulouard, Michel; Levallet, Guenaelle			A Biphasic and Brain-Region Selective Down-Regulation of Cyclic Adenosine Monophosphate Concentrations Supports Object Recognition in the Rat	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; LONG-TERM-MEMORY; MEDIAL PREFRONTAL CORTEX; 5-HT4 RECEPTOR AGONISTS; KINASE-A; PHOSPHODIESTERASE ISOZYMES; CARDIAC MYOCYTES; MESSENGER-RNA; IN-VITRO; PARTICULATE PHOSPHODIESTERASE-4	Background: We aimed to further understand the relationship between cAMP concentration and mnesic performance. Methods and Findings: Rats were injected with milrinone (PDE3 inhibitor, 0.3 mg/kg, i.p.), rolipram (PDE4 inhibitor, 0.3 mg/kg, i.p.) and/or the selective 5-HT4R agonist RS 67333 (1 mg/kg, i.p.) before testing in the object recognition paradigm. Cyclic AMP concentrations were measured in brain structures linked to episodic-like memory (i.e. hippocampus, prefrontal and perirhinal cortices) before or after either the sample or the testing phase. Except in the hippocampus of rolipram treated-rats, all treatment increased cAMP levels in each brain sub-region studied before the sample phase. After the sample phase, cAMP levels were significantly increased in hippocampus (1.8 fold), prefrontal (1.3 fold) and perirhinal (1.3 fold) cortices from controls rat while decreased in prefrontal cortex (similar to 0.83 to 0.62 fold) from drug-treated rats (except for milrinone+RS 67333 treatment). After the testing phase, cAMP concentrations were still increased in both the hippocampus (2.76 fold) and the perirhinal cortex (2.1 fold) from controls animals. Minor increase were reported in hippocampus and perirhinal cortex from both rolipram (respectively, 1.44 fold and 1.70 fold) and milrinone (respectively 1.46 fold and 1.56 fold)-treated rat. Following the paradigm, cAMP levels were significantly lower in the hippocampus, prefrontal and perirhinal cortices from drug-treated rat when compared to controls animals, however, only drug-treated rats spent longer time exploring the novel object during the testing phase (inter-phase interval of 4 h). Conclusions: Our results strongly suggest that a "pre-sample" early increase in cAMP levels followed by a specific lowering of cAMP concentrations in each brain sub-region linked to the object recognition paradigm support learning efficacy after a middle-term delay.	[Hotte, Maite; Dauphin, Francois; Freret, Thomas; Boulouard, Michel; Levallet, Guenaelle] Univ Caen Basse Normandie, GMPc, EA4259, IFR 146, Caen, France; [Hotte, Maite] Univ Rouen, NeoVasc, EA 4309, IHURBM,IFRMP23, Rouen, France; [Levallet, Guenaelle] CHU Caen, Serv Anat Pathol, F-14000 Caen, France	Universite de Caen Normandie; Universite de Rouen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Hotte, M (corresponding author), Univ Caen Basse Normandie, GMPc, EA4259, IFR 146, Caen, France.	levallet-g@chu-caen.fr	Dauphin, Francois/B-1642-2012; freret, thomas/AAA-2491-2019; Levallet, Guenaelle GBL/L-1637-2015; freret, thomas/B-2068-2012; Michel, Boulouard/N-9028-2015	freret, thomas/0000-0002-4446-4451; freret, thomas/0000-0002-4446-4451; Michel, Boulouard/0000-0003-3825-8659				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Aujla H, 2001, BEHAV NEUROSCI, V115, P1204, DOI 10.1037//0735-7044.115.6.1204; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bernabeu R, 1996, NEUROREPORT, V7, P585, DOI 10.1097/00001756-199601310-00050; Bernabeu R, 1997, BRAZ J MED BIOL RES, V30, P961, DOI 10.1590/S0100-879X1997000800008; Besheer J, 1999, BEHAV BRAIN RES, V103, P35, DOI 10.1016/S0166-4328(99)00021-2; Bonaventure P, 2000, SYNAPSE, V36, P35, DOI 10.1002/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO;2-Y; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Bussey TJ, 2000, BEHAV BRAIN RES, V111, P187, DOI 10.1016/S0166-4328(00)00155-8; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Connolly DA, 1996, MEMORY, V4, P243, DOI 10.1080/096582196388942; DESJARDINS S, 1995, DRUG CHEM TOXICOL, V18, P43, DOI 10.3109/01480549509017857; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dousa Thomas P., 1998, Cell Biochemistry and Biophysics, V29, P19, DOI 10.1007/BF02737826; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; EDELSON J, 1986, CIRCULATION, V73, P145; Egawa T, 1997, JPN J PHARMACOL, V75, P275, DOI 10.1254/jjp.75.275; EGLEN RM, 1995, BRIT J PHARMACOL, V115, P1387, DOI 10.1111/j.1476-5381.1995.tb16628.x; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Fontana DJ, 1997, NEUROPHARMACOLOGY, V36, P689, DOI 10.1016/S0028-3908(97)00055-5; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Galeotti N, 1998, J PHARMACOL EXP THER, V286, P1115; Giorgi M, 2004, BEHAV BRAIN RES, V154, P99, DOI 10.1016/j.bbr.2004.01.024; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; GRIEBEL G, 1991, PHARMACOL BIOCHEM BE, V39, P321, DOI 10.1016/0091-3057(91)90186-6; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Hotte M, 2006, BEHAV BRAIN RES, V171, P127, DOI 10.1016/j.bbr.2006.03.026; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Houslay MD, 2003, BIOCHEM SOC T, V31, P1186; Hoyer D, 2004, P ANN INT IEEE EMBS, V26, P628; Huang Z, 2001, CURR OPIN CHEM BIOL, V5, P432, DOI 10.1016/S1367-5931(00)00224-6; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kelly MP, 2008, LEARN MEMORY, V15, P75, DOI 10.1101/lm.723708; King MV, 2008, TRENDS PHARMACOL SCI, V29, P482, DOI 10.1016/j.tips.2008.07.001; KRAUSE W, 1988, XENOBIOTICA, V18, P561, DOI 10.3109/00498258809041693; Lamirault L, 2003, PROG NEURO-PSYCHOPH, V27, P185, DOI 10.1016/S0278-5846(02)00351-2; Lamirault L, 2001, NEUROPHARMACOLOGY, V41, P844, DOI 10.1016/S0028-3908(01)00123-X; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Letty S, 1997, NEUROPHARMACOLOGY, V36, P681, DOI 10.1016/S0028-3908(96)00169-4; Levallet G, 2008, J ENDOCRINOL, V197, P45, DOI 10.1677/JOE-07-0497; Levallet G, 2009, PSYCHOPHARMACOLOGY, V202, P125, DOI 10.1007/s00213-008-1283-8; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Lindsay CA, 1998, J PEDIATR-US, V132, P329, DOI 10.1016/S0022-3476(98)70454-8; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Marchetti E, 2008, NEUROBIOL LEARN MEM, V90, P185, DOI 10.1016/j.nlm.2008.03.010; Marchetti E, 2000, NEUROPHARMACOLOGY, V39, P2017, DOI 10.1016/S0028-3908(00)00038-1; MATOUSOVIC K, 1995, J CLIN INVEST, V96, P401, DOI 10.1172/JCI118049; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Meneses A, 2007, BEHAV BRAIN RES, V184, P81, DOI 10.1016/j.bbr.2007.06.026; Monti B, 2006, NEUROPSYCHOPHARMACOL, V31, P278, DOI 10.1038/sj.npp.1300813; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Moser PC, 2002, J PHARMACOL EXP THER, V302, P731, DOI 10.1124/jpet.102.034249; O'Donnell JM, 1999, PHARMACOL BIOCHEM BE, V63, P185, DOI 10.1016/S0091-3057(98)00267-6; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Orsetti M, 2003, LEARN MEMORY, V10, P420, DOI 10.1101/lm.67303; Parker A, 1998, EUR J NEUROSCI, V10, P3044, DOI 10.1046/j.1460-9568.1998.00306.x; Perez-Garcia G, 2008, BEHAV BRAIN RES, V195, P139, DOI 10.1016/j.bbr.2008.07.033; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Prickaerts J, 2002, EUR J PHARMACOL, V436, P83, DOI 10.1016/S0014-2999(01)01614-4; Pullar CE, 2006, FASEB J, V20, P76, DOI 10.1096/fj.05-4188com; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; RANDT CT, 1982, PHARMACOL BIOCHEM BE, V17, P677, DOI 10.1016/0091-3057(82)90344-6; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Restivo L, 2008, NEUROPSYCHOPHARMACOL, V33, P2427, DOI 10.1038/sj.npp.1301644; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rodriguez R, 2004, J APPL PHYSIOL, V97, P439, DOI 10.1152/japplphysiol.01115.2003; Rutten K, 2008, PSYCHOPHARMACOLOGY, V196, P643, DOI 10.1007/s00213-007-0999-1; Rutten K, 2006, NEUROBIOL LEARN MEM, V85, P132, DOI 10.1016/j.nlm.2005.09.002; Rutten K, 2007, EUR J PHARMACOL, V558, P107, DOI 10.1016/j.ejphar.2006.11.041; Rutten K, 2011, NEUROPHARMACOLOGY, V61, P138, DOI 10.1016/j.neuropharm.2011.03.020; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Silvestre JS, 1999, J PSYCHOPHARMACOL, V13, P274, DOI 10.1177/026988119901300309; Sim ATR, 2006, PHARMACOL THERAPEUT, V112, P425, DOI 10.1016/j.pharmthera.2006.04.011; Taylor JR, 1999, J NEUROSCI, V19; Terry AV, 1998, PSYCHOPHARMACOLOGY, V135, P407, DOI 10.1007/s002130050529; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; van Donkelaar EL, 2008, EUR J PHARMACOL, V600, P98, DOI 10.1016/j.ejphar.2008.10.027; Vilaro MT, 1996, MOL BRAIN RES, V43, P356, DOI 10.1016/S0169-328X(96)00248-3; Warburton EC, 2010, NEUROPSYCHOLOGIA, V48, P2262, DOI 10.1016/j.neuropsychologia.2009.12.022; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhang HT, 2009, CURR PHARM DESIGN, V15, P1688, DOI 10.2174/138161209788168092; Zhang HT, 2000, PSYCHOPHARMACOLOGY, V150, P311, DOI 10.1007/s002130000414; Zhang HT, 2004, NEUROPSYCHOPHARMACOL, V29, P1432, DOI 10.1038/sj.npp.1300440; Zhang HT, 2000, NEUROPSYCHOPHARMACOL, V23, P198, DOI 10.1016/S0893-133X(00)00108-1; Zhao J, 2010, NEUROPHARMACOLOGY, V58, P774, DOI 10.1016/j.neuropharm.2009.12.008	99	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32244	10.1371/journal.pone.0032244	http://dx.doi.org/10.1371/journal.pone.0032244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359674	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200143
J	Lacar, B; Herman, P; Hartman, NW; Hyder, F; Bordey, A				Lacar, Benjamin; Herman, Peter; Hartman, Nathaniel W.; Hyder, Fahmeed; Bordey, Angelique			S Phase Entry of Neural Progenitor Cells Correlates with Increased Blood Flow in the Young Subventricular Zone	PLOS ONE			English	Article							STEM-CELLS; IN-VIVO; OLFACTORY-BULB; VASCULAR NICHE; DENTATE GYRUS; GROWTH-FACTOR; CYCLE LENGTH; ADULT-RAT; BRAIN; PROLIFERATION	The postnatal subventricular zone (SVZ) contains proliferating neural progenitor cells in close proximity to blood vessels. Insults and drug treatments acutely stimulate cell proliferation in the SVZ, which was assessed by labeling cells entering S phase. Although G1-to-S progression is metabolically demanding on a minute-to-hour time scale, it remains unknown whether increased SVZ cell proliferation is accompanied by a local hemodynamic response. This neurovascular coupling provides energy substrates to active neuronal assemblies. Transcardial dye perfusion revealed the presence of capillaries throughout the SVZ that constrict upon applications of the thromboxane A(2) receptor agonist U-46119 in acute brain slice preparations. We then monitored in vivo blood flow using laser Doppler flowmetry via a microprobe located either in the SVZ or a mature network. U-46119 injections into the lateral ventricle decreased blood flow in the SVZ and the striatum, which are near the ventricle. A 1-hour ventricular injection of epidermal and basic fibroblast growth factor (EGF and bFGF) significantly increased the percentage of Sox2 transcription factor-positive cells in S phase 1.5 hours post-injection. This increase was accompanied by a sustained rise in blood flow in the SVZ but not in the striatum. Direct growth factor injections into the cortex did not alter local blood flow, ruling out direct effects on capillaries. These findings suggest that an acute increase in the number of G1-to-S cycling SVZ cells is accompanied by neurometabolic-vascular coupling, which may provide energy and nutrient for cell cycle progression.	[Lacar, Benjamin; Hartman, Nathaniel W.; Bordey, Angelique] Yale Univ, Sch Med, Dept Neurosurg & Cellular & Mol Physiol, New Haven, CT 06520 USA; [Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Magnet Resonance Res Ctr, New Haven, CT USA; [Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Lacar, B (corresponding author), Yale Univ, Sch Med, Dept Neurosurg & Cellular & Mol Physiol, New Haven, CT 06520 USA.	angelique.bordey@yale.edu	Hyder, Fahmeed/A-2644-2015; Herman, Peter/E-7028-2010; Hartman, Nathaniel/P-7654-2014	Hyder, Fahmeed/0000-0001-7822-4002; Herman, Peter/0000-0003-2218-9652; Hartman, Nathaniel/0000-0003-4976-5525	National Institutes of Health (NIH) [R01 DC007681, P30 NS-052519]; Pardee foundation; National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS052519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) grant R01 DC007681 and the Pardee foundation (AB), by NIH grant P30 NS-052519 (FH), and by a National Science Foundation Graduate Research Fellowship (BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bordey A, 2006, CELL CYCLE, V5, P722, DOI 10.4161/cc.5.7.2614; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fabricius M, 1996, J CEREBR BLOOD F MET, V16, P156, DOI 10.1097/00004647-199601000-00018; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kawamura H, 2003, J PHYSIOL-LONDON, V551, P787, DOI 10.1113/jphsiol.2003.047977; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Lacar B, 2011, EUR J NEUROSCI, V34, P1895, DOI 10.1111/j.1460-9568.2011.07901.x; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Montcouquiol M, 2001, J NEUROSCI, V21, P974, DOI 10.1523/JNEUROSCI.21-03-00974.2001; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Radley JJ, 2003, BRAIN RES, V966, P1, DOI 10.1016/S0006-8993(02)03989-6; Roy C S, 1890, J Physiol, V11, P85; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sanganahalli BG, 2009, J NEUROSCI, V29, P1707, DOI 10.1523/JNEUROSCI.5549-08.2009; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SHIPLEY GD, 1983, EXP CELL RES, V146, P261, DOI 10.1016/0014-4827(83)90128-3; Singleton MR, 2003, EMBO J, V22, P4579, DOI 10.1093/emboj/cdg441; Smith CM, 1998, DEV DYNAM, V213, P220, DOI 10.1002/(SICI)1097-0177(199810)213:2<220::AID-AJA7>3.0.CO;2-I; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; YEN A, 1978, EXP CELL RES, V114, P389, DOI 10.1016/0014-4827(78)90497-4; Young SZ, 2011, EUR J NEUROSCI, V33, P1123, DOI 10.1111/j.1460-9568.2011.07611.x; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237	42	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31960	10.1371/journal.pone.0031960	http://dx.doi.org/10.1371/journal.pone.0031960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359646	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200115
J	Magnoni, LJ; Vraskou, Y; Palstra, AP; Planas, JV				Magnoni, Leonardo J.; Vraskou, Yoryia; Palstra, Arjan P.; Planas, Josep V.			AMP-Activated Protein Kinase Plays an Important Evolutionary Conserved Role in the Regulation of Glucose Metabolism in Fish Skeletal Muscle Cells	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GLUT4 TRANSLOCATION; INSULIN SENSITIVITY; SIGNALING PATHWAYS; INTRACELLULAR POOL; GLYCOGEN-SYNTHASE; METFORMIN ACTION; GENE-EXPRESSION; AICAR TREATMENT; RAT MUSCLES	AMPK, a master metabolic switch, mediates the observed increase of glucose uptake in locomotory muscle of mammals during exercise. AMPK is activated by changes in the intracellular AMP:ATP ratio when ATP consumption is stimulated by contractile activity but also by AICAR and metformin, compounds that increase glucose transport in mammalian muscle cells. However, the possible role of AMPK in the regulation of glucose metabolism in skeletal muscle has not been investigated in other vertebrates, including fish. In this study, we investigated the effects of AMPK activators on glucose uptake, AMPK activity, cell surface levels of trout GLUT4 and expression of GLUT1 and GLUT4 as well as the expression of enzymes regulating glucose disposal and PGC1 alpha in trout myotubes derived from a primary muscle cell culture. We show that AICAR and metformin significantly stimulated glucose uptake (1.6 and 1.3 fold, respectively) and that Compound C completely abrogated the stimulatory effects of the AMPK activators on glucose uptake. The combination of insulin and AMPK activators did not result in additive nor synergistic effects on glucose uptake. Moreover, exposure of trout myotubes to AICAR and metformin resulted in an increase in AMPK activity (3.8 and 3 fold, respectively). We also provide evidence suggesting that stimulation of glucose uptake by AMPK activators in trout myotubes may take place, at least in part, by increasing the cell surface and mRNA levels of trout GLUT4. Finally, AICAR increased the mRNA levels of genes involved in glucose disposal (hexokinase, 6-phosphofructokinase, pyruvate kinase and citrate synthase) and mitochondrial biogenesis (PGC-1 alpha) and did not affect glycogen content or glycogen synthase mRNA levels in trout myotubes. Therefore, we provide evidence, for the first time in non-mammalian vertebrates, suggesting a potentially important role of AMPK in stimulating glucose uptake and utilization in the skeletal muscle of fish.	[Magnoni, Leonardo J.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; IBUB, Barcelona, Spain	University of Barcelona; University of Barcelona	Magnoni, LJ (corresponding author), Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain.	jplanas@ub.edu	Magnoni, Leonardo Julián/A-6275-2011; Palstra, Arjan/B-4122-2013	Magnoni, Leonardo Julián/0000-0001-8449-6071; Planas, Josep/0000-0002-6525-9617	Ministerio de Ciencia e Innovacion, Spain [CSD2007-0002, AGL2009-07006]; European Commission [235581]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (CSD2007-0002 and AGL2009-07006) to JVP. LJM was supported by a FP7-PIIF-2009 fellowship (Marie Curie Action) from the European Commission (GLUCOSE USE IN FISH) with grant agreement number 235581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2005, DIABETOLOGIA, V48, P1173, DOI 10.1007/s00125-005-1741-3; Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Bonen A, 2009, APPL PHYSIOL NUTR ME, V34, P307, DOI 10.1139/H09-008; BONTEMPS F, 1986, J CLIN INVEST, V77, P824, DOI 10.1172/JCI112379; Capilla E, 2002, AM J PHYSIOL-ENDOC M, V283, pE44, DOI 10.1152/ajpendo.00065.2002; Castillo J, 2006, AM J PHYSIOL-REG I, V290, pR1683, DOI 10.1152/ajpregu.00294.2005; CODERRE L, 1995, J BIOL CHEM, V270, P27584, DOI 10.1074/jbc.270.46.27584; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Diaz M, 2007, ENDOCRINOLOGY, V148, P5248, DOI 10.1210/en.2007-0265; Diaz M, 2007, J EXP BIOL, V210, P2346, DOI 10.1242/jeb.002857; Diaz M, 2009, AM J PHYSIOL-REG I, V296, pR794, DOI 10.1152/ajpregu.90673.2008; DOBSON GP, 1987, J EXP BIOL, V129, P125; Dohm GL, 2002, J APPL PHYSIOL, V93, P782, DOI 10.1152/japplphysiol.01266.2001; Fauconneau F, 2000, CELL TISSUE RES, V301, P459, DOI 10.1007/s004419900168; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HERTZ Y, 1989, AQUACULTURE, V80, P175, DOI 10.1016/0044-8486(89)90283-4; HOCHACHKA PW, 1992, J APPL PHYSIOL, V73, P1697, DOI 10.1152/jappl.1992.73.5.1697; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; Holloszy JO, 1996, REV PHYSIOL BIOCH P, V128, P99; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Jibb LA, 2008, J EXP BIOL, V211, P3111, DOI 10.1242/jeb.019117; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Keppler D., 1974, METHOD ENZYMAT AN, V3, P1127, DOI DOI 10.1242/JEB.037275; Klip A, 1996, SEMIN CELL DEV BIOL, V7, P229, DOI 10.1006/scdb.1996.0031; KUBO K, 1986, AM J PHYSIOL, V250, pE100, DOI 10.1152/ajpendo.1986.250.1.E100; Kudo N, 1996, BBA-LIPID LIPID MET, V1301, P67, DOI 10.1016/0005-2760(96)00013-6; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lau G, 2011, J COMP PHYSIOL B, P1; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; LeMoine CMR, 2010, J COMP PHYSIOL B, V180, P151, DOI 10.1007/s00360-009-0398-5; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888; Musi N, 2003, ACTA PHYSIOL SCAND, V178, P337, DOI 10.1046/j.1365-201X.2003.01168.x; NEUFER PD, 1993, AM J PHYSIOL, V265, pC1597; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; Ojuka EO, 2000, J APPL PHYSIOL, V88, P1072, DOI 10.1152/jappl.2000.88.3.1072; Panserat S, 2009, AM J PHYSIOL-REG I, V297, pR707, DOI 10.1152/ajpregu.00120.2009; Planas JV, 2000, FEBS LETT, V481, P266, DOI 10.1016/S0014-5793(00)02020-2; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020228; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; REN JM, 1994, J BIOL CHEM, V269, P14396; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Roy D, 1996, BIOCHEM BIOPH RES CO, V223, P147, DOI 10.1006/bbrc.1996.0860; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Stenslokken KO, 2008, AM J PHYSIOL-REG I, V295, pR1803, DOI 10.1152/ajpregu.90590.2008; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Vraskou Y, 2011, AM J PHYSIOL-REG I, V300, pR716, DOI 10.1152/ajpregu.00514.2010; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zierath JR, 2002, J APPL PHYSIOL, V93, P773, DOI 10.1152/japplphysiol.00126.2002	82	70	74	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31219	10.1371/journal.pone.0031219	http://dx.doi.org/10.1371/journal.pone.0031219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359576	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200045
J	Potter, CMF; Schobesberger, S; Lundberg, MH; Weinberg, PD; Mitchell, JA; Gorelik, J				Potter, Claire M. F.; Schobesberger, Sophie; Lundberg, Martina H.; Weinberg, Peter D.; Mitchell, Jane A.; Gorelik, Julia			Shape and Compliance of Endothelial Cells after Shear Stress In Vitro or from Different Aortic Regions: Scanning Ion Conductance Microscopy Study	PLOS ONE			English	Article							LOCAL MECHANICAL-PROPERTIES; NITRIC-OXIDE RELEASE; LIVING CELLS; ATHEROGENESIS	Objective: To measure the elongation and compliance of endothelial cells subjected to different patterns of shear stress in vitro, and to compare these parameters with the elongation and compliance of endothelial cells from different regions of the intact aorta. Materials and Methods: Porcine aortic endothelial cells were cultured for 6 days under static conditions or on an orbital shaker. The shaker generated a wave of medium, inducing pulsatile shear stress with a preferred orientation at the edge of the well or steadier shear stress with changing orientation at its centre. The topography and compliance of these cells and cells from the inner and outer curvature of ex vivo porcine aortic arches were measured by scanning ion conductance microscopy (SICM). Results: Cells cultured under oriented shear stress were more elongated and less compliant than cells grown under static conditions or under shear stress with no preferred orientation. Cells from the outer curvature of the aorta were more elongated and less compliant than cells from the inner curvature. Conclusion: The elongation and compliance of cultured endothelial cells vary according to the pattern of applied shear stress, and are inversely correlated. A similar inverse correlation occurs in the aortic arch, with variation between regions thought to experience different haemodynamic stresses.	[Potter, Claire M. F.; Schobesberger, Sophie; Lundberg, Martina H.; Mitchell, Jane A.; Gorelik, Julia] Natl Heart & Lung Inst, London, England; [Potter, Claire M. F.; Schobesberger, Sophie; Weinberg, Peter D.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London; Imperial College London	Potter, CMF (corresponding author), Natl Heart & Lung Inst, London, England.	j.a.mitchell@ic.ac.uk; j.gorelik@ic.ac.uk	; Slingsby, Martina H/B-1476-2015	Gorelik, Julia/0000-0003-1148-9158; Slingsby, Martina H/0000-0002-2620-7582; Lundberg, Martina H/0000-0001-6369-3041	British Heart Foundation Centre of Research Excellence at Imperial College London BHF [RE/08/02]; BBSRC [BB/D522711/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D522711/1] Funding Source: researchfish; British Heart Foundation [NH/10/3/28574] Funding Source: researchfish	British Heart Foundation Centre of Research Excellence at Imperial College London BHF; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	British Heart Foundation Centre of Research Excellence at Imperial College London BHF RE/08/02 (http://www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogle RG, 1996, J PHYSIOL-LONDON, V490, P229, DOI 10.1113/jphysiol.1996.sp021138; Bond AR, 2011, ARTERIOSCL THROM VAS, V31, P543, DOI 10.1161/ATVBAHA.110.219683; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; ESKIN SG, 1984, MICROVASC RES, V28, P87, DOI 10.1016/0026-2862(84)90031-1; Feneberg W, 2004, BIOPHYS J, V87, P1338, DOI 10.1529/biophysj.103.037044; FLAHERTY JT, 1972, CIRC RES, V30, P23, DOI 10.1161/01.RES.30.1.23; GOODE TB, 1977, ATHEROSCLEROSIS, V27, P235, DOI 10.1016/0021-9150(77)90061-2; Gorelik J, 2002, BIOPHYS J, V83, P3296, DOI 10.1016/S0006-3495(02)75330-7; HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851; Helmke BP, 2002, ANN BIOMED ENG, V30, P284, DOI 10.1114/1.1467926; Helmlinger GG, 1991, J BIOMECHANICAL ENG, P123; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Korchev YE, 1997, J MICROSC-OXFORD, V188, P17, DOI 10.1046/j.1365-2818.1997.2430801.x; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; Malek AM, 1996, J CELL SCI, V109, P713; Miragoli M, 2011, J R SOC INTERFACE, V8, P913, DOI 10.1098/rsif.2010.0597; Mott RE, 2007, AM J PHYSIOL-CELL PH, V293, pC1616, DOI 10.1152/ajpcell.00457.2006; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; REIDY MA, 1977, ATHEROSCLEROSIS, V28, P463, DOI 10.1016/0021-9150(77)90073-9; Sanchez D, 2008, BIOPHYS J, V95, P3017, DOI 10.1529/biophysj.108.129551; SATO M, 1987, ARTERIOSCLEROSIS, V7, P276, DOI 10.1161/01.ATV.7.3.276; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46	28	24	28	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31228	10.1371/journal.pone.0031228	http://dx.doi.org/10.1371/journal.pone.0031228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359578	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200047
J	Pottiez, G; Jagadish, T; Yu, F; Letendre, S; Ellis, R; Duarte, NA; Grant, I; Gendelman, HE; Fox, HS; Ciborowski, P				Pottiez, Gwenael; Jagadish, Teena; Yu, Fang; Letendre, Scott; Ellis, Ronald; Duarte, Nichole A.; Grant, Igor; Gendelman, Howard E.; Fox, Howard S.; Ciborowski, Pawel			Plasma Proteomic Profiling in HIV-1 Infected Methamphetamine Abusers	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CLINICAL PROTEOMICS; YOUNG-ADULTS; HIV; BIOMARKERS; DISORDERS; SEX; MEN; RELIABILITY; COMPLEMENT	We wanted to determine whether methamphetamine use affects a subset of plasma proteins in HIV-infected persons. Plasma samples from two visits were identified for subjects from four groups: HIV+, ongoing, persistent METH use; HIV+, short-term METH abstinent; HIV+, long term METH abstinence; HIV negative, no history of METH use. Among 390 proteins identified, 28 showed significant changes in expression in the HIV+/persistent METH+ group over the two visits, which were not attributable to HIV itself. These proteins were involved in complement, coagulation pathways and oxidative stress. Continuous METH use is an unstable condition, altering levels of a number of plasma proteins.	[Pottiez, Gwenael; Jagadish, Teena; Gendelman, Howard E.; Fox, Howard S.; Ciborowski, Pawel] Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Yu, Fang] Univ Nebraska, Med Ctr, Omaha, NE USA; [Letendre, Scott; Ellis, Ronald; Duarte, Nichole A.; Grant, Igor] Univ Calif San Diego, San Diego, CA 92103 USA	University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Diego	Pottiez, G (corresponding author), Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	pciborowski@unmc.edu	Letendre, Scott L./GLU-6874-2022; Ellis, Ronald/K-3543-2015; Yu, Fang/B-9874-2013; Gendelman, Howard E/G-8242-2012	Ellis, Ronald/0000-0003-4931-752X; Fox, Howard/0000-0003-2032-374X	National Institutes of Health [P01DA026146, P30MH062261, P01NS043985, P50 DA26306]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA026306, P01DA026146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants P01DA026146, P30MH062261, P01NS043985, and P50 DA26306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadet JL, 2007, NEUROTOX RES, V12, P181, DOI 10.1007/BF03033915; Cadet JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015643; Chana G, 2006, NEUROLOGY, V67, P1486, DOI 10.1212/01.wnl.0000240066.02404.e6; Ciborowski P, 2009, BIOMARK MED, V3, P771, DOI [10.2217/bmm.09.63, 10.2217/BMM.09.63]; Clark T, 2010, AIDS BEHAV; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Dunn BK, 2011, RECENT RESULTS CANC, V188, P21, DOI 10.1007/978-3-642-10858-7_3; Fournier PE, 2011, ANN REV MICROBIOL; Haverland N, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-137; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Imai K, 2011, BIOMED CHROMATOGR, V25, P59, DOI 10.1002/bmc.1541; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kiyatkin EA, 2009, INT REV NEUROBIOL, V88, P65, DOI 10.1016/S0074-7742(09)88004-5; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Letendre S, 2007, J INFECT DIS, V196, P361, DOI 10.1086/519285; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marshall BDL, 2010, ADDICTION, V105, P991, DOI 10.1111/j.1360-0443.2010.02932.x; Mertens I, 2004, PHARMACOGENOMICS, V5, P657, DOI 10.1517/14622416.5.6.657; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Newsome SD, 2011, NEUROLOGY, V76, P787, DOI 10.1212/WNL.0b013e31820e7b4e; Peck JA, 2005, J ADDICT DIS, V24, P115, DOI 10.1300/J069v24n03_10; Pendyala G, 2010, J PROTEOME RES, V9, P352, DOI 10.1021/pr900685u; PERRICONE R, 1987, CLIN EXP IMMUNOL, V70, P500; Potula R, 2010, J IMMUNOL, V185, P2867, DOI 10.4049/jimmunol.0903691; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Robins L.N., 1991, PSYCHIAT DISORDERS A; Rozek W, 2008, PROTEOM CLIN APPL, V2, P1498, DOI 10.1002/prca.200780114; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Semple SJ, 2006, ARCH SEX BEHAV, V35, P461, DOI 10.1007/s10508-006-9045-3; Semple SJ, 2003, AIDS EDUC PREV, V15, P133, DOI 10.1521/aeap.15.3.133.23835; Silberring J, 2010, TRAC-TREND ANAL CHEM, V29, P128, DOI 10.1016/j.trac.2009.11.007; Stoiber H, 2001, IMMUNOL REV, V180, P168, DOI 10.1034/j.1600-065X.2001.1800115.x; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Thomas DM, 2010, J NEUROCHEM; Westover AN, 2008, DRUG ALCOHOL DEPEN, V96, P49, DOI 10.1016/j.drugalcdep.2008.01.027; Westover AN, 2007, ARCH GEN PSYCHIAT, V64, P495, DOI 10.1001/archpsyc.64.4.495; White SR, 2002, SEMIN RESP CRIT CARE, V23, P27, DOI 10.1055/s-2002-20586; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Zetterberg H, 2008, ACTA NEUROL SCAND, V118, P1, DOI 10.1111/j.1600-0404.2007.00985.x	47	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31031	10.1371/journal.pone.0031031	http://dx.doi.org/10.1371/journal.pone.0031031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359561	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200030
J	Di Franco, A; Gillanders, BM; De Benedetto, G; Pennetta, A; De Leo, GA; Guidetti, P				Di Franco, Antonio; Gillanders, Bronwyn M.; De Benedetto, Giuseppe; Pennetta, Antonio; De Leo, Giulio A.; Guidetti, Paolo			Dispersal Patterns of Coastal Fish: Implications for Designing Networks of Marine Protected Areas	PLOS ONE			English	Article							REEF FISH; LARVAL DISPERSAL; OTOLITH CHEMISTRY; TRACE-ELEMENTS; SPATIAL SCALE; HABITAT USE; SEA BREAM; JUVENILE; POPULATIONS; CONNECTIVITY	Information about dispersal scales of fish at various life history stages is critical for successful design of networks of marine protected areas, but is lacking for most species and regions. Otolith chemistry provides an opportunity to investigate dispersal patterns at a number of life history stages. Our aim was to assess patterns of larval and post-settlement (i.e. between settlement and recruitment) dispersal at two different spatial scales in a Mediterranean coastal fish (i.e. white sea bream, Diplodus sargus sargus) using otolith chemistry. At a large spatial scale (similar to 200 km) we investigated natal origin of fish and at a smaller scale (similar to 30 km) we assessed "site fidelity" (i.e. post-settlement dispersal until recruitment). Larvae dispersed from three spawning areas, and a single spawning area supplied post-settlers (proxy of larval supply) to sites spread from 100 to 200 km of coastline. Post-settlement dispersal occurred within the scale examined of similar to 30 km, although about a third of post-settlers were recruits in the same sites where they settled. Connectivity was recorded both from a MPA to unprotected areas and vice versa. The approach adopted in the present study provides some of the first quantitative evidence of dispersal at both larval and post-settlement stages of a key species in Mediterranean rocky reefs. Similar data taken from a number of species are needed to effectively design both single marine protected areas and networks of marine protected areas.	[Di Franco, Antonio; Guidetti, Paolo] Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci Etecnol Biol & Ambientali DiSTeB, Lecce, Italy; [Gillanders, Bronwyn M.] Univ Adelaide, So Seas Ecol Labs, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [De Benedetto, Giuseppe; Pennetta, Antonio] Univ Salento, Lab Anal Chim Ambiente & Beni Culturali, Dipartimento Beni Arti & Storia, Lecce, Italy; [De Leo, Giulio A.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy	University of Salento; University of Adelaide; University of Salento; University of Parma	Di Franco, A (corresponding author), Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci Etecnol Biol & Ambientali DiSTeB, Lecce, Italy.	difry@libero.it	De Leo, Giulio/AAC-5098-2019; De Benedetto, Giuseppe Egidio/G-9470-2012; Gillanders, Bronwyn/B-4218-2013; Di Franco, Antonio/A-8796-2010	De Leo, Giulio/0000-0002-4186-3369; De Benedetto, Giuseppe Egidio/0000-0002-0832-5470; Pennetta, Antonio/0000-0002-6760-9393; Gillanders, Bronwyn/0000-0002-7680-2240; Di Franco, Antonio/0000-0003-3411-7015; Guidetti, Paolo/0000-0002-7983-8775	Total Foundation; Italian Ministero Istruzione Universita (MIUR) [2008E7KBAE]	Total Foundation(Total SA); Italian Ministero Istruzione Universita (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was funded by Total Foundation (http://foundation.total.com/foundation/total-foundation-200090.html) and the Italian Ministero Istruzione Universita (MIUR) (PRIN Project: protocol no. 2008E7KBAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A., 2008, STATUS MARINE PROTEC; Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Berumen ML, 2010, CORAL REEFS, V29, P883, DOI 10.1007/s00338-010-0652-z; Bishop MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014267; Botsford LW, 2001, ECOL LETT, V4, P144; Brophy D, 2004, MAR BIOL, V144, P779, DOI 10.1007/s00227-003-1240-3; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; D'Anna G, 2011, ITAL J ZOOL, V78, P255, DOI 10.1080/11250000903464059; Di Franco A, 2011, ITAL J ZOOL, V78, P182, DOI 10.1080/11250003.2011.566227; Di Franco A, 2011, BIOL LETTERS, V7, P454, DOI 10.1098/rsbl.2010.1149; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Elsdon TS, 2003, MAR ECOL PROG SER, V260, P263, DOI 10.3354/meps260263; Fontes J, 2009, MAR ECOL PROG SER, V387, P51, DOI 10.3354/meps08116; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; Frederick JL, 1997, MAR ECOL PROG SER, V150, P65, DOI 10.3354/meps150065; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; GARCIARUBIES A, 1995, MAR BIOL, V124, P35, DOI 10.1007/BF00349144; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gillanders BM, 1996, MAR ECOL PROG SER, V141, P13, DOI 10.3354/meps141013; Gillanders BM, 2005, ESTUAR COAST SHELF S, V64, P47, DOI 10.1016/j.ecss.2005.02.005; Gillanders BM, 2002, MAR ECOL PROG SER, V240, P215, DOI 10.3354/meps240215; Gillanders BM, 2003, MAR ECOL PROG SER, V247, P281, DOI 10.3354/meps247281; Gillanders BM, 2001, J FISH BIOL, V59, P350, DOI 10.1006/jfbi.2001.1643; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hamilton SL, 2008, P NATL ACAD SCI USA, V105, P1561, DOI 10.1073/pnas.0707676105; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lockwood DR, 2002, THEOR POPUL BIOL, V61, P297, DOI 10.1006/tpbi.2002.1572; MacPherson E, 1998, J EXP MAR BIOL ECOL, V220, P127, DOI 10.1016/S0022-0981(97)00086-5; Miller JA, 2004, CAN J FISH AQUAT SCI, V61, P1723, DOI 10.1139/F04-111; Miller MJ, 2002, J EXP MAR BIOL ECOL, V267, P15, DOI 10.1016/S0022-0981(01)00348-3; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pinsky ML, 2010, EVOLUTION, V64, P2688, DOI 10.1111/j.1558-5646.2010.01003.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Ross SW, 2002, ENVIRON BIOL FISH, V63, P161, DOI 10.1023/A:1014287917297; Ruttenberg BI, 2008, CAN J FISH AQUAT SCI, V65, P1181, DOI 10.1139/F08-052; Ruttenberg BI, 2005, MAR ECOL PROG SER, V297, P273, DOI 10.3354/meps297273; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sanchez-Lamadrid A, 2001, FISHERIES MANAG ECOL, V8, P271, DOI 10.1046/j.1365-2400.2001.00249.x; Sandin SA, 2005, MAR FRESHWATER RES, V56, P725, DOI 10.1071/MF04144; Shanks AL, 2003, ECOL APPL, V13, pS159; Shima JS, 2010, J ANIM ECOL, V79, P1308, DOI 10.1111/j.1365-2656.2010.01733.x; Smith KM, 2005, T AM FISH SOC, V134, P1159, DOI 10.1577/T04-149.1; Standish JD, 2008, MAR ECOL PROG SER, V356, P259, DOI 10.3354/meps07244; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; TSUKAMOTO K, 1989, J FISH BIOL, V35, P59; Ungfors A, 2007, FISH RES, V84, P345, DOI 10.1016/j.fishres.2006.11.031; Vasconcelos RP, 2008, ESTUAR COAST SHELF S, V79, P317, DOI 10.1016/j.ecss.2008.04.006; Vigliola L, 2000, CAN J FISH AQUAT SCI, V57, P1291, DOI 10.1139/cjfas-57-6-1291; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	68	65	65	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31681	10.1371/journal.pone.0031681	http://dx.doi.org/10.1371/journal.pone.0031681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355388	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300088
J	Kawashima, S; Ueki, Y; Kato, T; Matsukawa, N; Mima, T; Hallett, M; Ito, K; Ojika, K				Kawashima, Shoji; Ueki, Yoshino; Kato, Takashi; Matsukawa, Noriyuki; Mima, Tatsuya; Hallett, Mark; Ito, Kengo; Ojika, Kosei			Changes in Striatal Dopamine Release Associated with Human Motor-Skill Acquisition	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LONG-TERM POTENTIATION; BASAL GANGLIA; SYNAPTIC PLASTICITY; PARKINSONS-DISEASE; PREFRONTAL CORTEX; HAND MOVEMENT; HUMAN-BRAIN; MEMORY; CONSOLIDATION	The acquisition of new motor skills is essential throughout daily life and involves the processes of learning new motor sequence and encoding elementary aspects of new movement. Although previous animal studies have suggested a functional importance for striatal dopamine release in the learning of new motor sequence, its role in encoding elementary aspects of new movement has not yet been investigated. To elucidate this, we investigated changes in striatal dopamine levels during initial skill-training (Day 1) compared with acquired conditions (Day 2) using C-11-raclopride positron-emission tomography. Ten volunteers learned to perform brisk contractions using their non-dominant left thumbs with the aid of visual feedback. On Day 1, the mean acceleration of each session was improved through repeated training sessions until performance neared asymptotic levels, while improved motor performance was retained from the beginning on Day 2. The C-11-raclopride binding potential (BP) in the right putamen was reduced during initial skill-training compared with under acquired conditions. Moreover, voxel-wise analysis revealed that C-11-raclopride BP was particularly reduced in the right antero-dorsal to the lateral part of the putamen. Based on findings from previous fMRI studies that show a gradual shift of activation within the striatum during the initial processing of motor learning, striatal dopamine may play a role in the dynamic cortico-striatal activation during encoding of new motor memory in skill acquisition.	[Kawashima, Shoji; Ueki, Yoshino; Matsukawa, Noriyuki; Ojika, Kosei] Nagoya City Univ, Dept Neurol & Neurosci, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Kato, Takashi; Ito, Kengo] Natl Ctr Geriatr & Gerontol, Dept Brain Sci & Mol Imaging, Res Inst, Obu, Aichi, Japan; [Mima, Tatsuya] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Hallett, Mark] NIH, Human Motor Control Sect, Bethesda, MD 20892 USA	Nagoya City University; National Center for Geriatrics & Gerontology; Kyoto University; National Institutes of Health (NIH) - USA	Kawashima, S (corresponding author), Nagoya City Univ, Dept Neurol & Neurosci, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi, Japan.	yueki@med.nagoya-cu.ac.jp		Mima, Tatsuya/0000-0001-7787-4855	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669, ZIANS003031] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ashe J, 1997, BEHAV BRAIN RES, V87, P255; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Breslin NP, 2000, GUT, V46, P93, DOI 10.1136/gut.46.1.93; Brooks DJ, 2001, J NEURAL TRANSM, V108, P1283, DOI 10.1007/s007020100005; Carson RE, 2000, NUCL MED BIOL, V27, P657, DOI 10.1016/S0969-8051(00)00138-4; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Donoghue JP, ACQUISITION MOTOR BE, P363; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Duff E, 2007, NEUROIMAGE, V34, P156, DOI 10.1016/j.neuroimage.2006.09.006; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; FARDE L, 1988, PSYCHOPHARMACOLOGY, V94, P471, DOI 10.1007/BF00212840; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; FRISTON KJ, 1995, P ROY SOC B-BIOL SCI, V261, P401, DOI 10.1098/rspb.1995.0166; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Goerendt IK, 2003, BRAIN, V126, P312, DOI 10.1093/brain/awg035; Gupta P, 2002, PSYCHOL REV, V109, P401, DOI 10.1037//0033-295X.109.2.401; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hallett M., 2005, MOTOR LEARNING HIGHE, P123; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652, DOI 10.1152/jn.1995.74.4.1652; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Ito H, 1999, NEUROIMAGE, V9, P235, DOI 10.1006/nimg.1998.0401; Jankowski J, 2009, NEUROIMAGE, V44, P1369, DOI 10.1016/j.neuroimage.2008.10.059; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Lappin JM, 2009, J CEREBR BLOOD F MET, V29, P554, DOI 10.1038/jcbfm.2008.146; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Levesque M, 2007, EXP BRAIN RES, V182, P499, DOI 10.1007/s00221-007-1010-4; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Ueki Y, 2006, ANN NEUROL, V59, P60, DOI 10.1002/ana.20692; Whishaw IQ, 2007, NEUROSCIENCE, V146, P86, DOI 10.1016/j.neuroscience.2007.01.034; WICKENS JR, 1995, SYNAPSE, V20, P281, DOI 10.1002/syn.890200402; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Willuhn I, 2008, NEUROSCIENCE, V153, P249, DOI 10.1016/j.neuroscience.2008.01.041; Willuhn I, 2009, BEHAV BRAIN RES, V199, P103, DOI 10.1016/j.bbr.2008.07.010; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	67	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31728	10.1371/journal.pone.0031728	http://dx.doi.org/10.1371/journal.pone.0031728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355391	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300091
J	Ren, LP; Chan, SMH; Zeng, XY; Laybutt, DR; Iseli, TJ; Sun, RQ; Kraegen, EW; Cooney, GJ; Turner, N; Ye, JM				Ren, Lu-Ping; Chan, Stanley M. H.; Zeng, Xiao-Yi; Laybutt, D. Ross; Iseli, Tristan J.; Sun, Ruo-Qiong; Kraegen, Edward W.; Cooney, Gregory J.; Turner, Nigel; Ye, Ji-Ming			Differing Endoplasmic Reticulum Stress Response to Excess Lipogenesis versus Lipid Oversupply in Relation to Hepatic Steatosis and Insulin Resistance	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ELEMENT-BINDING PROTEIN; OXIDATIVE STRESS; RAT-LIVER; IN-VIVO; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR COMPLICATIONS; MITOCHONDRIAL-FUNCTION; INDUCED OBESITY; CELL BIOLOGY	Mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been implicated in hepatic steatosis and insulin resistance. The present study investigated their roles in the development of hepatic steatosis and insulin resistance during de novo lipogenesis (DNL) compared to extrahepatic lipid oversupply. Male C57BL/6J mice were fed either a high fructose (HFru) or high fat (HFat) diet to induce DNL or lipid oversupply in/to the liver. Both HFru and HFat feeding increased hepatic triglyceride within 3 days (by 3.5 and 2.4 fold) and the steatosis remained persistent from 1 week onwards (p<0.01 vs Con). Glucose intolerance (iAUC increased by similar to 60%) and blunted insulin-stimulated hepatic Akt and GSK3 beta phosphorylation (similar to 40-60%) were found in both feeding conditions (p<0.01 vs Con, assessed after 1 week). No impairment of mitochondrial function was found (oxidation capacity, expression of PGC1 alpha, CPT1, respiratory complexes, enzymatic activity of citrate synthase & beta-HAD). As expected, DNL was increased (similar to 60%) in HFru-fed mice and decreased (32%) in HFat-fed mice (all p<0.05). Interestingly, associated with the upregulated lipogenic enzymes (ACC, FAS and SCD1), two (PERK/eIF2 alpha and IRE1/XBP1) of three ER stress pathways were significantly activated in HFru-fed mice. However, no significant ER stress was observed in HFat-fed mice during the development of hepatic steatosis. Our findings indicate that HFru and HFat diets can result in hepatic steatosis and insulin resistance without obvious mitochondrial defects via different lipid metabolic pathways. The fact that ER stress is apparent only with HFru feeding suggests that ER stress is involved in DNL per se rather than resulting from hepatic steatosis or insulin resistance.	[Ren, Lu-Ping; Chan, Stanley M. H.; Zeng, Xiao-Yi; Sun, Ruo-Qiong; Ye, Ji-Ming] RMIT Univ, Mol Pharmacol Diabet Grp, Hlth Innovat Res Inst, Melbourne, Vic, Australia; [Ren, Lu-Ping; Chan, Stanley M. H.; Zeng, Xiao-Yi; Sun, Ruo-Qiong; Ye, Ji-Ming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Ren, Lu-Ping; Zeng, Xiao-Yi; Laybutt, D. Ross; Iseli, Tristan J.; Kraegen, Edward W.; Cooney, Gregory J.; Turner, Nigel; Ye, Ji-Ming] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Kraegen, Edward W.; Cooney, Gregory J.; Turner, Nigel] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Garvan Institute of Medical Research; University of New South Wales Sydney	Ren, LP (corresponding author), RMIT Univ, Mol Pharmacol Diabet Grp, Hlth Innovat Res Inst, Melbourne, Vic, Australia.	jiming.ye@rmit.edu.au	Iseli, Tristan/A-9537-2012; Turner, Nigel/H-7176-2013	Turner, Nigel/0000-0002-0119-9328; Chan, Stanley/0000-0002-4103-9441; Zeng, Xiaoyi/0000-0002-0102-0367	National Health and Medical Research Council of Australia (NHMRC) [535921, 535930]; National Natural Science Grant of China [30971391]; NHMRC [535921]; Career Development Award	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Grant of China(National Natural Science Foundation of China (NSFC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Career Development Award	This work was supported by funding from a Program Grant (535921 allocation to JMY) and a Project Grant (535930 to JMY) of the National Health and Medical Research Council of Australia (NHMRC). LPR was a visiting fellow from the General Hospital of Hebei supported by National Natural Science Grant of China (30971391) and NHMRC Program Grant (535921 allocation to JMY). NT is supported by a Career Development Award, and EWK and GJC by Research Fellowships from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FK, 2005, CURR DRUG TARGETS, V6, P487, DOI 10.2174/1389450054021990; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Collison KS, 2009, OBESITY, V17, P2003, DOI 10.1038/oby.2009.58; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; DIETSCHY JM, 1984, J LIPID RES, V25, P1469; Djouadi F, 1997, BIOCHEM J, V324, P289, DOI 10.1042/bj3240289; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Garcia-Ruiz C, 2006, J GASTROEN HEPATOL, V21, pS3, DOI 10.1111/j.1440-1746.2006.04570.x; Gawrieh S, 2004, J INVEST MED, V52, P506, DOI 10.1136/jim-52-08-22; Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Koo HY, 2008, BBA-MOL BASIS DIS, V1782, P341, DOI 10.1016/j.bbadis.2008.02.007; Koo HY, 2009, BIOCHEM BIOPH RES CO, V390, P285, DOI 10.1016/j.bbrc.2009.09.109; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Lim JS, 2010, NAT REV GASTROENTERO; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Molero JC, 2006, DIABETES, V55, P708, DOI 10.2337/diabetes.55.03.06.db05-0312; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Perlemuter G, 2005, LIVER INT, V25, P946, DOI 10.1111/j.1478-3231.2005.01126.x; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Rodriguez-Calvo R, 2009, HEPATOLOGY, V49, P106, DOI 10.1002/hep.22570; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Sastre J, 2007, FRONT BIOSCI, V12, P1200, DOI 10.2741/2138; Satapati S, 2008, DIABETES, V57, P2012, DOI 10.2337/db08-0226; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Spolarics Z, 2000, BBA-MOL CELL BIOL L, V1487, P190, DOI 10.1016/S1388-1981(00)00093-7; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Verna EC, 2008, SEMIN LIVER DIS, V28, P407, DOI 10.1055/s-0028-1091985; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Vila L, 2008, HEPATOLOGY, V48, P1506, DOI 10.1002/hep.22523; Wierzbicki M, 2009, ADV MED SCI-POLAND, V54, P59, DOI 10.2478/v10039-009-0010-y; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Woodman OL, 2009, LIFE SCI, V85, P54, DOI 10.1016/j.lfs.2009.04.012; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002	61	87	95	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30816	10.1371/journal.pone.0030816	http://dx.doi.org/10.1371/journal.pone.0030816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355328	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300028
J	Sahlander, K; Larsson, K; Palmberg, L				Sahlander, Karin; Larsson, Kjell; Palmberg, Lena			Daily Exposure to Dust Alters Innate Immunity	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; SWINE-CONFINEMENT BUILDINGS; SOLUBLE ST2; INTERLEUKIN-1 RECEPTOR; HEALTHY-SUBJECTS; MYOCARDIAL-INFARCTION; ENDOTOXIN TOLERANCE; NUCLEOTIDE-SEQUENCE; AIRWAY RESPONSES; POTENTIAL ROLE	Pig farmers are exposed to organic material in pig barns on a daily basis and have signs of an ongoing chronic airway inflammation and increased prevalence of chronic inflammatory airway diseases, predominantly chronic bronchitis. Interestingly, the inflammatory response to acute exposure to organic dust is attenuated in farmers. The aim of the study was to closer characterize innate immunity features in blood and airways in farmers and in naive, non-exposed, controls. The expression of pattern recognition receptors (TLR2, TLR4 and CD14) whose ligands are abundant in pig barn dust and adhesion proteins (CD11b, CD62L and CD162L) on blood and sputum neutrophils in pig farmers and soluble TLR2 and CD14 (sTLR2 and sCD14) in blood and sputum were assessed in pig farmers and previously unexposed controls. The release of pro-inflammatory cytokines from blood cells stimulated with LPS ex vivo was measured in the absence and presence of anti-ST2. We also examined, in a separate study population, serum levels of soluble ST2 (sST2), before and after exposure in a pig barn and a bronchial LPS challenge. Farmers had signs of ongoing chronic inflammation with increased number of blood monocytes, and decreased expression of CD62L and CD162 on blood neutrophils. Farmers also had lower levels of sTLR2 and sCD14 in sputum and reduced expression of CD14 on sputum neutrophils than controls. Exposure to organic dust and LPS induced increase of serum sST2 in controls but not in farmers. In conclusion, farmers have signs of local and systemic inflammation associated with altered innate immunity characteristics.	[Sahlander, Karin; Larsson, Kjell; Palmberg, Lena] Karolinska Inst, Natl Inst Environm Med, Stockholm, Sweden	Karolinska Institutet	Sahlander, K (corresponding author), Karolinska Inst, Natl Inst Environm Med, Stockholm, Sweden.	karin.sahlander@ki.se			Swedish Farmer Foundation for Agricultural Research [H0635083]; Swedish Heart-Lung Foundation [20100180]; Karolinska Institutet	Swedish Farmer Foundation for Agricultural Research; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Farmer Foundation for Agricultural Research (H0635083), Swedish Heart-Lung Foundation (20100180) and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Cormier Y, 2004, SCAND J WORK ENV HEA, V30, P438, DOI 10.5271/sjweh.832; DONHAM KJ, 1986, AM J IND MED, V10, P294, DOI 10.1002/ajim.4700100318; Drost EM, 2002, EUR J IMMUNOL, V32, P393, DOI 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5; Eduard W, 2009, CHEST, V136, P716, DOI 10.1378/chest.08-2192; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Ferguson GT, 2000, CHEST, V117, P23; Feterowski C, 2005, INT IMMUNOL, V17, P1035, DOI 10.1093/intimm/dxh282; Israel-Assayag E, 2002, EUR RESPIR J, V19, P833, DOI 10.1183/09031936.02.02182001; Iversen M, 2000, EUR RESPIR J, V16, P404, DOI 10.1034/j.1399-3003.2000.016003404.x; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P474, DOI 10.1006/bbrc.1997.6810; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; LARSSON K, 1992, CHEST, V101, P767, DOI 10.1378/chest.101.3.767; LARSSON KA, 1994, AM J RESP CRIT CARE, V150, P973, DOI 10.1164/ajrccm.150.4.7921472; Le-Barillec K, 1999, J CLIN INVEST, V103, P1039, DOI 10.1172/JCI5779; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lecart S, 2002, EUR J IMMUNOL, V32, P2979, DOI 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li HJ, 2000, GENOMICS, V67, P284, DOI 10.1006/geno.2000.6269; Liew FY, 2005, IMMUNOL LETT, V96, P27, DOI 10.1016/j.imlet.2004.07.008; MALMBERG P, 1993, EUR RESPIR J, V6, P400; Mastej K, 2008, ACTA DIABETOL, V45, P183, DOI 10.1007/s00592-008-0040-0; Mok MY, 2010, RHEUMATOLOGY, V49, P520, DOI 10.1093/rheumatology/kep402; Monso E, 2004, AM J IND MED, V46, P357, DOI 10.1002/ajim.20077; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Palmberg L, 2002, SCAND J WORK ENV HEA, V28, P256, DOI 10.5271/sjweh.673; Pedersen B, 1996, EUR RESPIR J, V9, P524; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; RUPPERT J, 1993, ADV EXP MED BIOL, V329, P281; RUPPERT J, 1991, IMMUNOBIOLOGY, V182, P449, DOI 10.1016/S0171-2985(11)80209-3; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sahlander K, 2010, INNATE IMMUN-LONDON, V16, P27, DOI 10.1177/1753425909106317; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Smith TC, PLOS ONE, V4, pe4258; Strandberg K, 2008, J ASTHMA, V45, P201, DOI 10.1080/02770900801890372; Sundblad BM, 2009, EUR RESPIR J, V34, P80, DOI 10.1183/09031936.00105308; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wang Z, 1997, EUR RESPIR J, V10, P381, DOI 10.1183/09031936.97.10020381; Wang ZP, 1996, AM J RESP CRIT CARE, V154, P1261, DOI 10.1164/ajrccm.154.5.8912733; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE	48	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31646	10.1371/journal.pone.0031646	http://dx.doi.org/10.1371/journal.pone.0031646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355383	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300083
J	Sun, SS; Wang, QZ; Zhao, F; Chen, WT; Li, Z				Sun, Shisheng; Wang, Qinzhe; Zhao, Fei; Chen, Wentian; Li, Zheng			Prediction of Biological Functions on Glycosylation Site Migrations in Human Influenza H1N1 Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; N-LINKED GLYCOSYLATION; A VIRUS; HEMAGGLUTININ GLYCOSYLATION; STALK-LENGTH; NEURAMINIDASE; VIRULENCE; CLEAVAGE; PATHOGENICITY; GLYCOPROTEINS	Protein glycosylation alteration is typically employed by various viruses for escaping immune pressures from their hosts. Our previous work had shown that not only the increase of glycosylation sites (glycosites) numbers, but also glycosite migration might be involved in the evolution of human seasonal influenza H1N1 viruses. More importantly, glycosite migration was likely a more effectively alteration way for the host adaption of human influenza H1N1 viruses. In this study, we provided more bioinformatics and statistic evidences for further predicting the significant biological functions of glycosite migration in the host adaptation of human influenza H1N1 viruses, by employing homology modeling and in silico protein glycosylation of representative HA and NA proteins as well as amino acid variability analysis at antigenic sites of HA and NA. The results showed that glycosite migrations in human influenza viruses have at least five possible functions: to more effectively mask the antigenic sites, to more effectively protect the enzymatic cleavage sites of neuraminidase (NA), to stabilize the polymeric structures, to regulate the receptor binding and catalytic activities and to balance the binding activity of hemagglutinin (HA) with the release activity of NA. The information here can provide some constructive suggestions for the function research related to protein glycosylation of influenza viruses, although these predictions still need to be supported by experimental data.	[Sun, Shisheng; Wang, Qinzhe; Zhao, Fei; Chen, Wentian; Li, Zheng] Northwest Univ, Coll Life Sci, Lab Funct Glyc, Xian, Peoples R China	Northwest University Xi'an	Sun, SS (corresponding author), Northwest Univ, Coll Life Sci, Lab Funct Glyc, Xian, Peoples R China.	zhengli@nwu.edu.cn	Wang, Qinzhe/AAA-2964-2020; Sun, Shisheng/P-5027-2019	Sun, Shisheng/0000-0002-7242-7164	International S&T Cooperation Program [2009DFA32730]; Shaanxi Province of China [2010K12-02(5)]	International S&T Cooperation Program; Shaanxi Province of China	This work was supported by the International S&T Cooperation Program (2009DFA32730) and the Key Science and Technology Program (2010K12-02(5)) of the Shaanxi Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Chang SH, 2007, NUCLEIC ACIDS RES, V35, pD376, DOI 10.1093/nar/gkl779; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OHUCHI M, 1989, VIROLOGY, V168, P274, DOI 10.1016/0042-6822(89)90267-5; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Shi WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014454; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Varghese JN, 1983, NATURE, P303; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Wu ZLL, 2009, BIOCHEM BIOPH RES CO, V379, P749, DOI 10.1016/j.bbrc.2008.12.139; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040	40	30	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32119	10.1371/journal.pone.0032119	http://dx.doi.org/10.1371/journal.pone.0032119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355413	Green Submitted, gold, Green Published			2022-12-27	WOS:000302741300113
J	Martinon, S; Garcia, E; Gutierrez-Ospina, G; Mestre, H; Ibarra, A				Martinon, Susana; Garcia, Elisa; Gutierrez-Ospina, Gabriel; Mestre, Humberto; Ibarra, Antonio			Development of Protective Autoimmunity by Immunization with a Neural-Derived Peptide Is Ineffective in Severe Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROMOTES RECOVERY; T-CELLS; VACCINATION; RATS; MICROGLIA; GLUTAMATE; TOXICITY; ENCEPHALOMYELITIS; ACTIVATION	Protective autoimmunity (PA) is a physiological response to central nervous system trauma that has demonstrated to promote neuroprotection after spinal cord injury (SCI). To reach its beneficial effect, PA should be boosted by immunizing with neural constituents or neural-derived peptides such as A91. Immunizing with A91 has shown to promote neuroprotection after SCI and its use has proven to be feasible in a clinical setting. The broad applications of neural-derived peptides make it important to determine the main features of this anti-A91 response. For this purpose, adult Sprague-Dawley rats were subjected to a spinal cord contusion (SCC; moderate or severe) or a spinal cord transection (SCT; complete or incomplete). Immediately after injury, animals were immunized with PBS or A91. Motor recovery, T cell-specific response against A91 and the levels of IL-4, IFN-gamma and brain-derived neurotrophic factor (BDNF) released by A91-specific T (T-A91) cells were evaluated. Rats with moderate SCC, presented a better motor recovery after A91 immunization. Animals with moderate SCC or incomplete SCT showed significant T cell proliferation against A91 that was characterized chiefly by the predominant production of IL-4 and the release of BDNF. In contrast, immunization with A91 did not promote a better motor recovery in animals with severe SCC or complete SCT. In fact, T cell proliferation against A91 was diminished in these animals. The present results suggest that the effective development of PA and, consequently, the beneficial effects of immunizing with A91 significantly depend on the severity of SCI. This could mainly be attributed to the lack of T-A91 cells which predominantly showed to have a Th2 phenotype capable of producing BDNF, further promoting neuroprotection.	[Martinon, Susana; Garcia, Elisa; Ibarra, Antonio] Ctr Invest Proyecto CAMINA AC, Mexico City, DF, Mexico; [Garcia, Elisa; Mestre, Humberto; Ibarra, Antonio] Univ Anahuac Mexico Norte, Fac Ciencias Salud, Huixquilucan, Estado De Mexic, Mexico; [Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico	Universidad Anahuac; Universidad Nacional Autonoma de Mexico	Martinon, S (corresponding author), Ctr Invest Proyecto CAMINA AC, Mexico City, DF, Mexico.	iantonio65@yahoo.com	Mestre, Humberto/AAO-5848-2020; Martiñón, Susana/AAE-2807-2020	Mestre, Humberto/0000-0001-5876-5397; Ibarra, Antonio/0000-0003-2489-4689; garcia vences, edna elisa/0000-0001-7588-3846; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	National Council of Science and Technology of Mexico 'CONACYT) [57204]; Camina Research Center; Universidad Anahuac Mexico Norte	National Council of Science and Technology of Mexico 'CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Camina Research Center; Universidad Anahuac Mexico Norte	This work was partially supported by the National Council of Science and Technology of Mexico 'CONACYT), grant No. 57204, Camina Research Center and Universidad Anahuac Mexico Norte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Avidan H, 2004, EUR J IMMUNOL, V34, P3434, DOI 10.1002/eji.200424883; Bakalash S, 2002, INVEST OPHTH VIS SCI, V43, P2648; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106; Garcia E, 2011, J NEUROSCI IN PRESS; Gaur A, 1997, J NEUROIMMUNOL, V74, P149, DOI 10.1016/S0165-5728(96)00220-2; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Ibarra A, 2007, SPINAL CORD, V45, P380, DOI 10.1038/sj.sc.3101972; Ibarra A, 2004, EUR J NEUROSCI, V19, P2984, DOI 10.1111/j.0953-816X.2004.03402.x; Ibarra A, 2010, NEUROSCI LETT, V476, P62, DOI 10.1016/j.neulet.2010.04.003; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Martinon S, 2007, EUR J NEUROSCI, V26, P403, DOI 10.1111/j.1460-9568.2007.05650.x; Morris KR, 2009, TUBERCULOSIS, V89, P294, DOI 10.1016/j.tube.2009.03.004; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Schori H, 2005, TOXICOL SCI, V87, P163, DOI 10.1093/toxsci/kfi237; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shaked I, 2004, J NEUROIMMUNOL, V146, P84, DOI 10.1016/j.jneuroim.2003.10.049; Stier KS, 2009, J EXP BIOL, V212, P2084, DOI 10.1242/jeb.024406; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32027	10.1371/journal.pone.0032027	http://dx.doi.org/10.1371/journal.pone.0032027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348141	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400059
J	Chen, ZF; Wang, H; Matsumura, K; Qian, PY				Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Qian, Pei-Yuan			Expression of Calmodulin and Myosin Light Chain Kinase during Larval Settlement of the Barnacle Balanus amphitrite	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CYPRIS LARVAE; MESSENGER-RNA; METAMORPHOSIS; GENE; PHOSPHORYLATION; PURIFICATION; INVOLVEMENT; CLONING; MODULATOR	Barnacles are one of the most common organisms in intertidal areas. Their life cycle includes seven free-swimming larval stages and sessile juvenile and adult stages. The transition from the swimming to the sessile stages, referred to as larval settlement, is crucial for their survivor success and subsequent population distribution. In this study, we focused on the involvement of calmodulin (CaM) and its binding proteins in the larval settlement of the barnacle, Balanus (=Amphibalanus) amphitrite. The full length of CaM gene was cloned from stage II nauplii of B. amphitrite (referred to as Ba-CaM), encoding 149 amino acid residues that share a high similarity with published CaMs in other organisms. Quantitative real-time PCR showed that Ba-CaM was highly expressed in cyprids, the stage at which swimming larvae are competent to attach and undergo metamorphosis. In situ hybridization revealed that the expressed Ba-CaM gene was localized in compound eyes, posterior ganglion and cement glands, all of which may have essential functions during larval settlement. Larval settlement assays showed that both the CaM inhibitor compound 48/80 and the CaM-dependent myosin light chain kinase (MLCK) inhibitor ML-7 effectively blocked barnacle larval settlement, whereas Ca2+/CaM-dependent kinase II (CaMKII) inhibitors did not show any clear effects. The subsequent real-time PCR assay showed a higher expression level of Ba-MLCK gene in larval stages than in adults, suggesting an important role of Ba-MLCK gene in larval development and competency. Overall, the results suggest that CaM and CaM-dependent MLCK function during larval settlement of B. amphitrite.	[Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, KAUST Global Collaborat Res Program, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Chen, ZF (corresponding author), Hong Kong Univ Sci & Technol, KAUST Global Collaborat Res Program, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	WANG, Hao/D-1063-2012	Qian, Pei-Yuan/0000-0003-4074-9078	King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Areas of Excellence (AoE) of Hong Kong Special Administrative Region [AOE/P-04/04-2-II]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Areas of Excellence (AoE) of Hong Kong Special Administrative Region	This work was supported by an award (SA-C0040/UK-C0016) from King Abdullah University of Science and Technology and an Areas of Excellence (AoE) project of Hong Kong Special Administrative Region (AOE/P-04/04-2-II) to Pei-Yuan Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.T., 1994, BARNACLES STRUCTURE; BARNES H, 1977, J EXP MAR BIOL ECOL, V27, P195, DOI 10.1016/0022-0981(77)90124-1; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; Carafoli E, 1999, CALCIUM CELLULAR REG, P656; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CLARE AS, 1992, J EXP ZOOL, V262, P436, DOI 10.1002/jez.1402620410; Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276; CLARE AS, 1995, J EXP BIOL, V198, P655; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; Di Gregorio A, 1998, DEV GROWTH DIFFER, V40, P387; Dreanno C, 2006, P ROY SOC B-BIOL SCI, V273, P2721, DOI 10.1098/rspb.2006.3649; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Gao YP, 2009, COMP BIOCHEM PHYS B, V152, P216, DOI 10.1016/j.cbpb.2008.11.006; GIETZEN K, 1983, BIOCHEM J, V216, P611, DOI 10.1042/bj2160611; HARDY DO, 1988, J MOL BIOL, V199, P223, DOI 10.1016/0022-2836(88)90392-0; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; Huo LF, 2004, ENDOCRINOLOGY, V145, P5056, DOI 10.1210/en.2004-0584; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; KNIGHTJONES EW, 1953, NATURE, V171, P1109, DOI 10.1038/1711109a0; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Li HL, 2010, J EXP MAR BIOL ECOL, V389, P45, DOI 10.1016/j.jembe.2010.03.019; Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012; Luan J, 2010, CHIN J OCEANOL LIMN, V28, P1221, DOI 10.1007/s00343-010-9035-0; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; MICHAEL RH, 1992, LIFE SCI, V51, P1881, DOI 10.1016/0024-3205(92)90040-V; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; NOJIMA H, 1989, J MOL BIOL, V208, P269, DOI 10.1016/0022-2836(89)90388-4; NOJIMA H, 1987, J MOL BIOL, V193, P439, DOI 10.1016/0022-2836(87)90258-0; Okano K, 1996, J EXP BIOL, V199, P2131; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; PEQUEUX A, 1992, MAR BIOL, V113, P65, DOI 10.1007/BF00367639; SEAMON KB, 1980, BIOCHEMISTRY-US, V19, P207, DOI 10.1021/bi00542a031; SENTERRELESENFANTS S, 1995, J CELL BIOCHEM, V58, P445, DOI 10.1002/jcb.240580407; SHRODE LD, 1995, AM J PHYSIOL-CELL PH, V269, pC257, DOI 10.1152/ajpcell.1995.269.1.C257; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; TAKENAKA M, 1993, DEV GROWTH DIFFER, V35, P245; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; THOMAS WK, 1991, GENETICS, V128, P269; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Walker G., 1987, Crustacean Issues, V5, P307; WATTERSON DM, 1980, J BIOL CHEM, V255, P962; Wongpanya Ratree, 2007, ScienceAsia, V33, P165, DOI 10.2306/scienceasia1513-1874.2007.33.165; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16; Yamamoto H, 1998, J EXP ZOOL, V280, P8, DOI 10.1002/(SICI)1097-010X(19980101)280:1<8::AID-JEZ2>3.0.CO;2-S; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yamamoto H, 1997, J EXP ZOOL, V278, P349, DOI 10.1002/(SICI)1097-010X(19970815)278:6<349::AID-JEZ2>3.0.CO;2-O; Yamamoto H, 1996, J EXP ZOOL, V275, P339, DOI 10.1002/(SICI)1097-010X(19960801)275:5<339::AID-JEZ2>3.0.CO;2-Q; YAMANAKA MK, 1987, NUCLEIC ACIDS RES, V15, P3335, DOI 10.1093/nar/15.8.3335; YAZAWA M, 1980, J BIOCHEM, V87, P1313, DOI 10.1093/oxfordjournals.jbchem.a132869; Ye QR, 1997, GENE, V194, P63, DOI 10.1016/S0378-1119(97)00155-8	64	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31337	10.1371/journal.pone.0031337	http://dx.doi.org/10.1371/journal.pone.0031337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348072	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900042
J	Muntinghe, FLH; Abdulahad, WH; Huitema, MG; Damman, J; Seelen, MA; Lems, SPM; Hepkema, BG; Navis, G; Westra, J				Muntinghe, Friso L. H.; Abdulahad, Wayel H.; Huitema, Minke G.; Damman, Jeffrey; Seelen, Marc A.; Lems, Simon P. M.; Hepkema, Bouke G.; Navis, Gerjan; Westra, Johanna			CCR5 Delta 32 Genotype Leads to a Th2 Type Directed Immune Response in ESRD Patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CHEMOKINE RECEPTOR CCR5; DIALYSIS PATIENTS; NEOINTIMA FORMATION; TNF-ALPHA; T-CELLS; ATHEROSCLEROSIS; MICE; INFLAMMATION; RANTES	Background: In patients with end stage renal disease (ESRD) we observed protection from inflammation-associated mortality in CCR5 Delta 32 carriers, leading to CCR5 deficiency, suggesting impact of CCR5 Delta 32 on inflammatory processes. Animal studies have shown that CCR5 deficiency is associated with a more pronounced Th2 type immune response, suggesting that in human CCR5 Delta 32 carriers the immune response may be more Th2 type directed. So, in the present study we determined the Th1-Th2 type directed immune response in ESRD patients carrying and not carrying the CCR5 Delta 32 genetic variant after stimulation. Methodology/Principal Findings: We tested this hypothesis by determining the levels of IFN-gamma and IL-4 and the distribution of Th1, Th2 and Th17 directed circulating CD4+ and CD8+ T cells and regulatory T cells (Tregs) after stimulation in ESRD patients with (n = 10) and without (n = 9) the CCR5 Delta 32 genotype. The extracellular levels of IFN-gamma and IL-4 did not differ between CCR5 Delta 32 carriers and non carriers. However, based on their intracellular cytokine profile the percentages IL-4 secreting CD4+ and CD8+ T cells carrying the CCR5 Delta 32 genotype were significantly increased (p = 0.02, respectively p = 0.02) compared to non carriers, indicating a more Th2 type directed response. Based on their intracellular cytokine profile the percentages IFN-gamma and IL-17 secreting T cells did not differ between carriers and non-carriers nor did the percentage Tregs, indicating that the Th1, Th17 and T regulatory response was not affected by the CCR5 Delta 32 genotype. Conclusions/Significance: This first, functional human study shows a more pronounced Th2 type immune response in CCR5 Delta 32 carriers compared to non carriers. These differences may be involved in the previously observed protection from inflammation-associated mortality in ESRD patients carrying CCR5 Delta 32.	[Muntinghe, Friso L. H.; Abdulahad, Wayel H.; Huitema, Minke G.; Damman, Jeffrey; Seelen, Marc A.; Lems, Simon P. M.; Hepkema, Bouke G.; Navis, Gerjan; Westra, Johanna] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	University of Groningen	Muntinghe, FLH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.	f.l.h.muntinghe@umcg.nl		/0000-0003-3109-4487				Abdi R, 2002, DIABETES, V51, P2489, DOI 10.2337/diabetes.51.8.2489; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Carter LL, 1996, CURR OPIN IMMUNOL, V8, P336, DOI 10.1016/S0952-7915(96)80122-1; Chen SA, 2010, J INNATE IMMUN, V2, P325, DOI 10.1159/000314626; Clark VJ, 2001, HUM GENET, V108, P484, DOI 10.1007/s004390100512; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Dehmel S, 2010, EUR J IMMUNOL, V40, P267, DOI 10.1002/eji.200939652; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Gonzalez P, 2001, GENES IMMUN, V2, P191, DOI 10.1038/sj.gene.6363760; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hendrikx TK, 2009, NEPHROL DIAL TRANSPL, V24, P1969, DOI 10.1093/ndt/gfp005; Kawai T, 1999, J IMMUNOL, V163, P3269; Kovesdy CP, 2009, J AM SOC NEPHROL, V20, P1429, DOI 10.1681/ASN.2009050510; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Muntinghe FLH, 2011, PHARMACOGENET GENOM, V21, P417, DOI 10.1097/FPC.0b013e3283472990; Muntinghe FLH, 2011, CYTOKINE, V53, P16, DOI 10.1016/j.cyto.2010.09.001; Muntinghe FLH, 2009, DIABETES RES CLIN PR, V86, P140, DOI 10.1016/j.diabres.2009.08.013; Muntinghe FLH, 2009, J AM SOC NEPHROL, V20, P1641, DOI 10.1681/ASN.2008040432; Pai JK, 2006, ATHEROSCLEROSIS, V186, P132, DOI 10.1016/j.atherosclerosis.2005.06.041; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Szalai C, 2001, ATHEROSCLEROSIS, V158, P233, DOI 10.1016/S0021-9150(01)00423-3; van Wanrooij EJA, 2005, ARTERIOSCL THROM VAS, V25, P2642, DOI 10.1161/01.ATV.0000192018.90021.c0; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wilcox J N, 1994, J Atheroscler Thromb, V1 Suppl 1, pS10; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31257	10.1371/journal.pone.0031257	http://dx.doi.org/10.1371/journal.pone.0031257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348061	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900035
J	Wainszelbaum, MJ; Liu, JL; Kong, C; Srikanth, P; Samovski, D; Su, X; Stahl, PD				Wainszelbaum, Marisa J.; Liu, Jialu; Kong, Chen; Srikanth, Priya; Samovski, Dmitri; Su, Xiong; Stahl, Philip D.			TBC1D3, a Hominoid-Specific Gene, Delays IRS-1 Degradation and Promotes Insulin Signaling by Modulating p70 S6 Kinase Activity	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; COPY NUMBER VARIATION; CELL-TRANSFORMATION; REGULATORY SUBUNIT; PP2A COMPLEXES; PHOSPHORYLATION; SUBSTRATE-1; PROTEIN; CANCER; IDENTIFICATION	Insulin/IGF-1 signaling plays a pivotal role in the regulation of cellular homeostasis through its control of glucose metabolism as well as due to its effects on cell proliferation. Aberrant regulation of insulin signaling has been repeatedly implicated in uncontrolled cell growth and malignant transformations. TBC1D3 is a hominoid specific gene previously identified as an oncogene in breast and prostate cancers. Our efforts to identify the molecular mechanisms of TBC1D3-induced oncogenesis revealed the role of TBC1D3 in insulin/IGF-1 signaling pathway. We document here that TBC1D3 intensifies insulin/IGF-1-induced signal transduction through intricate, yet elegant fine-tuning of signaling mechanisms. We show that TBC1D3 expression substantially delayed ubiquitination and degradation of insulin receptor substrate-1 (IRS-1). This effect is achieved through suppression of serine phosphorylation at S636/639, S307 and S312 of IRS-1, which are key phosphorylation sites required for IRS-1 degradation. Furthermore, we report that the effect of TBC1D3 on IRS-1:S636/639 phosphorylation is mediated through TBC1D3-induced activation of protein phosphatase 2A (PP2A), followed by suppression of T389 phosphorylation on p70 S6 kinase (S6K). TBC1D3 specifically interacts with PP2A regulatory subunit B56 gamma, indicating that TBC1D3 and PP2A B56 gamma operate jointly to promote S6K:T389 dephosphorylation. These findings suggest that TBC1D3 plays an unanticipated and potentially unique role in the fine-tuning of insulin/IGF-1 signaling, while providing novel insights into the regulation of tumorigenesis by a hominoid-specific protein.	[Wainszelbaum, Marisa J.; Liu, Jialu; Kong, Chen; Srikanth, Priya; Samovski, Dmitri; Su, Xiong; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Ctr Human Nutr, St Louis, MO 63110 USA; [Su, Xiong] Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wainszelbaum, MJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Ctr Human Nutr, St Louis, MO 63110 USA.	xsu@.wustl.edu; pstahl@wustl.edu	Samovski, Dmitri/AAQ-2014-2020; Samovski, Dmitri/K-3705-2019; Stahl, Philip/D-6315-2012	Samovski, Dmitri/0000-0002-6860-6688; Srikanth, Priya/0000-0002-9669-0434	National Health Institute [GM086566]; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM086566] Funding Source: NIH RePORTER	National Health Institute; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Health Institute grant GM086566 and a grant from the McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; BOURAHALFON S, 2008, AM J PHYSL ENDOCRINO; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho I, 2010, DNA CELL BIOL, V29, P473, DOI 10.1089/dna.2009.0997; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; CHUANG LM, 1994, J BIOL CHEM, V269, P27645; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hafen E, 2004, SWISS MED WKLY, V134, P711; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hatanaka H, 2010, CANCER SCI, V101, P54, DOI 10.1111/j.1349-7006.2009.01348.x; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; HUEBNER K, 1988, ONCOGENE, V3, P449; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Molloy CA, 2000, J BIOL CHEM, V275, P12565, DOI 10.1074/jbc.275.17.12565; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Morelli C, 2003, ONCOGENE, V22, P4007, DOI 10.1038/sj.onc.1206436; Muneer S, 2002, GENOMICS, V79, P344, DOI 10.1006/geno.2002.6721; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; Pei L, 2002, CANCER RES, V62, P5420; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31225	10.1371/journal.pone.0031225	http://dx.doi.org/10.1371/journal.pone.0031225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348058	Green Published, gold			2022-12-27	WOS:000302733900033
J	Zanin, RF; Braganhol, E; Bergamin, LS; Campesato, LFI; Zanotto, A; Moreira, JCF; Morrone, FB; Sevigny, J; Schetinger, MRC; Wyse, ATD; Battastini, AMO				Zanin, Rafael Fernandes; Braganhol, Elizandra; Bergamin, Leticia Scussel; Ingrassia Campesato, Luis Felipe; Zanotto Filho, Alfeu; Fonseca Moreira, Jose Claudio; Morrone, Fernanda Bueno; Sevigny, Jean; Chitolina Schetinger, Maria Rosa; de Souza Wyse, Angela Terezinha; Oliveira Battastini, Ana Maria			Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5 '-Nucleotidase	PLOS ONE			English	Article							MURINE REPRODUCTIVE-TRACT; PERITONEAL-MACROPHAGES; ALTERNATIVE ACTIVATION; ATP-DIPHOSPHOHYDROLASE; CYTOKINE PRODUCTION; ECTO-NUCLEOTIDASES; ENDOTHELIAL-CELLS; EXTRACELLULAR ATP; ARGINASE ISOFORMS; HUMAN MONOCYTES	Macrophages are key elements in the inflammatory process, whereas depending on the micro-environmental stimulation they exhibit a pro-inflammatory (classical/M1) or an anti-inflammatory/reparatory (alternative/M2) phenotype. Extracellular ATP can act as a danger signal whereas adenosine generally serves as a negative feedback mechanism to limit inflammation. The local increase in nucleotides communication is controlled by ectonucleotidases, such as members of the ectonucleoside triphosphate diphosphohydrolase (E-NTPDase) family and ecto-5'-nucleotidase/CD73 (ecto-5'-NT). In the present work we evaluated the presence of these enzymes in resident mice M1 (macrophages stimulated with LPS), and M2 (macrophages stimulated with IL-4) macrophages. Macrophages were collected by a lavage of the mice (6-8 weeks) peritoneal cavity and treated for 24 h with IL-4 (10 ng/mL) or LPS (10 ng/mL). Nitrite concentrations were measured using the Greiss reaction. Supernatants were harvested to determine cytokines and the ATPase, ADPase and AMPase activities were determined by the malachite green method and HPLC analysis. The expression of selected surface proteins was evaluated by flow cytometry. The results reveal that M1 macrophages presented a decreased ATP and AMP hydrolysis in agreement with a decrease in NTPDase1, -3 and ecto-5'-nucleotidase expression compared to M2. In contrast, M2 macrophages showed a higher ATP and AMP hydrolysis and increased NTPDase1, -3 and ecto-5'-nucleotidase expression compared to M1 macrophages. Therefore, macrophages of the M1 phenotype lead to an accumulation of ATP while macrophages of the M2 phenotype may rapidly convert ATP to adenosine. The results also showed that P1 and P2 purinoreceptors present the same mRNA profile in both phenotypes. In addition, M2 macrophages, which have a higher ATPase activity, were less sensitive to cell death. In conclusion, these changes in ectoenzyme activities might allow macrophages to adjust the outcome of the extracellular purinergic cascade in order to fine-tune their functions during the inflammatory set.	[Zanin, Rafael Fernandes; Braganhol, Elizandra; Bergamin, Leticia Scussel; Ingrassia Campesato, Luis Felipe; Zanotto Filho, Alfeu; Fonseca Moreira, Jose Claudio; de Souza Wyse, Angela Terezinha; Oliveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil; [Morrone, Fernanda Bueno] Pontificia Univ Catolica Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil; [Sevigny, Jean] Univ Quebec, Ctr Hosp, Ctr Rech Rheumatol & Immunol, Ste Foy, PQ G1V 2M3, Canada; [Chitolina Schetinger, Maria Rosa] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Quim, BR-97119900 Santa Maria, RS, Brazil; [Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Laval University; University of Quebec; Universidade Federal de Santa Maria (UFSM); Laval University	Zanin, RF (corresponding author), Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil.	rafaelzaninn@gmail.com	Morrone, Fernanda/AAH-6044-2020; Sévigny, Jean/AGH-9323-2022; Braganhol, Elizandra/C-6439-2013; Battastini, Ana M/E-2809-2012; moreira, jose claudio/AAO-6400-2021; Bueno Morrone, Fernanda/K-8405-2012; Sevigny, Jean/E-8039-2012; Wyse, Angela TS/K-6104-2013; ZANOTTO-FILHO, ALFEU/A-8172-2016; Schetinger, Maria Rosa Chitolina/I-7658-2019; Morrone, Fernanda B/K-7703-2015	Morrone, Fernanda/0000-0002-2709-2801; Sévigny, Jean/0000-0003-2922-1600; Battastini, Ana M/0000-0001-6068-3278; Sevigny, Jean/0000-0003-2922-1600; Wyse, Angela TS/0000-0001-8769-1147; ZANOTTO-FILHO, ALFEU/0000-0002-4188-3095; Morrone, Fernanda B/0000-0002-2709-2801; Chitolina Schetinger, Maria Rosa/0000-0002-5240-8935	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- Brasil; CNPq; Fonds de Recherche en Sante du Quebec	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- Brasil. R. F. Zanin and E. Braganhol were recipients of CNPq fellowships and J. Sevigny of a Junior 2 scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2007, PURINERG SIGNAL, V3, P13, DOI 10.1007/s11302-006-9033-z; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bonder CS, 1998, J IMMUNOL, V160, P4048; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brone B, 2007, IMMUNOL LETT, V113, P83, DOI 10.1016/j.imlet.2007.07.015; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; CHEUNG DL, 1990, IMMUNOLOGY, V71, P70; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Coutinho-Silva R, 2001, AM J PHYSIOL-CELL PH, V280, pC81, DOI 10.1152/ajpcell.2001.280.1.C81; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; FENTON MJ, 1992, J IMMUNOL, V149, P1283; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; FRASSETTO SS, 1993, MOL CELL BIOCHEM, V129, P47, DOI 10.1007/BF00926575; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gratchev A, 2001, SKIN PHARMACOL APPL, V14, P272, DOI 10.1159/000056357; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Grinthal A, 2007, BIOCHEMISTRY-US, V46, P279, DOI 10.1021/bi061052p; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Kittel A, 2007, INT J DEV NEUROSCI, V25, P275, DOI 10.1016/j.ijdevneu.2007.05.007; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Krishna S, 2006, NUCLEIC ACIDS RES, V34, P2455, DOI 10.1093/nar/gkl140; Kukulski F, 2007, J LEUKOCYTE BIOL, V81, P1269, DOI 10.1189/jlb.1206758; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Li RWS, 2008, AM J PHYSIOL-HEART C, V295, pH1177, DOI 10.1152/ajpheart.91513.2007; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis CA, 1999, AM J PHYSIOL-REG I, V276, pR237, DOI 10.1152/ajpregu.1999.276.1.R237; Martin-Satue M, 2009, HISTOCHEM CELL BIOL, V131, P615, DOI 10.1007/s00418-008-0551-3; Martin-Satue M, 2010, HISTOCHEM CELL BIOL, V133, P659, DOI 10.1007/s00418-010-0704-z; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 1999, J IMMUNOL, V163, P3771; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schebesch C, 1997, IMMUNOLOGY, V92, P478, DOI 10.1046/j.1365-2567.1997.00371.x; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Sevigny J, 1997, BBA-GEN SUBJECTS, V1334, P73, DOI 10.1016/S0304-4165(96)00079-7; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Wink MR, 2003, CANCER LETT, V198, P211, DOI 10.1016/S0304-3835(03)00308-2; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Zimmermann H, 2001, DRUG DEVELOP RES, V52, P44, DOI 10.1002/ddr.1097	62	82	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31205	10.1371/journal.pone.0031205	http://dx.doi.org/10.1371/journal.pone.0031205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348056	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900032
J	Joo, KM; Jin, J; Kang, BG; Lee, SJ; Kim, KH; Yang, H; Lee, YA; Cho, YJ; Im, YS; Lee, DS; Lim, DH; Kim, DH; Um, HD; Lee, SH; Lee, JI; Nam, DH				Joo, Kyeung Min; Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Cho, Yu Jin; Im, Yong-Seok; Lee, Dong-Sup; Lim, Do-Hoon; Kim, Dong Hyun; Um, Hong-Duck; Lee, Sang-Hun; Lee, Jung-Ii; Nam, Do-Hyun			Trans-Differentiation of Neural Stem Cells: A Therapeutic Mechanism Against the Radiation Induced Brain Damage	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEUROGENESIS; RADIOTHERAPY; METASTASES; MANAGEMENT; RESECTION	Radiation therapy is an indispensable therapeutic modality for various brain diseases. Though endogenous neural stem cells (NSCs) would provide regenerative potential, many patients nevertheless suffer from radiation-induced brain damage. Accordingly, we tested beneficial effects of exogenous NSC supplementation using in vivo mouse models that received whole brain irradiation. Systemic supplementation of primarily cultured mouse fetal NSCs inhibited radiation-induced brain atrophy and thereby preserved brain functions such as short-term memory. Transplanted NSCs migrated to the irradiated brain and differentiated into neurons, astrocytes, or oligodendrocytes. In addition, neurotrophic factors such as NGF were significantly increased in the brain by NSCs, indicating that both paracrine and replacement effects could be the therapeutic mechanisms of NSCs. Interestingly, NSCs also differentiated into brain endothelial cells, which was accompanied by the restoration the cerebral blood flow that was reduced from the irradiation. Inhibition of the VEGF signaling reduced the migration and trans-differentiation of NSCs. Therefore, trans-differentiation of NSCs into brain endothelial cells by the VEGF signaling and the consequential restoration of the cerebral blood flow would also be one of the therapeutic mechanisms of NSCs. In summary, our data demonstrate that exogenous NSC supplementation could prevent radiation-induced functional loss of the brain. Therefore, successful combination of brain radiation therapy and NSC supplementation would provide a highly promising therapeutic option for patients with various brain diseases.	[Joo, Kyeung Min; Cho, Yu Jin; Lee, Dong-Sup] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Joo, Kyeung Min; Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Canc Stem Cell Res Ctr, Samsung Med Ctr, Seoul, South Korea; [Joo, Kyeung Min; Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Im, Yong-Seok; Lee, Jung-Ii; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Lim, Do-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Dong Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Mol & Cellular Imaging, Seoul, South Korea; [Um, Hong-Duck] Korea Inst Radiol & Med Sci, Lab Radiat Tumor Physiol, Seoul, South Korea; [Lee, Sang-Hun] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Institute of Radiological & Medical Sciences; Hanyang University	Joo, KM (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea.	jilee.lee@samsung.com; nsnam@skku.edu	Um, Hong-Duk/AAH-3733-2021; Lee, Dong-Sup/J-2777-2012	Kim, Dong Hyun/0000-0001-9018-2781	Future-based Technology Development Program [2010-0020232]; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea; Samsung Biomedical Research Institute [SBRI B(C)-A7-220-3]	Future-based Technology Development Program; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Samsung Biomedical Research Institute(Samsung)	This work was supported by the grant for the Future-based Technology Development Program (2010-0020232) funded by the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea (D.H. Nam) and by the Samsung Biomedical Research Institute grant, #SBRI B(C)-A7-220-3 (J.I. Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah S, 2008, ANN NY ACAD SCI, V1138, P22, DOI 10.1196/annals.1414.005; Biswas G, 2006, J Cancer Res Ther, V2, P5; Butler Jerome M, 2006, Curr Treat Options Oncol, V7, P517, DOI 10.1007/s11864-006-0026-5; Ciardiello F, 2003, CLIN CANCER RES, V9, P1546; Davey P, 2002, CNS DRUGS, V16, P325, DOI 10.2165/00023210-200216050-00005; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; DEANGELIS LM, 1989, NEUROSURGERY, V24, P798, DOI 10.1227/00006123-198906000-00002; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Donnelly EH, 2010, SOUTH MED J, V103, P541, DOI 10.1097/SMJ.0b013e3181ddd571; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gourmelon P., 2005, BR J RADIOL S, V78, P62; Ishii K, 2000, NEURORADIOLOGY, V42, P787, DOI 10.1007/s002340000404; Jones Jesse, 2007, Neurosurg Focus, V23, pE7; Keime-Guibert F, 1998, J NEUROL, V245, P695, DOI 10.1007/s004150050271; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Langer CJ, 2005, J CLIN ONCOL, V23, P6207, DOI 10.1200/JCO.2005.03.145; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; O'Neill BP, 2003, INT J RADIAT ONCOL, V55, P1169, DOI 10.1016/S0360-3016(02)04379-1; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Regine WF, 2001, INT J RADIAT ONCOL, V51, P711, DOI 10.1016/S0360-3016(01)01676-5; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stepanova OI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1194, DOI 10.1134/S0006297907110041; Taimur Sadaf, 2003, Curr Treat Options Oncol, V4, P89, DOI 10.1007/s11864-003-0035-6; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Wahlsten D, 2005, BEHAV BRAIN RES, V165, P36, DOI 10.1016/j.bbr.2005.06.047; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wardlaw JM, 2001, NEUROLOGY, V57, pS69, DOI 10.1212/WNL.57.suppl_2.S69; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yee SH, 2005, NUCL MED COMMUN, V26, P901, DOI 10.1097/00006231-200510000-00009	37	33	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e25936	10.1371/journal.pone.0025936	http://dx.doi.org/10.1371/journal.pone.0025936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347993	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730900001
J	Kubiak, RJ; McLean, AR				Kubiak, Ruben J.; McLean, Angela R.			Why Was the 2009 Influenza Pandemic in England So Small?	PLOS ONE			English	Article							A H1N1 VIRUS; TRANSMISSION	The "Swine flu'' pandemic of 2009 caused world-wide infections and deaths. Early efforts to understand its rate of spread were used to predict the probable future number of cases, but by the end of 2009 it was clear that these predictions had substantially overestimated the pandemic's eventual impact. In England, the Health Protection Agency made announcements of the number of cases of disease, which turned out to be surprisingly low for an influenza pandemic. The agency also carried out a serological survey half-way through the English epidemic. In this study, we use a mathematical model to reconcile early estimates of the rate of spread of infection, weekly data on the number of cases in the 2009 epidemic in England and the serological status of the English population at the end of the first pandemic wave. Our results reveal that if there are around 19 infections (i.e., seroconverters) for every reported case then the three data-sets are entirely consistent with each other. We go on to discuss when in the epidemic such a high ratio of seroconverters to cases of disease might have been detected, either through patterns in the case reports or through even earlier serological surveys.	[Kubiak, Ruben J.; McLean, Angela R.] Univ Oxford, Dept Zool, Oxford Martin Sch, Inst Emerging Infect, Oxford OX1 3PS, England	University of Oxford	Kubiak, RJ (corresponding author), Univ Oxford, Dept Zool, Oxford Martin Sch, Inst Emerging Infect, S Parks Rd, Oxford OX1 3PS, England.	ruben.kubiak@zoo.ox.ac.uk			Oxford Martin School; Engineering and Physical Sciences Research Council; All Souls College	Oxford Martin School; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); All Souls College	RJK gratefully acknowledges funding for this work from the Oxford Martin School and the Engineering and Physical Sciences Research Council. ARM is a Senior Research Fellow of All Souls College whose support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chen HW, 2009, OPT LASER TECHNOL, V41, P1, DOI 10.1016/j.optlastec.2008.05.003; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Silva UC, 2009, EUROSURVEILLANCE, V14, P11; Directgov, 2009, SCH TERM DAT; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Health Protection Agency, 2009, WEEKL PAND FLU MED U; Health Protection Agency, 2009, WEEKL NAT IN REP; Health Protection Agency, 2009, SYN METH US EST NUMB; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Mims CA, 2000, MIMS PATHOGENESIS IN, P474; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Office for National Statistics, 2009, 2009 POP EST ENGL; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Prachayangprecha S, 2010, J HEALTH POPUL NUTR, V28, P537, DOI 10.3329/jhpn.v28i6.6601; Salez N, 2011, CLIN MICROBIOL INFEC, P4; Scherer A, 2002, BRIT MED BULL, V62, P187, DOI 10.1093/bmb/62.1.187; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; [No title captured]	27	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30223	10.1371/journal.pone.0030223	http://dx.doi.org/10.1371/journal.pone.0030223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348001	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730900006
J	Nogales-Gadea, G; Consuegra-Garcia, I; Rubio, JC; Arenas, J; Cuadros, M; Camara, Y; Torres-Torronteras, J; Fiuza-Luces, C; Lucia, A; Martin, MA; Garcia-Arumi, E; Andreu, AL				Nogales-Gadea, Gisela; Consuegra-Garcia, Ines; Rubio, Juan C.; Arenas, Joaquin; Cuadros, Marc; Camara, Yolanda; Torres-Torronteras, Javier; Fiuza-Luces, Carmen; Lucia, Alejandro; Martin, Miguel A.; Garcia-Arumi, Elena; Andreu, Antoni L.			A Transcriptomic Approach to Search for Novel Phenotypic Regulators in McArdle Disease	PLOS ONE			English	Article							RETICULUM CA2+ ATPASE; GLYCOGEN-SYNTHASE ACTIVITY; SKELETAL-MUSCLE; BRODY-DISEASE; PHOSPHORYLASE; EXERCISE; INSULIN; SERCA1; GENE; PHOSPHOROLYSIS	McArdle disease is caused by lack of glycogen phosphorylase (GP) activity in skeletal muscle. Patients experience exercise intolerance, presenting as early fatigue and contractures. In this study, we investigated the effects produced by a lack of GP on several genes and proteins of skeletal muscle in McArdle patients. Muscle tissue of 35 patients and 7 healthy controls were used to identify abnormalities in the patients' transcriptomic profile using low-density arrays. Gene expression was analyzed for the influence of variables such as sex and clinical severity. Differences in protein expression were studied by immunoblotting and 2D electrophoresis analysis, and protein complexes were examined by two-dimensional, blue native gel electrophoresis (BN-PAGE). A number of genes including those encoding acetyl-coA carboxylase beta, m-cadherin, calpain III, creatine kinase, glycogen synthase (GS), and sarcoplasmic reticulum calcium ATPase 1 (SERCA1), were found to be downregulated in patients. Specifically, compared to controls, GS and SERCA1 proteins were reduced by 50% and 75% respectively; also, unphosphorylated GS and SERCA1 were highly downregulated. On BN-PAGE analysis, GP was present with GS in two muscle protein complexes. Our findings revealed some issues that could be important in understanding the physiological consequences of McArdle disease: (i) SERCA1 downregulation in patients could result in impaired calcium transport in type II (fast-twitch) muscle fibers, leading to early fatigability during exercise tasks involving type II fibers (which mostly use glycolytic metabolism), i. e. isometric exercise, lifting weights or intense dynamic exercise (stair climbing, bicycling, walking at a very brisk pace), (ii) GP and GS were found together in two protein complexes, which suggests a new regulatory mechanism in the activity of these glycogen enzymes.	[Nogales-Gadea, Gisela; Cuadros, Marc; Camara, Yolanda; Torres-Torronteras, Javier; Garcia-Arumi, Elena; Andreu, Antoni L.] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain; [Nogales-Gadea, Gisela] Univ Autonoma Barcelona, Inst Recerca HSCSP, Expt Neurol Lab, E-08193 Barcelona, Spain; [Nogales-Gadea, Gisela; Consuegra-Garcia, Ines; Rubio, Juan C.; Arenas, Joaquin; Cuadros, Marc; Camara, Yolanda; Torres-Torronteras, Javier; Martin, Miguel A.; Garcia-Arumi, Elena; Andreu, Antoni L.] Hosp Univ 12 Octubre, Spain Ctr Invest, Inst Salud Carlos III, Spanish Network Res Rare Dis CIBERER, Madrid, Spain; [Consuegra-Garcia, Ines] Hosp Univ 12 Octubre, Inst Invest, Unidad Prote, Madrid, Spain; [Rubio, Juan C.] Hosp Univ 12 Octubre, Inst Invest, Unidad Genom, Madrid, Spain; [Fiuza-Luces, Carmen; Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain; [Martin, Miguel A.] Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; European University of Madrid; Hospital Universitario 12 de Octubre	Nogales-Gadea, G (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain.	elena.garcia@vhir.org	Torres-Torronteras, Javier/K-4974-2014; Cámara, Yolanda/P-2540-2019; Martin, Miguel A/S-2758-2018; Garcia-Arumi, Elena/ABH-4229-2020; Nogales-Gadea, Gisela/N-4004-2014; Cámara, Yolanda/K-4597-2014; Lucia, Alejandro/M-2759-2014	Torres-Torronteras, Javier/0000-0002-6092-9458; Martin, Miguel A/0000-0003-4741-772X; Nogales-Gadea, Gisela/0000-0002-7414-212X; Cámara, Yolanda/0000-0003-2458-6942; Lucia, Alejandro/0000-0002-3025-2060; Garcia-Arumi, Elena/0000-0003-0096-3336; Fiuza-Luces, Carmen/0000-0001-8131-7007; ANDREU, antonio luis/0000-0002-3936-3234; Lucia, Alejandro/0000-0002-5565-0997; Arenas, Joaquin/0000-0002-2877-5049	Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria [PS0901359, PS0900194, PI10/00036, CA08/00203, CA05/0039, PI07/00232]; Instituto de Salud Carlos III [CD10/00027]; Comunidad de Madrid	Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants PS0901359, PS0900194 and PI10/00036 from Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria. GN is a recipient of a Instituto de Salud Carlos III-Sara Borrell post-doctoral fellowship number CD10/00027. IG, JCR and MC were supported by contracts from Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria CA08/00203, CA05/0039 and PI07/00232 respectively. MAM was supported by the programme 'Intensificacion de la Actividad Investigadora' from Instituto de Salud Carlos III, and Comunidad de Madrid. IG, JCR, JA, MAM are members of Unit U723, and ALA, EGA, GN, MC, JT of Unit U701 CIBER de Enfermedades Raras. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; CUENDA A, 1993, BIOCHEM BIOPH RES CO, V196, P1127, DOI 10.1006/bbrc.1993.2368; CUENDA A, 1991, FEBS LETT, V283, P273, DOI 10.1016/0014-5793(91)80606-4; DiMauro S., 2002, Current Molecular Medicine (Hilversum), V2, P189, DOI 10.2174/1566524024605770; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; Dubowitz V., MUSCLE BIOPSY PRACTI; ELLIOT DL, 1989, MEDICINE, V68, P163, DOI 10.1097/00005792-198905000-00004; Garcia-Consuegra I, 2009, J MED GENET, V46, P198, DOI 10.1136/jmg.2008.059469; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Haller RG, 1998, NEUROLOGY, V50, P37, DOI 10.1212/WNL.50.1.37; Jensen J, 2006, AM J PHYSIOL-ENDOC M, V290, pE154, DOI 10.1152/ajpendo.00330.2005; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Lucia A, 2008, NAT CLIN PRACT NEURO, V4, P568, DOI 10.1038/ncpneuro0913; Martinuzzi A, 2003, ANN NEUROL, V53, P497, DOI 10.1002/ana.10499; MEYER F, 1970, J BIOL CHEM, V245, P6642; MOMMAERTS WFHM, 1959, P NATL ACAD SCI USA, V45, P791, DOI 10.1073/pnas.45.6.791; Mutalik VK, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-19; Nadaj-Pakleza AA, 2009, MUSCLE NERVE, V40, P350, DOI 10.1002/mus.21351; Nielsen JN, 2002, J PHYSIOL-LONDON, V541, P979, DOI 10.1113/jphysiol.2002.018044; Nielsen JN, 2002, AM J PHYSIOL-ENDOC M, V282, pE1267, DOI 10.1152/ajpendo.00526.2001; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nogales-Gadea G, 2008, HUM MUTAT, V29, P277, DOI 10.1002/humu.20649; Nogales-Gadea G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013164; Nogues M, 1996, Z NATURFORSCH C, V51, P591; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 2000, HUM GENET, V106, P482, DOI 10.1007/s004390000297; Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Rae DE, 2010, EUR J APPL PHYSIOL, V110, P1047, DOI 10.1007/s00421-010-1585-5; Rubio JC, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9474; SCHMID R, 1959, J CLIN INVEST, V38, P2044, DOI 10.1172/JCI103983; Vissing J, 2003, NEW ENGL J MED, V349, P2503, DOI 10.1056/NEJMoa031836; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P566, DOI 10.1210/jc.82.2.566; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Zange J, 2003, MUSCLE NERVE, V27, P728, DOI 10.1002/mus.10377	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31718	10.1371/journal.pone.0031718	http://dx.doi.org/10.1371/journal.pone.0031718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347505	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730200033
J	Failes, TW; Mitic, G; Abdel-Halim, H; Po'uha, ST; Liu, M; Hibbs, DE; Kavallaris, M				Failes, Timothy W.; Mitic, Gorjana; Abdel-Halim, Heba; Po'uha, Sela T.; Liu, Marjorie; Hibbs, David E.; Kavallaris, Maria			Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells	PLOS ONE			English	Article							III BETA-TUBULIN; GROWTH ARREST; LUNG-CANCER; DRUG-TARGET; IN-VIVO; OVEREXPRESSION; AMPLIFICATION; SENSITIVITY; ACTIVATION; APOPTOSIS	Aurora kinase inhibitors are new mitosis-targeting drugs currently in clinical trials for the treatment of haematological and solid malignancies. However, knowledge of the molecular factors that influence sensitivity and resistance remains limited. Herein, we developed and characterised an in vitro leukaemia model of resistance to the Aurora B inhibitor ZM447439. Human T-cell acute lymphoblastic leukaemia cells, CCRF-CEM, were selected for resistance in 4 mu M ZM447439. CEM/AKB4 cells showed no cross-resistance to tubulin-targeted and DNA-damaging agents, but were hypersensitive to an Aurora kinase A inhibitor. Sequencing revealed a mutation in the Aurora B kinase domain corresponding to a G160E amino acid substitution. Molecular modelling of drug binding in Aurora B containing this mutation suggested that resistance is mediated by the glutamate substitution preventing formation of an active drug-binding motif. Progression of resistance in the more highly selected CEM/AKB8 and CEM/AKB16 cells, derived sequentially from CEM/AKB4 in 8 and 16 mu M ZM447439 respectively, was mediated by additional defects. These defects were independent of Aurora B and multi-drug resistance pathways and are associated with reduced apoptosis mostly likely due to reduced inhibition of the catalytic activity of aurora kinase B in the presence of drug. Our findings are important in the context of the use of these new targeted agents in treatment regimes against leukaemia and suggest resistance to therapy may arise through multiple independent mechanisms.	[Failes, Timothy W.; Mitic, Gorjana; Po'uha, Sela T.; Liu, Marjorie; Kavallaris, Maria] Univ New S Wales, Childrens Canc Inst Australia, Randwick, NSW, Australia; [Abdel-Halim, Heba; Hibbs, David E.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Kavallaris, Maria] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney	Failes, TW (corresponding author), Univ New S Wales, Childrens Canc Inst Australia, Randwick, NSW, Australia.	m.kavallaris@ccia.unsw.edu.au	Kavallaris, Maria/J-5240-2014		Children's Cancer Institute Australia for Medical Research; Cancer Institute New South Wales [06-589]; Cancer Council New South Wales; University of New South Wales; Oncology Children's Foundation; National Health and Medical Research Council [568611]	Children's Cancer Institute Australia for Medical Research; Cancer Institute New South Wales; Cancer Council New South Wales(Cancer Council New South Wales); University of New South Wales; Oncology Children's Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales and Sydney Children's Hospital, and by grants from the Cancer Institute New South Wales (Dr. Failes and Dr. Kavallaris; #06-589), Cancer Council New South Wales (Dr. Kavallaris), University of New South Wales Early Career Researcher Grant (Dr. Failes) and Oncology Children's Foundation (Dr. Kavallaris and Dr. Po'uha). Dr. Failes was supported by a Vice Chancellors Postdoctoral Fellowship, University of New South Wales, and Dr. Kavallaris is supported by a National Health and Medical Research Council Senior Research Fellowship (#568611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AST, 1994, NUCLEIC ACIDS RES, V22, P5769; Andersen CB, 2008, ACS CHEM BIOL, V3, P180, DOI 10.1021/cb700200w; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; [Anonymous], 2008, MACROMODEL V 9 6; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bolanos-Garcia VM, 2005, INT J BIOCHEM CELL B, V37, P1572, DOI 10.1016/j.biocel.2005.02.021; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Don S, 2004, MOL CANCER THER, V3, P1137; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Gan PP, 2007, CANCER RES, V67, P9356, DOI 10.1158/0008-5472.CAN-07-0509; Gifford AJ, 1998, INT J CANCER, V78, P176, DOI 10.1002/(SICI)1097-0215(19981005)78:2<176::AID-IJC10>3.3.CO;2-F; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Ikezoe T, 2007, MOL CANCER THER, V6, P1851, DOI 10.1158/1535-7163.MCT-07-0067; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Li DH, 2003, CLIN CANCER RES, V9, P991; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Pihan GA, 2001, CANCER RES, V61, P2212; Po'uha ST, 2010, ONCOGENE, V29, P597, DOI 10.1038/onc.2009.367; *SCHROD LLC, 2008, MAESTR V 8 5; *SCHROD LLC, 2008, GLID V 5 0; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sharma SV, CELL, V141, P69; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Walsby E, 2008, HAEMATOLOGICA, V93, P662, DOI 10.3324/haematol.12148; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700	37	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30734	10.1371/journal.pone.0030734	http://dx.doi.org/10.1371/journal.pone.0030734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359551	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200020
J	Luchetti, A; Filareto, A; Sanchez, M; Ferraguti, G; Lucarelli, M; Novelli, G; Sangiuolo, F; Malgieri, A				Luchetti, Andrea; Filareto, Antonio; Sanchez, Massimo; Ferraguti, Giampiero; Lucarelli, Marco; Novelli, Giuseppe; Sangiuolo, Federica; Malgieri, Arianna			Small Fragment Homologous Replacement: Evaluation of Factors Influencing Modification Efficiency in an Eukaryotic Assay System	PLOS ONE			English	Article							TARGETED GENE REPAIR; CELL-CYCLE; S-PHASE; DNA; RECOMBINATION; ATM; IDENTIFICATION; REPLICATION; INHIBITION; THERAPY	Homologous Replacement is used to modify specific gene sequences of chromosomal DNA in a process referred to as "Small Fragment Homologous Replacement", where DNA fragments replace genomic target resulting in specific sequence changes. To optimize the efficiency of this process, we developed a reporter based assay system where the replacement frequency is quantified by cytofluorimetric analysis following restoration of a stably integrated mutated eGFP gene in the genome of SV-40 immortalized mouse embryonic fibroblasts (MEF-SV-40). To obtain the highest correction frequency with this system, several parameters were considered: fragment synthesis and concentration, cell cycle phase and methylation status of both fragment and recipient genome. In addition, different drugs were employed to test their ability to improve technique efficiency. SFHR-mediated genomic modification resulted to be stably transmitted for several cell generations and confirmed at transcript and genomic levels. Modification efficiency was estimated in a range of 0.01-0.5%, further increasing when PARP-1 repair pathway was inhibited. In this study, for the first time SFHR efficiency issue was systematically approached and in part addressed, therefore opening new potential therapeutic ex-vivo applications.	[Luchetti, Andrea; Filareto, Antonio; Sangiuolo, Federica; Malgieri, Arianna] Univ Roma Tor Vergata, Sch Med, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Rome, Italy; [Sanchez, Massimo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Ferraguti, Giampiero; Lucarelli, Marco] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Novelli, Giuseppe] Natl Agcy Evaluat Univ & Res ANVUR, Rome, Italy; [Novelli, Giuseppe] Osped San Pietro Fatebenefratelli, Rome, Italy	University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); Sapienza University Rome	Luchetti, A (corresponding author), Univ Roma Tor Vergata, Sch Med, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Rome, Italy.	sangiuolo@med.uniroma2.it	sangiuolo, federica/I-4392-2019; Lucarelli, Marco/AAC-1667-2019; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Sanchez, Massimo/AAD-1746-2021; Novelli, Giuseppe/A-5195-2013	sangiuolo, federica/0000-0002-6227-4248; Novelli, Giuseppe/0000-0002-7781-602X; Sanchez, Massimo/0000-0003-3696-7582; Novelli, Giuseppe/0000-0002-7781-602X; Lucarelli, Marco/0000-0002-5538-2494; FERRAGUTI, Giampiero/0000-0001-6129-4071	Fondazione Cenci Bolognetti; Fondazione Roma	Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Fondazione Roma(Fondazione RomaEuropean Commission)	This work was supported by Fondazione Cenci Bolognetti and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; Althaus FR, 2005, ONCOGENE, V24, P11, DOI 10.1038/sj.onc.1208382; Bedayat B, 2010, OLIGONUCLEOTIDES, V20, P7, DOI 10.1089/oli.2009.0205; Brachman EE, 2005, DNA REPAIR, V4, P445, DOI 10.1016/j.dnarep.2004.11.007; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Calabrese G, 1996, HUM GENET, V97, P414; CAPECCHI MR, 1994, SCI AM, V270, P52, DOI 10.1038/scientificamerican0394-52; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Colosimo A, 2001, MOL THER, V3, P178, DOI 10.1006/mthe.2000.0242; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; de Semir D, 2006, CURR GENE THER, V6, P481, DOI 10.2174/156652306777934847; Engstrom JU, 2008, CELL CYCLE, V7, P1402, DOI 10.4161/cc.7.10.5826; Fischer A, 2008, LANCET, V371, P2044, DOI 10.1016/S0140-6736(08)60874-0; Goncz KK, 2006, OLIGONUCLEOTIDES, V16, P213, DOI 10.1089/oli.2006.16.213; Goncz KK, 2002, GENE THER, V9, P691, DOI 10.1038/sj.gt.3301743; Gruenert DC, 2003, J CLIN INVEST, V112, P637, DOI 10.1172/JCI200319773; Gruenert DC, 1999, GENE THER, V6, P1347, DOI 10.1038/sj.gt.3301011; Gruenert DC, 1998, CURR RES MOL THER, V1, P607; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hu YL, 2005, MOL BIOTECHNOL, V29, P197, DOI 10.1385/MB:29:3:197; Joshi MU, 2008, BIOTECHNIQUES, V45, P247, DOI 10.2144/000112913; Kapsa R, 2001, HUM GENE THER, V12, P629, DOI 10.1089/104303401300057324; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kunzelmann K, 1996, GENE THER, V3, P859; Leclerc X, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-35; Maurisse R, 2006, ANN NY ACAD SCI, V1082, P120, DOI 10.1196/annals.1348.063; Noel G, 2006, MOL CANCER THER, V5, P564, DOI 10.1158/1535-7163.MCT-05-0418; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Sangiuolo F, 2005, HUM GENE THER, V16, P869, DOI 10.1089/hum.2005.16.869; Sangiuolo F, 2008, FRONT BIOSCI-LANDMRK, V13, P2989, DOI 10.2741/2904; Sangiuolo Federica, 2002, BMC Med Genet, V3, P8, DOI 10.1186/1471-2350-3-8; Sargent RG, 2011, OLIGONUCLEOTIDES, V21, P55, DOI 10.1089/oli.2010.0273; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Semionov A, 2003, BIOCHEM CELL BIOL, V81, P17, DOI 10.1139/O02-172; Semionov A, 1999, NUCLEIC ACIDS RES, V27, P4526, DOI 10.1093/nar/27.22.4526; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; Spitalieri P, 2009, CLONING STEM CELLS, V11, P535, DOI 10.1089/clo.2009.0046; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Todaro M, 2007, HUM MUTAT, V28, P816, DOI 10.1002/humu.20494; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Zayed H, 2006, HUM GENE THER, V17, P158, DOI 10.1089/hum.2006.17.158	48	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30851	10.1371/journal.pone.0030851	http://dx.doi.org/10.1371/journal.pone.0030851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359552	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200021
J	Suli, A; Watson, GM; Rubel, EW; Raible, DW				Suli, Arminda; Watson, Glen M.; Rubel, Edwin W.; Raible, David W.			Rheotaxis in Larval Zebrafish Is Mediated by Lateral Line Mechanosensory Hair Cells	PLOS ONE			English	Article							DANIO-RERIO; CIRCADIAN RHYTHMICITY; CHICK COCHLEA; SENSORY BASIS; CAVE FISH; REGENERATION; SYSTEM; FM1-43; RHEOTROPISM; NEUROMASTS	The lateral line sensory system, found in fish and amphibians, is used in prey detection, predator avoidance and schooling behavior. This system includes cell clusters, called superficial neuromasts, located on the surface of head and trunk of developing larvae. Mechanosensory hair cells in the center of each neuromast respond to disturbances in the water and convey information to the brain via the lateral line ganglia. The convenient location of mechanosensory hair cells on the body surface has made the lateral line a valuable system in which to study hair cell damage and regeneration. One way to measure hair cell survival and recovery is to assay behaviors that depend on their function. We built a system in which orientation against constant water flow, positive rheotaxis, can be quantitatively assessed. We found that zebrafish larvae perform positive rheotaxis and that, similar to adult fish, larvae use both visual and lateral line input to perform this behavior. Disruption or damage of hair cells in the absence of vision leads to a marked decrease in rheotaxis that recovers upon hair cell repair or regeneration.	[Suli, Arminda; Raible, David W.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Watson, Glen M.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Rubel, Edwin W.; Raible, David W.] Univ Washington, VM Bloedel Hearing Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Louisiana Lafayette; University of Washington; University of Washington Seattle	Suli, A (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	draible@u.washington.edu		Suli, Arminda/0000-0003-2690-8407; Raible, David/0000-0002-5342-5841	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01DC005987]; Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005987] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC005987 to DWR from the National Institute on Deafness and Other Communication Disorders (NIDCD) (www.nidcd.nih.gov), and a research grant from the Hearing Health Foundation (www.drf.org) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; Bagatto B, 2001, J EXP BIOL, V204, P4335; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Behra M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000455; Berg A, 2002, HEARING RES, V174, P296, DOI 10.1016/S0378-5955(02)00705-0; Blaxter J. H. S., 1989, MECHANOSENSORY LATER, P482; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Clark DT, 1981, VISUAL RESPONSES DEV; Coffin AB, 2010, ZEBRAFISH, V7, P3, DOI 10.1089/zeb.2009.0639; COTANCHE DA, 1987, HEARING RES, V30, P181, DOI 10.1016/0378-5955(87)90135-3; CRUZ RM, 1987, ARCH OTOLARYNGOL, V113, P1058; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; Feitl KE, 2010, J EXP BIOL, V213, P3131, DOI 10.1242/jeb.045518; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; HOEKSTRA D, 1985, ENVIRON BIOL FISH, V12, P111, DOI 10.1007/BF00002763; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; JONES JE, 1993, J NEUROSCI, V13, P1022; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Lyon EP, 1904, AM J PHYSIOL, V12, P149, DOI 10.1152/ajplegacy.1904.12.2.149; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; McHenry MJ, 2009, BIOL LETTERS, V5, P477, DOI 10.1098/rsbl.2009.0048; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Meyers JR, 2003, J NEUROSCI, V23, P4054; Montgomery JC, 1997, MAR FRESHW BEHAV PHY, V30, P209, DOI 10.1080/10236249709379026; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Nishikawa S, 1996, J HISTOCHEM CYTOCHEM, V44, P733, DOI 10.1177/44.7.8675994; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Westerfield M, 2007, ZEBRAFISH BOOK; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3	44	106	106	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29727	10.1371/journal.pone.0029727	http://dx.doi.org/10.1371/journal.pone.0029727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359538	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200007
J	Weiss, VL; Lee, TH; Song, H; Kouo, TS; Black, CM; Sgouros, G; Jaffee, EM; Armstrong, TD				Weiss, Vivian L.; Lee, Timothy H.; Song, Hong; Kouo, Theodore S.; Black, Chelsea M.; Sgouros, George; Jaffee, Elizabeth M.; Armstrong, Todd D.			Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; MAMMARY-TUMORS; EXPRESSION; MEMORY; IMMUNITY; CANCER; ANTIGEN; CYCLOPHOSPHAMIDE; MECHANISMS; RECEPTOR	Background: Cancer vaccines are designed to activate and enhance cancer-antigen-targeted T cells that are suppressed through multiple mechanisms of immune tolerance in cancer-bearing hosts. T regulatory cell (Treg) suppression of tumor-specific T cells is one barrier to effective immunization. A second mechanism is the deletion of high avidity tumor-specific T cells, which leaves a less effective low avidity tumor specific T cell repertoire available for activation by vaccines. Treg depleting agents including low dose cyclophosphamide (Cy) and antibodies that deplete CD25-expressing Tregs have been used with limited success to enhance the potency of tumor-specific vaccines. In addition, few studies have evaluated mechanisms that activate low avidity cancer antigen-specific T cells. Therefore, we developed high and low avidity HER-2/neu-specific TCR transgenic mouse colonies specific for the same HER-2/neu epitope to define the tolerance mechanisms that specifically affect high versus low avidity tumor-specific T cells. Methodology/Principal Findings: High and low avidity CD8(+) T cell receptor (TCR) transgenic mice specific for the breast cancer antigen HER-2/neu (neu) were developed to provide a purified source of naive, tumor-specific T cells that can be used to study tolerance mechanisms. Adoptive transfer studies into tolerant FVB/N-derived HER-2/neu transgenic (neu-N) mice demonstrated that high avidity, but not low avidity, neu-specific T cells are inhibited by Tregs as the dominant tolerizing mechanism. High avidity T cells persisted, produced IFN gamma, trafficked into tumors, and lysed tumors after adoptive transfer into mice treated with a neu-specific vaccine and low dose Cy to deplete Tregs. Analysis of Treg subsets revealed a Cy-sensitive CD4(+)Foxp3(+)CD25(low) tumor-seeking migratory phenotype, characteristic of effector/memory Tregs, and capable of high avidity T cell suppression. Conclusion/Significance: Depletion of CD25(low) Tregs allows activation of tumor-clearing high avidity T cells. Thus, the development of agents that specifically deplete Treg subsets should translate into more effective immunotherapies while avoiding autoimmunity.	[Weiss, Vivian L.; Lee, Timothy H.; Song, Hong; Kouo, Theodore S.; Black, Chelsea M.; Sgouros, George; Jaffee, Elizabeth M.; Armstrong, Todd D.] Johns Hopkins Univ, Sidney Kimmel Canc Ctr Johns Hopkins, Sch Med, Baltimore, MD 21218 USA; [Weiss, Vivian L.; Lee, Timothy H.; Song, Hong; Kouo, Theodore S.; Black, Chelsea M.; Sgouros, George; Jaffee, Elizabeth M.; Armstrong, Todd D.] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD USA; [Weiss, Vivian L.; Kouo, Theodore S.; Jaffee, Elizabeth M.] Johns Hopkins Univ, Grad Program Immunol, Sch Med, Baltimore, MD USA; [Song, Hong; Sgouros, George] Johns Hopkins Univ, Dept Radiol & Nucl Med, Sch Med, Baltimore, MD USA; [Black, Chelsea M.; Jaffee, Elizabeth M.] Johns Hopkins Univ, Grad Program Cellular & Mol Med, Sch Med, Baltimore, MD USA; [Jaffee, Elizabeth M.] Johns Hopkins Univ, Grad Program Pharmacol, Sch Med, Baltimore, MD USA; [Jaffee, Elizabeth M.] Skip Viragh Pancreat Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Weiss, VL (corresponding author), Johns Hopkins Univ, Sidney Kimmel Canc Ctr Johns Hopkins, Sch Med, Baltimore, MD 21218 USA.	tarmstro@jhmi.edu		Song, Hong/0000-0003-3997-6468; Jaffee, Elizabeth/0000-0003-3841-6549	National Institutes of Health [R01CA122081]; National Cancer Institute SPORE [P50CA088843]; American Association for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA122081, P50CA088843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health R01CA122081, and National Cancer Institute SPORE grant in breast cancer P50CA088843. This work was also supported by the American Association for Cancer Research (www.AACR.org) Centennial Pre-doctoral Research Fellowship awarded to VLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui-Jamali MA, 1997, BIOCHEM CELL BIOL, V75, P315, DOI 10.1139/bcb-75-4-315; Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; BRECHBIEL MW, 1991, J CHEM SOC CHEM COMM, P1169, DOI 10.1039/c39910001169; Butler NS, 2011, CELL MICROBIOL, V13, P925, DOI 10.1111/j.1462-5822.2011.01594.x; Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265; Colantonio L, 1999, BLOOD, V94, P2981, DOI 10.1182/blood.V94.9.2981.421k27_2981_2989; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; den Boer AT, 2004, J IMMUNOL, V172, P6074, DOI 10.4049/jimmunol.172.10.6074; Disis ML, 1997, ADV CANCER RES, V71, P343, DOI 10.1016/S0065-230X(08)60103-7; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Dutoit V, 2001, CANCER RES, V61, P5850; Emens LA, 2009, J CLIN ONCOL, V27, P5911, DOI 10.1200/JCO.2009.23.3494; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Ercolini AM, 2003, J IMMUNOL, V170, P4273, DOI 10.4049/jimmunol.170.8.4273; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Haworth O, 2008, RHEUMATOLOGY, V47, P1329, DOI 10.1093/rheumatology/ken263; Hege KM, 2006, INT REV IMMUNOL, V25, P321, DOI 10.1080/08830180600992498; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Janicki CN, 2008, CANCER RES, V68, P2993, DOI 10.1158/0008-5472.CAN-07-5008; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim PS, 2008, J CLIN INVEST, V118, P1700, DOI 10.1172/JCI34333; Kimpfler S, 2009, J IMMUNOL, V183, P6330, DOI 10.4049/jimmunol.0900609; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lin YC, 2009, J IMMUNOL, V182, P6095, DOI 10.4049/jimmunol.0803829; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lyman MA, 2005, J IMMUNOL, V174, P2563, DOI 10.4049/jimmunol.174.5.2563; Machiels JPH, 2001, CANCER RES, V61, P3689; Manning EA, 2007, CLIN CANCER RES, V13, P3951, DOI 10.1158/1078-0432.CCR-07-0374; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Mattei F, 2009, EUR J IMMUNOL, V39, P1807, DOI 10.1002/eji.200939233; McMahan RH, 2007, SEMIN CANCER BIOL, V17, P317, DOI 10.1016/j.semcancer.2007.06.006; Mittendorf EA, 2010, EXPERT REV VACCINES, V9, P89, DOI [10.1586/erv.09.144, 10.1586/ERV.09.144]; Murata S, 2006, J IMMUNOL, V176, P974, DOI 10.4049/jimmunol.176.2.974; Nakahara T, 2010, BLOOD, V115, P4384, DOI 10.1182/blood-2009-11-251231; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; NIKULA TK, 1995, NUCL MED BIOL, V22, P387, DOI 10.1016/0969-8051(94)00126-5; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Ohtani H, 2009, J PATHOL, V217, P21, DOI 10.1002/path.2448; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Radojcic V, 2010, CANCER IMMUNOL IMMUN, V59, P137, DOI 10.1007/s00262-009-0734-3; Reilly RT, 2000, CANCER RES, V60, P3569; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sasaki K, 2008, J IMMUNOL, V181, P104, DOI 10.4049/jimmunol.181.1.104; Schiavoni G, 2000, BLOOD, V95, P2024, DOI 10.1182/blood.V95.6.2024; SCHULZ M, 1991, EUR J IMMUNOL, V21, P1181, DOI 10.1002/eji.1830210513; Shafer-Weaver KA, 2009, CANCER RES, V69, P6256, DOI 10.1158/0008-5472.CAN-08-4516; Shi MQ, 2007, BIOCHEM BIOPH RES CO, V360, P702, DOI 10.1016/j.bbrc.2007.06.126; Singh NJ, 2006, NAT CLIN PRACT RHEUM, V2, P44, DOI 10.1038/ncprheum0049; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Yi HF, 2006, CELL MOL IMMUNOL, V3, P189; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102	73	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31962	10.1371/journal.pone.0031962	http://dx.doi.org/10.1371/journal.pone.0031962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359647	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200116
J	Yang, LJ; Shen, JQ; He, SS; Hu, GY; Shen, J; Wang, F; Xu, L; Dai, WQ; Xiong, J; Ni, JB; Guo, CY; Wan, R; Wang, XP				Yang, LiJuan; Shen, JiaQing; He, ShanShan; Hu, GuoYong; Shen, Jie; Wang, Feng; Xu, Ling; Dai, WeiQi; Xiong, Jie; Ni, JianBo; Guo, ChuanYong; Wan, Rong; Wang, XingPeng			L-Cysteine Administration Attenuates Pancreatic Fibrosis Induced by TNBS in Rats by Inhibiting the Activation of Pancreatic Stellate Cell	PLOS ONE			English	Article							LIVER FIBROSIS; TGF-BETA; GROWTH; EXPRESSION; MICE; OVEREXPRESSION; NRF2; PROLIFERATION; MEDIATORS; CYTOKINES	Background and Aims: Recent studies have shown that activated pancreatic stellate cells (PSCs) play a major role in pancreatic fibrogenesis. We aimed to study the effect of L-cysteine administration on fibrosis in chronic pancreatitis (CP) induced by trinitrobenzene sulfonic acid (TNBS) in rats and on the function of cultured PSCs. Methods: CP was induced by TNBS infusion into rat pancreatic ducts. L-cysteine was administrated for the duration of the experiment. Histological analysis and the contents of hydroxyproline were used to evaluate pancreatic damage and fibrosis. Immunohistochemical analysis of alpha-SMA in the pancreas was performed to detect the activation of PSCs in vivo. The collagen deposition related proteins and cytokines were determined by western blot analysis. DNA synthesis of cultured PSCs was evaluated by BrdU incorporation. We also evaluated the effect of L-cysteine on the cell cycle and cell activation by flow cytometry and immunocytochemistry. The expression of PDGFR beta, TGF beta RII, collagen 1 alpha 1 and alpha-SMA of PSCs treated with different concentrations of L-cysteine was determined by western blot. Parameters of oxidant stress were evaluated in vitro and in vivo. Nrf2, NQO1, HO-1, IL-1 beta expression were evaluated in pancreas tissues by qRT-PCR. Results: The inhibition of pancreatic fibrosis by L-cysteine was confirmed by histological observation and hydroxyproline assay. alpha-SMA, TIMP1, IL-1 beta and TGF-beta 1 production decreased compared with the untreated group along with an increase in MMP2 production. L-cysteine suppressed the proliferation and extracellular matrix production of PSCs through down-regulating of PDGFR beta and TGF beta RII. Concentrations of MDA+4-HNE were decreased by L-cysteine administration along with an increase in GSH levels both in tissues and cells. In addition, L-cysteine increased the mRNA expression of Nrf2, NQO1 and HO-1 and reduced the expression of IL-1 beta in L-cysteine treated group when compared with control group. Conclusion: L-cysteine treatment attenuated pancreatic fibrosis in chronic pancreatitis in rats.	[Yang, LiJuan; Shen, JiaQing; Wang, XingPeng] Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [He, ShanShan; Hu, GuoYong; Shen, Jie; Wang, Feng; Xu, Ling; Dai, WeiQi; Xiong, Jie; Ni, JianBo; Guo, ChuanYong; Wan, Rong; Wang, XingPeng] Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Yang, LJ (corresponding author), Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	wangxingpeng@hotmail.com	He, Shanshan/P-5691-2014	Guo, Chuanyong/0000-0002-6527-4673	National High Technology Research and Development Program of China (863 Program) [2009AA02Z116]; National Natural Science Foundation of China [30971359]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant from the National High Technology Research and Development Program of China (863 Program) (no. 2009AA02Z116) and by the National Natural Science Foundation of China (no. 30971359). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 2000, GASTROENTEROLOGY, V118, P780, DOI 10.1016/S0016-5085(00)70148-X; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bentrem DJ, 2003, CRIT CARE MED, V31, pS582, DOI 10.1097/01.CCM.0000081428.35729.73; Bhardwaj P, 2009, GASTROENTEROLOGY, V136, P149, DOI 10.1053/j.gastro.2008.09.028; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Buchholz M, 2005, J MOL MED, V83, P795, DOI 10.1007/s00109-005-0680-2; Casini A, 2000, J PATHOL, V192, P81; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Clain JE, 1999, SURG CLIN N AM, V79, P829, DOI 10.1016/S0039-6109(05)70046-3; Ebert M, 1998, DIGEST DIS SCI, V43, P567, DOI 10.1023/A:1018867209170; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Friess H, 2002, EUR J GASTROEN HEPAT, V14, P971, DOI 10.1097/00042737-200209000-00007; Girish BN, 2011, J PANCREAS, V12, P11; Gukovskaya AS, 1997, J CLIN INVEST, V100, P1853, DOI 10.1172/JCI119714; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Horie T, 2003, BIOCHEM BIOPH RES CO, V305, P94, DOI 10.1016/S0006-291X(03)00691-0; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Jaster R, 2002, GUT, V51, P579, DOI 10.1136/gut.51.4.579; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Khalid A, 2002, EUR J GASTROEN HEPAT, V14, P943, DOI 10.1097/00042737-200209000-00004; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kirk GR, 2006, J GASTROINTEST SURG, V10, P499, DOI 10.1016/j.gassur.2005.08.035; Kruse ML, 2000, REGUL PEPTIDES, V90, P47, DOI 10.1016/S0167-0115(00)00104-X; Laugier R, 2002, EUR J GASTROEN HEPAT, V14, P951, DOI 10.1097/00042737-200209000-00005; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lemke M, 2006, PANCREATOLOGY, V6, P486, DOI 10.1159/000094666; Levy MJ, 2003, GASTROINTEST ENDOSC, V57, P923, DOI 10.1016/S0016-5107(03)70036-4; Luttenberger T, 2000, LAB INVEST, V80, P47, DOI 10.1038/labinvest.3780007; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Marrache F, 2008, GASTROENTEROLOGY, V135, P1277, DOI 10.1053/j.gastro.2008.06.078; MARTENSSON J, 1986, AM J GASTROENTEROL, V81, P1179; Matsui H, 2004, J HEPATOL, V40, P917, DOI 10.1016/j.jhep.2004.02.011; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Morimitsu Y, 2002, J BIOL CHEM, V277, P3456, DOI 10.1074/jbc.M110244200; Neuschwander-Tetri BA, 2000, LAB INVEST, V80, P143, DOI 10.1038/labinvest.3780018; Ohashi S, 2006, ANTIOXID REDOX SIGN, V8, P1835, DOI 10.1089/ars.2006.8.1835; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Phillips PA, 2003, GUT, V52, P275, DOI 10.1136/gut.52.2.275; Puig-Divi V, 1999, DIGESTION, V60, P166, DOI 10.1159/000007643; PuigDivi V, 1996, PANCREAS, V13, P417, DOI 10.1097/00006676-199611000-00012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; REED DJ, 1977, BIOCHEM BIOPH RES CO, V77, P1257, DOI 10.1016/S0006-291X(77)80115-0; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Shek FWT, 2002, AM J PATHOL, V160, P1787, DOI 10.1016/S0002-9440(10)61125-X; Shimizu K, 2008, J GASTROEN HEPATOL, V23, pS119, DOI 10.1111/j.1440-1746.2007.05296.x; Talukdar R, 2008, J GASTROEN HEPATOL, V23, P34, DOI 10.1111/j.1440-1746.2007.05206.x; Tasci I, 2007, PANCREAS, V35, P366, DOI 10.1097/mpa.0b013e31806dbaaa; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; VanLaethem JL, 1996, GASTROENTEROLOGY, V110, P576, DOI 10.1053/gast.1996.v110.pm8566606; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Vogelmann R, 2001, AM J PHYSIOL-GASTR L, V280, pG164, DOI 10.1152/ajpgi.2001.280.1.G164; Yan MX, 2006, BIOCHEM BIOPH RES CO, V347, P192, DOI 10.1016/j.bbrc.2006.06.063; Yoo BM, 2005, PANCREATOLOGY, V5, P165, DOI 10.1159/000085268; Yoo BM, 2005, PANCREAS, V30, pE71, DOI 10.1097/01.mpa.0000157388.54016.0a; Zeki S, 2002, J GASTROEN HEPATOL, V17, P606, DOI 10.1046/j.1440-1746.2002.02733.x; Zhang W, 2010, PANCREAS, V39, P293, DOI 10.1097/MPA.0b013e3181bb90b5	60	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31807	10.1371/journal.pone.0031807	http://dx.doi.org/10.1371/journal.pone.0031807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359633	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200102
J	Zakas, C; Schult, N; McHugh, D; Jones, KL; Wares, JP				Zakas, Christina; Schult, Nancy; McHugh, Damhnait; Jones, Kenneth L.; Wares, John P.			Transcriptome Analysis and SNP Development Can Resolve Population Differentiation of Streblospio benedicti, a Developmentally Dimorphic Marine Annelid	PLOS ONE			English	Article							DEVELOPING SEA-URCHIN; NONSYNONYMOUS SUBSTITUTIONS; BENTHIC INVERTEBRATES; GENE-EXPRESSION; LARVAL ECOLOGY; EVOLUTION; PATTERNS; MODES; RECRUITMENT; DISPERSAL	Next-generation sequencing technology is now frequently being used to develop genomic tools for non-model organisms, which are generally important for advancing studies of evolutionary ecology. One such species, the marine annelid Streblospio benedicti, is an ideal system to study the evolutionary consequences of larval life history mode because the species displays a rare offspring dimorphism termed poecilogony, where females can produce either many small offspring or a few large ones. To further develop S. benedicti as a model system for studies of life history evolution, we apply 454 sequencing to characterize the transcriptome for embryos, larvae, and juveniles of this species, for which no genomic resources are currently available. Here we performed a de novo alignment of 336,715 reads generated by a quarter GS-FLX (Roche 454) run, which produced 7,222 contigs. We developed a novel approach for evaluating the site frequency spectrum across the transcriptome to identify potential signatures of selection. We also developed 84 novel single nucleotide polymorphism (SNP) markers for this species that are used to distinguish coastal populations of S. benedicti. We validated the SNPs by genotyping individuals of different developmental modes using the BeadXPress Golden Gate assay (Illumina). This allowed us to evaluate markers that may be associated with life-history mode.	[Zakas, Christina; Wares, John P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Schult, Nancy; McHugh, Damhnait] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Jones, Kenneth L.] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA	University System of Georgia; University of Georgia; Colgate University; University of Colorado System; University of Colorado Anschutz Medical Campus	Zakas, C (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	christinazakas@gmail.com	Jones, Kenneth/GXF-4945-2022	Wares, John/0000-0003-1827-0669; Zakas, Christina/0000-0002-9998-848X	Picker Interdisciplinary Science Institute at Colgate University; University of Georgia Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER; Directorate For Geosciences [1029526] Funding Source: National Science Foundation	Picker Interdisciplinary Science Institute at Colgate University; University of Georgia Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funds from the Picker Interdisciplinary Science Institute at Colgate University to DM, and the University of Georgia Research Foundation to JPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto FS, 2011, MOL ECOL, V20, P560, DOI 10.1111/j.1365-294X.2010.04963.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Collin R, 2001, MOL ECOL, V10, P2249, DOI 10.1046/j.1365-294X.2001.01372.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Doyle J. J., 1987, PHYTOCHEM B, P11; EMLET RB, 1995, DEV BIOL, V167, P405, DOI 10.1006/dbio.1995.1037; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foltz DW, 2010, EVOL DEV, V12, P222, DOI 10.1111/j.1525-142X.2010.00406.x; Foltz DW, 2004, GENETICA, V122, P115, DOI 10.1023/B:GENE.0000041002.97173.1e; Foltz DW, 2003, J MOL EVOL, V57, P607, DOI 10.1007/s00239-003-2495-5; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; FU YX, 1993, GENETICS, V133, P693; Giard MA, 1905, COMP REND 6 C INT ZO, P617; Gibson G, 2010, INVERTEBR BIOL, V129, P328, DOI 10.1111/j.1744-7410.2010.00213.x; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Hart M, 2000, SEMIN CELL DEV BIOL, V11, P411, DOI 10.1006/scdb.2000.0194; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; HENRY JJ, 1990, DEV BIOL, V141, P55, DOI 10.1016/0012-1606(90)90101-N; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; JABLONSKI D, 1986, B MAR SCI, V39, P565; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; Krug PJ, 2011, AM MALACOL BULL, V29, P169, DOI 10.4003/006.029.0210; LEVIN LA, 1991, EVOLUTION, V45, P380, DOI 10.1111/j.1558-5646.1991.tb04412.x; LEVIN LA, 1984, BIOL BULL, V166, P494, DOI 10.2307/1541157; LEVIN LA, 1990, ECOLOGY, V71, P2191, DOI 10.2307/1938632; Levin Lisa A., 1995, P1; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M, 2009, GENETICS, V182, P295, DOI 10.1534/genetics.109.100479; Mahon AR, 2009, MAR BIOL RES, V5, P172, DOI 10.1080/17451000802317683; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marsh AG, 2005, J EXP ZOOL PART B, V304B, P238, DOI 10.1002/jez.b.21037; McEdward LR, 2000, SEMIN CELL DEV BIOL, V11, P403, DOI 10.1006/scdb.2000.0193; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi Stephen R., 1995, P369; Pannell JR, 2003, EVOLUTION, V57, P949; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Pernet B, 2006, MAR BIOL, V149, P803, DOI 10.1007/s00227-006-0266-8; Pernet B, 2010, EVOL DEV, V12, P618, DOI 10.1111/j.1525-142X.2010.00446.x; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Raff RA, 2000, EVOL DEV, V2, P102, DOI 10.1046/j.1525-142x.2000.00035.x; Schulze SR, 2000, EVOLUTION, V54, P1247; Skibinski DOF, 2004, MOL BIOL EVOL, V21, P1753, DOI 10.1093/molbev/msh193; Sotka EE, 2005, ECOL LETT, V8, P448, DOI 10.1111/j.1461-0248.2004.00719.x; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; STRATHMANN RR, 1990, AM ZOOL, V30, P197; STRATHMANN RR, 1978, EVOLUTION, V32, P894, DOI 10.1111/j.1558-5646.1978.tb04642.x; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Todd CD, 1998, HYDROBIOLOGIA, V375-76, P1, DOI 10.1023/A:1017007527490; Todd CD, 1998, J EXP MAR BIOL ECOL, V228, P1, DOI 10.1016/S0022-0981(98)00005-7; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wakeley J, 2008, MOL BIOL EVOL, V25, P2615, DOI 10.1093/molbev/msn209; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; WRAY GA, 1989, DEV BIOL, V132, P458, DOI 10.1016/0012-1606(89)90242-X; Wray Gregory A., 1995, P413	63	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31613	10.1371/journal.pone.0031613	http://dx.doi.org/10.1371/journal.pone.0031613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359608	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200077
J	Dacheux, D; Landrein, N; Thonnus, M; Gilbert, G; Sahin, A; Wodrich, H; Robinson, DR; Bonhivers, M				Dacheux, Denis; Landrein, Nicolas; Thonnus, Magali; Gilbert, Guillaume; Sahin, Annelise; Wodrich, Harald; Robinson, Derrick R.; Bonhivers, Melanie			A MAP6-Related Protein Is Present in Protozoa and Is Involved in Flagellum Motility	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; COLD-STABLE MICROTUBULES; INDUCIBLE EXPRESSION SYSTEM; IPG STRIP PREFRACTIONATION; TRYPANOSOMA-BRUCEI-BRUCEI; LC-MS/MS IDENTIFICATION; PARAFLAGELLAR ROD; STOP PROTEINS; CELL-CYCLE; AFRICAN TRYPANOSOMES	In vertebrates the microtubule-associated proteins MAP6 and MAP6d1 stabilize cold-resistant microtubules. Cilia and flagella have cold-stable microtubules but MAP6 proteins have not been identified in these organelles. Here, we describe TbSAXO as the first MAP6-related protein to be identified in a protozoan, Trypanosoma brucei. Using a heterologous expression system, we show that TbSAXO is a microtubule stabilizing protein. Furthermore we identify the domains of the protein responsible for microtubule binding and stabilizing and show that they share homologies with the microtubule-stabilizing Mn domains of the MAP6 proteins. We demonstrate, in the flagellated parasite, that TbSAXO is an axonemal protein that plays a role in flagellum motility. Lastly we provide evidence that TbSAXO belongs to a group of MAP6-related proteins (SAXO proteins) present only in ciliated or flagellated organisms ranging from protozoa to mammals. We discuss the potential roles of the SAXO proteins in cilia and flagella function.	[Dacheux, Denis; Landrein, Nicolas; Thonnus, Magali; Gilbert, Guillaume; Sahin, Annelise; Wodrich, Harald; Robinson, Derrick R.; Bonhivers, Melanie] Univ Bordeaux, UMR 5234, Bordeaux, France; [Dacheux, Denis; Landrein, Nicolas; Thonnus, Magali; Gilbert, Guillaume; Sahin, Annelise; Wodrich, Harald; Robinson, Derrick R.; Bonhivers, Melanie] CNRS, UMR 5234, Bordeaux, France; [Dacheux, Denis] Inst Polytech Bordeaux, UMR 5234, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Dacheux, D (corresponding author), Univ Bordeaux, UMR 5234, Bordeaux, France.	melanie.bonhivers@u-bordeaux2.fr	Wodrich, Harald/P-1777-2019; Dacheux, Denis/AGF-5359-2022; Bonhivers, Melanie/Z-5889-2019	Wodrich, Harald/0000-0002-4764-1708; Bonhivers, Melanie/0000-0001-9179-8473; LANDREIN, Nicolas/0000-0001-8875-4242; DACHEUX, Denis/0000-0002-9956-4839	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) Blanc [ANR-09-BLAN-0074]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR) Blanc(French National Research Agency (ANR))	Work in the lab was supported by Centre National de la Recherche Scientifique (CNRS) Projets Exploratoires/Premier Soutien (PEPS) 2009 and Agence Nationale de la Recherche (ANR) Blanc (ANR-09-BLAN-0074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; BAAS PW, 1994, J CELL SCI, V107, P135; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; Baker MA, 2008, PROTEOMICS, V8, P2312, DOI 10.1002/pmic.200700876; BALABAN N, 1989, CELL MOTIL CYTOSKEL, V14, P393, DOI 10.1002/cm.970140309; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bastin P, 1999, J CELL SCI, V112, P3769; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; BEHNKE O, 1967, J CELL SCI, V2, P169; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bonhivers M, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-21; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Boucher N, 2007, J BIOL CHEM, V282, P13780, DOI 10.1074/jbc.M700780200; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Chen YL, 2003, MOL BIOCHEM PARASIT, V126, P275, DOI 10.1016/S0166-6851(02)00276-1; Dehmelt L, 2003, J NEUROSCI, V23, P9479; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Detmer E, 1997, EUR J CELL BIOL, V72, P378; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DYE RB, 1993, J BIOL CHEM, V268, P6847; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Felgner H, 1997, J CELL BIOL, V138, P1067, DOI 10.1083/jcb.138.5.1067; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Guerrero K, 2010, MOL CELL BIOCHEM, V337, P239, DOI 10.1007/s11010-009-0304-1; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hall N, 2003, NUCLEIC ACIDS RES, V31, P4864, DOI 10.1093/nar/gkg674; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HEMPHILL A, 1992, J CELL BIOL, V117, P95, DOI 10.1083/jcb.117.1.95; HESKETH JE, 1984, NEUROSCI LETT, V51, P155, DOI 10.1016/0304-3940(84)90543-3; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; Hinchcliffe EH, 1998, J CELL SCI, V111, P585; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; IMBODEN M, 1995, PARASITOLOGY, V110, P249, DOI 10.1017/S0031182000080835; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; KOSIK KS, 1994, CELL MOTIL CYTOSKEL, V28, P195, DOI 10.1002/cm.970280302; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Linck RW, 2003, PROTIST, V154, P299, DOI 10.1078/143446103322454086; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MACRAE TH, 1990, BIOCHEM J, V265, P87, DOI 10.1042/bj2650087; Maga JA, 1999, J CELL SCI, V112, P2753; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Norrander JM, 2000, MOL BIOL CELL, V11, P201, DOI 10.1091/mbc.11.1.201; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; PIROLLET F, 1989, BIOCHEMISTRY-US, V28, P835, DOI 10.1021/bi00428a064; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2011, EUKARYOT CELL, V10, P884, DOI 10.1128/EC.00298-10; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; SASSE R, 1988, J CELL SCI, V90, P577; Schneider A, 1997, J CELL SCI, V110, P431; SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431; SCHNEIDER A, 1988, SCIENCE, V241, P459, DOI 10.1126/science.3393912; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; SEEBECK T, 1983, MOL BIOCHEM PARASIT, V9, P197, DOI 10.1016/0166-6851(83)90097-X; Setter PW, 2006, EXP CELL RES, V312, P2880, DOI 10.1016/j.yexcr.2006.05.014; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Smith EF, 1997, CELL MOTIL CYTOSKEL, V38, P1; SOUTOPADRON T, 1993, MEM I OSWALDO CRUZ, V88, P517, DOI 10.1590/S0074-02761993000400004; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; TORRES A, 1989, J PROTOZOOL, V36, P113, DOI 10.1111/j.1550-7408.1989.tb01056.x; Vedrenne C, 2002, MOL BIOL CELL, V13, P1058, DOI 10.1091/mbc.01-06-0298; WALLIN M, 1995, INT REV CYTOL, V157, P1, DOI 10.1016/S0074-7696(08)62155-5; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Yi P, 2010, J CELL SCI, V123, P1060, DOI 10.1242/jcs.059717; Yoshida T, 1996, CELL MOTIL CYTOSKEL, V33, P252, DOI 10.1002/(SICI)1097-0169(1996)33:4<252::AID-CM2>3.0.CO;2-B	108	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31344	10.1371/journal.pone.0031344	http://dx.doi.org/10.1371/journal.pone.0031344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355359	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300059
J	Lammens, T; Swerts, K; Derycke, L; De Craemer, A; De Brouwer, S; De Preter, K; Van Roy, N; Vandesompele, J; Speleman, F; Philippe, J; Benoit, Y; Beiske, K; Bracke, M; Laureys, G				Lammens, Tim; Swerts, Katrien; Derycke, Lara; De Craemer, Annemie; De Brouwer, Sara; De Preter, Katleen; Van Roy, Nadine; Vandesompele, Jo; Speleman, Frank; Philippe, Jan; Benoit, Yves; Beiske, Klaus; Bracke, Marc; Laureys, Genevieve			N-Cadherin in Neuroblastoma Disease: Expression and Clinical Significance	PLOS ONE			English	Article							CELL-ADHESION; TUMOR PROGRESSION; METASTASIS; INVASION; SUPPRESSES; PEPTIDE; ADH-1; GENE; DIFFERENTIATION; OSTEOSARCOMA	One of the first and most important steps in the metastatic cascade is the loss of cell-cell and cell-matrix interactions. N-cadherin, a crucial mediator of homotypic and heterotypic cell-cell interactions, might play a central role in the metastasis of neuroblastoma (NB), a solid tumor of neuroectodermal origin. Using Reverse Transcription Quantitative PCR (RT-qPCR), Western blot, immunocytochemistry and Tissue MicroArrays (TMA) we demonstrate the expression of N-cadherin in neuroblastoma tumors and cell lines. All neuroblastic tumors (n = 356) and cell lines (n = 10) expressed various levels of the adhesion protein. The N-cadherin mRNA expression was significantly lower in tumor samples from patients suffering metastatic disease. Treatment of NB cell lines with the N-cadherin blocking peptide ADH-1 (Exherin, Adherex Technologies Inc.), strongly inhibited tumor cell proliferation in vitro by inducing apoptosis. Our results suggest that N-cadherin signaling may play a role in neuroblastoma disease, marking involvement of metastasis and determining neuroblastoma cell viability.	[Lammens, Tim; Swerts, Katrien; De Craemer, Annemie; Benoit, Yves; Laureys, Genevieve] Ghent Univ Hosp, Dept Pediat Hematol Oncol, Ghent, Belgium; [Derycke, Lara; Bracke, Marc] Ghent Univ Hosp, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [De Brouwer, Sara; De Preter, Katleen; Van Roy, Nadine; Vandesompele, Jo; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Philippe, Jan] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium; [Beiske, Klaus] Univ Oslo, Rikshosp, Dept Pathol, N-0027 Oslo, Norway	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Oslo; National Hospital Norway	Lammens, T (corresponding author), Ghent Univ Hosp, Dept Pediat Hematol Oncol, Ghent, Belgium.	tim.lammens@ugent.be	philippé, jan/AAG-8964-2019; De Preter, Katleen/I-7135-2013; Philippé, Jan/A-1027-2008; Vandesompele, Jo/W-3411-2018; laureys, genevieve/AAG-2390-2021; speleman, frank/AAR-5184-2020	philippé, jan/0000-0003-4857-5746; De Preter, Katleen/0000-0002-7726-5096; Philippé, Jan/0000-0003-4857-5746; Vandesompele, Jo/0000-0001-6274-0184; speleman, frank/0000-0002-6628-8559; Lammens, Tim/0000-0001-8733-4027	Kinderkankerfonds; Foundation against Cancer; "Emmanuel Van Der Schueren" from the Flemish League against Cancer; Belgian program of Interuniversity Poles of Attraction	Kinderkankerfonds; Foundation against Cancer; "Emmanuel Van Der Schueren" from the Flemish League against Cancer; Belgian program of Interuniversity Poles of Attraction	This work was supported by the Kinderkankerfonds, the Foundation against Cancer, an "Emmanuel Van Der Schueren" grant from the Flemish League against Cancer and the Belgian program of Interuniversity Poles of Attraction, initiated by the Belgian State, Prime Minister's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amitay R, 2001, AM J PATHOL, V159, P43, DOI 10.1016/S0002-9440(10)61671-9; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Augustine CK, 2008, CANCER RES, V68, P3777, DOI 10.1158/0008-5472.CAN-07-5949; Beasley GM, 2009, CANCER-AM CANCER SOC, V115, P4766, DOI 10.1002/cncr.24509; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; BRODEUR GM, 1988, J CLIN ONCOL, V6, P1874, DOI 10.1200/JCO.1988.6.12.1874; Brodeur GM, 1993, PRINCIPLES PRACTICE, P739; Burden-gulley SM, 1999, PEPTIDES, V31, P842; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Erez N, 2004, EXP CELL RES, V294, P366, DOI 10.1016/j.yexcr.2003.11.033; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Kashima T, 2003, INT J CANCER, V104, P147, DOI 10.1002/ijc.10931; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Li G, 2001, CANCER RES, V61, P3819; Makrigiannakis A, 1999, AM J PATHOL, V154, P1391, DOI 10.1016/S0002-9440(10)65393-X; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nevo I, 2010, INT J CANCER, V126, P1570, DOI 10.1002/ijc.24889; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Peluso JJ, 1997, BIOCHEM PHARMACOL, V54, P847, DOI 10.1016/S0006-2952(97)00118-4; Peluso JJ, 1996, ENDOCRINOLOGY, V137, P1196, DOI 10.1210/en.137.4.1196; Perotti A, 2009, ANN ONCOL, V20, P741, DOI 10.1093/annonc/mdn695; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PULLMAN WE, 1992, NATURE, V356, P529, DOI 10.1038/356529a0; Qiao JB, 2008, P NATL ACAD SCI USA, V105, P12891, DOI 10.1073/pnas.0711861105; Shintani Y, 2008, INT J CANCER, V122, P71, DOI 10.1002/ijc.23027; Soler AP, 1997, HUM PATHOL, V28, P734, DOI 10.1016/S0046-8177(97)90184-2; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Swerts K, 2005, J HISTOCHEM CYTOCHEM, V53, P1433, DOI 10.1369/jhc.5C6661.2005; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Zeng Y, 2007, CANCER RES, V67, P2331, DOI 10.1158/0008-5472.CAN-06-3041	41	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31206	10.1371/journal.pone.0031206	http://dx.doi.org/10.1371/journal.pone.0031206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355346	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300046
J	Otten, C; van der Ven, PF; Lewrenz, I; Paul, S; Steinhagen, A; Busch-Nentwich, E; Eichhorst, J; Wiesner, B; Stemple, D; Strahle, U; Furst, DO; Abdelilah-Seyfried, S				Otten, Cecile; van der Ven, Peter F.; Lewrenz, Ilka; Paul, Sandeep; Steinhagen, Almut; Busch-Nentwich, Elisabeth; Eichhorst, Jenny; Wiesner, Burkhard; Stemple, Derek; Straehle, Uwe; Fuerst, Dieter O.; Abdelilah-Seyfried, Salim			Xirp Proteins Mark Injured Skeletal Muscle in Zebrafish	PLOS ONE			English	Article							INTERCALATED DISK PROTEIN; HEART REGENERATION; CARDIAC MORPHOGENESIS; CONDUCTION DEFECTS; REGULATORY FACTORS; XIN-REPEATS; MXIN-ALPHA; GENE; LOCALIZATION; EXPRESSION	Myocellular regeneration in vertebrates involves the proliferation of activated progenitor or dedifferentiated myogenic cells that have the potential to replenish lost tissue. In comparison little is known about cellular repair mechanisms within myocellular tissue in response to small injuries caused by biomechanical or cellular stress. Using a microarray analysis for genes upregulated upon myocellular injury, we identified zebrafish Xin-actin-binding repeat-containing protein1 (Xirp1) as a marker for wounded skeletal muscle cells. By combining laser-induced micro-injury with proliferation analyses, we found that Xirp1 and Xirp2a localize to nascent myofibrils within wounded skeletal muscle cells and that the repair of injuries does not involve cell proliferation or Pax7(+) cells. Through the use of Xirp1 and Xirp2a as markers, myocellular injury can now be detected, even though functional studies indicate that these proteins are not essential in this process. Previous work in chicken has implicated Xirps in cardiac looping morphogenesis. However, we found that zebrafish cardiac morphogenesis is normal in the absence of Xirp expression, and animals deficient for cardiac Xirp expression are adult viable. Although the functional involvement of Xirps in developmental and repair processes currently remains enigmatic, our findings demonstrate that skeletal muscle harbours a rapid, cell-proliferation-independent response to injury which has now become accessible to detailed molecular and cellular characterizations.	[Otten, Cecile; Abdelilah-Seyfried, Salim] Max Delbruck Ctr MDC Mol Med, Berlin, Germany; [van der Ven, Peter F.; Lewrenz, Ilka; Steinhagen, Almut; Fuerst, Dieter O.] Univ Bonn, Dept Mol Cell Biol, Inst Cell Biol, Bonn, Germany; [Paul, Sandeep; Straehle, Uwe] Inst Toxicol & Genet, Karlsruhe, Germany; [Paul, Sandeep] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Busch-Nentwich, Elisabeth; Stemple, Derek] Wellcome Trust Sanger Inst, Cambridge, England; [Eichhorst, Jenny; Wiesner, Burkhard] Leibniz Inst Mol Pharmacol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bonn; University of Southern California; Wellcome Trust Sanger Institute; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Otten, C (corresponding author), Max Delbruck Ctr MDC Mol Med, Berlin, Germany.	salim@mdc-berlin.de	Otten, Cecile/HGC-9281-2022; Paul, Sandeep/F-6824-2010; Straehle, Uwe/K-7054-2013; Fürst, Dieter O./H-8561-2013	Fürst, Dieter O./0000-0001-8805-6444; Paul, Sandeep/0000-0002-2721-1874; van der Ven, Peter/0000-0002-9750-8913; Otten, Cecile/0000-0002-8230-7350				Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Beatham J, 2006, NEUROMUSCULAR DISORD, V16, P437, DOI 10.1016/j.nmd.2006.05.013; Behra M, 2004, TOXICOL SCI, V77, P325, DOI 10.1093/toxsci/kfh020; Bit-Avragim N, 2008, DEV DYNAM, V237, P83, DOI 10.1002/dvdy.21389; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Choi SJ, 2007, J BIOL CHEM, V282, P36024, DOI 10.1074/jbc.M707639200; Duka A, 2006, AM J HYPERTENS, V19, P275, DOI 10.1016/j.amjhyper.2005.08.017; Grosskurth SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002857; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Hawke TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1636, DOI 10.1152/ajpcell.00124.2007; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lowe T, 2007, HUM MOL GENET, V16, P1351, DOI 10.1093/hmg/ddm085; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Otten J, 2010, CARDIOVASC RES, V85, P739, DOI 10.1093/cvr/cvp345; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rohr S, 2006, DEVELOPMENT, V133, P107, DOI 10.1242/dev.02182; Sinn HW, 2002, DEV DYNAM, V225, P1, DOI 10.1002/dvdy.10131; Steffen LS, 2007, DEV BIOL, V309, P180, DOI 10.1016/j.ydbio.2007.06.015; Stellabotte F, 2007, DEVELOPMENT, V134, P1253, DOI 10.1242/dev.000067; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; THISSE C, 1993, DEVELOPMENT, V119, P1203; van der Ven PFM, 2006, EXP CELL RES, V312, P2154, DOI 10.1016/j.yexcr.2006.03.015; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; Walker Michael G., 2001, Mini-Reviews in Medicinal Chemistry, V1, P197, DOI 10.2174/1389557013407034; Wang DZ, 1999, DEVELOPMENT, V126, P1281; Wang QC, 2010, CIRC RES, V106, P1468, DOI 10.1161/CIRCRESAHA.109.212787; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227	35	27	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31041	10.1371/journal.pone.0031041	http://dx.doi.org/10.1371/journal.pone.0031041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355335	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300035
J	Sehlin, D; Englund, H; Simu, B; Karlsson, M; Ingelsson, M; Nikolajeff, F; Lannfelt, L; Pettersson, FE				Sehlin, Dag; Englund, Hillevi; Simu, Barbro; Karlsson, Mikael; Ingelsson, Martin; Nikolajeff, Fredrik; Lannfelt, Lars; Pettersson, Frida Ekholm			Large Aggregates Are the Major Soluble Ab Species in AD Brain Fractionated with Density Gradient Ultracentrifugation	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ATOMIC-FORCE MICROSCOPY; POTENTIATION IN-VIVO; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; NEURITIC DEGENERATION; SECRETED OLIGOMERS; PLAQUE-FORMATION; MOLECULAR-BASIS; PEPTIDE	Soluble amyloid-beta (A beta) aggregates of various sizes, ranging from dimers to large protofibrils, have been associated with neurotoxicity and synaptic dysfunction in Alzheimer's Disease (AD). To investigate the properties of biologically relevant A beta species, brain extracts from amyloid beta protein precursor (A beta PP) transgenic mice and AD patients as well as synthetic A beta preparations were separated by size under native conditions with density gradient ultracentrifugation. The fractionated samples were then analyzed with atomic force microscopy (AFM), ELISA, and MTT cell viability assay. Based on AFM appearance and immunoreactivity to our protofibril selective antibody mAb158, synthetic A beta 42 was divided in four fractions, with large aggregates in fraction 1 and the smallest species in fraction 4. Synthetic A beta aggregates from fractions 2 and 3 proved to be most toxic in an MTT assay. In A beta PP transgenic mouse brain, the most abundant soluble A beta species were found in fraction 2 and consisted mainly of A beta 40. Also in AD brains, A beta was mainly found in fraction 2 but primarily as A beta 42. All biologically derived A beta from fraction 2 was immunologically discriminated from smaller species with mAb158. Thus, the predominant species of biologically derived soluble A beta, natively separated by density gradient ultracentrifugation, were found to match the size of the neurotoxic, 80-500 kDa synthetic A beta protofibrils and were equally detected with mAb158.	[Sehlin, Dag; Englund, Hillevi; Simu, Barbro; Ingelsson, Martin; Lannfelt, Lars; Pettersson, Frida Ekholm] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Karlsson, Mikael; Nikolajeff, Fredrik] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden	Uppsala University; Uppsala University	Sehlin, D (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	Dag.Sehlin@pubcare.uu.se	Karlsson, Mikael/D-6703-2019	Karlsson, Mikael/0000-0002-2011-0851; Sehlin, Dag/0000-0002-9430-3859	Hjarnfonden; Bertil Hallstens forskningsstiftelse; Swedish Research Council [2004-2167, 2006-6326, 2006-3464, 2003-5546]; Alzheimerfonden; Stiftelsen Gamla Tjanarinnor	Hjarnfonden; Bertil Hallstens forskningsstiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission); Alzheimerfonden; Stiftelsen Gamla Tjanarinnor	This work was funded by Hjarnfonden (http://www.hjarnfonden.se/); Bertil Hallstens forskningsstiftelse (no website available); The Swedish Research Council, grant numbers 2004-2167 to DS, 2006-6326 and 2006-3464 to MI, and 2003-5546 to LL (http://www.vr.se/); Alzheimerfonden (http://www.alzheimerfonden.se/); and Stiftelsen Gamla Tjanarinnor (http://www.seb.se/pow/wcp/index.asp?ss=/pow/wcp/templates/sebarticle.cfmc.asp%3FDUID%3DDUID_1A751099EE6353A6C125779-F00285A2D% 2520%26xsl%3Dsebarticle.xsl%26sitekey%3Dseb.se%26lang%3Dse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2009, NEUROBIOL DIS, V36, P425, DOI 10.1016/j.nbd.2009.08.007; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ostergren A, 2005, PIGM CELL RES, V18, P306, DOI 10.1111/j.1600-0749.2005.00239.x; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Schneider SW, 1998, KIDNEY BLOOD PRESS R, V21, P256, DOI 10.1159/000025869; Sehlin D, 2010, NEURODEGENER DIS; Sehlin D, 2010, J ALZHEIMERS DIS, V21, P1295, DOI 10.3233/JAD-2010-100609; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Upadhaya AR, 2011, J CELL MOL IN PRESS; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007	52	58	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32014	10.1371/journal.pone.0032014	http://dx.doi.org/10.1371/journal.pone.0032014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355408	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300108
J	Tapanila, L; Roberts, EM				Tapanila, Leif; Roberts, Eric M.			The Earliest Evidence of Holometabolan Insect Pupation in Conifer Wood	PLOS ONE			English	Article							FOREST NATIONAL-PARK; CHINLE FORMATION; EVOLUTION; ARIZONA; ICHNOFOSSILS; TERRESTRIAL; UTAH; USA	Background: The pre-Jurassic record of terrestrial wood borings is poorly resolved, despite body fossil evidence of insect diversification among xylophilic clades starting in the late Paleozoic. Detailed analysis of borings in petrified wood provides direct evidence of wood utilization by invertebrate animals, which typically comprises feeding behaviors. Methodology/Principal Findings: We describe a U-shaped boring in petrified wood from the Late Triassic Chinle Formation of southern Utah that demonstrates a strong linkage between insect ontogeny and conifer wood resources. Xylokrypta durossi new ichnogenus and ichnospecies is a large excavation in wood that is backfilled with partially digested xylem, creating a secluded chamber. The tracemaker exited the chamber by way of a small vertical shaft. This sequence of behaviors is most consistent with the entrance of a larva followed by pupal quiescence and adult emergence - hallmarks of holometabolous insect ontogeny. Among the known body fossil record of Triassic insects, cupedid beetles (Coleoptera: Archostemata) are deemed the most plausible tracemakers of Xylokrypta, based on their body size and modern xylobiotic lifestyle. Conclusions/Significance: This oldest record of pupation in fossil wood provides an alternative interpretation to borings once regarded as evidence for Triassic bees. Instead Xylokrypta suggests that early archostematan beetles were leaders in exploiting wood substrates well before modern clades of xylophages arose in the late Mesozoic.	[Tapanila, Leif] Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA; [Tapanila, Leif] Idaho Museum Nat Hist, Div Earth Sci, Pocatello, ID USA; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia	Idaho; Idaho State University; James Cook University	Tapanila, L (corresponding author), Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA.	tapaleif@isu.edu	Roberts, Eric/J-1836-2014	Roberts, Eric/0000-0002-8583-7437	Idaho State University Research Committee [AS11-3U]	Idaho State University Research Committee	This study received partial funding support from Idaho State University Research Committee grant #AS11-3U. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexeev AV, 1999, AMBA PROJECTS, P5; Ash S.R., 2003, UTAH GEOLOGICAL SURV, V35, P3; Beutel RG, 2002, SYST ENTOMOL, V27, P169, DOI 10.1046/j.1365-3113.2002.00172.x; Blakey R. C., 2009, REGIONAL PALEOGEOGRA; Bromley RG, 2007, SEDIMENT GEOL, V200, P141, DOI 10.1016/j.sedgeo.2006.11.007; BROWN ROLAND W., 1934, JOUR WASHINGTON ACAD SCI, V24, P532; Crowson R. A, 1975, ATT 10 C NAZ IT ENT, P47; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Genise J.F., 1995, ICHNOS, V3, P287, DOI DOI 10.1080/10420949509386399; Genise JF, 2004, GEOL SOC SPEC PUBL, V228, P419, DOI 10.1144/GSL.SP.2004.228.01.19; Genise JF, 2007, CRETACEOUS RES, V28, P545, DOI 10.1016/j.cretres.2006.08.007; Genise Jorge F., 1996, Ichnos, V4, P199; Genise Jorge F., 2000, Ichnos, V7, P267; Genise Jorge F., 2000, Ichnos, V7, P115; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; Haack R. A., 1986, NUTR ECOLOGY INSECTS, P449; HAMILTON WD, 1978, S R ENTOMOL SOC LOND, V9, P154; Hasiotis ST, 2003, PALAEOGEOGR PALAEOCL, V192, P259, DOI 10.1016/S0031-0182(02)00689-2; Hasiotis ST, 1997, PLATEAU J MUSEUM NO, V1, P20; Hasiotis ST, 1998, NATL PARK SERVICE PA, P116; Labandeira CC, 1997, PALAIOS, V12, P319, DOI 10.2307/3515334; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Lawrence IF, 1982, ANNU REV ECOL SYST, V12, P261; Leymerie M.A., 1842, B SOC GEOL FR, V5, P1; Linck O., 1949, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart B, V4-6, P180; Linsley E. Gorton, 1942, PROC NEW ENGLAND ZOOL CLUB, V21, P17; Lucas SG, 2010, PALAEOGEOGR PALAEOCL, V286, P194, DOI 10.1016/j.palaeo.2010.01.010; Martz JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009329; Miller DG, 2009, ENTOMOL EXP APPL, V132, P126, DOI 10.1111/j.1570-7458.2009.00880.x; Moore I., 1976, MEMOIRS NATL MUSEUM, P521; PONOMARENKO AG, 1966, PALEONTOL ZH, P47; Ponomarenko Alexandr G., 2003, Acta Zoologica Cracoviensia, V46, P319; Prochnow SJ, 2006, PALAEOGEOGR PALAEOCL, V232, P53, DOI 10.1016/j.palaeo.2005.08.011; Ramezani J, 2011, GEOL SOC AM BULL, V123, P2142, DOI 10.1130/B30433.1; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Roselli F.L., 1939, B SOC AMIGOS CIENC N, V1, P72; Roselli F.L., 1987, PUBLICACIONES MUSEO, V1, P1; SS Beus, 1987, CENTENNIAL FIELD GUI, V2, P405; STATZ GEORG, 1952, PALAEONTOGRAPHICA, V102A, P1; Thenius E., 1979, ANN NATURHISTORISCHE, V82, P177; Tillyard R.J., 1916, PUBLICATIONS GEOLOGI, V253, P1; WALKER M. V., 1938, PROC U S NATION MUS, V85, P137; Zeuner F. E., 1961, Verhandlungen XI Internationaler Kongress fuer Entomologie Wien 1960, V1, P304	44	25	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31668	10.1371/journal.pone.0031668	http://dx.doi.org/10.1371/journal.pone.0031668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355387	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302741300087
J	Weiss, WR; Jiang, CG				Weiss, Walter R.; Jiang, Chengyong George			Protective CD8+T lymphocytes in Primates Immunized with Malaria Sporozoites	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; T-CELLS; CIRCUMSPOROZOITE PROTEIN; STERILE PROTECTION; RHESUS-MONKEYS; LIVER STAGES; RESPONSES; YOELII; INDUCTION; INJECTION	Live attenuated malaria vaccines are more potent than the recombinant protein, bacterial or viral platform vaccines that have been tested, and an attenuated sporozoite vaccine against falciparum malaria is being developed for humans. In mice, attenuated malaria sporozoite vaccines induce CD8(+) T cells that kill parasites developing in the liver. We were curious to know if CD8(+) T cells were also important in protecting primates against malaria. We immunized 9 rhesus monkeys with radiation attenuated Plasmodium knowlesi sporozoites, and found that 5 did not develop blood stage infections after challenge with live sporozoites. We then injected 4 of these protected monkeys with cM-T807, a monoclonal antibody to the CD8 molecule which depletes T cells. The fifth monkey received equivalent doses of normal IgG. In 3 of the 4 monkeys receiving cM-T807 circulating CD8(+) T cells were profoundly depleted. When re-challenged with live sporozoites all 3 of these depleted animals developed blood stage malaria. The fourth monkey receiving cM-T807 retained many circulating CD8(+) T cells. This monkey, and the vaccinated monkey receiving normal IgG, did not develop blood stage malaria at re-challenge with live sporozoites. Animals were treated with antimalarial drugs and rested for 4 months. During this interval CD8(+) T cells re-appeared in the circulation of the depleted monkeys. When all vaccinated animals received a third challenge with live sporozoites, all 5 monkeys were once again protected and did not develop blood stage malaria infections. These data indicate that CD8(+) T cells are important effector cells protecting monkeys against malaria sporozoite infection. We believe that malaria vaccines which induce effector CD8+ T cells in humans will have the best chance of protecting against malaria.	[Weiss, Walter R.; Jiang, Chengyong George] USN, Med Res Ctr, Dept Infect Dis, Silver Spring, MD USA	United States Department of Defense; United States Navy	Weiss, WR (corresponding author), USN, Med Res Ctr, Dept Infect Dis, Silver Spring, MD USA.	walter.weiss@verizon.net			U.S. Army Medical Research Materiel Command [6000.RAD1.F.A0309]	U.S. Army Medical Research Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by funds allocated to the Naval Medical Research Center by the U.S. Army Medical Research Materiel Command (work unit 6000.RAD1.F.A0309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL A, 1990, J EXP MED, V172, P1083, DOI 10.1084/jem.172.4.1083; Belmonte M, 2003, J PARASITOL, V89, P602, DOI 10.1645/0022-3395(2003)089[0602:TIOPYI]2.0.CO;2; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Epstein JE, 2011, SCIENCE; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; Jiang G, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-135; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Vanderberg J, 2007, AM J PATHOL, V171, P1405, DOI 10.2353/ajpath.2007.070661; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; WEISS WR, 1989, J IMMUNOL, V143, P4263; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	27	84	86	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31247	10.1371/journal.pone.0031247	http://dx.doi.org/10.1371/journal.pone.0031247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355349	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300049
J	White, HN; Meng, QH				White, Henry N.; Meng, Qing-Hai			Diversification of Specificity after Maturation of the Antibody Response to the HIV gp41 Epitope ELDKWA	PLOS ONE			English	Article							PRIMARY IMMUNE-RESPONSE; IMMUNODEFICIENCY-VIRUS TYPE-1; MEMORY B-CELLS; GERMINAL-CENTERS; AFFINITY MATURATION; IN-SITU; MONOCLONAL-ANTIBODY; SOMATIC MUTATION; VARIABLE REGION; ANTIGEN	During maturing antibody responses the increase in affinity for target antigens is achieved by genetic diversification of antibody genes followed by selection for improved binding. The effect this process has on the specificity of antibody for variants of the antigen is not well-defined, despite the potential role of antibody diversification in generating enhanced protection against pathogen escape mutants, or novel specificities after vaccination. To investigate this, a library of single amino-acid substitution epitope variants has been screened with serum obtained at different time-points after immunization of mice with the HIV gp41 peptide epitope ELDKWA. The serum IgG response is shown to mature and increase affinity for ELDKWA, and the titre and affinity of IgG against most epitope variants tested increases. Furthermore there is a bias towards high affinity serum IgG binding to variant epitopes with conservative substitutions, although underlying this trend there is also significant binding to many epitopes with non-conservative substitutions. Thus, maturation of the antibody response to a single epitope results in a broadening of the high-affinity response toward variant epitopes. This implies that many pathogen epitope escape variants that could manifest as single amino-acid substitutions would not emerge by escaping immune surveillance.	[White, Henry N.; Meng, Qing-Hai] UCL, Dept Mol Immunol, Inst Child Hlth, London, England	University of London; University College London	White, HN (corresponding author), UCL, Dept Mol Immunol, Inst Child Hlth, London, England.	harry.white@plymouth.ac.uk		white, harry/0000-0001-8186-7789	Wellcome Trust [062578]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant number 062578 (www.wellcome.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; FISH S, 1991, J EXP MED, V173, P665, DOI 10.1084/jem.173.3.665; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Hornbeck P, 1991, CURRENT PROTOCOLS IM; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kalinke U, 1996, IMMUNITY, V5, P639, DOI 10.1016/S1074-7613(00)80277-0; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; PALFREYMAN JW, 1984, J IMMUNOL METHODS, V75, P383, DOI 10.1016/0022-1759(84)90122-4; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; RUDIKOFF S, 1982, P NATL ACAD SCI-BIOL, V79, P1979, DOI 10.1073/pnas.79.6.1979; SCHILDBACH JF, 1991, J BIOL CHEM, V266, P4640; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; SPERLING R, 1983, J IMMUNOL, V131, P882; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31555	10.1371/journal.pone.0031555	http://dx.doi.org/10.1371/journal.pone.0031555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348106	gold, Green Submitted, Green Published			2022-12-27	WOS:000302737400035
J	Tang, SN; Fu, JS; Shankar, S; Srivastava, RK				Tang, Su-Ni; Fu, Junsheng; Shankar, Sharmila; Srivastava, Rakesh K.			EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer	PLOS ONE			English	Article							NF-KAPPA-B; EPIDERMAL-GROWTH-FACTOR; GREEN-TEA CONSUMPTION; (-)-EPIGALLOCATECHIN GALLATE; CELL-CYCLE; MOLECULAR TARGETS; FACTOR RECEPTOR; SUPPRESSION; POLYPHENOLS; ACTIVATION	Background: Signal Transducer and Activator of Transcription 3 (STAT3) is an oncogene, which promotes cell survival, proliferation, motility and progression in cancer cells. Targeting STAT3 signaling may lead to the development of novel therapeutic approaches for human cancers. Here, we examined the effects of epigallocathechin gallate (EGCG) on STAT3 signaling in pancreatic cancer cells, and assessed the therapeutic potential of EGCG with gemcitabine or JAK3 inhibitor CP690550 (Tasocitinib) for the treatment and/or prevention of pancreatic cancer. Methodology/Principal Findings: Cell viability and apoptosis were measured by XTT assay and TUNEL staining, respectively. Gene and protein expressions were measured by qRT-PCR and Western blot analysis, respectively. The results revealed that EGCG inhibited the expression of phospho and total JAK3 and STAT3, STAT3 transcription and activation, and the expression of STAT3-regulated genes, resulting in the inhibition of cell motility, migration and invasion, and the induction of caspase-3 and PARP cleavage. The inhibition of STAT3 enhanced the inhibitory effects of EGCG on cell motility and viability. Additionally, gemcitabine and CP690550 alone inhibited STAT3 target genes and synergized with EGCG to inhibit cell viability and induce apoptosis in pancreatic cancer cells. Conclusions/Significance: Overall, these results suggest that EGCG suppresses the growth, invasion and migration of pancreatic cancer cells, and induces apoptosis by interfering with the STAT3 signaling pathway. Moreover, EGCG further enhanced the therapeutic potential of gemcitabine and CP690550 against pancreatic cancer.	[Tang, Su-Ni; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA; [Fu, Junsheng; Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Tang, SN (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA.	rsrivastava@kumc.edu			National Institutes of Health [R01CA125262, RO1CA114469, RO1CA125262-02S1]; Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE [R01CA114469, R01CA125262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grants from the National Institutes of Health (R01CA125262,RO1CA114469 and RO1CA125262-02S1) and the Kansas Bioscience Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Adhami VM, 2004, CANCER RES, V64, P8715, DOI 10.1158/0008-5472.CAN-04-2840; Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Ahmad N, 2000, BIOCHEM BIOPH RES CO, V275, P328, DOI 10.1006/bbrc.2000.3297; Ahmad N, 2000, ARCH BIOCHEM BIOPHYS, V376, P338, DOI 10.1006/abbi.2000.1742; Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Ahn HY, 1999, MOL BIOL CELL, V10, P1093, DOI 10.1091/mbc.10.4.1093; Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; [Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Balasubramanian S, 2010, CARCINOGENESIS, V31, P496, DOI 10.1093/carcin/bgp314; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Borie Dominic C, 2003, Curr Opin Investig Drugs, V4, P1297; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Cooper JE, 2010, CLIN NEPHROL, V73, P333; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Dong ZG, 1997, CANCER RES, V57, P4414; Dreosti IE, 1997, CRIT REV FOOD SCI, V37, P761, DOI 10.1080/10408399709527801; Fujiki H, 2002, CANCER LETT, V188, P9, DOI 10.1016/S0304-3835(02)00379-8; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gupta S, 2004, ONCOGENE, V23, P2507, DOI 10.1038/sj.onc.1207353; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji BT, 1997, INT J CANCER, V70, P255, DOI 10.1002/(SICI)1097-0215(19970127)70:3&lt;255::AID-IJC1&gt;3.0.CO;2-W; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Lee N, 2004, J COMP NEUROL, V474, P535, DOI 10.1002/cne.20140; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Liau SS, 2008, CLIN CANCER RES, V14, P1470, DOI 10.1158/1078-0432.CCR-07-1450; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Park HB, 2010, TRANSPLANTATION, V90, P825, DOI 10.1097/TP.0b013e3181f24e59; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4881, DOI 10.2741/2435; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P5039, DOI 10.2741/2446; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Siegelin MD, 2008, NEUROSCI LETT, V448, P161, DOI 10.1016/j.neulet.2008.10.036; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; SPORN MB, 1976, CANCER RES, V36, P2699; STONER GD, 1995, J CELL BIOCHEM, P169; Syed DN, 2007, ONCOGENE, V26, P673, DOI 10.1038/sj.onc.1209829; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tomillero A, 2009, Methods Find Exp Clin Pharmacol, V31, P661; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; West K, 2009, CURR OPIN INVEST DR, V10, P491; YU GP, 1995, CANCER CAUSE CONTROL, V6, P532, DOI 10.1007/BF00054162; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zapatka M, 2007, ONCOGENE, V26, P1417, DOI 10.1038/sj.onc.1209918	72	80	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31067	10.1371/journal.pone.0031067	http://dx.doi.org/10.1371/journal.pone.0031067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348037	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900021
J	Martins, AH; Alves, JM; Perez, D; Carrasco, M; Torres-Rivera, W; Eterovic, VA; Ferchmin, PA; Ulrich, H				Martins, Antonio H.; Alves, Janaina M.; Perez, Dinely; Carrasco, Marimee; Torres-Rivera, Wilmarie; Eterovic, Vesna A.; Ferchmin, Pedro A.; Ulrich, Henning			Kinin-B2 Receptor Mediated Neuroprotection after NMDA Excitotoxicity Is Reversed in the Presence of Kinin-B1 Receptor Agonists	PLOS ONE			English	Article							METHYL-D-ASPARTATE; EMBRYONAL CARCINOMA-CELLS; ACUTE HIPPOCAMPAL SLICES; FOCAL CEREBRAL-ISCHEMIA; BRAIN EDEMA FORMATION; LF 16-0687 MS; NEURONAL DIFFERENTIATION; NICOTINIC RECEPTORS; B2 RECEPTOR; BRADYKININ	Background: Kinins, with bradykinin and des-Arg(9)-bradykinin being the most important ones, are pro-inflammatory peptides released after tissue injury including stroke. Although the actions of bradykinin are in general well characterized; it remains controversial whether the effects of bradykinin are beneficial or not. Kinin-B2 receptor activation participates in various physiological processes including hypotension, neurotransmission and neuronal differentiation. The bradykinin metabolite des-Arg(9)-bradykinin as well as Lys-des-Arg(9)-bradykinin activates the kinin-B1 receptor known to be expressed under inflammatory conditions. We have investigated the effects of kinin-B1 and B2 receptor activation on N-methyl-Daspartate (NMDA)-induced excitotoxicity measured as decreased capacity to produce synaptically evoked population spikes in the CA1 area of rat hippocampal slices. Principal Findings: Bradykinin at 10 nM and 1 mu M concentrations triggered a neuroprotective cascade via kinin-B2 receptor activation which conferred protection against NMDA-induced excitotoxicity. Recovery of population spikes induced by 10 nM bradykinin was completely abolished when the peptide was co-applied with the selective kinin-B2 receptor antagonist HOE-140. Kinin-B2 receptor activation promoted survival of hippocampal neurons via phosphatidylinositol 3-kinase, while MEK/MAPK signaling was not involved in protection against NMDA-evoked excitotoxic effects. However, 100 nM Lys-des-Arg(9)-bradykinin, a potent kinin-B1 receptor agonist, reversed bradykinin-induced population spike recovery. The inhibition of population spikes recovery was reversed by PD98059,showing that MEK/MAPK was involved in the induction of apoptosis mediated by the B1 receptor. Conclusions: Bradykinin exerted protection against NMDA-induced excitotoxicity which is reversed in the presence of a kinin-B1 receptor agonist. As bradykinin is converted to the kinin-B1 receptor metabolite des-Arg(9)-bradykinin by carboxypeptidases, present in different areas including in brain, our results provide a mechanism for the neuroprotective effect in vitro despite of the deleterious effect observed in vivo.	[Martins, Antonio H.; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Alves, Janaina M.] Univ Fed Sao Paulo, Dept Neurol Neurocirurgia, Sao Paulo, Brazil; [Martins, Antonio H.; Perez, Dinely; Carrasco, Marimee; Torres-Rivera, Wilmarie; Eterovic, Vesna A.; Ferchmin, Pedro A.] Univ Cent Caribe, Dept Biochem, Bayamon, PR USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Martins, AH (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	ferchmin@gmail.com; henning@iq.usp.br	Ulrich, Henning/AAX-8586-2021; Ulrich, Henning/C-5245-2013	Ulrich, Henning/0000-0002-2114-3815; Ulrich, Henning/0000-0002-2114-3815	NIH [P20RR016470-AABRE, U01NS063555, U54 NS39408-SNRP, G12 RR03035-RCMI]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2006/61285-9]; Foundation Segarra (San Juan, Puerto Rico); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPESP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035, P20RR016470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM050695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS063555, U54NS039408] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation Segarra (San Juan, Puerto Rico); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grants P20RR016470-AABRE (AHM), U01NS063555 (PAF), U54 NS39408-SNRP (PAF and VAE) and G12 RR03035-RCMI (UCC) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Project No. 2006/61285-9; HU). The authors also acknowledge the generous support by Foundation Segarra (San Juan, Puerto Rico) (to VAE) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; to HU). AHM's postdoctoral and JMA's Ph.D. thesis research was funded by FAPESP and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1971, EXP BRAIN RES, V13, P208; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Bellucci F, 2009, BRIT J PHARMACOL, V158, P1996, DOI 10.1111/j.1476-5381.2009.00511.x; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Chao J, 2005, EXP PHYSIOL, V90, P291, DOI 10.1113/expphysiol.2004.028464; Christiansen SC, 2002, J IMMUNOL, V169, P2054, DOI 10.4049/jimmunol.169.4.2054; Cruden NLM, 2008, EXPERT OPIN PHARMACO, V9, P2383, DOI [10.1517/14656566.9.13.2383, 10.1517/14656566.9.13.2383 ]; Danielisova V, 2008, NEUROCHEM RES, V33, P1057, DOI 10.1007/s11064-007-9550-3; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Ehrenfeld P, 2011, CANCER LETT, V301, P106, DOI 10.1016/j.canlet.2010.09.020; Ferchmin PA, 2005, J NEUROSCI RES, V82, P631, DOI 10.1002/jnr.20666; Ferchmin PA, 2003, J PHARMACOL EXP THER, V305, P1071, DOI 10.1124/jpet.102.048173; Ferchmin PA, 2000, BRAIN RES, V859, P273, DOI 10.1016/S0006-8993(00)01973-9; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; FRANCEL PC, 1992, J NEUROTRAUM, V9, pS27; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; Howl J, 2003, EXPERT OPIN THER TAR, V7, P277, DOI 10.1517/eott.7.2.277.23782; Joseph K, 2005, ADV IMMUNOL, V86, P159, DOI 10.1016/S0065-2776(04)86005-X; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; Kohno T, 2008, J NEUROSCI, V28, P4533, DOI 10.1523/JNEUROSCI.5349-07.2008; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Martins AH, 2008, CYTOM PART A, V73A, P361, DOI 10.1002/cyto.a.20519; Miho Y, 1999, CELL DEATH DIFFER, V6, P463, DOI 10.1038/sj.cdd.4400506; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; OLNEY JW, 1994, PSYCHOPHARMACOL BULL, V30, P533; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Regoli D, 2001, BIOL CHEM, V382, P31, DOI 10.1515/BC.2001.005; SCHURR A, 1995, J NEUROSCI METH, V59, P129, DOI 10.1016/0165-0270(94)00203-S; Small DL, 1997, NEUROSCI LETT, V232, P87, DOI 10.1016/S0304-3940(97)00592-2; Trujillo CA, 2009, CYTOM PART A, V75A, P38, DOI 10.1002/cyto.a.20666; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Xia CF, 2006, HYPERTENSION, V47, P752, DOI 10.1161/01.HYP.0000214867.35632.0e; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Yin H, 2005, J BIOL CHEM, V280, P8022, DOI 10.1074/jbc.M407179200; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6	39	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30755	10.1371/journal.pone.0030755	http://dx.doi.org/10.1371/journal.pone.0030755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348022	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730900015
J	Iannaccone, S; Zhou, Y; Walterhouse, D; Taborn, G; Landini, G; Lannaccone, P				Iannaccone, Stephen; Zhou, Yue; Walterhouse, David; Taborn, Greg; Landini, Gabriel; lannaccone, Philip			Three Dimensional Visualization and Fractal Analysis of Mosaic Patches in Rat Chimeras: Cell Assortment in Liver, Adrenal Cortex and Cornea	PLOS ONE			English	Article							CENTRIPETAL MIGRATION; EPITHELIAL-CELLS; CLONAL ORIGIN; STEM-CELLS; MOUSE; PATTERN; EXPRESSION; GEOMETRY; LIMBAL; ORGANOGENESIS	The production of organ parenchyma in a rapid and reproducible manner is critical to normal development. In chimeras produced by the combination of genetically distinguishable tissues, mosaic patterns of cells derived from the combined genotypes can be visualized. These patterns comprise patches of contiguously similar genotypes and are different in different organs but similar in a given organ from individual to individual. Thus, the processes that produce the patterns are regulated and conserved. We have previously established that mosaic patches in multiple tissues are fractal, consistent with an iterative, recursive growth model with simple stereotypical division rules. Fractal dimensions of various tissues are consistent with algorithmic models in which changing a single variable (e. g. daughter cell placement after division) switches the mosaic pattern from islands to stripes of cells. Here we show that the spiral pattern previously observed in mouse cornea can also be visualized in rat chimeras. While it is generally held that the pattern is induced by stem cell division dynamics, there is an unexplained discrepancy in the speed of cellular migration and the emergence of the pattern. We demonstrate in chimeric rat corneas both island and striped patterns exist depending on the age of the animal. The patches that comprise the pattern are fractal, and the fractal dimension changes with the age of the animal and indicates the constraint in patch complexity as the spiral pattern emerges. The spiral patterns are consistent with a loxodrome. Such data are likely to be relevant to growth and cell division in organ systems and will help in understanding how organ parenchyma are generated and maintained from multipotent stem cell populations located in specific topographical locations within the organ. Ultimately, understanding algorithmic growth is likely to be essential in achieving organ regeneration in vivo or in vitro from stem cell populations.	[Iannaccone, Stephen; Walterhouse, David; Taborn, Greg; lannaccone, Philip] Northwestern Univ, Childrens Mem Res Ctr, Chicago, IL 60611 USA; [Zhou, Yue] Univ Chicago, Ctr Reprod Med & Fertil, Chicago, IL 60637 USA; [Landini, Gabriel] Univ Birmingham, Sch Dent, Birmingham, W Midlands, England	Northwestern University; University of Chicago; University of Birmingham	Iannaccone, S (corresponding author), Northwestern Univ, Childrens Mem Res Ctr, Chicago, IL 60611 USA.	pmi@northwestern.edu		Landini, Gabriel/0000-0002-9689-0989	NIH from NEI [EY020946]; George M. Eisenberg Foundation for Charities; NATIONAL EYE INSTITUTE [R21EY020946] Funding Source: NIH RePORTER	NIH from NEI; George M. Eisenberg Foundation for Charities; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by NIH EY020946 from the NEI and the George M. Eisenberg Foundation for Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; CHAUDHURI A, 1983, VISION RES, V23, P1351, DOI 10.1016/0042-6989(83)90146-3; Collinson JM, 2004, INT J DEV BIOL, V48, P793, DOI 10.1387/ijdb.041885jc; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; DEAMANT FD, 1987, J CELL SCI, V88, P305; Dua HS, 2009, OPHTHALMOLOGY, V116, P856, DOI 10.1016/j.ophtha.2008.12.017; Dvorscak L, 2008, INVEST OPHTH VIS SCI, V49, P910, DOI 10.1167/iovs.07-1324; Henriksson JT, 2009, INVEST OPHTH VIS SCI, V50, P3648, DOI 10.1167/iovs.08-2941; Iannaccone P, 2002, FASEB J, V16, P41, DOI 10.1096/fj.02-0451fje; Iannaccone P, 1996, FRACTAL GEOMETRY BIO; IANNACCONE PM, 1988, CELL DIFFER DEV, V25, P77, DOI 10.1016/0922-3371(88)90103-7; IANNACCONE PM, 1978, J CELL SCI, V29, P249; IANNACCONE PM, 1987, DEVELOPMENT, V99, P187; IANNACCONE PM, 1987, CELL DIFFER DEV, V21, P79, DOI 10.1016/0045-6039(87)90415-5; IANNACCONE PM, 1987, J EXP ZOOL, V243, P217, DOI 10.1002/jez.1402430207; IANNACCONE PM, 1990, FASEB J, V4, P1508, DOI 10.1096/fasebj.4.5.2307328; IANNACCONE PM, 1989, J THEOR BIOL, V141, P363, DOI 10.1016/S0022-5193(89)80119-5; Iannaccone PM, 1996, FRACTAL GEOMETRY BIO, P189; KHOKHA MK, 1994, DEV BIOL, V165, P545, DOI 10.1006/dbio.1994.1274; Landini G, 2011, J MICROSC-OXFORD, V241, P1, DOI 10.1111/j.1365-2818.2010.03454.x; Landini G, 2000, FASEB J, V14, P823, DOI 10.1096/fasebj.14.5.823; LAVKER RM, 1991, INVEST OPHTH VIS SCI, V32, P1864; Leiper LJ, 2009, INVEST OPHTH VIS SCI, V50, P1122, DOI 10.1167/iovs.08-2812; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P344, DOI 10.1073/pnas.58.1.344; Morley SD, 1996, MOL ENDOCRINOL, V10, P585, DOI 10.1210/me.10.5.585; Mort RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-4; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; NG YK, 1992, DEV BIOL, V151, P419, DOI 10.1016/0012-1606(92)90182-G; NG YK, 1992, CURR TOP DEV BIOL, V27, P235, DOI 10.1016/S0070-2153(08)60536-0; Novak MM, 1998, FRACTALS COMPLEXITY; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Sherwin T, 2010, OPHTHALMOLOGY, V117, P190, DOI 10.1016/j.ophtha.2009.08.006; Thompson DAW, 1943, GROWTH FORM, P748; WEINBERG WC, 1985, SCIENCE, V227, P524, DOI 10.1126/science.3966159; WEINBERG WC, 1987, CARCINOGENESIS, V8, P565, DOI 10.1093/carcin/8.4.565; Weisstein EW, 2011, STEREOGRAPHIC PROJEC	40	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31609	10.1371/journal.pone.0031609	http://dx.doi.org/10.1371/journal.pone.0031609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347498	gold, Green Submitted, Green Published			2022-12-27	WOS:000302180600043
J	Molina-Pena, R; Alvarez, MM				Molina-Pena, Rodolfo; Moises Alvarez, Mario			A Simple Mathematical Model Based on the Cancer Stem Cell Hypothesis Suggests Kinetic Commonalities in Solid Tumor Growth	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; INITIATING CELLS; DIFFERENTIATION THERAPY; COLORECTAL-CANCER; PROGENITOR CELLS; DYNAMICS; BIOLOGY; TARGET; LINES; SUBPOPULATION	Background: The Cancer Stem Cell (CSC) hypothesis has gained credibility within the cancer research community. According to this hypothesis, a small subpopulation of cells within cancerous tissues exhibits stem-cell-like characteristics and is responsible for the maintenance and proliferation of cancer. Methodologies/Principal Findings: We present a simple compartmental pseudo-chemical mathematical model for tumor growth, based on the CSC hypothesis, and derived using a "chemical reaction" approach. We defined three cell subpopulations: CSCs, transit progenitor cells, and differentiated cells. Each event related to cell division, differentiation, or death is then modeled as a chemical reaction. The resulting set of ordinary differential equations was numerically integrated to describe the time evolution of each cell subpopulation and the overall tumor growth. The parameter space was explored to identify combinations of parameter values that produce biologically feasible and consistent scenarios. Conclusions/Significance: Certain kinetic relationships apparently must be satisfied to sustain solid tumor growth and to maintain an approximate constant fraction of CSCs in the tumor lower than 0.01 (as experimentally observed): (a) the rate of symmetrical and asymmetrical CSC renewal must be in the same order of magnitude; (b) the intrinsic rate of renewal and differentiation of progenitor cells must be half an order of magnitude higher than the corresponding intrinsic rates for cancer stem cells; (c) the rates of apoptosis of the CSC, transit amplifying progenitor (P) cells, and terminally differentiated (D) cells must be progressively higher by approximately one order of magnitude. Simulation results were consistent with reports that have suggested that encouraging CSC differentiation could be an effective therapeutic strategy for fighting cancer in addition to selective killing or inhibition of symmetric division of CSCs.	[Molina-Pena, Rodolfo; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico	Tecnologico de Monterrey	Molina-Pena, R (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.	Mario.alvarez@itesm.mx		Alvarez, Mario Moises/0000-0002-9131-5344	Tecnologico de Monterrey [CAT122]; Mexican Council for Science and Technology (CONACYT)	Tecnologico de Monterrey; Mexican Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors gratefully acknowledge the financial support provided by the Tecnologico de Monterrey through the research chair CAT122, by the Mexican Council for Science and Technology (CONACYT) in the form of a scholarship awarded to Rodolfo Molina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cocciadiferro L, 2009, ANN NY ACAD SCI, V1155, P257, DOI 10.1111/j.1749-6632.2009.03696.x; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Daukste L, 2009, J THEOR BIOL, V260, P563, DOI 10.1016/j.jtbi.2009.06.019; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dingli D, 2007, CELL CYCLE, V6, P461, DOI 10.4161/cc.6.4.3853; Dingli D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000345; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000503; Friel AM, 2008, CELL CYCLE, V7, P242, DOI 10.4161/cc.7.2.5207; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; Ganguly R, 2007, CELL PROLIFERAT, V40, P338, DOI 10.1111/j.1365-2184.2007.00434.x; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gudjonsson T, 2005, APMIS, V113, P922, DOI 10.1111/j.1600-0463.2005.apm_371.x; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Jagani Z, 2008, ADV EXP MED BIOL, V615, P331, DOI 10.1007/978-1-4020-6554-5_15; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kang MK, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-15; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Kim PS, 2008, B MATH BIOL, V70, P1994, DOI 10.1007/s11538-008-9336-z; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lodish H., 2004, MOL CELL BIOL; Loebinger MR, 2008, BRIT J CANCER, V98, P380, DOI 10.1038/sj.bjc.6604185; Los M, 2009, EUR J PHARMACOL, V625, P1, DOI 10.1016/j.ejphar.2009.10.008; Mackenzie IC, 2008, ANN ONCOL, V19, P40, DOI 10.1093/annonc/mdn306; Maitland NJ, 2007, ERNST SCHERING FOUND, V5, P155, DOI 10.1007/2789_2007_050; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Pacheco JM, 2009, J THEOR BIOL, V259, P635, DOI 10.1016/j.jtbi.2009.04.003; Pan YY, 2008, INT J CLIN EXP MED, V1, P260; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Sagar J, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-9; Saini V, 2010, CANCER SCI, V101, P16, DOI 10.1111/j.1349-7006.2009.01371.x; Scatena R, 2011, EXPERT OPIN BIOL TH, V11, P875, DOI 10.1517/14712598.2011.573780; Schmidt C, 2008, NAT BIOTECHNOL, V26, P366, DOI 10.1038/nbt0408-366c; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Soltysova A, 2005, NEOPLASMA, V52, P435; Tan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023383; Turner C, 2009, CELL PROLIFERAT, V42, P529, DOI 10.1111/j.1365-2184.2009.00619.x; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Winquist RJ, 2009, BIOCHEM PHARMACOL, V78, P326, DOI 10.1016/j.bcp.2009.03.020; Yanamoto S, 2011, ORAL ONCOLO IN PRESS	75	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e26233	10.1371/journal.pone.0026233	http://dx.doi.org/10.1371/journal.pone.0026233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363395	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600001
J	Antony, ML; Kim, SH; Singh, SV				Antony, Marie Lue; Kim, Su-Hyeong; Singh, Shivendra V.			Critical Role of p53 Upregulated Modulator of Apoptosis in Benzyl Isothiocyanate-Induced Apoptotic Cell Death	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; BREAST-CANCER; PUMA; BAX; GROWTH; PHOSPHORYLATION; CONSTITUENT; INHIBITION; PROTEINS; ARREST	Benzyl isothiocyanate (BITC), a constituent of edible cruciferous vegetables, decreases viability of cancer cells by causing apoptosis but the mechanism of cell death is not fully understood. The present study was undertaken to determine the role of Bcl-2 family proteins in BITC-induced apoptosis using MDA-MB-231 (breast), MCF-7 (breast), and HCT-116 (colon) human cancer cells. The B-cell lymphoma 2 interacting mediator of cell death (Bim) protein was dispensable for proapoptotic response to BITC in MCF-7 and MDA-MB-231 cells as judged by RNA interference studies. Instead, the BITC-treated MCF-7 and MDA-MB-231 cells exhibited upregulation of p53 upregulated modulator of apoptosis (PUMA) protein. The BITC-mediated induction of PUMA was relatively more pronounced in MCF-7 cells due to the presence of wild-type p53 compared with MDA-MB-231 with mutant p53. The BITC-induced apoptosis was partially but significantly attenuated by RNA interference of PUMA in MCF-7 cells. The PUMA knockout variant of HCT-116 cells exhibited significant resistance towards BITC-induced apoptosis compared with wild-type HCT-116 cells. Attenuation of BITC-induced apoptosis in PUMA knockout HCT-116 cells was accompanied by enhanced G2/M phase cell cycle arrest due to induction of p21 and down regulation of cyclin-dependent kinase 1 protein. The BITC treatment caused a decrease in protein levels of Bcl-xL (MCF-7 and MDA-MB-231 cells) and Bcl-2 (MCF-7 cells). Ectopic expression of Bcl-xL in MCF-7 and MDA-MB-231 cells and that of Bcl-2 in MCF-7 cells conferred protection against proapoptotic response to BITC. Interestingly, the BITC-treated MDA-MB-231 cells exhibited induction of Bcl-2 protein expression, and RNA interference of Bcl-2 in this cell line resulted in augmentation of BITC-induced apoptosis. The BITC-mediated inhibition of MDA-MB-231 xenograft growth in vivo was associated with the induction of PUMA protein in the tumor. In conclusion, the results of the present study indicate that Bim-independent apoptosis by BITC in cancer cells is mediated by PUMA.	[Antony, Marie Lue] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Antony, ML (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	singhs@upmc.edu	Antony, Marie Lue/AAB-3952-2019		National Cancer Institute at the National Institutes of Health [RO1 CA129347-05, P30 CA047904]; NATIONAL CANCER INSTITUTE [R01CA129347, P30CA047904] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by a research grant from the National Cancer Institute at the National Institutes of Health [RO1 CA129347-05 (SVS)]. This research project used the Tissue and Research Pathology Facility supported by a grant from the National Cancer Institute at the National Institutes of Health (P30 CA047904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Herman-Antosiewicz A, 2005, J BIOL CHEM, V280, P28519, DOI 10.1074/jbc.M501443200; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kim EJ, 2011, BREAST CANCER RES TR, V130, P61, DOI 10.1007/s10549-010-1299-8; Kim SH, 2011, CARCINOGENESIS, V32, P359, DOI 10.1093/carcin/bgq267; Kim SH, 2010, CANCER PREV RES, V3, P718, DOI 10.1158/1940-6207.CAPR-10-0048; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Park K, 2009, EXP MOL MED, V41, P371, DOI 10.3858/emm.2009.41.6.042; Powolny AA, 2011, JNCI-J NATL CANCER I, V103, P571, DOI 10.1093/jnci/djr029; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Qiao SL, 2012, NEUROCHEM RES, V37, P417, DOI 10.1007/s11064-011-0628-6; Sahin K, 2011, NUTR CANCER, V63, P1279, DOI 10.1080/01635581.2011.606955; Sakata M, 2011, ASIAN PAC J CANCER P, V12, P567; Sehrawat A, 2011, CANCER PREV RES, V4, P1107, DOI 10.1158/1940-6207.CAPR-10-0306; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Warin R, 2010, MOL CARCINOGEN, V49, P500, DOI 10.1002/mc.20600; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiao D, 2006, CLIN CANCER RES, V12, P6836, DOI 10.1158/1078-0432.CCR-06-1273; Xiao D, 2011, MOL PHARMACOL, V79, P499, DOI 10.1124/mol.110.068551; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang YS, 2003, MOL CANCER THER, V2, P1045	48	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32267	10.1371/journal.pone.0032267	http://dx.doi.org/10.1371/journal.pone.0032267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359675	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000302796200144
J	Chen, CR; Salazar, LM; McLachlan, SM; Rapoport, B				Chen, Chun-Rong; Salazar, Larry M.; McLachlan, Sandra M.; Rapoport, Basil			Novel Information on the Epitope of an Inverse Agonist Monoclonal Antibody Provides Insight into the Structure of the TSH Receptor	PLOS ONE			English	Article							GLYCOPROTEIN HORMONE-RECEPTORS; THYROTROPIN RECEPTOR; CRYSTAL-STRUCTURE; HINGE REGION; CONSTITUTIVE ACTIVITY; STIMULATING-HORMONE; GRAVES-DISEASE; BINDING-SITE; DOMAIN; RESIDUES	The TSH receptor (TSHR) comprises an extracellular leucine-rich domain (LRD) linked by a hinge region to the transmembrane domain (TMD). Insight into the orientation of these components to each other is required for understanding how ligands activate the receptor. We previously identified residue E251 at the LRD-hinge junction as contributing to coupling TSH binding with receptor activation. However, a single residue cannot stabilize the LRD-hinge unit. Therefore, based on the LRD crystal structure we selected for study four other potential LRD-hinge interface charged residues. Alanine substitutions of individual residues K244, E247, K250 and R255 (as well as previously known E251A) did not affect TSH binding or function. However, the cumulative mutation of these residues in varying permutations, primarily K250A and R255A when associated with E251A, partially uncoupled TSH binding and function. These data suggest that these three residues, spatially very close to each other at the LRD base, interact with the hinge region. Unexpectedly and most important, monoclonal antibody CS-17, a TSHR inverse agonist whose epitope straddles the LRD-hinge, was found to interact with residues K244 and E247 at the base of the convex LRD surface. These observations, together with the functional data, exclude residues K244 and E247 from the TSHR LRD-hinge interface. Further, for CS-17 accessibility to K244 and E247, the concave surface of the TSHR LRD must be tilted forwards towards the hinge region and plasma membrane. Overall, these data provide insight into the mechanism by which ligands either activate the TSHR or suppress its constitutive activity.	[Chen, Chun-Rong; Salazar, Larry M.; McLachlan, Sandra M.; Rapoport, Basil] Cedars Sinai Med Ctr, Thyroid Autoimmune Dis Unit, Los Angeles, CA 90048 USA; [Chen, Chun-Rong; McLachlan, Sandra M.; Rapoport, Basil] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, CR (corresponding author), Cedars Sinai Med Ctr, Thyroid Autoimmune Dis Unit, Los Angeles, CA 90048 USA.	rapoportb@cshs.org			National Institutes of Health [DK 19289, DK 54684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289, R01DK054684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants DK 19289 (to BR) and DK 54684 (to SMM) and donations from Dr. Boris Catz (private clinical practioner, Los Angeles, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Chen CR, 2008, ENDOCRINOLOGY, V149, P3427, DOI 10.1210/en.2008-0207; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Chen CR, 2009, ENDOCRINOLOGY, V150, P3401, DOI 10.1210/en.2008-1800; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Costagliola S, 1998, FEBS LETT, V436, P427, DOI 10.1016/S0014-5793(98)01177-6; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Johnstone AP, 2003, CLIN ENDOCRINOL, V59, P437, DOI 10.1046/j.1365-2265.2003.01864.x; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOSUGI S, 1991, BIOCHEM BIOPH RES CO, V180, P1118, DOI 10.1016/S0006-291X(05)81182-9; Miguel RN, 2008, J MOL ENDOCRINOL, V41, P145, DOI 10.1677/JME-08-0040; Miguel RN, 2009, J MOL ENDOCRINOL, V42, P381, DOI 10.1677/JME-08-0152; Miguel RN, 2004, THYROID, V14, P991, DOI 10.1089/thy.2004.14.991; Mizutori Y, 2008, J CLIN ENDOCR METAB, V94, P935; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sanders J, 2003, LANCET, V362, P126, DOI 10.1016/S0140-6736(03)13866-4; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31973	10.1371/journal.pone.0031973	http://dx.doi.org/10.1371/journal.pone.0031973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359649	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200118
J	Khurana, S; Raina, H; Pappas, V; Raufman, JP; Pallone, TL				Khurana, Sandeep; Raina, Hema; Pappas, Valeria; Raufman, Jean-Pierre; Pallone, Thomas L.			Effects of Deoxycholylglycine, a Conjugated Secondary Bile Acid, on Myogenic Tone and Agonist-Induced Contraction in Rat Resistance Arteries	PLOS ONE			English	Article							FXR-MEDIATED REGULATION; FARNESOID-X-RECEPTOR; SMOOTH-MUSCLE; EXPRESSION; CHANNELS; HYPERTENSION; SENSITIVITY; ACTIVATION; CONTRIBUTE; PREGNANCY	Background: Bile acids (BAs) regulate cardiovascular function via diverse mechanisms. Although in both health and disease serum glycine-conjugated BAs are more abundant than taurine-conjugated BAs, their effects on myogenic tone (MT), a key determinant of systemic vascular resistance (SVR), have not been examined. Methodology/Principal Findings: Fourth-order mesenteric arteries (170-250 mu m) isolated from Sprague-Dawley rats were pressurized at 70 mmHg and allowed to develop spontaneous constriction, i.e., MT. Deoxycholylglycine (DCG; 0.1-100 mu M), a glycine-conjugated major secondary BA, induced reversible, concentration-dependent reduction of MT that was similar in endothelium-intact and -denuded arteries. DCG reduced the myogenic response to stepwise increase in pressure (20 to 100 mmHg). Neither atropine nor the combination of L-NAME (a NOS inhibitor) plus indomethacin altered DCG-mediated reduction of MT. K+ channel blockade with glibenclamide (K-ATP), 4-aminopyradine (K-V), BaCl2 (K-IR) or tetraethylammonium (TEA, K-Ca) were also ineffective. In Fluo-2-loaded arteries, DCG markedly reduced vascular smooth muscle cell (VSM) Ca2+ fluorescence (similar to 50%). In arteries incubated with DCG, physiological salt solution (PSS) with high Ca2+ (4 mM) restored myogenic response. DCG reduced vascular tone and VSM cytoplasmic Ca2+ responses (similar to 50%) of phenylephrine (PE)- and Ang II-treated arteries, but did not affect KCl-induced vasoconstriction. Conclusion: In rat mesenteric resistance arteries DCG reduces pressure- and agonist-induced vasoconstriction and VSM cytoplasmic Ca2+ responses, independent of muscarinic receptor, NO or K+ channel activation. We conclude that BAs alter vasomotor responses, an effect favoring reduced SVR. These findings are likely pertinent to vascular dysfunction in cirrhosis and other conditions associated with elevated serum BAs.	[Khurana, Sandeep; Raufman, Jean-Pierre] VA Maryland Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD USA; [Raina, Hema] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Pappas, Valeria; Pallone, Thomas L.] Univ Maryland Hosp, Dept Med, Div Nephrol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Khurana, S (corresponding author), VA Maryland Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD USA.	skhurana@medicine.umaryland.edu			National Instituters of Health (NIH) [K08 DK081479, R01DK067621, R37DK042495, P01HL078870, R01CA107345, R01CA120407]; Baltimore Research and Education Foundation; NATIONAL CANCER INSTITUTE [R01CA120407, R01CA107345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081479, R37DK042495, R01DK067621] Funding Source: NIH RePORTER	National Instituters of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baltimore Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SK is supported by National Instituters of Health (NIH) grant K08 DK081479 and the Baltimore Research and Education Foundation. TLP is supported by NIH grants R01DK067621, R37DK042495 and P01HL078870. JPR is supported by NIH grants R01CA107345 and R01CA120407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azer SA, 1996, J GASTROEN HEPATOL, V11, P208, DOI 10.1111/j.1440-1746.1996.tb00064.x; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Brophy CM, 2000, AM J PHYSIOL-HEART C, V278, pH991, DOI 10.1152/ajpheart.2000.278.3.H991; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; CHRISTENSEN KL, 1993, J VASC RES, V30, P73, DOI 10.1159/000158978; Dopico AM, 2002, J GEN PHYSIOL, V119, P251, DOI 10.1085/jgp.119.3.251; FENGERGRON J, 1995, J PHYSIOL-LONDON, V488, P753, DOI 10.1113/jphysiol.1995.sp021006; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Goto K, 2004, J PHYSIOL-LONDON, V561, P215, DOI 10.1113/jphysiol.2004.070458; Hagedorn KA, 2007, HYPERTENSION, V49, P328, DOI 10.1161/01.HYP.0000253478.51950.27; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Hilgers RHP, 2006, AM J PHYSIOL-HEART C, V291, pH216, DOI 10.1152/ajpheart.01383.2005; Hill MA, 2001, J APPL PHYSIOL, V91, P973, DOI 10.1152/jappl.2001.91.2.973; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Khurana S, 2005, EUR J PHARMACOL, V517, P103, DOI 10.1016/j.ejphar.2005.05.037; Khurana S, 2011, CTS-CLIN TRANSL SCI, V4, P210, DOI 10.1111/j.1752-8062.2011.00272.x; Koenigsberger M, 2008, BIOPHYS J, V95, P2728, DOI 10.1529/biophysj.108.131136; KOWALSKI HJ, 1953, J CLIN INVEST, V32, P1025, DOI 10.1172/JCI102813; Kutluay E, 2005, BIOPHYS J, V88, P1018, DOI 10.1529/biophysj.104.052043; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; LINNET K, 1983, GUT, V24, P249, DOI 10.1136/gut.24.3.249; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Nakajima T, 2000, BRIT J PHARMACOL, V130, P1457, DOI 10.1038/sj.bjp.0703471; NEALE G, 1971, GUT, V12, P145, DOI 10.1136/gut.12.2.145; OHKUBO H, 1984, GASTROENTEROLOGY, V86, P514; Osborn JW, 2011, CURR HYPERTENS REP, V13, P221, DOI 10.1007/s11906-011-0188-9; PAK JM, 1993, HEPATOLOGY, V18, P1175; PAK JM, 1994, BRIT J PHARMACOL, V112, P1209, DOI 10.1111/j.1476-5381.1994.tb13212.x; Pazzi P, 2002, ALIMENT PHARM THER, V16, P1547, DOI 10.1046/j.1365-2036.2002.01314.x; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Ploug KB, 2010, EUR J PHARMACOL, V637, P109, DOI 10.1016/j.ejphar.2010.03.027; Raina H, 2010, AM J PHYSIOL-HEART C, V298, pH2093, DOI 10.1152/ajpheart.01045.2009; Raufman JP, 2002, EUR J PHARMACOL, V457, P77, DOI 10.1016/S0014-2999(02)02690-0; Raufman JP, 2002, PHARMACOLOGY, V65, P215, DOI 10.1159/000064347; Raufman JP, 1998, AM J PHYSIOL-GASTR L, V274, pG997, DOI 10.1152/ajpgi.1998.274.6.G997; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; Song JG, 2009, ANESTHESIOLOGY, V111, P561, DOI 10.1097/ALN.0b013e3181adf49f; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Zhang QH, 2008, CARDIOVASC RES, V77, P560, DOI 10.1093/cvr/cvm068; Zhang Z, 2010, AM J PHYSIOL-RENAL, V299, pF862, DOI 10.1152/ajprenal.00321.2010	47	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32006	10.1371/journal.pone.0032006	http://dx.doi.org/10.1371/journal.pone.0032006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359652	Green Submitted, gold, Green Published			2022-12-27	WOS:000302796200121
J	Li, R; Qin, W; Zhang, YT; Jiang, TZ; Yu, CS				Li, Rui; Qin, Wen; Zhang, Yunting; Jiang, Tianzi; Yu, Chunshui			The Neuronal Correlates of Digits Backward Are Revealed by Voxel-Based Morphometry and Resting-State Functional Connectivity Analyses	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; VERBAL WORKING-MEMORY; SUPERIOR TEMPORAL GYRUS; MEDIAL FRONTAL-CORTEX; SHORT-TERM-MEMORY; BRAIN ACTIVATION; SENTENCE COMPREHENSION; RESPONSE-INHIBITION; LANGUAGE PRODUCTION; NETWORKS	Digits backward (DB) is a widely used neuropsychological measure that is believed to be a simple and effective index of the capacity of the verbal working memory. However, its neural correlates remain elusive. The aim of this study is to investigate the neural correlates of DB in 299 healthy young adults by combining voxel-based morphometry (VBM) and resting-state functional connectivity (rsFC) analyses. The VBM analysis showed positive correlations between the DB scores and the gray matter volumes in the right anterior superior temporal gyrus (STG), the right posterior STG, the left inferior frontal gyrus and the left Rolandic operculum, which are four critical areas in the auditory phonological loop of the verbal working memory. Voxel-based correlation analysis was then performed between the positive rsFCs of these four clusters and the DB scores. We found that the DB scores were positively correlated with the rsFCs within the salience network (SN), that is, between the right anterior STG, the dorsal anterior cingulate cortex and the right fronto-insular cortex. We also found that the DB scores were negatively correlated with the rsFC within an anti-correlation network of the SN, between the right posterior STG and the left posterior insula. Our findings suggest that DB performance is related to the structural and functional organizations of the brain areas that are involved in the auditory phonological loop and the SN.	[Li, Rui; Qin, Wen; Zhang, Yunting; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Jiang, Tianzi] Chinese Acad Sci, LIAMA Ctr Computat Med, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Li, R (corresponding author), Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	cjr.zhangyunting@vip.163.com; jiangtz@nlpr.ia.ac.cn; chunshuiyu@yahoo.cn	QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012	QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of Tianjin [11JCZDJC19300]; Natural Science Foundation of China [30870694, 30730036]; National Basic Research Program of China (973 program) [2010CB732506]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of Tianjin (No. 11JCZDJC19300), Natural Science Foundation of China (Nos. 30870694 and 30730036), and National Basic Research Program of China (973 program, No. 2010CB732506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alain C, 2009, CEREB CORTEX, V19, P305, DOI 10.1093/cercor/bhn082; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Amici S, 2007, J NEUROSCI, V27, P6282, DOI 10.1523/JNEUROSCI.1331-07.2007; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Awh E, 1999, NAT NEUROSCI, V2, P853, DOI 10.1038/13145; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A. D, 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Becker JT, 1999, BRAIN COGNITION, V41, P27, DOI 10.1006/brcg.1999.1094; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Buchsbaum BR, 2008, J COGNITIVE NEUROSCI, V20, P762, DOI 10.1162/jocn.2008.20501; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chein JM, 2001, CEREB CORTEX, V11, P1003, DOI 10.1093/cercor/11.11.1003; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; Crinion JT, 2009, HUM BRAIN MAPP, V30, P4108, DOI 10.1002/hbm.20832; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gerton BK, 2004, NEUROPSYCHOLOGIA, V42, P1781, DOI 10.1016/j.neuropsychologia.2004.04.023; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Gong YX, MANUAL MODIFIED WECH; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Gruber O, 2007, J NEURAL TRANSM, V114, P1047, DOI 10.1007/s00702-007-0634-7; Hale T Sigi, 2007, J Atten Disord, V11, P125; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Heim S, 2003, NEUROREPORT, V14, P2031, DOI 10.1097/00001756-200311140-00005; Hoshi Y, 2000, COGNITIVE BRAIN RES, V9, P339, DOI 10.1016/S0926-6410(00)00006-9; Jamison HL, 2006, CEREB CORTEX, V16, P1266, DOI 10.1093/cercor/bhj068; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KESSLAK JP, 1991, NEUROLOGY, V41, P51, DOI 10.1212/WNL.41.1.51; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Lattner S, 2005, HUM BRAIN MAPP, V24, P11, DOI 10.1002/hbm.20065; Leff AP, 2009, BRAIN, V132, P3401, DOI 10.1093/brain/awp273; Lenartowicz A, 2005, J COGNITIVE NEUROSCI, V17, P1026, DOI 10.1162/0898929054475127; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Lidzba K, 2011, BRAIN LANG, V119, P6, DOI 10.1016/j.bandl.2011.02.003; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Luo Q, 2007, NEUROIMAGE, V38, P631, DOI 10.1016/j.neuroimage.2007.07.051; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osaka M, 2003, NEUROIMAGE, V18, P789, DOI 10.1016/S1053-8119(02)00032-0; Dadin CO, 2009, ACTAS ESP PSIQUIATRI, V37, P68; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Peeva MG, 2010, NEUROIMAGE, V50, P626, DOI 10.1016/j.neuroimage.2009.12.065; Petit L, 2007, RESTOR NEUROL NEUROS, V25, P211; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Pourtois G, 2010, NEUROPSYCHOLOGIA, V48, P1144, DOI 10.1016/j.neuropsychologia.2009.12.020; Richardson FM, 2011, J COGNITIVE NEUROSCI, V23, P3746, DOI 10.1162/jocn_a_00060; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rothmayr C, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-56; Salmon E, 1996, BRAIN, V119, P1617, DOI 10.1093/brain/119.5.1617; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2010, BRAIN STRUCT FUNCT, V214, P465, DOI 10.1007/s00429-010-0263-z; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Steven MC, 2007, BEHAV BRAIN RES, V181, P12, DOI 10.1016/j.bbr.2007.03.023; Sun XW, 2005, NEUROIMAGE, V26, P36, DOI 10.1016/j.neuroimage.2005.01.022; Taki Y, 2011, BRAIN COGNITION, V75, P170, DOI 10.1016/j.bandc.2010.11.008; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; TONKONOGY J, 1981, ARCH NEUROL-CHICAGO, V38, P486, DOI 10.1001/archneur.1981.00510080048005; Turkeltaub PE, 2010, BRAIN LANG, V114, P1, DOI 10.1016/j.bandl.2010.03.008; van Ettinger-Veenstra HM, 2010, NEUROIMAGE, V49, P3481, DOI 10.1016/j.neuroimage.2009.10.041; Vaz Ivanilde Aparecida, 2010, Pró-Fono R. Atual. Cient., V22, P95, DOI 10.1590/S0104-56872010000200005; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Veroude K, 2010, BRAIN LANG, V113, P21, DOI 10.1016/j.bandl.2009.12.005; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wild-Wall N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00186; Wilde NJ, 2004, J CLIN EXP NEUROPSYC, V26, P539, DOI 10.1080/13803390490496605; Wynn RM, 2009, PSYCHOL REP, V105, P625, DOI 10.2466/PR0.105.2.625-632; Yeatman JD, 2010, BRAIN LANG, V114, P72, DOI 10.1016/j.bandl.2009.11.006; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029	108	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31877	10.1371/journal.pone.0031877	http://dx.doi.org/10.1371/journal.pone.0031877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359639	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200108
J	Agrillo, C; Piffer, L; Bisazza, A; Butterworth, B				Agrillo, Christian; Piffer, Laura; Bisazza, Angelo; Butterworth, Brian			Evidence for Two Numerical Systems That Are Similar in Humans and Guppies	PLOS ONE			English	Article							NUMEROSITY JUDGMENTS; RHESUS-MONKEYS; LARGE NUMBERS; SPONTANEOUS DISCRIMINATION; ANALOG MAGNITUDES; PAN-TROGLODYTES; OBJECT FILES; FISH; INFANTS; QUANTITY	Background: Humans and non-human animals share an approximate non-verbal system for representing and comparing numerosities that has no upper limit and for which accuracy is dependent on the numerical ratio. Current evidence indicates that the mechanism for keeping track of individual objects can also be used for numerical purposes; if so, its accuracy will be independent of numerical ratio, but its capacity is limited to the number of items that can be tracked, about four. There is, however, growing controversy as to whether two separate number systems are present in other vertebrate species. Methodology/Principal Findings: In this study, we compared the ability of undergraduate students and guppies to discriminate the same numerical ratios, both within and beyond the small number range. In both students and fish the performance was ratio-independent for the numbers 1-4, while it steadily increased with numerical distance when larger numbers were presented. Conclusions/Significance: Our results suggest that two distinct systems underlie quantity discrimination in both humans and fish, implying that the building blocks of uniquely human mathematical abilities may be evolutionarily ancient, dating back to before the divergence of bony fish and tetrapod lineages.	[Agrillo, Christian; Piffer, Laura; Bisazza, Angelo] Univ Padua, Dept Gen Psychol, Padua, Italy; [Butterworth, Brian] UCL, Inst Cognit Neurosci, London, England	University of Padua; University of London; University College London	Agrillo, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	christian.agrillo@unipd.it		Agrillo, Christian/0000-0002-7391-8934; Bisazza, Angelo/0000-0003-0209-7638	University of Padova	University of Padova	This research was funded by research grant "Progetto di Eccellenza CARIPARO 2007", and "Progetto Giovani Studiosi 2010" from University of Padova to Christian Agrillo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2007, ETHOL ECOL EVOL, V19, P145, DOI 10.1080/08927014.2007.9522574; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2011, COGNITION, V119, P281, DOI 10.1016/j.cognition.2010.10.022; Agrillo C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015232; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Ansari D, 2007, J COGNITIVE NEUROSCI, V19, P1845, DOI 10.1162/jocn.2007.19.11.1845; AOKI T, 1977, TOHOKU PSYCHOL FOLIA, V36, P15; ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; Beran MJ, 2008, PLOS BIOL, V6, P221, DOI 10.1371/journal.pbio.0060019; Beran MJ, 2007, J EXP PSYCHOL-ANIM B, V33, P42, DOI 10.1037/0097-7403.33.1.42; Beran MJ, 2006, Q J EXP PSYCHOL, V59, P2065, DOI 10.1080/17470210600701171; Binoy VV, 2004, CURR SCI INDIA, V86, P207; Bisazza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015516; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Cordes S, 2009, DEV PSYCHOL, V45, P1583, DOI 10.1037/a0015666; Dadda M, 2009, P ROY SOC B-BIOL SCI, V276, P4399, DOI 10.1098/rspb.2009.1406; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; Dehaene S., 1997, NUMBER SENSE; Demeyere N, 2010, NEUROCASE, V16, P219, DOI 10.1080/13554790903405719; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flombaum JI, 2005, COGNITION, V97, P315, DOI 10.1016/j.cognition.2004.09.004; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Glover S, 2004, PSYCHON B REV, V11, P791, DOI 10.3758/BF03196706; Gomez-Laplaza LM, 2010, ANIM COGN, P1; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P565, DOI 10.1007/s10071-011-0392-7; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Hyde DC, 2009, J COGNITIVE NEUROSCI, V21, P1039, DOI 10.1162/jocn.2009.21090; INGLE D, 1968, BRAIN BEHAV EVOLUT, V1, P58, DOI 10.1159/000125493; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jennions MD, 2003, BEHAV ECOL, V14, P438, DOI 10.1093/beheco/14.3.438; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Keppel G, 1991, DESIGN ANAL RES HDB; Ledesma JM, 2008, BEHAV PROCESS, V77, P384, DOI 10.1016/j.beproc.2007.10.006; Maggard MA, 2003, SURGERY, V134, P275, DOI 10.1067/msy.2003.235; MARK RF, 1966, EXP NEUROL, V16, P215, DOI 10.1016/0014-4886(66)90100-2; Matsuzawa T, 2009, CURR OPIN NEUROBIOL, V19, P92, DOI 10.1016/j.conb.2009.04.007; Maxwell SE, 2004, PSYCHOL METHODS, V9, P147, DOI 10.1037/1082-989X.9.2.147; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Piffer L, 2011, ANIM COGN, DOI [10.1007/s10071-10011-10447- 10079, DOI 10.1007/S10071-10011-10447-10079]; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Rugani R, 2008, J EXP PSYCHOL-ANIM B, V34, P388, DOI 10.1037/0097-7403.34.3.388; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Sokal RR, 1995, BIOMETRY; Sovrano VA, 1999, BEHAV BRAIN RES, V106, P175, DOI 10.1016/S0166-4328(99)00105-9; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; STARKEY P, 1980, SCIENCE, V210, P1033, DOI 10.1126/science.7434014; Stoianov I, 2012, NAT NEUROSCI, V15, P194, DOI 10.1038/nn.2996; Tomonaga M, 2002, ANIM LEARN BEHAV, V30, P143, DOI 10.3758/BF03192916; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; vanMarle K, 2009, COGNITION, V111, P302, DOI 10.1016/j.cognition.2009.01.011; Vetter P, 2011, J COGNITIVE NEUROSCI, V23, P728, DOI 10.1162/jocn.2010.21472; Ward C, 2007, ANIM COGN, V10, P71, DOI 10.1007/s10071-006-0042-7; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	71	122	125	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31923	10.1371/journal.pone.0031923	http://dx.doi.org/10.1371/journal.pone.0031923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355405	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300105
J	Maher, LA; Richter, T; Macdonald, D; Jones, MD; Martin, L; Stock, JT				Maher, Lisa A.; Richter, Tobias; Macdonald, Danielle; Jones, Matthew D.; Martin, Louise; Stock, Jay T.			Twenty Thousand-Year-Old Huts at a Hunter-Gatherer Settlement in Eastern Jordan	PLOS ONE			English	Article							PLEISTOCENE; LEVANT; PREHISTORY; SEDENTISM; CULTURE; ORIGINS	Ten thousand years before Neolithic farmers settled in permanent villages, hunter-gatherer groups of the Epipalaeolithic period (c. 22-11,600 cal BP) inhabited much of southwest Asia. The latest Epipalaeolithic phase (Natufian) is well-known for the appearance of stone-built houses, complex site organization, a sedentary lifestyle and social complexity-precursors for a Neolithic way of life. In contrast, pre-Natufian sites are much less well known and generally considered as campsites for small groups of seasonally-mobile hunter-gatherers. Work at the Early and Middle Epipalaeolithic aggregation site of Kharaneh IV in eastern Jordan highlights that some of these earlier sites were large aggregation base camps not unlike those of the Natufian and contributes to ongoing debates on their duration of occupation. Here we discuss the excavation of two 20,000-year-old hut structures at Kharaneh IV that pre-date the renowned stone houses of the Natufian. Exceptionally dense and extensive occupational deposits exhibit repeated habitation over prolonged periods, and contain structural remains associated with exotic and potentially symbolic caches of objects (shell, red ochre, and burnt horn cores) that indicate substantial settlement of the site pre-dating the Natufian and outside of the Natufian homeland as currently understood.	[Maher, Lisa A.] Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94720 USA; [Richter, Tobias] Univ Copenhagen, Dept Reg & Cross Cultural Studies, Copenhagen, Denmark; [Macdonald, Danielle] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada; [Jones, Matthew D.] Univ Nottingham, Dept Geog, Nottingham NG7 2RD, England; [Martin, Louise] UCL, Inst Archaeol, London, England; [Stock, Jay T.] Univ Cambridge, Div Biol Anthropol, Cambridge, England	University of California System; University of California Berkeley; University of Copenhagen; University of Toronto; University of Nottingham; University of London; University College London; University of Cambridge	Maher, LA (corresponding author), Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94720 USA.	maher@berkeley.edu	Stock, Jay T/B-6453-2011; Richter, Tobias/AEX-8549-2022	Stock, Jay T/0000-0003-0147-8631; Macdonald, Danielle/0000-0002-0061-9343; Jones, Matthew/0000-0001-8116-5568; Richter, Tobias/0000-0001-9902-8852	Council for British Research in the Levant; University of Cambridge; University College London; University of Copenhagen; Arts and Humanities Research Council of Britain [AH/E009484/1]; Kharaneh IV field crews; local Department of Antiquities Representative; Zuhayr al-Zubay; Department of Antiquities of Jordan; AHRC [AH/E009484/1] Funding Source: UKRI; NERC [NRCF010002] Funding Source: UKRI; Arts and Humanities Research Council [AH/E009484/1] Funding Source: researchfish; Natural Environment Research Council [NRCF010002] Funding Source: researchfish	Council for British Research in the Levant; University of Cambridge(University of Cambridge); University College London(General Electric); University of Copenhagen; Arts and Humanities Research Council of Britain(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Kharaneh IV field crews; local Department of Antiquities Representative; Zuhayr al-Zubay; Department of Antiquities of Jordan; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research is supported by the Council for British Research in the Levant, University of Cambridge, University College London, and the University of Copenhagen, and is funded by the Arts and Humanities Research Council of Britain (AH/E009484/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Kharaneh IV field crews of 2008-2010, our local Department of Antiquities Representative for 2010, Zuhayr al-Zubay, and the Director General of the Department of Antiquities of Jordan for their support. We would like to acknowledge a special thank you to our collaborator Ahmad Lash for his help and support with our community initiatives and our work on-site. We also thank Nigel Goring-Morris and Ofer Bar-Yosef for comments and comparative information during excavation of the hut structures. Thank you also to two anonymous reviewers for their comments on this paper.	Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Betts AVG, HARRA HAMAD EXCAVATI, V1; Boyd B, 2006, WORLD ARCHAEOL, V38, P164, DOI 10.1080/00438240600688398; Byrd BF, 2005, J ARCHAEOL RES, V13, P231, DOI 10.1007/s10814-005-3107-2; Copeland L, HAMMER ROCK STUDIE 1; Edwards Phillip C, 1989, J MEDITERR ARCHAEOL, V2, P5; Enzel Y, 2008, GLOBAL PLANET CHANGE, V60, P165, DOI 10.1016/j.gloplacha.2007.02.003; Finlayson B, 2011, P NATL ACAD SCI USA, V108, P8183, DOI 10.1073/pnas.1017642108; Garrard A., 1994, LATE QUATERNARY CHRO, P177; Garrard A.N., 1992, PALEORIENT, V18, P47, DOI DOI 10.3406/PALE0.1992.4562; Gilead I, 1988, PALEORIENT, V14, P177; Goring-Morris A. N., 1995, ARCHEOLOGY SOC HOLY, P141; Goring-Morris A. N., 2003, BAR INT SERIES, V1122, P65; Goring-Morris AN, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P239, DOI 10.1007/978-1-4020-8539-0_10; Goring-Morris AN., 2009, TRANSITIONS PREHISTO, P185; Goring-Morris N., 1998, PALEORIENT, V23, P71; Grosman L, 2007, BEFORE FARMING, V4, P1; Hardy-Smith T, 2004, J ANTHROPOL ARCHAEOL, V23, P253, DOI 10.1016/j.jaa.2004.05.001; Jones M, 2010, 7 INT C ARCH ANC NEA; Jones MD, 2011, QUATERNARY RES, V76, P363, DOI 10.1016/j.yqres.2011.07.005; Kuijt I., 2000, LIFE NEOLITHIC FARMI, P19, DOI DOI 10.1007/0-306-47166-3_2; Maher L, 2012, EVOLUTIONAR IN PRESS; Maher L, JORDANS PRE IN PRESS; Maher LA, 2010, LANDSCAPES TRANSITIO, P34; Maher LA, 2011, CAMB ARCHAEOL J, V21, P1, DOI 10.1017/S0959774311000011; Maher LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015815; Martin L, 2010, LEVANT, V42, P107, DOI 10.1179/175638010X12797237885613; Moore AMT, 2000, VILLAGE EUPHRATES FO; Muheisen M., 1988, BRIT ARCHAEOLOGICAL, Vvol. 396, P353; Muheisen M, 1983, RECHERCHES EPIPALEOL; Muheisen M., 1995, PALEORIENT, V21, P75, DOI DOI 10.3406/PALEO.1995.4610; Nadel D, 1999, ANTIQUITY, V73, P755, DOI 10.1017/S0003598X00065509; Nadel D, 2001, RADIOCARBON, V43, P1167; Nadel D, 23000 YEAR OLD FISHE; Nadel D, 1995, NATURE CULTURE C LIE, P373; Nadel D., 1994, PALEORIENT, V20, P113, DOI DOI 10.3406/paleo.1994.4605; Richter R, 2011, STUDIES EARLY NEAR E, V13, P33; Richter T, 2010, ANTIQUITY, V84, P321, DOI 10.1017/S0003598X00066606; Richter T., 2010, PALEORIENT, V35, P49, DOI [10.3406/paleo.2009.5298, DOI 10.3406/PALEO.2009.5298]; Richter T, 2011, CAMB ARCHAEOL J, V21, P95, DOI 10.1017/S0959774311000060; Robinson SA, 2006, QUATERNARY SCI REV, V25, P1517, DOI 10.1016/j.quascirev.2006.02.006; Rollefson G., 2001, ANN DEP ANTIQ JORDAN, V45, P71; Rolston S. L., 1982, ANN DEP ANTIQUITIES, V26, P221; Verhoeven M, 2004, J WORLD PREHIST, V18, P179, DOI 10.1007/s10963-004-4361-9; Watkins T, 2006, MADR ACT 5 C INT ARQ, P427; Watkins T, 2010, LANDSCAPES TRANSITIO, P106; Watkins T., 1992, PALEORIENT, V18, P63, DOI DOI 10.3406/paleo.1992.4563	47	70	70	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31447	10.1371/journal.pone.0031447	http://dx.doi.org/10.1371/journal.pone.0031447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	925DP	22355366	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300066
J	Nikdin, H; Olsson, ML; Hultenby, K; Sugars, RV				Nikdin, Hero; Olsson, Marie-Louise; Hultenby, Kjell; Sugars, Rachael V.			Osteoadherin Accumulates in the Predentin towards the Mineralization Front in the Developing Tooth	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; KERATAN SULFATE PROTEOGLYCAN; COLLAGEN FIBRILLOGENESIS; EXTRACELLULAR-MATRIX; TARGETED DISRUPTION; RAT INCISOR; IMMUNOHISTOCHEMICAL LOCALIZATION; DENTIN MINERALIZATION; DECORIN-BINDING; DEFICIENT MICE	Background: Proteoglycans (PG) are known to be involved in the organization and assembly of the extracellular matrix (ECM) prior to mineral deposition. Osteoadherin (OSAD), a keratan sulphate PG is a member of the small leucine-rich (SLRP) family of PGs and unlike other SLRPs, OSAD expression is restricted to mineralized tissues. It is proposed to have a high affinity for hydroxyapatite and has been shown to be expressed by mature osteoblasts but its exact role remains to be elucidated. Methodology/Principal Findings: We investigated the protein distribution of OSAD in the developing mouse tooth using immunohistochemistry and compared its expression with other SLRPs, biglycan (BGN), decorin (DCN) and fibromodulin (FMD). OSAD was found to be specifically localized in the predentin layer of the tooth and focused at the mineralization front. These studies were confirmed at the ultrastructural level using electron microscopy (iEM), where the distribution of immunogold labeled OSAD particles were quantified and significant amounts were found in the predentin, forming a gradient towards the mineralization front. In addition, iEM results revealed OSAD to lie in close association with collagen fibers, further suggesting an important role for OSAD in the organization of the ECM. The expression profile of mineralization-related SLRP genes by rat dental pulp cells exposed to mineralization inducing factors, showed an increase in all SLRP genes. Indeed, OSAD expression was significantly increased during the mineralization process, specifically following, matrix maturation, and finally mineral deposition. Alizarin Red S staining for calcium deposition showed clear bone-like nodules, which support matrix maturation and mineralization. Conclusions: These studies provide new evidence for the role of OSAD in the mineralization process and its specific localization in the predentin layer accumulating at the mineralization front highlighting its role in tooth development.	[Nikdin, Hero; Olsson, Marie-Louise; Sugars, Rachael V.] Karolinska Inst, Dept Dent Med, Huddinge, Sweden; [Hultenby, Kjell] Karolinska Inst, Huddinge Univ Hosp, Clin Res Ctr, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Nikdin, H (corresponding author), Karolinska Inst, Dept Dent Med, Huddinge, Sweden.	Rachael.Sugars@ki.se	Sugars, Rachael/O-9423-2019	Sugars, Rachael/0000-0003-4843-6260	Stockholm County Council; Karolinska Institutet; Swedish Graduate School in Odontological Science	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Graduate School in Odontological Science	The study was supported by funds from Stockholm County Council, research funds of Karolinska Institutet, and the Swedish Graduate School in Odontological Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083; [Anonymous], 1979, STEREOLOGICAL METHOD; Buchaille R, 2000, BONE, V27, P265, DOI 10.1016/S8756-3282(00)00310-0; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Couble ML, 2004, HISTOCHEM CELL BIOL, V121, P47, DOI 10.1007/s00418-003-0608-2; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Embery G, 2001, CRIT REV ORAL BIOL M, V12, P331, DOI 10.1177/10454411010120040401; FISHER LW, 1983, J BIOL CHEM, V258, P2723; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FUKAE M, 1994, CALCIFIED TISSUE INT, V55, P426, DOI 10.1007/BF00298556; GOLDBERG M, 1993, HISTOCHEM J, V25, P781; Goldberg M, 2006, J HISTOCHEM CYTOCHEM, V54, P525, DOI 10.1369/jhc.5A6650.2005; GOLDBERG M, 1995, INT J DEV BIOL, V39, P93; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldberg M, 2003, CONNECT TISSUE RES, V44, P143, DOI 10.1080/03008200390223927; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Hall RC, 1997, ARCH ORAL BIOL, V42, P783, DOI 10.1016/S0003-9969(97)00024-1; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Hocking AM, 1998, MATRIX BIOL, V17, P1; HULTENBY K, 1991, MATRIX, V11, P206, DOI 10.1016/S0934-8832(11)80160-5; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Lillesaar C, 2003, NEUROSCIENCE, V119, P443, DOI 10.1016/S0306-4522(02)00938-7; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; Patel M, 2009, ARCH ORAL BIOL, V54, P898, DOI 10.1016/j.archoralbio.2009.06.008; Petersson U, 2003, EUR J ORAL SCI, V111, P128, DOI 10.1034/j.1600-0722.2003.00027.x; Ramstad VE, 2003, CALCIFIED TISSUE INT, V72, P57, DOI 10.1007/s00223-002-2047-9; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rehn AP, 2008, CALCIFIED TISSUE INT, V82, P454, DOI 10.1007/s00223-008-9138-1; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; Septier D, 1998, HISTOCHEM J, V30, P275, DOI 10.1023/A:1003216024158; Septier D, 2001, CALCIFIED TISSUE INT, V69, P38, DOI 10.1007/s002230020047; Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; TAKAGI M, 1990, J HISTOCHEM CYTOCHEM, V38, P319, DOI 10.1177/38.3.1689334; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; Waddington RJ, 2003, MATRIX BIOL, V22, P153, DOI 10.1016/S0945-053X(03)00019-2; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	46	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31525	10.1371/journal.pone.0031525	http://dx.doi.org/10.1371/journal.pone.0031525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355375	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300075
J	Singh, PK; Rai, RK; Alagarajan, M; Singh, L				Singh, Prashant Kumar; Rai, Rajesh Kumar; Alagarajan, Manoj; Singh, Lucky			Determinants of Maternity Care Services Utilization among Married Adolescents in Rural India	PLOS ONE			English	Article							CHILD HEALTH-SERVICES; REPRODUCTIVE-HEALTH; UTTAR-PRADESH; SAFE-MOTHERHOOD; ANTENATAL CARE; MORTALITY; COUNTRIES; PREGNANCY; RELIGION; PROGRAM	Background: Coupled with the largest number of maternal deaths, adolescent pregnancy in India has received paramount importance due to early age at marriage and low contraceptive use. The factors associated with the utilization of maternal healthcare services among married adolescents in rural India are poorly discussed. Methodology/Principal Findings: Using the data from third wave of National Family Health Survey (2005-06), available in public domain for the use by researchers, this paper examines the factors associated with the utilization of maternal healthcare services among married adolescent women (aged 15-19 years) in rural India. Three components of maternal healthcare service utilization were measured: full antenatal care, safe delivery, and postnatal care within 42 days of delivery for the women who gave births in the last five years preceding the survey. Considering the framework on causes of maternal mortality proposed by Thaddeus and Maine (1994), selected socioeconomic, demographic, and cultural factors influencing outcome events were included as the predictor variables. Bi-variate analyses including chi-square test to determine the difference in proportion, and logistic regression to understand the net effect of predictor variables on selected outcomes were applied. Findings indicate the significant differences in the use of selected maternal healthcare utilization by educational attainment, economic status and region of residence. Muslim women, and women belonged to Scheduled Castes, Scheduled Tribes, and Other Backward Classes are less likely to avail safe delivery services. Additionally, adolescent women from the southern region utilizing the highest maternal healthcare services than the other regions. Conclusions: The present study documents several socioeconomic and cultural factors affecting the utilization of maternal healthcare services among rural adolescent women in India. The ongoing healthcare programs should start targeting household with married adolescent women belonging to poor and specific sub-groups of the population in rural areas to address the unmet need for maternal healthcare service utilization.	[Singh, Prashant Kumar; Alagarajan, Manoj] Int Inst Populat Sci, Dept Dev Studies, Mumbai, Maharashtra, India; [Rai, Rajesh Kumar] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel	International Institute for Population Sciences; Hebrew University of Jerusalem; Hadassah University Medical Center	Singh, PK (corresponding author), Int Inst Populat Sci, Dept Dev Studies, Mumbai, Maharashtra, India.	prashant_iips@yahoo.co.in	Alagarajan, Manoj/AAT-5001-2020	Singh, Prashant Kumar/0000-0003-1742-5534; Rai, Rajesh Kumar/0000-0002-5249-9937; Singh, Lucky/0000-0003-2590-6135	Government of India From University Grants Commission; Ministry of Health and Family Welfare, Government of India; Hebrew University; Hadassah Medical Organization, Jerusalem, Israel; FOGARTY INTERNATIONAL CENTER [D43TW009120] Funding Source: NIH RePORTER	Government of India From University Grants Commission; Ministry of Health and Family Welfare, Government of India; Hebrew University; Hadassah Medical Organization, Jerusalem, Israel; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Dr. Prashant Singh and Dr. Lucky Singh are supported by the Government of India/National Eligibility Test Doctoral Fellowship Award from University Grants Commission and Ministry of Health and Family Welfare, Government of India. Dr. Rai is supported by the International Master of Public Health Scholarship from Hebrew University, and Hadassah Medical Organization, Jerusalem, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuja Call to Action, 2008, INCREASE INVESTMENTS; Addai I, 2000, J BIOSOC SCI, V32, P1; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; Basant R, 2007, ECON POLIT WEEKLY, V42, P828; Bhagat R. B., 2005, Economic and Political Weekly, V40, P411; Bhalotra S, 2009, 4009 IZA; Bhalotra S, 2009, HDB MUSLIMS INDIA; Bhat P. N. M., 2005, Economic and Political Weekly, V40, P385; Bhaumik SK, 2006, 819 U MICH W DAV I; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Borooah VK, 2005, J DEV STUD, V41, P1369, DOI 10.1080/00220380500186960; Celik Y, 2000, SOC SCI MED, V50, P1797, DOI 10.1016/S0277-9536(99)00418-9; Chanana K, 1996, GIRLS' SCHOOLING, WOMEN'S AUTONOMY AND FERTILITY CHANGE IN SOUTH ASIA, P107; Chatters LM, 2000, ANNU REV PUBL HEALTH, V21, P233; Desai S, 2008, DEMOGRAPHY, V45, P245; Deshpande A, 2000, AM ECON REV, V90, P322, DOI 10.1257/aer.90.2.322; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Ellison CG, 1998, HEALTH EDUC BEHAV, V25, P700, DOI 10.1177/109019819802500603; Fatusi AO, 2010, J ADOLESCENCE, V33, P499, DOI 10.1016/j.adolescence.2010.05.019; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Gage AL, 2006, POP STUD-J DEMOG, V60, P271, DOI 10.1080/00324720600895934; Government of India, 2005, JAN SUR YOJ; Government of India, 2011, MAT MORT IND 2007 09; Government of India, 2008, CONST IND MOD 1 DEC; Government of India Planning Commission, 2007, POV EST 2004 05; Griffiths P, 2002, SOC SCI MED, V55, P775, DOI 10.1016/S0277-9536(01)00202-7; Gyimah SO, 2006, SOC SCI MED, V62, P2930, DOI 10.1016/j.socscimed.2005.11.034; Hampton T, 2010, JAMA-J AM MED ASSOC, V304, P509, DOI 10.1001/jama.2010.1009; Hazarika I, 2011, MATERN CHILD HLTH J, V15, P1381, DOI 10.1007/s10995-010-0687-3; Hussein J, 2010, BJOG-INT J OBSTET GY, V117, P304, DOI 10.1111/j.1471-0528.2009.02457.x; ICRW, 2010, NEW INS PREV CHILD M; Indian Legislature, 1929, INDIAN GAZETTE ACT N; International Institute for Population Sciences (IIPS) and Population Council, 2010, YOUTH IND SIT NEEDS; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF, VII; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF, V1; Jafarey S, 2008, INT J GYNECOL OBSTET, V102, P179, DOI 10.1016/j.ijgo.2008.03.018; Jejeebhoy SJ, 2002, STUD FAMILY PLANN, V33, P299, DOI 10.1111/j.1728-4465.2002.00299.x; Jensen R., 2003, GENDER DEV, V11, P9, DOI DOI 10.1080/741954311; Kandel DB, 2004, AM J PUBLIC HEALTH, V94, P128, DOI 10.2105/AJPH.94.1.128; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Klingberg-Allvin M, 2010, SEX REPROD HEALTHC, V1, P15, DOI 10.1016/j.srhc.2009.09.002; Kulkarni P. M., 2005, Economic and Political Weekly, V40, P403; Kumar Satish, 2005, Indian J Public Health, V49, P163; LEGRAND TK, 1993, STUD FAMILY PLANN, V24, P137, DOI 10.2307/2939229; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Louis P, 2003, ECON POLIT WEEKLY, V38, P2475; Mahmood N, 1996, Pak Dev Rev, V35, P1; Matthews Z, 2005, J BIOSOC SCI, V37, P385, DOI 10.1017/S0021932004006911; Miah M. M. R, 1992, INT REV MOD SOCIOL, V22, P99; Ministry of Health and Family Welfare, 2011, SERV PROV MAN UND HL, VI; Ministry of Health and Family Welfare, 2005, MIN HLTH FAM WELF AN; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; Mohanty SK, 2009, J BIOSOC SCI, V41, P381, DOI 10.1017/S002193200800309X; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; Nasir JA, 2011, J BIOSOC SCI, V43, P587, DOI 10.1017/S0021932011000216; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Omar K, 2010, INT J GYNECOL OBSTET, V111, P220, DOI 10.1016/j.ijgo.2010.06.023; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Pande R, 2003, AM ECON REV, V93, P1132, DOI 10.1257/000282803769206232; Pathak PK, 2010, ASIAN POPUL STUD, V6, P173, DOI 10.1080/17441730.2010.494444; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Patton GC, 2010, J ADOLESCENT HEALTH, V47, P427, DOI 10.1016/j.jadohealth.2010.08.019; Raghupathy S, 1996, SOC SCI MED, V43, P459, DOI 10.1016/0277-9536(95)00411-4; Rai RK, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1161, DOI [10.1177/1010539512436883, 10.1177/101053951]; Rai RK, 2012, MATERN CHILD HLTH J, V16, P1139, DOI 10.1007/s10995-011-0886-6; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; Ram F, 2006, J BIOSOC SCI, V38, P433, DOI 10.1017/S0021932005026453; Rani M, 2004, INT FAM PLAN PERSPEC, V30, P110, DOI 10.1363/3011004; Rasheed S, 2011, INT J GYNECOL OBSTET, V112, P21, DOI 10.1016/j.ijgo.2010.08.006; Reynolds HW, 2006, INT FAM PLAN PERSPEC, V32, P6, DOI 10.1363/3200606; Robinson R., 2007, ECON POLIT WEEKLY, P839; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Rosenfield A, 2008, NEW ENGL J MED, V359, P1869, DOI 10.1056/NEJMp0806807; Sachar Rajindar, 2006, SOCIAL EC ED STATUS; Saikia N, 2009, J BIOSOC SCI, V41, P329, DOI 10.1017/S0021932008003209; Salam A, 2006, J OBSTET GYN INDIA, V56, P123; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; Santhya KG, 2008, EARLY MARRIAGE SEXUA; Saroha Ekta, 2008, J Midwifery Womens Health, V53, pe41, DOI 10.1016/j.jmwh.2008.05.002; Sau R, 2001, ECON POLIT WEEKLY, V34, P3607; Schuon F, 1994, UNDERSTANDING ISLAM; SHARIFF A, 1995, ECON POLIT WEEKLY, V30, P2947; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; SPSS, 2006, STAT PACK SOC SCI; Srinivasan K, 1991, ECON POLIT WEEKLY, V34, P3052; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Sugathan KS, 2001, PROMOTING I DELIVERI; Sunil TS, 2006, SOC SCI MED, V62, P1943, DOI 10.1016/j.socscimed.2005.09.004; Takyi BK, 2003, SOC SCI MED, V56, P1221, DOI 10.1016/S0277-9536(02)00122-3; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thind A, 2005, J FAM PLAN REPROD H, V31, P34, DOI 10.1783/0000000052972762; Thorat S, BLOCKED CASTE EC DIS; Tuddenham SA, 2010, INT J GYNECOL OBSTET, V109, P245, DOI 10.1016/j.ijgo.2010.01.016; UNAIDS, 1998, AIDS ED IM SPIR MOT; United Nations, 2009, UN MILL DEV GOALS; United Nations Children's Fund, 2011, PROGR CHILDR WORLD F; United Nations Population Found, 2009, CONC ASS JAN SUR YOJ; Verma K, 2001, J OBSTET GYNAECOL RE, V27, P183, DOI 10.1111/j.1447-0756.2001.tb01249.x; Vissandjee B, 1997, PUBLIC HEALTH, V111, P135, DOI 10.1016/S0033-3506(97)00572-6; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; WHO, 2008, AD PREGN; World Health Organization, 1998, BAS NEWB RES PRACT G; World Health Organization(WHO), 2006, PROV EFF ANT CAR INT; Yadav Kapil, 2009, Indian J Community Med, V34, P3, DOI 10.4103/0970-0218.45368	108	191	191	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31666	10.1371/journal.pone.0031666	http://dx.doi.org/10.1371/journal.pone.0031666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355386	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300086
J	Wang, C; Liu, ZH; Huang, X				Wang, Chao; Liu, Zhonghua; Huang, Xun			Rab32 Is Important for Autophagy and Lipid Storage in Drosophila	PLOS ONE			English	Article							FAT STORAGE; DROPLETS; PROTEINS; REVEALS; ADIPOGENESIS; HOMEOSTASIS; METABOLISM; REGULATOR; PERILIPIN; DELIVERY	Lipids are essential components of all organisms. Within cells, lipids are mainly stored in a specific type of organelle, called the lipid droplet. The molecular mechanisms governing the dynamics of lipid droplets have been little explored. The protein composition of lipid droplets has been analyzed in numerous proteomic studies, and a large number of lipid droplet-associated proteins have been identified, including Rab small GTPases. Rab proteins are known to participate in many intracellular membranous events; however, their exact role in lipid droplets is largely unexplored. Here we systematically investigate the roles of Drosophila Rab family proteins in lipid storage in the larval adipose tissue, fat body. Rab32 and several other Rabs were found to affect the size of lipid droplets as well as lipid levels. Further studies showed that Rab32 and Rab32 GEF/Claret may be involved in autophagy, consequently affecting lipid storage. Loss-of-function mutants of several components in the autophagy pathway result in similar effects on lipid storage. These results highlight the potential functions of Rabs in regulating lipid metabolism.	[Wang, Chao; Liu, Zhonghua; Huang, Xun] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, C (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	xhuang@genetics.ac.cn		Huang, Xun/0000-0002-2653-8293	Ministry of Science and Technology of China (MOST) [2009CB919000]; National Natural Science Foundation of China (NSFC) [30830069, 31071253]; Chinese Academy of Sciences	Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	Research reported here was supported by grants 2009CB919000 from the Ministry of Science and Technology of China (MOST) and 30830069 and 31071253 from the National Natural Science Foundation of China (NSFC). X.H. is funded by the One Hundred Talents program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kohler K, 2009, AUTOPHAGY, V5, P980; Kuhnlein RP, 2010, BBA-MOL CELL BIOL L, V1801, P215, DOI 10.1016/j.bbalip.2009.09.006; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Ma JP, 2004, P NATL ACAD SCI USA, V101, P11652, DOI 10.1073/pnas.0401926101; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	44	74	78	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32086	10.1371/journal.pone.0032086	http://dx.doi.org/10.1371/journal.pone.0032086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348149	gold, Green Published, Green Submitted			2022-12-27	WOS:000302737400063
J	Naranjo-Suarez, S; Carlson, BA; Tsuji, PA; Yoo, MH; Gladyshev, VN; Hatfield, DL				Naranjo-Suarez, Salvador; Carlson, Bradley A.; Tsuji, Petra A.; Yoo, Min-Hyuk; Gladyshev, Vadim N.; Hatfield, Dolph L.			HIF-Independent Regulation of Thioredoxin Reductase 1 Contributes to the High Levels of Reactive Oxygen Species Induced by Hypoxia	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; INDUCIBLE FACTOR; GENE-EXPRESSION; COMPLEX-III; ACTIVATION; TRANSCRIPTION; ANGIOGENESIS; ALPHA; ROS; FACTOR-1-ALPHA	Cellular adaptation to hypoxic conditions mainly involves transcriptional changes in which hypoxia inducible factors (HIFs) play a critical role. Under hypoxic conditions, HIF protein is stabilized due to inhibition of the activity of prolyl hydroxylases (EGLNs). Because the reaction carried out by these enzymes uses oxygen as a co-substrate it is generally accepted that the hypoxic inhibition of EGLNs is due to the reduction in oxygen levels. However, several studies have reported that hypoxic generation of mitochondrial reactive oxygen species (ROS) is required for HIF stabilization. Here, we show that hypoxia downregulates thioredoxin reductase 1 (TR1) mRNA and protein levels. This hypoxic TR1 regulation is HIF independent, as HIF stabilization by EGLNs inhibitors does not affect TR1 expression and HIF deficiency does not block TR1 hypoxic-regulation, and it has an effect on TR1 function, as hypoxic conditions also reduce TR1 activity. We found that, when cultured under hypoxic conditions, TR1 deficient cells showed a larger accumulation of ROS compared to control cells, whereas TR1 over-expression was able to block the hypoxic generation of ROS. Furthermore, the changes in ROS levels observed in TR1 deficient or TR1 over-expressing cells did not affect HIF stabilization or function. These results indicate that hypoxic TR1 down-regulation is important in maintaining high levels of ROS under hypoxic conditions and that HIF stabilization and activity do not require hypoxic generation of ROS.	[Naranjo-Suarez, Salvador; Carlson, Bradley A.; Tsuji, Petra A.; Yoo, Min-Hyuk; Hatfield, Dolph L.] Natl Canc Inst, Lab Canc Prevent, Mol Biol Selenium Sect, Bethesda, MD 20892 USA; [Tsuji, Petra A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21205 USA; [Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; Towson University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Naranjo-Suarez, S (corresponding author), Natl Canc Inst, Lab Canc Prevent, Mol Biol Selenium Sect, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov	Gladyshev, Vadim N/J-6187-2013; Suarez, Salvador Naranjo/K-8450-2017; Gladyshev, Vadim N/A-9894-2013	Suarez, Salvador Naranjo/0000-0002-7038-0753; Gladyshev, Vadim/0000-0002-0372-7016	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NIH; NATIONAL CANCER INSTITUTE [ZIABC010889, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health (to DLH) and NIH grants (to VNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FU T, 1992, BIOCHEM J, V283, P347, DOI 10.1042/bj2830347; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Miller TW, 2009, CHEM REV, V109, P3099, DOI 10.1021/cr8005125; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SETA KA, 2002, SCI STKE, V146, pRE11, DOI DOI 10.1126/STKE.2002.146.RE11; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, RNA, V13, P921, DOI 10.1261/rna.533007; Yoo MH, 2010, ANTIOXID REDOX SIGN, V12, P819, DOI 10.1089/ars.2009.2891; ZULUETA JJ, 1995, AM J RESP CELL MOL, V12, P41, DOI 10.1165/ajrcmb.12.1.7529030	40	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30470	10.1371/journal.pone.0030470	http://dx.doi.org/10.1371/journal.pone.0030470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348009	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900009
J	Wijesuriya, M; Gulliford, M; Charlton, J; Vasantharaja, L; Viberti, G; Gnudi, L; Karalliedde, J				Wijesuriya, Mahen; Gulliford, Martin; Charlton, Judith; Vasantharaja, Laksha; Viberti, Giancarlo; Gnudi, Luigi; Karalliedde, Janaka			High Prevalence of Cardio-Metabolic Risk Factors in a Young Urban Sri-Lankan Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; CHILDHOOD OBESITY; CHRONIC DISEASES; OVERWEIGHT; ADOLESCENTS; DEFINITION; CHILDREN; HEALTH	Background: South-Asian's are predisposed to early onset type 2 diabetes (T2DM). The prevalence of cardio-metabolic risk-factors in young Sri-Lankans is unknown. Methodology/Principal Findings: To determine by questionnaire and anthropometry the prevalence of first degree family history (FH) of T2DM, physical inactivity, raised waist circumference (WC) and raised body mass index (BMI) in a representative healthy urban population selected by cluster sampling. Those with >= 2 risk-factors were evaluated for metabolic syndrome (MS) and recruited for an intervention trial. Of 23,296 participants screened, 22,507 (53% Female) were eligible [8,497 aged 10-14 yrs, 4,763 aged 15-19 yrs and 9,247 aged 20-40 yrs]. 51% had none of the 4 risk-factors, 26% 1 risk-factor and 23% (5,163) >= 2 risk-factors of whom 4,532 were assessed for MS. Raised BMI was noted in 19.7% aged 10-14 yrs, 15.3% between 15-19 yrs, and between 20-40 yrs, 27.4% of males vs. 21.8% of females p<0.001. Prevalence of raised WC was greater in females for each age group: 42.7% vs. 32.1%; 28.1% vs. 16.1%; 34.5% vs. 25.7% (p<0.05 for all) as was physical inactivity: 39.9% vs. 14.5%; 51.7% vs. 20.0%; 62.7% vs. 41.3% which rose in both sexes with age (p<0.05 for all). FH of T2DM was present in 26.2%. In 4532 (50%, 16 yrs) with >= 2 risk-factors, impaired fasting glycaemia/impaired glucose tolerance (pre-diabetes) prevalence was 16%. MS was more prevalent in males [10-16 yrs (13.0% vs. 8.8%), 16-40 yrs (29.5% vs. 20.0%) p<0.001 for both]. Conclusions/Significance: There is a high prevalence of modifiable cardio-metabolic risk-factors in young urban Sri-Lankans with significant gender differences. A primary prevention intervention trial is ongoing in this cohort. Clinical Trial Registration Number SLCTR/2008/World Health Organization (WHO) international clinical trial registry platform.	[Wijesuriya, Mahen; Vasantharaja, Laksha] Natl Diabet Ctr, Diabet Assoc Sri Lanka, Colombo, Sri Lanka; [Viberti, Giancarlo; Gnudi, Luigi; Karalliedde, Janaka] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England; [Gulliford, Martin; Charlton, Judith] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Wijesuriya, M (corresponding author), Natl Diabet Ctr, Diabet Assoc Sri Lanka, Colombo, Sri Lanka.	j.karalliedde@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075; Karalliedde, Janaka/0000-0002-2617-8320; gnudi, luigi/0000-0002-6353-630X	BRIDGES from the International Diabetes Federation; Lilly Diabetes; Nelson R Mandela School of Medicine, Durban, South Africa; University of Pittsburgh, Pittsburgh USA	BRIDGES from the International Diabetes Federation; Lilly Diabetes; Nelson R Mandela School of Medicine, Durban, South Africa; University of Pittsburgh, Pittsburgh USA(University of Pittsburgh)	This project is supported by a BRIDGES Grant from the International Diabetes Federation. BRIDGES, an International Diabetes Federation Project, is supported by an educational grant from Lilly Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support and advice of Professor Motala (Nelson R Mandela School of Medicine, Durban, South Africa) and Professor Linda Siminerio (University of Pittsburgh, Pittsburgh USA). We acknowledge the contribution of Dr Thilinie Jayasekera, Ms Talya Fernando, Dr Nuwan Ranawaka for their help with this work. We wish to thank Dr Varsha, Dr Mahesh (MV Diabetes Centre, WHO collaborating centre for research education and training in diabetes, Chennai India) and Dr Arambepola (University of Colombo Sri Lanka) for their advice and input as members of the DIABRISK-SL independent study advisory committee. We also wish to thank all the participants of the study.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anjana RM, 2009, METABOLISM, V58, P344, DOI 10.1016/j.metabol.2008.10.006; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; de Silva K. S. H., 2006, CEYLON MEDICAL JOURNAL, V51, P105; Department of Census and Statistics, 2001, CENS REP 2001; Genuth S, 2003, DIABETES CARE, V26, P3160; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; Jafar TH, 2008, ARCH DIS CHILD, V93, P373, DOI 10.1136/adc.2007.125641; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Katulanda P, 2010, OBES REV, V11, P751, DOI 10.1111/j.1467-789X.2010.00746.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mohan V, 2001, DIABETIC MED, V18, P280, DOI 10.1046/j.1464-5491.2001.00421.x; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Ramachandran A, 2007, DIABETES CARE, V30, P1828, DOI 10.2337/dc06-2097; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Wickramasinghe V. P., 2004, Ceylon Medical Journal, V49, P114; Wijesuriya M, 2009, PREVALENCE CENTRAL O; World Health Organization, 1999, DEF DIAGN CLASS DI 1; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31309	10.1371/journal.pone.0031309	http://dx.doi.org/10.1371/journal.pone.0031309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348068	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900040
J	Schuetz, JM; Daley, D; Graham, J; Berry, BR; Gallagher, RP; Connors, JM; Gascoyne, RD; Spinelli, JJ; Brooks-Wilson, AR				Schuetz, Johanna M.; Daley, Denise; Graham, Jinko; Berry, Brian R.; Gallagher, Richard P.; Connors, Joseph M.; Gascoyne, Randy D.; Spinelli, John J.; Brooks-Wilson, Angela R.			Genetic Variation in Cell Death Genes and Risk of Non-Hodgkin Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; GERMINAL-CENTER; FOLLICULAR LYMPHOMA; NEGATIVE REGULATOR; GERMLINE VARIATION; GENOMIC CONTROL; MICRORNA GENES; BREAST-CANCER; ASSOCIATION	Background: Non-Hodgkin lymphomas are a heterogeneous group of solid tumours that constitute the 5th highest cause of cancer mortality in the United States and Canada. Poor control of cell death in lymphocytes can lead to autoimmune disease or cancer, making genes involved in programmed cell death of lymphocytes logical candidate genes for lymphoma susceptibility. Materials and Methods: We tested for genetic association with NHL and NHL subtypes, of SNPs in lymphocyte cell death genes using an established population-based study. 17 candidate genes were chosen based on biological function, with 123 SNPs tested. These included tagSNPs from HapMap and novel SNPs discovered by re-sequencing 47 cases in genes for which SNP representation was judged to be low. The main analysis, which estimated odds ratios by fitting data to an additive logistic regression model, used European ancestry samples that passed quality control measures (569 cases and 547 controls). A two-tiered approach for multiple testing correction was used: correction for number of tests within each gene by permutation-based methodology, followed by correction for the number of genes tested using the false discovery rate. Results: Variant rs928883, near miR-155, showed an association (OR per A-allele: 2.80 [95% CI: 1.63-4.82]; p(F) = 0.027) with marginal zone lymphoma that is significant after correction for multiple testing. Conclusions: This is the first reported association between a germline polymorphism at a miRNA locus and lymphoma.	[Schuetz, Johanna M.; Brooks-Wilson, Angela R.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Schuetz, Johanna M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Daley, Denise] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Graham, Jinko] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada; [Berry, Brian R.] Royal Jubilee Hosp, Dept Pathol, Victoria, BC, Canada; [Gallagher, Richard P.; Spinelli, John J.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Connors, Joseph M.] BC Canc Agcy, Div Med Oncol, Vancouver, BC, Canada; [Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Simon Fraser University; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Simon Fraser University	Schuetz, JM (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	abrooks-wilson@bcgsc.ca	Spinelli, John J./B-6210-2013; Brooks-Wilson, Angela/E-9399-2012; Connors, Joseph/AAF-5284-2019; Graham, JInko/ABE-1507-2021	Spinelli, John J./0000-0002-9119-3287; Brooks-Wilson, Angela/0000-0003-1009-6408; Connors, Joseph/0000-0002-1361-7531; Graham, JInko/0000-0003-4568-1228	Canadian Institutes for Health Research (CIHR); Canadian Cancer Society; Alberta Heritage Foundation for Medical Research	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and the Canadian Cancer Society. J.M.S. was supported by the Lionel McLeod Award of the Alberta Heritage Foundation for Medical Research and by CIHR. D. D. holds a Tier II Canadian Research Chair (Genetic Epidemiology of Common Complex Diseases). A.B.-W. is a Senior Scholar and D. D. and J.G. are Scholars of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Au WY, 2005, ANN HEMATOL, V84, P506, DOI 10.1007/s00277-005-1028-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund M, 2006, BLOOD, V108, P3623, DOI 10.1182/blood-2006-06-032367; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; Do TN, 2009, CANCER GENET CYTOGEN, V195, P31, DOI 10.1016/j.cancergencyto.2009.05.009; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Eischen CM, 2004, ONCOGENE, V23, P8931, DOI 10.1038/sj.onc.1208052; Enjuanes A, 2008, CANCER RES, V68, P10178, DOI 10.1158/0008-5472.CAN-08-2221; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Halaschek-Wiener J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006641; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johansson A, 2007, HUM GENET, V122, P141, DOI 10.1007/s00439-007-0379-2; Jung I, 2009, BRIT J HAEMATOL, V144, P138, DOI 10.1111/j.1365-2141.2008.07424.x; Kelly JL, 2010, CANCER EPIDEM BIOMAR, V19, P2847, DOI 10.1158/1055-9965.EPI-10-0581; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Mead S, 2008, HUM MUTAT, V29, P1452, DOI 10.1002/humu.20782; Morton LM, 2009, CANCER EPIDEM BIOMAR, V18, P1259, DOI 10.1158/1055-9965.EPI-08-1037; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuetz JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-117; Scott K, 2008, HAEMATOL-HEMATOL J, V93, P1597, DOI 10.3324/haematol.13159; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shen J, 2009, INT J CANCER, V124, P1178, DOI 10.1002/ijc.24008; Sipahimalani P, 2007, INT J CANCER, V121, P1967, DOI 10.1002/ijc.22888; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Susova S, 2006, CANCER LETT, V238, P142, DOI 10.1016/j.canlet.2005.07.015; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Villa-Morales M, 2010, CARCINOGENESIS, V31, P2165, DOI 10.1093/carcin/bgq201; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Wrench D, 2009, HAEMATOL-HEMATOL J, V94, P148, DOI 10.3324/haematol.13533; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang R, 2010, BREAST CANC RES TREA; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Yuille MR, 1999, BRIT J HAEMATOL, V107, P384, DOI 10.1046/j.1365-2141.1999.01722.x; Zenz T, 2008, HAEMATOL-HEMATOL J, V93, P1111, DOI 10.3324/haematol.12738; Zhang YW, 2005, JNCI-J NATL CANCER I, V97, P1616, DOI 10.1093/jnci/dji344; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	63	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31560	10.1371/journal.pone.0031560	http://dx.doi.org/10.1371/journal.pone.0031560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347493	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600042
J	Braunschweig, M; Jagannathan, V; Gutzwiller, A; Bee, G				Braunschweig, Martin; Jagannathan, Vidhya; Gutzwiller, Andreas; Bee, Giuseppe			Investigations on Transgenerational Epigenetic Response Down the Male Line in F2 Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; DNA METHYLATION; INHERITANCE; ALLELE	We investigated the nutritional effects on carcass traits, gene expression and DNA methylation in a three generation Large White pig feeding experiment. A group of experimental (E) F0 boars were fed a standard diet supplemented with high amounts of methylating micronutrients whereas a control group (C) of F0 boars received a standard diet. These differentially fed F0 boars sired F1 boars which then sired 60 F2 pigs. Carcass traits were compared between 36 F2 descendants of E F0 boars and 24 F2 descendants of C F0 boars. The two F2 offspring groups differed with respect to backfat percentage (P = 0.03) and tended to differ with respect to adipose tissue (P = 0.09), fat thickness at the 10th rib (P = 0.08) and at the croup (P = 0.09) as well as percentages of shoulder (P = 0.07). Offspring from the experimental F0 boars had a higher percentage of shoulder and were leaner compared to the control group. Gene expression profiles showed significant twofold differences in mRNA level between 8 C F2 offspring and 8 E F2 offspring for 79, 64 and 53 genes for muscle, liver and kidney RNA, respectively. We found that in liver and muscle respective pathways of lipid metabolism and metabolic pathway were over-represented for the differentially expressed genes between these groups. A DNA methylation analysis in promoters of differentially expressed genes indicated a significant difference in DNA methylation at the IYD gene. If these responses on carcass traits, gene expression and DNA methylation withstand verification and can indeed be attributed to transgenerational epigenetic inheritance, it would open up pioneering application in pork production and would have implications for human health.	[Braunschweig, Martin; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Gutzwiller, Andreas; Bee, Giuseppe] Agroscope Liebefeld Posieux, Fed Res Stn Anim Prod, Posieux, Switzerland	University of Bern; Swiss Federal Research Station Agroscope	Braunschweig, M (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	martin.braunschweig@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019	Jagannathan, Vidhya/0000-0002-8155-0041	European Commission [FOOD-CT-2006-016250]	European Commission(European CommissionEuropean Commission Joint Research Centre)	These results are part of the SABRE research project that has been co-financed by the European Commission, within the 6th Framework Programme, contract No. FOOD-CT-2006-016250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The text represents the authors' views and does not necessarily represent a position of the Commission, who will not be liable for the use made of such information.	ALP (Agroscope Liebefeld-Posieux), 2005, APP AL REC TABL VAL; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baker DH, 2006, J NUTR, V136, p1670S, DOI 10.1093/jn/136.6.1670S; Bee G, 2004, J ANIM SCI, V82, P826; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Braunschweig MH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-47; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gutzwiller A, 2009, VET REC, V165, P598, DOI 10.1136/vr.165.20.598; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; National Research Council (NRC), 1987, VIT TOL AN; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	28	81	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30583	10.1371/journal.pone.0030583	http://dx.doi.org/10.1371/journal.pone.0030583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359544	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200013
J	Sabat, R; Chanwangpong, A; Schneider-Burrus, S; Metternich, D; Kokolakis, G; Kurek, A; Philipp, S; Uribe, D; Wolk, K; Sterry, W				Sabat, Robert; Chanwangpong, Akewit; Schneider-Burrus, Sylke; Metternich, Deborah; Kokolakis, Georgios; Kurek, Agata; Philipp, Sandra; Uribe, Daniela; Wolk, Kerstin; Sterry, Wolfram			Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HIDRADENITIS SUPPURATIVA; CARDIOVASCULAR-DISEASE; PSORIASIS; RISK; KERATINOCYTES; INFLIXIMAB; ADALIMUMAB; PRECURSOR; IMMUNITY	Background: Acne inversa (AI; also designated as Hidradenitis suppurativa) is a common chronic inflammatory skin disease, localized in the axillary, inguinal and perianal skin areas that causes painful, fistulating sinuses with malodorous purulence and scars. Several chronic inflammatory diseases are associated with the metabolic syndrome and its consequences including arteriosclerosis, coronary heart disease, myocardial infraction, and stroke. So far, the association of AI with systemic metabolic alterations is largely unexplored. Methods and Findings: A hospital-based case-control study in 80 AI patients and 100 age- and sex-matched control participants was carried out. The prevalence of central obesity (odds ratio 5.88), hypertriglyceridemia (odds ratio 2.24), hypo-HDL-cholesterolemia (odds ratio 4.56), and hyperglycemia (odds ratio 4.09) in AI patients was significantly higher than in controls. Furthermore, the metabolic syndrome, previously defined as the presence of at least three of the five alterations listed above, was more common in those patients compared to controls (40.0% versus 13.0%; odds ratio 4.46, 95% confidence interval 2.02 to 9.96; P < 0.001). AI patients with metabolic syndrome also had more pronounced metabolic alterations than controls with metabolic syndrome. Interestingly, there was no correlation between the severity or duration of the disease and the levels of respective parameters or the number of criteria defining the metabolic syndrome. Rather, the metabolic syndrome was observed in a disproportionately high percentage of young AI patients. Conclusions: This study shows for the first time that AI patients have a high prevalence of the metabolic syndrome and all of its criteria. It further suggests that the inflammation present in AI patients does not have a major impact on the development of metabolic alterations. Instead, evidence is given for a role of metabolic alterations in the development of AI. We recommend monitoring of AI patients in order to correct their modifiable cardiovascular risk factors.	[Sabat, Robert; Chanwangpong, Akewit; Schneider-Burrus, Sylke; Kurek, Agata; Uribe, Daniela; Sterry, Wolfram] Univ Hosp Charite, Dept Dermatol & Allergy, Berlin, Germany; [Sabat, Robert; Metternich, Deborah; Kokolakis, Georgios; Philipp, Sandra; Wolk, Kerstin] Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol, Berlin, Germany; [Sabat, Robert; Kokolakis, Georgios; Philipp, Sandra; Wolk, Kerstin] Univ Hosp Charite, Psoriasis Res & Treatment Ctr, Dept Dermatol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sabat, R (corresponding author), Univ Hosp Charite, Dept Dermatol & Allergy, Berlin, Germany.	robert.sabat@charite.de	Wolk, Kerstin/O-1205-2013	Kokolakis, Georgios/0000-0002-8042-7885; Wolk, Kerstin/0000-0002-7689-4130				Alikhan A, 2009, J AM ACAD DERMATOL, V60, P539, DOI 10.1016/j.jaad.2008.11.911; Arenbergerova M, 2010, INT J DERMATOL, V49, P1445, DOI 10.1111/j.1365-4632.2010.04638.x; Bieniek A, 2010, DERMATOL SURG, V36, P1998, DOI 10.1111/j.1524-4725.2010.01763.x; Boehncke WH, 2009, J DTSCH DERMATOL GES; Chung CP, 2008, ATHEROSCLEROSIS, V196, P756, DOI 10.1016/j.atherosclerosis.2007.01.004; Cohen AD, 2008, DERMATOLOGY, V216, P152, DOI 10.1159/000111512; Dziurla R, 2010, IMMUNOL LETT, V131, P97, DOI 10.1016/j.imlet.2010.02.008; Esmann S, 2011, ACTA DERM VENEREOL; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gener G, 2009, DERMATOLOGY, V219, P148, DOI 10.1159/000228334; Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x; Grant A, 2010, J AM ACAD DERMATOL, V62, P205, DOI 10.1016/j.jaad.2009.06.050; Harde V, 2009, J DTSCH DERMATOL GES, V7, P139, DOI 10.1111/j.1610-0387.2008.06918.x; Haslund P, 2009, ACTA DERM-VENEREOL, V89, P595, DOI 10.2340/00015555-0747; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Jemec GBE, 1996, J AM ACAD DERMATOL, V35, P191, DOI 10.1016/S0190-9622(96)90321-7; Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712.x, 10.1111/j.1600-0625.2008.00712_1.x]; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Love TJ, 2010, ARCH DERMATOL; Matusiak L, 2010, ACTA DERM-VENEREOL, V90, P264, DOI 10.2340/00015555-0866; Meixner D, 2008, J DTSCH DERMATOL GES, V6, P189, DOI 10.1111/j.1610-0387.2007.06492.x; Mekkes JR, 2008, BRIT J DERMATOL, V158, P370, DOI 10.1111/j.1365-2133.2007.08332.x; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Rompel R, 2000, DERMATOL SURG, V26, P638, DOI 10.1046/j.1524-4725.2000.00043.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Sartorius K, 2009, BRIT J DERMATOL, V161, P831, DOI 10.1111/j.1365-2133.2009.09198.x; van Rappard DC, 2011, J EUR ACAD DERMATOL; von Laffert M, 2011, BRIT J DERMATOL, V164, P367, DOI 10.1111/j.1365-2133.2010.10034.x; von Laffert M, 2010, EXP DERMATOL, V19, P533, DOI 10.1111/j.1600-0625.2009.00915.x; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wegenka UM, 2010, CYTOKINE GROWTH F R, V21, P353, DOI 10.1016/j.cytogfr.2010.08.001; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; 2001, JAMA, V285, P2486	41	154	156	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31810	10.1371/journal.pone.0031810	http://dx.doi.org/10.1371/journal.pone.0031810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359634	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200103
J	Valtonen, TM; Kangassalo, K; Polkki, M; Rantala, MJ				Valtonen, Terhi M.; Kangassalo, Katariina; Polkki, Mari; Rantala, Markus J.			Transgenerational Effects of Parental Larval Diet on Offspring Development Time, Adult Body Size and Pathogen Resistance in Drosophila melanogaster	PLOS ONE			English	Article							MATING SUCCESS; LIFE-HISTORY; EGG SIZE; GENERATION; EVOLUTION; TRAITS; ENVIRONMENT; MECHANISMS; NUTRITION; BENEFITS	Environmental conditions experienced by parents are increasingly recognized to affect offspring performance. We set out to investigate the effect of parental larval diet on offspring development time, adult body size and adult resistance to the bacterium Serratia marcescens in Drosophila melanogaster. Flies for the parental generation were raised on either poor or standard diet and then mated in the four possible sex-by-parental diet crosses. Females that were raised on poor food produced larger offspring than females that were raised on standard food. Furthermore, male progeny sired by fathers that were raised on poor food were larger than male progeny sired by males raised on standard food. Development times were shortest for offspring whose one parent (mother or the father) was raised on standard and the other parent on poor food and longest for offspring whose parents both were raised on poor food. No evidence for transgenerational effects of parental diet on offspring disease resistance was found. Although paternal effects have been previously demonstrated in D. melanogaster, no earlier studies have investigated male-mediated transgenerational effects of diet in this species. The results highlight the importance of not only considering the relative contribution each parental sex has on progeny performance but also the combined effects that the two sexes may have on offspring performance.	[Valtonen, Terhi M.; Kangassalo, Katariina; Polkki, Mari; Rantala, Markus J.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Turku	Valtonen, TM (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	terval@utu.fi			Finnish Cultural Foundation; Academy of Finland	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland)	This study was supported by the Finnish Cultural Foundation to TMV and by the Academy of Finland to MJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; Azevedo RBR, 1997, AM NAT, V150, P250, DOI 10.1086/286065; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Bonduriansky R, 2007, J EVOLUTION BIOL, V20, P2379, DOI 10.1111/j.1420-9101.2007.01419.x; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Bubli OA, 1998, EVOLUTION, V52, P619, DOI [10.2307/2411097, 10.1111/j.1558-5646.1998.tb01661.x]; Bubliy OA, 2000, HEREDITAS, V133, P59, DOI 10.1111/j.1601-5223.2000.00059.x; Burger JMS, 2007, AGING CELL, V6, P63, DOI 10.1111/j.1474-9726.2006.00261.x; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Crill WD, 1996, EVOLUTION, V50, P1205, DOI [10.2307/2410661, 10.1111/j.1558-5646.1996.tb02361.x]; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Devevey G, 2010, FUNCT ECOL, V24, P178, DOI 10.1111/j.1365-2435.2009.01609.x; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Friberg U, 2012, BIOL LETTERS, V8, P71, DOI 10.1098/rsbl.2011.0608; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Frost PC, 2010, OECOLOGIA, V162, P865, DOI 10.1007/s00442-009-1517-4; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Garcia-Gonzalez F, 2007, CURR BIOL, V17, P32, DOI 10.1016/j.cub.2006.10.054; GIESEL JT, 1988, EVOLUTION, V42, P1348, DOI 10.1111/j.1558-5646.1988.tb04194.x; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Guzman-Novoa E, 2005, J HERED, V96, P376, DOI 10.1093/jhered/esi038; HUEY RB, 1995, HEREDITY, V74, P216, DOI 10.1038/hdy.1995.30; Hunt J, 2000, EVOLUTION, V54, P936, DOI 10.1111/j.0014-3820.2000.tb00093.x; Ivy TM, 2007, J EVOLUTION BIOL, V20, P479, DOI 10.1111/j.1420-9101.2006.01269.x; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Joshi A, 2004, J GENET, V83, P13, DOI 10.1007/BF02715824; KARR TL, 1991, MECH DEVELOP, V34, P101, DOI 10.1016/0925-4773(91)90047-A; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Magiafoglou A, 2003, FUNCT ECOL, V17, P664, DOI 10.1046/j.1365-2435.2003.00774.x; MARKOW TA, 1984, SCIENCE, V224, P302, DOI 10.1126/science.224.4646.302; McGraw LA, 2007, BIOL LETTERS, V3, P607, DOI 10.1098/rsbl.2007.0334; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Miller CW, 2007, P ROY SOC B-BIOL SCI, V274, P1279, DOI 10.1098/rspb.2006.0413; Miller GA, 2009, BIOL LETTERS, V5, P845, DOI 10.1098/rsbl.2009.0495; Mitchell SE, 2005, P ROY SOC B-BIOL SCI, V272, P2601, DOI 10.1098/rspb.2005.3253; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; PARTRIDGE L, 1987, ANIM BEHAV, V35, P468, DOI 10.1016/S0003-3472(87)80272-5; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; PARTRIDGE L, 1993, EVOLUTION, V47, P213, DOI 10.1111/j.1558-5646.1993.tb01211.x; Pischedda A, 2011, P ROY SOC B-BIOL SCI, V278, P2165, DOI 10.1098/rspb.2010.2272; Prasad NG, 2003, EVOL ECOL RES, V5, P903; RIDLEY M, 1978, ANIM BEHAV, V26, P904, DOI 10.1016/0003-3472(78)90156-2; Roff Derek, 2002, pi; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; SANTOS M, 1988, HEREDITY, V61, P255, DOI 10.1038/hdy.1988.113; Smedley SR, 1996, P NATL ACAD SCI USA, V93, P809, DOI 10.1073/pnas.93.2.809; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smith EM, 2007, J NUTR, V137, P2006, DOI 10.1093/jn/137.9.2006; Taborsky B, 2006, P ROY SOC B-BIOL SCI, V273, P741, DOI 10.1098/rspb.2005.3347; TALLAMY DW, 1984, BIOSCIENCE, V34, P20, DOI 10.2307/1309421; Valtonen TM, 2011, J EVOLUTION BIOL, V24, P196, DOI 10.1111/j.1420-9101.2010.02157.x; Valtonen TM, 2010, EVOL BIOL, V37, P49, DOI 10.1007/s11692-009-9078-3; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; WATSON MJO, 1995, AUST J ZOOL, V43, P51, DOI 10.1071/ZO9950051; Wenzel U, 2006, GENES NUTR, V1, P85, DOI 10.1007/BF02829950; West-Eberhard Mary Jane, 2003, pi; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; ZEH DW, 1985, AM ZOOL, V25, P785	81	70	72	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31611	10.1371/journal.pone.0031611	http://dx.doi.org/10.1371/journal.pone.0031611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359607	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200076
J	De Franceschi, L; Scardoni, G; Tomelleri, C; Danek, A; Walker, RH; Jung, HH; Bader, B; Mazzucco, S; Dotti, MT; Siciliano, A; Pantaleo, A; Laudanna, C				De Franceschi, Lucia; Scardoni, Giovanni; Tomelleri, Carlo; Danek, Adrian; Walker, Ruth H.; Jung, Hans H.; Bader, Benedikt; Mazzucco, Sara; Dotti, Maria Teresa; Siciliano, Angela; Pantaleo, Antonella; Laudanna, Carlo			Computational Identification of Phospho-Tyrosine Sub-Networks Related to Acanthocyte Generation in Neuroacanthocytosis	PLOS ONE			English	Article							ANION TRANSPORT ACTIVITY; CHOREA-ACANTHOCYTOSIS; BIOLOGICAL NETWORKS; MCLEOD-SYNDROME; GENE ONTOLOGY; PROTEIN; MEMBRANE; CYTOSCAPE; PHOSPHORYLATION; ORGANIZATION	Acanthocytes, abnormal thorny red blood cells (RBC), are one of the biological hallmarks of neuroacanthocytosis syndromes (NA), a group of rare hereditary neurodegenerative disorders. Since RBCs are easily accessible, the study of acanthocytes in NA may provide insights into potential mechanisms of neurodegeneration. Previous studies have shown that changes in RBC membrane protein phosphorylation state affect RBC membrane mechanical stability and morphology. Here, we coupled tyrosine-phosphoproteomic analysis to topological network analysis. We aimed to predict signaling sub-networks possibly involved in the generation of acanthocytes in patients affected by the two core NA disorders, namely McLeod syndrome (MLS, XK-related, Xk protein) and chorea-acanthocytosis (ChAc, VPS13A-related, chorein protein). The experimentally determined phosphoproteomic data-sets allowed us to relate the subsequent network analysis to the pathogenetic background. To reduce the network complexity, we combined several algorithms of topological network analysis including cluster determination by shortest path analysis, protein categorization based on centrality indexes, along with annotation-based node filtering. We first identified XK- and VPS13A-related protein-protein interaction networks by identifying all the interactomic shortest paths linking Xk and chorein to the corresponding set of proteins whose tyrosine phosphorylation was altered in patients. These networks include the most likely paths of functional influence of Xk and chorein on phosphorylated proteins. We further refined the analysis by extracting restricted sets of highly interacting signaling proteins representing a common molecular background bridging the generation of acanthocytes in MLS and ChAc. The final analysis pointed to a novel, very restricted, signaling module of 14 highly interconnected kinases, whose alteration is possibly involved in generation of acanthocytes in MLS and ChAc.	[De Franceschi, Lucia; Tomelleri, Carlo; Siciliano, Angela] Univ Verona, Dept Med, I-37100 Verona, Italy; [Scardoni, Giovanni; Laudanna, Carlo] Univ Verona, Dept Pathol & Diag, I-37100 Verona, Italy; [Scardoni, Giovanni; Laudanna, Carlo] Univ Verona, Ctr Biomed Comp, I-37100 Verona, Italy; [Danek, Adrian; Bader, Benedikt] Klinicum Univ Munchen, Neurol Klin & Poliklin, Munich, Germany; [Walker, Ruth H.] James J Peters Vet Affairs Med Ctr, Dept Neurol, New York, NY USA; [Walker, Ruth H.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Jung, Hans H.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Mazzucco, Sara] Univ Verona, Dept Neurosci, I-37100 Verona, Italy; [Dotti, Maria Teresa] Univ Siena, Dept Neurol, I-53100 Siena, Italy; [Pantaleo, Antonella] Univ Turin, Dept Biol Mol & Med Chem, Turin, Italy	University of Verona; University of Verona; University of Verona; University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; University of Verona; University of Siena; University of Turin	De Franceschi, L (corresponding author), Univ Verona, Dept Med, I-37100 Verona, Italy.	lucia.defranceschi@univr.it	DE FRANCESCHI, Lucia/AAB-8652-2022; Pantaleo, Antonella/ABA-5190-2020; Danek, Adrian/G-7339-2011	DE FRANCESCHI, Lucia/0000-0001-7093-777X; Danek, Adrian/0000-0001-8857-5383	Telethon [GP07007]; Advocacy on Neuro-acanthocytosis; AIRC (Associazione Italiana per la Ricerca sul Cancro) e Fondazione Cariverona	Telethon(Fondazione Telethon); Advocacy on Neuro-acanthocytosis; AIRC (Associazione Italiana per la Ricerca sul Cancro) e Fondazione Cariverona(Fondazione AIRC per la ricerca sul cancro)	Grants from Telethon grant (GP07007, LDF) and Advocacy on Neuro-acanthocytosis (LDF, AD, BB, RW) and AIRC (Associazione Italiana per la Ricerca sul Cancro) e Fondazione Cariverona (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Bader B, 2011, MOVEMENT DISORD, V25, P127; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Candiano G, 2002, ELECTROPHORESIS, V23, P292, DOI 10.1002/1522-2683(200202)23:2<292::AID-ELPS292>3.0.CO;2-5; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chiarugi P, 2000, J BIOL CHEM, V275, P4640, DOI 10.1074/jbc.275.7.4640; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Danek A, 2005, CURR OPIN NEUROL, V18, P386, DOI 10.1097/01.wco.0000173464.01888.e9; Danek A, 2005, J NEUROL SCI, V229, P171, DOI 10.1016/j.jns.2004.11.024; De Franceschi L, 1998, EXP HEMATOL, V26, P869; de Franceschi L, 2008, NEUROACANTHOCYTOSIS, VII; De Franceschi L, 2011, BLOOD, V118, P5652, DOI 10.1182/blood-2011-05-355339; De Franceschi L, 2008, PROTEOMICS, V8, P4695, DOI 10.1002/pmic.200700596; Dijkstra E, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dobson-Stone C, 2004, ANN NEUROL, V56, P299, DOI 10.1002/ana.20200; Dobson-Stone C, 2002, EUR J HUM GENET, V10, P773, DOI 10.1038/sj.ejhg.5200866; Faggioni G, 2006, MOL CELL PROBE, V20, P27, DOI 10.1016/j.mcp.2005.08.003; Gan JJ, 2011, NEUROLOGY, V76, pA590; Hsu KL, 2009, INT J BIOCHEM CELL B, V41, P1536, DOI 10.1016/j.biocel.2008.12.016; Jung HH, 2001, ANN NEUROL, V49, P384, DOI 10.1002/ana.76; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Kruger M, 2011, J BIOL CHEM; Kwoh CK, 2007, CELL MOL LIFE SCI, V64, P1739, DOI 10.1007/s00018-007-7053-7; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451, DOI 10.1074/jbc.R800056200; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; OLIVIERI O, 1994, BLOOD, V84, P315; Olivieri O, 1997, HAEMATOLOGICA, V82, P648; Pantaleo A, 2010, J PROTEOMICS, V73, P445, DOI 10.1016/j.jprot.2009.08.011; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pasini EM, 2010, J PROTEOMICS, V73, P403, DOI 10.1016/j.jprot.2009.06.005; Pasini EM, 2010, J PROTEOMICS, V73, P421, DOI 10.1016/j.jprot.2009.07.004; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pieroni E, 2008, PROTEOMICS, V8, P799, DOI 10.1002/pmic.200700767; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Rampoldi L, 2002, J MOL MED-JMM, V80, P475, DOI 10.1007/s00109-002-0349-z; Rubio JP, 1997, AM J HUM GENET, V61, P899, DOI 10.1086/514876; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siciliano A, BLOOD CELLS MOL DIS, V44, P233; Walker RHSV, 2011, MOVEMENT DI IN PRESS; Walker RH, 2007, MOVEMENT DISORD, V22, P244, DOI 10.1002/mds.21224; Walker RH, 2007, TRANSFUSION, V47, P299, DOI 10.1111/j.1537-2995.2007.01106.x; Walker RH, 2006, MOVEMENT DISORD, V21, P1794, DOI 10.1002/mds.21108; zurHausen JD, 1997, EUR J IMMUNOL, V27, P2643, DOI 10.1002/eji.1830271025	49	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31015	10.1371/journal.pone.0031015	http://dx.doi.org/10.1371/journal.pone.0031015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355334	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000302741300034
J	McCluskey, AJ; Bolewska-Pedyczak, E; Jarvik, N; Chen, G; Sidhu, SS; Gariepy, J				McCluskey, Andrew J.; Bolewska-Pedyczak, Eleonora; Jarvik, Nick; Chen, Gang; Sidhu, Sachdev S.; Gariepy, Jean			Charged and Hydrophobic Surfaces on the A Chain of Shiga-Like Toxin 1 Recognize the C-Terminal Domain of Ribosomal Stalk Proteins	PLOS ONE			English	Article							N-GLYCOSIDASE ACTIVITY; ESCHERICHIA-COLI O157-H7; GTPASE-ASSOCIATED CENTER; RICIN A-CHAIN; SACCHAROMYCES-CEREVISIAE; P-PROTEINS; ENDOPLASMIC-RETICULUM; SHIGELLA-DYSENTERIAE; STRUCTURAL-CHARACTERIZATION; INACTIVATING PROTEIN	Shiga-like toxins are ribosome-inactivating proteins (RIP) produced by pathogenic E. coli strains that are responsible for hemorrhagic colitis and hemolytic uremic syndrome. The catalytic A(1) chain of Shiga-like toxin 1 (SLT-1), a representative RIP, first docks onto a conserved peptide SD[D/E]DMGFGLFD located at the C-terminus of all three eukaryotic ribosomal stalk proteins and halts protein synthesis through the depurination of an adenine base in the sarcin-ricin loop of 28S rRNA. Here, we report that the A(1) chain of SLT-1 rapidly binds to and dissociates from the C-terminal peptide with a monomeric dissociation constant of 13 mu M. An alanine scan performed on the conserved peptide revealed that the SLT-1 A(1) chain interacts with the anionic tripeptide DDD and the hydrophobic tetrapeptide motif FGLF within its sequence. Based on these 2 peptide motifs, SLT-1 A(1) variants were generated that displayed decreased affinities for the stalk protein C-terminus and also correlated with reduced ribosome-inactivating activities in relation to the wild-type A(1) chain. The toxin-peptide interaction and subsequent toxicity were shown to be mediated by cationic and hydrophobic docking surfaces on the SLT-1 catalytic domain. These docking surfaces are located on the opposite face of the catalytic cleft and suggest that the docking of the A(1) chain to SDDDMGFGLFD may reorient its catalytic domain to face its RNA substrate. More importantly, both the delineated A(1) chain ribosomal docking surfaces and the ribosomal peptide itself represent a target and a scaffold, respectively, for the design of generic inhibitors to block the action of RIPs.	[McCluskey, Andrew J.; Gariepy, Jean] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Bolewska-Pedyczak, Eleonora; Gariepy, Jean] Sunnybrook Res Inst, Toronto, ON, Canada; [Jarvik, Nick; Chen, Gang; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Gariepy, Jean] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	McCluskey, AJ (corresponding author), Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada.	gariepy@sri.utoronto.ca		Chen, Gang/0000-0002-6304-9173	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was supported by an operation grant to J.G. from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub MJ, 2008, BIOCHEM BIOPH RES CO, V369, P314, DOI 10.1016/j.bbrc.2008.01.170; Bai Y, 2010, TOXICON, V56, P526, DOI 10.1016/j.toxicon.2010.05.009; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Brigotti M, 1997, TOXICON, V35, P1431, DOI 10.1016/S0041-0101(96)00225-5; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Di R, 2011, TOXICON, V57, P525, DOI 10.1016/j.toxicon.2010.12.006; Endo Y, 1988, Nucleic Acids Symp Ser, P139; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frank C, 2011, N ENGL J MED; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; GARRED O, 1995, J BIOL CHEM, V270, P10817; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Grela P, 2007, BIOCHEMISTRY-US, V46, P1988, DOI 10.1021/bi0616450; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; HOVDE CJ, 1988, P NATL ACAD SCI USA, V85, P2568, DOI 10.1073/pnas.85.8.2568; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Johannes L, 1998, TRENDS CELL BIOL, V8, P158, DOI 10.1016/S0962-8924(97)01209-9; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Korennykh AV, 2007, RNA, V13, P1391, DOI 10.1261/rna.619707; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; KOZLOV YV, 1993, J MOL BIOL, V232, P704, DOI 10.1006/jmbi.1993.1421; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Kupferschmidt K, 2011, SCIENCE, V333, P27, DOI 10.1126/science.333.6038.27; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; Lea N, 1999, MICROBIOL-UK, V145, P999, DOI 10.1099/13500872-145-5-999; Li XP, 2010, J BIOL CHEM, V285, P41463, DOI 10.1074/jbc.M110.171793; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McCluskey AJ, 2007, PROTEIN SCI, V16, P2726, DOI 10.1110/ps.072894407; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; Naganuma T, 2007, GENES CELLS, V12, P501, DOI 10.1111/j.1365-2443.2007.01067.x; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Pang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017883; Perez-Fernandez J, 2005, BIOCHEMISTRY-US, V44, P5532, DOI 10.1021/bi047332r; Qin SB, 2009, P NATL ACAD SCI USA, V106, P6974, DOI 10.1073/pnas.0900291106; RILEY LW, 1987, ANNU REV MICROBIOL, V41, P383, DOI 10.1146/annurev.micro.41.1.383; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Santos C, 2005, MOL MICROBIOL, V58, P217, DOI 10.1111/j.1365-2958.2005.04816.x; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Tchorzewski M, 2003, BIOCHEMISTRY-US, V42, P3399, DOI 10.1021/bi0206006; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; Voelker R, 2011, JAMA-J AM MED ASSOC, V306, P29, DOI 10.1001/jama.2011.889; YAMASAKI S, 1991, MICROB PATHOGENESIS, V11, P1, DOI 10.1016/0882-4010(91)90088-R; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051	60	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31191	10.1371/journal.pone.0031191	http://dx.doi.org/10.1371/journal.pone.0031191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355345	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300045
J	Ortiz-Pelaez, A; Ashenafi, G; Roger, F; Waret-Szkuta, A				Ortiz-Pelaez, Angel; Ashenafi, Getaneh; Roger, Francois; Waret-Szkuta, Agnes			Can Geographical Factors Determine the Choices of Farmers in the Ethiopian Highlands to Trade in Livestock Markets?	PLOS ONE			English	Article							SOCIAL NETWORKS; MOUTH-DISEASE; EXPONENTIAL FAMILY; GREAT-BRITAIN; MARKOV GRAPHS; MODELS; WATER; SHEEP	Proximity and affiliation to the local market appear to be two of the most relevant factors to explain farmer's choices to select a particular trading point. Physical barriers may limit the options, especially in developing countries. A network of villages linked by traders/farmer-traders sharing livestock markets was built with field data collected in 75 villages from 8 kebelles in the Wassona Werna wereda of the Ethiopian Highlands. Two exponential random graph models were fitted with various geographical and demographic attributes of the nodes (dyadic independent model) and three internal network structures (dyadic dependent model). Several diagnostic methods were applied to assess the goodness of fit of the models. The odds of an edge where the distance to the main market Debre Behran and the difference in altitude between two connected villages are both large increases significantly so that villages far away from the main market and at different altitude are more likely to be linked in the network than randomly. The odds of forming an edge between two villages in Abamote or Gudoberet kebelles are approximately 75% lower than an edge between villages in any other kebelles (p<0.05). The conditional log-odds of two villages forming a tie that is not included in a triangle, a 2-star or a 3-star is extremely low, increasing the odds significantly (p<0.05) each time a node is in a 2-star structure and decreasing it when a node is in a 3-star (p<0.05) or in a triangle formation (p<0.05)), conditional on the rest of the network. Two major constraining factors, namely distance and altitude, are not deterrent for the potential contact of susceptible small ruminant populations in the Highlands of Ethiopia.	[Ashenafi, Getaneh] NVI, Debre Zeit, Ethiopia; [Roger, Francois] CIRAD, AGIRs Unit, Montpellier, France; [Waret-Szkuta, Agnes] Univ London Royal Vet Coll, Hawkshead, Herts, England	CIRAD; University of London; University of London Royal Veterinary College		angortpel@yahoo.com	Ortiz-Pelaez, Angel/I-8657-2014	ROGER, FRANCOIS/0000-0002-1573-6833; Waret-Szkuta, Agnes/0000-0002-6175-4418	EU [INCO-CT-2004-003670 RP/PPR MARKVAC]	EU(European Commission)	This study was carried out as part of the EU funded INCO-CT-2004-003670 RP/PPR MARKVAC project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklilu Y., 2002, AUDIT LIVESTOCK MARK, VI; Belachew H, 2005, ASSESSMENT LIVESTOCK; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Bronsvoort BMD, 2004, PREV VET MED, V66, P127, DOI 10.1016/j.prevetmed.2004.09.010; FAO, FAOTAT DAT; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Goodreau S., 2008, J STAT SOFTWARE, V24; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; Handcock M.S., 2008, J STAT SOFTWARE, V24; Handcock Mark S., 2003, STATNET SOFTWARE TOO; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Hunter D. R., 2008, J STAT SOFTWARE, V24, DOI [10.18637/jss.v024.i08, DOI 10.18637/JSS.V024.I08]; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Kolaczyk ED, 2009, STAT ANAL NETWORK DA; Magalhaes RJS, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-10; Malm A, 2010, SECUR J, V23, P52, DOI 10.1057/sj.2009.18; Mansley LM, 2003, VET REC, V153, P43, DOI 10.1136/vr.153.2.43; MLCSL, 2010, LIV MARK 21 CENT REV; MUKASAMUGERWA E, 1995, SMALL RUMINANT RES, V17, P167, DOI 10.1016/0921-4488(95)00663-6; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Robins G, 2007, SOC NETWORKS, V29, P215; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robinson SE, 2007, PREV VET MED, V81, P21, DOI 10.1016/j.prevetmed.2007.04.011; Snijders T. A. B., 2002, J SOCIAL STRUCTURE, V3, P2; Tibbo M., 2006, PRODUCTIVITY HLTH IN; Tranmer M, 2010, STAT MODELS SOCIAL N; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Waret-Szkuta A, 2011, EPIDEMIOL INFECT, V139, P875, DOI 10.1017/S0950268810001718; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wasserman S., 2005, MODELS METHODS SOCIA, P148, DOI DOI 10.1017/CBO9780511811395.008; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	34	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30710	10.1371/journal.pone.0030710	http://dx.doi.org/10.1371/journal.pone.0030710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355324	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300024
J	Brieger, A; Plotz, G; Hinrichsen, I; Passmann, S; Adam, R; Zeuzem, S				Brieger, Angela; Plotz, Guido; Hinrichsen, Inga; Passmann, Sandra; Adam, Ronja; Zeuzem, Stefan			C-Terminal Fluorescent Labeling Impairs Functionality of DNA Mismatch Repair Proteins	PLOS ONE			English	Article							MISSENSE MUTATIONS; NUCLEAR IMPORT; HMUTL-ALPHA; HUMAN MLH1; MUTL; HMLH1; PMS2; DIMERIZATION; EXPRESSION; INTERFACE	The human DNA mismatch repair (MMR) process is crucial to maintain the integrity of the genome and requires many different proteins which interact perfectly and coordinated. Germline mutations in MMR genes are responsible for the development of the hereditary form of colorectal cancer called Lynch syndrome. Various mutations mainly in two MMR proteins, MLH1 and MSH2, have been identified so far, whereas 55% are detected within MLH1, the essential component of the heterodimer MutL alpha (MLH1 and PMS2). Most of those MLH1 variants are pathogenic but the relevance of missense mutations often remains unclear. Many different recombinant systems are applied to filter out disease-associated proteins whereby fluorescent tagged proteins are frequently used. However, dye labeling might have deleterious effects on MutL alpha's functionality. Therefore, we analyzed the consequences of N- and C-terminal fluorescent labeling on expression level, cellular localization and MMR activity of MutL alpha. Besides significant influence of GFP- or Red-fusion on protein expression we detected incorrect shuttling of single expressed C-terminal GFP-tagged PMS2 into the nucleus and found that C-terminal dye labeling impaired MMR function of MutL alpha. In contrast, N-terminal tagged MutL alpha s retained correct functionality and can be recommended both for the analysis of cellular localization and MMR efficiency.	[Brieger, Angela; Plotz, Guido; Hinrichsen, Inga; Passmann, Sandra; Adam, Ronja; Zeuzem, Stefan] Univ Frankfurt M, Dept Med 1, Frankfurt, Germany	Goethe University Frankfurt	Brieger, A (corresponding author), Univ Frankfurt M, Dept Med 1, Frankfurt, Germany.	a.brieger@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Plotz, Guido/K-8446-2012	Plotz, Guido/0000-0001-5314-9739	Wilhelm Sander-Stiftung [2005.085.2]; Deutsche Krebsstiftung [109651]; Goethe-University Frankfurt	Wilhelm Sander-Stiftung; Deutsche Krebsstiftung; Goethe-University Frankfurt	This work was supported by grant 2005.085.2 of the Wilhelm Sander-Stiftung, grant 109651 of the Deutsche Krebsstiftung and institutional funds of the Goethe-University Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brieger A, 2002, GUT, V51, P677, DOI 10.1136/gut.51.5.677; Brieger A, 2005, MOL CARCINOGEN, V43, P51, DOI 10.1002/mc.20081; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Brieger A, 2011, GENE CHROMOSOME CANC, V50, P59, DOI 10.1002/gcc.20832; Brieger A, 2010, PROTEOMICS, V10, P3343, DOI 10.1002/pmic.200900672; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Castillejo A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-12; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Christensen LL, 2009, FAM CANCER, V8, P489, DOI 10.1007/s10689-009-9274-4; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Han WP, 2005, J BIOL CHEM, V280, P5089, DOI 10.1074/jbc.M408757200; Hardt K, 2011, FAM CANCER, V10, P273, DOI 10.1007/s10689-011-9431-4; Her CT, 2002, DNA REPAIR, V1, P719, DOI 10.1016/S1568-7864(02)00079-4; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Jager AC, 2001, ONCOGENE, V20, P3590, DOI 10.1038/sj.onc.1204467; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Leong V, 2009, MOL CARCINOGEN, V48, P742, DOI 10.1002/mc.20514; Lutzen A, 2008, MUTAT RES-FUND MOL M, V645, P44, DOI 10.1016/j.mrfmmm.2008.08.015; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Mac Partlin M, 2003, ONCOGENE, V22, P819, DOI 10.1038/sj.onc.1206252; Mohd AB, 2006, DNA REPAIR, V5, P347, DOI 10.1016/j.dnarep.2005.11.001; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Ou JH, 2009, GENE CHROMOSOME CANC, V48, P340, DOI 10.1002/gcc.20644; Plotz G, 2006, BIOCHEM BIOPH RES CO, V340, P852, DOI 10.1016/j.bbrc.2005.12.096; Plotz G, 2003, NUCLEIC ACIDS RES, V31, P3217, DOI 10.1093/nar/gkg420; Plotz G, 2006, NUCLEIC ACIDS RES, V34, P6574, DOI 10.1093/nar/gkl944; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; Raevaara TE, 2004, GENE CHROMOSOME CANC, V40, P261, DOI 10.1002/gcc.20040; Raevaara TE, 2003, GASTROENTEROLOGY, V125, P501, DOI 10.1016/S0016-5085(03)00905-3; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Weinheimer I, 2010, BIOL CHEM, V391, P271, DOI [10.1515/BC.2010.022, 10.1515/bc.2010.022]; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003	35	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31863	10.1371/journal.pone.0031863	http://dx.doi.org/10.1371/journal.pone.0031863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348133	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400053
J	Galante, M; Garin, O; Sicuri, E; Cots, F; Garcia-Altes, A; Ferrer, M; Dominguez, A; Alonso, J				Galante, Mariana; Garin, Olatz; Sicuri, Elisa; Cots, Francesc; Garcia-Altes, Anna; Ferrer, Montserrat; Dominguez, Angela; Alonso, Jordi			Health Services Utilization, Work Absenteeism and Costs of Pandemic Influenza A (H1N1) 2009 in Spain: A Multicenter-Longitudinal Study	PLOS ONE			English	Article							ECONOMIC BURDEN; IMPACT; DISEASE; HOSPITALIZATION; COMPLICATIONS; CONSEQUENCES; CHILDREN	Background: The aim of this study was to estimate healthcare resource utilization, work absenteeism and cost per patient with pandemic influenza (H1N1) 2009, from its beginning to March 2010, in Spain. We also estimated the economic impact on healthcare services. Methods and Findings: Longitudinal, descriptive, multicenter study of in-and outpatients with confirmed diagnosis of influenza A (H1N1) in Spain. Temporal distribution of cases was comparable to that in Spain. Information of healthcare and social resources used from one week before admission (inpatient) or index-medical visit (outpatient) until recovery was gathered. Unit cost was imputed to utilization frequency for the monetary valuation of use. Mean cost per patient was calculated. A sensitivity analysis was conducted, and variables correlated with cost per patient were identified. Economic impact on the healthcare system was estimated using healthcare costs per patient and both, the reported number of confirmed and clinical cases in Spain. 172 inpatients and 224 outpatients were included. Less than 10% were over 65 years old and more than 50% had previous comorbidities. 12.8% of inpatients were admitted to the Intensive Care Unit. Mean length of hospital stay of patients not requiring critical care was 5 days (SD=4.4). All working-inpatients and 91.7% working-outpatients went on sick leave. On average, work absenteeism was 30.5 days (SD=20.7) for the first ones and 9 days (SD=6.3) for the latest. Caregivers of 21.7% of inpatients and 8.5% of outpatients also had work absenteeism during 10.7 and 4.1 days on average respectively. Mean cost was (sic)6,236/inpatient (CI95%=1,384-14,623) and (sic)940/outpatient (CI95%=66-3,064). The healthcare economic burden of patients with confirmed influenza was (sic)144,773,577 (IC95% 13,753,043-383,467,535). More than 86% of expenditures were a result of outpatients' utilization. Conclusion: Cost per H1N1-patient did not defer much from seasonal influenza estimates. Hospitalizations and work absenteeism represented the highest cost per patient.	[Galante, Mariana; Garin, Olatz; Sicuri, Elisa; Cots, Francesc; Garcia-Altes, Anna; Ferrer, Montserrat; Dominguez, Angela; Alonso, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Galante, Mariana; Garin, Olatz; Ferrer, Montserrat; Alonso, Jordi] IMIM Res Inst Hosp Mar, Hlth Serv Res Grp, Barcelona, Spain; [Garin, Olatz; Alonso, Jordi] Univ Pompeu Fabra, Barcelona, Spain; [Sicuri, Elisa] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, CRESIB, Barcelona, Spain; [Cots, Francesc] IMIM Hosp Mar, Epidemiol & Evaluat Dept, Barcelona, Spain; [Garcia-Altes, Anna] Catalan Agcy Hlth Informat Assessment & Qual CAHI, Barcelona, Spain; [Ferrer, Montserrat] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; ISGlobal; CRESIB; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; University of Barcelona	Galante, M (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	jalonso@imim.es	Garin, Olatz/K-5468-2013; Sicuri, Elisa/L-8012-2014; Alonso, Jordi/A-5514-2010; Ferrer, Montse/A-5510-2010	Garin, Olatz/0000-0001-6193-0779; Sicuri, Elisa/0000-0002-2499-2732; Alonso, Jordi/0000-0001-8627-9636; Ferrer, Montse/0000-0001-9867-7391	Instituto de Salud Carlos III (ISCIII) [GR09/0026]	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission)	This study was funded by the Instituto de Salud Carlos III (ISCIII GR09/0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Badia Llach Xavier, 2006, Aten Primaria, V38, P260; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Brouwers L, 2009, EUROSURVEILLANCE, V14, P5; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; CMP Medicom Editorial S.A., 2010, VAD ES; Concejalia de Sanidad, 2010, B OF COM MADR ORDEN, V629; Cots F, 2010, COST ACTIVITAT ASIST, P14; Cox F, 2000, MedGenMed, V2, pE34; Domingo-Salvany A., 2000, ATEN PRIM, V25, P350, DOI [10.1016/s0212-6567(00)78518-0, DOI 10.1016/S0212-6567(00)78518-0]; Dominguez A, 2011, REV ESP SALUD PUBLIC, V85, P3, DOI 10.1590/S1135-57272011000100002; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Duncan B, 2009, EUROSURVEILLANCE, V14, P15; Esposito S, 2011, J INFECTION, V62, P379, DOI 10.1016/j.jinf.2011.02.015; Fairbrother G, 2010, VACCINE, V28, P4913, DOI 10.1016/j.vaccine.2010.05.036; Gisbert JP, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-90; Hassan F, 2009, AM J PREV MED, V36, P292, DOI 10.1016/j.amepre.2008.11.016; Instituto Catalan de Salud, 2010, SLT3832009 I CAT SAL, V5325; Instituto Nacional de Estadistica, 2010, ENC AN COST LAB 2008; Jefferson T, 2010, HEALTH TECHNOL ASSES, V14, P355, DOI 10.3310/hta14460-05; Karageorgopoulos DE, 2011, PLOS ONE, V6; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Lambert SB, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-11; Camara AL, 2010, REV ESP SALUD PUBLIC, V84, P569, DOI [10.1590/S1135-57272010000500009, 10.1590/s1135-57272010000500009]; Loza E, 2009, ARTHRIT RHEUM-ARTHR, V61, P158, DOI 10.1002/art.24214; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; Pachon J, 2010, INFECCIONES VIAS RES; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Santa-Olalla P, 2010, EURO SURVEILL, V15, P19667; Scholze J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-529; Serrano Herranz R, 2010, INFECCIONES VIAS RES; Moros MJS, 2010, REV ESP SALUD PUBLIC, V84, P463, DOI 10.1590/s1135-57272010000500002; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Teruel A, 2011, FRANCIA VENDE EXCEDE; Tora-Rocamora I, 2011, OCCUP ENV MED; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Xue Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-724	42	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31696	10.1371/journal.pone.0031696	http://dx.doi.org/10.1371/journal.pone.0031696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348122	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400044
J	Ssematimba, A; Hagenaars, TJ; de Jong, MCM				Ssematimba, Amos; Hagenaars, Thomas J.; de Jong, Mart C. M.			Modelling the Wind-Borne Spread of Highly Pathogenic Avian Influenza Virus between Farms	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; SWINE-FEVER VIRUS; LIVESTOCK BUILDINGS; COMMERCIAL POULTRY; AIRBORNE SPREAD; A VIRUS; EPIDEMIC; FOOT; RISK; TRANSMISSION	A quantitative understanding of the spread of contaminated farm dust between locations is a prerequisite for obtaining much-needed insight into one of the possible mechanisms of disease spread between farms. Here, we develop a model to calculate the quantity of contaminated farm-dust particles deposited at various locations downwind of a source farm and apply the model to assess the possible contribution of the wind-borne route to the transmission of Highly Pathogenic Avian Influenza virus (HPAI) during the 2003 epidemic in the Netherlands. The model is obtained from a Gaussian Plume Model by incorporating the dust deposition process, pathogen decay, and a model for the infection process on exposed farms. Using poultry-and avian influenza-specific parameter values we calculate the distance-dependent probability of between-farm transmission by this route. A comparison between the transmission risk pattern predicted by the model and the pattern observed during the 2003 epidemic reveals that the wind-borne route alone is insufficient to explain the observations although it could contribute substantially to the spread over short distance ranges, for example, explaining 24% of the transmission over distances up to 25 km.	[Ssematimba, Amos; Hagenaars, Thomas J.] Univ Wageningen & Res Ctr, CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands; [Ssematimba, Amos; de Jong, Mart C. M.] Wageningen Univ, Dept Anim Sci, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Ssematimba, A (corresponding author), Univ Wageningen & Res Ctr, CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands.	amos.ssematimba@wur.nl	Ssematimba, Amos/S-3217-2019; de Jong, Mart C.M./GQQ-0825-2022	Ssematimba, Amos/0000-0002-5407-2478; de Jong, Mart C.M./0000-0002-5339-1995	Dutch Ministry of Economic Affairs, Agriculture and Innovation	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This work was funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation under the framework: Fonds Economische Structuurverstrekking/Economic Challenges Fund (FES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink A., 2007, PROCESSES FACTORS AF; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Berge WF, 2000, MATH MODELS ESTIMATI; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Bos MEH, 2009, PREV VET MED, V88, P278, DOI 10.1016/j.prevetmed.2008.12.003; Bouma A, 2003, PREV VET MED, V57, P155, DOI 10.1016/S0167-5877(02)00217-9; Cannon RM, 1999, ENVIRON INT, V25, P713, DOI 10.1016/S0160-4120(99)00049-5; Davis J, 2009, TRANSBOUND EMERG DIS, V56, P31, DOI 10.1111/j.1865-1682.2008.01060.x; DAWSON JR, 1990, J AGR ENG RES, V47, P235, DOI 10.1016/0021-8634(90)80044-U; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DIGIOVANNI F, 1990, J APPL METEOROL, V29, P1352, DOI 10.1175/1520-0450(1990)029&lt;1352:OTMMOP&gt;2.0.CO;2; DONALDSON AI, 1982, VET REC, V110, P53, DOI 10.1136/vr.110.3.53; DRUETT HA, 1952, NATURE, V170, P288, DOI 10.1038/170288a0; EC, 1999, OFF J EUR COMMUNITIE, V203, P53; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; GLOSTER J, 1984, VET REC, V114, P234, DOI 10.1136/vr.114.10.234; Gloster J, 2003, VET REC, V152, P525, DOI 10.1136/vr.152.17.525; GLOSTER J, 1981, VET REC, V108, P370, DOI 10.1136/vr.108.17.370; Gustafsson G, 1990, GASER DAMM FJADERFAS, V68, P68; Gustafsson G, CIGR EJOURNAL, VVIII; HALVORSON DA, 1980, AVIAN DIS, V24, P288, DOI 10.2307/1589789; Hess GD, 2008, ENVIRON MODEL ASSESS, V13, P209, DOI 10.1007/s10666-007-9097-3; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; JULIAN RJ, 1989, AVIAN DIS, V33, P174, DOI 10.2307/1591084; Koerkamp PWGG, 1999, J AGR ENG RES, V73, P363, DOI 10.1006/jaer.1999.0426; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Lange A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000536; LIGHTHART B, 1987, APPL ENVIRON MICROB, V53, P1580, DOI 10.1128/AEM.53.7.1580-1583.1987; Mintiens K, 2003, PREV VET MED, V60, P27, DOI 10.1016/S0167-5877(03)00080-1; Pampori Z. A., 2007, International Journal of Poultry Science, V6, P578; PETERSON EW, 1977, MICROBIAL ECOL, V4, P67, DOI 10.1007/BF02010430; Power C. A., 2005, Bulletin of the Aquaculture Association of Canada, V105, P7; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Spekreijse D, 2011, VET MICROBIOL, V147, P59, DOI 10.1016/j.vetmic.2010.06.012; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; Takai H, 1998, J AGR ENG RES, V70, P59, DOI 10.1006/jaer.1997.0280; Thomas ME, 2005, PREV VET MED, V69, P1, DOI 10.1016/j.prevetmed.2004.12.001; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yushu HE, 2006, DUST SPATIAL DISTRIB	45	48	49	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31114	10.1371/journal.pone.0031114	http://dx.doi.org/10.1371/journal.pone.0031114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348042	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400009
J	Meng, YJ; Shao, CG				Meng, Yijun; Shao, Chaogang			Large-Scale Identification of Mirtrons in Arabidopsis and Rice	PLOS ONE			English	Article							SMALL RNAS; PARALLEL ANALYSIS; PLANT MICRORNAS; RESOURCE; BIOGENESIS; DROSOPHILA; DATABASE; TARGETS; SIRNAS; SERVER	A new catalog of microRNA (miRNA) species called mirtrons has been discovered in animals recently, which originate from spliced introns of the gene transcripts. However, only one putative mirtron, osa-MIR1429, has been identified in rice (Oryza sativa). We employed a high-throughput sequencing (HTS) data-and structure-based approach to do a genome-wide search for the mirtron candidate in both Arabidopsis (Arabidopsis thaliana) and rice. Five and eighteen candidates were discovered in the two plants respectively. To investigate their biological roles, the targets of these mirtrons were predicted and validated based on degradome sequencing data. The result indicates that the mirtrons could guide target cleavages to exert their regulatory roles post-transcriptionally, which needs further experimental validation.	[Meng, Yijun] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Shao, Chaogang] Huzhou Univ, Coll Life Sci, Huzhou, Peoples R China	Hangzhou Normal University; Huzhou University	Meng, YJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	mengyijun@zju.edu.cn; shaocg@hutc.zj.cn			National Natural Sciences Foundation of China [31100937]; Hangzhou Normal University	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University	This work was funded by the National Natural Sciences Foundation of China [31100937], the Starting Grant funded by Hangzhou Normal University [Yijun Meng]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2010, NAT GENET, V42, P6, DOI 10.1038/ng0110-6; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Johnson C, 2007, NUCLEIC ACIDS RES, V35, pD829, DOI 10.1093/nar/gkl991; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Meng YJ, 2011, BRIEF BIOINFORM, V12, P645, DOI 10.1093/bib/bbq091; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Westholm JO, 2011, BIOCHIMIE, V93, P1897, DOI 10.1016/j.biochi.2011.06.017; Yuan QP, 2003, NUCLEIC ACIDS RES, V31, P229, DOI 10.1093/nar/gkg059; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	30	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31163	10.1371/journal.pone.0031163	http://dx.doi.org/10.1371/journal.pone.0031163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348048	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900026
J	Zhou, YH; Wei, X; Lu, J; Ye, XF; Wu, MJ; Xu, JF; Qin, YY; He, J				Zhou, Yu-Hao; Wei, Xin; Lu, Jian; Ye, Xiao-Fei; Wu, Mei-Jing; Xu, Jin-Fang; Qin, Ying-Yi; He, Jia			Effects of Combined Aspirin and Clopidogrel Therapy on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK; PREVENTION; GUIDELINES; CORONARY; SURGERY; EVENTS; BIAS	Background: Aspirin and clopidogrel monotherapies are effective treatments for preventing vascular disease. However, new evidence has emerged regarding the use of combined aspirin and clopidogrel therapy to prevent cardiovascular events. We therefore performed a comprehensive systematic review and meta-analysis to evaluate the benefits and harms of combined aspirin and clopidogrel therapy on major cardiovascular outcomes. Methodology/Principal Findings: We systematically searched Medline, Embase, the Cochrane Central Register of Controlled Trials, reference lists of articles, and proceedings of major meetings to identify studies to fit our analysis. Eligible studies were randomized controlled trials assessing the effect of combined aspirin and clopidogrel therapy compared with aspirin or clopidogrel monotherapy. We identified 7 trials providing data with a total of 48248 patients. These studies reported 5134 major cardiovascular events, 1626 myocardial infarctions, 1927 strokes, and 1147 major bleeding events. Overall, the addition of aspirin to clopidogrel therapy as compared to single drug therapy resulted in a 9% RR reduction (95%CI, 2 to 17) in major cardiovascular events, 14% RR reduction (95%CI, 3 to 24) in myocardial infarction, 16% RR reduction (95%CI, 1 to 28) in stroke, and 62% RR increase (95%CI, 26 to 108) in major bleeding events. We also present the data as ARR to explore net value as the reduction in cardiovascular events. Overall, we observed that combined therapy yielded 1.06% decrease (95%CI, 0.23% to 1.99%) in major cardiovascular events and 1.23% increase (95%CI, 0.52% to 2.14%) in major bleeding events. Conclusion/Significance: Although the addition of aspirin to clopidogrel resulted in small relative reductions in major cardiovascular events, myocardial infarction, and stroke, it also resulted in a relative increase in major bleeding events. In absolute terms the benefits of combined therapy, a 1.06% reduction in major cardiovascular events, does not outweigh the harms, a 1.23% increase in major bleeding events.	[Zhou, Yu-Hao; Lu, Jian; Ye, Xiao-Fei; Wu, Mei-Jing; Xu, Jin-Fang; Qin, Ying-Yi; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Wei, Xin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Zhou, YH (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com		He, Jia/0000-0002-2338-9501	National Nature Science Foundation of China [30872186, 81072388]; leading talents of science in Shanghai [022]; Program of Shanghai Subject Chief Scientist [09XD1405500]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); leading talents of science in Shanghai; Program of Shanghai Subject Chief Scientist	This study was supported by the National Nature Science Foundation of China (30872186, 81072388), a grant from the leading talents of science in Shanghai 2010 (022) and a grant was sponsored by Program of Shanghai Subject Chief Scientist (09XD1405500). The funder had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2006, HEART S5, V91, pv1; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; De Berardis Giorgia, 2009, BMJ, V339, pb4531, DOI 10.1136/bmj.b4531; Deeks J, 2009, COCHRANE HDB SYSTEMA; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kulik A, 2010, CIRCULATION, V122, P2680, DOI 10.1161/CIRCULATIONAHA.110.978007; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	29	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31642	10.1371/journal.pone.0031642	http://dx.doi.org/10.1371/journal.pone.0031642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348116	gold, Green Published			2022-12-27	WOS:000302733900059
J	Jollivet, D; Mary, J; Gagniere, N; Tanguy, A; Fontanillas, E; Boutet, I; Hourdez, S; Segurens, B; Weissenbach, J; Poch, O; Lecompte, O				Jollivet, Didier; Mary, Jean; Gagniere, Nicolas; Tanguy, Arnaud; Fontanillas, Eric; Boutet, Isabelle; Hourdez, Stephane; Segurens, Beatrice; Weissenbach, Jean; Poch, Olivier; Lecompte, Odile			Proteome Adaptation to High Temperatures in the Ectothermic Hydrothermal Vent Pompeii Worm	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; THERMAL-STABILITY; SEQUENCE-ANALYSIS; DISULFIDE BONDS; THERMOSTABILITY; EVOLUTION; SELECTION; PROTEINS; INSIGHTS; MODEL	Taking advantage of the massive genome sequencing effort made on thermophilic prokaryotes, thermal adaptation has been extensively studied by analysing amino acid replacements and codon usage in these unicellular organisms. In most cases, adaptation to thermophily is associated with greater residue hydrophobicity and more charged residues. Both of these characteristics are positively correlated with the optimal growth temperature of prokaryotes. In contrast, little information has been collected on the molecular 'adaptive' strategy of thermophilic eukaryotes. The Pompeii worm A. pompejana, whose transcriptome has recently been sequenced, is currently considered as the most thermotolerant eukaryote on Earth, withstanding the greatest thermal and chemical ranges known. We investigated the amino-acid composition bias of ribosomal proteins in the Pompeii worm when compared to other lophotrochozoans and checked for putative adaptive changes during the course of evolution using codon-based Maximum likelihood analyses. We then provided a comparative analysis of codon usage and amino-acid replacements from a greater set of orthologous genes between the Pompeii worm and Paralvinella grasslei, one of its closest relatives living in a much cooler habitat. Analyses reveal that both species display the same high GC-biased codon usage and amino-acid patterns favoring both positively-charged residues and protein hydrophobicity. These patterns may be indicative of an ancestral adaptation to the deep sea and/or thermophily. In addition, the Pompeii worm displays a set of amino-acid change patterns that may explain its greater thermotolerance, with a significant increase in Tyr, Lys and Ala against Val, Met and Gly. Present results indicate that, together with a high content in charged residues, greater proportion of smaller aliphatic residues, and especially alanine, may be a different path for metazoans to face relatively 'high' temperatures and thus a novelty in thermophilic metazoans.	[Jollivet, Didier; Mary, Jean; Tanguy, Arnaud; Fontanillas, Eric; Boutet, Isabelle; Hourdez, Stephane] CNRS, UMR 7144, Roscoff, France; [Jollivet, Didier; Mary, Jean; Tanguy, Arnaud; Fontanillas, Eric; Boutet, Isabelle; Hourdez, Stephane] Univ Paris 06, UPMC, Stn Biolog Roscoff, Roscoff, France; [Gagniere, Nicolas; Poch, Olivier; Lecompte, Odile] IGBMC, Dept Struct Biol & Genom, Illkirch Graffenstaden, France; [Segurens, Beatrice; Weissenbach, Jean] Genoscope Ctr Natl Sequencage, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jollivet, D (corresponding author), CNRS, UMR 7144, Roscoff, France.	jollivet@sb-roscoff.fr	Mary, Jean/H-2344-2011; Lecompte, Odile/N-7992-2019; Lecompte, Odile/F-4741-2011	Mary, Jean/0000-0002-2438-8383; Lecompte, Odile/0000-0002-2005-460X; Lecompte, Odile/0000-0002-2005-460X; Boutet, Isabelle/0000-0003-0619-9316	EU [COGE-CT-2004-505403]; ANR [05-BLAN-0407]; Region Bretagne (PRIRE Amethyst)	EU(European Commission); ANR(French National Research Agency (ANR)); Region Bretagne (PRIRE Amethyst)(Region Bretagne)	This work was funded by the EU FP6 Network of Excellence "Marine Genomics Europe'' (contract EC No COGE-CT-2004-505403, coord. C. Boyen), the ANR 05-BLAN-0407 "AlviStresAdapt'' (coord. D. Jollivet) and the Region Bretagne (PRIRE Amethyst: coord. D. Jollivet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; ARGOS P, 1979, BIOCHEMISTRY-US, V18, P5698, DOI 10.1021/bi00592a028; Bailly X, 2002, MOL BIOL EVOL, V19, P1421, DOI 10.1093/oxfordjournals.molbev.a004205; Berezovsky IN, 2005, PLOS COMPUT BIOL, V1, P322, DOI 10.1371/journal.pcbi.0010047; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; Borgi MA, 2004, BIOCHIMIE, V86, P561, DOI 10.1016/j.biochi.2004.07.003; Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; CHEVALDONNE P, 1992, NATURE, V359, P593, DOI 10.1038/359593b0; DAHLHOFF E, 1991, PHYSIOL ZOOL, V64, P1490, DOI 10.1086/physzool.64.6.30158226; DAOPIN S, 1990, PROTEINS, V7, P198, DOI 10.1002/prot.340070208; de Vendittis E, 2008, J THEOR BIOL, V250, P156, DOI 10.1016/j.jtbi.2007.09.006; Desbruyeres D, 1998, DEEP-SEA RES PT II, V45, P383, DOI 10.1016/S0967-0645(97)00083-0; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Farias Savio T, 2003, Genet Mol Res, V2, P383; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2002, PHYLIP PHYLOGENETIC; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Girguis PR, 2006, SCIENCE, V312, P231, DOI 10.1126/science.1125286; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HAYMON RM, 1984, SCIENCE, V223, P1407, DOI 10.1126/science.223.4643.1407; Henscheid KL, 2005, BBA-GENE STRUCT EXPR, V1727, P197, DOI 10.1016/j.bbaexp.2005.01.008; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Hourdez S, 2000, PHYSIOL BIOCHEM ZOOL, V73, P365, DOI 10.1086/316755; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; JOLLIVET D, 1995, MAR ECOL PROG SER, V123, P125, DOI 10.3354/meps123125; Jollivet D, 1996, BIODIVERS CONSERV, V5, P1619, DOI 10.1007/BF00052119; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Little CTS, 1999, PALAEONTOLOGY, V42, P1043, DOI 10.1111/1475-4983.00110; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Paz A, 2004, P NATL ACAD SCI USA, V101, P2951, DOI 10.1073/pnas.0308594100; PEDEN JF, 1999, THESIS U NOTTINGHAM; Piccino P, 2004, P ROY SOC B-BIOL SCI, V271, P2351, DOI 10.1098/rspb.2004.2852; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Sicot FX, 2000, J MOL BIOL, V302, P811, DOI 10.1006/jmbi.2000.4505; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Takano K, 1997, BIOCHEMISTRY-US, V36, P688, DOI 10.1021/bi9621829; Tanguy A, 2007, GENE, V408, P27; Thangudu RR, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-55; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang GZ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-263; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu Z, 2003, J BACTERIOL, V185, P4038, DOI 10.1128/JB.185.14.4038-4049.2003; Yang Z., 2000, PHYLOGENETIC ANAL MA; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x	62	13	13	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31150	10.1371/journal.pone.0031150	http://dx.doi.org/10.1371/journal.pone.0031150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348046	gold, Green Published			2022-12-27	WOS:000302730900020
J	Laparra, JM; Olivares, M; Gallina, O; Sanz, Y				Laparra, Jose Moises; Olivares, Marta; Gallina, Onofrio; Sanz, Yolanda			Bifidobacterium longum CECT 7347 Modulates Immune Responses in a Gliadin-Induced Enteropathy Animal Model	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; REAL-TIME PCR; NF-KAPPA-B; CELIAC-DISEASE; GENE-EXPRESSION; TRANSGENIC MICE; T-CELLS; GLUTEN; RATS; INFLAMMATION	Coeliac disease (CD) is an autoimmune disorder triggered by gluten proteins (gliadin) that involves innate and adaptive immunity. In this study, we hypothesise that the administration of Bifidobacterium longum CECT 7347, previously selected for reducing gliadin immunotoxic effects in vitro, could exert protective effects in an animal model of gliadin-induced enteropathy. The effects of this bacterium were evaluated in newborn rats fed gliadin alone or sensitised with interferon (IFN)-gamma and fed gliadin. Jejunal tissue sections were collected for histological, NF kappa B mRNA expression and cytokine production analyses. Leukocyte populations and T-cell subsets were analysed in peripheral blood samples. The possible translocation of the bacterium to different organs was determined by plate counting and the composition of the colonic microbiota was quantified by real-time PCR. Feeding gliadin alone reduced enterocyte height and peripheral CD4+ cells, but increased CD4+/Foxp3+ T and CD8+ cells, while the simultaneous administration of B. longum CECT 7347 exerted opposite effects. Animals sensitised with IFN-gamma and fed gliadin showed high cellular infiltration, reduced villi width and enterocyte height. Sensitised animals also exhibited increased NF kappa B mRNA expression and TNF-alpha production in tissue sections. B. longum CECT 7347 administration increased NFkB expression and IL-10, but reduced TNF-alpha, production in the enteropathy model. In sensitised gliadin-fed animals, CD4+, CD4+/Foxp3+ and CD8+ T cells increased, whereas the administration of B. longum CECT 7347 reduced CD4+ and CD4+/Foxp3+ cell populations and increased CD8+ T cell populations. The bifidobacterial strain administered represented between 75-95% of the total bifidobacteria isolated from all treated groups, and translocation to organs was not detected. These findings indicate that B. longum attenuates the production of inflammatory cytokines and the CD4+ T-cell mediated immune response in an animal model of gliadin-induced enteropathy.	[Laparra, Jose Moises; Olivares, Marta; Gallina, Onofrio; Sanz, Yolanda] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Laparra, JM (corresponding author), Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Valencia, Spain.	yolsanz@iata.csic.es	Sanz, Yolanda/H-5498-2012; Llopis, Jose Moises Laparra/M-2882-2015; Sevilla, Marta Olivares/A-7691-2019; Olivares, Marta/O-9899-2019; Llopis, José Moisés Laparra/AAB-6151-2019	Sanz, Yolanda/0000-0002-1615-1976; Llopis, Jose Moises Laparra/0000-0002-9378-2552; Olivares, Marta/0000-0002-7966-2781; Llopis, José Moisés Laparra/0000-0002-9378-2552	Spanish Ministry of Science and Innovation (MICINN, Spain) [AGL2007-66126-C03-01/ALI, CEN-20091006, CSD2007-00063]; Consejo Superior de Investigaciones Cientificas (CSIC, National Research Council); MICINN, Spain [CEN-20091006]	Spanish Ministry of Science and Innovation (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC, National Research Council); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants AGL2007-66126-C03-01/ALI, CEN-20091006 and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation (MICINN, Spain). The scholarship to Dr. Gallina from Consejo Superior de Investigaciones Cientificas (CSIC, National Research Council) is fully acknowledged. Dr. Laparra has a postdoctoral contract within the programme "Juan de la Cierva'' (MICINN, Spain) and Dr. Olivares has a contract supported by grant CEN-20091006 (MICINN, Spain), which are also acknowledged. The funders had no role in any stage of study design, data collection, execution interpretation of the results or decision to publish and preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; [Anonymous], LAB RAT, VI; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Collado MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-232; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; D'Arienzo R, 2011, SCAND J IMMUNOL, V74, P335, DOI 10.1111/j.1365-3083.2011.02582.x; D'Arienzo R, 2009, EUR J IMMUNOL, V39, P3552, DOI 10.1002/eji.200839161; De Palma G, 2010, J LEUKOCYTE BIOL, V87, P765, DOI 10.1189/jlb.0709471; Frisullo G, 2009, HUM IMMUNOL, V70, P430, DOI 10.1016/j.humimm.2009.04.006; Hoffman RA, 2000, AM J PHYSIOL-GASTR L, V278, pG886, DOI 10.1152/ajpgi.2000.278.6.G886; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kivling A, 2008, ANN NY ACAD SCI, V1150, P273, DOI 10.1196/annals.1447.018; Kozakova H, 2000, PHYSIOL RES, V49, P665; Laparra JM, 2010, J CELL BIOCHEM, V109, P801, DOI 10.1002/jcb.22459; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Medina M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-19; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Stepankova R, 2003, J PEDIATR GASTR NUTR, V36, P96, DOI 10.1097/00005176-200301000-00018; Stepankova R, 1996, SCAND J GASTROENTERO, V31, P551, DOI 10.3109/00365529609009127; Sutas Y, 1997, J PEDIATR GASTR NUTR, V24, P162, DOI 10.1097/00005176-199702000-00009; Terrazzano G, 2007, J IMMUNOL, V179, P372, DOI 10.4049/jimmunol.179.1.372; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; TlaskalovaHogenova H, 1997, ANN NY ACAD SCI, V815, P503, DOI 10.1111/j.1749-6632.1997.tb52115.x; TRONCONE R, 1991, GUT, V32, P871, DOI 10.1136/gut.32.8.871; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wieser H, 2008, CEREAL CHEM, V85, P1, DOI 10.1094/CCHEM-85-1-0001; WILLIAMS JG, 1992, J LEUKOCYTE BIOL, V52, P579, DOI 10.1002/jlb.52.6.579; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	40	98	100	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30744	10.1371/journal.pone.0030744	http://dx.doi.org/10.1371/journal.pone.0030744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348021	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730900014
J	Tang, Q; Qin, D; Lv, ZG; Zhu, XL; Ma, XT; Yan, Q; Zeng, Y; Guo, YY; Feng, NH; Lu, C				Tang, Qiao; Qin, Di; Lv, Zhigang; Zhu, Xiaolei; Ma, Xinting; Yan, Qin; Zeng, Yi; Guo, Yuanyuan; Feng, Ninghan; Lu, Chun			Herpes Simplex Virus Type 2 Triggers Reactivation of Kaposi's Sarcoma-Associated Herpesvirus from Latency and Collaborates with HIV-1 Tat	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; LYTIC CYCLE REPLICATION; LYMPHOMA CELL-LINE; GENE-EXPRESSION; INFECTION; KSHV; HUMAN-HERPESVIRUS-8; ACTIVATION; INDUCTION	Kaposi's sarcoma-associated herpesvirus (KSHV) infection was necessary but not sufficient for Kaposi's sarcoma (KS) development without other cofactors. Previously, we identified that both human immunodeficiency type 1 (HIV-1) Tat and herpes simplex virus 1 (HSV-1) were important cofactors reactivating KSHV from latency. Here, we further investigated the potential of herpes simplex virus 2 (HSV-2) to influence KSHV replication and examined the role of Tat in this procedure. We demonstrated that HSV-2 was a potentially important factor in the pathogenesis of KS, as determined by production of lytic phase mRNA transcripts, viral proteins and infectious viral particles in BCBL-1 cells. These results were further confirmed by an RNA interference experiment using small interfering RNA targeting KSHV Rta and a luciferase reporter assay testing Rta promoter-driven luciferase activity. Mechanistic studies showed that HSV-2 infection activated nuclear factor-kappa B (NF-kappa B) signaling pathway. Inhibition of NF-kappa B pathway enhanced HSV-2-mediated KSHV activation, whereas activation of NF-kappa B pathway suppressed KSHV replication in HSV-2-infected BCBL-1 cells. Additionally, ectopic expression of Tat enhanced HSV-2-induced KSHV replication. These novel findings suggest a role of HSV-2 in the pathogenesis of KS and provide the first laboratory evidence that Tat may participate HSV-2-mediated KSHV activation, implying the complicated pathogenesis of acquired immunodeficiency syndrome (AIDS)-related KS (AIDS-KS) patients.	[Tang, Qiao; Lu, Chun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao; Qin, Di; Lv, Zhigang; Zhu, Xiaolei; Ma, Xinting; Yan, Qin; Guo, Yuanyuan; Lu, Chun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Lv, Zhigang] Jiangsu Prov Official Hosp, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Zeng, Yi] Youjiang Med Coll Nationalities, Dept Microbiol & Immunol, Bose, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Youjiang Medical University for Nationalities; Nanjing Medical University	Tang, Q (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	clu@njmu.edu.cn	Feng, ninghan/ABB-3726-2021; Feng, Ninghan/ABA-8996-2021	Lu, Chun/0000-0002-6078-9352	National Basic Research Program of China (973 Program) [2011CB504803]; National Natural Science Foundation of China [30972619, 30900064, 81071345]; Natural Science Foundation of Ministry of Education of Jiangsu Province [10KJA310032, 09KJB310007]; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund) [20093234120004]; Nanjing Medical Science and Technique Development Foundation [ZKX10002]; Ministry of Health of Jiangsu Province [XK200731]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ministry of Education of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund); Nanjing Medical Science and Technique Development Foundation; Ministry of Health of Jiangsu Province	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504803 http://www.973.gov.cn/English/Index.aspx), National Natural Science Foundation of China (grants 30972619 to CL, 30900064 to DQ, and 81071345 to YZ http://www.nsfc.gov.cn/Portal0/default124.htm), Natural Science Foundation of Ministry of Education of Jiangsu Province (great project 10KJA310032 to CL and grant 09KJB310007 to DQ http://www.jsjyt.gov.cn/), Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund, grant 20093234120004 to DQ http://www.cutech.edu.cn/cn/index.htm), the Key Program of Nanjing Medical Science and Technique Development Foundation (ZKX10002 to QT http://www.njh.gov.cn/), and the Ministry of Health of Jiangsu Province (grant XK200731 http://www.jswst.gov.cn/gb/jsswst/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Arora Anita, 2007, Cancer Treat Res, V133, P21; Bergstrom T, 1996, INTERVIROLOGY, V39, P176, DOI 10.1159/000150493; Blauvelt A, 1997, NEW ENGL J MED, V336, P1837, DOI 10.1056/NEJM199706193362517; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Canadas MP, 2010, J CLIN VIROL; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen XY, 2009, NEOPLASIA, V11, P1272, DOI 10.1593/neo.09494; Deng H, 2007, CURR TOP MICROBIOL, V312, P157; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gray R, 2010, NEW ENGL J MED, V362, P1740, DOI 10.1056/NEJMc1002408; Grossmann C, 2008, VIROLOGY, V375, P94, DOI 10.1016/j.virol.2007.12.044; Hancock MH, 2010, J VIROL, V84, P1366, DOI 10.1128/JVI.01727-09; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Johnston C, 2008, J INFECT DIS, V198, P31, DOI 10.1086/588676; Kao YS, 1999, AM J HEMATOL, V62, P93, DOI 10.1002/(SICI)1096-8652(199910)62:2<93::AID-AJH5>3.3.CO;2-Z; Katano H, 2000, JPN J INFECT DIS, V53, P137; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Kim YC, 2000, J DERMATOL SCI, V24, P38, DOI 10.1016/S0923-1811(00)00080-3; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Li H, 2009, BIOCHEM BIOPH RES CO, V379, P686, DOI 10.1016/j.bbrc.2008.12.150; Li XD, 2011, J VIROL, V85, P715, DOI 10.1128/JVI.01742-10; Lu C, 2005, AM J PATHOL, V166, P173, DOI 10.1016/S0002-9440(10)62242-0; Malmgaard L, 2000, J GEN VIROL, V81, P3011, DOI 10.1099/0022-1317-81-12-3011; Malope BI, 2008, AIDS, V22, P519, DOI 10.1097/QAD.0b013e3282f46582; Merat R, 2002, INT J CANCER, V97, P791, DOI 10.1002/ijc.10086; Muller WJ, 2009, J GEN VIROL, V90, P1153, DOI 10.1099/vir.0.008771-0; Nikolic DS, 2010, J INVEST DERMATOL, V130, P352, DOI 10.1038/jid.2009.227; ONeill E, 1997, J VIROL, V71, P4791, DOI 10.1128/JVI.71.6.4791-4797.1997; OSTROVE JM, 1987, J VIROL, V61, P3726, DOI 10.1128/JVI.61.12.3726-3732.1987; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Palo G, 2001, Herpes, V8, P50; Powles T, 2009, ANN ONCOL, V20, P775, DOI 10.1093/annonc/mdn697; Qin D, 2008, CELL MICROBIOL, V10, P713, DOI 10.1111/j.1462-5822.2007.01079.x; Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240; Sarmati L, 2007, J MED VIROL, V79, P167, DOI 10.1002/jmv.20774; Schafer SL, 1996, J VIROL, V70, P6937, DOI 10.1128/JVI.70.10.6937-6946.1996; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Suligoi B, 2005, AM J TROP MED HYG, V72, P33, DOI 10.4269/ajtmh.2005.72.33; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Sunil Meena, 2010, Curr Infect Dis Rep, V12, P147, DOI 10.1007/s11908-010-0092-5; Tan Darrell H S, 2009, Can J Infect Dis Med Microbiol, V20, pe1; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Volpi A, 2004, J MED VIROL, V74, P467, DOI 10.1002/jmv.20200; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31652	10.1371/journal.pone.0031652	http://dx.doi.org/10.1371/journal.pone.0031652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347501	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200029
J	Chiu, PH; Hsieh, HY; Wang, SC				Chiu, Pei-Hsun; Hsieh, Hsin-Ying; Wang, Sun-Chong			Prescriptions of Traditional Chinese Medicine Are Specific to Cancer Types and Adjustable to Temperature Changes	PLOS ONE			English	Article							DIAGNOSIS; SUBTYPE	Targeted cancer therapies, with specific molecular targets, ameliorate the side effect issue of radiation and chemotherapy and also point to the development of personalized medicine. Combination of drugs targeting multiple pathways of carcinogenesis is potentially more fruitful. Traditional Chinese medicine (TCM) has been tailoring herbal mixtures for individualized healthcare for two thousand years. A systematic study of the patterns of TCM formulas and herbs prescribed to cancers is valuable. We analysed a total of 187,230 TCM prescriptions to 30 types of cancer in Taiwan in 2007, a year's worth of collection from the National Health Insurance reimbursement database (Taiwan). We found that a TCM cancer prescription consists on average of two formulas and four herbs. We show that the percentage weights of TCM formulas and herbs in a TCM prescription follow Zipf's law with an exponent around 0.6. TCM prescriptions to benign neoplasms have a larger Zipf's exponent than those to malignant cancers. Furthermore, we show that TCM prescriptions, via weighted combination of formulas and herbs, are specific to not only the malignancy of neoplasms but also the sites of origins of malignant cancers. From the effects of formulas and natures of herbs that were heavily prescribed to cancers, that cancers are a 'warm and stagnant' syndrome in TCM can be proposed, suggesting anti-inflammatory regimens for better prevention and treatment of cancers. We show that TCM incorporated relevant formulas to the prescriptions to cancer patients with a secondary morbidity. We compared TCM prescriptions made in different seasons and identified temperatures as the environmental factor that correlates with changes in TCM prescriptions in Taiwan. Lung cancer patients were among the patients whose prescriptions were adjusted when temperatures drop. The findings of our study provide insight to TCM cancer treatment, helping dialogue between modern western medicine and TCM for better cancer care.	[Chiu, Pei-Hsun; Hsieh, Hsin-Ying; Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli Taoyuan, Taiwan; [Wang, Sun-Chong] Ctr Addict & Mental Hlth, Epigenet Lab, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Chiu, PH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli Taoyuan, Taiwan.	scwang@ncu.edu.tw			National Science Council, Taiwan (Republic of China) [97-2112-M-008-003-MY3]	National Science Council, Taiwan (Republic of China)(Ministry of Science and Technology, Taiwan)	This work was funded in part by the National Science Council, Taiwan (Republic of China) grant # 97-2112-M-008-003-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamic L, 2011, NATURE, V474, P164, DOI 10.1038/474164a; Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Benz RW, 2008, J CHEM INF MODEL, V48, P1138, DOI 10.1021/ci700353m; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311; Ha LQ, 2003, P 19 INT C COMP LING, P315; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris ESJ, 2011, SCI TOTAL ENVIRON, V409, P4297, DOI 10.1016/j.scitotenv.2011.07.032; Hsieh HY, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/neq050; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Li S.Z, 1982, BEN CAO GANG MU; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Patwardhan B, 2005, EVID-BASED COMPL ALT, V2, P465, DOI 10.1093/ecam/neh140; R Core Team, 2020, R LANG ENV STAT COMP; Sawyers CL, 2007, NATURE, V449, P993, DOI 10.1038/449993a; Sung JJY, 2004, ALIMENT PHARM THER, V20, P1205, DOI 10.1111/j.1365-2036.2004.02242.x; Unschuld PU, 2003, HUANG DI NEI JING SU WEN: NATURE, KNOWLEDGE, IMAGERY IN AN ANCIENT CHINESE MEDICAL TEXT, P1, DOI 10.1525/california/9780520233225.001.0001; Wang S-C, 2008, DNA METHYLATION MICR; Wiseman N, 2009, JIN GUI YAO LUE ESSE; Wu FM, 2001, COLLECTED EXEGESIS R; Yang S, 1998, DIVINE FARMERS MAT M; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang GG, 2004, ALTERN THER HEALTH M, V10, P58; Zhang Zhogjing, 1999, SHANG HAN LUN COLD D	30	15	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31648	10.1371/journal.pone.0031648	http://dx.doi.org/10.1371/journal.pone.0031648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359613	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200082
J	de Feijter, JM; de Grave, WS; Muijtjens, AM; Scherpbier, AJJA; Koopmans, RP				de Feijter, Jeantine M.; de Grave, Willem S.; Muijtjens, Arno M.; Scherpbier, Albert J. J. A.; Koopmans, Richard P.			A Comprehensive Overview of Medical Error in Hospitals Using Incident-Reporting Systems, Patient Complaints and Chart Review of Inpatient Deaths	PLOS ONE			English	Review							PREVENTABLE ADVERSE EVENTS; CLOSED MALPRACTICE CLAIMS; INTERNATIONAL CLASSIFICATION; DIAGNOSTIC ERROR; SAFETY; CARE; RECORD; TIME	Background: Incident reporting systems (IRS) are used to identify medical errors in order to learn from mistakes and improve patient safety in hospitals. However, IRS contain only a small fraction of occurring incidents. A more comprehensive overview of medical error in hospitals may be obtained by combining information from multiple sources. The WHO has developed the International Classification for Patient Safety (ICPS) in order to enable comparison of incident reports from different sources and institutions. Methods: The aim of this paper was to provide a more comprehensive overview of medical error in hospitals using a combination of different information sources. Incident reports collected from IRS, patient complaints and retrospective chart review in an academic acute care hospital were classified using the ICPS. The main outcome measures were distribution of incidents over the thirteen categories of the ICPS classifier "Incident type", described as odds ratios (OR) and proportional similarity indices (PSI). Results: A total of 1012 incidents resulted in 1282 classified items. Large differences between data from IRS and patient complaints (PSI = 0.32) and from IRS and retrospective chart review (PSI = 0.31) were mainly attributable to behaviour (OR = 6.08), clinical administration (OR = 5.14), clinical process (OR = 6.73) and resources (OR = 2.06). Conclusions: IRS do not capture all incidents in hospitals and should be combined with complementary information about diagnostic error and delayed treatment from patient complaints and retrospective chart review. Since incidents that are not recorded in IRS do not lead to remedial and preventive action in response to IRS reports, healthcare centres that have access to different incident detection methods should harness information from all sources to improve patient safety.	[de Feijter, Jeantine M.; de Grave, Willem S.; Muijtjens, Arno M.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Educ Dev & Res, Maastricht, Netherlands; [Scherpbier, Albert J. J. A.] Maastricht Univ, Inst Med Educ, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Koopmans, Richard P.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	de Feijter, JM (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Educ Dev & Res, Maastricht, Netherlands.	j.defeijter@maastrichtuniversity.nl		de Feijter, Jeantine/0000-0003-1398-9551				Agoritsas T, 2005, J GEN INTERN MED, V20, P922, DOI 10.1111/j.1525-1497.2005.0225.x; Barach P, 2000, BMJ-BRIT MED J, V320, P759, DOI 10.1136/bmj.320.7237.759; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Blais R., 2008, J PATIENT SAF, V4, P9, DOI [10.1097/PTS.0b013e31816154a4, DOI 10.1097/PTS.0B013E31816154A4]; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Evans SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-41; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; Hutchinson A, 2009, QUAL SAF HEALTH CARE, V18, P5, DOI 10.1136/qshc.2007.022400; Jones KJ, 2004, J RURAL HEALTH, V20, P335, DOI 10.1111/j.1748-0361.2004.tb00047.x; Kachalia A, 2007, ANN EMERG MED, V49, P196, DOI 10.1016/j.annemergmed.2006.06.035; King A, 2010, QUAL SAF HEALTH CARE, V19, P148, DOI 10.1136/qshc.2008.030114; Kohn KT, 1999, TO ERR IS HUMAN BUIL; Kuosmanen L, 2008, J MED ETHICS, V34, P788, DOI 10.1136/jme.2008.024463; Lessing C, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.031435; Levtzion-Korach O, 2010, JT COMM J QUAL PATIE, V36, P402, DOI 10.1016/S1553-7250(10)36059-4; Meyer-Massetti C, 2011, AM J HEALTH-SYST PH, V68, P227, DOI 10.2146/ajhp100019; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; Milch CE, 2006, J GEN INTERN MED, V21, P165, DOI 10.1111/j.1525-1497.2006.00322.x; Moghadam JM, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.033654; Montini T, 2008, INT J QUAL HEALTH C, V20, P412, DOI 10.1093/intqhc/mzn041; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Olsen S, 2007, QUAL SAF HEALTH CARE, V16, P40, DOI 10.1136/qshc.2005.017616; Reason J, 1995, Qual Health Care, V4, P80, DOI 10.1136/qshc.4.2.80; Runciman W, 2009, INT J QUAL HEALTH C, V21, P18, DOI 10.1093/intqhc/mzn057; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Schulz S, 2009, STUD HEALTH TECHNOL, V150, P502, DOI 10.3233/978-1-60750-044-5-502; Sherman H, 2009, INT J QUAL HEALTH C, V21, P2, DOI 10.1093/intqhc/mzn054; Silas R, 2010, QUAL SAF HEALTH CARE, V19, P568, DOI 10.1136/qshc.2009.032979; Singh H, 2007, ARCH INTERN MED, V167, P2030, DOI 10.1001/archinte.167.19.2030; Solberg LI, 2008, JT COMM J QUAL PATIE, V34, P266, DOI 10.1016/S1553-7250(08)34033-1; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Thomson R, 2009, INT J QUAL HEALTH C, V21, P9, DOI 10.1093/intqhc/mzn055; Tuttle D, 2004, QUAL SAF HEALTH CARE, V13, P281, DOI 10.1136/qshc.2003.009100; VEGELIUS J, 1986, QUAL QUANT, V20, P437; Weingart SN, 2005, J GEN INTERN MED, V20, P830, DOI 10.1111/j.1525-1497.2005.0180.x; Weissman JS, 2008, ANN INTERN MED, V149, P100, DOI 10.7326/0003-4819-149-2-200807150-00006; Zegers M, 2009, QUAL SAF HEALTH CARE, V18, P297, DOI 10.1136/qshc.2007.025924; Zegers M, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-27	42	41	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31125	10.1371/journal.pone.0031125	http://dx.doi.org/10.1371/journal.pone.0031125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359567	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200036
J	Gergalova, G; Lykhmus, O; Kalashnyk, O; Koval, L; Chernyshov, V; Kryukova, E; Tsetlin, V; Komisarenko, S; Skok, M				Gergalova, Galyna; Lykhmus, Olena; Kalashnyk, Olena; Koval, Lyudmyla; Chernyshov, Volodymyr; Kryukova, Elena; Tsetlin, Victor; Komisarenko, Sergiy; Skok, Maryna			Mitochondria Express alpha 7 Nicotinic Acetylcholine Receptors to Regulate Ca2+ Accumulation and Cytochrome c Release: Study on Isolated Mitochondria	PLOS ONE			English	Article							OUTER-MEMBRANE; IONIC EVENTS; CHANNEL; VDAC; ACTIVATION; CHOLINE; LIVER; ANTIBODIES; DEFICIENT; SUBUNIT	Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that mediate synaptic transmission in the muscle and autonomic ganglia and regulate transmitter release in the brain. The nAChRs composed of alpha 7 subunits are also expressed in non-excitable cells to regulate cell survival and proliferation. Up to now, functional alpha 7 nAChRs were found exclusively on the cell plasma membrane. Here we show that they are expressed in mitochondria and regulate early proapoptotic events like cytochrome c release. The binding of alpha 7-specific antibody with mouse liver mitochondria was revealed by electron microscopy. Outer membranes of mitochondria from the wild-type and beta 2-/- but not alpha 7-/- mice bound alpha 7 nAChR-specific antibody and toxins: FITC-labeled alpha-cobratoxin or Alexa 555-labeled alpha-bungarotoxin. alpha 7 nAChR agonists (1 mu M acetylcholine, 10 mu M choline or 30 nM PNU-282987) impaired intramitochondrial Ca2+ accumulation and significantly decreased cytochrome c release stimulated with either 90 mu M CaCl2 or 0.5 mM H2O2. alpha 7-specific antagonist methyllicaconitine (50 nM) did not affect Ca2+ accumulation in mitochondria but attenuated the effects of agonists on cytochrome c release. Inhibitor of voltage-dependent anion channel (VDAC) 4,4'-diisothio-cyano-2,2'-stilbene disulfonic acid (0.5 mu M) decreased cytochrome c release stimulated with apoptogens similarly to alpha 7 nAChR agonists, and VDAC was co-captured with the alpha 7 nAChR from mitochondria outer membrane preparation in both direct and reverse sandwich ELISA. It is concluded that alpha 7 nAChRs are expressed in mitochondria outer membrane to regulate the VDAC-mediated Ca2+ transport and mitochondrial permeability transition.	[Gergalova, Galyna; Lykhmus, Olena; Kalashnyk, Olena; Koval, Lyudmyla; Chernyshov, Volodymyr; Komisarenko, Sergiy; Skok, Maryna] Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine; [Kryukova, Elena; Tsetlin, Victor] Russian Acad Sci, Dept Mol Bases Neurosignaling, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	National Academy of Sciences Ukraine; Palladin Institute of Biochemistry of NASU; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Gergalova, G (corresponding author), Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine.	skok@biochem.kiev.ua	Skok, Maryna/AAQ-9939-2020; Komisarenko, Sergiy/AAT-3457-2020; Tsetlin, Victor/X-2491-2018	Komisarenko, Serhiy/0000-0002-3244-3194; Skok, Maryna/0000-0002-5816-605X	European Molecular Biology Organization; Alzheimer Association; Russian Academy of Sciences	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the short-term fellowship of European Molecular Biology Organization, the Investigator Initiated Research Grant of Alzheimer Association and the grant P5 "Fundamental Sciences to Medicine" of Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 2006, J PHARMACOL EXP THER, V318, P268, DOI 10.1124/jpet.106.103135; Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; Bencherif M, 2009, ACTA PHARMACOL SIN, V30, P702, DOI 10.1038/aps.2009.37; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Chernyavsky AI, 2009, J BIOL CHEM, V284, P22140, DOI 10.1074/jbc.M109.011395; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Conti-Fine BM, 2000, EUR J PHARMACOL, V393, P279, DOI 10.1016/S0014-2999(00)00036-4; Cormier A, 2001, BRAIN RES, V900, P72, DOI 10.1016/S0006-8993(01)02254-5; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; Danne O, 2010, EXPERT REV MOL DIAGN, V10, P159, DOI 10.1586/ERM.10.2; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gergalova G, 2011, NEIROFIZIOLOGIA NEUR, V43, P225; Gergalova G L, 2011, Ukr Biokhim Zh (1999), V83, P13; Hampl V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001383; Ichimura T., 2011, J BIOPHYS CHEM, V2, P10, DOI [10.4236/jbpc.2011.21002, DOI 10.4236/JBPC.2011.21002]; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Kawamata J, 2011, J ALZHEIMERS DIS, V24, P95, DOI 10.3233/JAD-2011-110173; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Koval LA, 2008, INT J BIOCHEM CELL B, V40, P980, DOI 10.1016/j.biocel.2007.11.006; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Li YX, 2002, J NEUROCHEM, V81, P853, DOI 10.1046/j.1471-4159.2002.00891.x; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Lykhmus O, 2010, IMMUNOL LETT, V128, P68, DOI 10.1016/j.imlet.2009.11.006; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Oloris SCS, 2010, TOXICOL APPL PHARM, V242, P299, DOI 10.1016/j.taap.2009.10.020; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; RATINAUD MH, 1988, CYTOMETRY, V9, P206, DOI 10.1002/cyto.990090304; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Sharples Christopher G.V., 2001, NEURONAL NICOTINIC R, P1; Shelukhina IV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P749, DOI 10.1134/S0006297906070078; Shelukhina IV, 2009, J NEUROCHEM, V109, P1087, DOI 10.1111/j.1471-4159.2009.06033.x; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Singhal S, 2011, J NANOTECHNOL, V2011, DOI [10.1155/2011/930243, 10.1155/2011/456743]; Skok M, 2006, J NEUROIMMUNOL, V171, P86, DOI 10.1016/j.jneuroim.2005.09.011; Skok MV, 2009, J LEUKOCYTE BIOL, V86, P1, DOI 10.1189/JLB.0209106; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Song P, 2008, J PHARMACOL SCI, V106, P180, DOI 10.1254/jphs.FM0070091; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Teodoro JS, 2008, MITOCHONDRION, V8, P367, DOI 10.1016/j.mito.2008.07.008; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Ward MW, 2010, METHODS MOL BIOL, V591, P335, DOI 10.1007/978-1-60761-404-3_20	50	105	107	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31361	10.1371/journal.pone.0031361	http://dx.doi.org/10.1371/journal.pone.0031361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359587	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200056
J	Honnen, SJ; Buchter, C; Schroder, V; Hoffmann, M; Kohara, Y; Kampkotter, A; Bossinger, O				Honnen, Sebastian J.; Buechter, Christian; Schroeder, Verena; Hoffmann, Michael; Kohara, Yuji; Kampkoetter, Andreas; Bossinger, Olaf			C. elegans VANG-1 Modulates Life Span via Insulin/IGF-1-Like Signaling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DAF-16; OOCYTE MEIOTIC MATURATION; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; CELL POLARITY; OXIDATIVE STRESS; PLANAR POLARITY; FAMILY-MEMBER; GENE; WNT	The planar cell polarity (PCP) pathway is highly conserved from Drosophila to humans and a PCP-like pathway has recently been described in the nematode Caenorhabditis elegans. The developmental function of this pathway is to coordinate the orientation of cells or structures within the plane of an epithelium or to organize cell-cell intercalation required for correct morphogenesis. Here, we describe a novel role of VANG-1, the only C. elegans ortholog of the conserved PCP component Strabismus/Van Gogh. We show that two alleles of vang-1 and depletion of the protein by RNAi cause an increase of mean life span up to 40%. Consistent with the longevity phenotype vang-1 animals also show enhanced resistance to thermal- and oxidative stress and decreased lipofuscin accumulation. In addition, vang-1 mutants show defects like reduced brood size, decreased ovulation rate and prolonged reproductive span, which are also related to gerontogenes. The germline, but not the intestine or neurons, seems to be the primary site of vang-1 function. Life span extension in vang-1 mutants depends on the insulin/IGF-1-like receptor DAF-2 and DAF-16/FoxO transcription factor. RNAi against the phase II detoxification transcription factor SKN-1/Nrf2 also reduced vang-1 life span that might be explained by gradual inhibition of insulin/IGF-1-like signaling in vang-1. This is the first time that a key player of the PCP pathway is shown to be involved in the insulin/IGF-1-like signaling dependent modulation of life span in C. elegans.	[Honnen, Sebastian J.; Bossinger, Olaf] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Sch Med, Aachen, Germany; [Honnen, Sebastian J.; Buechter, Christian; Schroeder, Verena; Kampkoetter, Andreas] Univ Dusseldorf, Inst Toxicol, D-40225 Dusseldorf, Germany; [Hoffmann, Michael] Univ Dusseldorf, Dept Gen Pediat, Univ Childrens Hosp, D-40225 Dusseldorf, Germany; [Kohara, Yuji] Natl Inst Genet, Genome Biol Lab, Mishima, Shizuoka 411, Japan; [Kampkoetter, Andreas] Bayer Anim Hlth GmbH, Res & Dev, Leverkusen, Germany	RWTH Aachen University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Bayer AG	Honnen, SJ (corresponding author), Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Sch Med, Aachen, Germany.	olaf.bossinger@rwth-aachen.de		Honnen, Sebastian/0000-0002-7845-7807; Hoffmann, Michael/0000-0001-8677-5031	Deutsche Forschungsgemeinschaft [SFB590 TP B3]; NIH National Center for Research Resources (NCRR)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Deutsche Forschungsgemeinschaft (SFB590 TP B3) to OB. SH is a fellow of the Jurgen Manchot Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank: C. Cowan, A. Wodarz, A. Muller and J. Nelson for critical reading of the manuscript, N.J. Storm for sharing data, A. Dillin for providing daf-2 RNAi "feeding"-clone, the Mitani lab and the C. elegans Knockout Consortium for providing tm1422 and ok1142, respectively. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Braeckman BP, 2002, AGING CELL, V1, P82, DOI 10.1046/j.1474-9728.2002.00021.x; BRENNER S, 1974, GENETICS, V77, P71; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; De Castro E, 2004, FREE RADICAL BIO MED, V37, P139, DOI 10.1016/j.freeradbiomed.2004.04.021; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIEDMAN DB, 1988, GENETICS, V118, P75; Garigan D, 2002, GENETICS, V161, P1101; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; GOTTLIEB S, 1994, GENETICS, V137, P107; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; GREENSTEIN D, 1994, GENE DEV, V8, P1935, DOI 10.1101/gad.8.16.1935; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hekimi S, 2011, TRENDS CELL BIOL; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hoffmann M, 2010, DEV BIOL, V339, P268, DOI 10.1016/j.ydbio.2009.12.002; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Kampkotter A, 2007, ARCH TOXICOL, V81, P849, DOI 10.1007/s00204-007-0215-4; Kampkotter A, 2007, TOXICOLOGY, V234, P113, DOI 10.1016/j.tox.2007.02.006; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2008, PHILOS T R SOC B, V363, P1317, DOI 10.1098/rstb.2007.2250; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Landis JN, 2010, DEV DYN; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Luo SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000789; Luscombe NM, 2002, GENOME BIOL, V3; McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; Mirkovic I, 2011, NATURE STRUCTURAL MO; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okuyama T, 2010, J BIOL CHEM; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; Rose KL, 1997, DEV BIOL, V192, P59, DOI 10.1006/dbio.1997.8728; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Woolson RFC., 2002, STAT METHODS ANAL BI, Ved 2; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024	86	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32183	10.1371/journal.pone.0032183	http://dx.doi.org/10.1371/journal.pone.0032183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359667	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200136
J	Poreba, M; McGowan, S; Skinner-Adams, TS; Trenholme, KR; Gardiner, DL; Whisstock, JC; To, J; Salvesen, GS; Dalton, JP; Drag, M				Poreba, Marcin; McGowan, Sheena; Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.; Whisstock, James C.; To, Joyce; Salvesen, Guy S.; Dalton, John P.; Drag, Marcin			Fingerprinting the Substrate Specificity of M1 and M17 Aminopeptidases of Human Malaria, Plasmodium falciparum	PLOS ONE			English	Article							LEUCINE AMINOPEPTIDASE; LEUCYL AMINOPEPTIDASE; ANTIMALARIAL ACTIVITY; PARASITES; INHIBITORS; IDENTIFICATION; DEGRADATION; BESTATIN; STRATEGY; DESIGN	Background: Plasmodium falciparum, the causative agent of human malaria, expresses two aminopeptidases, PfM1AAP and PfM17LAP, critical to generating a free amino acid pool used by the intraerythrocytic stage of the parasite for proteins synthesis, growth and development. These exopeptidases are potential targets for the development of a new class of anti-malaria drugs. Methodology/Principal Findings: To define the substrate specificity of recombinant forms of these two malaria aminopeptidases we used a new library consisting of 61 fluorogenic substrates derived both from natural and unnatural amino acids. We obtained a detailed substrate fingerprint for recombinant forms of the enzymes revealing that PfM1AAP exhibits a very broad substrate tolerance, capable of efficiently hydrolyzing neutral and basic amino acids, while PfM17LAP has narrower substrate specificity and preferentially cleaves bulky, hydrophobic amino acids. The substrate library was also exploited to profile the activity of the native aminopeptidases in soluble cell lysates of P. falciparum malaria. Conclusions/Significance: This data showed that PfM1AAP and PfM17LAP are responsible for majority of the aminopeptidase activity in these extracts. These studies provide specific substrate and mechanistic information important for understanding the function of these aminopeptidases and could be exploited in the design of new inhibitors to specifically target these for anti-malaria treatment.	[Poreba, Marcin; Drag, Marcin] Wroclaw Univ Technol, Div Med Chem & Microbiol, Fac Chem, PL-50370 Wroclaw, Poland; [McGowan, Sheena; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [McGowan, Sheena; Whisstock, James C.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic, Australia; [Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.] Queensland Inst Med Res, Malaria Biol Lab, Brisbane, Qld 4006, Australia; [Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.] Griffith Univ, Joint Program, Griffith Med Res Coll, Brisbane, Qld 4111, Australia; [Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.] Univ Queensland, Sch Med, Royal Brisbane Hosp, Brisbane, Qld, Australia; [To, Joyce; Dalton, John P.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Salvesen, Guy S.; Drag, Marcin] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA USA	Wroclaw University of Science & Technology; Monash University; Monash University; QIMR Berghofer Medical Research Institute; Griffith University; Royal Brisbane & Women's Hospital; University of Queensland; McGill University; Sanford Burnham Prebys Medical Discovery Institute	Poreba, M (corresponding author), Wroclaw Univ Technol, Div Med Chem & Microbiol, Fac Chem, PL-50370 Wroclaw, Poland.	john.dalton@mcgill.ca; marcin.drag@pwr.wroc.pl	Dalton, John/K-4457-2014; Skinner-Adams, Tina S/A-9798-2012; Trenholme, Katharine/C-9244-2013; Gardiner, Don/G-4717-2010; McGowan, Sheena/C-4797-2014	Skinner-Adams, Tina S/0000-0001-7011-3850; Whisstock, James/0000-0003-4200-5611; McGowan, Sheena/0000-0001-6863-1106; To, Joyce/0000-0003-3482-4369	Foundation for Polish Science; Canadian Institute for Health Research	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	The source of funds are Foundation for Polish Science (www.fnp.org.pl) and Canadian Institute for Health Research (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh O, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-189; Cunningham E, 2008, ANTIMICROB AGENTS CH, V52, P3221, DOI 10.1128/AAC.01327-07; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Dev V, 2006, J INFECTION, V52, P131, DOI 10.1016/j.jinf.2005.02.033; Drag M, 2010, J BIOL CHEM, V285, P3310, DOI 10.1074/jbc.M109.060418; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Enserink M, 2008, SCIENCE, V321, P1620, DOI 10.1126/science.321.5896.1620b; Fidock DA, 2008, TRENDS PARASITOL, V24, P537, DOI 10.1016/j.pt.2008.09.005; Flipo M, 2003, BIOORG MED CHEM LETT, V13, P2659, DOI 10.1016/S0960-894X(03)00550-X; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Lew VL, 2004, BLOOD CELL MOL DIS, V32, P353, DOI 10.1016/j.bcmd.2004.01.006; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Maly DJ, 2002, J ORG CHEM, V67, P910, DOI 10.1021/jo016140o; Maric S, 2009, BIOCHEMISTRY-US, V48, P5435, DOI 10.1021/bi9003638; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Ragheb D, 2011, J BIOL CHEM     0609; Rosenthal PJ, 2002, CURR OPIN HEMATOL, V9, P140, DOI 10.1097/00062752-200203000-00010; Skinner-Adams TS, 2007, J MED CHEM, V50, P6024, DOI 10.1021/jm070733v; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Velmourougane G, 2011, J MED CHEM, V54, P1655, DOI 10.1021/jm101227t	29	58	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31938	10.1371/journal.pone.0031938	http://dx.doi.org/10.1371/journal.pone.0031938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359643	Green Published, gold			2022-12-27	WOS:000302796200112
J	Scotti, ML; Smith, KE; Butler, AM; Calcagno, SR; Crawford, HC; Leitges, M; Fields, AP; Murray, NR				Scotti, Michele L.; Smith, Kristin E.; Butler, Amanda M.; Calcagno, Shelly R.; Crawford, Howard C.; Leitges, Michael; Fields, Alan P.; Murray, Nicole R.			Protein Kinase C Iota Regulates Pancreatic Acinar-to-Ductal Metaplasia	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; EPITHELIAL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; TRANSGENIC MICE; TGF-ALPHA; CANCER; NESTIN; CARCINOGENESIS; PROGRESSION; EXPRESSION	Pancreatic acinar-to-ductal metaplasia (ADM) is associated with an increased risk of pancreatic cancer and is considered a precursor of pancreatic ductal adenocarcinoma. Transgenic expression of transforming growth factor alpha (TGF-alpha) or K-ras(G12D) in mouse pancreatic epithelium induces ADM in vivo. Protein kinase C iota (PKCi) is highly expressed in human pancreatic cancer and is required for the transformed growth and tumorigenesis of pancreatic cancer cells. In this study, PKCi expression was assessed in a mouse model of K-ras(G12D)-induced pancreatic ADM and pancreatic cancer. The ability of K-ras(G12D) to induce pancreatic ADM in explant culture, and the requirement for PKCi, was investigated. PKCi is elevated in human and mouse pancreatic ADM and intraepithelial neoplastic lesions in vivo. We demonstrate that K-ras(G12D) is sufficient to induce pancreatic ADM in explant culture, exhibiting many of the same morphologic and biochemical alterations observed in TGF-alpha-induced ADM, including a dependence on Notch activation. PKCi is highly expressed in both TGF-alpha- and K-ras(G12D)-induced pancreatic ADM and inhibition of PKCi significantly reduces TGF-alpha- and K-ras(G12D)-mediated ADM. Inhibition of PKCi suppresses K-ras(G12D)-induced MMP-7 expression and Notch activation, and exogenous MMP-7 restores K-ras(G12D)-mediated ADM in PKCi-depleted cells, implicating a K-ras(G12D)-PKCi-MMP-7 signaling axis that likely induces ADM through Notch activation. Our results indicate that PKCi is an early marker of pancreatic neoplasia and suggest that PKCi is a potential downstream target of K-ras(G12D) in pancreatic ductal metaplasia in vivo.	[Scotti, Michele L.; Smith, Kristin E.; Butler, Amanda M.; Calcagno, Shelly R.; Fields, Alan P.; Murray, Nicole R.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Crawford, Howard C.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Mayo Clinic; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Oslo	Scotti, ML (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	murray.nicole@mayo.edu	Leitges, Michael/AAN-1953-2021; Crawford, Howard/A-2874-2008	Saravia-Butler, Amanda M./0000-0001-7505-2743; Leitges, Michael/0000-0003-4203-6995	Mayo Clinic SPORE in Pancreatic Cancer [P50 CA102701]; NIH/NCI [R01CA140290-1, R01CA081436-13]; Fraternal Order of Eagles Cancer Research Fund Pilot Program; Daniel Foundation of Alabama; Mayo Clinic Foundation; NICHD; Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA140290, R01CA081436, P50CA102701, R01CA159222] Funding Source: NIH RePORTER	Mayo Clinic SPORE in Pancreatic Cancer; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fraternal Order of Eagles Cancer Research Fund Pilot Program; Daniel Foundation of Alabama; Mayo Clinic Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Mayo Clinic SPORE in Pancreatic Cancer Career Development award P50 CA102701 (N.R. Murray), NIH/NCI R01CA140290-1 (N.R. Murray), NIH/NCI R01CA081436-13 (A.P. Fields), Fraternal Order of Eagles Cancer Research Fund Pilot Program (N.R. Murray), Daniel Foundation of Alabama Postdoctoral Fellowship (M.L. Scotti) and The Mayo Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Brandy Edenfield, Shuhua Li, and Justin Weems of the Mayo Clinic, for excellent technical support and Dr. Pinku Mukherjee, University of North Carolina, for providing the P48-Cre mice. The CK-19 antibody (TROMAIII) was developed by Dr. Rolf Kemler, Max-Planck Institute, and obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We acknowledge the Mayo Clinic SPORE in Pancreatic Cancer Patient Registry and Tissue Core (supported by P50 CA102701 (Gloria Petersen, PI) and the Lustgarten Foundation for Pancreatic Cancer Research) for providing the biospecimens used in this study.	BOCKMAN DE, 1992, GASTROENTEROLOGY, V103, P1883, DOI 10.1016/0016-5085(92)91448-D; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; Calcagno SR, 2011, INFLAMM BOWEL DIS, V17, P1685, DOI 10.1002/ibd.21547; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Erdogan E, 2006, J BIOL CHEM, V281, P28450, DOI 10.1074/jbc.M606054200; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; del Pulgar TG, 2007, INT J BIOCHEM CELL B, V39, P2289, DOI 10.1016/j.biocel.2007.06.014; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Heid I, 2011, GASTROENTEROLOGY; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Leach SD, 2005, J CLIN GASTROENTEROL, V39, pS78, DOI 10.1097/01.mcg.0000155547.83901.a3; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Meszoely IM, 2001, CANCER J, V7, P242; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Murray NR, 2009, CANCER RES, V69, P656, DOI 10.1158/0008-5472.CAN-08-3001; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Regala RP, 2008, CANCER RES, V68, P5888, DOI 10.1158/0008-5472.CAN-08-0438; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	41	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30509	10.1371/journal.pone.0030509	http://dx.doi.org/10.1371/journal.pone.0030509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359542	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200011
J	Kemp, AH; Quintana, DS; Felmingham, KL; Matthews, S; Jelinek, HF				Kemp, Andrew H.; Quintana, Daniel S.; Felmingham, Kim L.; Matthews, Slade; Jelinek, Herbert F.			Depression, Comorbid Anxiety Disorders, and Heart Rate Variability in Physically Healthy, Unmedicated Patients: Implications for Cardiovascular Risk	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; NEUROVISCERAL INTEGRATION; ANTIDEPRESSANT TREATMENT; DSM-IV; MORTALITY; DISEASE; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATION; NETHERLANDS	Context: There is evidence that heart rate variability (HRV) is reduced in major depressive disorder (MDD), although there is debate about whether this effect is caused by medication or the disorder per se. MDD is associated with a two to fourfold increase in the risk of cardiac mortality, and HRV is a robust predictor of cardiac mortality; determining a direct link between HRV and not only MDD, but common comorbid anxiety disorders, will point to psychiatric indicators for cardiovascular risk reduction. Objective: To determine in physically healthy, unmedicated patients whether (1) HRV is reduced in MDD relative to controls, and (2) HRV reductions are driven by MDD alone, comorbid generalized anxiety disorder (GAD, characterized by anxious anticipation), or comorbid panic and posttraumatic stress disorders (PD/PTSD, characterized by anxious arousal). Design, Setting, and Patients: A case-control study in 2006 and 2007 on 73 MDD patients, including 24 without anxiety comorbidity, 24 with GAD, and 14 with PD/PTSD. Seventy-three MDD and 94 healthy age- and sex-matched control participants were recruited from the general community. Participants had no history of drug addiction, alcoholism, brain injury, loss of consciousness, stroke, neurological disorder, or serious medical conditions. There were no significant differences between the four groups in age, gender, BMI, or alcohol use. Main Outcome Measures: HRV was calculated from electrocardiography under a standardized short-term resting state condition. Results: HRV was reduced in MDD relative to controls, an effect associated with a medium effect size. MDD participants with comorbid generalized anxiety disorder displayed the greatest reductions in HRV relative to controls, an effect associated with a large effect size. Conclusions: Unmedicated, physically healthy MDD patients with and without comorbid anxiety had reduced HRV. Those with comorbid GAD showed the greatest reductions. Implications for cardiovascular risk reduction strategies in otherwise healthy patients with psychiatric illness are discussed.	[Kemp, Andrew H.; Quintana, Daniel S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Felmingham, Kim L.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Matthews, Slade] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Jelinek, Herbert F.] Charles Sturt Univ, Ctr Res Complex Syst, Albury, NSW, Australia; [Jelinek, Herbert F.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; Charles Sturt University; Macquarie University	Kemp, AH (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	andrew.kemp@sydney.edu.au	Quintana, Daniel S./H-2726-2019; Jelinek, Herbert/AAQ-6825-2020; Matthews, Slade/J-4939-2019; Kemp, Andrew Haddon/C-7984-2012; Jelinek, Herbert F/S-6779-2019	Quintana, Daniel S./0000-0003-2876-0004; Matthews, Slade/0000-0002-1652-543X; Kemp, Andrew Haddon/0000-0003-1146-3791; Jelinek, Herbert F/0000-0001-5457-6193	NHMRC [571101]; Australian Rotary Health/Hooton Family Scholarship; Australian National Health and Medical Research Council (NHMRC) [464863]; GlaxoSmithKline, Australia; Brain Resource; Johnson & Johnson Pharmaceutical Research and Development; RED Europe; BRAINnet under the governance of the BRAINnet Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Rotary Health/Hooton Family Scholarship; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); GlaxoSmithKline, Australia(GlaxoSmithKline); Brain Resource; Johnson & Johnson Pharmaceutical Research and Development(Johnson & JohnsonJohnson & Johnson USA); RED Europe; BRAINnet under the governance of the BRAINnet Foundation	AHK is supported by an NHMRC Career Development Award (571101) and DSQ by an Australian Rotary Health/Hooton Family Scholarship. This research was supported by an Australian National Health and Medical Research Council (NHMRC) Project Grant (464863) and a GlaxoSmithKline, Australia, Postgraduate Support Grant (2007-08). Brain Resource (http://www.brainresource.com) and Johnson & Johnson Pharmaceutical Research and Development, RED Europe also funded the project on which this study is based. Sponsors played no role in the analysis and interpretation of data, the preparation, review, or approval of the manuscript, or the decision to submit the paper for publication. The authors, AHK and DSQ, had full access to all of the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis.; The authors received funding for this study from commercial sources. These included GlaxoSmithKline, Australia, Postgraduate Support Grant (2007-08), which provided support to AHK for conference travel. Brain Resource and Johnson & Johnson Pharmaceutical Research and Development, RED Europe funded the research on which this study is based. AHK was employed on a part-time contractual basis to coordinate the research activities. These funding arrangements do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Indeed, the data on which the present study is based is made available by BRAINnet, www.BRAINnet.net, under the governance of the BRAINnet Foundation. BRAINnet is the scientific network that coordinates access to the Brain Resource International Database for independent scientific purposes.; We acknowledge the data and support provided by BRAINnet; www.BRAINnet.net, under the governance of the BRAINnet Foundation. BRAINnet is the scientific network that coordinates access to the Brain Resource International Database for independent scientific purposes.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Anuurad E, 2011, ARTERIOSCL THROM VAS, V31, P2151, DOI 10.1161/ATVBAHA.111.232348; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carnethon MR, 2002, AM J EPIDEMIOL, V155, P48, DOI 10.1093/aje/155.1.48; Carney Robert M, 2009, Cleve Clin J Med, V76 Suppl 2, pS13, DOI 10.3949/ccjm.76.s2.03; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Gordon E, 2003, NEUROPSYCHOPHARMACOL, V28, pS2, DOI 10.1038/sj.npp.1300136; Hickie IB, 2001, MED J AUSTRALIA, V175, pS10; Kemp AH, 2010, HEART RATE VARIABILI, P1, DOI [10.1016/j.biopsych.2010.07.030, DOI 10.1016/J.BIOPSYCH.2010.07.030]; Kemp A, 2011, ACTA NEUROPSYCHIATR, V23, P82, DOI 10.1111/j.1601-5215.2011.00535.x; Kemp AH, 2011, BIOL PSYCHIAT, V69, pE25, DOI 10.1016/j.biopsych.2010.10.035; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kop WJ, 2010, PSYCHOSOM MED, V72, P626, DOI 10.1097/PSY.0b013e3181eadd2b; Licht CMM, 2011, BIOL PSYCHIAT, V69, pE27, DOI 10.1016/j.biopsych.2010.12.039; Licht Carmilla M M, 2011, Biol Psychiatry, V69, pe3, DOI 10.1016/j.biopsych.2010.06.034; Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mogg K, 2005, COGNITIVE THER RES, V29, P29, DOI 10.1007/s10608-005-1646-y; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221; Pizzi C, 2010, ATHEROSCLEROSIS, V212, P292, DOI 10.1016/j.atherosclerosis.2010.04.038; Porges SW, 2011, POLYVAGAL THEORY NEU; Rottenberg J, 2007, BIOL PSYCHOL, V74, P200, DOI 10.1016/j.biopsycho.2005.08.010; Serrador J M, 1999, Heart, V82, pe9; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Taylor CB, 2010, INT J PSYCHOPHYSIOL, V78, P80, DOI 10.1016/j.ijpsycho.2010.04.006; Thayer JF, 1996, BIOL PSYCHIAT, V39, P255, DOI 10.1016/0006-3223(95)00136-0; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer Julian F, 2009, Cleve Clin J Med, V76 Suppl 2, pS23, DOI 10.3949/ccjm.76.s2.05; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tompkins W. J., 1993, BIOMEDICAL DIGITAL S; van Zyl LT, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-12; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Wilhelm KA, 2008, MED J AUSTRALIA, V188, pS114; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Ziegelstein RC, 2001, JAMA-J AM MED ASSOC, V286, P1621, DOI 10.1001/jama.286.13.1621	43	266	270	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30777	10.1371/journal.pone.0030777	http://dx.doi.org/10.1371/journal.pone.0030777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355326	Green Published, gold			2022-12-27	WOS:000302741300026
J	Benelli, D; Cialfi, S; Pinzaglia, M; Talora, C; Londei, P				Benelli, Dario; Cialfi, Samantha; Pinzaglia, Michela; Talora, Claudio; Londei, Paola			The Translation Factor eIF6 Is a Notch-Dependent Regulator of Cell Migration and Invasion	PLOS ONE			English	Article							INITIATION FACTOR-6; BINDING PROTEIN; EXPRESSION; P27(BBP); EIF-4E; GROWTH; TRANSFORMATION	A growing body of evidence indicates that protein factors controlling translation play an important role in tumorigenesis. The protein known as eIF6 is a ribosome anti-association factor that has been implicated in translational initiation and in ribosome synthesis. Over-expression of eIF6 is observed in many natural tumours, and causes developmental and differentiation defects in certain animal models. Here we show that the transcription of the gene encoding eIF6 is modulated by the receptor Notch-1, a protein involved in embryonic development and cell differentiation, as well as in many neoplasms. Inhibition of Notch-1 signalling by gamma-secretase inhibitors slowed down cell-cycle progression and reduced the amount of eIF6 in lymphoblastoid and ovarian cancer cell lines. Cultured ovarian cancer cell lines engineered to stably over-expressing eIF6 did not show significant changes in proliferation rate, but displayed an enhanced motility and invasive capacity. Inhibition of Notch-1 signalling in the cells over-expressing eIF6 was effective in slowing down the cell cycle, but did not reduce cell migration and invasion. On the whole, the results suggest that eIF6 is one of the downstream effectors of Notch-1 in the pathway that controls cell motility and invasiveness.	[Benelli, Dario; Pinzaglia, Michela; Londei, Paola] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy; [Talora, Claudio] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Cialfi, Samantha] Univ Roma La Sapienza, Dept Pediat & Infantile Neuropsychiat, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Benelli, D (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy.	londei@bce.uniroma1.it	Talora, Claduio/AIC-4932-2022; Benelli, Dario/D-3492-2012	Talora, Claduio/0000-0002-6973-2184; Benelli, Dario/0000-0002-1488-8392	Istituto Pasteur-Fondazione Cenci Bolognetti; Roma Sapienza University	Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Roma Sapienza University	This work was supported by funds to PL from the Istituto Pasteur-Fondazione Cenci Bolognetti project: "Translational regulation: from the Archaea to the Eukarya" and by funds from the Roma Sapienza University to PL for the project "Molecular markers in melanoma progression." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Carotenuto R, 2005, CELL MOL LIFE SCI, V62, P1641, DOI 10.1007/s00018-005-5153-9; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; De Marco N, 2010, CELL DEATH DIFFER, V17, P360, DOI 10.1038/cdd.2009.128; Donadini A, 2006, FEBS LETT, V580, P1983, DOI 10.1016/j.febslet.2006.02.068; Donadini A, 2001, GENE, V266, P35, DOI 10.1016/S0378-1119(01)00370-5; Flavin RJ, 2008, MODERN PATHOL, V21, P676, DOI 10.1038/modpathol.2008.33; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Ji Y, 2008, ONCOGENE, V27, P755, DOI 10.1038/sj.onc.1210667; Kato H, 1997, DEVELOPMENT, V124, P4133; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; Miluzio A, 2011, CANCER CELL, V19, P765, DOI 10.1016/j.ccr.2011.04.018; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Rosso P, 2004, HEAD NECK-J SCI SPEC, V26, P408, DOI 10.1002/hed.10401; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Sanvito F, 2000, CANCER RES, V60, P510; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Talora C, 2008, BBA-MOL BASIS DIS, V1782, P489, DOI 10.1016/j.bbadis.2008.06.008; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Vaccaro MC, 2006, MOL REPROD DEV, V73, P482, DOI 10.1002/mrd.20449; Wang MY, 2010, MED ONCOL, V27, P1329, DOI 10.1007/s12032-009-9384-8; Wang MY, 2010, BIOCHEM BIOPH RES CO, V393, P144, DOI 10.1016/j.bbrc.2010.01.103; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	33	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32047	10.1371/journal.pone.0032047	http://dx.doi.org/10.1371/journal.pone.0032047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348144	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400061
J	Ito, M; Nakajima, S; Fujisawa, D; Miyashita, M; Kim, Y; Shear, MK; Ghesquiere, A; Wall, MM				Ito, Masaya; Nakajima, Satomi; Fujisawa, Daisuke; Miyashita, Mitsunori; Kim, Yoshiharu; Shear, M. Katherine; Ghesquiere, Angela; Wall, Melanie M.			Brief Measure for Screening Complicated Grief: Reliability and Discriminant Validity	PLOS ONE			English	Article							BEREAVEMENT; PREVALENCE; POPULATION; INVENTORY	Background: Complicated grief, which is often under-recognized and under-treated, can lead to substantial impairment in functioning. The Brief Grief Questionnaire (BGQ) is a 5-item self-report or interview instrument for screening complicated grief. Although investigations with help-seeking samples suggest that the BGQ is valid and reliable, it has not been validated in a broader population. Methodology/Principal Findings: A questionnaire was mailed to a randomly selected sample (n = 5000) residing in one of 4 areas of Japan. The BCQ was examined for responders who were bereaved more than 6 months and less than 10 years (n = 915). Non-specific psychological distress was assessed with the K6 screening scale. Multiple group confirmatory factor analysis supported a uni-dimensional factor structure and the invariance of parameters across gender and age. Cronbach's alpha was sufficiently high (alpha = .75) to confirm internal consistency. Average Variance Extracted (0.39) was higher than the shared covariance (0.14) between BGQ and K6, suggesting discriminant validity. Conclusions: The results of this study support the reliability and validity of the BGQ in the Japanese population. Future studies should examine predictive validity by using structured interviews or more detailed scales for complicated grief.	[Ito, Masaya; Nakajima, Satomi; Kim, Yoshiharu] Natl Ctr Neurol & Psychiat, NIMH, Tokyo, Japan; [Ito, Masaya] Japan Soc Promot Sci, Tokyo, Japan; [Fujisawa, Daisuke] Natl Canc Ctr Hosp E, Psychooncol Div, Chiba, Japan; [Miyashita, Mitsunori] Tohoku Univ, Grad Sch Med, Dept Palliat Nursing Hlth Sci, Sendai, Miyagi 980, Japan; [Shear, M. Katherine; Ghesquiere, Angela] Columbia Univ, Sch Social Work, New York, NY USA; [Shear, M. Katherine; Wall, Melanie M.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Wall, Melanie M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA	National Center for Neurology & Psychiatry - Japan; Japan Society for the Promotion of Science; National Cancer Center - Japan; Tohoku University; Columbia University; Columbia University; Columbia University	Ito, M (corresponding author), Natl Ctr Neurol & Psychiat, NIMH, Tokyo, Japan.	masayait@ncnp.go.jp	Wall, Melanie/AAE-7828-2019; Fujisawa, Daisuke/AAR-5808-2021; Miyashita, Mitsunori/T-8327-2019	Miyashita, Mitsunori/0000-0002-7637-0409	Japan Society for the Promotion of Science; Ministry of Education, Sports, Science and Technology; Ministry of Health, Labor and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid for JSPS fellows awarded to MI from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research (B) to SN from the Ministry of Education, Sports, Science and Technology, and a Grant-in-Aid for Cancer Research to MM from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2011, ADJ DIS PROP REV G 0; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boelen PA, 2007, J CONSULT CLIN PSYCH, V75, P277, DOI 10.1037/0022-006X.75.2.277; Boelen PA, 2009, DEATH STUD, V33, P101, DOI 10.1080/07481180802602758; Farrell AM, 2010, J BUS RES, V63, P324, DOI 10.1016/j.jbusres.2009.05.003; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Fujisawa D, 2010, J AFFECT DISORDERS, V127, P352, DOI 10.1016/j.jad.2010.06.008; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; HODGES WF, 1969, J CONSULT CLIN PSYCH, V33, P430, DOI 10.1037/h0027813; *JAP MIN HLTH LAB, JAP MIN HLTH LAB WEL; Kersting A, 2011, J AFFECT DISORDERS, V131, P339, DOI 10.1016/j.jad.2010.11.032; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Newson RS, 2011, J AFFECT DISORDERS, V132, P231, DOI 10.1016/j.jad.2011.02.021; Piper WE, 2005, CAN J PSYCHIAT, V50, P680, DOI 10.1177/070674370505001106; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Shear KM, 2006, PSYCHIAT SERV, V57, P1291, DOI 10.1176/appi.ps.57.9.1291; Shear MK, 2011, DEPRESS ANXIETY, V28, P648, DOI 10.1002/da.20865; Shear MK, 2011, DEPRESS ANXIETY, V28, P103, DOI 10.1002/da.20780; Simon NM, 2007, COMPR PSYCHIAT, V48, P395, DOI 10.1016/j.comppsych.2007.05.002; Simon NM, 2011, DEPRESS ANXIETY, V28, P118, DOI 10.1002/da.20775; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Zisook S, 2009, WORLD PSYCHIATRY, V8, P67	26	78	78	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31209	10.1371/journal.pone.0031209	http://dx.doi.org/10.1371/journal.pone.0031209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925CF	22348057	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400012
J	Tsuruyama, T; Liu, WZ; Yoshikawa, K				Tsuruyama, Tatsuaki; Liu, Weizhi; Yoshikawa, Kenichi			In Vitro Murine Leukemia Retroviral Integration and Structure Fluctuation of Target DNA	PLOS ONE			English	Article							HOT-SPOTS; VIRUS; LYMPHOMAS; CANCER; GENE; MICE; SEQUENCES; PROMOTER; REGIONS; GENOME	Integration of the retroviral genome into host DNA is a critical step in the life cycle of a retrovirus. Although assays for in vitro integration have been developed, the actual DNA sequences targeted by murine leukemia retrovirus (MLV) during in vitro reproduction are unknown. While previous studies used artificial target sequences, we developed an assay using target DNA sequences from common MLV integration sites in Stat5a and c-myc in the genome of murine lymphomas and successfully integrated MLV into the target DNA in vitro. We calculated the free energy change during folding of the target sequence DNA and found a close correlation between the calculated free energy change and the number of integrations. Indeed, the integrations closely correlated with fluctuation of the structure of the target DNA segment. These data suggest that the fluctuation may generate a DNA structure favorable for in vitro integration into the target DNA. The approach described here can provide data on the biochemical properties of the integration reaction to which the target DNA structure may contribute.	[Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Sakyo Ku, Kyoto, Japan; [Liu, Weizhi; Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan [17013086]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labor and Welfare of Japan. Grant number is 17013086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; BOR YC, 1995, P NATL ACAD SCI USA, V92, P10334, DOI 10.1073/pnas.92.22.10334; CARTEAU S, 1993, ARCH BIOCHEM BIOPHYS, V300, P756, DOI 10.1006/abbi.1993.1105; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Higuchi Y, 2008, CHEM PHYS LETT, V461, P42, DOI 10.1016/j.cplett.2008.06.068; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Ishihara K, 1999, BBA-MOL CELL RES, V1451, P48, DOI 10.1016/S0167-4889(99)00090-7; Katz RA, 1998, J BIOL CHEM, V273, P24190, DOI 10.1074/jbc.273.37.24190; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Nielsen AA, 2005, J VIROL, V79, P67, DOI 10.1128/JVI.79.1.67-78.2005; RASSART E, 1986, J VIROL, V58, P96, DOI 10.1128/JVI.58.1.96-106.1986; REICIN AS, 1995, J VIROL, V69, P5904, DOI 10.1128/JVI.69.9.5904-5907.1995; Sorensen AB, 1996, J VIROL, V70, P4063; Sundaresan N, 2006, J PHYS CHEM A, V110, P8826, DOI 10.1021/jp061774q; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsukahara T, 2006, BIOCHEM BIOPH RES CO, V345, P1099, DOI 10.1016/j.bbrc.2006.05.007; Tsuruyama T, 2002, P NATL ACAD SCI USA, V99, P8253, DOI 10.1073/pnas.112202899; Tsuruyama T, 2011, AM J PATHOL, V178, P1374, DOI 10.1016/j.ajpath.2010.12.012; Tsuruyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013841; Tsuruyama T, 2010, J LEUKOCYTE BIOL, V88, P107, DOI 10.1189/jlb.1109748; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31533	10.1371/journal.pone.0031533	http://dx.doi.org/10.1371/journal.pone.0031533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348097	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400029
J	Gu, R; Bai, J; Ling, L; Ding, L; Zhang, N; Ye, JX; Ferro, A; Xu, BA				Gu, Rong; Bai, Jian; Ling, Lin; Ding, Liang; Zhang, Na; Ye, Jiaxin; Ferro, Albert; Xu, Biao			Increased Expression of Integrin-Linked Kinase Improves Cardiac Function and Decreases Mortality in Dilated Cardiomyopathy Model of Rats	PLOS ONE			English	Article							CELL-ADHESION; IN-VITRO; HEART; GROWTH; APOPTOSIS; FAILURE; TRANSPLANTATION; HYPERTROPHY; AUTOPHAGY; SURVIVAL	Aims: Integrin-linked kinase (ILK) is a multifunctional kinase linking the extracellular matrix to intracellular signaling pathways, whose activation in the heart gives rise to a number of functional consequences. The aim of this study is to demonstrate the therapeutic and survival benefit of cardiac ILK overexpression in a rat model of dilated cardiomyopathy. Methods and Results: The dilated cardiomyopathy model was generated in rats by intraperitoneal administration of six equal doses of doxorubicin over a 2 week period. Five weeks after the first injection, echocardiographic analysis demonstrated impaired cardiac function and, at that point, recombinant adenoviral vector harboring ILK cDNA or vehicle was injected into the myocardium, and the rats re-studied 4 weeks later. Compared with vehicle injection, ILK treatment ameliorated inflammatory cell infiltration and cardiomyocyte degeneration, as well as left ventricular dilation and dysfunction. ILK treatment was also associated with a reduction in apoptosis and an increase in proliferation of cardiomyocytes, as well as decreased oxidative stress and autophagic vacuole accumulation. Importantly, mortality was lower in rats following ILK treatment than in those following vehicle injection. In cultured neonatal rat cardiomyocytes, we also found that ILK overexpression protected against doxorubicin-induced apoptosis, giving rise to an increase in their proliferation. Conclusions: These data demonstrate for the first time that ILK gene therapy improves cardiac function and survival in a model of dilated cardiomyopathy, and this may be mediated through suppression of inflammation, prevention of ventricular remodeling, inhibition of cardiomyocyte apoptosis and autophagy, and stimulation of cardiomyocyte proliferation.	[Gu, Rong; Bai, Jian; Ling, Lin; Ding, Liang; Zhang, Na; Ye, Jiaxin; Xu, Biao] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London WC2R 2LS, England	Nanjing University; University of London; King's College London	Gu, R (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	xubiao@medmail.com.cn		Ding, Liang/0000-0002-1043-0923; Ferro, Albert/0000-0002-5486-9145	National Natural Science Foundation of China [30170370]; Jiangsu Key Laboratory for Molecular Medicine of Nanjing University [2008]; Natural Science Foundation of Jiangsu [BK2009036]; Outstanding Medical Talented Person Foundation of Jiangsu	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Outstanding Medical Talented Person Foundation of Jiangsu	This work was supported by grants to BX from the National Natural Science Foundation of China (Research Grant 30170370), Jiangsu Key Laboratory for Molecular Medicine of Nanjing University (Research Grant 2008), Natural Science Foundation of Jiangsu (BK2009036), and Outstanding Medical Talented Person Foundation of Jiangsu (2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2003, J AM COLL CARDIOL, V41, P753, DOI 10.1016/S0735-1097(02)02959-5; AMBLER GR, 1993, CARDIOVASC RES, V27, P1368, DOI 10.1093/cvr/27.7.1368; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Ishida M, 2004, J HEART LUNG TRANSPL, V23, P436, DOI 10.1016/S1053-2498(03)00220-1; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komamura K, 2004, HYPERTENSION, V44, P365, DOI 10.1161/01.HYP.0000139916.96375.47; Li LH, 2007, LAB INVEST, V87, P440, DOI 10.1038/labinvest.3700530; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lou H, 2004, J MOL CELL CARDIOL, V36, P683, DOI 10.1016/j.yjmcc.2004.03.004; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; Matoba S, 1999, CIRCULATION, V99, P817, DOI 10.1161/01.CIR.99.6.817; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Suzuki K, 2001, CIRCULATION, V104, pI213; Tsuneyoshi H, 2004, CIRCULATION, V110, pII174, DOI 10.1161/01.CIR.0000138348.77856.ef; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wong SCY, 1998, CIRCULATION, V98, P100, DOI 10.1161/01.CIR.98.2.100; Woo YJ, 2006, CIRCULATION, V114, pI206, DOI 10.1161/CIRCULATIONAHA.105.000455; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; Yamabi H, 2006, J THORAC CARDIOV SUR, V132, P1272, DOI 10.1016/j.jtcvs.2006.08.028; Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565	36	24	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31279	10.1371/journal.pone.0031279	http://dx.doi.org/10.1371/journal.pone.0031279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348065	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900037
J	Perez-Losada, J; Wu, D; DelRosario, R; Balmain, A; Mao, JH				Perez-Losada, Jesus; Wu, Di; DelRosario, Reyno; Balmain, Allan; Mao, Jian-Hua			Allele-Specific Deletions in Mouse Tumors Identify Fbxw7 as Germline Modifier of Tumor Susceptibility	PLOS ONE			English	Article							F-BOX PROTEIN; CYCLIN-E; UBIQUITIN LIGASE; DEPENDENT DEGRADATION; HUMAN CANCER; C-MYC; LOCI; MICE; SUPPRESSOR; NOTCH	Genome-wide association studies (GWAS) have been successful in finding associations between specific genetic variants and cancer susceptibility in human populations. These studies have identified a range of highly statistically significant associations between single nucleotide polymorphisms (SNPs) and susceptibility to development of a range of human tumors. However, the effect of each SNP in isolation is very small, and all of the SNPs combined only account for a relatively minor proportion of the total genetic risk (5-10%). There is therefore a major requirement for alternative routes to the discovery of genetic risk factors for cancer. We have previously shown using mouse models that chromosomal regions harboring susceptibility genes identified by linkage analysis frequently exhibit allele-specific genetic alterations in tumors. We demonstrate here that the Fbxw7 gene, a commonly mutated gene in a wide range of mouse and human cancers, shows allele-specific deletions in mouse lymphomas and skin tumors. Lymphomas from three different F1 hybrids show 100% allele-specificity in the patterns of allelic loss. Parental alleles from 129/Sv or Spretus/Gla mice are lost in tumors from F1 hybrids with C57BL/6 animals, due to the presence of a specific non-synonymous coding sequence polymorphism at the N-terminal portion of the gene. A specific genetic test of association between this SNP and lymphoma susceptibility in interspecific backcross mice showed a significant linkage (p = 0.001), but only in animals with a functional p53 gene. These data therefore identify Fbxw7 as a p53-dependent tumor susceptibility gene. Increased p53-dependent tumor susceptibility and allele-specific losses were also seen in a mouse skin model of skin tumor development. We propose that analysis of preferential allelic imbalances in tumors may provide an efficient means of uncovering genetic variants that affect mouse and human tumor susceptibility.	[Perez-Losada, Jesus; Wu, Di; DelRosario, Reyno; Balmain, Allan; Mao, Jian-Hua] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA; [Perez-Losada, Jesus] Univ Salamanca, Consejo Super Invest Cient, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Mao, Jian-Hua] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Perez-Losada, J (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu; JHMao@lbl.gov	Mao, Jian-Hua/EIZ-8595-2022; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Pérez-Losada, Jesús/0000-0003-2400-624X	NIH/NCI [R01 CA116481, U01 CA84244]; Office of Biological & Environmental Research, of the U. S. Department of Energy [DE-AC02-05CH11231]; Laboratory Directed Research & Development Program (LDRD); MICINN [PLE2009-119]; FIS [PI10/00328]; Fundacion Eugenio Rodriguez-Pascual; DOE [DE-FG02-03ER63630]; Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA116481] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Biological & Environmental Research, of the U. S. Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research & Development Program (LDRD); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); FIS(Instituto de Salud Carlos III); Fundacion Eugenio Rodriguez-Pascual; DOE(United States Department of Energy (DOE)); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grant R01 CA116481, Office of Biological & Environmental Research, of the U. S. Department of Energy under contract no. DE-AC02-05CH11231, and Laboratory Directed Research & Development Program (LDRD) to JHM; FEDER, MICINN (PLE2009-119), FIS (PI10/00328) and "Fundacion Eugenio Rodriguez-Pascual to JPL; and NIH/NCI grant U01 CA84244 and the DOE (DE-FG02-03ER63630) to AB. AB acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Fujii Y, 2006, CANCER SCI, V97, P729, DOI 10.1111/j.1349-7006.2006.00239.x; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Ginzinger DG, 2000, CANCER RES, V60, P5405; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hienonen T, 2006, INT J CANCER, V118, P505, DOI 10.1002/ijc.21344; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LI FP, 1969, J NATL CANCER I, V43, P1365; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Mao JH, 2003, CURR OPIN GENET DEV, V13, P14, DOI 10.1016/S0959-437X(03)00005-4; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nagase H, 2003, CANCER RES, V63, P4849; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Nagase H, 2001, CANCER RES, V61, P1305; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Perez-Losada J, 2005, CANCER RES, V65, P6488, DOI 10.1158/0008-5472.CAN-05-1294; Perez-Losada J, 2011, INTEGR BIOL-UK, V3, P316, DOI 10.1039/c0ib00094a; Stadler ZK, 2010, J CLIN ONCOL, V28, P4255, DOI 10.1200/JCO.2009.25.7816; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31301	10.1371/journal.pone.0031301	http://dx.doi.org/10.1371/journal.pone.0031301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348067	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900039
J	Goense, JBM; Feng, AS				Goense, Jozien B. M.; Feng, Albert S.			Effects of Noise Bandwidth and Amplitude Modulation on Masking in Frog Auditory Midbrain Neurons	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; RANA-PIPIENS COMPLEX; INFERIOR COLLICULUS; SPATIAL RELEASE; NATURAL SOUNDS; FREQUENCY-SELECTIVITY; SPECTRAL INTEGRATION; SONGBIRD FOREBRAIN; SIGNAL-DETECTION; GREY TREEFROGS	Natural auditory scenes such as frog choruses consist of multiple sound sources (i.e., individual vocalizing males) producing sounds that overlap extensively in time and spectrum, often in the presence of other biotic and abiotic background noise. Detection of a signal in such environments is challenging, but it is facilitated when the noise shares common amplitude modulations across a wide frequency range, due to a phenomenon called comodulation masking release (CMR). Here, we examined how properties of the background noise, such as its bandwidth and amplitude modulation, influence the detection threshold of a target sound (pulsed amplitude modulated tones) by single neurons in the frog auditory midbrain. We found that for both modulated and unmodulated masking noise, masking was generally stronger with increasing bandwidth, but it was weakened for the widest bandwidths. Masking was less for modulated noise than for unmodulated noise for all bandwidths. However, responses were heterogeneous, and only for a subpopulation of neurons the detection of the probe was facilitated when the bandwidth of the modulated masker was increased beyond a certain bandwidth - such neurons might contribute to CMR. We observed evidence that suggests that the dips in the noise amplitude are exploited by TS neurons, and observed strong responses to target signals occurring during such dips. However, the interactions between the probe and masker responses were nonlinear, and other mechanisms, e. g., selective suppression of the response to the noise, may also be involved in the masking release.	[Goense, Jozien B. M.; Feng, Albert S.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Goense, Jozien B. M.; Feng, Albert S.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Feng, Albert S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Goense, JBM (corresponding author), Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Spemannstr 38, Tubingen, Germany.	Jozien.Goense@tuebingen.mpg.de			National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R01DC-00663, R01DC-04998]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000663, R01DC004998] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (R01DC-00663, R01DC-04998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2007, ANIM BEHAV, V74, P549, DOI 10.1016/j.anbehav.2006.12.012; Bee MA, 2007, EUR J NEUROSCI, V26, P1979, DOI 10.1111/j.1460-9568.2007.05805.x; Biebel UW, 2002, HEARING RES, V169, P151, DOI 10.1016/S0378-5955(02)00459-8; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; Bregman A.S., 1990, AUDITORY SCENE ANAL; BROWN LE, 1972, SCIENCE, V176, P928, DOI 10.1126/science.176.4037.928; Buschermohle M, 2007, BIOL CYBERN, V97, P397, DOI 10.1007/s00422-007-0179-8; BUUS S, 1985, J ACOUST SOC AM, V78, P1958, DOI 10.1121/1.392652; Buus S, 1996, J ACOUST SOC AM, V99, P2288, DOI 10.1121/1.415416; EGGERMONT JJ, 1989, HEARING RES, V40, P147, DOI 10.1016/0378-5955(89)90108-1; Ehret G, 1997, J COMP PHYSIOL A, V181, P635, DOI 10.1007/s003590050146; EHRET G, 1980, J COMP PHYSIOL, V141, P13, DOI 10.1007/BF00611873; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; FANTINI DA, 1991, J ACOUST SOC AM, V90, P1876, DOI 10.1121/1.402374; Feng AS, 2000, ANNU REV PSYCHOL, V51, P699, DOI 10.1146/annurev.psych.51.1.699; Fishbach A, 2003, ADV NEURAL INFORM PR, P301; FROST JS, 1983, EVOLUTION, V37, P66, DOI 10.1111/j.1558-5646.1983.tb05514.x; FUZESSERY ZM, 1982, J COMP PHYSIOL, V146, P471, DOI 10.1007/BF00609443; Gai Y, 2006, J NEUROPHYSIOL, V96, P2451, DOI 10.1152/jn.00471.2006; GILBERT AG, 1980, HEARING RES, V2, P327, DOI 10.1016/0378-5955(80)90066-0; Gleich O, 2007, HEARING RES, V224, P101, DOI 10.1016/j.heares.2006.12.002; Goense JBM, 2005, J NEUROBIOL, V65, P22, DOI 10.1002/neu.20172; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GOOLER DM, 1992, J NEUROPHYSIOL, V67, P1, DOI 10.1152/jn.1992.67.1.1; HALL JW, 1991, Q J EXP PSYCHOL-A, V43, P349, DOI 10.1080/14640749108400977; HALL JW, 1984, J ACOUST SOC AM, V76, P50, DOI 10.1121/1.391005; HALL JW, 1988, J ACOUST SOC AM, V84, P1669, DOI 10.1121/1.397182; Hawley ML, 2005, HEARING RES, V204, P101, DOI 10.1016/j.heares.2005.01.005; Hofer SB, 2003, J NEUROSCI, V23, P5732; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; KAPLAN HM, 1969, FED PROC, V28, P1541; Klump GM, 2001, NEUROREPORT, V12, P1825, DOI 10.1097/00001756-200107030-00013; KLUMP GM, 1995, HEARING RES, V87, P157, DOI 10.1016/0378-5955(95)00087-K; Lane CC, 2005, J NEUROPHYSIOL, V94, P1180, DOI 10.1152/jn.01112.2004; Langemann U, 2005, J COMP PHYSIOL A, V191, P889, DOI 10.1007/s00359-005-0015-3; Langemann U, 2001, EUR J NEUROSCI, V13, P1025, DOI 10.1046/j.0953-816x.2001.01464.x; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; MCFADDEN D, 1986, J ACOUST SOC AM, V80, P1658, DOI 10.1121/1.394277; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; MOSS CF, 1986, J COMP PHYSIOL A, V159, P257, DOI 10.1007/BF00612308; NARINS PM, 1989, J ACOUST SOC AM, V85, P1255, DOI 10.1121/1.397456; NARINS PM, 1982, J COMP PHYSIOL, V147, P439, DOI 10.1007/BF00612008; Narins PM, 1988, EVOLUTION AMPHIBIAN; NELKEN I, 1994, J NEUROPHYSIOL, V71, P2446, DOI 10.1152/jn.1994.71.6.2446; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nelson PC, 2007, J NEUROPHYSIOL, V97, P522, DOI 10.1152/jn.00776.2006; Neuert V, 2004, J NEUROSCI, V24, P5789, DOI 10.1523/JNEUROSCI.0450-04.2004; Nieder A, 2001, EUR J NEUROSCI, V13, P1033, DOI 10.1046/j.0953-816x.2001.01465.x; Palmer AR, 1996, J NEUROPHYSIOL, V75, P780, DOI 10.1152/jn.1996.75.2.780; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pressnitzer D, 2001, J NEUROSCI, V21, P6377, DOI 10.1523/JNEUROSCI.21-16-06377.2001; Ratnam R, 1998, J NEUROPHYSIOL, V80, P2848, DOI 10.1152/jn.1998.80.6.2848; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; RICHARDS VM, 1987, J ACOUST SOC AM, V82, P1621, DOI 10.1121/1.395153; SAKITT B, 1973, NATURE, V241, P133, DOI 10.1038/241133a0; SCHALK TB, 1980, J ACOUST SOC AM, V67, P903, DOI 10.1121/1.383970; SCHOONEVELDT GP, 1987, J ACOUST SOC AM, V82, P1944, DOI 10.1121/1.395639; Schulze H, 1999, J COMP PHYSIOL A, V185, P493, DOI 10.1007/s003590050410; SCHWARTZ JJ, 1989, J COMP PHYSIOL A, V166, P37; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smalling JM, 2001, NEUROREPORT, V12, P3539, DOI 10.1097/00001756-200111160-00033; Suckow MA, 1999, PHARMACOL BIOCHEM BE, V63, P39, DOI 10.1016/S0091-3057(98)00237-8; Verhey JL, 2003, EXP BRAIN RES, V153, P405, DOI 10.1007/s00221-003-1607-1	67	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31589	10.1371/journal.pone.0031589	http://dx.doi.org/10.1371/journal.pone.0031589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348114	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900028
J	Allnutt, TF; McClanahan, TR; Andrefouet, S; Baker, M; Lagabrielle, E; McClennen, C; Rakotomanjaka, AJM; Tianarisoa, TF; Watson, R; Kremen, C				Allnutt, Thomas F.; McClanahan, Timothy R.; Andrefouet, Serge; Baker, Merrill; Lagabrielle, Erwann; McClennen, Caleb; Rakotomanjaka, Andry J. M.; Tianarisoa, Tantely F.; Watson, Reg; Kremen, Claire			Comparison of Marine Spatial Planning Methods in Madagascar Demonstrates Value of Alternative Approaches	PLOS ONE			English	Article							PROTECTED AREAS; CORAL-REEF; RESERVE NETWORKS; FISHERIES MANAGEMENT; SOCIOECONOMIC DATA; SOUTH-AFRICA; CONSERVATION; BIODIVERSITY; DESIGN; OCEAN	The Government of Madagascar plans to increase marine protected area coverage by over one million hectares. To assist this process, we compare four methods for marine spatial planning of Madagascar's west coast. Input data for each method was drawn from the same variables: fishing pressure, exposure to climate change, and biodiversity (habitats, species distributions, biological richness, and biodiversity value). The first method compares visual color classifications of primary variables, the second uses binary combinations of these variables to produce a categorical classification of management actions, the third is a target-based optimization using Marxan, and the fourth is conservation ranking with Zonation. We present results from each method, and compare the latter three approaches for spatial coverage, biodiversity representation, fishing cost and persistence probability. All results included large areas in the north, central, and southern parts of western Madagascar. Achieving 30% representation targets with Marxan required twice the fish catch loss than the categorical method. The categorical classification and Zonation do not consider targets for conservation features. However, when we reduced Marxan targets to 16.3%, matching the representation level of the "strict protection" class of the categorical result, the methods show similar catch losses. The management category portfolio has complete coverage, and presents several management recommendations including strict protection. Zonation produces rapid conservation rankings across large, diverse datasets. Marxan is useful for identifying strict protected areas that meet representation targets, and minimize exposure probabilities for conservation features at low economic cost. We show that methods based on Zonation and a simple combination of variables can produce results comparable to Marxan for species representation and catch losses, demonstrating the value of comparing alternative approaches during initial stages of the planning process. Choosing an appropriate approach ultimately depends on scientific and political factors including representation targets, likelihood of adoption, and persistence goals.	[Allnutt, Thomas F.; Baker, Merrill; Kremen, Claire] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [McClanahan, Timothy R.; McClennen, Caleb] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [Andrefouet, Serge] Inst Rech Dev, Noumea, New Caledonia; [Lagabrielle, Erwann] Inst Rech Dev, St Clotilde, Reunion, Reunion; [Lagabrielle, Erwann] Nelson Mandela Metropolitan Univ, Dept Bot, George, South Africa; [Rakotomanjaka, Andry J. M.; Tianarisoa, Tantely F.] Wildlife Conservat Soc, Madagascar Program, Antananarivo, Madagascar; [Watson, Reg] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of California System; University of California Berkeley; Wildlife Conservation Society; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Nelson Mandela University; University of British Columbia	Allnutt, TF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	tom.allnutt@berkeley.edu	McClanahan, Tim/K-4998-2019; Watson, Reg A/F-4850-2012; Lagabrielle, Erwann/AAM-9635-2020	Watson, Reg A/0000-0001-7201-8865; Lagabrielle, Erwann/0000-0002-8333-2750; Baker-Medard, Merrill/0000-0002-3724-8320; McClanahan, Timothy/0000-0001-5821-3584	MacArthur Foundation [07-89636-000-GSS, 07-89630-001-GSS]; Indian Ocean Commission; Fond Francais pour l'Environnement Mondial (FFEM); World Wildlife Fund; African Coelacanth Ecosystem Programme; National Research Foundation of South Africa; MacArthur Foundation [07-89636-000-GSS, 07-89630-001-GSS]; Indian Ocean Commission; Fond Francais pour l'Environnement Mondial (FFEM); World Wildlife Fund; African Coelacanth Ecosystem Programme; National Research Foundation of South Africa	MacArthur Foundation; Indian Ocean Commission; Fond Francais pour l'Environnement Mondial (FFEM); World Wildlife Fund; African Coelacanth Ecosystem Programme; National Research Foundation of South Africa(National Research Foundation - South Africa); MacArthur Foundation; Indian Ocean Commission; Fond Francais pour l'Environnement Mondial (FFEM); World Wildlife Fund; African Coelacanth Ecosystem Programme; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by MacArthur Foundation grants 07-89636-000-GSS and 07-89630-001-GSS. The fish catch model was developed from the "Sea Around Us" global catch database' This database was developed through a scientific collaboration between the University of British Columbia and the Pew Environment Group. The Indian Ocean Commission, Fond Francais pour l'Environnement Mondial and World Wildlife Fund funded the Indian Ocean Commission Protected Areas Network conservation planning workshop. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the John D. and Catherine T. MacArthur Foundation for supporting this work. The fish catch model was developed from the "Sea Around Us" global catch database. This database was developed through a scientific collaboration between the University of British Columbia and the Pew Environment Group. The Indian Ocean Commission, Fond Francais pour l'Environnement Mondial (FFEM) and World Wildlife Fund supported the Indian Ocean Commission Protected Areas Network conservation planning workshop. We greatly appreciate data contributions from A. Cooke and M. Samoily. E. Lagabrielle acknowledges the African Coelacanth Ecosystem Programme and the National Research Foundation of South Africa for co-funding its contribution to this research. Finally, we thank the editor, reviewers, and G. Powell and J. Watson for constructive comments on earlier drafts of the paper.	Airame S, 2003, ECOL APPL, V13, pS170; Anderson SC, FISH FISHER IN PRESS; Andrefouet S., 2009, ATLAS W INDIAN OCEAN; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Barnes DKA, 2009, J MAR BIOL ASSOC UK, V89, P1589, DOI 10.1017/S0025315409000113; Beck M. W., 2003, DRAFTING CONSERVATIO, P319; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BOYER TP, 2006, WORLD OCEAN DATABASE; Christie P, 2004, AM FISH S S, V42, P155; *CONV BIOL DIV, 2006, COP 8 8 ORD M C PART; Cooke A., 2003, P179; Crowder LB, 2000, B MAR SCI, V66, P799; Davies TE, 2009, FISHERIES MANAGEMENT; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Fishpool L. D., 2001, IMPORTANT BIRD AREAS; Fleishman E, 2006, ECOL INDIC, V6, P543, DOI 10.1016/j.ecolind.2005.07.005; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Gabrie C., 2000, P411; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Game ET, 2008, ECOL APPL, V18, P670, DOI 10.1890/07-1027.1; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harris Alasdair, 2010, Atoll Research Bulletin, P1; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Indian Ocean Commission, 2010, REG STRAT C IN PRESS; INSTAT (Institut National de la Statistique) [Madagascar] & ORC Macro, 2005, ENQ DEM SANT MAD 200; International Union for Conservation of Nature, 2005, P 5 IUCN WORLD PARKS; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Kiszka Jeremy, 2008, Western Indian Ocean Journal of Marine Science, V7, P119; Klein CJ, 2008, CONSERV LETT, V1, P44, DOI 10.1111/j.1755-263X.2008.00005.x; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lagabrielle E, 2009, MAPPING ANTHROPOGENI; Lagabrielle E, 2010, ENVIRON MODELL SOFTW, V25, P1413, DOI 10.1016/j.envsoft.2010.01.011; Laroche J., 1997, Fisheries Management and Ecology, V4, P285, DOI 10.1046/j.1365-2400.1997.00051.x; Le Corre M., 2009, Marine Ornithology, V37, P153; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Leslie H, 2003, ECOL APPL, V13, pS185; Leslie HM, 2005, CONSERV BIOL, V19, P1701, DOI 10.1111/j.1523-1739.2005.00268.x; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Linquist S, 2008, BIOL PHILOS, V23, P529, DOI 10.1007/s10539-007-9082-x; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; McClanahan TR, 2009, CONSERV BIOL, V23, P662, DOI 10.1111/j.1523-1739.2008.01154.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2009, MAR ECOL PROG SER, V380, P117, DOI 10.3354/meps07879; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2005, OCEAN COAST MANAGE, V48, P901, DOI 10.1016/j.ocecoaman.2005.03.005; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; McClanahan TR, 2011, GLOBAL CHANGE BIOL; McKenna SA, RAPID MARINE BIODIVE; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; McVean AR, 2006, FISH RES, V82, P280, DOI 10.1016/j.fishres.2006.06.016; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Ministere de l'Environnement et des Forets, 2010, ARR INT 52005 2010 2; Moat J., 2007, ATLAS VEGETATION MAD; Moilanen A, 2007, BIOL CONSERVATION, V134; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Norris S, 2006, BIOSCIENCE, V56, P960, DOI 10.1641/0006-3568(2006)56[960:MD]2.0.CO;2; Nowlis JS, 1999, FISH B-NOAA, V97, P604; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; PRESSEY RL, 1989, BIOL CONSERV, V50, P199, DOI 10.1016/0006-3207(89)90010-4; Rakotonirina Berthin, 1994, Oryx, V28, P51; Rakotoson LR, 2006, OCEAN COAST MANAGE, V49, P855, DOI 10.1016/j.ocecoaman.2006.08.003; Research Systems Incorporated, 2004, ENV VIS IM ENVI US G; Rodwell Lynda D., 2002, Natural Resource Modeling, V15, P453; Rosenbaum H., 2003, NATURAL HIST MADAGAS, P217; RUCKELSHAUS M, 2009, MAR SCI, V26, P26; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; SAPM, 2010, PROT AR MAD DIG GIS; Schartl M, 2005, NATURE, V435, P901, DOI 10.1038/435901a; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Sheppard Charles R.C., 2000, P3; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Veron J. E. N., 2005, RAPID MARINE BIODIVE, P23; Wabnitz CCC, 2010, FRONT ECOL ENVIRON, V8, P124, DOI 10.1890/080109; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Watson R, 2006, FISH RES, V79, P97, DOI 10.1016/j.fishres.2006.01.010; Watson R, 2006, FISH RES, V79, P103, DOI 10.1016/j.fishres.2006.01.013; Watts M, 2009, ADV MARXAN COURSE MA, P39; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; World Bank, 2007, COMM LEV CENS DAT MA; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	97	41	42	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e28969	10.1371/journal.pone.0028969	http://dx.doi.org/10.1371/journal.pone.0028969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359534	gold, Green Published			2022-12-27	WOS:000302796200003
J	Chen, SF; Chang, YC; Nieh, S; Liu, CL; Yang, CY; Lin, YS				Chen, Su-Feng; Chang, Yun-Ching; Nieh, Shin; Liu, Chia-Lin; Yang, Chin-Yuh; Lin, Yaoh-Shiang			Nonadhesive Culture System as a Model of Rapid Sphere Formation with Cancer Stem Cell Properties	PLOS ONE			English	Article							PUTATIVE MARKER; E-CADHERIN; CARCINOMA; HEAD; IDENTIFICATION; MECHANISMS; POPULATION; THERAPY; CD133; LINE	Background: Cancer stem cells (CSCs) play an important role in tumor initiation, progression, and metastasis and are responsible for high therapeutic failure rates. Identification and characterization of CSC are crucial for facilitating the monitoring, therapy, or prevention of cancer. Great efforts have been paid to develop a more effective methodology. Nevertheless, the ideal model for CSC research is still evolving. In this study, we created a nonadhesive culture system to enrich CSCs from human oral squamous cell carcinoma cell lines with sphere formation and to characterize their CSC properties further. Methods: A nonadhesive culture system was designed to generate spheres from the SAS and OECM-1 cell lines. A subsequent investigation of their CSC properties, including stemness, self-renewal, and chemo- and radioresistance in vitro, as well as tumor initiation capacity in vivo, was also performed. Results: Spheres were formed cost-effectively and time-efficiently within 5 to 7 days. Moreover, we proved that these spheres expressed putative stem cell markers and exhibited chemoradiotherapeutic resistance, in addition to tumor-initiating and self-renewal capabilities. Conclusions: Using this nonadhesive culture system, we successfully established a rapid and cost-effective model that exhibits the characteristics of CSCs and can be used in cancer research.	[Chen, Su-Feng] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Chang, Yun-Ching; Liu, Chia-Lin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chang, Yun-Ching; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Chang, Yun-Ching; Nieh, Shin; Yang, Chin-Yuh; Lin, Yaoh-Shiang] Tri Serv Gen Hosp, Taipei, Taiwan; [Yang, Chin-Yuh] Natl Def Med Ctr, Dept Dent, Taipei, Taiwan; [Lin, Yaoh-Shiang] Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan	China Medical University Taiwan; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, SF (corresponding author), China Med Univ, Dept Dent Hyg, Taichung, Taiwan.	yaohshiang@gmail.com		mou, wenjun/0000-0002-7781-7671	Tri-Service General Hospital and National Defense Medical Centre [TSGH-C100-007-009-10-S02, TSGH-C100-161, TSGH-C100-155, I-29]; Department of Dental Hygiene, China Medical University [CMU99-N1-04-1]; National Science Council, Republic of China (Taiwan) [NSC 99-2320-B-039-028-MY3, NSC 100-2320-B-016-009]; Department of Health, Executive Yuan, Republic of China (Taiwan) [DOH100-TD-PB-111-TM007-22]	Tri-Service General Hospital and National Defense Medical Centre; Department of Dental Hygiene, China Medical University; National Science Council, Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Republic of China (Taiwan)	This study was partly supported by the Tri-Service General Hospital and National Defense Medical Centre: Grant No. TSGH-C100-007-009-10-S02, TSGH-C100-161, TSGH-C100-155 and I-29; Department of Dental Hygiene, China Medical University: Grant No. CMU99-N1-04-1; National Science Council, Republic of China (Taiwan): Grants No. NSC 99-2320-B-039-028-MY3 and NSC 100-2320-B-016-009; Department of Health, Executive Yuan, Republic of China (Taiwan): DOH100-TD-PB-111-TM007-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Swiahb JN, 2010, FUTURE ONCOL, V6, P837, DOI 10.2217/fon.10.35; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Costea DE, 2006, ORAL DIS, V12, P443, DOI 10.1111/j.1601-0825.2006.01264.x; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dubessy C, 2000, CRIT REV ONCOL HEMAT, V36, P179, DOI 10.1016/S1040-8428(00)00085-8; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hueng DY, 2011, J NEURO-ONCOL, V104, P45, DOI 10.1007/s11060-010-0469-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Le Tourneau C, 2010, B CANCER, V97, P1453, DOI 10.1684/bdc.2010.1226; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lippman SM, 2005, J CLIN ONCOL, V23, P346, DOI 10.1200/JCO.2005.09.128; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; OLASZ L, 1988, CANCER, V62, P1267, DOI 10.1002/1097-0142(19881001)62:7<1267::AID-CNCR2820620704>3.0.CO;2-G; Ouyang GL, 2010, CELL MOL LIFE SCI, V67, P2605, DOI 10.1007/s00018-010-0338-2; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shen SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023282; Song J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011456; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Timmins Nicholas E., 2004, Angiogenesis, V7, P97, DOI 10.1007/s10456-004-8911-7; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wei XD, 2009, HEAD NECK-J SCI SPEC, V31, P94, DOI 10.1002/hed.20935; Yanamoto S, 2011, ORAL ONCOL, V47, P855, DOI 10.1016/j.oraloncology.2011.06.501; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhang QZ, 2010, CANCER LETT, V289, P151, DOI 10.1016/j.canlet.2009.08.010; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013; Zhou L, 2007, LARYNGOSCOPE, V117, P455, DOI 10.1097/01.mlg.0000251586.15299.35	47	100	102	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31864	10.1371/journal.pone.0031864	http://dx.doi.org/10.1371/journal.pone.0031864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359637	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200106
J	Jaworski, JP; Krebs, SJ; Trovato, M; Kovarik, DN; Brower, Z; Sutton, WF; Waagmeester, G; Sartorius, R; D'Apice, L; Caivano, A; Doria-Rose, NA; Malherbe, D; Montefiori, DC; Barnett, S; De Berardinis, P; Haigwood, NL				Jaworski, Juan Pablo; Krebs, Shelly J.; Trovato, Maria; Kovarik, Dina N.; Brower, Zachary; Sutton, William F.; Waagmeester, Garrett; Sartorius, Rossella; D'Apice, Luciana; Caivano, Antonella; Doria-Rose, Nicole A.; Malherbe, Delphine; Montefiori, David C.; Barnett, Susan; De Berardinis, Piergiuseppe; Haigwood, Nancy L.			Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8(+) T Cells	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CELLULAR IMMUNE-RESPONSES; SIMIAN IMMUNODEFICIENCY; MONOCLONAL-ANTIBODIES; RHESUS-MONKEYS; MULTIENZYME COMPLEX; MUCOSAL CHALLENGE; GERMINAL-CENTERS; CHIMERIC VIRUS; HIGH-FREQUENCY	To obtain proof of concept for HIV vaccines, we generated recombinant multimeric particles displaying the HIV-1 Envelope (Env) third hypervariable region (V3) as an N-terminal fusion protein on the E2 subunit of the pyruvate dehydrogenase complex of Geobacillus stearothermophilus. The E2 scaffold self-assembles into a 60-mer core that is 24 nm in diameter, with a molecular weight of 1.5 MDa, similar to a virus like particle with up to 60 copies of a heterologous protein accessible on the surface. Env(V3)-E2 multimers were tested alone and in combination with Env(gp160) DNA in mice and rabbits. Following two or more co-immunizations with Env(V3)-E2 and Env gp160 DNA, all 18 rabbits developed potent autologous neutralizing antibodies specific for V3 in six weeks. These neutralizing antibodies were sustained for 16 weeks without boosting, and comparable responses were obtained when lipopolysaccharide, a contaminant from expression in E. coli, was removed. Co-immunizations of Env(V3)-E2 and DNA expressing gp160 elicited moderate CD8-specific responses and Env-specific antibodies in mice. Co-immunization with DNA and E2 was superior to individual or sequential vaccination with these components in eliciting both neutralizing antibodies in rabbits and CD8(+) T cell responses in mice. Co-immunization with DNA and multimeric E2 scaffolds appears to offer a highly effective means of eliciting rapid, specific, and sustained immune responses that may be a useful approach for other vaccine targets.	[Jaworski, Juan Pablo; Krebs, Shelly J.; Brower, Zachary; Sutton, William F.; Waagmeester, Garrett; Malherbe, Delphine; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA; [Trovato, Maria; Sartorius, Rossella; D'Apice, Luciana; Caivano, Antonella; De Berardinis, Piergiuseppe] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Kovarik, Dina N.; Haigwood, Nancy L.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Doria-Rose, Nicole A.] Seattle Biomed Res Inst, Viral Vaccines Program, Seattle, WA 98109 USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Barnett, Susan] Novartis, Cambridge, MA USA	Oregon Health & Science University; Oregon National Primate Research Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Washington; University of Washington Seattle; Center for Infectious Disease Research; Duke University; Novartis	Jaworski, JP (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.	haigwoon@ohsu.edu	De Berardinis, Piergiuseppe/HCI-0893-2022; SARTORIUS, ROSSELLA/G-8559-2016; sartorius, rossella/AAF-1623-2021; De Berardinis, Piergiuseppe/AAX-1049-2020; Haigwood, Nancy Logan/AAV-7484-2020; Jaworski, Juan/ABA-4503-2020; CAIVANO, ANTONELLA/J-8120-2018	sartorius, rossella/0000-0003-0153-9377; De Berardinis, Piergiuseppe/0000-0001-6579-1729; Jaworski, Juan/0000-0002-1311-060X; CAIVANO, ANTONELLA/0000-0003-2502-4060; Trovato, Maria/0000-0002-3831-6073; Haigwood, Nancy/0000-0002-1477-9575; D'Apice, Luciana/0000-0002-6513-2237	PHS [AI30034, R01-AI074379, R21-AI062418, P51-RR-000163, T32-A1074494]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074379, R21AI062418] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by PHS grants AI30034 (to DM), R01-AI074379 and R21-AI062418 (to NLH and PDB), P51-RR-000163 (to NLH), and T32-A1074494 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Barnett SW, 1997, VACCINE, V15, P869, DOI 10.1016/S0264-410X(96)00264-2; Barouch DH, 2001, J VIROL, V75, P2462, DOI 10.1128/JVI.75.5.2462-2467.2001; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buonaguro L, 2005, J VIROL, V79, P7059, DOI 10.1128/JVI.79.11.7059-7067.2005; Caivano A, 2010, VIROLOGY, V407, P296, DOI 10.1016/j.virol.2010.08.026; Cruz LJ, 2004, BIOCONJUGATE CHEM, V15, P112, DOI 10.1021/bc034119j; De Berardinis P, 2003, CURR HIV RES, V1, P441; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Domingo GJ, 2003, VACCINE, V21, P1502, DOI 10.1016/S0264-410X(02)00664-3; Domingo GJ, 2001, J MOL BIOL, V305, P259, DOI 10.1006/jmbi.2000.4311; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Doria-Rose NA, 2003, J VIROL, V77, P11563, DOI 10.1128/JVI.77.21.11563-11577.2003; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Graham BS, 2002, ANNU REV MED, V53, P207, DOI 10.1146/annurev.med.53.082901.104035; Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120; HAFFAR OK, 1991, VIROLOGY, V183, P487, DOI 10.1016/0042-6822(91)90978-K; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; HU SL, 1987, NATURE, V328, P721, DOI 10.1038/328721a0; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Iglesias E, 2005, MOL IMMUNOL, V42, P99, DOI 10.1016/j.molimm.2004.06.038; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661; Margolin DH, 2002, J VIROL, V76, P3965, DOI 10.1128/JVI.76.8.3965-3973.2002; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montefiori DM, 2004, CURRENT PRO IN PRESS; Mossman SP, 2004, AIDS RES HUM RETROV, V20, P425, DOI 10.1089/088922204323048177; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Quan FS, 2007, VACCINE, V25, P3841, DOI 10.1016/j.vaccine.2007.01.107; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039	55	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31464	10.1371/journal.pone.0031464	http://dx.doi.org/10.1371/journal.pone.0031464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359593	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200062
J	Kaur, H; Yung, LYL				Kaur, Harleen; Yung, Lin-Yue Lanry			Probing High Affinity Sequences of DNA Aptamer against VEGF(165)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR VEGF; IN-VITRO; SYSTEMATIC EVOLUTION; RNA INHIBITORS; SELECTION; HYPOXIA; MOLECULES; LIGANDS; BINDING	Vascular endothelial growth factor (VEGF(165)) is a potent angiogenic mitogen commonly overexpressed in cancerous cells. It contains two main binding domains, the receptor-binding domain (RBD) and the heparin-binding domain (HBD). This study attempted to identify the specific sequences of the VEa5 DNA aptamer that exhibit high binding affinity towards the VEGF(165) protein by truncating the original VEa5 aptamer into different segments. Using surface plasmon resonance (SPR) spectroscopy for binding affinity analysis, one of the truncated aptamers showed a >200-fold increase in the binding affinity for HBD. This truncated aptamer also exhibited high specificity to HBD with negligible binding affinity for VEGF(121), an isoform of VEGF lacking HBD. Exposing colorectal cancer cells to the truncated aptamer sequence further confirmed the binding affinity and specificity of the aptamer to the target VEGF(165) protein. Hence, our approach of aptamer truncation can potentially be useful in identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection.	[Kaur, Harleen; Yung, Lin-Yue Lanry] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore	National University of Singapore	Kaur, H (corresponding author), Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore.	cheyly@nus.edu.sg	Kaur, Harleen/AAJ-8789-2020; Yung, Lanry/B-6515-2009; K, Harleen/T-2613-2019	Yung, Lanry/0000-0001-7579-6347; 	Singapore Ministry of Education [MOE2008-T2-1-046, R279000282112]	Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by research funding from the Singapore Ministry of Education Academic Research Fund Tier 2 grant MOE2008-T2-1-046 and Tier 1 grant R279000282112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Berezovski M, 2005, J AM CHEM SOC, V127, P3165, DOI 10.1021/ja042394q; Bernimoulin M, 2009, J THROMB HAEMOST, V7, P1019, DOI 10.1111/j.1538-7836.2009.03434.x; Biesecker G, 1999, IMMUNOPHARMACOLOGY, V42, P219, DOI 10.1016/S0162-3109(99)00020-X; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Boomer RM, 2005, OLIGONUCLEOTIDES, V15, P183, DOI 10.1089/oli.2005.15.183; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Chelliserrykattil J, 2004, NAT BIOTECHNOL, V22, P1155, DOI 10.1038/nbt1001; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Davis JH, 2002, P NATL ACAD SCI USA, V99, P11616, DOI 10.1073/pnas.182095699; Davis KA, 1998, NUCLEIC ACIDS RES, V26, P3915, DOI 10.1093/nar/26.17.3915; Diener JL, 2009, J THROMB HAEMOST, V7, P1155, DOI 10.1111/j.1538-7836.2009.03459.x; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Hasegawa H, 2008, BIOTECHNOL LETT, V30, P829, DOI 10.1007/s10529-007-9629-6; Hasegawa H, 2008, SENSORS-BASEL, V8, P1090, DOI 10.3390/s8021090; Hernandez FJ, 2009, BIOORG MED CHEM LETT, V19, P6585, DOI 10.1016/j.bmcl.2009.10.039; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Jayasena SD, 1999, CLIN CHEM, V45, P1628; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Katilius E, 2007, NUCLEIC ACIDS RES, V35, P7626, DOI 10.1093/nar/gkm922; Kato T, 2000, NUCLEIC ACIDS RES, V28, P1963, DOI 10.1093/nar/28.9.1963; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; MINCHENKO A, 1994, LAB INVEST, V71, P374; Misono TS, 2005, ANAL BIOCHEM, V342, P312, DOI 10.1016/j.ab.2005.04.013; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Ninichuk V, 2008, AM J PATHOL, V172, P628, DOI 10.2353/ajpath.2008.070601; Oswald J, 2007, CANCER LETT, V254, P102, DOI 10.1016/j.canlet.2007.02.016; Pagratis NC, 1997, NAT BIOTECHNOL, V15, P68, DOI 10.1038/nbt0197-68; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Potty ASR, 2009, BIOPOLYMERS, V91, P145, DOI 10.1002/bip.21097; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Sayyed SG, 2009, DIABETOLOGIA, V52, P2445, DOI 10.1007/s00125-009-1493-6; Schmidt KS, 2004, NUCLEIC ACIDS RES, V32, P5757, DOI 10.1093/nar/gkh862; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; SHIMA DT, 1995, FEBS LETT, V370, P203, DOI 10.1016/0014-5793(95)00831-S; Somasunderam A, 2005, BIOCHEMISTRY-US, V44, P10388, DOI 10.1021/bi0507074; Tok JBH, 2008, CHEM COMMUN, P1883, DOI 10.1039/b717936g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; WALEH NS, 1995, CANCER RES, V55, P6222; Wrzesinski J, 2005, BIOCHEMISTRY-US, V44, P6257, DOI 10.1021/bi047397u; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	97	102	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31196	10.1371/journal.pone.0031196	http://dx.doi.org/10.1371/journal.pone.0031196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359573	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200042
J	Liu, Z; Xing, MZ				Liu, Zhi; Xing, Mingzhao			Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; DIFFERENTIATED THYROID-CARCINOMA; HISTONE DEACETYLASE INHIBITOR; GENE-EXPRESSION; NA+/I-SYMPORTER; THERAPEUTIC IMPLICATIONS; MELANOMA-CELLS; BREAST-CANCER; ACETYLATION; PATHWAYS	Background: This study was designed to explore the therapeutic potential of suppressing MAP kinase and PI3K/Akt pathways and histone deacetylase (HDAC) to induce the expression of sodium/iodide symporter (NIS) and radioiodine uptake in non-thyroid cancer cells. Methods: We tested the effects of the MEK inhibitor RDEA119, the Akt inhibitor perifosine, and the HDAC inhibitor SAHA on NIS expression in thirteen human cancer cell lines derived from melanoma, hepatic carcinoma, gastric carcinoma, colon carcinoma, breast carcinoma, and brain cancers. We also examined radioiodine uptake and histone acetylation at the NIS promoter in selected cells. Results: Overall, the three inhibitors could induce NIS expression, to various extents, in melanoma and all the epithelial carcinoma-derived cells but not in brain cancer-derived cells. SAHA was most effective and its effect could be significantly enhanced by RDEA119 and perifosine. The expression of NIS, at both mRNA and protein levels, was most robust in the melanoma cell M14, hepatic carcinoma cell HepG2, and the gastric carcinoma cell MKN-7 cell. Radioiodine uptake was correspondingly induced, accompanied by robust increase in histone acetylation at the NIS promoter, in these cells when treated with the three inhibitors. Conclusions: This is the first demonstration that simultaneously suppressing the MAP kinase and PI3K/Akt pathways and HDAC could induce robust NIS expression and radioiodine uptake in certain non-thyroid human cancer cells, providing novel therapeutic implications for adjunct radioiodine treatment of these cancers.	[Liu, Zhi; Xing, Mingzhao] Johns Hopkins Univ, Sch Med, Lab Cellular & Mol Thyroid Res, Div Endocrinol & Metab, Baltimore, MD 21218 USA	Johns Hopkins University	Liu, Z (corresponding author), Johns Hopkins Univ, Sch Med, Lab Cellular & Mol Thyroid Res, Div Endocrinol & Metab, Baltimore, MD 21218 USA.	mxing1@jhmi.edu	Liu, Zhi/D-2759-2012		National Institute of Health [CA134225]; NATIONAL CANCER INSTITUTE [R01CA134225] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institute of Health R01 grant CA134225 to Dr. Xing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arturi F, 1998, J CLIN ENDOCR METAB, V83, P2493, DOI 10.1210/jc.83.7.2493; Baker C. H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P167, DOI 10.2174/1568008043339839; BAKHEET SM, 1994, EUR J NUCL MED, V21, P604, DOI 10.1007/BF00285581; Caillou B, 1998, J CLIN ENDOCR METAB, V83, P4102, DOI 10.1210/jc.83.11.4102; Carafa V, 2011, RECENT PAT ANTI-CANC, V6, P131, DOI 10.2174/157489211793980088; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cho Je-Yoel, 2002, Current Gene Therapy, V2, P393, DOI 10.2174/1566523023347599; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Ellerhorst JA, 2006, ENDOCR-RELAT CANCER, V13, P1269, DOI 10.1677/erc.1.01239; GREENLER DP, 1989, CLIN NUCL MED, V14, P111, DOI 10.1097/00003072-198902000-00009; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Hou P, 2010, J CLIN ENDOCR METAB, V95, P820, DOI 10.1210/jc.2009-1888; Hou P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006200; Jhiang S M, 2000, Rev Endocr Metab Disord, V1, P205, DOI 10.1023/A:1010083132071; Jhiang SM, 1998, ENDOCRINOLOGY, V139, P4416, DOI 10.1210/en.139.10.4416; Kang DY, 2009, PATHOL INT, V59, P73, DOI 10.1111/j.1440-1827.2008.02331.x; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kitazono M, 2001, J CLIN ENDOCR METAB, V86, P3430, DOI 10.1210/jc.86.7.3430; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Li W, 2007, J CLIN ENDOCR METAB, V92, P1080, DOI 10.1210/jc.2006-2106; Liu Z, 2010, CLIN CANCER RES, V16, P6009, DOI 10.1158/1078-0432.CCR-10-1627; MacDonald VE, 2009, EPIGENETICS-US, V4, P139, DOI 10.4161/epi.4.3.8484; McCubrey JA, 2010, EXPERT OPIN EMERG DR, V15, P203, DOI 10.1517/14728210903282760; MCDOUGALL IR, 1995, CLIN NUCL MED, V20, P869, DOI 10.1097/00003072-199510000-00002; Morgenstern KE, 2005, OPHTHAL PLAST RECONS, V21, P337, DOI 10.1097/01.iop.0000179369.75569.a8; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Park HJ, 2000, THYROID, V10, P211, DOI 10.1089/thy.2000.10.211; Puppin C, 2005, ENDOCRINOLOGY, V146, P3967, DOI 10.1210/en.2005-0128; ROSENBAUM RC, 1988, CLIN NUCL MED, V13, P657, DOI 10.1097/00003072-198809000-00011; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Smanik PA, 1997, ENDOCRINOLOGY, V138, P3555, DOI 10.1210/en.138.8.3555; Spitzweg C, 1999, J CLIN ENDOCR METAB, V84, P4178, DOI 10.1210/jc.84.11.4178; Spitzweg C, 2002, CLIN ENDOCRINOL, V57, P559, DOI 10.1046/j.1365-2265.2002.01640.x; Spitzweg C, 2001, KIDNEY INT, V59, P1013, DOI 10.1046/j.1523-1755.2001.00584.x; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Zarnegar R, 2002, SURGERY, V132, P984, DOI 10.1067/msy.2002.128690	37	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31729	10.1371/journal.pone.0031729	http://dx.doi.org/10.1371/journal.pone.0031729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359623	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200092
J	Nie, Y; Tang, YQ; Li, Y; Chi, CQ; Cai, M; Wu, XL				Nie, Yong; Tang, Yue-Qin; Li, Yan; Chi, Chang-Qiao; Cai, Man; Wu, Xiao-Lei			The Genome Sequence of Polymorphum gilvum SL003B-26A1(T) Reveals Its Genetic Basis for Crude Oil Degradation and Adaptation to the Saline Soil	PLOS ONE			English	Article							GUDAONENSIS SP NOV.; ALKANE HYDROXYLASES; SYSTEM; BIODEGRADATION; BACTERIUM; CHEMOTAXIS; FAMILY; IDENTIFICATION; HYDROCARBONS; SURFACTANTS	Polymorphum gilvum SL003B-26A1(T) is the type strain of a novel species in the recently published novel genus Polymorphum isolated from saline soil contaminated with crude oil. It is capable of using crude oil as the sole carbon and energy source and can adapt to saline soil at a temperature of 45 degrees C. The Polymorphum gilvum genome provides a genetic basis for understanding how the strain could degrade crude oil and adapt to a saline environment. Genome analysis revealed the versatility of the strain for emulsifying crude oil, metabolizing aromatic compounds ( a characteristic specific to the Polymorphum gilvum genome in comparison with other known genomes of oil-degrading bacteria), as well as possibly metabolizing n-alkanes through the LadA pathway. In addition, COG analysis revealed Polymorphum gilvum SL003B-26A1(T) has significantly higher abundances of the proteins responsible for cell motility, lipid transport and metabolism, and secondary metabolite biosynthesis, transport and catabolism than the average levels found in all other genomes sequenced thus far, but lower abundances of the proteins responsible for carbohydrate transport and metabolism, defense mechanisms, and translation than the average levels. These traits support the adaptability of Polymorphum gilvum to a crude oil-contaminated saline environment. The Polymorphum gilvum genome could serve as a platform for further study of oil-degrading microorganisms for bioremediation and microbial-enhanced oil recovery in harsh saline environments.	[Nie, Yong; Tang, Yue-Qin; Li, Yan; Chi, Chang-Qiao; Cai, Man; Wu, Xiao-Lei] Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China	Peking University	Nie, Y (corresponding author), Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China.	xiaolei_wu@pku.edu.cn	Wu, Xiao-Lei/G-6882-2011	Wu, Xiao-Lei/0000-0002-9897-6903	National Natural Science Foundation of China [30870086, 31070107, 40821140541]; National High Technology Research and Development Program of China [2009AA063501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (30870086, 31070107 and 40821140541, http://www.nsfc.gov.cn) and the National High Technology Research and Development Program of China (2009AA063501, http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; BENSON S, 1979, J BACTERIOL, V140, P754, DOI 10.1128/JB.140.3.754-762.1979; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brown LR, 2010, CURR OPIN MICROBIOL, V13, P316, DOI 10.1016/j.mib.2010.01.011; Cai M, 2011, INT J SYST EVOL MICR, V61, P1767, DOI 10.1099/ijs.0.025932-0; Cai M, 2011, SYST APPL MICROBIOL, V34, P321, DOI 10.1016/j.syapm.2011.03.004; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Callaghan AV, 2008, BIOCHEM BIOPH RES CO, V366, P142, DOI 10.1016/j.bbrc.2007.11.094; Callaghan AV, 2011, ENV MICROBI IN PRESS; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Cock PJA, 2007, MOL BIOL EVOL, V24, P2355, DOI 10.1093/molbev/msm170; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Drepper T, 2006, FEMS MICROBIOL LETT, V258, P250, DOI 10.1111/j.1574-6968.2006.00228.x; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Feng L, 2007, P NATL ACAD SCI USA, V104, P5602, DOI 10.1073/pnas.0609650104; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Funhoff EG, 2006, J BACTERIOL, V188, P5220, DOI 10.1128/JB.00286-06; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gerischer U, 2002, J MOL MICROB BIOTECH, V4, P111; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grundmann O, 2008, ENVIRON MICROBIOL, V10, P376, DOI 10.1111/j.1462-2920.2007.01458.x; Gu J, 2007, INT J SYST EVOL MICR, V57, P250, DOI 10.1099/ijs.0.64522-0; Heermann R, 2004, CURR OPIN MICROBIOL, V7, P168, DOI 10.1016/j.mib.2004.02.008; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; HULTGREN SJ, 1991, ANNU REV MICROBIOL, V45, P383, DOI 10.1146/annurev.micro.45.1.383; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kleinsteuber S, 2006, APPL ENVIRON MICROB, V72, P3531, DOI 10.1128/AEM.72.5.3531-3542.2006; Kramer R, 2010, CHEM REC, V10, P217, DOI 10.1002/tcr.201000005; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Li SG, 2011, J BACTERIOL, V193, P2894, DOI 10.1128/JB.00333-11; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Maier RM, 2000, APPL MICROBIOL BIOT, V54, P625, DOI 10.1007/s002530000443; Maier T, 2001, BIOCHEM BIOPH RES CO, V286, P652, DOI 10.1006/bbrc.2001.5449; Margesin R, 2001, APPL MICROBIOL BIOT, V56, P650, DOI 10.1007/s002530100701; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MCFARLAND N, 1981, P NATL ACAD SCI-BIOL, V78, P2135, DOI 10.1073/pnas.78.4.2135; Nicholson CA, 2004, APPL ENVIRON MICROB, V70, P1222, DOI 10.1128/AEM.70.2.1222-1225.2004; Nie Y, 2011, APPL ENVIRON MICROB, V77, P7279, DOI 10.1128/AEM.00203-11; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; ROWSELL EH, 1995, J BACTERIOL, V177, P6011, DOI 10.1128/jb.177.20.6011-6014.1995; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J., 2001, MOL CLONING LAB MANU; Satpute SK, 2010, ADV EXP MED BIOL, V672, P14; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Singh A, 2007, BIOTECHNOL ADV, V25, P99, DOI 10.1016/j.biotechadv.2006.10.004; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Tondervik A, 2006, J BACTERIOL, V188, P4218, DOI 10.1128/JB.00513-05; Toren A, 2002, J BACTERIOL, V184, P165, DOI 10.1128/JB.184.1.165-170.2002; van Beilen JB, 2007, APPL MICROBIOL BIOT, V74, P13, DOI 10.1007/s00253-006-0748-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Walzer G, 2006, ENVIRON MICROBIOL, V8, P1026, DOI 10.1111/j.1462-2920.2006.00994.x; Wang XB, 2011, BIORESOURCE TECHNOL, V102, P7755, DOI 10.1016/j.biortech.2011.06.009; Wang YN, 2007, INT J SYST EVOL MICR, V57, P1222, DOI 10.1099/ijs.0.64973-0; Wang YN, 2007, INT J SYST EVOL MICR, V57, P911, DOI 10.1099/ijs.0.64826-0; WARD DM, 1978, APPL ENVIRON MICROB, V35, P353, DOI 10.1128/AEM.35.2.353-359.1978; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Williams RHN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-720; Wu XL, 2009, INT J SYST EVOL MICR, V59, P300, DOI 10.1099/ijs.0.65758-0; Yu SL, 2011, J ENVIRON SCI, V23, P1533, DOI 10.1016/S1001-0742(10)60585-2; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701; Yura T, 1999, CURR OPIN MICROBIOL, V2, P153, DOI 10.1016/S1369-5274(99)80027-7	78	36	37	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31261	10.1371/journal.pone.0031261	http://dx.doi.org/10.1371/journal.pone.0031261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359583	Green Submitted, gold, Green Published			2022-12-27	WOS:000302796200052
J	Roberts, DM; Pronobis, MI; Alexandre, KM; Rogers, GC; Poulton, JS; Schneider, DE; Jung, KC; Mckay, DJ; Peifer, M				Roberts, David M.; Pronobis, Mira I.; Alexandre, Kelly M.; Rogers, Gregory C.; Poulton, John S.; Schneider, Daniel E.; Jung, Kuo-Chen; Mckay, Daniel J.; Peifer, Mark			Defining Components of the beta catenin Destruction Complex and Exploring Its Regulation and Mechanisms of Action during Development	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; TUMOR-SUPPRESSOR PROTEIN; SEGMENT POLARITY GENE; NEGATIVE REGULATION; UBIQUITIN LIGASES; DROSOPHILA-MELANOGASTER; ADHERENS JUNCTION; TRANSGENIC RNAI; WINGLESS SIGNAL; ARMADILLO	Background: A subset of signaling pathways play exceptionally important roles in embryonic and post-embryonic development, and mis-regulation of these pathways occurs in most human cancers. One such pathway is the Wnt pathway. The primary mechanism keeping Wnt signaling off in the absence of ligand is regulated proteasomal destruction of the canonical Wnt effector beta catenin (or its fly homolog Armadillo). A substantial body of evidence indicates that SCF beta TrCP mediates beta cat destruction, however, an essential role for Roc1 has not been demonstrated in this process, as would be predicted. In addition, other E3 ligases have also been proposed to destroy bcat, suggesting that beta cat destruction may be regulated differently in different tissues. Methodology/Principal Findings: Here we used cultured Drosophila cells, human colon cancer cells, and Drosophila embryos and larvae to explore the machinery that targets Armadillo for destruction. Using RNAi in Drosophila S2 cells to examine which SCF components are essential for Armadillo destruction, we find that Roc1/Roc1a is essential for regulating Armadillo stability, and that in these cells the only F-box protein playing a detectable role is Slimb. Second, we find that while embryonic and larval Drosophila tissues use the same destruction complex proteins, the response of these tissues to destruction complex inactivation differs, with Armadillo levels more elevated in embryos. We provide evidence consistent with the possibility that this is due to differences in armadillo mRNA levels. Third, we find that there is no correlation between the ability of different APC2 mutant proteins to negatively regulate Armadillo levels, and their recently described function in positively-regulating Wnt signaling. Finally, we demonstrate that APC proteins lacking the N-terminal Armadillo-repeat domain cannot restore Armadillo destruction but retain residual function in negatively-regulating Wnt signaling. Conclusions/Significance: We use these data to refine our model for how Wnt signaling is regulated during normal development.	[Roberts, David M.; Alexandre, Kelly M.; Poulton, John S.; Schneider, Daniel E.; Jung, Kuo-Chen; Mckay, Daniel J.; Peifer, Mark] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Roberts, David M.; Poulton, John S.; Peifer, Mark] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roberts, David M.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; [Pronobis, Mira I.; Peifer, Mark] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Rogers, Gregory C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Franklin & Marshall College; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona	Roberts, DM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	david.roberts@fandm.edu; peifer@unc.edu		Pronobis, Mira/0000-0002-9861-6596; Peifer, Mark/0000-0003-1412-3987	National Institutes of Health [RO1 GM67236, NRSA F32 GM076898, T32 CA 009156, NRSA F32 GM095127]; Franklin and Marshall College; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076898, F32GM095127, R01GM067236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin and Marshall College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health RO1 GM67236 to M. P. [www.nih.gov], and by start-up funds from Franklin and Marshall College to D.M.R. [www.fandm.edu]. D.M.R was supported in part by National Institutes of Health NRSA F32 GM076898, J.S.P. by National Institutes of Health T32 CA 009156 and National Institutes of Health NRSA F32 GM095127 [all www.nih.gov], and M.P. supported in part by the Hooker Distinguished Professorship from the University of North Carolina at Chapel Hill [www.unc.edu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; BAKER NE, 1988, DEVELOPMENT, V103, P289; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donaldson TD, 2004, MOL BIOL CELL, V15, P4892, DOI 10.1091/mbc.E04-03-0180; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hayden MA, 2007, DEV BIOL, V305, P358, DOI 10.1016/j.ydbio.2007.02.018; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; LaFave MC, 2011, GENETICS, V188, P749, DOI 10.1534/genetics.111.129825; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McCartney BM, 2006, DEVELOPMENT, V133, P2407, DOI 10.1242/dev.02398; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1993, J CELL SCI, V105, P993; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peifer M, 2009, CSH PERSPECT BIOL, V1; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Rubinfeld B, 1997, CANCER RES, V57, P4624; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Tripathi R, 2007, J BIOSCIENCES, V32, P1133, DOI 10.1007/s12038-007-0114-0; Widmann TJ, 2009, DEV BIOL, V334, P161, DOI 10.1016/j.ydbio.2009.07.013; Wieschaus E., 1986, P199; Willert K, 1999, DEVELOPMENT, V126, P4165; Zimmerman SG, 2010, DEV BIOL, V340, P54, DOI 10.1016/j.ydbio.2010.01.021; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	46	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31284	10.1371/journal.pone.0031284	http://dx.doi.org/10.1371/journal.pone.0031284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359584	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200053
J	Rolf, HJ; Niebert, S; Niebert, M; Gaus, L; Schliephake, H; Wiese, KG				Rolf, Hans J.; Niebert, Sabine; Niebert, Marcus; Gaus, Lena; Schliephake, Henning; Wiese, K. Guenter			Intercellular Transport of Oct4 in Mammalian Cells: A Basic Principle to Expand a Stem Cell Niche?	PLOS ONE			English	Article							TUNNELING NANOTUBES; MEMBRANE NANOTUBES; DEFINED FACTORS; RECOMBINANT PROTEINS; INDUCED PLURIPOTENCY; HUMAN FIBROBLASTS; PROGENITOR CELLS; SOMATIC-CELLS; ANIMAL-CELLS; EXPRESSION	Background: The octamer-binding transcription factor 4 (Oct4) was originally described as a marker of embryonic stem cells. Recently, the role of Oct4 as a key regulator in pluripotency was shown by its ability to reprogram somatic cells in vitro, either alone or in concert with other factors. While artificial induction of pluripotency using transcription factors is possible in mammalian cell culture, it remains unknown whether a potential natural transfer mechanism might be of functional relevance in vivo. The stem cell based regeneration of deer antlers is a unique model for rapid and complete tissue regeneration in mammals and therefore most suitable to study such mechanisms. Here, the transfer of pluripotency factors from resident stem cell niche cells to differentiated cells could recruit more stem cells and start rapid tissue regeneration. Methodology/Principal Findings: We report on the ability of STRO-1(+) deer antlerogenic mesenchymal stem cells (DaMSCs) to transport Oct4 via direct cell-to-cell connections. Upon cultivation in stem cell expansion medium, we observed nuclear Oct4 expression in nearly all cells. A number of these cells exhibit Oct4 expression not only in the nucleus, but also with perinuclear localisation and within far-ranging intercellular connections. Furthermore, many cells showed intercellular connections containing both F-actin and alpha-tubulin and through which transport could be observed. To proof that intercellular Oct4-transfer has functional consequences in recipient cells we used a co-culture approach with STRO-1(+) DaMSCs and a murine embryonic fibroblast indicator cell line (Oct4-GFP MEF). In this cell line a reporter gene (GFP) under the control of an Oct4 responsive element is only expressed in the presence of Oct4. GFP expression in Oct4-GFP cells started after 24 hours of co-culture providing evidence of Oct4 transfer from STRO-1(+) DaMSCs to Oct4-GFP MEF target cells. Conclusions: Our findings indicate a possible mechanism for the expansion of a resident stem cell niche by induction of pluripotency in surrounding non-niche cells via transfer of transcription factors through intercellular connections. This provides a new approach to explain the rapid annual antler regrowth.	[Rolf, Hans J.; Niebert, Sabine; Gaus, Lena; Schliephake, Henning; Wiese, K. Guenter] Univ Goettingen, Res Grp Expt Osteol, Dept Maxillofacial Surg, Univ Med Ctr, Gottingen, Germany; [Niebert, Marcus] Univ Goettingen, Dept Neuro & Sensory Physiol, Univ Med Ctr, Gottingen, Germany	University of Gottingen; University of Gottingen	Rolf, HJ (corresponding author), Univ Goettingen, Res Grp Expt Osteol, Dept Maxillofacial Surg, Univ Med Ctr, Gottingen, Germany.	hrolf@uni-goettingen.de	Schliephake, Henning/I-8911-2019	Wiese, K. Gunter/0000-0001-6436-0468	German Research Society (DFG) [RO 2520/1-1/1-3]; German Research Society [DFG/RO 2520/1-1/1-3]	German Research Society (DFG)(German Research Foundation (DFG)); German Research Society(German Research Foundation (DFG))	The work was funded by the German Research Society (DFG/grant numbers: RO 2520/1-1/1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J. Schulz and S. Ahlborn for technical assistance with cell cultures. We would like to thank H. Reinecke and co-workers of the Wildlife Biology and Game Management, University of Goettingen, for keeping of animals and assistance with tissue sampling. We are indebted to Erika Kuzmova, Research Institute of Animal Production, University of Praha, for providing red deer tissue samples. Many thanks go to D. Raab, head of the forest district of the city of Goettingen, and his colleagues for providing pedicles of fallow deer kept in a forest enclosure in Goettingen. Special thanks go to Uwe and Horst Kierdorf, Department of Biology, University of Hildesheim, for their invaluable discussions. H. J. R. and co-workers are funded by the German Research Society (DFG/RO 2520/1-1/1-3).	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Goss R.J., 1983, DEER ANTLERS REGENER; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Ho R, 2011, J CELL PHYSIOL, V226, P868, DOI 10.1002/jcp.22450; Ji KH, 2008, ANN HEMATOL, V87, P431, DOI 10.1007/s00277-008-0470-3; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kierdorf U, 2010, DEER ANTLERS MODEL M; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Koga K, 2005, ANTICANCER RES, V25, P3703; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Niu XL, 2009, J CELL SCI, V122, P600, DOI 10.1242/jcs.031427; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; Panagopoulos I, 2008, ONCOL REP, V20, P1029, DOI 10.3892/or_00000105; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Ralston A, 2010, REPRODUCTION, V139, P35, DOI 10.1530/REP-09-0024; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Welstead GG, 2008, J VIS EXP; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Zani Brett G, 2010, Commun Integr Biol, V3, P215; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	53	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32287	10.1371/journal.pone.0032287	http://dx.doi.org/10.1371/journal.pone.0032287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359678	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200147
J	Shapira, A; Shapira, S; Gal-Tanamy, M; Zemel, R; Tur-Kaspa, R; Benhar, I				Shapira, Assaf; Shapira, Shiran; Gal-Tanamy, Meital; Zemel, Romy; Tur-Kaspa, Ran; Benhar, Itai			Removal of Hepatitis C Virus-Infected Cells by a Zymogenized Bacterial Toxin	PLOS ONE			English	Article							MESSENGER-RNA INTERFERASES; VIRAL REPLICATION COMPLEX; N-END-RULE; RECOMBINANT ADENOVIRUSES; MEMBRANE ASSOCIATION; ANTITOXIN SYSTEMS; SERINE-PROTEASE; DEATH; ACTIVATION; PROTEINS	Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and has become a global health threat. No HCV vaccine is currently available and treatment with antiviral therapy is associated with adverse side effects. Moreover, there is no preventive therapy for recurrent hepatitis C post liver transplantation. The NS3 serine protease is necessary for HCV replication and represents a prime target for developing anti HCV therapies. Recently we described a therapeutic approach for eradication of HCV infected cells that is based on protein delivery of two NS3 protease-activatable recombinant toxins we named "zymoxins". These toxins were inactivated by fusion to rationally designed inhibitory peptides via NS3-cleavable linkers. Once delivered to cells where NS3 protease is present, the inhibitory peptide is removed resulting in re-activation of cytotoxic activity. The zymoxins we described suffered from two limitations: they required high levels of protease for activation and had basal activities in the un-activated form that resulted in a narrow potential therapeutic window. Here, we present a solution that overcame the major limitations of the "first generation zymoxins" by converting MazF ribonuclease, the toxic component of the E. coli chromosomal MazEF toxin-antitoxin system, into an NS3-activated zymoxin that is introduced to cells by means of gene delivery. We constructed an expression cassette that encodes for a single polypeptide that incorporates both the toxin and a fragment of its potent natural antidote, MazE, linked via an NS3-cleavable linker. While covalently paired to its inhibitor, the ribonuclease is well tolerated when expressed in naive, healthy cells. In contrast, activating proteolysis that is induced by even low levels of NS3, results in an eradication of NS3 expressing model cells and HCV infected cells. Zymoxins may thus become a valuable tool in eradicating cells infected by intracellular pathogens that express intracellular proteases.	[Shapira, Assaf; Benhar, Itai] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Shapira, Assaf; Gal-Tanamy, Meital; Zemel, Romy; Tur-Kaspa, Ran] Tel Aviv Univ, Felsenstein Med Res Ctr, Sackler Sch Med, Mol Hepatol Res Lab, Petah Tiqwa, Israel; [Shapira, Shiran] Tel Aviv Med Ctr & Sch Med, Integrated Canc Prevent Ctr, Tel Aviv, Israel; [Shapira, Shiran] Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Dept Med D, Petah Tiqwa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Shapira, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel.	benhar@post.tau.ac.il		Benhar, Itai/0000-0002-0824-7177	Israel Science Foundation (ISF) [397/08]; Israel Ministry of Health [3-3981]	Israel Science Foundation (ISF)(Israel Science Foundation); Israel Ministry of Health	This research was supported by the Israel Science Foundation (ISF) (grant no. 397/08) (http://www.isf.org.il) and grant no. 3-3981 from the Israel Ministry of Health (http://www.health.gov.il/pages/default.asp?maincat = 14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Donepudi M, 2002, BIOPHYS CHEM, V101, P145, DOI 10.1016/S0301-4622(02)00151-5; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Falnes PO, 1999, BIOCHEM J, V343, P199, DOI 10.1042/0264-6021:3430199; Gal-Tanamy M, 2005, J MOL BIOL, V347, P991, DOI 10.1016/j.jmb.2005.02.020; Gal-Tanamy M, 2010, ANTIVIR RES, V88, P95, DOI 10.1016/j.antiviral.2010.08.001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2004, CELL, V116, P359, DOI 10.1016/S0092-8674(04)00116-3; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu EC, 2003, NAT BIOTECHNOL, V21, P519, DOI 10.1038/nbt817; Hsu JTA, 2006, CURR PHARM DESIGN, V12, P1301, DOI 10.2174/138161206776361110; Inouye M, 2006, J CELL PHYSIOL, V209, P670, DOI 10.1002/jcp.20801; Johnson RJ, 2006, FEBS J, V273, P5457, DOI 10.1111/j.1742-4658.2006.05536.x; Jucovic M, 2008, PROTEIN ENG DES SEL, V21, P631, DOI 10.1093/protein/gzn038; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Law SK, 2010, NUCL ACIDS RES; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Patick AK, 1998, CLIN MICROBIOL REV, V11, P614, DOI 10.1128/CMR.11.4.614; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shapira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015916; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Suzuki T, 2007, ADV DRUG DELIV REV; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Teramoto S, 1999, EUR RESPIR J, V13, P1125, DOI 10.1034/j.1399-3003.1999.13e31.x; TERAMOTO S, 1995, HUM GENE THER, V6, P1045, DOI 10.1089/hum.1995.6.8-1045; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Trahtenherts A, 2008, ANTIVIR RES, V77, P195, DOI 10.1016/j.antiviral.2007.12.013; Turcotte RF, 2008, AIDS RES HUM RETROVI; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Varshavsky A, 1995, COLD SPRING HARB SYM, V60, P461, DOI 10.1101/SQB.1995.060.01.051; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; Wersto RP, 1998, J VIROL, V72, P9491, DOI 10.1128/JVI.72.12.9491-9502.1998; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Zheng CY, 2000, BIOCHEM BIOPH RES CO, V274, P767, DOI 10.1006/bbrc.2000.3213	67	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32320	10.1371/journal.pone.0032320	http://dx.doi.org/10.1371/journal.pone.0032320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359682	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200151
J	Slater, H; Michael, E				Slater, Hannah; Michael, Edwin			Predicting the Current and Future Potential Distributions of Lymphatic Filariasis in Africa Using Maximum Entropy Ecological Niche Modelling	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; BANCROFTIAN FILARIASIS; GEOGRAPHIC-DISTRIBUTION; SPATIAL-ANALYSIS; VECTOR-BORNE; MALARIA; RISK; PREVALENCE; SCHISTOSOMIASIS	Modelling the spatial distributions of human parasite species is crucial to understanding the environmental determinants of infection as well as for guiding the planning of control programmes. Here, we use ecological niche modelling to map the current potential distribution of the macroparasitic disease, lymphatic filariasis (LF), in Africa, and to estimate how future changes in climate and population could affect its spread and burden across the continent. We used 508 community-specific infection presence data collated from the published literature in conjunction with five predictive environmental/climatic and demographic variables, and a maximum entropy niche modelling method to construct the first ecological niche maps describing potential distribution and burden of LF in Africa. We also ran the best-fit model against climate projections made by the HADCM3 and CCCMA models for 2050 under A2a and B2a scenarios to simulate the likely distribution of LF under future climate and population changes. We predict a broad geographic distribution of LF in Africa extending from the west to the east across the middle region of the continent, with high probabilities of occurrence in the Western Africa compared to large areas of medium probability interspersed with smaller areas of high probability in Central and Eastern Africa and in Madagascar. We uncovered complex relationships between predictor ecological niche variables and the probability of LF occurrence. We show for the first time that predicted climate change and population growth will expand both the range and risk of LF infection (and ultimately disease) in an endemic region. We estimate that populations at risk to LF may range from 543 and 804 million currently, and that this could rise to between 1.65 to 1.86 billion in the future depending on the climate scenario used and thresholds applied to signify infection presence.	[Slater, Hannah; Michael, Edwin] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Slater, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	emichael@nd.edu	Michael, Edwin/D-3388-2014	Slater, Hannah/0000-0003-4291-7899	Natural Environment Research Council, UK; Grantham Institute for Climate Change at Imperial College London; National Institutes of Health, USA [RO1 AI069387-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069387] Funding Source: NIH RePORTER	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grantham Institute for Climate Change at Imperial College London; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge the Natural Environment Research Council, UK, for a NERC/ESRC Interdisciplinary Research Studentship to HS. The authors also acknowledge the Grantham Institute for Climate Change at Imperial College London and the National Institutes of Health, USA (under grant number RO1 AI069387-01A1), for partial financial support of this work. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Brinkmann UK, 1976, PARASITOLOGY, V28, P71; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; Casaca V M, 1966, An Inst Med Trop (Lisb), V23, P127; Clements ACA, 2008, INT J PARASITOL, V38, P401, DOI 10.1016/j.ijpara.2007.08.001; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hartley S, 2006, ECOL LETT, V9, P1068, DOI 10.1111/j.1461-0248.2006.00954.x; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Juminer B, 1971, Archs Inst Pasteur Tunis, V48, P231; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lamontellerie M, 1972, ANN PARASITOLOGIE HU, V47, P743; Lardeux F, 1997, PARASITOLOGY, V114, P123, DOI 10.1017/S0031182096008359; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Lindsay SW, 2000, T ROY SOC TROP MED H, V94, P37, DOI 10.1016/S0035-9203(00)90431-0; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manga L, 2002, ANN TROP MED PARASIT, V96, pS129, DOI 10.1179/000349802125002473; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; McMichael AJ, 2003, INTERN MED J, V33, P554, DOI 10.1111/j.1445-5994.2003.00492.x; Meyrowitsch DW, 1998, ACTA TROP, V70, P335, DOI 10.1016/S0001-706X(98)00037-0; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 1997, PARASITOL TODAY, V13, P472, DOI 10.1016/S0169-4758(97)01151-4; Michael E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002936; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Ngwira Bagrey Mm, 2007, Filaria J, V6, P12, DOI 10.1186/1475-2883-6-12; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Onapa AW, 2005, ANN TROP MED PARASIT, V99, P141, DOI 10.1179/136485905X19829; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Richards F O Jr, 1993, Bull Pan Am Health Organ, V27, P52; Robinson TP, 1998, PARASITOL TODAY, V14, P457, DOI 10.1016/S0169-4758(98)01336-2; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; ROGERS DJ, 1993, PARASITOL TODAY, V9, P266, DOI 10.1016/0169-4758(93)90074-P; Roura-Pascual Nuria, 2008, Myrmecological News, V11, P67; Sabesan S, 2000, ANN TROP MED PARASIT, V94, P591, DOI 10.1080/00034983.2000.11813582; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowilem Mohamed M., 2006, Journal of the Egyptian Society of Parasitology, V36, P373; Srividya A, 2002, AM J TROP MED HYG, V67, P480, DOI 10.4269/ajtmh.2002.67.480; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Thompson DF, 1996, EMERG INFECT DIS, V2, P234, DOI 10.3201/eid0203.960313; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; WHO, 1992, LYMPH FIL DIS ITS CO; WHO, 2004, LYMPH FIL EL AFR REG; WHO/Department of Control of Neglected Tropical Diseases, 2009, WKLY EPIDEMIOL REC, V42, P437; WIJERS DJB, 1977, ANN TROP MED PARASIT, V71, P313, DOI 10.1080/00034983.1977.11687193; World Health Organization, 2005, WORLD HEALTH, P202; ZWEIG MH, 1993, CLIN CHEM, V39, P561	79	84	93	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32202	10.1371/journal.pone.0032202	http://dx.doi.org/10.1371/journal.pone.0032202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359670	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200139
J	Baryshyan, AL; Woods, W; Trimmer, BA; Kaplan, DL				Baryshyan, Amanda L.; Woods, William; Trimmer, Barry A.; Kaplan, David L.			Isolation and Maintenance-Free Culture of Contractile Myotubes from Manduca sexta Embryos	PLOS ONE			English	Article							TOBACCO HORNWORM; SKELETAL-MUSCLE; FLIGHT-MUSCLE; ENERGY-METABOLISM; JUVENILE-HORMONE; BOMBYX-MORI; CELL LINES; DROSOPHILA; TISSUE; DIFFERENTIATION	Skeletal muscle tissue engineering has the potential to treat tissue loss and degenerative diseases. However, these systems are also applicable for a variety of devices where actuation is needed, such as microelectromechanical systems (MEMS) and robotics. Most current efforts to generate muscle bioactuators are focused on using mammalian cells, which require exacting conditions for survival and function. In contrast, invertebrate cells are more environmentally robust, metabolically adaptable and relatively autonomous. Our hypothesis is that the use of invertebrate muscle cells will obviate many of the limitations encountered when mammalian cells are used for bioactuation. We focus on the tobacco hornworm, Manduca sexta, due to its easy availability, large size and well-characterized muscle contractile properties. Using isolated embryonic cells, we have developed culture conditions to grow and characterize contractile M. sexta muscles. The insect hormone 20-hydroxyecdysone was used to induce differentiation in the system, resulting in cells that stained positive for myosin, contract spontaneously for the duration of the culture, and do not require media changes over periods of more than a month. These cells proliferate under normal conditions, but the application of juvenile hormone induced further proliferation and inhibited differentiation. Cellular metabolism under normal and low glucose conditions was compared for C2C12 mouse and M. sexta myoblast cells. While differentiated C2C12 cells consumed glucose and produced lactate over one week as expected, M. sexta muscle did not consume significant glucose, and lactate production exceeded mammalian muscle production on a per cell basis. Contractile properties were evaluated using index of movement analysis, which demonstrated the potential of these cells to perform mechanical work. The ability of cultured M. sexta muscle to continuously function at ambient conditions without medium replenishment, combined with the interesting metabolic properties, suggests that this cell source is a promising candidate for further investigation toward bioactuator applications.	[Baryshyan, Amanda L.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Woods, William; Trimmer, Barry A.] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University; Tufts University	Baryshyan, AL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	David.Kaplan@tufts.edu		Trimmer, Barry/0000-0003-1782-7373	DARPA [DARPA - W911NF-11-1-0079]; Direct For Biological Sciences [1050908] Funding Source: National Science Foundation	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by DARPA (DARPA - W911NF-11-1-0079), as part of the ChemBots and M3 programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2008, J BIOTECHNOL, V133, P261, DOI 10.1016/j.jbiotec.2007.08.042; Akiyama Y, 2009, LAB CHIP, V9, P140, DOI 10.1039/b809299k; Auerswald L, 2000, J INSECT PHYSIOL, V46, P343, DOI 10.1016/S0022-1910(99)00187-0; BERNSTEIN SI, 1978, J CELL BIOL, V78, P856, DOI 10.1083/jcb.78.3.856; BROADIE K, 1992, ROUX ARCH DEV BIOL, V201, P364, DOI 10.1007/BF00365124; Buttgereit D, 1996, INT J DEV BIOL, V40, P189; Champlin DT, 1999, DEV GENES EVOL, V209, P265, DOI 10.1007/s004270050252; Chapman RF, 1998, INSECTS STRUCTURE FU; Das M, 2007, NAT PROTOC, V2, P1795, DOI 10.1038/nprot.2007.229; Dorfmann A, 2007, J R SOC INTERFACE, V4, P257, DOI 10.1098/rsif.2006.0163; DORN A, 1987, INT J INVER REP DEV, V11, P137, DOI 10.1080/01688170.1987.10510274; EIDE PE, 1975, IN VITRO CELL DEV B, V11, P395; FAUSTO AM, 1994, DEV GROWTH DIFFER, V36, P197; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Foe V. E., 1993, DEV DROSOPHILA MELAN, pCh 3; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Gawlitta D, 2007, J APPL PHYSIOL, V103, P464, DOI 10.1152/japplphysiol.01374.2006; Harrison JF, 2001, ANNU REV ENTOMOL, V46, P221, DOI 10.1146/annurev.ento.46.1.221; Haunerland NH, 1997, COMP BIOCHEM PHYS B, V117, P475, DOI 10.1016/S0305-0491(97)00185-5; Hegstrom CD, 1996, J NEUROBIOL, V29, P535; Herr H., 2004, J NEUROENG REHABIL, V1, P1; Horiguchi H, 2009, IEEE T NANOBIOSCI, V8, P349, DOI 10.1109/TNB.2009.2035282; Hull-Thompson J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000460; Josephson RK, 2000, J EXP BIOL, V203, P2667; JOSEPHSON RK, 1991, J PHYSIOL-LONDON, V442, P413, DOI 10.1113/jphysiol.1991.sp018800; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; LAW JH, 1989, J BIOL CHEM, V264, P16335; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Luedeman R, 1996, DEV BIOL, V173, P51, DOI 10.1006/dbio.1996.0006; Lynn DE, 1996, CYTOTECHNOLOGY, V20, P3, DOI 10.1007/BF00350384; Patel RT, 2006, ARCH INSECT BIOCHEM, V63, P73, DOI 10.1002/arch.20143; RHEUBEN MB, 1980, J EXP BIOL, V84, P103; Siaussat D, 2007, CELL MOL LIFE SCI, V64, P365, DOI 10.1007/s00018-007-6452-0; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Truman JW, 2007, INSECT BIOCHEM MOLEC, V37, P761, DOI 10.1016/j.ibmb.2007.05.011; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; Woods WA, 2008, J EXP BIOL, V211, P873, DOI 10.1242/jeb.006031	41	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31598	10.1371/journal.pone.0031598	http://dx.doi.org/10.1371/journal.pone.0031598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355379	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300079
J	Del Coso, J; Munoz-Fernandez, VE; Munoz, G; Fernandez-Elias, VE; Ortega, JF; Hamouti, N; Barbero, JC; Munoz-Guerra, J				Del Coso, Juan; Munoz-Fernandez, Victor E.; Munoz, Gloria; Fernandez-Elias, Valentin E.; Ortega, Juan F.; Hamouti, Nassim; Barbero, Jose C.; Munoz-Guerra, Jesus			Effects of a Caffeine-Containing Energy Drink on Simulated Soccer Performance	PLOS ONE			English	Article							SUPPLEMENT USE; POWER OUTPUT; EXERCISE; INGESTION; SPORTS; CARBOHYDRATE; TIME; INCREASES; TAURINE; FITNESS	Background: To investigate the effects of a caffeine-containing energy drink on soccer performance during a simulated game. A second purpose was to assess the post-exercise urine caffeine concentration derived from the energy drink intake. Methodology/Principal Findings: Nineteen semiprofessional soccer players ingested 630 +/- 52 mL of a commercially available energy drink (sugar-free Red Bull (R)) to provide 3 mg of caffeine per kg of body mass, or a decaffeinated control drink (0 mg/kg). After sixty minutes they performed a 15-s maximal jump test, a repeated sprint test (7x30 m; 30 s of active recovery) and played a simulated soccer game. Individual running distance and speed during the game were measured using global positioning satellite (GPS) devices. In comparison to the control drink, the ingestion of the energy drink increased mean jump height in the jump test (34.7 +/- 4.7 v 35.8 +/- 5.5 cm; P<0.05), mean running speed during the sprint test (25.6 +/- 2.1 v 26.3 +/- 1.8 km . h(-1); P<0.05) and total distance covered at a speed higher than 13 km . h(-1) during the game (1205 +/- 289 v 1436 +/- 326 m; P<0.05). In addition, the energy drink increased the number of sprints during the whole game (30 +/- 10 v 24 +/- 8; P<0.05). Post-exercise urine caffeine concentration was higher after the energy drink than after the control drink (4.1 +/- 1.0 v 0.1 +/- 0.1 mu g . mL(-1); P<0.05). Conclusions/significance: A caffeine-containing energy drink in a dose equivalent to 3 mg/kg increased the ability to repeatedly sprint and the distance covered at high intensity during a simulated soccer game. In addition, the caffeinated energy drink increased jump height which may represent a meaningful improvement for headers or when players are competing for a ball.	[Del Coso, Juan] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain; [Munoz-Fernandez, Victor E.] Univ Castilla La Mancha, Exercise Training Lab, Toledo, Spain; [Munoz, Gloria; Munoz-Guerra, Jesus] Spanish Antidoping Agcy, Doping Control Lab, Madrid, Spain; [Fernandez-Elias, Valentin E.; Ortega, Juan F.; Hamouti, Nassim] Univ Castilla La Mancha, Exercise Physiol Lab, Toledo, Spain; [Barbero, Jose C.] Univ Granada, Melilla, Spain	Camilo Jose Cela University; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Granada	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Fernández-Elías, Valentín E./ABD-7398-2021; Barbero-Alvarez, Jose Carlos/ABD-1205-2021; Barbero-Alvarez, José Carlos/AAN-1205-2021; Del Coso, Juan/AAC-7117-2020; Ortega, Juan Fernando F/L-4973-2014	Fernández-Elías, Valentín E./0000-0002-1459-5442; Barbero-Alvarez, Jose Carlos/0000-0002-4055-6332; Del Coso, Juan/0000-0002-5785-984X; Ortega, Juan Fernando F/0000-0003-3884-923X				Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021; Astorino TA, 2012, AMINO ACIDS, V42, P1803, DOI 10.1007/s00726-011-0900-8; Barbero-Alvarez JC, 2007, APUNTS EDUCACION FIS, V90, P33; Barbero-Alvarez JC, 2010, J SCI MED SPORT, V13, P232, DOI 10.1016/j.jsams.2009.02.005; Bruce CR, 2000, MED SCI SPORT EXER, V32, P1958, DOI 10.1097/00005768-200011000-00021; Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130; Candow DG, 2009, J STRENGTH COND RES, V23, P1271, DOI 10.1519/JSC.0b013e3181a026c2; Carr A, 2008, J SPORT MED PHYS FIT, V48, P472; Castagna C, 2003, J STRENGTH COND RES, V17, P775; Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; Da Silva NP, 2007, J SPORT MED PHYS FIT, V47, P270; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; Del Coso J, 2011, APPL PHYSIOL NUTR ME, V36, P555, DOI [10.1139/h11-052, 10.1139/H11-052]; Del Coso J, 2009, MED SCI SPORT EXER, V41, P164, DOI 10.1249/MSS.0b013e318184f45e; DELBEKE FT, 1984, INT J SPORTS MED, V5, P179, DOI 10.1055/s-2008-1025901; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Doherty M, 2004, J SPORT SCI, V22, P637, DOI 10.1080/02640410310001655741; Doherty M, 1998, INT J SPORT NUTR, V8, P95, DOI 10.1123/ijsn.8.2.95; Ferreira SE, 2004, ALCOHOL CLIN EXP RES, V28, P1408, DOI 10.1097/01.ALC.0000139822.74414.EC; Forbes SC, 2007, INT J SPORT NUTR EXE, V17, P433, DOI 10.1123/ijsnem.17.5.433; Froiland K, 2004, INT J SPORT NUTR EXE, V14, P104, DOI 10.1123/ijsnem.14.1.104; Gant N, 2010, INT J SPORT NUTR EXE, V20, P191, DOI 10.1123/ijsnem.20.3.191; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2008, MED SCI SPORT EXER, V40, P1835, DOI 10.1249/MSS.0b013e31817a8ad2; GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867; Hoffman JR, 2010, STRENGTH COND J, V32, P15, DOI 10.1519/SSC.0b013e3181bdafa0; Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-2; Ivy JL, 2009, INT J SPORT NUTR EXE, V19, P61, DOI 10.1123/ijsnem.19.1.61; Jenkins NT, 2008, INT J SPORT NUTR EXE, V18, P328, DOI 10.1123/ijsnem.18.3.328; Kristiansen M, 2005, INT J SPORT NUTR EXE, V15, P195, DOI 10.1123/ijsnem.15.2.195; Lara AJ, 2006, J SPORT MED PHYS FIT, V46, P419; LELO A, 1986, BRIT J CLIN PHARMACO, V22, P183, DOI 10.1111/j.1365-2125.1986.tb05247.x; Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245; Mujika I, 2009, J SPORT SCI, V27, P107, DOI 10.1080/02640410802428071; PASMAN WJ, 1995, INT J SPORTS MED, V16, P225, DOI 10.1055/s-2007-972996; Pierno S, 1998, J PHARMACOL EXP THER, V286, P1183; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Roberts SP, 2010, J SPORT SCI, V28, P833, DOI 10.1080/02640414.2010.484069; Skinner TL, 2010, MED SCI SPORT EXER, V42, P571, DOI 10.1249/MSS.0b013e3181b6668b; Stuart GR, 2005, MED SCI SPORT EXER, V37, P1998, DOI 10.1249/01.mss.0000177216.21847.8a; SUBOTICANEC K, 1990, INT J VITAM NUTR RES, V60, P81; van Nieuwenhoven MA, 2000, J APPL PHYSIOL, V89, P1079, DOI 10.1152/jappl.2000.89.3.1079; Wiles JD, 2006, J SPORT SCI, V24, P1165, DOI 10.1080/02640410500457687; Yeo SE, 2005, J APPL PHYSIOL, V99, P844, DOI 10.1152/japplphysiol.00170.2005; Zhang M, 2004, AMINO ACIDS, V26, P203, DOI 10.1007/s00726-003-0002-3	47	96	97	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31380	10.1371/journal.pone.0031380	http://dx.doi.org/10.1371/journal.pone.0031380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348079	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400019
J	Jabbour, AM; Gordon, L; Daunt, CP; Green, BD; Kok, CH; D'Andrea, R; Ekert, PG				Jabbour, Anissa M.; Gordon, Lavinia; Daunt, Carmel P.; Green, Benjamin D.; Kok, Chung H.; D'Andrea, Richard; Ekert, Paul G.			p53-Dependent Transcriptional Responses to Interleukin-3 Signaling	PLOS ONE			English	Article							CELL-DEATH; UP-REGULATION; DNA-DAMAGE; PUMA; APOPTOSIS; GENE; P53; SURVIVAL; LEUKEMIA; KINASE	p53 is critical in the normal response to a variety of cellular stresses including DNA damage and loss of p53 function is a common feature of many cancers. In hematological malignancies, p53 deletion is less common than in solid malignancies but is associated with poor prognosis and resistance to chemotherapy. Compared to their wild-type (WT) counterparts, hematopoietic progenitor cells lacking p53 have a greater propensity to survive cytokine loss, in part, due to the failure to transcribe Puma, a proapoptotic Bcl-2 family member. Using expression arrays, we have further characterized the differences that distinguish p53(-/-) cells from WT myeloid cells in the presence of Interleukin-3 (IL-3) to determine if such differences contribute to the increased clonogenicity and survival responses observed in p53(-/-) cells. We show that p53(-/-) cells have a deregulated intracellular signaling environment and display a more rapid and sustained response to IL-3. This was accompanied by an increase in active ERK1/2 and a dependence on an intact MAP kinase signaling pathway. Contrastingly, we find that p53(-/-) cells are independent on AKT for their survival. Thus, loss of p53 in myeloid cells results in an altered transcriptional and kinase signaling environment that favors enhanced cytokine signaling.	[Jabbour, Anissa M.; Daunt, Carmel P.; Green, Benjamin D.; Ekert, Paul G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Parkville, Vic 3052, Australia; [Jabbour, Anissa M.; Daunt, Carmel P.; Green, Benjamin D.; Ekert, Paul G.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Jabbour, Anissa M.; Green, Benjamin D.; Ekert, Paul G.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Gordon, Lavinia] Royal Childrens Hosp, Murdoch Childrens Res Inst, Bioinformat Unit, Parkville, Vic 3052, Australia; [Kok, Chung H.; D'Andrea, Richard] Univ Adelaide, Queen Elizabeth Hosp, Ctr Stem Cell Res, Dept Haematol SA Pathol,Dept Heamatol & Oncol, Adelaide, SA, Australia; [Kok, Chung H.; D'Andrea, Richard] Univ Adelaide, Queen Elizabeth Hosp, Ctr Stem Cell Res, Acute Leukaemia Lab, Adelaide, SA, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Walter & Eliza Hall Institute; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; SA Pathology; University of Adelaide; University of Adelaide	Jabbour, AM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Flemington Rd, Parkville, Vic 3052, Australia.	jabbour@wehi.edu.au; ekert@wehi.edu.au	Ekert, Paul/Q-1842-2015; Gordon, Lavinia C/L-1310-2016; Ekert, Paul G/C-7247-2013	Ekert, Paul/0000-0002-2976-8617; Gordon, Lavinia C/0000-0003-3469-8489; Ekert, Paul G/0000-0002-2976-8617; Jabbour, Anissa/0000-0002-2540-0372; D'Andrea, Richard/0000-0002-4915-4612	National Health and Research Council (NHMRC) [565212]; Sylvia and Charles Viertel Senior Medical Fellowship	National Health and Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Fellowship	This work is supported by the National Health and Research Council (NHMRC) project grant 565212 and was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS). PGE is supported by the Sylvia and Charles Viertel Senior Medical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Endo T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001211; Ferreira BI, 2008, HAEMATOLOGICA, V93, P670, DOI 10.3324/haematol.12221; Forconi F, 2008, BRIT J HAEMATOL, V143, P532, DOI 10.1111/j.1365-2141.2008.07373.x; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Jabbour AM, 2010, BLOOD, V115, P344, DOI 10.1182/blood-2009-07-230730; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Khandanpour C, 2010, STEM CELLS; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Kong YM, 2011, J BIOMED INFORM, V44, P48, DOI 10.1016/j.jbi.2010.05.001; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Labi V, 2010, GENE DEV, V24, P1602, DOI 10.1101/gad.1940210; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marfe G, 2011, EXP HEMATOL; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Michalak EM, 2010, GENE DEV, V24, P1608, DOI 10.1101/gad.1940110; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreland RT, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap004; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yin B, 2009, BLOOD, V113, P1075, DOI 10.1182/blood-2008-03-144436; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zola H, 2007, J IMMUNOL METHODS, V319, P1, DOI 10.1016/j.jim.2006.11.001	52	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31428	10.1371/journal.pone.0031428	http://dx.doi.org/10.1371/journal.pone.0031428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348085	gold, Green Published, Green Accepted			2022-12-27	WOS:000302737400021
J	Liu, D; Guo, H; Li, YF; Xu, XQ; Yang, K; Bai, Y				Liu, Dan; Guo, Hong; Li, Yafei; Xu, Xueqing; Yang, Kang; Bai, Yun			Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; GASTRIC CARDIAC ADENOCARCINOMA; ETS BINDING-SITE; COLORECTAL-CANCER; BREAST-CANCER; FUNCTIONAL POLYMORPHISM; LUNG-CARCINOMA; GENE PROMOTER; MATRIX-METALLOPROTEINASE-1 PROMOTER	Background: A variety of studies have evaluated the associations between polymorphisms in the promoter regions of Matrix metalloproteinases (MMPs) and cancer metastasis. However, the results remain inconclusive. To better understand the roles of MMP polymorphisms in metastasis, we conducted a comprehensive meta-analysis. Methods: Electronic databases were searched (from January 2000 to June 2011) for any MMP genetic association studies in metastasis. Overall and subgroup analyses were performed. Odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the associations between MMP polymorphisms and metastasis. Statistical analysis was performed with Review Manager 5.0 and STATA11.0. Results: Thirty-three studies addressing five MMP polymorphisms were analyzed among 10,516 cancer cases (4,059 metastasis-positive cases and 6,457 metastasis-negative cases). For MMP1 (21607) 1G/2G, genotype 2G/2G increased the overall risk of metastasis under the recessive model (OR = 1.44, 95% CI = 1.05-1.98). In subgroup analysis based on cancer type, associations were found in head/neck and breast cancer under the recessive model, and also in breast cancer under the dominant model. For MMP3 (21171) 5A/6A, the polymorphism decreased the overall risk of metastasis under two genetic models (recessive: OR = 0.80, 95% CI = 0.64-0.99, dominant: OR = 0.72, 95% CI = 0.56-0.93). The polymorphisms of MMP7 (2181) A/G and MMP9 (21562) C/T increased metastatic risk. However, no association was observed between MMP2 (21306) C/T and metastasis. Conclusions: Our investigations demonstrate that polymorphisms in the promoter regions of MMP1, 3, 7 and 9 might be associated with metastasis in some cancers. Further studies with large sample size for MMP2 should be conducted.	[Liu, Dan; Guo, Hong; Xu, Xueqing; Bai, Yun] Third Mil Med Univ, Coll Basic Med Sci, Dept Med Genet, Chongqing, Peoples R China; [Li, Yafei] Third Mil Med Univ, Coll Prevent Med, Dept Epidemiol, Chongqing, Peoples R China; [Yang, Kang] Third Mil Med Univ, Southwest Hosp, Dept Thorac & Cardiac Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Liu, D (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Med Genet, Chongqing, Peoples R China.	kangyang@mail.tmmu.edu.cn; baiyungene@gmail.com	guo, hong/C-2985-2012		National Natural Science Foundation of China [30872549]; Natural Science Foundation of CQ CSTC [2009BA5013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by the National Natural Science Foundation of China (No. 30872549) and Natural Science Foundation Project of CQ CSTC (2009BA5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak S, 2007, UROL INT, V79, P312, DOI 10.1159/000109715; Awakura Y, 2006, CANCER LETT, V241, P59, DOI 10.1016/j.canlet.2005.10.005; Ben Nasr H, 2007, CLIN CHIM ACTA, V384, P57, DOI 10.1016/j.cca.2007.05.018; Cao ZG, 2006, ORAL ONCOL, V42, P32, DOI [10.1016/j.oraloncology.2004.08.015, 10.1016/j.ooe.2005.08.006]; Cotignola J, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-9; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang SM, 2005, CARCINOGENESIS, V26, P481, DOI 10.1093/carcin/bgh327; Fong YC, 2004, CLIN CANCER RES, V10, P7329, DOI 10.1158/1078-0432.CCR-04-0900; Ghilardi G, 2002, CLIN CANCER RES, V8, P3820; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Hashimoto T, 2004, CANCER LETT, V211, P19, DOI 10.1016/j.canlet.2004.01.032; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Jin X, 2005, WORLD J GASTROENTERO, V11, P2385, DOI 10.3748/wjg.v11.i16.2385; Jormsjo S, 2001, ARTERIOSCL THROM VAS, V21, P1834, DOI 10.1161/hq1101.098229; Kondo S, 2005, INT J CANCER, V115, P368, DOI 10.1002/ijc.20849; Kouhkan F, 2008, CANCER INVEST, V26, P836, DOI 10.1080/07357900801953204; Krippl P, 2004, CLIN CANCER RES, V10, P3518, DOI 10.1158/1078-0432.CCR-04-0010; Lai HC, 2005, GYNECOL ONCOL, V96, P314, DOI 10.1016/j.ygyno.2004.09.065; Lei HX, 2007, BREAST CANCER RES TR, V103, P61, DOI 10.1007/s10549-006-9345-2; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matsumura S, 2005, J CANCER RES CLIN, V131, P19, DOI 10.1007/s00432-004-0621-4; Matsumura S, 2004, J CANCER RES CLIN, V130, P259, DOI 10.1007/s00432-004-0543-1; McColgan P, 2009, INT J CANCER, V125, P1473, DOI 10.1002/ijc.24441; O-Charoenrat P, 2006, INT J CANCER, V118, P2548, DOI 10.1002/ijc.21644; O-charoenrat P, 2006, ORAL ONCOL, V42, P257, DOI 10.1016/j.oraloncology.2005.07.008; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Rutter JL, 1998, CANCER RES, V58, P5321; Shimizu Y, 2008, AURIS NASUS LARYNX, V35, P381, DOI 10.1016/j.anl.2007.12.002; Smolarz Beata, 2003, Pol J Pathol, V54, P233; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Tu HF, 2006, J ORAL PATHOL MED, V35, P99, DOI 10.1111/j.1600-0714.2006.00370.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang YM, 2005, LUNG CANCER, V49, P155, DOI 10.1016/j.lungcan.2005.04.006; Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2006.04424.x; Wu CY, 2007, EUR J CANCER, V43, P799, DOI 10.1016/j.ejca.2006.10.022; Wu SH, 2011, J HUAZHONG U SCI-MED, V31, P114, DOI 10.1007/s11596-011-0161-5; Xing LL, 2007, WORLD J GASTROENTERO, V13, P4626, DOI 10.3748/wjg.v13.i34.4626; Yoon SO, 2003, J BIOCHEM MOL BIOL, V36, P128; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788; Zhang JH, 2005, CARCINOGENESIS, V26, P1748, DOI 10.1093/carcin/bgi144; Zhang JH, 2004, CARCINOGENESIS, V25, P2519, DOI 10.1093/carcin/bgh269	48	98	105	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31251	10.1371/journal.pone.0031251	http://dx.doi.org/10.1371/journal.pone.0031251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348060	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400013
J	Rasigade, JP; Raulin, O; Picaud, JC; Tellini, C; Bes, M; Grando, J; Ben Said, M; Claris, O; Etienne, J; Tigaud, S; Laurent, F				Rasigade, Jean-Philippe; Raulin, Olivia; Picaud, Jean-Charles; Tellini, Charlotte; Bes, Michele; Grando, Jacqueline; Ben Said, Mohamed; Claris, Olivier; Etienne, Jerome; Tigaud, Sylvestre; Laurent, Frederic			Methicillin-Resistant Staphylococcus capitis with Reduced Vancomycin Susceptibility Causes Late-Onset Sepsis in Intensive Care Neonates	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; FIELD GEL-ELECTROPHORESIS; BIRTH-WEIGHT INFANTS; BLOOD CULTURES; RESEARCH NETWORK; UNITED-STATES; AUREUS; BACTEREMIA; IDENTIFICATION; EPIDERMIDIS	Background: Coagulase-negative staphylococci, mainly Staphylococcus epidermidis, are the most frequent cause of late-onset sepsis (LOS) in the neonatal intensive care unit (NICU) setting. However, recent reports indicate that methicillin-resistant, vancomycin-heteroresistant Staphylococcus capitis could emerge as a significant pathogen in the NICU. We investigated the prevalence, clonality and vancomycin susceptibility of S. capitis isolated from the blood of NICU infants and compared these data to adult patients. Methodology/Principal Findings: We conducted a retrospective laboratory-based survey of positive blood cultures in NICU infants >= 3 days of age (n = 527) and in adult ICU patients >= 18 years of age (n = 1473) who were hospitalized from 2004 to 2009 in two hospital centers in Lyon, France. S. capitis was the most frequent pathogen in NICU infants, ahead of S. epidermidis (39.1% vs. 23.5% of positive blood cultures, respectively). Conversely, S. capitis was rarely found in adult ICU patients (1.0%) compared to S. epidermidis (15.3%). S. capitis bloodstream isolates were more frequently resistant to methicillin when collected from NICU infants than from adult patients (95.6% vs. 53.3%, respectively). Furthermore, we collected and characterized 53 S. capitis bloodstream isolates from NICU infants and adult patients from six distant cities. All methicillin-resistant S. capitis isolates from NICU infants were clonally related as determined by pulsed-field gel electrophoresis. These isolates harbored a type V-related staphylococcal chromosomal cassette mec element, and constantly showed either vancomycin resistance (37.5%) or heteroresistance (62.5%). Conversely, the isolates that were collected outside of the NICU were genetically diverse and displayed much lower rates of vancomycin resistance and heteroresistance (7.7% and 23.1%, respectively). Conclusions/Significance: A clonal population of methicillin-resistant S. capitis strains has spread into several French NICUs. These isolates exhibit reduced susceptibility to vancomycin, which is the most widely used antimicrobial agent in the NICU setting.	[Rasigade, Jean-Philippe; Bes, Michele; Etienne, Jerome; Laurent, Frederic] Univ Lyon, Natl Reference Ctr Staphylococci, INSERM, U851, Lyon, France; [Rasigade, Jean-Philippe; Raulin, Olivia; Tellini, Charlotte; Tigaud, Sylvestre; Laurent, Frederic] Hosp Civils Lyon, No Hosp Grp, Dept Clin Microbiol, Lyon, France; [Picaud, Jean-Charles; Ben Said, Mohamed] Hosp Civils Lyon, No Hosp Grp, Dept Neonatol, Lyon, France; [Grando, Jacqueline] Hosp Civils Lyon, Edouard Herriot Hosp Ctr, Dept Hyg & Epidemiol, Lyon, France; [Claris, Olivier] Hosp Civils Lyon, Eastern Hosp Grp, Dept Neonatol, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon	Rasigade, JP (corresponding author), Univ Lyon, Natl Reference Ctr Staphylococci, INSERM, U851, Lyon, France.	jean-philippe.rasigade@chu-lyon.fr	Laurent, Frederic/M-4719-2014; Rasigade, Jean-Philippe/AAE-1667-2021; LAURENT, Frederic/AGM-0706-2022; Rasigade, Jean-Philippe/L-9320-2014; ETIENNE, Jerome/C-5471-2014	Rasigade, Jean-Philippe/0000-0002-8264-0452; ETIENNE, Jerome/0000-0002-3348-3315; laurent, frederic/0000-0003-0609-9091	French Ministry of Health	French Ministry of Health	This work was supported by the French Ministry of Health. The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Bradford R, 2006, EUR J CLIN MICROBIOL, V25, P283, DOI 10.1007/s10096-006-0130-2; Brodie SB, 2000, PEDIATR INFECT DIS J, V19, P56, DOI 10.1097/00006454-200001000-00012; Centre de Coordination de la Lutte contre les Infections Associees aux Soins, 2011, RAPP SURV 2010 RES N; Cone LA, 2005, INT J INFECT DIS, V9, P335, DOI 10.1016/j.ijid.2004.08.004; Courcol R, 2010, REFERENTIEL MICROBIO, P367; D'mello D, 2008, J CLIN MICROBIOL, V46, P3124, DOI 10.1128/JCM.00592-08; de Silva GDI, 2002, J CLIN MICROBIOL, V40, P382, DOI 10.1128/JCM.40.02.382-388.2002; de Silva GDI, 2001, CLIN INFECT DIS, V33, P1520, DOI 10.1086/323338; European Committee on Antimicrobial Susceptibility Testing, 2010, CLIN BREAKP; European_Committee_on_Antimicrobial_Susceptibility_Testing, 2010, RAT EUCAST CLIN BREA; FREEMAN J, 1990, AM J DIS CHILD, V144, P324, DOI 10.1001/archpedi.1990.02150270074029; FREEMAN J, 1990, NEW ENGL J MED, V323, P301, DOI 10.1056/NEJM199008023230504; French Society for Microbiology, 2009, REC COM ANT SOC FRAN; Gaynes RP, 1996, PEDIATRICS, V98, P357; GEORGE CG, 1994, INT J SYST BACTERIOL, V44, P404, DOI 10.1099/00207713-44-3-404; GOERING RV, 1993, INFECT CONT HOSP EP, V14, P595; GRAY JE, 1995, PEDIATRICS, V95, P225; Grisold AJ, 2010, J INFECTION, V60, P44, DOI 10.1016/j.jinf.2009.10.045; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Guen CGL, 2007, J PERINATOL, V27, P713, DOI 10.1038/sj.jp.7211798; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Herwaldt LA, 1996, CLIN INFECT DIS, V22, P14, DOI 10.1093/clinids/22.1.14; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; JohnsonRobbins LA, 1996, BIOL NEONATE, V69, P249; Kim SD, 2000, INFECT CONT HOSP EP, V21, P213, DOI 10.1086/501747; KIRCHHOFF LV, 1985, INFECT CONT HOSP EP, V6, P479, DOI 10.1017/S0195941700063591; Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x; Klingenberg C, 2004, J ANTIMICROB CHEMOTH, V54, P889, DOI 10.1093/jac/dkh453; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Martineau F, 2001, J CLIN MICROBIOL, V39, P2541, DOI 10.1128/JCM.39.7.2541-2547.2001; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Nadarajah R, 2010, AM J CLIN PATHOL, V133, P844, DOI 10.1309/AJCPMV1P0VKUAZRD; Nalmas S, 2008, HEART LUNG, V37, P380, DOI 10.1016/j.hrtlng.2007.09.005; Ng PC, 2006, PEDIATR INFECT DIS J, V25, P652, DOI 10.1097/01.inf.0000225785.32137.d3; Patel SJ, 2009, PEDIATR INFECT DIS J, V28, P1047, DOI 10.1097/INF.0b013e3181b12484; Reseau d'alerte d'investigation et de surveillance des infections nosocomiales (Raisin), 2009, ENQ NAT PREV INF NOS; Ruhe J, 2004, EUR J CLIN MICROBIOL, V23, P495, DOI 10.1007/s10096-004-1134-4; Satola SW, 2011, J CLIN MICROBIOL, V49, P177, DOI 10.1128/JCM.01128-10; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 1996, J PEDIATR-US, V129, P63, DOI 10.1016/S0022-3476(96)70191-9; Van Der Zwet WC, 2002, J CLIN MICROBIOL, V40, P2520, DOI 10.1128/JCM.40.7.2520-2525.2002; Vaudaux P, 2010, ANTIMICROB AGENTS CH, V54, P3861, DOI 10.1128/AAC.00269-10; Wang Shih-Min, 1999, Journal of Microbiology Immunology and Infection, V32, P26	44	69	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31548	10.1371/journal.pone.0031548	http://dx.doi.org/10.1371/journal.pone.0031548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348102	gold, Green Submitted, Green Published			2022-12-27	WOS:000302737400033
J	Egger, A; Samardzija, M; Sothilingam, V; Tanimoto, N; Lange, C; Salatino, S; Fang, L; Garcia-Garrido, M; Beck, S; Okoniewski, MJ; Neutzner, A; Seeliger, MW; Grimm, C; Handschin, C				Egger, Anna; Samardzija, Marijana; Sothilingam, Vithiyanjali; Tanimoto, Naoyuki; Lange, Christina; Salatino, Silvia; Fang, Lei; Garcia-Garrido, Marina; Beck, Susanne; Okoniewski, Michal J.; Neutzner, Albert; Seeliger, Mathias W.; Grimm, Christian; Handschin, Christoph			PGC-1 alpha Determines Light Damage Susceptibility of the Murine Retina	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENERGY-METABOLISM; PGC-1 COACTIVATORS; PHOTORECEPTORS; EXPRESSION; EXERCISE; PGC1-ALPHA; MECHANISMS; PIGMENTOSA; APOPTOSIS	The peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) proteins are key regulators of cellular bioenergetics and are accordingly expressed in tissues with a high energetic demand. For example, PGC-1 alpha and PGC-1 beta control organ function of brown adipose tissue, heart, brain, liver and skeletal muscle. Surprisingly, despite their prominent role in the control of mitochondrial biogenesis and oxidative metabolism, expression and function of the PGC-1 coactivators in the retina, an organ with one of the highest energy demands per tissue weight, are completely unknown. Moreover, the molecular mechanisms that coordinate energy production with repair processes in the damaged retina remain enigmatic. In the present study, we thus investigated the expression and function of the PGC-1 coactivators in the healthy and the damaged retina. We show that PGC-1 alpha and PGC-1 beta are found at high levels in different structures of the mouse retina, most prominently in the photoreceptors. Furthermore, PGC-1 alpha knockout mice suffer from a striking deterioration in retinal morphology and function upon detrimental light exposure. Gene expression studies revealed dysregulation of all major pathways involved in retinal damage and apoptosis, repair and renewal in the PGC-1 alpha knockouts. The light-induced increase in apoptosis in vivo in the absence of PGC-1 alpha was substantiated in vitro, where overexpression of PGC-1 alpha evoked strong anti-apoptotic effects. Finally, we found that retinal levels of PGC-1 expression are reduced in different mouse models for retinitis pigmentosa. We demonstrate that PGC-1 alpha is a central coordinator of energy production and, importantly, all of the major processes involved in retinal damage and subsequent repair. Together with the observed dysregulation of PGC-1 alpha and PGC-1 beta in retinitis pigmentosa mouse models, these findings thus imply that PGC-1 alpha might be an attractive target for therapeutic approaches aimed at retinal degeneration diseases.	[Egger, Anna; Salatino, Silvia; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland; [Samardzija, Marijana; Lange, Christina; Grimm, Christian] Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, Schlieren, Switzerland; [Sothilingam, Vithiyanjali; Tanimoto, Naoyuki; Beck, Susanne; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Div Expt Ophthalmol, Tubingen, Germany; [Neutzner, Albert] Univ Basel Hosp, Dept Med, Univ Eye Clin, CH-4031 Basel, Switzerland; [Okoniewski, Michal J.] Funct Genom Ctr UNI ETH Zurich, Zurich, Switzerland	University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel	Egger, A (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.	christoph.handschin@unibas.ch	Neutzner, Albert/ABC-4368-2020; Samardzija, Marijana/B-9245-2008; Handschin, Christoph/E-6886-2015	Samardzija, Marijana/0000-0003-0991-4653; Handschin, Christoph/0000-0003-0603-1097; Grimm, Christian/0000-0001-9318-4352; Neutzner, Albert/0000-0001-9254-5558; Salatino, Silvia/0000-0003-1286-3076	Swiss National Science Foundation; SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung"; Roche Research Foundation; United Mitochondrial Disease Foundation (UMDF); University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung"; Roche Research Foundation; United Mitochondrial Disease Foundation (UMDF); University of Basel	This project was funded by the Swiss National Science Foundation, the SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung", the Roche Research Foundation, the United Mitochondrial Disease Foundation (UMDF) and the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Ershov AV, 2000, J NEUROSCI RES, V60, P328, DOI 10.1002/(SICI)1097-4547(20000501)60:3<328::AID-JNR7>3.0.CO;2-5; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Handschin C, 2011, CELL METAB, V13, P351, DOI 10.1016/j.cmet.2011.03.008; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Herzlich Alexandra A, 2009, Open Biol J, V2, P141; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Kim HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P589, DOI 10.1093/abbs/gmr053; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nathans J, 1987, ANNU REV NEUROSCI, V10, P2897; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sahel J, 2010, DEV OPHTHALMOL, V47, P160, DOI 10.1159/000320079; Samardzija M, 2006, INVEST OPHTH VIS SCI, V47, P5181, DOI 10.1167/iovs.06-0556; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu L, 2010, NEUROSCIENCE, V169, P23, DOI 10.1016/j.neuroscience.2010.04.063; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638	41	35	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31272	10.1371/journal.pone.0031272	http://dx.doi.org/10.1371/journal.pone.0031272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348062	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900036
J	Giussani, DA; Camm, EJ; Niu, YG; Richter, HG; Blanco, CE; Gottschalk, R; Blake, EZ; Horder, KA; Thakor, AS; Hansell, JA; Kane, AD; Wooding, FBP; Cross, CM; Herrera, EA				Giussani, Dino A.; Camm, Emily J.; Niu, Youguo; Richter, Hans G.; Blanco, Carlos E.; Gottschalk, Rachel; Blake, E. Zachary; Horder, Katy A.; Thakor, Avnesh S.; Hansell, Jeremy A.; Kane, Andrew D.; Wooding, F. B. Peter; Cross, Christine M.; Herrera, Emilio A.			Developmental Programming of Cardiovascular Dysfunction by Prenatal Hypoxia and Oxidative Stress	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; INTIMA-MEDIA THICKNESS; FETAL HYPOXIA; NITRIC-OXIDE; HEART SUSCEPTIBILITY; REPERFUSION INJURY; VASCULAR FUNCTION; CONTROLLED-TRIAL; PREGNANT-WOMEN; HIGH-ALTITUDE	Fetal hypoxia is a common complication of pregnancy. It has been shown to programme cardiac and endothelial dysfunction in the offspring in adult life. However, the mechanisms via which this occurs remain elusive, precluding the identification of potential therapy. Using an integrative approach at the isolated organ, cellular and molecular levels, we tested the hypothesis that oxidative stress in the fetal heart and vasculature underlies the molecular basis via which prenatal hypoxia programmes cardiovascular dysfunction in later life. In a longitudinal study, the effects of maternal treatment of hypoxic (13% O-2) pregnancy with an antioxidant on the cardiovascular system of the offspring at the end of gestation and at adulthood were studied. On day 6 of pregnancy, rats (n = 20 per group) were exposed to normoxia or hypoxia 6 vitamin C. At gestational day 20, tissues were collected from 1 male fetus per litter per group (n = 10). The remaining 10 litters per group were allowed to deliver. At 4 months, tissues from 1 male adult offspring per litter per group were either perfusion fixed, frozen, or dissected for isolated organ preparations. In the fetus, hypoxic pregnancy promoted aortic thickening with enhanced nitrotyrosine staining and an increase in cardiac HSP70 expression. By adulthood, offspring of hypoxic pregnancy had markedly impaired NO-dependent relaxation in femoral resistance arteries, and increased myocardial contractility with sympathetic dominance. Maternal vitamin C prevented these effects in fetal and adult offspring of hypoxic pregnancy. The data offer insight to mechanism and thereby possible targets for intervention against developmental origins of cardiac and peripheral vascular dysfunction in offspring of risky pregnancy.	[Giussani, Dino A.; Camm, Emily J.; Niu, Youguo; Richter, Hans G.; Blanco, Carlos E.; Gottschalk, Rachel; Blake, E. Zachary; Horder, Katy A.; Thakor, Avnesh S.; Hansell, Jeremy A.; Kane, Andrew D.; Wooding, F. B. Peter; Cross, Christine M.; Herrera, Emilio A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Herrera, Emilio A.] Univ Chile, ICBM, Lab Func & Reactividad Vasc, Fac Med,Programa Fisiopatol, Santiago, Chile	University of Cambridge; Universidad de Chile	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	dag26@cam.ac.uk	Herrera, Emilio A/H-5992-2018; Kane, Andrew D/C-5876-2013; Richter, Hans/D-6273-2013	Herrera, Emilio A/0000-0002-6342-085X; Kane, Andrew D/0000-0001-9488-4086; Richter, Hans/0000-0002-7224-9388; Giussani, Dino/0000-0002-1308-1204	The British Heart Foundation; The Biotechnology and Biological Sciences Research Council; The Isaac Newton Trust; The Sir Jules Thorn Trust; The Lister Institute; The Wellcome Trust; The Physiological Society; British Heart Foundation [PG/10/99/28656] Funding Source: researchfish	The British Heart Foundation(British Heart Foundation); The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Isaac Newton Trust; The Sir Jules Thorn Trust; The Lister Institute; The Wellcome Trust(Wellcome TrustEuropean Commission); The Physiological Society; British Heart Foundation(British Heart Foundation)	The work was supported by The British Heart Foundation, The Biotechnology and Biological Sciences Research Council, The Isaac Newton Trust, The Sir Jules Thorn Trust, The Lister Institute, The Wellcome Trust and The Physiological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; Akira M, 2006, J PEDIATR-US, V148, P49, DOI 10.1016/j.jpeds.2005.06.044; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Barker DJP, 1998, MOTHERS BABIES DIS L; Basson M, 2008, NATURE, V451, P903, DOI 10.1038/451903a; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Cartwright JE, 2007, ADV EXP MED BIOL, V618, P113; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cosmi E, 2009, OBSTET GYNECOL, V114, P1109, DOI 10.1097/AOG.0b013e3181bb23d3; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Danson EJ, 2009, J MOL CELL CARDIOL, V46, P482, DOI 10.1016/j.yjmcc.2008.12.013; Fridovich I., 1978, FREE RADICALS BIOL, P239; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Giussani DA, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P178, DOI 10.1017/CBO9780511544699.013; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Halliwell B, 2004, FREE RADICALS BIOL M; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; Herrera EA, 2012, J VASC RES, V49, P50, DOI 10.1159/000330666; Herrera EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009250; IRIYAMA K, 1984, ANAL BIOCHEM, V141, P238, DOI 10.1016/0003-2697(84)90451-2; Jackson TS, 1998, CIRC RES, V83, P916; Kim YH, 2005, J KOREAN MED SCI, V20, P13, DOI 10.3346/jkms.2005.20.1.13; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1348, DOI 10.1152/ajpregu.1989.256.6.R1348; Koklu E, 2006, HORM RES, V65, P269, DOI 10.1159/000092536; Kontic-Vucinic O, 2008, J PERINAT MED, V36, P282, DOI 10.1515/JPM.2008.063; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; LUCAS A, 1991, CIBA F SYMP, V156, P38; Massey LK, 2005, J NUTR, V135, P1673, DOI 10.1093/jn/135.7.1673; Mayhew TM, 2003, PLACENTA, V24, P191, DOI 10.1053/plac.2002.0895; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Morton JS, 2011, J APPL PHYSIOL, V110, P1073, DOI 10.1152/japplphysiol.01174.2010; Pagano G, 2004, CARCINOGENESIS, V25, P1899, DOI 10.1093/carcin/bgh194; Patterson AJ, 2010, CURR MOL MED, V10, P653; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Richardson BS, 1998, COMP BIOCHEM PHYS A, V119, P717, DOI 10.1016/S1095-6433(98)01010-1; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; Rueda-Clausen CF, 2011, CARDIOVASC RES, V90, P285, DOI 10.1093/cvr/cvq363; Ruijtenbeek K, 2000, CIRCULATION, V102, P2892; RUMBOLD A, 2008, COCHRANE DB SYST REV, V1; Salinas CE, 2010, J DEV ORIG HLTH DIS, V1, P60, DOI 10.1017/S2040174409990043; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Thakor AS, 2010, J PHYSIOL-LONDON, V588, P4235, DOI 10.1113/jphysiol.2010.196402; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Williams SJ, 2005, J PHYSIOL-LONDON, V565, P125, DOI 10.1113/jphysiol.2005.084889; Witlin AG, 2002, BIOL REPROD, V67, P1025, DOI 10.1095/biolreprod.101.002196; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Zhang LB, 2005, J SOC GYNECOL INVEST, V12, P2, DOI 10.1016/j.jsgi.2004.09.004	61	196	198	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31017	10.1371/journal.pone.0031017	http://dx.doi.org/10.1371/journal.pone.0031017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348036	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900020
J	Tinkerhess, MJ; Healy, L; Morgan, M; Sujkowski, A; Matthys, E; Zheng, L; Wessells, RJ				Tinkerhess, Martin J.; Healy, Lindsey; Morgan, Matthew; Sujkowski, Alyson; Matthys, Erin; Zheng, Li; Wessells, Robert J.			The Drosophila PGC-1 alpha Homolog spargel Modulates the Physiological Effects of Endurance Exercise	PLOS ONE			English	Article							INDUCED MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; COACTIVATOR; EXPRESSION; LONGEVITY; INCREASE; PGC-1; ADAPTATIONS; MECHANISMS	Endurance exercise is an inexpensive intervention that is thought to provide substantial protection against several age-related pathologies, as well as inducing acute changes to endurance capacity and metabolism. Recently, it has been established that endurance exercise induces conserved alterations in physiological capacity in the invertebrate Drosophila model. If the genetic factors underlying these exercise-induced physiological alterations are widely conserved, then invertebrate genetic model systems will become a valuable tool for testing of genetic and pharmacological mimetics for endurance training. Here, we assess whether the Drosophila homolog of the vertebrate exercise response gene PGC-1 alpha spargel (srl) is necessary or sufficient to induce exercise-dependent phenotypes. We find that reduction of srl expression levels acutely compromises negative geotaxis ability and reduces exercise-induced improvement in both negative geotaxis and time to exhaustion. Conversely, muscle/heart specific srl overexpression improves negative geotaxis and cardiac performance in unexercised flies. In addition, we find that srl overexpression mimics some, but not all, exercise-induced phenotypes, suggesting that other factors also act in parallel to srl to regulate exercise-induced physiological changes in muscle and heart.	[Tinkerhess, Martin J.; Healy, Lindsey; Morgan, Matthew; Sujkowski, Alyson; Matthys, Erin; Zheng, Li; Wessells, Robert J.] Univ Michigan, Inst Gerontol, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Tinkerhess, MJ (corresponding author), Univ Michigan, Inst Gerontol, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	wessells@umich.edu	Wessells, Robert/AAG-3406-2020	Wessells, Robert/0000-0002-4516-3183; Sujkowski, Alyson/0000-0002-9909-9279	NIH [(R21) 5R21HL104262-02]; Nathan Shock Center of Excellence in the Basic Biology of Aging [NIA P30 A6013283-13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nathan Shock Center of Excellence in the Basic Biology of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH Exploratory/Developmental Research Grant Award (R21) 5R21HL104262-02; http://grants.nih.gov/grants/funding/r21.htm; Nathan Shock Center of Excellence in the Basic Biology of Aging Pilot Award NIA P30 A6013283-13; http://sitemaker.umich.edu/nsc/pilot_award_competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Davidson SR, 2006, MED SCI SPORT EXER, V38, P250, DOI 10.1249/01.mss.0000183179.86594.4f; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Holloszy JO, 1997, J APPL PHYSIOL, V82, P399, DOI 10.1152/jappl.1997.82.2.399; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	27	47	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31633	10.1371/journal.pone.0031633	http://dx.doi.org/10.1371/journal.pone.0031633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348115	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900058
J	Johnson-Huang, LM; Pensabene, CA; Shah, KR; Pierson, KC; Kikuchi, T; Lentini, T; Gilleaudeau, P; Sullivan-Whalen, M; Cueto, I; Khatcherian, A; Hyder, LA; Suarez-Farinas, M; Krueger, JG; Lowes, MA				Johnson-Huang, Leanne M.; Pensabene, Cara A.; Shah, Kejal R.; Pierson, Katherine C.; Kikuchi, Toyoko; Lentini, Tim; Gilleaudeau, Patricia; Sullivan-Whalen, Mary; Cueto, Inna; Khatcherian, Artemis; Hyder, Luke A.; Suarez-Farinas, Mayte; Krueger, James G.; Lowes, Michelle A.			Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSES; EFALIZUMAB; INNATE; TRAFFICKING; INCREASE; THERAPY	To understand the development of new psoriasis lesions, we studied a group of moderate-to-severe psoriasis patients who experienced a relapse after ceasing efalizumab (anti-CD11a, Raptiva, Genentech). There were increased CD3(+) T cells, neutrophils, CD11c(+) and CD83(+) myeloid dendritic cells (DCs), but no increase in CD1c(+) resident myeloid DCs. In relapsed lesions, there were many CD11c(+) CD1c(-), inflammatory myeloid DCs identified by TNFSF10/TRAIL, TNF, and iNOS. CD11c(+) cells in relapsed lesions co-expressed CD14 and CD16 in situ. Efalizumab induced an improvement in many psoriasis genes, and during relapse, the majority of these genes reversed back to a lesional state. Gene Set Enrichment Analysis (GSEA) of the transcriptome of relapsed tissue showed that many of the gene sets known to be present in psoriasis were also highly enriched in relapse. Hence, on ceasing efalizumab, T cells and myeloid cells rapidly enter the skin to cause classic psoriasis.	[Johnson-Huang, Leanne M.; Pensabene, Cara A.; Shah, Kejal R.; Pierson, Katherine C.; Kikuchi, Toyoko; Lentini, Tim; Gilleaudeau, Patricia; Sullivan-Whalen, Mary; Cueto, Inna; Khatcherian, Artemis; Hyder, Luke A.; Suarez-Farinas, Mayte; Krueger, James G.; Lowes, Michelle A.] Rockefeller Univ, Lab Investigat Dermatol, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Johnson-Huang, LM (corresponding author), Rockefeller Univ, Lab Investigat Dermatol, 1230 York Ave, New York, NY 10021 USA.	lowesm@rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012; Pillay, Nischalan/F-9536-2012; Lowes, Michelle A/G-9585-2016	Suarez-Farinas, Mayte/0000-0001-8712-3553; Lowes, Michelle A/0000-0003-4256-478X	Rockefeller University [UL1RR024143]; CTSA Medical Students; Milstein Program in Medical Research; Doris Duke Foundation; Dana Foundation; NIH [K23 AR052404]; Linda and Leonard Berkowitz;  [K23 AR052404-04S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR052404] Funding Source: NIH RePORTER	Rockefeller University; CTSA Medical Students; Milstein Program in Medical Research; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Dana Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Linda and Leonard Berkowitz; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research was supported by a Rockefeller University Clinical and Translational Science Award grant UL1RR024143; CAP was supported by the CTSA Medical Students program; KRS was supported by the Milstein Program in Medical Research, who also provided partial support to MS-F; LMJ-H and MAL were supported by the Doris Duke Foundation; KCP was supported by the Dana Foundation; TL was supported by K23 AR052404-04S1; MAL is also supported by NIH K23 AR052404; LMJ-H is also supported by the Linda and Leonard Berkowitz Postdoctoral Fellowship. JGK has served as a consultant for Genentech, who provided efalizumab for the clinical trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Capsoni F, 2008, INT J IMMUNOPATH PH, V21, P437, DOI 10.1177/039463200802100224; Carey W, 2006, J AM ACAD DERMATOL, V54, pS171, DOI 10.1016/j.jaad.2005.10.029; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Gordon KB, 2005, ARCH DERMATOL, V141, P82, DOI 10.1001/archderm.141.1.82; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Guttman-Yassky E, 2008, J INVEST DERMATOL, V128, P1182, DOI 10.1038/jid.2008.4; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Harper EG, 2009, J INVEST DERMATOL; Johnson-Huang LM, 2010, J INVEST DERMATOL; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kothary N, 2011, J AM ACAD DERMATOL; Krueger JG, 2008, J INVEST DERMATOL, V128, P2615, DOI 10.1038/jid.2008.98; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2005, BMC DERMATOL, V5, DOI 10.1186/1471-5945-5-9; Mee JB, 2006, CYTOKINE, V33, P72, DOI 10.1016/j.cyto.2005.12.001; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Pugashetti R, 2009, J DERMATOL TREAT, V20, P132, DOI 10.1080/09546630902984596; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Seminara NM, 2010, SEMIN CUTAN MED SURG, V29, P16, DOI 10.1016/j.sder.2010.01.001; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Suarez-Farinas M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-294; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Vugmeyster Y, 2004, CLIN IMMUNOL, V113, P38, DOI 10.1016/j.clim.2004.06.001; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	34	24	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30308	10.1371/journal.pone.0030308	http://dx.doi.org/10.1371/journal.pone.0030308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348003	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730900007
J	Talundzic, E; Shah, S; Fawole, O; Owino, S; Moore, JM; Peterson, DS				Talundzic, Eldin; Shah, Sheel; Fawole, Ope; Owino, Simon; Moore, Julie M.; Peterson, David S.			Sequence Polymorphism, Segmental Recombination and Toggling Amino Acid Residues within the DBL3X Domain of the VAR2CSA Placental Malaria Antigen	PLOS ONE			English	Article							CHONDROITIN-SULFATE-A; PREGNANCY-ASSOCIATED MALARIA; FALCIPARUM-INFECTED ERYTHROCYTES; UMBILICAL-CORD BLOOD; PLASMODIUM-FALCIPARUM; VAR GENE; DIVERSIFYING SELECTION; PROTEIN-SEQUENCE; WESTERN KENYA; BINDING SITE	Plasmodium falciparum malaria remains one of the world's foremost health problems, primarily in highly endemic regions such as Sub-Saharan Africa, where it is responsible for substantial morbidity, mortality and economic losses. Malaria is a significant cause of severe disease and death in pregnant women and newborns, with pathogenesis being associated with expression of a unique variant of the multidomain Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) called VAR2CSA. Here, we characterize the polymorphism of the DBL3X domain of VAR2CSA and identify regions under selective pressure among placental parasites from women living in endemic western Kenya. In addition to significant levels of polymorphism, our analysis reveals evidence for diversification through intra-segmental recombination and novel mutations that likely contributed to the high number of unique VAR2CSA sequence types identified in this study. Interestingly, we also identified a number of critical residues that may be implicated in immune evasion through switching (or toggling) to alternative amino acids, including an arginine residue within the predicted binding pocket in subdomain III, which was previously implicated in binding to placental CSA. Overall, these findings are important for understanding parasite diversity in pregnant women and will be useful for identifying epitopes and variants of DBL3X to be included in a vaccine against placental malaria.	[Talundzic, Eldin; Shah, Sheel; Fawole, Ope; Owino, Simon; Moore, Julie M.; Peterson, David S.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Moore, Julie M.; Peterson, David S.] Univ Georgia, Ctr Trop & Emerging Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Talundzic, E (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	dspete@uga.edu		Peterson, David/0000-0003-4394-6181	National Institutes of Health [R01 AI050240]; University of Georgia Department of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Department of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant R01 AI050240 to JMM, and University of Georgia Department of Infectious Diseases research funds to DSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Baum J, 2003, GENETICS, V163, P1327; Beck S, 2001, AM J TROP MED HYG, V65, P631, DOI 10.4269/ajtmh.2001.65.631; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brolin KJM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r117; Chamberlin A, 2011, BRIT J NUTR, V106, pS131, DOI 10.1017/S0007114511001826; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Drummond PB, 2005, MOL BIOCHEM PARASIT, V140, P241, DOI 10.1016/j.molbiopara.2005.01.003; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2007, INT J PARASITOL, V37, P273, DOI 10.1016/j.ijpara.2006.11.011; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hoffmann EHE, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-24; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Jiang HY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r33; Kassberger F, 2002, PARASITOL RES, V88, P1073, DOI 10.1007/s00436-002-0715-3; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Magliery TJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-240; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Mayengue PI, 2004, TROP MED INT HEALTH, V9, P949, DOI 10.1111/j.1365-3156.2004.01294.x; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McHenry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020192; Moore JM, 1997, J IMMUNOL METHODS, V209, P93, DOI 10.1016/S0022-1759(97)00162-2; Moore RM, 1997, AM J VET RES, V58, P1145; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Othoro C, 2006, CLIN VACCINE IMMUNOL, V13, P568, DOI 10.1128/CVI.13.5.568-574.2006; Perrault SD, 2009, AM J TROP MED HYG, V80, P119, DOI 10.4269/ajtmh.2009.80.119; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2011, J INFECT DIS, V203, P1679, DOI 10.1093/infdis/jir168; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Schleiermacher D, 2001, AM J TROP MED HYG, V64, P303, DOI 10.4269/ajtmh.2001.64.303; Schleiermacher D, 2002, INFECT GENET EVOL, V2, P97, DOI 10.1016/S1567-1348(02)00085-0; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Singh K, 2010, J BIOL CHEM, V285, P24855, DOI 10.1074/jbc.M110.118612; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Tamura K, 2011, MOL BIOL EVOL; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	66	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31565	10.1371/journal.pone.0031565	http://dx.doi.org/10.1371/journal.pone.0031565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347496	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200026
J	Bolton, KJ; McCaw, JM; Forbes, K; Nathan, P; Robins, G; Pattison, P; Nolan, T; McVernon, J				Bolton, Kirsty J.; McCaw, James M.; Forbes, Kristian; Nathan, Paula; Robins, Garry; Pattison, Philippa; Nolan, Terry; McVernon, Jodie			Influence of Contact Definitions in Assessment of the Relative Importance of Social Settings in Disease Transmission Risk	PLOS ONE			English	Article							MIXING PATTERNS; INFECTIOUS-DISEASES; SPREAD; NETWORKS; PARAMETERS; RELEVANT; CHILDREN; MODELS; AGENTS	Background: Realistic models of disease transmission incorporating complex population heterogeneities require input from quantitative population mixing studies. We use contact diaries to assess the relative importance of social settings in respiratory pathogen spread using three measures of person contact hours (PCH) as proxies for transmission risk with an aim to inform bipartite network models of respiratory pathogen transmission. Methods and Findings: Our survey examines the contact behaviour for a convenience sample of 65 adults, with each encounter classified as occurring in a work, retail, home, social, travel or "other" setting. The diary design allows for extraction of PCH-interaction (cumulative time in face-face conversational or touch interaction with contacts) -analogous to the contact measure used in several existing surveys - as well as PCH-setting (product of time spent in setting and number of people present) and PCH-reach (product of time spent in setting and number of people in close proximity). Heterogeneities in day-dependent distribution of risk across settings are analysed using partitioning and cluster analyses and compared between days and contact measures. Although home is typically the highest-risk setting when PCH measures isolate two-way interactions, its relative importance compared to social and work settings may reduce when adopting a more inclusive contact measure that considers the number and duration of potential exposure events. Conclusions: Heterogeneities in location-dependent contact behaviour as measured by contact diary studies depend on the adopted contact definition. We find that contact measures isolating face-face conversational or touch interactions suggest that contact in the home dominates, whereas more inclusive contact measures indicate that home and work settings may be of higher importance. In the absence of definitive knowledge of the contact required to facilitate transmission of various respiratory pathogens, it is important for surveys to consider alternative contact measures.	[Bolton, Kirsty J.; McCaw, James M.; Forbes, Kristian; Nathan, Paula; Nolan, Terry; McVernon, Jodie] Univ Melbourne, Melbourne Sch Populat Hlth, Vaccine & Immunisat Res Grp, Parkville, Vic 3052, Australia; [Robins, Garry; Pattison, Philippa] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia; [McCaw, James M.; Nolan, Terry; McVernon, Jodie] Murdoch Childrens Res Inst, Parkville, Vic, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute	Bolton, KJ (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Vaccine & Immunisat Res Grp, Parkville, Vic 3052, Australia.	kbolton@unimelb.edu.au	Nolan, Terry/A-2236-2008	Nolan, Terry/0000-0001-6018-3863; McCaw, James/0000-0002-2452-3098; Robins, Garry/0000-0001-7538-5804; Bolton, Kirsty/0000-0003-0487-4701; McVernon, Jodie/0000-0001-9774-1961; Pattison, Philippa/0000-0001-9626-2897	University of Melbourne [600530]; National Health and Medical Research Council [566635]	University of Melbourne(University of Melbourne); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The pilot contact diary study was funded by the Melbourne Research Grants Scheme of the University of Melbourne (600530). K. Bolton acknowledges support from a University of Melboure McKenzie Fellowship. J. McVernon is supported by a National Health and Medical Research Council Career Development Award (566635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Duerr HP, 2007, EPIDEMIOL INFECT, V135, P1124, DOI 10.1017/S0950268807007959; Eames KTD, 2009, EPIDEMICS-NETH, V1, P70, DOI 10.1016/j.epidem.2008.12.001; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gelbard R, 2007, DATA KNOWL ENG, V63, P155, DOI 10.1016/j.datak.2007.01.002; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Halloran ME, 2006, AM J EPIDEMIOL, V164, P945, DOI 10.1093/aje/kwj318; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Kretzschmar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005931; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	23	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30893	10.1371/journal.pone.0030893	http://dx.doi.org/10.1371/journal.pone.0030893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359553	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200022
J	Garavaglia, M; Rossi, E; Landini, P				Garavaglia, Marco; Rossi, Elio; Landini, Paolo			The Pyrimidine Nucleotide Biosynthetic Pathway Modulates Production of Biofilm Determinants in Escherichia coli	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; GENE-EXPRESSION; MULTICELLULAR BEHAVIOR; AGGREGATIVE BEHAVIOR; CELLULOSE PRODUCTION; RDAR MORPHOTYPE; PROTEIN; AGFD; COLONIZATION	Bacteria are often found in multicellular communities known as biofilms, which constitute a resistance form against environmental stresses. Extracellular adhesion and cell aggregation factors, responsible for bacterial biofilm formation and maintenance, are tightly regulated in response to physiological and environmental cues. We show that, in Escherichia coli, inactivation of genes belonging to the de novo uridine monophosphate (UMP) biosynthetic pathway impairs production of curli fibers and cellulose, important components of the bacterial biofilm matrix, by inhibiting transcription of the csgDEFG operon, thus preventing production of the biofilm master regulator CsgD protein. Supplementing growth media with exogenous uracil, which can be converted to UMP through the pyrimidine nucleotide salvage pathway, restores csgDEFG transcription and curli production. In addition, however, exogenous uracil triggers cellulose production, particularly in strains defective in either carB or pyrB genes, which encode enzymes catalyzing the first steps of de novo UMP biosynthesis. Our results indicate the existence of tight and complex links between pyrimidine metabolism and curli/cellulose production: transcription of the csgDEFG operon responds to pyrimidine nucleotide availability, while cellulose production is triggered by exogenous uracil in the absence of active de novo UMP biosynthesis. We speculate that perturbations in the UMP biosynthetic pathways allow the bacterial cell to sense signals such as starvation, nucleic acids degradation, and availability of exogenous pyrimidines, and to adapt the production of the extracellular matrix to the changing environmental conditions.	[Garavaglia, Marco; Rossi, Elio; Landini, Paolo] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy	University of Milan	Garavaglia, M (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	paolo.landini@unimi.it	Landini, Paolo/B-7859-2017; Rossi, Elio/N-4802-2015	Landini, Paolo/0000-0003-0999-426X; Rossi, Elio/0000-0002-2042-608X	Italian Ministry for University and Research [RBPR05NWWC_004, 2008K37RHP]	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by the CHEM-PROFARMA-NET (Project RBPR05NWWC_004) and PRIN (Project 2008K37RHP) Research Programs of the Italian Ministry for University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Antoniani D, 2010, APPL MICROBIOL BIOT, V85, P1095, DOI 10.1007/s00253-009-2199-x; Attila C, 2009, APPL MICROBIOL BIOT, V82, P525, DOI 10.1007/s00253-009-1860-8; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Durand JMB, 2009, MICROBIOL-SGM, V155, P2498, DOI 10.1099/mic.0.028191-0; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gerstel U, 2003, MOL MICROBIOL, V49, P639, DOI 10.1046/j.1365-2958.2003.03594.x; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Gualdi L, 2008, MICROBIOL-SGM, V154, P2017, DOI 10.1099/mic.0.2008/018093-0; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Haugo AJ, 2002, MOL MICROBIOL, V45, P471, DOI 10.1046/j.1365-2958.2002.03023.x; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Le Minh PN, 2010, NUCLEIC ACIDS RES, V38, P6286, DOI 10.1093/nar/gkq385; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; Miller JH, EXPT MOL GENETICS; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Perrin C, 2009, APPL ENVIRON MICROB, V75, P1723, DOI 10.1128/AEM.02171-08; Pratt LA, 1998, MOL MICROBIOL, V29, P1225, DOI 10.1046/j.1365-2958.1998.01007.x; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Robbe-Saule V, 2006, J BACTERIOL, V188, P3983, DOI 10.1128/JB.00033-06; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sitaras C, 2011, ANAL BIOCHEM, V408, P328, DOI 10.1016/j.ab.2010.09.038; Tagliabue L, 2010, MICROBIOL-SGM, V156, P2901, DOI 10.1099/mic.0.041350-0; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; ValentinHansen P, 1996, MOL MICROBIOL, V20, P461, DOI 10.1046/j.1365-2958.1996.5341056.x; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	52	57	58	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31252	10.1371/journal.pone.0031252	http://dx.doi.org/10.1371/journal.pone.0031252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359582	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200051
J	Luan, S; Katsikopoulos, KV; Reimer, T				Luan, Shenghua; Katsikopoulos, Konstantinos V.; Reimer, Torsten			When Does Diversity Trump Ability (and Vice Versa) in Group Decision Making? A Simulation Study	PLOS ONE			English	Article							SIMPLE HEURISTICS; ROBUST BEAUTY; ACCURACY; INFORMATION; PERFORMANCE; RATIONALITY; PREFERENCES; STRATEGIES; HUMANS; RULES	It is often unclear which factor plays a more critical role in determining a group's performance: the diversity among members of the group or their individual abilities. In this study, we addressed this "diversity vs. ability" issue in a decision-making task. We conducted three simulation studies in which we manipulated agents' individual ability (or accuracy, in the context of our investigation) and group diversity by varying (1) the heuristics agents used to search task-relevant information (i.e., cues); (2) the size of their groups; (3) how much they had learned about a good cue search order; and (4) the magnitude of errors in the information they searched. In each study, we found that a manipulation reducing agents' individual accuracy simultaneously increased their group's diversity, leading to a conflict between the two. These conflicts enabled us to identify certain conditions under which diversity trumps individual accuracy, and vice versa. Specifically, we found that individual accuracy is more important in task environments in which cues differ greatly in the quality of their information, and diversity matters more when such differences are relatively small. Changing the size of a group and the amount of learning by an agent had a limited impact on this general effect of task environment. Furthermore, we found that a group achieves its highest accuracy when there is an intermediate amount of errors in the cue information, regardless of the environment and the heuristic used, an effect that we believe has not been previously reported and warrants further investigation.	[Luan, Shenghua] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Katsikopoulos, Konstantinos V.] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Reimer, Torsten] Purdue Univ, Dept Commun, W Lafayette, IN 47907 USA	Max Planck Society; Max Planck Society; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Luan, S (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Lentzeallee 94, Berlin, Germany.	shluan@mpib-berlin.mpg.de	Katsikopoulos, Konstantinos/B-6356-2012	Katsikopoulos, Konstantinos/0000-0002-9572-1980; Reimer, Torsten/0000-0002-7419-0076	Max Planck Institute for Human Development	Max Planck Institute for Human Development	This work was supported by a Postdoctoral Fellowship awarded to SL from the Max Planck Institute for Human Development, http://www.mpib-berlin.mpg.de/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Canonge S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019748; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Dieckmann A, 2004, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P309; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; ETTENSON R, 1987, PSYCHOL REP, V60, P227, DOI 10.2466/pr0.1987.60.1.227; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Garcia-Retamero R, 2006, P 28 ANN C COGN SCI, P1352; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P416; Gigone D, 1997, PSYCHOL BULL, V121, P149, DOI 10.1037/0033-2909.121.1.149; Gould J.L., 1988, HONEY BEE; GROFMAN B, 1983, THEOR DECIS, V15, P261, DOI 10.1007/BF00125672; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Hoffrage U, 2000, J EXP PSYCHOL LEARN, V26, P566, DOI 10.1037/0278-7393.26.3.566; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; Kammer JE, 2012, ADAPTIVE STRAT UNPUB; Katsikopoulos KV, 2006, J MATH PSYCHOL, V50, P488, DOI 10.1016/j.jmp.2006.06.001; Katsikopoulos KV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015505; Katsikopoulos KV, 2010, PSYCHOL REV, V117, P1259, DOI 10.1037/a0020418; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; King AJ, 2011, BIOL LETTERS, V7, P237, DOI 10.1098/rsbl.2010.0808; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Krause S, 2011, ANIM BEHAV, V81, P941, DOI 10.1016/j.anbehav.2010.12.018; Larson JR, 2007, SMALL GR RES, V38, P413, DOI 10.1177/1046496407301972; LAUGHLIN PR, 1986, J EXP SOC PSYCHOL, V22, P177, DOI 10.1016/0022-1031(86)90022-3; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mathieu J, 2008, J MANAGE, V34, P410, DOI 10.1177/0149206308316061; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; Pirolli P, 1999, PSYCHOL REV, V106, P643, DOI 10.1037/0033-295X.106.4.643; Rakow T, 2004, THINK REASONING, V10, P1, DOI 10.1080/13546780342000016; Reimer T, 2006, THEOR DECIS, V60, P403, DOI 10.1007/s11238-005-4750-2; Sorkin RD, 2001, PSYCHOL REV, V108, P183, DOI 10.1037//0033-295X.108.1.183; Sumpter D. J. T., 2009, COLLECTIVE ANIMAL BE; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; van Knippenberg D, 2004, J APPL PSYCHOL, V89, P1008, DOI 10.1037/0021-9010.89.6.1008; Williams KY, 1998, RES ORGAN BEHAV, V20, P77; Wills AJ, 2009, J COMP PSYCHOL, V123, P391, DOI 10.1037/a0016216	41	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31043	10.1371/journal.pone.0031043	http://dx.doi.org/10.1371/journal.pone.0031043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359562	Green Submitted, gold, Green Published			2022-12-27	WOS:000302796200031
J	Ymele-Leki, P; Cao, SG; Sharp, J; Lambert, KG; McAdam, AJ; Husson, RN; Tamayo, G; Clardy, J; Watnick, PI				Ymele-Leki, Patrick; Cao, Shugeng; Sharp, Jared; Lambert, Kathleen G.; McAdam, Alexander J.; Husson, Robert N.; Tamayo, Giselle; Clardy, Jon; Watnick, Paula I.			A High-Throughput Screen Identifies a New Natural Product with Broad-Spectrum Antibacterial Activity	PLOS ONE			English	Article							VIBRIO-CHOLERAE; ANTIBIOTICS; INHIBITORS; QUINONES; SYSTEM; AGAR	Due to the inexorable invasion of our hospitals and communities by drug-resistant bacteria, there is a pressing need for novel antibacterial agents. Here we report the development of a sensitive and robust but low-tech and inexpensive high-throughput metabolic screen for novel antibiotics. This screen is based on a colorimetric assay of pH that identifies inhibitors of bacterial sugar fermentation. After validation of the method, we screened over 39,000 crude extracts derived from organisms that grow in the diverse ecosystems of Costa Rica and identified 49 with reproducible antibacterial effects. An extract from an endophytic fungus was further characterized, and this led to the discovery of three novel natural products. One of these, which we named mirandamycin, has broad-spectrum antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Vibrio cholerae, methicillin-resistant Staphylococcus aureus, and Mycobacterium tuberculosis. This demonstrates the power of simple high throughput screens for rapid identification of new antibacterial agents from environmental samples.	[Ymele-Leki, Patrick; Sharp, Jared; Husson, Robert N.; Watnick, Paula I.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Cao, Shugeng; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lambert, Kathleen G.; McAdam, Alexander J.] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Tamayo, Giselle] Univ Costa Rica, Inst Nacl Biodiversidad INBio, Unidad Estrateg Bioprospecc, San Jose, Costa Rica; [Tamayo, Giselle] Univ Costa Rica, Escuela Quim, San Jose, Costa Rica	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Universidad Costa Rica; Universidad Costa Rica	Ymele-Leki, P (corresponding author), Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.	paula.watnick@childrens.harvard.edu	Husson, Robert/Y-7288-2019; Tamayo, Giselle/J-3609-2015	Tamayo, Giselle/0000-0002-4912-8895	National Institutes of Health [U54 AI057159, NIHU01 TW007404, AI50032, AHA 09GRNT2280096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050032, N01AI050032, R56AI050032, R01AI037901, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by a National Institutes of Health U54 AI057159 to the Harvard NERCE facility, by NIHU01 TW007404 to JC and GT, and by AI50032 and AHA 09GRNT2280096 to PIW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Campbell J, 2010, CURR PROTOC CHEM BIO, V3; Cao SG, 2010, ORG LETT, V12, P4661, DOI 10.1021/ol101972g; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Fernandes P, 2006, NAT BIOTECHNOL, V24, P1497, DOI 10.1038/nbt1206-1497; Ferrand S, 2011, J BIOMOL SCREEN, V16, P637, DOI 10.1177/1087057111403927; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Houot L, 2008, J BACTERIOL, V190, P311, DOI 10.1128/JB.01410-07; Houot L, 2010, J BACTERIOL, V192, P3055, DOI 10.1128/JB.00213-10; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Liebeke M, 2008, MOL MICROBIOL, V69, P1513, DOI 10.1111/j.1365-2958.2008.06382.x; Mandal S, 2011, ASIAN PAC J TROP MED, V4, P573, DOI 10.1016/S1995-7645(11)60149-1; MCCORMACK WM, 1974, J INFECT DIS, V129, P497, DOI 10.1093/infdis/129.5.497; Mohamad S, 2011, J ETHNOPHARMACOL, V133, P1021, DOI 10.1016/j.jep.2010.11.037; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Parish CA, 2009, J NAT PROD, V72, P59, DOI 10.1021/np800528a; Pereira MP, 2009, ANTIMICROB AGENTS CH, V53, P2306, DOI 10.1128/AAC.01572-08; Pfeffer C, 2003, LETT APPL MICROBIOL, V36, P150, DOI 10.1046/j.1472-765X.2003.01280.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	26	32	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31307	10.1371/journal.pone.0031307	http://dx.doi.org/10.1371/journal.pone.0031307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359585	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200054
J	Cakir, B; Dagliyan, O; Dagyildiz, E; Baris, I; Kavakli, IH; Kizilel, S; Turkay, M				Cakir, Bilal; Dagliyan, Onur; Dagyildiz, Ezgi; Baris, Ibrahim; Kavakli, Ibrahim Halil; Kizilel, Seda; Turkay, Metin			Structure Based Discovery of Small Molecules to Regulate the Activity of Human Insulin Degrading Enzyme	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; BINDING FREE-ENERGY; SUBSTRATE RECOGNITION; IN-VIVO; DEGRADATION; INHIBITORS; NEPRILYSIN; DYNAMICS; DOCKING; DESIGN	Background: Insulin-degrading enzyme (IDE) is an allosteric Zn+2 metalloprotease involved in the degradation of many peptides including amyloid-beta, and insulin that play key roles in Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM), respectively. Therefore, the use of therapeutic agents that regulate the activity of IDE would be a viable approach towards generating pharmaceutical treatments for these diseases. Crystal structure of IDE revealed that N-terminal has an exosite which is similar to 30 angstrom away from the catalytic region and serves as a regulation site by orientation of the substrates of IDE to the catalytic site. It is possible to find small molecules that bind to the exosite of IDE and enhance its proteolytic activity towards different substrates. Methodology/Principal Findings: In this study, we applied structure based drug design method combined with experimental methods to discover four novel molecules that enhance the activity of human IDE. The novel compounds, designated as D3, D4, D6, and D10 enhanced IDE mediated proteolysis of substrate V, insulin and amyloid-b, while enhanced degradation profiles were obtained towards substrate V and insulin in the presence of D10 only. Conclusion/Significance: This paper describes the first examples of a computer-aided discovery of IDE regulators, showing that in vitro and in vivo activation of this important enzyme with small molecules is possible.	[Cakir, Bilal; Dagliyan, Onur; Dagyildiz, Ezgi; Baris, Ibrahim; Kavakli, Ibrahim Halil; Kizilel, Seda] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey; [Kavakli, Ibrahim Halil] Koc Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Turkay, Metin] Koc Univ, Dept Ind Engn, Istanbul, Turkey	Koc University; Koc University; Koc University	Cakir, B (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	hkavakli@ku.edu.tr; skizilel@ku.edu.tr; mturkay@ku.edu.tr	Turkay, Metin/F-9769-2011; Dagliyan, Onur/N-5683-2019; cakir, bilal/AAM-9147-2021; Kizilel, Seda/P-3959-2014; Kavakli, Ibrahim/AAF-5468-2020	Turkay, Metin/0000-0003-4769-6714; Dagliyan, Onur/0000-0003-1825-1011; cakir, bilal/0000-0003-4610-0317; Kizilel, Seda/0000-0001-9092-2698; Kavakli, Ibrahim/0000-0001-6624-3505; baris, ibrahim/0000-0003-2185-3259				[Anonymous], 2001, MOL CLONING LAB MANU; Armutlu P, 2009, LETT DRUG DES DISCOV, V6, P337, DOI 10.2174/1570180810906050337; Armutlu P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-411; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Dagliyan O, 2009, J CHEM INF MODEL, V49, P2403, DOI 10.1021/ci900247t; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GARCIA JV, 1989, J CELL BIOL, V109, P1301, DOI 10.1083/jcb.109.3.1301; HAMEL FG, 1991, DIABETES, V40, P436, DOI 10.2337/diabetes.40.4.436; Hentz NG, 1997, ANAL CHEM, V69, P4994, DOI 10.1021/ac970726m; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Kavakli IH, 2001, J BIOL CHEM, V276, P40834, DOI 10.1074/jbc.M106310200; Kruger DM, 2010, CHEMMEDCHEM, V5, P148, DOI 10.1002/cmdc.200900314; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; ROSE K, 1988, BIOCHEM J, V256, P847, DOI 10.1042/bj2560847; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Woodward PW, 2006, J BIOMOL SCREEN, V11, P5, DOI 10.1177/1087057105280779	37	26	29	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31787	10.1371/journal.pone.0031787	http://dx.doi.org/10.1371/journal.pone.0031787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355395	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300095
J	Engler, DA; Gupta, S; Growdon, WB; Drapkin, RI; Nitta, M; Sergent, PA; Allred, SF; Gross, J; Deavers, MT; Kuo, WL; Karlan, BY; Rueda, BR; Orsulic, S; Gershenson, DM; Birrer, MJ; Gray, JW; Mohapatra, G				Engler, David A.; Gupta, Sumeet; Growdon, Whitfield B.; Drapkin, Ronny I.; Nitta, Mai; Sergent, Petra A.; Allred, Serena F.; Gross, Jenny; Deavers, Michael T.; Kuo, Wen-Lin; Karlan, Beth Y.; Rueda, Bo R.; Orsulic, Sandra; Gershenson, David M.; Birrer, Michael J.; Gray, Joe W.; Mohapatra, Gayatry			Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; TUMOR-SUPPRESSOR; LOW-GRADE; EXPRESSION PROFILES; CYCLIN-E; C-MYC; ADVANCED-STAGE; HUMAN-BREAST; PHASE-III; IN-VIVO	Ovarian cancer is the fifth leading cause of cancer death in women. Ovarian cancers display a high degree of complex genetic alterations involving many oncogenes and tumor suppressor genes. Analysis of the association between genetic alterations and clinical endpoints such as survival will lead to improved patient management via genetic stratification of patients into clinically relevant subgroups. In this study, we aim to define subgroups of high-grade serous ovarian carcinomas that differ with respect to prognosis and overall survival. Genome-wide DNA copy number alterations (CNAs) were measured in 72 clinically annotated, high-grade serous tumors using high-resolution oligonucleotide arrays. Two clinically annotated, independent cohorts were used for validation. Unsupervised hierarchical clustering of copy number data derived from the 72 patient cohort resulted in two clusters with significant difference in progression free survival (PFS) and a marginal difference in overall survival (OS). GISTIC analysis of the two clusters identified altered regions unique to each cluster. Supervised clustering of two independent large cohorts of high-grade serous tumors using the classification scheme derived from the two initial clusters validated our results and identified 8 genomic regions that are distinctly different among the subgroups. These 8 regions map to 8p21.3, 8p23.2, 12p12.1, 17p11.2, 17p12, 19q12, 20q11.21 and 20q13.12; and harbor potential oncogenes and tumor suppressor genes that are likely to be involved in the pathogenesis of ovarian carcinoma. We have identified a set of genetic alterations that could be used for stratification of high-grade serous tumors into clinically relevant treatment subgroups.	[Engler, David A.; Allred, Serena F.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Nitta, Mai; Mohapatra, Gayatry] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gupta, Sumeet] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Growdon, Whitfield B.; Sergent, Petra A.; Rueda, Bo R.] Massachusetts Gen Hosp, Dept Vincent Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Drapkin, Ronny I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kuo, Wen-Lin; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Gross, Jenny; Karlan, Beth Y.; Orsulic, Sandra] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Deavers, Michael T.; Gershenson, David M.] Univ Texas MD Anderson Canc Ctr, Dept Pathol & Gynecol Oncol, Houston, TX 77030 USA; [Birrer, Michael J.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Brigham Young University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cedars Sinai Medical Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital	Engler, DA (corresponding author), Brigham Young Univ, Dept Stat, Provo, UT 84602 USA.	gmohapatra@partners.org	Gray, Joe/AAX-9549-2020; Drapkin, Ronny/E-9944-2016	Sergent, Petra/0000-0002-8244-8209; Drapkin, Ronny/0000-0002-6912-6977	Office of Science, Office of Biological & Environmental Research, of the U. S. Department of Energy [DE-AC02-05CH11231]; National Cancer Institute [P50 CA 83639, RC4 CA 156551]; Dana Farber/Harvard Cancer Center Ovarian SPORE [P50 CA105009]; Ovarian Cancer Research Fund; Michael Wall Gynecologic Oncology Research Fund; NATIONAL CANCER INSTITUTE [RC4CA156551, P50CA105009, P50CA083639, U10CA027469, U10CA037517] Funding Source: NIH RePORTER	Office of Science, Office of Biological & Environmental Research, of the U. S. Department of Energy(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Farber/Harvard Cancer Center Ovarian SPORE; Ovarian Cancer Research Fund; Michael Wall Gynecologic Oncology Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Director, Office of Science, Office of Biological & Environmental Research, of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231, the National Cancer Institute grant P50 CA 83639 (JWG), the National Cancer Institute grant RC4 CA 156551 (MJB), Dana Farber/Harvard Cancer Center Ovarian SPORE P50 CA105009 (SO and BRR), Ovarian Cancer Research Fund (SO and BRR), and by the Michael Wall Gynecologic Oncology Research Fund (GM). The GOG component was supported by the National Cancer Institute grants to the Gynecologic Oncology Group (GOG) Administrative Office (Philip DiSaia U10 CA027469), GOG Tissue Bank (Philip DiSaia U10CA027469 and U24 CA011479), and the GOG Statistical Data Center (John Blessing U10 CA037517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3; BAKER VV, 1990, GYNECOL ONCOL, V38, P340, DOI 10.1016/0090-8258(90)90069-W; BALVERTLOCHT HR, 1991, GYNECOL ONCOL, V42, P3, DOI 10.1016/0090-8258(91)90222-Q; Berchuck A, 2009, CLIN CANCER RES, V15, P2448, DOI 10.1158/1078-0432.CCR-08-2430; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Biagi JJ, 2003, INT J GYNECOL CANCER, V13, P231, DOI 10.1111/j.1525-1438.2003.13356.x; Bodmer W, 2003, GYNECOL ONCOL, V88, pS22, DOI 10.1006/gyno.2002.6678; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; Bruening W, 1999, CANCER RES, V59, P4973; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Caserta D, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-10; Cazillis M, 2004, ONCOGENE, V23, P4735, DOI 10.1038/sj.onc.1207619; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Dimitriadou E, 2006, E1071 MISC FUNCTIONS, pe1071; Dinh P, 2008, CRIT REV ONCOL HEMAT, V67, P103, DOI 10.1016/j.critrevonc.2008.01.012; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; du Bois A, 1999, ANN ONCOL, V10, P35, DOI 10.1023/A:1008355317514; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Farley J, 2003, CANCER RES, V63, P1235; Farley J, 2009, GYNECOL ONCOL, V113, P341, DOI 10.1016/j.ygyno.2009.02.009; Feller SM, 2006, CURR PHARM DESIGN, V12, P529, DOI 10.2174/138161206775474369; FIGO cancer committee, 1986, GYNECOL ONCOL, V25, P383; Gabeau-Lacet D, 2009, J NEUROPATH EXP NEUR, V68, P1155, DOI 10.1097/NEN.0b013e3181ba3952; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Gray JW, 2003, GYNECOL ONCOL, V88, pS16, DOI 10.1006/gyno.2002.6677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; IWABUCHI H, 1995, CANCER RES, V55, P6172; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang C, 2004, J BIOL CHEM, V279, P27781, DOI 10.1074/jbc.M401809200; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Kawamura K, 2004, CANCER RES, V64, P4800, DOI 10.1158/0008-5472.CAN-03-3908; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; KOHLER MF, 1993, J NATL CANCER I, V85, P1513, DOI 10.1093/jnci/85.18.1513; Korkola JE, 2008, GENE CHROMOSOME CANC, V47, P43, DOI 10.1002/gcc.20504; KRAG KJ, 1989, GYNECOL ONCOL, V34, P88, DOI 10.1016/0090-8258(89)90114-5; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Lin BY, 2009, PROTEOM CLIN APPL, V3, P853, DOI 10.1002/prca.200800141; Lin CQ, 2000, CANCER RES, V60, P1332; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mok SC, 1996, ONCOGENE, V12, P1895; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Nakayama N, 2010, CANCER-AM CANCER SOC, V116, P2621, DOI 10.1002/cncr.24987; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Neijt JP, 2000, J CLIN ONCOL, V18, P3084, DOI 10.1200/JCO.2000.18.17.3084; Niedner H, 2001, MOL PHARMACOL, V60, P1153, DOI 10.1124/mol.60.6.1153; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Peterson D, 2010, CANCER RES, V70, P6325, DOI 10.1158/0008-5472.CAN-10-0015; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Ramaswamy S, 2002, J CLIN ONCOL, V20, P1932, DOI 10.1200/JCO.2002.20.7.1932; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Sandercock J, 2002, BRIT J CANCER, V87, P815, DOI 10.1038/sj.bjc.6600567; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schindl M, 2003, CLIN CANCER RES, V9, P779; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Schuldiner O, 1996, P NATL ACAD SCI USA, V93, P7143, DOI 10.1073/pnas.93.14.7143; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sonoda G, 1997, GENE CHROMOSOME CANC, V20, P320; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Straehle C, 2009, CRIT CARE MED, V37, pS22, DOI 10.1097/CCM.0b013e3181921598; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; van de Wiel MA, 2007, CANCER INFORM, V3, P55; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yamada SD, 2002, CANCER RES, V62, P6717; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Yoshikawa R, 2006, WORLD J GASTROENTERO, V12, P5884, DOI 10.3748/wjg.v12.i36.5884; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhou W, 2007, ONCOL RES, V16, P405, DOI 10.3727/000000007783980873; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	106	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30996	10.1371/journal.pone.0030996	http://dx.doi.org/10.1371/journal.pone.0030996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355333	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300033
J	Janse, I; Bok, JM; Hamidjaja, RA; Hodemaekers, HM; van Rotterdam, BJ				Janse, Ingmar; Bok, Jasper M.; Hamidjaja, Raditijo A.; Hodemaekers, Hennie M.; van Rotterdam, Bart J.			Development and Comparison of Two Assay Formats for Parallel Detection of Four Biothreat Pathogens by Using Suspension Microarrays	PLOS ONE			English	Article							REAL-TIME PCR; THE-EXPONENTIAL (LATE)-PCR; BACILLUS-ANTHRACIS; YERSINIA-PESTIS; FRANCISELLA-TULARENSIS; ASYMMETRIC PCR; IDENTIFICATION; GENES; PANEL; SYSTEM	Microarrays provide a powerful analytical tool for the simultaneous detection of multiple pathogens. We developed diagnostic suspension microarrays for sensitive and specific detection of the biothreat pathogens Bacillus anthracis, Yersinia pestis, Francisella tularensis and Coxiella burnetii. Two assay chemistries for amplification and labeling were developed, one method using direct hybridization and the other using target-specific primer extension, combined with hybridization to universal arrays. Asymmetric PCR products for both assay chemistries were produced by using a multiplex asymmetric PCR amplifying 16 DNA signatures (16-plex). The performances of both assay chemistries were compared and their advantages and disadvantages are discussed. The developed microarrays detected multiple signature sequences and an internal control which made it possible to confidently identify the targeted pathogens and assess their virulence potential. The microarrays were highly specific and detected various strains of the targeted pathogens. Detection limits for the different pathogen signatures were similar or slightly higher compared to real-time PCR. Probit analysis showed that even a few genomic copies could be detected with 95% confidence. The microarrays detected DNA from different pathogens mixed in different ratios and from spiked or naturally contaminated samples. The assays that were developed have a potential for application in surveillance and diagnostics.	[Janse, Ingmar; Bok, Jasper M.; Hamidjaja, Raditijo A.; van Rotterdam, Bart J.] Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Hodemaekers, Hennie M.] Natl Inst Publ Hlth & Environm RIVM, Lab Toxicol Pathol & Genet, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Janse, I (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands.	Ingmar.Janse@rivm.nl		van Rotterdam, Bart/0000-0003-2837-9465; Hamidjaja, Raditijo/0000-0002-5655-2299	National Institute for Public Health and the Environment (RIVM)	National Institute for Public Health and the Environment (RIVM)	The work was funded by a strategic research grant (SOR) from the National Institute for Public Health and the Environment (RIVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boving MK, 2009, J CLIN MICROBIOL, V47, P908, DOI 10.1128/JCM.01966-08; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Cirino NM, 2004, EXPERT REV MOL DIAGN, V4, P841, DOI 10.1586/14737159.4.6.841; Coker PR, 2003, J CLIN MICROBIOL, V41, P1212, DOI 10.1128/JCM.41.3.1212-1218.2003; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Janse I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-314; Kuske CR, 2006, J FORENSIC SCI, V51, P548, DOI 10.1111/j.1556-4029.2006.00131.x; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Luna VA, 2006, J CLIN MICROBIOL, V44, P2367, DOI 10.1128/JCM.00154-06; Merante F, 2007, J CLIN VIROL, V40, pS31, DOI 10.1016/S1386-6532(07)70007-0; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Olschlager S, 2010, J CLIN MICROBIOL, V48, P2009, DOI 10.1128/JCM.02351-09; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Reddington K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023481; Regan JF, 2008, ANAL CHEM, V80, P7422, DOI 10.1021/ac801125x; Rutjes SA, 2005, APPL ENVIRON MICROB, V71, P3734, DOI 10.1128/AEM.71.7.3734-3740.2005; Sanchez JA, 2004, P NATL ACAD SCI USA, V101, P1933, DOI 10.1073/pnas.0305476101; Smieja M, 2001, J CLIN MICROBIOL, V39, P1796, DOI 10.1128/JCM.39.5.1796-1801.2001; Stewart A, 2008, J MED MICROBIOL, V57, P324, DOI 10.1099/jmm.0.47485-0; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tomaso H, 2007, MOL CELL PROBE, V21, P12, DOI 10.1016/j.mcp.2006.06.001; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06	28	20	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31958	10.1371/journal.pone.0031958	http://dx.doi.org/10.1371/journal.pone.0031958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355407	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300107
J	Lundgren, TK; Nakahata, K; Fritz, N; Rebellato, P; Zhang, SB; Uhlen, P				Lundgren, T. Kalle; Nakahata, Katsutoshi; Fritz, Nicolas; Rebellato, Paola; Zhang, Songbai; Uhlen, Per			RET PLC gamma Phosphotyrosine Binding Domain Regulates Ca2+ Signaling and Neocortical Neuronal Migration	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GDNF FAMILY; CELL-PROLIFERATION; CALCIUM; ACTIVATION; GFR-ALPHA-1; EXPRESSION; MUTATION; DIFFERENTIATION; DYSFUNCTION	The receptor tyrosine kinase RET plays an essential role during embryogenesis in regulating cell proliferation, differentiation, and migration. Upon glial cell line-derived neurotrophic factor (GDNF) stimulation, RET can trigger multiple intracellular signaling pathways that in concert activate various downstream effectors. Here we report that the RET receptor induces calcium (Ca2+) signaling and regulates neocortical neuronal progenitor migration through the Phospholipase-C gamma (PLC gamma) binding domain Tyr1015. This signaling cascade releases Ca2+ from the endoplasmic reticulum through the inositol 1,4,5-trisphosphate receptor and stimulates phosphorylation of ERK1/2 and CaMKII. A point mutation at Tyr1015 on RET or small interfering RNA gene silencing of PLC gamma block the GDNF-induced signaling cascade. Delivery of the RET mutation to neuronal progenitors in the embryonic ventricular zone using in utero electroporation reveal that Tyr1015 is necessary for GDNF-stimulated migration of neurons to the cortical plate. These findings demonstrate a novel RET mediated signaling pathway that elevates cytosolic Ca2+ and modulates neuronal migration in the developing neocortex through the PLC gamma binding domain Tyr1015.	[Lundgren, T. Kalle; Nakahata, Katsutoshi; Fritz, Nicolas; Rebellato, Paola; Zhang, Songbai; Uhlen, Per] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Lundgren, T. Kalle] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lundgren, TK (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	per.uhlen@ki.se	Fritz, Nicolas/P-1290-2019; Lundgren, Kalle/E-9056-2015; Fritz, Nicolas/N-1030-2013	Fritz, Nicolas/0000-0002-9722-7425; Lundgren, Kalle/0000-0001-6781-762X; Fritz, Nicolas/0000-0002-9722-7425; Uhlen, Per/0000-0003-1446-1062; Zhang, Songbai/0000-0002-2033-8389	Swedish Research Council [Dnr 2005-6682, 2007-5977, 2009-3364, 2010-4392]; Foundation for Strategic Research (CEDB); Knut and Alice Wallenberg Foundation (CLICK); Royal Swedish Academy of Sciences; Ake Wiberg's Foundation; Magnus Bergvall's Foundation; Fredrik and Ingrid Thuring's Foundation; Swedish Society for Medical Research; Uehara Memorial Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Strategic Research (CEDB); Knut and Alice Wallenberg Foundation (CLICK)(Knut & Alice Wallenberg Foundation); Royal Swedish Academy of Sciences; Ake Wiberg's Foundation; Magnus Bergvall's Foundation; Fredrik and Ingrid Thuring's Foundation; Swedish Society for Medical Research; Uehara Memorial Foundation(Uehara Memorial Foundation)	This study was supported by the Swedish Research Council (www.vr.se, Dnr 2005-6682, 2007-5977, 2009-3364, 2010-4392, DBRM), the Foundation for Strategic Research (CEDB), the Knut and Alice Wallenberg Foundation (CLICK and Research Fellow to PU), The Royal Swedish Academy of Sciences (PU), Ake Wiberg's Foundation (PU), Magnus Bergvall's Foundation (PU), Fredrik and Ingrid Thuring's Foundation (PU), the Swedish Society for Medical Research (PU and TKL), and the Uehara Memorial Foundation (KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Asai N, 1996, J BIOL CHEM, V271, P17644, DOI 10.1074/jbc.271.30.17644; Asai N, 2006, DEVELOPMENT, V133, P4507, DOI 10.1242/dev.02616; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Borodinsky Laura N, 2006, Sci STKE, V2006, ppe22, DOI 10.1126/stke.3362006pe22; Borrello MG, 1996, MOL CELL BIOL, V16, P2151; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; Daza RAM, 2007, COLD SPRING HARB PRO; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Jiao L, 2011, CELL RES, V21, P327, DOI 10.1038/cr.2010.139; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; Lundgren TK, 2008, J CELL BIOCHEM, V104, P879, DOI 10.1002/jcb.21671; Malmersjo S, 2010, STEM CELLS DEV, V19, P1355, DOI 10.1089/scd.2009.0436; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Mijatovic J, 2007, J NEUROSCI, V27, P4799, DOI 10.1523/JNEUROSCI.5647-06.2007; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Richardson DS, 2009, CANCER RES, V69, P4861, DOI 10.1158/0008-5472.CAN-08-4425; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Rusciano MR, 2010, ENDOCR-RELAT CANCER, V17, P113, DOI 10.1677/ERC-09-0214; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Santoro M, 2004, CELL MOL LIFE SCI, V61, P2954, DOI 10.1007/s00018-004-4276-8; Schmutzler BS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-22; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Uchida M, 2006, J CELL SCI, V119, P3067, DOI 10.1242/jcs.03043; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Yu T, 1998, J NEUROSCI, V18, P4684; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	51	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31258	10.1371/journal.pone.0031258	http://dx.doi.org/10.1371/journal.pone.0031258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355350	Green Submitted, gold, Green Published			2022-12-27	WOS:000302741300050
J	Zhang, X; You, XN; Wang, Q; Zhang, T; Du, YM; Lv, N; Zhang, Z; Zhang, S; Shan, CL; Ye, LH; Zhang, XD				Zhang, Xuan; You, Xiaona; Wang, Qi; Zhang, Tao; Du, Yumei; Lv, Na; Zhang, Zhao; Zhang, Shuai; Shan, Changliang; Ye, Lihong; Zhang, Xiaodong			Hepatitis B Virus X Protein Drives Multiple Cross-Talk Cascade Loops Involving NF-kappa B, 5-LOX, OPN and Capn4 to Promote Cell Migration	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLISM; CALPAIN SMALL-SUBUNIT; HBX PROTEIN; INCREASES MIGRATION; UP-REGULATION; OSTEOPONTIN; EXPRESSION; METASTASIS; ACTIVATION; OVEREXPRESSION	Hepatitis B virus X protein (HBx) plays an important role in the development of hepatocellular carcinoma (HCC). However, the mechanism remains unclear. Recently, we have reported that HBx promotes hepatoma cell migration through the upregulation of calpain small subunit 1 (Capn4). In addition, several reports have revealed that osteopontin (OPN) plays important roles in tumor cell migration. In this study, we investigated the signaling pathways involving the promotion of cell migration mediated by HBx. We report that HBx stimulates several factors in a network manner to promote hepatoma cell migration. We showed that HBx was able to upregulate the expression of osteopontin (OPN) through 5-lipoxygenase (5-LOX) in HepG2-X/H7402-X (stable HBx-transfected cells) cells. Furthermore, we identified that HBx could increase the expression of 5-LOX through nuclear factor-kappa B (NF-kappa B). We also found that OPN could upregulate Capn4 through NF-kappa B. Interestingly, we showed that Capn4 was able to upregulate OPN through NF-kappa B in a positive feedback manner, suggesting that the OPN and Capn4 proteins involving cell migration affect each other in a network through NF-kappa B. Importantly, NF-kappa B plays a crucial role in the regulation of 5-LOX, OPN and Capn4. Thus, we conclude that HBx drives multiple cross-talk cascade loops involving NF-kappa B, 5-LOX, OPN and Capn4 to promote cell migration. This finding provides new insight into the mechanism involving the promotion of cell migration by HBx.	[Zhang, Xuan; You, Xiaona; Wang, Qi; Zhang, Tao; Du, Yumei; Lv, Na; Zhang, Shuai; Shan, Changliang; Zhang, Xiaodong] Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China; [Zhang, Zhao; Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, X (corresponding author), Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Zhang, Tao/F-4366-2018	Zhang, Tao/0000-0002-4749-6774; You, Xiaona/0000-0001-9996-1466; Zhang, Shuai/0000-0003-0272-0856	National Basic Research Program of China (973 Program) [2007CB914804, 2007CB914802, 2009CB521702]; National Natural Science Foundation of China [81071624]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by National Basic Research Program of China (973 Program, No. 2007CB914804, No. 2007CB914802, No. 2009CB521702) and National Natural Science Foundation of China (No. 81071624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Covey TM, 2007, ONCOGENE, V26, P5784, DOI 10.1038/sj.onc.1210391; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dwarakanath RS, 2004, J MOL CELL CARDIOL, V36, P585, DOI 10.1016/j.yjmcc.2004.02.007; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; Jessen KA, 2004, BREAST CANCER RES, V6, pR157, DOI 10.1186/bcr768; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kreunin P, 2004, PROTEOMICS, V4, P2754, DOI 10.1002/pmic.200300767; Lara-Pezzi E, 2002, J CLIN INVEST, V110, P1831, DOI 10.1172/JCI200215887; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; Lara-Pezzi E, 2001, J HEPATOL, V34, P409, DOI 10.1016/S0168-8278(00)00090-8; Lee YM, 2010, VIRUS GENES, V40, P37, DOI 10.1007/s11262-009-0416-4; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Ou DP, 2007, INT J CANCER, V120, P1208, DOI 10.1002/ijc.22452; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shimada M, 2008, J BIOL CHEM, V283, P21002, DOI 10.1074/jbc.M710354200; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; You JC, 2009, ENDOCRINOLOGY, V150, P1607, DOI 10.1210/en.2008-0616; Zhang F, 2010, J MED VIROL, V82, P920, DOI 10.1002/jmv.21753; Zhang H, 2008, ACTA PHARMACOL SIN, V29, P473, DOI 10.1111/j.1745-7254.2008.00764.x; Zhang JL, 2005, ARCH VIROL, V150, P721, DOI 10.1007/s00705-004-0446-0; Zhang X, 2010, ACTA PHARMACOL SIN, V31, P593, DOI 10.1038/aps.2010.36; Zhou Y, 2010, J BIOL CHEM, V285, P12159, DOI 10.1074/jbc.M109.067629	46	17	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31458	10.1371/journal.pone.0031458	http://dx.doi.org/10.1371/journal.pone.0031458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355367	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300067
J	Fridlender, ZG; Sun, J; Mishalian, I; Singhal, S; Cheng, GJ; Kapoor, V; Horng, W; Fridlender, G; Bayuh, R; Worthen, GS; Albelda, SM				Fridlender, Zvi G.; Sun, Jing; Mishalian, Inbal; Singhal, Sunil; Cheng, Guanjun; Kapoor, Veena; Horng, Wenhwai; Fridlender, Gil; Bayuh, Rachel; Worthen, G. Scott; Albelda, Steven M.			Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils	PLOS ONE			English	Article							T-CELLS; CANCER; MODEL; PHENOTYPE; IDENTIFICATION; POLARIZATION; INFILTRATION; RECRUITMENT; MACROPHAGES; INHIBITION	The role of myeloid cells in supporting cancer growth is well established. Most work has focused on myeloid-derived suppressor cells (MDSC) that accumulate in tumor-bearing animals, but tumor-associated neutrophils (TAN) are also known to be capable of augmenting tumor growth. However, little is known about their evolution, phenotype, and relationship to naive neutrophils (NN) and to the granulocytic fraction of MDSC (G-MDSC). In the current study, a transcriptomics approach was used in mice to compare these cell types. Our data show that the three populations of neutrophils are significantly different in their mRNA profiles with NN and G-MDSC being more closely related to each other than to TAN. Structural genes and genes related to cell-cytotoxicity (i.e. respiratory burst) were significantly down-regulated in TAN. In contrast, many immune-related genes and pathways, including genes related to the antigen presenting complex (e. g. all six MHC-II complex genes), and cytokines (e.g. TNF-alpha, IL-1-alpha/beta), were up-regulated in G-MDSC, and further up-regulated in TAN. Thirteen of the 25 chemokines tested were markedly up-regulated in TAN compared to NN, including striking up-regulation of chemoattractants for T/B-cells, neutrophils and macrophages. This study characterizes different populations of neutrophils related to cancer, pointing out the major differences between TAN and the other neutrophil populations.	[Fridlender, Zvi G.; Mishalian, Inbal; Fridlender, Gil; Bayuh, Rachel] Hadassah Hebrew Univ Med Ctr, Inst Pulm Med, Jerusalem, Israel; [Fridlender, Zvi G.; Sun, Jing; Singhal, Sunil; Cheng, Guanjun; Kapoor, Veena; Albelda, Steven M.] Univ Penn, Thorac Oncol Res Lab, Philadelphia, PA 19104 USA; [Worthen, G. Scott] Univ Penn, Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Horng, Wenhwai] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; The Wistar Institute	Fridlender, ZG (corresponding author), Hadassah Hebrew Univ Med Ctr, Inst Pulm Med, Jerusalem, Israel.	fridlender@hadassah.org.il			National Cancer Institution [PO1 CA 66726]; Israel Cancer Association [20110103-B]; National Institute of Environmental Health Sciences (NIEHS), NIH [1 P30 ES013508-02]; NATIONAL CANCER INSTITUTE [P01CA066726] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Cancer Institution; Israel Cancer Association; National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Cancer Institution grant PO1 CA 66726 (S.M.A) and by an Israel Cancer Association grant 20110103-B (Z.G.F). This project was partially supported by grant number 1 P30 ES013508-02 from the National Institute of Environmental Health Sciences (NIEHS), NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; APPELBERG R, 1992, J LEUKOCYTE BIOL, V51, P472, DOI 10.1002/jlb.51.5.472; Ashtekar AR, 2003, TRENDS IMMUNOL, V24, P485, DOI 10.1016/S1471-4906(03)00235-7; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Bosotti R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S5; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Huang LT, 2007, PHYSIOL GENOMICS, V31, P114, DOI 10.1152/physiolgenomics.00053.2007; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kousis PC, 2007, CANCER RES, V67, P10501, DOI 10.1158/0008-5472.CAN-07-1778; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Morales JK, 2010, BREAST CANCER RES TR, V123, P39, DOI 10.1007/s10549-009-0622-8; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; OPDENAKKER G, 1992, IMMUNOL TODAY, V13, P463, DOI 10.1016/0167-5699(92)90079-M; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Piccard H., 2011, CRIT REV ONCOL HEMAT; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Raymond F, 2006, ANAL CHEM, V78, P6299, DOI 10.1021/ac060097t; Reiman JM, 2007, SEMIN CANCER BIOL, V17, P275, DOI 10.1016/j.semcancer.2007.06.009; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schmielau J, 2001, CANCER RES, V61, P4756; Shen L, 2007, CLIN EXP IMMUNOL, V149, P155, DOI 10.1111/j.1365-2249.2007.03376.x; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Tazawa H, 2003, AM J PATHOL, V163, P2221, DOI 10.1016/S0002-9440(10)63580-8; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Ueha S, 2011, INT IMMUNOPHARMACOL, V11, P783, DOI 10.1016/j.intimp.2011.03.003; van Gisbergen KPJM, 2005, TRENDS IMMUNOL, V26, P626, DOI 10.1016/j.it.2005.09.007; Wang LCS, 2009, NEOPLASIA, V11, P793, DOI 10.1593/neo.09506; White E. S., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P403, DOI 10.2174/1568011024606406; Wilderman MJ, 2005, CANCER RES, V65, P8379, DOI 10.1158/0008-5472.CAN-05-0920; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhelev DV, 2002, ANN BIOMED ENG, V30, P356, DOI 10.1114/1.1477446	53	226	242	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31524	10.1371/journal.pone.0031524	http://dx.doi.org/10.1371/journal.pone.0031524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348096	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400028
J	Kuerschner, L; Richter, D; Hannibal-Bach, HK; Gaebler, A; Shevchenko, A; Ejsing, CS; Thiele, C				Kuerschner, Lars; Richter, Doris; Hannibal-Bach, Hans Kristian; Gaebler, Anne; Shevchenko, Andrej; Ejsing, Christer S.; Thiele, Christoph			Exogenous Ether Lipids Predominantly Target Mitochondria	PLOS ONE			English	Article							HUMAN LEUKEMIC-CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHOLIPID EDELFOSINE; ANTITUMOR AGENTS; APOPTOSIS; ET-18-OCH3; MEMBRANE; ANALOGS; RAFTS; ACID	Ether lipids are ubiquitous constituents of cellular membranes with no discrete cell biological function assigned yet. Using fluorescent polyene-ether lipids we analyzed their intracellular distribution in living cells by microscopy. Mitochondria and the endoplasmic reticulum accumulated high amounts of ether-phosphatidylcholine and ether-phosphatidylethanolamine. Both lipids were specifically labeled using the corresponding lyso-ether lipids, which we established as supreme precursors for lipid tagging. Polyfosine, a fluorescent analogue of the anti-neoplastic ether lipid edelfosine, accumulated to mitochondria and induced morphological changes and cellular apoptosis. These data indicate that edelfosine could exert its pro-apoptotic power by targeting and damaging mitochondria and thereby inducing cellular apoptosis. In general, this study implies an important role of mitochondria in ether lipid metabolism and intracellular ether lipid trafficking.	[Kuerschner, Lars; Gaebler, Anne; Thiele, Christoph] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany; [Hannibal-Bach, Hans Kristian; Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Richter, Doris; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Bonn; University of Southern Denmark; Max Planck Society	Kuerschner, L (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany.	lars.kuerschner@uni-bonn.de	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276	Deutsche Forschungsgemeinschaft [SFB-TR 13, 83]; Danish Council for Independent Research [DOK1155860]; Lundbeckfonden [R45-A4342]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeckfonden(Lundbeckfonden)	This work was funded by the Deutsche Forschungsgemeinschaft (SFB-TR 13 and 83), the Danish Council for Independent Research (DOK1155860, CSE), and Lundbeckfonden (R45-A4342, CSE). Websites: http://www.dfg.de/en/index.jsp, http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research, http://www.lundbeckfonden.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausili A, 2008, J PHYS CHEM B, V112, P11643, DOI 10.1021/jp802165n; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Besson P, 1996, BIOCHEM PHARMACOL, V51, P1153, DOI 10.1016/0006-2952(96)00029-9; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Busto JV, 2007, BBA-BIOMEMBRANES, V1768, P1855, DOI 10.1016/j.bbamem.2007.04.025; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Cuvillier O, 1999, BLOOD, V94, P3583, DOI 10.1182/blood.V94.10.3583.422k31_3583_3592; Danker K, 2010, BRIT J PHARMACOL, V160, P36, DOI 10.1111/j.1476-5381.2009.00626.x; DIOMEDE L, 1993, INT J CANCER, V53, P124, DOI 10.1002/ijc.2910530123; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; HOFFMAN DR, 1992, BIOCHIM BIOPHYS ACTA, V1127, P74, DOI 10.1016/0005-2760(92)90203-8; HOULIHAN WJ, 1995, MED RES REV, V15, P157, DOI 10.1002/med.2610150302; Hsu FF, 2000, J MASS SPECTROM, V35, P596; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Massey JB, 1997, BIOPHYS J, V72, P1732, DOI 10.1016/S0006-3495(97)78819-2; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; MOLLINEDO F, 1993, BIOCHEM BIOPH RES CO, V192, P603, DOI 10.1006/bbrc.1993.1458; MUNDER PG, 1990, CHEM IMMUNOL, V49, P206; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; POST JA, 1988, FEBS LETT, V240, P78, DOI 10.1016/0014-5793(88)80343-0; Quesada E, 2004, J MED CHEM, V47, P5333, DOI 10.1021/jm049808a; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Tokumura A, 1997, CHEM PHYS LIPIDS, V86, P75, DOI 10.1016/S0009-3084(97)02664-9; Torrecillas A, 2006, INT J PHARMACEUT, V318, P28, DOI 10.1016/j.ijpharm.2006.03.008; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; VANBLITTERSWIJK WJ, 1987, LIPIDS, V22, P820, DOI 10.1007/BF02535537; Vink SR, 2007, CANCER TREAT REV, V33, P191, DOI 10.1016/j.ctrv.2006.12.001; VOGLER WR, 1985, EXP HEMATOL, V13, P629; WIEDER T, 1995, LIPIDS, V30, P389, DOI 10.1007/BF02536296; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zerp SF, 2008, ANTI-CANCER DRUG, V19, P65, DOI 10.1097/CAD.0b013e3282f16d36; ZOELLER RA, 1995, J LIPID RES, V36, P1866	49	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31342	10.1371/journal.pone.0031342	http://dx.doi.org/10.1371/journal.pone.0031342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348073	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400016
J	Todaro, MA; Dal Zotto, M; Jondelius, U; Hochberg, R; Hummon, WD; Kanneby, T; Rocha, CEF				Todaro, M. Antonio; Dal Zotto, Matteo; Jondelius, Ulf; Hochberg, Rick; Hummon, William D.; Kanneby, Tobias; Rocha, Carlos E. F.			Gastrotricha: A Marine Sister for a Freshwater Puzzle	PLOS ONE			English	Article							INTERRELATIONSHIPS; MACRODASYIDA; PHYLOGENY; GENERA	Background: Within an evolutionary framework of Gastrotricha Marinellina flagellata and Redudasys fornerise bear special interest, as they are the only Macrodasyida that inhabit freshwater ecosystems. Notwithstanding, these rare animals are poorly known; found only once (Austria and Brazil), they are currently systematised as incertae sedis. Here we report on the rediscovery of Redudasys fornerise, provide an account on morphological novelties and present a hypothesis on its phylogenetic relationship based on molecular data. Methodology/Principal Findings: Specimens were surveyed using DIC microscopy and SEM, and used to obtain the 18 S rRNA gene sequence; molecular data was analyzed cladistically in conjunction with data from 42 additional species belonging to the near complete Macrodasyida taxonomic spectrum. Morphological analysis, while providing new information on taxonomically relevant traits (adhesive tubes, protonephridia and sensorial bristles), failed to detect elements of the male system, thus stressing the parthenogenetic nature of the Brazilian species. Phylogenetic analysis, carried out with ML, MP and Bayesian approaches, yielded topologies with strong nodal support and highly congruent with each other. Among the supported groups is the previously undocumented clade showing the alliance between Redudasys fornerise and Dactylopodola agadasys; other strongly sustained clades include the densely sampled families Thaumastodermatidae and Turbanellidae and most genera. Conclusions/Significance: A reconsideration of the morphological traits of Dactylopodola agadasys in light of the new information on Redudasys fornerise makes the alliance between these two taxa very likely. As a result, we create Anandrodasys gen. nov. to contain members of the previously described D. agadasys and erect Redudasyidae fam. nov. to reflect this novel relationship between Anandrodasys and Redudasys. From an ecological perspective, the derived position of Redudasys, which is deeply nested within the Macrodasyida clade, unequivocally demonstrates that invasion of freshwater by gastrotrichs has taken place at least twice, in contrast with the single event hypothesis recently put forward.	[Todaro, M. Antonio; Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy; [Jondelius, Ulf; Kanneby, Tobias] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; [Hochberg, Rick] Univ Massachusetts Lowell, Dept Biol Sci, Lowell, MA USA; [Hummon, William D.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Rocha, Carlos E. F.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universita di Modena e Reggio Emilia; Swedish Museum of Natural History; University of Massachusetts System; University of Massachusetts Lowell; University System of Ohio; Ohio University; Universidade de Sao Paulo	Todaro, MA (corresponding author), Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy.	antonio.todaro@unimore.it	Jondelius, Ulf/AAF-7943-2020; Todaro, M. Antonio/H-1311-2013	Jondelius, Ulf/0000-0003-2847-2192; Todaro, M. Antonio/0000-0002-6353-7281; Dal Zotto, Matteo/0000-0003-1386-7626; Kanneby, Tobias/0000-0001-7151-5915	University of Sao Paulo [2007.1.466.41.5]; Italian MIUR; Swedish Taxonomy Initiative; US-National Science Foundation [n. DEB 0918499]	University of Sao Paulo; Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Swedish Taxonomy Initiative; US-National Science Foundation(National Science Foundation (NSF))	Collecting of Redudasys fornerise was done during a visit of MAT sponsored by University of Sao Paulo - Graduate Programs, grant no. 2007.1.466.41.5 (CEFR, PI). This study benefited from an Italian MIUR grants to MAT (PRIN-2007 "Approccio integrato all'identificazione dei Gastrotrichi marini"), and grants from the Swedish Taxonomy Initiative to UJ and the US-National Science Foundation (n. DEB 0918499) to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dal Zotto Matteo, 2010, Meiofauna Marina, V18, P41; Garraffoni ARS, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.60.495; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Hochberg Rick, 2003, Meiofauna Marina, V12, P37; Hochberg Rick, 2008, Meiofauna Marina, V16, P101; Hummon WD, 2010, GLOBAL DATABASE MARI; Hummon WD, 2010, ZOOTAXA, P1; Hummon WD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.94.794; Kanneby T, 2009, ZOOTAXA, P26, DOI 10.11646/zootaxa.2278.1.2; Kieneke A, 2008, ZOOL SCR, V37, P429, DOI 10.1111/j.1463-6409.2008.00334.x; KISIELEWSKI J, 1987, HYDROBIOLOGIA, V153, P23, DOI 10.1007/BF00005502; Nylander J.A.A, 2004, MRMODELTEST V2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petrov NB, 2007, MOL BIOL+, V41, P445, DOI 10.1134/S0026893307030107; Plazzi F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-209; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUTTNER-KOLISKO AGNES, 1955, OESTERREICH ZOOL ZEITSCHR, V6, P55; Sorensen MV, 2006, CLADISTICS, V22, P32, DOI 10.1111/j.1096-0031.2006.00085.x; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Todaro MA, 2006, ZOOL SCR, V35, P251, DOI 10.1111/j.1463-6409.2006.00228.x; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Todaro M. Antonio, 2008, Meiofauna Marina, V16, P3; Todaro MA, 2003, ZOOL ANZ, V242, P145, DOI 10.1078/0044-5231-00093	24	40	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31740	10.1371/journal.pone.0031740	http://dx.doi.org/10.1371/journal.pone.0031740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348127	Green Published, gold			2022-12-27	WOS:000302737400047
J	Edgar, JL; Paul, ES; Harris, L; Penturn, S; Nicol, CJ				Edgar, Joanne L.; Paul, Elizabeth S.; Harris, Lauren; Penturn, Sarah; Nicol, Christine J.			No Evidence for Emotional Empathy in Chickens Observing Familiar Adult Conspecifics	PLOS ONE			English	Article							STRESS; SYSTEM; PAIN	The capacity of animals to empathise is of high potential relevance to the welfare of group-housed domestic animals. Emotional empathy is a multifaceted and multilayered phenomenon which ranges from relatively simple processes such as emotional matching behaviour to more complex processes involving interaction between emotional and cognitive perspective taking systems. Our previous research has demonstrated that hens show clear behavioural and physiological responses to the mild distress of their chicks. To investigate whether this capacity exists outside the mother/offspring bond, we conducted a similar experiment in which domestic hens were exposed to the mild distress of unrelated, but familiar adult conspecifics. Each observer hen was exposed to two replicates of four conditions, in counterbalanced order; control (C); control with noise of air puff (CN); air puff to conspecific hen (APC); air puff to observer hen (APH). During each test, the observer hens' behaviour and physiology were measured throughout a 10 min pre-treatment and a 10 min treatment period. Despite showing signs of distress in response to an aversive stimulus directed at themselves (APH), and using methodology sufficiently sensitive to detect empathy-like responses previously, observer hens showed no behavioural or physiological responses to the mild distress of a familiar adult conspecific. The lack of behavioural and physiological response indicates that hens show no basis for emotional empathy in this context.	[Edgar, Joanne L.; Paul, Elizabeth S.; Harris, Lauren; Penturn, Sarah; Nicol, Christine J.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England	University of Bristol	Edgar, JL (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	j.edgar@bris.ac.uk	Nicol, Christine J/B-4841-2011	Nicol, Christine J/0000-0001-6734-2177; Edgar, Joanne/0000-0002-7729-1999	BBSRC Animal Welfare Initiative; Biotechnology and Biological Sciences Research Council [BB/C518949/1] Funding Source: researchfish	BBSRC Animal Welfare Initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC Animal Welfare Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; COLLIAS N, 1953, BEHAVIOUR, V5, P175, DOI 10.1163/156853953X00104; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Edgar JL, 2011, P ROY SOC B-BIOL SCI, V278, P3129, DOI 10.1098/rspb.2010.2701; Edgar JL, APPL ANIM B IN PRESS; Eisenberg N., 1986, ALTRUISTIC EMOTION C; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lowe JC, 2007, COMPUT ELECTRON AGR, V57, P74, DOI 10.1016/j.compag.2007.02.003; Lowe TE, 2005, ANIM WELFARE, V14, P35; Nicol CJ, 2009, ANIM BEHAV, V78, P413, DOI 10.1016/j.anbehav.2009.05.016; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2007, SOC NEUROSCI-UK, V2, P254, DOI 10.1080/17470910701376902; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011	16	22	24	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31542	10.1371/journal.pone.0031542	http://dx.doi.org/10.1371/journal.pone.0031542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348100	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900051
J	Yamagata, K; Iwamoto, D; Terashita, Y; Li, C; Wakayama, S; Hayashi-Takanaka, Y; Kimura, H; Saeki, K; Wakayama, T				Yamagata, Kazuo; Iwamoto, Daisaku; Terashita, Yukari; Li, Chong; Wakayama, Sayaka; Hayashi-Takanaka, Yoko; Kimura, Hiroshi; Saeki, Kazuhiro; Wakayama, Teruhiko			Fluorescence Cell Imaging and Manipulation Using Conventional Halogen Lamp Microscopy	PLOS ONE			English	Article							FULL-TERM DEVELOPMENT; MOUSE OOCYTES; MAMMALIAN OOCYTES; IN-VITRO; IMMUNOFLUORESCENCE; FERTILIZATION; ACTIVATION; SPINDLE; EMBRYOS; NUCLEI	Technologies for vitally labeling cells with fluorescent dyes have advanced remarkably. However, to excite fluorescent dyes currently requires powerful illumination, which can cause phototoxic damage to the cells and increases the cost of microscopy. We have developed a filter system to excite fluorescent dyes using a conventional transmission microscope equipped with a halogen lamp. This method allows us to observe previously invisible cell organelles, such as the metaphase spindle of oocytes, without causing phototoxicity. Cells remain healthy even after intensive manipulation under fluorescence observation, such as during bovine, porcine and mouse somatic cell cloning using nuclear transfer. This method does not require expensive epifluorescence equipment and so could help to reduce the science gap between developed and developing countries.	[Yamagata, Kazuo; Terashita, Yukari; Li, Chong; Wakayama, Sayaka; Wakayama, Teruhiko] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan; [Yamagata, Kazuo] Osaka Univ, Res Inst Microbial Res, Suita, Osaka, Japan; [Iwamoto, Daisaku; Saeki, Kazuhiro] Kinki Univ, Dept Genet Engn, Wakayama, Japan; [Terashita, Yukari] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan; [Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	RIKEN; Osaka University; Kindai University (Kinki University); Tohoku University; Osaka University	Yamagata, K (corresponding author), RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan.	teru@cdb.riken.jp	Hayashi, Yoko/GPT-4159-2022; Kimura, Hiroshi/B-9524-2015	Kimura, Hiroshi/0000-0003-0854-083X; HAYASHI, Yoko/0000-0002-0556-6738	Scientific Research in Priority Areas [15080211]; Grants-in-Aid for Scientific Research [23248048] Funding Source: KAKEN	Scientific Research in Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this research was provided by Scientific Research in Priority Areas (15080211) to T. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; HEIMER GV, 1972, J CLIN PATHOL, V25, P88, DOI 10.1136/jcp.25.1.88; Hoshino Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004142; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kishigami S, 2007, J REPROD DEVELOP, V53, P1207, DOI 10.1262/jrd.19067; LIDWELL OM, 1967, J CLIN PATHOL, V20, P214, DOI 10.1136/jcp.20.2.214; Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692; Ross PJ, 2006, BIOTECHNIQUES, V41, P741, DOI 10.2144/000112310; Silva CP, 1999, FERTIL STERIL, V71, P719, DOI 10.1016/S0015-0282(98)00530-5; Terasaki M., 1995, P327; Terashita Y, 2011, J REPROD DEVELOP, V57, P564, DOI 10.1262/jrd.11-015H; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Westhusin ME, 1996, THERIOGENOLOGY, V46, P243, DOI 10.1016/0093-691X(96)00181-1; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166	18	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31638	10.1371/journal.pone.0031638	http://dx.doi.org/10.1371/journal.pone.0031638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347500	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100080
J	Claes, IJJ; Schoofs, G; Regulski, K; Courtin, P; Chapot-Chartier, MP; Rolain, T; Hols, P; von Ossowski, I; Reunanen, J; de Vos, WM; Palva, A; Vanderleyden, J; De Keersmaecker, SCJ; Lebeer, S				Claes, Ingmar J. J.; Schoofs, Geert; Regulski, Krzysztof; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Rolain, Thomas; Hols, Pascal; von Ossowski, Ingemar; Reunanen, Justus; de Vos, Willem M.; Palva, Airi; Vanderleyden, Jos; De Keersmaecker, Sigrid C. J.; Lebeer, Sarah			Genetic and Biochemical Characterization of the Cell Wall Hydrolase Activity of the Major Secreted Protein of Lactobacillus rhamnosus GG	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; FUNCTIONAL-ANALYSIS; PEPTIDOGLYCAN; REVEALS; GROWTH; ENZYME; BL23	Lactobacillus rhamnosus GG (LGG) produces two major secreted proteins, designated here Msp1 (LGG_00324 or p75) and Msp2 (LGG_00031 or p40), which have been reported to promote the survival and growth of intestinal epithelial cells. Intriguingly, although each of these proteins shares homology with cell wall hydrolases, a physiological function that correlates with such an enzymatic activity remained to be substantiated in LGG. To investigate the bacterial function, we constructed knock-out mutants in the corresponding genes aiming to establish a genotype to phenotype relation. Microscopic examination of the msp1 mutant showed the presence of rather long and overly extended cell chains, which suggests that normal daughter cell separation is hampered. Subsequent observation of the LGG wild-type cells by immunofluorescence microscopy revealed that the Msp1 protein accumulates at the septum of exponential-phase cells. The cell wall hydrolyzing activity of the Msp1 protein was confirmed by zymogram analysis. Subsequent analysis by RP-HPLC and mass spectrometry of the digestion products of LGG peptidoglycan (PG) by Msp1 indicated that the Msp1 protein has D-glutamyl-L-lysyl endopeptidase activity. Immunofluorescence microscopy and the failure to construct a knock-out mutant suggest an indispensable role for Msp2 in priming septum formation in LGG.	[Claes, Ingmar J. J.; Schoofs, Geert; Vanderleyden, Jos; De Keersmaecker, Sigrid C. J.; Lebeer, Sarah] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Louvain, Belgium; [Regulski, Krzysztof; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, UMR1319 Micalis, F-78350 Jouy En Josas, France; [Regulski, Krzysztof; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Rolain, Thomas; Hols, Pascal] UCL, Inst Sci Vie, Louvain, Belgium; [von Ossowski, Ingemar; Reunanen, Justus; de Vos, Willem M.; Palva, Airi] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Lebeer, Sarah] Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium	KU Leuven; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain; University of Helsinki; Wageningen University & Research; University of Antwerp	Claes, IJJ (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Louvain, Belgium.	sarah.lebeer@biw.kuleuven.be	Lebeer, Sarah/S-9951-2019; Lebeer, Sarah/D-5156-2014; Claes, Ingmar/AAI-1910-2019; De Keersmaecker, Sigrid/ABB-5332-2021	Lebeer, Sarah/0000-0002-9400-6918; Lebeer, Sarah/0000-0002-9400-6918; Claes, Ingmar/0000-0003-4209-4116; De Keersmaecker, Sigrid/0000-0003-4198-4133; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; von Ossowski, Ingemar Eric/0000-0002-9899-671X	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Research Department of the Communaute francaise de Belgique; Le Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture; Institut nationale de la recherche agronomique (INRA); French National Institut for Agricultural Research; Marie Curie FP7 Initial Training Network Cross Talk [21553-2]; Academy of Finland [118165]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Department of the Communaute francaise de Belgique; Le Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture; Institut nationale de la recherche agronomique (INRA); French National Institut for Agricultural Research; Marie Curie FP7 Initial Training Network Cross Talk; Academy of Finland(Academy of Finland)	At the time of experiments, IJJC held a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) and SL was a postdoctoral researcher of the Fund for scientific research Vlaanderen, Belgium. Work of PH was supported by the Research Department of the Communaute francaise de Belgique (Concerted Research Action), and PH is Research Associate of the National fund for scientific research, Walloon, Belgium. TR held a doctoral fellowship from Le Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture. Work of MPCC was supported by Institut nationale de la recherche agronomique (INRA) or French National Institut for Agricultural Research. KR was the recipient of a fellowship from INRA and its PhD project received financial support from the Marie Curie FP7 Initial Training Network Cross Talk (grant agreement no21553-2). The work conducted in the group of AP is supported by the Academy of Finland (118165) and was part of the Center of Excellence in Microbial Food Safety Research at the University of Helsinki and the Academy of 377 Finland funded Research Program on Nutrition, Foods, and Health (ELVIRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; De Keersmaecker SCJ, 2006, APPL ENVIRON MICROB, V72, P4923, DOI 10.1128/AEM.02605-05; Goffin E, 2004, PERITON DIALYSIS INT, V24, P433; Harlow E., 1988, ANTIBODIES LAB MANUA; JOSSON K, 1989, PLASMID, V21, P9, DOI 10.1016/0147-619X(89)90082-6; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Lebeer S, 2011, MICROBIAL CELL FACTO; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lepeuple AS, 1998, APPL ENVIRON MICROB, V64, P4142; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Acosta MP, 2008, APPL ENVIRON MICROB, V74, P7824, DOI 10.1128/AEM.01712-08; Redko Y, 2007, APPL ENVIRON MICROB, V73, P5825, DOI 10.1128/AEM.00705-07; Sambrook J., 2002, MOL CLONING LAB MANU; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	22	56	60	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31588	10.1371/journal.pone.0031588	http://dx.doi.org/10.1371/journal.pone.0031588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359601	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200070
J	Garcia-Olmos, L; Salvador, CH; Alberquilla, A; Lora, D; Carmona, M; Garcia-Sagredo, P; Pascual, M; Munoz, A; Monteagudo, JL; Garcia-Lopez, F				Garcia-Olmos, Luis; Salvador, Carlos H.; Alberquilla, Angel; Lora, David; Carmona, Montserrat; Garcia-Sagredo, Pilar; Pascual, Mario; Munoz, Adolfo; Monteagudo, Jose Luis; Garcia-Lopez, Fernando			Comorbidity Patterns in Patients with Chronic Diseases in General Practice	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; MULTIPLE CHRONIC CONDITIONS; EXTERNAL VALIDITY; PRIMARY-CARE; FAMILY-PRACTICE; MULTIMORBIDITY; PREVALENCE; QUALITY; CONSEQUENCES; MORBIDITY	Introduction: Healthcare management is oriented toward single diseases, yet multimorbidity is nevertheless the rule and there is a tendency for certain diseases to occur in clusters. This study sought to identify comorbidity patterns in patients with chronic diseases, by reference to number of comorbidities, age and sex, in a population receiving medical care from 129 general practitioners in Spain, in 2007. Methods: A cross-sectional study was conducted in a health-area setting of the Madrid Autonomous Region (Comunidad Autonoma), covering a population of 198,670 individuals aged over 14 years. Multiple correspondences were analyzed to identify the clustering patterns of the conditions targeted. Results: Forty-two percent (95% confidence interval [CI]: 41.8-42.2) of the registered population had at least one chronic condition. In all, 24.5% (95% CI: 24.3-24.6) of the population presented with multimorbidity. In the correspondence analysis, 98.3% of the total information was accounted for by three dimensions. The following four, age- and sex-related comorbidity patterns were identified: pattern B, showing a high comorbidity rate; pattern C, showing a low comorbidity rate; and two patterns, A and D, showing intermediate comorbidity rates. Conclusions: Four comorbidity patterns could be identified which grouped diseases as follows: one showing diseases with a high comorbidity burden; one showing diseases with a low comorbidity burden; and two showing diseases with an intermediate comorbidity burden.	[Garcia-Olmos, Luis] Multiprofess Educ Unit Family & Community Care SW, Madrid, Spain; [Salvador, Carlos H.; Garcia-Sagredo, Pilar; Pascual, Mario; Munoz, Adolfo; Monteagudo, Jose Luis] Carlos III Inst Hlth, Telemed & E Hlth Unit, Madrid, Spain; [Alberquilla, Angel] Multiprofess Educ Unit Family & Community Care Ct, Madrid, Spain; [Lora, David] 12 Octubre Hosp Biomed Res Inst Imas12, Clin Epidemiol Unit, Octubre Univ Teaching Hosp 12, Madrid, Spain; [Carmona, Montserrat] Puerta Hierro Univ Teaching Hosp, Bioengn & Telemed Unit, Madrid, Spain; [Garcia-Lopez, Fernando] Puerta Hierro Univ Teaching Hosp, Clin Epidemiol Unit, Madrid, Spain	Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre	Garcia-Olmos, L (corresponding author), Multiprofess Educ Unit Family & Community Care SW, Madrid, Spain.	lgarcia.gapm02@salud.madrid.org	Carmona, Montserrat/F-7593-2010; Carrero, Adolfo Muñoz/M-7801-2016; Carmona, Montserrat/AAD-7263-2019; García López, Fernando/F-8504-2010; Pascual Carrasco, Mario/E-8566-2016	Carmona, Montserrat/0000-0002-4680-7745; Carrero, Adolfo Muñoz/0000-0002-0141-7751; Carmona, Montserrat/0000-0002-4680-7745; García López, Fernando/0000-0002-4802-2650; Pascual Carrasco, Mario/0000-0003-0893-2841	CENIT (MICINN-CDTI) [CEN-2007-1010]; Ministry of Health & Consumer Affairs [FIS PI08-0435]; MOBIS of the Spanish Vodafone Foundation; Madrid's Area 11 Primary Health Care Authority	CENIT (MICINN-CDTI); Ministry of Health & Consumer Affairs; MOBIS of the Spanish Vodafone Foundation; Madrid's Area 11 Primary Health Care Authority	This study was partially supported by the CENIT Program (MICINN-CDTI) [CEN-2007-1010 "Digital personal environment for health and wellbeing - AmiVital" project], a grant from the Ministry of Health & Consumer Affairs [FIS PI08-0435], and the MOBIS Program of the Spanish Vodafone Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Drs. Juan Jose Munoz (Managing Director) and Maria Teresa Alonso (Medical Director) of Madrid's Area 11 Primary Health Care Authority for the support received.	Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Beasley JW, 2004, ANN FAM MED, V2, P405, DOI 10.1370/afm.94; Black, 2005, CHRONIC CONDITIONS C; Bogner HR, 2008, ANN FAM MED, V6, P295, DOI 10.1370/afm.843; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Carmona M, 2011, FAM PRACT, V28, P128, DOI 10.1093/fampra/cmq084; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; De Maeseneer Jan M, 2003, Ann Fam Med, V1, P144, DOI 10.1370/afm.75; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2010, BMC HEALTH SERV RES, V10, P14; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fortin Martin, 2005, Can Fam Physician, V51, P244; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Greenacre MJ, 1984, THEORY APPL CORRES A, P137; Grumbach Kevin, 2003, Ann Fam Med, V1, P4, DOI 10.1370/afm.47; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; Loza E, 2009, SEMIN ARTHRITIS RHEU, V38, P312, DOI 10.1016/j.semarthrit.2008.01.004; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; O'Kelly S, 2011, RESP MED, V105, P236, DOI 10.1016/j.rmed.2010.07.019; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Steckler A, 2008, AM J PUBLIC HEALTH, V98, P9, DOI 10.2105/AJPH.2007.126847; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Weiner JP, 2005, J HOPKINS ACGH CASE, P163; Westert GP, 2001, EUR J PUBLIC HEALTH, V11, P365, DOI 10.1093/eurpub/11.4.365; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	39	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32141	10.1371/journal.pone.0032141	http://dx.doi.org/10.1371/journal.pone.0032141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359665	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200134
J	Koyama, H; Umeda, T; Nakamura, K; Higuchi, T; Kimura, A				Koyama, Hiroshi; Umeda, Tamiki; Nakamura, Kazuyuki; Higuchi, Tomoyuki; Kimura, Akatsuki			A High-Resolution Shape Fitting and Simulation Demonstrated Equatorial Cell Surface Softening during Cytokinesis and Its Promotive Role in Cytokinesis	PLOS ONE			English	Article							ANIMAL CYTOKINESIS; ADHERENT CELLS; MYOSIN-II; CONTRACTILE; MECHANISMS; DIVISION; CLEAVAGE; FORCES	Different models for animal cell cytokinesis posit that the stiffness of the equatorial cortex is either increased or decreased relative to the stiffness of the polar cortex. A recent work has suggested that the critical cytokinesis signaling complex centralspindlin may reduce the stiffness of the equatorial cortex by inactivating the small GTPase Rac. To determine if such a reduction occurs and if it depends on centralspindlin, we devised a method to estimate cortical bending stiffness with high spatio-temporal resolution from in vivo cell shapes. Using the early Caenorhabditis elegans embryo as a model, we show that the stiffness of the equatorial cell surface is reduced during cytokinesis, whereas the stiffness of the polar cell surface remains stiff. The equatorial reduction of stiffness was compromised in cells with a mutation in the gene encoding the ZEN-4/kinesin-6 subunit of centralspindlin. Theoretical modeling showed that the absence of the equatorial reduction of stiffness could explain the arrest of furrow ingression in the mutant. By contrast, the equatorial reduction of stiffness was sufficient to generate a cleavage furrow even without the constriction force of the contractile ring. In this regime, the contractile ring had a supportive contribution to furrow ingression. We conclude that stiffness is reduced around the equator in a centralspindlin-dependent manner. In addition, computational modeling suggests that proper regulation of stiffness could be sufficient for cleavage furrow ingression.	[Koyama, Hiroshi; Kimura, Akatsuki] Natl Inst Genet, Frontier Res Ctr, Cell Architecture Lab, Mishima, Shizuoka 411, Japan; [Koyama, Hiroshi; Higuchi, Tomoyuki; Kimura, Akatsuki] Res Org Informat & Syst, Transdisciplinary Res Intergrat Ctr, Tokyo, Japan; [Umeda, Tamiki] Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 657, Japan; [Nakamura, Kazuyuki] Meiji Univ, Kawasaki, Kanagawa, Japan; [Higuchi, Tomoyuki] Inst Stat Math, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); Kobe University; Meiji University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Koyama, H (corresponding author), Natl Inst Basic Biol, Div Embryol, Higashiyama 5-1, Okazaki, Aichi 444, Japan.	akkimura@lab.nig.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; DEULING HJ, 1976, BIOPHYS J, V16, P861, DOI 10.1016/S0006-3495(76)85736-0; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Hiramoto Y, 1990, ANN N Y ACAD SCI, V582, P22; Hotani H, 2003, BIOSYSTEMS, V71, P93, DOI 10.1016/S0303-2647(03)00113-8; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Miyoshi H, 2006, CELL MOTIL CYTOSKEL, V63, P208, DOI 10.1002/cm.20118; Noguchi H, 2005, P NATL ACAD SCI USA, V102, P14159, DOI 10.1073/pnas.0504243102; O'Connell CB, 2001, CURR BIOL, V11, P702, DOI 10.1016/S0960-9822(01)00181-6; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Reichl EM, 2005, TRENDS CELL BIOL, V15, P200, DOI 10.1016/j.tcb.2005.02.004; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Umeda T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011913; Uyeda TQP, 2000, CELL STRUCT FUNCT, V25, P1; Wang YL, 2001, CELL STRUCT FUNCT, V26, P633, DOI 10.1247/csf.26.633; WHITE JG, 1983, J THEOR BIOL, V101, P289, DOI 10.1016/0022-5193(83)90342-9; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102	28	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31607	10.1371/journal.pone.0031607	http://dx.doi.org/10.1371/journal.pone.0031607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359606	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200075
J	Mackenzie, NCW; Zhu, DX; Milne, EM; van 't Hof, R; Martin, A; Quarles, DL; Millan, JL; Farquharson, C; MacRae, VE				Mackenzie, Neil Charles Wallace; Zhu, Dongxing; Milne, Elspeth M.; van 't Hof, Rob; Martin, Aline; Quarles, Darryl Leigh; Millan, Jose Luis; Farquharson, Colin; MacRae, Vicky Elisabeth			Altered Bone Development and an Increase in FGF-23 Expression in Enpp1(-/-) Mice	PLOS ONE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; POSTERIOR LONGITUDINAL LIGAMENT; CELL MEMBRANE GLYCOPROTEIN-1; INORGANIC PYROPHOSPHATE; PATHOLOGICAL CALCIFICATION; VASCULAR CALCIFICATION; PATHOGENIC ROLE; MOUSE MODEL; CALCIUM; ANK	Nucleotide pyrophosphatase phosphodiesterase 1 (NPP1) is required for the conversion of extracellular ATP into inorganic pyrophosphate (PPi), a recognised inhibitor of hydroxyapatite (HA) crystal formation. A detailed phenotypic assessment of a mouse model lacking NPP1 (Enpp1(-/-)) was completed to determine the role of NPP1 in skeletal and soft tissue mineralization in juvenile and adult mice. Histopathological assessment of Enpp1(-/-) mice at 22 weeks of age revealed calcification in the aorta and kidney and ectopic cartilage formation in the joints and spine. Radiographic assessment of the hind-limb showed hyper-mineralization in the talocrural joint and hypo-mineralization in the femur and tibia. MicroCT analysis of the tibia and femur disclosed altered trabecular architecture and bone geometry at 6 and 22 weeks of age in Enpp1(-/-) mice. Trabecular number, trabecular bone volume, structure model index, trabecular and cortical thickness were all significantly reduced in tibiae and femurs from Enpp1(-/-) mice (P<0.05). Bone stiffness as determined by 3-point bending was significantly reduced in Enpp1(-/-) tibiae and femurs from 22-week-old mice (P<0.05). Circulating phosphate and calcium levels were reduced (P<0.05) in the Enpp1(-/-) null mice. Plasma levels of osteocalcin were significantly decreased at 6 weeks of age (P<0.05) in Enpp1(-/-) mice, with no differences noted at 22 weeks of age. Plasma levels of CTx (Ratlaps (TM)) and the phosphaturic hormone FGF-23 were significantly increased in the Enpp1(-/-) mice at 22 weeks of age (P<0.05). Fgf-23 messenger RNA expression in cavarial osteoblasts was increased 12-fold in Enpp1(-/-) mice compared to controls. These results indicate that Enpp1(-/-) mice are characterized by severe disruption to the architecture and mineralization of long-bones, dysregulation of calcium/phosphate homeostasis and changes in Fgf-23 expression. We conclude that NPP1 is essential for normal bone development and control of physiological bone mineralization.	[Mackenzie, Neil Charles Wallace; Zhu, Dongxing; Milne, Elspeth M.; Farquharson, Colin; MacRae, Vicky Elisabeth] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Mackenzie, Neil Charles Wallace; Zhu, Dongxing; Milne, Elspeth M.; Farquharson, Colin; MacRae, Vicky Elisabeth] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [van 't Hof, Rob] Univ Edinburgh, Rheumat Dis Unit, Mol Med Ctr, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA; [Martin, Aline; Quarles, Darryl Leigh] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; Sanford Burnham Prebys Medical Discovery Institute; University of Tennessee System; University of Tennessee Health Science Center	Mackenzie, NCW (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.	vicky.macrae@roslin.ed.ac.uk	farquharson, colin/C-2956-2011; Zhu, Dongxing/N-5059-2014; zhu, dongxing/AAM-4330-2020	farquharson, colin/0000-0002-4970-4039; zhu, dongxing/0000-0001-5419-438X; MacRae, Vicky/0000-0001-6306-7040; van 't Hof, Rob/0000-0002-8193-6788; Quarles, L. Darryl/0000-0002-5082-7896	Institute Strategic Programme Grant; Institute Career Path Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657, BB/F023928/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102, R01AR045955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER; BBSRC [BB/F023928/1, BBS/E/D/20221657] Funding Source: UKRI	Institute Strategic Programme Grant; Institute Career Path Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an Institute Strategic Programme Grant and Institute Career Path Fellowship funding from the Biotechnology and Biological Sciences Research Council (BBSRC; www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abate N, 2006, NAT CLIN PRACT ENDOC, V2, P694, DOI 10.1038/ncpendmet0367; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Anderson HC, 2005, AM J PATHOL, V166, P1711, DOI 10.1016/S0002-9440(10)62481-9; ANDERSON HC, 1990, AM J PATHOL, V136, P391; Baba H, 1997, EUR J HISTOCHEM, V41, P191; Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; CECIL RNA, 1978, METAB BONE DIS RELAT, V1, P89, DOI 10.1016/0221-8747(78)90043-7; CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chen IP, 2011, HUM MOL GENET, V20, P948, DOI 10.1093/hmg/ddq541; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Furusawa N, 1996, EUR J HISTOCHEM, V40, P199; HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hessle L, 2002, J BONE MINER RES, V17, pS128; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Huesa C, 2011, BONE, V48, P1066, DOI 10.1016/j.bone.2011.01.010; Johnson K, 2005, FRONT BIOSCI-LANDMRK, V10, P988, DOI 10.2741/1593; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Johnson K, 2001, J RHEUMATOL, V28, P2681; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; MAJESKA RJ, 1975, BIOCHIM BIOPHYS ACTA, V391, P51, DOI 10.1016/0005-2744(75)90151-5; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; MOSS DW, 1967, BIOCHEM J, V102, P53, DOI 10.1042/bj1020053; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nam HK, 2011, J BIOL CHEM, V286, P39059, DOI 10.1074/jbc.M111.221689; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Okawa A, 1999, CALCIFIED TISSUE INT, V64, P239, DOI 10.1007/s002239900610; Orriss IR, 2010, CURR OPIN PHARMACOL, V10, P322, DOI 10.1016/j.coph.2010.01.003; Owen HC, 2009, CALCIFIED TISSUE INT, V85, P326, DOI 10.1007/s00223-009-9276-0; Petersen CB, 2007, DEV COMP IMMUNOL, V31, P618, DOI 10.1016/j.dci.2006.08.012; Prosdocimo DA, 2009, AM J PHYSIOL-CELL PH, V296, pC828, DOI 10.1152/ajpcell.00619.2008; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; SAKAMOTO M, 1994, PATHOL INT, V44, P420, DOI 10.1111/j.1440-1827.1994.tb01705.x; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Sekrecka-Belniak A, 2010, BIOCHEM BIOPH RES CO, V391, P1432, DOI 10.1016/j.bbrc.2009.12.083; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624	61	105	106	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32177	10.1371/journal.pone.0032177	http://dx.doi.org/10.1371/journal.pone.0032177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359666	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200135
J	Shin, YJ; Sayed, AH; Shen, XL				Shin, Yong-Jun; Sayed, Ali H.; Shen, Xiling			Adaptive Models for Gene Networks	PLOS ONE			English	Article							FEEDBACK LOOP; P53; EXPRESSION; IDENTIFICATION; STRATEGIES; CIRCUIT; SYSTEMS	Biological systems are often treated as time-invariant by computational models that use fixed parameter values. In this study, we demonstrate that the behavior of the p53-MDM2 gene network in individual cells can be tracked using adaptive filtering algorithms and the resulting time-variant models can approximate experimental measurements more accurately than time-invariant models. Adaptive models with time-variant parameters can help reduce modeling complexity and can more realistically represent biological systems.	[Shin, Yong-Jun; Shen, Xiling] Cornell Univ, Ithaca, NY 14853 USA; [Sayed, Ali H.] Univ Calif Los Angeles, Los Angeles, CA USA	Cornell University; University of California System; University of California Los Angeles	Shin, YJ (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	xs66@cornell.edu	Sayed, Ali H/D-6251-2012	Sayed, Ali H/0000-0002-5125-5519	Cornell Stem Cell Program; National Institutes of Health [R01GM95990]; National Science Foundation [CCF-1011918, CCF-0942936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095990] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0942936, 1011918] Funding Source: National Science Foundation	Cornell Stem Cell Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by Cornell Stem Cell Program, National Institutes of Health grant R01GM95990 and National Science Foundation grants CCF-1011918 and CCF-0942936. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Cattivelli FS, 2010, IEEE T AUTOMAT CONTR, V55, P2069, DOI 10.1109/TAC.2010.2042987; Cattivelli FS, 2010, IEEE T SIGNAL PROCES, V58, P1035, DOI 10.1109/TSP.2009.2033729; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Gennemark P, 2007, IET SYST BIOL, V1, P120, DOI 10.1049/iet-syb:20050098; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Landau R.H., 2007, COMPUTATIONAL PHYS P; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Ljung L., 1999, SYSTEM IDENTIFICATIO; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; REGALIA PA, 1995, ADAPTIVE IIR FILTERI; Sayed A. H., 2008, ADAPTIVE FILTERS, DOI 10.1002/9780470374122; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	22	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31657	10.1371/journal.pone.0031657	http://dx.doi.org/10.1371/journal.pone.0031657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359614	Green Submitted, gold, Green Published			2022-12-27	WOS:000302796200083
J	Constant, A; Messiah, A; Felonneau, ML; Lagarde, E				Constant, Aymery; Messiah, Antoine; Felonneau, Marie-Line; Lagarde, Emmanuel			Investigating Helmet Promotion for Cyclists: Results from a Randomised Study with Observation of Behaviour, Using a Semi-Automatic Video System	PLOS ONE			English	Article							LONGITUDINAL DATA; BICYCLISTS; INJURIES; CHILDREN; MODELS	Introduction: Half of fatal injuries among bicyclists are head injuries. While helmet use is likely to provide protection, their use often remains rare. We assessed the influence of strategies for promotion of helmet use with direct observation of behaviour by a semi-automatic video system. Methods: We performed a single-centre randomised controlled study, with 4 balanced randomisation groups. Participants were non-helmet users, aged 18-75 years, recruited at a loan facility in the city of Bordeaux, France. After completing a questionnaire investigating their attitudes towards road safety and helmet use, participants were randomly assigned to three groups with the provision of "helmet only", "helmet and information" or "information only", and to a fourth control group. Bikes were labelled with a colour code designed to enable observation of helmet use by participants while cycling, using a 7-spot semi-automatic video system located in the city. A total of 1557 participants were included in the study. Results: Between October 15th 2009 and September 28th 2010, 2621 cyclists' movements, made by 587 participants, were captured by the video system. Participants seen at least once with a helmet amounted to 6.6% of all observed participants, with higher rates in the two groups that received a helmet at baseline. The likelihood of observed helmet use was significantly increased among participants of the "helmet only" group (OR = 7.73 [2.09-28.5]) and this impact faded within six months following the intervention. No effect of information delivery was found. Conclusion: Providing a helmet may be of value, but will not be sufficient to achieve high rates of helmet wearing among adult cyclists. Integrated and repeated prevention programmes will be needed, including free provision of helmets, but also information on the protective effect of helmets and strategies to increase peer and parental pressure.	[Constant, Aymery; Messiah, Antoine; Lagarde, Emmanuel] ISPED, INSERM U897 IFR99, Equipe Avenir Prevent & Prise Charge Traumatismes, Bordeaux, France; [Felonneau, Marie-Line] Univ Bordeaux 2, Social Psychol Dept, F-33076 Bordeaux, France; [Constant, Aymery] EHESP Sch Publ Hlth, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Constant, A (corresponding author), ISPED, INSERM U897 IFR99, Equipe Avenir Prevent & Prise Charge Traumatismes, Bordeaux, France.	aymery.constant@ehesp.fr	constant, aymery/ABD-9537-2021; Messiah, Antoine/GLT-9598-2022; Messiah, Antoine/M-1984-2018; Lagarde, Emmanuel/F-7132-2013	constant, aymery/0000-0001-9282-3036; Messiah, Antoine/0000-0003-4457-7381; Messiah, Antoine/0000-0003-4457-7381; Lagarde, Emmanuel/0000-0001-8031-7400	French Research Agency [ANR-07-TSFA-006-01]; French Institute for Prevention and Health Education (INPES) [140-07-DAS]; Region Aquitaine; AXA	French Research Agency(French National Research Agency (ANR)); French Institute for Prevention and Health Education (INPES); Region Aquitaine(Region Nouvelle-Aquitaine); AXA	The project was funded by the French Research Agency (grant ANR-07-TSFA-006-01), the French Institute for Prevention and Health Education (INPES; grant 140-07-DAS), and the Region Aquitaine. The project was also supported by a post-doctoral fellowship from the AXA research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2001, Inj Prev, V7, P89, DOI 10.1136/ip.7.2.89; Adams J, 2001, INJURY PREV, P90; Ajzen I, 1985, ACTION CONTROL, P11; Ajzen I., 1988, ATTITUDES PERSONALIT; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Caplow MP, 1995, AM J PREV MED, V11, P371, DOI 10.1016/S0749-3797(18)30415-X; Carnall D, 1999, BRIT MED J, V318, P1505, DOI 10.1136/bmj.318.7197.1505a; CHOUINARD E, 1995, J CLIN EPIDEMIOL, V48, P245, DOI 10.1016/0895-4356(94)00132-A; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; CUMMINGS KM, 1978, HEALTH EDUC QUART, V6, P394, DOI 10.1177/109019818700600406; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; ERA, 2016, RAILW SAF PERF EU; Forjuoh Samuel N, 2003, Med Sci Monit, V9, pCR436; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; JACQUES LB, 1994, PUBLIC HEALTH REP, V109, P296; KRISTIANSEN CM, 1984, PUBLIC HEALTH REP, V99, P384; Lajunen T, 2004, J SAFETY RES, V35, P115, DOI 10.1016/j.jsr.2003.09.020; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Marteau TM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d228; OCDE/OECD, 1998, SAF VULN ROAD US; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Robinson DL, 2007, ACCIDENT ANAL PREV, V39, P86, DOI 10.1016/j.aap.2006.06.007; Robinson DL, 1996, ACCIDENT ANAL PREV, V28, P463, DOI 10.1016/0001-4575(96)00016-4; Royal ST, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003985.pub2; Rusch MD, 2000, PLAST RECONSTR SURG, V106, P1451, DOI 10.1097/00006534-200012000-00001; Tebble NJ, 2004, J ADV NURS, V47, P417, DOI 10.1111/j.1365-2648.2004.03123.x; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; Thompson NJ, 2002, PATIENT EDUC COUNS, V46, P191, DOI 10.1016/S0738-3991(01)00212-9; Villamor E, 2008, CHILD CARE HLTH DEV, V34, P743, DOI 10.1111/j.1365-2214.2008.00882.x; Walker I, 2007, ACCIDENT ANAL PREV, V39, P417, DOI 10.1016/j.aap.2006.08.010; Wiechman S A, 2000, J Sci Med Sport, V3, P194, DOI 10.1016/S1440-2440(00)80081-X; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	34	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31651	10.1371/journal.pone.0031651	http://dx.doi.org/10.1371/journal.pone.0031651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355384	Green Published, gold			2022-12-27	WOS:000302741300084
J	Guerrero-Vargas, JA; Mourao, CBF; Quintero-Hernandez, V; Possani, LD; Schwartz, EF				Guerrero-Vargas, Jimmy A.; Mourao, Caroline B. F.; Quintero-Hernandez, Veronica; Possani, Lourival D.; Schwartz, Elisabeth F.			Identification and Phylogenetic Analysis of Tityus pachyurus and Tityus obscurus Novel Putative Na+-Channel Scorpion Toxins	PLOS ONE			English	Article							ANDROCTONUS-AUSTRALIS-HECTOR; MAMMALIAN SODIUM-CHANNELS; AMINO-ACID-SEQUENCE; SERRULATUS SCORPION; MASS-SPECTROMETRY; ALPHA-TOXINS; BETA-TOXINS; K+-CHANNELS; TRANSCRIPTOME ANALYSIS; VENEZUELAN SCORPION	Background: Colombia and Brazil are affected by severe cases of scorpionism. In Colombia the most dangerous accidents are caused by Tityus pachyurus that is widely distributed around this country. In the Brazilian Amazonian region scorpion stings are a common event caused by Tityus obscurus. The main objective of this work was to perform the molecular cloning of the putative Na+-channel scorpion toxins (NaScTxs) from T. pachyurus and T. obscurus venom glands and to analyze their phylogenetic relationship with other known NaScTxs from Tityus species. Methodology/Principal Findings: cDNA libraries from venom glands of these two species were constructed and five nucleotide sequences from T. pachyurus were identified as putative modulators of Na+-channels, and were named Tpa4, Tpa5, Tpa6, Tpa7 and Tpa8; the latter being the first anti-insect excitatory beta-class NaScTx in Tityus scorpion venom to be described. Fifteen sequences from T. obscurus were identified as putative NaScTxs, among which three had been previously described, and the others were named To4 to To15. The peptides Tpa4, Tpa5, Tpa6, To6, To7, To9, To10 and To14 are closely related to the alpha-class NaScTxs, whereas Tpa7, Tpa8, To4, To8, To12 and To15 sequences are more related to the beta-class NaScTxs. To5 is possibly an arthropod specific toxin. To11 and To13 share sequence similarities with both alpha and beta NaScTxs. By means of phylogenetic analysis using the Maximum Parsimony method and the known NaScTxs from Tityus species, these toxins were clustered into 14 distinct groups. Conclusions/Significance: This communication describes new putative NaScTxs from T. pachyurus and T. obscurus and their phylogenetic analysis. The results indicate clear geographic separation between scorpions of Tityus genus inhabiting the Amazonian and Mountain Andes regions and those distributed over the Southern of the Amazonian rainforest. Based on the consensus sequences for the different clusters, a new nomenclature for the NaScTxs is proposed.	[Guerrero-Vargas, Jimmy A.; Mourao, Caroline B. F.; Schwartz, Elisabeth F.] Univ Brasilia, Dept Ciencias Fisiol, Lab Toxinol, Brasilia, DF, Brazil; [Quintero-Hernandez, Veronica; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidade de Brasilia; Universidad Nacional Autonoma de Mexico	Guerrero-Vargas, JA (corresponding author), Univ Brasilia, Dept Ciencias Fisiol, Lab Toxinol, Brasilia, DF, Brazil.	efschwa@unb.br	Mourao, Caroline B F/A-2277-2013; Schwartz, Elisabeth Ferroni/AGE-4234-2022; Schwartz, Elisabeth/G-4531-2012; Possani, Lourival D/J-2397-2013; Guerrero-Vargas, Jimmy Alexander/AAC-1367-2019	Mourao, Caroline B F/0000-0003-3795-6025; Schwartz, Elisabeth Ferroni/0000-0001-8239-4055; Schwartz, Elisabeth/0000-0001-8239-4055; Guerrero-Vargas, Jimmy Alexander/0000-0002-0193-5508; Quintero-Hernandez, Veronica/0000-0002-1856-8134	National Council for Scientific and Technological Development Brazil/Consejo Nacional de Ciencia y Tecnologia (CNPq/CONACyT) [490068/2009-0]; CNPq [303003/2009-0, 472731/2008-4, 472533/2010-0, 553137/2007-7]; Foundation for Research Support of the Federal District (FAPDF) [193.000.472/2008]; Direcion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN204110]; CAPES	National Council for Scientific and Technological Development Brazil/Consejo Nacional de Ciencia y Tecnologia (CNPq/CONACyT); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the Federal District (FAPDF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Direcion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by National Council for Scientific and Technological Development Brazil/Consejo Nacional de Ciencia y Tecnologia (CNPq/CONACyT; www.conacyt.mx) (490068/2009-0) to EFS and LDP, CNPq (303003/2009-0; 472731/2008-4, 472533/2010-0) and Foundation for Research Support of the Federal District (FAPDF; www.fap.df.gov.br) (193.000.472/2008) to EFS, and Direcion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) IN204110 to LDP. JAGV and CBFM are students supported respectively by the Brazilian agencies CNPq (www.cnpq.br) (553137/2007-7) and CAPES (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MA, 2009, TOXICON, V53, P349, DOI 10.1016/j.toxicon.2008.12.007; Amaro I, 2011, IMMUNOL LETT, V139, P73, DOI 10.1016/j.imlet.2011.05.002; Asano ME, 1996, REV SOC BRASILEIRA M, V29, P243; Barona J, 2006, BBA-PROTEINS PROTEOM, V1764, P76, DOI 10.1016/j.bbapap.2005.08.010; Barona Jacqueline, 2004, Biomed., V24, P42; Batista CVF, 2004, J CHROMATOGR B, V803, P55, DOI 10.1016/j.jchromb.2003.09.002; Batista CVF, 2002, TOXICON, V40, P557, DOI 10.1016/S0041-0101(01)00252-5; Batista CVF, 2002, BBA-PROTEINS PROTEOM, V1601, P123, DOI 10.1016/S1570-9639(02)00458-2; Batista CVF, 2000, FEBS LETT, V486, P117, DOI 10.1016/S0014-5793(00)02253-5; Becerril B, 1997, TOXICON, V35, P821, DOI 10.1016/S0041-0101(96)00198-5; Becerril B, 1996, BIOCHEM J, V313, P753, DOI 10.1042/bj3130753; Ben Othmen A, 2009, ACTA TROP, V112, P77, DOI 10.1016/j.actatropica.2009.07.001; Blanc E, 1997, EUR J BIOCHEM, V247, P1118, DOI 10.1111/j.1432-1033.1997.01118.x; Borges A, 2006, COMP BIOCHEM PHYS C, V142, P240, DOI 10.1016/j.cbpc.2005.10.011; Borges A, 2004, TOXICON, V43, P671, DOI 10.1016/j.toxicon.2004.02.022; Borges A, 1999, TOXICON, V37, P867, DOI 10.1016/S0041-0101(98)00201-3; Borges A, 2005, ACTA CIENT VENEZ, V5, P56; Borges A, 2007, TOXICON, V50, P1005, DOI 10.1016/j.toxicon.2007.07.019; Borges A, 2010, WILD ENVIRON MED, V21, P282, DOI 10.1016/j.wem.2010.06.008; Borges A, 2010, TOXICON, V55, P436, DOI 10.1016/j.toxicon.2009.09.011; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; Bucaretchi Fabio, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P331, DOI 10.1590/S0036-46651995000400008; Caliskan F, 2006, TOXICON, V48, P12, DOI 10.1016/j.toxicon.2006.04.003; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cologna CT, 2009, PROTEIN PEPTIDE LETT, V16, P920, DOI 10.2174/092986609788923329; Corona M, 1996, TOXICON, V34, P251, DOI 10.1016/0041-0101(95)00129-8; Cupo Palmira, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P67, DOI 10.1590/S0036-46651994000100011; D'Suze G, 2004, TOXICON, V43, P263, DOI 10.1016/j.toxicon.2003.12.004; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2007, TOXICON, V49, P171, DOI 10.1016/j.toxicon.2006.09.016; De Sousa L, 2007, REV SOC BRAS MED TRO, V40, P681, DOI 10.1590/S0037-86822007000600017; Demeure K, 2010, J AM SOC MASS SPECTR, V21, P1906, DOI 10.1016/j.jasms.2010.07.009; Escoubas P, 2008, J MASS SPECTROM, V43, P279, DOI 10.1002/jms.1389; Escoubas P, 2006, TOXICON, V47, P609, DOI 10.1016/j.toxicon.2006.01.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Florez D.E., 2001, BIOTA COLOMB, V2, P25; Froy O, 2003, TOXICON, V42, P549, DOI 10.1016/S0041-0101(03)00236-8; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Garcia-Gomez BI, 2009, TOXICON, V53, P770, DOI 10.1016/j.toxicon.2009.02.011; Gómez C Juan Pablo, 2007, Rev. Fac. Nac. Salud Pública, V25, P50; Gonzalez-Sponga MA, 2002, B ACAD CIEN FIS MAT, VIXII, P49; Gordon D, 2003, EUR J BIOCHEM, V270, P2663, DOI 10.1046/j.1432-1033.2003.03643.x; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2001, FASEB J, V15, P1201, DOI 10.1096/fj.00-0571hyp; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Inceoglu B, 2001, EUR J BIOCHEM, V268, P5407, DOI 10.1046/j.0014-2956.2001.02479.x; JOVER E, 1980, BIOCHEM BIOPH RES CO, V95, P1607, DOI 10.1016/S0006-291X(80)80082-9; Junqueira-de-Azevedo ILM, 2006, GENETICS, V173, P877, DOI 10.1534/genetics.106.056515; Kalapothakis E, 2001, TOXICON, V39, P679, DOI 10.1016/S0041-0101(00)00194-X; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Lazo GR, 2001, BIOTECHNIQUES, V30, P1300, DOI 10.2144/01306bc03; LORET EP, 1991, BIOCHEMISTRY-US, V30, P633, DOI 10.1021/bi00217a007; Lourenco W, 2001, SCORPION BIOLOGY AND RESEARCH, P406; Lourenco Wilson R., 1994, Biogeographica (Paris), V70, P155; Lourengo W. R., 2008, EUSCORPIUS, V75, P1; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Mansuelle Pascal, 1992, Natural Toxins, V1, P119, DOI 10.1002/nt.2620010211; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Murgia AR, 2004, TOXICON, V43, P737, DOI 10.1016/j.toxicon.2004.02.014; Nei M., 2000, MOL EVOLUTION PHYLOG; Otero R, 2004, T ROY SOC TROP MED H, V98, P742, DOI 10.1016/j.trstmh.2003.12.018; Pardal Pedro Pereira de Oliveira, 2003, Rev Soc Bras Med Trop, V36, P349; Pimenta AMC, 2001, TOXICON, V39, P1009, DOI 10.1016/S0041-0101(00)00240-3; POSSANI LD, 1991, J BIOL CHEM, V266, P3178; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Roberts JL, 2006, MOL PHYLOGENET EVOL, V41, P149, DOI 10.1016/j.ympev.2006.05.005; Sanz L, 2008, J PROTEOMICS, V71, P46, DOI 10.1016/j.jprot.2007.10.004; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Soares Marcely Regina Martins, 2002, Rev. Soc. Bras. Med. Trop., V35, P359, DOI 10.1590/S0037-86822002000400013; Srairi-Abid N, 2005, BIOCHEM J, V388, P455, DOI 10.1042/BJ20041407; Tamura K, 2011, MOL BIOL EV IN PRESS; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Wilson E. O., BIODIVERSITY; Yao J, 2005, J BIOL CHEM, V280, P14819, DOI 10.1074/jbc.M412735200; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	84	44	111	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30478	10.1371/journal.pone.0030478	http://dx.doi.org/10.1371/journal.pone.0030478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355312	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300012
J	Matsuki, T; Zaka, M; Guerreiro, R; van der Brug, MP; Cooper, JA; Cookson, MR; Hardy, JA; Howell, BW				Matsuki, Tohru; Zaka, Mariam; Guerreiro, Rita; van der Brug, Marcel P.; Cooper, Jonathan A.; Cookson, Mark R.; Hardy, John A.; Howell, Brian W.			Identification of Stk25 as a Genetic Modifier of Tau Phosphorylation in Dab1-Mutant Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; SAD KINASES; MOUSE MODEL; REELIN; BINDING; DISABLED-1; BRAIN; PATHWAY; DAB1	Hyperphosphorylation of the microtubule binding protein Tau is a feature of a number of neurodegenerative diseases, including Alzheimer's disease. Tau is hyperphosphorylated in the hippocampus of dab1-null mice in a strain-dependent manner; however, it has not been clear if the Tau phosphorylation phenotype is a secondary effect of the morbidity of these mutants. The dab1 gene encodes a docking protein that is required for normal brain lamination and dendritogenesis as part of the Reelin signaling pathway. We show that dab1 gene inactivation after brain development leads to Tau hyperphosphorylation in anatomically normal mice. Genomic regions that regulate the phospho Tau phenotype in dab1 mutants have previously been identified. Using a microarray gene expression comparison between dab1-mutants from the high-phospho Tau expressing and low-phospho Tau expressing strains, we identified Stk25 as a differentially expressed modifier of dab1-mutant phenotypes. Stk25 knockdown reduces Tau phosphorylation in embryonic neurons. Furthermore, Stk25 regulates neuronal polarization and Golgi morphology in an antagonistic manner to Dab1. This work provides insights into the complex regulation of neuronal behavior during brain development and provides insights into the molecular cascades that regulate Tau phosphorylation.	[Matsuki, Tohru; Howell, Brian W.] SUNY Upstate Med Univ, Syracuse, NY USA; [Zaka, Mariam] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Guerreiro, Rita; van der Brug, Marcel P.; Cookson, Mark R.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Fred Hutchinson Cancer Center	Matsuki, T (corresponding author), SUNY Upstate Med Univ, Syracuse, NY USA.	howellb@upstate.edu	Cookson, Mark/AAW-2516-2021; Guerreiro, Rita J L/A-1327-2011; Hardy, John/C-2451-2009	Cookson, Mark/0000-0002-1058-3831; Hardy, John/0000-0002-3122-0423; Matsuki, Tohru/0000-0003-1832-2406; Howell, Brian/0000-0002-0204-0773; Guerreiro, Rita/0000-0001-5879-3486	National Institute of Neurological Disorders and Stroke intramural; State University of New York, Upstate Medical University; National Institutes of Health [CA41072]; National Institute on Aging; Alzheimers Research UK [ART-PPG2011A-14, ART-PG2010-1] Funding Source: researchfish; Medical Research Council [G0701075, MC_G1000735] Funding Source: researchfish; MRC [G0701075, MC_G1000735] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA041072, P30CA015704, R37CA041072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000947] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke intramural(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); State University of New York, Upstate Medical University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute of Neurological Disorders and Stroke intramural and State University of New York, Upstate Medical University startup funds for BWH, National Institutes of Health grant CA41072 to JAC, and National Institute on Aging intramural funds for MRC. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Botella-Lopez A, 2010, NEUROBIOL DIS, V37, P682, DOI 10.1016/j.nbd.2009.12.006; Brich J, 2003, J NEUROSCI, V23, P187; Chen KL, 2004, J CELL SCI, V117, P4527, DOI 10.1242/jcs.01320; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Silva R, 2003, NEUROPATH APPL NEURO, V29, P288, DOI 10.1046/j.1365-2990.2003.00463.x; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Hardy J, 2006, J NEUROCHEM, V97, P1690, DOI 10.1111/j.1471-4159.2006.03979.x; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang YC, 2004, BIOCHEM BIOPH RES CO, V318, P204, DOI 10.1016/j.bbrc.2004.04.023; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Lee VMY, 1996, ANN NY ACAD SCI, V777, P107, DOI 10.1111/j.1749-6632.1996.tb34408.x; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Muller T, 2011, CURR ALZHEIMER RES, V8, P573, DOI 10.2174/156720511796391827; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Persico AM, 2006, J NEURAL TRANSM, V113, P1373, DOI 10.1007/s00702-006-0441-6; Pramatarova A, 2008, MOL CELL NEUROSCI, V37, P178, DOI 10.1016/j.mcn.2007.09.008; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Trojanowski JQ, 2002, MED CLIN N AM, V86, P615, DOI 10.1016/S0025-7125(02)00002-0; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	50	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31152	10.1371/journal.pone.0031152	http://dx.doi.org/10.1371/journal.pone.0031152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355340	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300040
J	Nagpal, I; Raj, I; Subbarao, N; Gourinath, S				Nagpal, Isha; Raj, Isha; Subbarao, Naidu; Gourinath, Samudrala			Virtual Screening, Identification and In Vitro Testing of Novel Inhibitors of O-Acetyl-L-Serine Sulfhydrylase of Entamoeba histolytica	PLOS ONE			English	Article							VALIDATION; AMEBIASIS; CYSTEINE; BINDING; DOCKING; COMPLEX	The explosive epidemicity of amoebiasis caused by the facultative gastrointestinal protozoan parasite Entamoeba histolytica is a major public health problem in developing countries. Multidrug resistance and side effects of various available antiamoebic drugs necessitate the design of novel antiamobeic agents. The cysteine biosynthetic pathway is the critical target for drug design due to its significance in the growth, survival and other cellular activities of E. histolytica. Here, we have screened 0.15 million natural compounds from the ZINC database against the active site of the EhOASS enzyme (PDB ID. 3BM5, 2PQM), whose structure we previously determined to 2.4 A and 1.86 angstrom resolution. For this purpose, the incremental construction algorithm of GLIDE and the genetic algorithm of GOLD were used. We analyzed docking results for top ranking compounds using a consensus scoring function of X-Score to calculate the binding affinity and using ligplot to measure protein-ligand interactions. Fifteen compounds that possess good inhibitory activity against EhOASS active site were identified that may act as potential high affinity inhibitors. In vitro screening of a few commercially available compounds established their biological activity. The first ranked compound ZINC08931589 had a binding affinity of similar to 8.05 mu M and inhibited about 73% activity at 0.1 mM concentration, indicating good correlation between in silico prediction and in vitro inhibition studies. This compound is thus a good starting point for further development of strong inhibitors.	[Nagpal, Isha; Raj, Isha; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Nagpal, I (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	nsrao@mail.jnu.ac.in; sgourinath@mail.jnu.ac.in	Subbarao, Prof Naidu/AAZ-1832-2020	Subbarao, Prof Naidu/0000-0002-1720-2165; Raj, Isha/0000-0003-4686-0498	DBT; CSIR; Department of Biotechnology, Government of India, UGC; JNU	DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India, UGC; JNU	I.N. and I. R. thank DBT and CSIR for fellowships. The authors thank Programme Support on Molecular Parasitology by the Department of Biotechnology, Government of India, UGC resource networking and JNU capacity build-up grant for funding. The funders or funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Cudmore SL, 2004, CLIN MICROBIOL REV, V17, P783, DOI 10.1128/CMR.17.4.783-793.2004; DeLano W, 2002, PYMOL 0 99; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Krishna C, 2007, ACTA CRYSTALLOGR F, V63, P512, DOI 10.1107/S1744309107022154; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; Olivos-Garcia A, 2009, INFECT GENET EVOL, V9, P1033, DOI 10.1016/j.meegid.2009.04.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salles JM, 2007, EXPERT REV ANTI-INFE, V5, P893, DOI 10.1586/14787210.5.5.893; Stanley SL, 2006, PARASITOLOGY, V133, pS81, DOI [10.1017/S003118200600182X, 10.1017/S003118200600182x]; TAKEUCHI T, 1979, COMP BIOCHEM PHYS B, V62, P281, DOI 10.1016/0305-0491(79)90214-1; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882	17	58	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30305	10.1371/journal.pone.0030305	http://dx.doi.org/10.1371/journal.pone.0030305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355310	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300010
J	Nishiyama, R; Le, DT; Watanabe, Y; Matsui, A; Tanaka, M; Seki, M; Yamaguchi-Shinozaki, K; Shinozaki, K; Tran, LSP				Nishiyama, Rie; Le, Dung Tien; Watanabe, Yasuko; Matsui, Akihiro; Tanaka, Maho; Seki, Motoaki; Yamaguchi-Shinozaki, Kazuko; Shinozaki, Kazuo; Lam-Son Phan Tran			Transcriptome Analyses of a Salt-Tolerant Cytokinin-Deficient Mutant Reveal Differential Regulation of Salt Stress Response by Cytokinin Deficiency	PLOS ONE			English	Article							LATERAL ROOT DEVELOPMENT; IN-SILICO ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; FUNCTIONAL-ANALYSIS; SALINITY TOLERANCE; ABIOTIC STRESS; TRANSGENIC ARABIDOPSIS; BIOLOGICAL PROCESSES	Soil destruction by abiotic environmental conditions, such as high salinity, has resulted in dramatic losses of arable land, giving rise to the need of studying mechanisms of plant adaptation to salt stress aimed at creating salt-tolerant plants. Recently, it has been reported that cytokinins (CKs) regulate plant environmental stress responses through two-component systems. A decrease in endogenous CK levels could enhance salt and drought stress tolerance. Here, we have investigated the global transcriptional change caused by a reduction in endogenous CK content under both normal and salt stress conditions. Ten-day-old Arabidopsis thaliana wild-type (WT) and CK-deficient ipt1,3,5,7 plants were transferred to agar plates containing either 0 mM (control) or 200 mM NaCl and maintained at normal growth conditions for 24 h. Our experimental design allowed us to compare transcriptome changes under four conditions: WT-200 mM vs. WT-0 mM, ipt1,3,5,7-0 mM vs. WT-0 mM, ipt1,3,5,7-200 mM vs. ipt1,3,5,7-0 mM and ipt1,3,5,7-200 mM vs. WT-200 mM NaCl. Our results indicated that the expression of more than 10% of all of the annotated Arabidopsis genes was altered by CK deficiency under either normal or salt stress conditions when compared to WT. We found that upregulated expression of many genes encoding either regulatory proteins, such as NAC, DREB and ZFHD transcription factors and the calcium sensor SOS3, or functional proteins, such as late embryogenesis-abundant proteins, xyloglucan endo-transglycosylases, glycosyltransferases, glycoside hydrolases, defensins and glyoxalase I family proteins, may contribute to improved salt tolerance of CK-deficient plants. We also demonstrated that the downregulation of photosynthesis-related genes and the upregulation of several NAC genes may cause the altered morphological phenotype of CK-deficient plants. This study highlights the impact of CK regulation on the well-known stress-responsive signaling pathways, which regulate plant adaptation to high salinity as well as other environmental stresses.	[Nishiyama, Rie; Le, Dung Tien; Watanabe, Yasuko; Lam-Son Phan Tran] RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan; [Le, Dung Tien] Vietnamese Acad Agr Sci, Agr Genet Inst, Hanoi, Vietnam; [Matsui, Akihiro; Tanaka, Maho; Seki, Motoaki] RIKEN Plant Sci Ctr, Plant Genom Network Res Team, Yokohama, Kanagawa, Japan; [Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Gene Discovery Res Grp, Yokohama, Kanagawa, Japan	RIKEN; RIKEN; Japan International Research Center for Agricultural Sciences; RIKEN	Nishiyama, R (corresponding author), RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan.	tran@psc.riken.jp	Shinozaki, Kazuo/AAB-4945-2019; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Seki, Motoaki/I-2854-2012; Tran, Lam-Son P/A-1346-2009; Shinozaki, Kazuo/G-4202-2013; Le, Dung Tien/A-7276-2008; Matsui, Akihiro/C-7591-2017	Shinozaki, Kazuo/0000-0002-6317-9867; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Seki, Motoaki/0000-0001-8288-0467; Tran, Lam-Son P/0000-0001-9883-9768; Shinozaki, Kazuo/0000-0002-6317-9867; Le, Dung Tien/0000-0002-5117-3476; Matsui, Akihiro/0000-0002-3979-3947				Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Brini F, 2007, PLANT CELL REP, V26, P2017, DOI 10.1007/s00299-007-0412-x; Brugiere N, 2003, PLANT PHYSIOL, V132, P1228, DOI 10.1104/pp.102.017707; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x; Chinnusamy Viswanathan, 2006, Genet Eng (N Y), V27, P141, DOI 10.1007/0-387-25856-6_9; Choi J, 2011, TRENDS PLANT SCI, V16, P388, DOI 10.1016/j.tplants.2011.03.003; DESILVA J, 1994, J EXP BOT, V45, P1693, DOI 10.1093/jxb/45.Special_Issue.1693; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Horie T, 2006, PLANT CELL PHYSIOL, V47, P622, DOI 10.1093/pcp/pcj029; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Krishnaswamy SS, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-91; Lal S, 2008, TRANSGENIC RES, V17, P651, DOI 10.1007/s11248-007-9145-4; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P148, DOI 10.4161/psb.5.2.10411; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Li DF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-109; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Mason MG, 2010, PLANT J, V64, P753, DOI 10.1111/j.1365-313X.2010.04366.x; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mochida K, 2011, DNA RES, V18, P321, DOI 10.1093/dnares/dsr019; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Mochida K, 2010, DNA RES, V17, P303, DOI 10.1093/dnares/dsq021; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Roy SJ, 2011, CURR OPIN PLANT BIOL, V14, P232, DOI 10.1016/j.pbi.2011.03.002; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schaller G Eric, 2008, Arabidopsis Book, V6, pe0112, DOI 10.1199/tab.0112; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Singla-Pareek SL, 2003, P NATL ACAD SCI USA, V100, P14672, DOI 10.1073/pnas.2034667100; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; To TK, 2011, BIOCHEM BIOPH RES CO, V406, P414, DOI 10.1016/j.bbrc.2011.02.058; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Upadhyaya CP, 2011, BIOTECHNOL LETT, V33, P2297, DOI 10.1007/s10529-011-0684-7; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Vissenberg K, 2005, J EXP BOT, V56, P673, DOI 10.1093/jxb/eri048; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x	78	100	106	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32124	10.1371/journal.pone.0032124	http://dx.doi.org/10.1371/journal.pone.0032124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355415	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300115
J	Sati, S; Tanwar, VS; Kumar, KA; Patowary, A; Jain, V; Ghosh, S; Ahmad, S; Singh, M; Reddy, SU; Chandak, GR; Raghunath, M; Sivasubbu, S; Chakraborty, K; Scaria, V; Sengupta, S				Sati, Satish; Tanwar, Vinay Singh; Kumar, K. Anand; Patowary, Ashok; Jain, Vaibhav; Ghosh, Sourav; Ahmad, Shadab; Singh, Meghna; Reddy, S. Umakar; Chandak, Giriraj Ratan; Raghunath, Manchala; Sivasubbu, Sridhar; Chakraborty, Kausik; Scaria, Vinod; Sengupta, Shantanu			High Resolution Methylome Map of Rat Indicates Role of Intragenic DNA Methylation in Identification of Coding Region	PLOS ONE			English	Article							EPIGENETIC MODIFICATIONS; TRANSCRIPTIONAL REGULATION; CHROMATIN-STRUCTURE; GENOME; DIFFERENTIATION; EPIGENOME; INSTABILITY; CHALLENGES; DATABASE; REPEATS	DNA methylation is crucial for gene regulation and maintenance of genomic stability. Rat has been a key model system in understanding mammalian systemic physiology, however detailed rat methylome remains uncharacterized till date. Here, we present the first high resolution methylome of rat liver generated using Methylated DNA immunoprecipitation and high throughput sequencing (MeDIP-Seq) approach. We observed that within the DNA/RNA repeat elements, simple repeats harbor the highest degree of methylation. Promoter hypomethylation and exon hypermethylation were common features in both RefSeq genes and expressed genes (as evaluated by proteomic approach). We also found that although CpG islands were generally hypomethylated, about 6% of them were methylated and a large proportion (37%) of methylated islands fell within the exons. Notably, we obeserved significant differences in methylation of terminal exons (UTRs); methylation being more pronounced in coding/partially coding exons compared to the non-coding exons. Further, events like alternate exon splicing (cassette exon) and intron retentions were marked by DNA methylation and these regions are retained in the final transcript. Thus, we suggest that DNA methylation could play a crucial role in marking coding regions thereby regulating alternative splicing. Apart from generating the first high resolution methylome map of rat liver tissue, the present study provides several critical insights into methylome organization and extends our understanding of interplay between epigenome, gene expression and genome stability.	[Sati, Satish; Tanwar, Vinay Singh; Patowary, Ashok; Jain, Vaibhav; Ghosh, Sourav; Ahmad, Shadab; Singh, Meghna; Sivasubbu, Sridhar; Chakraborty, Kausik; Scaria, Vinod; Sengupta, Shantanu] CSIR Inst Genom & Integrat Biol, Delhi, India; [Kumar, K. Anand; Raghunath, Manchala] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Reddy, S. Umakar; Chandak, Giriraj Ratan] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sati, S (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	vinods@igib.in; shantanus@igib.res.in	Patowary, Ashok/AAT-5305-2020; Sati, Satish/F-3531-2012; Scaria, Vinod/B-2819-2008; Scaria, Vinod/AAS-3151-2021; Chakraborty, Kausik/AAL-5748-2021; Sati, Satish/Q-6951-2019; Tanwar, Vinay Singh/AAJ-5017-2021; Singh, Meghna/AAV-5262-2020; ghosh, sourav/H-8412-2012	Patowary, Ashok/0000-0001-7507-3907; Sati, Satish/0000-0001-8236-9466; Chandak, Giriraj Ratan/0000-0002-3095-9453; Scaria, Vinod/0000-0001-7644-7181; Singh, Meghna/0000-0002-7907-6571; chakraborty, kausik/0000-0001-6000-8379; Tanwar, Vinay/0000-0001-6168-2752	Department of Biotechnology, India [BT/PR4525/MED/14/533/2003]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology, India (BT/PR4525/MED/14/533/2003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2011, MAMM GENOME, V22, P249, DOI 10.1007/s00335-011-9318-6; Anastasiadou C, 2011, DNA CELL BIOL, V30, P267, DOI 10.1089/dna.2010.1094; Backdahl L, 2009, EPIGENETICS-US, V4, P248; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; Dion V, 2009, TRENDS GENET, V25, P288, DOI 10.1016/j.tig.2009.04.007; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Esteller M, 2005, EMBO REP, V6, P624, DOI 10.1038/sj.embor.7400456; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Koul Sanjay, 2002, Mol Cancer, V1, P8, DOI 10.1186/1476-4598-1-8; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rosenfeld CS, 2010, BIOL REPROD, V82, P473, DOI 10.1095/biolreprod.109.080952; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Szyf M, 2007, TOXICOL SCI, V100, P7, DOI 10.1093/toxsci/kfm177; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; Tomazou EM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-19; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang YM, 2010, GENOME RES, V20, P19, DOI 10.1101/gr.100073.109; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	69	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31621	10.1371/journal.pone.0031621	http://dx.doi.org/10.1371/journal.pone.0031621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355382	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300082
J	Bentink, S; Haibe-Kains, B; Risch, T; Fan, JB; Hirsch, MS; Holton, K; Rubio, R; April, C; Chen, J; Wickham-Garcia, E; Liu, J; Culhane, A; Drapkin, R; Quackenbush, J; Matulonis, UA				Bentink, Stefan; Haibe-Kains, Benjamin; Risch, Thomas; Fan, Jian-Bing; Hirsch, Michelle S.; Holton, Kristina; Rubio, Renee; April, Craig; Chen, Jing; Wickham-Garcia, Eliza; Liu, Joyce; Culhane, Aedin; Drapkin, Ronny; Quackenbush, John; Matulonis, Ursula A.			Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer	PLOS ONE			English	Article							STAGE-III; PHASE-II; SURVIVAL; PACLITAXEL; BEVACIZUMAB; VALIDATION; CISPLATIN; PROFILE; TRIAL	Ovarian cancer is the fifth leading cause of cancer death for women in the U.S. and the seventh most fatal worldwide. Although ovarian cancer is notable for its initial sensitivity to platinum-based therapies, the vast majority of patients eventually develop recurrent cancer and succumb to increasingly platinum-resistant disease. Modern, targeted cancer drugs intervene in cell signaling, and identifying key disease mechanisms and pathways would greatly advance our treatment abilities. In order to shed light on the molecular diversity of ovarian cancer, we performed comprehensive transcriptional profiling on 129 advanced stage, high grade serous ovarian cancers. We implemented a, re-sampling based version of the ISIS class discovery algorithm (rISIS: robust ISIS) and applied it to the entire set of ovarian cancer transcriptional profiles. rISIS identified a previously undescribed patient stratification, further supported by micro-RNA expression profiles, and gene set enrichment analysis found strong biological support for the stratification by extracellular matrix, cell adhesion, and angiogenesis genes. The corresponding "angiogenesis signature'' was validated in ten published independent ovarian cancer gene expression datasets and is significantly associated with overall survival. The subtypes we have defined are of potential translational interest as they may be relevant for identifying patients who may benefit from the addition of anti-angiogenic therapies that are now being tested in clinical trials.	[Bentink, Stefan; Haibe-Kains, Benjamin; Risch, Thomas; Holton, Kristina; Rubio, Renee; Culhane, Aedin; Quackenbush, John] Dana Farber Canc Inst, Dept Biostatist & Computat Biol, Boston, MA 02115 USA; [Liu, Joyce; Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Fan, Jian-Bing; April, Craig; Chen, Jing; Wickham-Garcia, Eliza] Illumina Inc, San Diego, CA USA; [Hirsch, Michelle S.; Drapkin, Ronny] Brigham & Womens Hosp, Dept Pathol, Div Womans & Perinatal Pathol, Boston, MA 02115 USA; [Drapkin, Ronny; Matulonis, Ursula A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bentink, Stefan; Haibe-Kains, Benjamin; Culhane, Aedin; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hirsch, Michelle S.; Liu, Joyce; Drapkin, Ronny; Matulonis, Ursula A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Illumina; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Bentink, S (corresponding author), Dana Farber Canc Inst, Dept Biostatist & Computat Biol, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu	Drapkin, Ronny/E-9944-2016; Haibe-Kains, Benjamin/D-3702-2011; Culhane, Aedin/AAG-8490-2019	Drapkin, Ronny/0000-0002-6912-6977; Haibe-Kains, Benjamin/0000-0002-7684-0079; Culhane, Aedin/0000-0002-1395-9734; Quackenbush, John/0000-0002-2702-5879	Dana-Farber/Harvard Cancer Center; Claudia Adams Barr Foundation; Kittredge Foundation; Dana-Farber Cancer Institute; National Cancer Institute [3P50 CA105009-05S1]; NATIONAL CANCER INSTITUTE [P50CA105009] Funding Source: NIH RePORTER	Dana-Farber/Harvard Cancer Center; Claudia Adams Barr Foundation; Kittredge Foundation; Dana-Farber Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Dana-Farber/Harvard Cancer Center Women's Cancer Program, the Claudia Adams Barr Foundation, the Kittredge Foundation, and the Dana-Farber Cancer Institute High Tech Fund. Additional support was provided by a grant from the National Cancer Institute (3P50 CA105009-05S1). The DASL assays were provided by Illumina, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.18_suppl.lba5007; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Burger RA, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba1; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; De Smet F, 2006, INT J GYNECOL CANCER, V16, P147, DOI 10.1111/j.1525-1438.2006.00321.x; Denkert C, 2009, J PATHOL, V218, P273, DOI 10.1002/path.2547; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Haibe-Kains B, 2011, 3 GENE MODEL R UNPUB; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Kapp AV, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-231; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JF, 2009, GYNECOL ONCOL, V115, P401, DOI 10.1016/j.ygyno.2009.08.023; Matulonis UA, 2009, J CLIN ONCOL, V27, P5601, DOI 10.1200/JCO.2009.23.2777; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Perren T, 2010, ANN ONCOL, V21, P2; Ruschhaupt M, 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1078; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; von Heydebreck A, 2001, Bioinformatics, V17 Suppl 1, pS107; Wong KK, 2001, BIOTECHNIQUES, V30, P670, DOI 10.2144/01303dd05; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	36	79	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30269	10.1371/journal.pone.0030269	http://dx.doi.org/10.1371/journal.pone.0030269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348002	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900005
J	Gallegos, KM; Conrady, DG; Karve, SS; Gunasekera, TS; Herr, AB; Weiss, AA				Gallegos, Karen M.; Conrady, Deborah G.; Karve, Sayali S.; Gunasekera, Thusitha S.; Herr, Andrew B.; Weiss, Alison A.			Shiga Toxin Binding to Glycolipids and Glycans	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SURFACE-PLASMON RESONANCE; ESCHERICHIA-COLI O157-H7; GLOBOTRIAOSYL CERAMIDE; B-SUBUNIT; ENDOTHELIAL-CELLS; RECEPTOR FUNCTION; HYBRID TOXINS; LIPID RAFTS; IN-VIVO	Background: Immunologically distinct forms of Shiga toxin (Stx1 and Stx2) display different potencies and disease outcomes, likely due to differences in host cell binding. The glycolipid globotriaosylceramide (Gb3) has been reported to be the receptor for both toxins. While there is considerable data to suggest that Gb3 can bind Stx1, binding of Stx2 to Gb3 is variable. Methodology: We used isothermal titration calorimetry (ITC) and enzyme-linked immunosorbent assay (ELISA) to examine binding of Stx1 and Stx2 to various glycans, glycosphingolipids, and glycosphingolipid mixtures in the presence or absence of membrane components, phosphatidylcholine, and cholesterol. We have also assessed the ability of glycolipids mixtures to neutralize Stx-mediated inhibition of protein synthesis in Vero kidney cells. Results: By ITC, Stx1 bound both Pk (the trisaccharide on Gb3) and P (the tetrasaccharide on globotetraosylceramide, Gb4), while Stx2 did not bind to either glycan. Binding to neutral glycolipids individually and in combination was assessed by ELISA. Stx1 bound to glycolipids Gb3 and Gb4, and Gb3 mixed with other neural glycolipids, while Stx2 only bound to Gb3 mixtures. In the presence of phosphatidylcholine and cholesterol, both Stx1 and Stx2 bound well to Gb3 or Gb4 alone or mixed with other neutral glycolipids. Pre-incubation with Gb3 in the presence of phosphatidylcholine and cholesterol neutralized Stx1, but not Stx2 toxicity to Vero cells. Conclusions: Stx1 binds primarily to the glycan, but Stx2 binding is influenced by residues in the ceramide portion of Gb3 and the lipid environment. Nanomolar affinities were obtained for both toxins to immobilized glycolipids mixtures, while the effective dose for 50% inhibition (ED50) of protein synthesis was about 10(-11) M. The failure of preincubation with Gb3 to protect cells from Stx2 suggests that in addition to glycolipid expression, other cellular components contribute to toxin potency.	[Gallegos, Karen M.; Conrady, Deborah G.; Karve, Sayali S.; Gunasekera, Thusitha S.; Herr, Andrew B.; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Gallegos, KM (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA.	alison.weiss@uc.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399; Weiss, Alison/0000-0002-4726-8376	National Institutes OF Health [R01 AI 064893, U01 AI 075498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075498, R01AI064893] Funding Source: NIH RePORTER	National Institutes OF Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes OF Health Grants R01 AI 064893 and U01 AI 075498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GD, 2006, J INFECT DIS, V193, P1120, DOI 10.1086/501472; BASTA M, 1989, J CLIN MICROBIOL, V27, P1617, DOI 10.1128/JCM.27.7.1617-1622.1989; Binnington B, 2002, NEUROCHEM RES, V27, P807, DOI 10.1023/A:1020261125008; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; BOULANGER J, 1990, J CLIN MICROBIOL, V28, P2830, DOI 10.1128/JCM.28.12.2830-2833.1990; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; CDC, 2005, ENT ESCH COL; Conrady DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015153; Cummings MD, 1998, BIOCHEMISTRY-US, V37, P1789, DOI 10.1021/bi971807f; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; DONOHUEROLFE A, 1991, REV INFECT DIS, V13, pS293; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Flagler MJ, 2010, BIOCHEMISTRY-US, V49, P1649, DOI 10.1021/bi902084y; Flagler MJ, 2010, DETERMINATION MOL BA, P242; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; HEAD SC, 1991, J BIOL CHEM, V266, P3617; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Huang J, 2010, BLOOD, V116, P3653, DOI 10.1182/blood-2010-02-271957; Hughes AK, 2000, KIDNEY INT, V57, P2350, DOI 10.1046/j.1523-1755.2000.00095.x; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kale RR, 2008, ANGEW CHEM INT EDIT, V47, P1265, DOI 10.1002/anie.200703680; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Kim Y-H, 1996, KOREAN J VET PUBLIC, V20, P55; Kitova EN, 2007, GLYCOBIOLOGY, V17, P1127, DOI 10.1093/glycob/cwm081; KOZLOV YV, 1988, GENE, V67, P213, DOI 10.1016/0378-1119(88)90398-8; Kulkarni AA, 2010, MED RES REV, V30, P327, DOI 10.1002/med.20196; Lewallen DM, 2009, CHEMBIOCHEM, V10, P1486, DOI 10.1002/cbic.200900211; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Liu F, 2011, BLOOD, V118, P3392, DOI 10.1182/blood-2011-06-363648; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Miura Y, 2002, ANAL BIOCHEM, V310, P27, DOI 10.1016/S0003-2697(02)00318-4; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; NORTON WT, 1975, J NEUROSCI RES, V1, P57, DOI 10.1002/jnr.490010106; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Ogawa-Goto K, 1998, NEUROCHEM RES, V23, P305, DOI 10.1023/A:1022497114813; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Scheiring J, 2008, PEDIATR NEPHROL, V23, P1749, DOI 10.1007/s00467-008-0935-6; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Shin IS, 2009, BMB REP, V42, P310, DOI 10.5483/BMBRep.2009.42.5.310; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; Takenaga M, 2000, J Infect Chemother, V6, P21, DOI 10.1007/s101560050044; TESH VL, 1991, MOL MICROBIOL, V5, P1817, DOI 10.1111/j.1365-2958.1991.tb00805.x; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; WADDELL T, 1988, BIOCHEM BIOPH RES CO, V152, P674, DOI 10.1016/S0006-291X(88)80091-3; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Whyte DA, 2008, PEDIATR REV, V29, P335, DOI 10.1542/pir.29-10-335; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	62	64	66	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30368	10.1371/journal.pone.0030368	http://dx.doi.org/10.1371/journal.pone.0030368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348006	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900007
J	Li, XQ; Tao, KM; Zhou, QH; Moher, D; Chen, HY; Wang, FZ; Ling, CQ				Li, Xiao-qian; Tao, Kun-ming; Zhou, Qing-hui; Moher, David; Chen, Hong-yun; Wang, Fu-zhe; Ling, Chang-quan			Endorsement of the CONSORT Statement by High-Impact Medical Journals in China: A Survey of Instructions for Authors and Published Papers	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; QUALITY	Background: The CONSORT Statement is a reporting guideline for authors when reporting randomized controlled trials (RCTs). It offers a standard way for authors to prepare RCT reports. It has been endorsed by many high-impact medical journals and by international editorial groups. This study was conducted to assess the endorsement of the CONSORT Statement by high-impact medical journals in China by reviewing their instructions for authors. Methodology/Principal Findings: A total of 200 medical journals were selected according to the Chinese Science and Technology Journal Citation Reports, 195 of which publish clinical research papers. Their instructions for authors were reviewed and all texts mentioning the CONSORT Statement or CONSORT extension papers were extracted. Any mention of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URM) developed by the International Committee of Medical Journal Editors (ICMJE) or 'clinical trial registration' was also extracted. For journals endorsing the CONSORT Statement, their most recently published RCT reports were retrieved and evaluated to assess whether the journals have followed what the CONSORT Statement required. Out of the 195 medical journals publishing clinical research papers, only six (6/195, 3.08%) mentioned 'CONSORT' in their instructions for authors; out of the 200 medical journals surveyed, only 14 (14/200, 7.00%) mentioned 'ICMJE' or 'URM' in their instructions for authors, and another five journals stated in their instructions for authors that clinical trials should have trial registration numbers and that priority would be given to clinical trials which had been registered. Among the 62 RCT reports published in the six journals endorsing the CONSORT Statement, 20 (20/62, 32.26%) contained flow diagrams and only three (3/62, 4.84%) provided trial registration information. Conclusions/Significance: Medical journals in China endorsing either the CONSORT Statement or the ICMJE's URM constituted a small percentage of the total; all of these journals used ambiguous language regarding what was expected of authors.	[Li, Xiao-qian; Zhou, Qing-hui; Chen, Hong-yun; Wang, Fu-zhe; Ling, Chang-quan] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Tao, Kun-ming] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Ling, Chang-quan] Shanghai Univ Tradit Chinese Med, E Inst Tradit Chinese Internal Med, Shanghai Municipal Educ Commiss, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; University of Ottawa; Ottawa Hospital Research Institute; Shanghai Municipal Education Commission (SHMEC); Shanghai University of Traditional Chinese Medicine	Li, XQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	zhouqinghui@sohu.com; lingchangquan@gmail.com	Moher, David/I-3408-2019; Ling, Changquan/J-2108-2016	Moher, David/0000-0003-2434-4206; Ling, Changquan/0000-0003-3476-6445; Tao, Kunming/0000-0002-1683-3424; Ling, Changquan/0000-0002-0037-4059	E-Institutes of Shanghai Municipal Education Commission [E03008]	E-Institutes of Shanghai Municipal Education Commission	This work was partly supported by the E-Institutes of Shanghai Municipal Education Commission (No. E03008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, GLOBAL RES REPORT CH; Adams J, 2010, GLOBAL RES REPORT US; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Davidoff Frank, 2003, J Am Osteopath Assoc, V103, P137; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Institute of Science and Technical Information of China, 2010, CHIN SCI TECHN J CIT; International Committee of Medical Journal, 2010, J CHIN INTEGR UNPUB, V8, P1101; International Committee of Medical Journal, 2009, J CHIN INTEGR UNPUB, V7, P295; International Committee of Medical Journal, 2010, J CHIN INTEGR UNPUB, V8, P901; International Committee of Medical Journal, 2009, J CHIN INTEGR UNPUB, V7, P195; International Committee of Medical Journal, 2010, J CHIN INTEGR UNPUB, V8, P1001; International Committee of Medical Journal, 2009, J CHIN INTEGR MED, V7, P95; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2010, ZHONG XI YI JIE HE X, V8, P701, DOI DOI 10.3736/JCIM20100801; Moher D, 2005, CHIN J EVID BASED ME, V5, P702; Moher David, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P601; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Schulz Kenneth F, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P604; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Wright JR, 2006, J CLIN ONCOL, V24, P843, DOI 10.1200/JCO.2005.02.6005; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Zhang DL, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-22	28	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30683	10.1371/journal.pone.0030683	http://dx.doi.org/10.1371/journal.pone.0030683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348017	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900011
J	Stokke, C; Flatten, I; Skarstad, K				Stokke, Caroline; Flatten, Ingvild; Skarstad, Kirsten			An Easy-To-Use Simulation Program Demonstrates Variations in Bacterial Cell Cycle Parameters Depending on Medium and Temperature	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; CHROMOSOME-REPLICATION; DIVISION CYCLE; DNA-REPLICATION; FLOW-CYTOMETRY; B-R; INITIATION; PROTEIN; B/R; DISTRIBUTIONS	Many studies are performed on chromosome replication and segregation in Escherichia coli and other bacteria capable of complex replication with C phases spanning several generations. For such investigations an understanding of the replication patterns, including copy numbers of origins and replication forks, is crucial for correct interpretation of the results. Flow cytometry is an important tool for generation of experimental DNA distributions of cell populations. Here, a Visual Basic based simulation program was written for the computation of theoretical DNA distributions for different choices of cell cycle parameters (C and D phase durations, doubling time etc). These cell cycle parameters can be iterated until the best fit between the experimental and theoretical DNA histograms is obtained. The Excel file containing the simulation software is attached as supporting information. Cultures of Escherichia coli were grown at twelve different media and temperature conditions, with following measurements by flow cytometry and simulation of the DNA distributions. A good fit was found for each growth condition by use of our simulation program. The resulting cell cycle parameters displayed clear inter-media differences in replication patterns, but indicated a high degree of temperature independence for each medium. The exception was the poorest medium (acetate), where the cells grew with overlapping replication cycles at 42 degrees C, but without at the lower temperatures. We have developed an easy-to-use tool for determination of bacteria's cell cycle parameters, and consequently the cells' chromosome configurations. The procedure only requires DNA distribution measurements by flow cytometry. Use of this simulation program for E. coli cultures shows that even cells growing quite slowly can have overlapping replication cycles. It is therefore always important not only to assume cells' replication patterns, but to actually determine the cell cycle parameters when changing growth conditions.	[Stokke, Caroline; Flatten, Ingvild; Skarstad, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway	University of Oslo	Stokke, C (corresponding author), Oslo Univ Hosp, Intervent Ctr, Oslo, Norway.	Kirsten.Skarstad@rr-research.no		Flatten, Ingvild/0000-0002-4213-1135	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The work was supported by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2008, GENES CELLS, V13, P181, DOI 10.1111/j.1365-2443.2007.01157.x; ALLMAN R, 1991, J BACTERIOL, V173, P7970, DOI 10.1128/jb.173.24.7970-7974.1991; Atlung T, 1999, J BACTERIOL, V181, P5557, DOI 10.1128/JB.181.18.5557-5562.1999; ATLUNG T, 1993, J BACTERIOL, V175, P6537, DOI 10.1128/jb.175.20.6537-6545.1993; Bipatnath M, 1998, J BACTERIOL, V180, P265, DOI 10.1128/JB.180.2.265-273.1998; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Fossum S, 2007, EMBO J, V26, P4514, DOI 10.1038/sj.emboj.7601871; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HELMSTETTER CE, 1976, J MOL BIOL, V102, P477, DOI 10.1016/0022-2836(76)90329-6; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Janniere L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000447; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KUBITSCHEK HE, 1978, J BACTERIOL, V136, P179, DOI 10.1128/JB.136.1.179-190.1978; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Molina F, 2004, MOL MICROBIOL, V52, P1597, DOI 10.1111/j.1365-2958.2004.04097.x; Morigen, 2009, GENES CELLS, V14, P643, DOI 10.1111/j.1365-2443.2009.01298.x; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Steen HB, 2001, CURR PROTOC CYTOM, P11; Stokke C, 2011, MICROBIOL-SGM, V157, P695, DOI 10.1099/mic.0.045112-0; SUEOKA N, 1965, GENETICS, V52, P747; WOLDRINGH CL, 1977, J BACTERIOL, V131, P270, DOI 10.1128/JB.131.1.270-279.1977; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016	28	36	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30981	10.1371/journal.pone.0030981	http://dx.doi.org/10.1371/journal.pone.0030981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348034	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900018
J	Walker, KAD; Morgan, C; Doak, SH; Dunstan, PR				Walker, Kelly-Ann D.; Morgan, Claire; Doak, Shareen H.; Dunstan, Peter R.			Quantum Dots for Multiplexed Detection and Characterisation of Prostate Cancer Cells Using a Scanning Near-Field Optical Microscope	PLOS ONE			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; E-CADHERIN EXPRESSION; ZONULA OCCLUDENS-1; MECHANISMS; INVASION; METASTASIS; LINES; BONE	In this study scanning near-field optical microscopy (SNOM) has been utilised in conjunction with quantum dot labelling to interrogate the biomolecular composition of cell membranes. The technique overcomes the limits of optical diffraction found in standard fluorescence microscopy and also yields vital topographic information. The technique has been applied to investigate cell-cell adhesion in human epithelial cells. This has been realised through immunofluorescence labelling of the cell-cell adhesion protein E-cadherin. Moreover, a dual labelling protocol has been optimised to facilitate a comparative study of the adhesion mechanisms and the effect of aberrant adhesion protein expression in both healthy and cancerous epithelial cells. This study reports clear differences in the morphology and phenotype of healthy and cancerous cells. In healthy prostate epithelial cells (PNT2), E-cadherin was predominantly located around the cell periphery and within filopodial extensions. The presence of E-cadherin appeared to be enhanced when cell-cell contact was established. In contrast, examination of metastatic prostate adenocarcinoma cells (PC-3) revealed no E-cadherin labelling around the periphery of the cells. This lack of functional E-cadherin in PC-3 cells coincided with a markedly different morphology and PC-3 cells were not found to form close cell-cell associations with their neighbours. We have demonstrated that with a fully optimised sample preparation methodology, multiplexed quantum dot labelling in conjunction with SNOM imaging can be successfully applied to interrogate biomolecular localisation within delicate cellular membranes.	[Walker, Kelly-Ann D.] Swansea Univ, Coll Engn, Multidisciplinary Nanotechnol Ctr, Swansea, W Glam, Wales; [Morgan, Claire; Doak, Shareen H.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Dunstan, Peter R.] Swansea Univ, Coll Sci, Multidisciplinary Nanotechnol Ctr, Dept Phys, Swansea, W Glam, Wales	Swansea University; Swansea University; Swansea University	Walker, KAD (corresponding author), Swansea Univ, Coll Engn, Multidisciplinary Nanotechnol Ctr, Singleton Pk, Swansea, W Glam, Wales.	k.d.walker@swansea.ac.uk	Dunstan, Peter/HII-2875-2022	Doak, Shareen/0000-0002-6753-1987; Dunstan, Peter/0000-0002-4337-4307; Morgan, Claire/0000-0002-3969-0710	EPSRC; St David's Medical Foundation; Prostate UK [G2009/27]; RCUK	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); St David's Medical Foundation; Prostate UK; RCUK(UK Research & Innovation (UKRI))	HEFCW are acknowledged for equipment investment (www.hefcw.ac.uk). EPSRC are acknowledged for providing PhD research student funding (www.EPSRC.ac.uk). Thanks to St David's Medical Foundation & Prostate UK (grant number: G2009/27) for supporting aspects of this work (www.prostateaction.org.uk). SH Doak is supported by an RCUK Academic Fellowship (www.rcuk.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Baylis RM, 2007, ULTRAMICROSCOPY, V107, P308, DOI 10.1016/j.ultramic.2006.08.005; Bryden AAG, 1999, BJU INT, V84, P1032; Chunthapong J, 2004, J CELL BIOCHEM, V91, P649, DOI 10.1002/jcb.20032; Clarke NW, 2009, ASIAN J ANDROL, V11, P57, DOI 10.1038/aja.2008.29; Davies G, 2000, J UROLOGY, V163, P985, DOI 10.1016/S0022-5347(05)67869-X; Galbraith CG, 2011, J CELL SCI, V124, P1607, DOI 10.1242/jcs.080085; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Hofer M, 2010, ULTRAMICROSCOPY, V110, P605, DOI 10.1016/j.ultramic.2010.02.019; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Mao QQ, 2010, CANCER INVEST, V28, P1013, DOI 10.3109/07357900802620844; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; MORTON RA, 1993, CANCER RES, V53, P3585; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Richmond PJM, 1997, CANCER RES, V57, P3189; Saha B, 2008, PROSTATE, V68, P78, DOI 10.1002/pros.20670; UMBAS R, 1994, CANCER RES, V54, P3929; Walker KAD, 2011, ULTRAMICROSCOPY, V111, P1200, DOI 10.1016/j.ultramic.2011.01.008; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zhong LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005945; Zhou Q, 2009, MOL CANCER THER, V8, P1684, DOI 10.1158/1535-7163.MCT-09-0191	26	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31592	10.1371/journal.pone.0031592	http://dx.doi.org/10.1371/journal.pone.0031592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347497	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730200027
J	Du, MF; Yin, XM; Zhang, SD; Zhu, B; Song, QS; An, SH				Du, Mengfang; Yin, Xinming; Zhang, Songdou; Zhu, Bin; Song, Qisheng; An, Shiheng			Identification of Lipases Involved in PBAN Stimulated Pheromone Production in Bombyx mori Using the DGE and RNAi Approaches	PLOS ONE			English	Article							ACTIVATING NEUROPEPTIDE PBAN; SIGNAL-TRANSDUCTION CASCADE; ADIPOSE-TISSUE; CDNA CLONING; BIOSYNTHESIS; SILKMOTH; HORMONE; EXPRESSION; SILKWORM; GENERATION	Background: Pheromone biosynthesis activating neuropeptide (PBAN) is a neurohormone that regulates sex pheromone synthesis in female moths. Bombyx mori is a model organism that has been used to explore the signal transduction pattern of PBAN, which is mediated by a G-protein coupled receptor (GPCR). Although significant progress has been made in elucidating PBAN-regulated lipolysis that releases the precursor of the sex pheromone, little is known about the molecular components involved in this step. To better elucidate the molecular mechanisms of PBAN-stimulated lipolysis of cytoplasmic lipid droplets (LDs), the associated lipase genes involved in PBAN-regulated sex pheromone biosynthesis were identified using digital gene expression (DGE) and subsequent RNA interference (RNAi). Results: Three DGE libraries were constructed from pheromone glands (PGs) at different developed stages, namely, 72 hours before eclosion (272 h), new emergence (0 h) and 72 h after eclosion (-72 h), to investigate the gene expression profiles during PG development. The DGE evaluated over 5.6 million clean tags in each PG sample and revealed numerous genes that were differentially expressed at these stages. Most importantly, seven lipases were found to be richly expressed during the key stage of sex pheromone synthesis and release (new emergence). RNAi-mediated knockdown confirmed for the first time that four of these seven lipases play important roles in sex pheromone synthesis. Conclusion: This study has identified four lipases directly involved in PBAN-stimulated sex pheromone biosynthesis, which improve our understanding of the lipases involved in releasing bombykol precursors from triacylglycerols (TAGs) within the cytoplasmic LDs.	[Du, Mengfang; Yin, Xinming; Zhang, Songdou; Zhu, Bin; An, Shiheng] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Henan Agricultural University; University of Missouri System; University of Missouri Columbia	Du, MF (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China.	anshiheng@yahoo.com.cn			Distinguished Professor Foundation of Henan Agricultural University [30600022]; Natural Science Foundation of Henan Province [2011B180021]	Distinguished Professor Foundation of Henan Agricultural University; Natural Science Foundation of Henan Province	This study was supported by a Distinguished Professor Foundation of Henan Agricultural University (No: 30600022) and Natural Science Foundation of Henan Province (No: 2011B180021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Hull JJ, 2010, INSECT MOL BIOL, V19, P553, DOI 10.1111/j.1365-2583.2010.01013.x; Hull JJ, 2009, J BIOL CHEM, V284, P31200, DOI 10.1074/jbc.M109.044198; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto S, 2002, INSECT BIOCHEM MOLEC, V32, P1447, DOI 10.1016/S0965-1748(02)00065-6; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; Matsumoto S, 2007, J INSECT PHYSIOL, V53, P752, DOI 10.1016/j.jinsphys.2007.02.014; Matsumoto S, 2010, VITAM HORM, V83, P425, DOI 10.1016/S0083-6729(10)83018-3; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Ohnishi A, 2011, J BIOL CHEM, V286, P24101, DOI 10.1074/jbc.M111.250555; Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rafaeli Ada, 2003, P107, DOI 10.1016/B978-012107151-6/50007-4; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Tsfadia O, 2008, INSECT BIOCHEM MOLEC, V38, P552, DOI 10.1016/j.ibmb.2008.01.005; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	30	26	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31045	10.1371/journal.pone.0031045	http://dx.doi.org/10.1371/journal.pone.0031045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359564	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200033
J	Gaston, J; Rios, BQ; Bartlett, R; Berchtold, C; Thibeault, SL				Gaston, Joel; Rios, Beatriz Quinchia; Bartlett, Rebecca; Berchtold, Craig; Thibeault, Susan L.			The Response of Vocal Fold Fibroblasts and Mesenchymal Stromal Cells to Vibration	PLOS ONE			English	Article							TISSUE-ENGINEERED BONE; FUNDAMENTAL-FREQUENCY; STEM-CELLS; BIOREACTOR; STIMULATION; COLLAGEN; STRAIN; GROWTH	Illumination of cellular changes caused by mechanical forces present within the laryngeal microenvironment may well guide strategies for tissue engineering the vocal fold lamina propria. The purpose of this study was to compare the response of human vocal fold fibroblasts (hVFF) and bone marrow mesenchymal stem cells (BM-MSC) to vibratory stimulus. In order to study these effects, a bioreactor capable of vibrating two cell seeded substrates was developed. The cell seeded substrates contact each other as a result of the sinusoidal frequency, producing a motion similar to the movement of true vocal folds. Utilizing this bioreactor, hVFF and BM-MSC were subjected to 200 Hz vibration and 20% strain for 8 hours. Immunohistochemistry (Ki-67 and TUNEL) was performed to examine cell proliferation and apoptosis respectively, while semi-quantitative RT-PCR was used to assess extracellular matrix related gene expression. HVFF significantly proliferated (p = 0.011) when subjected to 200 Hz vibration and 20% strain, while BM-MSC did not (p = 1.0). A statistically significant increase in apoptosis of BM-MSC (p = 0.0402) was observed under the experimental conditions; however high cell viability (96%) was maintained. HVFF did not have significantly altered apoptosis (p = 0.7849) when subjected to vibration and strain. Semi-quantitative RT-PCR results show no significant differences in expression levels of collagen I (BM-MSC p = 0.1951, hVFF p = v0.3629), fibronectin (BM-MSC p = 0.1951, hVFF p = 0.2513), and TGF-beta 1 (BM-MSC p = 0.2534, hVFF p = 0.6029) between vibratory and static conditions in either cell type. Finally, smooth muscle actin mRNA was not present in either vibrated or static samples, indicating that no myofibroblast differentiation occurred for either cell type. Together, these results demonstrate that BM-MSC may be a suitable alternative to hVFF for vocal fold tissue engineering. Further investigation into a larger number of gene markers, protein levels, increased number of donors and vibratory conditions are warranted.	[Gaston, Joel; Thibeault, Susan L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Rios, Beatriz Quinchia; Bartlett, Rebecca; Berchtold, Craig; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gaston, J (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	thibeault@surgery.wisc.edu			National Institutes of Health-National Institute for Deafness and other Communcation Disorders [R01 DC4336]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004336] Funding Source: NIH RePORTER	National Institutes of Health-National Institute for Deafness and other Communcation Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health-National Institute for Deafness and other Communcation Disorders R01 DC4336 and philanthropic support from David and Katherine Bradley. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Branski RC, 2009, ANN OTO RHINOL LARYN, V118, P218, DOI 10.1177/000348940911800310; Catten M, 1998, OTOLARYNG HEAD NECK, V118, P663, DOI 10.1177/019459989811800516; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Hahn MS, 2007, ANN BIOMED ENG, V35, P190, DOI 10.1007/s10439-006-9099-3; Hanson SE, 2010, LARYNGOSCOPE, V120, P546, DOI 10.1002/lary.20797; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; Hirano M, 1999, ACTA OTO-LARYNGOL, V119, P271; Hunter EJ, 2010, J SPEECH LANG HEAR R, V53, P862, DOI 10.1044/1092-4388(2009/09-0040); Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044; Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Kim SG, 2002, CELL STRUCT FUNCT, V27, P139, DOI 10.1247/csf.27.139; Klemuk SA, 2008, J ACOUST SOC AM, V124, P2330, DOI 10.1121/1.2973183; Laboureau J, 2004, EXP DERMATOL, V13, P70, DOI 10.1111/j.0906-6705.2004.00117.x; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4; Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Roddy KA, 2011, J BIOMECH, V44, P143, DOI 10.1016/j.jbiomech.2010.08.039; TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562; Titze IR, 2001, OCCUPATIONAL VOICE: CARE AND CURE, P1; Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wolchok JC, 2009, BIOMATERIALS, V30, P327, DOI 10.1016/j.biomaterials.2008.08.035	32	46	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30965	10.1371/journal.pone.0030965	http://dx.doi.org/10.1371/journal.pone.0030965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359557	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200026
J	Jayaraman, A; Chandrasekaran, A; Viswanathan, K; Raman, R; Fox, JG; Sasisekharan, R				Jayaraman, Akila; Chandrasekaran, Aarthi; Viswanathan, Karthik; Raman, Rahul; Fox, James G.; Sasisekharan, Ram			Decoding the Distribution of Glycan Receptors for Human-Adapted Influenza A Viruses in Ferret Respiratory Tract	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; TRANSMISSION; SPECIFICITY; INFECTION; CELLS; MODEL; HOST; HEMAGGLUTININ; PATHOGENESIS; CULTURES	Ferrets are widely used as animal models for studying influenza A viral pathogenesis and transmissibility. Human-adapted influenza A viruses primarily target the upper respiratory tract in humans (infection of the lower respiratory tract is observed less frequently), while in ferrets, upon intranasal inoculation both upper and lower respiratory tract are targeted. Viral tropism is governed by distribution of complex sialylated glycan receptors in various cells/tissues of the host that are specifically recognized by influenza A virus hemagglutinin (HA), a glycoprotein on viral surface. It is generally known that upper respiratory tract of humans and ferrets predominantly express alpha 2 -> 6 sialylated glycan receptors. However much less is known about the fine structure of these glycan receptors and their distribution in different regions of the ferret respiratory tract. In this study, we characterize distribution of glycan receptors going beyond terminal sialic acid linkage in the cranial and caudal regions of the ferret trachea (upper respiratory tract) and lung hilar region (lower respiratory tract) by multiplexing use of various plant lectins and human-adapted HAs to stain these tissue sections. Our findings show that the sialylated glycan receptors recognized by human-adapted HAs are predominantly distributed in submucosal gland of lung hilar region as a part of O-linked glycans. Our study has implications in understanding influenza A viral pathogenesis in ferrets and also in employing ferrets as animal models for developing therapeutic strategies against influenza.	[Jayaraman, Akila; Chandrasekaran, Aarthi; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram] Koch Inst Integrat Canc Res, Singapore Massachusetts Inst Technol Alliance Res, Dept Biol Engn, Harvard Massachusetts Inst Technol Div Hlth Sci &, Cambridge, MA USA; [Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Jayaraman, A (corresponding author), Koch Inst Integrat Canc Res, Singapore Massachusetts Inst Technol Alliance Res, Dept Biol Engn, Harvard Massachusetts Inst Technol Div Hlth Sci &, Cambridge, MA USA.	rams@mit.edu			Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Singapore-Massachusetts Institute of Technology Alliance for Research and Technology. The confocal microscopy analysis of the tissue sections was performed at the W. M. Keck Imaging Facility in the Whitehead Institute at Massachusetts Institute of Technology (MIT). The authors would like to acknowledge Dr. Nicki Parry and Chakib Boussahmain from the Division of Comparative Medicine (MIT) for providing the ferret lung hilar tissue sections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; GAMBARYAN AS, 1995, FEBS LETT, V366, P57, DOI 10.1016/0014-5793(95)00488-U; Garcia-Sastre A, 2010, AM J PATHOL, V176, P1584, DOI 10.2353/ajpath.2010.100066; HUSSEINI RH, 1983, J GEN VIROL, V64, P589, DOI 10.1099/0022-1317-64-3-589; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield KG, 2007, AM J PATHOL, V171, P1089, DOI 10.2353/ajpath.2007.070695; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Memoli MJ, 2011, J INFECT DIS, V203, P348, DOI 10.1093/infdis/jiq067; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; PERINI JM, 1991, EUR J BIOCHEM, V196, P321, DOI 10.1111/j.1432-1033.1991.tb15820.x; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Triana-Baltzer GB, 2010, J ANTIMICROB CHEMOTH, V65, P275, DOI 10.1093/jac/dkp421; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09	30	49	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e27517	10.1371/journal.pone.0027517	http://dx.doi.org/10.1371/journal.pone.0027517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359533	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200002
J	Lawless, C; Jurk, D; Gillespie, CS; Shanley, D; Saretzki, G; von Zglinicki, T; Passos, JF				Lawless, Conor; Jurk, Diana; Gillespie, Colin S.; Shanley, Daryl; Saretzki, Gabriele; von Zglinicki, Thomas; Passos, Joao F.			A Stochastic Step Model of Replicative Senescence Explains ROS Production Rate in Ageing Cell Populations	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; HUMAN FIBROBLASTS; SUPEROXIDE-DISMUTASE; SHORTENS TELOMERES; LUNG FIBROBLASTS; DNA-DAMAGE; IN-VIVO; ACCUMULATION; MITOCHONDRIA	Increases in cellular Reactive Oxygen Species (ROS) concentration with age have been observed repeatedly in mammalian tissues. Concomitant increases in the proportion of replicatively senescent cells in ageing mammalian tissues have also been observed. Populations of mitotic human fibroblasts cultured in vitro, undergoing transition from proliferation competence to replicative senescence are useful models of ageing human tissues. Similar exponential increases in ROS with age have been observed in this model system. Tracking individual cells in dividing populations is difficult, and so the vast majority of observations have been cross-sectional, at the population level, rather than longitudinal observations of individual cells. One possible explanation for these observations is an exponential increase in ROS in individual fibroblasts with time (e.g. resulting from a vicious cycle between cellular ROS and damage). However, we demonstrate an alternative, simple hypothesis, equally consistent with these observations which does not depend on any gradual increase in ROS concentration: the Stochastic Step Model of Replicative Senescence (SSMRS). We also demonstrate that, consistent with the SSMRS, neither proliferation-competent human fibroblasts of any age, nor populations of hTERT overexpressing human fibroblasts passaged beyond the Hayflick limit, display high ROS concentrations. We conclude that longitudinal studies of single cells and their lineages are now required for testing hypotheses about roles and mechanisms of ROS increase during replicative senescence.	[Lawless, Conor] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lawless, Conor; Jurk, Diana; Gillespie, Colin S.; Shanley, Daryl; Saretzki, Gabriele; von Zglinicki, Thomas; Passos, Joao F.] Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jurk, Diana; Shanley, Daryl; Saretzki, Gabriele; von Zglinicki, Thomas; Passos, Joao F.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gillespie, Colin S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Lawless, C (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Joao.Passos@ncl.ac.uk	Saretzki, Gabriele Christine/I-7175-2019	Saretzki, Gabriele Christine/0000-0003-2100-8223; Lawless, Conor/0000-0002-4186-8506; Passos, Joao/0000-0001-8765-1890; Jurk, Diana/0000-0003-4486-0857; Shanley, Daryl/0000-0003-3096-6386; von Zglinicki, Thomas/0000-0002-5939-0248; Gillespie, Colin/0000-0003-1787-0275	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom; BBSRC; BBSRC [BB/I020748/1, BB/H022384/1, BB/F010966/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H022384/1, BB/I020748/1, BB/F010966/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom. JFP is funded by a BBSRC David Phillips Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EK, 2010, AGING CELL, V9, P252, DOI 10.1111/j.1474-9726.2010.00555.x; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Allen RG, 1999, J CELL PHYSIOL, V180, P114, DOI 10.1002/(SICI)1097-4652(199907)180:1<114::AID-JCP13>3.0.CO;2-0; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890; de Magalhaes JP, 2006, EXP GERONTOL, V41, P1, DOI 10.1016/j.exger.2005.09.002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; MITSUI Y, 1976, EXP CELL RES, V100, P147, DOI 10.1016/0014-4827(76)90336-0; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Sitte N, 2001, EXP GERONTOL, V36, P475, DOI 10.1016/S0531-5565(00)00253-9; Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8; SMITH JR, 1980, SCIENCE, V207, P82; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	42	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32117	10.1371/journal.pone.0032117	http://dx.doi.org/10.1371/journal.pone.0032117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359661	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200130
J	Morales, O; Richard, A; Martin, N; Mrizak, D; Senechal, M; Miroux, C; Pancre, V; Rommelaere, J; Caillet-Fauquet, P; de Launoit, Y; Delhem, N				Morales, Olivier; Richard, Audrey; Martin, Nathalie; Mrizak, Dhafer; Senechal, Magalie; Miroux, Celine; Pancre, Veronique; Rommelaere, Jean; Caillet-Fauquet, Perrine; de Launoit, Yvan; Delhem, Nadira			Activation of a Helper and Not Regulatory Human CD4+T Cell Response by Oncolytic H-1 Parvovirus	PLOS ONE			English	Article							RESTRICTED TUMOR-ANTIGENS; CD4(+) T-CELLS; MINUTE VIRUS; ANTITUMOR IMMUNITY; REPLICATIVE FUNCTIONS; FUTURE-DIRECTIONS; IN-VIVO; MICE; CANCER; VIROTHERAPY	Background: H-1 parvovirus (H-1 PV), a rodent autonomous oncolytic parvovirus, has emerged as a novel class of promising anticancer agents, because of its ability to selectively find and destroy malignant cells. However, to probe H-1 PV multimodal antitumor potential one of the major prerequisites is to decipher H-1 PV direct interplay with human immune system, and so prevent any risk of impairment. Methodology/Principal findings: Non activated peripheral blood mononuclear cells (PBMCs) are not sensitive to H-1 PV cytotoxic effect. However, the virus impairs both activated PBMC proliferation ability and viability. This effect is related to H-1 PV infection as evidenced by Western blotting detection of H-1 PV main protein NS1. However, TCID50 experiments did not allow newly generated virions to be detected. Moreover, flow cytometry has shown that H-1 PV preferentially targets B lymphocytes. Despite seeming harmful at first sight, H-1 PV seems to affect very few NK cells and CD8+ T lymphocytes and, above all, clearly does not affect human neutrophils and one of the major CD4+ T lymphocyte subpopulation. Very interestingly, flow cytometry analysis and ELISA assays proved that it even activates human CD4+ T cells by increasing activation marker expression (CD69 and CD30) and both effective Th1 and Th2 cytokine secretion (IL-2, IFN-gamma and IL-4). In addition, H-1 PV action does not come with any sign of immunosuppressive side effect. Finally, we have shown the efficiency of H-1 PV on xenotransplanted human nasopharyngeal carcinoma, in a SCID mouse model reconstituted with human PBMC. Conclusions/Significance: Our results show for the first time that a wild-type oncolytic virus impairs some immune cell subpopulations while directly activating a Helper CD4+ T cell response. Thus, our data open numerous gripping perspectives of investigation and strongly argue for the use of H-1 PV as an anticancer treatment.	[Morales, Olivier; Richard, Audrey; Martin, Nathalie; Mrizak, Dhafer; Senechal, Magalie; Miroux, Celine; Pancre, Veronique; Caillet-Fauquet, Perrine; de Launoit, Yvan; Delhem, Nadira] Univ Lille Nord France, Inst Biol Lille, CNRS, Inst Pasteur Lille,UMR 8161, Lille, France; [Rommelaere, Jean] Deutsch Krebsforschungszentrum, Res Program Infect & Canc, D-6900 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Helmholtz Association; German Cancer Research Center (DKFZ)	Morales, O (corresponding author), Univ Lille Nord France, Inst Biol Lille, CNRS, Inst Pasteur Lille,UMR 8161, Lille, France.	nadira.delhem@ibl.fr	Pancre, Véronique/L-8206-2018; MORALES, Olivier/AAR-5337-2020	de Launoit, Yvan/0000-0003-1837-9808; MORALES, Olivier/0000-0002-2135-3265				Angelova AL, 2009, CLIN CANCER RES, V15, P511, DOI 10.1158/1078-0432.CCR-08-1088; CAILLETFAUQUET P, 1990, EMBO J, V9, P2989, DOI 10.1002/j.1460-2075.1990.tb07491.x; CORNELIS JJ, 1988, J VIROL, V62, P3438, DOI 10.1128/JVI.62.9.3438-3444.1988; Daeffler L, 2003, J VIROL, V77, P12466, DOI 10.1128/JVI.77.23.12466-12478.2003; DEBEECK AO, 1995, CELL GROWTH DIFFER, V6, P781; Deleu L, 1999, J VIROL, V73, P3877, DOI 10.1128/JVI.73.5.3877-3885.1999; Depil S, 2007, J IMMUNOTHER, V30, P215, DOI 10.1097/01.cji.0000211338.99137.4f; FAISST S, 1995, J VIROL, V69, P4538, DOI 10.1128/JVI.69.7.4538-4543.1995; Geletneky K, 2010, NEURO-ONCOLOGY, V12, P804, DOI 10.1093/neuonc/noq023; Grekova S, 2010, CANCER BIOL THER, V10, P1280, DOI 10.4161/cbt.10.12.13455; Hristov G, 2010, J VIROL, V84, P5909, DOI 10.1128/JVI.01797-09; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Lachmann S, 2003, J VIROL, V77, P8048, DOI 10.1128/JVI.77.14.8048-8060.2003; Moehler M, 2001, CANCER GENE THER, V8, P158, DOI 10.1038/sj.cgt.7700288; Moehler MH, 2005, HUM GENE THER, V16, P996, DOI 10.1089/hum.2005.16.996; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muharram G, 2010, BREAST CANCER RES TR, V121, P23, DOI 10.1007/s10549-009-0451-9; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Nomura T, 2005, CURR TOP MICROBIOL, V293, P287, DOI 10.1007/3-540-27702-1_13; Nuesch JPF, 2003, J VIROL, V77, P433, DOI 10.1128/JVI.77.1.433-442.2003; Ostrand-Rosenberg S, 2005, CANCER INVEST, V23, P413, DOI 10.1081/CNV-200067428; Penault-Llorca F, 2002, Cancer Radiother, V6 Suppl 1, p24s; Raykov Z, 2007, ONCOL REP, V17, P1493; Reilly R T, 2001, Curr Opin Investig Drugs, V2, P133; RHODE SL, 1985, J VIROL, V55, P886, DOI 10.1128/JVI.55.3.886-889.1985; ROMMELAERE J, 1991, J VIROL METHODS, V33, P233, DOI 10.1016/0166-0934(91)90024-T; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Thorne SH, 2004, EXPERT OPIN BIOL TH, V4, P1307, DOI 10.1517/14712598.4.8.1307; Toda M, 1999, HUM GENE THER, V10, P385, DOI 10.1089/10430349950018832; Wan YSY, 2010, IMMUNOLOGY, V130, P166, DOI 10.1111/j.1365-2567.2010.03289.x; Wang RF, 2003, METHODS, V29, P227, DOI 10.1016/S1046-2023(02)00345-6; Wang RF, 2001, TRENDS IMMUNOL, V22, P269, DOI 10.1016/S1471-4906(01)01896-8; White CA, 2001, ANNU REV MED, V52, P125, DOI 10.1146/annurev.med.52.1.125; Wilczynski JR, 2008, FRONT BIOSCI-LANDMRK, V13, P2266, DOI 10.2741/2840; Wizla P, 2010, ARCH VIROL, V155, P771, DOI 10.1007/s00705-010-0637-9; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Zhang W, 2009, J IMMUNOTOXICOL; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	39	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32197	10.1371/journal.pone.0032197	http://dx.doi.org/10.1371/journal.pone.0032197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359669	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200138
J	Singh, JP; Grann, M; Lichtenstein, P; Langstrom, N; Fazel, S				Singh, Jay P.; Grann, Martin; Lichtenstein, Paul; Langstrom, Niklas; Fazel, Seena			A Novel Approach to Determining Violence Risk in Schizophrenia: Developing a Stepped Strategy in 13,806 Discharged Patients	PLOS ONE			English	Article							SEVERE MENTAL-ILLNESS; AGGRESSIVE-BEHAVIOR; SUBSTANCE-ABUSE; BIRTH COHORT; FOLLOW-UP; DISORDERS; CRIME; TESTOSTERONE; PSYCHOPATHY; PSYCHOSIS	Clinical guidelines recommend that violence risk be assessed in schizophrenia. Current approaches are resource-intensive as they employ detailed clinical assessments of dangerousness for most patients. An alternative approach would be to first screen out patients at very low risk of future violence prior to more costly and time-consuming assessments. In order to implement such a stepped strategy, we developed a simple tool to screen out individuals with schizophrenia at very low risk of violent offending. We merged high quality Swedish national registers containing information on psychiatric diagnoses, socio-demographic factors, and violent crime. A cohort of 13,806 individuals with hospital discharge diagnoses of schizophrenia was identified and followed for up to 33 years for violent crime. Cox regression was used to determine risk factors for violent crime and construct the screening tool, the predictive validity of which was measured using four outcome statistics. The instrument was calibrated on 6,903 participants and cross-validated using three independent replication samples of 2,301 participants each. Regression analyses resulted in a tool composed of five items: male sex, previous criminal conviction, young age at assessment, comorbid alcohol abuse, and comorbid drug abuse. At 5 years after discharge, the instrument had a negative predictive value of 0.99 (95% CI = 0.98-0.99), meaning that very few individuals who the tool screened out (n = 2,359 out of original sample of 6,903) were subsequently convicted of a violent offence. Screening out patients who are at very low risk of violence prior to more detailed clinical assessment may assist the risk assessment process in schizophrenia.	[Singh, Jay P.; Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Grann, Martin; Langstrom, Niklas] Karolinska Inst, Ctr Violence Prevent, Stockholm, Sweden; [Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oxford; Karolinska Institutet; Karolinska Institutet	Singh, JP (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008; Langstrom, Niklas/C-5615-2009	Fazel, Seena/0000-0002-5383-5365; Langstrom, Niklas/0000-0002-2686-6799; lichtenstein, paul/0000-0003-3037-5287	Swedish Research Council (Medicine)	Swedish Research Council (Medicine)(Swedish Research Council)	Support for this study was provided by The Swedish Research Council (Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2004, PRACT GUID TREATM PA; Andrews D.A., 2006, PSYCHOL CRIMINAL CON, Vfourth; Andrews DA., 1995, LSI R LEVEL SERVICE; [Anonymous], 2009, SPSS WIND REL 17 0 1; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Bjorkly S, 2002, AGGRESS VIOLENT BEH, V7, P617, DOI 10.1016/S1359-1789(01)00049-0; Blair PR, 2008, CLIN PSYCHOL-SCI PR, V15, P346, DOI 10.1111/j.1468-2850.2008.00147.x; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Breslow NE, 1987, STAT METHODS CANC RE; Buckley PF, 2004, AM J PSYCHIAT, V161, P1712, DOI 10.1176/appi.ajp.161.9.1712; Cannon M, 2002, BRIT J PSYCHIAT, V180, P496, DOI 10.1192/bjp.180.6.496; COX DR, 1972, J R STAT SOC B, V34, P187; Dean K, 2007, PSYCHOL MED, V37, P547, DOI 10.1017/S0033291706008920; Dolmen L, 2001, BROTTSL 1 OL LAND; Farrington DP, 2004, TAKING STOCK DELINQU; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Green AI, 2007, AM J PSYCHIAT, V164, P402, DOI 10.1176/appi.ajp.164.3.402; Gupta S, 1998, PSYCHIAT SERV, V49, P1353, DOI 10.1176/ps.49.10.1353; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hanson R.K., 2004, PREDICTORS SEXUAL RE; Hansson L, 2001, ACTA PSYCHIAT SCAND, V103, P45, DOI 10.1034/j.1600-0447.2001.00083.x; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Honest H, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-4; Jones G, 2001, BRIT J PSYCHIAT, V179, P351, DOI 10.1192/bjp.179.4.351; Kass GV, 1980, J R STAT SOC C-APPL, P119; Khiroya R, 2009, PSYCHIATR BULL, V33, P129, DOI 10.1192/pb.bp.108.019810; Large MM, 2011, HARVARD REV PSYCHIAT, V19, P25, DOI 10.3109/10673229.2011.549770; Large MM, 2010, PSYCHIAT SERV, V61, P530, DOI 10.1176/appi.ps.61.5.530; LINDQVIST P, 1990, BRIT J PSYCHIAT, V157, P345, DOI 10.1192/bjp.157.3.345; MedCalc Software, 2010, MEDCALC VERS 11 3 8; Mills Jeremy F, 2006, Crim Behav Ment Health, V16, P155, DOI 10.1002/cbm.623; Monahan J, 2000, BRIT J PSYCHIAT, V176, P312, DOI 10.1192/bjp.176.4.312; Murrie DC, 2005, LAW HUMAN BEHAV, V29, P323, DOI 10.1007/s10979-005-2415-x; National Institute for Health and Clinical Excellence, 2009, COR INT TREATM MAN S; Pedhazur EJ., 1997, MULTIPLE REGRESSION, V3rd ed; Pilowsky DJ, 2009, AM J PUBLIC HEALTH, V99, P258, DOI 10.2105/AJPH.2008.139006; Pope HG, 2000, ARCH GEN PSYCHIAT, V57, P133, DOI 10.1001/archpsyc.57.2.133; Quinsey V. L., 2006, VIOLENT OFFENDERS AP, V2nd, DOI 10.1037/11367-000; Rasanen P, 1998, SCHIZOPHRENIA BULL, V24, P437, DOI 10.1093/oxfordjournals.schbul.a033338; Reutfors J, 2010, SCHIZOPHR RES, V123, P251, DOI 10.1016/j.schres.2010.07.014; Roaldset JO, 2011, EUR PSYCHIAT, V26, P85, DOI 10.1016/j.eurpsy.2010.04.002; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Singh JP, 2011, SCHIZOPHRENIA BULL, V37, P899, DOI 10.1093/schbul/sbr093; Singh JP, 2011, CLIN PSYCHOL REV, V31, P499, DOI 10.1016/j.cpr.2010.11.009; Singh JP, 2010, CRIM JUSTICE BEHAV, V37, P965, DOI 10.1177/0093854810374274; Sjostedt G., 2002, INT J FORENSIC MENT, V1, P179, DOI [DOI 10.1080/14999013.2002.10471172, https://doi.org/10.1080/14999013.2002.10471172]; Smith RA, 2011, CA-CANCER J CLIN, V61, P8, DOI 10.3322/caac.20096; Soyka M, 2007, SCHIZOPHR RES, V94, P89, DOI 10.1016/j.schres.2007.03.027; Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103; StataCorp, 2007, STATA STAT SOFTW REL; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Stuart HL, 2001, PSYCHIAT SERV, V52, P654, DOI 10.1176/appi.ps.52.5.654; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; Swartz MS, 1998, AM J PSYCHIAT, V155, P226; Swets J A, 2000, Psychol Sci Public Interest, V1, P1, DOI 10.1111/1529-1006.001; Szmukler G, 2001, PSYCHIATRIST, V25, P359; Taiminen T, 2001, SCHIZOPHR RES, V47, P199, DOI 10.1016/S0920-9964(00)00126-2; Viljoen JL, 2010, ASSESSMENT, V17, P377, DOI 10.1177/1073191109359587; Walsh E, 2004, SCHIZOPHR RES, V67, P247, DOI 10.1016/S0920-9964(03)00091-4; Walsh E, 2002, BRIT J PSYCHIAT, V180, P490, DOI 10.1192/bjp.180.6.490; WATTS D, 2004, J MENTAL HLTH, V13, P569; Webster C, 1995, COPING PSYCHIAT PSYC; Webster C.D., 2009, MANUAL SHORT TERM AS; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Wootton L, 2008, SCHIZOPHR RES, V101, P176, DOI 10.1016/j.schres.2007.12.490; World Health Organization, 2008, GLOB BURD DIS 2004 U	72	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31727	10.1371/journal.pone.0031727	http://dx.doi.org/10.1371/journal.pone.0031727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359622	gold, Green Published			2022-12-27	WOS:000302796200091
J	Su, HR; Jiang, L; Carter-Su, C; Rui, LY				Su, Haoran; Jiang, Lin; Carter-Su, Christin; Rui, Liangyou			Glucose Enhances Leptin Signaling through Modulation of AMPK Activity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIET-INDUCED OBESITY; ENERGY-BALANCE; CELL-GROWTH; OB RECEPTOR; FOOD-INTAKE; LONG FORM; RESISTANCE; IDENTIFICATION; MICE	Leptin exerts its action by binding to and activating the long form of leptin receptors (LEPRb). LEPRb activates JAK2 that subsequently phosphorylates and activates STAT3. The JAK2/STAT3 pathway is required for leptin control of energy balance and body weight. Defects in leptin signaling lead to leptin resistance, a primary risk factor for obesity. Body weight is also regulated by nutrients, including glucose. Defects in glucose sensing also contribute to obesity. Here we report crosstalk between leptin and glucose. Glucose starvation blocked the ability of leptin to stimulate tyrosyl phosphorylation and activation of JAK2 and STAT3 in a variety of cell types. Glucose dose-dependently enhanced leptin signaling. In contrast, glucose did not enhance growth hormone-stimulated phosphorylation of JAK2 and STAT5. Glucose starvation or 2-deoxyglucose-induced inhibition of glycolysis activated AMPK and inhibited leptin signaling; pharmacological inhibition of AMPK restored the ability of leptin to stimulate STAT3 phosphorylation. Conversely, pharmacological activation of AMPK was sufficient to inhibit leptin signaling and to block the ability of glucose to enhance leptin signaling. These results suggest that glucose and/or its metabolites play a permissive role in leptin signaling, and that glucose enhances leptin sensitivity at least in part by attenuating the ability of AMPK to inhibit leptin signaling.	[Su, Haoran; Jiang, Lin; Carter-Su, Christin; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Su, HR (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	Jiang, Lin/E-7468-2012		National Institutes of Health (NIH) [RO1-DK065122, RO1-DK073601, 5P60 DK20572, 5 P30 CA46592, P30AG013283, DK34933]; American Diabetes Association [1-09-RA-156]; Michigan Diabetes Research and Training Center; University of Michigan's Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R01DK065122, P30DK034933, R01DK073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants RO1-DK065122, RO1-DK073601, and RO1-DK073601 from the National Institutes of Health (NIH); and by a research award 1-09-RA-156 from the American Diabetes Association. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (funded by NIH 5P60 DK20572), the University of Michigan's Cancer Center (funded by NIH 5 P30 CA46592), the University of Michigan Nathan Shock Center (funded by NIH P30AG013283), and the University of Michigan Gut Peptide Research Center (funded by NIH DK34933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Campfield LA, 2003, PHYSIOL REV, V83, P25, DOI 10.1152/physrev.00019.2002; Carpenter LR, 1998, P NATL ACAD SCI USA, V95, P6061, DOI 10.1073/pnas.95.11.6061; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gong Y, 2007, J BIOL CHEM, V282, P31019, DOI 10.1074/jbc.M702838200; GONZALEZMANCHON C, 1991, NEUROENDOCRINOLOGY, V54, P373, DOI 10.1159/000125916; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hekerman P, 2005, FEBS J, V272, P109, DOI 10.1111/j.1432-1033.2004.04391.x; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Jiang L, 2008, J BIOL CHEM, V283, P28066, DOI 10.1074/jbc.M805545200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim HK, 2011, ENDOCRINOLOGY, V152, P4672, DOI 10.1210/en.2011-1221; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Li MH, 2007, ENDOCRINOLOGY, V148, P1615, DOI 10.1210/en.2006-1010; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MISELIS RR, 1975, AM J PHYSIOL, V229, P1438, DOI 10.1152/ajplegacy.1975.229.5.1438; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Morrison CD, 2007, ENDOCRINOLOGY, V148, P433, DOI 10.1210/en.2006-0672; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Routh VH, 2010, SENSORS-BASEL, V10, P9002, DOI 10.3390/s101009002; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Smit LS, 1997, ENDOCRINOLOGY, V138, P3426, DOI 10.1210/en.138.8.3426; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; White CL, 2008, AM J PHYSL ENDOCRINO; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	48	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31636	10.1371/journal.pone.0031636	http://dx.doi.org/10.1371/journal.pone.0031636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359610	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200079
J	Zhang, XM; Grusche, FA; Harvey, KF				Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.			Control of Tissue Growth and Cell Transformation by the Salvador/Warts/Hippo Pathway	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO SIGNALING PATHWAY; TRANSCRIPTIONAL OUTPUT; CONTACT INHIBITION; TEAD/TEF FAMILY; ORGAN SIZE; YAP; DROSOPHILA; DOMAIN; YORKIE	The Salvador-Warts-Hippo (SWH) pathway is an important regulator of tissue growth that is frequently subverted in human cancer. The key oncoprotein of the SWH pathway is the transcriptional co-activator, Yes-associated protein (YAP). YAP promotes tissue growth and transformation of cultured cells by interacting with transcriptional regulatory proteins via its WW domains, or, in the case of the TEAD1-4 transcription factors, an N-terminal binding domain. YAP possesses a putative transactivation domain in its C-terminus that is necessary to stimulate transcription factors in vitro, but its requirement for YAP function has not been investigated in detail. Interestingly, whilst the WW domains and TEAD-binding domain are highly conserved in the Drosophila melanogaster YAP orthologue, Yorkie, the majority of the C-terminal region of YAP is not present in Yorkie. To investigate this apparent conundrum, we assessed the functional roles of the YAP and Yorkie C-termini. We found that these regions were not required for Yorkie's ability to drive tissue growth in vivo, or YAP's ability to promote anchorage-independent growth or resistance to contact inhibition. However, the YAP transactivation domain was required for YAP's ability to induce cell migration and invasion. Moreover, a role for the YAP transactivation domain in cell transformation was uncovered when the YAP WW domains were mutated together with the transactivation domain. This shows that YAP can promote cell transformation in a flexible manner, presumably by contacting transcriptional regulatory proteins either via its WW domains or its transactivation domain.	[Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.] Peter MacCallum Canc Ctr, Cell Growth & Proliferat Lab, Melbourne, Vic, Australia; [Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne	Zhang, XM (corresponding author), Peter MacCallum Canc Ctr, Cell Growth & Proliferat Lab, Melbourne, Vic, Australia.	kieran.harvey@petermac.org	Harvey, Kieran/AAD-5268-2022	Harvey, Kieran/0000-0001-7845-369X	Sylvia and Charles Viertel Senior Medical Research Fellowship; Cure Cancer Australia; National Breast Cancer Foundation; Cancer Council Victoria; National Health and Medical Research Council of Australia	Sylvia and Charles Viertel Senior Medical Research Fellowship; Cure Cancer Australia; National Breast Cancer Foundation; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Sylvia and Charles Viertel Senior Medical Research Fellowship to KFH, a Cure Cancer Australia and National Breast Cancer Foundation Fellowship to XZ, a Cancer Council Victoria Fellowship to FAG and a Project Grant from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Oh H, 2011, DEV CELL, V20, P109, DOI 10.1016/j.devcel.2010.12.002; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	38	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31994	10.1371/journal.pone.0031994	http://dx.doi.org/10.1371/journal.pone.0031994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359650	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200119
J	Dehmer, M; Sivakumar, L				Dehmer, Matthias; Sivakumar, Lavanya			Recent Developments in Quantitative Graph Theory: Information Inequalities for Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; ENTROPY; INDEX	In this article, we tackle a challenging problem in quantitative graph theory. We establish relations between graph entropy measures representing the structural information content of networks. In particular, we prove formal relations between quantitative network measures based on Shannon's entropy to study the relatedness of those measures. In order to establish such information inequalities for graphs, we focus on graph entropy measures based on information functionals. To prove such relations, we use known graph classes whose instances have been proven useful in various scientific areas. Our results extend the foregoing work on information inequalities for graphs.	[Dehmer, Matthias; Sivakumar, Lavanya] UMIT, Inst Bioinformat & Translat Res, Hall In Tyrol, Australia		Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tyrol, Australia.	matthias.dehmer@umit.at	Selvaganesh, Lavanya/AAX-8445-2021	Selvaganesh, Lavanya/0000-0002-8208-5372	Austrian Science Fund [PN22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer and Lavanya Sivakumar thank the Austrian Science Fund (Project No. PN22029-N13) for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045102; BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BASAK SC, 1988, DISCRETE APPL MATH, V19, P17, DOI 10.1016/0166-218X(88)90004-2; Basak SC, 1999, TOPOLOGICAL INDICES, P563; Bertz SH, 1983, CHEM APPL TOPOLOGY G, P206; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D, 2003, MATH COMPUTATIONAL C; Bonchev D., 2003, COMPLEXITY INTRO FUN, DOI DOI 10.1201/9781482288247; Bonchev D, 1983, INFORM THEORETIC IND; Bonchev D, 2005, MATH COMPUTATIONAL C, pxx+344, DOI [10.1007/b136300.URLhttp://dx.doi.org/10.1007/b136300, DOI 10.1007/B136300.URL]; Butts CT, 2001, SOC NETWORKS, V23, P31, DOI 10.1016/S0378-8733(01)00030-2; Claussen JC, 2007, PHYSICA A, V375, P365, DOI 10.1016/j.physa.2006.08.067; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015733; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2010, APPL MATH COMPUT, V215, P4263, DOI 10.1016/j.amc.2009.12.051; Dehmer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003079; Emmert-Streib F, 2011, IET SYST BIOL, V5, P185, DOI 10.1049/iet-syb.2010.0025; Emmert-Streib F, 2006, P DMIN 05 INT C DAT, P477; Emmert-Streib F, 2007, APPL MATH COMPUT, V190, P1783, DOI 10.1016/j.amc.2007.02.095; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Korner J., 1973, T 6 PRAG C INF THEOR, P411; LI M, 1997, INTRO KOLMOGOROV COM; Mehler A, 2010, ENTROPY-SWITZ, V12, P1440, DOI 10.3390/e12061440; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shannon CE, 1997, MATH THEORY COMMUNIC; Simonyi G., 1995, COMBINATORIAL OPTIMI, V20, P399; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Wang J, 2009, L N INST COMP SCI SO, V4, P1178	35	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31395	10.1371/journal.pone.0031395	http://dx.doi.org/10.1371/journal.pone.0031395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355362	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300062
J	Martin, F; Nunez, C; Marin, MT; Laorden, ML; Kovacs, KJ; Milanes, MV				Martin, Fatima; Nunez, Cristina; Teresa Marin, M.; Luisa Laorden, M.; Kovacs, Krisztina J.; Victoria Milanes, M.			Involvement of Noradrenergic Transmission in the PVN on CREB Activation, TORC1 Levels, and Pituitary-Adrenal Axis Activity during Morphine Withdrawal	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ELEMENT-BINDING PROTEIN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; FACTOR GENE-EXPRESSION; MESSENGER-RNA; CATECHOLAMINERGIC PATHWAYS; SUPRAOPTIC NUCLEI; RAT HYPOTHALAMUS; BRAIN STRESS; PHOSPHORYLATION	Experimental and clinical findings have shown that administration of adrenoceptor antagonists alleviated different aspects of drug withdrawal and dependence. The present study tested the hypothesis that changes in CREB activation and phosphorylated TORC1 levels in the hypothalamic paraventricular nucleus (PVN) after naloxone-precipitated morphine withdrawal as well as the HPA axis activity arises from alpha(1)- and/or beta-adrenoceptor activation. The effects of morphine dependence and withdrawal on CREB phosphorylation (pCREB), phosphorylated TORC1 (pTORC1), and HPA axis response were measured by Western-blot, immunohistochemistry and radioimmunoassay in rats pretreated with prazosin (alpha(1)-adrenoceptor antagonist) or propranolol (beta-adrenoceptor antagonist). In addition, the effects of morphine withdrawal on MHPG (the main NA metabolite at the central nervous system) and NA content and turnover were evaluated by HPLC. We found an increase in MHPG and NA turnover in morphine-withdrawn rats, which were accompanied by increased pCREB immunoreactivity and plasma corticosterone concentrations. Levels of the inactive form of TORC1 (pTORC1) were decreased during withdrawal. Prazosin but not propranolol blocked the rise in pCREB level and the decrease in pTORC1 immunoreactivity. In addition, the HPA axis response to morphine withdrawal was attenuated in prazosin-pretreated rats. Present results suggest that, during acute morphine withdrawal, NA may control the HPA axis activity through CREB activation at the PVN level. We concluded that the combined increase in CREB phosphorylation and decrease in pTORC1 levels might represent, in part, two of the mechanisms of CREB activation at the PVN during morphine withdrawal.	[Martin, Fatima; Nunez, Cristina; Luisa Laorden, M.; Victoria Milanes, M.] Univ Murcia, Dept Pharmacol, Grp Cellular & Mol Pharmacol, Sch Med, Murcia, Spain; [Martin, Fatima; Nunez, Cristina; Luisa Laorden, M.; Victoria Milanes, M.] IMIB, Murcia, Spain; [Teresa Marin, M.] Univ Granada, Fac Pharm, Dept Pharm & Pharmaceut Technol, E-18071 Granada, Spain; [Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary	University of Murcia; University of Granada; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Martin, F (corresponding author), Univ Murcia, Dept Pharmacol, Grp Cellular & Mol Pharmacol, Sch Med, Murcia, Spain.	milanes@um.es	Núñez, Cristina/O-8288-2015; Milanés, M Victoria/K-6591-2017; Milanés, M. Victoria/AGB-4075-2022	Núñez, Cristina/0000-0002-0773-4950; Milanés, M Victoria/0000-0002-0984-2218; Milanés, M. Victoria/0000-0002-0984-2218	Ministerio de Ciencia e Innovacion [SAF2009-07178, SAF2010-17907]; Red de Trastornos Adictivos (RTA) [RD06/0001/1006]; Fundacion Seneca [15405/PI/10]; Agencia Regional de Ciencia y Tecnologia, Region de Murcia; University of Murcia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adictivos (RTA); Fundacion Seneca(Fundacion Seneca); Agencia Regional de Ciencia y Tecnologia, Region de Murcia; University of Murcia	This work was supported by Ministerio de Ciencia e Innovacion (SAF2009-07178 and SAF2010-17907), Red de Trastornos Adictivos (RTA; RD06/0001/1006) and Fundacion Seneca (15405/PI/10), Agencia Regional de Ciencia y Tecnologia, Region de Murcia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fatima Martin was supported by a fellowship from the Ministerio de Ciencia e Innovacion. Cristina Nunez was supported by a postdoctoral fellowship from the University of Murcia.	BARABAN SC, 1995, BRAIN RES, V676, P245, DOI 10.1016/0006-8993(95)00097-A; Bittinger MA, 2004, CURR BIOL, V2156, P2161; Blendy JA, 1998, J MOL MED-JMM, V76, P104, DOI 10.1007/s001090050197; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cecchi M, 2002, NEUROPHARMACOLOGY, V43, P1139, DOI 10.1016/S0028-3908(02)00292-7; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; COUCEYRO P, 1995, MOL PHARMACOL, V47, P29; CUNNINGHAM ET, 1988, J COMP NEUROL, V274, P60, DOI 10.1002/cne.902740107; Daftary SS, 2000, NEUROSCIENCE, V96, P743, DOI 10.1016/S0306-4522(00)00003-8; Day HEW, 1999, J NEUROSCI, V19, P10098; Deak T, 1999, ENDOCRINOLOGY, V140, P79, DOI 10.1210/en.140.1.79; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Dunn AJ, 2008, EUR J PHARMACOL, V583, P186, DOI 10.1016/j.ejphar.2007.11.069; Ferenczi S, 2010, NEUROCHEM INT, V57, P323, DOI 10.1016/j.neuint.2010.06.011; Forget B, 2010, NEUROPSYCHOPHARMACOL, V35, P1751, DOI 10.1038/npp.2010.42; FREEDMAN JE, 1985, J NEUROSCI, V5, P3016; GOLD MS, 1978, LANCET, V2, P599; Greenwell TN, 2009, PHARMACOL BIOCHEM BE, V91, P295, DOI 10.1016/j.pbb.2008.07.012; HARRIS GC, 1993, NEUROPSYCHOPHARMACOL, V9, P303, DOI 10.1038/npp.1993.66; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Itoi K, 1999, J NEUROSCI, V19, P5464; Itoi K, 1996, ENDOCRINOLOGY, V137, P2389, DOI 10.1210/en.137.6.2389; ITOI K, 1994, ENDOCRINOLOGY, V135, P2177, DOI 10.1210/en.135.5.2177; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; KATZ JL, 1986, PSYCHOPHARMACOLOGY, V88, P392; Kiss A, 2000, CELL MOL NEUROBIOL, V20, P683, DOI 10.1023/A:1007098724683; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Laorden ML, 2002, BRIT J PHARMACOL, V136, P67, DOI 10.1038/sj.bjp.0704684; Laorden ML, 2002, J NEUROCHEM, V83, P132, DOI 10.1046/j.1471-4159.2002.01123.x; Laorden ML, 2000, J PHARMACOL EXP THER, V293, P578; LIPOSITS Z, 1986, HISTOCHEMISTRY, V85, P95, DOI 10.1007/BF00491754; Liu Y, 2008, ENDOCRINOLOGY, V149, P3512, DOI 10.1210/en.2008-0052; Liu Y, 2010, ENDOCRINOLOGY, V151, P1109, DOI 10.1210/en.2009-0963; Maldonado R, 1997, NEUROSCI BIOBEHAV R, V21, P91, DOI 10.1016/0149-7634(95)00061-5; Martin F, 2011, BRIT J PHARMACOL, V163, P857, DOI 10.1111/j.1476-5381.2011.01287.x; Martin F, 2009, J NEUROCHEM, V110, P1422, DOI 10.1111/j.1471-4159.2009.06234.x; Martin-Fardon R, 2010, BRAIN RES, V1314, P145, DOI 10.1016/j.brainres.2009.12.027; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; Navarro-Zaragoza J, 2010, MOL PHARMACOL, V77, P864, DOI 10.1124/mol.109.062463; Nunez C, 2007, ENDOCRINOLOGY, V148, P5780, DOI 10.1210/en.2007-0510; Nunez C, 2007, J NEUROCHEM, V101, P1060, DOI 10.1111/j.1471-4159.2006.04421.x; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; Otis JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1912, DOI 10.1038/npp.2011.77; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; PLOTSKY PM, 1987, ENDOCRINOLOGY, V121, P924, DOI 10.1210/endo-121-3-924; Rasmussen DD, 2011, ALCOHOLISMNO; SAWCHENKO PE, 1983, J COMP NEUROL, V218, P121, DOI 10.1002/cne.902180202; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Shepard JD, 2005, J NEUROSCI, V25, P4073, DOI 10.1523/JNEUROSCI.0122-05.2005; Simpson TL, 2009, ALCOHOL CLIN EXP RES, V33, P255, DOI 10.1111/j.1530-0277.2008.00807.x; Thonberg H, 2002, BIOCHEM J, V364, P73, DOI 10.1042/bj3640073; TILDERS FJH, 1985, FED PROC, V44, P155; Walker BM, 2008, ALCOHOL, V42, P91, DOI 10.1016/j.alcohol.2007.12.002; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198	57	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31119	10.1371/journal.pone.0031119	http://dx.doi.org/10.1371/journal.pone.0031119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355339	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300039
J	Samuel, JC; Sankhulani, E; Qureshi, JS; Baloyi, P; Thupi, C; Lee, CN; Miller, WC; Cairns, BA; Charles, AG				Samuel, Jonathan C.; Sankhulani, Edward; Qureshi, Javeria S.; Baloyi, Paul; Thupi, Charles; Lee, Clara N.; Miller, William C.; Cairns, Bruce A.; Charles, Anthony G.			Under-Reporting of Road Traffic Mortality in Developing Countries: Application of a Capture-Recapture Statistical Model to Refine Mortality Estimates	PLOS ONE			English	Article							INJURY; EPIDEMIOLOGY	Road traffic injuries are a major cause of preventable death in sub-Saharan Africa. Accurate epidemiologic data are scarce and under-reporting from primary data sources is common. Our objectives were to estimate the incidence of road traffic deaths in Malawi using capture-recapture statistical analysis and determine what future efforts will best improve upon this estimate. Our capture-recapture model combined primary data from both police and hospital-based registries over a one year period (July 2008 to June 2009). The mortality incidences from the primary data sources were 0.075 and 0.051 deaths/1000 person-years, respectively. Using capture-recapture analysis, the combined incidence of road traffic deaths ranged 0.192-0.209 deaths/1000 person-years. Additionally, police data were more likely to include victims who were male, drivers or pedestrians, and victims from incidents with greater than one vehicle involved. We concluded that capture-recapture analysis is a good tool to estimate the incidence of road traffic deaths, and that capture-recapture analysis overcomes limitations of incomplete data sources. The World Health Organization estimated incidence of road traffic deaths for Malawi utilizing a binomial regression model and survey data and found a similar estimate despite strikingly different methods, suggesting both approaches are valid. Further research should seek to improve capture-recapture data through utilization of more than two data sources and improving accuracy of matches by minimizing missing data, application of geographic information systems, and use of names and civil registration numbers if available.	[Samuel, Jonathan C.; Qureshi, Javeria S.; Baloyi, Paul] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi; [Samuel, Jonathan C.; Qureshi, Javeria S.; Lee, Clara N.; Cairns, Bruce A.; Charles, Anthony G.] Univ N Carolina, Sch Med, Dept Surg, Chapel Hill, NC USA; [Sankhulani, Edward; Thupi, Charles] Natl Rd Safety Council, Lilongwe, Malawi; [Miller, William C.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Miller, William C.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Cairns, Bruce A.] Univ N Carolina, N Carolina Jaycee Burn Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Samuel, JC (corresponding author), Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi.	jsamuel@unch.unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	Doris Duke Charitable Foundation; NC Jaycee Burn Center at the University of North Carolina; National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental. [R24 TW007988]; University of North Carolina Center for AIDS Research [P30 AI50410]; University of North Carolina in Lilongwe, Malawi; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA154850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NC Jaycee Burn Center at the University of North Carolina; National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental.; University of North Carolina Center for AIDS Research; University of North Carolina in Lilongwe, Malawi; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Doris Duke Charitable Foundation, the NC Jaycee Burn Center at the University of North Carolina, and by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental & Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases Health, and National Institutes of Health Office of Women's Health and Research through the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988), and by the University of North Carolina Center for AIDS Research Developmental Award (P30 AI50410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors sincerely appreciate the work of the data collection and data entry clerks at Kamuzu Central Hospital and gratefully acknowledge the technical and administrative assistance and support from the University of North Carolina Project in Lilongwe, Malawi, without which this research would not have been possible.	American College of Surgeons Committee on Trauma, 2009, NAT TRAUM DAT BANK A; Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; Gemmell I, 2004, J EPIDEMIOL COMMUN H, V58, P758, DOI 10.1136/2003.008755; Hazen A, 2006, J NATL MED ASSOC, V98, P73; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Jacobs G., 2000, 445 TRL; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; LAPORTE RE, 1995, AM J EPIDEMIOL, V142, P1069, DOI 10.1093/oxfordjournals.aje.a117560; Meuleners LB, 2006, ACCIDENT ANAL PREV, V38, P170, DOI 10.1016/j.aap.2005.09.003; Mock C, 2004, AFRICAN J TRAUMA, V2, P53; Morrison A, 2000, Inj Prev, V6, P299, DOI 10.1136/ip.6.4.299; National Statistics Office of Malawi, 2008, 2008 POP HOUS CENS P; Peden M, 2002, INJURY LEADING CAUSE; Razzak JA, 1998, INT J EPIDEMIOL, V27, P866, DOI 10.1093/ije/27.5.866; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Sasser S., 2005, PREHOSPITAL TRAUMA C; Schuurman N, 2008, CAN J SURG, V51, P389; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Tercero F, 2004, ACCIDENT ANAL PREV, V36, P13, DOI 10.1016/S0001-4575(02)00109-4; World Health Organization, 2009, GLOB STAT REP ROAD S	20	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31091	10.1371/journal.pone.0031091	http://dx.doi.org/10.1371/journal.pone.0031091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355338	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300038
J	Schmitt, DM; O'Dee, DM; Horzempa, J; Carlson, PE; Russo, BC; Bales, JM; Brown, MJ; Nau, GJ				Schmitt, Deanna M.; O'Dee, Dawn M.; Horzempa, Joseph; Carlson, Paul E., Jr.; Russo, Brian C.; Bales, Jacqueline M.; Brown, Matthew J.; Nau, Gerard J.			A Francisella tularensis Live Vaccine Strain That Improves Stimulation of Antigen-Presenting Cells Does Not Enhance Vaccine Efficacy	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; TULAREMIA VACCINE; VIRULENCE; LVS; IMMUNIZATION; ACTIVATION; MICE; SECRETION; INFECTION; RESPONSES	Vaccination is a proven strategy to mitigate morbidity and mortality of infectious diseases. The methodology of identifying and testing new vaccine candidates could be improved with rational design and in vitro testing prior to animal experimentation. The tularemia vaccine, Francisella tularensis live vaccine strain (LVS), does not elicit complete protection against lethal challenge with a virulent type A Francisella strain. One factor that may contribute to this poor performance is limited stimulation of antigen-presenting cells. In this study, we examined whether the interaction of genetically modified LVS strains with human antigen-presenting cells correlated with effectiveness as tularemia vaccine candidates. Human dendritic cells infected with wild-type LVS secrete low levels of proinflammatory cytokines, fail to upregulate costimulatory molecules, and activate human T cells poorly in vitro. One LVS mutant, strain 13B47, stimulated higher levels of proinflammatory cytokines from dendritic cells and macrophages and increased costimulatory molecule expression on dendritic cells compared to wild type. Additionally, 13B47-infected dendritic cells activated T cells more efficiently than LVS-infected cells. A deletion allele of the same gene in LVS displayed similar in vitro characteristics, but vaccination with this strain did not improve survival after challenge with a virulent Francisella strain. In vivo, this mutant was attenuated for growth and did not stimulate T cell responses in the lung comparable to wild type. Therefore, stimulation of antigen-presenting cells in vitro was improved by genetic modification of LVS, but did not correlate with efficacy against challenge in vivo within this model system.	[Schmitt, Deanna M.; O'Dee, Dawn M.; Horzempa, Joseph; Carlson, Paul E., Jr.; Russo, Brian C.; Bales, Jacqueline M.; Brown, Matthew J.; Nau, Gerard J.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Horzempa, Joseph] W Liberty Univ, Dept Nat Sci & Math, W Liberty, WV USA; [Nau, Gerard J.] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA USA; [Nau, Gerard J.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schmitt, DM (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	gjnau@pitt.edu		Nau, Gerard/0000-0001-7921-8317	National Institutes of Health [AI074402, AI050018]; Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074402, T32AI060525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health grants AI074402 and AI050018 and institutional funding from the Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine. DMS is a recipient of T32 AI060525, "Immunology of Infectious Disease." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Baron G S, 1995, Methods Mol Biol, V47, P149; Barrett ADT, 2009, VACCINE, V27, pD2, DOI 10.1016/j.vaccine.2009.07.094; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Carlson PE, 2007, MICROB PATHOGENESIS, V42, P204, DOI 10.1016/j.micpath.2007.02.001; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; De Pascalis R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002494; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 2010, MICROBES INFECT, V12, P28, DOI 10.1016/j.micinf.2009.09.012; FOSHAY L, 1950, ANNU REV MICROBIOL, V4, P313, DOI 10.1146/annurev.mi.04.100150.001525; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Horzempa J, 2008, APPL ENVIRON MICROB, V74, P2161, DOI 10.1128/AEM.02360-07; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Jia QM, 2010, INFECT IMMUN, V78, P4341, DOI 10.1128/IAI.00192-10; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; KADULL PJ, 1950, J IMMUNOL, V65, P425; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Le Nouen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015017; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Loegering DJ, 2006, MICROB PATHOGENESIS, V41, P218, DOI 10.1016/j.micpath.2006.07.007; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Paranavitana C, 2010, J INTERF CYTOK RES, V30, P471, DOI 10.1089/jir.2009.0108; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quill H, 2004, NAT IMMUNOL, V5, P765, DOI 10.1038/ni0804-765; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Russo BC, 2011, INFECT IMMUN, V79, P3665, DOI 10.1128/IAI.00135-11; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; SMALL PLC, 1987, INFECT IMMUN, V55, P1674, DOI 10.1128/IAI.55.7.1674-1679.1987; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Titball RW, 2003, EXPERT OPIN BIOL TH, V3, P645, DOI 10.1517/14712598.3.4.645; Torres VJ, 2007, J IMMUNOL, V179, P5433, DOI 10.4049/jimmunol.179.8.5433; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; West TE, 2008, MICROBES INFECT, V10, P773, DOI 10.1016/j.micinf.2008.04.008; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335	65	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31172	10.1371/journal.pone.0031172	http://dx.doi.org/10.1371/journal.pone.0031172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355343	Green Published, Green Accepted, gold			2022-12-27	WOS:000302741300043
J	Srividya, I; Tirupataiah, S; Mishra, K				Srividya, Indukuri; Tirupataiah, Sirupangi; Mishra, Krishnaveni			Yeast Transcription Termination Factor Rtt103 Functions in DNA Damage Response	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; KU; GENOME; REPAIR; TELOMERE; GENES; MAINTENANCE; INSTABILITY; COMPLEX	YKu70/YKu80 is a heterodimer that is essential for repair of DNA double strand breaks through non-homologous end joining pathway in the yeast Saccharomyces cerevisiae. Yku70/80 proteins are associated with telomeres and are important for maintaining the integrity of telomeres. These proteins protect telomeres from recombination events, nuclease attacks, support the formation of heterochromatin at telomeres and anchor telomeres to the nuclear periphery. To identify components in molecular networks involved in the multiple functions of Yku70/80 complex, we performed a genetic screen for suppressors of yku70 deletion. One of the suppressors identified was RTT103, which encodes a protein implicated in transcription termination. We show that rtt103 Delta are sensitive to multiple forms of genome insults and that RTT103 is essential for recovery from DNA double strand breaks in the chromosome. We further show that Rtt103 associates with sites of DNA breaks and hence is likely to play a direct role in response to DNA damage.	[Srividya, Indukuri; Tirupataiah, Sirupangi; Mishra, Krishnaveni] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Srividya, I (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	kmsl@uohyd.ernet.in			University Grants Commission (UGC), India [F.31-287/2005(SR)]; Department of Science and Technology (DST-FIST); UGC-SAP (UGC); UGC	University Grants Commission (UGC), India(University Grants Commission, India); Department of Science and Technology (DST-FIST)(Department of Science & Technology (India)); UGC-SAP (UGC); UGC(University Grants Commission, India)	Funds for this study were obtained from the University Grants Commission (UGC), India via grant number F.31-287/2005(SR) and Department of Science and Technology (DST-FIST); and UGC-SAP (UGC special assistance program) to the Department of Biochemistry. IS and ST acknowledge fellowship support from UGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Enyenihi AH, 2003, GENETICS, V163, P47; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Fry RC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-313; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; JSaP Russell, MOL CLONING LAB MANU; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mages GJ, 1996, J BIOL CHEM, V271, P7910, DOI 10.1074/jbc.271.14.7910; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Mirkin N, 2008, NUCLEIC ACIDS RES, V36, P1792, DOI 10.1093/nar/gkn005; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; SANTOSROSA H, 1995, GENETICS, V139, P57; Scholes DT, 2001, GENETICS, V159, P1449; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Waples WG, 2009, MOL BIOL CELL, V20, P245, DOI 10.1091/mbc.E08-08-0879; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011	41	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31288	10.1371/journal.pone.0031288	http://dx.doi.org/10.1371/journal.pone.0031288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355353	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300053
J	Takara, K; Yamamoto, K; Matsubara, M; Minegaki, T; Takahashi, M; Yokoyama, T; Okumura, K				Takara, Kohji; Yamamoto, Kazuhiro; Matsubara, Mika; Minegaki, Tetsuya; Takahashi, Minoru; Yokoyama, Teruyoshi; Okumura, Katsuhiko			Effects of alpha-Adrenoceptor Antagonists on ABCG2/BCRP-Mediated Resistance and Transport	PLOS ONE			English	Article							SELECTIVE ALPHA(1)-ADRENOCEPTOR ANTAGONIST; CANCER CELL APOPTOSIS; HUMAN PROSTATE-CANCER; MULTIDRUG-RESISTANCE; ALPHA-1-ADRENOCEPTOR ANTAGONIST; ANTICANCER DRUGS; P-GLYCOPROTEIN; GROWTH; NAFTOPIDIL; INDUCTION	Acquired resistance of cancer cells to various chemotherapeutic agents is known as multidrug resistance, and remains a critical factor in the success of cancer treatment. It is necessary to develop the inhibitors for multidrug resistance. The aim of this study was to examine the effects of eight alpha-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport. Previously established HeLa/SN100 cells, which overexpress ABCG2/BCRP but not ABCB1/MDR1, were used. The effects of the antagonists on sensitivity to mitoxantrone and the transport activity of Hoehst33342, both substrates for ABCG2/BCRP, were evaluated using the WST-1 assay and cellular kinetics, respectively. ABCG2/BCRP mRNA expression and the cell cycle were also examined by real-time RT-PCR and flow cytometry, respectively. Sensitivity to mitoxantrone was reversed by the alpha-adrenoceptor antagonists in a concentration-dependent manner, although such effects were also found in the parental HeLa cells. Levels of ABCG2/BCRP mRNA expression were not influenced by the antagonists. The transport activity of Hoechst33342 was decreased by doxazosin and prazosin, but unaffected by the other antagonists. In addition, doxazosin and prazosin increased the proportion of S phase cells in the cultures treated with mitoxantrone, whereas the other alpha-adrenoceptor antagonists increased the percentage of cells in G2/M phase. These findings suggested that doxazosin and prazosin reversed resistance mainly by inhibiting ABCG2/BCRP-mediated transport, but the others affected sensitivity to mitoxantrone via a different mechanism.	[Takara, Kohji; Takahashi, Minoru; Yokoyama, Teruyoshi; Okumura, Katsuhiko] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Himeji, Hyogo, Japan; [Yamamoto, Kazuhiro; Matsubara, Mika; Minegaki, Tetsuya] Kyoto Pharmaceut Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kyoto 607, Japan	Himeji Dokkyo University; Kyoto Pharmaceutical University	Takara, K (corresponding author), Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Himeji, Hyogo, Japan.	takara@gm.himeji-du.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benning CM, 2002, CANCER RES, V62, P597; CRUISE JL, 1985, SCIENCE, V227, P749, DOI 10.1126/science.2982212; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Harris AM, 2007, J UROLOGY, V178, P2176, DOI 10.1016/j.juro.2007.06.043; Hori Y, 2011, CANCER PREV RES, V4, P87, DOI 10.1158/1940-6207.CAPR-10-0189; Hu ZW, 1996, J BIOL CHEM, V271, P8977, DOI 10.1074/jbc.271.15.8977; Kanda H, 2008, INT J CANCER, V122, P444, DOI 10.1002/ijc.23095; Kim RB, 1999, PHARMACEUT RES, V16, P408; Koceva-Chyla A, 2005, APOPTOSIS, V10, P1497, DOI 10.1007/s10495-005-1540-9; Kojima Y, 2009, PROSTATE, V69, P1521, DOI 10.1002/pros.21003; Liao CH, 2011, PROSTATE, V71, P976, DOI 10.1002/pros.21313; Litman T, 2000, J CELL SCI, V113, P2011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mulac D, 2011, TOXICOLOGY, V282, P112, DOI 10.1016/j.tox.2011.01.019; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Pan SL, 2003, J UROLOGY, V169, P724, DOI 10.1016/S0022-5347(05)64002-5; Partin JV, 2003, BRIT J CANCER, V88, P1615, DOI 10.1038/sj.bjc.6600961; Pool James L., 2001, International Urology and Nephrology, V33, P407, DOI 10.1023/A:1019504703485; Siddiqui EJ, 2005, ANTICANCER RES, V25, P4281; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Tahmatzopoulos A, 2004, EXPERT OPIN PHARMACO, V5, P1279, DOI 10.1517/14656566.5.6.1279; Takara K, 2002, BIOL PHARM BULL, V25, P771, DOI 10.1248/bpb.25.771; Takara K, 2009, ONCOL RES, V17, P527, DOI 10.3727/096504009789745601; Takara K, 2009, CANCER LETT, V278, P88, DOI 10.1016/j.canlet.2008.12.033; Xiao YL, 2006, MOL PHARMACEUT, V3, P45, DOI 10.1021/mp050088t; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhou L, 2009, DRUG METAB DISPOS, V37, P946, DOI 10.1124/dmd.108.024489	28	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30697	10.1371/journal.pone.0030697	http://dx.doi.org/10.1371/journal.pone.0030697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355323	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300023
J	Karle, AC; Oostingh, GJ; Mutschlechner, S; Ferreira, F; Lackner, P; Bohle, B; Fischer, GF; Vogt, AB; Duschl, A				Karle, Anette C.; Oostingh, Gertie J.; Mutschlechner, Sonja; Ferreira, Fatima; Lackner, Peter; Bohle, Barbara; Fischer, Gottfried F.; Vogt, Anne B.; Duschl, Albert			Nitration of the Pollen Allergen Bet v 1.0101 Enhances the Presentation of Bet v 1-Derived Peptides by HLA-DR on Human Dendritic Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROTEIN NITRATION; POSTTRANSLATIONAL MODIFICATION; SCAVENGER RECEPTORS; CHILDHOOD ASTHMA; AIR-POLLUTANTS; SELF-PROTEINS; CUTTING EDGE; B-CELL; ANTIGEN	Nitration of pollen derived allergens can occur by NO2 and ozone in polluted air and it has already been shown that nitrated major birch (Betula verrucosa) pollen allergen Bet v 1.0101 (Bet v 1) exhibits an increased potency to trigger an immune response. However, the mechanisms by which nitration might contribute to the induction of allergy are still unknown. In this study, we assessed the effect of chemically induced nitration of Bet v 1 on the generation of HLA-DR associated peptides. Human dendritic cells were loaded with unmodified Bet v 1 or nitrated Bet v 1, and the naturally processed HLA-DR associated peptides were subsequently identified by liquid chromatography-mass spectrometry. Nitration of Bet v 1 resulted in enhanced presentation of allergen-derived HLA-DR-associated peptides. Both the copy number of Bet v 1 derived peptides as well as the number of nested clusters was increased. Our study shows that nitration of Bet v 1 alters antigen processing and presentation via HLA-DR, by enhancing both the quality and the quantity of the Bet v 1-specific peptide repertoire. These findings indicate that air pollution can contribute to allergic diseases and might also shed light on the analogous events concerning the nitration of self-proteins.	[Karle, Anette C.; Vogt, Anne B.] F Hoffmann La Roche Ltd, Non Clin Drug Safety, Immunosafety, Basel, Switzerland; [Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Mutschlechner, Sonja; Bohle, Barbara] Med Univ Vienna, Ctr Physiol Pathophysiol & Immunol, Dept Pathophysiol, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Fischer, Gottfried F.] Univ Clin Blood Grp Serol & Transfus Med, Clin Dept Blood Grp Serol, Vienna, Austria	Roche Holding; Salzburg University; Medical University of Vienna	Karle, AC (corresponding author), Novartis Pharma AG, Basel, Switzerland.	anne.vogt@roche.com	Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011; Duschl, Albert/E-5872-2011; Oostingh, Gertie Janneke/HHC-1098-2022; Lackner, Peter/L-2900-2015	Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Duschl, Albert/0000-0002-7034-9860; Lackner, Peter/0000-0003-4681-6307; Bohle, Barbara/0000-0002-5105-7985; Oostingh, Gertie Janneke/0000-0001-5083-217X	Osterreichische Nationalbank [P10150]; Christian Doppler Laboratory for Allergy Diagnosis and Therapy; Christian Doppler Laboratory for Immunomodulation, Austria; University of Salzburg; Biomay AG, Vienna, Austria	Osterreichische Nationalbank; Christian Doppler Laboratory for Allergy Diagnosis and Therapy; Christian Doppler Laboratory for Immunomodulation, Austria; University of Salzburg; Biomay AG, Vienna, Austria	P10150 of the Osterreichische Nationalbank, the Christian Doppler Laboratory for Allergy Diagnosis and Therapy and the Christian Doppler Laboratory for Immunomodulation, Austria to F.F. A.D. and F.F. were supported by the priority program "BioScience and Health'' of the University of Salzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Barbara Bohle and Fatima Ferreira are supported by Biomay AG, Vienna, Austria. Anne Vogt is an employee of F. Hoffmann-La Roche Ltd. Anette Karle was an employee of F. Hoffmann-La Roche Ltd when she performed the experiments outlined in the present manuscript. The other authors declare no conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abraham R, 1997, J IMMUNOL, V158, P4029; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Cross AH, 1998, J NEUROIMMUNOL, V88, P45, DOI 10.1016/S0165-5728(98)00078-2; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; FATENEJAD S, 1993, P NATL ACAD SCI USA, V90, P12010, DOI 10.1073/pnas.90.24.12010; FISCHER GF, 1995, VOX SANG, V69, P328, DOI 10.1111/j.1423-0410.1995.tb00368.x; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Franze T, 2003, ANALYST, V128, P824, DOI 10.1039/b303132b; Gauderman WJ, 2005, EPIDEMIOLOGY, V16, P737, DOI 10.1097/01.ede.0000181308.51440.75; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006; GORGA JC, 1987, J BIOL CHEM, V262, P16087; Griffiths HR, 2006, FREE RADICAL BIO MED, V40, P488, DOI 10.1016/j.freeradbiomed.2005.08.039; Gruijthuijsen YK, 2006, INT ARCH ALLERGY IMM, V141, P265, DOI 10.1159/000095296; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Jahn-Schmid B, 2010, J ALLERGY CLIN IMMUN, V126, P1068, DOI 10.1016/j.jaci.2010.05.038; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lee YL, 2003, EUR RESPIR J, V21, P964, DOI 10.1183/09031936.03.00094602; Liu ZX, 2011, MOL BIOSYST, V7, P1197, DOI 10.1039/c0mb00279h; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Mutschlechner S, 2010, J ALLERGY CLIN IMMUN, V125, P711, DOI 10.1016/j.jaci.2009.10.052; Ohmori H, 2005, AUTOIMMUN REV, V4, P224, DOI 10.1016/j.autrev.2004.11.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Ring J, 2001, ANN ALLERG ASTHMA IM, V87, P2, DOI 10.1016/S1081-1206(10)62332-0; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Sarnat JA, 2007, CURR OPIN PULM MED, V13, P63, DOI 10.1097/MCP.0b013e3280117d25; Singh N, 1998, J IMMUNOL, V160, P4869; Smith MA, 1997, J NEUROSCI, V17, P2653; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Untersmayr E, 2011, PLOS ONE, V5; vanderVeen RC, 1997, J NEUROIMMUNOL, V77, P1, DOI 10.1016/S0165-5728(97)00013-1; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wallberg M, 2007, EUR J IMMUNOL, V37, P1986, DOI 10.1002/eji.200636912	43	48	49	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31483	10.1371/journal.pone.0031483	http://dx.doi.org/10.1371/journal.pone.0031483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348091	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400025
J	Fritz, HM; Buchholz, KR; Chen, XC; Durbin-Johnson, B; Rocke, DM; Conrad, PA; Boothroyd, JC				Fritz, Heather M.; Buchholz, Kerry R.; Chen, Xiucui; Durbin-Johnson, Blythe; Rocke, David M.; Conrad, Patricia A.; Boothroyd, John C.			Transcriptomic Analysis of Toxoplasma Development Reveals Many Novel Functions and Structures Specific to Sporozoites and Oocysts	PLOS ONE			English	Article							SURFACE-ANTIGEN; PARASITOPHOROUS VACUOLE; GONDII OOCYSTS; WATERBORNE TOXOPLASMOSIS; DIFFERENTIATION MUTANTS; PARASITE; PROTEIN; IDENTIFICATION; GENES; STAGE	Sexual reproduction of Toxoplasma gondii occurs exclusively within enterocytes of the definitive felid host. The resulting immature oocysts are excreted into the environment during defecation, where in the days following, they undergo a complex developmental process. Within each oocyst, this culminates in the generation of two sporocysts, each containing 4 sporozoites. A single felid host is capable of shedding millions of oocysts, which can survive for years in the environment, are resistant to most methods of microbial inactivation during water-treatment and are capable of producing infection in warm-blooded hosts at doses as low as 1-10 ingested oocysts. Despite its extremely interesting developmental biology and crucial role in initiating an infection, almost nothing is known about the oocyst stage beyond morphological descriptions. Here, we present a complete transcriptomic analysis of the oocyst from beginning to end of its development. In addition, and to identify genes whose expression is unique to this developmental form, we compared the transcriptomes of developing oocysts with those of in vitro-derived tachyzoites and in vivo-derived bradyzoites. Our results reveal many genes whose expression is specifically up-or down-regulated in different developmental stages, including many genes that are likely critical to oocyst development, wall formation, resistance to environmental destruction and sporozoite infectivity. Of special note is the up-regulation of genes that appear "off'' in tachyzoites and bradyzoites but that encode homologues of proteins known to serve key functions in those asexual stages, including a novel pairing of sporozoite-specific paralogues of AMA1 and RON2, two proteins that have recently been shown to form a crucial bridge during tachyzoite invasion of host cells. This work provides the first in-depth insight into the development and functioning of one of the most important but least studied stages in the Toxoplasma life cycle.	[Fritz, Heather M.; Conrad, Patricia A.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Buchholz, Kerry R.; Boothroyd, John C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Chen, Xiucui; Durbin-Johnson, Blythe; Rocke, David M.] Univ Calif Davis, Sch Med, Div Biostat, Davis, CA 95616 USA	University of California System; University of California Davis; Stanford University; University of California System; University of California Davis	Fritz, HM (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	paconrad@ucdavis.edu; john.boothroyd@stanford.edu	Rocke, David M/I-7044-2013	Rocke, David M/0000-0002-3958-7318; Buchholz, Kerry/0000-0001-9419-0076; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health (NIH) [AI41014, AI21423, RR07038, T32 AI7328]; Eukaryotic Pathogens - Driving Biological Projects grant; UC Davis Center for Food Animal Health; NSF-EID [1065990]; NIH from National Center for Research Resources [KO1RR031487]; American Cancer Society [119025-PF-10-165-01-MPC]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007038, K01RR031487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021423, R01AI041014, R37AI021423, T32AI007328] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010917] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eukaryotic Pathogens - Driving Biological Projects grant; UC Davis Center for Food Animal Health; NSF-EID; NIH from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants AI41014, AI21423 and a Eukaryotic Pathogens - Driving Biological Projects grant. Oocyst production was funded by UC Davis Center for Food Animal Health grant and NSF-EID grant # 1065990. HMF was supported by NIH T32 grant # RR07038 and NIH KO1 Award Number KO1RR031487 from the National Center for Research Resources. KB was supported by NIH training grant T32 AI7328 and a grant from the American Cancer Society Award # 119025-PF-10-165-01-MPC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSEN MS, 1995, J PARASITOL, V81, P107, DOI 10.2307/3284017; Ahn Hye-Jin, 2006, Korean Journal of Parasitology, V44, P303, DOI 10.3347/kjp.2006.44.4.303; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Aramini JJ, 1999, EPIDEMIOL INFECT, V122, P305, DOI 10.1017/S0950268899002113; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Bahl A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-603; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Buchholz KR, 2011, EUKARYOT CELL, V10, P1637, DOI 10.1128/EC.05182-11; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 2008, V47, P33; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Dabritz HA, 2007, JAVMA-J AM VET MED A, V231, P1676, DOI 10.2460/javma.231.11.1676; de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115; DUBEY JP, 1972, J PROTOZOOL, V19, P155, DOI 10.1111/j.1550-7408.1972.tb03431.x; Dumetre A, 2004, J MICROBIOL METH, V56, P427, DOI 10.1016/j.mimet.2003.11.020; Dumetre A, 2003, FEMS MICROBIOL REV, V27, P651, DOI 10.1016/S0168-6445(03)00071-8; Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178; Durbin B P, 2002, Bioinformatics, V18 Suppl 1, pS105; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; FRENKEL JK, 1990, J AM VET MED ASSOC, V196, P240; Friesen J, 2008, MOL BIOCHEM PARASIT, V157, P228, DOI 10.1016/j.molbiopara.2007.10.005; Fritz H, 2012, J MICROBIOL METH, V88, P47, DOI 10.1016/j.mimet.2011.10.010; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029955; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Hill D, 2011, J PARASITOL, V97, P328, DOI 10.1645/GE-2782.1; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; HUSKINSONMARK J, 1991, J INFECT DIS, V164, P170, DOI 10.1093/infdis/164.1.170; Innes EA, 2010, ZOONOSES PUBLIC HLTH, V57, P1, DOI 10.1111/j.1863-2378.2009.01276.x; Isaac-Renton J, 1998, APPL ENVIRON MICROB, V64, P2278; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KASPER LH, 1993, RES IMMUNOL, V144, P45, DOI 10.1016/S0923-2494(05)80097-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Kim JY, 2008, KOREAN J PARASITOL, V46, P209, DOI 10.3347/kjp.2008.46.4.209; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Mai K, 2011, INT J PARASITOL, V41, P1157, DOI 10.1016/j.ijpara.2011.07.001; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Manger ID, 1998, INFECT IMMUN, V66, P2237, DOI 10.1128/IAI.66.5.2237-2244.1998; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Matrajt M, 2002, MOL MICROBIOL, V44, P735, DOI 10.1046/j.1365-2958.2002.02904.x; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Munoz-Zanzi CA, 2010, EMERG INFECT DIS, V16, P1591, DOI 10.3201/eid1610.091674; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Possenti A, 2010, INT J PARASITOL, V40, P1639, DOI 10.1016/j.ijpara.2010.06.009; R Core Team, 2020, R LANG ENV STAT COMP; Rachinel N, 2004, J IMMUNOL, V173, P2725, DOI 10.4049/jimmunol.173.4.2725; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Rocke DLG, LMGENE LMGENE SOFTWA; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2008, INFECT IMMUN, V76, P2402, DOI 10.1128/IAI.01494-07; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; SEOL W, 1992, BIOCHEMISTRY-US, V31, P3550, DOI 10.1021/bi00128a032; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Speer CA, 1998, J PARASITOL, V84, P505, DOI 10.2307/3284713; Speer CA, 1995, MOL BIOCHEM PARASIT, V75, P75, DOI 10.1016/0166-6851(95)02515-4; SULZER AJ, 1986, AM J TROP MED HYG, V35, P290, DOI 10.4269/ajtmh.1986.35.290; Templeton TJ, 2004, INFECT IMMUN, V72, P980, DOI 10.1128/IAI.72.2.980-987.2004; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tilley M, 1997, INFECT IMMUN, V65, P4598, DOI 10.1128/IAI.65.11.4598-4605.1997; TOMAVO S, 1991, INFECT IMMUN, V59, P3750, DOI 10.1128/IAI.59.10.3750-3753.1991; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Trexler M, 2000, EUR J BIOCHEM, V267, P5751, DOI 10.1046/j.1432-1327.2000.01641.x; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Woof JM, 2002, BIOCHEM SOC T, V30, P491, DOI 10.1042/bst0300491; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5	89	109	115	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29998	10.1371/journal.pone.0029998	http://dx.doi.org/10.1371/journal.pone.0029998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22347997	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900003
J	Pilz, KS; Roggeveen, AB; Creighton, SE; Bennett, PJ; Sekuler, AB				Pilz, Karin S.; Roggeveen, Alexa B.; Creighton, Sarah E.; Bennett, Patrick J.; Sekuler, Allison B.			How Prevalent Is Object-Based Attention?	PLOS ONE			English	Article							VISUAL-ATTENTION; SPATIAL ATTENTION; SELECTION; INHIBITION; ALLOCATION; OCCLUSION; RETURN	Previous research suggests that visual attention can be allocated to locations in space (space-based attention) and to objects (object-based attention). The cueing effects associated with space-based attention tend to be large and are found consistently across experiments. Object-based attention effects, however, are small and found less consistently across experiments. In three experiments we address the possibility that variability in object-based attention effects across studies reflects low incidence of such effects at the level of individual subjects. Experiment 1 measured space-based and object-based cueing effects for horizontal and vertical rectangles in 60 subjects comparing commonly used target detection and discrimination tasks. In Experiment 2 we ran another 120 subjects in a target discrimination task in which rectangle orientation varied between subjects. Using parametric statistical methods, we found object-based effects only for horizontal rectangles. Bootstrapping methods were used to measure effects in individual subjects. Significant space-based cueing effects were found in nearly all subjects in both experiments, across tasks and rectangle orientations. However, only a small number of subjects exhibited significant object-based cueing effects. Experiment 3 measured only object-based attention effects using another common paradigm and again, using bootstrapping, we found only a small number of subjects that exhibited significant object-based cueing effects. Our results show that object-based effects are more prevalent for horizontal rectangles, which is in accordance with the theory that attention may be allocated more easily along the horizontal meridian. The fact that so few individuals exhibit a significant object-based cueing effect presumably is why previous studies of this effect might have yielded inconsistent results. The results from the current study highlight the importance of considering individual subject data in addition to commonly used statistical methods.	[Pilz, Karin S.; Creighton, Sarah E.; Bennett, Patrick J.; Sekuler, Allison B.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Roggeveen, Alexa B.] Sheridan Inst Technol & Adv Learning, Sheridan Elder Res Ctr, Oakville, ON, Canada	McMaster University	Pilz, KS (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	pilzk@mcmaster.ca	Pilz, Karin/U-7476-2017; Pilz, Karin S/ABI-7361-2020	Pilz, Karin/0000-0003-4566-9122; Pilz, Karin S/0000-0003-4566-9122	Canadian Institute of Health Research [528206]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by Canadian Institute of Health Research grant number 528206 to ABS and PJB (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2000, PERCEPT PSYCHOPHYS, V62, P818, DOI 10.3758/BF03206925; Abrams RA, 2002, EXP BRAIN RES, V142, P349, DOI 10.1007/s00221-001-0899-2; Avrahami J, 1999, PERCEPT PSYCHOPHYS, V61, P1604, DOI 10.3758/BF03213121; BAYLIS GC, 1993, J EXP PSYCHOL HUMAN, V19, P451, DOI 10.1037/0096-1523.19.3.451; Botta F, 2010, Q J EXP PSYCHOL, V63, P1590, DOI 10.1080/17470210903443836; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JM, 2007, PERCEPT PSYCHOPHYS, V69, P606, DOI 10.3758/BF03193918; Brown JM, 2006, ACTA PSYCHOL, V121, P199, DOI 10.1016/j.actpsy.2004.10.020; Carrasco M, 2001, SPATIAL VISION, V15, P61, DOI 10.1163/15685680152692015; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1134, DOI 10.3758/BF03208370; Cepeda NJ, 1999, ACTA PSYCHOL, V103, P1, DOI 10.1016/S0001-6918(99)00021-9; Chica AB, 2006, COGN NEUROPSYCHOL, V23, P1015, DOI 10.1080/02643290600588277; Davis G, 2005, VIS COGN, V12, P817, DOI 10.1080/13506280444000247; Drummond L, 2010, ATTEN PERCEPT PSYCHO, V72, P1743, DOI 10.3758/APP.72.7.1743; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Goldsmith M, 2003, J EXP PSYCHOL HUMAN, V29, P897, DOI 10.1037/0096-1523.29.5.897; Gottlob LR, 1999, J GEN PSYCHOL, V126, P261, DOI 10.1080/00221309909595366; Hecht LN, 2007, PSYCHON B REV, V14, P1205, DOI 10.3758/BF03193114; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kramer AF, 1999, PSYCHOL AGING, V14, P99, DOI 10.1037/0882-7974.14.1.99; Lamy D, 2000, PERCEPT PSYCHOPHYS, V62, P1272, DOI 10.3758/BF03212129; Lamy D, 2002, PERCEPT PSYCHOPHYS, V64, P52, DOI 10.3758/BF03194557; Lavie N, 1996, PERCEPT PSYCHOPHYS, V58, P1238, DOI 10.3758/BF03207556; Li XS, 2008, PSYCHON B REV, V15, P945, DOI 10.3758/PBR.15.5.945; List A, 2007, J EXP PSYCHOL HUMAN, V33, P1322, DOI 10.1037/0096-1523.33.6.1322; Luo CM, 2010, Q J EXP PSYCHOL, V63, P516, DOI 10.1080/17470210903004638; Mackeben M, 1999, SPATIAL VISION, V12, P51, DOI 10.1163/156856899X00030; Macquistan AD, 1997, PSYCHON B REV, V4, P512, DOI 10.3758/BF03214341; Marrara MT, 2003, PERCEPT PSYCHOPHYS, V65, P1103, DOI 10.3758/BF03194837; Montaser-Kouhsari L, 2009, ATTEN PERCEPT PSYCHO, V71, P1782, DOI 10.3758/APP.71.8.1782; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; Moore CM, 1998, PSYCHOL SCI, V9, P104, DOI 10.1111/1467-9280.00019; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Pratt J, 2001, PSYCHON B REV, V8, P721, DOI 10.3758/BF03196209; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; Saiki J, 2000, J EXP PSYCHOL HUMAN, V26, P424, DOI 10.1037/0096-1523.26.1.424; Shomstein S, 2004, PSYCHON B REV, V11, P247, DOI 10.3758/BF03196566; Tse PU, 2003, PSYCHOL SCI, V14, P91, DOI 10.1111/1467-9280.t01-1-01425; VECERA SP, 1994, J EXP PSYCHOL GEN, V123, P146, DOI 10.1037/0096-3445.123.2.146; Watson SE, 1999, PERCEPT PSYCHOPHYS, V61, P31, DOI 10.3758/BF03211947; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; Zenon A, 2009, VISION RES, V49, P1522, DOI 10.1016/j.visres.2009.03.010	47	27	28	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30693	10.1371/journal.pone.0030693	http://dx.doi.org/10.1371/journal.pone.0030693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925BB	22348018	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900012
J	Sasson, SC; Zaunders, JJ; Seddiki, N; Bailey, M; McBride, K; Koelsch, KK; Merlin, KM; Smith, DE; Cooper, DA; Kelleher, AD				Sasson, Sarah C.; Zaunders, John J.; Seddiki, Nabila; Bailey, Michelle; McBride, Kristin; Koelsch, Kersten K.; Merlin, Kate M.; Smith, Don E.; Cooper, David A.; Kelleher, Anthony D.			Progressive Activation of CD127+1322-Recent Thymic Emigrants into Terminally Differentiated CD127-132+T-Cells in HIV-1 Infection	PLOS ONE			English	Article							INTERLEUKIN-7 RECEPTOR EXPRESSION; CD8 T-CELLS; CD127 EXPRESSION; IL-7; EXPANSION; LYMPHOCYTES; PROLIFERATION; DYSFUNCTION; APOPTOSIS; CYTOKINES	Aim: HIV infection is associated with distortion of T-cell homeostasis and the IL-7/IL7R axis. Progressive infection results in loss of CD127+132- and gains in CD127-132+ CD4+ and CD8+ T-cells. We investigated the correlates of loss of CD127 from the T-cell surface to understand mechanisms underlying this homeostatic dysregulation. Methods: Peripheral and cord blood mononuclear cells (PBMCs; CBMC) from healthy volunteers and PBMC from patients with HIV infection were studied. CD127+132-, CD127+132+ and CD127-132+ T-cells were phenotyped by activation, differentiation, proliferation and survival markers. Cellular HIV-DNA content and signal-joint T-cell receptor excision circles (sjTRECs) were measured. Results: CD127+132- T-cells were enriched for naive cells while CD127-132+ T-cells were enriched for activated/terminally differentiated T-cells in CD4+ and CD8+ subsets in health and HIV infection. HIV was associated with increased proportions of activated/terminally differentiated CD127-132+ T-cells. In contrast to CD127+132- T-cells, CD127-132+ T-cells were Ki-67+Bcl-2(low) and contained increased levels of HIV-DNA. Naive CD127+132- T-cells contained a higher proportion of sjTRECs. Conclusion: The loss of CD127 from the T-cell surface in HIV infection is driven by activation of CD127+132- recent thymic emigrants into CD127-132+ activated/terminally differentiated cells. This process likely results in an irreversible loss of CD127 and permanent distortion of T-cell homeostasis. low	[Sasson, Sarah C.; Seddiki, Nabila; Bailey, Michelle; McBride, Kristin; Smith, Don E.; Cooper, David A.; Kelleher, Anthony D.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Sasson, Sarah C.; Zaunders, John J.; Seddiki, Nabila; Bailey, Michelle; McBride, Kristin; Koelsch, Kersten K.; Merlin, Kate M.; Cooper, David A.; Kelleher, Anthony D.] St Vincent Hosp, Ctr Appl Med Res, HIV Immunopthol Res Lab, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney	Sasson, SC (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	s.sasson@amr.org.au	Zaunders, John/J-6553-2012	Zaunders, John/0000-0002-5912-5989; Sasson, Sarah/0000-0002-5329-9072; Seddiki, Nabila/0000-0002-0379-8527	Australian Government Department of Health and Ageing; National Health and Medical Research Council; Bristol-Myers Squibb; Glaxo- SmithKline; Agouron; Abbott Australasia; Gilead Sciences; Boehringer Ingelheim; Merck Sharp Dohme; Roche Products	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bristol-Myers Squibb(Bristol-Myers Squibb); Glaxo- SmithKline(GlaxoSmithKline); Agouron; Abbott Australasia(Abbott Laboratories); Gilead Sciences(Gilead Sciences); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp Dohme(Merck & Company); Roche Products	This study was funded from the following sources: the Australian Government Department of Health and Ageing; the National Health and Medical Research Council via Project and program grants, a Dora Lush (Biomedical) PhD Scholarship (SCS) and a Practitioner Fellowship (ADK). The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.S. has received conference travel support, lectureship honoraria, or research grants from Bristol-Myers Squibb, Glaxo- SmithKline, Agouron, Abbott Australasia, Gilead Sciences, Boehringer Ingelheim, Merck Sharp & Dohme, and Roche Products; he does not own shares in any of these companies. All other authors: no conflicts declared. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.	Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; CARINI C, 1994, EUR J IMMUNOL, V24, P2927, DOI 10.1002/eji.1830241202; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Faller E, 2009, INT IMMUNOL, V21, P203, DOI 10.1093/intimm/dxn140; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; French Martyn, 2002, HIV Clin Trials, V3, P177; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Jiang Q, 2004, CELL SIGNAL, V16, P281, DOI 10.1016/S0898-6568(03)00138-4; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Mussini C, 2002, AIDS, V16, P1609, DOI 10.1097/00002030-200208160-00006; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seddon BaZ R, 2002, J IMMUNOL, P3752; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Smith DE, 2003, AIDS RES HUM RETROV, V19, P189, DOI 10.1089/088922203763315696; Soares MVD, 1998, J IMMUNOL, V161, P5909; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Webb LMC, 1999, IMMUNOLOGY, V98, P400, DOI 10.1046/j.1365-2567.1999.00906.x; Zaunders JJ, 2003, J INFECT DIS, V187, P1735, DOI 10.1086/375030; Zaunders JJ, 2003, BLOOD; Zhang SY, 2009, EUR J IMMUNOL, V39, P1425, DOI 10.1002/eji.200839059	39	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31148	10.1371/journal.pone.0031148	http://dx.doi.org/10.1371/journal.pone.0031148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348045	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900025
J	Nokia, MS; Sisti, HM; Choksi, MR; Shors, TJ				Nokia, Miriam S.; Sisti, Helene M.; Choksi, Monica R.; Shors, Tracey J.			Learning to Learn: Theta Oscillations Predict New Learning, which Enhances Related Learning and Neurogenesis	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; TRACE MEMORIES; DENTATE GYRUS; NEURONS; NAVIGATION; INCREASES; SURVIVAL; CELLS; RAT; ACQUISITION	Animals in the natural world continuously encounter learning experiences of varying degrees of novelty. New neurons in the hippocampus are especially responsive to learning associations between novel events and more cells survive if a novel and challenging task is learned. One might wonder whether new neurons would be rescued from death upon each new learning experience or whether there is an internal control system that limits the number of cells that are retained as a function of learning. In this experiment, it was hypothesized that learning a task that was similar in content to one already learned previously would not increase cell survival. We further hypothesized that in situations in which the cells are rescued hippocampal theta oscillations (3-12 Hz) would be involved and perhaps necessary for increasing cell survival. Both hypotheses were disproved. Adult male Sprague-Dawley rats were trained on two similar hippocampus-dependent tasks, trace and very-long delay eyeblink conditioning, while recording hippocampal local-field potentials. Cells that were generated after training on the first task were labeled with bromodeoxyuridine and quantified after training on both tasks had ceased. Spontaneous theta activity predicted performance on the first task and the conditioned stimulus induced a theta-band response early in learning the first task. As expected, performance on the first task correlated with performance on the second task. However, theta activity did not increase during training on the second task, even though more cells were present in animals that had learned. Therefore, as long as learning occurs, relatively small changes in the environment are sufficient to increase the number of surviving neurons in the adult hippocampus and they can do so in the absence of an increase in theta activity. In conclusion, these data argue against an upper limit on the number of neurons that can be rescued from death by learning.	[Nokia, Miriam S.; Sisti, Helene M.; Choksi, Monica R.; Shors, Tracey J.] Rutgers State Univ, Dept Psychol, Ctr Collaborat Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick	Nokia, MS (corresponding author), Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland.	miriam.nokia@jyu.fi	Nokia, Miriam/AAL-7599-2021	Nokia, Miriam/0000-0003-2222-6118	National Institutes of Health [MH-59970, ARRA-3R01MH059970-10S1]; National Science Foundation [IOB-0444364, IOS-0914386]; Academy of Finland; Emil Aaltonen Foundation; Jenny and Antti Wihuri Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Jenny and Antti Wihuri Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grant nos. MH-59970 and ARRA-3R01MH059970-10S1) and the National Science Foundation (grant nos. IOB-0444364 and IOS-0914386) to TJS. This work was also supported by grants from the Academy of Finland, Emil Aaltonen Foundation and Jenny and Antti Wihuri Foundation to MSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Anderson ML, 2011, EUR J NEUROSCI, V33, P175, DOI 10.1111/j.1460-9568.2010.07486.x; Asaka Y, 2005, P NATL ACAD SCI USA, V102, P13284, DOI 10.1073/pnas.0506515102; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; Dalla C, 2009, P NATL ACAD SCI USA, V106, P2927, DOI 10.1073/pnas.0809650106; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Fell J, 2011, J NEUROSCI, V31, P5392, DOI 10.1523/JNEUROSCI.3668-10.2011; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Griffin AL, 2004, BEHAV NEUROSCI, V118, P403, DOI 10.1037/0735-7044.118.2.403; Guderian S, 2009, P NATL ACAD SCI USA, V106, P5365, DOI 10.1073/pnas.0900289106; Hodes GE, 2009, NEUROSCIENCE, V163, P609, DOI 10.1016/j.neuroscience.2009.06.057; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; Itskov V, 2011, J NEUROSCI, V31, P2828, DOI 10.1523/JNEUROSCI.3773-10.2011; Jirenhed DA, 2011, CEREBELLUM, V10, P523, DOI 10.1007/s12311-011-0264-3; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Kuo AG, 2006, LEARN MEMORY, V13, P201, DOI 10.1101/lm.98406; Leuner B, 2007, HIPPOCAMPUS, V17, P434, DOI 10.1002/hipo.20278; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Lisman J, 2010, CURR BIOL, V20, pR490, DOI 10.1016/j.cub.2010.04.011; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Nokia MS, 2010, J NEUROSCI, V30, P11486, DOI 10.1523/JNEUROSCI.2165-10.2010; Nokia MS, 2010, HIPPOCAMPUS, V20, P457, DOI 10.1002/hipo.20696; Nokia MS, 2009, BEHAV NEUROSCI, V123, P631, DOI 10.1037/a0015334; Paxinos WC, 1998, RAT BRAIN STEREOTAXI, P256; PROKASY WF, 1984, PSYCHOPHYSIOLOGY, V21, P1, DOI 10.1111/j.1469-8986.1984.tb02309.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shors TJ, 2011, BEHAV BRAIN IN PRESS; Shors TJ, 2008, CELL STEM CELL, V3, P253, DOI 10.1016/j.stem.2008.08.010; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Urcelay GP, 2010, ANIM COGN, V13, P21, DOI 10.1007/s10071-009-0295-z; Waddell J, 2008, EUR J NEUROSCI, V27, P3020, DOI 10.1111/j.1460-9568.2008.06222.x; Waddell J, 2011, NEUROBIOL LEARN MEM, V95, P159, DOI 10.1016/j.nlm.2010.09.012; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044	43	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31375	10.1371/journal.pone.0031375	http://dx.doi.org/10.1371/journal.pone.0031375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348078	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900026
J	Ueno, T; Tomita, J; Kume, S; Kume, K				Ueno, Taro; Tomita, Jun; Kume, Shoen; Kume, Kazuhiko			Dopamine Modulates Metabolic Rate and Temperature Sensitivity in Drosophila melanogaster	PLOS ONE			English	Article							CIRCADIAN CLOCK; MUSHROOM BODIES; TARGETED EXPRESSION; GENE-EXPRESSION; SLEEP; PREFERENCE; BEHAVIOR; RECEPTOR; NEURONS; THERMOTAXIS	Homeothermal animals, such as mammals, maintain their body temperature by heat generation and heat dissipation, while poikilothermal animals, such as insects, accomplish it by relocating to an environment of their favored temperature. Catecholamines are known to regulate thermogenesis and metabolic rate in mammals, but their roles in other animals are poorly understood. The fruit fly, Drosophila melanogaster, has been used as a model system for the genetic studies of temperature preference behavior. Here, we demonstrate that metabolic rate and temperature sensitivity of some temperature sensitive behaviors are regulated by dopamine in Drosophila. Temperature-sensitive molecules like dTrpA1 and shi(ts) induce temperature-dependent behavioral changes, and the temperature at which the changes are induced were lowered in the dopamine transporter-defective mutant, fumin. The mutant also displays a preference for lower temperatures. This thermophobic phenotype was rescued by the genetic recovery of the dopamine transporter in dopamine neurons. Flies fed with a dopamine biosynthesis inhibitor (3-iodo-L-tyrosine), which diminishes dopamine signaling, exhibited preference for a higher temperature. Furthermore, we found that the metabolic rate is up-regulated in the fumin mutant. Taken together, dopamine has functions in the temperature sensitivity of behavioral changes and metabolic rate regulation in Drosophila, as well as its previously reported functions in arousal/sleep regulation.	[Ueno, Taro; Tomita, Jun; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Inst Embryol & Genet, Dept Stem Cell Biol, Kumamoto, Japan; [Kume, Shoen] Kumamoto Univ, Global COE program, Kumamoto, Japan	Kumamoto University; Kumamoto University	Ueno, T (corresponding author), Kumamoto Univ, Inst Embryol & Genet, Dept Stem Cell Biol, Kumamoto, Japan.	kkume@kumamoto-u.ac.jp	Ueno, Taro/AAN-7260-2021; Kume, Shoen/M-4356-2016	Ueno, Taro/0000-0003-3697-4301; Kume, Shoen/0000-0002-4292-205X; Kume, Kazuhiko/0000-0003-4232-1657	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [17024049]; Japanese Society for the Promotion of Science (JSPS) [15300108, 17300105, 22300132]; 21st Century Center of Excellence (COE); Global COE from MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE from MEXT	This work was supported by a grant-in-aid (17024049) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a grant-in-aid (15300108, 17300105, 22300132 to KK) from the Japanese Society for the Promotion of Science (JSPS); a 21st Century Center of Excellence (COE) grant; and a Global COE grant from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Bang S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001346; Billes SK, 2008, NEUROPSYCHOPHARMACOL, V33, P1287, DOI 10.1038/sj.npp.1301526; BRAND AH, 1993, DEVELOPMENT, V118, P401; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Glanville EJ, 2006, J EXP BIOL, V209, P4869, DOI 10.1242/jeb.02585; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Goto SG, 1998, J INSECT PHYSIOL, V44, P1233, DOI 10.1016/S0022-1910(98)00101-2; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HEINRICH B, 1979, SCIENCE, V205, P1269, DOI 10.1126/science.205.4412.1269; Heinrich B., 1993, HOT BLOODED INSECTS; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kume K., 2006, SLEEP BIOL RHYTHMS, V4, P263, DOI DOI 10.1111/J.1479-8425.2006.00225.X; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Makos MA, 2009, ANAL CHEM, V81, P1848, DOI 10.1021/ac802297b; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; R Core Team, 2020, R LANG ENV STAT COMP; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	50	34	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31513	10.1371/journal.pone.0031513	http://dx.doi.org/10.1371/journal.pone.0031513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347491	Green Submitted, Green Published, gold			2022-12-27	WOS:000302180600041
J	Butler, DL; Mattingley, JB; Cunnington, R; Suddendorf, T				Butler, David L.; Mattingley, Jason B.; Cunnington, Ross; Suddendorf, Thomas			Mirror, Mirror on the Wall, How Does My Brain Recognize My Image at All?	PLOS ONE			English	Article							VISUAL SELF-RECOGNITION; EMOTIONAL EXPRESSION; FACE RECOGNITION; FAMILIARITY; CHIMPANZEES; PERCEPTION; AWARENESS; MISIDENTIFICATION; REPRESENTATION; EVOLUTION	For decades researchers have used mirrors to study self-recognition. However, attempts to identify neural processes underlying this ability have used photographs instead. Here we used event related potentials (ERPs) to compare self-face recognition in photographs versus mirrors and found distinct neural signatures. Measures of visual self-recognition are therefore not independent of the medium employed.	[Butler, David L.; Mattingley, Jason B.; Cunnington, Ross; Suddendorf, Thomas] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mattingley, Jason B.; Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Butler, DL (corresponding author), Univ Queensland, Sch Psychol, McElwain Bldg, St Lucia, Qld, Australia.	davidbut@psy.uq.edu.au	Suddendorf, Thomas/A-1631-2017; Mattingley, Jason/J-1537-2014	Suddendorf, Thomas/0000-0003-3328-7442; Mattingley, Jason/0000-0003-0929-9216; Butler, David/0000-0002-7450-2121; Cunnington, Ross/0000-0002-7423-4809				American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; Bentin S, 2002, COGNITION, V86, pB1, DOI 10.1016/S0010-0277(02)00124-5; BIGELOW AE, 1981, J GENET PSYCHOL, V139, P11, DOI 10.1080/00221325.1981.10533432; BIRINGER F, 1992, J GERONTOL, V47, pP385, DOI 10.1093/geronj/47.6.P385; Breen N, 2001, NEUROCASE, V7, P239, DOI 10.1093/neucas/7.3.239; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2007, SCHIZOPHR RES, V95, P186, DOI 10.1016/j.schres.2007.06.015; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; Darwin C., 1877, MIND, V2, P285, DOI [10.1093/mind/os-2.7.285, DOI 10.1093/MIND/OS-2.7.285]; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Devue C, 2010, CONSCIOUSNE IN PRESS; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; EPSTEIN R, 1981, SCIENCE, V212, P695, DOI 10.1126/science.212.4495.695; Feusner JD, 2008, BODY IMAGE, V5, P3, DOI 10.1016/j.bodyim.2007.11.002; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; HARRINGTON A, 1989, COMPR PSYCHIAT, V30, P376, DOI 10.1016/0010-440X(89)90003-5; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; LETHMATE J, 1973, Zeitschrift fuer Tierpsychologie, V33, P248; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Marzi T, 2007, INT J PSYCHOPHYSIOL, V65, P182, DOI 10.1016/j.ijpsycho.2007.04.003; Miles H, 1994, ME CHANTEK DEV SELF; MOLCHAN SE, 1990, BRIT J PSYCHIAT, V157, P605, DOI 10.1192/bjp.157.4.605; Nielsen M, 2006, CHILD DEV, V77, P176, DOI 10.1111/j.1467-8624.2006.00863.x; Nielsen M, 2003, INFANT BEHAV DEV, V26, P213, DOI 10.1016/S0163-6383(03)00018-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips M L, 1996, Cogn Neuropsychiatry, V1, P153, DOI 10.1080/135468096396613; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Posada S, 2007, AM J PRIMATOL, V69, P576, DOI 10.1002/ajp.20355; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.2307/1131717; Povinelli DJ, 1997, ANIM BEHAV, V53, P1083, DOI 10.1006/anbe.1996.0303; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SPERRY RW, 1979, NEUROPSYCHOLOGIA, V17, P153, DOI 10.1016/0028-3932(79)90006-X; SUAREZ SD, 1981, J HUM EVOL, V10, P175, DOI 10.1016/S0047-2484(81)80016-4; Suddendorf T, 1999, J EXP CHILD PSYCHOL, V72, P157, DOI 10.1006/jecp.1998.2485; Suddendorf T, 2001, PSYCHOL BULL, V127, P629, DOI 10.1037//0033-2909.127.5.629; Suddendorf T, 2007, COGNITIVE DEV, V22, P185, DOI 10.1016/j.cogdev.2006.09.003; Suddendorf T, 2009, P R SOC B, V276, P1671, DOI 10.1098/rspb.2008.1754; Sui J, 2006, NEUROREPORT, V17, P423, DOI 10.1097/01.wnr.0000203357.65190.61; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Villarejo A, 2011, NEUROCASE, V17, P276, DOI 10.1080/13554794.2010.498427	50	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31452	10.1371/journal.pone.0031452	http://dx.doi.org/10.1371/journal.pone.0031452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359592	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200061
J	Corey, KE; Zheng, H; Mendez-Navarro, J; Delgado-Borrego, A; Dienstag, JL; Chung, RT				Corey, Kathleen E.; Zheng, Hui; Mendez-Navarro, Jorge; Delgado-Borrego, Aymin; Dienstag, Jules L.; Chung, Raymond T.		HALT-C Trial Grp	Serum Vitamin D Levels Are Not Predictive of the Progression of Chronic Liver Disease in Hepatitis C Patients with Advanced Fibrosis	PLOS ONE			English	Article							METABOLIC BONE-DISEASE; GROWTH-FACTOR-I; PARATHYROID-HORMONE; MINERAL DENSITY; PROLIFERATION; CIRRHOSIS; INSULIN; MECHANISMS; EXPRESSION	In animal models and human cross-sectional studies, vitamin D deficiency has been associated with liver disease progression. Vitamin D supplementation has been suggested as a treatment to prevent disease progression. We sought to evaluate the role of vitamin D levels in predicting chronic liver disease development. We conducted a nested case-control study of vitamin D levels in subjects with (cases) and without (controls) liver histologic progression or clinical decompensation over the course of the HALT-C Trial. Vitamin D levels were measured at 4 points over 45 months. 129 cases and 129 aged-matched controls were included. No difference in baseline vitamin D levels were found between cases and controls. (44.8 ng/mL vs. 44.0 ng/mL, P = 0.74). Vitamin D levels declined in cases and controls over time (P = 0.0005), however, there was no difference in the level of decline (P = 0.37). Among study subjects with diabetes mellitius, baseline vitamin D levels were higher in cases, 49.9 ng/mL, than controls, 36.3 ng/mL. (P = 0.03) In addition, baseline vitamin D levels were higher in black case subjects, 32.7 ng/mL, than in black control subjects, 25.2 ng/mL (P = 0.08) No difference in vitamin D levels was found between patients with and without progression of hepatitis C-associated liver disease over 4 years. Our data do not suggest any role for vitamin D supplementation in patients with advanced chronic hepatitis C and raise the possibility that higher vitamin D levels may be associated with disease progression.	[Corey, Kathleen E.; Mendez-Navarro, Jorge; Dienstag, Jules L.; Chung, Raymond T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Delgado-Borrego, Aymin] Univ Miami, Div Pediat Gastroenterol, Miami, FL USA; [Corey, Kathleen E.; Dienstag, Jules L.; Chung, Raymond T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Miami; Harvard University; Harvard Medical School	Corey, KE (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.	rtchung@partners.org	Kleiner, David E/N-2770-2013	Kleiner, David E/0000-0003-3442-4453; Dienstag, Jules/0000-0001-7024-0980	American College of Gastroenterology; National Institute of Diabetes & Digestive & Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Center for Minority Health and Health Disparities; General Clinical Research Center from the National Center for Research Resources, National Institutes of Health; Clinical and Translational Science Center from the National Center for Research Resources, National Institutes of Health; Hoffmann-La Roche, Inc.; National Institutes of Health; University of Massachusetts Medical Center, Worcester, MA [N01-DK-9-2326]; University of Connecticut Health Center, Farmington, CT [M01RR-06192]; Saint Louis University School of Medicine, St Louis, MO [N01-DK-9-2324]; Massachusetts General Hospital, Boston, MA [N01-DK-9-2319, M01RR-01066, 1 UL1 RR025758-01]; University of Colorado Denver, School of Medicine, Aurora, CO [N01-DK-9-2327, M01RR-00051, 1 UL1 RR 025780-01]; University of California - Irvine, Irvine, CA [N01-DK-9-2320, M01RR-00827]; University of Texas Southwestern Medical Center, Dallas, TX [N01-DK-9-2321, M01RR-00633, 1 UL1 RR024982-01]; University of Southern California, Los Angeles, CA [N01-DK-9-2325, M01RR-00043]; University of Michigan Medical Center, Ann Arbor, MI [N01-DK-9-2323, M01RR-00042, 1 UL1 RR024986]; Virginia Commonwealth University Health System, Richmond, VA [N01-DK-9-2322, M01RR-00065]; University of Washington, Seattle, WA [N01-DK-9-2318]; New England Research Institutes, Watertown, MA [N01-DK-9-2328]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827, M01RR000051, UL1RR024982, UL1RR025780, M01RR000065, UL1RR024986, UL1RR025758, M01RR006192, M01RR001066, M01RR000042, M01RR000633, M01RR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092326, N01DK092327, N01DK092319, N01DK092318, N01DK092323, N01DK092320, N01DK092324, N01DK092325, N01DK092321, N01DK092322] Funding Source: NIH RePORTER	American College of Gastroenterology(General Electric); National Institute of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); General Clinical Research Center from the National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Clinical and Translational Science Center from the National Center for Research Resources, National Institutes of Health; Hoffmann-La Roche, Inc.(Hoffmann-La Roche); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Medical Center, Worcester, MA; University of Connecticut Health Center, Farmington, CT; Saint Louis University School of Medicine, St Louis, MO; Massachusetts General Hospital, Boston, MA; University of Colorado Denver, School of Medicine, Aurora, CO; University of California - Irvine, Irvine, CA; University of Texas Southwestern Medical Center, Dallas, TX; University of Southern California, Los Angeles, CA; University of Michigan Medical Center, Ann Arbor, MI(University of Michigan System); Virginia Commonwealth University Health System, Richmond, VA; University of Washington, Seattle, WA(University of Washington); New England Research Institutes, Watertown, MA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was principally supported by a grant from the American College of Gastroenterology. Additional support was provided by the National Institute of Diabetes & Digestive & Kidney Diseases, the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the National Center for Minority Health and Health Disparities and by General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Additional funding to conduct this study was supplied by Hoffmann-La Roche, Inc., through a Cooperative Research and Development Agreement with the National Institutes of Health. Additional grants and contracts supporting the HALT-C Study are listed in the Acknowledgement section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; University of Massachusetts Medical Center, Worcester, MA: (Contract N01-DK-9-2326) Gyongyi Szabo, MD, Barbara F. Banner, MD, Maureen Cormier, RN, Donna Giansiracusa, RN; University of Connecticut Health Center, Farmington, CT: (Grant M01RR-06192) Herbert L. Bonkovsky, MD, Gloria Borders, RN, Michelle Kelley, RN, ANP; Saint Louis University School of Medicine, St Louis, MO: (Contract N01-DK-9-2324) Adrian M. Di Bisceglie, MD, Bruce Bacon, MD, Brent Neuschwander-Tetri, MD, Elizabeth M. Brunt, MD, Debra King, RN; Massachusetts General Hospital, Boston, MA: (Contract N01-DK-9-2319, Grant M01RR-01066; Grant 1 UL1 RR025758-01, Harvard Clinical and Translational Science Center) Andrea E. Reid, MD, Atul K. Bhan, MD, Wallis A. Molchen, David P. Lundmark; University of Colorado Denver, School of Medicine, Aurora, CO: (Contract N01-DK-9-2327, Grant M01RR-00051, Grant 1 UL1 RR 025780-01), Gregory T. Everson, MD, Thomas Trouillot, MD, Marcelo Kugelmas, MD, S. Russell Nash, MD, Jennifer DeSanto, RN, Carol McKinley, RN; University of California - Irvine, Irvine, CA: (Contract N01-DK-9-2320, Grant M01RR-00827) Timothy R. Morgan, MD, John C. Hoefs, MD, John R. Craig, MD, M. Mazen Jamal, MD, MPH, Muhammad Sheikh, MD, Choon Park, RN; University of Texas Southwestern Medical Center, Dallas, TX: (Contract N01-DK-9-2321, Grant M01RR-00633, Grant 1 UL1 RR024982-01, North and Central Texas Clinical and Translational Science Initiative) William M. Lee, MD, Thomas E. Rogers, MD, Peter F. Malet, MD, Janel Shelton, Nicole Crowder, LVN, Rivka Elbein, RN, BSN, Nancy Liston, MPH; University of Southern California, Los Angeles, CA: (Contract N01-DK-9-2325, Grant M01RR-00043) Karen L. Lindsay, MD, MMM, Sugantha Govindarajan, MD, Carol B. Jones, RN, Susan L. Milstein, RN; University of Michigan Medical Center, Ann Arbor, MI: (Contract N01-DK-9-2323, Grant M01RR-00042, Grant 1 UL1 RR024986, Michigan Center for Clinical and Health Research) Anna S. Lok, MD, Robert J. Fontana, MD, Joel K. Greenson, MD, Pamela A. Richtmyer, LPN, CCRC, R. Tess Bonham, BS; Virginia Commonwealth University Health System, Richmond, VA: (Contract N01-DK-9-2322, Grant M01RR-00065) Mitchell L. Shiffman, MD, Richard K. Sterling, MD, MSc, Melissa J. Contos, MD, A. Scott Mills, MD, Charlotte Hofmann, RN, Paula Smith, RN; University of Washington, Seattle, WA: (Contract N01-DK-9-2318) Chihiro Morishima, MD, David R. Gretch, MD, PhD, Minjun Chung Apodaca, BS, ASCP, Rohit Shankar, BC, ASCP, Natalia Antonov, M. Ed.; New England Research Institutes, Watertown, MA: (Contract N01-DK-9-2328) Kristin K. Snow, MSc, ScD, Anne M. Stoddard, ScD, May Yang, MPH	Abu-Mouch S, 2009, BENEFICIAL EFFECT VI; Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Azam ZAZ, 2008, GASTROENTEROLOGY, pA; BONKOVSKY HL, 1990, HEPATOLOGY, V12, P273, DOI 10.1002/hep.1840120214; Chen CC, 1996, J GASTROEN HEPATOL, V11, P417, DOI 10.1111/j.1440-1746.1996.tb00284.x; Cohen ML, 2001, KIDNEY INT, V59, P69, DOI 10.1046/j.1523-1755.2001.00467.x; CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Duarte MPC, 2001, J GASTROEN HEPATOL, V16, P1022, DOI 10.1046/j.1440-1746.2001.02561.x; Fisher L, 2007, CLIN GASTROENTEROL H, V5, P513, DOI 10.1016/j.cgh.2006.10.015; Foxton MR, 2006, AM J TRANSPLANT, V6, P1922, DOI 10.1111/j.1600-6143.2006.01408.x; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gallego-Rojo FJ, 1998, HEPATOLOGY, V28, P695, DOI 10.1002/hep.510280315; HOLICK MF, 1989, LANCET, V2, P1104; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Lok AS, 2011, GASTROENTEROLOGY, V140, P840, DOI 10.1053/j.gastro.2010.11.050; MASUDA S, 1989, J NUTR SCI VITAMINOL, V35, P225, DOI 10.3177/jnsv.35.225; Moosgaard B, 2005, CLIN ENDOCRINOL, V63, P506, DOI 10.1111/j.1365-2265.2005.02371.x; Muzzi A, 2005, J HEPATOL, V42, P41, DOI 10.1016/j.jhep.2004.09.022; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Petta S, 2008, HEPATOLOGY, V48, P28, DOI 10.1002/hep.22316; Pittas AG, 2010, J STEROID BIOCHEM, V121, P425, DOI 10.1016/j.jsbmb.2010.03.042; SAGGESE G, 1989, J ENDOCRINOL INVEST, V12, P329, DOI 10.1007/BF03349999; Shany S, 2001, STEROIDS, V66, P319, DOI 10.1016/S0039-128X(00)00154-9; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; Tan XY, 2007, J STEROID BIOCHEM, V103, P491, DOI 10.1016/j.jsbmb.2006.11.011; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572	28	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e27144	10.1371/journal.pone.0027144	http://dx.doi.org/10.1371/journal.pone.0027144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359532	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200001
J	Gao, GP; Yin, DH; Chen, SJ; Xia, F; Yang, J; Li, Q; Wang, W				Gao, Guanpeng; Yin, Danhan; Chen, Shengju; Xia, Fei; Yang, Jie; Li, Qing; Wang, Wei			Effect of Biocontrol Agent Pseudomonas fluorescens 2P24 on Soil Fungal Community in Cucumber Rhizosphere Using T-RFLP and DGGE	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; BIOLOGICAL-CONTROL; BACTERIAL DIVERSITY; AGRICULTURAL SOILS; RIBOSOMAL-RNA; 2,4-DIACETYLPHLOROGLUCINOL; CARBON; IDENTIFICATION; FRAGMENTS; SURVIVAL	Fungi and fungal community play important roles in the soil ecosystem, and the diversity of fungal community could act as natural antagonists of various plant pathogens. Biological control is a promising method to protect plants as chemical pesticides may cause environment pollution. Pseudomonas fluorescens 2P24 had strong inhibitory on Rastonia solanacearum, Fusarium oxysporum and Rhizoctonia solani, etc., and was isolated from the wheat rhizosphere take-all decline soils in Shandong province, China. However, its potential effect on soil fungal community was still unknown. In this study, the gfp-labeled P. fluorescens 2P24 was inoculated into cucumber rhizosphere, and the survival of 2P24 was monitored weekly. The amount decreased from 10(8) to 10(5) CFU/g dry soils. The effect of 2P24 on soil fungal community in cucumber rhizosphere was investigated using T-RFLP and DGGE. In T-RFLP analysis, principle component analysis showed that the soil fungal community was greatly influenced at first, digested with restriction enzyme Hinf I and Taq I. However, there was little difference as digested by different enzymes. DGGE results demonstrated that the soil fungal community was greatly shocked at the beginning, but it recovered slowly with the decline of P. fluorescens 2P24. Four weeks later, there was little difference between the treatment and control. Generally speaking, the effect of P. fluorescens 2P24 on soil fungal community in cucumber rhizosphere was just transient.	[Gao, Guanpeng; Yin, Danhan; Chen, Shengju; Xia, Fei; Yang, Jie; Li, Qing; Wang, Wei] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Gao, GP (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	weiwang@ecust.edu.cn			National Science Foundation of China [30871664]; Open Project for the State Key Laboratory of Bioreactor Engineering [2060204]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project for the State Key Laboratory of Bioreactor Engineering	This work was supported by the National Science Foundation of China (30871664) and Open Project for the State Key Laboratory of Bioreactor Engineering (2060204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALABOUVETTE C, 1990, BIOLOGICAL CONTROL OF SOIL-BORNE PLANT PATHOGENS, P27; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Bailey K. L., 2006, Handbook of sustainable weed management, P431; Bailey KL, 2010, BIOL CONTROL, V52, P221, DOI 10.1016/j.biocontrol.2009.05.003; Bangera MG, 1996, MOL PLANT MICROBE IN, V9, P83, DOI 10.1094/MPMI-9-0083; Bernbom N, 2006, J MICROBIOL METH, V66, P87, DOI 10.1016/j.mimet.2005.10.014; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Bruns TD, 1998, MOL ECOL, V7, P257, DOI 10.1046/j.1365-294X.1998.00337.x; Burke DJ, 2005, SOIL BIOL BIOCHEM, V37, P1683, DOI 10.1016/j.soilbio.2005.01.028; CARROLL H, 1995, APPL ENVIRON MICROB, V61, P3002, DOI 10.1128/AEM.61.8.3002-3007.1995; Cook RJ, 2000, ANNU REV PHYTOPATHOL, V38, P95, DOI 10.1146/annurev.phyto.38.1.95; Cronin D, 1997, APPL ENVIRON MICROB, V63, P1357, DOI 10.1128/AEM.63.4.1357-1361.1997; Cronin D, 1997, FEMS MICROBIOL ECOL, V23, P95, DOI 10.1111/j.1574-6941.1997.tb00394.x; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Entry JA, 2004, ENVIRON MANAGE, V33, pS363, DOI 10.1007/s00267-003-9145-y; Enwall K, 2009, LETT APPL MICROBIOL, V48, P145, DOI 10.1111/j.1472-765X.2008.02498.x; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Institute of Soil Science Chinese Academy of Sciences, 1978, SOIL PHYS CHEM AN SH; Jarosik V, 1996, MICROBIOL RES, V151, P177, DOI 10.1016/S0944-5013(96)80042-5; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Johnsen K, 2001, BIOL FERT SOILS, V33, P443, DOI 10.1007/s003740100351; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Marsh TL, 2000, APPL ENVIRON MICROB, V66, P3616, DOI 10.1128/AEM.66.8.3616-3620.2000; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; McSpadden Gardener BB, 2002, PLANT HLTH PROG, DOI [10.1094/PHP-2002-0510-01-RV, DOI 10.1094/PHP-2002-0510-01-RV]; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Natsch A, 1998, FEMS MICROBIOL ECOL, V27, P365, DOI 10.1111/j.1574-6941.1998.tb00552.x; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Prevost K, 2006, BIOCONTROL, V51, P533, DOI 10.1007/s10526-005-4240-z; Qing Y., 2009, MICROBIOLOGY, V155, P124; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Saravanakumar D, 2008, J APPL ENTOMOL, V132, P469, DOI 10.1111/j.1439-0418.2008.01278.x; Sarniguet A, 1995, P NATL ACAD SCI USA, V92, P12255, DOI 10.1073/pnas.92.26.12255; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Vahjen W, 1995, FEMS MICROBIOL ECOL, V18, P317; van Elsas JD, 1998, J MICROBIOL METH, V32, P133, DOI 10.1016/S0167-7012(98)00025-6; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; VANELSAS JD, 1992, BIOL FERT SOILS, V14, P14, DOI 10.1007/BF00336297; Wang JF, 2008, PLANT SOIL, V302, P45, DOI 10.1007/s11104-007-9453-8; Wei HL, 2006, ANTON LEEUW INT J G, V89, P267, DOI 10.1007/s10482-005-9028-8; Wei HaiLei, 2004, Acta Phytopathologica Sinica, V34, P80; WESSENDORF J, 1989, APPL MICROBIOL BIOT, V31, P97, DOI 10.1007/BF00252536; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu XG, 2010, FEMS MICROBIOL LETT, V309, P16, DOI 10.1111/j.1574-6968.2010.02009.x	50	47	51	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31806	10.1371/journal.pone.0031806	http://dx.doi.org/10.1371/journal.pone.0031806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359632	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200101
J	van Ierssel, SH; Hoymans, VY; Van Craenenbroeck, EM; Van Tendeloo, VF; Vrints, CJ; Jorens, PG; Conraads, VM				van Ierssel, Sabrina H.; Hoymans, Vicky Y.; Van Craenenbroeck, Emeline M.; Van Tendeloo, Viggo F.; Vrints, Christiaan J.; Jorens, Philippe G.; Conraads, Viviane M.			Endothelial Microparticles (EMP) for the Assessment of Endothelial Function: An In Vitro and In Vivo Study on Possible Interference of Plasma Lipids	PLOS ONE			English	Article							HYPERTRIGLYCERIDEMIA; DYSFUNCTION; YOUNG	Background: Circulating endothelial microparticles (EMP) reflect the condition of the endothelium and are of increasing interest in cardiovascular and inflammatory diseases. Recently, increased numbers of EMP following oral fat intake, possibly due to acute endothelial injury, have been reported. On the other hand, the direct interference of lipids with the detection of EMP has been suggested. This study aimed to investigate the effect of lipid-rich solutions, commonly administered in clinical practice, on the detection, both in vitro and in vivo, of EMP. Methods: For the in vitro assessment, several lipid-rich solutions were added to whole blood of healthy subjects (n = 8) and patients with coronary heart disease (n = 5). EMP (CD31+/CD42b-) were detected in platelet poor plasma by flow cytometry. For the in vivo study, healthy volunteers were evaluated on 3 different study-days: baseline evaluation, following lipid infusion and after a NaCl infusion. EMP quantification, lipid measurements and peripheral arterial tonometry were performed on each day. Results: Both in vitro addition and in vivo administration of lipids significantly decreased EMP (from 198.6 to 53.0 and from 272.6 to 90.6/mu l PPP, respectively, p = 0.001 and p = 0.012). The EMP number correlated inversely with the concentration of triglycerides, both in vitro and in vivo (r = -0.707 and -0.589, p < 0.001 and p = 0.021, respectively). The validity of EMP as a marker of endothelial function is supported by their inverse relationship with the reactive hyperemia index (r = -0.758, p = 0.011). This inverse relation was confounded by the intravenous administration of lipids. Conclusion: The confounding effect of high circulating levels of lipids, commonly found in patients that receive intravenous lipid-based solutions, should be taken into account when flow cytometry is used to quantify EMP.	[van Ierssel, Sabrina H.; Jorens, Philippe G.] Univ Antwerp UA, Antwerp Univ Hosp UZA, Dept Crit Care Med, Edegem, Belgium; [van Ierssel, Sabrina H.; Hoymans, Vicky Y.; Van Craenenbroeck, Emeline M.; Vrints, Christiaan J.; Conraads, Viviane M.] Univ Antwerp UA, Antwerp Univ Hosp UZA, Lab Cellular & Mol Cardiol, Edegem, Belgium; [Van Craenenbroeck, Emeline M.; Vrints, Christiaan J.; Conraads, Viviane M.] Univ Antwerp UA, Antwerp Univ Hosp UZA, Dept Cardiol, Edegem, Belgium; [Van Tendeloo, Viggo F.] Univ Antwerp UA, Antwerp Univ Hosp UZA, Ctr Cellular Therapy & Regenerat Med, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	van Ierssel, SH (corresponding author), Univ Antwerp UA, Antwerp Univ Hosp UZA, Dept Crit Care Med, Edegem, Belgium.	sabrina.vanierssel@ua.ac.be	Van Tendeloo, Viggo FI/A-1233-2010; Van Craenenbroeck, Emeline/AAG-4540-2020	Van Tendeloo, Viggo FI/0000-0003-3217-9917; Van Craenenbroeck, Emeline/0000-0001-7686-2668; van Ierssel, Sabrina H./0000-0003-2955-4130; Conraads, Viviane/0000-0002-5819-1503	Research Foundation Flanders, Belgium	Research Foundation Flanders, Belgium(FWO)	This work was suppported by a grant from the Research Foundation Flanders, Belgium, to Sabrina H. van Ierssel and Viviane M. Conraads (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6; Cantero M, 1998, THROMB RES, V91, P49, DOI 10.1016/S0049-3848(98)00044-9; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Devlin JW, 2005, PHARMACOTHERAPY, V25, P1348, DOI 10.1592/phco.2005.25.10.1348; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; DIMESKI G, 2008, CLIN BIOCHEM REV, V29, P43; Ferreira AC, 2004, CIRCULATION, V110, P3599, DOI 10.1161/01.CIR.0000148820.55611.6B; Fox SC, 2007, MEASUREMENT ENDOTHEL; Gokce N, 2001, AM J CARDIOL, V88, P153, DOI 10.1016/S0002-9149(01)01610-1; Harrison M, 2009, EUR J APPL PHYSIOL, V106, P555, DOI 10.1007/s00421-009-1050-5; Horstman Lawrence L., 2004, Keio Journal of Medicine, V53, P210, DOI 10.2302/kjm.53.210; Horstman LL, 2004, FRONT BIOSCI-LANDMRK, V9, P1118, DOI 10.2741/1270; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Kroll MH, 2004, CLIN CHEM, V50, P1968, DOI 10.1373/clinchem.2004.038075; Lekakis J, 2011, EUR J CARDIOVASC PRE; Llop J, 2003, CLIN NUTR, V22, P577, DOI 10.1016/S0261-5614(03)00082-7; Lundman P, 1997, CIRCULATION, V96, P3266; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Nitenberg A, 2006, DIABETES METAB, V32, p2S28, DOI 10.1016/S1262-3636(06)70482-7; Sustar V, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-47; Sutherland WHF, 2010, METABOLISM, V59, P446, DOI 10.1016/j.metabol.2009.07.033; Tyldum GA, 2009, J AM COLL CARDIOL, V53, P200, DOI 10.1016/j.jacc.2008.09.033; van Ierssel SH, 2010, THROMB RES, V125, P332, DOI 10.1016/j.thromres.2009.12.019	25	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31496	10.1371/journal.pone.0031496	http://dx.doi.org/10.1371/journal.pone.0031496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359595	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200064
J	Barrowman, J; Hamblet, C; Kane, MS; Michaelis, S				Barrowman, Jemima; Hamblet, Corinne; Kane, Megan S.; Michaelis, Susan			Requirements for Efficient Proteolytic Cleavage of Prelamin A by ZMPSTE24	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; PROTEASE INHIBITORS BLOCK; LAMIN-A PRECURSOR; RESTRICTIVE DERMOPATHY; MANDIBULOACRAL DYSPLASIA; ZINC METALLOPROTEINASE; NUCLEAR-LOCALIZATION; LMNA MUTATIONS; A/C GENE; LAMINOPATHIES	Background: The proteolytic maturation of the nuclear protein lamin A by the zinc metalloprotease ZMPSTE24 is critical for human health. The lamin A precursor, prelamin A, undergoes a multi-step maturation process that includes CAAX processing (farnesylation, proteolysis and carboxylmethylation of the C-terminal CAAX motif), followed by ZMPSTE24-mediated cleavage of the last 15 amino acids, including the modified C-terminus. Failure to cleave the prelamin A "tail", due to mutations in either prelamin A or ZMPSTE24, results in a permanently prenylated form of prelamin A that underlies the premature aging disease Hutchinson-Gilford Progeria Syndrome (HGPS) and related progeroid disorders. Methodology/Principal Findings: Here we have investigated the features of the prelamin A substrate that are required for efficient cleavage by ZMPSTE24. We find that the C-terminal 41 amino acids of prelamin A contain sufficient context to allow cleavage of the tail by ZMPSTE24. We have identified several mutations in amino acids immediately surrounding the cleavage site (between Y646 and L647) that interfere with efficient cleavage of the prelamin A tail; these mutations include R644C, L648A and N650A, in addition to the previously reported L647R. Our data suggests that 9 of the 15 residues within the cleaved tail that lie immediately upstream of the CAAX motif are not critical for ZMPSTE24-mediated cleavage, as they can be replaced by the 9 amino acid HA epitope. However, duplication of the same 9 amino acids (to increase the distance between the prenyl group and the cleavage site) impairs the ability of ZMPSTE24 to cleave prelamin A. Conclusions/Significance: Our data reveals amino acid preferences flanking the ZMPSTE24 cleavage site of prelamin A and suggests that spacing from the farnesyl-cysteine to the cleavage site is important for optimal ZMPSTE24 cleavage. These studies begin to elucidate the substrate requirements of an enzyme activity critical to human health and longevity.	[Barrowman, Jemima; Hamblet, Corinne; Kane, Megan S.; Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Barrowman, J (corresponding author), Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	michaelis@jhmi.edu			National Institutes of Health [GM41223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health (GM41223) to Susan Michaelis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Barrowman J, 2008, MOL BIOL CELL, V19, P5398, DOI 10.1091/mbc.E08-07-0704; Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Ben Yaou R, 2011, EUR J HUM GENET, V19, P647, DOI 10.1038/ejhg.2010.256; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Genschel J, 2001, Hum Mutat, V17, P154, DOI 10.1002/1098-1004(200102)17:2<154::AID-HUMU11>3.3.CO;2-I; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HENNEKES H, 1994, J CELL SCI, V107, P1019; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; Hudon SE, 2008, BIOCHEM BIOPH RES CO, V374, P365, DOI 10.1016/j.bbrc.2008.07.033; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mercuri E, 2005, MUSCLE NERVE, V31, P602, DOI 10.1002/mus.20293; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Moulson CL, 2007, HUM MUTAT, V28, P882, DOI 10.1002/humu.20536; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331; Rodriguez Sofia, 2010, Curr Aging Sci, V3, P81; Scaffidi P, 2005, PLOS BIOL, V3, P1855, DOI 10.1371/journal.pbio.0030395; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Smigiel R, 2010, AM J MED GENET A, V152A, P447, DOI 10.1002/ajmg.a.33221; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	49	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32120	10.1371/journal.pone.0032120	http://dx.doi.org/10.1371/journal.pone.0032120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355414	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300114
J	Huovinen, T; Brockmann, EC; Akter, S; Perez-Gamarra, S; Yla-Pelto, J; Liu, Y; Lamminmaki, U				Huovinen, Tuomas; Brockmann, Eeva-Christine; Akter, Sultana; Perez-Gamarra, Susan; Yla-Pelto, Jani; Liu, Yuan; Lamminmaki, Urpo			Primer Extension Mutagenesis Powered by Selective Rolling Circle Amplification	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; EXCISION-REPAIR PATHWAY; PHI-29 DNA-POLYMERASE; STRANDED PLASMID DNA; ESCHERICHIA-COLI; DEPURINATION; REPLICATION; LIBRARIES; DUTPASE; UNG	Primer extension mutagenesis is a popular tool to create libraries for in vitro evolution experiments. Here we describe a further improvement of the method described by T. A. Kunkel using uracil-containing single-stranded DNA as the template for the primer extension by additional uracil-DNA glycosylase treatment and rolling circle amplification (RCA) steps. It is shown that removal of uracil bases from the template leads to selective amplification of the nascently synthesized circular DNA strand carrying the desired mutations by phi29 DNA polymerase. Selective RCA (sRCA) of the DNA heteroduplex formed in Kunkel's mutagenesis increases the mutagenesis efficiency from 50% close to 100% and the number of transformants 300-fold without notable diversity bias. We also observed that both the mutated and the wild-type DNA were present in at least one third of the cells transformed directly with Kunkel's heteroduplex. In contrast, the cells transformed with sRCA product contained only mutated DNA. In sRCA, the complex cell-based selection for the mutant strand is replaced with the more controllable enzyme-based selection and less DNA is needed for library creation. Construction of a gene library of ten billion members is demonstrated with the described method with 240 nanograms of DNA as starting material.	[Huovinen, Tuomas; Brockmann, Eeva-Christine; Akter, Sultana; Perez-Gamarra, Susan; Yla-Pelto, Jani; Liu, Yuan; Lamminmaki, Urpo] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	University of Turku	Huovinen, T (corresponding author), Univ Turku, Dept Biochem & Food Chem, Turku, Finland.	tuomas.huovinen@utu.fi		Akter, Sultana/0000-0002-1939-7963; Huovinen, Tuomas/0000-0003-0960-3249	Finnish Agency of Technology and Innovation [40366/06]; National Doctoral Programme of Advanced Diagnostic Technologies and Applications [129793]	Finnish Agency of Technology and Innovation; National Doctoral Programme of Advanced Diagnostic Technologies and Applications	This work was supported by the Finnish Agency of Technology and Innovation (40366/06) and the National Doctoral Programme of Advanced Diagnostic Technologies and Applications (129793 for T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAAS PD, 1980, FEBS LETT, V110, P15, DOI 10.1016/0014-5793(80)80012-3; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Brockmann EC, 2011, PROTEIN ENG DES SEL; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Fujii R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh147; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; Huovinena T, 2011, PLASMID, V66, P47, DOI 10.1016/j.plasmid.2011.03.004; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; JUNG R, 1992, GENE, V121, P17, DOI 10.1016/0378-1119(92)90157-K; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Li FS, 1999, BIOTECHNIQUES, V27, P734, DOI 10.2144/99274st03; MARKVARDSEN P, 1995, BIOTECHNIQUES, V18, P370; SAGHER D, 1985, NUCLEIC ACIDS RES, V13, P4285, DOI 10.1093/nar/13.12.4285; Sandigursky M, 1998, NUCLEIC ACIDS RES, V26, P1282, DOI 10.1093/nar/26.5.1282; SCHAAPER RM, 1981, P NATL ACAD SCI-BIOL, V78, P1773, DOI 10.1073/pnas.78.3.1773; Serrano-Heras G, 2008, P NATL ACAD SCI USA, V105, P19044, DOI 10.1073/pnas.0808797105; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; TYE BK, 1977, J MOL BIOL, V117, P293, DOI 10.1016/0022-2836(77)90128-0; WARNER HR, 1981, J BACTERIOL, V145, P687, DOI 10.1128/JB.145.2.687-695.1981; Yagodkin A, 2007, NUCLEOS NUCLEOT NUCL, V26, P473, DOI 10.1080/15257770701426260	27	17	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31817	10.1371/journal.pone.0031817	http://dx.doi.org/10.1371/journal.pone.0031817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355397	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300097
J	Park, JH; Lee, S; Yu, HG; Kim, JI; Seo, JS				Park, Jung Hyun; Lee, Seungbok; Yu, Hyeong Gon; Kim, Jong-Il; Seo, Jeong-Sun			Copy Number Variation of Age-Related Macular Degeneration Relevant Genes in the Korean Population	PLOS ONE			English	Article							SUBRETINAL NEOVASCULARIZATION; ASSOCIATION; RECEPTOR; RISK; EXPRESSION; VARIANTS; DISEASE; LINKAGE; FAMILY; VLDLR	Purpose: Studies that analyzed single nucleotide polymorphisms (SNP) in various genes have shown that genetic factors are strongly associated with age-related macular degeneration (AMD) susceptibility. Copy number variation (CNV) may be an additional type of genetic variation that contributes to AMD pathogenesis. This study investigated CNV in 4 AMD-relevant genes in Korean AMD patients and control subjects. Methods: Four CNV candidate regions located in AMD-relevant genes (VEGFA, ARMS2/HTRA1, CFH and VLDLR), were selected based on the outcomes of our previous study which elucidated common CNVs in the Asian populations. Real-time PCR based TaqMan Copy Number Assays were performed on CNV candidates in 273 AMD patients and 257 control subjects. Results: The predicted copy number (PCN, 0, 1, 2 or 3+) of each region was called using the CopyCaller program. All candidate genes except ARMS2/HTRA1 showed CNV in at least one individual, in which losses of VEGFA and VLDLR represent novel findings in the Asian population. When the frequencies of PCN were compared, only the gain in VLDLR showed significant differences between AMD patients and control subjects (p = 0.025). Comparisons of the raw copy values (RCV) revealed that 3 of 4 candidate genes showed significant differences (2.03 vs. 1.92 for VEGFA, p<0.01; 2.01 vs. 1.97 for CFH, p<0.01; 1.97 vs. 2.01, p<0.01 for ARMS2/HTRA1). Conclusion: CNVs located in AMD-relevant genes may be associated with AMD susceptibility. Further investigations encompassing larger patient cohorts are needed to elucidate the role of CNV in AMD pathogenesis.	[Park, Jung Hyun; Yu, Hyeong Gon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Park, Jung Hyun] Inje Univ, Seoul Paik Hosp, Dept Ophthalmol, Seoul, South Korea; [Lee, Seungbok; Kim, Jong-Il; Seo, Jeong-Sun] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea; [Lee, Seungbok; Kim, Jong-Il; Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Jong-Il; Seo, Jeong-Sun] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Kim, Jong-Il; Seo, Jeong-Sun] Psoma Therapeut, Seoul, South Korea; [Seo, Jeong-Sun] Macrogen, Seoul, South Korea	Seoul National University (SNU); Inje University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Macrogen, Inc.	Park, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	hgonyu@snu.ac.kr; jongil@snu.ac.kr	Seo, Jeong-Sun/J-2763-2012; KIM, JONG-IL/D-1019-2011; Yu, Hyeong Gon/J-2772-2012	KIM, JONG-IL/0000-0002-7240-3744; Seungbok, Lee/0000-0002-3145-8714; Yu, Hyeong Gon/0000-0002-1795-202X	Ministry of Health & Welfare, the Republic of Korea [A080588]	Ministry of Health & Welfare, the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project (A080588), Ministry of Health & Welfare, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Galan A, 2010, OPHTHALMOLOGY, V117, P1769, DOI 10.1016/j.ophtha.2010.01.030; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Jiang AH, 2009, INVEST OPHTH VIS SCI, V50, P844, DOI 10.1167/iovs.08-2447; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Liu MM, 2011, INVEST OPHTH VIS SCI, V52, P3129, DOI 10.1167/iovs.10-6735; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Schmid-Kubista KE, 2009, INVEST OPHTH VIS SCI, V50, P5070, DOI 10.1167/iovs.09-3975; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31243	10.1371/journal.pone.0031243	http://dx.doi.org/10.1371/journal.pone.0031243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355348	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300048
J	Phillips, KA; Hopkins, WD				Phillips, Kimberley A.; Hopkins, William D.			Topography of the Chimpanzee Corpus Callosum	PLOS ONE			English	Article							DIFFUSION-TENSOR; FIBER COMPOSITION; SIGNAL INTENSITY; SEX-DIFFERENCES; WHITE-MATTER; EVOLUTION; SIZE; MORPHOLOGY; AGE; CONNECTIVITY	The corpus callosum (CC) is the largest commissural white matter tract in mammalian brains, connecting homotopic and heterotopic regions of the cerebral cortex. Knowledge of the distribution of callosal fibers projecting into specific cortical regions has important implications for understanding the evolution of lateralized structures and functions of the cerebral cortex. No comparisons of CC topography in humans and great apes have yet been conducted. We investigated the topography of the CC in 21 chimpanzees using high-resolution magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI). Tractography was conducted based on fiber assignment by continuous tracking (FACT) algorithm. We expected chimpanzees to display topographical organization similar to humans, especially concerning projections into the frontal cortical regions. Similar to recent studies in humans, tractography identified five clusters of CC fibers projecting into defined cortical regions: prefrontal; premotor and supplementary motor; motor; sensory; parietal, temporal and occipital. Significant differences in fractional anisotropy (FA) were found in callosal regions, with highest FA values in regions projecting to higher-association areas of posterior cortical (including parietal, temporal and occipital cortices) and prefrontal cortical regions (p<0.001). The lowest FA values were seen in regions projecting into motor and sensory cortical areas. Our results indicate chimpanzees display similar topography of the CC as humans, in terms of distribution of callosal projections and microstructure of fibers as determined by anisotropy measures.	[Phillips, Kimberley A.] Trinity Univ, Dept Psychol, San Antonio, TX 78212 USA; [Phillips, Kimberley A.] SW Natl Primate Res Ctr, Texas Biomed Res Inst, San Antonio, TX USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA	Trinity University; Texas Biomedical Research Institute	Phillips, KA (corresponding author), Trinity Univ, Dept Psychol, San Antonio, TX 78212 USA.	kimberley.phillips@trinity.edu	Phillips, Kimberley/P-1212-2016	Phillips, Kimberley/0000-0002-5517-3596	National Institute of Neurological Disorders and Stroke [NS070717, NS42867, HD60563]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD060563] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867, R15NS070717] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (grants NS070717 to KAP; NS42867 and HD60563 to WDH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders And Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2004, J COMPUTER ASSISTED, V28; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; ALLEN LS, 1991, J NEUROSCI, V11, P933; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Basser PJ, 1995, NMR BIOMED, V7-8, P583; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bonzano L, 2008, J NEUROSCI, V28, P3227, DOI 10.1523/JNEUROSCI.4076-07.2008; Brambilla P, 2004, J NEUROL NEUROSUR PS, V75, P221; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; Dorion AA, 2000, NEUROSCI RES, V36, P9, DOI 10.1016/S0168-0102(99)00102-9; DRIESEN NR, 1995, PSYCHOBIOLOGY, V23, P240; Dunham LA, 2006, BEHAV NEUROSCI, V120, P1025, DOI 10.1037/0735-7044.120.5.1025; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Fryer SL, 2008, BRAIN COGNITION, V67, P225, DOI 10.1016/j.bandc.2008.01.009; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; Highley JR, 1999, BRAIN, V122, P99, DOI 10.1093/brain/122.1.99; Hofer S, 2007, CEREB CORTEX; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hopkins WD, 2000, BEHAV NEUROSCI, V114, P739, DOI 10.1037//0735-7044.114.4.739; Hopkins WD, 2010, DEV PSYCHOBIOL, V52, P133, DOI 10.1002/dev.20421; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Innocenti GM, 2010, BRAIN STRUCT FUNCT, V215, P123, DOI 10.1007/s00429-010-0274-9; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Le Bihan D., 1995, DIFFUSION PERFUSION, V1st; Li LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012886; Olivares R, 2001, BRAIN BEHAV EVOLUT, V57, P98, DOI 10.1159/000047229; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Phillips KA, 2009, NEUROSCIENCE, V159, P1119, DOI 10.1016/j.neuroscience.2009.01.061; Phillips KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000792; Ramnani N, 2006, CEREB CORTEX, V16, P811, DOI 10.1093/cercor/bhj024; Rilling JK, 1999, NEUROREPORT, V10, P1453, DOI 10.1097/00001756-199905140-00012; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; ROSEN GD, 1989, NEUROSCIENCE, V33, P525, DOI 10.1016/0306-4522(89)90404-1; Sakai T, 2011, CURR BIOL, V21, P1; Schoenemann PT, 2006, ANNU REV ANTHROPOL, V35, P379, DOI 10.1146/annurev.anthro.35.081705.123210; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Wang F, 2008, BIOL PSYCHIAT, V64, P730, DOI 10.1016/j.biopsych.2008.06.001; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31941	10.1371/journal.pone.0031941	http://dx.doi.org/10.1371/journal.pone.0031941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355406	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300106
J	Reynolds, JR; O'Reilly, RC; Cohen, JD; Braver, TS				Reynolds, Jeremy R.; O'Reilly, Randall C.; Cohen, Jonathan D.; Braver, Todd S.			The Function and Organization of Lateral Prefrontal Cortex: A Test of Competing Hypotheses	PLOS ONE			English	Article							INFERIOR FRONTAL JUNCTION; COGNITIVE CONTROL; WORKING-MEMORY; NEURAL MECHANISMS; TRANSIENT; CONTEXT; FMRI; SCHIZOPHRENIA; MAINTENANCE; DYSFUNCTION	The present experiment tested three hypotheses regarding the function and organization of lateral prefrontal cortex (PFC). The first account (the information cascade hypothesis) suggests that the anterior-posterior organization of lateral PFC is based on the timing with which cue stimuli reduce uncertainty in the action selection process. The second account (the levels-of-abstraction hypothesis) suggests that the anterior-posterior organization of lateral PFC is based on the degree of abstraction of the task goals. The current study began by investigating these two hypotheses, and identified several areas of lateral PFC that were predicted to be active by both the information cascade and levels-of-abstraction accounts. However, the pattern of activation across experimental conditions was inconsistent with both theoretical accounts. Specifically, an anterior area of mid-dorsolateral PFC exhibited sensitivity to experimental conditions that, according to both accounts, should have selectively engaged only posterior areas of PFC. We therefore investigated a third possible account (the adaptive context maintenance hypothesis) that postulates that both posterior and anterior regions of PFC are reliably engaged in task conditions requiring active maintenance of contextual information, with the temporal dynamics of activity in these regions flexibly tracking the duration of maintenance demands. Activity patterns in lateral PFC were consistent with this third hypothesis: regions across lateral PFC exhibited transient activation when contextual information had to be updated and maintained in a trial-by-trial manner, but sustained activation when contextual information had to be maintained over a series of trials. These findings prompt a reconceptualization of current views regarding the anterior-posterior organization of lateral PFC, but do support other findings regarding the active maintenance role of lateral PFC in sequential working memory paradigms.	[Reynolds, Jeremy R.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [O'Reilly, Randall C.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	University of Denver; University of Colorado System; University of Colorado Boulder; Princeton University; Princeton University; Washington University (WUSTL)	Reynolds, JR (corresponding author), Univ Denver, Dept Psychol, Denver, CO 80208 USA.	jeremy.reynolds@psy.du.edu		O'Reilly, Randall/0000-0003-0322-4600; Braver, Todd/0000-0002-2631-3393	National Institute of Mental Health [MH069597, 2 RO1 MH66078]; National Research Service Award [5F32MH07530002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078, R01MH069597] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by grants MH069597 and 2 RO1 MH66078 from the National Institute of Mental Health, and a National Research Service Award (5F32MH07530002). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Botvinick MM, 2007, PHILOS T R SOC B, V362, P1615, DOI 10.1098/rstb.2007.2056; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Braver T S, 1999, Prog Brain Res, V121, P327; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012861; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Conturo T. E., 1996, Society for Neuroscience Abstracts, V22, P7; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Holmes AJ, 2005, SCHIZOPHR RES, V76, P199, DOI 10.1016/j.schres.2005.01.021; Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Lenartowicz A, 2010, COGN AFFECT BEHAV NE, V10, P298, DOI 10.3758/CABN.10.2.298; MacDonald AW, 2005, AM J PSYCHIAT, V162, P475, DOI 10.1176/appi.ajp.162.3.475; MacDonald AW, 2003, J ABNORM PSYCHOL, V112, P689, DOI 10.1037/0021-843X.112.4.689; Marklund P, 2007, NEUROIMAGE, V36, P1361, DOI 10.1016/j.neuroimage.2007.03.058; Marklund P, 2007, CORTEX, V43, P22, DOI 10.1016/S0010-9452(08)70443-X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Mozer MC, 2009, ADV NEURAL INFORM PR, V21, P1353; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Reynolds JR, 2009, COGNITION, V113, P281, DOI 10.1016/j.cognition.2009.05.015; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; Ruge H, 2009, NEUROPSYCHOLOGIA, V47, P1670, DOI 10.1016/j.neuropsychologia.2009.02.004; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Talairach J., 1988, COPLANAR STEREOTAXIC; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006	55	55	55	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30284	10.1371/journal.pone.0030284	http://dx.doi.org/10.1371/journal.pone.0030284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355309	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300009
J	Horgan, CP; Hanscom, SR; Kelly, EE; McCaffrey, MW				Horgan, Conor P.; Hanscom, Sara R.; Kelly, Eoin E.; McCaffrey, Mary W.			Tumor Susceptibility Gene 101 (TSG101) Is a Novel Binding-Partner for the Class II Rab11-FIPs	PLOS ONE			English	Article							RAB COUPLING PROTEIN; ESCRT MACHINERY; CLEAVAGE FURROW; CYTOKINESIS; COMPLEX; COMPARTMENT; MIDBODY; GTPASES; DIFFERENTIATION; PROLIFERATION	The Rab11-FIPs (Rab11-family interacting proteins; henceforth, FIPs) are a family of Rab11a/Rab11b/Rab25 GTPase effector proteins implicated in an assortment of intracellular trafficking processes. Through proteomic screening, we have identified TSG101 (tumor susceptibility gene 101), a component of the ESCRT-I (endosomal sorting complex required for transport) complex, as a novel FIP4-binding protein, which we find can also bind FIP3. We show that alpha-helical coiled-coil regions of both TSG101 and FIP4 mediate the interaction with the cognate protein, and that point mutations in the coiled-coil regions of both TSG101 and FIP4 abrogate the interaction. We find that expression of TSG101 and FIP4 mutants cause cytokinesis defects, but that the TSG101-FIP4 interaction is not required for localisation of TSG101 to the midbody/Flemming body during abscission. Together, these data suggest functional overlap between Rab11-controlled processes and components of the ESCRT pathway.	[Horgan, Conor P.; Hanscom, Sara R.; Kelly, Eoin E.; McCaffrey, Mary W.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Mol Cell Biol Lab, Cork, Ireland	University College Cork	Horgan, CP (corresponding author), Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Mol Cell Biol Lab, Cork, Ireland.	m.mccaffrey@ucc.ie			Science Foundation Ireland (SFI);  [08/RFP/NSC 1499];  [05/IN.3/B859, 09/IN.1/B2629]	Science Foundation Ireland (SFI)(Science Foundation Ireland); ; 	This work was supported by Science Foundation Ireland (SFI) Research Frontiers Programme (RFP) and Principal Investigator grants (08/RFP/NSC 1499 and 05/IN.3/B859, 09/IN.1/B2629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bodon G, 2011, J BIOL CHEM; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Horgan Conor P, 2012, Front Biosci (Schol Ed), V4, P547; Horgan CP, 2011, BIOCHEM SOC T, V39, P1202, DOI 10.1042/BST0391202; Horgan CP, 2011, CELL BIOL INT, V35, P171, DOI 10.1042/CBI20100284; Horgan CP, 2010, BIOCHEM BIOPH RES CO, V394, P387, DOI 10.1016/j.bbrc.2010.03.028; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Horgan CP, 2005, METHOD ENZYMOL, V403, P499, DOI 10.1016/S0076-6879(05)03044-2; Horgan CP, 2004, BIOCHEM BIOPH RES CO, V319, P83, DOI 10.1016/j.bbrc.2004.04.157; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kelly EE, 2010, BIOL CELL, V102, P51, DOI 10.1042/BC20090068; Krzyzaniak MA, 2009, TRAFFIC, V10, P1439, DOI 10.1111/j.1600-0854.2009.00967.x; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lindsay AJ, 2004, FEBS LETT, V571, P86, DOI 10.1016/j.febslet.2004.06.068; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Muto A, 2007, DEV DYNAM, V236, P214, DOI 10.1002/dvdy.21009; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Schonteich E, 2007, EUR J CELL BIOL, V86, P417, DOI 10.1016/j.ejcb.2007.05.004; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takahashi S, 2011, GENES CELLS, V16, P938, DOI 10.1111/j.1365-2443.2011.01538.x; Wallace DM, 2002, BIOCHEM BIOPH RES CO, V292, P909, DOI 10.1006/bbrc.2002.6736; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yasuda Jiro, 2005, Uirusu, V55, P281, DOI 10.2222/jsv.55.281	44	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32030	10.1371/journal.pone.0032030	http://dx.doi.org/10.1371/journal.pone.0032030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348143	gold, Green Submitted, Green Published			2022-12-27	WOS:000302737400060
J	Jimenez-Lopez, JC; Morales, S; Castro, AJ; Volkmann, D; Rodriguez-Garcia, MI; Alche, JD				Jimenez-Lopez, Jose C.; Morales, Sonia; Castro, Antonio J.; Volkmann, Dieter; Rodriguez-Garcia, Maria I.; de D. Alche, Juan			Characterization of Profilin Polymorphism in Pollen with a Focus on Multifunctionality	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; GENE FAMILY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; IMMUNOLOGICAL CHARACTERIZATION; FUNCTIONAL-CHARACTERIZATION; PHOSPHOINOSITIDE 3-KINASE; MULTIGENE FAMILY; PLANT PROFILIN; MAJOR ALLERGEN; CDNA CLONING	Profilin, a multigene family involved in actin dynamics, is a multiple partners-interacting protein, as regard of the presence of at least of three binding domains encompassing actin, phosphoinositide lipids, and poly-L-proline interacting patches. In addition, pollen profilins are important allergens in several species like Olea europaea L. (Ole e 2), Betula pendula (Bet v 2), Phleum pratense (Phl p 12), Zea mays (Zea m 12) and Corylus avellana (Cor a 2). In spite of the biological and clinical importance of these molecules, variability in pollen profilin sequences has been poorly pointed out up until now. In this work, a relatively high number of pollen profilin sequences have been cloned, with the aim of carrying out an extensive characterization of their polymorphism among 24 olive cultivars and the above mentioned plant species. Our results indicate a high level of variability in the sequences analyzed. Quantitative intra-specific/varietal polymorphism was higher in comparison to inter-specific/cultivars comparisons. Multi-optional posttranslational modifications, e.g. phosphorylation sites, physicochemical properties, and partners-interacting functional residues have been shown to be affected by profilin polymorphism. As a result of this variability, profilins yielded a clear taxonomic separation between the five plant species. Profilin family multifunctionality might be inferred by natural variation through profilin isovariants generated among olive germplasm, as a result of polymorphism. The high variability might result in both differential profilin properties and differences in the regulation of the interaction with natural partners, affecting the mechanisms underlying the transmission of signals throughout signaling pathways in response to different stress environments. Moreover, elucidating the effect of profilin polymorphism in adaptive responses like actin dynamics, and cellular behavior, represents an exciting research goal for the future.	[Jimenez-Lopez, Jose C.; Morales, Sonia; Castro, Antonio J.; Rodriguez-Garcia, Maria I.; de D. Alche, Juan] High Council Sci Res, Estac Expt Zaidin, Dept Biochem Cell & Mol Biol Plants, Granada, Spain; [Volkmann, Dieter] Univ Bonn, Dept Plant Cell Biol, Inst Cellular & Mol Bot, Bonn, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Bonn	Jimenez-Lopez, JC (corresponding author), High Council Sci Res, Estac Expt Zaidin, Dept Biochem Cell & Mol Biol Plants, Granada, Spain.	juandedios.alche@eez.csic.es	Rodriguez-Garcia, Maria/K-5833-2014; Castro, Antonio J/K-8091-2014; De Dios Alche, Juan/K-6079-2014; Jimenez-Lopez, Jose C./H-5896-2011	Rodriguez-Garcia, Maria/0000-0002-7664-3235; Castro, Antonio J/0000-0001-6664-8158; De Dios Alche, Juan/0000-0002-7547-6025; Jimenez-Lopez, Jose C./0000-0002-1470-360X	European Regional Development Fund [MCINN BFU 2004-00601/BFI, BFU 2008-00629, BFU2011-2277]; CICE (Junta de Andalucia) [P2010-CVI15767, P2010-AGR6274, P2011-CVI-7487]; coordinated project Spain/Germany [MEC HA2004-0094]; Spanish CSIC	European Regional Development Fund(European Commission); CICE (Junta de Andalucia)(Junta de Andalucia); coordinated project Spain/Germany; Spanish CSIC	This study was supported by the following European Regional Development Fund co-financed grants: MCINN BFU 2004-00601/BFI, BFU 2008-00629, BFU2011-22779, CICE (Junta de Andalucia) P2010-CVI15767, P2010-AGR6274 and P2011-CVI-7487, and by the coordinated project Spain/Germany MEC HA2004-0094. The funders had no role in the study, design or decision to publish.; JCJL and SM thank Spanish CSIC for their respective I3P-CSIC grants. The authors also want to thank Concepcion Martinez for her excellent technical assistance. The authors want to deeply thank the sources of pollen collections in Spain: 1) World olive germplasm bank, CIFA "Alameda del Obispo'' (Junta de Andalucia), Cordoba; 2) Estacion Experimental del Zaidin (CSIC), Granada; 3) Olive Culture Museum, Baeza, Jaen; 4) CIFA "Venta del Llano'', Jaen; and in Germany: The Botanic Garden (Bonn).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio-Fabre R, 2006, PLANT J, V47, P491, DOI 10.1111/j.1365-313X.2006.02787.x; Asturias JA, 1997, J ALLERGY CLIN IMMUN, V100, P365, DOI 10.1016/S0091-6749(97)70250-1; Asturias JA, 2004, J INVEST ALLERG CLIN, V14, P43; Asturias JA, 1997, CLIN EXP ALLERGY, V27, P1307, DOI 10.1111/j.1365-2222.1997.tb01176.x; Baluska F, 2002, TRENDS CELL BIOL, V12, P14, DOI 10.1016/S0962-8924(01)02208-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BINDER M, 1995, EUR J BIOCHEM, V233, P976, DOI 10.1111/j.1432-1033.1995.976_3.x; BLASCO R, 1991, J VIROL, V65, P4598, DOI 10.1128/JVI.65.9.4598-4608.1991; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Butler-Cole C, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-76; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deeks MJ, 2002, TRENDS PLANT SCI, V7, P492, DOI 10.1016/S1360-1385(02)02341-5; Di Nardo A, 2000, J CELL SCI, V113, P3795; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Fischer S, 1996, J ALLERGY CLIN IMMUN, V98, P189, DOI 10.1016/S0091-6749(96)70242-7; Games P. A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Gao ZS, 2005, THEOR APPL GENET, V111, P1087, DOI 10.1007/s00122-005-0034-z; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbon BC, 1998, PLANT CELL, V10, P981, DOI 10.1105/tpc.10.6.981; GIEHL K, 1994, EUR J BIOCHEM, V226, P681, DOI 10.1111/j.1432-1033.1994.tb20096.x; Guillen G, 1999, PLANT J, V19, P497, DOI 10.1046/j.1365-313X.1999.00542.x; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAUGWITZ M, 1991, J CELL SCI, V100, P481; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hess MW, 1997, SEX PLANT REPROD, V10, P283, DOI 10.1007/s004970050099; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; Huang SR, 1996, PLANT PHYSIOL, V111, P115, DOI 10.1104/pp.111.1.115; Jeong YM, 2006, PLANT PHYSIOL, V140, P196, DOI 10.1104/pp.105.071316; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; JOCKUSCH BM, 1974, EXP CELL RES, V89, P241, DOI 10.1016/0014-4827(74)90787-3; Kandasamy MK, 2002, CELL MOTIL CYTOSKEL, V52, P22, DOI 10.1002/cm.10029; Kandasamy MK, 2007, PLANT CELL, V19, P3111, DOI 10.1105/tpc.107.052621; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Kovar DR, 2000, PLANT CELL, V12, P583, DOI 10.1105/tpc.12.4.583; Kovar DR, 2001, BIOCHEM J, V358, P49, DOI 10.1042/0264-6021:3580049; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambrechts A, 1997, EMBO J, V16, P484, DOI 10.1093/emboj/16.3.484; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LARSSON H, 1988, BIOCHIM BIOPHYS ACTA, V953, P95, DOI 10.1016/0167-4838(88)90013-1; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Limmongkon A, 2004, BIOCHEM BIOPH RES CO, V324, P382, DOI 10.1016/j.bbrc.2004.09.071; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; MACHESKY LM, 1994, BIOCHEMISTRY-US, V33, P10815, DOI 10.1021/bi00201a032; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; MAZZOTTI G, 1995, J HISTOCHEM CYTOCHEM, V43, P181, DOI 10.1177/43.2.7822774; McDowell JM, 1996, GENETICS, V142, P587; MCLEAN BG, 1990, PLANT CELL, V2, P335, DOI 10.1105/tpc.2.4.335; MCLEAN BG, 1990, CELL MOTIL CYTOSKEL, V17, P276; MEAGHER RB, 1990, CELL MOTIL CYTOSKEL, V16, P164, DOI 10.1002/cm.970160303; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; MITTERMANN I, 1995, PLANT MOL BIOL, V27, P137, DOI 10.1007/BF00019185; Pierce J.R., 1980, INTRO INFORM THEORY; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; POLLARD TD, 1991, CELL MOTIL CYTOSKEL, V20, P169, DOI 10.1002/cm.970200209; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Rallo L., 2005, VARIEDADES OLIVO ESP; Ren HY, 2007, PROTOPLASMA, V230, P171, DOI 10.1007/s00709-006-0231-x; Rihs HP, 1999, J ALLERGY CLIN IMMUN, V104, P1293, DOI 10.1016/S0091-6749(99)70027-8; RIHS HP, 1994, INT ARCH ALLERGY IMM, V105, P190, DOI 10.1159/000236824; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schluter K, 1998, J CELL SCI, V111, P3261; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; SOHN RH, 1994, BIOESSAYS, V16, P465, DOI 10.1002/bies.950160705; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; STAIGER CJ, 1993, PLANT J, V4, P631, DOI 10.1046/j.1365-313X.1993.04040631.x; Staiger CJ, 1997, TRENDS PLANT SCI, V2, P275, DOI 10.1016/S1360-1385(97)86350-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorn KS, 1997, STRUCTURE, V5, P19, DOI 10.1016/S0969-2126(97)00163-9; VALENTA R, 1993, J BIOL CHEM, V268, P22777; Vantard M, 2002, CURR OPIN PLANT BIOL, V5, P502, DOI 10.1016/S1369-5266(02)00300-X; Vemuri B, 2001, CELL SIGNAL, V13, P433, DOI 10.1016/S0898-6568(01)00164-4; Vidali L, 1997, CELL MOTIL CYTOSKEL, V36, P323, DOI 10.1002/(SICI)1097-0169(1997)36:4<323::AID-CM3>3.0.CO;2-6; Volkmann D, 1999, MICROSC RES TECHNIQ, V47, P135, DOI 10.1002/(SICI)1097-0029(19991015)47:2<135::AID-JEMT6>3.0.CO;2-1; von Braun SS, 2008, PLANTA, V227, P1151, DOI 10.1007/s00425-007-0688-7; von Witsch M, 1998, EUR J CELL BIOL, V77, P303, DOI 10.1016/S0171-9335(98)80089-7; Wang HY, 2005, PLANTA, V222, P594, DOI 10.1007/s00425-005-0005-2; Wilkies DE, 2003, J EUKARYOT MICROBIOL, V50, P252, DOI 10.1111/j.1550-7408.2003.tb00130.x; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wopfner N, 2002, BIOL CHEM, V383, P1779, DOI 10.1515/BC.2002.199	99	25	136	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30878	10.1371/journal.pone.0030878	http://dx.doi.org/10.1371/journal.pone.0030878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348028	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400006
J	Julg, B; Poole, D; Ghebremichael, M; Castilla, C; Altfeld, M; Sunpath, H; Murphy, RA; Walker, BD				Julg, Boris; Poole, Danielle; Ghebremichael, Musie; Castilla, Carmen; Altfeld, Marcus; Sunpath, Henry; Murphy, Richard A.; Walker, Bruce D.			Factors Predicting Discordant Virological and Immunological Responses to Antiretroviral Therapy in HIV-1 Clade C Infected Zulu/Xhosa in South Africa	PLOS ONE			English	Article							CD4 CELL COUNT; 1-INFECTED PATIENTS; RECOVERY; COHORT; SUPPRESSION; INDIVIDUALS; COMMUNITY; OUTCOMES; SEX	Factors predicting suboptimal CD4 cell recovery have been studied in HIV clade-B infected US and European populations. It is, however, uncertain to what extent these results are applicable to HIV clade-C infected African populations. Multivariate analysis using logistic regression and longitudinal analyses using mixed models were employed to assess the impact of age, gender, baseline CD4 cell count, hemoglobin, body mass index (BMI), tuberculosis and other opportunistic co-infections, and frequencies of regimen change on CD4 cell recovery at 12 and 30 months and on overtime change in CD4 cells among 442 virologically suppressed South Africans. Despite adequate virological response 37% (95% CI:32%-42%) and 83% (95% CI:79%-86%) of patients on antiretroviral therapy failed to restore CD4 cell counts >= 200 cells/mm(3) after 12 and >= 500 cells/mm(3) after 30 months, respectively, in this South African cohort. Critical risk factors for inadequate recovery were older age (p = 0.001) and nadir CD4 cell count at ART initiation (p < 0.0001), while concurrent TB co-infection, BMI, baseline hemoglobin, gender and antiretroviral regimen were not significant risk factors. These data suggest that greater efforts are needed to identify and treat HAART-eligible patients prior to severe CD4 cell decline or achievement of advanced age.	[Julg, Boris; Poole, Danielle; Ghebremichael, Musie; Altfeld, Marcus; Walker, Bruce D.] MIT, Ragon Inst MGH, Boston, MA USA; [Julg, Boris; Poole, Danielle; Altfeld, Marcus; Walker, Bruce D.] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Julg, Boris; Poole, Danielle; Altfeld, Marcus; Walker, Bruce D.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Ghebremichael, Musie] Harvard Univ, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ghebremichael, Musie] Dana Farber Canc Inst, Boston, MA 02115 USA; [Castilla, Carmen] Univ Med & Dent New Jersey, Newark, NJ 07103 USA; [Sunpath, Henry] McCord Hosp, Durban, South Africa; [Murphy, Richard A.] Doctors Borders, Operat Support Unit, New York, NY USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Harvard University; Dana-Farber Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute	Julg, B (corresponding author), MIT, Ragon Inst MGH, Boston, MA USA.	bjulg@partners.org	Juelg, Boris/ABA-1955-2020; Altfeld, Marcus/AAE-7306-2019	Juelg, Boris/0000-0002-4687-9626; Altfeld, Marcus/0000-0001-5972-2997; Murphy, Richard/0000-0003-2249-7452	Mark and Lisa Schwartz Foundation; Doris Duke Distinguished Clinical Scientist Award; Howard Hughes Medical Institute; National Institutes of Health [AI30914]; Ragon Institute of MGH, MIT and Harvard; McCord Hospital; CDC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914, R37AI067073, P30AI060354] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Foundation; Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT and Harvard; McCord Hospital; CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Ragon Institute of MGH, MIT and Harvard, the Mark and Lisa Schwartz Foundation, a Doris Duke Distinguished Clinical Scientist Award to MA, and The Howard Hughes Medical Institute (to BDW). Further support was provided by National Institutes of Health grant AI30914 to BDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Roma Maharaj, Ansuri Singh and Fiona Samed from Sinikithemba ARV clinic at McCord hospital for their assistance in the collection of data; we wish to furthermore thank Claire Kerry and the management of McCord Hospital for support of this study. The Sinikithemba ARV clinic at Mc Cord hospital is a PEPFAR and CDC funded programme.	Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Khanna N, 2008, CLIN INFECT DIS, V47, P1093, DOI 10.1086/592113; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Nies-Kraske E, 2009, J INFECT DIS, V199, P1648, DOI 10.1086/598980; Patterson K, 2007, HIV MED, V8, P406, DOI 10.1111/j.1468-1293.2007.00485.x; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Wanchu A, 2010, INDIAN J PATHOL MICR, V53, P745, DOI 10.4103/0377-4929.72070	22	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31161	10.1371/journal.pone.0031161	http://dx.doi.org/10.1371/journal.pone.0031161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348047	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400011
J	Lavoie, PM; Ladd, M; Hirschfeld, AF; Huusko, J; Mahlman, M; Speert, DP; Hallman, M; Lacaze-Masmonteil, T; Turvey, SE				Lavoie, Pascal M.; Ladd, Mihoko; Hirschfeld, Aaron F.; Huusko, Johanna; Mahlman, Mari; Speert, David P.; Hallman, Mikko; Lacaze-Masmonteil, Thierry; Turvey, Stuart E.			Influence of Common Non-Synonymous Toll-like Receptor 4 Polymorphisms on Bronchopulmonary Dysplasia and Prematurity in Human Infants	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; HIGH-RISK INFANTS; ASP299GLY POLYMORPHISM; LUNG HYPERPERMEABILITY; GENETIC SUSCEPTIBILITY; TLR4 POLYMORPHISMS; IMMUNE GLOBULIN; YOUNG-CHILDREN; NITRIC-OXIDE; INFECTION	Bronchopulmonary dysplasia (BPD) is a common chronic lung disease and major risk factor for severe respiratory syncytial virus (RSV) infection among preterm infants. The Toll-like receptor 4 (TLR4) is involved in oxidative injury responses in the lungs. Two non-synonymous single nucleotide polymorphisms in the TLR4 gene have been associated with RSV infection in children. However, it is unclear to what extent this association is confounded by BPD or prematurity. In this study, we analyzed two population-based cohorts of preterm infants at risk for BPD as well as ethnicity-matched infants born at term, to test whether the TLR4 polymorphisms Asp299Gly (rs4986790) and Thr399Ile (rs4986791) are independently associated with BPD or premature birth. In a Canadian cohort (n = 269) composed of a majority of Caucasian preterm infants (BPD incidence of 38%), the TLR4-299 heterozygous genotype was significantly under-represented in infants without BPD (1.6% of infants versus 12% in infants with severe BPD) after adjusting for twins, ethnicity, gestational age, birth weight and gender (p = 0.014). This association was not replicated in a Finnish cohort (n = 434) of premature singletons or first-born siblings of Caucasian descent, although the incidence of BPD was substantially lower in this latter population (15%). We did not detect a significant association (>2-fold) between TLR4 genotypes and prematurity (p>0.05). We conclude that these TLR4 genotypes may have, at best, a modest influence on BPD severity in some populations of high-risk preterm infants. Further studies are warranted to clarify how clinical heterogeneity may impact genetic susceptibility to BPD.	[Lavoie, Pascal M.; Ladd, Mihoko; Hirschfeld, Aaron F.; Speert, David P.; Turvey, Stuart E.] Child & Family Res Inst British Columbia, Vancouver, BC, Canada; [Lavoie, Pascal M.] Univ British Columbia, Dept Pediat, Div Neonatol, Vancouver, BC V6T 1W5, Canada; [Speert, David P.; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada; [Huusko, Johanna; Mahlman, Mari; Hallman, Mikko] Oulu Univ, Cent Hosp, SF-90220 Oulu, Finland; [Huusko, Johanna; Mahlman, Mari; Hallman, Mikko] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; [Lacaze-Masmonteil, Thierry] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON K1N 6N5, Canada	Child & Family Research Institute; University of British Columbia; University of British Columbia; University of Oulu; University of Oulu; University of Ottawa; Children's Hospital of Eastern Ontario	Lavoie, PM (corresponding author), Child & Family Res Inst British Columbia, Vancouver, BC, Canada.	plavoie@cw.bc.ca	Hallman, Niilo/AHD-9810-2022; Huusko, Johanna M/H-9448-2019; Turvey, Stuart/HGV-1191-2022	Lavoie, Pascal/0000-0002-2205-0362; Turvey, Stuart/0000-0003-1599-1065	British Columbia Lung Association; Canadian Institutes of Health Research; Finnish Academy; Sigrid Juselius Foundation; Canadian Child Health Clinician-Scientist Program; Michael Smith Foundation for Health Research	British Columbia Lung Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Canadian Child Health Clinician-Scientist Program; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by the British Columbia Lung Association (to PML), the Canadian Institutes of Health Research (to DPS), the Finnish Academy and the Sigrid Juselius Foundation (to MH). PML and SET acknowledge support from Canadian Child Health Clinician-Scientist Program and the Michael Smith Foundation for Health Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2011, PEDIATRICS, V127, pE106, DOI 10.1542/peds.2010-0648; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bhandari V, 2006, PEDIATRICS, V117, P1901, DOI 10.1542/peds.2005-1414; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Connor E, 1997, PEDIATRICS, V99, P93; Douville RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012087; Goetghebuer T, 2004, PEDIATR PULM, V38, P321, DOI 10.1002/ppul.20069; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kamal-Bahl S, 2002, ARCH PEDIAT ADOL MED, V156, P1034, DOI 10.1001/archpedi.156.10.1034; Kleeberger SR, 2000, AM J RESP CELL MOL, V22, P620, DOI 10.1165/ajrcmb.22.5.3912; Kleeberger SR, 2001, AM J PHYSIOL-LUNG C, V280, pL326, DOI 10.1152/ajplung.2001.280.2.L326; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lavoie PM, 2008, PEDIATRICS, V122, P479, DOI 10.1542/peds.2007-2313; Lavoie PM, 2010, CURR OPIN PEDIATR, V22, P134, DOI 10.1097/MOP.0b013e328336eb85; Lofgren J, 2010, PEDIATR PULM, V45, P687, DOI 10.1002/ppul.21248; Lorenz E, 2002, PEDIATR RES, V52, P373, DOI 10.1203/01.PDR.0000025342.83436.53; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Puthothu B, 2006, DIS MARKERS, V22, P303, DOI 10.1155/2006/865890; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Rey G, 2008, MOL HUM REPROD, V14, P555, DOI 10.1093/molehr/gan049; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834	34	16	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31351	10.1371/journal.pone.0031351	http://dx.doi.org/10.1371/journal.pone.0031351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348075	gold, Green Submitted, Green Published			2022-12-27	WOS:000302737400017
J	Lundwall, RA; Guo, DC; Dannemiller, JL				Lundwall, Rebecca A.; Guo, Dong-Chuan; Dannemiller, James L.			Exogenous Visual Orienting Is Associated with Specific Neurotransmitter Genetic Markers: A Population-Based Genetic Association Study	PLOS ONE			English	Article							DOPAMINE-BETA-HYDROXYLASE; APOLIPOPROTEIN-E; VISUOSPATIAL ATTENTION; STRATIFICATION; POLYMORPHISMS; GENOTYPE; ADHD; BIAS; HERITABILITY; THREAT	Background: Currently, there is a sense that the spatial orienting of attention is related to genotypic variations in cholinergic genes but not to variations in dopaminergic genes. However, reexamination of associations with both cholinergic and dopaminergic genes is warranted because previous studies used endogenous rather than exogenous cues and costs and benefits were not analyzed separately. Examining costs (increases in response time following an invalid pre-cue) and benefits (decreases in response time following a valid pre-cue) separately could be important if dopaminergic genes (implicated in disorders such as attention deficit disorder) independently influence the different processes of orienting (e.g., disengage, move, engage). Methodology/Principal Findings: We tested normal subjects (N = 161) between 18 and 61 years. Participants completed a computer task in which pre-cues preceded the presence of a target. Subjects responded (with a key press) to the location of the target (right versus left of fixation). The cues could be valid (i.e., appear where the target would appear) or invalid (appear contralateral to where the target would appear). DNA sequencing assays were performed on buccal cells to genotype known genetic markers and these were examined for association with task scores. Here we show significant associations between visual orienting and genetic markers (on COMT, DAT1, and APOE; R(2)s from 4% to 9%). Conclusions/Significance: One measure in particular - the response time cost of a single dim, invalid cue - was associated with dopaminergic markers on COMT and DAT1. Additionally, variations of APOE genotypes based on the epsilon 2/epsilon 3/epsilon 4 alleles were also associated with response time differences produced by simultaneous cues with unequal luminances. We conclude that individual differences in visual orienting are related to several dopaminergic markers as well as to a cholinergic marker. These results challenge the view that orienting is not associated with genotypic variation in dopaminergic genes.	[Lundwall, Rebecca A.; Dannemiller, James L.] Rice Univ, Dept Psychol, Houston, TX 77251 USA; [Guo, Dong-Chuan] Univ Texas Hlth Sci Ctr, Dept Internal Med, Houston, TX USA	Rice University; University of Texas System; University of Texas Health Science Center Houston	Lundwall, RA (corresponding author), Rice Univ, Dept Psychol, Houston, TX 77251 USA.	beckylundwall@rice.edu	Lundwall, Rebecca/K-2506-2013	Lundwall, Rebecca/0000-0003-4036-9091	Rice Graduate Student Research Fellowship; Center for Clinical and Translational Science [UL1 RR024148]; Lynette S. Autrey Research grant; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Rice Graduate Student Research Fellowship; Center for Clinical and Translational Science; Lynette S. Autrey Research grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a Rice Graduate Student Research Fellowship to RAL, a grant from the Center for Clinical and Translational Science: (UL1 RR024148) to DCG, and a Lynette S. Autrey Research grant to JLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bellgrove MA, 2007, MOL PSYCHIATR, V12, P786, DOI 10.1038/sj.mp.4002022; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; Caporaso NE, 2002, CANCER EPIDEM BIOMAR, V11, P1544; Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Gabay S, 2010, PSYCHON B REV, V17, P47, DOI 10.3758/PBR.17.1.47; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; GIROS B, 1992, MOL PHARMACOL, V42, P383; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Greenwood PM, 2000, P NATL ACAD SCI USA, V97, P11661, DOI 10.1073/pnas.97.21.11661; Hegele RA, 2002, ARTERIOSCL THROM VAS, V22, P1058, DOI 10.1161/01.ATV.0000026801.56080.14; Hill A.B., 1971, PRINCIPLES MED STAT; Hubacek JA, 2008, EUR J HUM GENET, V16, P135, DOI 10.1038/sj.ejhg.5201941; Hutchison KE, 2004, PSYCHOL BULL, V130, P66, DOI 10.1037/0033-2909.130.1.66; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kean M, 2003, BRIT J PSYCHOL, V94, P373, DOI 10.1348/000712603767876280; Khlat M, 2004, CANCER EPIDEM BIOMAR, V13, P1660; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Kirley A, 2002, NEUROPSYCHOPHARMACOL, V27, P607; Kopeckova M, 2006, FOLIA BIOL-PRAGUE, V52, P194; Landry R, 2004, J CHILD PSYCHOL PSYC, V45, P1115, DOI 10.1111/j.1469-7610.2004.00304.x; Long AD, 1999, GENOME RES, V9, P720; Lowe N, 2004, AM J MED GENET B, V131B, P33, DOI 10.1002/ajmg.b.30071; LUCE RD, 1972, PSYCHOL REV, V79, P14, DOI 10.1037/h0031867; NISSEN MJ, 1977, PERCEPT PSYCHOPHYS, V22, P338, DOI 10.3758/BF03199699; Oie M, 1998, SCHIZOPHR RES, V34, P195, DOI 10.1016/S0920-9964(98)00092-9; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; Penn HE, 2006, CHILD NEUROPSYCHOL, V12, P57, DOI 10.1080/09297040500253546; Poirier J, 1996, J PSYCHIATR NEUROSCI, V21, P128; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Rastelli F, 2008, EXP BRAIN RES, V187, P439, DOI 10.1007/s00221-008-1316-x; Rihet P, 2002, PSYCHOPHARMACOLOGY, V163, P62, DOI 10.1007/s00213-002-1127-x; Rommelse NNJ, 2008, AM J MED GENET B, V147B, P1536, DOI 10.1002/ajmg.b.30848; Sarter M, 1999, ANN NY ACAD SCI, V877, P368, DOI 10.1111/j.1749-6632.1999.tb09277.x; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Starr JM, 2007, NEUROSCI LETT, V421, P57, DOI 10.1016/j.neulet.2007.05.023; Swanson J, 2001, CLIN NEUROSCI RES, V1, P207, DOI 10.1016/S1566-2772(01)00007-X; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang YT, 2006, CANCER EPIDEM BIOMAR, V15, P124, DOI 10.1158/1055-9965.EPI-05-0304; Waszak F, 2010, DEV PSYCHOL, V46, P337, DOI 10.1037/a0018541; Wright RD, 1995, CAN J EXP PSYCHOL, V49, P540, DOI 10.1037/1196-1961.49.4.540; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007; Zhao YQ, 2001, NEUROREPORT, V12, P2939, DOI 10.1097/00001756-200109170-00037	53	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30731	10.1371/journal.pone.0030731	http://dx.doi.org/10.1371/journal.pone.0030731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925CF	22348020	gold, Green Published, Green Submitted			2022-12-27	WOS:000302737400004
J	Madaro, L; Pelle, A; Nicoletti, C; Crupi, A; Marrocco, V; Bossi, G; Soddu, S; Bouche, M				Madaro, Luca; Pelle, Andrea; Nicoletti, Carmine; Crupi, Annunziata; Marrocco, Valeria; Bossi, Gianluca; Soddu, Silvia; Bouche, Marina			PKC Theta Ablation Improves Healing in a Mouse Model of Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; MDX MICE; GENE-EXPRESSION; INSULIN-RESISTANCE; T-LYMPHOCYTES; ACTIVATION; PATHWAY; CELLS; DEGENERATION; INHIBITION	Inflammation is a key pathological characteristic of dystrophic muscle lesion formation, limiting muscle regeneration and resulting in fibrotic and fatty tissue replacement of muscle, which exacerbates the wasting process in dystrophic muscles. Limiting immune response is thus one of the therapeutic options to improve healing, as well as to improve the efficacy of gene- or cell-mediated strategies to restore dystrophin expression. Protein kinase C theta (PKC theta) is a member of the PKCs family highly expressed in both immune cells and skeletal muscle; given its crucial role in adaptive, but also innate, immunity, it is being proposed as a valuable pharmacological target for immune disorders. In our study we asked whether targeting PKC theta could represent a valuable approach to efficiently prevent inflammatory response and disease progression in a mouse model of muscular dystrophy. We generated the bi-genetic mouse model mdx/theta(-/-), where PKC theta expression is lacking in mdx mice, the mouse model of Duchenne muscular dystrophy. We found that muscle wasting in mdx/theta(-/-) mice was greatly prevented, while muscle regeneration, maintenance and performance was significantly improved, as compared to mdx mice. This phenotype was associated to reduction in inflammatory infiltrate, pro-inflammatory gene expression and pro-fibrotic markers activity, as compared to mdx mice. Moreover, BM transplantation experiments demonstrated that the phenotype observed was primarily dependent on lack of PKC theta expression in hematopoietic cells. These results demonstrate a hitherto unrecognized role of immune-cell intrinsic PKC theta activity in the development of DMD. Although the immune cell population(s) involved remain unidentified, our findings reveal that PKC theta can be proposed as a new pharmacological target to counteract the disease, as well as to improve the efficacy of gene- or cell- therapy approaches.	[Madaro, Luca; Pelle, Andrea; Nicoletti, Carmine; Crupi, Annunziata; Marrocco, Valeria; Bouche, Marina] Sapienza Univ, DAHFMO, Unit Histol, Rome, Italy; [Madaro, Luca; Pelle, Andrea; Nicoletti, Carmine; Crupi, Annunziata; Marrocco, Valeria; Bouche, Marina] Sapienza Univ, DAHFMO, IIM, Rome, Italy; [Bossi, Gianluca; Soddu, Silvia] Regina Elena Inst Canc Res, Dept Expt Oncol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Madaro, L (corresponding author), Sapienza Univ, DAHFMO, Unit Histol, Rome, Italy.	marina.bouche@uniroma1.it	Bossi, Gianluca/B-9394-2017; Soddu, Silvia/K-2467-2018; Madaro, Luca/ABE-4683-2021; Bossi, Gianluca/G-8375-2016; Madaro, Luca/K-4629-2016; Bossi, Gianluca/ABH-6846-2020; Soddu, Silvia/ABH-6774-2020; Sampaolesi, Maurilio/H-6509-2013	Bossi, Gianluca/0000-0002-2947-1063; Soddu, Silvia/0000-0001-8526-0044; Madaro, Luca/0000-0003-0839-5724; Bossi, Gianluca/0000-0002-2947-1063; Madaro, Luca/0000-0003-0839-5724; Bossi, Gianluca/0000-0002-2947-1063; Soddu, Silvia/0000-0001-8526-0044; NICOLETTI, Carmine/0000-0001-5896-2040; Bouche, Marina/0000-0002-0938-5360; Sampaolesi, Maurilio/0000-0002-2422-3757; Crupi, Annunziata/0000-0002-5582-0749	Italian Ministry for University and Research; Sapienza University of Rome; French Association against Myopathies; Italian Space Agency; Duchenne Parent Project, Netherland, Fellowship	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; French Association against Myopathies; Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Duchenne Parent Project, Netherland, Fellowship	This work was supported by the Italian Ministry for University and Research, by the Sapienza University of Rome, by the French Association against Myopathies and by the Italian Space Agency. Dr. Madaro is recipient of a Duchenne Parent Project, Netherland, Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Balaban B, 2005, AM J PHYS MED REHAB, V84, P843, DOI 10.1097/01.phm.0000184156.98671.d0; Boschelli DH, 2009, CURR TOP MED CHEM, V9, P640, DOI 10.2174/156802609789007372; Consalvi S, 2011, MOL MED; Cooles FA, 2011, CURR OPIN RHEUMATOL; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; Eghtesad S, 2011, MOL MED; Ekmark M, 2003, J PHYSIOL-LONDON, V548, P259, DOI 10.1113/jphysiol.2002.036228; Evans NP, 2009, PM&R, V1, P755, DOI 10.1016/j.pmrj.2009.04.010; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2010, AM J PATHOL, V177, P248, DOI 10.2353/ajpath.2010.091176; Kwon Myung-Ja, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P367; Madaro L, 2011, MOL BIOL CELL, V22, P1409, DOI 10.1091/mbc.E10-10-0821; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Messina G, 2010, CELL, V140, P554, DOI 10.1016/j.cell.2010.01.027; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Messina S, 2009, EXP NEUROL, V220, P349, DOI 10.1016/j.expneurol.2009.09.015; Odom GL, 2011, MOL THER, V19, P36, DOI 10.1038/mt.2010.205; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Serra C, 2003, J CELL PHYSIOL, V196, P89, DOI 10.1002/jcp.10278; Siu PM, 2004, J APPL PHYSIOL, V97, P277, DOI 10.1152/japplphysiol.00534.2004; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sutcliffe EL, 2011, MOL CELL, V41, P704, DOI 10.1016/j.molcel.2011.02.030; Tang Y, 2010, GENE THER, V17, P1476, DOI 10.1038/gt.2010.110; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tokugawa S, 2009, NEUROPATHOLOGY, V29, P211, DOI 10.1111/j.1440-1789.2008.00967.x; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	37	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31515	10.1371/journal.pone.0031515	http://dx.doi.org/10.1371/journal.pone.0031515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348094	gold, Green Published, Green Submitted			2022-12-27	WOS:000302737400026
J	Ohuchi, H; Yamashita, T; Tomonari, S; Fujita-Yanagibayashi, S; Sakai, K; Noji, S; Shichida, Y				Ohuchi, Hideyo; Yamashita, Takahiro; Tomonari, Sayuri; Fujita-Yanagibayashi, Sari; Sakai, Kazumi; Noji, Sumihare; Shichida, Yoshinori			A Non-Mammalian Type Opsin 5 Functions Dually in the Photoreceptive and Non-Photoreceptive Organs of Birds	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MAMMALIAN NEURAL TISSUE; JAPANESE-QUAIL; CHICKEN RETINA; ARGININE-VASOTOCIN; ADRENAL-GLAND; AVIAN BRAIN; EXPRESSION; RHODOPSIN; NEURONS	A mammalian type opsin 5 (neuropsin) is a recently identified ultraviolet (UV)-sensitive pigment of the retina and other photosensitive organs in birds. Two other opsin 5-related molecules have been found in the genomes of non-mammalian vertebrates. However, their functions have not been examined as yet. Here, we identify the molecular properties of a second avian opsin 5, cOpn5L2 (chicken opsin 5-like 2), and its localization in the post-hatch chicken. Spectrophotometric analysis and radionucleotide-binding assay have revealed that cOpn5L2 is a UV-sensitive bistable pigment that couples with the Gi subtype of guanine nucleotide-binding protein (G protein). As a bistable pigment, it also shows the direct binding ability to agonist all-trans-retinal to activate G protein. The absorption maxima of UV-light-absorbing and visible light-absorbing forms were 350 and 521 nm, respectively. Expression analysis showed relatively high expression of cOpn5L2 mRNA in the adrenal gland, which is not photoreceptive but an endocrine organ, while lower expression was found in the brain and retina. At the protein level, cOpn5L2 immunoreactive cells were present in the chromaffin cells of the adrenal gland. In the brain, cOpn5L2 immunoreactive cells were found in the paraventricular and supraoptic nuclei of the anterior hypothalamus, known for photoreceptive deep brain areas. In the retina, cOpn5L2 protein was localized to subsets of cells in the ganglion cell layer and the inner nuclear layer. These results suggest that the non-mammalian type opsin 5 (Opn5L2) functions as a second UV sensor in the photoreceptive organs, while it might function as chemosensor using its direct binding ability to agonist all-trans-retinal in non-photoreceptive organs such as the adrenal gland of birds.	[Ohuchi, Hideyo; Tomonari, Sayuri; Noji, Sumihare] Univ Tokushima, Inst Sci & Technol, Grad Sch, Dept Life Syst, Tokushima 770, Japan; [Yamashita, Takahiro; Fujita-Yanagibayashi, Sari; Sakai, Kazumi; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan	Tokushima University; Kyoto University	Ohuchi, H (corresponding author), Univ Tokushima, Inst Sci & Technol, Grad Sch, Dept Life Syst, Tokushima 770, Japan.	hohuchi@bio.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [A06]; MEXT, Japan [22657057]; Takeda Science Foundation;  [20227002];  [21026019];  [23770074]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (grant numbers, 20227002, 21026019, 23770074) and the Global Center of Excellence Program (A06) "Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to TY, YS, and by a Grant-in-Aid for Challenging Exploratory Research of MEXT, Japan to HO, SN (22657057), and Takeda Science Foundation to TY (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Ball GF, 2008, PHILOS T R SOC B, V363, P231, DOI 10.1098/rstb.2007.2137; Bumsted-O'Brien KM, 2007, J COMP NEUROL, V505, P58, DOI 10.1002/cne.21458; Chaturvedi CM, 2000, GEN COMP ENDOCR, V117, P129, DOI 10.1006/gcen.1999.7400; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; D'Hondt E, 2000, BRAIN RES, V856, P55, DOI 10.1016/S0006-8993(99)02271-4; ERANKO O, 1957, NATURE, V179, P417, DOI 10.1038/179417b0; FARNER DS, 1980, ANNU REV PHYSIOL, V42, P457, DOI 10.1146/annurev.ph.42.030180.002325; Fernald RD, 2006, SCIENCE, V313, P1914, DOI 10.1126/science.1127889; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; FOSTER RG, 1988, CELL TISSUE RES, V253, P327, DOI 10.1007/BF00222289; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Jaliffa CO, 2001, BRAIN RES, V912, P195, DOI 10.1016/S0006-8993(01)02736-6; Jurkevich A, 2003, DOMEST ANIM ENDOCRIN, V25, P93, DOI 10.1016/S0739-7240(03)00048-1; KAZULA A, 1993, VISUAL NEUROSCI, V10, P621, DOI 10.1017/S0952523800005320; Kober AKMH, 2010, POULTRY SCI, V89, P1709, DOI 10.3382/ps.2009-00588; KUENZEL WJ, 1993, POULTRY SCI, V72, P959, DOI 10.3382/ps.0720959; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; LEE E, 1994, METHOD ENZYMOL, V237, P146; MILLAR T, 1985, NEUROSCI LETT, V61, P311, DOI 10.1016/0304-3940(85)90482-3; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Sanchez-Guardado LO, 2011, DEV DYNAM, V240, P1475, DOI 10.1002/dvdy.22621; Panzica GC, 2001, BRAIN RES REV, V37, P178, DOI 10.1016/S0165-0173(01)00118-7; Prakobsaeng N, 2011, GEN COMP ENDOCR, V171, P189, DOI 10.1016/j.ygcen.2011.01.007; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; de Lima LHRG, 2011, CHRONOBIOL INT, V28, P89, DOI 10.3109/07420528.2010.540685; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SANNA PP, 1992, NEUROSCIENCE, V47, P745, DOI 10.1016/0306-4522(92)90182-2; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Singh S, 2006, COMP BIOCHEM PHYS A, V143, P202, DOI 10.1016/j.cbpa.2005.11.022; Stanke JJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-13; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tomonari S, 2008, DEV DYNAM, V237, P1910, DOI 10.1002/dvdy.21611; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; VANGILS J, 1993, J COMP NEUROL, V334, P304, DOI 10.1002/cne.903340211; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107	47	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31534	10.1371/journal.pone.0031534	http://dx.doi.org/10.1371/journal.pone.0031534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348098	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400030
J	Otsuka, N; Han, HJ; Toyoizumi-Ajisaka, H; Nakamura, Y; Arakawa, Y; Shibayama, K; Kamachi, K				Otsuka, Nao; Han, Hyun-Ja; Toyoizumi-Ajisaka, Hiromi; Nakamura, Yukitsugu; Arakawa, Yoshichika; Shibayama, Keigo; Kamachi, Kazunari			Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan	PLOS ONE			English	Article							VIRULENCE FACTORS; CONTROLLED-TRIAL; ANTIGENIC VARIATION; ANTIBODIES; SECRETION; VACCINES; STRAINS; TOXIN; PARAPERTUSSIS; POLYMORPHISM	The adhesin pertactin (Prn) is one of the major virulence factors of Bordetella pertussis, the etiological agent of whooping cough. However, a significant prevalence of Prn-deficient (Prn(-)) B. pertussis was observed in Japan. The Prn(-) isolate was first discovered in 1997, and 33 (27%) Prn(-) isolates were identified among 121 B. pertussis isolates collected from 1990 to 2009. Sequence analysis revealed that all the Prn(-) isolates harbor exclusively the vaccine-type prn1 allele and that loss of Prn expression is caused by 2 different mutations: an 84-bp deletion of the prn signal sequence (prn1 Delta SS, n = 24) and an IS481 insertion in prn1 (prn1::IS481, n = 9). The frequency of Prn(-) isolates, notably those harboring prn1 Delta SS, significantly increased since the early 2000s, and Prn(-) isolates were subsequently found nationwide. Multilocus variable-number tandem repeat analysis (MLVA) revealed that 24 (73%) of 33 Prn(-) isolates belong to MLVA-186, and 6 and 3 Prn(-) isolates belong to MLVA-194 and MLVA-226, respectively. The 3 MLVA types are phylogenetically closely related, suggesting that the 2 Prn(-) clinical strains (harboring prn1 Delta SS and prn1::IS481) have clonally expanded in Japan. Growth competition assays in vitro also demonstrated that Prn(-) isolates have a higher growth potential than the Prn(+) back-mutants from which they were derived. Our observations suggested that human host factors (genetic factors and immune status) that select for Prn(-) strains have arisen and that Prn expression is not essential for fitness under these conditions.	[Otsuka, Nao; Han, Hyun-Ja; Toyoizumi-Ajisaka, Hiromi; Nakamura, Yukitsugu; Arakawa, Yoshichika; Shibayama, Keigo; Kamachi, Kazunari] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Otsuka, N (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	kamachi@nih.go.jp	Arakawa, Yoshichika/P-5997-2015	Kamachi, Kazunari/0000-0001-5259-1744	Ministry of Health, Labor and Welfare of Japan [09158691, 09158699]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by grants for Research on Emerging and Re-emerging Infectious Diseases (09158691 and 09158699) from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOYAMA T, 1986, J CLIN MICROBIOL, V23, P1046, DOI 10.1128/JCM.23.6.1046-1048.1986; Bassinet L, 2000, INFECT IMMUN, V68, P1934, DOI 10.1128/IAI.68.4.1934-1941.2000; Bouchez V, 2011, CLIN MICROBIOL INFEC, V17, P675, DOI 10.1111/j.1469-0691.2010.03303.x; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Caro V, 2006, MICROBES INFECT, V8, P2228, DOI 10.1016/j.micinf.2006.04.014; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; Cherry JD, 1997, PEDIATR INFECT DIS J, V16, pS90, DOI 10.1097/00006454-199704001-00004; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Han HJ, 2008, VACCINE, V26, P1530, DOI 10.1016/j.vaccine.2008.01.020; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hellwig SMM, 2003, J INFECT DIS, V188, P738, DOI 10.1086/377283; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Kurniawan J, 2010, EMERG INFECT DIS, V16, P297, DOI 10.3201/eid1602.081707; LEININGER E, 1992, INFECT IMMUN, V60, P2380, DOI 10.1128/IAI.60.6.2380-2385.1992; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Mastrantonio P, 1999, MICROBIOL-UK, V145, P2069, DOI 10.1099/13500872-145-8-2069; Miller JL, 2008, PLOS BIOL, V6, P1195, DOI 10.1371/journal.pbio.0060131; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nicholson TL, 2009, INFECT IMMUN, V77, P2136, DOI 10.1128/IAI.01379-08; Okada K, 2010, VACCINE, V28, P7626, DOI 10.1016/j.vaccine.2010.09.050; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Pradel E, 2000, INFECT IMMUN, V68, P1919, DOI 10.1128/IAI.68.4.1919-1927.2000; ROBERTS M, 1991, MOL MICROBIOL, V5, P1393, DOI 10.1111/j.1365-2958.1991.tb00786.x; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Stefanelli P, 2009, NEW MICROBIOL, V32, P159; Stibitz S, 1998, J BACTERIOL, V180, P4963, DOI 10.1128/JB.180.18.4963-4966.1998; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; van den Berg BM, 1999, INFECT IMMUN, V67, P1050, DOI 10.1128/IAI.67.3.1050-1055.1999; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8	46	108	112	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31985	10.1371/journal.pone.0031985	http://dx.doi.org/10.1371/journal.pone.0031985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348138	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400057
J	Caesar, I; Jonson, M; Nilsson, KPR; Thor, S; Hammarstrom, P				Caesar, Ina; Jonson, Maria; Nilsson, K. Peter R.; Thor, Stefan; Hammarstrom, Per			Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VIVO; AMYLOID PATHOLOGY; OXIDATIVE DAMAGE; INDUCED TOXICITY; PC12 CELLS; MODEL; DERIVATIVES; INHIBITORS; FIBRILS	The pathology of Alzheimer's disease (AD) is characterized by the presence of extracellular deposits of misfolded and aggregated amyloid-beta (A beta) peptide and intraneuronal accumulation of tangles comprised of hyperphosphorylated Tau protein. For several years, the natural compound curcumin has been proposed to be a candidate for enhanced clearance of toxic A beta amyloid. In this study we have studied the potency of feeding curcumin as a drug candidate to alleviate A beta toxicity in transgenic Drosophila. The longevity as well as the locomotor activity of five different AD model genotypes, measured relative to a control line, showed up to 75% improved lifespan and activity for curcumin fed flies. In contrast to the majority of studies of curcumin effects on amyloid we did not observe any decrease in the amount of A beta deposition following curcumin treatment. Conformation-dependent spectra from p-FTAA, a luminescent conjugated oligothiophene bound to A beta deposits in different Drosophila genotypes over time, indicated accelerated pre-fibrillar to fibril conversion of A beta(1-42) in curcumin treated flies. This finding was supported by in vitro fibrillation assays of recombinant A beta(1-42). Our study shows that curcumin promotes amyloid fibril conversion by reducing the pre-fibrillar/oligomeric species of A beta, resulting in a reduced neurotoxicity in Drosophila.	[Caesar, Ina; Jonson, Maria; Nilsson, K. Peter R.; Hammarstrom, Per] Linkoping Univ, Dept Chem, IFM, S-58183 Linkoping, Sweden; [Thor, Stefan] Linkoping Univ, Dept Clin & Expt Med, IKE, S-58183 Linkoping, Sweden	Linkoping University; Linkoping University	Caesar, I (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	perha@ifm.liu.se	Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X; Hammarstrom, Per/0000-0001-5827-3587	Knut and Alice Wallenberg foundation; Swedish Foundation for Strategic Research; Hjarnfonden; Swedish Research Council; Gustaf V. foundation; European Union	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Hjarnfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gustaf V. foundation; European Union(European Commission)	This work was supported by The Knut and Alice Wallenberg foundation (ST, PH, KPRN), a generous gift from Alice and Georg Olsson (PH and KPRN), the Swedish Foundation for Strategic Research (ST, PH and KPRN), ""Hjarnfonden"" (ST), the Swedish Research Council (ST and PH), the Gustaf V. foundation (ST), and the European Union FP-7 Health project LUPAS (PH and KPRN). PH and ST are Swedish Royal Academy of Science Research Fellows sponsored by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Berg I, 2009, NEURODEGENER DIS, V6, P127, DOI 10.1159/000213761; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Byeon SR, 2007, BIOORG MED CHEM LETT, V17, P1466, DOI 10.1016/j.bmcl.2006.10.090; Byun JH, 2008, BIOORG MED CHEM LETT, V18, P5591, DOI 10.1016/j.bmcl.2008.08.111; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; HAY BA, 1994, DEVELOPMENT, V120, P2121; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jurenka JS, 2009, ALTERN MED REV, V14, P141; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lin RZ, 2008, NEUROSCI LETT, V440, P344, DOI 10.1016/j.neulet.2008.05.070; Lord A, 2011, AM J PATHOL, V178, P2286, DOI 10.1016/j.ajpath.2011.01.052; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Minniti AN, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-2; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Qin XY, 2009, NEUROSCI LETT, V463, P158, DOI 10.1016/j.neulet.2009.07.047; Ran CZ, 2009, J AM CHEM SOC, V131, P15257, DOI 10.1021/ja9047043; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Ryu EK, 2006, J MED CHEM, V49, P6111, DOI 10.1021/jm0607193; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Young MW, 2000, SCI AM, V282, P64, DOI 10.1038/scientificamerican0300-64	49	102	108	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31424	10.1371/journal.pone.0031424	http://dx.doi.org/10.1371/journal.pone.0031424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348084	Green Submitted, Green Published, gold			2022-12-27	WOS:000302733900047
J	Wang, N; Khan, W; Smith, DL				Wang, Nan; Khan, Wajahatullah; Smith, Donald L.			Changes in Soybean Global Gene Expression after Application of Lipo-Chitooligosaccharide from Bradyrhizobium japonicum under Sub-Optimal Temperature	PLOS ONE			English	Article							SYMBIOTIC NITROGEN-FIXATION; NAC TRANSCRIPTION FACTORS; NOD-FACTOR; RAPID ALKALINIZATION; MEDICAGO-TRUNCATULA; FUNCTIONAL-ANALYSIS; MODEL LEGUME; EARLY GROWTH; PLANT; ROOT	Lipo-chitooligosaccharides (LCOs), signal compounds produced by N-2-fixing rhizobacteria after isoflavone induction, initiate nodule formation in host legumes. Given LCOs' structural similarity to pathogen-response-eliciting chitin oligomers, foliar application of LCOs was tested for ability to induce stress-related genes under optimal growth conditions. In order to study the effects of LCO foliar spray under stressed conditions, soybean (Glycine max) seedlings grown at optimal temperature were transferred to sub-optimal temperature. After a 5-day acclimation period, the first trifoliate leaves were sprayed with 10(-7) M LCO (NodBj-V (C-18:1, MeFuc)) purified from genistein-induced Bradyrhizobium japonicum culture, and harvested at 0 and 48 h following treatment. Microarray analysis was performed using Affymetrix GeneChip (R) Soybean Genome Arrays. Compared to the control at 48 h after LCO treatment, a total of 147 genes were differentially expressed as a result of LCO treatment, including a number of stress-related genes and transcription factors. In addition, during the 48 h time period following foliar spray application, over a thousand genes exhibited differential expression, including hundreds of those specific to the LCO-treated plants. Our results indicated that the dynamic soybean foliar transcriptome was highly responsive to LCO treatment. Quantitative real-time PCR (qPCR) validated the microarray data.	[Wang, Nan; Smith, Donald L.] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Khan, Wajahatullah] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair Unit, Riyadh 11451, Saudi Arabia	McGill University; King Saud University	Wang, N (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	Donald.Smith@McGill.Ca	Khan, Wajahatullah/J-9574-2012		Canadian Natural Sciences and Engineering Research Council of Canada (NSERC) through the Green Crop Network	Canadian Natural Sciences and Engineering Research Council of Canada (NSERC) through the Green Crop Network(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the Canadian Natural Sciences and Engineering Research Council of Canada (NSERC) for support through the Green Crop Network and a Discovery grant, both held by D. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Almaraz JJ, 2007, J PLANT PHYSIOL, V164, P1391, DOI 10.1016/j.jplph.2006.12.007; Asamizu E, 2005, MOL PLANT MICROBE IN, V18, P487, DOI 10.1094/MPMI-18-0487; Atti S, 2005, IRRIG DRAIN, V54, P15, DOI 10.1002/ird.153; Bae EK, 2006, TREE PHYSIOL, V26, P1405, DOI 10.1093/treephys/26.11.1405; Ben-Yaakov E, 2006, ISR J PLANT SCI, V54, P129, DOI 10.1560/IJPS_54_2_129; Benning Christoph, 2008, V27, P185; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boudichevskaia A, 2009, PLANT BREEDING, V128, P84, DOI 10.1111/j.1439-0523.2008.01537.x; Brechenimacher L, 2008, MOL PLANT MICROBE IN, V21, P631, DOI 10.1094/MPMI-21-5-0631; Chen H, 2009, CROP SCI, V49, P224, DOI 10.2135/cropsci2007.09.0536; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Colebatch G, 2002, MOL PLANT MICROBE IN, V15, P411, DOI 10.1094/MPMI.2002.15.5.411; CURRIER WW, 1976, PLANT PHYSIOL, V57, P820, DOI 10.1104/pp.57.5.820; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Dordas C, 2003, ANN BOT-LONDON, V91, P173, DOI 10.1093/aob/mcf115; Duzan HM, 2005, PLANT PHYSIOL BIOCH, V43, P1022, DOI 10.1016/j.plaphy.2005.08.004; Dyachok JV, 2002, PLANT PHYSIOL, V128, P523, DOI 10.1104/pp.010547; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Fang YW, 1998, PLANT PHYSIOL, V116, P53, DOI 10.1104/pp.116.1.53; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Felle HH, 1996, PLANT J, V10, P295, DOI 10.1046/j.1365-313X.1996.10020295.x; FIRMIN JL, 1986, NATURE, V324, P90, DOI 10.1038/324090a0; Fujiwara M, 2000, FEBS LETT, V481, P47, DOI 10.1016/S0014-5793(00)01965-7; Fukayama H, 2006, PLANT J, V47, P258, DOI 10.1111/j.1365-313X.2006.02779.x; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Garcia-Maurino S, 2003, PLANTA, V216, P648, DOI 10.1007/s00425-002-0893-3; GRANT D, 2002, SOYBASE USDA ARS SOY; Hagiwara-Komoda Y, 2008, VIROLOGY, V376, P132, DOI 10.1016/j.virol.2008.03.020; Haruta M, 2003, PLANT PHYSIOL, V131, P814, DOI 10.1104/pp.014597; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Hirsch Sibylle, 2009, P71, DOI 10.1007/978-3-540-89228-1_4; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamst E, 1998, Subcell Biochem, V29, P29; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kawasaki Ernest S, 2006, J Biomol Tech, V17, P200; Khan W, 2008, J PLANT PHYSIOL, V165, P1342, DOI 10.1016/j.jplph.2007.11.001; Khan W, 2011, PLANT GROWTH REGUL, V63, P243, DOI 10.1007/s10725-010-9521-6; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; KUCHITSU K, 1993, PROTOPLASMA, V174, P79, DOI 10.1007/BF01404046; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Lindsay J, 2007, THESIS MCGILL U; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Miransari M, 2006, COMMUN SOIL SCI PLAN, V37, P1103, DOI 10.1080/00103620600586391; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Moriyama Y, 2008, XENOBIOTICA, V38, P1107, DOI [10.1080/00498250701883753, 10.1080/00498250701883753 ]; Moura DS, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P33, DOI 10.1016/B978-012369442-3/50010-6; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pearce G, 2010, PEPTIDES, V31, P1973, DOI 10.1016/j.peptides.2010.08.012; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; PREVOST D, 1987, FEMS MICROBIOL ECOL, V45, P205, DOI 10.1016/0378-1097(87)90053-X; Prithiviraj B, 2003, PLANTA, V216, P437, DOI 10.1007/s00425-002-0928-9; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; SCHMIDT J, 1993, PLANT J, V4, P651, DOI 10.1046/j.1365-313X.1993.04040651.x; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shin Y, 2005, DEV DYNAM, V232, P432, DOI 10.1002/dvdy.20229; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Souleimanov A, 2002, J EXP BOT, V53, P1929, DOI 10.1093/jxb/erf034; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; TIMPTE C, 1995, PLANT J, V8, P561, DOI 10.1046/j.1365-313X.1995.8040561.x; van der Rest B, 2004, BIOCHEM J, V379, P601, DOI 10.1042/BJ20031489; van der Rest B, 2002, PLANT PHYSIOL, V130, P244, DOI 10.1104/pp.003392; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Yauk CL, 2007, ENVIRON MOL MUTAGEN, V48, P380, DOI 10.1002/em.20290; Yu B, 2002, P NATL ACAD SCI USA, V99, P5732, DOI 10.1073/pnas.082696499; ZHANG F, 1994, J EXP BOT, V45, P1467, DOI 10.1093/jxb/45.10.1467; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; ZHANG XQ, 1995, PLANT PHYSIOL, V108, P1561, DOI 10.1104/pp.108.4.1561	95	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31571	10.1371/journal.pone.0031571	http://dx.doi.org/10.1371/journal.pone.0031571			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348109	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900055
J	Zhou, WK; Huang, J; Watson, AM; Hong, Y				Zhou, Wenke; Huang, Juan; Watson, Annie M.; Hong, Yang			W::Neo: A Novel Dual-Selection Marker for High Efficiency Gene Targeting in Drosophila	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; ENDS-OUT; GENOME; MUTAGENESIS	We have recently developed a so-called genomic engineering approach that allows for directed, efficient and versatile modifications of Drosophila genome by combining the homologous recombination (HR)-based gene targeting with site-specific DNA integration. In genomic engineering and several similar approaches, a "founder" knock-out line must be generated first through HR-based gene targeting, which can still be a potentially time and resource intensive process. To significantly improve the efficiency and success rate of HR-based gene targeting in Drosophila, we have generated a new dual-selection marker termed W::Neo, which is a direct fusion between proteins of eye color marker White (W) and neomycin resistance (Neo). In HR-based gene targeting experiments, mutants carrying W::Neo as the selection marker can be enriched as much as fifty times by taking advantage of the antibiotic selection in Drosophila larvae. We have successfully carried out three independent gene targeting experiments using the W::Neo to generate genomic engineering founder knock-out lines in Drosophila.	[Zhou, Wenke; Huang, Juan; Watson, Annie M.; Hong, Yang] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhou, WK (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA.	yhong@pitt.edu			National Center for Research Resources [R21RR024869]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024869] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was supported by R21RR024869 from National Center for Research Resources http://www.ncrr.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Choi CM, 2009, SCIENCE, V324, P54, DOI 10.1126/science.1168275; Gao G, 2008, P NATL ACAD SCI USA, V105, P13999, DOI 10.1073/pnas.0805843105; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Huang J, 2011, GENETICS, V189, P391, DOI 10.1534/genetics.111.129247; Huang J, 2009, FLY, V3, P274, DOI 10.4161/fly.9978; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; Weng RF, 2009, GENETICS, V183, P399, DOI 10.1534/genetics.109.105213; XU T, 1993, DEVELOPMENT, V117, P1223	14	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31997	10.1371/journal.pone.0031997	http://dx.doi.org/10.1371/journal.pone.0031997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348139	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000302733900063
J	Schwilk, DW; Keeley, JE				Schwilk, Dylan W.; Keeley, Jon E.			A Plant Distribution Shift: Temperature, Drought or Past Disturbance?	PLOS ONE			English	Article							CLIMATE-CHANGE; FIRE HISTORY; CEANOTHUS; MOUNTAINS	Simple models of plant response to warming climates predict vegetation moving to cooler and/or wetter locations: in mountainous regions shifting upslope. However, species-specific responses to climate change are likely to be much more complex. We re-examined a recently reported vegetation shift in the Santa Rosa Mountains, California, to better understand the mechanisms behind the reported shift of a plant distribution upslope. We focused on five elevational zones near the center of the gradient that captured many of the reported shifts and which are dominated by fire-prone chaparral. Using growth rings, we determined that a major assumption of the previous work was wrong: past fire histories differed among elevations. To examine the potential effect that this difference might have on the reported upward shift, we focused on one species, Ceanothus greggii: a shrub that only recruits post-fire from a soil stored seedbank. For five elevations used in the prior study, we calculated time series of past per-capita mortality rates by counting growth rings on live and dead individuals. We tested three alternative hypotheses explaining the past patterns of mortality: 1) mortality increased over time consistent with climate warming, 2) mortality was correlated with drought indices, and 3) mortality peaked 40-50 years post fire at each site, consistent with self-thinning. We found that the sites were different ages since the last fire, and that the reported increase in the mean elevation of C. greggii was due to higher recent mortality at the lower elevations, which were younger sites. The time-series pattern of mortality was best explained by the self-thinning hypothesis and poorly explained by gradual warming or drought. At least for this species, the reported distribution shift appears to be an artifact of disturbance history and is not evidence of a climate warming effect.	[Schwilk, Dylan W.] Texas Tech Univ, Lubbock, TX 79409 USA; [Keeley, Jon E.] Western Ecol Res Ctr, Sequoia Kings Canyon Field Stn, US Geol Survey, Three Rivers, CA USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles	Schwilk, DW (corresponding author), Texas Tech Univ, Lubbock, TX 79409 USA.	dylan.schwilk@ttu.edu			USGS	USGS(United States Geological Survey)	This project was mostly unfunded; however, the field crew during the 2009 field work was partly funded by the USGS Multi-Hazards Demonstration Project funding to Jon Keeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AGEE JK, 1991, NORTHWEST SCI, V65, P188; Breshears DD, 2008, P NATL ACAD SCI USA, V105, P11591, DOI 10.1073/pnas.0806579105; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cairns DM, 2004, J ECOL, V92, P1019, DOI 10.1111/j.1365-2745.2004.00945.x; Cannone N, 2007, FRONT ECOL ENVIRON, V5, P360, DOI 10.1890/1540-9295(2007)5[360:UIOCCO]2.0.CO;2; CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Coale TH, 2011, ECOLOGY, V92, P1020, DOI 10.1890/i0012-9658-92-5-1020; Collett D, 2002, MODELLING BINARY DAT; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Ewers FW, 2003, OECOLOGIA, V136, P213, DOI 10.1007/s00442-003-1273-9; Halloy SRP, 2003, ARCT ANTARCT ALP RES, V35, P248, DOI 10.1657/1523-0430(2003)035[0248:CEOAPB]2.0.CO;2; Keeley J. E., 1993, Madrono, V40, P1; Keeley J.E., 2000, N AM TERRESTRIAL VEG, P203; KEELEY JE, 1992, J VEG SCI, V3, P79, DOI 10.2307/3236001; KEELEY JE, 1991, BOT REV, V57, P81, DOI 10.1007/BF02858766; Keeley JE, 2008, ECOL APPL, V18, P1530, DOI 10.1890/07-0836.1; Kelly A, 2007, THESIS CALIFORNIA ST; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Pinheiro J, 2000, MIXED EFFECTS MODELS; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; R Core Team, 2021, R LANGUAGE ENV STAT; SCHLESINGER WH, 1978, ECOLOGY, V59, P1256, DOI 10.2307/1938239; STEPHENSON JR, 1999, GTRPSW172 USDA FOR S; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740; Veblen TT, 2000, ECOL APPL, V10, P1178, DOI 10.1890/1051-0761(2000)010[1178:CAHIOF]2.0.CO;2; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wolf A, 2011, SCIENCE, V334, DOI 10.1126/science.1204607; Zabriskie J, 1977, PLANTS DEEP CANYON C; ZAMMIT CA, 1993, J ECOL, V81, P499, DOI 10.2307/2261528	33	23	23	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31173	10.1371/journal.pone.0031173	http://dx.doi.org/10.1371/journal.pone.0031173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348051	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730900021
J	Boudreau, LH; Maillet, J; LeBlanc, LM; Jean-Francois, J; Touaibia, M; Flamand, N; Surette, ME				Boudreau, Luc H.; Maillet, Jacques; LeBlanc, Luc M.; Jean-Francois, Jacques; Touaibia, Mohamed; Flamand, Nicolas; Surette, Marc E.			Caffeic Acid Phenethyl Ester and Its Amide Analogue Are Potent Inhibitors of Leukotriene Biosynthesis in Human Polymorphonuclear Leukocytes	PLOS ONE			English	Article							ARACHIDONIC-ACID; HUMAN NEUTROPHILS; 5-LIPOXYGENASE INHIBITOR; ADENOSINE; CAPE; RELEASE; B-4; TRANSLOCATION; METABOLITES; DERIVATIVES	Background: 5-lipoxygenase (5-LO) catalyses the transformation of arachidonic acid (AA) into leukotrienes (LTs), which are important lipid mediators of inflammation. LTs have been directly implicated in inflammatory diseases like asthma, atherosclerosis and rheumatoid arthritis; therefore inhibition of LT biosynthesis is a strategy for the treatment of these chronic diseases. Methodology/Principal Findings: Analogues of caffeic acid, including the naturally-occurring caffeic acid phenethyl ester (CAPE), were synthesized and evaluated for their capacity to inhibit 5-LO and LTs biosynthesis in human polymorphonuclear leukocytes (PMNL) and whole blood. Anti-free radical and anti-oxidant activities of the compounds were also measured. Caffeic acid did not inhibit 5-LO activity or LT biosynthesis at concentrations up to 10 mu M. CAPE inhibited 5-LO activity (IC50 0.13 mu M, 95% CI 0.08-0.23 mu M) more effectively than the clinically-approved 5-LO inhibitor zileuton (IC50 3.5 mu M, 95% CI 2.3-5.4 mu M). CAPE was also more effective than zileuton for the inhibition of LT biosynthesis in PMNL but the compounds were equipotent in whole blood. The activity of the amide analogue of CAPE was similar to that of zileuton. Inhibition of LT biosynthesis by CAPE was the result of the inhibition of 5-LO and of AA release. Caffeic acid, CAPE and its amide analog were free radical scavengers and antioxidants with IC50 values in the low mu M range; however, the phenethyl moiety of CAPE was required for effective inhibition of 5-LO and LT biosynthesis. Conclusions: CAPE is a potent LT biosynthesis inhibitor that blocks 5-LO activity and AA release. The CAPE structure can be used as a framework for the rational design of stable and potent inhibitors of LT biosynthesis.	[Boudreau, Luc H.; Maillet, Jacques; LeBlanc, Luc M.; Jean-Francois, Jacques; Touaibia, Mohamed; Surette, Marc E.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Boudreau, Luc H.; Flamand, Nicolas] Univ Laval, Fac Med, Dept Med, IUCPQ,Ctr Rech, Quebec City, PQ G1K 7P4, Canada	University of Moncton; Laval University	Boudreau, LH (corresponding author), Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada.	marc.surette@umoncton.ca	Surette, Marc/AAW-1078-2021; Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200; Boudreau, Luc H/0000-0002-3674-5026; LeBlanc, Luc/0000-0003-2944-2737	Heart and Stroke Foundation of Canada; New Brunswick Health Research Foundation; Canada Research Chairs Program; Fonds de la recherche en sante du Quebec; Canadian Arthritis Network	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); New Brunswick Health Research Foundation; Canada Research Chairs Program(Canada Research Chairs); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network	This work was supported by grants from the Heart and Stroke Foundation of Canada (to M. E. S.) and the New Brunswick Health Research Foundation (to M. T. and M. E. S.). M. E. S. is supported by the Canada Research Chairs Program. N.F. is the recipient of a scholarship award from the Fonds de la recherche en sante du Quebec. L. H. B. is the recipient of a graduate student award from the Canadian Arthritis Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger W, 2007, INT J CLIN PRACT, V61, P663, DOI 10.1111/j.1742-1241.2007.01320.x; BORGEAT P, 1990, METHOD ENZYMOL, V187, P98; Boudreau LH, 2011, FASEB J, V25, P1097, DOI 10.1096/fj.10-173856; Boudreau LH, 2009, NEW J CHEM, V33, P1932, DOI 10.1039/b907878a; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bruckner R, 2002, ADV ORGANIC CHEM REA, P238; CHAMULITRAT W, 1992, J BIOL CHEM, V267, P9574; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chen YY, 2009, CELL CYCLE, V8, P3488, DOI 10.4161/cc.8.21.9852; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Doiron J, 2009, BIOORG MED CHEM LETT, V19, P1118, DOI 10.1016/j.bmcl.2008.12.108; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2004, BRIT J PHARMACOL, V141, P552, DOI 10.1038/sj.bjp.0705654; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; FONTEH AN, 1993, J IMMUNOL, V151, P339; Garcia-Marcos L, 2003, DRUG SAFETY, V26, P483, DOI 10.2165/00002018-200326070-00004; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gokalp O, 2006, MOL CELL BIOCHEM, V290, P55, DOI 10.1007/s11010-006-9157-z; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; HATANO T, 1989, CHEM PHARM BULL, V37, P2016; Krump E, 1997, J EXP MED, V186, P1401, DOI 10.1084/jem.186.8.1401; Kunishima M, 1999, TETRAHEDRON, V55, P13159, DOI 10.1016/S0040-4020(99)00809-1; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Liegeois C, 2000, J AGR FOOD CHEM, V48, P1129, DOI 10.1021/jf9911242; Lin CF, 2005, CHEM PHARM BULL, V53, P1402, DOI 10.1248/cpb.53.1402; Liu MC, 1996, J ALLERGY CLIN IMMUN, V98, P859, DOI 10.1016/S0091-6749(96)80002-9; Mahapatra T, 2005, J CHEM RES, P629; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Michaluart P, 1999, CANCER RES, V59, P2347; Mirzoeva OK, 1996, PROSTAG LEUKOTR ESS, V55, P441, DOI 10.1016/S0952-3278(96)90129-5; Parlakpinar H, 2005, TOXICOLOGY, V207, P169, DOI 10.1016/j.tox.2004.08.024; Pergola C, 2010, EXPERT OPIN THER PAT, V20, P355, DOI 10.1517/13543771003602012; Radmark O, 2002, PROSTAG OTH LIPID M, V68-9, P211, DOI 10.1016/S0090-6980(02)00032-1; Rajan P, 2001, BIOORG MED CHEM LETT, V11, P215, DOI 10.1016/S0960-894X(00)00630-2; Rossi A, 2010, BRIT J PHARMACOL, V161, P555, DOI 10.1111/j.1476-5381.2010.00930.x; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Son S, 2001, CHEM PHARM BULL, V49, P236, DOI 10.1248/cpb.49.236; SUDINA GF, 1993, FEBS LETT, V329, P21, DOI 10.1016/0014-5793(93)80184-V; SURETTE ME, 1994, ANAL BIOCHEM, V216, P392, DOI 10.1006/abio.1994.1057; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Surette ME, 2003, CLIN THER, V25, P948, DOI 10.1016/S0149-2918(03)80116-9; Surette ME, 1996, BIOCHEMISTRY-US, V35, P9187, DOI 10.1021/bi9530245; Surette ME, 1999, MOL PHARMACOL, V56, P1055, DOI 10.1124/mol.56.5.1055; Thibault N, 2002, J LEUKOCYTE BIOL, V71, P367; WALSH CE, 1981, J BIOL CHEM, V256, P7228; Wang XY, 2006, BIOORGAN MED CHEM, V14, P4879, DOI 10.1016/j.bmc.2006.03.015	49	54	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31833	10.1371/journal.pone.0031833	http://dx.doi.org/10.1371/journal.pone.0031833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347509	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200037
J	Gibbons, HS; Krepps, MD; Ouellette, G; Karavis, M; Onischuk, L; Leonard, P; Broomall, S; Sickler, T; Betters, JL; McGregor, P; Donarum, G; Liem, A; Fochler, E; Mcnew, L; Rosenzweig, CN; Skowronski, E				Gibbons, Henry S.; Krepps, Michael D.; Ouellette, Gary; Karavis, Mark; Onischuk, Lisa; Leonard, Pascale; Broomall, Stacey; Sickler, Todd; Betters, Janet L.; McGregor, Paul; Donarum, Greg; Liem, Alvin; Fochler, Ed; Mcnew, Lauren; Rosenzweig, C. Nicole; Skowronski, Evan			Comparative Genomics of 2009 Seasonal Plague (Yersinia pestis) in New Mexico	PLOS ONE			English	Article							TANDEM REPEATS; DRAFT GENOME; PERSISTENCE; ORIENTALIS; EVOLUTION; SEQUENCE; STRAIN; AGENT	Plague disease caused by the Gram-negative bacterium Yersinia pestis routinely affects animals and occasionally humans, in the western United States. The strains native to the North American continent are thought to be derived from a single introduction in the late 19th century. The degree to which these isolates have diverged genetically since their introduction is not clear, and new genomic markers to assay the diversity of North American plague are highly desired. To assay genetic diversity of plague isolates within confined geographic areas, draft genome sequences were generated by 454 pyrosequencing from nine environmental and clinical plague isolates. In silico assemblies of Variable Number Tandem Repeat (VNTR) loci were compared to laboratory-generated profiles for seven markers. High-confidence SNPs and small Insertion/Deletions (Indels) were compared to previously sequenced Y. pestis isolates. The resulting panel of mutations allowed clustering of the strains and tracing of the most likely evolutionary trajectory of the plague strains. The sequences also allowed the identification of new putative SNPs that differentiate the 2009 isolates from previously sequenced plague strains and from each other. In addition, new insertion points for the abundant insertion sequences (IS) of Y. pestis are present that allow additional discrimination of strains; several of these new insertions potentially inactivate genes implicated in virulence. These sequences enable whole-genome phylogenetic analysis and allow the unbiased comparison of closely related isolates of a genetically monomorphic pathogen.	[Gibbons, Henry S.; Krepps, Michael D.; Ouellette, Gary; Karavis, Mark; Broomall, Stacey; Sickler, Todd; Betters, Janet L.; McGregor, Paul; Mcnew, Lauren; Rosenzweig, C. Nicole; Skowronski, Evan] USA, Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD USA; [Ouellette, Gary; McGregor, Paul] Sci Applicat Int Corp, Aberdeen Proving Ground, MD USA; [Onischuk, Lisa; Leonard, Pascale] New Mexico Dept Publ Hlth, Albuquerque, NM USA; [Donarum, Greg; Liem, Alvin; Fochler, Ed] OptiMetrics Inc, Abingdon, MD USA; [Krepps, Michael D.] Excet Inc, Springfield, VA USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Science Applications International Corporation (SAIC)	Gibbons, HS (corresponding author), USA, Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD USA.	henry.gibbons.civ@mail.mil		Gibbons, Henry/0000-0002-5603-8679	Defense Threat Reduction Agency (DTRA) [CB2847]; New Mexico Department of Health	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); New Mexico Department of Health	The work presented here was supported by the Defense Threat Reduction Agency (DTRA) under project number CB2847 to HSG, CNR, and ES and by the New Mexico Department of Health to LO and PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Auerbach RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000770; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Bearden SW, 2009, MICROBIOL-SGM, V155, P198, DOI 10.1099/mic.0.021170-0; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Cummings CA, 2009, FORENS SCI INT-GEN S, V2, P300, DOI 10.1016/j.fsigss.2009.08.097; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Drancourt M, 2006, LANCET INFECT DIS, V6, P234, DOI 10.1016/S1473-3099(06)70438-8; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Drancourt M, 2007, EMERG INFECT DIS, V13, P332, DOI 10.3201/eid1302.060197; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Karlyshev AV, 2001, INFECT IMMUN, V69, P7810, DOI 10.1128/IAI.69.12.7810-7819.2001; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Le Fleche P, 2001, BMC Microbiol, V1, P2; Link VB, 1955, US DEP H E W PUBL HL; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Nei M., 2000, MOL EVOLUATION PHYLO; New Mexico Department of Health, 2010, HUM PLAG NEW MEX CAS; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Touchman JW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000220; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016735; Vogler AJ, 2007, MUTAT RES-FUND MOL M, V616, P145, DOI 10.1016/j.mrfmmm.2006.11.007	33	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31604	10.1371/journal.pone.0031604	http://dx.doi.org/10.1371/journal.pone.0031604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359605	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200074
J	He, Z; Nguyen, CTO; Armitage, JA; Vingrys, AJ; Bui, BV				He, Zheng; Nguyen, Christine T. O.; Armitage, James A.; Vingrys, Algis J.; Bui, Bang V.			Blood Pressure Modifies Retinal Susceptibility to Intraocular Pressure Elevation	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR PERFUSION-PRESSURE; LASER-DOPPLER FLOWMETRY; NORMAL-TENSION GLAUCOMA; OPTIC-NERVE HEAD; SCOTOPIC THRESHOLD RESPONSE; CIRCADIAN FLUCTUATION; RISK-FACTORS; FLOW; ELECTRORETINOGRAM	Primary open angle glaucoma affects more than 67 million people. Elevated intraocular pressure (IOP) is a risk factor for glaucoma and may reduce nutrient availability by decreasing ocular perfusion pressure (OPP). An interaction between arterial blood pressure and IOP determines OPP; but the exact contribution that these factors have for retinal function is not fully understood. Here we sought to determine how acute modifications of arterial pressure will affect the susceptibility of neuronal function and blood flow to IOP challenge. Anaesthetized (ketamine:xylazine) Long-Evan rats with low (similar to 60 mmHg, sodium nitroprusside infusion), moderate (similar to 100 mmHg, saline), or high levels (similar to 160 mmHg, angiotensin II) of mean arterial pressure (MAP, n = 5-10 per group) were subjected to IOP challenge (10-120 mmHg, 5 mmHg steps every 3 minutes). Electroretinograms were measured at each IOP step to assess bipolar cell (b-wave) and inner retinal function (scotopic threshold response or STR). Ocular blood flow was measured using laser-Doppler flowmetry in groups with similar MAP level and the same IOP challenge protocol. Both b-wave and STR amplitudes decreased with IOP elevation. Retinal function was less susceptible to IOP challenge when MAP was high, whereas the converse was true for low MAP. Consistent with the effects on retinal function, higher IOP was needed to attenuated ocular blood flow in animals with higher MAP. The susceptibility of retinal function to IOP challenge can be ameliorated by acute high BP, and exacerbated by low BP. This is partially mediated by modifications in ocular blood flow.	[He, Zheng; Nguyen, Christine T. O.; Vingrys, Algis J.; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Armitage, James A.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Melbourne; Monash University	He, Z (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	bvb@unimelb.edu.au	Armitage, James A/A-8949-2012; Armitage, James/AAX-1294-2021; Bui, Bang/AAD-2679-2021	Bui, Bang/0000-0001-7298-1352; Nguyen, Christine/0000-0002-3298-3086; Armitage, James/0000-0002-3762-0911; Vingrys, Algis/0000-0001-5920-4604; He, Zheng/0000-0001-6496-3971	National Health and Medical Research Council (NHMRC) of Australia [566570]; Albert Shimmins Memorial Fund; National Heart Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Albert Shimmins Memorial Fund; National Heart Foundation(National Heart Foundation of Australia)	This study received funding support from the National Health and Medical Research Council (NHMRC grant 566570) of Australia and the Albert Shimmins Memorial Fund. JAA is a Monash Fellow and was supported by a National Heart Foundation Postgraduate Fellowship during the course of these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; Collignon N, 1998, INT OPHTHALMOL, V22, P19, DOI 10.1023/A:1006113109864; DEMAILLY P, 1984, OPHTHALMOLOGICA, V188, P65, DOI 10.1159/000309344; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Fredriksson I., 2007, LASER DOPPLER FLOWME; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; Frishman LJ, 1996, INVEST OPHTH VIS SCI, V37, P125; GRAHAM SL, 1995, OPHTHALMOLOGY, V102, P61; Graham SL, 1999, SURV OPHTHALMOL, V43, pS10, DOI 10.1016/S0039-6257(99)00016-8; GREHN F, 1983, INVEST OPHTH VIS SCI, V24, P347; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P603, DOI 10.1016/S0002-9394(14)70067-4; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; KAISER HJ, 1993, OPHTHALMOLOGICA, V207, P6, DOI 10.1159/000310398; KAISER HJ, 1993, GRAEF ARCH CLIN EXP, V231, P677, DOI 10.1007/BF00919280; KIEL JW, 1995, INVEST OPHTH VIS SCI, V36, P579; Kyhn MV, 2009, EXP EYE RES, V89, P1012, DOI 10.1016/j.exer.2009.08.014; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2002, ARCH OPHTHALMOL-CHIC, V120, P954, DOI 10.1001/archopht.120.7.954; Liang Y, 2009, INVEST OPHTH VIS SCI, V50, P2154, DOI 10.1167/iovs.08-2882; Memarzadeh F, 2010, INVEST OPHTH VIS SCI, V51, P2872, DOI 10.1167/iovs.08-2956; Meyer JH, 1996, BRIT J OPHTHALMOL, V80, P864, DOI 10.1136/bjo.80.10.864; Mitchell P, 2004, J GLAUCOMA, V13, P319, DOI 10.1097/00061198-200408000-00010; Naarendorp F, 2001, VISUAL NEUROSCI, V18, P641, DOI 10.1017/S0952523801184142; NAARENDORP F, 1991, VISION RES, V31, P1, DOI 10.1016/0042-6989(91)90068-G; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P608; Riva Charles E., 2001, International Ophthalmology, V23, P183, DOI 10.1023/A:1014433913240; SACHSENWEGER R, 1963, Klin Monbl Augenheilkd, V142, P625; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schmetterer L, 2007, SURV OPHTHALMOL, V52, pS134, DOI 10.1016/j.survophthal.2007.08.008; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Shepherd A.P, 1990, LASER DOPPLER BLOOD; SILIPRANDI R, 1988, INVEST OPHTH VIS SCI, V29, P558; Topouzis F, 2006, AM J OPHTHALMOL, V142, P60, DOI 10.1016/j.ajo.2006.02.055; YANCEY CM, 1988, INVEST OPHTH VIS SCI, V29, P700	45	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31104	10.1371/journal.pone.0031104	http://dx.doi.org/10.1371/journal.pone.0031104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359566	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200035
J	McClenahan, P; Troup, M; Scott, EK				McClenahan, Phil; Troup, Michael; Scott, Ethan K.			Fin-Tail Coordination during Escape and Predatory Behavior in Larval Zebrafish	PLOS ONE			English	Article							FAST-START PERFORMANCE; PECTORAL FIN; SPINAL INTERNEURONS; PREY CAPTURE; DANIO-RERIO; ELECTROMYOGRAPHIC ANALYSIS; LABRIFORM PROPULSION; SWIMMING MOVEMENTS; GOMPHOSUS-VARIUS; NEURAL-CONTROL	Larval zebrafish innately perform a suite of behaviors that are tightly linked to their evolutionary past, notably escape from threatening stimuli and pursuit and capture of prey. These behaviors have been carefully examined in the past, but mostly with regard to the movements of the trunk and tail of the larvae. Here, we employ kinematics analyses to describe the movements of the pectoral fins during escape and predatory behavior. In accord with previous studies, we find roles for the pectoral fins in slow swimming and immediately after striking prey. We find novel roles for the pectoral fins in long-latency, but not in short-latency C-bends. We also observe fin movements that occur during orienting J-turns and S-starts that drive high-velocity predatory strikes. Finally, we find that the use of pectoral fins following a predatory strike is scaled to the velocity of the strike, supporting a role for the fins in braking. The implications of these results for central control of coordinated movements are discussed, and we hope that these results will provide baselines for future analyses of cross-body coordination using mutants, morphants, and transgenic approaches.	[McClenahan, Phil; Troup, Michael; Scott, Ethan K.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Queensland	McClenahan, P (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	ethan.scott@uq.edu.au		Troup, Michael/0000-0002-8828-4735; Scott, Ethan/0000-0003-3150-9216	NARSAD, Brain and Behavior Research Foundation; University of Queensland; Australian Zebrafish Phenomics Facility (NHMRC) [455871]; Australian Research Council [DP110103612]	NARSAD, Brain and Behavior Research Foundation; University of Queensland(University of Queensland); Australian Zebrafish Phenomics Facility (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	ES is funded by a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation, the University of Queensland, the Australian Zebrafish Phenomics Facility (NHMRC Enabling Grant 455871), Australian Research Council Discovery Project Grant DP110103612, and an Australian Research Council Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley-Ross MA, 2002, J EXP ZOOL, V293, P561, DOI 10.1002/jez.10183; Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Danos N, 2007, J EXP BIOL, V210, P3374, DOI 10.1242/jeb.007484; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Drucker EG, 2003, J EXP BIOL, V206, P813, DOI 10.1242/jeb.00139; Drucker EG, 1997, J EXP BIOL, V200, P1709; Drucker EG, 2001, J EXP BIOL, V204, P431; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; FOREMAN MB, 1993, J NEUROSCI, V13, P4101; Friedrich RW, 2010, CURRENT BIOL, V20; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Green MH, 2011, J EXP BIOL, V214, P3111, DOI 10.1242/jeb.057497; Hale ME, 1996, AM ZOOL, V36, P695; Hale ME, 1999, J EXP BIOL, V202, P1465; Hale ME, 2006, J EXP BIOL, V209, P3708, DOI 10.1242/jeb.02449; HALL DH, 1985, J NEUROCYTOL, V14, P825, DOI 10.1007/BF01170831; Kamata R, 2003, COMP BIOCHEM PHYS A, V135, P435, DOI 10.1016/S1095-6433(03)00110-7; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; KIMMEL CB, 1980, J COMP PHYSIOL, V140, P343, DOI 10.1007/BF00606274; Koyama M, 2011, P NATL ACAD SCI USA, V108, P1170, DOI 10.1073/pnas.1012189108; LADICH F, 1992, BRAIN BEHAV EVOLUT, V39, P1, DOI 10.1159/000114099; Lauder GV, 2007, EXP FLUIDS, V43, P641, DOI 10.1007/s00348-007-0357-4; Liao JC, 2008, J NEUROSCI, V28, P12982, DOI 10.1523/JNEUROSCI.3330-08.2008; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; McLean DL, 2011, CURR OPIN NEUROBIOL, V21, P110, DOI 10.1016/j.conb.2010.09.011; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; Nakae M, 2007, ICHTHYOL RES, V54, P333, DOI 10.1007/s10228-007-0409-z; OKAMOTO H, 1991, DEV BIOL, V146, P49, DOI 10.1016/0012-1606(91)90445-9; Patterson SE, 2008, DEV DYNAM, V237, P307, DOI 10.1002/dvdy.21400; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Sankrithi NS, 2010, NEUROSCIENCE, V166, P970, DOI 10.1016/j.neuroscience.2010.01.003; Satou C, 2009, J NEUROSCI, V29, P6780, DOI 10.1523/JNEUROSCI.0801-09.2009; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Thorsen DH, 2007, J COMP NEUROL, V504, P168, DOI 10.1002/cne.21425; Thorsen DH, 2005, J MORPHOL, V266, P241, DOI 10.1002/jmor.10374; Thorsen DH, 2005, J MORPHOL, V263, P133, DOI 10.1002/jmor.10173; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; Walker JA, 1997, J EXP BIOL, V200, P1549; Walker JA, 2002, INTEGR COMP BIOL, V42, P1032, DOI 10.1093/icb/42.5.1032; Westneat MW, 2004, IEEE J OCEANIC ENG, V29, P674, DOI 10.1109/JOE.2004.833207; Westneat MW, 1997, J EXP BIOL, V200, P1881; Wilga CD, 1999, J EXP BIOL, V202, P2413; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323	52	36	36	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32295	10.1371/journal.pone.0032295	http://dx.doi.org/10.1371/journal.pone.0032295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359680	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200149
J	Hancock, T; Wicker, N; Takigawa, I; Mamitsuka, H				Hancock, Timothy; Wicker, Nicolas; Takigawa, Ichigaku; Mamitsuka, Hiroshi			Identifying Neighborhoods of Coordinated Gene Expression and Metabolite Profiles	PLOS ONE			English	Article							ESCHERICHIA-COLI; ROBUSTNESS; PROTEIN; IRON; INTEGRATION; PATHWAYS; NETWORK; SYSTEM; ENZYME; KNOWLEDGEBASE	In this paper we investigate how metabolic network structure affects any coordination between transcript and metabolite profiles. To achieve this goal we conduct two complementary analyses focused on the metabolic response to stress. First, we investigate the general size of any relationship between metabolic network gene expression and metabolite profiles. We find that strongly correlated transcript-metabolite profiles are sustained over surprisingly long network distances away from any target metabolite. Secondly, we employ a novel pathway mining method to investigate the structure of this transcript-metabolite relationship. The objective of this method is to identify a minimum set of metabolites which are the target of significantly correlated gene expression pathways. The results reveal that in general, a global regulation signature targeting a small number of metabolites is responsible for a large scale metabolic response. However, our method also reveals pathway specific effects that can degrade this global regulation signature and complicates the observed coordination between transcript-metabolite profiles.	[Hancock, Timothy; Takigawa, Ichigaku; Mamitsuka, Hiroshi] Kyoto Univ, Bioinformat Ctr, Kyoto, Japan; [Wicker, Nicolas] Univ Strasbourg, Lab Bioinformat & Genom Integrat, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hancock, T (corresponding author), Kyoto Univ, Bioinformat Ctr, Kyoto, Japan.	timhancock@kuicr.kyoto-u.ac.jp	Takigawa, Ichigaku/B-3823-2012; Mamitsuka, Hiroshi/R-1110-2016	Takigawa, Ichigaku/0000-0001-5633-995X; Mamitsuka, Hiroshi/0000-0002-6607-5617	BIRD, JST (Japan Science and Technology Agency); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23710233]	BIRD, JST (Japan Science and Technology Agency); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	H.M., T. H. and I. T. have been partially supported by BIRD, JST (Japan Science and Technology Agency). I. T. is also partially supported by the Grant-in-Aid for Scientificc Research 23710233 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m; Bradley PH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000270; Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Fischer D, 1998, J BACTERIOL, V180, P6203; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hancock T, 2010, BIOINFORMATICS, V26, P2128, DOI 10.1093/bioinformatics/btq344; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; IBM, 2008, IL CPLEX OPT VERS 11; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim PJ, 2007, P NATL ACAD SCI USA, V104, P13638, DOI 10.1073/pnas.0703262104; Koch D, 2007, BIOMETALS, V20, P759, DOI 10.1007/s10534-006-9039-6; Krin E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-273; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Kupiec M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100146; MANDELSTAM J, 1957, NATURE, V179, P1179, DOI 10.1038/1791179a0; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Metzner M, 2004, MOL MICROBIOL, V51, P799, DOI 10.1046/j.1365-2958.2003.03867.x; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takigawa I, 2008, BIOINFORMATICS, V24, P250, DOI 10.1093/bioinformatics/btm575; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vazirani V., 2001, APPROXIMATION ALGORI; WILLETTS NS, 1967, BIOCHEM J, V103, P453, DOI 10.1042/bj1030453	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31345	10.1371/journal.pone.0031345	http://dx.doi.org/10.1371/journal.pone.0031345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355360	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300060
J	Hoffmann, F; Kloas, W				Hoffmann, Frauke; Kloas, Werner			Estrogens Can Disrupt Amphibian Mating Behavior	PLOS ONE			English	Article							AFRICAN CLAWED FROGS; XENOPUS-LAEVIS; ENDOCRINE DISRUPTERS; SURFACE-WATER; WASTE-WATER; BISPHENOL-A; IN-VITRO; 17-ALPHA-ETHINYLESTRADIOL; PHARMACEUTICALS; GONADOTROPIN	The main component of classical contraceptives, 17 alpha-ethinylestradiol (EE2), has high estrogenic activity even at environmentally relevant concentrations. Although estrogenic endocrine disrupting compounds are assumed to contribute to the worldwide decline of amphibian populations by adverse effects on sexual differentiation, evidence for EE2 affecting amphibian mating behaviour is lacking. In this study, we demonstrate that EE2 exposure at five different concentrations (0.296 ng/L, 2.96 ng/L, 29.64 ng/L, 2.96 mu g/L and 296.4 mu g/L) can disrupt the mating behavior of adult male Xenopus laevis. EE2 exposure at all concentrations lowered male sexual arousal, indicated by decreased proportions of advertisement calls and increased proportions of the call type rasping, which characterizes a sexually unaroused state of a male. Additionally, EE2 at all tested concentrations affected temporal and spectral parameters of the advertisement calls, respectively. The classical and highly sensitive biomarker vitellogenin, on the other hand, was only induced at concentrations equal or higher than 2.96 mu g/L. If kept under control conditions after a 96 h EE2 exposure (2.96 mu g/L), alterations of male advertisement calls vanish gradually within 6 weeks and result in a lower sexual attractiveness of EE2 exposed males toward females as demonstrated by female choice experiments. These findings indicate that exposure to environmentally relevant EE2 concentrations can directly disrupt male mate calling behavior of X. laevis and can indirectly affect the mating behavior of females. The results suggest the possibility that EE2 exposure could reduce the reproductive success of EE2 exposed animals and these effects might contribute to the global problem of amphibian decline.	[Hoffmann, Frauke] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Kloas, Werner] Humboldt Univ, Inst Biol, Dept Endocrinol, D-10099 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Hoffmann, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany.	f.hoffmann@igb-berlin.de	Hoffmann, Frauke/H-5994-2015; Hoffmann, Frauke/F-9114-2017		German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU, Osnabruck, Germany) [AZ 20009/987]	German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU, Osnabruck, Germany)	The authors would like to thank the German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU, Osnabruck, Germany, http://www.dbu.de/stipendien_20008/987_db.html) for awarding a doctoral scholarship to Frauke Hoffmann (grant no. AZ 20009/987). There are no further external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2001, ACTA HYDROCH HYDROB, V29, P227, DOI 10.1002/1521-401X(200111)29:4<227::AID-AHEH227>3.0.CO;2-R; Arcand-Hoy LD, 1998, INT J TOXICOL, V17, P139, DOI 10.1080/109158198226675; BANCROFT J, 1974, BRIT J PSYCHIAT, V125, P310, DOI 10.1192/bjp.125.3.310; Belfroid AC, 1999, SCI TOTAL ENVIRON, V225, P101, DOI 10.1016/S0048-9697(98)00336-2; Bogi C, 2003, ENVIRON RES, V93, P195, DOI 10.1016/S0013-9351(03)00082-3; Brahic CJ, 2003, J COMP NEUROL, V464, P115, DOI 10.1002/cne.10772; Braun P, 2003, J CHROMATOGR A, V988, P41, DOI 10.1016/S0021-9673(02)02052-6; CAREY C, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432406; Colman JR, 2009, AQUAT TOXICOL, V91, P346, DOI 10.1016/j.aquatox.2008.12.001; Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Emperaire J C, 1969, Gynecol Prat, V20, P327; GERHARDT HC, 1978, J EXP BIOL, V74, P59; Hoffmann F, 2010, HORM BEHAV, V58, P653, DOI 10.1016/j.yhbeh.2010.06.008; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Jones OAH, 2001, ENVIRON TECHNOL, V22, P1383, DOI 10.1080/09593332208618186; KELLEY DB, 1976, HORM BEHAV, V7, P159, DOI 10.1016/0018-506X(76)90045-3; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5; Kloas W, 2002, INT REV CYTOL, V216, P1; KONISHI M, 1988, P NATL ACAD SCI USA, V85, P7006, DOI 10.1073/pnas.85.18.7006; Kuch HM, 2001, ENVIRON SCI TECHNOL, V35, P3201, DOI 10.1021/es010034m; Levy G, 2004, ENVIRON RES, V94, P102, DOI 10.1016/S0013-9351(03)00086-0; LOFTUSHI.JJ, 1971, COPEIA, P154; Lutz I, 2005, COMP BIOCHEM PHYS C, V141, P384, DOI 10.1016/j.cbpc.2005.08.003; MARIN ML, 1990, DEVELOPMENT, V110, P703; Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674; MORRELL JI, 1975, J COMP NEUROL, V164, P63, DOI 10.1002/cne.901640106; MURRAY MAF, 1975, J ENDOCRINOL, V67, P179, DOI 10.1677/joe.0.0670179; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; ORME ML, 1983, CLIN PHARMACOKINET, V8, P95, DOI 10.2165/00003088-198308020-00001; Partridge C, 2010, HORM BEHAV, V58, P800, DOI 10.1016/j.yhbeh.2010.08.002; Pawlowski S, 2004, ECOTOX ENVIRON SAFE, V57, P330, DOI 10.1016/j.ecoenv.2003.07.019; Prasad PJ, 2010, CONCEPTUAL PHARM; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; RUSSELL W. M. S., 1960, BEHAVIOUR, V15, P253, DOI 10.1163/156853960X00269; Saaristo M, 2010, CHEMOSPHERE, V79, P541, DOI 10.1016/j.chemosphere.2010.02.019; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; Sanderson H, 2004, REGUL TOXICOL PHARM, V39, P158, DOI 10.1016/j.yrtph.2003.12.006; Shen JH, 2001, TOXICOLOGY, V166, P71, DOI 10.1016/S0300-483X(01)00439-5; Stebbins RC., 1997, NATURAL HIST AMPHIBI; STUMPF M, 1996, VOM WASSER, V87, P251; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; Tobias ML, 2004, ANIM BEHAV, V67, P353, DOI 10.1016/j.anbehav.2003.03.016; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; Tobias ML, 1998, J NEUROBIOL, V37, P441, DOI 10.1002/(SICI)1097-4695(19981115)37:3<441::AID-NEU9>3.3.CO;2-X; Toppari J, 2002, SEMIN REPROD MED, V20, P305, DOI 10.1055/s-2002-35377; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Urbatzka R, 2007, COMP BIOCHEM PHYS C, V144, P310, DOI 10.1016/j.cbpc.2006.10.008; van Heusden AM, 2002, HUM REPROD UPDATE, V8, P345, DOI 10.1093/humupd/8.4.345; Vignal C, 2007, P ROY SOC B-BIOL SCI, V274, P479, DOI 10.1098/rspb.2006.3744; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Watson CS, 2011, J STEROID B IN PRESS; WETZEL DM, 1983, HORM BEHAV, V17, P388, DOI 10.1016/0018-506X(83)90048-X; Wu KH, 2001, NEUROENDOCRINOLOGY, V74, P22, DOI 10.1159/000054667; YAGER D, 1982, AM ZOOL, V22, P887; Yang EJ, 2007, P NATL ACAD SCI USA, V104, P2477, DOI 10.1073/pnas.0608391104	56	43	44	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32097	10.1371/journal.pone.0032097	http://dx.doi.org/10.1371/journal.pone.0032097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355410	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300110
J	Maurer, LM; Annis, DS; Mosher, DF				Maurer, Lisa M.; Annis, Douglas S.; Mosher, Deane F.			IGD Motifs, Which Are Required for Migration Stimulatory Activity of Fibronectin Type I Modules, Do Not Mediate Binding in Matrix Assembly	PLOS ONE			English	Article							CELL-SURFACE FIBRONECTIN; PLASMA FIBRONECTIN; TERMINAL MODULES; SITES; SEQUENCES; FRAGMENT; PROTEIN; MARKER; F1	Picomolar concentrations of proteins comprising only the N-terminal 70-kDa region (70K) of fibronectin (FN) stimulate cell migration into collagen gels. The Ile-Gly-Asp (IGD) motifs in four of the nine FN type 1 (FNI) modules in 70K are important for such migratory stimulating activity. The 70K region mediates binding of nanomolar concentrations of intact FN to cell-surface sites where FN is assembled. Using baculovirus, we expressed wildtype 70K and 70K with Ile-to-Ala mutations in (FNI)-F-3 and (FNI)-F-5; (FNI)-F-7 and (FNI)-F-9; or (FNI)-F-3, (FNI)-F-5, (FNI)-F-7, and (FNI)-F-9. Wildtype 70K and 70K with Ile-to-Ala mutations were equally active in binding to assembly sites of FN-null fibroblasts. This finding indicates that IGD motifs do not mediate the interaction between 70K and the cell-surface that is important for FN assembly. Further, FN fragment N-(FNIII)-F-3, which does not stimulate migration, binds to assembly sites on FN-null fibroblast. The Ile-to-Ala mutations had effects on the structure of FNI modules as evidenced by decreases in abilities of 70K with Ile-to-Ala mutations to bind to monoclonal antibody 5C3, which recognizes an epitope in (FNI)-F-9, or to bind to FUD, a polypeptide based on the F1 adhesin of Streptococcus pyogenes that interacts with 70K by the beta-zipper mechanism. These results suggest that the picomolar interactions of 70K with cells that stimulate cell migration require different conformations of FNI modules than the nanomolar interactions required for assembly.	[Maurer, Lisa M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maurer, LM (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805	National Institutes of Health [R01 HL021644]; American Heart Association [0815362G]; National Institutes of Aging [T32 AG000213]; PI Sanjay Asthana;  [P01 HL088594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594, R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PI Sanjay Asthana; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health Grant R01 HL021644 (to D. F. M.), an American Heart Association pre-doctoral training grant 0815362G (to L. M. M.), a National Institutes of Aging Grant T32 AG000213, PI Sanjay Asthana (to L. M. M.), and Program Project grant P01 HL088594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Ellis IR, 2010, CELL SIGNAL, V22, P1655, DOI 10.1016/j.cellsig.2010.06.005; Ellis IR, 2010, EXP CELL RES, V316, P2465, DOI 10.1016/j.yexcr.2010.04.003; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; ZERLAUTH G, 1984, AM J MED, V77, P685, DOI 10.1016/0002-9343(84)90366-8; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30615	10.1371/journal.pone.0030615	http://dx.doi.org/10.1371/journal.pone.0030615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355321	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300021
J	Mourao-Miranda, J; Oliveira, L; Ladouceur, CD; Marquand, A; Brammer, M; Birmaher, B; Axelson, D; Phillips, ML				Mourao-Miranda, Janaina; Oliveira, Leticia; Ladouceur, Cecile D.; Marquand, Andre; Brammer, Michael; Birmaher, Boris; Axelson, David; Phillips, Mary L.			Pattern Recognition and Functional Neuroimaging Help to Discriminate Healthy Adolescents at Risk for Mood Disorders from Low Risk Adolescents	PLOS ONE			English	Article							BIPOLAR DISORDER; PSYCHIATRIC-DISORDERS; FACIAL EXPRESSIONS; EMOTION PERCEPTION; DEPRESSED CHILDREN; MAJOR DEPRESSION; CLASSIFICATION; NEUROBIOLOGY; PSYCHOSIS; RESPONSES	Introduction: There are no known biological measures that accurately predict future development of psychiatric disorders in individual at-risk adolescents. We investigated whether machine learning and fMRI could help to: 1. differentiate healthy adolescents genetically at-risk for bipolar disorder and other Axis I psychiatric disorders from healthy adolescents at low risk of developing these disorders; 2. identify those healthy genetically at-risk adolescents who were most likely to develop future Axis I disorders. Methods: 16 healthy offspring genetically at risk for bipolar disorder and other Axis I disorders by virtue of having a parent with bipolar disorder and 16 healthy, age-and gender-matched low-risk offspring of healthy parents with no history of psychiatric disorders (12-17 year-olds) performed two emotional face gender-labeling tasks (happy/neutral; fearful/neutral) during fMRI. We used Gaussian Process Classifiers (GPC), a machine learning approach that assigns a predictive probability of group membership to an individual person, to differentiate groups and to identify those at-risk adolescents most likely to develop future Axis I disorders. Results: Using GPC, activity to neutral faces presented during the happy experiment accurately and significantly differentiated groups, achieving 75% accuracy (sensitivity = 75%, specificity = 75%). Furthermore, predictive probabilities were significantly higher for those at-risk adolescents who subsequently developed an Axis I disorder than for those at-risk adolescents remaining healthy at follow-up. Conclusions: We show that a combination of two promising techniques, machine learning and neuroimaging, not only discriminates healthy low-risk from healthy adolescents genetically at-risk for Axis I disorders, but may ultimately help to predict which at-risk adolescents subsequently develop these disorders.	[Mourao-Miranda, Janaina] UCL, Dept Comp Sci, London WC1E 6BT, England; [Mourao-Miranda, Janaina; Oliveira, Leticia; Marquand, Andre; Brammer, Michael] Kings Coll London, Dept Neuroimaging, London, England; [Oliveira, Leticia] Univ Fed Fluminense, Inst Biomed, Niteroi, RJ, Brazil; [Ladouceur, Cecile D.; Birmaher, Boris; Axelson, David; Phillips, Mary L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Phillips, Mary L.] Cardiff Univ, Dept Psychol Med, Cardiff, S Glam, Wales	University of London; University College London; University of London; King's College London; Universidade Federal Fluminense; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cardiff University	Mourao-Miranda, J (corresponding author), UCL, Dept Comp Sci, London WC1E 6BT, England.	j.mourao-miranda@cs.ucl.ac.uk	Mourao-Miranda, Janaina/AAT-2985-2021; Oliveira, Leticia/P-1159-2019; Mourao-Miranda, Janaina/AAS-2072-2021; Ladouceur, Cecile D/H-3124-2016; Marquand, Andre F/B-6050-2012; Brammer, Michael J/B-7128-2012	Oliveira, Leticia/0000-0002-8450-2264; Mourao-Miranda, Janaina/0000-0002-3309-8441; Marquand, Andre F/0000-0001-5903-203X; Brammer, Michael J/0000-0001-9800-2052	National Institute of Mental Health [R01MH076971, R01MH073953, K01MH083001, R01MH60952]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Welcome Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073953, R01MH076971, R01MH073801, K01MH083001, R01MH060952] Funding Source: NIH RePORTER; Medical Research Council [G0801418B] Funding Source: researchfish	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Welcome Trust(Wellcome Trust); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institute of Mental Health (R01MH076971 and R01MH073953 to MP, K01MH083001 to CD, R01MH60952 to BB). CD and MP are supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD). JMM is supported by the Welcome Trust. LO is supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Birmaher B, 2009, ARCH GEN PSYCHIAT, V66, P287, DOI 10.1001/archgenpsychiatry.2008.546; Bishop C. M, 2006, PATTERN RECOGNITION; Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359; DelBello MP, 2007, AM J PSYCHIAT, V164, P582, DOI 10.1176/appi.ajp.164.4.582; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; GELLER B, 1994, J AM ACAD CHILD PSY, V33, P461, DOI 10.1097/00004583-199405000-00003; Geller B, 2001, J AM ACAD CHILD PSY, V40, P673, DOI 10.1097/00004583-200106000-00012; George MS, 1998, BEHAV MODIF, V22, P192, DOI 10.1177/01454455980222007; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Johnson JG, 2000, AM J PSYCHIAT, V157, P1679, DOI 10.1176/appi.ajp.157.10.1679; Johnson SL, 2002, BIPOLAR UNIPOLAR DEP; Kaufman Joan, 1997, Journal of the American Academy of Child and Adolescent Psychiatry, V36, P1602, DOI 10.1016/S0890-8567(09)66571-0; Kessler RC, 2005, BIOL PSYCHIAT, V58, P668, DOI 10.1016/j.biopsych.2005.04.034; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Lundqvist D., 1998, KAROLINSKA DIRECTED; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Marquand AF, 2011, NEUROPSYCHOPHARMACOL, V36, P1237, DOI 10.1038/npp.2011.9; McIntyre RS, 2006, BIPOLAR DISORD, V8, P665, DOI 10.1111/j.1399-5618.2006.00355.x; National Institute of Mental Health, NAT I MENT HLTH STRA; Passarotti AM, 2009, SOC COGN AFFECT NEUR, V4, P387, DOI 10.1093/scan/nsp029; Pavuluri MN, 2005, J AM ACAD CHILD PSY, V44, P846, DOI 10.1097/01.chi.0000170554.23422.c1; Pereira F, 2011, NEUROIMAGE, V56, P476, DOI 10.1016/j.neuroimage.2010.05.026; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2007, AM J PSYCHIAT, V164, P697, DOI 10.1176/appi.ajp.164.5.697; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Thomas KM, 2001, ARCH GEN PSYCHIAT, V58, P1057, DOI 10.1001/archpsyc.58.11.1057	37	56	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e29482	10.1371/journal.pone.0029482	http://dx.doi.org/10.1371/journal.pone.0029482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355302	Green Published, gold, Green Accepted			2022-12-27	WOS:000302741300002
J	Schoolmeesters, A; Brown, DD; Fedorov, Y				Schoolmeesters, Angela; Brown, Daniel D.; Fedorov, Yuriy			Kinome-Wide Functional Genomics Screen Reveals a Novel Mechanism of TNF alpha-Induced Nuclear Accumulation of the HIF-1 alpha Transcription Factor in Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; KAPPA-B; REGULATOR; TRIB2	Hypoxia-inducible factor-1 (HIF-1) and its most important subunit, HIF-1 alpha, plays a central role in tumor progression by regulating genes involved in cancer cell survival, proliferation and metastasis. HIF-1 alpha activity is associated with nuclear accumulation of the transcription factor and regulated by several mechanisms including modulation of protein stability and degradation. Among recent advances are the discoveries that inflammation-induced cytokines and growth factors affect protein accumulation of HIF-1 alpha under normoxia conditions. TNF alpha, a major pro-inflammatory cytokine that promotes tumorigenesis is known as a stimulator of HIF-1 alpha activity. To improve our understanding of TNF alpha-mediated regulation of HIF-1 alpha nuclear accumulation we screened a kinase-specific siRNA library using a cell imaging-based HIF-1 alpha-eGFP chimera reporter assay. Interestingly, this systematic analysis determined that depletion of kinases involved in conventional TNF alpha signaling (IKK/NF kappa B and JNK pathways) has no detrimental effect on HIF-1 alpha accumulation. On the other hand, depletion of PRKAR2B, ADCK2, TRPM7, and TRIB2 significantly decreases the effect of TNF alpha on HIF-1 alpha stability in osteosarcoma and prostate cancer cell lines. These newly discovered regulators conveyed their activity through a non-conventional RELB-depended NF kappa B signaling pathway and regulation of superoxide activity. Taken together our data allow us to conclude that TNF alpha uses a distinct and complex signaling mechanism to induce accumulation of HIF-1 alpha in cancer cells. In summary, our results illuminate a novel mechanism through which cancer initiation and progression may be promoted by inflammatory cytokines, highlighting new potential avenues for fighting this disease.	[Schoolmeesters, Angela] Thermo Fisher Sci, Lafayette, CO USA; [Brown, Daniel D.; Fedorov, Yuriy] Thermo Fisher Sci, Pittsburgh, PA USA	Thermo Fisher Scientific; Thermo Fisher Scientific	Schoolmeesters, A (corresponding author), Thermo Fisher Sci, Lafayette, CO USA.	Yuriy.Fedorov@thermofisher.com			Thermo Fisher Scientific	Thermo Fisher Scientific	This work was funded by Thermo Fisher Scientific. There are no current external funding sources for this study.	Albina JE, 2001, AM J PHYSIOL-CELL PH, V281, pC1971, DOI 10.1152/ajpcell.2001.281.6.C1971; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chen RQ, 2009, J BIOL CHEM, V284, P16752, DOI 10.1074/jbc.M109.014316; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57; Guilbert A, 2009, AM J PHYSIOL-CELL PH, V297, pC493, DOI 10.1152/ajpcell.00624.2008; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Keeshan K, 2008, BLOOD CELL MOL DIS, V40, P119, DOI 10.1016/j.bcmd.2007.06.005; Kohl R, 2006, FREE RADICAL BIO MED, V40, P1430, DOI 10.1016/j.freeradbiomed.2005.12.012; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Tasken K, 1997, ADV SEC MESS PHOSPH, V31, P191; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Yee NS, 2011, DIS MODEL MECH, V4, P240, DOI 10.1242/dmm.004564	26	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31270	10.1371/journal.pone.0031270	http://dx.doi.org/10.1371/journal.pone.0031270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355351	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300051
J	Westgarth, C; Liu, JH; Heron, J; Ness, AR; Bundred, P; Gaskell, RM; German, AJ; McCune, S; Dawson, S				Westgarth, Carri; Liu, Jihong; Heron, Jon; Ness, Andrew R.; Bundred, Peter; Gaskell, Rosalind M.; German, Alexander J.; McCune, Sandra; Dawson, Susan			Dog Ownership during Pregnancy, Maternal Activity, and Obesity: A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; PET OWNERSHIP; HUMAN HEALTH; ACTIVITY PATTERNS; WEIGHT STATUS; RISK-FACTORS; WALKING; CHILDREN; EXERCISE	The Avon Longitudinal Study of Parents and Children (ALSPAC) is an observational study of 14273 UK pregnant singleton mothers in 1990/1991. We examined outcomes of self report of strenuous activity (hours per week) at 18 and 32 weeks of gestation, hours spent in leisure-time physical activities and types, and pre-pregnancy body mass index (BMI); overweight status was defined as pre-pregnancy BMI >= 25 and obesity BMI >= 30. Pet ownership and activity data were reported for 11,466 mothers. Twenty-five percent of mothers owned at least one dog. There was a positive relationship between participation in activity at least once a week and dog ownership (at 18 weeks, Odds ratio 1.27, 95% confidence interval 1.11-1.44, P<0.001). Dog owners were 50% more likely to achieve the recommended 3 hours activity per week, equivalent to 30 minutes per day, most days of the week (1.53, 1.35-1.72, P<0.001). Dog owners were also more likely to participate in brisk walking activity than those who did not have a dog (compared to no brisk walking 2-6 hrs per week 1.43, 1.23 to 1.67, P<0.001; 7+ hrs per week 1.80, 1.43 to 2.27, P<0.001). However, no association was found with any other types of activities and there was no association between dog ownership and weight status. During the time period studied, pregnant women who had dogs were more active, through walking, than those who did not own dogs. As walking is a low-risk exercise, participation of pregnant women in dog walking activities may be a useful context to investigate as part of a broader strategy to improve activity levels in pregnant women.	[Westgarth, Carri; Gaskell, Rosalind M.; Dawson, Susan] Univ Liverpool, Fac Hlth & Life Sci, Inst Infect & Global Hlth, Neston, Cheshire, England; [Liu, Jihong] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Heron, Jon] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Ness, Andrew R.] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [Bundred, Peter] Univ Liverpool, Fac Hlth & Life Sci, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [German, Alexander J.] Univ Liverpool, Fac Hlth & Life Sci, Inst Ageing & Chron Dis, Neston, Cheshire, England; [McCune, Sandra] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	University of Liverpool; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Bristol; University of Bristol; University of Liverpool; University of Liverpool; Mars; WALTHAM Petcare Science Institute	Westgarth, C (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Inst Infect & Global Hlth, Neston, Cheshire, England.	carri.westgarth@liverpool.ac.uk	Berryman, Katie/J-4236-2014; Liu, Jihong/Q-1364-2015; Heron, Jon/D-5884-2011; Ness, Andy R/M-7612-2013	Liu, Jihong/0000-0001-8685-3036; Heron, Jon/0000-0001-6199-5644; Ness, Andy R/0000-0003-3548-9523; German, Alexander/0000-0002-3017-7988	Medical Research Council; Wellcome Trust; UK Department of Health; Department of the Environment; Department of Education and the Environment; National Institutes of Health; WALTHAM Centre for Pet Nutrition (a subsidiary of Mars Petcare); Medical Research Council [G9815508] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UK Department of Health; Department of the Environment; Department of Education and the Environment; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WALTHAM Centre for Pet Nutrition (a subsidiary of Mars Petcare); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ALSPAC is supported by the Medical Research Council, Wellcome Trust, UK Department of Health, Department of the Environment, Department of Education and the Environment, National Institutes of Health, and a variety of medical research charities and commercial companies. This research was specifically funded by a grant from the WALTHAM Centre for Pet Nutrition (a subsidiary of Mars Petcare). The funding sources had no role in data collection and limited input to the analysis or interpretation of results from this study.	[Anonymous], 2010, DIET INT PHYS ACT IN; Bauman AE, 2001, MED J AUSTRALIA, V175, P632, DOI 10.5694/j.1326-5377.2001.tb143757.x; Brown SG, 2006, AM J PREV MED, V30, P131, DOI 10.1016/j.amepre.2005.10.007; Cedergren MI, 2007, OBSTET GYNECOL, V110, P759, DOI 10.1097/01.AOG.0000279450.85198.b2; Christian H, 2010, FAM COMMUNITY HEALTH, V33, P44, DOI 10.1097/FCH.0b013e3181c4e208; Clarke PE, 2005, ANN HUM BIOL, V32, P247, DOI 10.1080/03014460500049915; Coleman KJ, 2008, PREV MED, V47, P309, DOI 10.1016/j.ypmed.2008.05.007; Cutt H, 2008, AM J PUBLIC HEALTH, V98, P66, DOI 10.2105/AJPH.2006.103499; Cutt HE, 2008, J PHYS ACT HEALTH, V5, pS73, DOI 10.1123/jpah.5.s1.s73; Dempsey JC, 2004, DIABETES RES CLIN PR, V66, P203, DOI 10.1016/j.diabres.2004.03.010; Donahue SMA, 2010, MATERN CHILD HLTH J, V14, P235, DOI 10.1007/s10995-009-0441-x; Duncombe D, 2009, MIDWIFERY, V25, P430, DOI 10.1016/j.midw.2007.03.002; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Griffiths LJ, 2010, INT J OBESITY, V34, P624, DOI 10.1038/ijo.2010.10; Harris TJ, 2009, BRIT J SPORT MED, V43, P442, DOI 10.1136/bjsm.2008.048033; Headey B, 2003, MED J AUSTRALIA, V179, P460, DOI 10.5694/j.1326-5377.2003.tb05646.x; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P334, DOI 10.1111/j.1471-0528.2006.01230.x; Institute of Medicine (IOM), 2009, WEIGHT GAIN PREGN RE; Koivusilta LK, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000109; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Liu JH, 2010, J MATERN-FETAL NEO M, V23, P1249, DOI 10.3109/14767051003677970; Liu JH, 2011, EUR J EPIDEMIOL, V26, P237, DOI 10.1007/s10654-010-9538-1; Madsen M, 2007, BJOG-INT J OBSTET GY, V114, P1419, DOI 10.1111/j.1471-0528.2007.01496.x; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Mudd LM, 2009, PREV MED, V49, P194, DOI 10.1016/j.ypmed.2009.06.004; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; Olson D, 2009, CURR SPORT MED REP, V8, P147, DOI 10.1249/JSR.0b013e3181a61d51; PFMA, 2011, HIST DAT PP PET OWN; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Savitz DA, 2010, EPIDEMIOLOGY, V21, P291, DOI 10.1097/EDE.0b013e3181d3ca63; Sayburn A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4107; Schofield Grant, 2005, Health Promot J Austr, V16, P15; SERPELL J, 1991, J ROY SOC MED, V84, P717, DOI 10.1177/014107689108401208; Sternfeld B, 1999, PREV MED, V28, P313, DOI 10.1006/pmed.1998.0470; Thorpe RJ, 2006, J AGING PHYS ACTIV, V14, P154, DOI 10.1123/japa.14.2.154; Timperio A, 2008, HEALTH PROMOT J AUST, V19, P60, DOI 10.1071/HE08060; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Westgarth C, 2008, VET REC, V162, P436, DOI 10.1136/vr.162.14.436; Westgarth C, 2012, OBESITY FAC IN PRESS; Westgarth C, 2010, INT J ENV RES PUB HE, V7, P3704, DOI 10.3390/ijerph7103704; WHO, 2002, WORLD HLTH REP RED R	43	15	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31315	10.1371/journal.pone.0031315	http://dx.doi.org/10.1371/journal.pone.0031315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355356	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300056
J	Chen, X; Lepier, A; Berninger, B; Tolkovsky, AM; Herbert, J				Chen, Xia; Lepier, Alexandra; Berninger, Benedikt; Tolkovsky, Aviva M.; Herbert, Joe			Cultured Subventricular Zone Progenitor Cells Transduced with Neurogenin-2 Become Mature Glutamatergic Neurons and Integrate into the Dentate Gyrus	PLOS ONE			English	Article							PRONEURAL GENES; ADULT; DIFFERENTIATION; GENERATION; SURVIVAL; IDENTITY	We have previously shown that transplantation of immature DCX+/NeuN+/Prox1+ neurons (found in the neonatal DG), but not undifferentiated neuronal progenitor cells (NPCs) from ventral subventricular zone (SVZ), results in neuronal maturation in vivo within the dentate niche. Here we investigated whether we could enhance the integration of SVZ NPCs by forced expression of the proneural gene Neurogenin 2 (NEUROG2). NPCs cultured from neonatal GFP-transgenic rat SVZ for 7 days in a non-differentiating medium were transduced with a retrovirus encoding NEUROG2 and DsRed or the DsRed reporter gene alone (control). By 3 days post-transduction, the NEUROG2-transduced cells maintained in culture contained mostly immature neurons (91% DCX+; 76% NeuN+), whereas the control virus-transduced cells remained largely undifferentiated (30% DCX+; <1% NeuN+). At 6 weeks following transplantation into the DG of adult male rats, there were no neurons among the transplanted cells treated with the control virus but the majority of the NEUROG2-transduced DsRed+ SVZ cells became mature neurons (92% NeuN+; DCX-negative). Although the NEUROG2-transduced SVZ cells did not express the dentate granule neuron marker Prox1, most of the NEUROG2-transduced SVZ cells (78%) expressed the glutamatergic marker Tbr1, suggesting the acquisition of a glutamatergic phenotype. Moreover, some neurons extended dendrites into the molecular layer, grew axons containing Ankyrin G+ axonal initial segments, and projected into the CA3 region, thus resembling mature DG granule neurons. A proportion of NEUROG2 transduced cells also expressed c-Fos and P-CREB, two markers of neuronal activation. We conclude that NEUROG2-transduction is sufficient to promote neuronal maturation and integration of transplanted NPCs from SVZ into the DG.	[Chen, Xia; Tolkovsky, Aviva M.; Herbert, Joe] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Lepier, Alexandra; Berninger, Benedikt] Univ Munich, Inst Physiol, Dept Physiol Genom, D-8000 Munich, Germany; [Lepier, Alexandra; Berninger, Benedikt] Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Helmholtz Zentrum Munchen, Munich, Germany	University of Cambridge; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Chen, X (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.	amt@mole.bio.cam.ac.uk; jh24@cam.ac.uk	Herbert, Joe/K-5877-2013; Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782	John and Lucille van Geest Foundation; Wellcome Trust; Bundesministerium fur Bildung und Forschung	John and Lucille van Geest Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a studentship from the John and Lucille van Geest Foundation (XC) and a grant from the Wellcome Trust (JH). Work at LMU Munich was supported by a grant from the Bundesministerium fur Bildung und Forschung "Integration of stem cell derived neurons" (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Berninger B, 2007, EUR J NEUROSCI, V25, P2581, DOI 10.1111/j.1460-9568.2007.05509.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Chen X, 2011, PLOS ONE, P6; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017562; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Milosevic A, 2008, MOL CELL NEUROSCI, V39, P324, DOI 10.1016/j.mcn.2008.07.015; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ormerod BK, 2008, PHILOS T R SOC B, V363, P153, DOI 10.1098/rstb.2006.2018; Pinnock S., 2011, PLOS ONE, V5; Raedt R, 2009, EPILEPSY RES, V87, P148, DOI 10.1016/j.eplepsyres.2009.08.009; Sekiguchi M, 2009, NEUROSCI LETT, V452, P232, DOI 10.1016/j.neulet.2009.01.074; Shetty AK, 2008, J NEUROSCI RES, V86, P3062, DOI 10.1002/jnr.21764; Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Winpenny E, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-12; Winpenny E, 2010, CELL CYCLE, V9, P2259, DOI 10.4161/cc.9.12.12018; Yan RT, 2001, P NATL ACAD SCI USA, V98, P15014, DOI 10.1073/pnas.261455698; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189	36	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31547	10.1371/journal.pone.0031547	http://dx.doi.org/10.1371/journal.pone.0031547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348101	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400032
J	Cunningham, JA; Hodgins, DC; Toneatto, T; Murphy, M				Cunningham, John A.; Hodgins, David C.; Toneatto, Tony; Murphy, Michelle			A Randomized Controlled Trial of a Personalized Feedback Intervention for Problem Gamblers	PLOS ONE			English	Article							BRIEF MOTIVATIONAL INTERVENTION; DRINKING COLLEGE-STUDENTS; HAZARDOUS DRINKING; PROBLEM DRINKERS; FOLLOW-UP; RISK	Background: Personalized feedback is a promising self-help for problem gamblers. Such interventions have shown consistently positive results with other addictive behaviours, and our own pilot test of personalized normative feedback materials for gamblers yielded positive findings. The current randomized controlled trial evaluated the effectiveness, and the sustained efficacy, of the personalized feedback intervention materials for problem gamblers. Methodology/Principal Findings: Respondents recruited by a general population telephone screener of Ontario adults included gamblers with moderate and severe gambling problems. Those who agreed to participate were randomly assigned to receive: 1) the full personalized normative feedback intervention; 2) a partial feedback that contained all the feedback information provided to those in condition 1 but without the normative feedback content (i.e., no comparisons provided to general population gambling norms); or 3) a waiting list control condition. The primary hypothesis was that problem gamblers who received the personalized normative feedback intervention would reduce their gambling more than problem gamblers who did not receive any intervention (waiting list control condition) by the six-month follow-up. Conclusions/Significance: The study found no evidence for the impact of normative personalized feedback. However, participants who received, the partial feedback (without norms) reduced the number of days they gambled compared to participants who did not receive the intervention. We concluded that personalized feedback interventions were well received and the materials may be helpful at reducing gambling. Realistically, it can be expected that the personalized feedback intervention may have a limited, short term impact on the severity of participants' problem gambling because the intervention is just a brief screener. An Internet-based version of the personalized feedback intervention tool, however, may offer an easy to access and non-threatening portal that can be used to motivate participants to seek further help online or in person.	[Cunningham, John A.; Murphy, Michelle] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cunningham, John A.; Murphy, Michelle] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Cunningham, John A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Toneatto, Tony] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Hodgins, David C.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University of Calgary	Cunningham, JA (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.	John_Cunningham@camh.net		Cunningham, John/0000-0002-0668-5982; Hodgins, David/0000-0003-2737-5200	Ontario Problem Gambling Research Centre	Ontario Problem Gambling Research Centre	This study was supported by the Ontario Problem Gambling Research Centre. In addition, support to Centre for Addiction and Mental Health for salary of scientists and infrastructure has been provided by the Ontario Ministry of Health and Long Term Care. The views expressed here do not necessarily reflect those of the Ministry of Health and Long Term Care. JAC is also supported as the Canada Research Chair on Brief Interventions for Addictive Behaviours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTINELLI G, 1995, J DRUG EDUC, V25, P31, DOI 10.2190/XD56-D6WR-7195-EAL3; AGOSTINELLI G, 1994, J STUD ALCOHOL, V55, P327, DOI 10.15288/jsa.1994.55.327; [Anonymous], 1991, MOTIVATIONAL INTERVI; Baer JS, 2001, AM J PUBLIC HEALTH, V91, P1310, DOI 10.2105/AJPH.91.8.1310; Borsari B, 2000, J CONSULT CLIN PSYCH, V68, P728, DOI 10.1037//0022-006X.68.4.728; Cunningham JA, 2005, PSYCHIAT SERV, V56, P1024, DOI 10.1176/appi.ps.56.8.1024-a; Cunningham JA, 2002, J STUD ALCOHOL, V63, P649, DOI 10.15288/jsa.2002.63.649; Cunningham JA, 2006, ALCOHOL ALCOHOLISM, V41, P580, DOI 10.1093/alcalc/agl039; Cunningham JA, 2009, BEHAV THER, V40, P219, DOI 10.1016/j.beth.2008.06.005; CURRY SJ, 1991, J CONSULT CLIN PSYCH, V59, P318, DOI 10.1037/0022-006X.59.2.318; Curry SJ, 1992, PSYCHOL ADDICT BEHAV, V6, P175, DOI DOI 10.1037/H0080630; Ferris J., 2001, CANADIAN PROBLEM GAM, DOI DOI 10.1007/S10899-010-9224-Y; Hodgins DC, 2000, ADDICTION, V95, P777, DOI 10.1046/j.1360-0443.2000.95577713.x; Hodgins DC, 2004, PSYCHOL ADDICT BEHAV, V18, P293, DOI 10.1037/0893-164X.18.3.293; Hodgins DC, 2001, J CONSULT CLIN PSYCH, V69, P50, DOI 10.1037//0022-006X.69.1.50; HODGINS DC, 1997, BECOMING WINNER DEFE; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Larimer ME, 2003, PSYCHOL ADDICT BEHAV, V17, P235, DOI 10.1037/0893-164X.17.3.235; McCambridge J, 2008, ADDICTION, V103, P241, DOI 10.1111/j.1360-0443.2007.02080.x; MILLER WR, 1988, BEHAV PSYCHOTHER, V16, P251, DOI 10.1017/S0141347300014129; Murphy JG, 2001, PSYCHOL ADDICT BEHAV, V15, P373, DOI 10.1037/0893-164X.15.4.373; Rockloff MJ, 2004, J GAMBL STUD, V20, P121, DOI 10.1023/B:JOGS.0000022305.01606.da; SanchezCraig M, 1996, J CONSULT CLIN PSYCH, V64, P694; SPIVAK K, 1994, ADDICTION, V89, P1135, DOI 10.1111/j.1360-0443.1994.tb02790.x; Statistics Canada, 2003, CAN COMM HLTH SURV M; Takushi RY, 2004, J GAMBL STUD, V20, P83, DOI 10.1023/B:JOGS.0000016705.58903.8f; Toneatto T, 2003, QUIT REDUCE YOUR GAM; Toneatto T., 2007, HETEROGENEITY PROBLE	28	42	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31586	10.1371/journal.pone.0031586	http://dx.doi.org/10.1371/journal.pone.0031586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925CF	22348112	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400038
J	Lyke, KE; Dabo, A; Arama, C; Daou, M; Diarra, I; Wang, A; Plowe, CV; Doumbo, OK; Sztein, MB				Lyke, Kirsten E.; Dabo, Abdoulaye; Arama, Charles; Daou, Modibo; Diarra, Issa; Wang, Amy; Plowe, Christopher V.; Doumbo, Ogobara K.; Sztein, Marcelo B.			Reduced T Regulatory Cell Response during Acute Plasmodium falciparum Infection in Malian Children Co-Infected with Schistosoma haematobium	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; HUMAN PERIPHERAL-BLOOD; STAGE MALARIA VACCINE; GROWTH-FACTOR-BETA; IMMUNE-RESPONSES; INFLAMMATORY MARKERS; HELMINTH INFECTIONS; CYTOKINE PRODUCTION; MEDIATED-IMMUNITY; CEREBRAL MALARIA	Background: Regulatory T cells (Tregs) suppress host immune responses and participate in immune homeostasis. In co-infection, secondary parasite infections may disrupt the immunologic responses induced by a pre-existing parasitic infection. We previously demonstrated that schistosomiasis-positive (SP) Malian children, aged 4-8 years, are protected against the acquisition of malaria compared to matched schistosomiasis-negative (SN) children. Methods and Findings: To determine if Tregs contribute to this protection, we performed immunologic and Treg depletion in vitro studies using PBMC acquired from children with and without S. haematobium infection followed longitudinally for the acquisition of malaria. Levels of Tregs were lower in children with dual infections compared to children with malaria alone (0.49 versus 1.37%, respectively, P = 0.004) but were similar months later, during a period with negligible malaria transmission. The increased levels of Tregs in SN subjects were associated with suppressed serum Th1 cytokine levels, as well as elevated parasitemia compared to co-infected counterparts. Conclusions: These results suggest that lower levels of Tregs in helminth-infected children correlate with altered circulating cytokine and parasitologic results which may play a partial role in mediating protection against falciparum malaria.	[Lyke, Kirsten E.; Wang, Amy; Plowe, Christopher V.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Dabo, Abdoulaye; Daou, Modibo; Diarra, Issa; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Arama, Charles] Univ Stockholm, Dept Immunol, S-10691 Stockholm, Sweden; [Plowe, Christopher V.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University of Bamako; Stockholm University; Howard Hughes Medical Institute; Johns Hopkins University	Lyke, KE (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	KLyke@medicine.umaryland.edu			National Institute of Allergy and Infectious Diseases (NIAID/NIH) [AI49203, R-01 (AI067954)]; Doris Duke Clinical Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI049203, R01AI067954] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The clinical portion of the study was funded by a K23 award from the National Institute of Allergy and Infectious Diseases (NIAID/NIH) (AI49203). Immunologic assays were funded in part by a Doris Duke Clinical Development Award as well as an R-01 (AI067954) from NIAID/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Araujo MI, 2006, CHEM IMMUNOL ALLERGY, V90, P29, DOI 10.1159/000088879; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; CORACHAN M, 1992, AM J TROP MED HYG, V47, P6, DOI 10.4269/ajtmh.1992.47.6; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; DECLERCQ D, 1994, T ROY SOC TROP MED H, V88, P653, DOI 10.1016/0035-9203(94)90212-7; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Diallo TO, 2004, PARASITE IMMUNOL, V26, P365, DOI 10.1111/j.0141-9838.2004.00719.x; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Finney OC, 2010, EUR J IMMUNOL, V40, P47, DOI 10.1002/eji.200939708; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gillan V, 2005, INFECT IMMUN, V73, P4034, DOI 10.1128/IAI.73.7.4034-4042.2005; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ji JX, 2005, J IMMUNOL, V174, P7147, DOI 10.4049/jimmunol.174.11.7147; Long TTA, 2003, INT J PARASITOL, V33, P175, DOI 10.1016/S0020-7519(02)00261-8; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Lyke KE, 2005, INFECT IMMUN, V73, P5799, DOI 10.1128/IAI.73.9.5799-5808.2005; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Lyke KE, 2006, INFECT IMMUN, V74, P5718, DOI 10.1128/IAI.01822-05; Lyke KE, 2009, VACCINE, V27, P2171, DOI 10.1016/j.vaccine.2009.01.097; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mouk EMO, 2009, AM J TROP MED HYG, V80, P475, DOI 10.4269/ajtmh.2009.80.475; Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Nausch N, 2011, PLOS ONE, V6; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Remoue F, 2003, T ROY SOC TROP MED H, V97, P361, DOI 10.1016/S0035-9203(03)90170-2; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10; Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Tacket CO, 2000, INFECT IMMUN, V68, P1196, DOI 10.1128/IAI.68.3.1196-1201.2000; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Watanabe K, 2007, AM J TROP MED HYG, V77, P676, DOI 10.4269/ajtmh.2007.77.676	59	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31647	10.1371/journal.pone.0031647	http://dx.doi.org/10.1371/journal.pone.0031647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348117	gold, Green Published, Green Submitted			2022-12-27	WOS:000302737400039
J	Abush, H; Akirav, I				Abush, Hila; Akirav, Irit			Short- and Long-Term Cognitive Effects of Chronic Cannabinoids Administration in Late-Adolescence Rats	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; MEDIAL PREFRONTAL CORTEX; SPATIAL WORKING-MEMORY; RECEPTOR KNOCKOUT MICE; PITUITARY-ADRENAL AXIS; PATHWAY IN-VIVO; ADULT RATS; NUCLEUS-ACCUMBENS; CB1 RECEPTOR; PARIETAL CORTEX	The use of cannabis can impair cognitive function, especially short-term memory. A controversial question is whether long-term cannabis use during the late-adolescence period can cause irreversible deficits in higher brain function that persist after drug use stops. In order to examine the short-and long-term effects of chronic exposure to cannabinoids, rats were administered chronic i.p. treatment with the CB1/CB2 receptor agonist WIN55,212-2 (WIN; 1.2 mg/kg) for two weeks during the late adolescence period (post-natal days 45-60) and tested for behavioral and electrophysiological measures of cognitive performance 24 hrs, 10 and 30 days after the last drug injection. The impairing effects of chronic WIN on short-term memory in the water maze and the object recognition tasks as well as long-term potentiation (LTP) in the ventral subiculum (vSub)-nucleus accumbens (NAc) pathway were temporary as they lasted only 24 h or 10 d after withdrawal. However, chronic WIN significantly impaired hippocampal dependent short-term memory measured in the object location task 24 hrs, 10, 30, and 75 days after the last drug injection. Our findings suggest that some forms of hippocampal-dependent short-term memory are sensitive to chronic cannabinoid administration but other cognitive impairments are temporary and probably result from a residue of cannabinoids in the brain or acute withdrawal effects from cannabinoids. Understanding the effects of cannabinoids on cognitive function may provide us with tools to overcome these impairments and for cannabinoids to be more favorably considered for clinical use.	[Abush, Hila; Akirav, Irit] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel	University of Haifa	Abush, H (corresponding author), Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel.	irit.akirav@gmail.com						Abush H, 2010, HIPPOCAMPUS, V20, P1126, DOI 10.1002/hipo.20711; Aggleton JP, 2004, NEUROSCI BIOBEHAV R, V28, P611, DOI 10.1016/j.neubiorev.2004.08.007; Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Barna I, 2004, LIFE SCI, V75, P2959, DOI 10.1016/j.lfs.2004.06.006; BELUE RC, 1995, NEUROTOXICOL TERATOL, V17, P25, DOI 10.1016/0892-0362(94)00053-G; Brusberg M, 2009, J NEUROSCI, V29, P1554, DOI 10.1523/JNEUROSCI.5166-08.2009; Castellano C, 2003, CNS NEUROL DISORD-DR, V2, P389, DOI 10.2174/1568007033482670; COLLINS DR, 1994, EUR J PHARMACOL, V259, pR7, DOI 10.1016/0014-2999(94)90666-1; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Da Silva GE, 2002, PROG NEURO-PSYCHOPH, V26, P321, DOI 10.1016/S0278-5846(01)00275-5; DeCoteau WE, 1998, BEHAV NEUROSCI, V112, P68, DOI 10.1037/0735-7044.112.1.68; DEFONSECA FR, 1993, NEUROREPORT, V4, P135, DOI 10.1097/00001756-199302000-00005; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Dong Z, 2007, NEUROSCIENCE, V144, P845, DOI 10.1016/j.neuroscience.2006.10.018; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Ehrenreich H, 1999, PSYCHOPHARMACOLOGY, V142, P295, DOI 10.1007/s002130050892; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Ferrari F, 1999, PHARMACOL BIOCHEM BE, V64, P555, DOI 10.1016/S0091-3057(99)00106-9; Floresco SB, 1997, J NEUROSCI, V17, P1880; FRIDE E, 1995, BRAIN RES, V697, P83, DOI 10.1016/0006-8993(95)00790-W; Fride E, 1996, DEV BRAIN RES, V95, P131, DOI 10.1016/0165-3806(96)00087-9; Fride E, 1996, PSYCHONEUROENDOCRINO, V21, P157, DOI 10.1016/0306-4530(95)00039-9; Ganon-Elazar E, 2009, J NEUROSCI, V29, P11078, DOI 10.1523/JNEUROSCI.1223-09.2009; Garcia R, 1997, NEUROSCI LETT, V233, P41, DOI 10.1016/S0304-3940(97)00621-6; Gardner EL, 1998, NEUROBIOL DIS, V5, P502, DOI 10.1006/nbdi.1998.0219; Goldbart A, 2003, NEUROSCIENCE, V122, P585, DOI 10.1016/j.neuroscience.2003.08.054; Gonzalez S, 2005, PHARMACOL BIOCHEM BE, V81, P300, DOI 10.1016/j.pbb.2005.01.028; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Goodrich-Hunsaker NJ, 2008, NEUROBIOL LEARN MEM, V90, P389, DOI 10.1016/j.nlm.2008.05.002; Gorzalka BB, 2008, NEUROSCI BIOBEHAV R, V32, P1152, DOI 10.1016/j.neubiorev.2008.03.004; Hampson RE, 2003, HIPPOCAMPUS, V13, P543, DOI 10.1002/hipo.10081; Hanlon EC, 2004, PSYCHOPHARMACOLOGY, V172, P241, DOI 10.1007/s00213-003-1654-0; Harloe JP, 2008, LEARN MEMORY, V15, P806, DOI 10.1101/lm.1113008; Harvey MA, 2007, DRUG ALCOHOL REV, V26, P309, DOI 10.1080/09595230701247772; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hill MN, 2010, PROG NEURO-PSYCHOPH, V34, P791, DOI 10.1016/j.pnpbp.2009.11.001; Hill MN, 2010, P NATL ACAD SCI USA, V107, P9406, DOI 10.1073/pnas.0914661107; Hill MN, 2004, EUR J NEUROSCI, V20, P859, DOI 10.1111/j.1460-9568.2004.03522.x; Hofmann ME, 2011, J PHYSIOL-LONDON, V589, P3801, DOI 10.1113/jphysiol.2011.211482; Holter SM, 2005, EUR J PHARMACOL, V510, P69, DOI 10.1016/j.ejphar.2005.01.008; Iversen L, 2005, CURR OPIN PHARMACOL, V5, P69, DOI 10.1016/j.coph.2004.08.010; Jacobsen LK, 2004, ANN NY ACAD SCI, V1021, P384, DOI 10.1196/annals.1308.053; Jager G, 2006, PSYCHOPHARMACOLOGY, V185, P358, DOI 10.1007/s00213-005-0298-7; Jager Gerry, 2008, Curr Drug Abuse Rev, V1, P114; JOHANSSON E, 1989, EUR J CLIN PHARMACOL, V37, P273, DOI 10.1007/BF00679783; Kanayama G, 2004, PSYCHOPHARMACOLOGY, V176, P239, DOI 10.1007/s00213-004-1885-8; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Maroun M, 2003, J NEUROSCI, V23, P4406; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Moore NLT, 2010, J PHARMACOL EXP THER, V335, P294, DOI 10.1124/jpet.110.169359; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Niyuhire F, 2007, PSYCHOPHARMACOLOGY, V191, P223, DOI 10.1007/s00213-006-0650-6; NOWICKY AV, 1987, BRAIN RES BULL, V19, P663, DOI 10.1016/0361-9230(87)90052-9; O'Shea M, 2004, J PSYCHOPHARMACOL, V18, P502, DOI 10.1177/0269881104047277; O'Shea M, 2006, J PSYCHOPHARMACOL, V20, P611, DOI 10.1177/0269881106065188; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Pistis M, 2002, EUR J NEUROSCI, V15, P1795, DOI 10.1046/j.1460-9568.2002.02019.x; Pope HG, 1996, JAMA-J AM MED ASSOC, V275, P521, DOI 10.1001/jama.275.7.521; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Quinn HR, 2008, NEUROPSYCHOPHARMACOL, V33, P1113, DOI 10.1038/sj.npp.1301475; Ranganathan M, 2006, PSYCHOPHARMACOLOGY, V188, P425, DOI 10.1007/s00213-006-0508-y; Riedel G, 2005, HANDB EXP PHARMACOL, V168, P445; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Schneider M, 2005, BEHAV PHARMACOL, V16, P447, DOI 10.1097/00008877-200509000-00018; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; Schneider M, 2008, ADDICT BIOL, V13, P345, DOI 10.1111/j.1369-1600.2008.00117.x; Schneider M, 2007, EUR NEUROPSYCHOPHARM, V17, P180, DOI 10.1016/j.euroneuro.2006.03.009; Schotanus SM, 2008, J NEUROCHEM, V106, P1758, DOI 10.1111/j.1471-4159.2008.05512.x; SEAMANS JK, 1994, BEHAV NEUROSCI, V108, P456, DOI 10.1037/0735-7044.108.3.456; Segev A, 2011, PLOS ONE IN PRESS; Segev A, 2011, LEARN MEMORY, V18, P254, DOI 10.1101/lm.2110511; Sim-Selley LJ, 2006, MOL PHARMACOL, V70, P986, DOI 10.1124/mol.105.019612; Sim-Selley LJ, 2002, J PHARMACOL EXP THER, V303, P36, DOI 10.1124/jpet.102.035618; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STIGLICK A, 1985, PSYCHOPHARMACOLOGY, V85, P436, DOI 10.1007/BF00429660; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; Valverde O, 2005, HANDB EXP PHARMACOL, V168, P117; VANEDEN CG, 1990, PROG BRAIN RES, V85, P169; Warburton EC, 2010, NEUROPSYCHOLOGIA, V48, P2262, DOI 10.1016/j.neuropsychologia.2009.12.022; Wise LE, 2011, PSYCHOPHARMACOL 0511; Wise R, 2002, BIOL PSYCHIAT, P509; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; WOLFER DP, 1995, HIPPOCAMPUS, V5, P329, DOI 10.1002/hipo.450050406; Zhang Q, 2002, DRUG METAB DISPOS, V30, P1077, DOI 10.1124/dmd.30.10.1077	98	63	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31731	10.1371/journal.pone.0031731	http://dx.doi.org/10.1371/journal.pone.0031731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348124	Green Published, gold, Green Submitted			2022-12-27	WOS:000302733900061
J	Jeuland, MA; Pattanayak, SK				Jeuland, Marc A.; Pattanayak, Subhrendu K.			Benefits and Costs of Improved Cookstoves: Assessing the Implications of Variability in Health, Forest and Climate Impacts	PLOS ONE			English	Article							ACUTE RESPIRATORY-INFECTIONS; INDOOR AIR-POLLUTION; ENERGY; FUEL; COOKING; EMISSIONS; CHILDREN; BIOMASS; EFFICIENCY; DIFFUSION	Current attention to improved cook stoves (ICS) focuses on the "triple benefits'' they provide, in improved health and time savings for households, in preservation of forests and associated ecosystem services, and in reducing emissions that contribute to global climate change. Despite the purported economic benefits of such technologies, however, progress in achieving large-scale adoption and use has been remarkably slow. This paper uses Monte Carlo simulation analysis to evaluate the claim that households will always reap positive and large benefits from the use of such technologies. Our analysis allows for better understanding of the variability in economic costs and benefits of ICS use in developing countries, which depend on unknown combinations of numerous uncertain parameters. The model results suggest that the private net benefits of ICS will sometimes be negative, and in many instances highly so. Moreover, carbon financing and social subsidies may help enhance incentives to adopt, but will not always be appropriate. The costs and benefits of these technologies are most affected by their relative fuel costs, time and fuel use efficiencies, the incidence and cost-of-illness of acute respiratory illness, and the cost of household cooking time. Combining these results with the fact that households often find these technologies to be inconvenient or culturally inappropriate leads us to understand why uptake has been disappointing. Given the current attention to the scale up of ICS, this analysis is timely and important for highlighting some of the challenges for global efforts to promote ICS.	[Jeuland, Marc A.; Pattanayak, Subhrendu K.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27706 USA; [Jeuland, Marc A.; Pattanayak, Subhrendu K.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Pattanayak, Subhrendu K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Jeuland, MA (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27706 USA.	marc.jeuland@duke.edu	Pattanayak, Shakti Prasad/D-2190-2013	Pattanayak, Shakti Prasad/0000-0002-1629-2648				Adler T, 2010, ENVIRON HEALTH PERSP, V118, pA124, DOI 10.1289/ehp.118-a124; Adrianzen Marcos Agurto., 2010, ROLE SOCIAL CAPITAL; [Anonymous], 2007, ENERGY SUSTAIN DEV; Anozie AN, 2007, ENERGY, V32, P1283, DOI 10.1016/j.energy.2006.07.004; Bailis R, 2005, SCIENCE, V308, P98, DOI 10.1126/science.1106881; Bailis R, 2009, WORLD DEV, V37, P1694, DOI 10.1016/j.worlddev.2009.03.004; BARNES DF, 1993, WORLD BANK RES OBSER, V8, P119, DOI 10.1093/wbro/8.2.119; Beltramo T, 2010, PEER EFFECTS U UNPUB; Bhattacharya SC, 2002, BIOMASS BIOENERG, V22, P305, DOI 10.1016/S0961-9534(02)00008-9; Boardman A., 2005, COST BENEFIT ANAL CO; Bond T. C., 2004, ENERGY SUSTAIN DEV, V3, P20, DOI DOI 10.1016/S0973-0826(08)60464-0; Chen L, 2006, ECOL ECON, V58, P407, DOI 10.1016/j.ecolecon.2005.07.018; Desai M, 2003, INDOOR SMOKE SOLID F; Ezzati M, 2002, ENERG POLICY, V30, P815, DOI 10.1016/S0301-4215(01)00125-2; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Farsi M, 2007, ENVIRON DEV ECON, V12, P757, DOI 10.1017/S1355770X07003932; Ferraro PJ, 2012, REV ENV EC IN PRESS; Garcia-Frapolli E, 2010, ECOL ECON, V69, P2598, DOI 10.1016/j.ecolecon.2010.08.004; Gebreegziabher Z, 2011, ENERGY EC IN PRESS; Gundimeda H, 2008, ENERG ECON, V30, P517, DOI 10.1016/j.eneco.2006.10.014; Guptaa G, 2006, ECOL ECON, V57, P107, DOI 10.1016/j.ecolecon.2005.03.010; Hall RE, 2007, Q J ECON, V122, P39, DOI 10.1162/qjec.122.1.39; Heltberg R, 2005, ENVIRON DEV ECON, V10, P337, DOI 10.1017/S1355770X04001858; IPCC, 1997, GUID NAT GREENH GAS; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jetter JJ, 2009, BIOMASS BIOENERG, V33, P294, DOI 10.1016/j.biombioe.2008.05.014; Jeuland M, 2010, J DEV ECON, V91, P310, DOI 10.1016/j.jdeveco.2009.06.007; Jeuland M, 2009, WORLD BANK ECON REV, V23, P235, DOI 10.1093/wber/lhp006; Khaltaev N, 2007, GLOBAL SURVEILLANCE; Larson BA, 2002, SOC SCI MED, V55, P571, DOI 10.1016/S0277-9536(01)00188-5; Lewis JJ, 2011, DETERMINANTS STOVE A; Masera OR, 2000, WORLD DEV, V28, P2083, DOI 10.1016/S0305-750X(00)00076-0; McCracken JP, 1998, ENVIRON INT, V24, P739, DOI 10.1016/S0160-4120(98)00062-2; Mehta S., 2004, ENERGY SUSTAIN DEV, V8, P53, DOI DOI 10.1016/S0973-0826(08)60466-4; Mitchell A, 2010, INDOOR AIR POLLUTION; Monto AS, 1998, VACCINE, V16, P1582, DOI 10.1016/S0264-410X(98)00049-8; Mugo F, 1999, CHARCOAL TRADE KENYA; MUMFORD JL, 1992, J TOXICOL ENV HEALTH, V36, P151, DOI 10.1080/15287399209531629; PANDEY S, 1992, SOC SERV REV, V66, P582, DOI 10.1086/603949; Pant KP, 2008, ESTIMATING HLTH BENE; Pant KP, 2010, STOCKH ANN BANK C DE; Pattanayak SK, 2009, ANNU REV RESOUR ECON, V1, P183, DOI 10.1146/annurev.resource.050708.144053; Pokharel S, 2004, ENERGY, V29, P547, DOI 10.1016/j.energy.2003.10.015; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Saha S, 2008, AM PUBL HLTH ASS M A; Shastri C.M., 2002, ENERGY SUSTAIN DEV, V6, P63, DOI [10.1016/S0973-0826(08)60316-6, DOI 10.1016/S0973-0826(08)60316-6]; Smith K, 2004, INDOOR AIR POLLUTION, P1436; Smith K.R., 1994, ENERGY SUSTAIN DEV, V1, P23, DOI [10.1016/50973-0826(08)60067-8, DOI 10.1016/50973-0826(08)60067-8]; Smith KR, 2000, P NATL ACAD SCI USA, V97, P13286, DOI 10.1073/pnas.97.24.13286; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; Tan WC, 2003, RESPIROLOGY, V8, P192; Thakuri M., 2009, REVISITING NEED IMPR; TUPASI TE, 1988, J INFECT DIS, V157, P615, DOI 10.1093/infdis/157.4.615; UNFCC, 2010, CLEAN DEV MECH METH; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Von Schirnding Y, ADDRESSING IMPACT HO; Vose D., 1996, RISK ANAL QUANTITATI; Whittington Dale, 2008, Foundations and Trends in Microeconomics, V4, P469, DOI 10.1561/0700000030; Whittington D, 2011, SETTING PRI IN PRESS; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zaman K, 1997, J TROP PEDIATRICS, V43, P133, DOI 10.1093/tropej/43.3.133; Zhang JF, 1999, ENVIRON SCI TECHNOL, V33, P2311, DOI 10.1021/es9812406	63	130	132	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30338	10.1371/journal.pone.0030338	http://dx.doi.org/10.1371/journal.pone.0030338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925BB	22348005	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900006
J	Kuo, TC; Wang, CH; Lin, HC; Lin, YH; Lin, M; Lin, CM; Kuo, HS				Kuo, Tai-Chih; Wang, Chung-Ho; Lin, Hsiu-Chen; Lin, Yuan-Hau; Lin, Matthew; Lin, Chun-Mao; Kuo, Hsien-Shou			Assessment of Renal Function by the Stable Oxygen and Hydrogen Isotopes in Human Blood Plasma	PLOS ONE			English	Article							SERUM CREATININE; DEUTERIUM-OXIDE; WATER CHANNELS; NATURAL-WATERS; RATIOS; HAIR; AQUAPORIN-1; VASOPRESSIN; KIDNEY; RATS	Water (H2O) is the most abundant and important molecule of life. Natural water contains small amount of heavy isotopes. Previously, few animal model studies have shown that the isotopic composition of body water could play important roles in physiology and pathophysiology. Here we study the stable isotopic ratios of hydrogen (delta H-2) and oxygen (delta O-18) in human blood plasma. The stable isotopic ratio is defined and determined by delta(sample) = [(R-sample/R-STD)-1] * 1000, where R is the molar ratio of rare to abundant, for example, O-18/O-16. We observe that the delta H-2 and the delta O-18 in human blood plasma are associated with the human renal functions. The water isotope ratios of the delta H-2 and delta O-18 in human blood plasma of the control subjects are comparable to those of the diabetes subjects (with healthy kidney), but are statistically higher than those of the end stage renal disease subjects (p<0.001 for both ANOVA and Student's t-test). In addition, our data indicate the existence of the biological homeostasis of water isotopes in all subjects, except the end stage renal disease subjects under the haemodialysis treatment. Furthermore, the unexpected water contents (delta H-2 and delta O-18) in blood plasma of body water may shed light on a novel assessment of renal functions.	[Kuo, Tai-Chih; Lin, Hsiu-Chen; Lin, Chun-Mao; Kuo, Hsien-Shou] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Wang, Chung-Ho] Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan; [Lin, Hsiu-Chen] Taipei Med Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lin, Yuan-Hau] FU CHEN Hosp, Taipei, Taiwan; [Lin, Matthew] Garfield Med Ctr, Monterey Pk, CA USA	Taipei Medical University; Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University Hospital	Kuo, TC (corresponding author), Taipei Med Univ, Coll Med, Taipei, Taiwan.	hsiensaw@tmu.edu.tw		Wang, Chung-Ho/0000-0003-2014-6747; Lin, Hsiu-Chen/0000-0003-1076-1121; Lin, Chun-Mao/0000-0002-8366-4026				ARGENT NB, 1990, CLIN CHIM ACTA, V190, P185, DOI 10.1016/0009-8981(90)90172-O; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Bowen G. J., 2008, ONLINE ISOTOPES PREC; Bowen GJ, 2009, AM J PHYS ANTHROPOL, V139, P494, DOI 10.1002/ajpa.21008; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Branten AJW, 2005, NEPHROL DIAL TRANSPL, V20, P707, DOI 10.1093/ndt/gfh719; BRENNINKMEIJER CAM, 1987, CHEM GEOL, V66, P21, DOI 10.1016/0168-9622(87)90024-8; Cazacu M, 2001, DEUTERIUM VARIATION; Chakrabarti G, 1999, BIOCHEMISTRY-US, V38, P3067, DOI 10.1021/bi982461r; Chaplin M, 2011, WATER MOL LIQUID WAT; Chesson LA, 2010, FOOD CHEM, V119, P1250, DOI 10.1016/j.foodchem.2009.07.046; COLEMAN ML, 1982, ANAL CHEM, V54, P993, DOI 10.1021/ac00243a035; Combet S, 2008, AM J PHYSIOL-RENAL, V294, pF1408, DOI 10.1152/ajprenal.00437.2007; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; De Wit JC., 1980, GEOSTANDARD NEWSLETT, V4, P33, DOI [DOI 10.1111/J.1751-908X.1980.TB00270.X, 10.1111/j.1751-908X.1980.tb00270.x]; Dufner D, 2003, CURR OPIN CLIN NUTR, V6, P511, DOI 10.1097/00075197-200309000-00004; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; GONFIANTINI R, 1978, NATURE, V271, P534, DOI 10.1038/271534a0; HAGEMANN R, 1970, TELLUS, V22, P712, DOI 10.1111/j.2153-3490.1970.tb00540.x; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; KATZ JJ, 1957, JNCI-J NATL CANCER I, V18, P641; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P683; Kushner DJ, 1999, CAN J PHYSIOL PHARM, V77, P79, DOI 10.1139/cjpp-77-2-79; Lambert CP, 1999, EXP PHYSIOL, V84, P391, DOI 10.1017/S0958067099018266; Lloyd S., 2003, IEEE T INFORM THEORY, V28, P129; Mamonov AB, 2007, J GEN PHYSIOL, V130, P111, DOI 10.1085/jgp.200709810; NIELSEN S, 1993, AM J PHYSIOL, V265, pF204, DOI 10.1152/ajprenal.1993.265.2.F204; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; Peng TR, 2010, EARTH PLANET SC LETT, V289, P357, DOI 10.1016/j.epsl.2009.11.024; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Shankar A, 2010, VASC HEALTH RISK MAN, V6, P619; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; SOMLYAI G, 1993, FEBS LETT, V317, P1, DOI 10.1016/0014-5793(93)81479-J; STANSELL MJ, 1968, CLIN CHEM, V14, P1112; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; THOMSON JF, 1958, P SOC EXP BIOL MED, V97, P758, DOI 10.3181/00379727-97-23871; TSE RS, 1980, ANAL CHEM, V52, P2445, DOI 10.1021/ac50064a053; VASDEV S, 1991, HYPERTENSION, V18, P550, DOI 10.1161/01.HYP.18.4.550; Wang C.H., 2001, W PACIFIC EARTH SCI, V1, P429	49	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32137	10.1371/journal.pone.0032137	http://dx.doi.org/10.1371/journal.pone.0032137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348150	Green Published, Green Submitted, gold			2022-12-27	WOS:000302733900067
J	Mi, QS; Weiland, M; Qi, RQ; Gao, XH; Poisson, LM; Zhou, L				Mi, Qing-Sheng; Weiland, Matthew; Qi, Rui-Qun; Gao, Xing-Hua; Poisson, Laila M.; Zhou, Li			Identification of Mouse Serum miRNA Endogenous References by Global Gene Expression Profiles	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PLASMA MICRORNAS; BIOMARKERS; CANCER; NORMALIZATION; MIRBASE; TARGETS; DICER; DNA	MicroRNAs (miRNAs) are recently discovered small non-coding RNAs and can serve as serum biomarkers for disease diagnosis and prognoses. Lack of reliable serum miRNA endogenous references for normalization in miRNA gene expression makes single miRNA assays inaccurate. Using TaqMan (R) real-time PCR miRNA arrays with a global gene expression normalization strategy, we have analyzed serum miRNA expression profiles of 20 female mice of NOD/ShiLtJ (n = 8), NOR/LtJ (n = 6), and C57BL/6J (n = 6) at different ages and disease conditions. We identified five miRNAs, miR-146a, miR-16, miR-195, miR-30e and miR-744, to be stably expressed in all strains, which could serve as mouse serum miRNA endogenous references for single assay experiments.	[Mi, Qing-Sheng; Weiland, Matthew; Qi, Rui-Qun; Zhou, Li] Henry Ford Hlth Syst, Henry Ford Immunol Program, Detroit, MI 48202 USA; [Mi, Qing-Sheng; Weiland, Matthew; Qi, Rui-Qun; Zhou, Li] Henry Ford Hlth Syst, Dept Dermatol, Detroit, MI USA; [Mi, Qing-Sheng; Zhou, Li] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Qi, Rui-Qun; Gao, Xing-Hua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang, Peoples R China; [Poisson, Laila M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; China Medical University; Henry Ford Health System; Henry Ford Hospital	Mi, QS (corresponding author), Henry Ford Hlth Syst, Henry Ford Immunol Program, Detroit, MI 48202 USA.	qmi1@hfhs.org; lzhou1@hfhs.org			Henry Ford Health System [T71016, T71017]; Henry Ford Stubnitz [J80005]; Melanoma Research Alliance; Changjiang Scholars; Innovative Research Teams in Universities; Ministry of Education, China [IRT0760]; Shahani Foundation	Henry Ford Health System; Henry Ford Stubnitz; Melanoma Research Alliance; Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovative Research Teams in Universities; Ministry of Education, China(Ministry of Education, China); Shahani Foundation	This work was supported in part by a grant from Henry Ford Health System Start-up Grant for the Immunology Program (T71016 and T71017), Henry Ford Stubnitz Grant (J80005), Melanoma Research Alliance, and Changjiang Scholars and Innovative Research Teams in Universities, Ministry of Education, China (IRT0760), and the Shahani Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; LEON SA, 1977, CANCER RES, V37, P646; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; STROUN M, 1989, ONCOLOGY, V46, P318; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106; Zhou L, 2009, INT IMMUNOPHARMACOL, V9, P524, DOI 10.1016/j.intimp.2009.01.017	36	33	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31278	10.1371/journal.pone.0031278	http://dx.doi.org/10.1371/journal.pone.0031278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348064	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730900024
J	Rai, AK; Thakur, CP; Singh, A; Seth, T; Srivastava, SK; Singh, P; Mitra, DK				Rai, Ambak K.; Thakur, Chandreshwar P.; Singh, Amar; Seth, Tulika; Srivastava, Sandeep K.; Singh, Pushpendra; Mitra, Dipendra K.			Regulatory T Cells Suppress T Cell Activation at the Pathologic Site of Human Visceral Leishmaniasis	PLOS ONE			English	Article							IL-10; INFECTION; ANTIMONY; IMMUNOSUPPRESSION; ACCUMULATION; RESISTANCE; IMMUNITY; DONOVANI; INDIA	Suppression of T cell response is thought to be involved in the pathogenesis of visceral leishmaniasis (VL). Regulatory T cell (Treg) mediated immune-suppression is reported in animal models of Leishmania infection. However, their precise role among human patients still requires pathologic validation. The present study is aimed at understanding the frequency dynamics and function of Treg cells in the blood and bone marrow (BM) of VL patients. The study included 42 parasitologically confirmed patients, 17 healthy contact and 9 normal bone marrow specimens (NBM). We show i) the selective accumulation of Treg cells at one of the disease inflicted site(s), the BM, ii) their in vitro expansion in response to LD antigen and iii) persistence after successful chemotherapy. Results indicate that the Treg cells isolated from BM produces IL-10 and may inhibit T cell activation in IL-10 dependent manner. Moreover, we observed significantly higher levels of IL-10 among drug unresponsive patients, suggesting their critical role in suppression of immunity among VL patients. Our results suggest that IL-10 plays an important role in suppression of host immunity in human VL and possibly determines the efficacy of chemotherapy.	[Rai, Ambak K.; Singh, Amar; Srivastava, Sandeep K.; Singh, Pushpendra; Mitra, Dipendra K.] All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India; [Thakur, Chandreshwar P.] Balaji Utthan Sansthan, Patna, Bihar, India; [Seth, Tulika] All India Inst Med Sci, Dept Hematol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Rai, AK (corresponding author), All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India.	salilmitra1@yahoo.com	Rai, Ambak/ABI-3831-2020; Singh, Pushpendra/T-4248-2018; srivastava, sandeep/ABH-3565-2022	Singh, Pushpendra/0000-0002-7277-115X; srivastava, sandeep/0000-0002-9965-2257; SRIVASTAVA, SANDEEP/0000-0003-4484-0223; Rai, Ambak/0000-0002-6564-6342	Department of Biotechnology (Government of India) [BT/PR6737/Med/14/871/2005]; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the Department of Biotechnology (Government of India) for funding the work (Grant No.: BT/PR6737/Med/14/871/2005). The authors also thank Council of Scientific and Industrial Research (CSIR), Government of India for providing fellowships to Dr. Ambak K. Rai. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2003, IMMUNOLOGY, V109, P319, DOI 10.1046/j.1365-2567.2003.01678.x; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Goto H, 2004, BRAZ J MED BIOL RES, V37, P615, DOI 10.1590/S0100-879X2004000400020; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Joshi B, 2006, MOL CELL BIOCHEM, V287, P157, DOI 10.1007/s11010-006-9132-8; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Maurya R, 2010, PARASITE IMMUNOL, V32, P479, DOI 10.1111/j.1365-3024.2010.01219.x; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Saha S, 2007, J IMMUNOL, V179, P5592, DOI 10.4049/jimmunol.179.8.5592; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sundar S, 1997, J INFECT DIS, V176, P1117, DOI 10.1086/516526; Sundar S, 2006, INDIAN J MED RES, V123, P345; Thakur CP, 2004, INDIAN J MED RES, V120, P166; Thakur CP, 2003, T ROY SOC TROP MED H, V97, P409, DOI 10.1016/S0035-9203(03)90071-X; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	26	57	58	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31551	10.1371/journal.pone.0031551	http://dx.doi.org/10.1371/journal.pone.0031551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347492	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100079
J	Stark, FC; Gurnani, K; Sad, S; Krishnan, L				Stark, Felicity C.; Gurnani, Komal; Sad, Subash; Krishnan, Lakshmi			Lack of Functional Selectin Ligand Interactions Compromises Long Term Tumor Protection by CD8(+) T Cells	PLOS ONE			English	Article							P-SELECTIN; HOMEOSTATIC PROLIFERATION; LISTERIA-MONOCYTOGENES; FUC-TVII; MEMORY; MIGRATION; LYMPHOCYTES; EXPRESSION; TRAFFICKING; RECRUITMENT	Central memory CD8(+) T cells expressing the adhesion molecule CD62L (L-selectin) are potent mediators of anti-cancer immunity due to their ability to proliferate extensively upon antigen re-stimulation. The interaction of selectin with its ligands mediates leukocyte rolling along high endothelial venules. Mice deficient in alpha(1,3) Fucosyltransferase IV and VII (FtDKO) lack functional L, P and E selectin ligands. Thus, we addressed whether the lack of selectin ligand interactions alters tumor protection by CD8(+) T cells in FtDKO mice. Listeria monocytogenes-OVA (LM-OVA) infection evoked potent OVA-specific CD8(+) T cells that proliferated and contracted at similar kinetics and phenotype in FtDKO and wild-type mice. Additionally, OVA-specific CD8(+) T cells in both mouse strains exhibited similar phenotypic differentiation, in vivo cytolytic activity and IFN-gamma expression. However, FtDKO mice succumbed to B16-OVA tumors significantly earlier than wild-type mice. In contrast, FtDKO mice evoked strong recall memory CD8(+) T cell responses and protection to systemic LM-OVA re-challenge. The diminished tumor protection in FtDKO mice was not related to defective antigen presentation by dendritic cells or reduced proliferation of antigen-specific CD8(+) T cells. However, WT or FtDKO OVA-specific CD8(+) T cells showed significantly reduced ability to traffic to lymph nodes upon adoptive transfer into naive FtDKO recipients. Furthermore, FtDKO OVA-specific CD8(+) T cells displayed poor ability to infiltrate tumors growing in WT mice. These results reveal that selectin ligand expression on host endothelium as well CD8(+) T cells may be important for their efficient and continued extravasation into peripheral tumors.	[Stark, Felicity C.; Sad, Subash; Krishnan, Lakshmi] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Gurnani, Komal; Sad, Subash; Krishnan, Lakshmi] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Ottawa; National Research Council Canada	Stark, FC (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	Lakshmi.Krishnan@nrc-cnrc.gc.ca	Stark, Felicity/AAT-2342-2021	Stark, Felicity/0000-0002-7547-8493; Sad, Subash/0000-0002-2462-7137	Ontario Institute for Cancer Research [07-NOV-119]; Government of Ontario, Canada; National Research Council of Canada [65-OPS-481-e-0-1]; Ontario Graduate Student Scholarship	Ontario Institute for Cancer Research; Government of Ontario, Canada; National Research Council of Canada; Ontario Graduate Student Scholarship	This study was conducted in part with the support of the Ontario Institute for Cancer Research (Project # 07-NOV-119) through funding provided by the Government of Ontario, Canada. This project was also supported by funds from the National Research Council of Canada (Project # 65-OPS-481-e-0-1). FS was a recipient of Ontario Graduate Student Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Brinkman CC, 2008, J IMMUNOL, V181, P1814, DOI 10.4049/jimmunol.181.3.1814; Cai YH, 2006, J IMMUNOL, V176, P6568, DOI 10.4049/jimmunol.176.11.6568; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; EASTON EW, 1993, BLOOD, V81, P2978; Ehlers S, 2009, IMMUNOBIOLOGY, V214, P674, DOI 10.1016/j.imbio.2008.12.009; Erdmann I, 2002, J IMMUNOL, V168, P2139, DOI 10.4049/jimmunol.168.5.2139; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Ferguson AR, 2010, J IMMUNOL, V184, P4079, DOI 10.4049/jimmunol.0901903; Gunn GR, 2001, J IMMUNOL, V167, P6471, DOI 10.4049/jimmunol.167.11.6471; Harp JR, 2010, J IMMUNOL, V185, P5751, DOI 10.4049/jimmunol.1001878; Harp JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010973; Hinrichs CS, 2006, CURR OPIN IMMUNOL, V18, P363, DOI 10.1016/j.coi.2006.03.009; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Jones TR, 2003, J CLIN INVEST, V112, P1714, DOI 10.1172/JCI19391; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Liu LH, 2010, VACCINE, V28, P3883, DOI 10.1016/j.vaccine.2010.03.041; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Luangsay S, 2003, GASTROENTEROLOGY, V125, P491, DOI 10.1016/S0016-5085(03)00903-X; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Naito Y, 1998, CANCER RES, V58, P3491; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Patel KD, 2002, SEMIN IMMUNOL, V14, P73, DOI 10.1006/smim.2001.0344; Paterson Y, 2010, SEMIN IMMUNOL, V22, P183, DOI 10.1016/j.smim.2010.02.002; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sad S, 2003, CRIT REV IMMUNOL, V23, P129, DOI 10.1615/CritRevImmunol.v23.i12.70; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sasaki K, 2008, J IMMUNOL, V181, P104, DOI 10.4049/jimmunol.181.1.104; Schuster K, 2009, EUR J IMMUNOL, V39, P2981, DOI 10.1002/eji.200939330; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stark FC, 2009, CANCER RES, V69, P4327, DOI 10.1158/0008-5472.CAN-08-3160; Stekel DJ, 1998, SCAND J IMMUNOL, V47, P426; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tangney M, 2010, CURR GENE THER, V10, P46, DOI 10.2174/156652310790945539; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wirth TC, 2009, J IMMUNOL, V182, P6195, DOI 10.4049/jimmunol.0803315; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32211	10.1371/journal.pone.0032211	http://dx.doi.org/10.1371/journal.pone.0032211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359671	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200140
J	Veyrieras, JB; Gaffney, DJ; Pickrell, JK; Gilad, Y; Stephens, M; Pritchard, JK				Veyrieras, Jean-Baptiste; Gaffney, Daniel J.; Pickrell, Joseph K.; Gilad, Yoav; Stephens, Matthew; Pritchard, Jonathan K.			Exon-Specific QTLs Skew the Inferred Distribution of Expression QTLs Detected Using Gene Expression Array Data	PLOS ONE			English	Article							POPULATION; DISEASE; IMPACT; MAP	Mapping of expression quantitative trait loci (eQTLs) is an important technique for studying how genetic variation affects gene regulation in natural populations. In a previous study using Illumina expression data from human lymphoblastoid cell lines, we reported that cis-eQTLs are especially enriched around transcription start sites (TSSs) and immediately upstream of transcription end sites (TESs). In this paper, we revisit the distribution of eQTLs using additional data from Affymetrix exon arrays and from RNA sequencing. We confirm that most eQTLs lie close to the target genes; that transcribed regions are generally enriched for eQTLs; that eQTLs are more abundant in exons than introns; and that the peak density of eQTLs occurs at the TSS. However, we find that the intriguing TES peak is greatly reduced or absent in the Affymetrix and RNA-seq data. Instead our data suggest that the TES peak observed in the Illumina data is mainly due to exon-specific QTLs that affect 3' untranslated regions, where most of the Illumina probes are positioned. Nonetheless, we do observe an overall enrichment of eQTLs in exons versus introns in all three data sets, consistent with an important role for exonic sequences in gene regulation.	[Veyrieras, Jean-Baptiste; Gaffney, Daniel J.; Pickrell, Joseph K.; Gilad, Yoav; Stephens, Matthew; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Veyrieras, Jean-Baptiste] BioMiningLabs, Lyon, France; [Gaffney, Daniel J.; Pritchard, Jonathan K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago	Veyrieras, JB (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	jb.veyrieras@gmail.com; gilad@uchicago.edu; mstephens@uchicago.edu; pritch@uchicago.edu		Gaffney, Daniel/0000-0002-1529-1862	National Institutes of Health [GM084996, MH084703, MH090951]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090951, R01MH084703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (GM084996, MH084703 and MH090951) and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaffney D, 2011, DISSECTING IN PRESS; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Listgarten J, 2010, P NATL ACAD SCI USA, V107, P16465, DOI 10.1073/pnas.1002425107; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mosteller F, 1977, JSAI WORKSH; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	31	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30629	10.1371/journal.pone.0030629	http://dx.doi.org/10.1371/journal.pone.0030629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359548	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200017
J	Yu, YY; Lieu, S; Hu, D; Miclau, T; Colnot, C				Yu, Yan Yiu; Lieu, Shirley; Hu, Diane; Miclau, Theodore; Colnot, Celine			Site Specific Effects of Zoledronic Acid during Tibial and Mandibular Fracture Repair	PLOS ONE			English	Article							NITROGEN-CONTAINING BISPHOSPHONATES; OSTEOBLAST DIFFERENTIATION; CANCER-PATIENTS; BONE-MARROW; MOUSE MODEL; CELL FATE; OSTEONECROSIS; JAW; PROLIFERATION; EXPRESSION	Numerous factors can affect skeletal regeneration, including the extent of bone injury, mechanical loading, inflammation and exogenous molecules. Bisphosphonates are anticatabolic agents that have been widely used to treat a variety of metabolic bone diseases. Zoledronate (ZA), a nitrogen-containing bisphosphonate (N-BP), is the most potent bisphosphonate among the clinically approved bisphosphonates. Cases of bisphosphonate-induced osteonecrosis of the jaw have been reported in patients receiving long term N-BP treatment. Yet, osteonecrosis does not occur in long bones. The aim of this study was to compare the effects of zoledronate on long bone and cranial bone regeneration using a previously established model of non-stabilized tibial fractures and a new model of mandibular fracture repair. Contrary to tibial fractures, which heal mainly through endochondral ossification, mandibular fractures healed via endochondral and intramembranous ossification with a lesser degree of endochondral ossification compared to tibial fractures. In the tibia, ZA reduced callus and cartilage formation during the early stages of repair. In parallel, we found a delay in cartilage hypertrophy and a decrease in angiogenesis during the soft callus phase of repair. During later stages of repair, ZA delayed callus, cartilage and bone remodeling. In the mandible, ZA delayed callus, cartilage and bone remodeling in correlation with a decrease in osteoclast number during the soft and hard callus phases of repair. These results reveal a more profound impact of ZA on cartilage and bone remodeling in the mandible compared to the tibia. This may predispose mandible bone to adverse effects of ZA in disease conditions. These results also imply that therapeutic effects of ZA may need to be optimized using time and dose-specific treatments in cranial versus long bones.	[Yu, Yan Yiu; Lieu, Shirley; Hu, Diane; Miclau, Theodore; Colnot, Celine] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Colnot, Celine] Hop Necker Enfants Malad, INSERM, U781, Paris, France	University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Yu, YY (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA.	eline.colnot@inserm.fr	Colnot, Celine/D-4997-2017	Colnot, Celine/0000-0001-8423-8718	NIH-NIDCR [R03 DE016701]; NIH-NIAMS [R01 AR053645, R01 AR057344]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057344, R01AR053645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016701] Funding Source: NIH RePORTER	NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by NIH-NIDCR R03 DE016701 to CC, NIH-NIAMS R01 AR053645 to TM and R01 AR057344 to CC and TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanat N, 2007, J BONE MINER RES, V22, P867, DOI 10.1359/JBMR.070318; Amelio PD, 2008, J BONE MINER RES, V23, P373, DOI 10.1359/JBMR.071031; Ayala G, 2000, HUM PATHOL, V31, P341, DOI 10.1016/S0046-8177(00)80248-8; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Bellahcene A, 2007, ENDOTHELIUM-J ENDOTH, V14, P123, DOI 10.1080/10623320701347187; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; D'Aoust P, 2000, CELL TISSUE RES, V302, P353, DOI 10.1007/s004419900165; Durie BGM, 2005, NEW ENGL J MED, V353, P99; Eames BF, 2004, DEV DYNAM, V231, P4, DOI 10.1002/dvdy.20134; Eames BF, 2004, DEV BIOL, V274, P188, DOI 10.1016/j.ydbio.2004.07.006; Evans K D, 2009, Open Orthop J, V3, P83, DOI 10.2174/1874325000903010083; Evans KD, 2003, BONE, V32, P268, DOI 10.1016/S8756-3282(02)00974-2; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; Frith JC, 1997, J BONE MINER RES, V12, P1358, DOI 10.1359/jbmr.1997.12.9.1358; Fromigue O, 2002, J ENDOCRINOL INVEST, V25, P539, DOI 10.1007/BF03345497; Groothuis A, 2010, BONE, V47, P438, DOI 10.1016/j.bone.2010.05.026; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Kang JH, 2010, ANAT REC, V293, P786, DOI 10.1002/ar.21092; Kimachi K, 2011, N-S ARCH PHARMACOL, V383, P297, DOI 10.1007/s00210-010-0596-4; Kobayashi Y, 2010, J BONE MINER METAB, V28, P165, DOI 10.1007/s00774-009-0128-9; Koch FP, 2010, CLIN ORAL INVESTIG; Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66; Lesclous P, 2009, BONE, V45, P843, DOI 10.1016/j.bone.2009.07.011; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Little DG, 2005, J BONE MINER RES, V20, P2044, DOI 10.1359/JBMR.050712; Lopez-Jornet P, 2010, J ORAL PATHOL MED, V39, P697, DOI 10.1111/j.1600-0714.2010.00927.x; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Lu CY, 2011, J ORTHOP TRAUMA, V25, P494, DOI 10.1097/BOT.0b013e31822511e0; Lu CY, 2010, J ORTHOP RES, V28, P687, DOI 10.1002/jor.21033; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; McDonald MM, 2008, BONE, V43, P653, DOI 10.1016/j.bone.2008.05.019; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Ortega C, 2007, ACTA ONCOL, V46, P664, DOI 10.1080/02841860601185917; Perez-Amodio S, 2006, CALCIFIED TISSUE INT, V79, P245, DOI 10.1007/s00223-005-0289-z; Probst A, 1997, J INVEST SURG, V10, P77, DOI 10.3109/08941939709032137; Russell RGG, 2006, ANN NY ACAD SCI, V1068, P367, DOI 10.1196/annals.1346.041; Schionning JD, 1997, ACTA NEUROPATHOL, V94, P280, DOI 10.1007/s004010050704; Senel FC, 2010, ORAL SURG ORAL MED O, V109, P385, DOI 10.1016/j.tripleo.2009.10.011; Stresing V, 2011, BONE, V48, P259, DOI 10.1016/j.bone.2010.09.035; Sudhoff H, 2003, ANN OTO RHINOL LARYN, V112, P780, DOI 10.1177/000348940311200907; Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7; von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295	48	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31771	10.1371/journal.pone.0031771	http://dx.doi.org/10.1371/journal.pone.0031771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359627	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200096
J	Boncoraglio, G; Kilner, RM				Boncoraglio, Giuseppe; Kilner, Rebecca M.			Female Burying Beetles Benefit from Male Desertion: Sexual Conflict and Counter-Adaptation over Parental Investment	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; PATERNAL CARE; SELECTION; EVOLUTION	Sexual conflict drives the coevolution of sexually antagonistic traits, such that an adaptation in one sex selects an opposing coevolutionary response from the other. Although many adaptations and counteradaptations have been identified in sexual conflict over mating interactions, few are known for sexual conflict over parental investment. Here we investigate a possible coevolutionary sequence triggered by mate desertion in the burying beetle Nicrophorus vespilloides, where males commonly leave before their offspring reach independence. Rather than suffer fitness costs as a consequence, our data suggest that females rely on the male's absence to recoup some of the costs of larval care, presumably because they are then free to feed themselves on the carcass employed for breeding. Consequently, forcing males to stay until the larvae disperse reduces components of female fitness to a greater extent than caring for young singlehandedly. Therefore we suggest that females may have co-evolved to anticipate desertion by their partners so that they now benefit from the male's absence.	[Boncoraglio, Giuseppe; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Boncoraglio, G (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	gb406@cam.ac.uk	Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758	Marie Curie Intra-European Fellowship [PIEF-GA-2009-252120]	Marie Curie Intra-European Fellowship(European Commission)	This study was supported by Marie Curie Intra-European Fellowship PIEF-GA-2009-252120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V23, P297, DOI 10.1007/BF00300576; Cotter SC, 2010, ECOL LETT, V13, P1114, DOI 10.1111/j.1461-0248.2010.01500.x; Cotter SC, 2011, FUNCT ECOL, V25, P652, DOI 10.1111/j.1365-2435.2010.01819.x; Creighton JC, 2009, AM NAT, V174, P673, DOI 10.1086/605963; Eggert AK, 1997, EVOLUTION SOCIAL BEH, P219; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Jenkins EV, 2000, ANIM BEHAV, V60, P443, DOI 10.1006/anbe.2000.1487; LAZARUS J, 1990, ANIM BEHAV, V39, P672, DOI 10.1016/S0003-3472(05)80378-1; Lessells CM, 2006, PHILOS T R SOC B, V361, P301, DOI 10.1098/rstb.2005.1795; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; Muller JK, 1998, ECOL ENTOMOL, V23, P195, DOI 10.1046/j.1365-2311.1998.00119.x; Sakaluk SK, 1998, ETHOLOGY, V104, P553, DOI 10.1111/j.1439-0310.1998.tb00090.x; SCOTT MP, 1989, J INSECT BEHAV, V2, P133, DOI 10.1007/BF01053623; Smiseth PT, 2005, ANIM BEHAV, V69, P551, DOI 10.1016/j.anbehav.2004.06.004; Smiseth PT, 2003, P ROY SOC B-BIOL SCI, V270, P1773, DOI 10.1098/rspb.2003.2444; Szentirmai I, 2007, J EVOLUTION BIOL, V20, P1739, DOI 10.1111/j.1420-9101.2007.01392.x; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004; Ward RJS, 2009, BEHAV ECOL, V20, P1274, DOI 10.1093/beheco/arp132	22	54	55	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31713	10.1371/journal.pone.0031713	http://dx.doi.org/10.1371/journal.pone.0031713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355390	Green Published, gold, Green Submitted			2022-12-27	WOS:000302741300090
J	Chen, C; Deng, B; Qiao, M; Zheng, R; Chai, J; Ding, Y; Peng, J; Jiang, SW				Chen, Chen; Deng, Bing; Qiao, Mu; Zheng, Rong; Chai, Jin; Ding, Yi; Peng, Jian; Jiang, Siwen			Solexa Sequencing Identification of Conserved and Novel microRNAs in Backfat of Large White and Chinese Meishan Pigs	PLOS ONE			English	Article							ADIPOSE-TISSUE; BINDING-SITES; SMALL RNAS; EXPRESSION; CELL; ADIPOGENESIS; MECHANISM; MIR-122; MIRNAS; GROWTH	The domestic pig (Sus scrofa), an important species in animal production industry, is a right model for studying adipogenesis and fat deposition. In order to expand the repertoire of porcine miRNAs and further explore potential regulatory miRNAs which have influence on adipogenesis, high-throughput Solexa sequencing approach was adopted to identify miRNAs in backfat of Large White (lean type pig) and Meishan pigs (Chinese indigenous fatty pig). We identified 215 unique miRNAs comprising 75 known pre-miRNAs, of which 49 miRNA*s were first identified in our study, 73 miRNAs were overlapped in both libraries, and 140 were novelly predicted miRNAs, and 215 unique miRNAs were collectively corresponding to 235 independent genomic loci. Furthermore, we analyzed the sequence variations, seed edits and phylogenetic development of the miRNAs. 17 miRNAs were widely conserved from vertebrates to invertebrates, suggesting that these miRNAs may serve as potential evolutional biomarkers. 9 conserved miRNAs with significantly differential expressions were determined. The expression of miR-215, miR-135, miR-224 and miR-146b was higher in Large White pigs, opposite to the patterns shown by miR-1a, miR-133a, miR-122, miR-204 and miR-183. Almost all novel miRNAs could be considered pig-specific except ssc-miR-1343, miR-2320, miR-2326, miR-2411 and miR-2483 which had homologs in Bos taurus, among which ssc-miR-1343, miR-2320, miR-2411 and miR-2483 were validated in backfat tissue by stem-loop qPCR. Our results displayed a high level of concordance between the qPCR and Solexa sequencing method in 9 of 10 miRNAs comparisons except for miR-1a. Moreover, we found 2 miRNAs, miR-135 and miR-183, may exert impacts on porcine backfat development through WNT signaling pathway. In conclusion, our research develops porcine miRNAs and should be beneficial to study the adipogenesis and fat deposition of different pig breeds based on miRNAs.	[Chen, Chen; Deng, Bing; Qiao, Mu; Zheng, Rong; Chai, Jin; Ding, Yi; Jiang, Siwen] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Peoples R China; [Chen, Chen; Deng, Bing; Qiao, Mu; Zheng, Rong; Chai, Jin; Ding, Yi; Jiang, Siwen] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Anim Sci & Technol, Wuhan, Peoples R China; [Peng, Jian] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University	Chen, C (corresponding author), Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Peoples R China.	pengjianhzau@163.com; jswhzau@163.com	Ding, Yi/U-3314-2019; Xie, Huangming/B-2260-2012	Deng, Bing/0000-0002-7391-7018	Chinese Ministry of Science and Technology; Major Projects of Genetically Modified Animals [2009ZX08009-161B, 2009ZX08009-151B]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Major Projects of Genetically Modified Animals	This research was supported by grants from the Chinese Ministry of Science and Technology, the Major Projects of Genetically Modified Animals (2009ZX08009-161B, 2009ZX08009-151B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar ALG, 2010, FEBS LETT, V584, P4426, DOI 10.1016/j.febslet.2010.09.050; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Meng YJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S12; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	50	75	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31426	10.1371/journal.pone.0031426	http://dx.doi.org/10.1371/journal.pone.0031426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355364	gold, Green Published, Green Submitted			2022-12-27	WOS:000302741300064
J	Govind, K; Makinen, K; Savithri, HS				Govind, Kunduri; Makinen, Kristiina; Savithri, Handanahal S.			Sesbania Mosaic Virus (SeMV) Infectious Clone: Possible Mechanism of 3 ' and 5 ' End Repair and Role of Polyprotein Processing in Viral Replication	PLOS ONE			English	Article							COCKSFOOT-MOTTLE-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; TRANSIENT EXPRESSION SYSTEM; NATIVELY UNFOLDED VPG; RNA VIRUSES; P1 PROTEIN; SERINE-PROTEASE; VECTORS; CDNA; DNA	Sesbania mosaic virus (SeMV) is a positive stranded RNA virus belonging to the genus Sobemovirus. Construction of an infectious clone is an essential step for deciphering the virus gene functions in vivo. Using Agrobacterium based transient expression system we show that SeMV icDNA is infectious on Sesbania grandiflora and Cyamopsis tetragonoloba plants. The efficiency of icDNA infection was found to be significantly high on Cyamopsis plants when compared to that on Sesbania grandiflora. The coat protein could be detected within 6 days post infiltration in the infiltrated leaves. Different species of viral RNA (double stranded and single stranded genomic and subgenomic RNA) could be detected upon northern analysis, suggesting that complete replication had taken place. Based on the analysis of the sequences at the genomic termini of progeny RNA from SeMV icDNA infiltrated leaves and those of its 3' and 5' terminal deletion mutants, we propose a possible mechanism for 3' and 5' end repair in vivo. Mutation of the cleavage sites in the polyproteins encoded by ORF 2 resulted in complete loss of infection by the icDNA, suggesting the importance of correct polyprotein processing at all the four cleavage sites for viral replication. Complementation analysis suggested that ORF 2 gene products can act in trans. However, the trans acting ability of ORF 2 gene products was abolished upon deletion of the N-terminal hydrophobic domain of polyprotein 2a and 2ab, suggesting that these products necessarily function at the replication site, where they are anchored to membranes.	[Govind, Kunduri; Savithri, Handanahal S.] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Makinen, Kristiina] Univ Helsinki, Helsinki, Finland	Indian Institute of Science (IISC) - Bangalore; University of Helsinki	Govind, K (corresponding author), Indian Inst Sci, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in	KUNDURI, GOVIND/K-5133-2019; Mäkinen, Kristiina M/C-8650-2012	KUNDURI, GOVIND/0000-0003-4170-965X; Mäkinen, Kristiina M/0000-0001-8233-8942	Indo-Finnish [BT/IN/Finland/18/HSS/2007]; Department of Biotechnology; Department of Science and technology; Council for Scientific and Industrial Research (CSIR); Academy of Finland [121622]	Indo-Finnish; Department of Biotechnology; Department of Science and technology(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Academy of Finland(Academy of Finland)	We thank Indo-Finnish grant (BT/IN/Finland/18/HSS/2007), the Department of Biotechnology, the Department of Science and technology and the Council for Scientific and Industrial Research (CSIR) for financial support. Financial support from the Academy of Finland (grant 121622) for K.M. is gratefully acknowledged. K.Govind thanks CSIR for the senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai P, 2005, VIROLOGY, V338, P96, DOI 10.1016/j.virol.2005.05.013; Barr J, 2010, J GEN VIROL, V91, P1373, DOI 10.1099/vir.0.020818-0; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Bonneau C, 1998, VIROLOGY, V244, P79, DOI 10.1006/viro.1998.9100; BRUGIDOU C, 1995, VIROLOGY, V206, P108, DOI 10.1016/S0042-6822(95)80025-5; Chapman Sean N., 2008, V451, P477, DOI 10.1007/978-1-59745-102-4_32; Chowdhury SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015609; Chowdhury SR, 2011, FEBS J, V278, P257, DOI 10.1111/j.1742-4658.2010.07943.x; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; DATLA RSS, 1992, GENE, V122, P383, DOI 10.1016/0378-1119(92)90232-E; Eskelin K, 2010, J VIROL METHODS, V164, P101, DOI 10.1016/j.jviromet.2009.12.006; Govind K, 2010, VIROLOGY, V401, P280, DOI 10.1016/j.virol.2010.02.025; HARMON SA, 1991, J VIROL, V65, P2757, DOI 10.1128/JVI.65.5.2757-2760.1991; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; KLUMP WM, 1990, J VIROL, V64, P1573, DOI 10.1128/JVI.64.4.1573-1583.1990; Lacombe S, 2010, PLANT J, V61, P371, DOI 10.1111/j.1365-313X.2009.04062.x; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Li XJ, 2007, J GEN VIROL, V88, P1620, DOI 10.1099/vir.0.82627-0; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Lokesh GL, 2001, ARCH VIROL, V146, P209, DOI 10.1007/s007050170170; Makinen K, 2000, J GEN VIROL, V81, P2783, DOI 10.1099/0022-1317-81-11-2783; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Meier M, 2007, ARCH VIROL, V152, P635, DOI 10.1007/s00705-006-0867-z; Meier M, 2006, VIRUS GENES, V32, P321, DOI 10.1007/s11262-005-6917-x; MILLER WA, 1995, CRIT REV PLANT SCI, V14, P179, DOI 10.1080/713608119; Nair S, 2008, VIROLOGY, V382, P83, DOI 10.1016/j.virol.2008.08.034; Nair S, 2010, FEBS LETT, V584, P571, DOI 10.1016/j.febslet.2009.12.003; Nair S, 2010, VIROLOGY, V396, P106, DOI 10.1016/j.virol.2009.09.025; Olspert A, 2011, FEBS LETT, V585, P2979, DOI 10.1016/j.febslet.2011.08.009; Olspert A, 2011, J GEN VIROL, V92, P445, DOI 10.1099/vir.0.026476-0; Ryabov Eugene V., 2008, V451, P491, DOI 10.1007/978-1-59745-102-4_33; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sarmiento C, 2007, VIRUS RES, V123, P95, DOI 10.1016/j.virusres.2006.07.013; Satheshkumar PS, 2005, J BIOL CHEM, V280, P30291, DOI 10.1074/jbc.M504122200; Satheshkumar PS, 2004, VIROLOGY, V318, P429, DOI 10.1016/j.virol.2003.09.035; Sivakumaran K, 1998, VIROLOGY, V252, P376, DOI 10.1006/viro.1998.9489; SREENIVASULU P, 1982, CURR SCI INDIA, V51, P86; Tamm T, 2000, J VIROL, V74, P6231, DOI 10.1128/JVI.74.14.6231-6241.2000; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6	41	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31190	10.1371/journal.pone.0031190	http://dx.doi.org/10.1371/journal.pone.0031190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355344	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000302741300044
J	Wright, B; Pearce, H; Allgar, V; Miles, J; Whitton, C; Leon, I; Jardine, J; McCaffrey, N; Smith, R; Holbrook, I; Lewis, J; Goodall, D; Alderson-Day, B				Wright, Barry; Pearce, Helen; Allgar, Victoria; Miles, Jeremy; Whitton, Clare; Leon, Irene; Jardine, Jenny; McCaffrey, Nicola; Smith, Rob; Holbrook, Ian; Lewis, John; Goodall, David; Alderson-Day, Ben			A Comparison of Urinary Mercury between Children with Autism Spectrum Disorders and Control Children	PLOS ONE			English	Article							THIMEROSAL-CONTAINING VACCINES; PRENATAL METHYLMERCURY EXPOSURE; CONGENITAL MINAMATA DISEASE; DENTAL AMALGAM; HAIR; ASSOCIATION; POPULATION; TOXICOLOGY; TOXICITY	Background: Urinary mercury concentrations are used in research exploring mercury exposure. Some theorists have proposed that autism is caused by mercury toxicity. We set out to test whether mercury concentrations in the urine of children with autism were significantly increased or decreased compared to controls or siblings. Methods: Blinded cohort analyses were carried out on the urine of 56 children with autism spectrum disorders (ASD) compared to their siblings (n = 42) and a control sample of children without ASD in mainstream (n = 121) and special schools (n = 34). Results: There were no statistically significant differences in creatinine levels, in uncorrected urinary mercury levels or in levels of mercury corrected for creatinine, whether or not the analysis is controlled for age, gender and amalgam fillings. Conclusions: This study lends no support for the hypothesis of differences in urinary mercury excretion in children with autism compared to other groups. Some of the results, however, do suggest further research in the area may be warranted to replicate this in a larger group and with clear measurement of potential confounding factors.	[Wright, Barry; Whitton, Clare; Jardine, Jenny; McCaffrey, Nicola; Alderson-Day, Ben] N Yorkshire & York Primary Care Trust, York, N Yorkshire, England; [Pearce, Helen] Tees Esk & Wear Valleys NHS Fdn Trust, Durham, England; [Allgar, Victoria] Hull York Med Sch, York, N Yorkshire, England; [Miles, Jeremy] RAND Corp, Santa Monica, CA USA; [Leon, Irene; Lewis, John] Food & Environm Res Agcy, Sand Hutton, England; [Smith, Rob; Holbrook, Ian] York NHS Fdn Trust, York, N Yorkshire, England; [Goodall, David] York Univ, Dept Chem, York, N Yorkshire, England	University of Hull; University of York - UK; RAND Corporation; Food & Environment Research Agency; University of York - UK	Wright, B (corresponding author), N Yorkshire & York Primary Care Trust, York, N Yorkshire, England.	Barry.wright@nyypct.nhs.uk		Wright, Barry/0000-0002-8692-6001; Allgar, Victoria/0000-0002-5228-2623	Sir Samuel Scott of Yews Trust; London Law Trust; York and Selby Research and Development Committee; Selby and York Primary Care Trust	Sir Samuel Scott of Yews Trust; London Law Trust; York and Selby Research and Development Committee; Selby and York Primary Care Trust	This research was funded by Sir Samuel Scott of Yews Trust, The London Law Trust and The York Innovation Research Fund from the York and Selby Research and Development Committee, Selby and York Primary Care Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaria P, 2006, BRIT MED J, V333, P890, DOI 10.1136/bmj.38989.445845.7C; Baker JP, 2008, AM J PUBLIC HEALTH, V98, P244, DOI 10.2105/AJPH.2007.113159; BAKIR F, 1980, POSTGRAD MED J, V56, P1, DOI 10.1136/pgmj.56.651.1; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bellinger DC, 2006, JAMA-J AM MED ASSOC, V295, P1775, DOI 10.1001/jama.295.15.1775; Bernard S, 2001, MED HYPOTHESES, V56, P462, DOI 10.1054/mehy.2000.1281; Blaxill MF, 2004, MED HYPOTHESES, V62, P788, DOI 10.1016/j.mehy.2003.11.033; Blaxill MF, 2004, AM J PREV MED, V26, P91, DOI 10.1016/j.amepre.2003.10.019; Bradstreet JJ, 2003, J AM PHYS SURG, V8, P76; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; Custodio HM, 2005, ARCH ENVIRON HEALTH, V60, P17, DOI 10.3200/AEOH.60.1.17-23; Debes F, 2006, NEUROTOXICOL TERATOL, V28, P363, DOI [10.1016/j.ntt.2006.02.005, 10.1016/j.ntt.2006.02.004]; DeRouen TA, 2006, JAMA-J AM MED ASSOC, V295, P1784, DOI 10.1001/jama.295.15.1784; Eto K, 2000, NEUROPATHOLOGY, V20, pS14; FAGALA GE, 1992, J AM ACAD CHILD PSY, V31, P306, DOI 10.1097/00004583-199203000-00019; Fido A, 2005, AUTISM, V9, P290, DOI 10.1177/1362361305053255; Fombonne E, 2008, ARCH GEN PSYCHIAT, V65, P15, DOI 10.1001/archgenpsychiatry.2007.2; Food and Drug Administration, 2008, THIM CONT VACC ROUT; Geier DA, 2007, J TOXICOL ENV HEAL A, V70, P1723, DOI 10.1080/15287390701457712; Geier M.R., 2003, J AM PHYS SURG, V8, P6; Geier MR, 2003, EXP BIOL MED, V228, P660, DOI 10.1177/153537020322800603; Gerber JS, 2009, CLIN INFECT DIS, V48, P456, DOI 10.1086/596476; HARADA M, 1978, TERATOLOGY, V18, P285, DOI 10.1002/tera.1420180216; Health Protection Agency, 2008, CONF CAS MEASL MUMPS; Holmes AS, 2003, INT J TOXICOL, V22, P277, DOI 10.1080/10915810305120; Hviid A, 2003, JAMA-J AM MED ASSOC, V290, P1763, DOI 10.1001/jama.290.13.1763; Ibrahim D, 2006, CLIN LAB MED, V26, P67, DOI 10.1016/j.cll.2006.02.003; Institute of Medicine, 2004, IMM SAF REV VACC AUT; Ip P, 2004, J CHILD NEUROL, V19, P431, DOI 10.1177/088307380401900606; James SJ, 2009, AM J CLIN NUTR, V89, P425, DOI 10.3945/ajcn.2008.26615; Kondo K, 2000, J CHILD NEUROL, V15, P458, DOI 10.1177/088307380001500707; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Madsen KM, 2003, PEDIATRICS, V112, P604, DOI 10.1542/peds.112.3.604; Magos L, 2001, J APPL TOXICOL, V21, P1, DOI 10.1002/jat.721; Martin MD, 1996, J PHARMACOL EXP THER, V277, P239; Mutter J, 2007, CRIT REV TOXICOL, V37, P537, DOI 10.1080/10408440701385770; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Myers GJ, 2000, ENVIRON RES, V83, P275, DOI 10.1006/enrs.2000.4065; Nelson KB, 2003, PEDIATRICS, V111, P674, DOI 10.1542/peds.111.3.674; Owens SE, 2011, NEUROTOXICOLOGY, V32, P769, DOI 10.1016/j.neuro.2011.07.003; Parker SK, 2004, PEDIATRICS, V114, P793, DOI 10.1542/peds.2004-0434; Pichichero ME, 2002, LANCET, V360, P1737, DOI 10.1016/S0140-6736(02)11682-5; Ramirez GB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e289; Redwood L, 2001, NEUROTOXICOLOGY, V69, P1; RIMLAND B, 1983, J LEARN DISABIL, V16, P279, DOI 10.1177/002221948301600507; Soden SE, 2007, CLIN TOXICOL, V45, P476, DOI 10.1080/15563650701338195; Stehr-Green P, 2003, AM J PREV MED, V25, P101, DOI 10.1016/S0749-3797(03)00113-2; WECKER L, 1985, J MENT DEFIC RES, V29, P15; World Health Organisation, 1993, ICD 10 CLASS MENT B	51	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e29547	10.1371/journal.pone.0029547	http://dx.doi.org/10.1371/journal.pone.0029547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355303	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302741300003
J	Eftychi, C; Karagianni, N; Alexiou, M; Apostolaki, M; Kollias, G				Eftychi, Christina; Karagianni, Niki; Alexiou, Maria; Apostolaki, Maria; Kollias, George			Myeloid Takl Acts as a Negative Regulator of the LPS Response and Mediates Resistance to Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; KINASE TAK1; IN-VIVO; IMMUNE-RESPONSES; STEM-CELLS; INNATE; BETA; APOPTOSIS; MICE; INFLAMMATION	TGF beta-activated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, is considered a key intermediate in a multitude of innate immune signaling pathways. Yet, the specific role of TAK1 in the myeloid compartment during inflammatory challenges has not been revealed. To address this question, we generated myeloid-specific kinase-dead TAK1 mutant mice. TAK1 deficiency in macrophages results in impaired NF-kappa B and JNK activation upon stimulation with lipopolysaccharide (LPS). Moreover, TAK1-deficient macrophages and neutrophils show an enhanced inflammatory cytokine profile in response to LPS stimulation. Myeloid-specific TAK1 deficiency in mice leads to increased levels of circulating IL-1 beta, TNF and reduced IL-10 after LPS challenge and sensitizes them to LPS-induced endotoxemia. These results highlight an antiinflammatory role for myeloid TAK1, which is essential for balanced innate immune responses and host survival during endotoxemia.	[Eftychi, Christina; Karagianni, Niki; Alexiou, Maria; Apostolaki, Maria; Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Greece	Alexander Fleming Biomedical Sciences Research Center	Eftychi, C (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Greece.	g.kollias@fleming.gr	Kollias, George/A-7079-2012	Kollias, George/0000-0003-1867-3150	European Commission [Health-F2-2008-223404, Health-F2-2009-223151, HPRN-CT-2002-00255]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission grants, Masterswitch (Health-F2-2008-223404), INFLA(Information and Cancer Research in Europe)-CARE (Health-F2-2009-223151) and RTN (HPRN-CT-2002-00255) to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Courties G, 2010, BLOOD; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Sarkar S, 2011, MOL CELL BIOL, V31, P602, DOI 10.1128/MCB.00835-10; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1	27	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31550	10.1371/journal.pone.0031550	http://dx.doi.org/10.1371/journal.pone.0031550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348103	gold, Green Published			2022-12-27	WOS:000302737400034
J	Fogarty, ND; Vollmer, SV; Levitan, DR				Fogarty, Nicole D.; Vollmer, Steven V.; Levitan, Don R.			Weak Prezygotic Isolating Mechanisms in Threatened Caribbean Acropora Corals	PLOS ONE			English	Article							ANNULARIS SPECIES COMPLEX; REEF CORALS; REPRODUCTIVE ISOLATION; SCLERACTINIAN CORALS; GAMETE RECOGNITION; FERTILIZATION SUCCESS; CONSPECIFIC SPERM; GENETIC DIVERSITY; SPAWNING CORALS; SEA-URCHINS	The Caribbean corals, Acropora palmata and A. cervicornis, recently have undergone drastic declines primarily as a result of disease. Previous molecular studies have demonstrated that these species form a hybrid (A. prolifera) that varies in abundance throughout the range of the parental distribution. There is variable unidirectional introgression across loci and sites of A. palmata genes flowing into A. cervicornis. Here we examine the efficacy of prezygotic reproductive isolating mechanisms within these corals including spawning times and choice and no-choice fertilization crosses. We show that these species have subtly different mean but overlapping spawning times, suggesting that temporal isolation is likely not an effective barrier to hybridization. We found species-specific differences in gametic incompatibilities. Acropora palmata eggs were relatively resistant to hybridization, especially when conspecific sperm are available to outcompete heterospecific sperm. Acropora cervicornis eggs demonstrated no evidence for gametic incompatibility and no evidence of reduced viability after aging four hours. This asymmetry in compatibility matches previous genetic data on unidirectional introgression.	[Fogarty, Nicole D.; Levitan, Don R.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Vollmer, Steven V.] NE Univ, Ctr Marine Sci, Nahant, MA USA	State University System of Florida; Florida State University; Northeastern University	Fogarty, ND (corresponding author), Smithsonian Marine Stn, Ft Pierce, FL USA.	fogartyn@si.edu			Caribbean Coral Reef Ecosystems (CCRE) program [915]; Smithsonian Marine Science Network; PADI foundation; American Academy of Underwater Science; AWARE foundation; National Geographic Society [8230-07]; American Museum of Natural History; FSU; Marine Science Network; NSF [OCE-9911225]	Caribbean Coral Reef Ecosystems (CCRE) program; Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); PADI foundation; American Academy of Underwater Science; AWARE foundation; National Geographic Society(National Geographic Society); American Museum of Natural History; FSU; Marine Science Network; NSF(National Science Foundation (NSF))	Funding was supplied by the Caribbean Coral Reef Ecosystems (CCRE) program (http://www.ccre.si.edu/) contribution #915, The Smithsonian Marine Science Network (http://www.sms.si.edu/), the PADI foundation (http://www.padifoundation.org/), the American Academy of Underwater Science (http://www.aaus.org), the Project AWARE foundation (http://www.projectaware.org/), the National Geographic Society (8230-07; http://www.nationalgeographic.com/), the Lerner-Gray Memorial Fund of the American Museum of Natural History (http://rggs.amnh.org/pages/academics_and_research/fellowship_and_grant_opportunities), and FSU's International dissertation, Bennison, Gramling, and Short Fellowships to N.D. Fogarty. The Marine Science Network supplied funding to S.V. Vollmer, and NSF OCE-9911225 and the National Geographic Society (8230-07) supplied funding to D.R. Levitan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acropora Biological Review Team, 2005, ATL ACR STAT REV DOC; Adey WH, 1977, 3 INT S FLA COR REEF; Anderson E., 1949, INTROGRESSIVE HYBRID; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold ML, 2009, INT J MOL SCI, V10, P3836, DOI 10.3390/ijms10093836; ARNOLD ML, 1990, HEREDITY, V65, P297, DOI 10.1038/hdy.1990.99; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Babcock R, 1995, REPROD FERT DEVELOP, V7, P943, DOI 10.1071/RD9950943; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Bruckner AW, 2002, P CAR ACR WORKSH SIL, P184; Budd AF, 1999, PALEOBIOLOGY, V25, P188, DOI 10.1017/S009483730002649X; BUDD AF, 1994, J PALEONTOL, V68, P951, DOI 10.1017/S0022336000026585; Cairns SD, 1982, STONY CORALS CNIDARI; Cortes J., 2003, LATIN AM CORAL REEFS; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; de Graaf M, 1999, B MAR SCI, V64, P189; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; DOWLING TE, 1992, CONSERV BIOL, V6, P355, DOI 10.1046/j.1523-1739.1992.06030355.x; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Evans JP, 2005, EVOLUTION, V59, P106; Fogarty N.D., 2010, THESIS FLORIDA STATE; Fogarty ND, 2012, MAR ECO PRO IN PRESS; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; [FWRI DTNP], 2010, 2006 ANN REP FISH WI, P35; Geyer LB, 2005, EVOLUTION, V59, P97; Gill FB, 1994, P 21 INT ORN C AUG 2; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Grant PR, 1981, PLANT SPECIATION; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Harper FM, 2005, BIOL BULL-US, V209, P113, DOI 10.2307/3593129; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hemond EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008652; Hogarth WT, FED REG, V71, P26852; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; HUNT WG, 1973, HEREDITY, V31, P11; KEIM P, 1989, GENETICS, V123, P557; LANG J, 1998, STATUS CORAL REEFS N; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Levitan DR, 2011, EVOLUTION, V65, P1254, DOI 10.1111/j.1558-5646.2011.01235.x; Levitan DR, 2010, EVOLUTION, V64, P785, DOI 10.1111/j.1558-5646.2009.00850.x; Levitan Don R., 2005, P47; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Levitan DR, 2002, EVOLUTION, V56, P1599, DOI 10.1111/j.0014-3820.2002.tb01472.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; McNeill DF, 1997, GEOLOGY, V25, P891, DOI 10.1130/0091-7613(1997)025<0891:ELPFAO>2.3.CO;2; Mendelson TC, 2007, EVOLUTION, V61, P2596, DOI 10.1111/j.1558-5646.2007.00220.x; Miller DJ, 2003, MOL ECOL, V12, P805, DOI 10.1046/j.1365-294X.2003.01808.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; Rahman SM, 2004, COMP BIOCHEM PHYS A, V139, P469, DOI 10.1016/j.cbpb.2004.10.005; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Riginos C, 2006, MOL BIOL EVOL, V23, P1952, DOI 10.1093/molbev/msl062; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; STEINER SCC, 1995, B MAR SCI, V56, P899; Styan CA, 2008, EVOLUTION, V62, P3041, DOI 10.1111/j.1558-5646.2008.00521.x; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Thompson SL, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04442.x; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; Van Oppen MJH, 2002, MOL ECOL, V11, P1363, DOI 10.1046/j.1365-294X.2002.01527.x; VANVEGHEL MLJ, 1993, B MAR SCI, V52, P1017; Vargas-Angel B, 2006, CORAL REEFS, V25, P110, DOI 10.1007/s00338-005-0070-9; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; Willis B. L., 1985, P 5 INT COR REEF C, V4, P343; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Zlatarski Vassil N., 2010, Palaeoworld, V19, P333, DOI 10.1016/j.palwor.2010.09.012	82	55	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30486	10.1371/journal.pone.0030486	http://dx.doi.org/10.1371/journal.pone.0030486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348010	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400001
J	Forcheron, F; Agay, D; Scherthan, H; Riccobono, D; Herodin, F; Meineke, V; Drouet, M				Forcheron, Fabien; Agay, Diane; Scherthan, Harry; Riccobono, Diane; Herodin, Francis; Meineke, Viktor; Drouet, Michel			Autologous Adipocyte Derived Stem Cells Favour Healing in a Minipig Model of Cutaneous Radiation Syndrome	PLOS ONE			English	Article							ACUTE SINGLE EXPOSURES; LINEAGE CELLS; WOUND REPAIR; SWINE SKIN; X-RAYS; DIFFERENTIATION; QUANTIFICATION; THERAPY; BURNS	Cutaneous radiation syndrome (CRS) is the delayed consequence of localized skin exposure to high doses of ionizing radiation. Here we examined for the first time in a large animal model the therapeutic potential of autologous adipose tissue-derived stroma cells (ASCs). For experiments, Gottingen minipigs were locally gamma irradiated using a Co-60 source at the dose of 50 Gy and grafted (n = 5) or not (n = 8). ASCs were cultured in MEM-alpha with 10% fetal calf serum and basic fibroblast growth factor (2 ng.mL(-1)) and post irradiation were intradermally injected on days 25, 46, 67 and finally between days 95 and 115 (50 x 10(6) ASCs each time) into the exposed area. All controls exhibited a clinical evolution with final necrosis (day 91). In grafted pigs an ultimate wound healing was observed in four out of five grafted animals (day 130 +/- 28). Immunohistological analysis of cytokeratin expression showed a complete epidermis recovery. Grafted ASCs accumulated at the dermis/subcutis barrier in which they attracted numerous immune cells, and even an increased vasculature in one pig. Globally this study suggests that local injection of ASCs may represent a useful strategy to mitigate CRS.	[Forcheron, Fabien; Agay, Diane; Riccobono, Diane; Herodin, Francis; Drouet, Michel] Inst Rech Biomed Armees Antenne La Tronche, La Tronche, France; [Scherthan, Harry; Meineke, Viktor] Inst Radiobiol Bundeswehr, Munich, Germany		Forcheron, F (corresponding author), Inst Rech Biomed Armees Antenne La Tronche, La Tronche, France.	micheldrouet@crssa.net			Direction Generale de l'Armement (Paris, France)	Direction Generale de l'Armement (Paris, France)	This work was supported by a grant from Direction Generale de l'Armement (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay D, 2010, EXP HEMATOL, V38, P945, DOI 10.1016/j.exphem.2010.06.008; ARCHAMBEAU JO, 1984, RADIAT RES, V98, P37, DOI 10.2307/3576049; ARCHAMBEAU JO, 1979, RADIAT RES, V79, P298, DOI 10.2307/3575099; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Boquest AC, 2007, STEM CELLS, V25, P852, DOI 10.1634/stemcells.2006-0428; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Francois S, 2007, ANN HEMATOL, V86, P1, DOI 10.1007/s00277-006-0166-5; HOPEWELL JW, 1990, INT J RADIAT BIOL, V57, P751, DOI 10.1080/09553009014550911; Lefaix JL, 2005, NUCL RADIOLOGICAL BI, P87; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Papp A, 2006, PLAST RECONSTR SURG, V117, P889, DOI 10.1097/01.prs.0000197213.12989.03; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	18	61	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31694	10.1371/journal.pone.0031694	http://dx.doi.org/10.1371/journal.pone.0031694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348120	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400042
J	Guthe, HJT; Nedrebo, T; Tenstad, O; Wiig, H; Berg, A				Guthe, Hans Jorgen Timm; Nedrebo, Torbjorn; Tenstad, Olav; Wiig, Helge; Berg, Ansgar			Effect of Topical Anaesthetics on Interstitial Colloid Osmotic Pressure in Human Subcutaneous Tissue Sampled by Wick Technique	PLOS ONE			English	Article							PROTEIN-CONCENTRATION; HYDROSTATIC PRESSURES; NEPHROTIC SYNDROME; FLUID BALANCE; LIMB ISCHEMIA; EMLA CREAM; RAT SKIN; MECHANISMS; EDEMA; VENIPUNCTURE	Objectives: To measure colloid osmotic pressure in interstitial fluid (COPi) from human subcutaneous tissue with the modified wick technique in order to determine influence of topical application of anaesthetics, dry vs. wet wick and implantation time on COPi. Material and Methods: In 50 healthy volunteers interstitial fluid (IF) was collected by subcutaneous implantation of multifilamentous nylon wicks. Study subjects were allocated to two groups; one for comparing COPi obtained from dry and saline soaked wicks, and one for comparing COPi from unanaesthetized skin, and skin after application of a eutectic mixture of local anaesthetic (EMLA (R), Astra Zeneca) cream. IF was sampled from the skin of the shoulders, and implantation time was 30, 60, 75, 90 and 120 min. Colloid osmotic pressure was measured with a colloid osmometer. Pain assessment during the procedure was compared for EMLA cream and no topical anaesthesia using a visual analogue scale (VAS) in a subgroup of 10 subjects. Results: There were no significant differences between COPi obtained from dry compared to wet wicks, except that the values after 75 and 90 min. were somewhat higher for the dry wicks. Topical anaesthesia with EMLA cream did not affect COPi values. COPi decreased from 30 to 75 min. of implantation (23.2 +/- 4.4 mmHg to 19.6 +/- 2.9 mmHg, p = 0.008) and subsequently tended to increase until 120 min. EMLA cream resulted in significant lower VAS score for the procedure. Conclusion: COPi from subcutaneous tissue was easily obtained and fluid harvesting was well tolerated when topical anaesthetic was used. The difference in COPi assessed by dry and wet wicks between 75 min. and 90 min. of implantation was in accordance with previous reports. The use of topical analgesia did not influence COPi and topical analgesia may make the wick technique more acceptable for subjects who dislike technical procedures, including children.	[Guthe, Hans Jorgen Timm; Berg, Ansgar] Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway; [Nedrebo, Torbjorn; Tenstad, Olav; Wiig, Helge] Univ Bergen, Dept Biomed, Physiol Sect, Bergen, Norway; [Berg, Ansgar] Univ Bergen, Dept Clin Med, Paediat Sect, Bergen, Norway; [Nedrebo, Torbjorn] Haukeland Hosp, Dept Occupat Med, Hyperbar Med Unit, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Guthe, HJT (corresponding author), Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway.	hjgu@helse-bergen.no		Wiig, Helge/0000-0002-7740-8210	Helse Vest; Haukeland University Hospital [911441]	Helse Vest; Haukeland University Hospital	This work was supported by grants from Helse Vest, Haukeland University Hospital, Project number 911441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad F, 2001, ACTA PAEDIATR, V90, P160, DOI 10.1080/080352501300049325; Ashley EMC, 1999, ANAESTHESIA, V54, P466, DOI 10.1046/j.1365-2044.1999.00644.x; AstraZeneca, 2005, EML CREAM PROD INF; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; AUKLAND K, 1973, ACTA PHYSIOL SCAND, V88, P350, DOI 10.1111/j.1748-1716.1973.tb05464.x; AUKLAND K, 1974, ACTA PHYSIOL SCAND, V90, P485, DOI 10.1111/j.1748-1716.1974.tb05611.x; BATES DO, 1994, J PHYSIOL-LONDON, V477, P355, DOI 10.1113/jphysiol.1994.sp020197; BATES DO, 1993, CLIN SCI, V85, P737, DOI 10.1042/cs0850737; BJERRING P, 1989, BRIT J ANAESTH, V63, P655, DOI 10.1093/bja/63.6.655; European Union, 2008, EUR J HLTH LAW, V15, P223; FADNES HO, 1978, LYMPHOLOGY, V11, P165; FADNES HO, 1977, MICROVASC RES, V14, P11, DOI 10.1016/0026-2862(77)90137-6; Haaverstad R, 1996, INT J MICROCIRC, V16, P111, DOI 10.1159/000179159; Heltne JK, 1998, LAB ANIM-UK, V32, P439, DOI 10.1258/002367798780599848; Heradstveit BE, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-29; Khiabani HZ, 2000, EUR J VASC ENDOVASC, V19, P598, DOI 10.1053/ejvs.2000.1073; KOOMANS HA, 1985, NEPHRON, V40, P391, DOI 10.1159/000183505; KRAMER GC, 1986, MICROVASC RES, V32, P39, DOI 10.1016/0026-2862(86)90042-7; NILSSON A, 1994, ANAESTHESIA, V49, P70, DOI 10.1111/j.1365-2044.1994.tb03319.x; NODDELAND H, 1984, CLIN PHYSIOL, V4, P283, DOI 10.1111/j.1475-097X.1984.tb00804.x; NODDELAND H, 1982, SCAND J CLIN LAB INV, V42, P131; NODDELAND H, 1982, SCAND J CLIN LAB INV, V42, P139; NODDELAND H, 1982, SCAND J CLIN LAB INV, V42, P123; OIAN P, 1985, BRIT J OBSTET GYNAEC, V92, P1113; OIAN P, 1986, BRIT J OBSTET GYNAEC, V93, P235, DOI 10.1111/j.1471-0528.1986.tb07899.x; POULSEN HL, 1973, SCAND J CLIN LAB INV, V32, P167, DOI 10.3109/00365517309084345; Riendeau LA, 1999, REGION ANESTH PAIN M, V24, P165, DOI 10.1016/S1098-7339(99)90079-2; Semb KA, 1998, J CLIN ONCOL, V16, P3426, DOI 10.1200/JCO.1998.16.10.3426; Shaikh FM, 2009, DERMATOL SURG, V35, P948, DOI 10.1111/j.1524-4725.2009.01160.x; Starling E H, 1896, J Physiol, V19, P312; STRANDEN E, 1983, SCAND J CLIN LAB INV, V43, P233; TOLLAN A, 1993, ACTA OBSTET GYN SCAN, V72, P238, DOI 10.3109/00016349309068030; WIIG H, 1988, ACTA PHYSIOL SCAND, V132, P445, DOI 10.1111/j.1748-1716.1988.tb08351.x; WIIG H, 1988, ACTA PHYSIOL SCAND, V133, P167, DOI 10.1111/j.1748-1716.1988.tb08396.x; WILLATTS DG, 1985, BRIT J ANAESTH, V57, P1006, DOI 10.1093/bja/57.10.1006	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31332	10.1371/journal.pone.0031332	http://dx.doi.org/10.1371/journal.pone.0031332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348071	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400015
J	Liu, WM; Ren, Y; Bossert, A; Wang, XW; Dayawansa, S; Tong, J; He, XS; Smith, DH; Gelbard, HA; Huang, JH				Liu, Weimin; Ren, Yi; Bossert, Adam; Wang, Xiaowei; Dayawansa, Samantha; Tong, Jing; He, Xiaoshen; Smith, Douglas H.; Gelbard, Harris A.; Huang, Jason H.			Allotransplanted Neurons Used to Repair Peripheral Nerve Injury Do Not Elicit Overt Immunogenicity	PLOS ONE			English	Article							SCHWANN-CELLS; INTERFERON-GAMMA; CLASS-I; REGENERATION; AXONS; MOTONEURONS; EXPRESSION; ALLOGRAFTS; INSIGHTS	A major problem hindering the development of autograft alternatives for repairing peripheral nerve injuries is immunogenicity. We have previously shown successful regeneration in transected rat sciatic nerves using conduits filled with allogeneic dorsal root ganglion (DRG) cells without any immunosuppression. In this study, we re-examined the immunogenicity of our DRG neuron implanted conduits as a potential strategy to overcome transplant rejection. A biodegradable NeuraGen (R) tube was infused with pure DRG neurons or Schwann cells cultured from a rat strain differing from the host rats and used to repair 8 mm gaps in the sciatic nerve. We observed enhanced regeneration with allogeneic cells compared to empty conduits 16 weeks post-surgery, but morphological analyses suggest recovery comparable to the healthy nerves was not achieved. The degree of regeneration was indistinguishable between DRG and Schwann cell allografts although immunogenicity assessments revealed substantially increased presence of Interferon gamma (IFN-gamma) in Schwann cell allografts compared to the DRG allografts by two weeks post-surgery. Macrophage infiltration of the regenerated nerve graft in the DRG group 16 weeks post-surgery was below the level of the empty conduit (0.56 fold change from NG; p<0.05) while the Schwann cell group revealed significantly higher counts (1.29 fold change from NG; p<0.001). Major histocompatibility complex I (MHC I) molecules were present in significantly increased levels in the DRG and Schwann cell allograft groups compared to the hollow NG conduit and the Sham healthy nerve. Our results confirmed previous studies that have reported Schwann cells as being immunogenic, likely due to MHC I expression. Nerve gap injuries are difficult to repair; our data suggest that DRG neurons are superior medium to implant inside conduit tubes due to reduced immunogenicity and represent a potential treatment strategy that could be preferable to the current gold standard of autologous nerve transplant.	[Liu, Weimin; Ren, Yi; Bossert, Adam; Wang, Xiaowei; Dayawansa, Samantha; Tong, Jing; Huang, Jason H.] Univ Rochester, Dept Neurosurg, Rochester, NY 14627 USA; [Liu, Weimin; Ren, Yi; Bossert, Adam; Wang, Xiaowei; Dayawansa, Samantha; Tong, Jing; Gelbard, Harris A.; Huang, Jason H.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY USA; [Tong, Jing] Hebei Med Univ, Affiliated Hosp 4, Dept Neurosurg, Shijiazhuang, Hebei Province, Peoples R China; [He, Xiaoshen] Fourth Mil Univ, Xijing Hosp, Dept Neurosurg, Xian, Peoples R China; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Gelbard, Harris A.] Univ Rochester, Dept Neurol, Rochester, NY USA	University of Rochester; University of Rochester; Hebei Medical University; Air Force Military Medical University; University of Pennsylvania; Pennsylvania Medicine; University of Rochester	Liu, WM (corresponding author), Univ Rochester, Dept Neurosurg, Rochester, NY 14627 USA.	Jason_Huang@URMC.Rochester.edu	Huang, Jason H/J-4739-2019; Gelbard, Harris/M-9260-2019	Huang, Jason H/0000-0002-4426-0168; Gelbard, Harris/0000-0001-5095-7976	NIH [R01-NS067435]; SPAC from the University of Rochester Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPAC from the University of Rochester Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grant R01-NS067435 and a SPAC grant from the University of Rochester Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JR, 2000, MICROSURG, V20, P384, DOI 10.1002/1098-2752(2000)20:8<384::AID-MICR7>3.0.CO;2-W; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757; EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9; Ghaznavi AM, 2011, ANN PLAS SURG, V66, P273, DOI 10.1097/SAP.0b013e3181e6cff7; GUENARD V, 1992, J NEUROSCI, V12, P3310; GULATI AK, 1995, TRANSPLANTATION, V59, P1618, DOI 10.1097/00007890-199506150-00020; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; HARE GMT, 1993, TRANSPLANTATION, V56, P154, DOI 10.1097/00007890-199307000-00029; Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Huang JH, 2004, SURG NEUROL, V61, P372, DOI 10.1016/j.surneu.2003.08.006; Joseph MS, 2011, J NEUROSCI RES, V89, P365, DOI 10.1002/jnr.22557; Kerschensteiner M, 2009, NEUROSCIENCE, V158, P1122, DOI 10.1016/j.neuroscience.2008.09.009; LEBEAU JM, 1988, J NEUROCYTOL, V17, P161, DOI 10.1007/BF01674203; Linda H, 1998, EXP NEUROL, V150, P282, DOI 10.1006/exnr.1997.6768; MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Neumann H, 1997, J EXP MED, V186, P2023, DOI 10.1084/jem.186.12.2023; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; OLSSON T, 1989, J NEUROSCI, V9, P3870; Pattison JM, 1997, AM J MED SCI, V313, P257, DOI 10.1097/00000441-199705000-00002; Pedersen LE, 2011, IMMUNOGENETICS; Pfister BJ, 2006, J NEUROSCI METH, V153, P95, DOI 10.1016/j.jneumeth.2005.10.012; Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; VERT M, 1992, Clinical Materials, V10, P3, DOI 10.1016/0267-6605(92)90077-7; Wallquist W, 2005, J NEUROSCI, V25, P3692, DOI 10.1523/JNEUROSCI.5225-04.2005; Wu ZP, 2011, IMMUNOL LETT, V135, P118, DOI 10.1016/j.imlet.2010.10.011; Zanon RG, 2006, EXP NEUROL, V200, P521, DOI 10.1016/j.expneurol.2006.03.004	33	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31675	10.1371/journal.pone.0031675	http://dx.doi.org/10.1371/journal.pone.0031675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347502	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730200030
J	Duttagupta, R; DiRienzo, S; Jiang, R; Bowers, J; Gollub, J; Kao, J; Kearney, K; Rudolph, D; Dawany, NB; Showe, MK; Stamato, T; Getts, RC; Jones, KW				Duttagupta, Radha; DiRienzo, Sharon; Jiang, Rong; Bowers, Jessica; Gollub, Jeremy; Kao, Jessica; Kearney, Keith; Rudolph, David; Dawany, Noor B.; Showe, Michael K.; Stamato, Tom; Getts, Robert C.; Jones, Keith W.			Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; MICRORNA; EXPRESSION; PROFILES; POLYMORPHISMS; DISTINGUISH; DISCOVERY; PLATELETS; AUTOPHAGY	Inflammatory Bowel Disease - comprised of Crohn's Disease and Ulcerative Colitis (UC) - is a complex, multi-factorial inflammatory disorder of the gastrointestinal tract. In this study we have explored the utility of naturally occurring circulating miRNAs as potential blood-based biomarkers for non-invasive prediction of UC incidences. Whole genome maps of circulating miRNAs in micro-vesicles, Peripheral Blood Mononuclear Cells and platelets have been constructed from a cohort of 20 UC patients and 20 normal individuals. Through Significance Analysis of Microarrays, a signature of 31 differentially expressed platelet-derived miRNAs has been identified and biomarker performance estimated through a non-probabilistic binary linear classification using Support Vector Machines. Through this approach, classifier measurements reveal a predictive score of 92.8% accuracy, 96.2% specificity and 89.5% sensitivity in distinguishing UC patients from normal individuals. Additionally, the platelet-derived biomarker signature can be validated at 88% accuracy through qPCR assays, and a majority of the miRNAs in this panel can be demonstrated to sub-stratify into 4 highly correlated intensity based clusters. Analysis of predicted targets of these biomarkers reveal an enrichment of pathways associated with cytoskeleton assembly, transport, membrane permeability and regulation of transcription factors engaged in a variety of regulatory cascades that are consistent with a cell-mediated immune response model of intestinal inflammation. Interestingly, comparison of the miRNA biomarker panel and genetic loci implicated in IBD through genome-wide association studies identifies a physical linkage between hsa-miR-941 and a UC susceptibility loci located on Chr 20. Taken together, analysis of these expression maps outlines a promising catalog of novel platelet-derived miRNA biomarkers of clinical utility and provides insight into the potential biological function of these candidates in disease pathogenesis.	[Duttagupta, Radha; Jiang, Rong; Gollub, Jeremy; Kao, Jessica; Jones, Keith W.] Affymetrix Inc, Appl Reasearch Grp, Santa Clara, CA USA; [Bowers, Jessica; Getts, Robert C.] Genisphere LLC, Res & Dev, Hatfield, PA USA; [DiRienzo, Sharon; Stamato, Tom] Lankenau Inst Med Res, Wynnewood, PA USA; [Kearney, Keith; Rudolph, David] Lankenau Med Ctr, Div Gastroenterol, Wynnewood, PA USA; [Dawany, Noor B.; Showe, Michael K.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Affymetrix; Lankenau Medical Center; Lankenau Institute for Medical Research; Lankenau Medical Center; The Wistar Institute	Duttagupta, R (corresponding author), Affymetrix Inc, Appl Reasearch Grp, Santa Clara, CA USA.	Keith_Jones@affymetrix.com			Sharpe-Strumia Research Foundation of Bryn Mawr Hospital	Sharpe-Strumia Research Foundation of Bryn Mawr Hospital	Support for this work was provided by Sharpe-Strumia Research Foundation of Bryn Mawr Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bamias G, 2007, CURR OPIN GASTROEN, V23, P365, DOI 10.1097/MOG.0b013e3281c55eb2; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beniwal Poonam, 2010, Curr Gastroenterol Rep, V12, P479, DOI 10.1007/s11894-010-0145-9; Benjamini Y, 2001, ANN STAT, V29, P1165; Boni V, 2011, PHARMACOGENOMICS J, V11, P429, DOI 10.1038/tpj.2010.58; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Danese S, 2004, AM J GASTROENTEROL, V99, P938, DOI 10.1111/j.1572-0241.2004.04129.x; Danese S, 2011, AM J PHYSIOL-GASTR L, V300, pG716, DOI 10.1152/ajpgi.00472.2010; Elalamy I., 2008, EUR REV MED PHARMACO, V121, P843; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kwon JH, 2011, INFLAMMATORY BOWEL D; Landry P, 2009, NATURE STRUCTURAL MO; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Merrill AH, 1997, J NUTR, V127, pS830, DOI 10.1093/jn/127.5.830S; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Reid G, 2010, CRITICAL REV ONCOLOG; Roda G, 2010, INFLAMM BOWEL DIS, V16, P1239, DOI 10.1002/ibd.21212; Rybaczyk L, 2009, INFLAMM BOWEL DIS, V15, P971, DOI 10.1002/ibd.20893; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; SCHOEDON G, 1986, J INTERFERON RES, V6, P697, DOI 10.1089/jir.1986.6.697; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450	49	78	84	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31241	10.1371/journal.pone.0031241	http://dx.doi.org/10.1371/journal.pone.0031241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359580	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200049
J	Hu, RB; Chi, XY; Chai, GH; Kong, YZ; He, G; Wang, XY; Shi, DC; Zhang, DY; Zhou, GK				Hu, Ruibo; Chi, Xiaoyuan; Chai, Guohua; Kong, Yingzhen; He, Guo; Wang, Xiaoyu; Shi, Dachuan; Zhang, Dongyuan; Zhou, Gongke			Genome-Wide Identification, Evolutionary Expansion, and Expression Profile of Homeodomain-Leucine Zipper Gene Family in Poplar (Populus trichocarpa)	PLOS ONE			English	Article							MICRORNA-DIRECTED CLEAVAGE; CLASS IIIHD-ZIP; HD-ZIP; HOMEOBOX GENE; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; WATER-DEFICIT; CELL-DIFFERENTIATION; LEAF DEVELOPMENT; MICROARRAY DATA	Background: Homeodomain-leucine zipper (HD-ZIP) proteins are plant-specific transcriptional factors known to play crucial roles in plant development. Although sequence phylogeny analysis of Populus HD-ZIPs was carried out in a previous study, no systematic analysis incorporating genome organization, gene structure, and expression compendium has been conducted in model tree species Populus thus far. Principal Findings: In this study, a comprehensive analysis of Populus HD-ZIP gene family was performed. Sixty-three full-length HD-ZIP genes were found in Populus genome. These Populus HD-ZIP genes were phylogenetically clustered into four distinct subfamilies (HD-ZIP I-IV) and predominately distributed across 17 linkage groups (LG). Fifty genes from 25 Populus paralogous pairs were located in the duplicated blocks of Populus genome and then preferentially retained during the sequential evolutionary courses. Genomic organization analyses indicated that purifying selection has played a pivotal role in the retention and maintenance of Populus HD-ZIP gene family. Microarray analysis has shown that 21 Populus paralogous pairs have been differentially expressed across different tissues and under various stresses, with five paralogous pairs showing nearly identical expression patterns, 13 paralogous pairs being partially redundant and three paralogous pairs diversifying significantly. Quantitative real-time RT-PCR (qRT-PCR) analysis performed on 16 selected Populus HD-ZIP genes in different tissues and under both drought and salinity stresses confirms their tissue-specific and stress-inducible expression patterns. Conclusions: Genomic organizations indicated that segmental duplications contributed significantly to the expansion of Populus HD-ZIP gene family. Exon/intron organization and conserved motif composition of Populus HD-ZIPs are highly conservative in the same subfamily, suggesting the members in the same subfamilies may also have conservative functionalities. Microarray and qRT-PCR analyses showed that 89% (56 out of 63) of Populus HD-ZIPs were duplicate genes that might have been retained by substantial subfunctionalization. Taken together, these observations may lay the foundation for future functional analysis of Populus HD-ZIP genes to unravel their biological roles.	[Hu, Ruibo; Chai, Guohua; He, Guo; Wang, Xiaoyu; Shi, Dachuan; Zhang, Dongyuan; Zhou, Gongke] Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, Shandong Prov Key Lab Energy Genet, CAS Key Lab Biofuels, Qingdao, Shandong, Peoples R China; [Chi, Xiaoyuan] Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China; [Kong, Yingzhen] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University System of Georgia; University of Georgia	Hu, RB (corresponding author), Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, Shandong Prov Key Lab Energy Genet, CAS Key Lab Biofuels, Qingdao, Shandong, Peoples R China.	zhangdy@qibebt.ac.cn; zhougk@qibebt.ac.cn	zheng, yonghong/H-3700-2012; kong, yingzhen/AAB-1623-2022; Chai, Guohua/E-1270-2011; Hu, Ruibo/P-3471-2018	Chai, Guohua/0000-0002-2724-6516; Hu, Ruibo/0000-0001-6299-5320	National High-Tech Research and Development Program of China [2009AA10Z101, 2011AA100209]; National Basic Research Program of China [2012CB114501]; National Natural Science Foundation of China [30901157, 31000311]; Chinese Academy of Sciences; Qingdao Municipal Science and Technology Plan Project [11-2-4-8-(2)-jch]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2011SW055]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Qingdao Municipal Science and Technology Plan Project; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province	This study was supported by grants from the National High-Tech Research and Development Program of China ("863" program, 2009AA10Z101 and 2011AA100209), the National Basic Research Program of China ("973" program, 2012CB114501), the National Natural Science Foundation of China (30901157 and 31000311), the Program of 100 Distinguished Young Scientists of the Chinese Academy of Sciences, the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2011SW055), and the Qingdao Municipal Science and Technology Plan Project (11-2-4-8-(2)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; AOYAMA T, 1995, PLANT CELL, V7, P1773, DOI 10.1105/tpc.7.11.1773; Aso K, 1999, MOL BIOL EVOL, V16, P544, DOI 10.1093/oxfordjournals.molbev.a026135; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Barakat A, 2011, GENE, V479, P37, DOI 10.1016/j.gene.2011.02.008; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Carabelli M, 1996, P NATL ACAD SCI USA, V93, P3530, DOI 10.1073/pnas.93.8.3530; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Ciarbelli AR, 2008, PLANT MOL BIOL, V68, P465, DOI 10.1007/s11103-008-9383-8; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Cote CL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-273; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Dezar CA, 2011, J EXP BOT, V62, P1061, DOI 10.1093/jxb/erq339; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; Du JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017458; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Frank W, 1998, PLANT J, V15, P413, DOI 10.1046/j.1365-313X.1998.00222.x; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hanson J, 2001, PLANT MOL BIOL, V45, P247, DOI 10.1023/A:1006464907710; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hjellstrom M, 2003, PLANT CELL ENVIRON, V26, P1127, DOI 10.1046/j.1365-3040.2003.01037.x; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Itoh JI, 2008, PLANT PHYSIOL, V147, P1960, DOI 10.1104/pp.108.118679; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Johannesson H, 2001, PLANT MOL BIOL, V45, P63, DOI 10.1023/A:1006423324025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim YK, 2007, PLANT CELL REP, V26, P1179, DOI 10.1007/s00299-007-0340-9; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Masucci JD, 1996, DEVELOPMENT, V122, P1253; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; McHale NA, 2004, PLANT CELL, V16, P1730, DOI 10.1105/tpc.021816; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Ohashi Y, 2002, PLANT J, V29, P359, DOI 10.1046/j.0960-7412.2001.01214.x; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; RUBERTI I, 1991, EMBO J, V10, P1787, DOI 10.1002/j.1460-2075.1991.tb07703.x; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Shen B, 2006, PLANT MOL BIOL, V60, P377, DOI 10.1007/s11103-005-4110-1; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Soderman E, 1999, PLANT MOL BIOL, V40, P1073, DOI 10.1023/A:1006267013170; Steindler C, 1999, DEVELOPMENT, V126, P4235; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tahir M, 2008, PLANT PHYSIOL BIOCH, V46, P1031, DOI 10.1016/j.plaphy.2008.08.001; Tamura K, 2011, MOL BIOL EVOL; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Tuominen LK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-236; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Wang XF, 2006, BIOINFORMATICS, V22, P2955, DOI 10.1093/bioinformatics/btl525; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan YA, 2009, P NATL ACAD SCI USA, V106, P22020, DOI 10.1073/pnas.0906869106; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139; Zhong R, 2007, PLANT SIGNAL BEHAV, V2, P351, DOI 10.4161/psb.2.5.4119; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087	89	62	74	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31149	10.1371/journal.pone.0031149	http://dx.doi.org/10.1371/journal.pone.0031149			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359569	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200038
J	Lu, YH; Fu, BJ; Feng, XM; Zeng, Y; Liu, Y; Chang, RY; Sun, G; Wu, BF				Lu, Yihe; Fu, Bojie; Feng, Xiaoming; Zeng, Yuan; Liu, Yu; Chang, Ruiying; Sun, Ge; Wu, Bingfang			A Policy-Driven Large Scale Ecological Restoration: Quantifying Ecosystem Services Changes in the Loess Plateau of China	PLOS ONE			English	Article							LAND CONVERSION PROGRAM; FOR-GREEN PROGRAM; ENVIRONMENTAL-CHANGES; GRAIN; VEGETATION; IMPACT; PRODUCTIVITY; METAANALYSIS; ENHANCEMENT; IMPROVEMENT	As one of the key tools for regulating human-ecosystem relations, environmental conservation policies can promote ecological rehabilitation across a variety of spatiotemporal scales. However, quantifying the ecological effects of such policies at the regional level is difficult. A case study was conducted at the regional level in the ecologically vulnerable region of the Loess Plateau, China, through the use of several methods including the Universal Soil Loss Equation (USLE), hydrological modeling and multivariate analysis. An assessment of the changes over the period of 2000-2008 in four key ecosystem services was undertaken to determine the effects of the Chinese government's ecological rehabilitation initiatives implemented in 1999. These ecosystem services included water regulation, soil conservation, carbon sequestration and grain production. Significant conversions of farmland to woodland and grassland were found to have resulted in enhanced soil conservation and carbon sequestration, but decreased regional water yield under a warming and drying climate trend. The total grain production increased in spite of a significant decline in farmland acreage. These trends have been attributed to the strong socioeconomic incentives embedded in the ecological rehabilitation policy. Although some positive policy results have been achieved over the last decade, large uncertainty remains regarding long-term policy effects on the sustainability of ecological rehabilitation performance and ecosystem service enhancement. To reduce such uncertainty, this study calls for an adaptive management approach to regional ecological rehabilitation policy to be adopted, with a focus on the dynamic interactions between people and their environments in a changing world.	[Lu, Yihe; Fu, Bojie; Feng, Xiaoming; Liu, Yu; Chang, Ruiying] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zeng, Yuan; Wu, Bingfang] Chinese Acad Sci, Inst Remote Sensing Applicat, Beijing, Peoples R China; [Sun, Ge] US Forest Serv, USDA, So Res Stn, Raleigh, NC USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; United States Department of Agriculture (USDA); United States Forest Service	Lu, YH (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Sun, Ge/ABF-6673-2020; Fu, Bojie/B-1493-2009; Wu, Bingfang/AAD-7223-2022	chang, rui ying/0000-0002-0534-4502	National Basic Research Program of China [2009CB421104]; National Natural Science Foundation of China [40930528, 40971065]; State Forestry Administration [201004058]; CAS/SAFEA	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration; CAS/SAFEA(Chinese Academy of Sciences)	This work was financially supported by the National Basic Research Program of China (No. 2009CB421104), the National Natural Science Foundation of China (Nos. 40930528 and 40971065), the State Forestry Administration (No. 201004058), and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T.G., 2008, SW HYDROL, V7, P18; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2001, J GEOGR SCI; Aronson J, 2010, RESTOR ECOL, V18, P143, DOI 10.1111/j.1526-100X.2009.00638.x; Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Cai C., 2000, J SOIL WATER CONSERV, V2, P19, DOI [10.13870/j.cnki.stbcxb.2000.02.005, DOI 10.13870/J.CNKI.STBCXB.2000.02.005, 10.3321/j.issn:1009-2242.2000.02.005]; Cao ShiXiong, 2007, Scientia Agricultura Sinica, V40, P972; Cao SX, 2009, LAND USE POLICY, V26, P1182, DOI 10.1016/j.landusepol.2009.02.006; Cao SX, 2009, J APPL ECOL, V46, P536, DOI 10.1111/j.1365-2664.2008.01605.x; Chang ZW, 2002, SOIL WATER CONSERVAT, V29, P39; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; Ciesiolka CAA, 2006, J SOIL WATER CONSERV, V61, P223; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Feng ZD, 2006, PALAEOGEOGR PALAEOCL, V241, P440, DOI 10.1016/j.palaeo.2006.04.009; Gilioli G, 2007, ECOHEALTH, V4, P428, DOI 10.1007/s10393-007-0128-y; Halle S, 2007, RESTOR ECOL, V15, P358, DOI 10.1111/j.1526-100X.2007.00226.x; HAMON W. R., 1964, Publ. Int. Ass. sci. Hydrol. Symp. gen. Assembly Berkeley, V63, P52; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Hu CX, 2006, INT J SUST DEV WORLD, V13, P211, DOI 10.1080/13504500609469673; Kinnell PIA, 2008, EARTH SURF PROC LAND, V33, P1627, DOI 10.1002/esp.1629; Kinnell PIA, 2010, J HYDROL, V385, P384, DOI 10.1016/j.jhydrol.2010.01.024; Li CB, 2010, ENVIRON MANAGE, V45, P476, DOI 10.1007/s00267-009-9369-6; Li L, 2010, J FOOD AGRIC ENVIRON, V8, P1185; [李奇睿 Li Qirui], 2010, [水土保持通报, Bulletin of Soil and Water Conservation], V30, P206; Li W, 2008, FOREST ECOL MANAG, V255, P2467, DOI 10.1016/j.foreco.2008.01.006; Li Y., 2009, FOR CONSTR, V5, P3, DOI [10.3969/j.issn.1006-6918.2009.05.001, DOI 10.3969/J.ISSN.1006-6918.2009.05.001]; Liu GC, 2007, SOIL WATER CONSERVAT, V34, P11; Liu ZR, 2006, SOIL WATER CONSERVAT, V27, P30; Lou XT, 2010, J ANHUI AGR SCI, V38, P6057; Peng H, 2007, J FOREST, V105, P409; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Shang X, 2010, REV PALAEOBOT PALYNO, V160, P46, DOI 10.1016/j.revpalbo.2010.01.004; Shi MJ, 2011, SUSTAIN SCI, V6, P135, DOI 10.1007/s11625-011-0133-5; Soil Survey Office of Shaanxi Province, 1992, SOIL SHAANX; Sun AZ, 2010, J GEOGR SCI, V20, P177, DOI 10.1007/s11442-010-0177-y; Sun G, 2011, ECOHYDROLOGY, V4, P245, DOI 10.1002/eco.194; Tattari S, 2001, PHYS CHEM EARTH PT B, V26, P27, DOI 10.1016/S1464-1909(01)85010-3; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; WAHBA G, 1980, MON WEATHER REV, V108, P1122, DOI 10.1175/1520-0493(1980)108<1122:SNMMFV>2.0.CO;2; Wan YM, 1994, J SOIL WATER CONSERV, V8, P11; Wang C, 2007, J ENVIRON MANAGE, V85, P746, DOI 10.1016/j.jenvman.2006.04.025; Wang L, 2006, ENVIRON SCI POLICY, V9, P675, DOI 10.1016/j.envsci.2006.08.003; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Xie C, 2009, FORESTRY EC, V31, P56; Xin ZB, 2008, SCI CHINA SER D, V51, P67, DOI 10.1007/s11430-007-0137-2; Xu ZG, 2004, INT FOREST REV, V6, P317, DOI 10.1505/ifor.6.3.317.59976; Yao SB, 2010, ENVIRON MANAGE, V45, P541, DOI 10.1007/s00267-009-9416-3; Yin RS, 2010, ENVIRON MANAGE, V45, P442, DOI 10.1007/s00267-009-9387-4; Yu DY, 2009, INT J REMOTE SENS, V30, P4851, DOI 10.1080/01431160802680552; Yu T, 2010, ESTUARINE COASTAL SH, V86, P345, DOI DOI 10.1016/J.ECSS.2009.05.014; Zhang K, 2004, SOIL TILL RES, V76, P157, DOI 10.1016/j.still.2003.09.007; Zhang K, 2010, QUATERN INT, V227, P38, DOI 10.1016/j.quaint.2010.04.019; Zhang Q, 2009, WATER RESOUR MANAG, V23, P1157, DOI 10.1007/s11269-008-9320-2; [张万昌 ZHANG WanChang], 2008, [生态学报, Acta Ecologica Sinica], V28, P2495; Zhang XP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006711; [周芸 Zhou Yun], 2005, [现代免疫学, Current Immunology], V25, P11; Zhu QK, 2009, J NW FORESTRY U, V24, P219; 方精云, 2007, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V37, P804	59	383	422	68	496	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31782	10.1371/journal.pone.0031782	http://dx.doi.org/10.1371/journal.pone.0031782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359628	Green Published, gold			2022-12-27	WOS:000302796200097
J	Meisner, A; de Boer, W; Cornelissen, JHC; van der Putten, WH				Meisner, Annelein; de Boer, Wietse; Cornelissen, Johannes H. C.; van der Putten, Wim H.			Reciprocal Effects of Litter from Exotic and Congeneric Native Plant Species via Soil Nutrients	PLOS ONE			English	Article							SENECIO-JACOBAEA L; LEAF-LITTER; INVASIVE PLANTS; DECOMPOSITION RATES; TRAITS; ECOSYSTEM; IMPACTS; CARBON; CONSEQUENCES; ECOLOGY	Invasive exotic plant species are often expected to benefit exclusively from legacy effects of their litter inputs on soil processes and nutrient availability. However, there are relatively few experimental tests determining how litter of exotic plants affects their own growth conditions compared to congeneric native plant species. Here, we test how the legacy of litter from three exotic plant species affects their own performance in comparison to their congeneric natives that co-occur in the invaded habitat. We also analyzed litter effects on soil processes. In all three comparisons, soil with litter from exotic plant species had the highest respiration rates. In two out of the three exotic-native species comparisons, soil with litter from exotic plant species had higher inorganic nitrogen concentrations than their native congener, which was likely due to higher initial litter quality of the exotics. When litter from an exotic plant species had a positive effect on itself, it also had a positive effect on its native congener. We conclude that exotic plant species develop a legacy effect in soil from the invaded range through their litter inputs. This litter legacy effect results in altered soil processes that can promote both the exotic plant species and their native congener.	[Meisner, Annelein; van der Putten, Wim H.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [de Boer, Wietse] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Cornelissen, Johannes H. C.] Vrije Univ VU Amsterdam, Fac Earth & Life Sci, Dept Ecol Sci, Amsterdam, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam; Wageningen University & Research	Meisner, A (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.	A.Meisner@nioo.knaw.nl	van der Putten, Wim H/C-3707-2011; de Boer, Wietse/C-2737-2011; Meisner, Annelein/F-1778-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; de Boer, Wietse/0000-0002-5380-2993; Meisner, Annelein/0000-0002-8053-5712; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Research Council [865.05.002]	Dutch Research Council	This study was funded by the Dutch Research Council ALW-Vici project (number 865.05.002) to WHV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; Ashton IW, 2005, ECOL APPL, V15, P1263, DOI 10.1890/04-0741; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Barney JN, 2006, BIOL INVASIONS, V8, P703, DOI 10.1007/s10530-005-3174-9; BERENDSE F, 1994, J ECOL, V82, P187, DOI 10.2307/2261398; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Cadisch G., 1997, DRIVEN NATURE PLANT; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dassonville N, 2008, OECOLOGIA, V157, P131, DOI 10.1007/s00442-008-1054-6; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Ridder-Duine AS, 2006, PEDOBIOLOGIA, V50, P293, DOI 10.1016/j.pedobi.2006.03.004; Dietz H, 2002, PLANT ECOL, V158, P171, DOI 10.1023/A:1015567316004; Dirkse G. M., 2007, FLORA NIJMEGEN KLEEF; Dorrepaal E, 2007, OECOLOGIA, V151, P251, DOI 10.1007/s00442-006-0580-3; Drenovsky RE, 2007, BIOL INVASIONS, V9, P107, DOI 10.1007/s10530-006-0007-4; Ehrenfeld JG, 2004, WEED TECHNOL, V18, P1232, DOI 10.1614/0890-037X(2004)018[1232:IOISFB]2.0.CO;2; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Engelkes T, 2008, NATURE, V456, P946, DOI 10.1038/nature07474; Eppinga MB, 2011, J ECOL, V99, P503, DOI 10.1111/j.1365-2745.2010.01781.x; FACELLI JM, 1993, OECOLOGIA, V95, P277, DOI 10.1007/BF00323500; Farrer EC, 2009, ECOL APPL, V19, P398, DOI 10.1890/08-0485.1; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Godoy O, 2010, OECOLOGIA, V162, P781, DOI 10.1007/s00442-009-1512-9; Guesewell S, 2006, FUNCT ECOL, V20, P575, DOI 10.1111/j.1365-2435.2006.01141.x; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Hodkinson DJ, 1997, J APPL ECOL, V34, P1484, DOI 10.2307/2405264; Inderjit, 2011, ECOLOGY, V92, P316, DOI 10.1890/10-0400.1; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Koutika LS, 2007, BIOL FERT SOILS, V44, P331, DOI 10.1007/s00374-007-0210-1; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lachmuth S, 2011, NEW PHYTOL, V192, P529, DOI 10.1111/j.1469-8137.2011.03808.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Meisner A, 2011, J ECOL, V99, P1308, DOI 10.1111/j.1365-2745.2011.01858.x; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Olsson PA, 2003, NEW PHYTOL, V159, P7, DOI 10.1046/j.1469-8137.2003.00810.x; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pelser P.B., 2006, COMPOSITAE NEWSLETTE, V44, P1; Penuelas J, 2007, GLOBAL CHANGE BIOL, V13, P2563, DOI 10.1111/j.1365-2486.2007.01464.x; Petsikos C, 2007, AGR ECOSYST ENVIRON, V120, P325, DOI 10.1016/j.agee.2006.10.019; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Pysek Petr, 2007, V193, P97; Raizada P, 2008, P NATL A SCI INDIA B, V78, P288; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Rothstein DE, 2004, ECOSYSTEMS, V7, P805, DOI 10.1007/s10021-004-0009-y; Scharfy D, 2011, NEW PHYTOL, V189, P818, DOI 10.1111/j.1469-8137.2010.03531.x; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; Strickland MS, 2010, GLOBAL CHANGE BIOL, V16, P1338, DOI 10.1111/j.1365-2486.2009.02042.x; STUCKEY RONALD L., 1966, SIDA CONTRIB BOT, V2, P361; Tamis W. L. M., 2005, GORTERIA, V6, P135; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; van der Wal A, 2007, PLANT SOIL, V301, P189, DOI 10.1007/s11104-007-9437-8; van Grunsven RHA, 2010, GLOBAL CHANGE BIOL, V16, P380, DOI 10.1111/j.1365-2486.2009.01996.x; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; Vila M, 2006, J BIOGEOGR, V33, P853, DOI 10.1111/j.1365-2699.2005.01430.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; WALKER LR, 1991, ECOLOGY, V72, P1449, DOI 10.2307/1941117; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1998, J ECOL, V86, P405, DOI 10.1046/j.1365-2745.1998.00268.x; Wardle DA, 1995, AGR ECOSYST ENVIRON, V56, P19, DOI 10.1016/0167-8809(95)00636-2; WARDLE DA, 1987, NEW ZEAL J ECOL, V10, P67; Wolkovich EM, 2009, J VEG SCI, V20, P1121, DOI 10.1111/j.1654-1103.2009.01110.x; Yelenik SG, 2011, ECOLOGY, V92, P66, DOI 10.1890/10-0465.1	81	39	41	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31596	10.1371/journal.pone.0031596	http://dx.doi.org/10.1371/journal.pone.0031596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359604	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200073
J	Moreno, AA; Mukhtar, MS; Blanco, F; Boatwright, JL; Moreno, I; Jordan, MR; Chen, YI; Brandizzi, F; Dong, XN; Orellana, A; Pajerowska-Mukhtar, KM				Moreno, Adrian A.; Mukhtar, M. Shahid; Blanco, Francisca; Boatwright, Jon Lucas; Moreno, Ignacio; Jordan, Melissa R.; Chen, Yani; Brandizzi, Federica; Dong, Xinnian; Orellana, Ariel; Pajerowska-Mukhtar, Karolina M.			IRE1/bZIP60-Mediated Unfolded Protein Response Plays Distinct Roles in Plant Immunity and Abiotic Stress Responses	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SYSTEMIC ACQUIRED-RESISTANCE; PLASMA-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR XBP-1; ARABIDOPSIS-THALIANA; MESSENGER-RNA; DEFENSE RESPONSE; MAMMALIAN-CELLS; INNATE IMMUNITY; SALT STRESS	Endoplasmic reticulum (ER)-mediated protein secretion and quality control have been shown to play an important role in immune responses in both animals and plants. In mammals, the ER membrane-located IRE1 kinase/endoribonuclease, a key regulator of unfolded protein response (UPR), is required for plasma cell development to accommodate massive secretion of immunoglobulins. Plant cells can secrete the so-called pathogenesis-related (PR) proteins with antimicrobial activities upon pathogen challenge. However, whether IRE1 plays any role in plant immunity is not known. Arabidopsis thaliana has two copies of IRE1, IRE1a and IRE1b. Here, we show that both IRE1a and IRE1b are transcriptionally induced during chemically-induced ER stress, bacterial pathogen infection and treatment with the immune signal salicylic acid (SA). However, we found that IRE1a plays a predominant role in the secretion of PR proteins upon SA treatment. Consequently, the ire1a mutant plants show enhanced susceptibility to a bacterial pathogen and are deficient in establishing systemic acquired resistance (SAR), whereas ire1b is unaffected in these responses. We further demonstrate that the immune deficiency in ire1a is due to a defect in SA- and pathogen-triggered, IRE1-mediated cytoplasmic splicing of the bZIP60 mRNA, which encodes a transcription factor involved in the expression of UPR-responsive genes. Consistently, IRE1a is preferentially required for bZIP60 splicing upon pathogen infection, while IRE1b plays a major role in bZIP60 processing upon Tunicamycin (Tm)-induced stress. We also show that SA- dependent induction of UPR-responsive genes is altered in the bzip60 mutant resulting in a moderate susceptibility to a bacterial pathogen. These results indicate that the IRE1/bZIP60 branch of UPR is a part of the plant response to pathogens for which the two Arabidopsis IRE1 isoforms play only partially overlapping roles and that IRE1 has both bZIP60-dependent and bZIP60-independent functions in plant immunity.	[Moreno, Adrian A.; Blanco, Francisca; Moreno, Ignacio; Orellana, Ariel] Univ Andres Bello, FONDAP Ctr Genome Regulat, Nucleo Milenio Biotecnol Celular Vegetal, Ctr Biotecnol Vegetal,Fac Ciencias Biol, Santiago, Chile; [Mukhtar, M. Shahid; Boatwright, Jon Lucas; Jordan, Melissa R.; Pajerowska-Mukhtar, Karolina M.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Chen, Yani; Brandizzi, Federica] Michigan State Univ, DOE Plant Res Lab, E Lansing, MI 48824 USA; [Chen, Yani; Brandizzi, Federica] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC USA	Universidad Andres Bello; University of Alabama System; University of Alabama Birmingham; Michigan State University; United States Department of Energy (DOE); Michigan State University; Duke University	Moreno, AA (corresponding author), Univ Andres Bello, FONDAP Ctr Genome Regulat, Nucleo Milenio Biotecnol Celular Vegetal, Ctr Biotecnol Vegetal,Fac Ciencias Biol, Santiago, Chile.	kmukhtar@uab.edu	Blanco-Herrera, Francisca/AAF-7105-2020; Orellana, Ariel/AAE-4866-2021; Moreno, Adrian/H-4956-2019; Orellana, Ariel/E-2166-2014	Blanco-Herrera, Francisca/0000-0002-7497-9907; Orellana, Ariel/0000-0002-9243-808X; Orellana, Ariel/0000-0002-9243-808X; Mukhtar, Shahid/0000-0002-1104-6931; Moreno, Adrian/0000-0001-5125-2927; Boatwright, Lucas/0000-0003-4371-2457	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110954, 3100036]; ICM-PCB-MN [160-44F]; Basal Program [PFB-16]; Fondo de Financiamiento de Centros de Excelencia en Investigacion - Centro de Regulacion del Genoma; National Science Foundation [MCB-0519898]; National Aeronautics and Space Administration [NNH08ZTT003N NRA - 08-FSB_Prop-0052]; Hargitt Fellowship; University of Alabama Birmingham; Programa de Capital Humano Avanzado	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM-PCB-MN; Basal Program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Fondo de Financiamiento de Centros de Excelencia en Investigacion - Centro de Regulacion del Genoma; National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Hargitt Fellowship; University of Alabama Birmingham; Programa de Capital Humano Avanzado	This work was supported in part by Fondo Nacional de Desarrollo Cientifico y Tecnologico 1110954, Fondo Nacional de Desarrollo Cientifico y Tecnologico 3100036, ICM-PCB-MN 160-44F, Basal Program PFB-16, Fondo de Financiamiento de Centros de Excelencia en Investigacion - Centro de Regulacion del Genoma, a grant from National Science Foundation (MCB-0519898) to XD, a grant from National Aeronautics and Space Administration (NNH08ZTT003N NRA - 08-FSB_Prop-0052) to FB, the Hargitt Fellowship to KPM, University of Alabama Birmingham Gulf Oil Response Pilot Grants to MSM and KPM, University of Alabama Birmingham Faculty Development Grant to KPM and PhD fellowships from Programa de Capital Humano Avanzado to AAM and IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Fujita M, 2007, BIOCHEM BIOPH RES CO, V364, P250, DOI 10.1016/j.bbrc.2007.09.124; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2010, PLANT BIOTECHNOL, V27, P161, DOI 10.5511/plantbiotechnology.27.161; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaufman RJ, 2010, EMBO MOL MED, V2, P189, DOI 10.1002/emmm.201000076; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Lu DP, 2008, MOL GENET GENOMICS, V280, P199, DOI 10.1007/s00438-008-0356-z; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Mitsuya Y, 2009, J PLANT PHYSIOL, V166, P626, DOI 10.1016/j.jplph.2008.08.006; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Nishimura MT, 2010, PLANT J, V61, P1053, DOI 10.1111/j.1365-313X.2010.04131.x; Noh SJ, 2002, BBA-GENE STRUCT EXPR, V1575, P130, DOI 10.1016/S0167-4781(02)00237-3; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder ME, 2007, IRE1 UCSD NATURE MOL, DOI [10.1038/mp.a003134.003101, DOI 10.1038/MP.A003134.003101]; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shang J, 2004, BIOCHEM BIOPH RES CO, V317, P390, DOI 10.1016/j.bbrc.2004.03.058; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tateda C, 2008, J PLANT RES, V121, P603, DOI 10.1007/s10265-008-0185-5; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang MY, 2011, METHOD ENZYMOL, V489, P319, DOI 10.1016/B978-0-12-385116-1.00018-2; Wang MY, 2010, PLANT MOL BIOL, V73, P467, DOI 10.1007/s11103-010-9633-4; Ye CM, 2011, PLANT PHYSIOL, V156, P741, DOI 10.1104/pp.111.174110; Yoshida H, 2007, ANTIOXID REDOX SIGN, V9, P2323, DOI 10.1089/ars.2007.1800; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	57	140	145	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31944	10.1371/journal.pone.0031944	http://dx.doi.org/10.1371/journal.pone.0031944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359644	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200113
J	Sebastian-Serrano, A; Sandonis, A; Cardozo, M; Rodriguez-Tornos, FM; Bovolenta, P; Nieto, M				Sebastian-Serrano, Alvaro; Sandonis, Africa; Cardozo, Marcos; Rodriguez-Tornos, Fernanda M.; Bovolenta, Paola; Nieto, Marta			P alpha x6 Expression in Postmitotic Neurons Mediates the Growth of Axons in Response to SFRP1	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; GANGLION-CELL AXONS; BINOCULAR VISION; PAX6 EXPRESSION; CEREBRAL-CORTEX; IN-VIVO; GUIDANCE; SPECIFICATION; RECEPTOR; PROLIFERATION	During development, the mechanisms that specify neuronal subclasses are coupled to those that determine their axonal response to guidance cues. Pax6 is a homedomain transcription factor required for the specification of a variety of neural precursors. After cell cycle exit, Pax6 expression is often shut down in the precursor progeny and most postmitotic neurons no longer express detectable levels of the protein. There are however exceptions and high Pax6 protein levels are found, for example, in postmitotic retinal ganglion cells (RGCs), dopaminergic neurons of the olfactory bulb and the limbic system in the telencephalon. The function of Pax6 in these differentiating neurons remains mostly elusive. Here, we demonstrate that Pax6 mediates the response of growing axons to SFRP1, a secreted molecule expressed in several Pax6-positive forebrain territories. Forced expression of Pax6 in cultured postmitotic cortical neurons, which do not normally express Pax6, was sufficient to increment axonal length. Growth was blocked by the addition of anti-SFRP1 antibodies, whereas exogenously added SFRP1 increased axonal growth of Pax6-transfected neurons but not that of control or untransfected cortical neurons. In the reverse scenario, shRNA-mediated knock-down of Pax6 in mouse retinal explants specifically abolished RGCs axonal growth induced by SFRP1, but had no effect on RGCs differentiation and it did not modify the effect of Shh or Netrin on axon growth. Taken together these results demonstrate that expression of Pax6 is necessary and sufficient to render postmitotic neurons competent to respond to SFRP1. These results reveal a novel and unexpected function of Pax6 in postmitotic neurons and situate Pax6 and SFRP1 as pair regulators of axonal connectivity.	[Sebastian-Serrano, Alvaro; Rodriguez-Tornos, Fernanda M.; Nieto, Marta] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Sandonis, Africa; Cardozo, Marcos; Bovolenta, Paola] Consejo Super Invest Cient UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Sandonis, Africa; Cardozo, Marcos; Bovolenta, Paola] CIBER Enfermedades Raras, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sebastian-Serrano, A (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	mnlopez@cnb.csic.es	Sebastian-Serrano, Alvaro/Q-5982-2018; Nieto, Marta/F-1434-2013	Nieto, Marta/0000-0002-8349-8435; Cardozo, Marcos J/0000-0003-2246-2946; Bovolenta, Paola/0000-0002-1870-751X	(MICINN) Ministerio de Ciencia e Innovacion [SAF2008-00211, PIE-200820I166, BFU2007-61774]; Spanish Comunidad de Madrid [CCG08-CSIC/SAL-3464]	(MICINN) Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Comunidad de Madrid(Comunidad de Madrid)	This work was funded by the (MICINN) Ministerio de Ciencia e Innovacion grants (SAF2008-00211; PIE-200820I166; BFU2007-61774), and a grant from the Spanish Comunidad de Madrid CCG08-CSIC/SAL-3464. ASS from the MICINN (BES-2006-13901). FMR holds a fellowship from La Caixa foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alvarez-Rodiguez R, 2007, J BIOL CHEM, V282, P37170, DOI 10.1074/jbc.M705414200; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Augustine C, 2001, MECH DEVELOP, V109, P395, DOI 10.1016/S0925-4773(01)00533-0; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Baumer N, 2002, DEVELOPMENT, V129, P4535; BLACK MM, 1994, J NEUROSCI, V14, P857; Bovolenta P, 2005, J NEUROBIOL, V64, P405, DOI 10.1002/neu.20161; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chuman Y, 2004, PEPTIDES, V25, P1831, DOI 10.1016/j.peptides.2004.07.010; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Esteve P, 2003, J CELL SCI, V116, P2471, DOI 10.1242/jcs.00452; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Garcia-Frigola C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-103; Georgala PA, 2011, DEV NEUROBIOL; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hsieh YW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-32; Jones L, 2002, DEVELOPMENT, V129, P5041; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Lee R, 2008, J NEUROSCI, V28, P5910, DOI 10.1523/JNEUROSCI.0632-08.2008; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Mao WM, 2010, EXP EYE RES, V91, P552, DOI 10.1016/j.exer.2010.05.003; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Nural HF, 2004, J COMP NEUROL, V479, P399, DOI 10.1002/cne.20317; Osumi N, 1997, DEVELOPMENT, V124, P2961; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Rodger J, 2006, NEUROSCIENCE, V142, P1043, DOI 10.1016/j.neuroscience.2006.07.057; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Von Frowein J, 2002, MECH DEVELOP, V110, P249; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020	56	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31590	10.1371/journal.pone.0031590	http://dx.doi.org/10.1371/journal.pone.0031590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359602	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200071
J	Van Goor, D; Hyland, C; Schaefer, AW; Forscher, P				Van Goor, David; Hyland, Callen; Schaefer, Andrew W.; Forscher, Paul			The Role of Actin Turnover in Retrograde Actin Network Flow in Neuronal Growth Cones	PLOS ONE			English	Article							MYOSIN-II; F-ACTIN; BLEBBISTATIN INHIBITION; DEOXYRIBONUCLEASE-I; 2 POPULATIONS; LEADING-EDGE; LIM KINASE; POLYMERIZATION; FILAMENTS; COFILIN	The balance of actin filament polymerization and depolymerization maintains a steady state network treadmill in neuronal growth cones essential for motility and guidance. Here we have investigated the connection between depolymerization and treadmilling dynamics. We show that polymerization-competent barbed ends are concentrated at the leading edge and depolymerization is distributed throughout the peripheral domain. We found a high-to-low G-actin gradient between peripheral and central domains. Inhibiting turnover with jasplakinolide collapsed this gradient and lowered leading edge barbed end density. Ultrastructural analysis showed dramatic reduction of leading edge actin filament density and filament accumulation in central regions. Live cell imaging revealed that the leading edge retracted even as retrograde actin flow rate decreased exponentially. Inhibition of myosin II activity before jasplakinolide treatment lowered baseline retrograde flow rates and prevented leading edge retraction. Myosin II activity preferentially affected filopodial bundle disassembly distinct from the global effects of jasplakinolide on network turnover. We propose that growth cone retraction following turnover inhibition resulted from the persistence of myosin II contractility even as leading edge assembly rates decreased. The buildup of actin filaments in central regions combined with monomer depletion and reduced polymerization from barbed ends suggests a mechanism for the observed exponential decay in actin retrograde flow. Our results show that growth cone motility is critically dependent on continuous disassembly of the peripheral actin network.	[Van Goor, David; Hyland, Callen; Schaefer, Andrew W.; Forscher, Paul] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Van Goor, D (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	paul.forscher@yale.edu		Forscher, Paul/0000-0003-1988-5155	National Institutes of Health [RO1-NS28695, RO1 NS51786]; Nikon Partners-in-Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695, R01NS051786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nikon Partners-in-Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants RO1-NS28695 and RO1 NS51786 to P.F. and the Nikon Partners-in-Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2011, NEUROBIOL DIS, V41, P421, DOI 10.1016/j.nbd.2010.10.012; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chan AY, 1998, J CELL SCI, V111, P199; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; Heidemann Steven R., 1995, Cell Biochemistry and Biophysics, V27, P135; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; JANSON LW, 1991, J CELL BIOL, V114, P1005, DOI 10.1083/jcb.114.5.1005; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kiuchi T, 2011, J CELL BIOL, V193, P365, DOI 10.1083/jcb.201101035; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; KOLEGA J, 1991, J CELL BIOL, V114, P993, DOI 10.1083/jcb.114.5.993; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Novak IL, 2008, BIOPHYS J, V95, P1627, DOI 10.1529/biophysj.108.130096; PODOLSKI JL, 1988, J BIOL CHEM, V263, P638; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Thomann D, 2003, J MICROSC-OXFORD, V211, P230, DOI 10.1046/j.1365-2818.2003.01223.x; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Tsuji T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004921; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	59	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30959	10.1371/journal.pone.0030959	http://dx.doi.org/10.1371/journal.pone.0030959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359556	Green Published, gold, Green Submitted			2022-12-27	WOS:000302796200025
J	Xiang, Y; Qin, XQ; Liu, HJ; Tan, YR; Liu, C; Liu, CX				Xiang, Yang; Qin, Xiao-Qun; Liu, Hui-Jun; Tan, Yu-Rong; Liu, Chi; Liu, Cai-Xia			Identification of Transcription Factors Regulating CTNNAL1 Expression in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							ALPHA-CATENIN; RECEPTOR GENE; PROTEIN; AP-2; AP-2-ALPHA; PATHWAY; BINDING; TARGET; ACTIVATION; INDUCTION	Adhesion molecules play important roles in airway hyperresponsiveness or airway inflammation. Our previous study indicated catenin alpha-like 1 (CTNNAL1), an alpha-catenin-related protein, was downregulated in asthma patients and animal model. In this study, we observed that the expression of CTNNAL1 was increased in lung tissue of the ozone-stressed Balb/c mice model and in acute ozone stressed human bronchial epithelial cells (HBEC). In order to identify the possible DNA-binding proteins regulating the transcription of CTNNAL1 gene in HBEC, we designed 8 oligo- nucleotide probes corresponding to various regions of the CTNNAL1 promoter in electrophoretic mobility shift assays (EMSA). We detected 5 putative transcription factors binding sites within CTNNAL1 promoter region that can recruit LEF-1, AP-2 alpha and CREB respectively by EMSA and antibody supershift assay. Chromatin immunoprecipitation (ChIP) assay verified that AP-2 alpha and LEF-1 could be recruited to the CTNNAL1 promoter. Therefore we further analyzed the functions of putative AP-2 and LEF-1 sites within CTNNAL1 promoter by site-directed mutagenesis of those sites within pGL3/FR/luc. We observed a reduction in human CTNNAL1 promoter activity of mutants of both AP-2 alpha and LEF-1 sites. Pre-treatment with ASOs targeting LEF-1 and AP-2 alpha yielded significant reduction of ozone-stress- induced CTNNAL1 expression. The activation of AP-2 alpha and LEF-1, followed by CTNNAL1 expression, showed a correlation during a 16-hour time course. Our data suggest that a robust transcriptional CTNNAL1 up-regulation occurs during acute ozone-induced stress and is mediated at least in part by ozone-induced recruitments of LEF-1 and AP-2 alpha to the human CTNNAL1 promoter.	[Xiang, Yang; Qin, Xiao-Qun; Liu, Hui-Jun; Tan, Yu-Rong; Liu, Chi; Liu, Cai-Xia] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China	Central South University	Xiang, Y (corresponding author), Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China.	qinxiaoqun@mail.csu.edu.cn	Liu, Cai-Xia/AAL-2039-2020		National Natural Science Foundation of China [30800504, 30870917]; National Basic Research Program of China [2009CB522102]; Hunan College Innovation Program [10K079]; Natural Science Foundation of Hunan [09JJ3056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Hunan College Innovation Program; Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province)	This work was supported by grants #30800504, #30870917 from the National Natural Science Foundation of China, grant #2009CB522102 of National Basic Research Program of China (973 Program), grant #10K079 from the open fund of Hunan College Innovation Program, and grant #09JJ3056 from Natural Science Foundation of Hunan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Chen SY, 1999, ENDOCRINOLOGY, V140, P2100, DOI 10.1210/en.140.5.2100; Cheng YH, 2002, MOL CELL ENDOCRINOL, V191, P127, DOI 10.1016/S0303-7207(02)00081-3; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dutt P, 2004, CELL SIGNAL, V16, P201, DOI 10.1016/S0898-6568(03)00132-3; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Horsman S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-120; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Li H, 2006, ONCOGENE, V25, P5405, DOI 10.1038/sj.onc.1209534; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shimada T, 2007, INT J BIOCHEM CELL B, V39, P626, DOI 10.1016/j.biocel.2006.10.015; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tan YR, 2007, BIOCHEM J, V405, P131, DOI 10.1042/BJ20061754; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wang HV, 2004, DEV DYNAM, V231, P128, DOI 10.1002/dvdy.20119; Wankhade S, 2000, J BIOL CHEM, V275, P29701, DOI 10.1074/jbc.M000931200; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; Woltje M, 2000, J NEUROCHEM, V74, P1355, DOI 10.1046/j.1471-4159.2000.0741355.x; Xiang Y, 2008, J CELL BIOCHEM, V103, P920, DOI 10.1002/jcb.21461; Zhang JS, 1998, GENOMICS, V54, P149, DOI 10.1006/geno.1998.5458	28	11	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31158	10.1371/journal.pone.0031158	http://dx.doi.org/10.1371/journal.pone.0031158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359570	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200039
J	Xu, W; Chen, MH; Ge, NH; Xu, J				Xu, Wei; Chen, Minhui; Ge, Nanhai; Xu, Jun			Hemagglutinin from the H5N1 Virus Activates Janus Kinase 3 to Dysregulate Innate Immunity	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; AVIAN INFLUENZA-VIRUSES; EPITHELIAL-CELLS; ADHESION MOLECULES; HUMAN INFECTION; HUMANS; CORTICOSTEROIDS; TRACT; PROLIFERATION; PATHOGENESIS	Highly pathogenic avian influenza viruses (HPAIVs) cause severe disease in humans. There are no effective vaccines or antiviral therapies currently available to control fatal outbreaks due in part to the lack of understanding of virus-mediated immunopathology. In our study, we used hemagglutinin (HA) of H5N1 virus to investigate the related signaling pathways and their relationship to dysregulated innate immune reaction. We found the HA of H5N1 avian influenza triggered an abnormal innate immune signalling in the pulmonary epithelial cells, through an unusual process involving activation of Janus kinase 3 (JAK3) that is exclusively associated with gamma c chain and is essential for signaling via all gamma c cytokine receptors. By using a selective JAK3 inhibitor and JAK3 knockout mice, we have, for the first time, demonstrated the ability to target active JAK3 to counteract injury to the lungs and protect immunocytes from acute hypercytokinemia -induced destruction following the challenge of H5N1 HA in vitro and in vivo. On the basis of the present data, it appears that the efficacy of selective JAK3 inhibition is likely based on its ability to block multiple cytokines and protect against a superinflammatory response to pathogen-associated molecular patterns (PAMPs) attack. Our findings highlight the potential value of selective JAK3 inhibitor in treating the fatal immunopathology caused by H5N1 challenge.	[Xu, Wei; Chen, Minhui; Ge, Nanhai; Xu, Jun] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Xu, W (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	xufeili@vip.163.com			National Key Basic Research Program of China (973 Program) [2009CB522104]; National Natural Science Foundation of China [30230180, 30900576]; National High Technology Research and Development Program of China (863 Program) [2007AA022002]; China Postdoctoral Science Foundation [20100480734]; Yangcheng Scholars Research Program of Guangzhou Municipal Universities [10A024G]; Natural Science Foundation of Guangdong province, China [07117506]; Science and Technology Planning Project of Guangzhou City [2006Z3-E5081]; Science and Technology support program of Local Government in Guangzhou of China	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Yangcheng Scholars Research Program of Guangzhou Municipal Universities; Natural Science Foundation of Guangdong province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangzhou City; Science and Technology support program of Local Government in Guangzhou of China	This work was supported by grants from the National Key Basic Research Program of China (973 Program) (2009CB522104), the Key Program of National Natural Science Foundation of China (30230180), the National High Technology Research and Development Program of China (863 Program) (2007AA022002), the National Natural Science Foundation of China (30900576), the China Postdoctoral Science Foundation (20100480734), the Yangcheng Scholars Research Program of Guangzhou Municipal Universities (10A024G), the Key Program of Natural Science Foundation of Guangdong province, China (07117506), the Science and Technology Planning Project of Guangzhou City (2006Z3-E5081), and the Science and Technology support program of Local Government in Guangzhou of China (2009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2003, BIOORG MED CHEM LETT, V13, P3105, DOI 10.1016/S0960-894X(03)00657-7; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Annane D, 2006, CRIT CARE MED, V34, P22, DOI 10.1097/01.CCM.0000194723.78632.62; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Cetkovic-Cyrlje M, 2004, CURR PHARM DESIGN, V10, P1767, DOI 10.2174/1381612043384529; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Gomersall CD, 2004, INTENS CARE MED, V30, P381, DOI 10.1007/s00134-003-2143-y; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hacker G, 2006, CELL CYCLE, V5, P2421, DOI 10.4161/cc.5.21.3397; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hiemstra PS, 2004, J LEUKOCYTE BIOL, V75, P3, DOI 10.1189/jlb.0903410; Hutchinson KL, 2001, J MED VIROL, V65, P561, DOI 10.1002/jmv.2073; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG1044, DOI 10.1152/ajpgi.00184.2004; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; JORENS PG, 1992, CYTOKINE, V4, P592, DOI 10.1016/1043-4666(92)90025-M; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lewandowski D, 2006, J IMMUNOL, V177, P479, DOI 10.4049/jimmunol.177.1.479; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mer M, 1998, CHEST, V114, P426, DOI 10.1378/chest.114.2.426; Miyamoto T, 2002, AVIAN DIS, V46, P10, DOI 10.1637/0005-2086(2002)046[0010:LPRDET]2.0.CO;2; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; O'Neill LAJ, 2008, NAT IMMUNOL, V9, P459, DOI 10.1038/ni0508-459; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sandrock C, 2007, CRIT CARE, V11, DOI 10.1186/cc5675; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wan XF, 2005, ARCH VIROL, V150, P1257, DOI 10.1007/s00705-004-0474-9; West K, 2009, CURR OPIN INVEST DR, V10, P491; WHO, 2010, CUM NUMB CONF HUM CA; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31721	10.1371/journal.pone.0031721	http://dx.doi.org/10.1371/journal.pone.0031721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359619	Green Submitted, gold, Green Published			2022-12-27	WOS:000302796200088
J	Liang, Y; Arakawa, K; Ueta, K; Matsushita, Y; Kuriyama, C; Martin, T; Du, FY; Liu, Y; Xu, JN; Conway, B; Conway, J; Polidori, D; Ways, K; Demarest, K				Liang, Yin; Arakawa, Kenji; Ueta, Kiichiro; Matsushita, Yasuaki; Kuriyama, Chiaki; Martin, Tonya; Du, Fuyong; Liu, Yi; Xu, June; Conway, Bruce; Conway, Jamie; Polidori, David; Ways, Kirk; Demarest, Keith			Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models	PLOS ONE			English	Article							SELECTIVE SGLT2 INHIBITOR; PROXIMAL TUBULAR CELLS; INSULIN-SECRETION; COTRANSPORTER; SODIUM; DAPAGLIFLOZIN; HYPERGLYCEMIA; TRANSPORTERS; T-1095; HOMEOSTASIS	Background: Canagliflozin is a sodium glucose co-transporter (SGLT) 2 inhibitor in clinical development for the treatment of type 2 diabetes mellitus (T2DM). Methods: C-14-alpha-methylglucoside uptake in Chinese hamster ovary-K cells expressing human, rat, or mouse SGLT2 or SGLT1; H-3-2-deoxy-D-glucose uptake in L6 myoblasts; and 2-electrode voltage clamp recording of oocytes expressing human SGLT3 were analyzed. Graded glucose infusions were performed to determine rate of urinary glucose excretion (UGE) at different blood glucose (BG) concentrations and the renal threshold for glucose excretion (RTG) in vehicle or canagliflozin-treated Zucker diabetic fatty (ZDF) rats. This study aimed to characterize the pharmacodynamic effects of canagliflozin in vitro and in preclinical models of T2DM and obesity. Results: Treatment with canagliflozin 1 mg/kg lowered RTG from 415 +/- 12 mg/dl to 94 +/- 10 mg/dl in ZDF rats while maintaining a threshold relationship between BG and UGE with virtually no UGE observed when BG was below RTG. Canagliflozin dose-dependently decreased BG concentrations in db/db mice treated acutely. In ZDF rats treated for 4 weeks, canagliflozin decreased glycated hemoglobin (HbA1c) and improved measures of insulin secretion. In obese animal models, canagliflozin increased UGE and decreased BG, body weight gain, epididymal fat, liver weight, and the respiratory exchange ratio. Conclusions: Canagliflozin lowered RTG and increased UGE, improved glycemic control and beta-cell function in rodent models of T2DM, and reduced body weight gain in rodent models of obesity.	[Liang, Yin; Martin, Tonya; Du, Fuyong; Xu, June; Conway, Bruce; Conway, Jamie; Demarest, Keith] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA USA; [Arakawa, Kenji; Ueta, Kiichiro; Matsushita, Yasuaki; Kuriyama, Chiaki] Mitsubishi Tanabe Pharma Corp, Pharmacol Lab, Toda, Saitama, Japan; [Liu, Yi; Polidori, David] Johnson & Johnson Pharmaceut Res & Dev LLC, La Jolla, CA USA; [Ways, Kirk] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA	Johnson & Johnson; Johnson & Johnson USA; Mitsubishi Tanabe Pharma Corporation; Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA	Liang, Y (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA USA.	yliang@its.jnj.com			Johnson & Johnson Pharmaceutical Research & Development, LLC; Janssen Global Services, LLC	Johnson & Johnson Pharmaceutical Research & Development, LLC(Johnson & JohnsonJohnson & Johnson USA); Janssen Global Services, LLC	Johnson & Johnson Pharmaceutical Research & Development, LLC. sponsored this study. Editorial assistance was provided by Phase Five Communications, Inc., and supported by Janssen Global Services, LLC. The authors are all employees of Johnson & Johnson Pharmaceutical Research & Development, LLC. or Mitsubishi Tanabe Pharma Corporation, and as such, designed the studies, participated in data collection and analysis, made the decision to publish, and prepared the manuscript.	Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Bakris GL, 2009, KIDNEY INT, V75, P1272, DOI 10.1038/ki.2009.87; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; FARBER SJ, 1951, J CLIN INVEST, V30, P125, DOI 10.1172/JCI102424; Freitas HS, 2008, ENDOCRINOLOGY, V149, P717, DOI 10.1210/en.2007-1088; Fujimori Y, 2009, EUR J PHARMACOL, V609, P148, DOI 10.1016/j.ejphar.2009.03.007; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kamran M, 1997, J AM SOC NEPHROL, V8, P943; Kloeckener-Gruissem B, 2008, AM J HUM GENET, V82, P772, DOI 10.1016/j.ajhg.2007.12.013; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Magni Lalo, 2007, J Diabetes Sci Technol, V1, P804; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P101, DOI 10.3109/00365517109090668; Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473; Nomura S, 2010, J MED CHEM, V53, P6355, DOI 10.1021/jm100332n; Nunoi K, 2002, CLIN EXP PHARMACOL P, V29, P386, DOI 10.1046/j.1440-1681.2002.03671.x; Oku A, 2000, EUR J PHARMACOL, V391, P183, DOI 10.1016/S0014-2999(00)00016-9; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Rave K, 2006, NEPHROL DIAL TRANSPL, V21, P2166, DOI 10.1093/ndt/gfl175; Rosenstock J, 2010, DIABETES, V59, pA78; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; Santer R, 2010, CLIN J AM SOC NEPHRO, V5, P133, DOI 10.2215/CJN.04010609; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Ueta K, 2005, LIFE SCI, V76, P2655, DOI 10.1016/j.lfs.2004.09.038; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Vestri S, 2001, J MEMBRANE BIOL, V182, P105, DOI 10.1007/s00232-001-0036-y; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 1998, AM J PHYSIOL-GASTR L, V275, pG879, DOI 10.1152/ajpgi.1998.275.5.G879; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6	42	169	172	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30555	10.1371/journal.pone.0030555	http://dx.doi.org/10.1371/journal.pone.0030555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355316	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300016
J	Thompson, JD; Shibahara, G; Rajan, S; Pel, J; Marziali, A				Thompson, Jason D.; Shibahara, Gosuke; Rajan, Sweta; Pel, Joel; Marziali, Andre			Winnowing DNA for Rare Sequences: Highly Specific Sequence and Methylation Based Enrichment	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE; ELECTROPHORESIS; SENSITIVITY; MUTATIONS	Rare mutations in cell populations are known to be hallmarks of many diseases and cancers. Similarly, differential DNA methylation patterns arise in rare cell populations with diagnostic potential such as fetal cells circulating in maternal blood. Unfortunately, the frequency of alleles with diagnostic potential, relative to wild-type background sequence, is often well below the frequency of errors in currently available methods for sequence analysis, including very high throughput DNA sequencing. We demonstrate a DNA preparation and purification method that through non-linear electrophoretic separation in media containing oligonucleotide probes, achieves 10,000 fold enrichment of target DNA with single nucleotide specificity, and 100 fold enrichment of unmodified methylated DNA differing from the background by the methylation of a single cytosine residue.	[Thompson, Jason D.; Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada; [Shibahara, Gosuke; Rajan, Sweta; Pel, Joel; Marziali, Andre] Boreal Genom Inc, Vancouver, BC, Canada	University of British Columbia	Thompson, JD (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.	andre@phas.ubc.ca			National Human Genome Research Institute (NHGRI) [R01 HG004873-01]; Genome British Columbia [SOF111]; National Research Council (NRC) [702024]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004873] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Genome British Columbia; National Research Council (NRC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Human Genome Research Institute (NHGRI) Award Number R01 HG004873-01, Genome British Columbia Award Number SOF111, and National Research Council Industrial Research Assistance Program (NRC-IRAP) Project Number 702024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau S, 2009, ANAL BIOANAL CHEM, V393, P171, DOI 10.1007/s00216-008-2460-7; Broemeling David J, 2008, JALA Charlottesv Va, V13, P40, DOI 10.1016/j.jala.2007.10.008; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Fischer C, 2001, LAB INVEST, V81, P827, DOI 10.1038/labinvest.3780292; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Frumin LL, 2001, J BIOCHEM BIOPH METH, V48, P269, DOI 10.1016/S0165-022X(01)00161-0; Halperin A, 2004, BIOPHYS J, V86, P718, DOI 10.1016/S0006-3495(04)74150-8; Jeffreys AJ, 2003, GENOME RES, V13, P2316, DOI 10.1101/gr.1214603; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Mahony JB, 2000, J CLIN MICROBIOL, V38, P2622, DOI 10.1128/JCM.38.7.2622-2627.2000; Marziall A, 2005, ELECTROPHORESIS, V26, P82, DOI 10.1002/elps.200406140; MONIA BP, 1992, J BIOL CHEM, V267, P19954; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Pel J, 2009, P NATL ACAD SCI USA, V106, P14796, DOI 10.1073/pnas.0907402106; SANGHVI YS, 1993, NUCLEIC ACIDS RES, V21, P3197, DOI 10.1093/nar/21.14.3197; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Smieja M, 2001, J CLIN MICROBIOL, V39, P1796, DOI 10.1128/JCM.39.5.1796-1801.2001; Sun XY, 2002, NAT BIOTECHNOL, V20, P186, DOI 10.1038/nbt0202-186; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Warmlander S, 2002, J BIOL CHEM, V277, P28491, DOI 10.1074/jbc.M202989200; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	18	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31597	10.1371/journal.pone.0031597	http://dx.doi.org/10.1371/journal.pone.0031597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355378	Green Published, gold			2022-12-27	WOS:000302741300078
J	Walker, AA; Weisman, S; Church, JS; Merritt, DJ; Mudie, ST; Sutherland, TD				Walker, Andrew A.; Weisman, Sarah; Church, Jeffrey S.; Merritt, David J.; Mudie, Stephen T.; Sutherland, Tara D.			Silk from Crickets: A New Twist on Spinning	PLOS ONE			English	Article							GRYLLACRIDIDS ORTHOPTERA; INSECT; FIBROIN; NEST; MORI; ULTRASTRUCTURE; RECOGNITION; SPINNERET; PROTEINS; SPIDERS	Raspy crickets (Orthoptera: Gryllacrididae) are unique among the orthopterans in producing silk, which is used to build shelters. This work studied the material composition and the fabrication of cricket silk for the first time. We examined silk-webs produced in captivity, which comprised cylindrical fibers and flat films. Spectra obtained from micro-Raman experiments indicated that the silk is composed of protein, primarily in a beta-sheet conformation, and that fibers and films are almost identical in terms of amino acid composition and secondary structure. The primary sequences of four silk proteins were identified through a mass spectrometry/cDNA library approach. The most abundant silk protein was large in size (300 and 220 kDa variants), rich in alanine, glycine and serine, and contained repetitive sequence motifs; these are features which are shared with several known beta-sheet forming silk proteins. Convergent evolution at the molecular level contrasts with development by crickets of a novel mechanism for silk fabrication. After secretion of cricket silk proteins by the labial glands they are fabricated into mature silk by the labium-hypopharynx, which is modified to allow the controlled formation of either fibers or films. Protein folding into beta-sheet structure during silk fabrication is not driven by shear forces, as is reported for other silks.	[Walker, Andrew A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Merritt, David J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Mudie, Stephen T.] Australian Synchrotron, Clayton, Vic, Australia	Australian National University; University of Queensland	Walker, AA (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	Tara.Sutherland@csiro.au	Sutherland, Tara/B-5635-2009; Weisman, Sarah/B-5091-2009; Merritt, David J/D-2318-2010; Walker, Andrew/D-2665-2012	Merritt, David J/0000-0002-8573-7508; Walker, Andrew/0000-0003-1296-6593; Sutherland, Tara/0000-0001-5211-4593	Australian National University; Commonwealth Scientific and Industrial Research Organisation (CSIRO)	Australian National University(Australian National University); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Dr. Walker was supported by a PhD scholarship from Australian National University. Additional funding by the Commonwealth Scientific and Industrial Research Organisation (CSIRO). Part of this research was undertaken at the SAXS/WAXS beamline at the Australian Synchrotron, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158; Akai H, 1998, MICROSCOPIC ANATOMY; ASAKURA T, 1994, SILK PRODUCTION PROC, P1; Britton E. B, 1970, INSECTS AUSTR TXB ST; Church JS, 1997, BIOPOLYMERS, V42, P7, DOI 10.1002/(SICI)1097-0282(199707)42:1<7::AID-BIP2>3.0.CO;2-S; Clotuche G, 2009, MICROSC RES TECHNIQ, V72, P659, DOI 10.1002/jemt.20712; CODDINGTON JA, 1989, J ARACHNOL, V17, P71; Collin MA, 2009, INSECT BIOCHEM MOLEC, V39, P75, DOI 10.1016/j.ibmb.2008.10.004; COLONNACESARI F, 1975, J MOL BIOL, V95, P71, DOI 10.1016/0022-2836(75)90336-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Field L.H., 2001, BIOL WETAS KING CRIC; Frushour B.G., 1975, ADV INFRARED RAMAN S, V1, P35; Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f; Hale RJ, 2000, AUST J ZOOL, V48, P643, DOI 10.1071/ZO00053; Hale Roderick J., 2001, P95, DOI 10.1079/9780851994086.0095; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; ISHAY JS, 1990, J MORPHOL, V203, P11, DOI 10.1002/jmor.1052030103; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Lockwood JA, 1996, AUST J ZOOL, V44, P129, DOI 10.1071/ZO9960129; Lucas F., 1968, Comprehensive Biochem, V26, P475; MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5; Maskell F. G., 1927, Transactions and Proceedings of the New Zealand Institute, V57, P637; Moriya M, 2008, POLYMER, V49, P5665, DOI 10.1016/j.polymer.2008.10.024; MORTON SR, 1983, AUST J ZOOL, V31, P557, DOI 10.1071/ZO9830557; NAGASHIMA T, 1991, Cytologia (Tokyo), V56, P679; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Okada S, 2008, INT J BIOL MACROMOL, V43, P271, DOI 10.1016/j.ijbiomac.2008.06.007; RENTZ D C F, 1990, Invertebrate Taxonomy, V3, P1053; Rentz D. C. F., 1996, GRASSHOPPER COUNTRY; RENTZ DC, 1973, P ACAD NAT SCI PHILA, V125, P89; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rudall K. M., 1962, COMP BIOCH, P397; Sehnal F, 2008, PRION, V2, P145, DOI 10.4161/pri.2.4.7489; Sorensen GS, 2006, ARTHROPOD STRUCT DEV, V35, P3, DOI 10.1016/j.asd.2005.10.002; Sutherland TD, 2007, MOL BIOL EVOL, V24, P2424, DOI 10.1093/molbev/msm171; Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6; Twardowshi J., 1994, RAMAN IR SPECTROSCOP; Vollrath F, 2006, SOFT MATTER, V2; Weisman S, 2008, BIOMACROMOLECULES, V9, P3065, DOI 10.1021/bm8005853; Weisman S, 2009, J STRUCT BIOL, V168, P467, DOI 10.1016/j.jsb.2009.07.002; WEYGOLDT P, 1966, SCIENCE, V153, P1647, DOI 10.1126/science.153.3744.1647; Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413	45	22	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30408	10.1371/journal.pone.0030408	http://dx.doi.org/10.1371/journal.pone.0030408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355311	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300011
J	Schaefer, MH; Fontaine, JF; Vinayagam, A; Porras, P; Wanker, EE; Andrade-Navarro, MA				Schaefer, Martin H.; Fontaine, Jean-Fred; Vinayagam, Arunachalam; Porras, Pablo; Wanker, Erich E.; Andrade-Navarro, Miguel A.			HIPPIE: Integrating Protein Interaction Networks with Experiment Based Quality Scores	PLOS ONE			English	Article							INTERACTION DATABASE; MAP; ORGANISMS; FRAMEWORK; UPDATE; YEAST	Protein function is often modulated by protein-protein interactions (PPIs) and therefore defining the partners of a protein helps to understand its activity. PPIs can be detected through different experimental approaches and are collected in several expert curated databases. These databases are used by researchers interested in examining detailed information on particular proteins. In many analyses the reliability of the characterization of the interactions becomes important and it might be necessary to select sets of PPIs of different confidence levels. To this goal, we generated HIPPIE (Human Integrated Protein-Protein Interaction rEference), a human PPI dataset with a normalized scoring scheme that integrates multiple experimental PPI datasets. HIPPIE's scoring scheme has been optimized by human experts and a computer algorithm to reflect the amount and quality of evidence for a given PPI and we show that these scores correlate to the quality of the experimental characterization. The HIPPIE web tool (available at http://cbdm.mdc-berlin.de/tools/hippie) allows researchers to do network analyses focused on likely true PPI sets by generating subnetworks around proteins of interest at a specified confidence level.	[Schaefer, Martin H.; Fontaine, Jean-Fred; Vinayagam, Arunachalam; Porras, Pablo; Wanker, Erich E.; Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Vinayagam, Arunachalam] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Porras, Pablo] EMBL EBI, Cambridge, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL)	Schaefer, MH (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	miguel.andrade@mdc-berlin.de	Andrade, Miguel A/B-6565-2008; Arunachalam, Vinayagam/J-7925-2012; Fontaine, Jean-Fred/GNP-2904-2022; Porras, Pablo/AAH-6223-2020	Andrade, Miguel A/0000-0001-6650-1711; Arunachalam, Vinayagam/0000-0003-0091-4497; Fontaine, Jean-Fred/0000-0002-1101-4091; Porras, Pablo/0000-0002-8429-8793; Wanker, Erich/0000-0001-8072-1630; Schaefer, Martin/0000-0001-7503-6364	German Ministry of Education and Research (BMBF) [01GS08170]; Helmholtz Alliance in Systems Biology (Germany)	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance in Systems Biology (Germany)	This work was supported by the German Ministry of Education and Research (BMBF) [grant number 01GS08170], and by the Helmholtz Alliance in Systems Biology (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S16; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Isserlin R, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq037; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280	36	227	231	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31826	10.1371/journal.pone.0031826	http://dx.doi.org/10.1371/journal.pone.0031826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348130	Green Published, Green Submitted, gold			2022-12-27	WOS:000302737400049
J	Rozas, D; Gullon, S; Mellado, RP				Rozas, Daniel; Gullon, Sonia; Mellado, Rafael P.			A Novel Two-Component System Involved in the Transition to Secondary Metabolism in Streptomyces coelicolor	PLOS ONE			English	Article							SUBTILIS FUNCTIONAL GENOMICS; BIOSYNTHETIC GENE-CLUSTER; PROTEINS; SEQUENCE; PROTEOME; MODEL; DEGU; SIPY	Background: Bacterial two-component signal transduction regulatory systems are the major set of signalling proteins frequently mediating responses to changes in the environment. They typically consist of a sensor, a membrane-associated histidine kinase and a cytoplasmic response regulator. The membrane-associated sensor detects the environmental signal or stress, whereas the cytoplasmic regulatory protein controls the cellular response usually by gene transcription modulation. Methodology/PrincipalFindings: The Streptomyces coelicolor two genes operon SCO5784-SCO5785 encodes a two-component system, where SCO5784 encodes a histidine-kinase sensor and SCO5785 encodes a response regulator protein. When the expression level of the regulator gene decreases, the antibiotic synthesis and sporulation is delayed temporarily in addition to some ribosomal genes became up regulated, whereas the propagation of the regulatory gene in high copy number results in the earlier synthesis of antibiotics and sporulation, as well as the down regulation of some ribosomal genes and, moreover, in the overproduction of several extracellular proteins. Therefore, this two-component system in S. coelicolor seems to influence various processes characterised by the transition from primary to secondary metabolism, as determined by proteomic and transcriptomic analyses. Conclusions/Significance: Propagation of SCO5785 in multicopy enhances the production of antibiotics as well as secretory proteins. In particular, the increase in the expression level of secretory protein encoding genes, either as an artefactual or real effect of the regulator, could be of potential usefulness when using Streptomyces strains as hosts for homologous or heterologous extracellular protein production.	[Rozas, Daniel; Gullon, Sonia; Mellado, Rafael P.] Ctr Nacl Biotecnol CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rozas, D (corresponding author), Ctr Nacl Biotecnol CSIC, Madrid, Spain.	rpmellado@cnb.csic.es	Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009	Rozas, Daniel/0000-0003-2418-0926	Spanish Ministry of Science and Innovation [BIO2003-03948, BIO2006-12762]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants BIO2003-03948 and BIO2006-12762 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Chater KF, 1998, MICROBIOL-UK, V144, P1465, DOI 10.1099/00221287-144-6-1465; Escutia MR, 2006, PROTEOMICS, V6, P4137, DOI 10.1002/pmic.200500927; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; FERNANDEZMORENO MA, 1994, J BIOL CHEM, V269, P24854; GIBERT M, 1995, CRIT REV BIOTECHNOL, V15, P13, DOI 10.3109/07388559509150530; Gordon ND, 2008, J BACTERIOL, V190, P894, DOI 10.1128/JB.01759-07; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; HOBBS G, 1989, APPL MICROBIOL BIOT, V31, P272; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Hopwood D. A., 1985, GENETIC MANIPULATION; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Hyyrylainen HL, 2005, APPL MICROBIOL BIOT, V67, P389, DOI 10.1007/s00253-005-1898-1; Ichinose K, 1998, CHEM BIOL, V5, P647, DOI 10.1016/S1074-5521(98)90292-7; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KOJIMA S, 1990, PROTEIN ENG, V3, P527; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; MartinezCosta OH, 1996, J BIOL CHEM, V271, P10627, DOI 10.1074/jbc.271.18.10627; McArthur M, 2008, P NATL ACAD SCI USA, V105, P1020, DOI 10.1073/pnas.0710724105; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Paget MSB, 1999, MOL MICROBIOL, V33, P97, DOI 10.1046/j.1365-2958.1999.01452.x; Palacin A, 2002, J BACTERIOL, V184, P4875, DOI 10.1128/JB.184.17.4875-4880.2002; Pang XH, 2004, ANTIMICROB AGENTS CH, V48, P575, DOI 10.1128/AAC.48.2.575-588.2004; Paradela A, 2010, TALANTA, V80, P1496, DOI 10.1016/j.talanta.2009.06.083; Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sun JH, 2001, J BACTERIOL, V183, P3488, DOI 10.1128/JB.183.11.3488-3498.2001; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Xu DL, 2010, APPL ENVIRON MICROB, V76, P7741, DOI 10.1128/AEM.00819-10	36	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31760	10.1371/journal.pone.0031760	http://dx.doi.org/10.1371/journal.pone.0031760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347508	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200036
J	Belacortu, Y; Weiss, R; Kadener, S; Paricio, N				Belacortu, Yaiza; Weiss, Ron; Kadener, Sebastian; Paricio, Nuria			Transcriptional Activity and Nuclear Localization of Cabut, the Drosophila Ortholog of Vertebrate TGF-beta-Inducible Early-Response Gene (TIEG) Proteins	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; OF-FUNCTION SCREEN; IMPORTIN-ALPHA; DORSAL CLOSURE; REPRESSOR DOMAINS; ZINC-FINGERS; CELL-GROWTH; SIGNALS NLS; OLI-NEU; BINDING	Background: Cabut (Cbt) is a C2H2-class zinc finger transcription factor involved in embryonic dorsal closure, epithelial regeneration and other developmental processes in Drosophila melanogaster. Cbt orthologs have been identified in other Drosophila species and insects as well as in vertebrates. Indeed, Cbt is the Drosophila ortholog of the group of vertebrate proteins encoded by the TGF-beta-inducible early-response genes (TIEGs), which belong to Sp1-like/Kruppel-like family of transcription factors. Several functional domains involved in transcriptional control and subcellular localization have been identified in the vertebrate TIEGs. However, little is known of whether these domains and functions are also conserved in the Cbt protein. Methodology/Principal Findings: To determine the transcriptional regulatory activity of the Drosophila Cbt protein, we performed Gal4-based luciferase assays in S2 cells and showed that Cbt is a transcriptional repressor and able to regulate its own expression. Truncated forms of Cbt were then generated to identify its functional domains. This analysis revealed a sequence similar to the mSin3A-interacting repressor domain found in vertebrate TIEGs, although located in a different part of the Cbt protein. Using beta-Galactosidase and eGFP fusion proteins, we also showed that Cbt contains the bipartite nuclear localization signal (NLS) previously identified in TIEG proteins, although it is non-functional in insect cells. Instead, a monopartite NLS, located at the amino terminus of the protein and conserved across insects, is functional in Drosophila S2 and Spodoptera exigua Sec301 cells. Last but not least, genetic interaction and immunohistochemical assays suggested that Cbt nuclear import is mediated by Importin-alpha 2. Conclusions/Significance: Our results constitute the first characterization of the molecular mechanisms of Cbt-mediated transcriptional control as well as of Cbt nuclear import, and demonstrate the existence of similarities and differences in both aspects of Cbt function between the insect and the vertebrate TIEG proteins.	[Belacortu, Yaiza; Paricio, Nuria] Univ Valencia, Dept Genet, Fac CC Biol, Burjassot, Spain; [Weiss, Ron; Kadener, Sebastian] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	University of Valencia; Hebrew University of Jerusalem	Belacortu, Y (corresponding author), Univ Valencia, Dept Genet, Fac CC Biol, Burjassot, Spain.	nuria.paricio@uv.es	Paricio, Nuria/K-2184-2014	Paricio, Nuria/0000-0001-7193-2532; BELACORTU, YAIZA/0000-0001-7342-2237	Gobierno de La Rioja; Ministerio de Educacion y Ciencia [BFU2004-00498, BFU2007-63213]; Conselleria d'Empresa, Universitat i Ciencia [PROMETEO/2010/081, ACOMP/2010/242]; Career Development Award (HFSP); Israel Science Foundation	Gobierno de La Rioja; Ministerio de Educacion y Ciencia(Spanish Government); Conselleria d'Empresa, Universitat i Ciencia; Career Development Award (HFSP); Israel Science Foundation(Israel Science Foundation)	YB was supported by a predoctoral fellowship from the Gobierno de La Rioja. This work was supported in part by grants from Ministerio de Educacion y Ciencia (BFU2004-00498 and BFU2007-63213) and Conselleria d'Empresa, Universitat i Ciencia (PROMETEO/2010/081 and ACOMP/2010/242) to NP, and by the Career Development Award (HFSP) and Israel Science Foundation personal grant to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Belacortu Y, 2011, GENE EXPR PATTERNS, V11, P190, DOI 10.1016/j.gep.2010.11.004; Bender H, 2004, J NEUROSCI RES, V75, P344, DOI 10.1002/jnr.10856; Blanco E, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-94; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Bulow MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015171; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; Chalaux E, 1999, FEBS LETT, V457, P478, DOI 10.1016/S0014-5793(99)01051-0; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Chen CL, 1999, MOL CELL BIOL, V19, P307; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Chen ZL, 2010, GENOMICS, V95, P111, DOI 10.1016/j.ygeno.2009.11.001; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 2000, AM J PHYSIOL-GASTR L, V278, pG513, DOI 10.1152/ajpgi.2000.278.4.G513; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Dockendorff TC, 1999, BIOL CHEM, V380, P1263, DOI 10.1515/BC.1999.161; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Giarre M, 2002, J STRUCT BIOL, V140, P279, DOI 10.1016/S1047-8477(02)00543-9; Gohla G, 2008, J CELL BIOCHEM, V104, P850, DOI 10.1002/jcb.21669; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hirota T, 2010, GENES CELLS, V15, P111, DOI 10.1111/j.1365-2443.2009.01371.x; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim J, 2010, BIOCHEM BIOPH RES CO, V401, P412, DOI 10.1016/j.bbrc.2010.09.068; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; Mason DA, 2003, GENETICS, V165, P1943; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; Minidorff EN, 2007, GENETICS, V176, P2247, DOI 10.1534/genetics.107.072819; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Mosca TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015223; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Munoz-Descalzo S, 2005, DEV BIOL, V287, P168, DOI 10.1016/j.ydbio.2005.08.048; Munoz-Descalzo S, 2007, DEV GENES EVOL, V217, P289, DOI 10.1007/s00427-007-0144-5; Munoz-Soriano V, 2011, FLY, V5, P88, DOI 10.4161/fly.5.2.15457; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Pang YP, 2003, FEBS LETT, V548, P108, DOI 10.1016/S0014-5793(03)00749-X; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RIHS HP, 1989, EMBO J, V8, P1479, DOI 10.1002/j.1460-2075.1989.tb03531.x; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Rodriguez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018418; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seetharam A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-276; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Spain MM, 2010, J BIOL CHEM, V285, P27457, DOI 10.1074/jbc.M110.130245; Spittau B, 2007, J CELL BIOCHEM, V101, P712, DOI 10.1002/jcb.21228; Spittau B, 2012, CELL TISSUE RES, V347, P65, DOI 10.1007/s00441-011-1186-6; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Tamanini F, 2005, METHOD ENZYMOL, V393, P418, DOI 10.1016/S0076-6879(05)93020-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; Tuncher A, 2005, J MOL BIOL, V352, P517, DOI 10.1016/j.jmb.2005.06.068; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wang ZY, 2004, GENE, V325, P25, DOI 10.1016/j.gene.2003.09.045; Wong Li Chin, 2006, J Vis Exp, P52, DOI 10.3791/52; Yatsu J, 2008, INT J DEV BIOL, V52, P913, DOI 10.1387/ijdb.082576jy; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhao T, 2008, GENETICS, V178, P883, DOI 10.1534/genetics.107.082487	105	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32004	10.1371/journal.pone.0032004	http://dx.doi.org/10.1371/journal.pone.0032004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359651	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200120
J	Choo, YM; Lee, KS; Yoon, HJ; Qiu, YL; Wan, H; Sohn, MR; Sohn, HD; Jin, BR				Choo, Young Moo; Lee, Kwang Sik; Yoon, Hyung Joo; Qiu, Yuling; Wan, Hu; Sohn, Mi Ri; Sohn, Hung Dae; Jin, Byung Rae			Antifibrinolytic Role of a Bee Venom Serine Protease Inhibitor That Acts as a Plasmin Inhibitor	PLOS ONE			English	Article							PSEUDONAJA-TEXTILIS; BLOOD-COAGULATION; APROTININ; EVOLUTION; PURIFICATION; HEMOSTASIS; ENZYME	Bee venom is a rich source of pharmacologically active substances. In this study, we identified a bumblebee (Bombus ignitus) venom Kunitz-type serine protease inhibitor (Bi-KTI) that acts as a plasmin inhibitor. Bi-KTI showed no detectable inhibitory effect on factor Xa, thrombin, or tissue plasminogen activator. In contrast, Bi-KTI strongly inhibited plasmin, indicating that it acts as an antifibrinolytic agent; however, this inhibitory ability was two-fold weaker than that of aprotinin. The fibrin(ogen)olytic activities of B. ignitus venom serine protease (Bi-VSP) and plasmin in the presence of Bi-KTI indicate that Bi-KTI targets plasmin more specifically than Bi-VSP. These findings demonstrate a novel mechanism by which bumblebee venom affects the hemostatic system through the antifibrinolytic activity of Bi-KTI and through Bi-VSP-mediated fibrin(ogen) olytic activities, raising interest in Bi-KTI and Bi-VSP as potential clinical agents.	[Choo, Young Moo; Lee, Kwang Sik; Qiu, Yuling; Wan, Hu; Sohn, Mi Ri; Sohn, Hung Dae; Jin, Byung Rae] Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea; [Yoon, Hyung Joo] Natl Acad Agr Sci, Dept Agr Biol, Suwon, South Korea	Dong A University	Choo, YM (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea.	brjin@dau.ac.kr	Wan, Hu/W-8453-2019	Wan, Hu/0000-0002-8123-3759	Rural Development Administration, Republic of Korea [200901OFT102966290]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Agenda Project (200901OFT102966290) of the Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Choo YM, 2010, COMP BIOCHEM PHYS B, V156, P168, DOI 10.1016/j.cbpb.2010.03.007; Choo YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010393; DAVIS R, 1995, DRUGS, V49, P954, DOI 10.2165/00003495-199549060-00008; Flight S, 2005, PATHOPHYSIOL HAEMO T, V34, P188, DOI 10.1159/000092421; Flight SM, 2009, BRIT J HAEMATOL, V145, P207, DOI 10.1111/j.1365-2141.2009.07605.x; He JY, 2007, FEBS LETT, V581, P2965, DOI 10.1016/j.febslet.2007.05.047; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Koh YS, 2001, TOXICON, V39, P555, DOI 10.1016/S0041-0101(00)00169-0; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Masci PP, 2000, BLOOD COAGUL FIBRIN, V11, P385, DOI 10.1097/00001721-200006000-00011; Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X; Millers EKI, 2009, FEBS J, V276, P3163, DOI 10.1111/j.1742-4658.2009.07034.x; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; Qiu YL, 2011, TOXICOL APPL PHARM, V255, P207, DOI 10.1016/j.taap.2011.06.020; Roystone D, 1990, BLOOD COAGUL FIBRIN, V1, P53; Segal H, 2000, LANCET, V355, P1289, DOI 10.1016/S0140-6736(00)02105-X; SHAFQAT J, 1990, FEBS LETT, V275, P6, DOI 10.1016/0014-5793(90)81426-O; SIDDIQI AR, 1991, FEBS LETT, V294, P141, DOI 10.1016/0014-5793(91)81361-B; Sinauridze EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019969; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Xin Y, 2009, COMP BIOCHEM PHYS B, V154, P195, DOI 10.1016/j.cbpb.2009.06.003	25	60	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32269	10.1371/journal.pone.0032269	http://dx.doi.org/10.1371/journal.pone.0032269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359676	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200145
J	Dorsey, ER				Dorsey, E. Ray		Huntington Study Grp COHORT Invest	Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study	PLOS ONE			English	Article							REDUCED PENETRANCE ALLELES; AGE-OF-ONSET; TRINUCLEOTIDE REPEAT; SUICIDE RISK; HD; CAG; INSTABILITY; LENGTH; GENE; FAMILIES	Background: Careful characterization of the phenotype and genotype of Huntington disease (HD) can foster better understanding of the condition. Methods: We conducted a cohort study in the United States, Canada, and Australia of members of families affected by HD. We collected demographic and clinical data, conducted the Unified Huntington's Disease Rating Scale and Mini-Mental State Examination, and determined Huntingtin trinucleotide CAG repeat length. We report primarily on cross-sectional baseline data from this recently completed prospective, longitudinal, observational study. Results: As of December 31, 2009, 2,318 individuals enrolled; of these, 1,985 (85.6%) were classified into six analysis groups. Three groups had expanded CAG alleles (36 repeats or more): individuals with clinically diagnosed HD [n = 930], and clinically unaffected first-degree relatives who had previously pursued [n = 248] or not pursued [n = 112] predictive DNA testing. Three groups lacked expanded alleles: first-degree relatives who had previously pursued [n = 41] or not pursued [n = 224] genetic testing, and spouses and caregivers [n = 430]. Baseline mean performance differed across groups in all motor, behavioral, cognitive, and functional measures (p<0.001). Clinically unaffected individuals with expanded alleles weighed less (76.0 vs. 79.6 kg; p = 0.01) and had lower cognitive scores (28.5 vs. 29.1 on the Mini Mental State Examination; p = 0.008) than individuals without expanded alleles. The frequency of "high normal" repeat lengths (27 to 35) was 2.5% and repeat lengths associated with reduced penetrance (36 to 39) was 2.7%. Conclusion: Baseline analysis of COHORT study participants revealed differences that emerge prior to clinical diagnosis. Longitudinal investigation of this cohort will further characterize the natural history of HD and genetic and biological modifiers.	[Dorsey, E. Ray; Huntington Study Grp COHORT Invest] Johns Hopkins Med, Dept Neurol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Dorsey, ER (corresponding author), Johns Hopkins Med, Dept Neurol, Baltimore, MD USA.	ray.dorsey@jhmi.edu		Walker, Francis/0000-0002-7817-9421; Frucht, Steven/0000-0002-4653-0491; Vik, Stacie/0000-0001-5331-8854	CHDI Foundation, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER	CHDI Foundation, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	CHDI Foundation, Inc. (http://www.highqfoundation.org/) funded the ongoing study and contributed to the study's design, analysis, interpretation of data, writing of the report, and the decision to publish. The sponsor had no role in data collection.	Andreassen OA, 2001, NEUROREPORT, V12, P3371, DOI 10.1097/00001756-200110290-00044; Dennhardt J, 2010, J CLIN NEUROSCI, V17, P1066, DOI 10.1016/j.jocn.2009.11.011; DIMAIO L, 1993, J MED GENET, V30, P293, DOI 10.1136/jmg.30.4.293; Duff K, 2010, NEUROLOGY, V75, P500, DOI 10.1212/WNL.0b013e3181eccfa2; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; European Huntington's Disease Registry, AB EHDN REG; FARRER LA, 1986, AM J MED GENET, V24, P305, DOI 10.1002/ajmg.1320240211; FARRER LA, 1985, AM J PHYS ANTHROPOL, V67, P185, DOI 10.1002/ajpa.1330670304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HARPER PS, 1992, HUM GENET, V89, P365; Hendricks AE, 2009, AM J MED GENET A, V149A, P1375, DOI 10.1002/ajmg.a.32901; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marder K, 2009, NEUROLOGY, V73, P385, DOI 10.1212/WNL.0b013e3181b04aa2; McCusker EA, 2000, MED J AUSTRALIA, V173, P187, DOI 10.5694/j.1326-5377.2000.tb125598.x; McNeil SM, 1997, HUM MOL GENET, V6, P775, DOI 10.1093/hmg/6.5.775; Nance MA, 1998, AM J HUM GENET, V62, P1243, DOI 10.1086/301846; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2005, AM J PSYCHIAT, V162, P725, DOI 10.1176/appi.ajp.162.4.725; Perlis RH, 2010, AM J PSYCHIAT, V167, P574, DOI 10.1176/appi.ajp.2009.09070973; Quarrell OWJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045120; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SCHOENFELD M, 1984, J NEUROL NEUROSUR PS, V47, P1283, DOI 10.1136/jnnp.47.12.1283; Sequeiros J, 2010, CLIN GENET, V78, P381, DOI 10.1111/j.1399-0004.2010.01388.x; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Wheeler VC, 2007, J MED GENET, V44, P695, DOI 10.1136/jmg.2007.050930; Zeng WQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-62	30	77	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29522	10.1371/journal.pone.0029522	http://dx.doi.org/10.1371/journal.pone.0029522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359536	gold, Green Submitted, Green Published			2022-12-27	WOS:000302796200005
J	Gauglitz, GG; Zedler, S; von Spiegel, F; Fuhr, J; von Donnersmarck, GH; Faist, E				Gauglitz, Gerd G.; Zedler, Siegfried; von Spiegel, Felix; Fuhr, Jasmin; von Donnersmarck, Guido Henkel; Faist, Eugen			Functional Characterization of Cultured Keratinocytes after Acute Cutaneous Burn Injury	PLOS ONE			English	Article							HYPERTROPHIC SCAR FORMATION; NECROSIS-FACTOR-ALPHA; GROWTH FACTOR-ALPHA; STEM-CELL THERAPY; CLINICAL-APPLICATIONS; PEDIATRIC BURNS; SKIN; EXPRESSION; KELOIDS; RECEPTOR	Background: In addition to forming the epithelial barrier against the outside environment keratinocytes are immunologically active cells. In the treatment of severely burned skin, cryoconserved keratinocyte allografts gain in importance. It has been proposed that these allografts accelerate wound healing also due to the expression of a favourable - keratinocyte-derived - cytokine and growth factor milieu. Methods: In this study the morphology and cytokine expression profile of keratinocytes from skin after acute burn injury was compared to non-burned skin. Skin samples were obtained from patients after severe burn injury and healthy controls. Cells were cultured and secretion of selected inflammatory mediators was quantified using Bioplex Immunoassays. Immunohistochemistry was performed to analyse further functional and morphologic parameters. Results: Histology revealed increased terminal differentiation of keratinocytes (CK10, CK11) in allografts from non-burned skin compared to a higher portion of proliferative cells (CK5, vimentin) in acute burn injury. Increased levels of IL-1 alpha, IL-2, IL-4, IL-10, IFN-gamma and TNF alpha could be detected in culture media of burn injury skin cultures. Both culture groups contained large amounts of IL-1RA. IL-6 and GM-CSF were increased during the first 15 days of culture of burned skin compared to control skin. Levels of VEGF, FGF-basic, TGF-beta und G-CSF were high in both but not significantly different. Cryoconservation led to a diminished mediator synthesis except for higher levels of intracellular IL-1 alpha and IL-1 beta. Conclusion: Skin allografts from non-burned skin show a different secretion pattern of keratinocyte-derived cytokines and inflammatory mediators compared to keratinocytes after burn injury. As these secreted molecules exert auto- and paracrine effects and subsequently contribute to healing and barrier restoration after acute burn injury therapies affecting this specific cytokine/growth factor micromilieu could be beneficial in burned patients.	[Gauglitz, Gerd G.] Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Zedler, Siegfried; Faist, Eugen] Univ Munich, Dept Surg, Munich, Germany; [von Spiegel, Felix; Fuhr, Jasmin; von Donnersmarck, Guido Henkel] Community Hosp Bogenhausen, Dept Plast & Reconstruct Surg, Burn Unit, Munich, Germany	University of Munich; University of Munich; Munchen Klinik	Gauglitz, GG (corresponding author), Univ Munich, Dept Dermatol & Allergy, Munich, Germany.	gerd.gauglitz@med.uni-muenchen.de						Adriessen MP, 1998, J PATHOL, V186, P192, DOI 10.1002/(SICI)1096-9896(1998100)186:2<192::AID-PATH163>3.0.CO;2-X; Aktas G, 2000, HISTOCHEM CELL BIOL, V113, P227; ANTONIADES HN, 1993, AM J PATHOL, V142, P1099; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2; Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0; Barret JP, 2000, ANN SURG, V231, P869, DOI 10.1097/00000658-200006000-00011; Blome-Eberwein S, 2002, Burns, V28 Suppl 1, pS10; Bock O, 2005, ACTA DERM-VENEREOL, V85, P216, DOI 10.1080/00015550410025453; Boyce S T, 1996, Tissue Eng, V2, P255, DOI 10.1089/ten.1996.2.255; Branski LK, 2009, BURNS, V35, P171, DOI 10.1016/j.burns.2008.03.009; Corral CJ, 1999, ARCH SURG-CHICAGO, V134, P200, DOI 10.1001/archsurg.134.2.200; Garfein ES, 2003, CLIN PLAST SURG, V30, P485, DOI 10.1016/S0094-1298(03)00067-1; Gauglitz GG, 2011, MOL PHARMACEUT, V8, P1471, DOI 10.1021/mp2001457; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Kose O, 2008, DERMATOL SURG, V34, P336, DOI 10.1111/j.1524-4725.2007.34067.x; Lee TY, 1999, ANN PLAS SURG, V43, P179; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Muller M., 2007, TOTAL BURN CARE, V3, P177; Munster AM, 1996, ANN SURG, V224, P372, DOI 10.1097/00000658-199609000-00013; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Nashan D, 1999, HAUTARZT, V50, P680, DOI 10.1007/s001050050981; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Niessen FB, 2004, J PATHOL, V202, P121, DOI 10.1002/path.1502; OCONNOR NE, 1981, LANCET, V1, P75; Ohta Yukinori, 1994, Journal of Dermatology (Tokyo), V21, P301; ONO I, 1994, SCAND J PLAST RECONS, V28, P269, DOI 10.3109/02844319409022010; Pellegrini G, 1998, MED BIOL ENG COMPUT, V36, P778, DOI 10.1007/BF02518885; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; PIERCE GF, 1989, J CELL BIOL, V109, P429, DOI 10.1083/jcb.109.1.429; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RICHARD JL, 1995, DIABETES CARE, V18, P64, DOI 10.2337/diacare.18.1.64; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; SCHULTZ GS, 1987, SCIENCE, V235, P350, DOI 10.1126/science.3492044; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Spiekstra SW, 2005, EXP DERMATOL, V14, P109, DOI 10.1111/j.0906-6705.2005.00226.x; Szulgit G, 2002, J INVEST DERMATOL, V118, P409, DOI 10.1046/j.0022-202x.2001.01680.x; Wood FM, 2006, BURNS, V32, P538, DOI 10.1016/j.burns.2006.02.025; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Wood LC, 1996, J INVEST DERMATOL, V106, P397, DOI 10.1111/1523-1747.ep12343392; Xia W, 2004, WOUND REPAIR REGEN, V12, P546, DOI 10.1111/j.1067-1927.2004.012507.x; Zhang J Z, 1994, Exp Dermatol, V3, P164, DOI 10.1111/j.1600-0625.1994.tb00273.x	46	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29942	10.1371/journal.pone.0029942	http://dx.doi.org/10.1371/journal.pone.0029942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359539	gold, Green Published, Green Submitted			2022-12-27	WOS:000302796200008
J	McRonald, FE; Risk, JM; Hodges, NJ				McRonald, Fiona E.; Risk, Janet M.; Hodges, Nikolas J.			Protection from Intracellular Oxidative Stress by Cytoglobin in Normal and Cancerous Oesophageal Cells	PLOS ONE			English	Article							DNA-DAMAGE; IN-VITRO; OVEREXPRESSION PROTECTS; HUMAN NEUROGLOBIN; LIGAND-BINDING; GLOBIN FAMILY; COMET ASSAY; TOC LOCUS; EXPRESSION; TYLOSIS	Cytoglobin is an intracellular globin of unknown function that is expressed mostly in cells of a myofibroblast lineage. Possible functions of cytoglobin include buffering of intracellular oxygen and detoxification of reactive oxygen species. Previous work in our laboratory has demonstrated that cytoglobin affords protection from oxidant-induced DNA damage when over expressed in vitro, but the importance of this in more physiologically relevant models of disease is unknown. Cytoglobin is a candidate for the tylosis with oesophageal cancer gene, and its expression is strongly down-regulated in non-cancerous oesophageal biopsies from patients with TOC compared with normal biopsies. Therefore, oesophageal cells provide an ideal experimental model to test our hypothesis that downregulation of cytoglobin expression sensitises cells to the damaging effects of reactive oxygen species, particularly oxidative DNA damage, and that this could potentially contribute to the TOC phenotype. In the current study, we tested this hypothesis by manipulating cytoglobin expression in both normal and oesophageal cancer cell lines, which have normal physiological and no expression of cytoglobin respectively. Our results show that, in agreement with previous findings, over expression of cytoglobin in cancer cell lines afforded protection from chemically-induced oxidative stress but this was only observed at non-physiological concentrations of cytoglobin. In addition, down regulation of cytoglobin in normal oesophageal cells had no effect on their sensitivity to oxidative stress as assessed by a number of end points. We therefore conclude that normal physiological concentrations of cytoglobin do not offer cytoprotection from reactive oxygen species, at least in the current experimental model.	[McRonald, Fiona E.; Hodges, Nikolas J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [McRonald, Fiona E.; Risk, Janet M.] Univ Liverpool, Sch Dent, Liverpool L69 3BX, Merseyside, England	University of Birmingham; University of Liverpool	McRonald, FE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	n.hodges@bham.ac.uk		McRonald, Fiona/0000-0001-7226-9461; Risk, Janet/0000-0002-8770-7783; hodges, nikolas/0000-0002-3306-7688	Cancer Research UK [C7738/A10476]	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK project grant C7738/A10476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank M, 2011, PLOS1; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Duez P, 2003, MUTAGENESIS, V18, P159, DOI 10.1093/mutage/18.2.159; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Fang JY, 2011, RADIAT RES, V176, P198, DOI 10.1667/RR2517.1; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; He X, 2011, PROTEIN J, V30, P437, DOI 10.1007/s10930-011-9340-2; Hodges NJ, 2008, MUTAGENESIS, V23, P293, DOI 10.1093/mutage/gen013; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kelsell DP, 1996, HUM MOL GENET, V5, P857, DOI 10.1093/hmg/5.6.857; Langan JE, 2004, HUM GENET, V114, P534, DOI 10.1007/s00439-004-1100-3; Thuy LTT, 2011, AM J PATHOL, V179, P1050, DOI 10.1016/j.ajpath.2011.05.006; Lechauve C, 2010, FEBS J, V277, P2696, DOI [10.1111/j.1742-4658.2010.07686.x, 10.1111/j.1742-464X.2010.07686.x]; Lee AJ, 2005, CANCER EPIDEM BIOMAR, V14, P497, DOI 10.1158/1055-9965.EPI-04-0295; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Makino M, 2006, ACTA CRYSTALLOGR D, V62, P671, DOI 10.1107/S0907444906013813; Man KNM, 2008, TOXICOL LETT, V183, P36, DOI 10.1016/j.toxlet.2008.09.015; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; McRonald FE, 2006, HUM MOL GENET, V15, P1271, DOI 10.1093/hmg/ddl042; Mimura I, 2010, AM J PHYSIOL-RENAL, V299, pF1120, DOI 10.1152/ajprenal.00145.2010; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Nishi H, 2011, AM J PATHOL, V178, P128, DOI 10.1016/j.ajpath.2010.11.011; NISHIHIRA T, 1979, GANN, V70, P575; Olive PL, 2005, CYTOM PART A, V66A, P1, DOI 10.1002/cyto.a.20154; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Ren Y, 2005, CLIN CANCER RES, V11, P6190, DOI 10.1158/1078-0432.CCR-04-2553; Risk JM, 2002, ONCOGENE, V21, P6395, DOI 10.1038/sj.onc.1205768; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Shahabi M, 2004, INT J ONCOL, V25, P389; Shaw RJ, 2009, BRIT J CANCER, V101, P139, DOI 10.1038/sj.bjc.6605121; Shigematsu A, 2008, HEMOGLOBIN, V32, P287, DOI 10.1080/03630260802017261; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Stagner JI, 2009, ISLETS, V1, P50, DOI 10.4161/isl.1.1.8936; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Toyokuni S, 2008, IUBMB LIFE, V60, P441, DOI 10.1002/iub.61; Xinarianos G, 2006, HUM MOL GENET, V15, P2038, DOI 10.1093/hmg/ddl128; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027	50	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30587	10.1371/journal.pone.0030587	http://dx.doi.org/10.1371/journal.pone.0030587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359545	Green Submitted, Green Published, gold			2022-12-27	WOS:000302796200014
J	Zhang, L; Wilson, DP				Zhang, Lei; Wilson, David P.			Trends in Notifiable Infectious Diseases in China: Implications for Surveillance and Population Health Policy	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; SEXUALLY-TRANSMITTED-DISEASES; FEMALE SEX WORKERS; HEPATITIS-B; DRUG-USERS; ANTIRETROVIRAL THERAPY; RESISTANT TUBERCULOSIS; SOUTHWESTERN CHINA; HEMORRHAGIC-FEVER; MEASLES VIRUSES	This study aimed to analyse trends in notifiable infectious diseases in China, in their historical context. Both English and Chinese literature was searched and diseases were categorised according to the type of disease or transmission route. Temporal trends of morbidity and mortality rates were calculated for eight major infectious diseases types. Strong government commitment to public health responses and improvements in quality of life has led to the eradication or containment of a wide range of infectious diseases in China. The overall infectious diseases burden experienced a dramatic drop during 1975-1995, but since then, it reverted and maintained a gradual upward trend to date. Most notifiable diseases are contained at a low endemic level; however, local small-scale outbreaks remain common. Tuberculosis, as a bacterial infection, has re-emerged since the 1990s and has become prevalent in the country. Sexually transmitted infections are in a rapid, exponential growth phase, spreading from core groups to the general population. Together human immunodeficiency virus (HIV), they account for 39% of all death cases due to infectious diseases in China in 2008. Zoonotic infections, such as severe acute respiratory syndrome (SARS), rabies and influenza, pose constant threats to Chinese residents and remain the most deadly disease type among the infected individuals. Therefore, second-generation surveillance of behavioural risks or vectors associated with pathogen transmission should be scaled up. It is necessary to implement public health interventions that target HIV and relevant coinfections, address transmission associated with highly mobile populations, and reduce the risk of cross-species transmission of zoonotic pathogens.	[Zhang, Lei; Wilson, David P.] Univ New S Wales, Fac Med, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Zhang, L (corresponding author), Univ New S Wales, Fac Med, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.	lzhang@kirby.unsw.edu.au	Zhang, Lei/D-4039-2011; Wilson, David P/G-4614-2013	Zhang, Lei/0000-0003-2343-084X; 	Australian Government Department of Health and Ageing; Australian Research Council [FT0991990]; University of New South Wales	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Research Council(Australian Research Council); University of New South Wales	This study was funded from the following sources: the Australian Government Department of Health and Ageing; Australian Research Council (FT0991990); the University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinger Carmen, 2008, Promot Educ, V15, P24, DOI 10.1177/1025382307088095; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2010, REV HIV HCV INFECT D; Beyrer C, 2003, JAMA-J AM MED ASSOC, V289, P1303, DOI 10.1001/jama.289.10.1303; Bi P, 2005, VECTOR-BORNE ZOONOT, V5, P95, DOI 10.1089/vbz.2005.5.95; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Chen XY, 2004, LANCET, V364, P417; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Chiba Y, 2001, B WORLD HEALTH ORGAN, V79, P103; Chinese Ministry of Health, 2008, CHIN HLTH YB 2008; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Ci W, 2000, CHINA J PREVENTIVE M, V34, P67; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cong X, 2006, CHINESE J CONTROL EN, V21, P159; Cunningham AL, 2006, SEX TRANSM INFECT, V82, P164, DOI 10.1136/sti.2005.016899; Dong F, 2007, J CHIN MOD MED, V4, P598; Dong ZJ, 2005, CHINESE RURAL HLTH S, V09, P20; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Fang Y, 2008, J AGR FOOD CHEM, V56, P2079, DOI 10.1021/jf800150z; Fine PEM, 2009, J INFECT DIS, V200, P673, DOI 10.1086/605331; Flucount. org, 2010, WORLD LAB VER SWIN F; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; He Q, 2009, SEX TRANSM INFECT, DOI sti. 2009.035808; HIV/AIDS MoHPsRoCJUNPo, 2006, 2005 UPD HIV AIDS; Hu R, 2008, RABIES CHINA UPDATE; Hu RL, 2008, EPIDEMIOL INFECT, V136, P1556, DOI 10.1017/S0950268807000131; Jiang XY, 2008, SOUTH MED J, V101, P914, DOI 10.1097/SMJ.0b013e31817c13ab; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Lam WK, 2003, RESPIROLOGY, V8, pS2, DOI 10.1046/j.1440-1843.2003.00516.x; Li B, 2006, J SE CHINA NATL DEFE, V8, P395; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liu DH, 2008, INT J MED INFORM, V77, P630, DOI 10.1016/j.ijmedinf.2007.10.011; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Meng SL, 2007, VIRUS RES, V124, P125, DOI 10.1016/j.virusres.2006.10.011; Miao Z, 2003, CHINESE J AIDS STD, V9, P54; Ministry of Health, 2006, 2006 YB CHIN HLTH ST; National Bureau of Statistics of China, 2010, 2010 YB CHIN HLTH ST; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Pirkle C, 2007, SEX TRANSM DIS, V34, P695, DOI 10.1097/01.olq.0000260989.70866.94; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P2401, DOI 10.1073/pnas.91.7.2401; Qian H, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P225; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Si H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-113; Soriano V, 2006, J ANTIMICROB CHEMOTH, V57, P815, DOI 10.1093/jac/dkl068; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; State council AIDS working committee office and UN themem group on HIV/AIDS in China, 2004, JOINT ASS HIV AIDS P; Tang XC, 2005, EMERG INFECT DIS, V11, P1970, DOI 10.3201/eid1112.050271; Tarantola A, 2010, EUROSURVEILLANCE, V15, P8; Tedaldi E, 2008, CLIN INFECT DIS, V47, P1468, DOI 10.1086/593102; Tu G, 1999, CNINESE J BIOL; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; van den Berg T, 2009, REV SCI TECH OIE, V28, P93; Wang D, 2010, JPN J INFECT DIS, V63, P368; Wang KA, 1997, J INFECT DIS, V175, pS105, DOI 10.1093/infdis/175.Supplement_1.S105; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LX, 2003, J INFECT DIS, V187, pS252, DOI 10.1086/368045; Wang S, 1999, CHINA CHINESE J ENDE, V20, P7; WHO, 2008, CUM NUMB CONF RM HUM; World Health Organization, 1996, WHO EXP CONS RAB, P88; World Health Organization, 2005, GLOB RUB CONTR SURV; Wu NP, 2003, CHINESE MED J-PEKING, V116, P1318; Xiang B., 2003, MIGRATION HLTH CHINA, V17, P1; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; Xu ZY, 2008, J VIRAL HEPATITIS, V15, P33, DOI 10.1111/j.1365-2893.2008.01026.x; YANG BP, 1995, PEDIATR INFECT DIS J, V14, P308, DOI 10.1097/00006454-199504000-00011; Yang G. J., 2005, Parassitologia (Rome), V47, P127; Yang HH, 2001, J INFECT DIS, V183, P1775, DOI 10.1086/320729; Yang HH, 2001, B WORLD HEALTH ORGAN, V79, P625; Yu W L, 1989, Zhonghua Liu Xing Bing Xue Za Zhi, V10, P257; Ze W, 2001, EXPANDED PROGRAM IMM; Zeng G, 1997, CHINESE J EPIDEMIOLO, P18; Zhang C-h, 2009, FOREIGN MED SCI SECT, V30, P104; Zhang J, 2003, J CHINA AIDS STD, V9, P984; Zhang JP, 1999, CHINESE J ENDEMIOLOG, V20, P377; Zhang L, 2009, BUILD BETT INF DIS S; Zhang S, 2001, SHANGHHAI J PREVENTI, V12, P253; Zhang Sheng-Nian, 2002, Environ Health Prev Med, V7, P132, DOI 10.1265/ehpm.2002.132; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-120; Zhang YZ, 2006, VIRUS RES, V121, P179, DOI 10.1016/j.virusres.2006.05.010; Zhang YZ, 2005, EMERG INFECT DIS, V11, P1983; Zhao ZY, 2009, CHINESE MED J-PEKING, V122, P2241, DOI 10.3760/cma.j.issn.0366-6999.2009.19.010; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	92	55	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31076	10.1371/journal.pone.0031076	http://dx.doi.org/10.1371/journal.pone.0031076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359565	Green Published, Green Submitted, gold			2022-12-27	WOS:000302796200034
J	Carlisle, AB; Kim, SL; Semmens, BX; Madigan, DJ; Jorgensen, SJ; Perle, CR; Anderson, SD; Chapple, TK; Kanive, PE; Block, BA				Carlisle, Aaron B.; Kim, Sora L.; Semmens, Brice X.; Madigan, Daniel J.; Jorgensen, Salvador J.; Perle, Christopher R.; Anderson, Scot D.; Chapple, Taylor K.; Kanive, Paul E.; Block, Barbara A.			Using Stable Isotope Analysis to Understand the Migration and Trophic Ecology of Northeastern Pacific White Sharks (Carcharodon carcharias)	PLOS ONE			English	Article							TUNA THUNNUS-OBESUS; CARBON ISOTOPES; COLLAGEN-SYNTHESIS; NITROGEN ISOTOPES; NATURAL-ABUNDANCE; GUADALUPE ISLAND; DIVING BEHAVIOR; FEEDING ECOLOGY; DIET; TURNOVER	The white shark (Carcharodon carcharias) is a wide-ranging apex predator in the northeastern Pacific (NEP). Electronic tagging has demonstrated that white sharks exhibit a regular migratory pattern, occurring at coastal sites during the late summer, autumn and early winter and moving offshore to oceanic habitats during the remainder of the year, although the purpose of these migrations remains unclear. The purpose of this study was to use stable isotope analysis (SIA) to provide insight into the trophic ecology and migratory behaviors of white sharks in the NEP. Between 2006 and 2009, 53 white sharks were biopsied in central California to obtain dermal and muscle tissues, which were analyzed for stable isotope values of carbon (delta C-13) and nitrogen (delta N-15). We developed a mixing model that directly incorporates movement data and tissue incorporation (turnover) rates to better estimate the relative importance of different focal areas to white shark diet and elucidate their migratory behavior. Mixing model results for muscle showed a relatively equal dietary contribution from coastal and offshore regions, indicating that white sharks forage in both areas. However, model results indicated that sharks foraged at a higher relative rate in coastal habitats. There was a negative relationship between shark length and muscle delta C-13 and delta N-15 values, which may indicate ontogenetic changes in habitat use related to onset of maturity. The isotopic composition of dermal tissue was consistent with a more rapid incorporation rate than muscle and may represent more recent foraging. Low offshore consumption rates suggest that it is unlikely that foraging is the primary purpose of the offshore migrations. These results demonstrate how SIA can provide insight into the trophic ecology and migratory behavior of marine predators, especially when coupled with electronic tagging data.	[Carlisle, Aaron B.; Madigan, Daniel J.; Jorgensen, Salvador J.; Perle, Christopher R.; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Kim, Sora L.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Semmens, Brice X.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Jorgensen, Salvador J.] Monterey Bay Aquarium, Monterey, CA USA; [Anderson, Scot D.] Point Reyes Natl Seashore, Inverness, CA USA; [Chapple, Taylor K.] Univ Calif Davis, Davis, CA 95616 USA; [Chapple, Taylor K.] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Kanive, Paul E.] Montana State Univ, Bozeman, MT 59717 USA	Stanford University; University of California System; University of California Santa Cruz; University of California System; University of California San Diego; Scripps Institution of Oceanography; Monterey Bay Aquarium Research Institute; University of California System; University of California Davis; Max Planck Society; Montana State University System; Montana State University Bozeman	Carlisle, AB (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	aaroncar@stanford.edu		Carlisle, Aaron/0000-0003-0796-6564	Alfred P. Sloan Foundation; David and Lucile Packard Foundation; Gordon and Betty Moore Foundation; Monterey Bay Aquarium Foundation; Office of Naval Research; Stanford University's School of Humanities and Sciences	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Monterey Bay Aquarium Foundation; Office of Naval Research(Office of Naval Research); Stanford University's School of Humanities and Sciences	Funding was provided by the Alfred P. Sloan Foundation, the David and Lucile Packard Foundation, the Gordon and Betty Moore Foundation, Monterey Bay Aquarium Foundation, the Office of Naval Research, and Stanford University's School of Humanities and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley DG, 1985, MEM S CALIF ACAD SCI, V9, P109; Anderson SD, 2003, CALIF FISH GAME, V89, P96; [Anonymous], 2020, ECONOMIST 0326; Babraj JA, 2005, AM J PHYSIOL-ENDOC M, V289, pE864, DOI 10.1152/ajpendo.00243.2005; BERGER WH, 1989, PRODUCTIVITY OCEAN P, P429; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bower JR, 2005, FISH RES, V76, P39, DOI 10.1016/j.fishres.2005.05.009; Bump JK, 2007, P ROY SOC B-BIOL SCI, V274, P2471, DOI 10.1098/rspb.2007.0700; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; Cailliet G.M., 1985, Memoirs of the Southern California Academy of Sciences, V9, P49; CAREY FG, 1982, COPEIA, P254; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Carlson JK, 2004, CRC MAR BIOL SER, P203; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Compagno LJV, 2001, SHARKS WORLD ANNOT; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; DUNTON KH, 1989, MAR ECOL PROG SER, V56, P89, DOI 10.3354/meps056089; El-Harake WA, 1998, AM J PHYSIOL-ENDOC M, V274, pE586, DOI 10.1152/ajpendo.1998.274.4.E586; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Evans DH, 2004, CRC MAR BIOL SER, P247; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.1890/0012-9658(2002)083[2162:UACASI]2.0.CO;2; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Francis TB, 2011, ECOL LETT, V14, P364, DOI 10.1111/j.1461-0248.2011.01597.x; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Fry B, 2006, STABLE ISOTOPES ECOL; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GILMARTIN M, 1974, J EXP MAR BIOL ECOL, V16, P181, DOI 10.1016/0022-0981(74)90019-7; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Graham B.S., 2007, TROPHIC DYNAMICS MOV; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; GRAHAM JB, 1990, J EXP BIOL, V151, P175; Hedges LV, 2014, STAT METHODS META AN; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Ichii T, 2009, MAR ECOL PROG SER, V378, P1, DOI 10.3354/meps07873; Jacoby DMP, 2012, FISH FISH, V13, P399, DOI 10.1111/j.1467-2979.2011.00436.x; Jarman WM, 1996, ENVIRON SCI TECHNOL, V30, P654, DOI 10.1021/es950392n; Johnson SP, 2009, ECOL RES, V24, P855, DOI 10.1007/s11284-008-0559-0; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Kim S. L., 2011, ENVIRON BIOL FISH, DOI [10.1007/s10641-10011-19860-10649, DOI 10.1007/S10641-10011-19860-10649]; Kim SL, 2010, THESIS U CALIFORNIA; Kim SL, 2011, ENVIRON BIOL FISH, DOI [10.1007/s10641-10011-19919-10647, DOI 10.1007/S10641-10011-19919-10647]; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; LEBOEUF BJ, 1982, FISH B-NOAA, V80, P891; Logan J, 2006, OECOLOGIA, V147, P391, DOI 10.1007/s00442-005-0277-z; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Long DJ, 1996, GREAT WHITE SHARKS, P263, DOI 10.1016/B978-012415031-7/50025-2; Long DJ, 1996, GREAT WHITE SHARKS, P293, DOI 10.1016/B978-012415031-7/50028-8; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Malcolm H., 2001, REV BIOL STATUS WHIT; Matsumoto Takayuki, 2008, Inter-American Tropical Tuna Commission Bulletin, V24, P3; McCosker J.E., 1985, Memoirs of the Southern California Academy of Sciences, V9, P123; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Miller TW, 2008, LIMNOL OCEANOGR, V53, P1493, DOI 10.4319/lo.2008.53.4.1493; Mollet HF, 2000, FISH B-NOAA, V98, P299; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; Nardoto GB, 2006, SCI AGR, V63, P579, DOI 10.1590/S0103-90162006000600012; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Okamoto Hiroaki, 2003, Inter-American Tropical Tuna Commission Bulletin, V22, P221; Parry MP, 2008, MAR BIOL, V153; Parry MP, 2003, TROPHIC ECOLOGY 2 OM, P287; Pearcy WC, 1993, CAN J FISH AQUAT SCI, V50; PEARCY WG, 1983, DEEP-SEA RES, V30, P427, DOI 10.1016/0198-0149(83)90076-6; Perry RI, 1999, CAN J FISH AQUAT SCI, V56, P2477, DOI 10.1139/cjfas-56-12-2477; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pratt HL, 1996, GREAT WHITE SHARKS, P131, DOI 10.1016/B978-012415031-7/50014-8; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Ragen TJ, 1999, CONSERVATION MANAGEM, P223; RAU GH, 1983, ECOLOGY, V64, P1314, DOI 10.2307/1937843; Roper C.F.E., 1975, Smithsonian Contributions to Zoology, VNo. 209, P1; Rosenberg M.S., 2000, STAT SOFTWARE METAAN; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; SAINO T, 1987, DEEP-SEA RES, V34, P807, DOI 10.1016/0198-0149(87)90038-0; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Smith K, 2007, CURR OPIN CLIN NUTR, V10, P582, DOI 10.1097/MCO.0b013e328285d858; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Taylor L., 1985, Memoirs of the Southern California Academy of Sciences, V9, P41; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; THOMAS CJ, 1993, MAR ECOL PROG SER, V95, P19, DOI 10.3354/meps095019; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Topperoff AK, 1997, DIET HARBOR PROPOISE, P103; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Waite AM, 2007, DEEP-SEA RES PT II, V54, P1055, DOI 10.1016/j.dsr2.2006.12.010; Wallman HL, 2006, ENVIRON BIOL FISH, V75, P259, DOI 10.1007/s10641-006-0025-1; Watanabe H, 2006, J FISH BIOL, V68, P1436, DOI 10.1111/j.0022-1112.2006.01027.x; Watanabe H, 2006, MAR ECOL PROG SER, V315, P187, DOI 10.3354/meps315187; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; West JB, ISOCAPES UNDERSTANDI; Witteveen BH, 2009, MAR ECOL PROG SER, V393, P173, DOI 10.3354/meps08231; Witteveen BH, 2009, MAR ECOL PROG SER, V379, P299, DOI 10.3354/meps07900; Zhang HY, 2009, J EXP MAR BIOL ECOL, V381, pS80, DOI 10.1016/j.jembe.2009.07.014; Zuyev G, 2002, B MAR SCI, V71, P1019	131	120	121	0	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30492	10.1371/journal.pone.0030492	http://dx.doi.org/10.1371/journal.pone.0030492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355313	Green Published, gold			2022-12-27	WOS:000302741300013
J	Descamps, S; Jenouvrier, S; Gilchrist, HG; Forbes, MR				Descamps, Sebastien; Jenouvrier, Stephanie; Gilchrist, H. Grant; Forbes, Mark R.			Avian Cholera, a Threat to the Viability of an Arctic Seabird Colony?	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; LONG-LIVED BIRD; PASTEURELLA-MULTOCIDA; CLIMATE-CHANGE; POPULATION; VARIABILITY; DYNAMICS; SURVIVAL; BIODIVERSITY; EXTINCTION	Evidence that infectious diseases cause wildlife population extirpation or extinction remains anecdotal and it is unclear whether the impacts of a pathogen at the individual level can scale up to population level so drastically. Here, we quantify the response of a Common eider colony to emerging epidemics of avian cholera, one of the most important infectious diseases affecting wild waterfowl. We show that avian cholera has the potential to drive colony extinction, even over a very short period. Extinction depends on disease severity (the impact of the disease on adult female survival) and disease frequency (the number of annual epidemics per decade). In case of epidemics of high severity (i.e., causing > 30% mortality of breeding females), more than one outbreak per decade will be unsustainable for the colony and will likely lead to extinction within the next century; more than four outbreaks per decade will drive extinction to within 20 years. Such severity and frequency of avian cholera are already observed, and avian cholera might thus represent a significant threat to viability of breeding populations. However, this will depend on the mechanisms underlying avian cholera transmission, maintenance, and spread, which are currently only poorly known.	[Descamps, Sebastien] Norwegian Polar Res Inst, Tromso, Norway; [Descamps, Sebastien; Forbes, Mark R.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Jenouvrier, Stephanie] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jenouvrier, Stephanie] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Gilchrist, H. Grant] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada	Norwegian Polar Institute; Carleton University; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Descamps, S (corresponding author), Norwegian Polar Res Inst, Tromso, Norway.	sebastien.descamps@npolar.no	Forbes, Mark R/B-3575-2013	Forbes, Mark/0000-0002-2288-3209; jenouvrier, stephanie/0000-0003-3324-2383	Canadian Wildlife Service-Environment Canada; Nunavut Wildlife Management Board; Greenland Institute of Natural Resources; Polar Continental Shelf Project; Fonds Quebecois de la Recherche sur la Nature et les Technologies; Canadian Network of Centres of Excellence ArcticNet; Natural Sciences and Engineering Research Council of Canada; Department of Indian Affairs and Northern Canada	Canadian Wildlife Service-Environment Canada; Nunavut Wildlife Management Board; Greenland Institute of Natural Resources; Polar Continental Shelf Project(Natural Resources Canada); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); Canadian Network of Centres of Excellence ArcticNet; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Department of Indian Affairs and Northern Canada	The study was supported by the Canadian Wildlife Service-Environment Canada (http://www.ec.gc.ca/), Nunavut Wildlife Management Board (http://www.nwmb.com/), Greenland Institute of Natural Resources (http://www.natur.gl/), Polar Continental Shelf Project (http://polar.nrcan.gc.ca/), Fonds Quebecois de la Recherche sur la Nature et les Technologies (http://www.fqrnt.gouv.qc.ca/), Canadian Network of Centres of Excellence ArcticNet (http://www.arcticnet.ulaval.ca/), Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), and the Department of Indian Affairs and Northern Canada (http://www.ainc-inac.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchong JA, 2006, J WILDLIFE DIS, V42, P33, DOI 10.7589/0090-3558-42.1.33; Buttler EI, J WILDLIFE IN PRESS; Buttler EI, 2009, THESIS CARLETON U OT; Caswell, 2000, MATRIX POPULATION MO; Cole RA, 1999, FIELD MANUAL WILDLIF, P48; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Descamps S, 2011, J AVIAN BIOL, V42, P39, DOI 10.1111/j.1600-048X.2010.05196.x; Descamps S, 2010, OIKOS, V119, P1526, DOI 10.1111/j.1600-0706.2010.18508.x; Descamps S, 2009, BIOL LETTERS, V5, P278, DOI 10.1098/rsbl.2008.0704; Dobson A, 2009, ECOLOGY, V90, P920, DOI 10.1890/08-0736.1; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; FRIEND M, 2006, 1285 US GEOL SURV; GORDUS AG, 1993, J WILDLIFE DIS, V29, P367, DOI 10.7589/0090-3558-29.2.367; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Samuel MD, 2005, J WILDLIFE DIS, V41, P48, DOI 10.7589/0090-3558-41.1.48; Samuel Michael D., 2007, P239, DOI 10.1002/9780470344668.ch12; Sandercock BK, 2011, J ANIM ECOL, V80, P244, DOI 10.1111/j.1365-2656.2010.01769.x; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waller LJ, 2007, AFR J MAR SCI, V29, P105, DOI 10.2989/AJMS.2007.29.1.9.74	33	46	48	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e29659	10.1371/journal.pone.0029659	http://dx.doi.org/10.1371/journal.pone.0029659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355304	Green Published, gold			2022-12-27	WOS:000302741300004
J	Ishikawa, K; Wan, L; Calzavacca, P; Bellomo, R; Bailey, M; May, CN				Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; Bellomo, Rinaldo; Bailey, Michael; May, Clive N.			The Effects of Terlipressin on Regional Hemodynamics and Kidney Function in Experimental Hyperdynamic Sepsis	PLOS ONE			English	Article							RESISTANT SEPTIC SHOCK; ORGAN BLOOD-FLOW; VASOPRESSIN INFUSION; NOREPINEPHRINE; HEALTHY; HYPOTENSION; CHILDREN; SHEEP; RATS	Background and Aims: Although terlipressin (TP) may improve renal function in cirrhotic patients, its use in sepsis remains controversial due to concerns about regional ischemia. We investigated the effects of TP on regional hemodynamics and kidney function in experimental hyperdynamic sepsis. Methods: We studied thirteen merino ewes in a university physiology laboratory using a randomized controlled cross over design. We implanted flow probes around the pulmonary, circumflex coronary, superior mesenteric, renal and iliac arteries. We injected live Escherichia coli and induced hyperdynamic sepsis. We treated animals with either bolus vehicle or a single dose of TP (sTP = 1 mg). In a second group, after 1 mg of TP, two additional bolus injections (mTP) of 0.5 mg were given at 2 hourly intervals. Main Results: sTP (1 mg) significantly increased mean arterial pressure (MAP) (74 to 89 mmHg; P<0.0001) creatinine clearance (31 to 85 mL/min; P<0.0001) and urine output (24 to 307 mL/hr) (P<0.0001). However, it decreased CO (5.7 to 3.9 L/min; p<0.0001), coronary blood flow (CBF) (43 to 32 mL/min; p<0.0001) and mesenteric blood flow (MBF) (944 to 625 mL/min; p = 0.004) and increased blood lactate (2.1 to 4.0 mmol/L; p<0.0001). Extra doses of TP caused little additional effect. Conclusions: In hyperdynamic sepsis, bolus TP transiently improves MAP and renal function, but reduces CO, CBF and MBF, and increases blood lactate. Caution should be applied when prescribing bolus TP in septic patients at risk of coronary or mesenteric ischemia.	[Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; May, Clive N.] Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia; [Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; Bellomo, Rinaldo] Austin Hlth, Dept Med, Melbourne, Vic, Australia; [Bellomo, Rinaldo; Bailey, Michael] Monash Univ, Sch Epidemiol & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University	Ishikawa, K (corresponding author), Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia.	rinaldo.bellomo@austin.org.au	Calzavacca, Paolo/AAN-1225-2020; Bailey, Michael J/A-4499-2012	Calzavacca, Paolo/0000-0001-8175-3693; Bailey, Michael J/0000-0002-5551-1401; Bellomo, Rinaldo/0000-0002-1650-8939	National Health Medical Research Council (NHMRC), Australia [454615]; Victorian Government; Iwate Medical University; NHMRC [566819]	National Health Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Iwate Medical University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the National Health Medical Research Council (NHMRC), Australia (454615) and the Victorian Government's Operational Infrastructure Support Program. KI was supported by a research fellowship from Iwate Medical University, and CNM was supported by an NHMRC Research Fellowship (566819). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese J, 2005, CRIT CARE MED, V33, P1897, DOI 10.1097/01.CCM.0000178182.37639.D6; Asfar P, 2003, CRIT CARE MED, V31, P215, DOI 10.1097/00003246-200301000-00033; Broking K, 2008, SHOCK, V29, P71; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Delmas A, 2005, CRIT CARE, V9, P212, DOI 10.1188/cc2945; Di Giantomasso D, 2006, ANAESTH INTENS CARE, V34, P427, DOI 10.1177/0310057X0603400408; Di Giantomasso D, 2005, INTENS CARE MED, V31, P454, DOI 10.1007/s00134-005-2580-x; Di Giantomasso D, 2003, INTENS CARE MED, V29, P1774, DOI 10.1007/s00134-003-1736-9; EDWARDS RM, 1989, AM J PHYSIOL, V256, pF274, DOI 10.1152/ajprenal.1989.256.2.F274; Escorsell A, 1997, J HEPATOL, V26, P621, DOI 10.1016/S0168-8278(97)80428-X; Gordon AC, 2010, INTENS CARE MED, V36, P83, DOI 10.1007/s00134-009-1687-x; Holmes CL, 2009, CURR OPIN CRIT CARE, V15, P398, DOI 10.1097/MCC.0b013e32832e96ef; Jing L, 2007, CRIT CARE, V11, DOI 10.1186/cc5717; Krishnagopalan Sreenandh, 2002, Curr Opin Crit Care, V8, P376, DOI 10.1097/00075198-200210000-00003; Lange M, 2008, INTENS CARE MED, V34, P821, DOI 10.1007/s00134-007-0946-y; Lange M, 2007, SHOCK, V28, P623, DOI 10.1097/shk.0b013e18050c78d; Leone M, 2004, SHOCK, V22, P314, DOI 10.1097/01.shk.0000136097.42048.bd; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medel J, 2001, ANESTH ANALG, V93, P53; Michel F, 2007, AM J EMERG MED, V25, pe861; Morelli A, 2004, INTENS CARE MED, V30, P597, DOI 10.1007/s00134-003-2094-3; Morelli A, 2005, ANESTHESIOLOGY, V102, P12, DOI 10.1097/00000542-200501000-00006; Morelli A, 2009, EXPERT OPIN PHARMACO, V10, P2569, DOI 10.1517/14656560903257808; Morelli A, 2009, CRIT CARE, V13, DOI 10.1186/cc7990; Morelli A, 2008, BEST PRACT RES-CLIN, V22, P317, DOI 10.1016/j.bpa.2008.02.006; NILSSON G, 1990, DRUG EXP CLIN RES, V16, P307; Rajekar H, 2011, J GASTROEN HEPATOL, V26, P109, DOI 10.1111/j.1440-1746.2010.06583.x; Rodriguez-Nunez A, 2004, INTENS CARE MED, V30, P477, DOI 10.1007/s00134-003-2114-3; Rodriguez-Nunez A, 2006, CRIT CARE, V10, DOI 10.1186/cc3984; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Ryckwaert F, 2009, CRIT CARE MED, V37, P876, DOI 10.1097/CCM.0b013e31819b8199; Scharte M, 2001, CRIT CARE MED, V29, P1756, DOI 10.1097/00003246-200109000-00017; Singer M, 2008, BEST PRACT RES-CLIN, V22, P359, DOI 10.1016/j.bpa.2008.03.005; SOLOMON MA, 1994, AM J PHYSIOL, V266, pH757, DOI 10.1152/ajpheart.1994.266.2.H757; Stephan F, 1998, LANCET, V351, P1249, DOI 10.1016/S0140-6736(05)79315-6; Umgelter A, 2008, INTENS CARE MED, V34, P390, DOI 10.1007/s00134-007-0877-7; Wan L, 2009, CRIT CARE, V13, DOI 10.1186/cc8185; WEBB RL, 1986, AM J PHYSIOL, V251, pH1244, DOI 10.1152/ajpheart.1986.251.6.H1244	38	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e29693	10.1371/journal.pone.0029693	http://dx.doi.org/10.1371/journal.pone.0029693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355305	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300005
J	Kanju, PM; Parameshwaran, K; Sims-Robinson, C; Uthayathas, S; Josephson, EM; Rajakumar, N; Dhanasekaran, M; Suppiramaniam, V				Kanju, Patrick M.; Parameshwaran, Kodeeswaran; Sims-Robinson, Catrina; Uthayathas, Subramaniam; Josephson, Eleanor M.; Rajakumar, Nagalingam; Dhanasekaran, Muralikrishnan; Suppiramaniam, Vishnu			Selective Cholinergic Depletion in Medial Septum Leads to Impaired Long Term Potentiation and Glutamatergic Synaptic Currents in the Hippocampus	PLOS ONE			English	Article							192 IGG-SAPORIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; WORKING-MEMORY; SPATIAL WORKING; BASAL FOREBRAIN; NMDA RECEPTORS; MUSCARINIC RECEPTORS; IMMUNOTOXIC LESIONS; STRATEGY SELECTION; RAT HIPPOCAMPUS	Cholinergic depletion in the medial septum (MS) is associated with impaired hippocampal-dependent learning and memory. Here we investigated whether long term potentiation (LTP) and synaptic currents, mediated by alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA) and N-methyl-D-aspartate (NMDA) receptors in the CA1 hippocampal region, are affected following cholinergic lesions of the MS. Stereotaxic intra-medioseptal infusions of a selective immunotoxin, 192-saporin, against cholinergic neurons or sterile saline were made in adult rats. Four days after infusions, hippocampal slices were made and LTP, whole cell, and single channel (AMPA or NMDA receptor) currents were recorded. Results demonstrated impairment in the induction and expression of LTP in lesioned rats. Lesioned rats also showed decreases in synaptic currents from CA1 pyramidal cells and synaptosomal single channels of AMPA and NMDA receptors. Our results suggest that MS cholinergic afferents modulate LTP and glutamatergic currents in the CA1 region of the hippocampus, providing a potential synaptic mechanism for the learning and memory deficits observed in the rodent model of selective MS cholinergic lesioning.	[Kanju, Patrick M.; Parameshwaran, Kodeeswaran; Sims-Robinson, Catrina; Uthayathas, Subramaniam; Dhanasekaran, Muralikrishnan; Suppiramaniam, Vishnu] Auburn Univ, Dept Pharmacal Sci, Auburn, AL 36849 USA; [Kanju, Patrick M.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Parameshwaran, Kodeeswaran] Auburn Univ, Dept Pathobiol, Auburn, AL 36849 USA; [Sims-Robinson, Catrina] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Uthayathas, Subramaniam] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Josephson, Eleanor M.] Auburn Univ, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Rajakumar, Nagalingam] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Auburn University System; Auburn University; Duke University; Auburn University System; Auburn University; University of Michigan System; University of Michigan; Emory University; Auburn University System; Auburn University; Western University (University of Western Ontario)	Kanju, PM (corresponding author), Auburn Univ, Dept Pharmacal Sci, Auburn, AL 36849 USA.	suppivd@auburn.edu	Uthayathas, subramaniam/GRY-0774-2022	Robinson, Catrina/0000-0003-4776-5839				Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; AMBROSINGERSON J, 1993, P NATL ACAD SCI USA, V90, P7903, DOI 10.1073/pnas.90.16.7903; Andre JM, 2011, NEUROPHARMACOLOGY, V60, P617, DOI 10.1016/j.neuropharm.2010.12.004; ARAUJO DM, 1988, J NEUROCHEM, V50, P1914, DOI 10.1111/j.1471-4159.1988.tb02497.x; AUERBACH JM, 1994, J NEUROPHYSIOL, V72, P2034, DOI 10.1152/jn.1994.72.4.2034; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BARTUS RT, 1985, PHARMACOL BIOCHEM BE, V23, P125, DOI 10.1016/0091-3057(85)90139-X; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Baxter MG, 1996, BEHAV NEUROSCI, V110, P460; BAXTER MG, 1995, BEHAV NEUROSCI, V109, P714, DOI 10.1037/0735-7044.109.4.714; Benfenati Fabio, 2007, Acta Biomed, V78 Suppl 1, P58; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BERGERSWEENEY J, 1994, J NEUROSCI, V14, P4507; Birthelmer A, 2003, BRAIN RES BULL, V59, P371, DOI 10.1016/S0361-9230(02)00930-9; Bizon JL, 2003, HIPPOCAMPUS, V13, P676, DOI 10.1002/hipo.10113; BLITZER RD, 1990, NEUROSCI LETT, V119, P207, DOI 10.1016/0304-3940(90)90835-W; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Ciamei A, 2001, PSYCHOPHARMACOLOGY, V154, P126, DOI 10.1007/s002130000584; Cobb SR, 2005, J PHYSIOL-LONDON, V562, P81, DOI 10.1113/jphysiol.2004.076539; Daulatzai MA, 2010, J ALZHEIMERS DIS, V20, P355, DOI 10.3233/JAD-2010-1374; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Easton A, 2010, HIPPOCAMPUS; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Fitz NF, 2008, BRAIN RES BULL, V77, P356, DOI 10.1016/j.brainresbull.2008.08.016; Fletcher BR, 2007, HIPPOCAMPUS, V17, P227, DOI 10.1002/hipo.20261; Frielingsdorf H, 2006, BEHAV BRAIN RES, V168, P37, DOI 10.1016/j.bbr.2005.10.008; Gibbs RB, 2007, NEUROBIOL LEARN MEM, V88, P19, DOI 10.1016/j.nlm.2007.03.007; GIVENS B, 1995, NEUROBIOL LEARN MEM, V63, P269, DOI 10.1006/nlme.1995.1031; Gould TJ, 2005, LEARN MEMORY, V12, P389, DOI 10.1101/lm.89105; HAGAN JJ, 1988, BEHAV BRAIN RES, V27, P9, DOI 10.1016/0166-4328(88)90105-2; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; HEPLER DJ, 1985, J NEUROSCI, V5, P866; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Holmes WR, 2006, J NEUROPHYSIOL, V96, P1478, DOI 10.1152/jn.00248.2006; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; Jafari-Sabet M, 2006, BEHAV BRAIN RES, V169, P120, DOI 10.1016/j.bbr.2005.12.011; Janis LS, 1998, BEHAV BRAIN RES, V90, P23; Johnson DA, 2002, BRAIN RES, V943, P132, DOI 10.1016/S0006-8993(02)02623-9; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Jonasson Z, 2004, EUR J NEUROSCI, V20, P3041, DOI 10.1111/j.1460-9568.2004.03739.x; Jouvenceau A, 1997, SYNAPSE, V26, P292, DOI 10.1002/(SICI)1098-2396(199707)26:3<292::AID-SYN10>3.0.CO;2-Y; JOUVENCEAU A, 1994, NEUROREPORT, V5, P1781, DOI 10.1097/00001756-199409080-00024; Kamsler A, 2010, P NATL ACAD SCI USA, V107, P1618, DOI 10.1073/pnas.0912540107; Kanju PM, 2008, EXP NEUROL, V214, P55, DOI 10.1016/j.expneurol.2008.07.010; KELSEY JE, 1988, BEHAV NEUROSCI, V102, P289; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Kirby BP, 2003, BEHAV BRAIN RES, V143, P41, DOI 10.1016/S0166-4328(03)00005-6; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Kuczewski N, 2005, EUR J NEUROSCI, V21, P1807, DOI 10.1111/j.1460-9568.2005.04014.x; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Lehmann O, 2003, EUR J NEUROSCI, V18, P651, DOI 10.1046/j.1460-9568.2003.02745.x; Levin ED, 1998, PHARMACOL BIOCHEM BE, V61, P335, DOI 10.1016/S0091-3057(98)00109-9; Levin ED, 2003, BRAIN RES BULL, V61, P489, DOI 10.1016/S0361-9230(03)00183-7; Lim CS, 2011, NEUROSCIENCE; Lin Y, 2006, P NATL ACAD SCI USA, V103, P19902, DOI 10.1073/pnas.0609924104; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mansvelder HD, 2009, SEMIN CELL DEV BIOL, V20, P432, DOI 10.1016/j.semcdb.2009.01.007; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; MARKOWSKA AL, 1995, J NEUROSCI, V15, P2063, DOI 10.1523/JNEUROSCI.15-03-02063.1995; Martin MA, 2007, BEHAV BRAIN RES, V183, P78, DOI 10.1016/j.bbr.2007.05.026; Matsuyama S, 2000, EUR J NEUROSCI, V12, P3741, DOI 10.1046/j.1460-9568.2000.00259.x; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; McMahan RW, 1997, HIPPOCAMPUS, V7, P130, DOI 10.1002/(SICI)1098-1063(1997)7:2<130::AID-HIPO2>3.0.CO;2-R; MHARZI M, 1992, BEHAV BRAIN RES, V49, P159, DOI 10.1016/S0166-4328(05)80160-3; MIYAMOTO M, 1987, BRAIN RES, V419, P19, DOI 10.1016/0006-8993(87)90564-6; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Moreira KM, 2005, BRAIN RES BULL, V67, P504, DOI 10.1016/j.brainresbull.2005.07.019; Morgan SL, 2001, J NEUROPHYSIOL, V86, P1289, DOI 10.1152/jn.2001.86.3.1289; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Navakkode S, 2011, HIPPOCAMPUS; Ohno M, 1996, EUR J PHARMACOL, V312, P145, DOI 10.1016/0014-2999(96)00580-8; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Figueredo LZP, 2008, BRAIN RES BULL, V77, P71, DOI 10.1016/j.brainresbull.2008.05.008; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; Pizzo DP, 1999, J NEUROSCI METH, V91, P9, DOI 10.1016/S0165-0270(99)00057-6; Placzek AN, 2009, ACTA PHARMACOL SIN, V30, P752, DOI 10.1038/aps.2009.39; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Rezayof A, 2010, LIFE SCI, V86, P260, DOI 10.1016/j.lfs.2009.12.008; Robinson H P, 1993, EXS, V63, P250; Salter MW, 2009, FRONT NEUROSCI, P123; Shen JM, 1996, BEHAV NEUROSCI, V110, P1181, DOI 10.1037/0735-7044.110.5.1181; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; Tsukada H, 2005, NEUROPSYCHOPHARMACOL, V30, P2144, DOI 10.1038/sj.npp.1300745; Vaglenova J, 2008, NEUROBIOL LEARN MEM, V90, P527, DOI 10.1016/j.nlm.2008.06.009; Vaithianathan H, 2005, CELL BIOCHEM BIOPHYS, V42, P75, DOI 10.1385/CBB:42:1:075; van der Staay FJ, 2006, HIPPOCAMPUS, V16, P1061, DOI 10.1002/hipo.20229; Walsh TJ, 1996, BRAIN RES, V726, P69, DOI 10.1016/S0006-8993(96)00271-5; Winters BD, 2004, BEHAV NEUROSCI, V118, P546, DOI 10.1037/0735-7044.118.3.546; Xu F, 2006, BRAIN RES, V1121, P22, DOI 10.1016/j.brainres.2006.08.129; Yamazaki Y, 2002, BRAIN RES, V946, P148, DOI 10.1016/S0006-8993(02)02935-9; Yamazaki Y, 2006, EUR J NEUROSCI, V23, P1819, DOI 10.1111/j.1460-9568.2006.04714.x; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	101	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31073	10.1371/journal.pone.0031073	http://dx.doi.org/10.1371/journal.pone.0031073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355337	Green Submitted, gold, Green Published			2022-12-27	WOS:000302741300037
J	Lataillade, M; Chiarella, J; Yang, R; DeGrosky, M; Uy, J; Seekins, D; Simen, B; St John, E; Moreno, E; Kozal, M				Lataillade, Max; Chiarella, Jennifer; Yang, Rong; DeGrosky, Michelle; Uy, Jonathan; Seekins, Daniel; Simen, Birgitte; St John, Elizabeth; Moreno, Elizabeth; Kozal, Michael			Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; VIRAL VARIANTS; STRATEGIES; IMPACT; HIV-1	Background: It is unknown whether HIV-positive patients experiencing virologic failure (VF) on boosted-PI (PI/r) regimens without drug resistant mutations (DRM) by standard genotyping harbor low-level PI resistant variants. CASTLE compared the efficacy of atazanavir/ritonavir (ATV/r) with lopinavir/ritonavir (LPV/r), each in combination with TVD in ARV-naive subjects. Objective: To determine if VF on an initial PI/r-based regimen possess low-level resistant variants that may affect a subsequent PI-containing regimen. Methods/Results: Patients experiencing VF on a Tenofovir/Emtricitabine+PI/r regimen were evaluated by ultra deep sequencing (UDS) for mutations classified/weighted by Stanford HIVdb. Samples were evaluated for variants to 0.4% levels. 36 VF subjects were evaluated by UDS; 24 had UDS for PI and RT DRMs. Of these 24, 19 (79.2%) had any DRM by UDS. The most common UDS-detected DRM were NRTI in 18 subjects: M184V/I (11), TAMs(7) & K65R(4); PI DRMs were detected in 9 subjects: M46I/V(5), F53L(2), I50V(1), D30N(1), and N88S(1). The remaining 12 subjects, all with VLs<10,000, had protease gene UDS, and 4 had low-level PI DRMs: F53L(2), L76V(1), I54S(1), G73S(1). Overall, 3/36(8.3%) subjects had DRMs identified with Stanford-HIVdb weights >12 for ATV or LPV: N88S (at 0.43% level-mutational load 1,828) in 1 subject on ATV; I50V (0.44%-mutational load 110) and L76V (0.52%-mutational load 20) in 1 subject each, both on LPV. All VF samples remained phenotypically susceptible to the treatment PI/r. Conclusion: Among persons experiencing VF without PI DRMs with standard genotyping on an initial PI/r regimen, low-level variants possessing major PI DRMs were present in a minority of cases, occurred in isolation, and did not result in phenotypic resistance. NRTI DRMs were detected in a high proportion of subjects. These data suggest that PIs may remain effective in subjects experiencing VF on a PI/r-based regimen when PI DRMs are not detected by standard or UDS genotyping.	[Lataillade, Max; Yang, Rong; DeGrosky, Michelle] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA; [Lataillade, Max; Chiarella, Jennifer; Kozal, Michael] Yale Univ, Sch Med, New Haven, CT USA; [Lataillade, Max; Chiarella, Jennifer; Kozal, Michael] Vet Affairs Hlth Care Syst, New Haven, CT USA; [Uy, Jonathan; Seekins, Daniel] Bristol Myers Squibb Co, Res & Dev, Plainsboro, NJ USA; [Simen, Birgitte; St John, Elizabeth; Moreno, Elizabeth] 454 Life Sci Roche Co, Branford, CT USA	Bristol-Myers Squibb; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Bristol-Myers Squibb	Lataillade, M (corresponding author), Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA.	Max.lataillade@BMS.com		Kozal, Michael/0000-0002-3100-8254; , Michael/0000-0002-7719-7396; Simen, Birgitte/0000-0003-0503-0973	Bristol-Myers Squibb, Global Clinical Research; Bristol Myers Squibb; Merck; Pfizer; Gilead; Abbott; Bristol-Myers Squibb; Stanford University	Bristol-Myers Squibb, Global Clinical Research; Bristol Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Pfizer(Pfizer); Gilead(Gilead Sciences); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Stanford University(Stanford University)	Funds for this study were provided by Bristol-Myers Squibb, Global Clinical Research. The funders participated in study design and data collection.; The authors have read the journal's policy and have the following conflicts: Max Lataillade, Rong Yang, Michelle DeGrosky, Daniel Seekins, Jonathan Uy, and Donnie McGrath are employees of Bristol Myers Squibb, who funded this study. Yale University receives grant support from Merck, Pfizer, Gilead, Abbott and Bristol-Myers Squibb for studies that MJK serves as the principal investigator. Michael J. Kozal receives royalties from a patent owned by Stanford University for some HIV diagnostic tests. Elizabeth P. St. John and Birgitte B. Simen are employees of 454 Life Sciences-Roche Co. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The four patent numbers are: 5,631,128; 5,650,268; 5,856,086; and US RE38,352E.	Kozal MJ, 2007, HIV CLIN TRIALS, V8, P357, DOI 10.1310/hct0806-357; Lataillade M, 2008, J INT AIDS SOC S1, V11, pP180; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2008, 48 ANN ICAAC IDSA 46; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1, P1; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Synovate HIV Market Research, 2009, SYNOVATE HIV MARKET; Underwood MR, 2009, J INFECT DIS, V199, P84, DOI 10.1086/595296	14	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30118	10.1371/journal.pone.0030118	http://dx.doi.org/10.1371/journal.pone.0030118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355307	Green Submitted, gold, Green Published			2022-12-27	WOS:000302741300007
J	Rigato, PO; Maciel, M; Goldoni, AL; Piubelli, OG; Orii, NM; Marques, ET; August, JT; Duarte, AJD; Sato, MN				Rigato, Paula Ordonhez; Maciel, Milton, Jr.; Goldoni, Adriana Leticia; Piubelli, Orlando Guerra; Orii, Noemia Mie; Marques, Ernesto Torres; August, Joseph Thomas; da Silva Duarte, Alberto Jose; Sato, Maria Notomi			Maternal LAMP/p55gagHIV-1 DNA Immunization Induces In Utero Priming and a Long-Lasting Immune Response in Vaccinated Neonates	PLOS ONE			English	Article							EARLY-LIFE; T-CELL; HYPERSENSITIVITY RESPONSE; ALLERGEN EXPOSURE; MEMBRANE-PROTEIN; II COMPARTMENT; TRANSMISSION; MICE; GAG; SENSITIZATION	Infants born to HIV-infected mothers are at high risk of becoming infected during gestation or the breastfeeding period. A search is thus warranted for vaccine formulations that will prevent mother-to-child HIV transmission. The LAMP/gag DNA chimeric vaccine encodes the HIV-1 p55gag fused to the lysosome-associated membrane protein-1 (LAMP-1) and has been shown to enhance anti-Gag antibody (Ab) and cellular immune responses in adult and neonatal mice; such a vaccine represents a new concept in antigen presentation. In this study, we evaluated the effect of LAMP/gag DNA immunization on neonates either before conception or during pregnancy. LAMP/gag immunization of BALB/c mice before conception by the intradermal route led to the transfer of anti-Gag IgG1 Ab through the placenta and via breastfeeding. Furthermore, there were an increased percentage of CD4+ CD25+ Foxp3+ T cells in the spleens of neonates. When offspring were immunized with LAMP/gag DNA, the anti-Gag Ab response and the Gag-specific IFN-gamma-secreting cells were decreased. Inhibition of anti-Gag Ab production and cellular responses were not observed six months after immunization, indicating that maternal immunization did not interfere with the long-lasting memory response in offspring. Injection of purified IgG in conjunction with LAMP/gag DNA immunization decreased humoral and cytotoxic T-cell responses. LAMP/gag DNA immunization by intradermal injection prior to conception promoted the transfer of Ab, leading to a diminished response to Gag without interfering with the development of anti-Gag T- and B-cell memory. Finally, we assessed responses after one intravenous injection of LAMP/gag DNA during the last five days of pregnancy. The intravenous injection led to in utero immunization. In conclusion, DNA vaccine enconding LAMP-1 with Gag and other HIV-1 antigens should be considered in the development of a protective vaccine for the maternal/fetal and newborn periods.	[Rigato, Paula Ordonhez; Goldoni, Adriana Leticia; Piubelli, Orlando Guerra; Orii, Noemia Mie; da Silva Duarte, Alberto Jose; Sato, Maria Notomi] Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, Dept Dermatol,LIM 56, Sao Paulo, Brazil; [Maciel, Milton, Jr.] USN, Enter Dis Dept, Infect Dis Directorate, Med Res Ctr, Silver Spring, MD USA; [Marques, Ernesto Torres] Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [August, Joseph Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Universidade de Sao Paulo; United States Department of Defense; United States Navy; Johns Hopkins University	Rigato, PO (corresponding author), Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, Dept Dermatol,LIM 56, Sao Paulo, Brazil.	marisato@usp.br	Sato, Maria N/C-2853-2012; Marques, Ernesto T. A/L-4967-2013; Sato, Maria N/C-1196-2012; Publica, Inct Saude/J-9544-2013; Goldoni, Adriana Leticia/I-1912-2012; Ordonhez Rigato, Paula/J-3618-2012; Marques, Ernesto/L-4514-2013	Marques, Ernesto T. A/0000-0003-3826-9358; Sato, Maria N/0000-0002-7911-1824; Goldoni, Adriana Leticia/0000-0002-4298-8526; Marques, Ernesto/0000-0003-3826-9358; RIGATO, PAULA ORDONHEZ/0000-0002-4416-3544	Ministerio da Saude do Brasil [914BRA1101]; Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP) [2004/14443-2]; Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	Ministerio da Saude do Brasil; Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	This work was supported by Ministerio da Saude do Brasil - Programa Nacional de HIV/AIDS/DST (914BRA1101), Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP n<SUP>o</SUP> 2004/14443-2) and Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Becquet R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007397; BOGEN B, 1993, EMBO J, V12, P357, DOI 10.1002/j.1460-2075.1993.tb05664.x; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; de Brito CA, 2009, IMMUNOTHERAPY-UK, V1, P883, DOI 10.2217/IMT.09.38; Fusaro AE, 2002, INT ARCH ALLERGY IMM, V127, P208, DOI 10.1159/000053865; Fusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x; Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x; Gerdts V, 2000, NAT MED, V6, P929, DOI 10.1038/78699; Goldoni AL, 2011, IMMUNOBIOLOGY, V216, P505, DOI 10.1016/j.imbio.2010.08.007; Hassett DE, 1997, J VIROL, V71, P7881, DOI 10.1128/JVI.71.10.7881-7888.1997; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Lohman-Payne B, 2010, CLIN PERINATOL, V37, P787, DOI 10.1016/j.clp.2010.08.005; Manickan E, 1997, J CLIN INVEST, V100, P2371, DOI 10.1172/JCI119777; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; Okuda K, 2001, J IMMUNOL, V167, P5478, DOI 10.4049/jimmunol.167.9.5478; Rigato PO, 2010, VIROLOGY, V406, P37, DOI 10.1016/j.virol.2010.06.050; Rigato PO, 2009, IMMUNOTHERAPY-UK, V1, P141, DOI 10.2217/1750743X.1.1.141; Rinaldi M, 2006, VACCINE, V24, P4586, DOI 10.1016/j.vaccine.2005.08.030; Sedegah M, 2003, J IMMUNOL, V171, P3148, DOI 10.4049/jimmunol.171.6.3148; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L; UNAIDS, 2010, AIDS EP UPD; Victor JR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-11; Victor JR, 2003, J ALLERGY CLIN IMMUN, V111, P269, DOI 10.1067/mai.2003.39; Xin Ke-Qin, 2002, Biological Procedures Online, V3, P91, DOI 10.1251/bpo27; Xin KQ, 2003, J GENE MED, V5, P438, DOI 10.1002/jgm.356	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31608	10.1371/journal.pone.0031608	http://dx.doi.org/10.1371/journal.pone.0031608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355381	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300081
J	Sudo, H; Mizoguchi, A; Kawauchi, J; Akiyama, H; Takizawa, S				Sudo, Hiroko; Mizoguchi, Atsuko; Kawauchi, Junpei; Akiyama, Hideo; Takizawa, Satoko			Use of Non-Amplified RNA Samples for Microarray Analysis of Gene Expression	PLOS ONE			English	Article							AMPLIFICATION; SIGNATURE; PLATFORM; CELLS; BIAS	Demand for high quality gene expression data has driven the development of revolutionary microarray technologies. The quality of the data is affected by the performance of the microarray platform as well as how the nucleic acid targets are prepared. The most common method for target nucleic acid preparation includes in vitro transcription amplification of the sample RNA. Although this method requires a small amount of starting material and is reported to have high reproducibility, there are also technical disadvantages such as amplification bias and the long, laborious protocol. Using RNA derived from human brain, breast and colon, we demonstrate that a non-amplification method, which was previously shown to be inferior, could be transformed to a highly quantitative method with a dynamic range of five orders of magnitude. Furthermore, the correlation coefficient calculated by comparing microarray assays using non-amplified samples with qRT-PCR assays was approximately 0.9, a value much higher than when samples were prepared using amplification methods. Our results were also compared with data from various microarray platforms studied in the MicroArray Quality Control (MAQC) project. In combination with micro-columnar 3D-Gene (TM) microarray, this non-amplification method is applicable to a variety of genetic analyses, including biomarker screening and diagnostic tests for cancer.	[Sudo, Hiroko; Mizoguchi, Atsuko; Kawauchi, Junpei; Akiyama, Hideo; Takizawa, Satoko] Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa, Japan	Toray Industries, Inc.	Sudo, H (corresponding author), Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa, Japan.	Hiroko_Sudo@nts.toray.co.jp						Boelens MC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-277; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Cousins RJ, 2003, P NATL ACAD SCI USA, V100, P6952, DOI 10.1073/pnas.0732111100; Croner RS, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/837170; Degrelle SA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-46; Duftner N, 2008, GENOMICS, V91, P108, DOI 10.1016/j.ygeno.2007.09.004; Fehlbaum P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni047; Gilbert I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp193; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Ichikawa M, 2010, J BIOCHEM, V148, P557, DOI 10.1093/jb/mvq087; Kerkhoven RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001980; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lang JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-326; Nagino K, 2006, J BIOCHEM, V139, P697, DOI 10.1093/jb/mvj086; Nilsen TW, 1997, J THEOR BIOL, V187, P273, DOI 10.1006/jtbi.1997.0446; Nygaard V, 2006, NUCLEIC ACIDS RES, V34, P996, DOI 10.1093/nar/gkj499; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Soon LL, 2003, J BIOL CHEM, V278, P11465, DOI 10.1074/jbc.M210945200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Xu ZJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S8	25	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31397	10.1371/journal.pone.0031397	http://dx.doi.org/10.1371/journal.pone.0031397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355363	Green Submitted, Green Published, gold			2022-12-27	WOS:000302741300063
J	Yu, J; Zhang, YY; Zhang, XB; Rudic, RD; Bauer, PM; Altieri, DC; Sessa, WC				Yu, Jun; Zhang, Yuanyuan; Zhang, Xinbo; Rudic, R. Daniel; Bauer, Philip M.; Altieri, Dario C.; Sessa, William C.			Endothelium Derived Nitric Oxide Synthase Negatively Regulates the PDGF-Survivin Pathway during Flow-Dependent Vascular Remodeling	PLOS ONE			English	Article							BLOOD-FLOW; IN-VIVO; APOPTOSIS; CELLS; EXPRESSION; INHIBITION; CANCER; GENE; MIGRATION; INJURY	Chronic alterations in blood flow initiate structural changes in vessel lumen caliber to normalize shear stress. The loss of endothelial derived nitric oxide synthase (eNOS) in mice promotes abnormal flow dependent vascular remodeling, thus uncoupling mechanotransduction from adaptive vascular remodeling. However, the mechanisms of how the loss of eNOS promotes abnormal remodeling are not known. Here we show that abnormal flow-dependent remodeling in eNOS knockout mice (eNOS (-/-)) is associated with activation of the platelet derived growth factor (PDGF) signaling pathway leading to the induction of the inhibitor of apoptosis, survivin. Interfering with PDGF signaling or survivin function corrects the abnormal remodeling seen in eNOS (-/-) mice. Moreover, nitric oxide (NO) negatively regulates PDGF driven survivin expression and cellular proliferation in cultured vascular smooth muscle cells. Collectively, our data suggests that eNOS negatively regulates the PDGF-survivin axis to maintain proportional flow-dependent luminal remodeling and vascular quiescence.	[Yu, Jun; Zhang, Yuanyuan; Zhang, Xinbo; Rudic, R. Daniel; Bauer, Philip M.; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Yu, Jun; Zhang, Yuanyuan; Zhang, Xinbo] Yale Univ, Sch Med, Internal Med Sect Cardiovasc Med, New Haven, CT USA; [Altieri, Dario C.] Wistar Inst Canc Ctr, Philadelphia, PA USA	Yale University; Yale University; The Wistar Institute	Yu, J (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.	jun.yu@yale.edu	Sessa, William C/B-6844-2011; zhang, yuanyuan/GYA-4428-2022; Rudic, Dan/B-3432-2016	Sessa, William C/0000-0001-5759-1938; Rudic, Dan/0000-0001-9122-3127	American Heart Association; NIH [HL64793, HL 61371, HL 64793, HL 081190, HL 096670, HL54131, CA78810, CA90917]; NATIONAL CANCER INSTITUTE [R01CA090917, R01CA078810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089576, R01HL064793, R01HL081190, R01HL096670, R01HL054131, R37HL061371, R37HL054131, R01HL061371] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from American Heart Association to JY and grants from NIH (HL64793, HL 61371, HL 64793, HL 081190 and HL 096670 to WCS and HL54131, CA78810 and CA90917 to DCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 1999, LAB INVEST, V79, P1327; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; Chao JI, 2004, J BIOL CHEM, V279, P20267, DOI 10.1074/jbc.M312381200; Dai X, CIRC RES; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Gibbons GH, 1996, SCIENCE, V272, P689, DOI 10.1126/science.272.5262.689; Grossman D, 2001, P NATL ACAD SCI USA, V98, P635, DOI 10.1073/pnas.230450097; Gurjar MV, 1999, ARTERIOSCL THROM VAS, V19, P2871, DOI 10.1161/01.ATV.19.12.2871; Jacob A, 2002, AM J PHYSIOL-CELL PH, V283, pC704, DOI 10.1152/ajpcell.00110.2002; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Kritz AB, 2008, MOL THER, V16, P1798, DOI 10.1038/mt.2008.188; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; LANGILLE BL, 1989, AM J PHYSIOL, V256, pH931, DOI 10.1152/ajpheart.1989.256.4.H931; Mondy JS, 1997, CIRC RES, V81, P320, DOI 10.1161/01.RES.81.3.320; Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Ohashi H, 2004, CIRC RES, V94, P785, DOI 10.1161/01.RES.0000121103.03275.EC; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Rudic RD, 2000, CIRC RES, V86, P1160; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Rudic RD, 1999, AM J HUM GENET, V64, P673, DOI 10.1086/302304; Sandirasegarane L, 2000, AM J PHYSIOL-CELL PH, V279, pC225, DOI 10.1152/ajpcell.2000.279.1.C225; Sharma RV, 1999, AM J PHYSIOL-HEART C, V276, pH1450, DOI 10.1152/ajpheart.1999.276.5.H1450; Tran J, 1999, BIOCHEM BIOPH RES CO, V264, P781, DOI 10.1006/bbrc.1999.1589; Yamasaki Y, 2001, CIRC RES, V88, P630, DOI 10.1161/01.RES.88.6.630; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102	31	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31495	10.1371/journal.pone.0031495	http://dx.doi.org/10.1371/journal.pone.0031495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355372	Green Published, Green Submitted, gold			2022-12-27	WOS:000302741300072
J	Huang, Y; Zhao, JX; Yan, X; Zhu, MJ; Long, NM; McCormick, RJ; Ford, SP; Nathanielsz, PW; Du, M				Huang, Yan; Zhao, Jun-Xing; Yan, Xu; Zhu, Mei-Jun; Long, Nathan M.; McCormick, Richard J.; Ford, Stephen P.; Nathanielsz, Peter W.; Du, Min			Maternal Obesity Enhances Collagen Accumulation and Cross-Linking in Skeletal Muscle of Ovine Offspring	PLOS ONE			English	Article							ADIPOSE-TISSUE; TGF-BETA; INSULIN-RESISTANCE; METABOLIC SYNDROME; LYSYL OXIDASE; MURINE MODEL; GROWTH; EXPRESSION; DIET; RAT	Maternal obesity (MO) has harmful effects on both fetal development and subsequent offspring health. We previously demonstrated that MO enhances collagen accumulation in fetal skeletal muscle, but its impact on mature offspring muscle collagen accumulation is unknown. Ewes were fed either a control diet (Con, fed 100% of NRC nutrient recommendations) or obesogenic diet (OB, fed 150% of NRC nutrient recommendations) from 60 days before conception to birth. All ewes received the Con diet during lactation. Male offspring were euthanized at 2.5 years (mean) and the left Longissimus dorsi (LD) muscle and semitendinosus (ST) muscle were sampled. Collagen concentration increased by 37.8 +/- 19.0% (P<0.05) in LD and 31.2616.0% (P<0.05) in ST muscle of OB compared to Con offspring muscle. Mature collagen cross-linking (pyridinoline concentration) was increased for 22.3 +/- 7.4% and 36.3 +/- 9.9% (P<0.05) in LD and ST muscle of OB group respectively. Expression of lysyl oxidase, lysyl hydroxylase-2b (LH2b) and prolyl 4-hydroxylase (P4HA) was higher in OB LD and ST muscle. In addition, the expression of metalloproteinases (MMPs) was lower but tissue inhibitor of metalloproteinases (TIMPs) was higher in OB offspring muscle, indicating reduced collagen remodeling. MO enhanced collagen content and cross-linking in offspring muscle, which might be partially due to reduced collagen remodeling. Our observation that the collagen content and cross-linking are enhanced in MO offspring muscle is significant, because fibrosis is known to impair muscle functions and is a hallmark of muscle aging.	[Huang, Yan; Zhao, Jun-Xing; Yan, Xu; Zhu, Mei-Jun; Long, Nathan M.; McCormick, Richard J.; Ford, Stephen P.; Du, Min] Univ Wyoming, Dept Anim Sci, Dev Biol Grp, Ctr Study Fetal Programming, Laramie, WY 82071 USA; [Nathanielsz, Peter W.] Univ Texas San Antonio, Hlth Sci Ctr, Ctr Pregnancy & Newborn Res, San Antonio, TX USA; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Wyoming; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; Washington State University	Huang, Y (corresponding author), Univ Wyoming, Dept Anim Sci, Dev Biol Grp, Ctr Study Fetal Programming, Laramie, WY 82071 USA.	min.du@wsu.edu	Huang, Yan/C-8202-2014; Zhu, Mei-Jun/A-4248-2013; Du, Min/H-4311-2011; Yan, Xu/T-1427-2019	Huang, Yan/0000-0001-9464-6889; Du, Min/0000-0002-7232-072X; Yan, Xu/0000-0001-8547-4210; Nathanielsz, Peter/0000-0001-8410-6280	National Institutes of Health [HD057506, HD067449]; U.S. Department of Agriculture [2008-35206-18826]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grants HD057506 and HD067449, as well as Research Initiative Grant 2008-35206-18826 from the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RV, 2003, REPRODUCTION, P183; Bayol SA, 2005, J PHYSIOL-LONDON, V567, P951, DOI 10.1113/jphysiol.2005.088989; Bayol SA, 2009, EUR J NUTR, V48, P62, DOI 10.1007/s00394-008-0760-5; Beggs ML, 2004, AGING CELL, V3, P353, DOI 10.1111/j.1474-9728.2004.00135.x; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Das UG, 1999, AM J PHYSIOL-REG I, V276, pR809, DOI 10.1152/ajpregu.1999.276.3.R809; Dziembowska M, 2007, BIOCHEM BIOPH RES CO, V354, P1101, DOI 10.1016/j.bbrc.2007.01.113; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; FASS, 2010, GUID CAR US AGR AN A; FOIDART M, 1981, ARCH NEUROL-CHICAGO, V38, P152, DOI 10.1001/archneur.1981.00510030046006; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Greenwood PL, 2000, J ANIM SCI, V78, P50; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; HAY WW, 1984, AM J PHYSIOL, V246, pE237, DOI 10.1152/ajpendo.1984.246.3.E237; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1254, DOI 10.1152/ajpendo.00015.2010; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Karunaratne JF, 2005, J ANAT, V207, P763, DOI 10.1111/j.1469-7580.2005.00494.x; Klotz S, 2005, CIRCULATION, V112, P364, DOI 10.1161/CIRCULATIONAHA.104.515106; Lahoute C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003910; Lee RC, 2001, CAN J APPL PHYSIOL, V26, P102, DOI 10.1139/h01-008; LEHTO M, 1985, RES EXP MED, V185, P95, DOI 10.1007/BF01854894; LIGHT N, 1985, MEAT SCI, V13, P137, DOI 10.1016/0309-1740(85)90054-3; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Martinez DA, 2003, DIABETES RES CLIN PR, V59, P1, DOI 10.1016/S0168-8227(02)00178-X; Mehan RS, 2011, CELLS TISSUES ORGANS; Miller TA, 2001, AM J PHYSIOL-REG I, V281, pR1710, DOI 10.1152/ajpregu.2001.281.5.R1710; Morgan J, 2010, MUSCLE NERVE    0825; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Muhlhausler BS, 2007, ENDOCRINOLOGY, V148, P878, DOI 10.1210/en.2006-1115; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nathanielsz PW, 2006, ILAR J, V47, P73, DOI 10.1093/ilar.47.1.73; National Research Council (U.S.). Subcommittee on Sheep Nutrition, 1985, NUTR REQ SHEEP, pvii; Nissen PM, 2003, J ANIM SCI, V81, P3018; Oben JA, 2010, BIOCHEM BIOPH RES CO, V394, P24, DOI 10.1016/j.bbrc.2010.02.057; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Reusens B, 2007, CURR DRUG TARGETS, V8, P935; Salvadori C, 2005, MUSCLE NERVE, V31, P192, DOI 10.1002/mus.20252; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sebert SP, 2009, ENDOCRINOLOGY, V150, P634, DOI 10.1210/en.2008-0542; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Tayebjee MH, 2003, J HYPERTENS, V21, P2211, DOI 10.1097/00004872-200312000-00002; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; Vohr BR, 2008, J MATERN-FETAL NEO M, V21, P149, DOI 10.1080/14767050801929430; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x; Yan X, 2011, BIOL REPROD IN PRESS; Yan X, 2011, BIOL REPROD, V85, P172, DOI 10.1095/biolreprod.110.089649; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Yan X, 2010, ENDOCRINOLOGY, V151, P380, DOI 10.1210/en.2009-0849; Yu QL, 2006, HYPERTENSION, V48, P98, DOI 10.1161/01.HYP.0000227247.27111.B2; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633; Zibadi S, 2009, AM J PHYSIOL-HEART C, V297, pH976, DOI 10.1152/ajpheart.00398.2009; Zimmerman SD, 2001, AM J PHYSIOL-HEART C, V281, pH1816, DOI 10.1152/ajpheart.2001.281.4.H1816	63	28	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31691	10.1371/journal.pone.0031691	http://dx.doi.org/10.1371/journal.pone.0031691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348119	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302737400041
J	Qi, YF; Fu, XQ; Xiong, ZG; Zhang, HT; Hill, SM; Rowan, BG; Dong, Y				Qi, Yanfeng; Fu, Xueqi; Xiong, Zhenggang; Zhang, Haitao; Hill, Steven M.; Rowan, Brian G.; Dong, Yan			Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; IN-VIVO; SELENIUM; APOPTOSIS; CELLS; PHOSPHORYLATION; DOXORUBICIN; SURVIVAL; MODEL	A major challenge in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast cancer. Here we provide the first preclinical evidence that a second-generation selenium compound, methylseleninic acid, significantly enhances the anticancer efficacy of paclitaxel in triple-negative breast cancer. Through combination-index value calculation, we demonstrated that methylseleninic acid synergistically enhanced the growth inhibitory effect of paclitaxel in triple-negative breast cancer cells. The synergism was attributable to more pronounced induction of caspase-mediated apoptosis, arrest of cell cycle progression at the G2/M checkpoint, and inhibition of cell proliferation. Treatment of SCID mice bearing MDA-MB-231 triple-negative breast cancer xenografts for four weeks with methylseleninic acid (4.5 mg/kg/day, orally) and paclitaxel (10 mg/kg/week, through intraperitoneal injection) resulted in a more pronounced inhibition of tumor growth compared with either agent alone. The attenuated tumor growth correlated with a decrease in tumor cell proliferation and an induction of apoptosis. The in vivo study also indicated the safety of using methylseleninic acid in the combination regime. Our findings thus provide strong justification for the further development of methylseleninic acid and paclitaxel combination therapy for the treatment of triple-negative breast cancer.	[Qi, Yanfeng; Hill, Steven M.; Rowan, Brian G.; Dong, Yan] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Biol Struct, New Orleans, LA 70112 USA; [Qi, Yanfeng; Hill, Steven M.; Rowan, Brian G.; Dong, Yan] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Cellular Biol, New Orleans, LA 70112 USA; [Zhang, Haitao; Dong, Yan] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China; [Xiong, Zhenggang; Zhang, Haitao] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Pathol & Lab Med, New Orleans, LA 70112 USA	Tulane University; Tulane University; Jilin University; Tulane University	Qi, YF (corresponding author), Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Biol Struct, 1430 Tulane Ave, New Orleans, LA 70112 USA.	ydong@tulane.edu	Qi, Yanfeng/G-5311-2013	Dong, Yan/0000-0003-1622-5354	National Cancer Institute [K01CA114252]; American Cancer Society [RSG-07-218-01-TBE]; Mary Kay Foundation [019-11]; Louisiana Cancer Research Consortium; Tulane Cancer Center; Department of Structural and Cellular Biology, Tulane University School of Medicine; NATIONAL CANCER INSTITUTE [K01CA114252] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Mary Kay Foundation; Louisiana Cancer Research Consortium; Tulane Cancer Center; Department of Structural and Cellular Biology, Tulane University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grant K01CA114252 (YD), American Cancer Society grant RSG-07-218-01-TBE (YD), Mary Kay Foundation grant 019-11 (YD), Louisiana Cancer Research Consortium Start-up Fund (YD and HZ), Tulane Cancer Center Developmental Fund (YD), and Departmental Seed Fund from the Department of Structural and Cellular Biology, Tulane University School of Medicine (YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LS, 2011, J NUTR; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dong Y, 2003, CANCER RES, V63, P52; Fost C, 2011, ONCOL REP, V25, P1481, DOI 10.3892/or.2011.1188; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Hu H, 2008, CLIN CANCER RES, V14, P1150, DOI 10.1158/1078-0432.CCR-07-4037; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Ip C, 2000, CANCER RES, V60, P2882; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang WQ, 2009, MOL CANCER THER, V8, P682, DOI 10.1158/1535-7163.MCT-08-0908; Kotsopoulos J, 2010, CANCER CAUSE CONTROL, V21, P679, DOI 10.1007/s10552-009-9495-8; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1832; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li HJ, 2004, JNCI-J NATL CANCER I, V96, P696, DOI 10.1093/jnci/djh125; Li S, 2007, ANTICANCER RES, V27, P3075; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu SA, 2010, MOL CANCER THER, V9, P2016, DOI 10.1158/1535-7163.MCT-09-0924; Matsuyoshi S, 2006, BRIT J CANCER, V94, P532, DOI 10.1038/sj.bjc.6602955; Matsuyoshi S, 2006, PATHOBIOLOGY, V73, P205, DOI 10.1159/000096022; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohta Y, 2009, CHEM RES TOXICOL, V22, P1795, DOI 10.1021/tx900202m; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Reid ME, 2004, J TRACE ELEM MED BIO, V18, P69, DOI 10.1016/j.jtemb.2004.03.004; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Suzana S, 2009, SINGAP MED J, V50, P265; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vogt TM, 2007, AM J EPIDEMIOL, V166, P280, DOI 10.1093/aje/kwm075; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Yamanaka K, 2011, INT J ONCOL, V39, P569, DOI 10.3892/ijo.2011.1077; Zeng Q, 2010, EUR J CANCER, V46, P1132, DOI 10.1016/j.ejca.2010.01.014	38	83	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31539	10.1371/journal.pone.0031539	http://dx.doi.org/10.1371/journal.pone.0031539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22448277	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400031
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22558416	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22558416	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Core Team, 2020, R LANG ENV STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22558416	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEM B, P11; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	22558416	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	22558416	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200040
